


  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzenesulfonyl chloride
C6H4BrClO2S
98-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 Br 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
703-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 3.0800 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 0.0000 2.8736 0.0 0
M  V30 6 Br 8.4700 1.5400 0.0 0
M  V30 7 C 3.8500 1.5400 0.0 0
M  V30 8 C 4.6200 0.2064 0.0 0
M  V30 9 C 4.6200 2.8736 0.0 0
M  V30 10 C 6.1600 0.2064 0.0 0
M  V30 11 C 6.1600 2.8736 0.0 0
M  V30 12 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-58-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 703-12-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-17790308
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolone derivatives as nitroxyl donors useful in
treatment of heart failure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kalish, Vincent Jacob; Frost, Lisa Marie; Brookfield, Frederick Arthur;
Courtney, Stephen Martin; North, Carl Leslie; Conroy, Matthew Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017070081 A1 2017-04-27

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
2-(1,1-Dimethylethyl) 3-ethyl 6-[3-(1,1-dimethylethyl)-5-[[[[3-(3-pyridinylox...
C36H42N6O6
897374-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.5721 9.6860 0.0 0
M  V30 2 C 14.0784 10.0062 0.0 0
M  V30 3 N 15.1090 8.8618 0.0 0
M  V30 4 O 14.5544 11.4709 0.0 0
M  V30 5 C 10.3672 14.6384 0.0 0
M  V30 6 C 9.1213 13.7331 0.0 0
M  V30 7 C 8.9604 15.2647 0.0 0
M  V30 8 C 11.6130 15.5436 0.0 0
M  V30 9 C 3.0800 6.6684 0.0 0
M  V30 10 O 2.3100 8.0022 0.0 0
M  V30 11 O 2.3100 5.3347 0.0 0
M  V30 12 C 0.7700 8.0022 0.0 0
M  V30 13 C 0.0000 9.3358 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 O 5.3900 2.6674 0.0 0
M  V30 16 O 3.0800 4.0011 0.0 0
M  V30 17 C 4.6200 1.3336 0.0 0
M  V30 18 C 3.2864 2.1036 0.0 0
M  V30 19 C 3.8500 0.0000 0.0 0
M  V30 20 C 5.9538 0.5636 0.0 0
M  V30 21 O 20.1825 7.2132 0.0 0
M  V30 22 N 10.0100 10.6695 0.0 0
M  V30 23 C 11.5417 10.8304 0.0 0
M  V30 24 N 9.3837 12.0764 0.0 0
M  V30 25 C 11.8619 12.3368 0.0 0
M  V30 26 C 10.5281 13.1068 0.0 0
M  V30 27 C 9.2400 9.3358 0.0 0
M  V30 28 C 7.7000 9.3358 0.0 0
M  V30 29 C 10.0100 8.0022 0.0 0
M  V30 30 C 6.9300 8.0022 0.0 0
M  V30 31 C 9.2400 6.6684 0.0 0
M  V30 32 C 7.7000 6.6684 0.0 0
M  V30 33 C 5.3900 8.0022 0.0 0
M  V30 34 C 6.9300 5.3347 0.0 0
M  V30 35 C 4.6200 6.6684 0.0 0
M  V30 36 N 5.3900 5.3347 0.0 0
M  V30 37 C 16.6153 9.1820 0.0 0
M  V30 38 C 17.6457 8.0374 0.0 0
M  V30 39 C 17.0911 10.6465 0.0 0
M  V30 40 C 19.1521 8.3576 0.0 0
M  V30 41 C 18.5975 10.9667 0.0 0
M  V30 42 C 19.6280 9.8223 0.0 0
M  V30 43 C 21.6890 7.5334 0.0 0
M  V30 44 C 22.1648 8.9981 0.0 0
M  V30 45 C 22.7194 6.3890 0.0 0
M  V30 46 C 23.6711 9.3183 0.0 0
M  V30 47 N 24.2256 6.7092 0.0 0
M  V30 48 C 24.7017 8.1737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 37
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 26
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 35
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 36
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 21 40
M  V30 23 1 21 43
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 22 27
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 2 31 32
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 47 1 43 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 47
M  V30 51 1 46 48
M  V30 52 2 47 48
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[3-(1,1-Dimethylethyl)-5-[[[[3-(3-pyridinyloxy)phenyl]amino]carbonyl]amino]...
C30H33N7O3
897369-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.5502 6.8342 0.0 0
M  V30 2 C 10.0101 6.8342 0.0 0
M  V30 3 N 9.2401 8.1678 0.0 0
M  V30 4 O 9.2401 5.5005 0.0 0
M  V30 5 C 12.6773 1.5316 0.0 0
M  V30 6 C 14.2089 1.3706 0.0 0
M  V30 7 C 12.5162 0.0000 0.0 0
M  V30 8 C 11.1456 1.6925 0.0 0
M  V30 9 C 21.4622 7.8124 0.0 0
M  V30 10 N 22.4928 8.9568 0.0 0
M  V30 11 O 21.9382 6.3477 0.0 0
M  V30 12 C 23.9991 8.6366 0.0 0
M  V30 13 O 4.6201 10.8353 0.0 0
M  V30 14 N 13.8517 5.3396 0.0 0
M  V30 15 C 12.3202 5.5005 0.0 0
M  V30 16 N 14.1719 3.8331 0.0 0
M  V30 17 C 11.6937 4.0937 0.0 0
M  V30 18 C 12.8382 3.0631 0.0 0
M  V30 19 C 14.8822 6.4840 0.0 0
M  V30 20 C 16.3886 6.1638 0.0 0
M  V30 21 C 14.4063 7.9487 0.0 0
M  V30 22 C 17.4190 7.3082 0.0 0
M  V30 23 C 15.4367 9.0931 0.0 0
M  V30 24 C 16.9432 8.7729 0.0 0
M  V30 25 C 18.9255 6.9880 0.0 0
M  V30 26 C 17.9736 9.9173 0.0 0
M  V30 27 C 19.9559 8.1326 0.0 0
M  V30 28 N 19.4801 9.5971 0.0 0
M  V30 29 C 7.7001 8.1678 0.0 0
M  V30 30 C 6.9301 9.5016 0.0 0
M  V30 31 C 6.9301 6.8342 0.0 0
M  V30 32 C 5.3901 9.5016 0.0 0
M  V30 33 C 5.3901 6.8342 0.0 0
M  V30 34 C 4.6201 8.1678 0.0 0
M  V30 35 C 3.0800 10.8353 0.0 0
M  V30 36 C 2.3100 9.5016 0.0 0
M  V30 37 C 2.3100 12.1690 0.0 0
M  V30 38 C 0.7700 9.5016 0.0 0
M  V30 39 N 0.7700 12.1690 0.0 0
M  V30 40 C 0.0000 10.8353 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 29
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 27
M  V30 13 1 10 12
M  V30 14 1 13 32
M  V30 15 1 13 35
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 19
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 2 23 24
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 1 35 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 897374-86-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 897369-22-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-2831357
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolyl phenyl ureas as enzyme modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Petillo, Peter A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20080113967 A1 2008-05-15

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
2-(1,1-Dimethylethyl) 3-ethyl 6-[3-(1,1-dimethylethyl)-5-[[[[3-(3-pyridinylox...
C36H42N6O6
897374-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.5721 9.6860 0.0 0
M  V30 2 C 14.0784 10.0062 0.0 0
M  V30 3 N 15.1090 8.8618 0.0 0
M  V30 4 O 14.5544 11.4709 0.0 0
M  V30 5 C 10.3672 14.6384 0.0 0
M  V30 6 C 9.1213 13.7331 0.0 0
M  V30 7 C 8.9604 15.2647 0.0 0
M  V30 8 C 11.6130 15.5436 0.0 0
M  V30 9 C 3.0800 6.6684 0.0 0
M  V30 10 O 2.3100 8.0022 0.0 0
M  V30 11 O 2.3100 5.3347 0.0 0
M  V30 12 C 0.7700 8.0022 0.0 0
M  V30 13 C 0.0000 9.3358 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 O 5.3900 2.6674 0.0 0
M  V30 16 O 3.0800 4.0011 0.0 0
M  V30 17 C 4.6200 1.3336 0.0 0
M  V30 18 C 3.2864 2.1036 0.0 0
M  V30 19 C 3.8500 0.0000 0.0 0
M  V30 20 C 5.9538 0.5636 0.0 0
M  V30 21 O 20.1825 7.2132 0.0 0
M  V30 22 N 10.0100 10.6695 0.0 0
M  V30 23 C 11.5417 10.8304 0.0 0
M  V30 24 N 9.3837 12.0764 0.0 0
M  V30 25 C 11.8619 12.3368 0.0 0
M  V30 26 C 10.5281 13.1068 0.0 0
M  V30 27 C 9.2400 9.3358 0.0 0
M  V30 28 C 7.7000 9.3358 0.0 0
M  V30 29 C 10.0100 8.0022 0.0 0
M  V30 30 C 6.9300 8.0022 0.0 0
M  V30 31 C 9.2400 6.6684 0.0 0
M  V30 32 C 7.7000 6.6684 0.0 0
M  V30 33 C 5.3900 8.0022 0.0 0
M  V30 34 C 6.9300 5.3347 0.0 0
M  V30 35 C 4.6200 6.6684 0.0 0
M  V30 36 N 5.3900 5.3347 0.0 0
M  V30 37 C 16.6153 9.1820 0.0 0
M  V30 38 C 17.6457 8.0374 0.0 0
M  V30 39 C 17.0911 10.6465 0.0 0
M  V30 40 C 19.1521 8.3576 0.0 0
M  V30 41 C 18.5975 10.9667 0.0 0
M  V30 42 C 19.6280 9.8223 0.0 0
M  V30 43 C 21.6890 7.5334 0.0 0
M  V30 44 C 22.1648 8.9981 0.0 0
M  V30 45 C 22.7194 6.3890 0.0 0
M  V30 46 C 23.6711 9.3183 0.0 0
M  V30 47 N 24.2256 6.7092 0.0 0
M  V30 48 C 24.7017 8.1737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 37
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 26
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 35
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 36
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 21 40
M  V30 23 1 21 43
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 22 27
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 2 31 32
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 47 1 43 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 47
M  V30 51 1 46 48
M  V30 52 2 47 48
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[3-(1,1-Dimethylethyl)-5-[[[[3-(3-pyridinyloxy)phenyl]amino]carbonyl]amino]...
C30H33N7O3
897369-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.5502 6.8342 0.0 0
M  V30 2 C 10.0101 6.8342 0.0 0
M  V30 3 N 9.2401 8.1678 0.0 0
M  V30 4 O 9.2401 5.5005 0.0 0
M  V30 5 C 12.6773 1.5316 0.0 0
M  V30 6 C 14.2089 1.3706 0.0 0
M  V30 7 C 12.5162 0.0000 0.0 0
M  V30 8 C 11.1456 1.6925 0.0 0
M  V30 9 C 21.4622 7.8124 0.0 0
M  V30 10 N 22.4928 8.9568 0.0 0
M  V30 11 O 21.9382 6.3477 0.0 0
M  V30 12 C 23.9991 8.6366 0.0 0
M  V30 13 O 4.6201 10.8353 0.0 0
M  V30 14 N 13.8517 5.3396 0.0 0
M  V30 15 C 12.3202 5.5005 0.0 0
M  V30 16 N 14.1719 3.8331 0.0 0
M  V30 17 C 11.6937 4.0937 0.0 0
M  V30 18 C 12.8382 3.0631 0.0 0
M  V30 19 C 14.8822 6.4840 0.0 0
M  V30 20 C 16.3886 6.1638 0.0 0
M  V30 21 C 14.4063 7.9487 0.0 0
M  V30 22 C 17.4190 7.3082 0.0 0
M  V30 23 C 15.4367 9.0931 0.0 0
M  V30 24 C 16.9432 8.7729 0.0 0
M  V30 25 C 18.9255 6.9880 0.0 0
M  V30 26 C 17.9736 9.9173 0.0 0
M  V30 27 C 19.9559 8.1326 0.0 0
M  V30 28 N 19.4801 9.5971 0.0 0
M  V30 29 C 7.7001 8.1678 0.0 0
M  V30 30 C 6.9301 9.5016 0.0 0
M  V30 31 C 6.9301 6.8342 0.0 0
M  V30 32 C 5.3901 9.5016 0.0 0
M  V30 33 C 5.3901 6.8342 0.0 0
M  V30 34 C 4.6201 8.1678 0.0 0
M  V30 35 C 3.0800 10.8353 0.0 0
M  V30 36 C 2.3100 9.5016 0.0 0
M  V30 37 C 2.3100 12.1690 0.0 0
M  V30 38 C 0.7700 9.5016 0.0 0
M  V30 39 N 0.7700 12.1690 0.0 0
M  V30 40 C 0.0000 10.8353 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 29
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 27
M  V30 13 1 10 12
M  V30 14 1 13 32
M  V30 15 1 13 35
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 19
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 2 23 24
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 1 35 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 897374-86-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 897369-22-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-7205270
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A solution of 2-t-butyl 3-ethyl
6-(3-t-butyl-5-(3-(3-(pyridin-3-yloxy)phenyl)ureido)-1H-pyrazol-1-yl)-3,4-dihydroisoquinoline-2,3(1H)-dicarboxylate
(available from Example 179, 0.102 g, 0.160 mmol) in 3N HCl in MeOH (5
mL) was stirred for 1h. The solvent was evaporated and the residue was
redissolved in 8N methylamine in EtOH and stirred at RT overnight. The
solvent was evaporated, the residue was purified by reverse phase
chromatography and coevaporation with THF/HCI to yield
1-(3-t-butyl-1-(3-(methylcarbamoyl)-1,2,3,4-tetrahydroisoquinolin-6-yl)-1H-pyrazol-5-yl)-3-(3-(pyridin-3-
yloxy)phenyl)urea (20 mg, 92% yield) as a white solid. 1H NMR (400 MHz,
CD3OD): 0 8.67 (d,J = 2.8 Hz, 1H), 8.60 (d, J = 5.6 Hz, 1H), 8.23 (ddd, J
= 8.8, 2.8, and 1.0 Hz, 1H), 8.06 (dd, J = 8.8, and 5.6 Hz, 1H), 7.58 (t,
J= 2.2 Hz, 1H), 7.54 (d, J = 8.0 Hz, 1H), 7.50 (t, J = 7.6 Hz, 2H), 7.43
(t, J= 8.2 Hz, 1H), 7.26 (dd, J = 8.0, and 1.6 Hz, 1H), 6.90 (ddd, J =
8.4, 2.0, and 0.8 Hz, 1H), 6.64 (s, 1H), 4.56 (d, J = 16.4 Hz, 1H), 4.52
(d, J = 16.4 Hz, 1H), 4.28 (dd, J = 11.6, and 4.8 Hz, 1H), 3.50 (dd,J=
17.2, and 4.8 Hz, 1H), 2.86 (s, 3H), 1.38 (s, 9H), amide, urea and amine
protons not visible, one proton is buried under the MeOH peak,
methylamide protons split due to rotation barrier; MS (EI) m/z: 540.3
(M+H+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolyl phenyl ureas as enzyme modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Petillo, Peter A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006071940 A2 2006-07-06

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(4aR,5R,12bR)-1,2,3,4,4a,5,6,8,9,12b-Decahydro-5-(4-hydroxyphenyl)-10H-ph...
C23H24O3
907213-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 6.6685 0.0 0
M  V30 2 O 15.4000 4.0011 0.0 0
M  V30 3 C 6.1600 4.0011 0.0 0
M  V30 4 C 6.9300 2.6674 0.0 0 CFG=2
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 8.4700 2.6674 0.0 0 CFG=2
M  V30 8 C 6.1600 1.3336 0.0 0
M  V30 9 C 8.4700 5.3347 0.0 0
M  V30 10 C 6.1600 6.6685 0.0 0
M  V30 11 C 3.8500 5.3347 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0 CFG=2
M  V30 13 C 9.2400 1.3336 0.0 0
M  V30 14 C 6.9300 0.0000 0.0 0
M  V30 15 C 4.6200 6.6685 0.0 0
M  V30 16 O 2.3100 5.3347 0.0 0
M  V30 17 C 8.4700 0.0000 0.0 0
M  V30 18 C 3.8500 8.0021 0.0 0
M  V30 19 C 1.5400 6.6685 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 10.7800 4.0011 0.0 0
M  V30 22 C 11.5500 2.6674 0.0 0
M  V30 23 C 11.5500 5.3347 0.0 0
M  V30 24 C 13.0900 2.6674 0.0 0
M  V30 25 C 13.0900 5.3347 0.0 0
M  V30 26 C 13.8600 4.0011 0.0 0
M  V30 27 H 5.3900 2.6674 0.0 0
M  V30 28 H 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 19
M  V30 2 1 2 26
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 4 27 CFG=3
M  V30 9 1 5 9
M  V30 10 2 5 10
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 7 13
M  V30 14 1 7 28 CFG=3
M  V30 15 1 8 14
M  V30 16 1 9 12
M  V30 17 1 10 15
M  V30 18 2 11 15
M  V30 19 1 11 16
M  V30 20 1 12 21 CFG=1
M  V30 21 1 13 17
M  V30 22 1 14 17
M  V30 23 1 15 18
M  V30 24 1 16 19
M  V30 25 1 18 20
M  V30 26 1 19 20
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 4 7 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(4bR,8aR,9R)-4b,5,6,7,8,8a,9,10-Octahydro-3-hydroxy-9-(4-hydroxyphenyl)-N...
C24H29NO3
907213-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 7.7002 0.0 0
M  V30 2 C 2.6673 4.6201 0.0 0
M  V30 3 C 2.6673 3.0801 0.0 0
M  V30 4 C 1.3337 2.3101 0.0 0
M  V30 5 N 1.3337 0.7700 0.0 0
M  V30 6 O 0.0000 3.0801 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 14.6707 2.3101 0.0 0
M  V30 9 C 6.6685 6.9302 0.0 0
M  V30 10 C 8.0022 7.7002 0.0 0 CFG=2
M  V30 11 C 6.6685 5.3901 0.0 0
M  V30 12 C 5.3348 7.7002 0.0 0
M  V30 13 C 9.3358 6.9302 0.0 0 CFG=2
M  V30 14 C 8.0022 9.2402 0.0 0
M  V30 15 C 8.0022 4.6201 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 4.0010 6.9302 0.0 0
M  V30 18 C 9.3358 5.3901 0.0 0 CFG=2
M  V30 19 C 10.6697 7.7002 0.0 0
M  V30 20 C 9.3358 10.0102 0.0 0
M  V30 21 C 4.0010 5.3901 0.0 0
M  V30 22 C 10.6697 9.2402 0.0 0
M  V30 23 C 10.6697 4.6201 0.0 0
M  V30 24 C 12.0033 5.3901 0.0 0
M  V30 25 C 10.6697 3.0801 0.0 0
M  V30 26 C 13.3370 4.6201 0.0 0
M  V30 27 C 12.0033 2.3101 0.0 0
M  V30 28 C 13.3370 3.0801 0.0 0
M  V30 29 H 6.6685 8.4702 0.0 0
M  V30 30 H 10.6697 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 28
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 10 29 CFG=1
M  V30 15 1 11 15
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 13 19
M  V30 20 1 13 30 CFG=1
M  V30 21 1 14 20
M  V30 22 1 15 18
M  V30 23 1 16 21
M  V30 24 2 17 21
M  V30 25 1 18 23 CFG=3
M  V30 26 1 19 22
M  V30 27 1 20 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 10 13 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 907213-85-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 907213-86-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4050794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 36
3-[3-Hydroxy-9-(4-hydroxy-phenyl)-4b,5,6,7,8,8a,9,10-octahydro-phenanthren-2-yl]-N-methyl-propionamide.
Combine
5-(4-Hydroxy-phenyl)-1,2,3,4,4a,5,6,8,9,12b-decahydro-11-oxa-benzo[a]anthracen-10-one
(0.014g, 0.04 mmol) and excess methylamine (40% in water) in
tetrahydrofuran (1 ml). After 30 minutes, remove solvent in vacuo,
dissolve in ethyl acetate and dry over anhydrous sodium sulfate. Remove
solvent in vacuo to yield the titled compound (0.014g, 92%). 1H NMR
(DMSO-d6) 9.19 (s, 1H), 9.02 (s, 1H), 7.11 (d, J=8.8 Hz, 2H), 6.83 (s,
1H), 6.79 (s, 1H), 6.73 (d, J=8.4 Hz, 2H), 3.1 (m, 3H), 2.7 (m, 3H), 2.58
(s, 3H), 2.35 (m, 2H), 1.9 (m, 1H), 1.6 (m, 2H), 1.4 (m, 1H), 1.75-0.9
(m, 5H). MS m/: 378 (M-1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted tetralins as selective estrogen receptor-β
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Krishnan, Venkatesh; Kroin, Julian Stanley; Norman, Bryan Hurst; Thomas,
Elizabeth Marie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006088716 A1 2006-08-24

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl propiolate
C4H4O2
922-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3336 0.0 0
M  V30 2 C 3.8500 1.3336 0.0 0
M  V30 3 O 1.5400 2.6673 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 5.3900 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3,4-dicarboxylic acid, 1-methyl-, 3,4-dimethyl ester
C9H11NO4
73529-28-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 5.3026 0.0 0
M  V30 2 O 0.7700 5.3026 0.0 0
M  V30 3 O 3.0801 6.6363 0.0 0
M  V30 4 C 0.0000 6.6363 0.0 0
M  V30 5 C 5.6422 4.9524 0.0 0
M  V30 6 O 7.1485 4.6323 0.0 0
M  V30 7 O 5.1664 6.4170 0.0 0
M  V30 8 C 8.1791 5.7767 0.0 0
M  V30 9 C 3.4372 0.0000 0.0 0
M  V30 10 C 3.0801 3.9690 0.0 0
M  V30 11 C 4.6118 3.8079 0.0 0
M  V30 12 C 2.4537 2.5620 0.0 0
M  V30 13 C 4.9320 2.3016 0.0 0
M  V30 14 N 3.5981 1.5316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 922-67-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 73529-28-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29778838
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 616-47-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pyrroles and thiazolanes promoted by N-methylimidazole in
water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rostami-Charati, Faramarz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2014), 25(14), 2030-2032

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chlorophenothiazine
C12H8ClNS
92-39-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 9.3360 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 N 4.0012 3.0801 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 S 4.0012 0.0000 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 8.0023 2.3101 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 8.0023 0.7700 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 8 12
M  V30 13 2 9 11
M  V30 14 2 10 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-10H-phenothiazin-2-amine
C13H12N2S
2934-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 3.0801 0.0 0
M  V30 2 C 10.6697 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 5.3348 0.7700 0.0 0
M  V30 5 N 4.0012 3.0801 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 S 4.0012 0.0000 0.0 0
M  V30 8 C 6.6685 0.0000 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 8.0023 0.7700 0.0 0
M  V30 13 C 1.3337 3.0801 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 9 13
M  V30 14 2 10 12
M  V30 15 2 11 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 92-39-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2934-14-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41358068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3053754-41-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM see experimental details, catalyst prepared and used, selective mono
arylation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM P,N-Coordinating Ylide-Functionalized Phosphines (NYPhos): A Ligand
Platform for the Selective Monoarylation of Small Nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Loeffler, Julian; Kaiser, Nicolas; Knyszek, Daniel; Krischer, Felix;
Joerges, Mike; Feichtner, Kai-Stephan; Gessner, Viktoria H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(36), e202408947

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-formyl-8-nonynoate
C11H16O3
925422-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 7.7000 4.0011 0.0 0
M  V30 7 O 5.3900 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 O 0.7700 5.3347 0.0 0
M  V30 11 O 3.0800 6.6685 0.0 0
M  V30 12 C 10.0100 5.3347 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 C 10.7800 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 3 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-1-methyl-5-(4-pentyn-1-yl)-2(1H)-pyridinone
C11H15NO
925422-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 1.5400 0.0 0
M  V30 6 C 0.0000 3.0801 0.0 0
M  V30 7 O 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 N 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 3 4 5
M  V30 6 1 6 11
M  V30 7 2 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 925422-82-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 925422-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12871266
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of 1.602 g of alkyne A (8.17 mmol) and 20.41 mL of methyl
amine (40.8 mmol, 2.0 M in THF) in 25 mL of toluene was added 8.17 mL of
glacial acetic acid via syringe. A Dean-Stark apparatus was attached and
the reaction mixture was heated to reflux and stirred for 4 h. The
reaction mixture was cooled to rt, diluted with diethyl ether, and washed
twice with a saturated solution of sodium bicarbonate. The combined
aqueous fractions were extracted twice with diethyl ether. The combined
organic fractions were dried over sodium sulfate, filtered, and
concentrated in vacuo to afford a yellow oil. The crude oil was purified
by column chromatography on triethylamine washed silica gel (6:1→3:1→1:1
hexanes:ethyl acetate) to give 1.333 g (92 %) of the title compound B as
a yellow solid. The solid was recrystallized from ethanol and hexanes to
give an off-yellow solid of mp 64-66 °C. IR (neat): 3305, 2939, 2117,
1660 cm-1. 1H NMR (400 MHz, CDCl3): δ 5.76 (s, 1H), 2.99 (s, 3H),
2.47-2.43 (m, 2H), 2.21-2.10 (m, 6H), 1.94 (t, J = 2.6 Hz, 1H), 1.64-1.57
(m, 2H). 13C NMR (100 MHz, CDCl3): δ 169.9, 127.0, 119.3, 84.9, 69.8,
34.6, 33.5, 32.0, 27.3, 25.1, 18.8. MS (ESI): 200 (M + Na)+. Anal. Calcd
for C11H15NO: C, 74.54; H, 8.53; N, 7.90. Found: C, 74.45; H, 8.62; N,
7.71.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enamides and Enesulfonamides as Nucleophiles: Formation of Complex Ring
Systems through a Platinum(II)-Catalyzed Addition/Friedel-Crafts Pathway
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kozak, Jennifer A.; Dodd, Jennifer M.; Harrison, Tyler J.; Jardine,
Katherine J.; Patrick, Brian O.; Dake, Gregory R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(18), 6929-6935

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[5-[[4-[(5R)-2-Oxo-3-(tetrahydro-2H-pyran-4-yl)-5-(3-thienyl)-1-imidazolid...
C30H34N4O4S2
926639-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.8391 7.9129 0.0 0
M  V30 2 C 12.4285 5.2023 0.0 0
M  V30 3 S 15.5085 10.5370 0.0 0
M  V30 4 C 21.6685 10.5370 0.0 0
M  V30 5 O 22.4385 11.8707 0.0 0
M  V30 6 O 22.4385 9.2034 0.0 0
M  V30 7 N 6.2684 5.2023 0.0 0
M  V30 8 C 5.3632 3.9564 0.0 0 CFG=2
M  V30 9 C 5.3632 6.4482 0.0 0
M  V30 10 C 3.8987 4.4323 0.0 0
M  V30 11 N 3.8987 5.9723 0.0 0
M  V30 12 C 7.8085 5.2023 0.0 0
M  V30 13 C 8.5785 6.5359 0.0 0
M  V30 14 C 8.5785 3.8687 0.0 0
M  V30 15 C 10.1185 6.5359 0.0 0
M  V30 16 C 10.1185 3.8687 0.0 0
M  V30 17 N 10.8885 5.2023 0.0 0
M  V30 18 C 5.8391 2.4917 0.0 0
M  V30 19 C 7.3038 2.0159 0.0 0
M  V30 20 C 4.9340 1.2459 0.0 0
M  V30 21 C 7.3038 0.4759 0.0 0
M  V30 22 S 5.8391 0.0000 0.0 0
M  V30 23 C 2.6528 6.8775 0.0 0
M  V30 24 C 2.8137 8.4091 0.0 0
M  V30 25 C 1.2459 6.2510 0.0 0
M  V30 26 C 1.5679 9.3143 0.0 0
M  V30 27 C 0.0000 7.1563 0.0 0
M  V30 28 O 0.1609 8.6878 0.0 0
M  V30 29 C 13.1985 6.5359 0.0 0
M  V30 30 C 12.4285 7.8696 0.0 0
M  V30 31 C 14.7385 6.5359 0.0 0
M  V30 32 C 13.1985 9.2034 0.0 0
M  V30 33 N 15.5085 7.8696 0.0 0
M  V30 34 C 14.7385 9.2034 0.0 0
M  V30 35 C 17.0485 10.5370 0.0 0
M  V30 36 C 17.8185 11.8707 0.0 0
M  V30 37 C 17.8185 9.2034 0.0 0
M  V30 38 C 19.3585 11.8707 0.0 0
M  V30 39 C 19.3585 9.2034 0.0 0
M  V30 40 C 20.1285 10.5370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 2 29
M  V30 4 1 3 34
M  V30 5 1 3 35
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 4 40
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 12
M  V30 12 1 8 10
M  V30 13 1 8 18 CFG=3
M  V30 14 1 9 11
M  V30 15 1 10 11
M  V30 16 1 11 23
M  V30 17 1 12 13
M  V30 18 1 12 14
M  V30 19 1 13 15
M  V30 20 1 14 16
M  V30 21 1 15 17
M  V30 22 1 16 17
M  V30 23 1 18 19
M  V30 24 2 18 20
M  V30 25 2 19 21
M  V30 26 1 20 22
M  V30 27 1 21 22
M  V30 28 1 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 28
M  V30 34 1 29 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 34
M  V30 40 2 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[[5-[[4-[(5R)-2-oxo-3-(tetrahydro-2H-pyran-4-yl)-5-(3-thienyl)-1-i...
C31H37N5O3S2
926639-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.8391 7.9129 0.0 0
M  V30 2 C 12.4285 5.2023 0.0 0
M  V30 3 S 15.5085 10.5370 0.0 0
M  V30 4 C 21.6685 10.5370 0.0 0
M  V30 5 N 22.4385 11.8707 0.0 0
M  V30 6 O 22.4385 9.2034 0.0 0
M  V30 7 C 23.9785 11.8707 0.0 0
M  V30 8 N 6.2684 5.2023 0.0 0
M  V30 9 C 5.3632 3.9564 0.0 0 CFG=2
M  V30 10 C 5.3632 6.4482 0.0 0
M  V30 11 C 3.8987 4.4323 0.0 0
M  V30 12 N 3.8987 5.9723 0.0 0
M  V30 13 C 7.8085 5.2023 0.0 0
M  V30 14 C 8.5785 3.8687 0.0 0
M  V30 15 C 8.5785 6.5359 0.0 0
M  V30 16 C 10.1185 3.8687 0.0 0
M  V30 17 C 10.1185 6.5359 0.0 0
M  V30 18 N 10.8885 5.2023 0.0 0
M  V30 19 C 5.8391 2.4917 0.0 0
M  V30 20 C 7.3038 2.0159 0.0 0
M  V30 21 C 4.9340 1.2459 0.0 0
M  V30 22 C 7.3038 0.4759 0.0 0
M  V30 23 S 5.8391 0.0000 0.0 0
M  V30 24 C 2.6528 6.8775 0.0 0
M  V30 25 C 2.8137 8.4091 0.0 0
M  V30 26 C 1.2459 6.2510 0.0 0
M  V30 27 C 1.5679 9.3143 0.0 0
M  V30 28 C 0.0000 7.1563 0.0 0
M  V30 29 O 0.1609 8.6878 0.0 0
M  V30 30 C 13.1985 6.5359 0.0 0
M  V30 31 C 14.7385 6.5359 0.0 0
M  V30 32 C 12.4285 7.8696 0.0 0
M  V30 33 C 15.5085 7.8696 0.0 0
M  V30 34 N 13.1985 9.2034 0.0 0
M  V30 35 C 14.7385 9.2034 0.0 0
M  V30 36 C 17.0485 10.5370 0.0 0
M  V30 37 C 17.8185 9.2034 0.0 0
M  V30 38 C 17.8185 11.8707 0.0 0
M  V30 39 C 19.3585 9.2034 0.0 0
M  V30 40 C 19.3585 11.8707 0.0 0
M  V30 41 C 20.1285 10.5370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 18
M  V30 3 1 2 30
M  V30 4 1 3 35
M  V30 5 1 3 36
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 4 41
M  V30 9 1 5 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 13
M  V30 13 1 9 11
M  V30 14 1 9 19 CFG=3
M  V30 15 1 10 12
M  V30 16 1 11 12
M  V30 17 1 12 24
M  V30 18 1 13 14
M  V30 19 1 13 15
M  V30 20 1 14 16
M  V30 21 1 15 17
M  V30 22 1 16 18
M  V30 23 1 17 18
M  V30 24 1 19 20
M  V30 25 2 19 21
M  V30 26 2 20 22
M  V30 27 1 21 23
M  V30 28 1 22 23
M  V30 29 1 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 35 1 30 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 926639-41-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 926639-74-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9681472
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure: General Procedure
E: EDCI coupling. To a stirred solution of a primary or secondary amine
(1 equivalent), a carboxylic acid (1.1-2.0 equivalents),
1-hydroxy-benzotriazole hydrate (HOBT) (1.1-2.0 equivalents) and
diisopropylethylamine (DIPEA) or N-methylmorpholine (NMM) (1.5-3
equivalents) in CH2Cl2 or DMF (concentration ∼0.05-1.5M) was added
1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (EDCI)
(1.1-2.0 equivalents). The solution was stirred at room temperature for
1-3 days and concentrated in vacuo. In a standard work-up, the mixture
was diluted with CH2Cl2 or EtOAc and washed consecutively with saturated
aqueous NaHCO3 and brine. The organic layer was dried (Na2SO4 or MgSO4),
filtered and concentrated under reduced pressure. The crude material was
purified by flash column chromatography or by radial chromatography on
silica gel. COMPOUND 14:
4-[4-(R)-3-Cyclohexyl-2-oxo-5-phenyl-imidazolidin-1-yl)-piperidin-1-ylmethyl]-N-cydopentyl-benzamide
COMPOUND 325:
N-Methyl-4-(5-{4-[(R)-2-oxo-3-(tetrahydro-pyran-4-yl)-5-thiophen-3-yl-imidazolidin-1-yl]-piperidin-1-ylmethyl}-pyridin-2-ylsulfanyl)-benzamide.
Following general procedure E:
4-(5-{4-[(R)-2-oxo-3-(tetrahydro-pyran-4-yl)-5-thiophen-3-yl-imidazolidin-1-yl]-piperidin-1-ylmethyl}-pyridin-2-ylsulfanyl)-benzoic
acid (COMPOUND 292) afforded COMPOUND 325 as a white foam (56 mg, 92%).
.1H NMR (CDCl3) δ 1.16-1.25 (m, 1H), 1.40-1.44 (m, 1H), 1.64-1.70 (m,
5H), 1.82-2.01 (m, 3H), 2.65- 2.69 (m, 1H), 2.81-2.84 (m, 1H), 3.03 (d,
3H, J= 4.8 Hz), 3.09 (dd, 1H, J= 8.1, 6.3 Hz), 3.36 (s, 2H), 3.44-3.67
(m, 4H), 3.98-4.02 (m, 3H), 4.72 (dd, 1H, J= 8.7, 6.3 Hz), 6.14 (br s,
1H), 6.98(d, 1H,J=8.4Hz), 7.04-7.06(m, 1H), 7.18-7.19(m, 1H), 7.31 (dd,
1H,J=4.8,3.0Hz), 7.43 (dd, 1H, J= 8.4, 2.1 Hz), 7.57 (d, 2H, J= 8.1 Hz),
7.75 (d, 2H, J= 8.4 Hz), 8.30 (d, 1H,J= 1.8 Hz); 13C NMR (CDCl3) δ 28.94,
29.87,30.10,30.36,48.47,48.71,51.65,51.81,52.99,
53.16,59.34,67.18,67.25,77.28,122.26,122.51, 125.73, 127.07, 127.92,
131.28, 133.41, 134.51, 136.04, 137.76, 143.45, 150.28, 157.78, 159.64,
167.52; ES-MS m/z 614 (M+Na). Anal. Calcd. for C31H37N5O3S2·1.3H2O: C,
60.52; H, 6.49; N, 11.38. Found: C, 60.15; H, 6.41; N,l1.72.
$DTYPE RXN:VAR(1):NOTES
$DATUM N-methylmorpholine and DMF can also be used as reagent and solvent
respectively
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted imidazolidinones and related compounds as chemokine receptor
binding compounds and their preparation, pharmaceutical compositions and
use in the treatment of infection of target cells by human
immunodeficiency virus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yuanxi; Bourque, Elyse; Zhu, Yongbao; McEachern, Ernest J.; Harwig,
Curtis; Skerlj, Renato T.; Bridger, Gary J.; Li, Tong-Shuang; Metz,
Markus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007022371 A2 2007-02-22

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R,4S)-2-Chlorobicyclo[2.2.1]heptane-2-carbonyl chloride
C8H10Cl2O
929601-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5789 0.9911 0.0 0
M  V30 2 Cl 1.4002 0.0000 0.0 0
M  V30 3 O 4.0266 0.4658 0.0 0
M  V30 4 Cl 0.8639 1.9778 0.0 0
M  V30 5 C 2.3100 2.5074 0.0 0 CFG=1
M  V30 6 C 1.5400 3.8318 0.0 0 CFG=2
M  V30 7 C 3.8500 2.5074 0.0 0
M  V30 8 C 3.0800 4.3040 0.0 0
M  V30 9 C 2.3100 5.1664 0.0 0
M  V30 10 C 4.6200 3.8318 0.0 0 CFG=1
M  V30 11 C 3.8500 5.1664 0.0 0
M  V30 12 H 0.0000 3.8292 0.0 0
M  V30 13 H 6.1600 3.8292 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 5 1 CFG=3
M  V30 4 1 5 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8 CFG=1
M  V30 8 1 6 9
M  V30 9 1 6 12
M  V30 10 1 7 10
M  V30 11 1 10 8 CFG=1
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 1 10 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 5 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R,4S)-2-Chloro-N-methylbicyclo[2.2.1]heptane-2-carboxamide
C9H14ClNO
929601-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3584 3.3922 0.0 0
M  V30 2 N 5.6920 2.6222 0.0 0
M  V30 3 O 4.3584 4.9321 0.0 0
M  V30 4 C 7.0255 3.3922 0.0 0
M  V30 5 Cl 4.0157 1.4435 0.0 0
M  V30 6 C 3.0246 2.6222 0.0 0 CFG=1
M  V30 7 C 2.0423 1.4468 0.0 0 CFG=2
M  V30 8 C 2.4995 4.0699 0.0 0
M  V30 9 C 1.0732 2.7334 0.0 0
M  V30 10 C 0.5253 1.7153 0.0 0
M  V30 11 C 0.9919 4.3420 0.0 0 CFG=1
M  V30 12 C 0.0000 3.1631 0.0 0
M  V30 13 H 2.5700 0.0000 0.0 0
M  V30 14 H 0.4691 5.7905 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 6 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 6 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9 CFG=1
M  V30 9 1 7 10
M  V30 10 1 7 13
M  V30 11 1 8 11
M  V30 12 1 11 9 CFG=1
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 1 11 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 6 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 929601-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 929601-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-12267608
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Gaseous dry 8a was introduced during 0.5 h into a stirred solution of
exo-13b (10.0 g, 51.8 mmol) in dry dichloromethane (80 mL), kept at 0 °C.
Stirring was continued without cooling for 4 h followed by extraction of
the mixture with aq HCl (2M, 2×20 mL), water (2×20 mL) and sat aq NaHCO3
(2×20 mL), drying with NaCO3 and distillation of the solvent under vacuum
to afford a pale yellow solid (9.02 g, 92%, mp 84-85 °C).
Recrystallization from pet ether (50 mL) yielded colorless needles (8.85
g, 91%). mp 86-87 °C, 1H NMR (600 MHz, C6D6, Fig. 6, 8): δ = 1.15 (tdd, J
= 1.5, 2.6, 9.9 Hz, 1 H; 7-Hanti), 1.17-1.26 (m, 2 H; 5-Hexo, 6-Hexo),
1.27−1.32 (m, 1-H; 5-Hendo), 1.37−1.42 (m, 1 H; 6-Hendo), 1.93 (dm, J =
13.9 Hz, 1 H; 3-Hexo), 2.01 (dm, J = 9.9 Hz, 1 H; 7-Hsyn), 2.05 (br mc, 1
H, 4-H), 2.25 (br d, J = 3.5 Hz, 1 H; 1-H), 2.38 (d, J = 4.8 Hz, 3 H;
CH3), 2.91 (dd, J = 2.7, 13.9 Hz, 1 H; 3-Hendo), 5.71 (br s, 1 H; NH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Configuration, and 15N NMR Spectra of Iminoaziridines.
Synthons Equivalent to Three Components of the Ugi Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quast, Helmut; Aldenkortt, Sven; Freudenreich, Bernd; Schaefer, Peter;
Hagedorn, Manfred; Lehmann, Jens; Banert, Klaus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(5), 1659-1666

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4,6-dichloro-1,3,5-triazine
C3H2Cl2N4
933-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6200 0.0 0
M  V30 2 Cl 5.3349 4.6200 0.0 0
M  V30 3 N 2.6674 0.0000 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2-methyl-1,3,5-triazine-2,4-diamine
C4H6ClN5
5425-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 6.6686 3.8500 0.0 0
M  V30 3 Cl 2.6675 0.0000 0.0 0
M  V30 4 N 0.0000 4.6201 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 N 4.0011 2.3100 0.0 0
M  V30 7 N 2.6675 4.6201 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 N 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 933-20-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5425-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3685597
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Methylmelamines: Synthesis, Characterization, and Physical Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM List, Manuela; Puchinger, Helmut; Gabriel, Herbert; Monkowius, Uwe;
Schwarzinger, Clemens
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2016), 81(10), 4066-4075

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibenzo[c,h]xanthylium, 5,6,8,9-tetrahydro-3,11-dimethoxy-, perchlorate
C23H21O3.ClO4
93523-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 6.1600 0.0 0
M  V30 2 C 0.0000 4.6200 0.0 0
M  V30 3 O 13.3370 6.1600 0.0 0
M  V30 4 C 13.3370 4.6200 0.0 0
M  V30 5 C 5.3348 9.2401 0.0 0
M  V30 6 C 4.0010 8.4701 0.0 0
M  V30 7 C 5.3348 10.7801 0.0 0
M  V30 8 O 6.6685 8.4701 0.0 0 CHG=1 VAL=3
M  V30 9 C 2.6673 9.2401 0.0 0
M  V30 10 C 4.0010 6.9301 0.0 0
M  V30 11 C 6.6685 11.5502 0.0 0
M  V30 12 C 4.0010 11.5502 0.0 0
M  V30 13 C 8.0022 9.2401 0.0 0
M  V30 14 C 1.3337 8.4701 0.0 0
M  V30 15 C 2.6673 10.7801 0.0 0
M  V30 16 C 2.6673 6.1600 0.0 0
M  V30 17 C 8.0022 10.7801 0.0 0
M  V30 18 C 9.3360 8.4701 0.0 0
M  V30 19 C 1.3337 6.9301 0.0 0
M  V30 20 C 9.3358 11.5502 0.0 0
M  V30 21 C 10.6697 9.2401 0.0 0
M  V30 22 C 9.3360 6.9301 0.0 0
M  V30 23 C 10.6697 10.7801 0.0 0
M  V30 24 C 12.0033 8.4701 0.0 0
M  V30 25 C 10.6697 6.1600 0.0 0
M  V30 26 C 12.0033 6.9301 0.0 0
M  V30 27 Cl 6.6685 1.5400 0.0 0 VAL=7
M  V30 28 O 5.1285 1.5400 0.0 0
M  V30 29 O 8.2085 1.5400 0.0 0
M  V30 30 O 6.6685 0.0000 0.0 0
M  V30 31 O 6.6685 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 3 4
M  V30 4 1 3 26
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 12 15
M  V30 18 2 13 17
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 2 18 22
M  V30 25 1 20 23
M  V30 26 1 21 23
M  V30 27 2 21 24
M  V30 28 1 22 25
M  V30 29 1 24 26
M  V30 30 2 25 26
M  V30 31 2 27 28
M  V30 32 2 27 29
M  V30 33 2 27 30
M  V30 34 1 27 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibenz[c,h]acridinium, 5,6,8,9-tetrahydro-3,11-dimethoxy-14-methyl-, perchlor...
C24H24NO2.ClO4
2904546-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.9301 0.0 0
M  V30 2 O 0.0000 6.1600 0.0 0
M  V30 3 C 0.0000 4.6200 0.0 0
M  V30 4 O 13.3370 6.1600 0.0 0
M  V30 5 C 13.3370 4.6200 0.0 0
M  V30 6 C 5.3348 9.2401 0.0 0
M  V30 7 C 4.0010 8.4701 0.0 0
M  V30 8 C 5.3348 10.7801 0.0 0
M  V30 9 N 6.6685 8.4701 0.0 0 CHG=1 VAL=4
M  V30 10 C 2.6673 9.2401 0.0 0
M  V30 11 C 4.0010 6.9301 0.0 0
M  V30 12 C 6.6685 11.5502 0.0 0
M  V30 13 C 4.0010 11.5502 0.0 0
M  V30 14 C 8.0022 9.2401 0.0 0
M  V30 15 C 2.6673 10.7801 0.0 0
M  V30 16 C 1.3337 8.4701 0.0 0
M  V30 17 C 2.6673 6.1600 0.0 0
M  V30 18 C 8.0022 10.7801 0.0 0
M  V30 19 C 9.3360 8.4701 0.0 0
M  V30 20 C 1.3337 6.9301 0.0 0
M  V30 21 C 9.3360 11.5502 0.0 0
M  V30 22 C 10.6697 9.2401 0.0 0
M  V30 23 C 9.3360 6.9301 0.0 0
M  V30 24 C 10.6697 10.7801 0.0 0
M  V30 25 C 12.0033 8.4701 0.0 0
M  V30 26 C 10.6697 6.1600 0.0 0
M  V30 27 C 12.0033 6.9301 0.0 0
M  V30 28 Cl 6.6685 1.5400 0.0 0 VAL=7
M  V30 29 O 5.1285 1.5400 0.0 0
M  V30 30 O 8.2085 1.5400 0.0 0
M  V30 31 O 6.6685 0.0000 0.0 0
M  V30 32 O 6.6685 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 4 5
M  V30 5 1 4 27
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 2 10 16
M  V30 16 1 11 17
M  V30 17 1 12 18
M  V30 18 1 13 15
M  V30 19 2 14 18
M  V30 20 1 14 19
M  V30 21 1 16 20
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 19 23
M  V30 26 1 21 24
M  V30 27 1 22 24
M  V30 28 2 22 25
M  V30 29 1 23 26
M  V30 30 1 25 27
M  V30 31 2 26 27
M  V30 32 2 28 29
M  V30 33 2 28 30
M  V30 34 2 28 31
M  V30 35 1 28 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 93523-87-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2904546-66-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35001830
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM IndiFluors: A New Full-Visible Color-Tunable Donor-Acceptor-Donor
(D1-A-D2) Fluorophore Family for Ratiometric pH Imaging during Mitophagy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Munan, Subrata; Kottarathil, Shamna; Joseph, Manu M.; Jana, Anal; Ali,
Mudassar; Mapa, Koyeli; Maiti, Kaustabh Kumar; Samanta, Animesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sensors (2024), 9(7), 3502-3510

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-bromo-α-(diethoxyphosphinyl)-γ-oxobenzenebutanoate
C16H22BrO6P
947623-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 P 4.0010 5.3901 0.0 0 VAL=5
M  V30 3 C 6.6685 5.3901 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 O 2.6673 6.1601 0.0 0
M  V30 6 O 4.7710 6.7238 0.0 0
M  V30 7 O 3.2310 4.0563 0.0 0
M  V30 8 C 8.0022 4.6201 0.0 0
M  V30 9 O 4.0010 2.3101 0.0 0
M  V30 10 O 6.6685 2.3101 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 4.0010 8.0575 0.0 0
M  V30 13 O 8.0022 3.0801 0.0 0
M  V30 14 C 4.0010 0.7700 0.0 0
M  V30 15 C 0.0000 6.1601 0.0 0
M  V30 16 C 4.7710 9.3911 0.0 0
M  V30 17 C 2.6673 0.0000 0.0 0
M  V30 18 Br 13.3370 7.7002 0.0 0
M  V30 19 C 9.3360 5.3901 0.0 0
M  V30 20 C 9.3360 6.9302 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 10.6697 7.7002 0.0 0
M  V30 23 C 12.0033 5.3901 0.0 0
M  V30 24 C 12.0033 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 1 6 12
M  V30 12 2 8 13
M  V30 13 1 8 19
M  V30 14 1 9 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 14 17
M  V30 18 1 18 24
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[5-(4-bromophenyl)-1-methyl-2-oxo-3-pyrrolidinyl]phosphonate
C15H21BrNO4P
1037575-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.0010 4.0010 0.0 0 VAL=5
M  V30 2 O 2.6673 3.2310 0.0 0
M  V30 3 O 4.7710 2.6673 0.0 0
M  V30 4 O 3.2310 5.3348 0.0 0
M  V30 5 C 1.3337 4.0010 0.0 0
M  V30 6 C 4.0010 1.3337 0.0 0
M  V30 7 C 0.0000 3.2310 0.0 0
M  V30 8 C 4.7710 0.0000 0.0 0
M  V30 9 O 4.3514 7.3332 0.0 0
M  V30 10 C 7.6286 8.0297 0.0 0
M  V30 11 Br 13.8985 4.6452 0.0 0
M  V30 12 C 5.3348 4.7710 0.0 0
M  V30 13 C 5.4958 6.3027 0.0 0
M  V30 14 C 6.7417 4.1447 0.0 0
M  V30 15 N 7.0021 6.6229 0.0 0
M  V30 16 C 7.7721 5.2892 0.0 0
M  V30 17 C 9.3038 5.1282 0.0 0
M  V30 18 C 9.9301 3.7213 0.0 0
M  V30 19 C 10.2090 6.3740 0.0 0
M  V30 20 C 11.4617 3.5604 0.0 0
M  V30 21 C 11.7406 6.2131 0.0 0
M  V30 22 C 12.3669 4.8063 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 9 13
M  V30 10 1 10 15
M  V30 11 1 11 22
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 947623-46-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037575-79-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14368831
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and cytotoxic activity of γ-aryl substituted
α-alkylidene-γ-lactones and α-alkylidene-γ-lactams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Albrecht, Anna; Koszuk, Jacek F.; Modranka, Jakub; Rozalski, Marek;
Krajewska, Urszula; Janecka, Anna; Studzian, Kazimierz; Janecki, Tomasz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2008), 16(9), 4872-4882

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[2-(Methylsulfonyl)-4-pyrimidinyl]oxy]-1,2-benzenediamine
C11H12N4O3S
952490-49-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 2.6674 0.0 0
M  V30 2 S 1.5400 5.3349 0.0 0 VAL=6
M  V30 3 C 0.0000 5.3349 0.0 0
M  V30 4 O 1.5400 6.8749 0.0 0
M  V30 5 O 1.5400 3.7949 0.0 0
M  V30 6 N 10.7800 0.0000 0.0 0
M  V30 7 N 12.3200 2.6674 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 6.1600 5.3349 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 6.6685 0.0 0
M  V30 13 N 3.8500 6.6685 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 8.4700 1.3338 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 10.0100 1.3338 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 19 C 10.7800 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 11
M  V30 7 1 6 17
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[2-(Methylamino)-4-pyrimidinyl]oxy]-1,2-benzenediamine
C11H13N5O
769961-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 N 10.6697 3.0801 0.0 0
M  V30 3 C 12.0033 2.3101 0.0 0
M  V30 4 N 0.0000 3.0801 0.0 0
M  V30 5 N 0.0000 0.0000 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 N 8.0022 3.0801 0.0 0
M  V30 8 C 6.6685 0.7700 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 8.0022 0.0000 0.0 0
M  V30 11 N 9.3360 0.7700 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 4.0012 0.7700 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 2.6673 0.0000 0.0 0
M  V30 17 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 4 15
M  V30 6 1 5 17
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 952490-49-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 769961-35-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8275577
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of 4-(2-methanesulfonyl-pyrimidin-4-yloxy)-benzene-
1,2-diamine (39h; 400 mg, 1.4 mmol) in anhydrous THF (4 mL) was added
CH3NH2 (2 M in THF, 1 mL, 2.0 mmol). The solution was heated to 80 °C for
1 h, and the mixture was allowed to cool to rt and concentrated in vacuo.
The material was purified by column chromatography (0-10% MeOH/CH2Cl2
with 1% NH4OH) to yield 4-(2-methylamino-pyrimidin-4-yloxy)-benzene-1,2-
diamine (300 mg, 92%), which was used directly in the next step.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Evaluation of Orally Active Benzimidazoles and
Benzoxazoles as Vascular Endothelial Growth Factor-2 Receptor Tyrosine
Kinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Potashman, Michele H.; Bready, James; Coxon, Angela; DeMelfi, Thomas M.
Jr.; DiPietro, Lucian; Doerr, Nicholas; Elbaum, Daniel; Estrada, Juan;
Gallant, Paul; Germain, Julie; Gu, Yan; Harmange, Jean-Christophe;
Kaufman, Stephen A.; Kendall, Rick; Kim, Joseph L.; Kumar, Gondi N.;
Long, Alexander M.; Neervannan, Seshadri; Patel, Vinod F.; Polverino,
Anthony; Rose, Paul; Van der Plas, Simon; Whittington, Douglas; Zanon,
Roger; Zhao, Huilin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2007), 50(18), 4351-4373

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-(3-fluorophenyl)thiazole
C10H7ClFNS
953736-97-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3038 3.4372 0.0 0
M  V30 2 Cl 10.2089 4.6831 0.0 0
M  V30 3 F 0.0000 3.0801 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 N 6.7417 2.4536 0.0 0
M  V30 6 S 5.4958 4.6116 0.0 0
M  V30 7 C 7.7721 3.5981 0.0 0
M  V30 8 C 7.0021 4.9318 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 4.0010 0.7700 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Fluorophenyl)-N-methyl-4-thiazolemethanamine
C11H11FN2S
1248644-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3038 3.4372 0.0 0
M  V30 2 N 10.2090 4.6831 0.0 0
M  V30 3 C 11.7406 4.5221 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 C 5.3348 3.0801 0.0 0
M  V30 6 N 6.7416 2.4536 0.0 0
M  V30 7 S 5.4957 4.6116 0.0 0
M  V30 8 C 7.7722 3.5981 0.0 0
M  V30 9 C 7.0022 4.9318 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 4.0011 0.7700 0.0 0
M  V30 13 C 1.3337 2.3100 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 953736-97-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1248644-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24398633
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural and Activity Relationships of
6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fan, Dongguang; Wang, Bin; Stelitano, Giovanni; Savkova, Karin; Shi, Rui;
Huszar, Stanislav; Han, Quanquan; Mikusova, Katarina; Chiarelli, Laurent
R.; Lu, Yu; Qiao, Chunhua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14526-14539

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
5,6-Anhydro-1-deoxy-1-(hydroxymethyl)-2,3,4-tris-O-(phenylmethyl)-L-chiro-ino...
C28H30O5
956470-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6696 6.9300 0.0 0
M  V30 2 C 12.0032 7.7000 0.0 0
M  V30 3 C 5.3347 10.0100 0.0 0
M  V30 4 O 5.3347 11.5500 0.0 0
M  V30 5 O 8.0021 5.3900 0.0 0
M  V30 6 C 6.6685 4.6200 0.0 0
M  V30 7 O 5.3347 6.9300 0.0 0
M  V30 8 C 4.0011 7.7000 0.0 0
M  V30 9 C 9.3358 9.2400 0.0 0 CFG=1
M  V30 10 C 8.0021 10.0100 0.0 0 CFG=1
M  V30 11 C 9.3358 7.7000 0.0 0 CFG=2
M  V30 12 O 9.3358 10.7800 0.0 0
M  V30 13 C 6.6685 9.2400 0.0 0 CFG=1
M  V30 14 C 8.0021 6.9300 0.0 0 CFG=1
M  V30 15 C 6.6685 7.7000 0.0 0 CFG=1
M  V30 16 C 13.3369 6.9300 0.0 0
M  V30 17 C 13.3369 5.3900 0.0 0
M  V30 18 C 14.6705 7.7000 0.0 0
M  V30 19 C 14.6705 4.6200 0.0 0
M  V30 20 C 16.0043 6.9300 0.0 0
M  V30 21 C 16.0043 5.3900 0.0 0
M  V30 22 C 6.6685 3.0800 0.0 0
M  V30 23 C 5.3349 2.3100 0.0 0
M  V30 24 C 8.0021 2.3100 0.0 0
M  V30 25 C 5.3347 0.7700 0.0 0
M  V30 26 C 8.0021 0.7700 0.0 0
M  V30 27 C 6.6685 0.0000 0.0 0
M  V30 28 C 2.6674 6.9300 0.0 0
M  V30 29 C 2.6674 5.3900 0.0 0
M  V30 30 C 1.3338 7.7000 0.0 0
M  V30 31 C 1.3338 4.6200 0.0 0
M  V30 32 C 0.0000 6.9300 0.0 0
M  V30 33 C 0.0000 5.3900 0.0 0
M  V30 34 H 10.8758 9.2400 0.0 0
M  V30 35 H 7.2321 11.3436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=3
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 1 13 3 CFG=3
M  V30 6 1 5 6
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 22
M  V30 9 1 7 8
M  V30 10 1 15 7 CFG=3
M  V30 11 1 8 28
M  V30 12 1 9 10
M  V30 13 1 9 11
M  V30 14 1 9 12
M  V30 15 1 9 34 CFG=3
M  V30 16 1 10 12
M  V30 17 1 10 13
M  V30 18 1 10 35 CFG=3
M  V30 19 1 11 14
M  V30 20 1 13 15
M  V30 21 1 14 15
M  V30 22 2 16 17
M  V30 23 1 16 18
M  V30 24 1 17 19
M  V30 25 2 18 20
M  V30 26 2 19 21
M  V30 27 1 20 21
M  V30 28 2 22 23
M  V30 29 1 22 24
M  V30 30 1 23 25
M  V30 31 2 24 26
M  V30 32 2 25 27
M  V30 33 1 26 27
M  V30 34 2 28 29
M  V30 35 1 28 30
M  V30 36 1 29 31
M  V30 37 2 30 32
M  V30 38 2 31 33
M  V30 39 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 9 10 11 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dideoxy-2-(hydroxymethyl)-3-(methylamino)-1,5,6-tris-O-(phenylmethyl)-D-m...
C29H35NO5
956470-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 5.3900 0.0 0
M  V30 2 C 6.6685 4.6200 0.0 0
M  V30 3 O 10.6696 6.9300 0.0 0
M  V30 4 C 12.0032 7.7000 0.0 0
M  V30 5 O 5.3347 6.9300 0.0 0
M  V30 6 C 4.0011 7.7000 0.0 0
M  V30 7 C 10.6696 10.0100 0.0 0
M  V30 8 O 10.6696 11.5500 0.0 0
M  V30 9 O 5.3347 10.0100 0.0 0
M  V30 10 N 8.0021 11.5500 0.0 0
M  V30 11 C 6.6685 12.3200 0.0 0
M  V30 12 C 8.0021 6.9300 0.0 0 CFG=2
M  V30 13 C 9.3358 7.7000 0.0 0 CFG=2
M  V30 14 C 6.6685 7.7000 0.0 0 CFG=1
M  V30 15 C 9.3358 9.2400 0.0 0 CFG=2
M  V30 16 C 6.6685 9.2400 0.0 0 CFG=2
M  V30 17 C 8.0021 10.0100 0.0 0 CFG=2
M  V30 18 C 6.6685 3.0800 0.0 0
M  V30 19 C 5.3347 2.3100 0.0 0
M  V30 20 C 8.0021 2.3100 0.0 0
M  V30 21 C 5.3347 0.7700 0.0 0
M  V30 22 C 8.0021 0.7700 0.0 0
M  V30 23 C 6.6685 0.0000 0.0 0
M  V30 24 C 13.3369 6.9300 0.0 0
M  V30 25 C 14.6705 7.7000 0.0 0
M  V30 26 C 13.3369 5.3900 0.0 0
M  V30 27 C 16.0043 6.9300 0.0 0
M  V30 28 C 14.6705 4.6200 0.0 0
M  V30 29 C 16.0043 5.3900 0.0 0
M  V30 30 C 2.6674 6.9300 0.0 0
M  V30 31 C 1.3338 7.7000 0.0 0
M  V30 32 C 2.6674 5.3900 0.0 0
M  V30 33 C 0.0000 6.9300 0.0 0
M  V30 34 C 1.3338 4.6200 0.0 0
M  V30 35 C 0.0000 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 13 3 CFG=1
M  V30 6 1 4 24
M  V30 7 1 5 6
M  V30 8 1 14 5 CFG=1
M  V30 9 1 6 30
M  V30 10 1 7 8
M  V30 11 1 15 7 CFG=1
M  V30 12 1 16 9 CFG=3
M  V30 13 1 10 11
M  V30 14 1 17 10 CFG=1
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 12 13 14 15 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 956470-42-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 956470-44-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-1272402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7791-03-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An unexpected access to 5-epi-cyclophellitol: a new cyclitol member
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Serrano, Pedro; Egido-Gabas, Meritxell; Llebaria, Amadeu; Delgado,
Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2007), 18(16), 1971-1974

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-azido-3-(4-methoxyphenyl)-2-propenoate
C11H11N3O3
98081-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 N 4.6200 2.6674 0.0 0
M  V30 5 O 1.5400 5.3347 0.0 0
M  V30 6 O 1.5400 2.6674 0.0 0
M  V30 7 N 3.8500 1.3338 0.0 0 CHG=1 VAL=4
M  V30 8 C 0.0000 5.3347 0.0 0
M  V30 9 N 3.0800 0.0000 0.0 0 CHG=-1
M  V30 10 O 10.7800 5.3347 0.0 0
M  V30 11 C 11.5500 6.6685 0.0 0
M  V30 12 C 6.1600 5.3347 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 6.6685 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 8.4700 6.6685 0.0 0
M  V30 17 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Azido-3-(4-methoxyphenyl)-N-methyl-2-propenamide
C11H12N4O2
1443676-79-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 N 4.6200 2.6674 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0
M  V30 6 O 1.5400 2.6674 0.0 0
M  V30 7 N 3.8500 1.3338 0.0 0 CHG=1 VAL=4
M  V30 8 C 0.0000 5.3347 0.0 0
M  V30 9 N 3.0800 0.0000 0.0 0 CHG=-1
M  V30 10 O 10.7800 5.3347 0.0 0
M  V30 11 C 11.5500 6.6685 0.0 0
M  V30 12 C 6.1600 5.3347 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 6.6685 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 8.4700 6.6685 0.0 0
M  V30 17 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98081-75-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1443676-79-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5119307
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A synthetic approach to GFP chromophore analogs from 3-azidocinnamates.
Role of methyl rotors in chromophore photophysics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baranov, Mikhail S.; Solntsev, Kyril M.; Lukyanov, Konstantin A.;
Yampolsky, Ilia V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2013), 49(51),
5778-5780

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(methylamino)-2-butenoate
C7H13NO2
21759-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 1.3337 0.0 0
M  V30 2 C 4.6201 2.6673 0.0 0
M  V30 3 C 2.3101 1.3337 0.0 0
M  V30 4 O 6.1601 2.6673 0.0 0
M  V30 5 O 3.8501 4.0010 0.0 0
M  V30 6 N 1.5400 2.6673 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 6.9302 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 10 C 8.4702 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21759-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20777785
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of indole-3-carboxamide derivatives
as antioxidant agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Erfang; Zhang, Lan; Xiao, Chuying; Meng, Guangpeng; Zhang, Bingqi;
Hu, Jianshu; Wan, David Chi-Cheong; Meng, Qingguo; Jin, Zhe; Hu, Chun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2019), 30(12), 2157-2159

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(methylamino)-2-butenoate
C7H13NO2
21759-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 1.3337 0.0 0
M  V30 2 C 4.6201 2.6673 0.0 0
M  V30 3 C 2.3101 1.3337 0.0 0
M  V30 4 O 6.1601 2.6673 0.0 0
M  V30 5 O 3.8501 4.0010 0.0 0
M  V30 6 N 1.5400 2.6673 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 6.9302 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 10 C 8.4702 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21759-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9562145
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Ag-Cu bimetallic nanoparticle catalyst prepared and
used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bimetallic Ag-Cu alloy nanoparticles as a highly active catalyst for the
enamination of 1,3-dicarbonyl compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rout, Lipeeka; Kumar, Aniket; Dhaka, Rajendra S.; Dash, Priyabrat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2016), 6(55), 49923-49940

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
(4-Bromophenyl)acetic acid
C8H7BrO2
1878-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 O 6.1601 0.0000 0.0 0
M  V30 4 O 8.4702 1.3337 0.0 0
M  V30 5 Br 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzeneacetamide
C9H10BrNO
7713-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 Br 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1878-68-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7713-76-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15316860
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Preparation of Analogues of 5. Phenylacetic
acid (55 mmol) in toluene (25 mL) was treated with thionyl chloride (66
mmol, 1.2 equiv) and anhydrous N,N'-dimethylformamide (63 mmol, 1.14
equiv) under nitrogen. A slight exotherm was noted, and the clear
solution was heated at 40°C for 30 min. TLC analysis (10%
methanol/dichloromethane reaction mixture quenched into methanol or
methylamine solution) was used to monitor the reaction. The resulting
acid chloride solution was added into a cooled (0-5°C) methylamine
solution (275 mmol, 5.0 equiv) through an addition funnel over
approximately 30 min, while maintaining the internal temperature at ≤
20°C. Cooling was removed, and the reaction was stirred for 30 min, at
which point HPLC analysis showed the reaction was complete. The
suspension was diluted with water (50 mL) and extracted with EtOAc (50
mL). The organic layer was washed with saturated NaHCO3 (50 mL) and brine
(50 mL) and concentrated to give the desired product as a white solid.
N-Methyl 4-bromophenylacetamide,(5a):15 white solid; yield: 91%; HPLC
>99%. Spectral data were consistent with those reported in the
literature.
$DTYPE RXN:VAR(1):NOTES
$DATUM scalable, product of stage 1 added in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process Development and Pilot-Scale Synthesis of New Cyclization
Conditions of Substituted Phenylacetamides to
Tetrahydroisoquinoline-2-ones Using Eaton's Reagent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ulysse, Luckner G.; Yang, Qiang; McLaws, Mark D.; Keefe, Daniel K.;
Guzzo, Peter R.; Haney, Brian P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2010), 14(1), 225-228

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzenesulfonyl chloride
C6H4BrClO2S
2905-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 Cl 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 Br 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3336 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
98192-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3336 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-25-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98192-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-18629175
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dynamic Covalent Chemistry within Biphenyl Scaffolds: Reversible Covalent
Bonding, Control of Selectivity, and Chirality Sensing with a Single
System
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ni, Cailing; Zha, Daijun; Ye, Hebo; Hai, Yu; Zhou, Yuntao; Anslyn, Eric
V.; You, Lei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2018), 57(5), 1300-1305

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-oxopentanoate
C6H10O3
30414-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 O 1.3337 2.3100 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-(methylamino)-2-pentenoate
C7H13NO2
1280735-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 0.7700 2.6674 0.0 0
M  V30 4 N 3.0800 1.3338 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 O 5.3900 5.3349 0.0 0
M  V30 9 O 5.3900 2.6674 0.0 0
M  V30 10 C 6.9300 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30414-53-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1280735-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24256125
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Naphthridine compounds and analogs for use as protein kinase modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bannen, Lynne; Xu, Wei; Wang, Yong; Raub, Andrew; Spangler, Benjamin;
Salvant, Justin; Tso, Kin; Jiang, Faming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021173591 A1 2021-09-02

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1-fluoro-2-nitrobenzene
C6H3BrFNO2
364-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
53484-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-73-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53484-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23348497
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1,3,4-oxadiazole derivatives as histone deacetylase 6
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Chang Sik; Oh, Jung Taek; Yun, Hokeun; Song, Hyeseung; Kim, Hyunjin
Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020240492 A1 2020-12-03

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-5-nitropyrimidine
C4HCl2N3O2
49845-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 N 4.6201 1.3337 0.0 0
M  V30 10 N 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-5-nitro-4-pyrimidinamine
C5H5ClN4O2
89283-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 N 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 49845-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89283-49-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39036812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 3,4-dihydroisoquinolin-1(2H)-one derivatives
and related uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bock, Mark G.; Harrison, David; Scanlon, Jane E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023240134 A1 2023-12-14

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36095301
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational design and development of novel NAE inhibitors for the treatment
of pancreatic cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Cheng; Lu, Peng; Gong, Lei; Zhu, Li-Juan; An, Yuanyuan; Wang, Yubin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Medicinal Chemistry Research (2023), 32(3), 442-474

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl N-cyano-4-[2-[(3-endo)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[...
C36H40N6O
716344-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0396 4.6088 0.0 0
M  V30 2 C 9.5129 6.0559 0.0 0
M  V30 3 C 15.5572 6.6513 0.0 0
M  V30 4 O 15.5572 8.1913 0.0 0
M  V30 5 N 16.8909 5.8813 0.0 0
M  V30 6 C 16.8909 4.3413 0.0 0
M  V30 7 N 16.8909 2.8013 0.0 0
M  V30 8 C 2.3305 6.0034 0.0 0
M  V30 9 C 11.5562 4.3413 0.0 0
M  V30 10 C 11.5562 5.8813 0.0 0
M  V30 11 C 12.8898 3.5713 0.0 0
M  V30 12 C 12.8898 6.6513 0.0 0
M  V30 13 C 14.2236 4.3413 0.0 0
M  V30 14 N 14.2236 5.8813 0.0 0
M  V30 15 C 11.0295 2.8941 0.0 0
M  V30 16 C 9.5129 2.6268 0.0 0
M  V30 17 C 12.0194 1.7145 0.0 0
M  V30 18 C 8.9862 1.1796 0.0 0
M  V30 19 C 11.4926 0.2673 0.0 0
M  V30 20 C 9.9760 0.0000 0.0 0
M  V30 21 N 7.9963 6.3232 0.0 0
M  V30 22 C 6.8410 7.0192 0.0 0 CFG=1
M  V30 23 C 6.4640 6.0236 0.0 0 CFG=2
M  V30 24 C 6.2436 8.6727 0.0 0
M  V30 25 C 5.8030 5.9757 0.0 0
M  V30 26 C 5.8104 7.7425 0.0 0
M  V30 27 C 5.5535 4.6248 0.0 0
M  V30 28 C 4.7049 8.3673 0.0 0 CFG=1
M  V30 29 C 16.8909 8.9613 0.0 0
M  V30 30 C 18.2245 8.1913 0.0 0
M  V30 31 C 16.8909 10.5013 0.0 0
M  V30 32 C 19.5583 8.9613 0.0 0
M  V30 33 C 18.2245 11.2713 0.0 0
M  V30 34 C 19.5583 10.5013 0.0 0
M  V30 35 N 3.1843 8.6115 0.0 0
M  V30 36 C 2.4882 9.9852 0.0 0
M  V30 37 C 2.0930 7.5251 0.0 0
M  V30 38 C 0.9667 9.7477 0.0 0
M  V30 39 C 3.0432 11.4217 0.0 0
M  V30 40 N 0.7224 8.2271 0.0 0
M  V30 41 C 0.0000 10.9466 0.0 0
M  V30 42 C 2.0767 12.6206 0.0 0
M  V30 43 C 0.5552 12.3831 0.0 0
M  V30 44 H 8.0311 7.9966 0.0 0
M  V30 45 H 7.3252 4.7469 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 3 14
M  V30 7 1 4 29
M  V30 8 1 5 6
M  V30 9 3 6 7
M  V30 10 1 8 37
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 15
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 1 22 44 CFG=3
M  V30 29 1 23 26
M  V30 30 1 23 27
M  V30 31 1 23 45 CFG=1
M  V30 32 1 24 28
M  V30 33 1 25 27
M  V30 34 1 26 28
M  V30 35 1 28 35 CFG=3
M  V30 36 2 29 30
M  V30 37 1 29 31
M  V30 38 1 30 32
M  V30 39 2 31 33
M  V30 40 2 32 34
M  V30 41 1 33 34
M  V30 42 1 35 36
M  V30 43 1 35 37
M  V30 44 1 36 38
M  V30 45 2 36 39
M  V30 46 2 37 40
M  V30 47 1 38 40
M  V30 48 2 38 41
M  V30 49 1 39 42
M  V30 50 1 41 43
M  V30 51 2 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 22 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Cyano-N′-methyl-4-[2-[(3-endo)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyc...
C31H39N7
716357-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0396 4.6088 0.0 0
M  V30 2 C 9.5129 6.0559 0.0 0
M  V30 3 C 15.5572 6.6513 0.0 0
M  V30 4 N 16.8909 5.8813 0.0 0
M  V30 5 N 15.5572 8.1913 0.0 0
M  V30 6 C 18.2245 6.6513 0.0 0
M  V30 7 C 16.8909 8.9613 0.0 0
M  V30 8 N 19.5583 7.4213 0.0 0
M  V30 9 C 2.3305 6.0034 0.0 0
M  V30 10 C 11.5562 4.3413 0.0 0
M  V30 11 C 11.5562 5.8813 0.0 0
M  V30 12 C 12.8898 3.5713 0.0 0
M  V30 13 C 12.8898 6.6513 0.0 0
M  V30 14 C 14.2236 4.3413 0.0 0
M  V30 15 N 14.2236 5.8813 0.0 0
M  V30 16 C 11.0295 2.8941 0.0 0
M  V30 17 C 12.0194 1.7145 0.0 0
M  V30 18 C 9.5129 2.6268 0.0 0
M  V30 19 C 11.4926 0.2673 0.0 0
M  V30 20 C 8.9862 1.1796 0.0 0
M  V30 21 C 9.9760 0.0000 0.0 0
M  V30 22 N 7.9963 6.3232 0.0 0
M  V30 23 C 6.8410 7.0192 0.0 0 CFG=1
M  V30 24 C 6.4640 6.0236 0.0 0 CFG=2
M  V30 25 C 6.2436 8.6727 0.0 0
M  V30 26 C 5.8030 5.9757 0.0 0
M  V30 27 C 5.8104 7.7425 0.0 0
M  V30 28 C 5.5535 4.6248 0.0 0
M  V30 29 C 4.7049 8.3673 0.0 0 CFG=1
M  V30 30 N 3.1843 8.6115 0.0 0
M  V30 31 C 2.4882 9.9852 0.0 0
M  V30 32 C 2.0930 7.5251 0.0 0
M  V30 33 C 0.9667 9.7477 0.0 0
M  V30 34 C 3.0432 11.4217 0.0 0
M  V30 35 N 0.7224 8.2271 0.0 0
M  V30 36 C 0.0000 10.9466 0.0 0
M  V30 37 C 2.0767 12.6206 0.0 0
M  V30 38 C 0.5552 12.3831 0.0 0
M  V30 39 H 8.0311 7.9966 0.0 0
M  V30 40 H 7.3252 4.7469 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 22
M  V30 4 2 3 4 CFG=2
M  V30 5 1 3 5
M  V30 6 1 3 15
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 3 6 8
M  V30 10 1 9 32
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 23 39 CFG=3
M  V30 29 1 24 27
M  V30 30 1 24 28
M  V30 31 1 24 40 CFG=1
M  V30 32 1 25 29
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 29 30 CFG=3
M  V30 36 1 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 2 31 34
M  V30 40 2 32 35
M  V30 41 1 33 35
M  V30 42 2 33 36
M  V30 43 1 34 37
M  V30 44 1 36 38
M  V30 45 2 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 23 24 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 716344-76-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 716357-87-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10737320
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [2-(4-Phenyl-4-piperidinyl)ethyl]amine based CCR5 antagonists:
derivatizations at the N-terminal of the piperidine ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Duan, Maosheng; Aquino, Christopher; Ferris, Robert; Kazmierski, Wieslaw
M.; Kenakin, Terry; Koble, Cecilia; Wheelan, Pat; Watson, Chris;
Youngman, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(6), 1610-1613

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(1,3-benzodioxol-5-ylmethyl)-N-(3-bromopropyl)carbamate
C16H22BrNO4
888313-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 6.6685 0.0 0
M  V30 2 N 7.0574 5.3348 0.0 0
M  V30 3 C 8.5974 5.3348 0.0 0
M  V30 4 C 6.2873 4.0010 0.0 0
M  V30 5 O 9.3674 6.6685 0.0 0
M  V30 6 O 9.3674 4.0010 0.0 0
M  V30 7 C 7.0574 2.6673 0.0 0
M  V30 8 C 10.9074 6.6685 0.0 0
M  V30 9 C 6.2873 1.3337 0.0 0
M  V30 10 C 10.9074 5.1285 0.0 0
M  V30 11 C 12.4475 6.6685 0.0 0
M  V30 12 C 10.9074 8.2085 0.0 0
M  V30 13 Br 7.0574 0.0000 0.0 0
M  V30 14 C 2.4373 8.0022 0.0 0
M  V30 15 C 1.6672 6.6685 0.0 0
M  V30 16 C 3.9773 8.0022 0.0 0
M  V30 17 O 1.4068 9.1466 0.0 0
M  V30 18 C 2.4373 5.3348 0.0 0
M  V30 19 O 0.1609 6.9887 0.0 0
M  V30 20 C 4.7473 6.6685 0.0 0
M  V30 21 C 0.0000 8.5202 0.0 0
M  V30 22 C 3.9773 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(1,3-benzodioxol-5-ylmethyl)-N-[3-(methylamino)propyl]car...
C17H26N2O4
888313-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 6.6685 0.0 0
M  V30 2 N 7.0574 5.3348 0.0 0
M  V30 3 C 6.2873 4.0010 0.0 0
M  V30 4 C 8.5974 5.3348 0.0 0
M  V30 5 O 7.0574 2.6673 0.0 0
M  V30 6 O 4.7473 4.0010 0.0 0
M  V30 7 C 9.3674 6.6685 0.0 0
M  V30 8 C 6.2873 1.3337 0.0 0
M  V30 9 C 10.9074 6.6685 0.0 0
M  V30 10 C 7.6212 0.5637 0.0 0
M  V30 11 C 5.5173 0.0000 0.0 0
M  V30 12 C 4.9537 2.1037 0.0 0
M  V30 13 N 11.6775 8.0022 0.0 0
M  V30 14 C 13.2175 8.0022 0.0 0
M  V30 15 C 2.4373 8.0022 0.0 0
M  V30 16 C 1.6672 6.6685 0.0 0
M  V30 17 C 3.9773 8.0022 0.0 0
M  V30 18 O 1.4068 9.1466 0.0 0
M  V30 19 C 2.4373 5.3348 0.0 0
M  V30 20 O 0.1609 6.9887 0.0 0
M  V30 21 C 4.7473 6.6685 0.0 0
M  V30 22 C 0.0000 8.5202 0.0 0
M  V30 23 C 3.9773 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 2 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 888313-54-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 888313-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7754009
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of compound 2d:
Benzo[1,3]dioxol-5ylmethyl-(3-methylamino-propyl)-carbamic acid
tert-butyl ester. Benzo[1 ,3]dioxol-5-ylmethyl-(3-bromo-propyl)- carbamic
acid tert-butyl ester (23.0 g, 61.8. mmol) was diluted in methylamine
(2.00M in THF, 300 mL, 600 mmol) at rt under an atmosphere of nitrogen
and stirred at ambient temperature for 16 h. The solvent was evaporated
and saturated sodium carbonate solution was added. The solution was
extracted with ethyl acetate (2x 150 mL), dried over Na2SO4, filtered and
concentrated under reduced pressure to give 18.2 g (91%) of
benzo[1,3]dioxol-5-ylinethyl-(3-inethylamino-propyl)-carbamic acid
tert-butyl ester as a clear oil.
Benzo[1,3]dioxol-5ylmethyl-(3-methylamino-propyl)-carbamic acid
tert-butyl ester. yield 18.2 g (91%) [M+H]+ 323.09
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic inhibitors of inducible nitric oxide synthase
dimerization for therapeutic use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gahman, Timothy C.; Lang, Hengyuan; Herbert, Mark R.; Thayer, Angelina
M.; Hassig, Christian A.; Noble, Stewart A.; Cousins, Russell D.; Zhuang,
Hui; Santos, Christopher R.; Chen, Xiaohong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060116515 A1 2006-06-01

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzenesulfonyl chloride
C7H7ClO3S
98-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 O 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 0.2064 0.0 0
M  V30 9 C 3.8500 2.8736 0.0 0
M  V30 10 C 5.3900 0.2064 0.0 0
M  V30 11 C 5.3900 2.8736 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzenesulfonamide
C8H11NO3S
7010-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 1.3337 0.0 0 VAL=6
M  V30 2 N 1.3337 0.5637 0.0 0
M  V30 3 O 1.8975 2.6673 0.0 0
M  V30 4 O 3.4375 0.0000 0.0 0
M  V30 5 C 0.0000 1.3337 0.0 0
M  V30 6 O 8.0023 4.4137 0.0 0
M  V30 7 C 9.3360 3.6437 0.0 0
M  V30 8 C 4.0012 2.1037 0.0 0
M  V30 9 C 4.0012 3.6437 0.0 0
M  V30 10 C 5.3348 1.3337 0.0 0
M  V30 11 C 5.3348 4.4137 0.0 0
M  V30 12 C 6.6685 2.1037 0.0 0
M  V30 13 C 6.6685 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7010-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-15636369
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7758-98-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Silver-promoted cinnamamidyl radical-mediated oxidative cascade
cyclization: highly regioselective synthesis of phosphorylated
azaspiro[4.5]decenones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Zhao-Zhao; Zheng, Lan; Yan, Xiao-Biao; Jin, Dong-Po; He, Yu-Tao;
Liang, Yong-Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(19), 4507-4510

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
98-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 N 0.7700 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenesulfonamide
C7H8N2O4S
6319-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6319-45-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-22071896
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylation and alkenylation of activated alkyl halides using sulfonamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johnson, Stuart; Kovacs, Ervin; Greaney, Michael F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2020), 56(21),
3222-3224

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Chlorophenyl)methylene]methanamine
C8H8ClN
13114-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13114-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31477759
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 16898-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, green chemistry-solvent, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4,4'-Trimethylenedipiperidine, a safe and greener alternative for
piperidine, catalyzed the synthesis of N-methyl imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gorjian, Hayedeh; Khaligh, Nader Ghaffari
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2022), 48(5), 2035-2045

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Chlorophenyl)methylene]methanamine
C8H8ClN
13114-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13114-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4069451
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thiazolidinones Derived from Dynamic Systemic Resolution of Complex
Reversible-Reaction Networks
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yan; Ramstroem, Olof
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2014), 20(12), 3288-3291

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Chlorophenyl)methylene]methanamine
C8H8ClN
13114-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13114-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11897098
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cholinesterase inhibitors: SAR and enzyme inhibitory activity of
3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piazzi, Lorna; Belluti, Federica; Bisi, Alessandra; Gobbi, Silvia; Rizzo,
Stefano; Bartolini, Manuela; Andrisano, Vincenza; Recanatini, Maurizio;
Rampa, Angela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2007), 15(1), 575-585

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-5-carboxaldehyde
C9H7NO
1196-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 C 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 N 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-5-methanamine
C10H12N2
709649-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 C 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 N 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1196-69-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32682500
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-indolyl indazolecarboxamides and indolecarboxamides as
STING antagonists and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hailong; Zhong, Wenge; Huang, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022105930 A1 2022-05-27

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-5-carboxaldehyde
C9H7NO
1196-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 C 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 N 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-5-methanamine
C10H12N2
709649-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 C 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 N 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1196-69-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11577200
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 107 Preparation of (1H-Indol-5-ylmethyl)methylamine [0864]
Indole-5-carbaldehyde (1.0 g, 6.9 mmol) was dissolved in anhydrous
methanol (15 mL). Methylamine (9.9 mL of 2M solution in methanol, 19.8
mmol) was added and the reaction was stirred for 3 hr. The solution was
concentrated to a yellow oil and then dissolved into anhydrous methanol
(20 mL). Sodium borohydride (262 mg, 6.9 mmol) was added and the mixture
was stirred overnight. Water (1 mL) was added and the solution was
concentrated. Sodium hydroxide (5 mL, 1N) was added and the product was
extracted with ethyl acetate (3×20 mL), dried over MgSO4 and concentrated
to afford the title compound as a brown oil (980 mg, 91%). 1H NMR (200
MHz, CDCl3) δ 8.60 (s, 1H), 7.56 (s, 1H), 7.35-7.15 (m, 3H), 6.55 (m,1H),
3.85 (s, 2H), 2.49 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-5-carboxaldehyde
C9H7NO
1196-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 C 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 N 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-5-methanamine
C10H12N2
709649-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 C 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 N 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1196-69-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3153404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-5-carboxaldehyde
C9H7NO
1196-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 C 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 N 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-5-methanamine
C10H12N2
709649-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 C 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 N 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1196-69-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9830901
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of (1H-Indol-5-ylmethyl)methylamine Indole-5-carbaldehyde
(1.0 g, 6.9 mmol) was dissolved in anhydrous methanol (15 mL).
Methylamine (9.9 mL of 2M solution in methanol, 19.8 mmol) was added and
the reaction was stirred for 3 hr. The solution was concentrated to a
yellow oil and then dissolved into anhydrous methanol (20 mL). Sodium
borohydride (262 mg, 6.9 mmol) was added and the mixture was stirred
overnight. Water (1 mL) was added and the solution was concentrated.
Sodium hydroxide (5 mL, 1N) was added and the product was extracted with
ethyl acetate (3 x 20 mL), dried over MgSO4 and concentrated to afford
the title compound as a brown oil. (1H-Indol-5-ylmethyl)methylamine,
yield 980 mg, 91%. 1H NMR (200 MHz, CDCl3) δ 8.60 (s, 1H), 7.56 (s, 1H),
7.35-7.15 (m, 3H), 6.55 (m, 1H), 3.85 (s, 2H), 2.49 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitropyridine
C5H3ClN2O2
13091-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 N 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitro-4-pyridinamine
C6H7N3O2
1633-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 N 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13091-23-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1633-41-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1536564
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM I. Methyl-(3-nitro-pyridin-4-yl)-amine. To a suspension of 21.9 g (0.14
mol) 4-chloro-3-nitro-pyridine in 100 ml dichloromethane were cautiously
added 62 ml (0.71 mol) methyl amine (40%-solution in water) and the
reaction was heated to 40°C. After stirring for 1h, the reaction mixture
was poured into water (100 ml), the precipitate collected by filtration
and dried in vacuo to afford 20 g (91%) of the title compound as a yellow
solid. m.p. 159°-162°C.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazo[4,5-c]pyridines for the treatment of
gastrointestinal disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buhr, Wilm; Zimmermann, Peter Jan; Brehm, Christof; Palmer, Andreas;
Simon, Wolfgang-Alexander; Postius, Stefan; Kromer, Wolfgang; Chiesa, M.
Vittoria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005026164 A1 2005-03-24

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-3-nitrobenzoic acid
C7H4FNO4
317-46-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 3.0800 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 4.6200 0.0 0
M  V30 4 F 4.0011 4.6200 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
124341-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 6.6686 4.6201 0.0 0
M  V30 5 O 8.0022 2.3100 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 317-46-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 124341-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35167562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterobifunctional compounds as CDK2 degraders and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zheng, Xiaozhang; Zhang, Yi; Aversa, Robert; Zhu, Xiao; Collier, Philip
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022236058 A1 2022-11-10

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-3-nitrobenzoic acid
C7H4FNO4
317-46-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 3.0800 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 4.6200 0.0 0
M  V30 4 F 4.0011 4.6200 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
124341-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 6.6686 4.6201 0.0 0
M  V30 5 O 8.0022 2.3100 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 317-46-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 124341-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24567638
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 77-92-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as MDM2 degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021188948 A1 2021-09-23

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-3-nitrobenzoic acid
C7H4FNO4
317-46-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 3.0800 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 4.6200 0.0 0
M  V30 4 F 4.0011 4.6200 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
124341-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 6.6686 4.6201 0.0 0
M  V30 5 O 8.0022 2.3100 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 317-46-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 124341-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24033042
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzothiazole derivatives as IRAK degraders and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weiss, Matthew M.; Zheng, Xiaozhang; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021127283 A2 2021-06-24

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-3-nitrobenzoic acid
C7H4FNO4
317-46-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 3.0800 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 4.6200 0.0 0
M  V30 4 F 4.0011 4.6200 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
124341-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 6.6686 4.6201 0.0 0
M  V30 5 O 8.0022 2.3100 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 317-46-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 124341-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23734709
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhang, Yi;
Fleming, Paul R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020264499 A1 2020-12-30

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-1,3-dinitrobenzene
C6H3ClN2O4
606-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 3.0800 0.0 0 VAL=5
M  V30 2 O 1.3336 4.6200 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 Cl 4.0011 4.6200 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,6-dinitroaniline
C7H7N3O4
5910-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 N 6.6686 3.0800 0.0 0 VAL=5
M  V30 4 O 6.6686 4.6201 0.0 0
M  V30 5 O 8.0022 2.3100 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 606-21-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5910-19-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6573760
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2,6-Dinitro-N-methylaniline: Methylamine (4.5 ml of 2.0 M solution in
THF) was added to a stirred solution of 2-chloro-1,3-dinitrobenzene (0.90
g, 4.4 mmol) in 40 ml of THF and stirred for 30 min. The reaction was
quenched by the addition of water and ether. The aqueous layer was
separated and extracted twice with ether. The combined organic extracts
were washed with saturated NaHCO3, brine and dried over magnesium
sulfate. Filtration, removal of solvent and purification of residue via
Biotage chromatography eluting with 20% ethyl acetate/ dichloromethane to
gave 0.80 g (91 %) of product. 1H NMR (CDCl3) δ 2.89 (d, 3H, J = 5.6 Hz),
6.75 (t, 1H, J = 8.1 Hz), 8.18 (d, 2H, J = 8.3 Hz).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of nitrogen-containing fused heterocyclic compounds like
benzimidazoles and benzothiazoles as CRF receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gyorkos, Albert Charles; Corrette, Christopher Peter; Cho, Suk Young;
Turner, Timothy Mark; Pratt, Scott Alan; Aso, Kazuyoshi; Kori, Masakuni;
Gyoten, Michiyo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005044793 A2 2005-05-19

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1,3-difluoro-4-nitrobenzene
C6H2BrF2NO2
103977-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 5.3901 0.0000 0.0 0
M  V30 6 F 6.9302 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-3-fluoro-N-methyl-6-nitrobenzenamine
C7H6BrFN2O2
1393179-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 5.3900 1.3338 0.0 0
M  V30 7 F 6.9300 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 10
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103977-78-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1393179-36-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12683287
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as selective inhibitors of the p110
delta isoform of PI3K for treating inflammation, immune diseases and
cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heald, Robert; Price, Stephen; Safina, Brian; Savy, Pascal Pierre
Alexandre; Seward, Eileen Mary; Sutherlin, Daniel P.; Waszkowycz, Bohdan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20120202785 A1 2012-08-09

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloropretadalafil
C22H19ClN2O5
171489-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7046 8.9402 0.0 0
M  V30 2 C 9.0383 9.7102 0.0 0
M  V30 3 O 6.3709 9.7102 0.0 0
M  V30 4 Cl 9.0383 11.2502 0.0 0
M  V30 5 C 10.3721 7.4001 0.0 0
M  V30 6 O 11.7058 6.6301 0.0 0
M  V30 7 O 10.3721 8.9402 0.0 0
M  V30 8 C 13.0394 7.4001 0.0 0
M  V30 9 C 6.3709 6.6301 0.0 0 CFG=1
M  V30 10 C 6.3709 5.0901 0.0 0
M  V30 11 N 7.7046 7.4001 0.0 0
M  V30 12 C 7.7046 4.3201 0.0 0
M  V30 13 N 5.2265 4.0597 0.0 0
M  V30 14 C 9.0383 6.6301 0.0 0 CFG=1
M  V30 15 C 7.3844 2.8138 0.0 0
M  V30 16 C 9.0383 5.0901 0.0 0
M  V30 17 C 5.8529 2.6527 0.0 0
M  V30 18 C 8.2897 1.5679 0.0 0
M  V30 19 C 5.2265 1.2459 0.0 0
M  V30 20 C 7.6633 0.1609 0.0 0
M  V30 21 C 6.1316 0.0000 0.0 0
M  V30 22 C 5.0373 7.4001 0.0 0
M  V30 23 C 3.7035 6.6301 0.0 0
M  V30 24 C 5.0373 8.9402 0.0 0
M  V30 25 C 2.3698 7.4001 0.0 0
M  V30 26 C 3.7035 9.7102 0.0 0
M  V30 27 C 2.3698 8.9402 0.0 0
M  V30 28 O 0.9052 6.9243 0.0 0
M  V30 29 O 0.9052 9.4160 0.0 0
M  V30 30 C 0.0000 8.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=1
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Tadalafil
C22H19N3O4
171596-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.7101 0.0 0
M  V30 2 O 0.0000 6.6301 0.0 0
M  V30 3 C 0.0000 9.7101 0.0 0
M  V30 4 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 5 C 5.3348 5.0901 0.0 0
M  V30 6 N 4.0011 7.4001 0.0 0
M  V30 7 C 4.0011 4.3201 0.0 0
M  V30 8 N 6.4792 4.0597 0.0 0
M  V30 9 C 2.6673 6.6301 0.0 0 CFG=1
M  V30 10 C 4.0011 8.9401 0.0 0
M  V30 11 C 4.3213 2.8138 0.0 0
M  V30 12 C 2.6673 5.0901 0.0 0
M  V30 13 C 5.8529 2.6527 0.0 0
M  V30 14 C 1.3337 7.4001 0.0 0
M  V30 15 C 2.6673 9.7101 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 6.4792 1.2459 0.0 0
M  V30 18 N 1.3337 8.9401 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5741 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 8.0021 6.6301 0.0 0
M  V30 23 C 6.6684 8.9401 0.0 0
M  V30 24 C 9.3359 7.4001 0.0 0
M  V30 25 C 8.0021 9.7101 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 27 O 10.8005 6.9242 0.0 0
M  V30 28 O 10.8005 9.4160 0.0 0
M  V30 29 C 11.7057 8.1701 0.0 0
M  V30 30 H 1.3337 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 21 CFG=3
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 1 9 30 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 2 11 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 19 20
M  V30 26 1 21 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 24 27
M  V30 32 2 25 26
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 171489-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171596-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15756821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 350493-08-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, ionic liquid used (solvent)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved synthesis of tadalafil using dimethyl carbonate and ionic
liquids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Earle, Martyn J.; Noe, Marco; Perosa, Alvise; Seddon, Kenneth R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(3), 1204-1211

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzoyl chloride
C7H4ClFO
403-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methylbenzamide
C8H8FNO
701-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 F 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 701-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-11464496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quantitative insights into energy contributions of intermolecular
interactions in fluorine and trifluoromethyl substituted isomeric
N-phenylacetamides and N-methylbenzamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Panini, Piyush; Chopra, Deepak
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM CrystEngComm (2013), 15(18), 3711-3733

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxybenzoic acid
C7H6O3
99-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 O 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxy-N-methylbenzamide
C8H9NO2
15788-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15788-97-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11368152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (i) 3-Hydroxy-N-methylbenzamide A mixture of 3-hydroxybenzoic acid (1.3
g, 9.4 mmol) and a ethanolic methylamine solution (33 %, 1.5 ml, 12.1
mmol) were stirred at 60 °C for 48 h, then the solvent was evaporated in
vacuo, and the residue redissolved in a small volume of ethanol. The
product precipitated from the solution by the addition of ethyl acetate.
The precipitate was collected by filtration and dried to give the
subtitle compound. Yield 1.3 g, 91 %. 1H-NMR (400MHz, DMSO-d6): δ 7.32
(m, 1H), 7.29 (d, 1H, J= 7.6), 7.09 (t, 1H, J= 7.6), 6.73 (dm, 1H, J=
7.(5), 2.37 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of new piperidinyl derivatives such as
1-phenyl-4-piperidino-1-butanones as modulators of chemokine receptor
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gustafsson, Joergen; Hossain, Nafizal; Nilsson, Stinabritt
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003018566 A1 2003-03-06

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxybenzoic acid
C7H6O3
99-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 O 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxy-N-methylbenzamide
C8H9NO2
15788-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15788-97-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9866817
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of new substituted 4-(4-piperidinyl)morpholines as modulators
of chemokine receptor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gustafsson, Joergen; Hossain, Nafizal; Nilsson, Stinabritt
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003018576 A1 2003-03-06

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloropyrimidine
C4H2Cl2N2
1193-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.0800 0.0 0
M  V30 2 Cl 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 1.3338 0.7700 0.0 0
M  V30 7 N 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methylpyrimidin-4-amine
C5H6ClN3
65766-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 N 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 N 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1193-21-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65766-32-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6602999
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Integrating docking scores, interaction profiles and molecular
descriptors to improve the accuracy of molecular docking: Toward the
discovery of novel Akt1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhan, Wenhu; Li, Daqiang; Che, Jinxin; Zhang, Liangren; Yang, Bo; Hu,
Yongzhou; Liu, Tao; Dong, Xiaowu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2014), 7511-20

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Diethyl-4-fluoro-3-nitrobenzamide
C11H13FN2O3
474018-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 8.0023 3.8501 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 F 1.3337 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 4.0012 4.6201 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Diethyl-4-(methylamino)-3-nitrobenzamide
C12H17N3O3
474019-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 C 8.0022 2.3100 0.0 0
M  V30 6 C 10.6695 3.8500 0.0 0
M  V30 7 C 9.3359 1.5400 0.0 0
M  V30 8 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 9 O 0.0000 3.8500 0.0 0
M  V30 10 O 1.3337 6.1601 0.0 0
M  V30 11 N 1.3337 1.5400 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 5.3348 3.8500 0.0 0
M  V30 14 C 4.0011 4.6201 0.0 0
M  V30 15 C 5.3348 2.3100 0.0 0
M  V30 16 C 2.6673 3.8500 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 18 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 474018-94-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 474019-20-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1478381
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1. N,N-diethyl-4-(methylamino)-3-nitrobenzamide To a mixture of
N,N-diethyl-4-fluoro-3-nitrobenzamide (0.050 g, 0.21 mmol, 1 equiv) and
ethanol (3 mL) were added triethylamine (38 μL, 0.27 mmol, 1.3 equiv) and
a 2M solution of methylamine in THF (125 μL, 0.250 mmol, 1.2 equiv). The
mixture was stirred at 75 °C for 4 hours. Complete consumption of
starting material was observed by TLC. Ethanol was removed under reduced
pressure. The resulting residue was diluted in ethyl acetate. The organic
layer was washed once with a 5% aqueous KHSO4 solution, once with a
saturated aqueous NaHCO3 solution, once with brine and dried over
anhydrous Na2SO4. Ethyl acetate was removed under reduced pressure. The
resulting residue was purified by column chromatography on silica gel
(hexanes/EtOAc, 50:50) to afford
N,N-diethyl-4-(methylamino)-3-nitrobenzamide (0.048 g) in 91% yield,
N,N-diethyl-4-(methylamino)-3-nitrobenzamide, Yield (0.048 g) 91% 1H NMR
(400 MHz, CHLOROFORM-D) δ ppm 1.22 (t, J=7.13 Hz, 6 H) 3.07 (d, J=5.08
Hz, 3 H) 3.30 - 3.57 (m, 4 H) 6.88 (d, J=8.98 Hz, 1 H) 7.60 (ddd, J=8.84,
2.10, 0.78 Hz, 1 H) 8.12 - 8.23 (m, 1 H) 8.29 (d, J=1.95 Hz, 1 H); MS
(ESI) m/z 252.2 (M+H)+, 293.2 (M+CH3CN)+, 503,3 (2M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives, processes for preparing them, pharmaceutical
compositions containing them, and their use as modulators of cannabinoid
receptor 2 (CB2)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Page, Daniel; Yang, Hua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007091950 A1 2007-08-16

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,8-naphthalic anhydride
C12H5BrO3
81-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 Br 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 6.1600 0.0 0
M  V30 12 C 6.6685 3.8500 0.0 0
M  V30 13 C 5.3347 6.1600 0.0 0
M  V30 14 O 1.3336 2.3100 0.0 0
M  V30 15 C 6.6685 2.3100 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 14
M  V30 16 1 11 16
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-1,8-naphthalimide
C13H8BrNO2
4116-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 5.3349 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 Br 8.4700 4.0011 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 N 1.5400 2.6674 0.0 0
M  V30 16 C 6.1600 5.3349 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 15
M  V30 17 1 12 17
M  V30 18 2 13 16
M  V30 19 2 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4116-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-196770
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A simple naphthalimide-based receptor for selective recognition of
fluoride anion
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Misra, Arvind; Shahid, Mohammad; Dwivedi, Pratibha; Srivastava, Priyanka;
Ali, Rashid; Razi, Syed S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2013), (2), 133-145

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluorobenzoyl chloride
C7H4ClFO
393-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methylbenzamide
C8H8FNO
52833-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 F 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 393-52-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52833-63-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-21005152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Base-promoted chemodivergent formation of 1,4-benzoxazepin-5(4H)-ones and
1,3-benzoxazin-4(4H)-ones switched by solvents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Qian; Wang, Yunpeng; Hua, Ruimao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2019), 24(20), 3773pp.

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluorobenzoyl chloride
C7H4ClFO
393-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methylbenzamide
C8H8FNO
52833-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 F 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 393-52-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52833-63-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-7606456
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2.2. Synthesis. Benzamides 3 and 4 were prepared from the corresponding
acid chlorides and methylamine following standard Shotten-Bauman
conditions. Briefly, the chlorides (1 g) were added dropwise to a 40 wt %
aqueous solution of methylamine (20 mL), and the resulting mixtures
allowed to stir at room temperature for 24 h. The solutions were then
acidified to pH ~2 with 12 M HCl and extracted with ethyl acetate (3 x 30
mL). The combined organic extracts were then washed with water (1 x 30
mL) and dried over anhydrous MgSO4. The solvent was then removed under
reduced pressure to yield the final products. N-Methyl-2-fluorobenzamide
(3) as a pale yellow solid, yield 91%. mp: 40-42 °C. 1H NMR (400 MHz,
CDCl3): δ 8.06 (1H, ddd, J = 7.8, 4JHF = 7.8, J = 2.0), 7.43 (1H, dddd, J
= 8.3, J = 7.6, 4JHF = 5.3, J = 2.0), 7.22 (1H, ddd, J = 7.8, J = 7.6, J
= 1.0), 7.12 (1H, ddd, 3JHF = 12.2, J = 8.3, J = 1.0), 6.78 (1H, bs),
3.05 (3H, dd, J = 4.8, 6JHF = 1.1). 13C NMR (100 MHz, CDCl3): δ 164.4
(2JCF = 2.9 Hz), 161.0 (1JCF = 246.6), 133.5 (3JCF = 9.5), 132.4 (3JCF
2.2 Hz), 125.2 (4JCF = 3.6 Hz), 121.4 (2JCF = 11.7 Hz), 116.3 (2JCF =
24.9 Hz), 27.2.
$DTYPE RXN:VAR(1):NOTES
$DATUM Schotten-Baumann conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular Hydrogen Bonding in ortho-Substituted Arylamide Oligomers:
A Computational and Experimental Study of ortho-Fluoro- and
ortho-Chloro-N-methylbenzamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Galan, Jhenny F.; Brown, Jodian; Wildin, Jayme L.; Liu, Zhiwei; Liu,
Dahui; Moyna, Guillermo; Pophristic, Vojislava
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Physical Chemistry B (2009), 113(38), 12809-12815

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
9H-Xanthene-9-acetic acid
C15H12O3
1217-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 5.3900 0.0 0
M  V30 2 C 6.6685 4.6200 0.0 0
M  V30 3 O 8.0021 5.3900 0.0 0
M  V30 4 O 6.6685 3.0800 0.0 0
M  V30 5 C 4.0011 3.0800 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 5.3347 2.3100 0.0 0
M  V30 9 C 2.6674 5.3900 0.0 0
M  V30 10 O 1.3336 3.0800 0.0 0
M  V30 11 C 2.6674 0.7700 0.0 0
M  V30 12 C 5.3347 0.7700 0.0 0
M  V30 13 C 1.3336 4.6200 0.0 0
M  V30 14 C 2.6674 6.9300 0.0 0
M  V30 15 C 4.0011 0.0000 0.0 0
M  V30 16 C 0.0000 5.3900 0.0 0
M  V30 17 C 1.3336 7.7000 0.0 0
M  V30 18 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 13
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-9H-xanthene-9-acetamide
C16H15NO2
524743-89-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 5.3900 0.0 0
M  V30 2 C 6.6684 4.6200 0.0 0
M  V30 3 N 8.0021 5.3900 0.0 0
M  V30 4 O 6.6684 3.0800 0.0 0
M  V30 5 C 9.3358 4.6200 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 2.6674 5.3900 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 2.6674 6.9300 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 O 1.3336 3.0800 0.0 0
M  V30 14 C 0.0000 5.3900 0.0 0
M  V30 15 C 1.3336 7.7000 0.0 0
M  V30 16 C 2.6674 0.7700 0.0 0
M  V30 17 C 5.3347 0.7700 0.0 0
M  V30 18 C 0.0000 6.9300 0.0 0
M  V30 19 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 13
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1217-58-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 524743-89-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12235823
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 103-83-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel non-peptidic β-alanine piperazine amide derivatives
and their optimization to achiral, easily accessible, potent and
selective somatostatin sst1 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Troxler, Thomas; Hurth, Konstanze; Mattes, Henri; Prashad, Mahavir;
Schoeffter, Philippe; Langenegger, Daniel; Enz, Albert; Hoyer, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(5), 1305-1309

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Benzyloxy)-2-(hydroxymethyl)-4-pyrone
C13H12O4
15771-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 C 11.5500 2.6674 0.0 0
M  V30 5 O 12.3200 4.0011 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 7.7000 1.3338 0.0 0
M  V30 8 C 7.7000 4.0011 0.0 0
M  V30 9 C 9.2400 1.3338 0.0 0
M  V30 10 O 9.2400 4.0011 0.0 0
M  V30 11 C 10.0100 2.6674 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 0.7700 5.3349 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 2 3 7
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Hydroxymethyl)-1-methyl-5-(phenylmethoxy)-4(1H)-pyridinone
C14H15NO3
89539-51-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 C 10.0100 5.3349 0.0 0
M  V30 5 C 11.5500 2.6674 0.0 0
M  V30 6 O 12.3200 1.3338 0.0 0
M  V30 7 C 6.9300 2.6674 0.0 0
M  V30 8 C 7.7000 1.3338 0.0 0
M  V30 9 C 7.7000 4.0011 0.0 0
M  V30 10 C 9.2400 1.3338 0.0 0
M  V30 11 N 9.2400 4.0011 0.0 0
M  V30 12 C 10.0100 2.6674 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 2.3100 5.3349 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.7700 5.3349 0.0 0
M  V30 18 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 2 3 8
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15771-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89539-51-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29127426
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Michael addition, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Kojic acid derived hydroxypyridinone-chloroquine hybrids: Synthesis,
crystal structure, antiplasmodial activity and β-haematin inhibition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andayi, Warren Andrew; Egan, Timothy J.; Chibale, Kelly
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2014), 24(15), 3263-3267

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
1694-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0009 0.0 0 VAL=6
M  V30 2 Cl 6.1600 4.0009 0.0 0
M  V30 3 O 4.6200 2.4609 0.0 0
M  V30 4 O 4.6200 5.5409 0.0 0
M  V30 5 N 3.0800 1.3336 0.0 0 VAL=5
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 O 4.6200 1.3336 0.0 0
M  V30 8 C 3.0800 4.0009 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.0000 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenesulfonamide
C7H8N2O4S
23530-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 5.3900 5.3349 0.0 0
M  V30 3 O 5.9536 3.2311 0.0 0
M  V30 4 O 3.2864 4.7711 0.0 0
M  V30 5 C 6.9300 5.3349 0.0 0
M  V30 6 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 7 O 2.3100 5.3349 0.0 0
M  V30 8 O 0.0000 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 1.5400 1.3338 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-92-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23530-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-18982208
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM FD5180, a Novel Protein Kinase Affinity Probe, and the Effect of Bead
Loading on Protein Kinase Identification
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deane, Fiona M.; Lin, Andrew J. S.; Hains, Peter G.; Pilgrim, Sarah L.;
Robinson, Phillip J.; McCluskey, Adam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2017), 2(7), 3828-3838

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluorobenzoyl chloride
C7H4ClFO
1711-07-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 F 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N-methylbenzamide
C8H8FNO
701-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 F 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1711-07-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 701-39-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-9358519
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quantitative insights into energy contributions of intermolecular
interactions in fluorine and trifluoromethyl substituted isomeric
N-phenylacetamides and N-methylbenzamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Panini, Piyush; Chopra, Deepak
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM CrystEngComm (2013), 15(18), 3711-3733

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
2-Fluoro-4-nitrobenzoic acid
C7H4FNO4
403-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methyl-4-nitrobenzamide
C8H7FN2O3
915087-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 4.0011 6.1601 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 403-24-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915087-24-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7739233
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of 91. N-Methyl-2-fluoro-4-nitrobenzamide, 91a. Thionyl
chloride (2.38 g, 20 mmol) was added slowly to a solution of
2-fluoro-4-nitrobenzoic acid (2.97 g, 16 mmol) in DMF (50 mL) cooled at
-5 °C. The mixture was stirred for an additional 1 h at -5 °C.
Methylamine (0.62 g, 20 mmol; freshly distilled from its 40% aqueous
solution) was added to the reaction medium. The second mixture was
stirred for an addi- tional 1 h. Ethyl acetate (300 mL) was added to the
mixture, which was washed with brine (3 x 150 mL). The organic layer was
dried over MgSO4 and concentrated to yield 91a (2.89 g, 14.6 mmol, 91%)
as a yellow solid. N-Methyl-2-fluoro-4-nitrobenzamide, 91a, yield (2.89
g, 14.6 mmol, 91%) 1H NMR (acetone-d6, 400 MHz) δ 3.05 (d, J=4.3Hz, 3H),
6.31 (dd, J=13.5, 2.1Hz, 1H), 6.40 (dd, J= 8.5, 2.1 Hz, 1H), 7.64 (dd, J=
8.6, 8.6 Hz, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Activity Relationship for Thiohydantoin Androgen Receptor
Antagonists for Castration-Resistant Prostate Cancer (CRPC)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Michael E.; Ouk, Samedy; Yoo, Dongwon; Sawyers, Charles L.; Chen,
Charlie; Tran, Chris; Wongvipat, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(7), 2779-2796

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloroquinazoline
C8H4Cl2N2
607-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.3100 0.0000 0.0 0
M  V30 2 Cl 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 N 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-4-quinazolinamine
C9H8ClN3
83260-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3349 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 Cl 5.3900 0.0000 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 N 5.3900 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 607-68-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83260-68-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14481625
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Chloro-N-methylquinazolin-4-amine (5). Methanamine in ethanol (40%,
w/v, 0.24 mL, 2.76 mmol) and DiPEA (357 mg, 2.76 mmol) were added to a
suspension of 2,4-dichloroquinazoline (2) (500 mg, 2.51 mmol) in EtOH (20
mL) and stirred at rt. After 4.5 h the reaction mixture was concentrated
under reduced pressure to a volume of 1 mL. The resulting mixture was
diluted with water (25mL) and extracted with EtOAc. The combined organic
extracts were dried over anhydrous sodium sulfate, filtered and
concentrated under reduced pressure to yield 5. White solid, yield 444
mg, 2.29 mmol, 91%. 1H NMR (250 MHz, CDCl3) δ ppm 7.86-7.61 (m, 3H), 7.44
(m, 1H), 6.11 (br s, 1H), 3.22 (d, J = 4.9, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Structure-Activity Relationships of Highly Potent
5-HT3 Receptor Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Verheij, Mark H. P.; Thompson, Andrew J.; van Muijlwijk-Koezen,
Jacqueline E.; Lummis, Sarah C. R.; Leurs, Rob; de Esch, Iwan J. P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(20), 8603-8614

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl itaconate
C7H10O4
617-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0
M  V30 6 O 1.3337 2.3100 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 O 8.0022 1.5400 0.0 0
M  V30 9 O 6.6684 3.8500 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 9.3359 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-4-methoxycarbonyl-2-pyrrolidone
C7H11NO3
59857-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 O 6.6363 3.2587 0.0 0
M  V30 3 O 5.3026 5.5688 0.0 0
M  V30 4 C 7.9700 4.0287 0.0 0
M  V30 5 O 0.0000 2.9016 0.0 0
M  V30 6 C 1.6751 0.0000 0.0 0
M  V30 7 C 3.9690 3.2587 0.0 0
M  V30 8 C 2.5620 3.8850 0.0 0
M  V30 9 C 3.8079 1.7271 0.0 0
M  V30 10 C 1.5316 2.7406 0.0 0
M  V30 11 N 2.3016 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 5 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 617-52-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59857-86-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22607859
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and elaboration of N-methylpyrrolidone as an acetamide fragment
substitute in bromodomain inhibition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hilton-Proctor, J. P.; Ilyichova, O.; Zheng, Z.; Jennings, I. G.;
Johnstone, R. W.; Shortt, J.; Mountford, S. J.; Scanlon, M. J.; Thompson,
P. E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2019), 27(24), 115157

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-pyridinecarboxaldehyde
C6H4BrNO
31181-90-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 N 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-pyridinemethanamine
C7H9BrN2
915707-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 N 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 31181-90-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915707-70-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35087707
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of methylamine (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryl compounds useful in the treatment of cognitive
disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ward, Simon; Atack, John; Ashall-Kelly, Alexander; Baldwin, Alex; Foley,
David; Jones, Heulyn; Yu, Wai Leung; Brand, Stephen; Natarajan,
Srinivasan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022234271 A1 2022-11-10

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dichloro-1,4-naphthoquinone
C10H4Cl2O2
117-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 Cl 6.9300 2.6674 0.0 0
M  V30 4 Cl 5.3900 0.0000 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3-(methylamino)-1,4-naphthalenedione
C11H8ClNO2
15252-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 6.6685 4.6200 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 Cl 6.6685 1.5400 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117-80-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15252-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-14006656
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antiproliferative, DNA intercalation and redox cycling activities of
dioxonaphtho[2,3-d]imidazolium analogs of YM155: A structure-activity
relationship study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ho, Si-Han Sherman; Sim, Mei-Yi; Yee, Wei-Loong Sherman; Yang, Tianming;
Yuen, Shyi-Peng John; Go, Mei-Lin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2015), 10442-56

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dichloro-1,4-naphthoquinone
C10H4Cl2O2
117-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 Cl 6.9300 2.6674 0.0 0
M  V30 4 Cl 5.3900 0.0000 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3-(methylamino)-1,4-naphthalenedione
C11H8ClNO2
15252-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 6.6685 4.6200 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 Cl 6.6685 1.5400 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117-80-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15252-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-17152789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A simple synthesis of 3,4-dihydrobenzo[f]quinoxalin-6(2H)-one derivatives
substituted in the ring B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Castro-Castillo, Vicente; Suarez-Rozas, Cristian; Simpson, Sebastian;
Barriga-Gonzalez, Andres
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2017),
53(5), 553-559

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dichloro-1,4-naphthoquinone
C10H4Cl2O2
117-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 Cl 6.9300 2.6674 0.0 0
M  V30 4 Cl 5.3900 0.0000 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3-(methylamino)-1,4-naphthalenedione
C11H8ClNO2
15252-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 6.6685 4.6200 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 Cl 6.6685 1.5400 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117-80-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15252-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-8536329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Naphthaquinones as methyltransferase inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luo, Minkui; Sanchez, Glorymar Ibanez; Blum, Gil Joseph; Yang, Li
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015172076 A1 2015-11-12

$RFMT $RIREG SCHEME49 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethylamino)benzaldehyde
C9H11NO
100-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4,5-dimethoxy-α-[(4-methylphenyl)sulfonyl]benzeneacetonitrile
C17H16ClNO4S
1245716-04-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 6.6684 0.0 0
M  V30 2 S 6.9300 6.6684 0.0 0 VAL=6
M  V30 3 C 4.6200 8.0021 0.0 0
M  V30 4 O 6.9300 8.2084 0.0 0
M  V30 5 O 6.9300 5.1284 0.0 0
M  V30 6 N 3.8500 9.3358 0.0 0
M  V30 7 O 0.7700 4.0011 0.0 0
M  V30 8 C 0.0000 5.3347 0.0 0
M  V30 9 Cl 5.3900 1.3336 0.0 0
M  V30 10 O 2.3100 1.3336 0.0 0
M  V30 11 C 3.0800 0.0000 0.0 0
M  V30 12 C 13.0900 6.6684 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 8.4700 6.6684 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 10.7800 8.0021 0.0 0
M  V30 23 C 10.7800 5.3347 0.0 0
M  V30 24 C 11.5500 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 19
M  V30 7 3 3 6
M  V30 8 1 7 8
M  V30 9 1 7 16
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 1 10 18
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-(3-Chloro-4,5-dimethoxyphenyl)-1-methyl-1H-imidazol-5-yl]-N,N-dimethylbe...
C20H22ClN3O2
1245716-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6486 0.1437 0.0 0
M  V30 2 O 0.7700 5.1046 0.0 0
M  V30 3 C 0.0000 3.7710 0.0 0
M  V30 4 Cl 5.3900 7.7721 0.0 0
M  V30 5 O 2.3100 7.7721 0.0 0
M  V30 6 C 0.7700 7.7721 0.0 0
M  V30 7 N 11.0433 6.8541 0.0 0
M  V30 8 C 10.5675 8.3188 0.0 0
M  V30 9 C 12.5498 6.5339 0.0 0
M  V30 10 C 5.3900 2.4374 0.0 0
M  V30 11 C 6.9215 2.2764 0.0 0
M  V30 12 N 4.7637 1.0304 0.0 0
M  V30 13 N 7.2417 0.7700 0.0 0
M  V30 14 C 5.9081 0.0000 0.0 0
M  V30 15 C 4.6200 3.7710 0.0 0
M  V30 16 C 3.0800 3.7710 0.0 0
M  V30 17 C 5.3900 5.1046 0.0 0
M  V30 18 C 2.3100 5.1046 0.0 0
M  V30 19 C 4.6200 6.4384 0.0 0
M  V30 20 C 3.0800 6.4384 0.0 0
M  V30 21 C 7.9521 3.4208 0.0 0
M  V30 22 C 7.4761 4.8855 0.0 0
M  V30 23 C 9.4584 3.1006 0.0 0
M  V30 24 C 8.5067 6.0299 0.0 0
M  V30 25 C 10.4888 4.2450 0.0 0
M  V30 26 C 10.0129 5.7097 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 19
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 26
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 11 21
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-10-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1245716-04-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1245716-11-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-12979072
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
1-Methyl-4-(3'-chloro-4',5'-dimethoxyphenyl)-5-(4''-methoxy-
3''-nitrophenyl)imidazole (7a): Typical Procedure. A mixture of
4-methoxy-3-nitrobenzaldehyde (76 mg, 0.42 mmol) and 33% MeNH2/ethanol
(260 μL, 2.10 mmol) in ethanol (15 mL) was treated with AcOH (150 μL) and
refluxed for 2 h. After the mixture was cooled down to room temperature,
compound 6a (153 mg, 0.42 mmol) dissolved in DME (10 mL) and K2CO3 (500
mg, 3.62 mmol) were added. The reaction mixture was refluxed for 3 h. The
solvent was evaporated and the residue diluted with ethyl acetate, washed
with water and brine, dried over Na2SO4, filtered, and concentrated in
vacuum. The residue was purified by column chromatography (silica gel
60). Yield: 110 mg (0.26 mmol, 62%); yellow oil.
1-Methyl-4-(3'-chloro-4',5'-dimethoxyphenyl)-5-(4''-N,N-dimethylaminophenyl)-imidazole
(7d): Analogously to the synthesis of compound 7a, compound 7d was
prepared from 4-N,N-dimethylaminobenzaldehyde (63 mg, 0.42 mmol), 33%
MeNH2/ethanol (260 μL, 2.10 mmol) and acetic acid (150 μL) in boiling
ethanol (15 mL) giving the imine intermediate, which was treated with
compound 6a (153 mg, 0.42 mmol), dissolved in DME (10 mL), and K2CO3 (500
mg, 3.62 mmol). After workup, the residue was purified by column
chromatography (silica gel 60). Yield: 140 mg (0.38 mmol, 91%); colorless
oil. Rf = 0.67 (ethyl acetate/methanol 95:5); νmax(ATR)/cm-1 2935, 2825,
1612, 1552, 1516, 1485, 1397, 1357, 1316, 1261, 1228, 1187, 1165, 1108,
1047, 1000, 944, 881, 857, 818, 762, 721, 660; 1H NMR (300 MHz, CDCl3) δ
2.96 (6 H, s), 3.39 (3 H, s), 3.59 (3 H, s), 3.76 (3 H, s), 6.72 (2 H, d,
J = 8.9 Hz), 7.00 (1 H, d, J = 1.9 Hz), 7.11 (2 H, d, J = 8.9 Hz), 7.16
(1 H, d, J = 1.9 Hz), 7.46 (1 H, s); 13C NMR (75.5 MHz, CDCl3) δ 31.8,
40.2, 55.5, 60.5, 108.8, 112.3, 116.8, 119.2, 127.7, 129.7, 131.3, 131.6,
135.9, 136.7, 143.2, 150.5, 153.0; m/z (EI) 373 (36) [M+], 371 (100)
[M+], 356 (42), 281 (10), 72 (19), 59 (34).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and
-N-methylimidazoles That Are Cytotoxic against Combretastatin A Resistant
Tumor Cells and Vascular Disrupting in a Cisplatin Resistant Germ Cell
Tumor Model
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schobert, Rainer; Biersack, Bernhard; Dietrich, Andrea; Effenberger,
Katharina; Knauer, Sebastian; Mueller, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(18), 6595-6602

$RFMT $RIREG SCHEME50 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethylamino)benzaldehyde
C9H11NO
100-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-5-[isocyano[(4-methylphenyl)sulfonyl]methyl]-2,3-dimethoxybenzene
C17H16ClNO4S
1257227-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 6.6684 0.0 0
M  V30 2 S 6.9300 6.6684 0.0 0 VAL=6
M  V30 3 N 4.6200 8.0021 0.0 0 CHG=1 VAL=4
M  V30 4 O 6.9300 8.2084 0.0 0
M  V30 5 O 6.9300 5.1284 0.0 0
M  V30 6 C 3.8500 9.3358 0.0 0 CHG=-1
M  V30 7 O 0.7700 4.0011 0.0 0
M  V30 8 C 0.0000 5.3347 0.0 0
M  V30 9 Cl 5.3900 1.3336 0.0 0
M  V30 10 O 2.3100 1.3336 0.0 0
M  V30 11 C 3.0800 0.0000 0.0 0
M  V30 12 C 13.0900 6.6684 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 8.4700 6.6684 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 10.7800 8.0021 0.0 0
M  V30 23 C 10.7800 5.3347 0.0 0
M  V30 24 C 11.5500 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 19
M  V30 7 3 3 6
M  V30 8 1 7 8
M  V30 9 1 7 16
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 1 10 18
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-(3-Chloro-4,5-dimethoxyphenyl)-1-methyl-1H-imidazol-5-yl]-N,N-dimethylbe...
C20H22ClN3O2
1245716-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6486 0.1437 0.0 0
M  V30 2 O 0.7700 5.1046 0.0 0
M  V30 3 C 0.0000 3.7710 0.0 0
M  V30 4 Cl 5.3900 7.7721 0.0 0
M  V30 5 O 2.3100 7.7721 0.0 0
M  V30 6 C 0.7700 7.7721 0.0 0
M  V30 7 N 11.0433 6.8541 0.0 0
M  V30 8 C 10.5675 8.3188 0.0 0
M  V30 9 C 12.5498 6.5339 0.0 0
M  V30 10 C 5.3900 2.4374 0.0 0
M  V30 11 C 6.9215 2.2764 0.0 0
M  V30 12 N 4.7637 1.0304 0.0 0
M  V30 13 N 7.2417 0.7700 0.0 0
M  V30 14 C 5.9081 0.0000 0.0 0
M  V30 15 C 4.6200 3.7710 0.0 0
M  V30 16 C 3.0800 3.7710 0.0 0
M  V30 17 C 5.3900 5.1046 0.0 0
M  V30 18 C 2.3100 5.1046 0.0 0
M  V30 19 C 4.6200 6.4384 0.0 0
M  V30 20 C 3.0800 6.4384 0.0 0
M  V30 21 C 7.9521 3.4208 0.0 0
M  V30 22 C 7.4761 4.8855 0.0 0
M  V30 23 C 9.4584 3.1006 0.0 0
M  V30 24 C 8.5067 6.0299 0.0 0
M  V30 25 C 10.4888 4.2450 0.0 0
M  V30 26 C 10.0129 5.7097 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 19
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 26
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 11 21
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-10-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1257227-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1245716-11-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-15230031
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 3)
1-Methyl-4-(3-chloro-4,5-dimethoxyphenyl)-5-(4-methoxy-3-nitrophenyl)imidazole
5a. A mixture of 4-methoxy-3-nitrobenzaldehyde (76 mg, 0.42 mmol) and 33%
MeNH2/ethanol (260 μL, 2.10 mmol) in ethanol (15 mL) was treated with
acetic acid (150 μL) and refluxed for 2 h. After cooling to room
temperature, compound 4a (153 mg, 0.42 mmol) dissolved in dimethoxyethane
(10 mL) and K2CO3 (500 mg, 3.62 mmol) was added and the reaction mixture
was refluxed for another 3 h. The solvent was evaporated, the residue
diluted with ethyl acetate, washed with water and brine, dried over
Na2SO4 , filtered and concentrated in vacuum. The residue was purified by
column chromatography (silica gel 60). 7)
1-Methyl-4-(3'-chloro-4',5'-dimethoxyphenyl)-5-(4"-N,N-dimethylaminophenyl)-imidazole
5d Analogously to the synthesis of compound 5a, compound 5d was prepared
from 4-N,N-dimethylaminobenzaldehyde (63 mg, 0.42 mmol), 33%
MeNH2/ethanol (260 μL, 2.10 mmol) and acetic acid (150 μL) in boiling
ethanol (15 mL) giving the imine intermediate, which was treated with
compound 4a (153 mg, 0.42 mmol), dissolved in DME (10 mL), and K2CO3 (500
mg, 3.62 mmol). After workup, the residue was purified by column
chromatography (silica gel 60). Yield: 140 mg (0.38 mmol, 91 %);
colorless oil. Rf = 0.67 (ethyl acetate/methanol 95:5); ν max (ATR)/cm-1
2935, 2825, 1612, 1552, 1516, 1485, 1397, 1357, 1316, 1261 , 1228, 1187,
1165, 1108, 1047, 1000, 944, 881 , 857, 818, 762, 721 , 660; 1H NMR (300
MHz, CDCl3) δ 2.96 (6 H, s), 3.39 (3 H, s), 3.59 (3 H, s), 3.76 (3 H, s),
6.72 (2 H, d, J = 8.9 Hz), 7.00 (1 H, d, J = 1.9 Hz), 7.11 (2 H, d, J =
8.9 Hz), 7.16 (1 H, d, J = 1.9 Hz), 7.46 (1 H, s); 13C NMR (75.5 MHz,
CDCl3) δ 31.8, 40.2, 55.5, 60.5, 108.8, 112.3, 116.8, 119.2, 127.7,
129.7, 131.3, 131.6, 135.9, 136.7, 143.2, 150.5, 153.0; m/z (EI) 373 (36)
[M+], 371 (100) [M+], 356 (42), 281 (10), 72 (19), 59 (34).
$DTYPE RXN:VAR(1):NOTES
$DATUM product further converted into (HCl) salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combretastatin analogs for use in the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schobert, Rainer; Biersack, Bernhard; Mueller, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011138409 A1 2011-11-10

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-bromo-1-[(dimethylamino)sulfonyl]-5-nitro-1H-benzimidazole-6-carboxy...
C11H11BrN4O6S
1001242-28-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.0406 4.6245 0.0 0 VAL=6
M  V30 2 N 9.1852 3.5941 0.0 0
M  V30 3 O 9.0712 5.7690 0.0 0
M  V30 4 O 7.0102 3.4801 0.0 0
M  V30 5 C 8.8650 2.0876 0.0 0
M  V30 6 C 10.6497 4.0699 0.0 0
M  V30 7 Br 8.3910 7.9566 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 O 3.0800 1.3338 0.0 0
M  V30 10 O 0.7700 2.6674 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 N 0.7700 5.3347 0.0 0 VAL=5
M  V30 13 O 0.0000 6.6685 0.0 0
M  V30 14 O 0.0000 4.0011 0.0 0
M  V30 15 N 6.8963 5.6549 0.0 0
M  V30 16 C 5.3900 5.3347 0.0 0
M  V30 17 C 7.0572 7.1866 0.0 0
M  V30 18 C 4.6200 6.6685 0.0 0
M  V30 19 C 4.6200 4.0011 0.0 0
M  V30 20 N 5.6504 7.8129 0.0 0
M  V30 21 C 3.0800 6.6685 0.0 0
M  V30 22 C 3.0800 4.0011 0.0 0
M  V30 23 C 2.3100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 15
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 17
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 22
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 2 12 14
M  V30 14 1 12 23
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 2 17 20
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[(dimethylamino)sulfonyl]-2-(methylamino)-5-nitro-1H-benzimidazole-6...
C12H15N5O6S
1199810-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.8704 7.9855 0.0 0 VAL=6
M  V30 2 N 6.5501 9.4918 0.0 0
M  V30 3 O 8.3767 8.3057 0.0 0
M  V30 4 O 5.3640 7.6652 0.0 0
M  V30 5 C 5.0855 9.9677 0.0 0
M  V30 6 C 7.6946 10.5222 0.0 0
M  V30 7 N 9.9310 6.6228 0.0 0
M  V30 8 C 11.2648 5.8528 0.0 0
M  V30 9 C 2.3100 4.0009 0.0 0
M  V30 10 O 1.5400 5.3347 0.0 0
M  V30 11 O 1.5400 2.6673 0.0 0
M  V30 12 C 0.0000 5.3347 0.0 0
M  V30 13 N 3.8500 1.3336 0.0 0 VAL=5
M  V30 14 O 4.6200 0.0000 0.0 0
M  V30 15 O 2.3100 1.3336 0.0 0
M  V30 16 C 6.1600 5.3347 0.0 0
M  V30 17 N 7.1906 6.4791 0.0 0
M  V30 18 C 6.9300 4.0009 0.0 0
M  V30 19 C 4.6200 5.3347 0.0 0
M  V30 20 C 8.5974 5.8528 0.0 0
M  V30 21 C 6.1600 2.6673 0.0 0
M  V30 22 N 8.4364 4.3212 0.0 0
M  V30 23 C 3.8500 4.0009 0.0 0
M  V30 24 C 4.6200 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 8
M  V30 8 1 7 20
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 23
M  V30 12 1 10 12
M  V30 13 2 13 14
M  V30 14 2 13 15
M  V30 15 1 13 24
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 2 18 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 2 20 22
M  V30 24 1 21 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1001242-28-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1199810-54-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9906546
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM High-Affinity Inhibitors of tRNA-Guanine Transglycosylase Replacing the
Function of a Structural Water Cluster
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kohler, Philipp C.; Ritschel, Tina; Schweizer, W. Bernd; Klebe, Gerhard;
Diederich, Francois
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2009), 15(41), 10809-10817,
S10809/1-S10809/18

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-iodobenzaldehyde
C7H4ClIO
1001334-22-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 I 0.0000 4.0011 0.0 0
M  V30 4 Cl 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-iodo-N-methylbenzenemethanamine
C8H9ClIN
1697850-12-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 I 3.0800 0.0000 0.0 0
M  V30 5 Cl 0.0000 5.3349 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1001334-22-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1697850-12-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-21105390
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
1-(2-azaspiro[3.3]heptan-6-yl)-5,6-dihydro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine
derivatives as V1a receptor antagonists for treating neuropsychological
disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jones, Robert M.; Urbano, Mariangela; Brandt, Gary; Hardick, David;
Knight, Chris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018226769 A1 2018-12-13

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-2-(2-methylpropoxy)benzaldehyde
C12H16O3
100256-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 2.6674 0.0 0
M  V30 2 C 2.3100 2.6674 0.0 0
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 C 0.0000 1.3338 0.0 0
M  V30 5 C 2.3100 0.0000 0.0 0
M  V30 6 C 2.3100 5.3347 0.0 0
M  V30 7 O 1.5400 6.6685 0.0 0
M  V30 8 O 6.9300 2.6674 0.0 0
M  V30 9 C 8.4700 2.6674 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 3.8500 5.3347 0.0 0
M  V30 12 C 6.1600 4.0011 0.0 0
M  V30 13 C 4.6200 6.6685 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 6.1600 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 11
M  V30 8 1 8 9
M  V30 9 1 8 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methyl-2-(2-methylpropoxy)benzenemethanamine
C13H21NO2
894851-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 N 8.0023 5.3901 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0
M  V30 9 O 1.3337 4.6201 0.0 0
M  V30 10 C 0.0000 5.3901 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 5.3901 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 5.3348 6.9302 0.0 0
M  V30 15 C 2.6675 6.9302 0.0 0
M  V30 16 C 4.0012 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 13
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100256-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894851-37-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13904637
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) (2-Isobutoxy-3-methoxybenzyl)methylamine [1293] A solution of
methylamine (64 mL of a 2.0 M solution in MeOH, 128 mmol) was added to
2-isobutoxy-3-methoxybenzaldehyde (2.45 g, 11.9 mmol) and the solution
was stirred for 18 h. The solution was concentrated under reduced
pressure. The resulting clear oil was dissolved in EtOH (64 mL) and
treated with NaBH 4 (0.616 g, 16.3 mmol). After stirring for 7 h, the
mixture was concentrated under reduced pressure and then dissolved in 1 N
NaOH (57 mL). The mixture was extracted with Et2O (3×75 mL). The combined
organics were washed with brine (2×100 mL), dried (Na2SO4) and
concentrated to yield the title compound (2.43 g, 91%) as a light yellow
oil. 1H NMR (300 MHz, DMSO-d6) δ 7.01-6.88 (m, 3H), 3.76 (s, 3H), 3.63
(t, J=6.4 Hz, 3H), 2.25 (s, 3H), 2.00-1.93 (m, 1H), 1.84 (br s, 1H), 0.98
(d, J=6.6 Hz, 6H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-2-(2-methylpropoxy)benzaldehyde
C12H16O3
100256-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 2.6674 0.0 0
M  V30 2 C 2.3100 2.6674 0.0 0
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 C 0.0000 1.3338 0.0 0
M  V30 5 C 2.3100 0.0000 0.0 0
M  V30 6 C 2.3100 5.3347 0.0 0
M  V30 7 O 1.5400 6.6685 0.0 0
M  V30 8 O 6.9300 2.6674 0.0 0
M  V30 9 C 8.4700 2.6674 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 3.8500 5.3347 0.0 0
M  V30 12 C 6.1600 4.0011 0.0 0
M  V30 13 C 4.6200 6.6685 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 6.1600 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 11
M  V30 8 1 8 9
M  V30 9 1 8 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methyl-2-(2-methylpropoxy)benzenemethanamine
C13H21NO2
894851-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 N 8.0023 5.3901 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0
M  V30 9 O 1.3337 4.6201 0.0 0
M  V30 10 C 0.0000 5.3901 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 5.3901 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 5.3348 6.9302 0.0 0
M  V30 15 C 2.6675 6.9302 0.0 0
M  V30 16 C 4.0012 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 13
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100256-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894851-37-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7139990
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) (2-Isobutoxy-3-methoxybenzyl)methylamine A solution of methylamine (64
mL of a 2.0 M solution in MeOH, 128 mmol) was added to
2-isobutoxy-3-methoxybenzaldehyde (2.45 g, 11.9 mmol) and the solution
was stirred for 18 h. The solution was concentrated under reduced
pressure. The resulting clear oil was dissolved in EtOH (64 mL) and
treated with NaBH4 (0.616 g, 16.3 mmol). After stirring for 7 h, the
mixture was concentrated under reduced pressure and then dissolved in 1 N
NaOH (57 mL). The mixture was extracted with Et2O (3×75 mL). The combined
organics were washed with brine (2×100 mL), dried (Na2SO4) and
concentrated to yield the title compound (2.43 g, 91%) as a light yellow
oil: 1H NMR (300 MHz, DMSO-d6 ) δ 7.01-6.88 (m, 3H), 3.76 (s, 3H), 3.63
(t, J = 6.4 Hz, 3H), 2.25 (s, 3H), 2.00-1.93 (m, 1H), 1.84 (br s, 1H),
0.98 (d, J = 6.6 Hz, 6H). C13H21NO2 Exact Mass: 223.16.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl acrylamide compounds as FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manning, David Douglas; Decornez, Helene Yvonne; Surman, Matthew David;
Martin, Fernando J. L.; Ramnauth, Jailall; Toro, Andras; Berman, Judd M.;
Sampson, Peter; Pauls, Henry; Sargent, Bruce Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2568914 A1 2005-12-04

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Benzofurancarboxaldehyde
C9H6O2
10035-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 C 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-benzofuranmethanamine
C10H11NO
389845-58-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 C 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 O 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10035-16-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 389845-58-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14364238
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 336 Preparation of
(E)-N-(benzofuran-5-ylmethyl)-N-methyl-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
a) benzofuran-5-yl-N-methylmethanamine [1456] Benzofuran-5-carbaldehyde
(315 mg, 2.16 mmol) was dissolved in anhydrous methanol (10 mL).
Methylamine (0.86 mL of 33% solution in ethanol, 6.91 mmol) was added and
the reaction was stirred for 3 h. The solution was concentrated to a
brown oil and then dissolved in anhydrous methanol (10 mL). Sodium
borohydride (83.2 mg, 2.20 mmol) was added and the mixture was stirred
overnight at room temperature. Water (5 mL) was added and the solution
was concentrated. Sodium hydroxide (10 mL, 1N) was added and the aqueous
layer was extracted with ethyl acetate (3×20 mL). Combined organic layers
were dried over MgSO4, filtered and concentrated to afford
benzofuran-5-yl-N-methylmethanamine (316 mg, 91%) as a light brown oil.
1H NMR (400 MHz, DMSO-d6) δ 7.93 (s, 1H), 7.56 (s, 1H), 7.50 (d, J=8.4
Hz, 1H), 7.25 (d, J=8.4 Hz, 1H), 6.90 (s, 1H), 3.70 (s, 2H), 3.17 (s,
3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Benzofurancarboxaldehyde
C9H6O2
10035-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 C 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-benzofuranmethanamine
C10H11NO
389845-58-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 C 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 O 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10035-16-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 389845-58-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9922731
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) benzofuran-5-yl-N-methylmethanamine Benzofuran-5-carbaldehyde (315 mg,
2.16 mmol) was dissolved in anhydrous methanol (10 mL). Methylamine (0.86
mL of 33% solution in ethanol, 6.91 mmol) was added and the reaction was
stirred for 3 h. The solution was concentrated to a brown oil and then
dissolved in anhydrous methanol (10 mL). Sodium borohydride (83.2 mg,
2.20 mmol) was added and the mixture was stirred overnight at room
temperature. Water (5 mL) was added and the solution was concentrated.
Sodium hydroxide (10 mL, 1N) was added and the aqueous layer was
extracted with ethyl acetate (3×20 mL). Combined organic layers were
dried over MgSO4, filtered and concentrated to afford
benzofuran-5-yl-N-methylmethanamine (316 mg, 91%) as a light brown oil:
1H NMR (400 MHz, DMSO-d 6) δ 7.93 (s, 1H), 7.56 (s, 1H), 7.50 (d, J = 8.4
Hz, 1H), 7.25 (d, J = 8.4 Hz, 1H), 6.90 (s, 1H), 3.70 (s, 2H), 3.17 (s,
3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl acrylamide compounds as FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manning, David Douglas; Decornez, Helene Yvonne; Surman, Matthew David;
Martin, Fernando J. L.; Ramnauth, Jailall; Toro, Andras; Berman, Judd M.;
Sampson, Peter; Pauls, Henry; Sargent, Bruce Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2568914 A1 2005-12-04

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[2,4-bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]ben...
C25H29N5O4
1009298-75-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.0800 0.0 0
M  V30 2 C 4.0011 10.0100 0.0 0
M  V30 3 C 14.6705 6.9300 0.0 0
M  V30 4 O 16.0041 7.7000 0.0 0
M  V30 5 O 14.6705 5.3900 0.0 0
M  V30 6 C 17.3379 6.9300 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 6.6685 5.3900 0.0 0
M  V30 9 N 4.0011 5.3900 0.0 0
M  V30 10 C 6.6685 6.9300 0.0 0
M  V30 11 C 8.0021 4.6200 0.0 0
M  V30 12 C 4.0011 6.9300 0.0 0
M  V30 13 N 5.3347 7.7000 0.0 0
M  V30 14 N 8.0021 7.7000 0.0 0
M  V30 15 C 9.3358 5.3900 0.0 0
M  V30 16 C 9.3358 6.9300 0.0 0
M  V30 17 N 5.3347 3.0800 0.0 0
M  V30 18 C 4.0011 2.3100 0.0 0 CFG=1
M  V30 19 C 6.6685 2.3100 0.0 0
M  V30 20 C 4.0011 0.7700 0.0 0
M  V30 21 C 6.6685 0.7700 0.0 0
M  V30 22 O 5.3347 0.0000 0.0 0
M  V30 23 N 2.6674 7.7000 0.0 0
M  V30 24 C 2.6674 9.2400 0.0 0 CFG=1
M  V30 25 C 1.3338 6.9300 0.0 0
M  V30 26 C 1.3338 10.0100 0.0 0
M  V30 27 C 0.0000 7.7000 0.0 0
M  V30 28 O 0.0000 9.2400 0.0 0
M  V30 29 C 10.6694 7.7000 0.0 0
M  V30 30 C 12.0032 6.9300 0.0 0
M  V30 31 C 10.6694 9.2400 0.0 0
M  V30 32 C 13.3369 7.7000 0.0 0
M  V30 33 C 12.0032 10.0100 0.0 0
M  V30 34 C 13.3369 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 18 1 CFG=3
M  V30 2 1 24 2 CFG=3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 32
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 2 12 13
M  V30 17 1 12 23
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 1 16 29
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 18 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
AZD 2014
C25H30N6O3
1009298-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.0800 0.0 0
M  V30 2 C 4.0011 10.0100 0.0 0
M  V30 3 C 14.6705 6.9300 0.0 0
M  V30 4 N 16.0041 7.7000 0.0 0
M  V30 5 O 14.6705 5.3900 0.0 0
M  V30 6 C 17.3379 6.9300 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 6.6685 5.3900 0.0 0
M  V30 9 N 4.0011 5.3900 0.0 0
M  V30 10 C 6.6685 6.9300 0.0 0
M  V30 11 C 8.0021 4.6200 0.0 0
M  V30 12 C 4.0011 6.9300 0.0 0
M  V30 13 N 5.3347 7.7000 0.0 0
M  V30 14 N 8.0021 7.7000 0.0 0
M  V30 15 C 9.3358 5.3900 0.0 0
M  V30 16 C 9.3358 6.9300 0.0 0
M  V30 17 N 5.3347 3.0800 0.0 0
M  V30 18 C 4.0011 2.3100 0.0 0 CFG=1
M  V30 19 C 6.6685 2.3100 0.0 0
M  V30 20 C 4.0011 0.7700 0.0 0
M  V30 21 C 6.6685 0.7700 0.0 0
M  V30 22 O 5.3347 0.0000 0.0 0
M  V30 23 N 2.6674 7.7000 0.0 0
M  V30 24 C 2.6674 9.2400 0.0 0 CFG=1
M  V30 25 C 1.3338 6.9300 0.0 0
M  V30 26 C 1.3338 10.0100 0.0 0
M  V30 27 C 0.0000 7.7000 0.0 0
M  V30 28 O 0.0000 9.2400 0.0 0
M  V30 29 C 10.6694 7.7000 0.0 0
M  V30 30 C 12.0032 6.9300 0.0 0
M  V30 31 C 10.6694 9.2400 0.0 0
M  V30 32 C 13.3369 7.7000 0.0 0
M  V30 33 C 12.0032 10.0100 0.0 0
M  V30 34 C 13.3369 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 18 1 CFG=3
M  V30 2 1 24 2 CFG=3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 32
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 2 12 13
M  V30 17 1 12 23
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 1 16 29
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 18 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1009298-75-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1009298-59-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20778291
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Practical synthesis of Vistusertib (AZD2014), an ATP competitive mTOR
inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shen, Guobing; Liu, Miaoqing; Lu, Jianjun; Meng, Tao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2019), 60(52), 151333

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
3-[[3′-[(2-Hydroxyethoxy)methyl][1,1′-biphenyl]-4-yl]methyl]-1-oxa-3-azaspiro...
C24H29NO4
1012785-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1590 1.3628 0.0 0
M  V30 2 O 2.0983 0.0000 0.0 0
M  V30 3 C 14.4950 3.6728 0.0 0
M  V30 4 O 15.8286 4.4428 0.0 0
M  V30 5 C 17.1624 3.6728 0.0 0
M  V30 6 C 18.4961 4.4428 0.0 0
M  V30 7 O 19.8298 3.6728 0.0 0
M  V30 8 C 2.1579 3.9845 0.0 0
M  V30 9 C 3.6644 3.6644 0.0 0
M  V30 10 O 1.3879 2.6509 0.0 0
M  V30 11 C 3.0631 5.2304 0.0 0
M  V30 12 C 0.6263 4.1455 0.0 0
M  V30 13 N 3.8253 2.1328 0.0 0
M  V30 14 C 2.4185 1.5063 0.0 0
M  V30 15 C 2.4368 6.6374 0.0 0
M  V30 16 C 0.0000 5.5524 0.0 0
M  V30 17 C 0.9052 6.7983 0.0 0
M  V30 18 C 6.4928 2.1328 0.0 0
M  V30 19 C 6.4928 3.6728 0.0 0
M  V30 20 C 7.8265 1.3628 0.0 0
M  V30 21 C 7.8265 4.4428 0.0 0
M  V30 22 C 9.1601 2.1328 0.0 0
M  V30 23 C 9.1601 3.6728 0.0 0
M  V30 24 C 10.4938 4.4428 0.0 0
M  V30 25 C 11.8276 3.6728 0.0 0
M  V30 26 C 10.4938 5.9829 0.0 0
M  V30 27 C 13.1613 4.4428 0.0 0
M  V30 28 C 11.8276 6.7529 0.0 0
M  V30 29 C 13.1613 5.9829 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 18
M  V30 3 2 2 14
M  V30 4 1 3 4
M  V30 5 1 3 27
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[3′-[[2-(Methylamino)ethoxy]methyl][1,1′-biphenyl]-4-yl]methyl]-1-oxa-3-az...
C25H32N2O3
1012785-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1590 1.3628 0.0 0
M  V30 2 O 2.0981 0.0000 0.0 0
M  V30 3 C 14.4950 3.6728 0.0 0
M  V30 4 O 15.8286 4.4428 0.0 0
M  V30 5 C 17.1624 3.6728 0.0 0
M  V30 6 C 18.4961 4.4428 0.0 0
M  V30 7 N 19.8298 3.6728 0.0 0
M  V30 8 C 21.1635 4.4428 0.0 0
M  V30 9 C 2.1579 3.9845 0.0 0
M  V30 10 C 3.6644 3.6644 0.0 0
M  V30 11 O 1.3879 2.6509 0.0 0
M  V30 12 C 3.0631 5.2304 0.0 0
M  V30 13 C 0.6263 4.1455 0.0 0
M  V30 14 N 3.8253 2.1328 0.0 0
M  V30 15 C 2.4185 1.5063 0.0 0
M  V30 16 C 2.4368 6.6374 0.0 0
M  V30 17 C 0.0000 5.5524 0.0 0
M  V30 18 C 0.9052 6.7983 0.0 0
M  V30 19 C 6.4928 2.1328 0.0 0
M  V30 20 C 6.4928 3.6728 0.0 0
M  V30 21 C 7.8265 1.3628 0.0 0
M  V30 22 C 7.8265 4.4428 0.0 0
M  V30 23 C 9.1601 2.1328 0.0 0
M  V30 24 C 9.1601 3.6728 0.0 0
M  V30 25 C 10.4938 4.4428 0.0 0
M  V30 26 C 11.8276 3.6728 0.0 0
M  V30 27 C 10.4938 5.9829 0.0 0
M  V30 28 C 13.1613 4.4428 0.0 0
M  V30 29 C 11.8276 6.7529 0.0 0
M  V30 30 C 13.1613 5.9829 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 19
M  V30 3 2 2 15
M  V30 4 1 3 4
M  V30 5 1 3 28
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 24 25
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1012785-36-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012785-35-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-9133585
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure: Example 11.1:
3-[4'-(2-Dimethylamino-ethoxymethyl)-biphenyl-4-ylmethyl]-1-oxa-3-aza-spiro[4.5]decan-2-one.
3-[4'-(2-Hydroxy-ethoxymethyl)-biphenyl-4-ylmethyl]-1-oxa-3-aza-spiro[4.5]decan-2-one
(85 mg, 0.215 mmol) was mixed with triethylamine (0.09 mL, 0.644 mmol) in
DCM (3 mL). The mixture was cooled in ice-water bath. Methane
sulfonylchloride (3.3 uL, 0.49mmol) was added and the reaction mixture
was allowed to warm to room temperature. The stirring was continued for
further 2 hours. The reaction mixture was quenched with saturate NaHCO3
aqueous solution (3 mL). The aqueous phase was extracted with DCM (3 × 3
mL). The combined organic phase was dried over sodium sulfate and
concentrated to give a brown oil which was mixed with dimethyl amine (4
mL, 6.44 mmol) in a screw cap vial and heated at 60-70°C for 3.5 hours.
The reaction mixture was concentrated, redissolved in DCM (5 mL) and
stirred with saturated NaHCO3 aqueous solution (3 mL). The aqueous phase
was extracted with DCM (3 × 4 mL). The combined organic phases were dried
over sodium sulfate and concentrated to give a pale brown oil, which was
purified on silica gel eluting with DCM containing 1-2.5% 2M ammonia in
methanol.
3-[3'-(2-Methylamino-ethoxymethyl)-biphenyl-4-ylmethyl]-1-oxa-3-aza-spiro[4.5]decan-2-one.
Colorless oil, 56mg, 91.4%. 1H NMR (300 MHz, CDCl3): δ (ppm) = 7.59 (d,
3H), 7.56 (d, 1H), 7.42 (t, 1H), 7.32 (d, 3H), 4.69 (s, 2H), 4.58 (s,
2H), 3.63 (t, 2H), 3.13 (s, 2H), 2.79 (br, 2H), 2.44 (s, 3H), 1.76 (m,
4H), 1.48 (m, 7H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of spiro-oxazolidinone compounds and their use as
metabotropic glutamate receptor potentiators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Isaac, Methvin; Slassi, Abdelmalik; Egle, Ian; Clayton, Joshua; Joseph,
Babu; Ma, Fupeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008032191 A2 2008-03-20

$RFMT $RIREG SCHEME57 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4,5-difluoro-2-nitro-, methyl ester
C8H5F2NO4
1015433-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 6.9300 5.3347 0.0 0
M  V30 3 O 6.9300 2.6674 0.0 0
M  V30 4 C 8.4700 5.3347 0.0 0
M  V30 5 N 4.6200 1.3338 0.0 0 VAL=5
M  V30 6 O 6.1600 1.3338 0.0 0
M  V30 7 O 3.8500 0.0000 0.0 0
M  V30 8 F 1.5400 6.6685 0.0 0
M  V30 9 F 0.0000 4.0011 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 3.8500 2.6674 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 8 14
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[[(1,1-dimethylethoxy)carbonyl]methylamino]-4-fluoro-2-nitrobenzoate
C14H17FN2O6
1015435-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 O 5.3347 1.5400 0.0 0
M  V30 3 O 2.6673 1.5400 0.0 0
M  V30 4 C 5.3347 0.0000 0.0 0
M  V30 5 N 1.3336 3.8500 0.0 0 VAL=5
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 O 1.3336 2.3100 0.0 0
M  V30 8 N 6.6684 6.9300 0.0 0
M  V30 9 C 8.0020 6.1600 0.0 0
M  V30 10 C 6.6684 8.4700 0.0 0
M  V30 11 O 9.3358 6.9300 0.0 0
M  V30 12 O 8.0020 4.6200 0.0 0
M  V30 13 C 10.6694 6.1600 0.0 0
M  V30 14 C 9.8994 4.8264 0.0 0
M  V30 15 C 12.0031 5.3900 0.0 0
M  V30 16 C 11.4394 7.4936 0.0 0
M  V30 17 F 4.0011 8.4700 0.0 0
M  V30 18 C 4.0011 3.8500 0.0 0
M  V30 19 C 2.6673 4.6200 0.0 0
M  V30 20 C 5.3347 4.6200 0.0 0
M  V30 21 C 2.6673 6.1600 0.0 0
M  V30 22 C 5.3347 6.1600 0.0 0
M  V30 23 C 4.0011 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 22
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 17 23
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1015433-96-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1015435-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19644
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: To a solution of 10a in acetonitrile (20 mL), was added t-butyl
pyrocarbonate (3.3 g, 15 mmol) and N,N-dimethylaminopyridine (0.68 g, 5.6
mmol). The mixture was stirred for a few minutes, diluted with water and
extracted twice with DCM. The combined organic layer was dried over
magnesium sulfate, filtered, and concentrated to afford carbamate, 10b as
thick yellow syrup. (4.2 g, 91% for two steps). 10b, yield (4.2 g, 91%)
(DMSO, 400 MHz): ô 8.17 (d, 1H), 7.96 (d, 1H), 3.83 (s, 3H), 3.17 (s,
3H), 1.36 (s, 9H).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2,4-quinazolinedione and 1,3-benzoxazin-4-one derivatives
and their related analogs as platelet ADP receptor inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Scarborough, Robert M.; Bauer, Shawn M.; Pandey, Anjali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008036843 A2 2008-03-27

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2,4-dichloroquinazoline
C8H3BrCl2N2
102393-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.8500 0.0000 0.0 0
M  V30 2 Cl 8.4700 2.6674 0.0 0
M  V30 3 Br 0.0000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 N 6.1600 4.0011 0.0 0
M  V30 7 C 3.8500 5.3349 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 6.9300 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 N 6.1600 1.3338 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 13
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-chloro-N-methyl-4-quinazolinamine
C9H7BrClN3
1600320-04-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 1.3338 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 Br 0.0000 5.3347 0.0 0
M  V30 4 Cl 8.4700 4.0011 0.0 0
M  V30 5 C 3.8500 4.0011 0.0 0
M  V30 6 C 4.6200 5.3347 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 6.1600 5.3347 0.0 0
M  V30 10 C 3.8500 6.6685 0.0 0
M  V30 11 N 6.1600 2.6674 0.0 0
M  V30 12 C 1.5400 5.3347 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 12
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 102393-82-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1600320-04-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20834439
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazolinediamine derivatives for use as antibiotics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manetsch, Roman; Van Horn, Kurt S.; Burda, Whittney; Shaw, Lindsey N.;
Fleeman, Renee; Barber, Megan; Flanigan, David Lawrence
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US10323007 B1 2019-06-18

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2,4-dichloroquinazoline
C8H3BrCl2N2
102393-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.8500 0.0000 0.0 0
M  V30 2 Cl 8.4700 2.6674 0.0 0
M  V30 3 Br 0.0000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 N 6.1600 4.0011 0.0 0
M  V30 7 C 3.8500 5.3349 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 6.9300 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 N 6.1600 1.3338 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 13
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-chloro-N-methyl-4-quinazolinamine
C9H7BrClN3
1600320-04-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 1.3338 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 Br 0.0000 5.3347 0.0 0
M  V30 4 Cl 8.4700 4.0011 0.0 0
M  V30 5 C 3.8500 4.0011 0.0 0
M  V30 6 C 4.6200 5.3347 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 6.1600 5.3347 0.0 0
M  V30 10 C 3.8500 6.6685 0.0 0
M  V30 11 N 6.1600 2.6674 0.0 0
M  V30 12 C 1.5400 5.3347 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 12
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 102393-82-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1600320-04-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17729928
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Characterizing the antimicrobial activity of N2,N4-disubstituted
quinazoline-2,4-diamines toward multidrug-resistant Acinetobacter
baumannii
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fleeman, Renee; Van Horn, Kurt S.; Barber, Megan M.; Burda, Whittney N.;
Flanigan, David L.; Manetsch, Roman; Shaw, Lindsey N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Antimicrobial Agents and Chemotherapy (2017), 61(6), e00059/1-e00059/11

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-(6-Bromo-2-pyridinyl)-N6-[6-[(6-bromo-2-pyridinyl)methylamino]-2-pyridinyl...
C23H21Br2N7
1032745-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6694 1.5400 0.0 0
M  V30 2 C 10.6694 0.0000 0.0 0
M  V30 3 N 5.3347 1.5400 0.0 0
M  V30 4 C 5.3347 0.0000 0.0 0
M  V30 5 N 16.0041 1.5400 0.0 0
M  V30 6 C 16.0041 0.0000 0.0 0
M  V30 7 Br 0.0000 1.5400 0.0 0
M  V30 8 Br 21.3389 1.5400 0.0 0
M  V30 9 C 9.3358 2.3100 0.0 0
M  V30 10 N 8.0020 1.5400 0.0 0
M  V30 11 C 9.3358 3.8500 0.0 0
M  V30 12 C 6.6684 2.3100 0.0 0
M  V30 13 C 8.0020 4.6200 0.0 0
M  V30 14 C 6.6684 3.8500 0.0 0
M  V30 15 C 12.0031 2.3100 0.0 0
M  V30 16 N 13.3369 1.5400 0.0 0
M  V30 17 C 12.0031 3.8500 0.0 0
M  V30 18 C 14.6705 2.3100 0.0 0
M  V30 19 C 13.3369 4.6200 0.0 0
M  V30 20 C 14.6705 3.8500 0.0 0
M  V30 21 C 4.0011 2.3100 0.0 0
M  V30 22 N 2.6673 1.5400 0.0 0
M  V30 23 C 4.0011 3.8500 0.0 0
M  V30 24 C 1.3336 2.3100 0.0 0
M  V30 25 C 2.6673 4.6200 0.0 0
M  V30 26 C 1.3336 3.8500 0.0 0
M  V30 27 C 17.3378 2.3100 0.0 0
M  V30 28 N 18.6716 1.5400 0.0 0
M  V30 29 C 17.3378 3.8500 0.0 0
M  V30 30 C 20.0052 2.3100 0.0 0
M  V30 31 C 18.6716 4.6200 0.0 0
M  V30 32 C 20.0052 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 1 15
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 3 21
M  V30 7 1 5 6
M  V30 8 1 5 18
M  V30 9 1 5 27
M  V30 10 1 7 24
M  V30 11 1 8 30
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 14
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2,N6-Dimethyl-N2-[6-(methylamino)-2-pyridinyl]-N6-[6-[methyl[6-(methylamino)...
C25H29N9
1032745-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0031 1.5400 0.0 0
M  V30 2 C 12.0031 0.0000 0.0 0
M  V30 3 N 6.6684 1.5400 0.0 0
M  V30 4 C 6.6684 0.0000 0.0 0
M  V30 5 N 17.3378 1.5400 0.0 0
M  V30 6 C 17.3378 0.0000 0.0 0
M  V30 7 N 1.3336 1.5400 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 N 22.6725 1.5400 0.0 0
M  V30 10 C 24.0061 2.3100 0.0 0
M  V30 11 C 10.6694 2.3100 0.0 0
M  V30 12 N 9.3356 1.5400 0.0 0
M  V30 13 C 10.6694 3.8500 0.0 0
M  V30 14 C 8.0020 2.3100 0.0 0
M  V30 15 C 9.3356 4.6200 0.0 0
M  V30 16 C 8.0020 3.8500 0.0 0
M  V30 17 C 13.3367 2.3100 0.0 0
M  V30 18 N 14.6705 1.5400 0.0 0
M  V30 19 C 13.3367 3.8500 0.0 0
M  V30 20 C 16.0041 2.3100 0.0 0
M  V30 21 C 14.6705 4.6200 0.0 0
M  V30 22 C 16.0041 3.8500 0.0 0
M  V30 23 C 5.3347 2.3100 0.0 0
M  V30 24 N 4.0009 1.5400 0.0 0
M  V30 25 C 5.3347 3.8500 0.0 0
M  V30 26 C 2.6673 2.3100 0.0 0
M  V30 27 C 4.0009 4.6200 0.0 0
M  V30 28 C 2.6673 3.8500 0.0 0
M  V30 29 C 18.6714 2.3100 0.0 0
M  V30 30 N 20.0052 1.5400 0.0 0
M  V30 31 C 18.6714 3.8500 0.0 0
M  V30 32 C 21.3389 2.3100 0.0 0
M  V30 33 C 20.0052 4.6200 0.0 0
M  V30 34 C 21.3389 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 3 4
M  V30 5 1 3 14
M  V30 6 1 3 23
M  V30 7 1 5 6
M  V30 8 1 5 20
M  V30 9 1 5 29
M  V30 10 1 7 8
M  V30 11 1 7 26
M  V30 12 1 9 10
M  V30 13 1 9 32
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1032745-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1032745-42-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8686608
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: An autoclave equipped with a magnetic stir bar
was charged with 1 (20.58 g, 60 mmol) and 250 mL methylamine alcohol
solution (27-32%). Then it was heated to 160-170 °C for 24 h. After
cooling to room temperature, the solvent was removed under reduced
pressure. The residue was dissolved in CH2Cl2 (400 mL) and washed with
saturated Na2CO3 solution (100 mL) and brine (3×150 mL). The aqueous
phase was re-extracted with dichloromethane (3×150 mL), and the combined
organic phase was dried over anhydrous Na2SO4. After removal of solvent,
the residue was chromatographed on a silica gel column (100-200) with a
mixture of petroleum ether and ethyl acetate as the mobile phase to give
pure 3 (14.47g, 99%) as a white solid. Compound 7 was prepared from 6 by
a similar procedure to the synthesis of 5. Quantities: 6 (4.44 g, 8
mmol), 100 mL methylamine alcohol solution (27-32%). The product was a
light yellow solid (3.30 g, 91%). mp 155-156 °C; IR (KBr) ν 3274, 2886,
1599, 1562, 1530, 1436, 1416, 1405 cm-1; 1H NMR (300 MHz, CDCl3) δ
7.30~7.18 (m, 4H), 6.68 (d, J = 8.0 Hz, 4H), 6.44 (d, J = 7.9 Hz, 2H),
5.91 (d, J = 8.0 Hz, 2H), 4.42 (br.s, 2H), 3.52 (s, 3H), 3.49 (s, 6H),
2.83 (d, J = 4.8 Hz , 6H); 13C NMR (75 MHz, CDCl3) δ 158.9, 157.0, 156.4,
156.3, 138.6, 137.5, 106.0, 105.8, 103.5, 98.3, 35.6, 35.6, 29.2; MS (EI)
m/z (%) 457 (3), 456 (20), 455 [M]+(100), 348 (19), 242 (14); Anal. Calcd
for C25H29N9: C, 65.91; H, 6.42; N, 27.67. Found: C, 65.94; H, 6.53; N,
27.41.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Large Macrocyclic Azacalix[n]pyridines (n = 6 - 9) and Their
Complexation with Fullerenes C60 and C70
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, En-Xuan; Wang, De-Xian; Zheng, Qi-Yu; Wang, Mei-Xiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2008), 10(12), 2565-2568

$RFMT $RIREG SCHEME60 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3,4-Tetrahydro-1,6-dimethyl-8-quinolinecarboxaldehyde
C12H15NO
104524-40-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0
M  V30 2 O 6.9302 5.3348 0.0 0
M  V30 3 C 3.0801 6.6687 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 C 2.3101 2.6675 0.0 0
M  V30 6 C 3.0801 4.0012 0.0 0
M  V30 7 C 3.0801 1.3338 0.0 0
M  V30 8 C 0.7700 2.6675 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 N 2.3101 5.3348 0.0 0
M  V30 11 C 4.6201 1.3338 0.0 0
M  V30 12 C 0.0000 4.0012 0.0 0
M  V30 13 C 5.3901 2.6675 0.0 0
M  V30 14 C 0.7700 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Methoxyethylidene)glycine ethyl ester
C7H13NO3
2135836-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 2.6673 2.3101 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 1.3337 1.5400 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4 CFG=2
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z)-3,5-Dihydro-2,3-dimethyl-5-[(1,2,3,4-tetrahydro-1,6-dimethyl-8-quinoliny...
C17H21N3O
2781061-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 4.0012 6.9302 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 O 8.3956 5.9829 0.0 0
M  V30 5 C 10.6376 3.4930 0.0 0
M  V30 6 C 8.9624 0.5914 0.0 0
M  V30 7 C 4.0012 3.8501 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 1.3338 3.8501 0.0 0
M  V30 11 N 2.6675 6.1601 0.0 0
M  V30 12 C 2.6675 1.5400 0.0 0
M  V30 13 C 1.3338 2.3101 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 1.3338 6.9302 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 17 C 6.6687 3.8501 0.0 0
M  V30 18 C 8.0755 4.4764 0.0 0
M  V30 19 N 6.8296 2.3185 0.0 0
M  V30 20 N 9.1059 3.3320 0.0 0
M  V30 21 C 8.3359 1.9983 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 1 17
M  V30 3 1 2 11
M  V30 4 1 3 12
M  V30 5 2 4 18
M  V30 6 1 5 20
M  V30 7 1 6 21
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104524-40-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2135836-32-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2781061-39-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32390368
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of julolidine derivatives via SnCl4-promoted spirocyclization
of (1-alkyltetrahydroquinolin-8-yl)methylidene-1H-imidazol-5(4H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shirokova, Vasilissa V.; Smirnov, Alexander Yu.; Zaitseva, Elvira R.;
Baleeva, Nadezhda S.; Mikhaylov, Andrey A.; Baranov, Mikhail S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2022),
58(4-5), 255-259

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
(1R)-2,2-Dimethyl-3-methylenecyclopentaneacetic acid
C10H16O2
104672-38-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.1901 0.0 0
M  V30 2 C 6.6363 1.9601 0.0 0
M  V30 3 O 7.9700 1.1901 0.0 0
M  V30 4 O 6.6363 3.5002 0.0 0
M  V30 5 C 1.3161 0.4284 0.0 0
M  V30 6 C 3.3320 0.0000 0.0 0
M  V30 7 C 0.0000 2.3171 0.0 0
M  V30 8 C 3.9690 1.9601 0.0 0 CFG=1
M  V30 9 C 2.5620 1.3337 0.0 0
M  V30 10 C 3.8079 3.4917 0.0 0
M  V30 11 C 1.5316 2.4782 0.0 0
M  V30 12 C 2.3016 3.8119 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 9
M  V30 6 1 6 9
M  V30 7 2 7 11
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R)-N,2,2-Trimethyl-3-methylenecyclopentaneacetamide
C11H19NO
2171510-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.1901 0.0 0
M  V30 2 C 6.6363 1.9602 0.0 0
M  V30 3 N 7.9700 1.1901 0.0 0
M  V30 4 O 6.6363 3.5002 0.0 0
M  V30 5 C 9.3037 1.9602 0.0 0
M  V30 6 C 1.3161 0.4284 0.0 0
M  V30 7 C 3.3320 0.0000 0.0 0
M  V30 8 C 0.0000 2.3171 0.0 0
M  V30 9 C 3.9688 1.9602 0.0 0 CFG=1
M  V30 10 C 2.5620 1.3337 0.0 0
M  V30 11 C 3.8079 3.4917 0.0 0
M  V30 12 C 1.5316 2.4782 0.0 0
M  V30 13 C 2.3016 3.8119 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 10
M  V30 7 1 7 10
M  V30 8 2 8 12
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104672-38-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2171510-11-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20176677
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 59483-84-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and preliminary biological evaluations of (+)-isocampholenic
acid-derived amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Groselj, Uros; Golobic, Amalija; Knez, Damijan; Hrast, Martina; Gobec,
Stanislav; Ricko, Sebastijan; Svete, Jurij
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2016), 20(3), 667-676

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
2-[(3R)-3-[[(1,1-Dimethylethoxy)carbonyl]methylamino]-4-methylpentyl]-4-thiaz...
C16H26N2O4S
1053805-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.2638 4.0012 0.0 0
M  V30 2 C 6.7238 4.0012 0.0 0
M  V30 3 C 5.9538 2.6673 0.0 0 CFG=2
M  V30 4 N 4.4137 2.6673 0.0 0
M  V30 5 C 6.7238 1.3337 0.0 0
M  V30 6 C 3.6437 4.0012 0.0 0
M  V30 7 C 3.6437 1.3337 0.0 0
M  V30 8 C 8.2638 1.3337 0.0 0
M  V30 9 C 5.9538 0.0000 0.0 0
M  V30 10 O 2.1037 4.0012 0.0 0
M  V30 11 O 4.4137 5.3348 0.0 0
M  V30 12 C 1.3337 5.3348 0.0 0
M  V30 13 C 2.6673 6.1048 0.0 0
M  V30 14 C 0.5637 6.6685 0.0 0
M  V30 15 C 0.0000 4.5648 0.0 0
M  V30 16 C 12.2925 7.6286 0.0 0
M  V30 17 O 12.4535 9.1601 0.0 0
M  V30 18 O 13.5384 6.7233 0.0 0
M  V30 19 C 9.0338 5.3348 0.0 0
M  V30 20 N 10.5654 5.4958 0.0 0
M  V30 21 S 8.4075 6.7417 0.0 0
M  V30 22 C 10.8856 7.0022 0.0 0
M  V30 23 C 9.5519 7.7722 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 22
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-methyl-N-[(1R)-2-methyl-1-[2-[4-[(methylamino)carbonyl]-2...
C17H29N3O3S
2761307-75-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.8748 6.1601 0.0 0
M  V30 2 C 5.5411 5.3901 0.0 0
M  V30 3 C 4.2073 6.1601 0.0 0 CFG=2
M  V30 4 N 2.8737 5.3901 0.0 0
M  V30 5 C 4.2073 7.7001 0.0 0
M  V30 6 C 2.8737 3.8501 0.0 0
M  V30 7 C 1.5400 6.1601 0.0 0
M  V30 8 C 2.8737 8.4701 0.0 0
M  V30 9 C 5.5411 8.4701 0.0 0
M  V30 10 O 1.5400 3.0800 0.0 0
M  V30 11 O 4.2073 3.0800 0.0 0
M  V30 12 C 1.5400 1.5400 0.0 0
M  V30 13 C 3.0800 1.5400 0.0 0
M  V30 14 C 1.5400 0.0000 0.0 0
M  V30 15 C 0.0000 1.5400 0.0 0
M  V30 16 C 12.1774 5.0329 0.0 0
M  V30 17 N 13.0826 3.7871 0.0 0
M  V30 18 O 12.8037 6.4399 0.0 0
M  V30 19 C 14.6142 3.9480 0.0 0
M  V30 20 C 8.2085 5.3901 0.0 0
M  V30 21 N 9.6154 6.0164 0.0 0
M  V30 22 S 8.3694 3.8585 0.0 0
M  V30 23 C 10.6459 4.8720 0.0 0
M  V30 24 C 9.8758 3.5384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 23
M  V30 19 1 17 19
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1053805-76-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761307-75-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31556519
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and antitumor activity evaluation of pretubulysin
analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Xiangrong; Fan, Meixia; Qi, Junhui; Yao, Lei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2021), 98(3), 341-351

$RFMT $RIREG SCHEME63 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl acetoacetate
C5H8O3
105-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-Chalcone
C15H12O
614-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 2.6673 3.8501 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 11 C 8.0023 2.3101 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 10.6697 2.3101 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 4 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C21H19NO2
2119616-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 5.3348 0.0 0
M  V30 2 O 1.5400 6.6685 0.0 0
M  V30 3 O 1.5400 4.0012 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 N 3.8501 8.0023 0.0 0
M  V30 6 C 4.6201 9.3360 0.0 0
M  V30 7 C 4.6201 4.0012 0.0 0
M  V30 8 C 3.8501 5.3348 0.0 0
M  V30 9 C 6.1601 4.0012 0.0 0
M  V30 10 C 4.6201 6.6685 0.0 0
M  V30 11 C 6.9302 5.3348 0.0 0
M  V30 12 C 6.1601 6.6685 0.0 0
M  V30 13 C 3.8501 2.6675 0.0 0
M  V30 14 C 4.6201 1.3337 0.0 0
M  V30 15 C 2.3101 2.6675 0.0 0
M  V30 16 C 3.8501 0.0000 0.0 0
M  V30 17 C 1.5400 1.3337 0.0 0
M  V30 18 C 2.3101 0.0000 0.0 0
M  V30 19 C 8.4702 5.3348 0.0 0
M  V30 20 C 9.2402 6.6685 0.0 0
M  V30 21 C 9.2402 4.0012 0.0 0
M  V30 22 C 10.7802 6.6685 0.0 0
M  V30 23 C 10.7802 4.0012 0.0 0
M  V30 24 C 11.5503 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 11 19
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-45-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 614-47-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2119616-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30769624
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 118-75-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3109-63-5
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 55120-75-7
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, no solvent, global time 4 h
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amine-Triggered Highly Facile Oxidative Benzannulation Reaction for the
Synthesis of Anthranilates under Solvent-Free Calcium(II) Catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yaragorla, Srinivasarao; Dada, Ravikrishna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2017), 2(8), 4859-4869

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[Bis(ethylthio)methylene]-5-(2-furanyl)-3-oxo-4-pentenamide
C14H17NO3S2
1055323-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7722 3.8501 0.0 0
M  V30 2 C 6.4384 4.6201 0.0 0
M  V30 3 S 9.1059 4.6201 0.0 0
M  V30 4 S 7.7722 2.3101 0.0 0
M  V30 5 C 5.1048 3.8501 0.0 0
M  V30 6 C 6.4384 6.1601 0.0 0
M  V30 7 C 10.4396 3.8501 0.0 0
M  V30 8 C 9.1059 1.5400 0.0 0
M  V30 9 C 5.1048 2.3101 0.0 0
M  V30 10 O 3.7711 4.6201 0.0 0
M  V30 11 N 7.7722 6.9302 0.0 0
M  V30 12 O 5.1048 6.9302 0.0 0
M  V30 13 C 11.7733 4.6201 0.0 0
M  V30 14 C 9.1059 0.0000 0.0 0
M  V30 15 C 3.7711 1.5400 0.0 0
M  V30 16 C 2.4373 2.3101 0.0 0
M  V30 17 C 1.0304 1.6837 0.0 0
M  V30 18 O 2.2763 3.8416 0.0 0
M  V30 19 C 0.0000 2.8281 0.0 0
M  V30 20 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 2 9 15 CFG=2
M  V30 15 1 15 16
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(2-Furanyl)-1,4,5,6-tetrahydro-1-methyl-2-(methylamino)-4-oxo-3-pyridinecar...
C12H15N3O3
1055323-80-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 1.3338 0.0 0
M  V30 2 N 2.3101 1.3338 0.0 0
M  V30 3 C 3.0801 0.0000 0.0 0
M  V30 4 O 2.3101 6.6687 0.0 0
M  V30 5 C 0.7700 4.0012 0.0 0
M  V30 6 N 0.0000 2.6675 0.0 0
M  V30 7 O 0.0000 5.3348 0.0 0
M  V30 8 C 5.3901 4.0012 0.0 0
M  V30 9 N 4.6201 2.6675 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 3.0801 2.6675 0.0 0
M  V30 12 C 3.0801 5.3348 0.0 0
M  V30 13 C 2.3101 4.0012 0.0 0
M  V30 14 C 6.9302 4.0012 0.0 0
M  V30 15 C 7.8354 2.7553 0.0 0
M  V30 16 O 7.8354 5.2470 0.0 0
M  V30 17 C 9.3000 3.2311 0.0 0
M  V30 18 C 9.3000 4.7712 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 2 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1055323-65-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1055323-80-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-13761481
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
1-Methyl-2-(methylamino)-4-oxo-6-p-tolyl-1,4,5,6-tetrahydropyridine-3-carboxamide
(3a); Typical Procedure To a soln of 1a (323 mg, 1.0 mmol) in DMF (5 mL)
was added aq 30% MeNH2 (0.31 mL, 3.0 mmol) at r.t. The reaction mixture
was stirred for 12 h at r.t. and then poured into brine (50 mL); the
resulting mixture was extracted with CH2Cl2 (3 × 20 mL). The combined
organic phase was washed with H2O (3 × 30 mL), dried (anhyd MgSO4),
filtered and concentrated under reduced pressure. The crude product was
purified by flash chromatography (silica gel, petroleum ether-Et2O, 2:1)
to give 3a
6-(Furan-2-yl)-1-methyl-2-(methylamino)-4-oxo-1,4,5,6-tetrahydropyridine-3-carboxamide
(3g). Yellow solid, yield 91% Mp 162-163 °C. IR (KBr): 1258, 1562, 2968,
3140, 3323 cm-1. 1H NMR (500 MHz, CDCl3): δ = 2.75 (dd, J = 16.5, 5.0 Hz,
1 H), 2.86-2.97 (m, 4 H), 3.12 (s, 3 H), 4.48 (dd, J = 5.5, 5.0 Hz, 1 H),
5.24 (br, 1 H), 6.20 (d, J = 3.0 Hz, 1 H), 6.29 (d, J = 1.5 Hz, 1 H),
7.35 (s, 1 H), 9.73 (br, 1 H), 11.22 (br, 1 H). 13C NMR (125 MHz, CDCl3):
δ = 32.7, 37.7, 40.6, 55.5, 92.0, 108.0, 110.7, 142.8, 151.9, 169.6,
171.9, 188.5. Anal. Calcd for C12H15N3O3: C, 57.82; H, 6.07; N, 16.86.
Found: C, 57.93; H, 6.12; N, 16.72.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [5C + 1C/N/S/Se] annulations of α-alkenoyl α-carbamoyl ketene
dithioacetals: a facile and convenient synthesis of salicylamide,
nicotinamide and thio/selenopyran-3-carboxamide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Dongwei; Xu, Xianxiu; Liu, Qun; Dong, Song
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2008), (12), 1895-1901

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N6-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N2-[(phenylmethoxy)carbonyl]-L-lysine
C29H30N2O6
105751-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 8.0021 0.0 0
M  V30 2 O 6.7708 8.0021 0.0 0
M  V30 3 C 7.5408 6.6684 0.0 0
M  V30 4 N 9.0808 6.6684 0.0 0
M  V30 5 O 6.7708 5.3348 0.0 0
M  V30 6 C 9.8508 5.3348 0.0 0
M  V30 7 C 11.3909 5.3348 0.0 0
M  V30 8 C 12.1609 4.0011 0.0 0
M  V30 9 C 13.7009 4.0011 0.0 0
M  V30 10 C 14.4709 2.6673 0.0 0 CFG=1
M  V30 11 N 16.0109 2.6673 0.0 0
M  V30 12 C 13.7009 1.3337 0.0 0
M  V30 13 C 16.7809 4.0011 0.0 0
M  V30 14 O 14.4709 0.0000 0.0 0
M  V30 15 O 12.1609 1.3337 0.0 0
M  V30 16 O 18.3209 4.0011 0.0 0
M  V30 17 O 16.0109 5.3348 0.0 0
M  V30 18 C 19.0909 5.3348 0.0 0
M  V30 19 C 4.4608 9.3359 0.0 0
M  V30 20 C 2.9293 9.4968 0.0 0
M  V30 21 C 5.0873 10.7427 0.0 0
M  V30 22 C 2.6091 11.0031 0.0 0
M  V30 23 C 1.7849 8.4664 0.0 0
M  V30 24 C 3.9427 11.7731 0.0 0
M  V30 25 C 6.5518 11.2185 0.0 0
M  V30 26 C 1.1444 11.4791 0.0 0
M  V30 27 C 0.3202 8.9422 0.0 0
M  V30 28 C 4.2629 13.2795 0.0 0
M  V30 29 C 6.8720 12.7250 0.0 0
M  V30 30 C 0.0000 10.4485 0.0 0
M  V30 31 C 5.7276 13.7554 0.0 0
M  V30 32 C 20.6309 5.3348 0.0 0
M  V30 33 C 21.4009 6.6684 0.0 0
M  V30 34 C 21.4009 4.0011 0.0 0
M  V30 35 C 22.9409 6.6684 0.0 0
M  V30 36 C 22.9409 4.0011 0.0 0
M  V30 37 C 23.7109 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 16 18
M  V30 19 1 18 32
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 2 21 25
M  V30 26 1 22 24
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 2 24 28
M  V30 30 1 25 29
M  V30 31 1 26 30
M  V30 32 2 27 30
M  V30 33 1 28 31
M  V30 34 2 29 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-5-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-[(methylam...
C30H33N3O5
1472651-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 9.3356 0.0 0
M  V30 2 O 5.8243 8.0020 0.0 0
M  V30 3 C 7.3643 8.0020 0.0 0
M  V30 4 N 8.1343 6.6684 0.0 0
M  V30 5 O 8.1343 9.3356 0.0 0
M  V30 6 C 9.6743 6.6684 0.0 0
M  V30 7 C 10.4443 5.3347 0.0 0
M  V30 8 C 11.9843 5.3347 0.0 0
M  V30 9 C 12.7543 4.0009 0.0 0
M  V30 10 C 14.2943 4.0009 0.0 0 CFG=1
M  V30 11 N 15.0643 5.3347 0.0 0
M  V30 12 C 15.0643 2.6673 0.0 0
M  V30 13 C 16.6043 5.3347 0.0 0
M  V30 14 N 14.2943 1.3336 0.0 0
M  V30 15 O 16.6043 2.6673 0.0 0
M  V30 16 O 17.3743 6.6684 0.0 0
M  V30 17 O 17.3743 4.0009 0.0 0
M  V30 18 C 15.0643 0.0000 0.0 0
M  V30 19 C 18.9143 6.6684 0.0 0
M  V30 20 C 3.5143 9.3356 0.0 0
M  V30 21 C 2.6091 10.5816 0.0 0
M  V30 22 C 2.6091 8.0898 0.0 0
M  V30 23 C 1.1445 10.1056 0.0 0
M  V30 24 C 2.9292 12.0879 0.0 0
M  V30 25 C 1.1445 8.5656 0.0 0
M  V30 26 C 2.9292 6.5835 0.0 0
M  V30 27 C 0.0000 11.1362 0.0 0
M  V30 28 C 1.7849 13.1183 0.0 0
M  V30 29 C 0.0000 7.5352 0.0 0
M  V30 30 C 1.7849 5.5529 0.0 0
M  V30 31 C 0.3202 12.6425 0.0 0
M  V30 32 C 0.3202 6.0289 0.0 0
M  V30 33 C 19.6843 8.0020 0.0 0
M  V30 34 C 18.9143 9.3356 0.0 0
M  V30 35 C 21.2243 8.0020 0.0 0
M  V30 36 C 19.6843 10.6694 0.0 0
M  V30 37 C 21.9943 9.3356 0.0 0
M  V30 38 C 21.2243 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 16 19
M  V30 20 1 19 33
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 2 22 26
M  V30 27 1 23 25
M  V30 28 2 23 27
M  V30 29 1 24 28
M  V30 30 2 25 29
M  V30 31 1 26 30
M  V30 32 1 27 31
M  V30 33 2 28 31
M  V30 34 1 29 32
M  V30 35 2 30 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105751-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1472651-05-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14695932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and structural characterization of the individual
diastereoisomers of a cross-stapled alkene-bridged nisin DE-ring mimic
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Slootweg, Jack C.; Kemmink, Johan; Liskamp, Rob M. J.; Rijkers, Dirk T.
S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2013), 11(43), 7486-7496

$RFMT $RIREG SCHEME66 STEP1
$RXN



  4  1
$MOL
4-Methylaniline
C7H9N
106-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Formylchromone
C10H6O3
17422-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 C 6.6686 1.5400 0.0 0
M  V30 3 O 8.0022 2.3100 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 4.0011 4.6201 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C22H16N2O4
3007812-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.9694 4.9894 0.0 0
M  V30 2 O 7.9108 10.7800 0.0 0
M  V30 3 O 1.9694 10.4106 0.0 0
M  V30 4 C 0.0000 7.7000 0.0 0
M  V30 5 C 5.2435 0.0000 0.0 0
M  V30 6 N 5.2435 6.1600 0.0 0
M  V30 7 C 6.5772 6.9300 0.0 0
M  V30 8 C 3.9098 6.9300 0.0 0
M  V30 9 C 6.5772 8.4700 0.0 0
M  V30 10 O 7.9108 6.1600 0.0 0
M  V30 11 C 3.9098 8.4700 0.0 0
M  V30 12 C 2.4452 6.4541 0.0 0
M  V30 13 C 5.2435 9.2400 0.0 0
M  V30 14 C 7.9108 9.2400 0.0 0
M  V30 15 C 9.2445 6.9300 0.0 0
M  V30 16 C 2.4452 8.9459 0.0 0
M  V30 17 N 1.5400 7.7000 0.0 0
M  V30 18 C 9.2445 8.4700 0.0 0
M  V30 19 C 10.5783 6.1600 0.0 0
M  V30 20 C 10.5783 9.2400 0.0 0
M  V30 21 C 11.9119 6.9300 0.0 0
M  V30 22 C 11.9119 8.4700 0.0 0
M  V30 23 C 5.2435 4.6200 0.0 0
M  V30 24 C 3.9098 3.8500 0.0 0
M  V30 25 C 6.5772 3.8500 0.0 0
M  V30 26 C 3.9098 2.3100 0.0 0
M  V30 27 C 6.5772 2.3100 0.0 0
M  V30 28 C 5.2435 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 14
M  V30 3 2 3 16
M  V30 4 1 4 17
M  V30 5 1 5 28
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 23
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 11 13
M  V30 17 1 11 16
M  V30 18 1 12 17
M  V30 19 1 14 18
M  V30 20 1 15 18
M  V30 21 2 15 19
M  V30 22 1 16 17
M  V30 23 2 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 106-49-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 17422-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3007812-48-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38332503
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convenient Synthesis of Functionalized Tetracyclic
Dihydrochromeno[2,3-b]pyrrolo[3,4-e]pyridine-triones via Four-Component
Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alizadeh, Abdolali; Rostampoor, Azar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2024), 56(2), 267-274

$RFMT $RIREG SCHEME67 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propargyl bromide
C3H3Br
106-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 Br 4.0010 0.7700 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Azidoethyl)-1H-indole
C10H10N4
161957-64-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.9554 0.0 0
M  V30 2 C 7.4148 3.1854 0.0 0
M  V30 3 N 8.7486 3.9554 0.0 0
M  V30 4 N 10.0823 3.1854 0.0 0 CHG=1 VAL=4
M  V30 5 N 11.4160 2.4154 0.0 0 CHG=-1
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 4.5864 1.6538 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 N 3.3405 3.8119 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 4.7475 3.1854 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-(1H-Indol-2-yl)ethyl]-N-methyl-1H-1,2,3-triazole-4-methanamine
C14H17N5
1649448-73-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5772 1.5400 0.0 0
M  V30 2 C 7.3472 2.8737 0.0 0
M  V30 3 C 12.5030 4.5489 0.0 0
M  V30 4 N 13.9098 3.9224 0.0 0
M  V30 5 C 15.1558 4.8276 0.0 0
M  V30 6 C 2.6674 0.7700 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 4.1320 0.2941 0.0 0
M  V30 9 C 1.3338 0.0000 0.0 0
M  V30 10 N 4.1320 2.7859 0.0 0
M  V30 11 C 1.3338 3.0800 0.0 0
M  V30 12 C 5.0372 1.5400 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 N 8.8872 2.8737 0.0 0
M  V30 16 C 9.7924 4.1195 0.0 0
M  V30 17 N 9.7924 1.6278 0.0 0
M  V30 18 C 11.2571 3.6437 0.0 0
M  V30 19 N 11.2571 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-96-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 161957-64-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1649448-73-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7001870
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective (in stage 2), click reaction in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization, and antimicrobial screening of
ethylene-spaced bis-heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Babul Reddy, A.; Hymavathi, R. V.; Narayana Swamy, G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2014), 51(4), 1119-1123

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
5-(5-Methoxy-2-nitrophenyl)-1H-pyrrole-2-carboxylic acid
C12H10N2O5
1072149-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3337 0.0 0 VAL=5
M  V30 2 O 3.8500 0.0000 0.0 0
M  V30 3 O 6.1601 1.3337 0.0 0
M  V30 4 O 1.5400 6.6684 0.0 0
M  V30 5 C 0.0000 6.6684 0.0 0
M  V30 6 C 9.7759 5.6763 0.0 0
M  V30 7 O 11.1827 5.0499 0.0 0
M  V30 8 O 9.6148 7.2079 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 2.6675 0.0 0
M  V30 11 C 3.8500 5.3348 0.0 0
M  V30 12 C 2.3100 2.6675 0.0 0
M  V30 13 C 2.3100 5.3348 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 15 C 6.1601 4.0011 0.0 0
M  V30 16 N 7.0653 5.2470 0.0 0
M  V30 17 C 7.0653 2.7552 0.0 0
M  V30 18 C 8.5298 4.7711 0.0 0
M  V30 19 C 8.5298 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(5-Methoxy-2-nitrophenyl)-N-methyl-1H-pyrrole-2-carboxamide
C13H13N3O4
1072149-56-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3336 0.0 0 VAL=5
M  V30 2 O 3.8500 0.0000 0.0 0
M  V30 3 O 6.1600 1.3336 0.0 0
M  V30 4 O 1.5400 6.6684 0.0 0
M  V30 5 C 0.0000 6.6684 0.0 0
M  V30 6 C 9.7757 5.6763 0.0 0
M  V30 7 N 11.1826 5.0498 0.0 0
M  V30 8 O 9.6147 7.2079 0.0 0
M  V30 9 C 12.4285 5.9551 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 3.8500 2.6674 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 1.5400 4.0011 0.0 0
M  V30 16 C 6.1600 4.0011 0.0 0
M  V30 17 N 7.0652 5.2470 0.0 0
M  V30 18 C 7.0652 2.7552 0.0 0
M  V30 19 C 8.5298 4.7711 0.0 0
M  V30 20 C 8.5298 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 19
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1072149-77-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072149-56-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9598697
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phenylpyrrole derivatives as neural and inducible nitric oxide synthase
(nNOS and iNOS) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lopez Cara, Luisa C.; Camacho, M. Encarnacion; Carrion, M. Dora; Tapias,
Victor; Gallo, Miguel A.; Escames, Germaine; Acuna-Castroviejo, Dario;
Espinosa, Antonio; Entrena, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2009), 44(6), 2655-2666

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl chloroacetate
C6H11ClO2
107-59-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 2.3101 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 0.5638 2.8737 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 2.1038 0.2064 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 O 4.0012 0.0000 0.0 0
M  V30 9 Cl 6.6687 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylglycine 1,1-dimethylethyl ester
C7H15NO2
5616-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 6.6687 1.5400 0.0 0
M  V30 7 C 2.1037 0.2064 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 C 0.5637 2.8737 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107-59-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5616-81-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2507484
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and nucleic acid binding studies of novel pyrrolidinyl PNA
carrying an N-amino-N-methylglycine spacer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vilaivan, Tirayut; Suparpprom, Chaturong; Duanglaor, Preeyanut;
Harnyuttanakorn, Pongchai; Lowe, Gordon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2003), 44(8), 1663-1666

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-3-(bromomethyl)benzonitrile
C8H5Br2N
1086429-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 Br 0.0000 2.3101 0.0 0
M  V30 3 Br 4.0012 4.6201 0.0 0
M  V30 4 C 6.6687 3.0801 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 3 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-3-[(methylamino)methyl]benzonitrile
C9H9BrN2
1454849-50-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 Br 4.0012 4.6201 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 N 0.0000 3.8501 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 3 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1086429-87-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1454849-50-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14642296
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 4: To a solution of compound 250 (11.9 g, 43.3 mmol) in THF (100 mL)
was added a solution of methylamine (2M in THF, 215 mL, 0.43 mol) at -10
°C ~ 0 °C under a nitrogen atmosphere. After the addition, the mixture
was allowed to warm to room temperature and stirred for 2 hours. TLC
(petroleum ether / EtOAc = 5:1) showed the reaction was completed. The
mixture was diluted with water (200 mL), and extracted with EtOAc (200 mL
x 2). The combined organic layers were washed with brine (200 mL), dried
over Na2SO4, and concentrated. Compound 251 (8.9 g, 91%).as a yellow
solid. 1H NMR (400 MHz, CDCl3) δ 7.67-7.65 (d, 1H), 7.58-7.56 (d, 1H),
7.43-7.39 (t, 1H), 3.87 (s, 2H), 2.47 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic derivatives for the treatment of proliferative diseases and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bailey, Simon; Burke, Benjamin Joseph; Collins, Michael Raymond; Cui,
Jingrong Jean; Deal, Judith Gail; Hoffman, Robert Louis; Huang, Qinhua;
Johnson, Ted William; Kania, Robert Steven; Kath, John Charles; Le,
Phuong Thi Quy; McTigue, Michele Ann; Palmer, Cynthia Louise; Richardson,
Paul Francis; Sach, Neal William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013132376 A1 2013-09-12

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Dimethylamino)methylene]-N-(4-methylphenyl)-3-oxobutanamide
C14H18N2O2
1088988-15-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 O 5.3900 1.3338 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 0.0000 5.3349 0.0 0
M  V30 12 C 11.5500 4.0011 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 7.7000 5.3349 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 9.2400 5.3349 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 13
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylamino)methylene]-N-(4-methylphenyl)-3-oxobutanamide
C13H16N2O2
2197964-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 11 C 11.5500 4.0011 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 7.7000 2.6674 0.0 0
M  V30 14 C 7.7000 5.3349 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1088988-15-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2197964-19-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18916609
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Oxidative Cyclization Reactions of α-Acyl Acrylamides: A
Synthetic Route to Substituted Isoxazol-3(2H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Jingwen; Rao, Chitturi Bhujanga; Zhang, Qian; Zhang, Rui; Liang,
Yongjiu; Zhang, Ning; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2018), 50(9), 1875-1882

$RFMT $RIREG SCHEME72 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetophenone
C8H8O
98-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenol
C6H6O
108-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenol, 2-[1-(methylamino)-1-phenylethyl]-
C15H17NO
845674-44-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6200 0.0 0
M  V30 2 N 2.6673 6.1600 0.0 0
M  V30 3 C 1.1273 4.6200 0.0 0
M  V30 4 C 1.3336 6.9300 0.0 0
M  V30 5 O 0.0000 3.0800 0.0 0
M  V30 6 C 2.6673 3.0800 0.0 0
M  V30 7 C 1.3336 2.3100 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 0.7700 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 2.6673 0.0000 0.0 0
M  V30 12 C 4.2073 4.6200 0.0 0
M  V30 13 C 4.9773 3.2864 0.0 0
M  V30 14 C 4.9773 5.9536 0.0 0
M  V30 15 C 6.5173 3.2864 0.0 0
M  V30 16 C 6.5173 5.9536 0.0 0
M  V30 17 C 7.2873 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 1 12
M  V30 5 1 2 4
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-86-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 108-95-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 845674-44-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29154534
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):NOTES
$DATUM reactant assumed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile synthesis of 3,4-dialkyl-3,4-dihydro-2H-1,3-benzoxazin-2-ones
and naphthoxazin-2-ones and their reactions with organolithium and
grignard reagents - preparation of N-[1-(2'-hydroxyphenyl)alkyl]amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cimarelli, Cristina; Palmieri, Gianni; Volpini, Emanuela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canadian Journal of Chemistry (2004), 82(8), 1314-1321

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3′-Dimethyl (2S,3′S,9′aS)-2′,3′,9′,9′a-tetrahydro-5′-oxospiro[pyrrolidine-2...
C16H22N2O5
1096168-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 4.4743 0.0 0
M  V30 2 O 1.3338 5.2442 0.0 0
M  V30 3 O 2.6674 2.9343 0.0 0
M  V30 4 C 0.0000 4.4743 0.0 0
M  V30 5 O 7.8821 5.4423 0.0 0
M  V30 6 C 10.1548 3.7231 0.0 0
M  V30 7 O 11.6453 3.3356 0.0 0
M  V30 8 O 9.7451 5.2074 0.0 0
M  V30 9 C 12.7261 4.4325 0.0 0
M  V30 10 C 5.4079 4.6179 0.0 0 CFG=2
M  V30 11 N 4.0010 5.2442 0.0 0
M  V30 12 C 6.9039 4.2528 0.0 0
M  V30 13 C 6.4383 5.7623 0.0 0
M  V30 14 C 4.1897 3.6758 0.0 0
M  V30 15 C 4.1619 6.7758 0.0 0
M  V30 16 N 7.5513 2.8554 0.0 0
M  V30 17 C 5.6684 7.0959 0.0 0
M  V30 18 C 4.1666 2.1360 0.0 0
M  V30 19 C 6.8625 1.4781 0.0 0 CFG=1
M  V30 20 C 9.0740 2.6260 0.0 0 CFG=2
M  V30 21 C 5.3560 1.1579 0.0 0
M  V30 22 C 7.9595 0.3973 0.0 0
M  V30 23 C 9.3264 1.1068 0.0 0
M  V30 24 H 6.4306 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 20 6 CFG=3
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13 CFG=1
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 1 15 17
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 18 21
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 19 24 CFG=3
M  V30 25 1 20 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (2S,3′S,9′aS)-2′,3′,9′,9′a-tetrahydro-3′-[(methylamino)carbonyl]-5′-ox...
C16H23N3O4
1096168-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 4.4743 0.0 0
M  V30 2 O 1.3338 5.2442 0.0 0
M  V30 3 O 2.6674 2.9343 0.0 0
M  V30 4 C 0.0000 4.4743 0.0 0
M  V30 5 O 7.8821 5.4423 0.0 0
M  V30 6 C 10.1548 3.7231 0.0 0
M  V30 7 N 11.6453 3.3356 0.0 0
M  V30 8 O 9.7451 5.2074 0.0 0
M  V30 9 C 12.7261 4.4325 0.0 0
M  V30 10 C 5.4079 4.6179 0.0 0 CFG=2
M  V30 11 N 4.0010 5.2442 0.0 0
M  V30 12 C 6.9039 4.2528 0.0 0
M  V30 13 C 6.4383 5.7623 0.0 0
M  V30 14 C 4.1897 3.6758 0.0 0
M  V30 15 C 4.1619 6.7758 0.0 0
M  V30 16 N 7.5513 2.8554 0.0 0
M  V30 17 C 5.6684 7.0959 0.0 0
M  V30 18 C 4.1666 2.1360 0.0 0
M  V30 19 C 6.8625 1.4781 0.0 0 CFG=1
M  V30 20 C 9.0740 2.6260 0.0 0 CFG=2
M  V30 21 C 5.3560 1.1579 0.0 0
M  V30 22 C 7.9595 0.3973 0.0 0
M  V30 23 C 9.3264 1.1068 0.0 0
M  V30 24 H 6.4306 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 20 6 CFG=3
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13 CFG=1
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 1 15 17
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 18 21
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 19 24 CFG=3
M  V30 25 1 20 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1096168-50-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1096168-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2640432
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new spirocyclic proline-based lactam as efficient type II' β-turn
inducing peptidomimetic
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lesma, Giordano; Colombo, Alessia; Sacchetti, Alessandro; Silvani,
Alessandra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2008), 49(52), 7423-7425

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-(hydroxymethyl)-4-methoxy-2-pyridinecarboxylate
C9H11NO4
109880-39-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 O 8.0023 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 O 2.6675 0.0000 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 4.0012 5.3901 0.0 0
M  V30 11 N 5.3348 3.0801 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 8
M  V30 8 1 7 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Hydroxymethyl)-4-methoxy-N-methyl-2-pyridinecarboxamide
C9H12N2O3
1000896-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 N 8.0023 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 O 2.6675 0.0000 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 4.0012 5.3901 0.0 0
M  V30 11 N 5.3348 3.0801 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 8
M  V30 8 1 7 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109880-39-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000896-31-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10388564
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-24-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6381-59-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 3-(hydroxymethyl)-N,5-dimethyl-benzamide was
prepared from:-A solution of trimethylaluminium (2M in toluene, 25 ml,
12.5 mmol) was added dropwise at-50°C to a stirred solution of methyl
3-(hydroxymethyl)-5-methyl-benzoate (3.5g, 20 mmol) and methylamine (2.0M
solution in THF, 50 ml, 100 mmol) in dry THF (100ml). The reaction
mixture was stirred for 15 mins at-50°C, then at 20°C for 18 h. The
reaction was cooled to-50°C and quenched with saturated potassium sodium
tartrate solution and stirred for 1 h. The reaction mixture was extracted
with ethyl acetate (2 × 50 ml) and washed with saturated brine solution
(25 ml). The extracts were dried (MgSO4), filtered and evaporated. The
crude product was purified by silica column chromatography, eluting with
a gradient of 0-5% methanol in dichloromethane. The pure fractions were
combined and evaporated to dryness to give
3-(hydroxymethyl)-N,5-dimethyl-benzamide as an oil (3.7g, ∼ 100%).
6-(Hydroxymethyl)-4-methoxy-N-methyl-pyridine-2-carboxamide used as
starting material was prepared following the procedure for
3-(hydroxymethyl)-N,5-dimethyl-benzamide in Example 142, but starting
from methyl 6-(hydroxymethyl)-4-methoxy-pyridine-2-carboxylate(1.5g, 7.6
mmol), trimethylaluminium (2M in toluene, 19 ml, 9.5 mmol) and
methylamine(2.0M solution in THF, 19 ml, 38 mmol). The crude product was
purified by silica column chromatography, eluting with a gradient of 0-5%
methanol in dichloromethane. Pure fractions were combined and evaporated
to give to give the title compound as a white solid (1.36g,91%). 1H NMR
(399.9 MHz, DMSO-d6) δ 2.82-2.83 (3H, m), 3.90 (3H, s), 4.59 (2H, d),
5.41-5.48 (1H, m), 7.14 (1H, d), 7.40 (1H, d), 8.67-8.69 (1H, m). MS m/z:
197 (MH+)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimidine derivatives useful in the treatment of cancer and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buttar, David; Foote, Kevin Michael; Nowak, Thorsten; Rudge, David Alan;
Theoclitou, Maria-Elena; Thomas, Andrew Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008001070 A1 2008-01-03

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromopyridine
C5H4BrN
1120-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 N 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)pyridine
C6H8N2
1121-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 N 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1120-87-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1121-58-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5280559
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Copper-Catalyzed on
Water Ullmann Reaction. A mixture of an aryl halide (10.0 mmol), 30%
aqueous methylamine solution (5.4mL, 50 mmol), copper powder (0.032 g,
0.5 mmol), and a stirring bar was sealed in a 30 mL screwed tube and
stirred electromagnetically in an oil bath at 100 °C. During the
reaction, most of the copper powder was dissolved. After the reaction was
completed or proceeded to the times in Tables 1-3, the reaction mixture
was cooled to room temperature and ethyl acetate (20 mL) was added to
extract the aryl amine. The organic layer was separated and the aqueous
layer was extracted by ethyl acetate (3 x 10 mL). The combined extracts
were dried by anhydrous sodium sulfate and the solvent was removed under
reduced pressure to give crude product that was purified by silica gel
column chromatography (eluent: petroleum ether/ethyl acetate). The pure
product. 4-Methylaminopyridine (Table 2-21) The reaction of
4-bromopyridine (1.580 g, 10 mmol), aqueous methylamine (5.4 mL, 5 eq),
copper powder (0.032 g, 5 mol%) produced 0.988 g (91.4 %) of
4-methylaminopyridine as a yellow oil. 1H NMR (300 MHz, d 6-DMSO) δ
(ppm): 2.70–2.72(d, J = 4.5 Hz, 3H), 6.46–6.48(d, J = 5.1 Hz, 2H),
8.04–8.06(d, J = 5.1 Hz, 2H); 13C NMR (75 MHz, d 6-DMSO) δ (ppm): 28.0,
106.3, 148.7, 153.9.
$DTYPE RXN:VAR(1):NOTES
$DATUM Ullmann amination, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Facile and Practical Copper Powder-Catalyzed, Organic Solvent- and
Ligand-Free Ullmann Amination of Aryl Halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Jiao; Zhang, Xi-Ru; Chang, Ning-Hui; Wang, Jie; Wei, Jun-Fa; Shi,
Xian-Ying; Chen, Zhan-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(4), 1180-1183

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzenemethanamine
C8H10BrN
699-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 699-03-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4346162
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of (4-Bromo-benzyl)-methyl-amine In an autoclave, a mixture
of 4-bromobenzaldehyde (2.08 g, 11.15 mmol) and methylamine 2M solution
in methanol (25 mL, 33.44 mmol) was stirred at 65°C for 4 h. After
cooling to rt, sodium borohydride (633 mg, 16.72 mmol) was added
portionwise. The reaction mixture was stirred at rt for 30 min, then
concentrated in vacuo. The resulting residue was dissolved in EA (30 ml.)
and the organic layer washed with a sat. NaHCO3 solution (10 mL). The aq.
phase was basified with few drops of 1N NaOH (pH=13) and extracted twice
with EA. The combined organic extracts were washed with brine, dried
(MgSO4), filtered and concentrated under reduced pressure to afford the
title compound as a colorless oil (2.04 g, 91%), which was used for the
next step without further purification. HPLC conditions: Analytic: (A)
Agilent 1100 series with UV/Vis and MS detection (MS: Thermo Finnigan
single quadrupole). Columns (4.6x50 mm, 5 μm): Zorbax SB-AQ, Zorbax
Extend C18 or Waters X-Bridge C18. Acidic conditions: eluents: A: MeCN,
B: H2O + 0.04% TFA. Gradient 5 to 95% A over 1.5 min. Flow rate: 4.5
mL/min. LC-MS (analytic A, Zorbax SB-AQ column, acidic conditions): tR =
0.61 min; [M+H]+ = 241.06 (MeCN adduct).
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel bis-amides as antimalarial agents and their preparation and use in
the treatment of protozoal infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aissaoui, Hamed; Boss, Christoph; Corminboeuf, Olivier; Frantz,
Marie-Celine; Grisostomi, Corinna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010058353 A1 2010-05-27

$RFMT $RIREG SCHEME77 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Fluoro-3-pyridinyl)-5-(3-thienylthio)-2-thiophenecarboxaldehyde
C14H8FNOS3
1138034-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.7281 6.6373 0.0 0
M  V30 2 F 1.3336 2.9645 0.0 0
M  V30 3 C 6.2948 1.2459 0.0 0
M  V30 4 O 5.3896 0.0000 0.0 0
M  V30 5 C 4.0011 4.5045 0.0 0
M  V30 6 C 5.4079 5.1310 0.0 0
M  V30 7 C 4.1620 2.9730 0.0 0
M  V30 8 S 6.4383 3.9865 0.0 0
M  V30 9 C 5.6683 2.6528 0.0 0
M  V30 10 C 2.6673 5.2745 0.0 0
M  V30 11 C 1.3336 4.5045 0.0 0
M  V30 12 C 2.6673 6.8145 0.0 0
M  V30 13 N 0.0000 5.2745 0.0 0
M  V30 14 C 1.3336 7.5845 0.0 0
M  V30 15 C 0.0000 6.8145 0.0 0
M  V30 16 C 7.1928 7.1131 0.0 0
M  V30 17 C 7.6686 8.5778 0.0 0
M  V30 18 C 8.4386 6.2079 0.0 0
M  V30 19 C 9.2086 8.5778 0.0 0
M  V30 20 S 9.6845 7.1131 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 16
M  V30 3 1 2 11
M  V30 4 2 3 4
M  V30 5 1 3 9
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 10
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[4-(2-fluoro-3-pyridinyl)-5-(3-thienylthio)-2-thienyl]me...
C20H21FN2O2S3
1138034-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.2937 5.7153 0.0 0
M  V30 2 F 6.4057 1.7290 0.0 0
M  V30 3 C 7.5965 6.8425 0.0 0
M  V30 4 N 8.9301 6.0725 0.0 0
M  V30 5 C 10.2638 6.8425 0.0 0
M  V30 6 C 8.9301 4.5324 0.0 0
M  V30 7 O 11.5975 6.0725 0.0 0
M  V30 8 O 10.2638 8.3825 0.0 0
M  V30 9 C 12.9313 6.8425 0.0 0
M  V30 10 C 12.1613 8.1761 0.0 0
M  V30 11 C 14.2649 7.6125 0.0 0
M  V30 12 C 13.7013 5.5088 0.0 0
M  V30 13 C 4.5954 4.2207 0.0 0
M  V30 14 C 3.8254 5.5544 0.0 0
M  V30 15 C 6.1017 4.5409 0.0 0
M  V30 16 S 4.8558 6.6989 0.0 0
M  V30 17 C 6.2627 6.0725 0.0 0
M  V30 18 C 3.9689 2.8138 0.0 0
M  V30 19 C 4.8742 1.5679 0.0 0
M  V30 20 C 2.4374 2.6528 0.0 0
M  V30 21 N 4.2478 0.1611 0.0 0
M  V30 22 C 1.8111 1.2460 0.0 0
M  V30 23 C 2.7161 0.0000 0.0 0
M  V30 24 C 1.6674 7.1223 0.0 0
M  V30 25 C 2.4374 8.4560 0.0 0
M  V30 26 C 0.1609 7.4425 0.0 0
M  V30 27 C 1.4070 9.6005 0.0 0
M  V30 28 S 0.0000 8.9740 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 24
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 13 18
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138034-24-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138034-78-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6422802
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 99 tert-butyl
({4-(2-fluoropyridin-3-yl)-5-[(thiophen-3-yl)thio]thiophen-2-yl}methyl)methylcarbamate
4-(2-Fluoropyridin-3-yl)-5-[(thiophen-3-yl)thio]thiophene-2-carbaldehyde
(173 mg) was dissolved in a mixed solvent of tetrahydrofuran (2 mL) and
methanol (1 mL), 40% methylamine-methanol solution (0.552 mL) was added,
and the mixture was stirred at room temperature for 18 hr. The reaction
mixture was concentrated under reduced pressure, and the residue was
dissolved in methanol (2 mL). Sodium borohydride (102 mg) was added, and
the mixture was stirred at room temperature for 6 hr. The solvent was
evaporated under reduced pressure, 1 mol/L hydrochloric acid was added to
the residue, and the mixture was stirred at room temperature for 1 hr.
The reaction mixture was concentrated under reduced pressure, and the
residue was dissolved in ethyl acetate (5 mL) and saturated aqueous
sodium hydrogen carbonate solution (5 mL). Di-tert-butyl bicarbonate (161
mg) was added at room temperature, and the mixture was stirred for 1.5
hr. The reaction mixture was extracted with ethyl acetate, and the
extract was washed successively with saturated aqueous sodium hydrogen
carbonate solution and saturated brine, dried over anhydrous sodium
sulfate, and concentrated under reduced pressure. The residue was
purified by silica gel column chromatography (eluent: hexane-ethyl
acetate=17:3&#x2192;1:1) to give the title compound as a colorless oil
(213 mg, yield 91%). 1H-NMR (CDCl3) &#x03B4; : 1.48 (9H, s), 2.90 (3H,
s), 4.49 (2H, brs), 6.87 (1H, dd, J=5.1, 1.3 Hz), 7.01 (1H, d, J=2.4 Hz),
7.05 (1H, brs), 7.18-7.32 (2H, m), 7.81-7.95 (1H, m), 8.16-8.24 (1H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 5-[(6-chloro-3-pyridinyl)thio]-1-(2-fluoro-4-m...
C18H15ClFN3O2S
1138037-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4233 8.6445 0.0 0
M  V30 2 F 1.1091 6.5096 0.0 0
M  V30 3 C 5.2962 3.3420 0.0 0
M  V30 4 O 4.0504 2.4367 0.0 0
M  V30 5 O 6.7032 2.7156 0.0 0
M  V30 6 C 4.2114 0.9052 0.0 0
M  V30 7 C 2.9654 0.0000 0.0 0
M  V30 8 C 0.0000 11.7277 0.0 0
M  V30 9 Cl 12.5833 8.6445 0.0 0
M  V30 10 N 4.1218 7.1499 0.0 0
M  V30 11 C 5.6533 7.3108 0.0 0
M  V30 12 N 3.8016 5.6435 0.0 0
M  V30 13 C 6.2798 5.9041 0.0 0
M  V30 14 C 5.1353 4.8735 0.0 0
M  V30 15 C 3.0914 8.2943 0.0 0
M  V30 16 C 1.5850 7.9741 0.0 0
M  V30 17 C 3.5673 9.7590 0.0 0
M  V30 18 C 0.5546 9.1186 0.0 0
M  V30 19 C 2.5368 10.9034 0.0 0
M  V30 20 C 1.0304 10.5832 0.0 0
M  V30 21 C 7.9633 8.6445 0.0 0
M  V30 22 C 8.7333 9.9783 0.0 0
M  V30 23 C 8.7333 7.3108 0.0 0
M  V30 24 C 10.2733 9.9783 0.0 0
M  V30 25 N 10.2733 7.3108 0.0 0
M  V30 26 C 11.0433 8.6445 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 20
M  V30 10 1 9 26
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 5-[(6-chloro-3-pyridinyl)thio]-1-(2-fluoro-4-methy...
C17H14ClFN4OS
1138037-61-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4233 7.7394 0.0 0
M  V30 2 F 1.1091 5.6044 0.0 0
M  V30 3 C 5.2962 2.4367 0.0 0
M  V30 4 N 4.0504 1.5315 0.0 0
M  V30 5 O 6.7032 1.8104 0.0 0
M  V30 6 C 4.2114 0.0000 0.0 0
M  V30 7 C 0.0000 10.8225 0.0 0
M  V30 8 Cl 12.5833 7.7394 0.0 0
M  V30 9 N 4.1218 6.2447 0.0 0
M  V30 10 C 5.6533 6.4056 0.0 0
M  V30 11 N 3.8016 4.7384 0.0 0
M  V30 12 C 6.2798 4.9988 0.0 0
M  V30 13 C 5.1353 3.9684 0.0 0
M  V30 14 C 3.0914 7.3891 0.0 0
M  V30 15 C 1.5850 7.0689 0.0 0
M  V30 16 C 3.5673 8.8538 0.0 0
M  V30 17 C 0.5546 8.2134 0.0 0
M  V30 18 C 2.5368 9.9981 0.0 0
M  V30 19 C 1.0304 9.6780 0.0 0
M  V30 20 C 7.9633 7.7394 0.0 0
M  V30 21 C 8.7333 9.0731 0.0 0
M  V30 22 C 8.7333 6.4056 0.0 0
M  V30 23 C 10.2733 9.0731 0.0 0
M  V30 24 N 10.2733 6.4056 0.0 0
M  V30 25 C 11.0433 7.7394 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 7 19
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-61-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5804923
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 283
5-[(6-chloropyridin-3-yl)thio]-1-(2-fluoro-4-methylphenyl)-N-methyl-1H-pyrazole-3-carboxamide
To a solution of ethyl
5-[(6-chloropyridin-3-yl)thio]-1-(2-fluoro-4-methylphenyl)-1H-pyrazole-3-carboxylate
(968 mg) in methanol (5 mL) was added 40% methylamine-methanol solution
(5 mL) at room temperature. The mixture was stirred for 1 hr, and
concentrated under reduced pressure, and the residue was purified by
silica gel column chromatography (eluent: hexane-ethyl
acetate=4:1&#x2192;1:1) to give the title compound as colorless crystals
(843 mg, yield 91%). 1H-NMR (CDCl3) &#x03B4; : 2.43 (3H, s), 2.97 (3H, d,
J=5.1 Hz), 6.83 (1H, br), 7.00-7.01 (1H, m), 7.04 (1H, s), 7.11-7.19 (3H,
m), 7.34-7.38 (2H, m), 8.03-8.04 (1H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 1-(2-fluorophenyl)-5-(phenylsulfonyl)-, ethyl ...
C18H15FN2O4S
1138037-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.3755 4.0011 0.0 0 VAL=6
M  V30 2 O 5.7091 3.2311 0.0 0
M  V30 3 O 3.0418 4.7711 0.0 0
M  V30 4 F 3.5673 9.6709 0.0 0
M  V30 5 C 8.4041 7.6284 0.0 0
M  V30 6 O 9.6500 6.7232 0.0 0
M  V30 7 O 8.5650 9.1601 0.0 0
M  V30 8 C 11.0569 7.3497 0.0 0
M  V30 9 C 12.3028 6.4445 0.0 0
M  V30 10 N 4.5191 6.7417 0.0 0
M  V30 11 C 5.1455 5.3347 0.0 0
M  V30 12 N 5.6635 7.7721 0.0 0
M  V30 13 C 6.6770 5.4958 0.0 0
M  V30 14 C 6.9972 7.0021 0.0 0
M  V30 15 C 3.0127 7.0618 0.0 0
M  V30 16 C 2.5368 8.5264 0.0 0
M  V30 17 C 1.9823 5.9173 0.0 0
M  V30 18 C 1.0306 8.8466 0.0 0
M  V30 19 C 0.4759 6.2375 0.0 0
M  V30 20 C 0.0000 7.7022 0.0 0
M  V30 21 C 3.6055 2.6674 0.0 0
M  V30 22 C 2.0655 2.6674 0.0 0
M  V30 23 C 4.3755 1.3336 0.0 0
M  V30 24 C 1.2955 1.3336 0.0 0
M  V30 25 C 3.6055 0.0000 0.0 0
M  V30 26 C 2.0655 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 1 21
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 14
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 1-(2-fluorophenyl)-N-methyl-5-(phenylsulfonyl)-
C17H14FN3O3S
1138038-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 5.8690 0.0 0 VAL=6
M  V30 2 O 4.7711 7.2026 0.0 0
M  V30 3 O 3.2311 4.5352 0.0 0
M  V30 4 F 6.1362 0.5546 0.0 0
M  V30 5 C 9.3036 4.7418 0.0 0
M  V30 6 N 9.9301 6.1486 0.0 0
M  V30 7 O 10.2089 3.4960 0.0 0
M  V30 8 C 11.4617 6.3097 0.0 0
M  V30 9 N 5.4958 3.5673 0.0 0
M  V30 10 C 5.3347 5.0990 0.0 0
M  V30 11 N 7.0021 3.2471 0.0 0
M  V30 12 C 6.7417 5.7253 0.0 0
M  V30 13 C 7.7721 4.5809 0.0 0
M  V30 14 C 4.3513 2.5369 0.0 0
M  V30 15 C 4.6715 1.0306 0.0 0
M  V30 16 C 2.8866 3.0127 0.0 0
M  V30 17 C 3.5271 0.0000 0.0 0
M  V30 18 C 1.7422 1.9823 0.0 0
M  V30 19 C 2.0624 0.4760 0.0 0
M  V30 20 C 2.6674 6.6390 0.0 0
M  V30 21 C 1.3336 5.8690 0.0 0
M  V30 22 C 2.6674 8.1790 0.0 0
M  V30 23 C 0.0000 6.6390 0.0 0
M  V30 24 C 1.3336 8.9490 0.0 0
M  V30 25 C 0.0000 8.1790 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 20
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-46-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138038-33-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2873462
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 328
1-(2-fluorophenyl)-N-methyl-5-(phenylsulfonyl)-1H-pyrazole-3-carboxamide
To ethyl 1-(2-fluorophenyl)-5-(phenylsulfonyl)-1H-pyrazole-3-carboxylate
(46 mg) was added 40% methylamine-methanol solution (3 mL), and the
mixture was stirred at room temperature for 3 hr, and concentrated under
reduced pressure to give the title compound as a white solid (40.2 mg,
yield 91%). 1H-NMR (CDCl3) &#x03B4; : 2.96 (3H, d, J=4.9 Hz), 6.79 (1H,
brs), 7.09 (1H, t, J=8.9 Hz), 7.22-7.31 (1H, m), 7.31-7.46 (3H, m),
7.48-7.64 (5H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,7-Bis(2,4,6-trimethylphenyl)pyrano[4,3-c]pyran-1,5-dione
C26H24O4
113816-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3338 0.0 0
M  V30 2 C 4.6201 6.6687 0.0 0
M  V30 3 O 9.2402 6.6687 0.0 0
M  V30 4 C 0.0000 4.0012 0.0 0
M  V30 5 O 8.4702 0.0000 0.0 0
M  V30 6 C 13.0903 5.3348 0.0 0
M  V30 7 C 13.0903 0.0000 0.0 0
M  V30 8 C 17.7104 2.6675 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 3.8501 2.6675 0.0 0
M  V30 11 C 3.8501 5.3348 0.0 0
M  V30 12 C 2.3101 2.6675 0.0 0
M  V30 13 C 2.3101 5.3348 0.0 0
M  V30 14 C 1.5400 4.0012 0.0 0
M  V30 15 C 6.1601 4.0012 0.0 0
M  V30 16 C 6.9302 2.6675 0.0 0
M  V30 17 O 6.9302 5.3348 0.0 0
M  V30 18 C 8.4702 2.6675 0.0 0
M  V30 19 C 8.4702 5.3348 0.0 0
M  V30 20 C 9.2402 4.0012 0.0 0
M  V30 21 C 9.2402 1.3338 0.0 0
M  V30 22 C 10.7802 4.0012 0.0 0
M  V30 23 O 10.7802 1.3338 0.0 0
M  V30 24 C 11.5503 2.6675 0.0 0
M  V30 25 C 13.0903 2.6675 0.0 0
M  V30 26 C 13.8603 4.0012 0.0 0
M  V30 27 C 13.8603 1.3338 0.0 0
M  V30 28 C 15.4003 4.0012 0.0 0
M  V30 29 C 15.4003 1.3338 0.0 0
M  V30 30 C 16.1704 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 11
M  V30 3 2 3 19
M  V30 4 1 4 14
M  V30 5 2 5 21
M  V30 6 1 6 26
M  V30 7 1 7 27
M  V30 8 1 8 30
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 1 18 21
M  V30 22 1 19 20
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 24 25
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-oxo-3-[2-oxo-2-(2,4,6-trimethylphenyl)ethyl]-6-(2,4,6-trimethylphe...
C27H29NO4
260979-57-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.0900 2.6674 0.0 0
M  V30 2 C 13.0900 8.0021 0.0 0
M  V30 3 C 8.4700 2.6674 0.0 0
M  V30 4 N 9.2400 1.3336 0.0 0
M  V30 5 O 6.9300 2.6674 0.0 0
M  V30 6 C 8.4700 0.0000 0.0 0
M  V30 7 O 8.4700 8.0021 0.0 0
M  V30 8 C 17.7100 5.3347 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 6.1600 6.6684 0.0 0
M  V30 11 O 6.9300 8.0021 0.0 0
M  V30 12 C 4.6200 9.3358 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 0.0000 6.6684 0.0 0
M  V30 15 C 13.0900 5.3347 0.0 0
M  V30 16 C 13.8600 4.0011 0.0 0
M  V30 17 C 13.8600 6.6684 0.0 0
M  V30 18 C 15.4000 4.0011 0.0 0
M  V30 19 C 15.4000 6.6684 0.0 0
M  V30 20 C 16.1700 5.3347 0.0 0
M  V30 21 C 11.5500 5.3347 0.0 0
M  V30 22 C 10.7800 4.0011 0.0 0
M  V30 23 O 10.7800 6.6684 0.0 0
M  V30 24 C 9.2400 4.0011 0.0 0
M  V30 25 C 9.2400 6.6684 0.0 0
M  V30 26 C 8.4700 5.3347 0.0 0
M  V30 27 C 4.6200 6.6684 0.0 0
M  V30 28 C 3.8500 8.0021 0.0 0
M  V30 29 C 3.8500 5.3347 0.0 0
M  V30 30 C 2.3100 8.0021 0.0 0
M  V30 31 C 2.3100 5.3347 0.0 0
M  V30 32 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 24
M  V30 6 1 4 6
M  V30 7 2 7 25
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 26
M  V30 11 2 10 11
M  V30 12 1 10 27
M  V30 13 1 12 28
M  V30 14 1 13 29
M  V30 15 1 14 32
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113816-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 260979-57-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-806789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and spectral properties of the nitrogen analogs of (E)-
5,5'-diaryl-3,3'-bifuranylidene-2,2'-diones and their derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Irikawa, Hajime; Adachi, Norihide
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2000), 53(1), 135-142

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[2-[2-[2-(2-bromoethoxy)ethoxy]ethoxy]ethyl]phosphonate
C12H26BrO6P
1148026-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.0801 3.0801 0.0 0 VAL=5
M  V30 2 C 4.4139 3.8501 0.0 0
M  V30 3 O 1.7464 2.3101 0.0 0
M  V30 4 O 2.3101 4.4137 0.0 0
M  V30 5 O 3.8501 1.7462 0.0 0
M  V30 6 C 5.7476 3.0801 0.0 0
M  V30 7 C 1.7464 0.7700 0.0 0
M  V30 8 C 0.7700 4.4137 0.0 0
M  V30 9 O 7.0812 3.8501 0.0 0
M  V30 10 C 0.4127 0.0000 0.0 0
M  V30 11 C 0.0000 5.7474 0.0 0
M  V30 12 C 8.4149 3.0801 0.0 0
M  V30 13 C 9.7487 3.8501 0.0 0
M  V30 14 O 11.0824 3.0801 0.0 0
M  V30 15 C 12.4161 3.8501 0.0 0
M  V30 16 C 13.7499 3.0801 0.0 0
M  V30 17 O 15.0836 3.8501 0.0 0
M  V30 18 C 16.4172 3.0801 0.0 0
M  V30 19 C 17.7509 3.8501 0.0 0
M  V30 20 Br 19.0847 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-3,6,9-trioxa-12-azatridec-1-ylphosphonate
C13H30NO6P
1527504-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.0801 3.0801 0.0 0 VAL=5
M  V30 2 C 4.4139 3.8501 0.0 0
M  V30 3 O 1.7464 2.3101 0.0 0
M  V30 4 O 2.3101 4.4137 0.0 0
M  V30 5 O 3.8501 1.7462 0.0 0
M  V30 6 C 5.7476 3.0801 0.0 0
M  V30 7 C 1.7464 0.7700 0.0 0
M  V30 8 C 0.7700 4.4137 0.0 0
M  V30 9 O 7.0812 3.8501 0.0 0
M  V30 10 C 0.4127 0.0000 0.0 0
M  V30 11 C 0.0000 5.7474 0.0 0
M  V30 12 C 8.4149 3.0801 0.0 0
M  V30 13 C 9.7487 3.8501 0.0 0
M  V30 14 O 11.0824 3.0801 0.0 0
M  V30 15 C 12.4161 3.8501 0.0 0
M  V30 16 C 13.7497 3.0801 0.0 0
M  V30 17 O 15.0836 3.8501 0.0 0
M  V30 18 C 16.4172 3.0801 0.0 0
M  V30 19 C 17.7509 3.8501 0.0 0
M  V30 20 N 19.0846 3.0801 0.0 0
M  V30 21 C 20.4184 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1148026-98-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1527504-28-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2723303
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Monomers for adhesive polymers: 11. Structure-adhesive properties
relationships of new hydrolytically stable acidic monomers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Catel, Yohann; Fischer, Urs Karl; Moszner, Norbert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polymer International (2013), 62(12), 1717-1728

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Propanediol, 1-phenyl-, 3-methanesulfonate, (1R)-
C10H14O4S
115290-78-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.2073 0.0 0 CFG=2
M  V30 2 C 5.3900 2.8736 0.0 0
M  V30 3 O 5.3900 5.5409 0.0 0
M  V30 4 C 6.9300 2.8736 0.0 0
M  V30 5 O 7.7000 1.5400 0.0 0
M  V30 6 S 9.2400 1.5400 0.0 0 VAL=6
M  V30 7 C 9.2400 3.0800 0.0 0
M  V30 8 O 10.7800 1.5400 0.0 0
M  V30 9 O 9.2400 0.0000 0.0 0
M  V30 10 C 3.0800 4.2073 0.0 0
M  V30 11 C 2.3100 5.5409 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 0.7700 5.5409 0.0 0
M  V30 14 C 0.7700 2.8736 0.0 0
M  V30 15 C 0.0000 4.2073 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-[2-(Methylamino)ethyl]benzenemethanol
C10H15NO
115290-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6684 1.5400 0.0 0
M  V30 5 N 8.0022 2.3100 0.0 0
M  V30 6 C 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 115290-78-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 115290-81-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5754838
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective hydrogenation of β-keto esters using chiral
diphosphine-ruthenium complexes: Optimization for academic and industrial
purposes and synthetic applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ratovelomanana-Vidal, V.; Girard, C.; Touati, R.; Tranchier, J. P.; Ben
Hassine, B.; Genet, J. P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2003), 345(1+2), 261-274

$RFMT $RIREG SCHEME83 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-chloro-2-hydroxy-4-[(4-methoxyphenyl)methoxy]benzoate
C16H15ClO5
644971-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 2.6674 0.0 0
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 Cl 6.9300 0.0000 0.0 0
M  V30 4 O 3.8500 5.3349 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 O 1.5400 1.3338 0.0 0
M  V30 7 O 1.5400 4.0011 0.0 0
M  V30 8 C 0.0000 1.3338 0.0 0
M  V30 9 O 15.4000 4.0011 0.0 0
M  V30 10 C 16.1700 5.3349 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 C 6.1600 1.3338 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 11.5500 5.3349 0.0 0
M  V30 20 C 13.0900 2.6674 0.0 0
M  V30 21 C 13.0900 5.3349 0.0 0
M  V30 22 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 1 3 12
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenesulfonic acid, 3-nitro-, (2S)-2-oxiranylmethyl ester
C9H9NO6S
115314-14-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.4137 4.2074 0.0 0 VAL=6
M  V30 2 O 3.6437 2.8737 0.0 0
M  V30 3 O 5.1838 5.5412 0.0 0
M  V30 4 O 3.0801 4.9774 0.0 0
M  V30 5 C 2.1037 2.8737 0.0 0
M  V30 6 N 9.7487 4.2074 0.0 0 VAL=5
M  V30 7 O 11.0824 3.4374 0.0 0
M  V30 8 O 9.7487 5.7474 0.0 0
M  V30 9 C 5.7476 3.4374 0.0 0
M  V30 10 C 7.0812 4.2074 0.0 0
M  V30 11 C 5.7476 1.8973 0.0 0
M  V30 12 C 8.4149 3.4374 0.0 0
M  V30 13 C 7.0812 1.1273 0.0 0
M  V30 14 C 8.4149 1.8973 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0 CFG=1
M  V30 16 C 1.3337 0.0000 0.0 0
M  V30 17 O 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 15 5 CFG=3
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 12
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-Chloro-4-[(4-methoxyphenyl)methoxy]-N-methyl-2-[(2S)-2-oxiranylmethoxy]benz...
C19H20ClNO5
1003567-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 4.2075 0.0 0
M  V30 2 C 4.6201 2.8737 0.0 0
M  V30 3 C 2.3100 6.8748 0.0 0
M  V30 4 N 1.5400 8.2086 0.0 0
M  V30 5 O 1.5400 5.5411 0.0 0
M  V30 6 C 0.0000 8.2086 0.0 0
M  V30 7 O 8.4701 6.8748 0.0 0
M  V30 8 C 9.2401 5.5411 0.0 0
M  V30 9 Cl 6.9301 9.5423 0.0 0
M  V30 10 O 15.4002 5.5411 0.0 0
M  V30 11 C 16.1702 4.2075 0.0 0
M  V30 12 C 4.6201 5.5411 0.0 0
M  V30 13 C 3.8500 6.8748 0.0 0
M  V30 14 C 6.1601 5.5411 0.0 0
M  V30 15 C 4.6201 8.2086 0.0 0
M  V30 16 C 6.9301 6.8748 0.0 0
M  V30 17 C 6.1601 8.2086 0.0 0
M  V30 18 C 3.8500 1.5400 0.0 0 CFG=1
M  V30 19 C 2.5164 0.7700 0.0 0
M  V30 20 O 3.8500 0.0000 0.0 0
M  V30 21 C 10.7801 5.5411 0.0 0
M  V30 22 C 11.5501 4.2075 0.0 0
M  V30 23 C 11.5501 6.8748 0.0 0
M  V30 24 C 13.0901 4.2075 0.0 0
M  V30 25 C 13.0901 6.8748 0.0 0
M  V30 26 C 13.8602 5.5411 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 18 2 CFG=1
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 16
M  V30 10 1 8 21
M  V30 11 1 9 17
M  V30 12 1 10 11
M  V30 13 1 10 26
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 644971-05-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 115314-14-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1003567-10-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-010-CAS-4463721
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: 5-Chloro-4-[(4-methoxybenzyl)oxy]-N-methyl-2-[(2S)-oxiran-2-
ylmethoxy]benzamide A suspension of methyl
5-chloro-2-hydroxy-4-[(4-methoxybenzyl)oxy]benzoate (1.61 g, 5.0 mmol) in
the solution of methylamine in ethanol (33 % wt, 25 ml) was stirred at
room temperature overnight, then at 60 °C for 4 h to form a solution. The
solvent was removed in vacuo, affording
5-chloro-2-hydroxy-4-[(4-methoxybenzyl)oxy]-N-methylbenzamide as red
powder. This intermediate was dissolved in DMF (20 ml). To the solution
were added cesium carbonate (1.96 g, 6.0 mmol) and (26)-oxiran-2-ylmethyl
3-nitrobenzenesulfonate (1.30 g, 5.0 mmol). The suspension was stirred at
room temperature overnight. The reaction mixture was partitioned between
ethyl acetate and H2O. The organic layer was dried over Na2SO4, and
filtered. The solvent was removed in vacuo, the subtitled compound as red
solid (1.71 g, 91 %). 1H-NMR (CDCl3, 400 MHz): δ 8.21(s, 1H), 7.67 (d, J
= 4.4, NH), 7.37 (d, J=8.76, 2H), 6.92 (d, J=8.76, 2H), 6.58 (s, 1H),
5.11 (s, 2H), 4.44-4.39 (m, 1H), 4.01-3.96 (m, 1H), 3.82 (s, 3H),
3.39-3.34 (m, 1H), 2.98 (d, J=4.9, 3H), 2.96-2.95 (m, 1H), 2.82-2.79 (m,
1H); APCI-MS: m/z 378 (MH+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of spirobenzofuranpiperidines as modulators of chemokine CCR1
receptor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Elkins, Barry; Ennis, David; Eriksson, Tomas; Gibson, Scott; Gu, Eric;
Hassall, Ian; Hemmerling, Martin; Josefsson, Bo-Goeran; Ivanova,
Svetlana; Kavitake, Santosh; Kumar, Sythana Suresh; Kumar, Vinod;
Lingesha, Sidda; Mensonides-Harsema, Marguerite; Merifield, Eric; Mo,
John; Pavey, John; Pimm, Austen; Reuberson, James; Rogers, Mike; Schulz,
Haakan; Strandberg, Per; Wang, Zhengyu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008010765 A1 2008-01-24

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[2-bromo-4-(2,2-dichloroethenyl)phenoxy]methyl]-α-(methoxyimin...
C19H16BrCl2NO4
1159342-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 2.6674 2.3100 0.0 0
M  V30 4 O 5.3347 0.7700 0.0 0
M  V30 5 O 6.6685 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6685 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 Br 10.6696 6.9300 0.0 0
M  V30 12 C 13.3369 2.3100 0.0 0
M  V30 13 C 14.6705 3.0800 0.0 0
M  V30 14 Cl 16.0043 2.3100 0.0 0
M  V30 15 Cl 14.6705 4.6200 0.0 0
M  V30 16 C 4.0011 4.6200 0.0 0
M  V30 17 C 5.3347 5.3900 0.0 0
M  V30 18 C 2.6674 5.3900 0.0 0
M  V30 19 C 5.3347 6.9300 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 4.0011 7.7000 0.0 0
M  V30 22 C 9.3358 4.6200 0.0 0
M  V30 23 C 10.6696 5.3900 0.0 0
M  V30 24 C 9.3358 3.0800 0.0 0
M  V30 25 C 12.0032 4.6200 0.0 0
M  V30 26 C 10.6696 2.3100 0.0 0
M  V30 27 C 12.0032 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[2-Bromo-4-(2,2-dichloroethenyl)phenoxy]methyl]-α-(methoxyimino)-N-me...
C19H17BrCl2N2O3
1159342-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 2.6674 2.3100 0.0 0
M  V30 4 N 5.3347 0.7700 0.0 0
M  V30 5 O 6.6685 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6685 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 Br 10.6696 6.9300 0.0 0
M  V30 12 C 13.3369 2.3100 0.0 0
M  V30 13 C 14.6705 3.0800 0.0 0
M  V30 14 Cl 14.6705 4.6200 0.0 0
M  V30 15 Cl 16.0043 2.3100 0.0 0
M  V30 16 C 4.0011 4.6200 0.0 0
M  V30 17 C 5.3347 5.3900 0.0 0
M  V30 18 C 2.6674 5.3900 0.0 0
M  V30 19 C 5.3347 6.9300 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 4.0011 7.7000 0.0 0
M  V30 22 C 9.3358 4.6200 0.0 0
M  V30 23 C 10.6696 5.3900 0.0 0
M  V30 24 C 9.3358 3.0800 0.0 0
M  V30 25 C 12.0032 4.6200 0.0 0
M  V30 26 C 10.6696 2.3100 0.0 0
M  V30 27 C 12.0032 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-45-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-46-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2610870
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and SAR of methoxyiminoacetate and methoxyiminoacetamide
derivatives as strobilurin analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hwang, In-Cheon; Kim, Joo-Kyung; Kim, Hyung-Ho; Kyung, Suk-Hun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bulletin of the Korean Chemical Society (2009), 30(7), 1475-1480

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[2-bromo-4-(2,2-dichloroethenyl)phenoxy]methyl]-α-(methoxyimin...
C19H16BrCl2NO4
1159342-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 2.6674 2.3100 0.0 0
M  V30 4 O 5.3347 0.7700 0.0 0
M  V30 5 O 6.6685 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6685 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 Br 10.6696 6.9300 0.0 0
M  V30 12 C 13.3369 2.3100 0.0 0
M  V30 13 C 14.6705 3.0800 0.0 0
M  V30 14 Cl 16.0043 2.3100 0.0 0
M  V30 15 Cl 14.6705 4.6200 0.0 0
M  V30 16 C 4.0011 4.6200 0.0 0
M  V30 17 C 5.3347 5.3900 0.0 0
M  V30 18 C 2.6674 5.3900 0.0 0
M  V30 19 C 5.3347 6.9300 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 4.0011 7.7000 0.0 0
M  V30 22 C 9.3358 4.6200 0.0 0
M  V30 23 C 10.6696 5.3900 0.0 0
M  V30 24 C 9.3358 3.0800 0.0 0
M  V30 25 C 12.0032 4.6200 0.0 0
M  V30 26 C 10.6696 2.3100 0.0 0
M  V30 27 C 12.0032 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[2-Bromo-4-(2,2-dichloroethenyl)phenoxy]methyl]-α-(methoxyimino)-N-me...
C19H17BrCl2N2O3
1159342-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 2.6674 2.3100 0.0 0
M  V30 4 N 5.3347 0.7700 0.0 0
M  V30 5 O 6.6685 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6685 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 Br 10.6696 6.9300 0.0 0
M  V30 12 C 13.3369 2.3100 0.0 0
M  V30 13 C 14.6705 3.0800 0.0 0
M  V30 14 Cl 14.6705 4.6200 0.0 0
M  V30 15 Cl 16.0043 2.3100 0.0 0
M  V30 16 C 4.0011 4.6200 0.0 0
M  V30 17 C 5.3347 5.3900 0.0 0
M  V30 18 C 2.6674 5.3900 0.0 0
M  V30 19 C 5.3347 6.9300 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 4.0011 7.7000 0.0 0
M  V30 22 C 9.3358 4.6200 0.0 0
M  V30 23 C 10.6696 5.3900 0.0 0
M  V30 24 C 9.3358 3.0800 0.0 0
M  V30 25 C 12.0032 4.6200 0.0 0
M  V30 26 C 10.6696 2.3100 0.0 0
M  V30 27 C 12.0032 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-45-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-46-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3838775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 40: Preparation of
(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
Example 54: Preparation of
(E)-2-(2-((2-bromo-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
The procedure of Example 40 was repeated except for using
methyl-(E)-2-(2-((2-bromo-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate(0.473g,
1mmol) obtained in Example 53 instead of
methyl-(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate
to obtain the title compound (0.430g, 91%). 1H-NMR(CDCl3, TMS)δ(ppm):
2.90(d, 3H), 3.94(s, 3H), 5.07(s, 2H), 6.70(s. 1H), 6.77-7.77(m, 8H) MS :
471.8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of methoxyiminobenzene compounds as agrochemical fungicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joo-Kyung; Kim, Hyung-Ho; Hwang, In-Cheon; Nam, Ho-Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009072837 A2 2009-06-11

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[3-chloro-4-(2,2-dichloroethenyl)phenoxy]methyl]-α-(methoxyimi...
C19H16Cl3NO4
1159342-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 4.6201 0.0 0
M  V30 2 C 9.3358 5.3901 0.0 0
M  V30 3 N 12.0033 5.3901 0.0 0
M  V30 4 O 9.3358 6.9302 0.0 0
M  V30 5 O 8.0022 4.6201 0.0 0
M  V30 6 O 13.3370 4.6201 0.0 0
M  V30 7 C 8.0022 7.7002 0.0 0
M  V30 8 C 14.6707 5.3901 0.0 0
M  V30 9 C 8.0022 3.0801 0.0 0
M  V30 10 O 6.6685 2.3101 0.0 0
M  V30 11 Cl 1.3337 2.3101 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 1.3337 6.9302 0.0 0
M  V30 14 Cl 0.0000 7.7002 0.0 0
M  V30 15 Cl 2.6673 7.7002 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 9.3358 2.3101 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 9.3358 0.7700 0.0 0
M  V30 20 C 12.0033 0.7700 0.0 0
M  V30 21 C 10.6697 0.0000 0.0 0
M  V30 22 C 5.3348 3.0801 0.0 0
M  V30 23 C 4.0010 2.3101 0.0 0
M  V30 24 C 5.3348 4.6201 0.0 0
M  V30 25 C 2.6673 3.0801 0.0 0
M  V30 26 C 4.0010 5.3901 0.0 0
M  V30 27 C 2.6673 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 25
M  V30 13 2 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[3-Chloro-4-(2,2-dichloroethenyl)phenoxy]methyl]-α-(methoxyimino)-N-m...
C19H17Cl3N2O3
1159342-50-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 4.6201 0.0 0
M  V30 2 C 9.3358 5.3901 0.0 0
M  V30 3 N 12.0033 5.3901 0.0 0
M  V30 4 N 9.3358 6.9302 0.0 0
M  V30 5 O 8.0022 4.6201 0.0 0
M  V30 6 O 13.3370 4.6201 0.0 0
M  V30 7 C 8.0022 7.7002 0.0 0
M  V30 8 C 14.6707 5.3901 0.0 0
M  V30 9 C 8.0022 3.0801 0.0 0
M  V30 10 O 6.6685 2.3101 0.0 0
M  V30 11 Cl 1.3337 2.3101 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 1.3337 6.9302 0.0 0
M  V30 14 Cl 0.0000 7.7002 0.0 0
M  V30 15 Cl 2.6673 7.7002 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 9.3358 2.3101 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 9.3358 0.7700 0.0 0
M  V30 20 C 12.0033 0.7700 0.0 0
M  V30 21 C 10.6697 0.0000 0.0 0
M  V30 22 C 5.3348 3.0801 0.0 0
M  V30 23 C 4.0010 2.3101 0.0 0
M  V30 24 C 5.3348 4.6201 0.0 0
M  V30 25 C 2.6673 3.0801 0.0 0
M  V30 26 C 4.0010 5.3901 0.0 0
M  V30 27 C 2.6673 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 25
M  V30 13 2 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-49-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-50-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4081575
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 40: Preparation of
(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
Example 58: Preparation of
(E)-2-(2-((3-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
The procedure of Example 40 was repeated except for using
methyl-(E)-2-(2-((3-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate(0.428g,
1mmol) obtained in Example 57 instead of
methyl-(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate
to obtain the title compound (0.389g, 91%). 1H-NMR(CDCl3, TMS)δ(ppm):
2.91(d, 3H), 3.99(s, 3H), 5.08(s, 2H), 6.82(s, 1H), 6.83-6.88(m, 1H),
7.04(s, 1H), 7.21-7.50(m, 6H) MS : 426.0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of methoxyiminobenzene compounds as agrochemical fungicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joo-Kyung; Kim, Hyung-Ho; Hwang, In-Cheon; Nam, Ho-Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009072837 A2 2009-06-11

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[2-(2,2-dibromoethenyl)-4-methylphenoxy]methyl]-α-(methoxyimin...
C20H19Br2NO4
1159342-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0101 5.3348 0.0 0
M  V30 2 C 9.2401 4.0011 0.0 0
M  V30 3 N 11.5501 5.3348 0.0 0
M  V30 4 O 10.0101 2.6675 0.0 0
M  V30 5 O 7.7001 4.0011 0.0 0
M  V30 6 O 12.3201 6.6684 0.0 0
M  V30 7 C 9.2401 1.3337 0.0 0
M  V30 8 C 13.8602 6.6684 0.0 0
M  V30 9 C 6.9301 5.3348 0.0 0
M  V30 10 O 5.3901 5.3348 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 0.7700 5.3348 0.0 0
M  V30 13 Br 0.0000 4.0011 0.0 0
M  V30 14 Br 0.0000 6.6684 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 9.2401 6.6684 0.0 0
M  V30 17 C 7.7001 6.6684 0.0 0
M  V30 18 C 10.0101 8.0022 0.0 0
M  V30 19 C 6.9301 8.0022 0.0 0
M  V30 20 C 9.2401 9.3359 0.0 0
M  V30 21 C 7.7001 9.3359 0.0 0
M  V30 22 C 4.6201 4.0011 0.0 0
M  V30 23 C 3.0800 4.0011 0.0 0
M  V30 24 C 5.3901 2.6675 0.0 0
M  V30 25 C 2.3100 2.6675 0.0 0
M  V30 26 C 4.6201 1.3337 0.0 0
M  V30 27 C 3.0800 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 23
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 15 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[2-(2,2-Dibromoethenyl)-4-methylphenoxy]methyl]-α-(methoxyimino)-N-me...
C20H20Br2N2O3
1159342-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0101 5.3348 0.0 0
M  V30 2 C 9.2401 4.0011 0.0 0
M  V30 3 N 11.5501 5.3348 0.0 0
M  V30 4 N 10.0101 2.6675 0.0 0
M  V30 5 O 7.7001 4.0011 0.0 0
M  V30 6 O 12.3201 6.6684 0.0 0
M  V30 7 C 9.2401 1.3337 0.0 0
M  V30 8 C 13.8602 6.6684 0.0 0
M  V30 9 C 6.9301 5.3348 0.0 0
M  V30 10 O 5.3901 5.3348 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 0.7700 5.3348 0.0 0
M  V30 13 Br 0.0000 6.6684 0.0 0
M  V30 14 Br 0.0000 4.0011 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 9.2401 6.6684 0.0 0
M  V30 17 C 7.7001 6.6684 0.0 0
M  V30 18 C 10.0101 8.0022 0.0 0
M  V30 19 C 6.9301 8.0022 0.0 0
M  V30 20 C 9.2401 9.3359 0.0 0
M  V30 21 C 7.7001 9.3359 0.0 0
M  V30 22 C 4.6201 4.0011 0.0 0
M  V30 23 C 3.0800 4.0011 0.0 0
M  V30 24 C 5.3901 2.6675 0.0 0
M  V30 25 C 2.3100 2.6675 0.0 0
M  V30 26 C 4.6201 1.3337 0.0 0
M  V30 27 C 3.0800 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 23
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 15 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-62-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5923034
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 40: Preparation of
(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
Example 70: Preparation of
(E)-2-(2-((2-(2,2-dibromovinyl)-4-methylphenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
The procedure of Example 40 was repeated except for using
methyl-(E)-2-(2-((2-(2,2-dibromovinyl)-4-methylphenoxy)methyl)phenyl)-2-methoxyiminoacetate(0.497g,
1mmol) obtained in Example 69 instead of
methyl-(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate
to obtain the title compound (0.452g, 91%). 1H-NMR(CDCl3, TMS)δ(ppm):
2.34(s, 3H), 2.85(d, 3H), 3.93(s, 3H), 4.97(s, 2H), 6.69-6.75(m, 2H),
7.11(s, 1H), 7.04-7.67(m, 6H) MS : 493.9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of methoxyiminobenzene compounds as agrochemical fungicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joo-Kyung; Kim, Hyung-Ho; Hwang, In-Cheon; Nam, Ho-Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009072837 A2 2009-06-11

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[2-(2,2-dibromoethenyl)-4-fluorophenoxy]methyl]-α-(methoxyimin...
C19H16Br2FNO4
1159342-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0101 5.3348 0.0 0
M  V30 2 C 9.2401 4.0011 0.0 0
M  V30 3 N 11.5501 5.3348 0.0 0
M  V30 4 O 10.0101 2.6675 0.0 0
M  V30 5 O 7.7001 4.0011 0.0 0
M  V30 6 O 12.3201 6.6684 0.0 0
M  V30 7 C 9.2401 1.3337 0.0 0
M  V30 8 C 13.8602 6.6684 0.0 0
M  V30 9 C 6.9301 5.3348 0.0 0
M  V30 10 O 5.3901 5.3348 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 0.7700 5.3348 0.0 0
M  V30 13 Br 0.0000 4.0011 0.0 0
M  V30 14 Br 0.0000 6.6684 0.0 0
M  V30 15 F 2.3100 0.0000 0.0 0
M  V30 16 C 9.2401 6.6684 0.0 0
M  V30 17 C 7.7001 6.6684 0.0 0
M  V30 18 C 10.0101 8.0022 0.0 0
M  V30 19 C 6.9301 8.0022 0.0 0
M  V30 20 C 9.2401 9.3359 0.0 0
M  V30 21 C 7.7001 9.3359 0.0 0
M  V30 22 C 4.6201 4.0011 0.0 0
M  V30 23 C 3.0800 4.0011 0.0 0
M  V30 24 C 5.3901 2.6675 0.0 0
M  V30 25 C 2.3100 2.6675 0.0 0
M  V30 26 C 4.6201 1.3337 0.0 0
M  V30 27 C 3.0800 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 23
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 15 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[2-(2,2-Dibromoethenyl)-4-fluorophenoxy]methyl]-α-(methoxyimino)-N-me...
C19H17Br2FN2O3
1159342-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0101 5.3348 0.0 0
M  V30 2 C 9.2401 4.0011 0.0 0
M  V30 3 N 11.5501 5.3348 0.0 0
M  V30 4 N 10.0101 2.6675 0.0 0
M  V30 5 O 7.7001 4.0011 0.0 0
M  V30 6 O 12.3201 6.6684 0.0 0
M  V30 7 C 9.2401 1.3337 0.0 0
M  V30 8 C 13.8602 6.6684 0.0 0
M  V30 9 C 6.9301 5.3348 0.0 0
M  V30 10 O 5.3901 5.3348 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 0.7700 5.3348 0.0 0
M  V30 13 Br 0.0000 6.6684 0.0 0
M  V30 14 Br 0.0000 4.0011 0.0 0
M  V30 15 F 2.3100 0.0000 0.0 0
M  V30 16 C 9.2401 6.6684 0.0 0
M  V30 17 C 7.7001 6.6684 0.0 0
M  V30 18 C 10.0101 8.0022 0.0 0
M  V30 19 C 6.9301 8.0022 0.0 0
M  V30 20 C 9.2401 9.3359 0.0 0
M  V30 21 C 7.7001 9.3359 0.0 0
M  V30 22 C 4.6201 4.0011 0.0 0
M  V30 23 C 3.0800 4.0011 0.0 0
M  V30 24 C 5.3901 2.6675 0.0 0
M  V30 25 C 2.3100 2.6675 0.0 0
M  V30 26 C 4.6201 1.3337 0.0 0
M  V30 27 C 3.0800 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 23
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 15 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-72-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-73-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3476844
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 40: Preparation of
(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
Example 80: Preparation of
(E)-2-(2-((2-(2,2-dibromovinyl)-4-fluorophenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
The procedure of Example 40 was repeated except for using
methyl-(E)-2-(2-((2-(2,2-dibromovinyl)-4-fluorophenoxy)methyl)phenyl)-2-methoxyiminoacetate(0.501g,
1mmol) obtained in Example 79 instead of
methyl-(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate
to obtain the title compound (0.455g, 91%). 1H-NMR(CDCl3, TMS)δ(ppm):
2.90(d, 3H), 3.98(s, 3H), 5.07(s, 2H), 6.87(s, 1H), 6.90-6.94(m, 1H),
7.11(s, 1H), 7.14-7.62(m, 6H) MS : 497.9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of methoxyiminobenzene compounds as agrochemical fungicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joo-Kyung; Kim, Hyung-Ho; Hwang, In-Cheon; Nam, Ho-Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009072837 A2 2009-06-11

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-[[[2-(4-chlorophenyl)-4-thiazolyl]methyl]thio]-4-[4-(2-hydroxyetho...
C25H16Cl2N4O2S2
1163271-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 6.1601 0.0 0
M  V30 2 N 10.6697 7.7002 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 N 6.6685 0.7700 0.0 0
M  V30 5 S 13.3370 4.6201 0.0 0
M  V30 6 C 14.6707 3.8501 0.0 0
M  V30 7 Cl 10.6697 0.0000 0.0 0
M  V30 8 O 4.0010 6.9302 0.0 0
M  V30 9 C 2.6673 6.1601 0.0 0
M  V30 10 C 1.3337 6.9302 0.0 0
M  V30 11 O 0.0000 6.1601 0.0 0
M  V30 12 Cl 24.5682 4.4943 0.0 0
M  V30 13 C 9.3358 3.8501 0.0 0
M  V30 14 C 10.6697 4.6201 0.0 0
M  V30 15 C 9.3358 2.3101 0.0 0
M  V30 16 C 12.0033 3.8501 0.0 0
M  V30 17 C 10.6697 1.5400 0.0 0
M  V30 18 N 12.0033 2.3101 0.0 0
M  V30 19 C 8.0022 4.6201 0.0 0
M  V30 20 C 8.0022 6.1601 0.0 0
M  V30 21 C 6.6685 3.8501 0.0 0
M  V30 22 C 6.6685 6.9302 0.0 0
M  V30 23 C 5.3348 4.6201 0.0 0
M  V30 24 C 5.3348 6.1601 0.0 0
M  V30 25 C 16.0045 4.6201 0.0 0
M  V30 26 N 17.4113 3.9938 0.0 0
M  V30 27 C 16.1654 6.1517 0.0 0
M  V30 28 C 18.4417 5.1382 0.0 0
M  V30 29 S 17.6717 6.4718 0.0 0
M  V30 30 C 19.9735 4.9772 0.0 0
M  V30 31 C 20.8787 6.2231 0.0 0
M  V30 32 C 20.5998 3.5703 0.0 0
M  V30 33 C 22.4103 6.0622 0.0 0
M  V30 34 C 22.1314 3.4093 0.0 0
M  V30 35 C 23.0366 4.6552 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 14
M  V30 3 3 3 4
M  V30 4 1 3 15
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 25
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 12 35
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 19
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[[2-(4-Chlorophenyl)-4-thiazolyl]methyl]thio]-4-[4-(2-hydroxyethoxy)phenyl...
C26H20ClN5O2S2
1239234-38-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 6.9302 0.0 0
M  V30 2 N 10.6697 8.4702 0.0 0
M  V30 3 C 8.0022 2.3101 0.0 0
M  V30 4 N 6.6685 1.5400 0.0 0
M  V30 5 S 13.3370 5.3901 0.0 0
M  V30 6 C 14.6707 4.6201 0.0 0
M  V30 7 N 10.6697 0.7700 0.0 0
M  V30 8 C 12.0033 0.0000 0.0 0
M  V30 9 O 4.0010 7.7002 0.0 0
M  V30 10 C 2.6673 6.9302 0.0 0
M  V30 11 C 1.3337 7.7002 0.0 0
M  V30 12 O 0.0000 6.9302 0.0 0
M  V30 13 Cl 24.5682 5.2643 0.0 0
M  V30 14 C 9.3358 4.6201 0.0 0
M  V30 15 C 10.6697 5.3901 0.0 0
M  V30 16 C 9.3358 3.0801 0.0 0
M  V30 17 C 12.0033 4.6201 0.0 0
M  V30 18 C 10.6697 2.3101 0.0 0
M  V30 19 N 12.0033 3.0801 0.0 0
M  V30 20 C 8.0022 5.3901 0.0 0
M  V30 21 C 6.6685 4.6201 0.0 0
M  V30 22 C 8.0022 6.9302 0.0 0
M  V30 23 C 5.3348 5.3901 0.0 0
M  V30 24 C 6.6685 7.7002 0.0 0
M  V30 25 C 5.3348 6.9302 0.0 0
M  V30 26 C 16.0045 5.3901 0.0 0
M  V30 27 N 17.4113 4.7638 0.0 0
M  V30 28 C 16.1654 6.9217 0.0 0
M  V30 29 C 18.4417 5.9082 0.0 0
M  V30 30 S 17.6717 7.2419 0.0 0
M  V30 31 C 19.9735 5.7473 0.0 0
M  V30 32 C 20.5998 4.3403 0.0 0
M  V30 33 C 20.8787 6.9931 0.0 0
M  V30 34 C 22.1314 4.1793 0.0 0
M  V30 35 C 22.4103 6.8322 0.0 0
M  V30 36 C 23.0366 5.4252 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 15
M  V30 3 3 3 4
M  V30 4 1 3 16
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 26
M  V30 8 1 7 8
M  V30 9 1 7 18
M  V30 10 1 9 10
M  V30 11 1 9 25
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 36
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 20
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1163271-54-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1239234-38-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17455696
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Neladenoson Bialanate Hydrochloride: A Prodrug of a Partial Adenosine A1
Receptor Agonist for the Chronic Treatment of Heart Diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meibom, Daniel; Albrecht-Kuepper, Barbara; Diedrichs, Nicole; Huebsch,
Walter; Kast, Raimund; Kraemer, Thomas; Krenz, Ursula; Lerchen,
Hans-Georg; Mittendorf, Joachim; Nell, Peter G.; Suessmeier, Frank;
Vakalopoulos, Alexandros; Zimmermann, Katja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2017), 12(10), 728-737

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Methyl β-(acetyloxy)-2-chloro-α-methylene-3-quinolinepropanoate
C16H14ClNO4
1173927-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.8501 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 O 6.6685 2.3101 0.0 0
M  V30 4 C 9.3360 3.8501 0.0 0
M  V30 5 C 8.0022 6.1601 0.0 0
M  V30 6 C 5.3348 1.5400 0.0 0
M  V30 7 O 10.6697 4.6201 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 O 4.0012 2.3101 0.0 0
M  V30 11 C 12.0033 3.8501 0.0 0
M  V30 12 Cl 6.6685 6.9302 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 4.0012 3.8501 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 N 4.0012 6.9302 0.0 0
M  V30 18 C 2.6673 6.1601 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 1.3337 6.9302 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 22 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 12 15
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 1 17 18
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,2-dihydro-1-methylbenzo[b][1,8]naphthyridine-3-carboxylate
C15H14N2O2
1296240-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.0000 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 O 10.6697 3.8501 0.0 0
M  V30 4 O 9.3360 6.1601 0.0 0
M  V30 5 C 12.0033 4.6201 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 N 4.0012 1.5400 0.0 0
M  V30 9 N 6.6685 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 1.3337 1.5400 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1173927-42-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1296240-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6827023
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction monitored by TLC; "base-free" one-pot two step amination
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Base-free amination of BH acetates of
2-chloroquinolinyl-3-carboxaldehydes: a facile route to the synthesis of
N-substituted-1,2-dihydrobenzo[b][1,8]naphthyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Bhawana; Chandra, Atish; Singh, Radhey M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(13), 2441-2446

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Methyl β-(acetyloxy)-2-chloro-α-methylene-3-quinolinepropanoate
C16H14ClNO4
1173927-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.8501 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 O 6.6685 2.3101 0.0 0
M  V30 4 C 9.3360 3.8501 0.0 0
M  V30 5 C 8.0022 6.1601 0.0 0
M  V30 6 C 5.3348 1.5400 0.0 0
M  V30 7 O 10.6697 4.6201 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 O 4.0012 2.3101 0.0 0
M  V30 11 C 12.0033 3.8501 0.0 0
M  V30 12 Cl 6.6685 6.9302 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 4.0012 3.8501 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 N 4.0012 6.9302 0.0 0
M  V30 18 C 2.6673 6.1601 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 1.3337 6.9302 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 22 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 12 15
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 1 17 18
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,2-dihydro-1-methylbenzo[b][1,8]naphthyridine-3-carboxylate
C15H14N2O2
1296240-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.0000 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 O 10.6697 3.8501 0.0 0
M  V30 4 O 9.3360 6.1601 0.0 0
M  V30 5 C 12.0033 4.6201 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 N 4.0012 1.5400 0.0 0
M  V30 9 N 6.6685 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 1.3337 1.5400 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1173927-42-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1296240-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1548222
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction monitored by TLC; "base-free" one-pot two step amination, no
solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Base-free amination of BH acetates of
2-chloroquinolinyl-3-carboxaldehydes: a facile route to the synthesis of
N-substituted-1,2-dihydrobenzo[b][1,8]naphthyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Bhawana; Chandra, Atish; Singh, Radhey M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(13), 2441-2446

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Methyl β-(acetyloxy)-2-chloro-α-methylene-3-quinolinepropanoate
C16H14ClNO4
1173927-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.8501 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 O 6.6685 2.3101 0.0 0
M  V30 4 C 9.3360 3.8501 0.0 0
M  V30 5 C 8.0022 6.1601 0.0 0
M  V30 6 C 5.3348 1.5400 0.0 0
M  V30 7 O 10.6697 4.6201 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 O 4.0012 2.3101 0.0 0
M  V30 11 C 12.0033 3.8501 0.0 0
M  V30 12 Cl 6.6685 6.9302 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 4.0012 3.8501 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 N 4.0012 6.9302 0.0 0
M  V30 18 C 2.6673 6.1601 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 1.3337 6.9302 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 22 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 12 15
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 1 17 18
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,2-dihydro-1-methylbenzo[b][1,8]naphthyridine-3-carboxylate
C15H14N2O2
1296240-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.0000 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 O 10.6697 3.8501 0.0 0
M  V30 4 O 9.3360 6.1601 0.0 0
M  V30 5 C 12.0033 4.6201 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 N 4.0012 1.5400 0.0 0
M  V30 9 N 6.6685 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 1.3337 1.5400 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1173927-42-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1296240-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5788538
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction monitored by TLC; "base-free" one-pot two step amination
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Base-free amination of BH acetates of
2-chloroquinolinyl-3-carboxaldehydes: a facile route to the synthesis of
N-substituted-1,2-dihydrobenzo[b][1,8]naphthyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Bhawana; Chandra, Atish; Singh, Radhey M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(13), 2441-2446

$RFMT $RIREG SCHEME91 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatoic anhydride
C8H5NO3
118-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Carboxybenzaldehyde
C8H6O3
119-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1,2,3,4-Tetrahydro-3-methyl-4-oxo-2-quinazolinyl)benzoic acid
C16H14N2O3
2056875-22-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 6.6687 0.0 0
M  V30 2 C 3.0801 1.3338 0.0 0
M  V30 3 O 2.3101 0.0000 0.0 0
M  V30 4 O 4.6201 1.3338 0.0 0
M  V30 5 O 7.7002 6.6687 0.0 0
M  V30 6 C 4.6201 4.0012 0.0 0
M  V30 7 N 5.3901 2.6675 0.0 0
M  V30 8 N 5.3901 5.3348 0.0 0
M  V30 9 C 6.9302 2.6675 0.0 0
M  V30 10 C 6.9302 5.3348 0.0 0
M  V30 11 C 7.7002 4.0012 0.0 0
M  V30 12 C 7.7002 1.3338 0.0 0
M  V30 13 C 9.2402 4.0012 0.0 0
M  V30 14 C 9.2402 1.3338 0.0 0
M  V30 15 C 10.0102 2.6675 0.0 0
M  V30 16 C 3.0801 4.0012 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 0.7700 2.6675 0.0 0
M  V30 20 C 0.7700 5.3348 0.0 0
M  V30 21 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 2 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 11
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-48-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 119-67-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2056875-22-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21079885
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52337-09-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of 2,3-dihydroquinazolin-4(1H)-ones catalyzed by
titanium silicon oxide nanopowder in aqueous media
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mekala, Ramamohan; Madhubabu, M. V.; Dhanunjaya, G.; Regati, Sridhar;
Chandrasekhar, K. B.; Sarva, Jayaprakash
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2017), 47(2), 121-130

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4,5,6,7-tetrabromo-1H-benzimidazole-1-acetate
C11H8Br4N2O2
1196457-24-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.3777 0.0 0
M  V30 2 C 8.7355 2.9019 0.0 0
M  V30 3 O 9.8799 3.9323 0.0 0
M  V30 4 O 9.0557 1.3956 0.0 0
M  V30 5 C 11.3446 3.4564 0.0 0
M  V30 6 C 12.4890 4.4869 0.0 0
M  V30 7 Br 4.6201 5.3350 0.0 0
M  V30 8 Br 1.5400 0.0000 0.0 0
M  V30 9 Br 1.5400 5.3350 0.0 0
M  V30 10 Br 0.0000 2.6675 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 3.8501 1.3338 0.0 0
M  V30 13 N 6.1264 2.3473 0.0 0
M  V30 14 C 3.8501 4.0011 0.0 0
M  V30 15 C 2.3100 1.3338 0.0 0
M  V30 16 N 4.8805 0.1893 0.0 0
M  V30 17 C 6.2873 0.8158 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 1.5400 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 14
M  V30 8 1 8 15
M  V30 9 1 9 18
M  V30 10 1 10 19
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6,7-Tetrabromo-N-methyl-1H-benzimidazole-1-acetamide
C10H7Br4N3O
1196457-30-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 1.9572 0.0 0
M  V30 2 C 8.7355 2.4330 0.0 0
M  V30 3 N 9.8799 1.4026 0.0 0
M  V30 4 O 9.0557 3.9393 0.0 0
M  V30 5 C 11.3446 1.8785 0.0 0
M  V30 6 Br 4.6200 0.0000 0.0 0
M  V30 7 Br 1.5400 5.3349 0.0 0
M  V30 8 Br 1.5400 0.0000 0.0 0
M  V30 9 Br 0.0000 2.6674 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 N 6.1264 2.9876 0.0 0
M  V30 13 C 3.8500 1.3338 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 N 4.8806 5.1456 0.0 0
M  V30 16 C 6.2874 4.5191 0.0 0
M  V30 17 C 2.3100 1.3338 0.0 0
M  V30 18 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 13
M  V30 7 1 7 14
M  V30 8 1 8 17
M  V30 9 1 9 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1196457-24-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1196457-30-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3374875
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gianoncelli, Alessandra; Cozza, Giorgio; Orzeszko, Andrzej; Meggio,
Flavio; Kazimierczuk, Zygmunt; Pinna, Lorenzo A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2009), 17(20), 7281-7289

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-[5-(Dimethylamino)-6,8-quinolinediyl]bis[2,2,2-trifluoroethanone]
C15H10F6N2O2
1197821-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.6437 0.0 0
M  V30 2 C 1.3337 2.1037 0.0 0
M  V30 3 C 0.0000 4.4137 0.0 0
M  V30 4 C 6.6685 6.7238 0.0 0
M  V30 5 C 8.0023 5.9538 0.0 0
M  V30 6 O 6.6685 8.2638 0.0 0
M  V30 7 F 8.7723 7.2874 0.0 0
M  V30 8 F 9.3360 5.1838 0.0 0
M  V30 9 F 7.2323 4.6201 0.0 0
M  V30 10 C 4.0012 2.1037 0.0 0
M  V30 11 C 5.3348 1.3337 0.0 0
M  V30 12 O 2.6675 1.3337 0.0 0
M  V30 13 F 6.1048 2.6673 0.0 0
M  V30 14 F 6.6685 0.5637 0.0 0
M  V30 15 F 4.5648 0.0000 0.0 0
M  V30 16 C 2.6675 5.9538 0.0 0
M  V30 17 C 4.0012 6.7238 0.0 0
M  V30 18 C 2.6675 4.4137 0.0 0
M  V30 19 C 1.3337 6.7238 0.0 0
M  V30 20 C 5.3348 5.9538 0.0 0
M  V30 21 N 4.0012 8.2638 0.0 0
M  V30 22 C 4.0012 3.6437 0.0 0
M  V30 23 C 1.3337 8.2638 0.0 0
M  V30 24 C 5.3348 4.4137 0.0 0
M  V30 25 C 2.6675 9.0338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 20
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 22
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 2 18 22
M  V30 22 2 19 23
M  V30 23 2 20 24
M  V30 24 2 21 25
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-[5-(Methylamino)-6,8-quinolinediyl]bis[2,2,2-trifluoroethanone]
C14H8F6N2O2
1359873-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.7238 0.0 0
M  V30 2 C 8.0023 5.9538 0.0 0
M  V30 3 O 6.6685 8.2638 0.0 0
M  V30 4 F 8.7723 7.2874 0.0 0
M  V30 5 F 9.3360 5.1838 0.0 0
M  V30 6 F 7.2323 4.6201 0.0 0
M  V30 7 N 1.3337 3.6437 0.0 0
M  V30 8 C 0.0000 4.4137 0.0 0
M  V30 9 C 4.0012 2.1037 0.0 0
M  V30 10 C 5.3348 1.3337 0.0 0
M  V30 11 O 2.6675 1.3337 0.0 0
M  V30 12 F 4.5648 0.0000 0.0 0
M  V30 13 F 6.6685 0.5637 0.0 0
M  V30 14 F 6.1048 2.6673 0.0 0
M  V30 15 C 4.0012 6.7238 0.0 0
M  V30 16 C 2.6675 5.9538 0.0 0
M  V30 17 C 5.3348 5.9538 0.0 0
M  V30 18 N 4.0012 8.2638 0.0 0
M  V30 19 C 2.6675 4.4137 0.0 0
M  V30 20 C 1.3337 6.7238 0.0 0
M  V30 21 C 5.3348 4.4137 0.0 0
M  V30 22 C 2.6675 9.0338 0.0 0
M  V30 23 C 4.0012 3.6437 0.0 0
M  V30 24 C 1.3337 8.2638 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 8
M  V30 8 1 7 19
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 23
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 2 19 23
M  V30 23 2 20 24
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1197821-11-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1359873-19-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-6955797
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile and convenient method for the synthesis of
6,8-bis(trifluoroacetyl)quinolin-5-amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shibata, Dai; Medebielle, Maurice; Hatakenaka, Mizuki; Okada, Etsuji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2012), 84(2), 1277-1284

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-α-(methoxyimino)-2-[[[3-(4-methoxyphenyl)-1-methyl-1H-pyrazol-5-y...
C22H23N3O5
1202873-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 6.7115 0.0 0
M  V30 2 C 4.6200 6.7115 0.0 0
M  V30 3 N 2.3100 8.0453 0.0 0
M  V30 4 O 5.3900 8.0453 0.0 0
M  V30 5 O 5.3900 5.3779 0.0 0
M  V30 6 O 0.7700 8.0453 0.0 0
M  V30 7 C 4.6200 9.3790 0.0 0
M  V30 8 C 0.0000 9.3790 0.0 0
M  V30 9 C 4.6200 4.0442 0.0 0
M  V30 10 O 5.3900 2.7106 0.0 0
M  V30 11 C 7.3592 0.0000 0.0 0
M  V30 12 O 14.2834 7.1013 0.0 0
M  V30 13 C 15.6902 6.4750 0.0 0
M  V30 14 C 2.3100 5.3779 0.0 0
M  V30 15 C 3.0800 4.0442 0.0 0
M  V30 16 C 0.7700 5.3779 0.0 0
M  V30 17 C 2.3100 2.7106 0.0 0
M  V30 18 C 0.0000 4.0442 0.0 0
M  V30 19 C 0.7700 2.7106 0.0 0
M  V30 20 C 6.9300 2.7106 0.0 0
M  V30 21 C 7.8353 3.9564 0.0 0
M  V30 22 N 7.8353 1.4647 0.0 0
M  V30 23 C 9.2998 3.4806 0.0 0
M  V30 24 N 9.2998 1.9406 0.0 0
M  V30 25 C 10.5457 4.3858 0.0 0
M  V30 26 C 10.3847 5.9173 0.0 0
M  V30 27 C 11.9526 3.7593 0.0 0
M  V30 28 C 11.6306 6.8225 0.0 0
M  V30 29 C 13.1985 4.6645 0.0 0
M  V30 30 C 13.0376 6.1961 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 1 10 20
M  V30 12 1 11 22
M  V30 13 1 12 13
M  V30 14 1 12 30
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-α-(Methoxyimino)-2-[[[3-(4-methoxyphenyl)-1-methyl-1H-pyrazol-5-yl]oxy]m...
C22H24N4O4
1202873-85-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 6.7115 0.0 0
M  V30 2 C 4.6200 6.7115 0.0 0
M  V30 3 N 2.3100 8.0453 0.0 0
M  V30 4 N 5.3900 8.0453 0.0 0
M  V30 5 O 5.3900 5.3779 0.0 0
M  V30 6 O 0.7700 8.0453 0.0 0
M  V30 7 C 4.6200 9.3790 0.0 0
M  V30 8 C 0.0000 9.3790 0.0 0
M  V30 9 C 4.6200 4.0442 0.0 0
M  V30 10 O 5.3900 2.7106 0.0 0
M  V30 11 C 7.3592 0.0000 0.0 0
M  V30 12 O 14.2834 7.1013 0.0 0
M  V30 13 C 15.6902 6.4750 0.0 0
M  V30 14 C 2.3100 5.3779 0.0 0
M  V30 15 C 3.0800 4.0442 0.0 0
M  V30 16 C 0.7700 5.3779 0.0 0
M  V30 17 C 2.3100 2.7106 0.0 0
M  V30 18 C 0.0000 4.0442 0.0 0
M  V30 19 C 0.7700 2.7106 0.0 0
M  V30 20 C 6.9300 2.7106 0.0 0
M  V30 21 C 7.8353 3.9564 0.0 0
M  V30 22 N 7.8353 1.4647 0.0 0
M  V30 23 C 9.2998 3.4806 0.0 0
M  V30 24 N 9.2998 1.9406 0.0 0
M  V30 25 C 10.5457 4.3858 0.0 0
M  V30 26 C 10.3847 5.9173 0.0 0
M  V30 27 C 11.9526 3.7593 0.0 0
M  V30 28 C 11.6306 6.8225 0.0 0
M  V30 29 C 13.1985 4.6645 0.0 0
M  V30 30 C 13.0376 6.1961 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 1 10 20
M  V30 12 1 11 22
M  V30 13 1 12 13
M  V30 14 1 12 30
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1202873-73-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1202873-85-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4204068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Procedure for the Synthesis of the Compounds
6. The compounds 5 (3.00 mmol) were dissolved in 5 mL of THF, and a
slight excess of a methylamine solution (25-30%) was added dropwise to
the solution. The mixture was refluxed for 1 h (the reaction was
monitored by TLC) and then concentrated. Water was added to the residue
and extracted three times with 50mL of ethyl acetate, and the combined
organic extracts were dried and concentrated. The crude product was
purified via silica gel column chromatography. The compounds 6. Compound
6f: Yield 91.0% of oil. 1H NMR (300 MHz, CDCl3) δ7.62-7.64 (m, 1H,
Ph-6-H), 7.42-7.46 (m, 2H, 3-Ph-2,6-2H), 7.34-7.40 (m, 3H, Ph-3,4,5-3H),
7.21-7.25 (m, 2H, 3-Ph-3,5-2H), 6.78 (m, 1H, NH), 5.80 (s, 1H, Py-4-H),
5.04 (s, 2H, CH2), 3.96 (s, 3H, OCH3), 3.82 (s, 3H, Ph-OCH3), 3.68 (s,
3H, NCH3), 2.91-2.93 (d, J=4.8HZ, 3H, NHCH3); Anal. Calcd for: C, 64.69;
H, 5.92; N, 13.72; Found: C, 64.85; H, 5.83; N, 13.80.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biological Activity of New
(E)-α-(Methoxyimino)benzeneacetate Derivatives Containing a Substituted
Pyrazole Ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Miao; Liu, Chang-Ling; Yang, Ji-Chun; Zhang, Jin-Bo; Li, Zhi-Nian;
Zhang, Hong; Li, Zheng-Ming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Agricultural and Food Chemistry (2010), 58(5), 2664-2667

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[[3-(4-chlorophenyl)-1,4-dimethyl-1H-pyrazol-5-yl]oxy]methyl]-...
C22H22ClN3O4
1202873-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.0630 6.7528 0.0 0
M  V30 2 O 8.0023 5.3901 0.0 0
M  V30 3 C 6.6686 4.6201 0.0 0
M  V30 4 C 8.3525 2.0579 0.0 0
M  V30 5 Cl 17.8997 4.7459 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 N 2.6675 2.3100 0.0 0
M  V30 9 O 5.3348 0.7700 0.0 0
M  V30 10 O 6.6686 3.0800 0.0 0
M  V30 11 O 1.3338 3.0800 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 11.7733 4.1020 0.0 0
M  V30 15 C 10.7429 5.2464 0.0 0
M  V30 16 N 11.0033 2.7683 0.0 0
M  V30 17 C 9.3359 4.6201 0.0 0
M  V30 18 N 9.4968 3.0885 0.0 0
M  V30 19 C 13.3049 4.2629 0.0 0
M  V30 20 C 14.2101 3.0171 0.0 0
M  V30 21 C 13.9312 5.6699 0.0 0
M  V30 22 C 15.7416 3.1780 0.0 0
M  V30 23 C 15.4629 5.8308 0.0 0
M  V30 24 C 16.3680 4.5849 0.0 0
M  V30 25 C 5.3348 5.3901 0.0 0
M  V30 26 C 4.0011 4.6201 0.0 0
M  V30 27 C 5.3348 6.9301 0.0 0
M  V30 28 C 2.6675 5.3901 0.0 0
M  V30 29 C 4.0011 7.7001 0.0 0
M  V30 30 C 2.6675 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 3 25
M  V30 5 1 4 18
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 26
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 19
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[[3-(4-Chlorophenyl)-1,4-dimethyl-1H-pyrazol-5-yl]oxy]methyl]-α-(meth...
C22H23ClN4O3
1202873-88-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.0630 6.7528 0.0 0
M  V30 2 O 8.0023 5.3901 0.0 0
M  V30 3 C 6.6686 4.6201 0.0 0
M  V30 4 C 8.3525 2.0579 0.0 0
M  V30 5 Cl 17.8997 4.7459 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 N 2.6675 2.3100 0.0 0
M  V30 9 N 5.3348 0.7700 0.0 0
M  V30 10 O 6.6686 3.0800 0.0 0
M  V30 11 O 1.3338 3.0800 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 11.7733 4.1020 0.0 0
M  V30 15 C 10.7429 5.2464 0.0 0
M  V30 16 N 11.0033 2.7683 0.0 0
M  V30 17 C 9.3359 4.6201 0.0 0
M  V30 18 N 9.4968 3.0885 0.0 0
M  V30 19 C 13.3049 4.2629 0.0 0
M  V30 20 C 13.9312 5.6699 0.0 0
M  V30 21 C 14.2101 3.0171 0.0 0
M  V30 22 C 15.4629 5.8308 0.0 0
M  V30 23 C 15.7416 3.1780 0.0 0
M  V30 24 C 16.3680 4.5849 0.0 0
M  V30 25 C 5.3348 5.3901 0.0 0
M  V30 26 C 4.0011 4.6201 0.0 0
M  V30 27 C 5.3348 6.9301 0.0 0
M  V30 28 C 2.6675 5.3901 0.0 0
M  V30 29 C 4.0011 7.7001 0.0 0
M  V30 30 C 2.6675 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 3 25
M  V30 5 1 4 18
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 26
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 19
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1202873-76-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1202873-88-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2362826
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Procedure for the Synthesis of the Compounds
6. The compounds 5 (3.00 mmol) were dissolved in 5 mL of THF, and a
slight excess of a methylamine solution (25-30%) was added dropwise to
the solution. The mixture was refluxed for 1 h (the reaction was
monitored by TLC) and then concentrated. Water was added to the residue
and extracted three times with 50mL of ethyl acetate, and the combined
organic extracts were dried and concentrated. The crude product was
purified via silica gel column chromatography. The compounds 6. Compound
6i: Yield 90.6% of oil. IR(KBr)ν: 3230(s, NH), 2925 (s, C-H), 1660 (s,
C=O), 1500 (s, C=N), 1460 (s, CH3), 1300 (m, C-N), 1180 (s, C-O), 840,
750 (s, Ph-H)cm-1; 1H NMR (300 MHz, CDCl3) δ7.59-7.61 (m, 1H, Ph-6-H),
7.40-7.45 (m, 4H, 3-Ph-2,3,5,6-4H), 7.23-7.25 (m, 2H, Ph-3,5-2H), 7.23
(m, 1H, Ph-4-H), 6.78 (b s, 1H, NH), 5.14 (s, 2H, CH2), 3.96 (s, 3H,
OCH3), 3.60 (s, 3H, NCH3), 2.89-2.91 (d, J=4.5HZ, 3H, NHCH3), 1.83 (s,
3H, Py-CH3); Anal. Calcd for: C, 61.90; H, 5.43; N, 13.12; Found: C,
61.79; H, 5.50; N, 13.17.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biological Activity of New
(E)-α-(Methoxyimino)benzeneacetate Derivatives Containing a Substituted
Pyrazole Ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Miao; Liu, Chang-Ling; Yang, Ji-Chun; Zhang, Jin-Bo; Li, Zhi-Nian;
Zhang, Hong; Li, Zheng-Ming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Agricultural and Food Chemistry (2010), 58(5), 2664-2667

$RFMT $RIREG SCHEME96 STEP1
$RXN



  4  1
$MOL
Oxfenicine
C8H9NO3
32462-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.1601 0.0 0 CFG=2
M  V30 2 C 1.3337 6.9302 0.0 0
M  V30 3 N 4.0010 6.9302 0.0 0
M  V30 4 O 0.0000 6.1601 0.0 0
M  V30 5 O 1.3337 8.4702 0.0 0
M  V30 6 O 2.6673 0.0000 0.0 0
M  V30 7 C 2.6673 4.6201 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 1.3337 3.8501 0.0 0
M  V30 10 C 4.0010 2.3101 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-carboxaldehyde
C8H6O3
120-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 O 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trifluoroacetic anhydride
C4F6O3
407-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 C 6.6687 2.3101 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 C 1.3337 2.3101 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 F 8.0023 3.0801 0.0 0
M  V30 9 F 5.8986 3.6437 0.0 0
M  V30 10 F 7.4387 0.9764 0.0 0
M  V30 11 F 0.0000 3.0801 0.0 0
M  V30 12 F 2.1037 3.6437 0.0 0
M  V30 13 F 0.5637 0.9764 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-[(1,3-Benzodioxol-5-ylmethyl)(2,2,2-trifluoroacetyl)amino]-4-hydroxy-N...
C19H17F3N2O5
461664-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1600 0.0 0 CFG=1
M  V30 2 N 5.3347 6.9300 0.0 0
M  V30 3 C 2.6673 6.9300 0.0 0
M  V30 4 C 6.6684 6.1600 0.0 0
M  V30 5 C 5.3347 8.4700 0.0 0
M  V30 6 N 1.3336 6.1600 0.0 0
M  V30 7 O 2.6673 8.4700 0.0 0
M  V30 8 C 4.0011 9.2400 0.0 0
M  V30 9 O 6.6684 9.2400 0.0 0
M  V30 10 C 0.0000 6.9300 0.0 0
M  V30 11 F 2.6673 10.0101 0.0 0
M  V30 12 F 4.7711 10.5737 0.0 0
M  V30 13 F 3.2311 7.9064 0.0 0
M  V30 14 O 4.0011 0.0000 0.0 0
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 2.6673 3.8500 0.0 0
M  V30 17 C 5.3347 3.8500 0.0 0
M  V30 18 C 2.6673 2.3100 0.0 0
M  V30 19 C 5.3347 2.3100 0.0 0
M  V30 20 C 4.0011 1.5400 0.0 0
M  V30 21 C 8.0020 6.9300 0.0 0
M  V30 22 C 9.3358 6.1600 0.0 0
M  V30 23 C 8.0020 8.4700 0.0 0
M  V30 24 C 10.6695 6.9300 0.0 0
M  V30 25 C 9.3358 9.2400 0.0 0
M  V30 26 C 10.6695 8.4700 0.0 0
M  V30 27 O 12.1340 6.4542 0.0 0
M  V30 28 O 12.1340 8.9459 0.0 0
M  V30 29 C 13.0392 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 21
M  V30 9 1 5 8
M  V30 10 2 5 9
M  V30 11 1 6 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 14 20
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 24 27
M  V30 28 2 25 26
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 32462-30-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 120-57-0
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 407-25-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 461664-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-688018
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 129037-71-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reagent, PS-borohydride stage 5, polyvinylpyridine and
poly-DMAP stage 6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of the amaryllidaceae alkaloid (+)-plicamine and its
unnatural enantiomer by using solid-supported reagents and scavengers in
a multistep sequence of reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baxendale, Ian R.; Ley, Steven V.; Piutti, Claudia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2002), 41(12), 2194-2197

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-Chloroacridine
C13H8ClN
1207-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 C 2.6674 3.8500 0.0 0
M  V30 3 C 2.6674 2.3100 0.0 0
M  V30 4 N 4.0011 4.6200 0.0 0
M  V30 5 C 1.3336 4.6200 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 0.0000 3.8500 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 6.6685 4.6200 0.0 0
M  V30 13 C 6.6685 1.5400 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 10 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-9-acridinamine
C14H12N2
22739-29-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 2.6675 4.6201 0.0 0
M  V30 6 C 1.3337 2.3100 0.0 0
M  V30 7 C 5.3348 3.0800 0.0 0
M  V30 8 N 4.0011 5.3901 0.0 0
M  V30 9 C 1.3337 5.3901 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 6.6686 2.3100 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 6.6686 5.3901 0.0 0
M  V30 15 C 8.0022 3.0800 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 2 8 11
M  V30 13 2 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1207-69-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22739-29-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5671866
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-95-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A real-time fluorescence assay for measuring N-dealkylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mayer, Richard T.; Dolence, E. Kurt; Mayer, Gabriele E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Drug Metabolism and Disposition (2007), 35(1), 103-109

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-Chloroacridine
C13H8ClN
1207-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 C 2.6674 3.8500 0.0 0
M  V30 3 C 2.6674 2.3100 0.0 0
M  V30 4 N 4.0011 4.6200 0.0 0
M  V30 5 C 1.3336 4.6200 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 0.0000 3.8500 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 6.6685 4.6200 0.0 0
M  V30 13 C 6.6685 1.5400 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 10 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-9-acridinamine
C14H12N2
22739-29-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 2.6675 4.6201 0.0 0
M  V30 6 C 1.3337 2.3100 0.0 0
M  V30 7 C 5.3348 3.0800 0.0 0
M  V30 8 N 4.0011 5.3901 0.0 0
M  V30 9 C 1.3337 5.3901 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 6.6686 2.3100 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 6.6686 5.3901 0.0 0
M  V30 15 C 8.0022 3.0800 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 2 8 11
M  V30 13 2 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1207-69-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22739-29-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2631990
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE I Synthesis of 9-N-(methylamino)acridine Free Amine [0018]
9-N-(Methylamino)acridine is prepared by the following reaction (Scheme
I), the details of which are described herein below. [0019] Anhydrous
phenol (22.0 g, 234.1 mmoles) was placed into a 250 mL 3-neck round
bottom flask equipped with a magnetic stirring bar, reflux condenser,
thermometer, dry ice/acetone condenser and positive pressure nitrogen
source. Anhydrous chloroform (100 mL) was added and the mixture stirred
and cooled in a sodium chloride ice bath until the internal temperature
was −10° C. The dry ice condenser was filled with acetone and dry ice
while using caution that the system remained under a positive atmosphere
of nitrogen. Methylamine gas flow was slowly initiated resulting in
condensation of the gas to a liquid and this process was continued until
the phenol/chloroform solution was saturated. Saturation was determined
by initiation of refluxing of methylamine upon removal of the cooling
bath. To this solution at an internal temperature of −10° C. was added
dropwise using an addition funnel a solution of 9-chloroacridine (5.0 g,
23.4 mmoles) in 25 mL of anhydrous chloroform. This was followed by
another 25 mL anhydrous chloroform to complete the addition. The reaction
mixture was stirred for 1 hour at -10° C. then warmed to room temperature
and stirred for 2 hours. During this ambient temperature stirring the dry
ice acetone condenser was kept full to help prevent escape of the
methylamine from the reaction vessel. At the end of this 2 hour period
the solution was slowly warmed to an internal temperature of 50-55° C.
using an oil bath. The mixture was maintained at this temperature
overnight. Sampling of the reaction mixture and analysis by gas
chromatography/mass spectroscopy indicated the absence of starting
9-chloroacridine (tR=6.4 minutes) and the appearance of a new peak at
tR=7.5 minutes corresponding to the desired product. This GC/EI-MS was
obtained on an Agilent model 6890 and 5973 instrument and an Agilent
Technologies HP-5MS 30 m×0.25 mm 0.25 μm capillary column utilizing the
following temperature run profile: Starting at 150° C. for 1 minute then
ramping at 25° C. per minute to 300° C. and holding for 4 minutes. [0020]
The reaction mixture was cooled to room temperature and transferred to a
500 mL separatory funnel with the aid of 50 mL of chloroform. This
solution was washed with 100 mL of 13% aqueous sodium hydroxide solution.
This aqueous phase was extracted with 100 mL choroform. The pooled
organic phases were washed with one 100 mL portion of 10% aqueous sodium
hydroxide and two 100 mL portions of saturated aqueous sodium chloride
solution, then dried over solid anhydrous sodium sulfate and finally
filtered through a bed of sodium sulfate. This solution was concentrated
to dryness by rotary evaporation to afford a yellow/brown solid. The
solid was dissolved in 200 mL of boiling hot anhydrous acetonitrile and
left to cool under a nitrogen environment at ambient room temperature
resulting in crystallization. The solid was collected by suction
filtration and washed with hexanes. The mother liquor was concentrated
and a second crop of crystals obtained similar to that described above.
The solid material was dried under high vacuum overnight to afford 4.431
grams (91% yield) of a yellow powder as the free base. [0021]
Characterization data: MP 172-173° C. (uncorrected); GC/EI-MS tR=7.47
minutes; m/z 208; 1H NMR (CDCl3) δ 8.13 (d, 2H, J=8.8 Hz, aromatic), 8.03
(d, 2H, J =8.7 Hz, aromatic), 7.62 (t, 2H, J =7.1 and 8.1 Hz, aromatic),
7.29 (t, 2H, J=7.4 and 8.0 Hz, aromatic), 5.72 (br s, 1H, NH), 3.51 (s,
3H, CH3); 13C NMR (CDCl3) δ 151.93, 149.12, 129.77, 128.93, 122.85,
122.47, 115.82, 37.44; Anal. Calcd for C14H12N2 (208): C, 80.74; H, 5.81;
N, 13.45. Found: C, 80.09; H, 5.84; N, 13.22.
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM assays employing novel 9-N-alkylacridine substrates for measuring P
450-mediated N-dealkylation, and drug screening applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mayer, Gabriele E.; Dolence, E. Kurt; Mayer, Richard T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070015235 A1 2007-01-18

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-nitro-4-(trifluoromethyl)benzene
C7H3ClF3NO2
121-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 3.0801 0.0 0 VAL=5
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 Cl 6.6687 0.0000 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 F 2.1037 4.4137 0.0 0
M  V30 7 F 0.0000 3.8501 0.0 0
M  V30 8 F 0.5638 1.7464 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitro-4-(trifluoromethyl)aniline
C8H7F3N2O2
20200-22-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3336 0.0 0 VAL=5
M  V30 2 O 0.7700 1.3336 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 N 0.7700 4.0009 0.0 0
M  V30 5 C 0.0000 5.3347 0.0 0
M  V30 6 C 6.9300 4.0009 0.0 0
M  V30 7 F 6.9300 2.4609 0.0 0
M  V30 8 F 8.4700 4.0009 0.0 0
M  V30 9 F 6.9300 5.5409 0.0 0
M  V30 10 C 3.0800 2.6673 0.0 0
M  V30 11 C 2.3100 4.0009 0.0 0
M  V30 12 C 4.6200 2.6673 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 5.3900 4.0009 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121-17-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20200-22-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38331811
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Insecticidal Activity of Novel Trifluoromethylbenzimidazole
Linked N-Phenylamide Compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shi, Jian-Jun; Li, Wei-Wei; Tan, Cheng-Xia; Hu, Dong-Song; Han, Liang;
Xu, Tian-Ming; Liu, Xing-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2024), 44(9), 6125-6135

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-5-fluorobenzenesulfonyl chloride
C6H3BrClFO2S
1214342-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 4.6201 0.0 0 VAL=6
M  V30 2 Cl 0.0000 5.3901 0.0 0
M  V30 3 O 0.5638 3.2864 0.0 0
M  V30 4 O 2.1038 5.9538 0.0 0
M  V30 5 Br 6.6687 4.6201 0.0 0
M  V30 6 F 4.0012 0.0000 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-5-fluoro-N-methylbenzenesulfonamide
C7H7BrFNO2S
1198614-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 2 N 6.6687 5.3901 0.0 0
M  V30 3 O 6.1048 3.2864 0.0 0
M  V30 4 O 4.5648 5.9538 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 Br 0.0000 4.6201 0.0 0
M  V30 7 F 2.6675 0.0000 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6675 1.5400 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1214342-44-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1198614-92-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32027530
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-[(1H-pyrazol-4-yl)oxy]pyrazin-2-amine compounds as HPK1
inhibitor and application
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Sanjia; Li, Jing; Wang, Zhiwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022068848 A1 2022-04-07

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3R)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-ca...
C15H15ClN2O3
1217811-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.4000 2.6673 0.0 0
M  V30 2 O 6.6300 1.3336 0.0 0
M  V30 3 O 8.9401 2.6673 0.0 0
M  V30 4 C 7.4000 0.0000 0.0 0
M  V30 5 C 8.9401 5.3347 0.0 0
M  V30 6 C 9.7101 6.6684 0.0 0
M  V30 7 O 9.7101 4.0009 0.0 0
M  V30 8 Cl 11.2501 6.6684 0.0 0
M  V30 9 C 4.3200 5.3347 0.0 0
M  V30 10 C 2.8137 5.6549 0.0 0
M  V30 11 C 5.0900 6.6684 0.0 0
M  V30 12 C 5.0900 4.0009 0.0 0
M  V30 13 C 2.6527 7.1864 0.0 0
M  V30 14 C 1.5679 4.7497 0.0 0
M  V30 15 C 6.6300 6.6684 0.0 0
M  V30 16 N 4.0596 7.8128 0.0 0
M  V30 17 C 6.6300 4.0009 0.0 0 CFG=2
M  V30 18 C 1.2459 7.8128 0.0 0
M  V30 19 C 0.1609 5.3760 0.0 0
M  V30 20 N 7.4000 5.3347 0.0 0
M  V30 21 C 0.0000 6.9076 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 17 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 20
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 1 13 16
M  V30 18 2 13 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 2 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(12aR)-2,3,6,7,12,12a-Hexahydro-2-methylpyrazino[1′,2′:1,6]pyrido[3,4-b]indol...
C15H15N3O2
2245250-32-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 6.1600 0.0 0
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 C 0.0000 4.6200 0.0 0
M  V30 4 C 6.6684 3.8500 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0
M  V30 6 C 8.1331 4.3259 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 5.3347 1.5400 0.0 0
M  V30 9 N 8.1331 1.8341 0.0 0
M  V30 10 C 9.0383 3.0800 0.0 0
M  V30 11 C 8.7594 5.7328 0.0 0
M  V30 12 C 4.0011 3.8500 0.0 0 CFG=2
M  V30 13 N 4.0011 2.3100 0.0 0
M  V30 14 C 10.5698 3.2409 0.0 0
M  V30 15 C 10.2909 5.8937 0.0 0
M  V30 16 C 2.6673 4.6200 0.0 0
M  V30 17 C 2.6673 1.5400 0.0 0
M  V30 18 C 11.1961 4.6479 0.0 0
M  V30 19 N 1.3336 3.8500 0.0 0
M  V30 20 C 1.3336 2.3100 0.0 0
M  V30 21 H 4.0011 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 2 2 17
M  V30 3 1 3 19
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 10
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 12 16
M  V30 18 1 12 21 CFG=3
M  V30 19 1 13 17
M  V30 20 1 14 18
M  V30 21 2 15 18
M  V30 22 1 16 19
M  V30 23 1 17 20
M  V30 24 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1217811-48-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2245250-32-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-19204585
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of furyl/thienyl β-carboline derivatives as potent and
selective PDE5 inhibitors with excellent vasorelaxant effect
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zheng, Hongbo; Wu, Yifeng; Sun, Bin; Cheng, Chuanle; Qiao, Yanan; Jiang,
Yuehua; Zhao, Shengtian; Xie, Zhiyu; Tan, Jing; Lou, Hongxiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 158767-780

$RFMT $RIREG SCHEME101 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Phenyl-3-buten-2-one
C10H10O
122-57-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-(1,2-Ethynediyl)bis[4-chlorobenzene]
C14H8Cl2
1820-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.3336 0.0 0
M  V30 2 C 7.7000 1.3336 0.0 0
M  V30 3 Cl 0.0000 1.3336 0.0 0
M  V30 4 Cl 13.8600 1.3336 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 1.5400 1.3336 0.0 0
M  V30 11 C 9.2400 1.3336 0.0 0
M  V30 12 C 10.0100 0.0000 0.0 0
M  V30 13 C 10.0100 2.6673 0.0 0
M  V30 14 C 11.5500 0.0000 0.0 0
M  V30 15 C 11.5500 2.6673 0.0 0
M  V30 16 C 12.3200 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 1 3 10
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyridinium, 2,3-bis(4-chlorophenyl)-1,6-dimethyl-4-phenyl-, tetrafluoroborate...
C25H20Cl2N.BF4
1651170-80-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 13.8602 0.0 0
M  V30 2 C 5.3348 15.4002 0.0 0
M  V30 3 Cl 5.3348 4.6200 0.0 0
M  V30 4 Cl 12.0033 8.4701 0.0 0
M  V30 5 C 5.3348 10.7801 0.0 0
M  V30 6 C 6.6685 11.5502 0.0 0
M  V30 7 C 4.0012 11.5502 0.0 0
M  V30 8 N 6.6685 13.0902 0.0 0 CHG=1 VAL=4
M  V30 9 C 4.0012 13.0902 0.0 0
M  V30 10 C 5.3348 13.8602 0.0 0
M  V30 11 C 5.3348 9.2401 0.0 0
M  V30 12 C 4.0012 8.4701 0.0 0
M  V30 13 C 6.6685 8.4701 0.0 0
M  V30 14 C 4.0012 6.9301 0.0 0
M  V30 15 C 6.6685 6.9301 0.0 0
M  V30 16 C 5.3348 6.1600 0.0 0
M  V30 17 C 8.0022 10.7801 0.0 0
M  V30 18 C 9.3360 11.5502 0.0 0
M  V30 19 C 8.0022 9.2401 0.0 0
M  V30 20 C 10.6697 10.7801 0.0 0
M  V30 21 C 9.3360 8.4701 0.0 0
M  V30 22 C 10.6697 9.2401 0.0 0
M  V30 23 C 2.6673 10.7801 0.0 0
M  V30 24 C 1.3337 11.5502 0.0 0
M  V30 25 C 2.6673 9.2401 0.0 0
M  V30 26 C 0.0000 10.7801 0.0 0
M  V30 27 C 1.3337 8.4701 0.0 0
M  V30 28 C 0.0000 9.2401 0.0 0
M  V30 29 B 6.0017 1.5400 0.0 0 CHG=3 VAL=4
M  V30 30 F 4.4617 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 31 F 7.5417 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 32 F 6.0017 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 33 F 6.0017 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 16
M  V30 4 1 4 22
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 6 17
M  V30 10 2 7 9
M  V30 11 1 7 23
M  V30 12 2 8 10
M  V30 13 1 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 29 32
M  V30 35 1 29 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-57-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1820-42-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1651170-80-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3372840
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 13755-29-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12354-85-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of
Pyridinium Salts from Unsaturated Ketones, Amines and Alkynes A sealed
tube containing [Cp*RhCl2]2 (1.0 mol %), NaBF4 (0.31 mmol) and
Cu(OAc)2.H2O (0.56 mmol) was evacuated and purged with nitrogen gas three
times. Then, vinyl ketone 1 (0.34 mmol), amine 2 (0.28 mmol) and alkyne 3
(0.34 mmol) in MeOH (2.0 mL) were added to the system via syringe under a
nitrogen atmosphere and the reaction was allowed to stir at 80 °C for 24
h. When the reaction was completed, the mixture was diluted with CH2Cl2
(10 mL) and filtered through a Celite pad and the Celite pad was washed
several times with CH2Cl2 (50 mL). The combined filtrate was concentrated
in vacuo and the residue was purified by column chromatography on silica
gel using DCM/MeOH (95:5) as eluent. The desired pure product 4.
1,6-Dimethyl-2,3,4-triphenylpyridin-1-ium tetrafluoroborate (4a)
2,3-Bis(4-chlorophenyl)-1,6-dimethyl-4-phenylpyridin-1-ium
tetrafluoroborate (4e) Brown solid (125 mg, 91%). m.p. 101-103 °C; 1H NMR
(400 MHz, CDCl3): δ 7.75 (s, 1 H), 7.34 (d, J = 8.4 Hz, 2 H), 7.28-7.25
(m, 3 H), 7.19 (t, J = 7.6 Hz, 2 H), 7.09 (d, J = 7.6 Hz, 2 H), 6.94 (d,
J = 8.4 Hz, 2 H), 6.78 (d, J = 8.4 Hz, 2 H), 3.97 (s, 3 H), 2.97 (s, 3
H); 13C NMR (100 MHz, CDCl3): δ 157.1 (C), 155.3 (C), 154.3 (C), 137.5
(C), 136.5 (C), 135.6 (C), 134.1 (C), 132.5 (C), 131.7 (2 CH), 130.9 (2
CH), 130.2 (C), 129.6 (CH), 129.5 (CH), 129.3 (2 CH), 129.0 (2 CH), 128.5
(2 CH), 128.3 (2 CH), 43.5 (CH3), 22.4 (CH3); HRMS (FAB+) cal for
C25H20Cl2N+ 404.0967, found 404.0972; IR (KBr): 3062, 2923, 2854, 1619,
1542, 1496, 1465, 1388, 1342, 1265 and 1056 (ν B-F) cm-1 .
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhodium(III)-Catalyzed Vinylic C-H Activation: A Direct Route toward
Pyridinium Salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luo, Ching-Zong; Jayakumar, Jayachandran; Gandeepan, Parthasarathy; Wu,
Yun-Ching; Cheng, Chien-Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(4), 924-927

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-8-methyl-2-(trifluoromethyl)imidazo[1,2-a]pyridine
C9H6F4N2
1227385-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 0.0000 0.0 0
M  V30 2 F 4.6078 5.7904 0.0 0
M  V30 3 C 6.5770 3.0800 0.0 0
M  V30 4 F 6.5770 4.6200 0.0 0
M  V30 5 F 8.1170 3.0800 0.0 0
M  V30 6 F 6.5770 1.5400 0.0 0
M  V30 7 C 2.6673 2.3100 0.0 0
M  V30 8 N 2.6673 3.8500 0.0 0
M  V30 9 N 4.1320 1.8340 0.0 0
M  V30 10 C 1.3336 1.5400 0.0 0
M  V30 11 C 4.1320 4.3259 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 5.0370 3.0800 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 13
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 13
M  V30 15 2 12 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,8-Dimethyl-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-amine
C10H10F3N3
1620629-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6078 1.1444 0.0 0
M  V30 2 C 3.5773 0.0000 0.0 0
M  V30 3 C 1.3336 6.9349 0.0 0
M  V30 4 C 6.5770 3.8549 0.0 0
M  V30 5 F 6.5770 5.3949 0.0 0
M  V30 6 F 8.1170 3.8549 0.0 0
M  V30 7 F 6.5770 2.3149 0.0 0
M  V30 8 N 2.6673 3.0849 0.0 0
M  V30 9 C 2.6673 4.6249 0.0 0
M  V30 10 C 4.1320 2.6091 0.0 0
M  V30 11 C 1.3336 2.3149 0.0 0
M  V30 12 N 4.1320 5.1008 0.0 0
M  V30 13 C 1.3336 5.3949 0.0 0
M  V30 14 C 5.0370 3.8549 0.0 0
M  V30 15 C 0.0000 3.0849 0.0 0
M  V30 16 C 0.0000 4.6249 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 14
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 2 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227385-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620629-52-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14816383
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
Methyl-(6-methyl-2-trifluoromethylimidazo[1,2-a]pyridin-3-yl)amine (4a).
A solution of imidazopyridine 2a (2.2 g, 0.01 mol) and methylamine 3
(0.93 g, 0.03 mol) in CH3CN (20 mL) was heated in a sealed vessel for 6 h
at 80 °C. Then, the reaction mixture was poured into H2O (50 mL), A
precipitate formed was filtered off and recrystallized from 50% aq.
ethanol.
Methyl-(8-methyl-2-trifluoromethylimidazo[1,2-a]pyridin-3-yl)amine (4b).
The yield was 2.0 g (91%). M.p. 94-96 °C. Found (%): C, 52.56; H, 4.59;
N, 18.18. C10H10F3N3. Calculated (%): C, 52.40; H, 4.40; N, 18.33. 1H NMR
(CDCl3), δ: 2.36 (s, 3 H, Me); 2.84 (d, 3 H, MeN, J = 5.4 Hz); 3.16
(br.s, 1 H, NH); 7.00 (d, 1 H, CHAr, J = 9.0 Hz); 7.47 (d, 1 H, CHAr, J =
9.0 Hz); 7.84 (s, 1 H, CHAr). 19F NMR (CDCl3), δ: 16.86 s.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modification of biologically active amides and amines by
fluoro-containing heterocycles 10. γ-Carbolines modified by
2-trifluoromethylimidazo[1,2-a]pyridin-3-ylpropionamide fragments
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bachurin, S. O.; Sokolov, V. B.; Aksinenko, A. Yu.; Epishina, T. A.;
Goreva, T. V.; Grigor'ev, V. V.; Zamoiskii, V. L.; Gabrel'yan, A. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2013), 62(11), 2438-2441

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2,3,3a,7a,9,10,10a,12a-octahydro-5-hydroxy-3,7a,10,12a-tetramethyl-4H,...
C22H28O7
1229114-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.0574 2.6673 0.0 0
M  V30 2 C 7.9711 9.4090 0.0 0
M  V30 3 C 3.9774 2.6673 0.0 0
M  V30 4 O 4.7474 1.3336 0.0 0
M  V30 5 O 2.4374 2.6673 0.0 0
M  V30 6 C 3.9774 0.0000 0.0 0
M  V30 7 C 0.7621 5.4225 0.0 0
M  V30 8 C 1.7271 10.6528 0.0 0
M  V30 9 C 12.0182 5.9581 0.0 0
M  V30 10 C 6.2874 6.6684 0.0 0
M  V30 11 C 4.7474 6.6684 0.0 0
M  V30 12 C 7.0574 5.3347 0.0 0
M  V30 13 O 7.0574 8.0020 0.0 0
M  V30 14 C 3.9774 5.3347 0.0 0
M  V30 15 C 3.9774 8.0020 0.0 0
M  V30 16 C 6.2874 4.0011 0.0 0
M  V30 17 C 8.5974 5.3347 0.0 0
M  V30 18 C 8.5974 8.0020 0.0 0
M  V30 19 C 4.7474 4.0011 0.0 0
M  V30 20 O 2.4374 5.3347 0.0 0
M  V30 21 C 2.4374 8.0020 0.0 0
M  V30 22 C 9.3674 6.6684 0.0 0
M  V30 23 O 9.6278 9.1466 0.0 0
M  V30 24 C 1.6674 6.6684 0.0 0
M  V30 25 C 1.4070 9.1466 0.0 0
M  V30 26 C 10.8737 6.9886 0.0 0
M  V30 27 C 11.0348 8.5201 0.0 0
M  V30 28 O 0.1609 6.9886 0.0 0
M  V30 29 C 0.0000 8.5201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 18
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 19
M  V30 6 1 4 6
M  V30 7 1 7 24
M  V30 8 1 8 25
M  V30 9 1 9 26
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 2 16 19
M  V30 22 1 17 22
M  V30 23 1 18 22
M  V30 24 1 18 23
M  V30 25 1 20 24
M  V30 26 1 21 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 24 28
M  V30 31 1 25 29
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,3a,7a,9,10,10a,12a-Octahydro-5-hydroxy-N,3,7a,10,12a-pentamethyl-4H,11H-d...
C22H29NO6
1229114-52-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.0574 2.6673 0.0 0
M  V30 2 C 7.9711 9.4090 0.0 0
M  V30 3 C 3.9774 2.6673 0.0 0
M  V30 4 N 4.7474 1.3336 0.0 0
M  V30 5 O 2.4374 2.6673 0.0 0
M  V30 6 C 3.9774 0.0000 0.0 0
M  V30 7 C 0.7621 5.4225 0.0 0
M  V30 8 C 1.7271 10.6528 0.0 0
M  V30 9 C 12.0182 5.9581 0.0 0
M  V30 10 C 6.2874 6.6684 0.0 0
M  V30 11 C 4.7474 6.6684 0.0 0
M  V30 12 C 7.0574 5.3347 0.0 0
M  V30 13 O 7.0574 8.0020 0.0 0
M  V30 14 C 3.9774 5.3347 0.0 0
M  V30 15 C 3.9774 8.0020 0.0 0
M  V30 16 C 6.2874 4.0011 0.0 0
M  V30 17 C 8.5974 5.3347 0.0 0
M  V30 18 C 8.5974 8.0020 0.0 0
M  V30 19 C 4.7474 4.0011 0.0 0
M  V30 20 O 2.4374 5.3347 0.0 0
M  V30 21 C 2.4374 8.0020 0.0 0
M  V30 22 C 9.3674 6.6684 0.0 0
M  V30 23 O 9.6278 9.1466 0.0 0
M  V30 24 C 1.6674 6.6684 0.0 0
M  V30 25 C 1.4070 9.1466 0.0 0
M  V30 26 C 10.8737 6.9886 0.0 0
M  V30 27 C 11.0348 8.5201 0.0 0
M  V30 28 O 0.1609 6.9886 0.0 0
M  V30 29 C 0.0000 8.5201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 18
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 19
M  V30 6 1 4 6
M  V30 7 1 7 24
M  V30 8 1 8 25
M  V30 9 1 9 26
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 2 16 19
M  V30 22 1 17 22
M  V30 23 1 18 22
M  V30 24 1 18 23
M  V30 25 1 20 24
M  V30 26 1 21 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 24 28
M  V30 31 1 25 29
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1229114-50-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1229114-52-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9238816
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Xyloketal B Formamide (13). A mixture of
compound 12 (105 mg, 0.26 mmol) and 5mL of ammonia was stirred at 50°C
for 6 h and then poured into water. The aqueous layer was extracted with
Et2O (3 x 20 mL). The combined organic extracts were washed with
saturated brine, dried over anhydrous MgSO4, and concentrated in vacuo.
Purification by flash chromatograghy using petroleum ether and ethyl
acetate as the eluant afforded the title compound (88.3 mg, 87.3%) as a
light-yellow solid; Preparation of Compound 14. The title compound was
obtained from 12 and methylamine with a procedure similar to that for
compound 13. Yield,90.8%; light-yellowsolid; mp 53-54°C. 1H NMR(CDCl3,
400 MHz) δ: 4.168 (t, J = 8.0 Hz, 2H), 3.547 (t, J = 8.0 Hz, 2H), 2.948
(q, J = 4.8 Hz, 3H), 2.860 (m, 2H), 2.629 (m, 2H), 2.085 (m, 2H), 1.935
(m, 3H), 1.536 (s, 3H), 1.509 (s, 3H), 1.074 (d, J = 6.0 Hz, 6H). 13C
NMR(CDCl3) δ: 170.914, 161.186, 154.376, 150.838, 109.226, 108.135,
99.273, 97.367, 96.552, 74.310, 74.094, 47.450, 47.186, 35.529, 35.188,
26.066, 23.142, 22.842, 18.643, 18.357, 16.023, 15.903. HREIMS m/z
403.1987 (calculated for C22H29O6N1, 403.1989).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Novel Xyloketal Derivatives and Their
Vasorelaxing Activities in Rat Thoracic Aorta and Angiogenic Activities
in Zebrafish Angiogenesis Screen
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Zhongliang; Li, Yiying; Xiang, Qi; Pei, Zhong; Liu, Xilin; Lu,
Bingtai; Chen, Ling; Wang, Guanlei; Pang, Jiyan; Lin, Yongcheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(12), 4642-4653

$RFMT $RIREG SCHEME104 STEP1
$RXN



  3  1
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Phenyl-α-(2-phenylethynyl)benzenemethanol
C21H16O
1522-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.6201 0.0 0
M  V30 2 C 6.1601 4.6201 0.0 0
M  V30 3 O 4.6201 6.1601 0.0 0
M  V30 4 C 7.7001 4.6201 0.0 0
M  V30 5 C 4.6201 3.0800 0.0 0
M  V30 6 C 3.2864 2.3100 0.0 0
M  V30 7 C 5.9537 2.3100 0.0 0
M  V30 8 C 3.2864 0.7700 0.0 0
M  V30 9 C 5.9537 0.7700 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 3.0800 4.6201 0.0 0
M  V30 12 C 2.3100 5.9537 0.0 0
M  V30 13 C 2.3100 3.2864 0.0 0
M  V30 14 C 0.7700 5.9537 0.0 0
M  V30 15 C 0.7700 3.2864 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 9.2401 4.6201 0.0 0
M  V30 18 C 10.0101 5.9537 0.0 0
M  V30 19 C 10.0101 3.2864 0.0 0
M  V30 20 C 11.5501 5.9537 0.0 0
M  V30 21 C 11.5501 3.2864 0.0 0
M  V30 22 C 12.3201 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 1 11
M  V30 5 3 2 4
M  V30 6 1 4 17
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,6-Dihydro-1,2-dimethyl-4,6,6-triphenyl-3-pyridinyl)ethanone
C27H25NO
2756614-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.0313 4.0011 0.0 0
M  V30 2 C 3.5713 1.3338 0.0 0
M  V30 3 C 6.6513 1.3338 0.0 0
M  V30 4 C 5.8813 0.0000 0.0 0
M  V30 5 O 8.1913 1.3338 0.0 0
M  V30 6 C 4.3413 5.3348 0.0 0
M  V30 7 C 5.8813 5.3348 0.0 0
M  V30 8 N 3.5713 4.0011 0.0 0
M  V30 9 C 6.6513 4.0011 0.0 0
M  V30 10 C 4.3413 2.6675 0.0 0
M  V30 11 C 5.8813 2.6675 0.0 0
M  V30 12 C 4.6088 6.8514 0.0 0
M  V30 13 C 6.0559 7.3782 0.0 0
M  V30 14 C 3.4290 7.8413 0.0 0
M  V30 15 C 6.3233 8.8948 0.0 0
M  V30 16 C 3.6965 9.3579 0.0 0
M  V30 17 C 5.1436 9.8847 0.0 0
M  V30 18 C 2.8941 5.8616 0.0 0
M  V30 19 C 2.6268 7.3782 0.0 0
M  V30 20 C 1.7145 4.8717 0.0 0
M  V30 21 C 1.1796 7.9049 0.0 0
M  V30 22 C 0.2673 5.3984 0.0 0
M  V30 23 C 0.0000 6.9150 0.0 0
M  V30 24 C 8.1913 4.0011 0.0 0
M  V30 25 C 8.9613 5.3348 0.0 0
M  V30 26 C 8.9613 2.6675 0.0 0
M  V30 27 C 10.5013 5.3348 0.0 0
M  V30 28 C 10.5013 2.6675 0.0 0
M  V30 29 C 11.2714 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 6 18
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 9 24
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1522-13-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2756614-43-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25851841
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3109-63-5
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 34946-82-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Calcium-Catalyzed Intramolecular Hydroamination-Deacylation Reaction of
in situ formed β-Amino Allenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yaragorla, Srinivasarao; Latha, Dandugula Sneha; Rajesh, Pallava
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2021), 363(24), 5486-5492

$RFMT $RIREG SCHEME105 STEP1
$RXN



  3  1
$MOL
Iridium, di-μ-chlorodichlorobis[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclo...
C20H30Cl4Ir2
12354-84-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.5489 5.0684 0.0 0 CHG=-1 VAL=1
M  V30 2 C 0.0000 7.6734 0.0 0
M  V30 3 C 4.1079 7.6734 0.0 0
M  V30 4 C 2.3262 7.7870 0.0 0
M  V30 5 C 1.7817 7.7870 0.0 0
M  V30 6 C 2.0432 9.1248 0.0 0
M  V30 7 Cl 5.9946 4.0564 0.0 0 CHG=-1 VAL=1
M  V30 8 C 6.5628 1.4386 0.0 0
M  V30 9 C 2.4570 1.4515 0.0 0
M  V30 10 C 4.2365 1.3357 0.0 0
M  V30 11 C 4.7833 1.3357 0.0 0
M  V30 12 C 4.5002 0.0000 0.0 0
M  V30 13 Ir 2.0432 5.4972 0.0 0 CHG=3 VAL=8
M  V30 14 C 0.7611 7.5104 0.0 0 VAL=5
M  V30 15 C 3.3489 7.5104 0.0 0 CHG=-1 VAL=4
M  V30 16 C 2.5278 7.0366 0.0 0 VAL=5
M  V30 17 C 1.5801 7.0366 0.0 0 VAL=5
M  V30 18 C 2.0432 8.3466 0.0 0 VAL=5
M  V30 19 Cl 4.5002 5.4972 0.0 0 CHG=-1 VAL=2
M  V30 20 Cl 2.0389 3.6276 0.0 0 CHG=-1 VAL=2
M  V30 21 Ir 4.5002 3.6276 0.0 0 CHG=3 VAL=8
M  V30 22 C 5.8059 1.6123 0.0 0 CHG=-1 VAL=4
M  V30 23 C 3.2181 1.6123 0.0 0 VAL=5
M  V30 24 C 4.0350 2.0883 0.0 0 VAL=5
M  V30 25 C 4.9848 2.0883 0.0 0 VAL=5
M  V30 26 C 4.5002 0.7783 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 3 15
M  V30 4 1 4 16
M  V30 5 1 5 17
M  V30 6 1 6 18
M  V30 7 1 7 21
M  V30 8 1 8 22
M  V30 9 1 9 23
M  V30 10 1 10 24
M  V30 11 1 11 25
M  V30 12 1 12 26
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 13 19
M  V30 19 1 13 20
M  V30 20 1 14 17
M  V30 21 2 14 18
M  V30 22 1 15 16
M  V30 23 1 15 18
M  V30 24 2 16 17
M  V30 25 1 19 21
M  V30 26 1 20 21
M  V30 27 1 21 22
M  V30 28 1 21 23
M  V30 29 1 21 24
M  V30 30 1 21 25
M  V30 31 1 21 26
M  V30 32 1 22 25
M  V30 33 1 22 26
M  V30 34 1 23 24
M  V30 35 2 23 26
M  V30 36 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1S,2S)-2-Amino-1,2-diphenylethyl]-2,3,4,5,6-pentafluorobenzenesulfonamide
C20H15F5N2O2S
313342-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 2 N 5.3900 6.6684 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 4 S 6.9300 6.6684 0.0 0 VAL=6
M  V30 5 N 6.9300 4.0011 0.0 0
M  V30 6 O 6.9300 5.1284 0.0 0
M  V30 7 O 6.9300 8.2084 0.0 0
M  V30 8 F 8.4700 9.3358 0.0 0
M  V30 9 F 8.4700 4.0011 0.0 0
M  V30 10 F 11.5500 9.3358 0.0 0
M  V30 11 F 11.5500 4.0011 0.0 0
M  V30 12 F 13.0900 6.6684 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 2.3100 6.6684 0.0 0
M  V30 16 C 0.7700 4.0011 0.0 0
M  V30 17 C 0.7700 6.6684 0.0 0
M  V30 18 C 0.0000 5.3347 0.0 0
M  V30 19 C 4.6200 2.6674 0.0 0
M  V30 20 C 3.0800 2.6674 0.0 0
M  V30 21 C 5.3900 1.3336 0.0 0
M  V30 22 C 2.3100 1.3336 0.0 0
M  V30 23 C 4.6200 0.0000 0.0 0
M  V30 24 C 3.0800 0.0000 0.0 0
M  V30 25 C 8.4700 6.6684 0.0 0
M  V30 26 C 9.2400 8.0021 0.0 0
M  V30 27 C 9.2400 5.3347 0.0 0
M  V30 28 C 10.7800 8.0021 0.0 0
M  V30 29 C 10.7800 5.3347 0.0 0
M  V30 30 C 11.5500 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5 CFG=1
M  V30 6 1 3 19
M  V30 7 2 4 6
M  V30 8 2 4 7
M  V30 9 1 4 25
M  V30 10 1 8 26
M  V30 11 1 9 27
M  V30 12 1 10 28
M  V30 13 1 11 29
M  V30 14 1 12 30
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C31H32F4IrN3O2S
2265915-40-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 4.5691 0.0 0
M  V30 2 C 2.5011 5.1544 0.0 0
M  V30 3 C 2.5089 4.0033 0.0 0
M  V30 4 C 2.5987 0.6009 0.0 0
M  V30 5 C 2.6221 8.5412 0.0 0
M  V30 6 C 9.7469 1.2408 0.0 0
M  V30 7 O 11.7720 7.5814 0.0 0
M  V30 8 O 13.2430 6.6098 0.0 0
M  V30 9 F 12.1817 0.0000 0.0 0
M  V30 10 F 15.4632 5.7514 0.0 0
M  V30 11 F 15.4905 0.0000 0.0 0
M  V30 12 F 17.1293 2.8757 0.0 0
M  V30 13 Ir 6.7347 4.5028 0.0 0 CHG=3 VAL=8
M  V30 14 C 1.4164 4.5691 0.0 0 CHG=-1 VAL=4
M  V30 15 C 3.8707 5.5212 0.0 0 VAL=5
M  V30 16 C 3.8707 3.6170 0.0 0 VAL=5
M  V30 17 C 2.9147 1.9783 0.0 0 VAL=5
M  V30 18 C 2.9147 7.1561 0.0 0 VAL=5
M  V30 19 N 10.0044 6.4069 0.0 0 CHG=-1 VAL=3
M  V30 20 N 6.7347 8.3149 0.0 0 VAL=4
M  V30 21 N 10.0161 2.6299 0.0 0 CHG=-1 VAL=3
M  V30 22 C 10.0044 8.3149 0.0 0
M  V30 23 S 11.8969 6.1689 0.0 0 VAL=6
M  V30 24 C 8.3695 9.2709 0.0 0
M  V30 25 C 11.9281 2.8757 0.0 0
M  V30 26 C 12.8606 4.5223 0.0 0
M  V30 27 C 12.8918 1.2252 0.0 0
M  V30 28 C 14.7569 4.5223 0.0 0
M  V30 29 C 14.7803 1.2252 0.0 0
M  V30 30 C 15.7129 2.8757 0.0 0
M  V30 31 C 11.2296 9.0251 0.0 0
M  V30 32 C 11.2296 10.5585 0.0 0
M  V30 33 C 12.5641 8.2564 0.0 0
M  V30 34 C 12.5641 11.3272 0.0 0
M  V30 35 C 13.8907 9.0251 0.0 0
M  V30 36 C 13.8907 10.5585 0.0 0
M  V30 37 C 8.3695 10.6873 0.0 0
M  V30 38 C 7.0390 11.4520 0.0 0
M  V30 39 C 9.7001 11.4520 0.0 0
M  V30 40 C 7.0390 12.9894 0.0 0
M  V30 41 C 9.7001 12.9894 0.0 0
M  V30 42 C 8.3695 13.7581 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 15
M  V30 3 1 3 16
M  V30 4 1 4 17
M  V30 5 1 5 18
M  V30 6 1 6 21
M  V30 7 2 7 23
M  V30 8 2 8 23
M  V30 9 1 9 27
M  V30 10 1 10 28
M  V30 11 1 11 29
M  V30 12 1 12 30
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 13 19
M  V30 19 1 13 20
M  V30 20 1 13 21
M  V30 21 1 14 17
M  V30 22 1 14 18
M  V30 23 1 15 16
M  V30 24 2 15 18
M  V30 25 2 16 17
M  V30 26 1 19 22
M  V30 27 1 19 23
M  V30 28 1 20 24
M  V30 29 1 21 25
M  V30 30 1 22 24
M  V30 31 1 22 31
M  V30 32 1 23 26
M  V30 33 1 24 37
M  V30 34 1 25 26
M  V30 35 2 25 27
M  V30 36 2 26 28
M  V30 37 1 27 29
M  V30 38 1 28 30
M  V30 39 2 29 30
M  V30 40 2 31 32
M  V30 41 1 31 33
M  V30 42 1 32 34
M  V30 43 2 33 35
M  V30 44 2 34 36
M  V30 45 1 35 36
M  V30 46 2 37 38
M  V30 47 1 37 39
M  V30 48 1 38 40
M  V30 49 2 39 41
M  V30 50 2 40 42
M  V30 51 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 12354-84-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 313342-24-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2265915-40-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19606979
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cleavage of N-H Bond of Ammonia via Metal-Ligand Cooperation Enables
Rational Design of a Conceptually New Noyori-Ikariya Catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dub, Pavel A.; Matsunami, Asuka; Kuwata, Shigeki; Kayaki, Yoshihito
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2019), 141(6), 2661-2677

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-7-(1-methylethoxy)-2-oxo-2H-1-benzopyran-8-carboxaldehyde
C14H14O4
1238397-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1601 0.0 0
M  V30 2 O 6.6685 6.9302 0.0 0
M  V30 3 C 2.6673 0.0000 0.0 0
M  V30 4 O 8.0023 4.6201 0.0 0
M  V30 5 C 9.3360 3.8501 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 C 10.6697 4.6201 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 O 2.6673 4.6201 0.0 0
M  V30 13 C 5.3348 1.5400 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 C 6.6685 3.8501 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 17 C 6.6685 2.3101 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 3 14
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-7-(1-methylethoxy)-8-[(methylimino)methyl]-2H-1-benzopyran-2-one
C15H17NO3
1238397-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 N 6.6684 1.5400 0.0 0
M  V30 3 C 6.6684 0.0000 0.0 0
M  V30 4 O 8.0022 3.8500 0.0 0
M  V30 5 C 9.3359 4.6201 0.0 0
M  V30 6 C 9.3359 6.1601 0.0 0
M  V30 7 C 10.6695 3.8500 0.0 0
M  V30 8 C 2.6673 8.4701 0.0 0
M  V30 9 O 0.0000 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 4.0011 6.1601 0.0 0
M  V30 13 O 2.6673 3.8500 0.0 0
M  V30 14 C 6.6684 4.6201 0.0 0
M  V30 15 C 2.6673 6.9301 0.0 0
M  V30 16 C 5.3348 6.9301 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 6.6684 6.1601 0.0 0
M  V30 19 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 15
M  V30 9 2 9 17
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1238397-21-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1238397-30-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3520183
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anti-AIDS agents 82: Synthesis of
seco-(3'R,4'R)-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK)
derivatives as novel anti-HIV agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Jian; Qian, Keduo; Zhang, Bei-Na; Chen, Ying; Xia, Peng; Yu,
Donglei; Xia, Yi; Yang, Zheng-Yu; Chen, Chin-Ho; Morris-Natschke, Susan
L.; Lee, Kuo-Hsiung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2010), 18(12), 4363-4373

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Phenylmethyl)-2-[2-(2-pyridinyl)ethyl]-1H-benzimidazole-5-carboxylic acid
C22H19N3O2
1242166-04-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2753 3.7534 0.0 0
M  V30 2 C 9.2446 6.4640 0.0 0
M  V30 3 C 10.0146 7.7976 0.0 0
M  V30 4 C 1.3338 8.0040 0.0 0
M  V30 5 O 1.3338 9.5440 0.0 0
M  V30 6 O 0.0000 7.2340 0.0 0
M  V30 7 C 5.3347 5.6940 0.0 0
M  V30 8 N 6.7994 5.2181 0.0 0
M  V30 9 C 5.3347 7.2340 0.0 0
M  V30 10 C 4.0011 4.9240 0.0 0
M  V30 11 C 7.7046 6.4640 0.0 0
M  V30 12 N 6.7994 7.7099 0.0 0
M  V30 13 C 4.0011 8.0040 0.0 0
M  V30 14 C 2.6674 5.6940 0.0 0
M  V30 15 C 2.6674 7.2340 0.0 0
M  V30 16 C 6.2449 2.6091 0.0 0
M  V30 17 C 4.7384 2.9292 0.0 0
M  V30 18 C 6.7207 1.1444 0.0 0
M  V30 19 C 3.7080 1.7849 0.0 0
M  V30 20 C 5.6903 0.0000 0.0 0
M  V30 21 C 4.1839 0.3202 0.0 0
M  V30 22 C 11.5546 7.7976 0.0 0
M  V30 23 C 12.3246 6.4640 0.0 0
M  V30 24 N 12.3246 9.1314 0.0 0
M  V30 25 C 13.8646 6.4640 0.0 0
M  V30 26 C 13.8646 9.1314 0.0 0
M  V30 27 C 14.6346 7.7976 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 1 3 22
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 4 15
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 2 11 12
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1-(phenylmethyl)-2-[2-(2-pyridinyl)ethyl]-1H-benzimidazole-5-carboxa...
C23H22N4O
1242166-06-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2753 3.7534 0.0 0
M  V30 2 C 9.2446 6.4640 0.0 0
M  V30 3 C 10.0146 7.7976 0.0 0
M  V30 4 C 1.3338 8.0040 0.0 0
M  V30 5 N 1.3338 9.5440 0.0 0
M  V30 6 O 0.0000 7.2340 0.0 0
M  V30 7 C 0.0000 10.3140 0.0 0
M  V30 8 C 5.3347 5.6940 0.0 0
M  V30 9 N 6.7994 5.2181 0.0 0
M  V30 10 C 5.3347 7.2340 0.0 0
M  V30 11 C 4.0011 4.9240 0.0 0
M  V30 12 C 7.7046 6.4640 0.0 0
M  V30 13 N 6.7994 7.7099 0.0 0
M  V30 14 C 4.0011 8.0040 0.0 0
M  V30 15 C 2.6674 5.6940 0.0 0
M  V30 16 C 2.6674 7.2340 0.0 0
M  V30 17 C 6.2449 2.6091 0.0 0
M  V30 18 C 4.7384 2.9292 0.0 0
M  V30 19 C 6.7207 1.1444 0.0 0
M  V30 20 C 3.7080 1.7849 0.0 0
M  V30 21 C 5.6903 0.0000 0.0 0
M  V30 22 C 4.1839 0.3202 0.0 0
M  V30 23 C 11.5546 7.7976 0.0 0
M  V30 24 C 12.3246 9.1314 0.0 0
M  V30 25 N 12.3246 6.4640 0.0 0
M  V30 26 C 13.8646 9.1314 0.0 0
M  V30 27 C 13.8646 6.4640 0.0 0
M  V30 28 C 14.6346 7.7976 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 12
M  V30 5 1 3 23
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 4 16
M  V30 9 1 5 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 2 12 13
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1242166-04-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1242166-06-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14994182
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel benzimidazole derivatives as inhibitors of
hepatitis B virus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luo, Yu; Yao, Jia-Ping; Yang, Li; Feng, Chun-Lan; Tang, Wei; Wang,
Gui-Feng; Zuo, Jian-Pin; Lu, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2010), 18(14), 5048-5055

$RFMT $RIREG SCHEME108 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2S,3E)-1-[2-[(1S)-1-Hydroxy-3-methylbutyl]-4-thiazolyl]-4-iodo-2-methyl-3...
C18H28INO3S
1245503-27-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.4137 5.3347 0.0 0 CFG=2
M  V30 2 O 3.6437 6.6684 0.0 0
M  V30 3 C 3.6437 4.0011 0.0 0 CFG=1
M  V30 4 C 2.1037 6.6684 0.0 0
M  V30 5 C 4.4137 2.6674 0.0 0
M  V30 6 C 2.1037 4.0011 0.0 0
M  V30 7 C 1.3336 8.0022 0.0 0
M  V30 8 O 1.3336 5.3347 0.0 0
M  V30 9 C 3.6437 1.3336 0.0 0
M  V30 10 C 2.6674 8.7722 0.0 0
M  V30 11 C 0.5636 9.3358 0.0 0
M  V30 12 C 0.0000 7.2322 0.0 0
M  V30 13 I 4.4137 0.0000 0.0 0
M  V30 14 C 9.5695 7.0100 0.0 0 CFG=1
M  V30 15 C 10.9763 6.3836 0.0 0
M  V30 16 O 9.4085 8.5415 0.0 0
M  V30 17 C 12.2223 7.2887 0.0 0
M  V30 18 C 12.0612 8.8204 0.0 0
M  V30 19 C 13.6291 6.6624 0.0 0
M  V30 20 C 5.9537 5.3347 0.0 0
M  V30 21 N 6.8589 6.5806 0.0 0
M  V30 22 C 6.8589 4.0889 0.0 0
M  V30 23 C 8.3236 6.1047 0.0 0
M  V30 24 S 8.3236 4.5647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=3
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 2 5 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 1 14 16 CFG=1
M  V30 16 1 14 23
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 20 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 3 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Thiazoledimethanol, α4-[(1S,2E)-3-iodo-1-methyl-2-propen-1-yl]-α2-(2-meth...
C15H23IN2O3S
1245503-28-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 O 3.8500 5.3347 0.0 0
M  V30 3 C 3.8500 2.6674 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 N 1.5400 6.6684 0.0 0
M  V30 7 O 1.5400 4.0011 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 6.1600 1.3336 0.0 0
M  V30 10 C 0.0000 6.6684 0.0 0
M  V30 11 C 9.7758 5.6763 0.0 0 CFG=1
M  V30 12 C 11.1826 5.0498 0.0 0 CFG=1
M  V30 13 O 9.6147 7.2079 0.0 0
M  V30 14 C 12.4285 5.9551 0.0 0
M  V30 15 C 11.3435 3.5183 0.0 0
M  V30 16 C 13.8354 5.3287 0.0 0
M  V30 17 I 15.0813 6.2340 0.0 0
M  V30 18 C 6.1600 4.0011 0.0 0
M  V30 19 N 7.0652 5.2470 0.0 0
M  V30 20 S 7.0652 2.7552 0.0 0
M  V30 21 C 8.5298 4.7711 0.0 0
M  V30 22 C 8.5298 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 11 12
M  V30 12 1 11 13 CFG=1
M  V30 13 1 11 21
M  V30 14 1 12 14
M  V30 15 1 12 15 CFG=3
M  V30 16 2 14 16
M  V30 17 1 16 17
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1245503-27-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1245503-28-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-5171093
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 22560-16-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of an Iejimalide-archazolid chimera
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moulin, Emilie; Nevado, Cristina; Gagnepain, Julien; Kelter, Gerhard;
Fiebig, Heinz-Herbert; Fuerstner, Alois
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2010), 66(33), 6421-6428

$RFMT $RIREG SCHEME109 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-methoxybenzaldehyde
C8H7FO2
351-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 2.6673 0.0 0
M  V30 2 O 7.7002 4.0010 0.0 0
M  V30 3 F 2.3101 0.0000 0.0 0
M  V30 4 O 0.7700 2.6673 0.0 0
M  V30 5 C 0.0000 4.0010 0.0 0
M  V30 6 C 5.3901 2.6673 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 4.6201 4.0010 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 3.0801 4.0010 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4,5-dimethoxy-α-[(4-methylphenyl)sulfonyl]benzeneacetonitrile
C17H16ClNO4S
1245716-04-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 6.6684 0.0 0
M  V30 2 S 6.9300 6.6684 0.0 0 VAL=6
M  V30 3 C 4.6200 8.0021 0.0 0
M  V30 4 O 6.9300 8.2084 0.0 0
M  V30 5 O 6.9300 5.1284 0.0 0
M  V30 6 N 3.8500 9.3358 0.0 0
M  V30 7 O 0.7700 4.0011 0.0 0
M  V30 8 C 0.0000 5.3347 0.0 0
M  V30 9 Cl 5.3900 1.3336 0.0 0
M  V30 10 O 2.3100 1.3336 0.0 0
M  V30 11 C 3.0800 0.0000 0.0 0
M  V30 12 C 13.0900 6.6684 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 8.4700 6.6684 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 10.7800 8.0021 0.0 0
M  V30 23 C 10.7800 5.3347 0.0 0
M  V30 24 C 11.5500 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 19
M  V30 7 3 3 6
M  V30 8 1 7 8
M  V30 9 1 7 16
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 1 10 18
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3-Chloro-4,5-dimethoxyphenyl)-5-(3-fluoro-4-methoxyphenyl)-1-methyl-1H-imi...
C19H18ClFN2O3
1245716-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3466 0.1437 0.0 0
M  V30 2 O 11.2252 5.1047 0.0 0
M  V30 3 C 11.9952 3.7710 0.0 0
M  V30 4 Cl 6.6051 7.7722 0.0 0
M  V30 5 F 0.0000 3.9249 0.0 0
M  V30 6 O 9.6852 7.7722 0.0 0
M  V30 7 C 11.2252 7.7722 0.0 0
M  V30 8 O 0.9517 6.8542 0.0 0
M  V30 9 C 1.4276 8.3189 0.0 0
M  V30 10 C 6.6051 2.4374 0.0 0
M  V30 11 C 5.0736 2.2765 0.0 0
M  V30 12 N 7.2316 1.0304 0.0 0
M  V30 13 N 4.7534 0.7700 0.0 0
M  V30 14 C 6.0871 0.0000 0.0 0
M  V30 15 C 7.3751 3.7710 0.0 0
M  V30 16 C 8.9152 3.7710 0.0 0
M  V30 17 C 6.6051 5.1047 0.0 0
M  V30 18 C 9.6852 5.1047 0.0 0
M  V30 19 C 7.3751 6.4385 0.0 0
M  V30 20 C 8.9152 6.4385 0.0 0
M  V30 21 C 4.0432 3.4208 0.0 0
M  V30 22 C 2.5367 3.1007 0.0 0
M  V30 23 C 4.5190 4.8855 0.0 0
M  V30 24 C 1.5063 4.2451 0.0 0
M  V30 25 C 3.4886 6.0299 0.0 0
M  V30 26 C 1.9822 5.7098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 19
M  V30 5 1 5 24
M  V30 6 1 6 7
M  V30 7 1 6 20
M  V30 8 1 8 9
M  V30 9 1 8 26
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 11 21
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 351-54-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1245716-04-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1245716-09-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-1428611
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
1-Methyl-4-(3'-chloro-4',5'-dimethoxyphenyl)-5-(4''-methoxy-
3''-nitrophenyl)imidazole (7a): Typical Procedure. A mixture of
4-methoxy-3-nitrobenzaldehyde (76 mg, 0.42 mmol) and 33% MeNH2/ethanol
(260 μL, 2.10 mmol) in ethanol (15 mL) was treated with AcOH (150 μL) and
refluxed for 2 h. After the mixture was cooled down to room temperature,
compound 6a (153 mg, 0.42 mmol) dissolved in DME (10 mL) and K2CO3 (500
mg, 3.62 mmol) were added. The reaction mixture was refluxed for 3 h. The
solvent was evaporated and the residue diluted with ethyl acetate, washed
with water and brine, dried over Na2SO4, filtered, and concentrated in
vacuum. The residue was purified by column chromatography (silica gel
60). Yield: 110 mg (0.26 mmol, 62%); yellow oil.
1-Methyl-4-(3'-chloro-4',5'-dimethoxyphenyl)-5-(3''-fluoro-4''-methoxyphenyl)-imidazole
(7c): Analogously to the synthesis of compound 7a, compound 7c was
prepared from 3-fluoro-4-methoxybenzaldehyde (65 mg, 0.42 mmol), 33%
MeNH2/ethanol (260 μL, 2.10 mmol) and acetic acid (150 μL) in boiling
ethanol (15 mL) giving the imine intermediate, which was treated with
compound 6a (153 mg, 0.42 mmol), dissolved in DME (10 mL), and K2CO3 (500
mg, 3.62 mmol). After workup, the residue was purified by column
chromatography (silica gel 60). Yield: 150 mg (0.38 mmol, 91%); colorless
gum. Rf = 0.27 (ethyl acetate/methanol 95:5); νmax (ATR)/cm-1 2937, 2837,
1601, 1553, 1512, 1487, 1462, 1419, 1301, 1067, 1233, 1166, 1131, 1046,
1022, 999, 896, 873, 829, 815, 761, 734, 719, 656; 1H NMR (300 MHz,
CDCl3) δ 3.39 (3 H, s), 3.61 (3 H, s), 3.75 (3 H, s), 3.87 (3 H, s),
6.9-7.0 (5 H, m), 7.45 (1 H, s); 13C NMR (75.5 MHz, CDCl3) δ 31.9, 55.6,
56.1, 60.5, 109.0, 113.7, 118.0, 118.2, 119.4, 122.4, 122.5, 126.9,
127.5, 127.8, 131.0, 136.7, 137.2, 143.6, 148.0, 148.1, 150.5, 153.2,
153.8; m/z (EI) 379 (15), 378 (65) [M+], 377 (41), 376 (100) [M+], 363
(26), 361 (67).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and
-N-methylimidazoles That Are Cytotoxic against Combretastatin A Resistant
Tumor Cells and Vascular Disrupting in a Cisplatin Resistant Germ Cell
Tumor Model
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schobert, Rainer; Biersack, Bernhard; Dietrich, Andrea; Effenberger,
Katharina; Knauer, Sebastian; Mueller, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(18), 6595-6602

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-(1R,2R)-1,2-Cyclohexanediylbis[2-methoxy-3-[(2-thioxo-3-thiazolidinyl)ca...
C30H32N4O6S4
1252673-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 18.7325 6.6685 0.0 0
M  V30 2 O 19.5025 5.3348 0.0 0
M  V30 3 O 17.1925 4.0012 0.0 0
M  V30 4 C 18.7325 4.0012 0.0 0
M  V30 5 C 14.1124 4.0012 0.0 0
M  V30 6 N 12.5724 4.0012 0.0 0
M  V30 7 O 14.8824 2.6673 0.0 0
M  V30 8 S 22.0647 7.0187 0.0 0
M  V30 9 N 9.4923 4.0012 0.0 0
M  V30 10 C 7.9523 4.0012 0.0 0
M  V30 11 O 7.1823 2.6673 0.0 0
M  V30 12 O 4.8722 4.0012 0.0 0
M  V30 13 C 3.3322 4.0012 0.0 0
M  V30 14 C 3.3322 6.6685 0.0 0
M  V30 15 O 2.5622 5.3348 0.0 0
M  V30 16 S 0.0000 7.0187 0.0 0
M  V30 17 C 17.1925 6.6685 0.0 0
M  V30 18 C 16.4225 5.3348 0.0 0
M  V30 19 C 16.4225 8.0022 0.0 0
M  V30 20 C 14.8824 5.3348 0.0 0
M  V30 21 C 14.8824 8.0022 0.0 0
M  V30 22 C 14.1124 6.6685 0.0 0
M  V30 23 N 19.5025 8.0022 0.0 0
M  V30 24 C 21.0341 8.1633 0.0 0
M  V30 25 C 18.8762 9.4091 0.0 0
M  V30 26 S 21.3543 9.6696 0.0 0
M  V30 27 C 20.0206 10.4396 0.0 0
M  V30 28 C 11.8024 2.6673 0.0 0 CFG=2
M  V30 29 C 10.2623 2.6673 0.0 0 CFG=2
M  V30 30 C 12.5724 1.3337 0.0 0
M  V30 31 C 9.4923 1.3337 0.0 0
M  V30 32 C 11.8024 0.0000 0.0 0
M  V30 33 C 10.2623 0.0000 0.0 0
M  V30 34 C 7.1823 5.3348 0.0 0
M  V30 35 C 5.6422 5.3348 0.0 0
M  V30 36 C 7.9523 6.6685 0.0 0
M  V30 37 C 4.8722 6.6685 0.0 0
M  V30 38 C 7.1823 8.0022 0.0 0
M  V30 39 C 5.6422 8.0022 0.0 0
M  V30 40 N 2.5622 8.0022 0.0 0
M  V30 41 C 1.0306 8.1633 0.0 0
M  V30 42 C 3.1885 9.4091 0.0 0
M  V30 43 S 0.7104 9.6696 0.0 0
M  V30 44 C 2.0441 10.4396 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 23
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 20
M  V30 9 1 28 6 CFG=3
M  V30 10 2 8 24
M  V30 11 1 9 10
M  V30 12 1 29 9 CFG=1
M  V30 13 2 10 11
M  V30 14 1 10 34
M  V30 15 1 12 13
M  V30 16 1 12 35
M  V30 17 2 14 15
M  V30 18 1 14 37
M  V30 19 1 14 40
M  V30 20 2 16 41
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 1 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 28 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,3-Benzenedicarboxamide, N1,N1′-(1R,2R)-1,2-cyclohexanediylbis[2-methoxy-N3-...
C26H32N4O6
1252673-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 4.0011 0.0 0
M  V30 2 C 2.3100 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 N 8.4700 4.0011 0.0 0
M  V30 5 O 6.1600 2.6674 0.0 0
M  V30 6 C 2.3100 6.6685 0.0 0
M  V30 7 N 1.5400 8.0021 0.0 0
M  V30 8 O 1.5400 5.3347 0.0 0
M  V30 9 C 0.0000 8.0021 0.0 0
M  V30 10 N 11.5500 4.0011 0.0 0
M  V30 11 C 13.0900 4.0011 0.0 0
M  V30 12 O 13.8600 2.6674 0.0 0
M  V30 13 O 16.1700 4.0011 0.0 0
M  V30 14 C 17.7100 4.0011 0.0 0
M  V30 15 C 17.7100 6.6685 0.0 0
M  V30 16 N 18.4800 8.0021 0.0 0
M  V30 17 O 18.4800 5.3347 0.0 0
M  V30 18 C 20.0200 8.0021 0.0 0
M  V30 19 C 4.6200 5.3347 0.0 0
M  V30 20 C 6.1600 5.3347 0.0 0
M  V30 21 C 3.8500 6.6685 0.0 0
M  V30 22 C 6.9300 6.6685 0.0 0
M  V30 23 C 4.6200 8.0021 0.0 0
M  V30 24 C 6.1600 8.0021 0.0 0
M  V30 25 C 9.2400 2.6674 0.0 0 CFG=2
M  V30 26 C 10.7800 2.6674 0.0 0 CFG=2
M  V30 27 C 8.4700 1.3336 0.0 0
M  V30 28 C 11.5500 1.3336 0.0 0
M  V30 29 C 9.2400 0.0000 0.0 0
M  V30 30 C 10.7800 0.0000 0.0 0
M  V30 31 C 13.8600 5.3347 0.0 0
M  V30 32 C 15.4000 5.3347 0.0 0
M  V30 33 C 13.0900 6.6685 0.0 0
M  V30 34 C 16.1700 6.6685 0.0 0
M  V30 35 C 13.8600 8.0021 0.0 0
M  V30 36 C 15.4000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 20
M  V30 6 1 25 4 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 21
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 26 10 CFG=3
M  V30 13 2 11 12
M  V30 14 1 11 31
M  V30 15 1 13 14
M  V30 16 1 13 32
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 15 34
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1252673-04-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1252673-06-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-13348143
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Strong Circularly Polarized Luminescence from Highly Emissive Terbium
Complexes in Aqueous Solution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Samuel, Amanda P. S.; Lunkley, Jamie L.; Muller, Gilles; Raymond, Kenneth
N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Inorganic Chemistry (2010), (21), 3343-3347

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[8-Chloro-3-[(1S)-1-[[2-(methylsulfonyl)pyrazolo[1,5-a]-1,3,5-triazin-4-yl]...
C21H21ClN8O3S
1256279-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7238 6.6685 0.0 0 CFG=2
M  V30 2 N 5.9538 8.0022 0.0 0
M  V30 3 C 5.9538 5.3348 0.0 0
M  V30 4 O 9.0338 0.0000 0.0 0
M  V30 5 Cl 13.6539 5.3348 0.0 0
M  V30 6 S 1.3337 5.3348 0.0 0 VAL=6
M  V30 7 C 0.5637 4.0012 0.0 0
M  V30 8 O 2.6673 4.5648 0.0 0
M  V30 9 O 0.0000 6.1048 0.0 0
M  V30 10 C 9.0338 5.3348 0.0 0
M  V30 11 C 8.2638 6.6685 0.0 0
M  V30 12 N 10.5739 5.3348 0.0 0
M  V30 13 C 9.0338 8.0022 0.0 0
M  V30 14 C 11.3439 6.6685 0.0 0
M  V30 15 C 10.5739 8.0022 0.0 0
M  V30 16 C 12.8839 6.6685 0.0 0
M  V30 17 C 11.3439 9.3360 0.0 0
M  V30 18 C 13.6539 8.0022 0.0 0
M  V30 19 C 12.8839 9.3360 0.0 0
M  V30 20 N 8.2638 4.0012 0.0 0
M  V30 21 C 9.0338 2.6673 0.0 0
M  V30 22 C 6.7238 4.0012 0.0 0
M  V30 23 C 8.2638 1.3337 0.0 0
M  V30 24 C 5.9538 2.6673 0.0 0
M  V30 25 N 6.7238 1.3337 0.0 0
M  V30 26 C 4.4137 8.0022 0.0 0
M  V30 27 N 3.6437 9.3360 0.0 0
M  V30 28 N 3.6437 6.6685 0.0 0
M  V30 29 C 2.1037 9.3360 0.0 0
M  V30 30 N 4.1196 10.8006 0.0 0
M  V30 31 C 2.1037 6.6685 0.0 0
M  V30 32 N 1.3337 8.0022 0.0 0
M  V30 33 C 1.6278 10.8006 0.0 0
M  V30 34 C 2.8737 11.7058 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 11
M  V30 4 1 2 26
M  V30 5 2 4 23
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 6 31
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 20
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 27 30
M  V30 33 1 28 31
M  V30 34 1 29 32
M  V30 35 2 29 33
M  V30 36 2 30 34
M  V30 37 2 31 32
M  V30 38 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-[8-Chloro-3-[(1S)-1-[[2-(methylamino)pyrazolo[1,5-a]-1,3,5-triazin-4-yl]ami...
C21H22ClN9O
1256279-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 2 N 7.7000 8.0020 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 Cl 0.0000 5.3347 0.0 0
M  V30 6 N 12.3201 5.3347 0.0 0
M  V30 7 C 13.8601 5.3347 0.0 0
M  V30 8 C 4.6200 5.3347 0.0 0
M  V30 9 C 5.3900 6.6684 0.0 0
M  V30 10 N 3.0800 5.3347 0.0 0
M  V30 11 C 4.6200 8.0020 0.0 0
M  V30 12 C 2.3100 6.6684 0.0 0
M  V30 13 C 3.0800 8.0020 0.0 0
M  V30 14 C 0.7700 6.6684 0.0 0
M  V30 15 C 2.3100 9.3358 0.0 0
M  V30 16 C 0.0000 8.0020 0.0 0
M  V30 17 C 0.7700 9.3358 0.0 0
M  V30 18 N 5.3900 4.0011 0.0 0
M  V30 19 C 4.6200 2.6673 0.0 0
M  V30 20 C 6.9300 4.0011 0.0 0
M  V30 21 C 5.3900 1.3336 0.0 0
M  V30 22 C 7.7000 2.6673 0.0 0
M  V30 23 N 6.9300 1.3336 0.0 0
M  V30 24 C 9.2400 8.0020 0.0 0
M  V30 25 N 10.0101 9.3358 0.0 0
M  V30 26 N 10.0101 6.6684 0.0 0
M  V30 27 C 11.5501 9.3358 0.0 0
M  V30 28 N 9.5342 10.8004 0.0 0
M  V30 29 C 11.5501 6.6684 0.0 0
M  V30 30 N 12.3201 8.0020 0.0 0
M  V30 31 C 12.0259 10.8004 0.0 0
M  V30 32 C 10.7801 11.7056 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 9
M  V30 4 1 2 24
M  V30 5 2 4 21
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 29
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 18
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 2 27 31
M  V30 34 2 28 32
M  V30 35 2 29 30
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1256279-42-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1256279-50-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3060391
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-4-(8-Chloro-3-{1-[2-(methylamino)pyrazol[1,5-a][1,3,5]triazin-4-ylamino]ethyl}quinolin-2-yl)piperazin-2-one
To a solution of Example 2 (84 mg, 0.17 mmol) in 1,4-dioxane (1.5 mL) was
added methylamine (0.17 mL, 0.34 mmol; 2M in THF). The reaction mixture
was heated at 50°C for 2 h. After cooling, the solvent was removed in
vacuo. The residue obtained was extracted with EtOAc (20 mL) and washed
with saturated aqueous NaHCO3 solution (2 x 10 mL). The organic layer was
separated, dried (MgSO4) and the solvent was removed in vacuo.
Purification by column chromatography (SiO2, 0-5% MeOH in DCM) gave the
title compound (69 mg, 91%) which, after freeze-drying, was obtained as a
white solid.
(S)-4-(8-Chloro-3-{1-[2-(methylamino)pyrazol[1,5-a][1,3,5]triazin-4-ylamino]ethyl}quinolin-2-yl)piperazin-2-one,
yield 69 mg, 91%. δH (CDCl3) 8.10 (1H, s), 7.80 (1H, d, J 2.10 Hz), 7.69
(1H, dd, J 7.52, 1.29 Hz), 7.58 (1H, dd, J 8.07, 1.30 Hz), 6.79 (2H, d, J
6.81 Hz), 6.04-6.00 (1H, m), 5.99-5.97 (1H, m), 5.56-5.41 (2H, m),
4.58-4.43 (2H, m), 4.27-4.18 (2H, m), 3.63-3.48 (2H, m), 2.91 (3H, d,
J4.87 Hz), 1.51 (3H, d, J 6.65 Hz). LCMS (ES+) 452/454 (M+H)+, RT 2.36
minutes (Method 2).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused bicyclic pyrazole derivatives as PI3 kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allen, Daniel Rees; Brown, Julien Alistair; Buerli, Roland; Haughan, Alan
Findlay; Langham, Barry John; Matteucci, Mizio; Owens, Andrew Pate;
Raphy, Gilles; Sharpe, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010133836 A1 2010-11-25

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Hydroxy-N′-[(1R)-1-phenylethyl]urea
C9H12N2O2
1256930-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0 CFG=1
M  V30 2 N 5.3347 2.3100 0.0 0
M  V30 3 C 4.0011 4.6200 0.0 0
M  V30 4 C 6.6684 3.0800 0.0 0
M  V30 5 N 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 4.6200 0.0 0
M  V30 7 O 9.3358 3.0800 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Methylene-N-[(1R)-1-phenylethyl]hydrazinecarboxamide
C10H13N3O
1276112-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0 CFG=1
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0012 4.6201 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 N 8.0023 2.3101 0.0 0
M  V30 6 O 6.6685 4.6201 0.0 0
M  V30 7 N 9.3360 3.0801 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1256930-81-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1276112-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29821568
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 5492-69-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the reaction of
carbamoyl nitroso compounds and amines: nBu4NIO4 was added to a solution
of the N-hydroxyurea1 (100 mol %) and the amine (1500 mol %) in CH2Cl2 or
MeOH/CH2Cl2 at 0 °C (H2O/ice cooling bath) and the mixture was stirred at
the same temperature for 5-10 min. The reaction mixture was washed with
10% aqueous HCl and extracted with CH2Cl2 (3×). The combined organic
layers were dried over Na2SO4 and the solvents were removed under reduced
pressure. The residue was purified by flash chromatography on silica gel
as indicated. (R)-2-Methylene-N-(1-phenylethyl)hydrazinecarboxamide (6)
Following the general procedure, (R)-1-hydroxy-3-(1-phenylethyl)urea (70
mg, 0.39 mmol, 100 mol %), nBu4NIO4 (170 mg, 0.39 mmol, 100 mol %) and
methanamine (≈ 1 mL) in CH2Cl2 (10 mL)afforded, after flash
chromatography (silica gel, AcOEt/hexane 1:2.5 → 1:2), 68 mg (91% yield)
of the title compound 6 as a colorless oil. 1H-NMR (400 MHz, CDCl3): δ
10.00 (br s, 1H), 7.4-7.2 (m, 5H), 6.69 (d, J = 11.7 Hz, 1H), 6.36 (d, J
= 8.0 Hz, 1H), 6.17 (d, J = 11.7 Hz, 1H), 5.09 (quin, J = 4 × 7.1 Hz,
1H), 1.56 (d, J = 6.9 Hz, 3H) ppm. 13C-NMR (100 MHz, CDCl3): δ 155.9,
143.9, 130.7, 128.5, 127.0, 125.9, 49.0, 22.7 ppm. FT-IR (NaCl): ν 3241,
3085, 3064, 3031, 2973, 2930, 2875, 1673 (C=O), 1530 cm-1. MS (ESI+) m/z
(%) 246 ([M + Na]+, 88), 214 ([M + H]+, 100). HRMS (ESI+) calcd for
C10H13N3NaO 214.0951; found 214.0951.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Semicarbazones from N-Hydroxyureas and Amines: A Novel Entry in the
Reactivity of the Acyl Nitroso Group
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Paz, Jairo; Perez-Balado, Carlos; Iglesias, Beatriz; Munoz, Luis
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2011), 13(7), 1800-1803

$RFMT $RIREG SCHEME113 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-methoxybenzaldehyde
C8H7FO2
351-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 2.6673 0.0 0
M  V30 2 O 7.7002 4.0010 0.0 0
M  V30 3 F 2.3101 0.0000 0.0 0
M  V30 4 O 0.7700 2.6673 0.0 0
M  V30 5 C 0.0000 4.0010 0.0 0
M  V30 6 C 5.3901 2.6673 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 4.6201 4.0010 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 3.0801 4.0010 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-5-[isocyano[(4-methylphenyl)sulfonyl]methyl]-2,3-dimethoxybenzene
C17H16ClNO4S
1257227-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 6.6684 0.0 0
M  V30 2 S 6.9300 6.6684 0.0 0 VAL=6
M  V30 3 N 4.6200 8.0021 0.0 0 CHG=1 VAL=4
M  V30 4 O 6.9300 8.2084 0.0 0
M  V30 5 O 6.9300 5.1284 0.0 0
M  V30 6 C 3.8500 9.3358 0.0 0 CHG=-1
M  V30 7 O 0.7700 4.0011 0.0 0
M  V30 8 C 0.0000 5.3347 0.0 0
M  V30 9 Cl 5.3900 1.3336 0.0 0
M  V30 10 O 2.3100 1.3336 0.0 0
M  V30 11 C 3.0800 0.0000 0.0 0
M  V30 12 C 13.0900 6.6684 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 8.4700 6.6684 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 10.7800 8.0021 0.0 0
M  V30 23 C 10.7800 5.3347 0.0 0
M  V30 24 C 11.5500 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 19
M  V30 7 3 3 6
M  V30 8 1 7 8
M  V30 9 1 7 16
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 1 10 18
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3-Chloro-4,5-dimethoxyphenyl)-5-(3-fluoro-4-methoxyphenyl)-1-methyl-1H-imi...
C19H18ClFN2O3
1245716-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3466 0.1437 0.0 0
M  V30 2 O 11.2252 5.1047 0.0 0
M  V30 3 C 11.9952 3.7710 0.0 0
M  V30 4 Cl 6.6051 7.7722 0.0 0
M  V30 5 F 0.0000 3.9249 0.0 0
M  V30 6 O 9.6852 7.7722 0.0 0
M  V30 7 C 11.2252 7.7722 0.0 0
M  V30 8 O 0.9517 6.8542 0.0 0
M  V30 9 C 1.4276 8.3189 0.0 0
M  V30 10 C 6.6051 2.4374 0.0 0
M  V30 11 C 5.0736 2.2765 0.0 0
M  V30 12 N 7.2316 1.0304 0.0 0
M  V30 13 N 4.7534 0.7700 0.0 0
M  V30 14 C 6.0871 0.0000 0.0 0
M  V30 15 C 7.3751 3.7710 0.0 0
M  V30 16 C 8.9152 3.7710 0.0 0
M  V30 17 C 6.6051 5.1047 0.0 0
M  V30 18 C 9.6852 5.1047 0.0 0
M  V30 19 C 7.3751 6.4385 0.0 0
M  V30 20 C 8.9152 6.4385 0.0 0
M  V30 21 C 4.0432 3.4208 0.0 0
M  V30 22 C 2.5367 3.1007 0.0 0
M  V30 23 C 4.5190 4.8855 0.0 0
M  V30 24 C 1.5063 4.2451 0.0 0
M  V30 25 C 3.4886 6.0299 0.0 0
M  V30 26 C 1.9822 5.7098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 19
M  V30 5 1 5 24
M  V30 6 1 6 7
M  V30 7 1 6 20
M  V30 8 1 8 9
M  V30 9 1 8 26
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 11 21
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 351-54-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1257227-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1245716-09-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-13101149
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 3)
1-Methyl-4-(3-chloro-4,5-dimethoxyphenyl)-5-(4-methoxy-3-nitrophenyl)imidazole
5a. A mixture of 4-methoxy-3-nitrobenzaldehyde (76 mg, 0.42 mmol) and 33%
MeNH2/ethanol (260 μL, 2.10 mmol) in ethanol (15 mL) was treated with
acetic acid (150 μL) and refluxed for 2 h. After cooling to room
temperature, compound 4a (153 mg, 0.42 mmol) dissolved in dimethoxyethane
(10 mL) and K2CO3 (500 mg, 3.62 mmol) was added and the reaction mixture
was refluxed for another 3 h. The solvent was evaporated, the residue
diluted with ethyl acetate, washed with water and brine, dried over
Na2SO4 , filtered and concentrated in vacuum. The residue was purified by
column chromatography (silica gel 60). 5)
1-Methyl-4-(3'-chloro-4',5'-dimethoxyphenyl)-5-(3"-fluoro-4"-methoxyphenyl)-imidazole
5c Analogously to the synthesis of compound 5a, compound 5c was prepared
from 3-fluoro-4-methoxybenzaldehyde (65 mg, 0.42 mmol), 33% MeNH2/ethanol
(260 μL, 2.10 mmol) and acetic acid (150 μl) in boiling ethanol (15 mL)
giving the imine intermediate, which was treated with compound 4a (153
mg, 0.42 mmol), dissolved in DME (10 mL), and K2CO3 (500 mg, 3.62 mmol).
After workup, the residue was purified by column chromatography (silica
gel 60). Yield: 150 mg (0.38 mmol, 91%); colorless gum. Rf = 0.27 (ethyl
acetate/m ethanol 95:5); ν max (ATR)/cm-1 2937, 2837, 1601 , 1553, 1512,
1487, 1462, 1419, 1301 , 1067, 1233, 1166, 1131 , 1046, 1022, 999; 896,
873, 829, 815, 761 , 734, 719, 656; 1H NMR (300 MHz, CDCl3) δ 3.39 (3 H,
s), 3.61 (3 H, s), 3.75 (3 H, s), 3.87 (3 H, s), 6.9-7.0 (5 H, m), 7.45
(1 H, s); 13C NMR (75.5 MHz, CDCl3) δ 31.9, 55.6, 56.1 , 60.5, 109.0,
113.7, 118.0, 118.2, 119.4, 122.4, 122.5, 126.9, 127.5, 127.8, 131.0,
136.7, 137.2, 143.6, 148.0, 148.1 , 150.5, 153.2, 153.8; m/z (EI) 379
(15), 378 (65) [M+], 377 (41 ), 376 (100) [M+], 363 (26), 361 (67).
$DTYPE RXN:VAR(1):NOTES
$DATUM product further converted into (HCl) salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combretastatin analogs for use in the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schobert, Rainer; Biersack, Bernhard; Mueller, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011138409 A1 2011-11-10

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Ethanediol, 1-(2-nitrophenyl)-, 2-(4-methylbenzenesulfonate)
C15H15NO6S
1262031-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0012 0.0 0
M  V30 2 C 5.3901 5.3348 0.0 0
M  V30 3 O 5.3901 2.6675 0.0 0
M  V30 4 O 6.9302 5.3348 0.0 0
M  V30 5 S 7.7002 6.6687 0.0 0 VAL=6
M  V30 6 O 8.4702 8.0023 0.0 0
M  V30 7 O 6.3665 7.4387 0.0 0
M  V30 8 N 3.0801 1.3337 0.0 0 VAL=5
M  V30 9 O 2.3101 0.0000 0.0 0
M  V30 10 O 4.6201 1.3337 0.0 0
M  V30 11 C 13.0352 3.5886 0.0 0
M  V30 12 C 3.0801 4.0012 0.0 0
M  V30 13 C 2.3101 2.6675 0.0 0
M  V30 14 C 2.3101 5.3348 0.0 0
M  V30 15 C 0.7700 2.6675 0.0 0
M  V30 16 C 0.7700 5.3348 0.0 0
M  V30 17 C 0.0000 4.0012 0.0 0
M  V30 18 C 9.0340 5.8986 0.0 0
M  V30 19 C 9.0340 4.3586 0.0 0
M  V30 20 C 10.3677 6.6687 0.0 0
M  V30 21 C 10.3677 3.5886 0.0 0
M  V30 22 C 11.7013 5.8986 0.0 0
M  V30 23 C 11.7013 4.3586 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 18
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 13
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[(Methylamino)methyl]-2-nitrobenzenemethanol
C9H12N2O3
103854-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 O 3.8500 5.3349 0.0 0
M  V30 4 N 6.9300 5.3349 0.0 0
M  V30 5 C 8.4700 5.3349 0.0 0
M  V30 6 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 7 O 2.3100 5.3349 0.0 0
M  V30 8 O 0.0000 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 1.5400 1.3338 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1262031-90-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 103854-12-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8191863
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sequential gene silencing using wavelength-selective caged morpholino
oligonucleotides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamazoe, Sayumi; Liu, Qingyang; McQuade, Lindsey E.; Deiters, Alexander;
Chen, James K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2014), 53(38), 10114-10118

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloro(η5-2,4-cyclopentadien-1-yl)[4-(1,1-dimethylethyl)-1-[2-(diphenylphosph...
C26H30ClN2PRu
1268669-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.8680 7.1927 0.0 0 CHG=-1 VAL=1
M  V30 2 C 0.9945 9.5427 0.0 0
M  V30 3 C 0.0000 8.9695 0.0 0
M  V30 4 C 0.4212 10.5372 0.0 0
M  V30 5 C 1.5709 10.5372 0.0 0
M  V30 6 Ru 4.3137 4.9630 0.0 0 CHG=4 VAL=9
M  V30 7 C 8.6369 4.9091 0.0 0 CHG=-1 VAL=4
M  V30 8 C 6.6416 4.1332 0.0 0 VAL=5
M  V30 9 C 6.6416 5.6819 0.0 0 VAL=5
M  V30 10 C 7.4176 7.0122 0.0 0 VAL=5
M  V30 11 C 7.4176 2.8030 0.0 0 VAL=5
M  V30 12 P 3.5282 3.6454 0.0 0 VAL=4
M  V30 13 C 3.5378 6.3059 0.0 0 CHG=-2 VAL=4
M  V30 14 C 1.9763 3.6454 0.0 0
M  V30 15 N 1.9890 6.3059 0.0 0
M  V30 16 N 3.5409 8.9695 0.0 0
M  V30 17 C 1.2067 4.9820 0.0 0
M  V30 18 C 1.2130 7.6361 0.0 0
M  V30 19 C 1.9890 8.9695 0.0 0
M  V30 20 C 5.1340 2.3437 0.0 0
M  V30 21 C 5.1340 1.0990 0.0 0
M  V30 22 C 6.2140 2.9677 0.0 0
M  V30 23 C 6.2140 0.4751 0.0 0
M  V30 24 C 7.2940 2.3437 0.0 0
M  V30 25 C 7.2940 1.0990 0.0 0
M  V30 26 C 3.5282 2.4957 0.0 0
M  V30 27 C 2.4451 1.8718 0.0 0
M  V30 28 C 4.6051 1.8718 0.0 0
M  V30 29 C 2.4451 0.6239 0.0 0
M  V30 30 C 4.6051 0.6239 0.0 0
M  V30 31 C 3.5282 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 19
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 2 6 13
M  V30 13 1 7 10
M  V30 14 1 7 11
M  V30 15 1 8 9
M  V30 16 2 8 11
M  V30 17 2 9 10
M  V30 18 1 12 14
M  V30 19 1 12 20
M  V30 20 1 12 26
M  V30 21 1 13 15
M  V30 22 1 13 16
M  V30 23 1 14 17
M  V30 24 1 15 17
M  V30 25 1 15 18
M  V30 26 1 16 19
M  V30 27 2 18 19
M  V30 28 2 20 21
M  V30 29 1 20 22
M  V30 30 1 21 23
M  V30 31 2 22 24
M  V30 32 2 23 25
M  V30 33 1 24 25
M  V30 34 2 26 27
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 2 28 30
M  V30 38 2 29 31
M  V30 39 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ruthenium(1+), (η5-2,4-cyclopentadien-1-yl)[4-(1,1-dimethylethyl)-1-[2-(diphe...
C27H35N3PRu.F6P
1268669-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.3169 11.4750 0.0 0 VAL=4
M  V30 2 C 5.4484 12.1279 0.0 0
M  V30 3 C 0.9952 13.7571 0.0 0
M  V30 4 C 0.0000 13.1834 0.0 0
M  V30 5 C 0.4215 14.7523 0.0 0
M  V30 6 C 1.5721 14.7523 0.0 0
M  V30 7 Ru 4.3169 9.1740 0.0 0 CHG=4 VAL=9
M  V30 8 C 8.6433 9.1201 0.0 0 CHG=-1 VAL=4
M  V30 9 C 6.6465 8.3435 0.0 0 VAL=5
M  V30 10 C 6.6465 9.8934 0.0 0 VAL=5
M  V30 11 C 7.4230 11.2246 0.0 0 VAL=5
M  V30 12 C 7.4230 7.0124 0.0 0 VAL=5
M  V30 13 P 3.5308 7.8554 0.0 0 VAL=4
M  V30 14 C 3.5403 10.5178 0.0 0 CHG=-2 VAL=4
M  V30 15 C 1.9778 7.8554 0.0 0
M  V30 16 N 1.9905 10.5178 0.0 0
M  V30 17 N 3.5435 13.1834 0.0 0
M  V30 18 C 1.2076 9.1930 0.0 0
M  V30 19 C 1.2139 11.8490 0.0 0
M  V30 20 C 1.9905 13.1834 0.0 0
M  V30 21 C 5.1378 6.5528 0.0 0
M  V30 22 C 5.1378 5.3072 0.0 0
M  V30 23 C 6.2186 7.1772 0.0 0
M  V30 24 C 6.2186 4.6828 0.0 0
M  V30 25 C 7.2994 6.5528 0.0 0
M  V30 26 C 7.2994 5.3072 0.0 0
M  V30 27 C 3.5308 6.7049 0.0 0
M  V30 28 C 2.4469 6.0805 0.0 0
M  V30 29 C 4.6085 6.0805 0.0 0
M  V30 30 C 2.4469 4.8317 0.0 0
M  V30 31 C 4.6085 4.8317 0.0 0
M  V30 32 C 3.5308 4.2073 0.0 0
M  V30 33 P 4.3216 1.3337 0.0 0 CHG=5 VAL=6
M  V30 34 F 2.7816 1.3337 0.0 0 CHG=-1 VAL=1
M  V30 35 F 5.8617 1.3337 0.0 0 CHG=-1 VAL=1
M  V30 36 F 3.5516 2.6673 0.0 0 CHG=-1 VAL=1
M  V30 37 F 5.0916 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 38 F 5.0916 2.6673 0.0 0 CHG=-1 VAL=1
M  V30 39 F 3.5516 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 1 8 11
M  V30 15 1 8 12
M  V30 16 1 9 10
M  V30 17 2 9 12
M  V30 18 2 10 11
M  V30 19 1 13 15
M  V30 20 1 13 21
M  V30 21 1 13 27
M  V30 22 1 14 16
M  V30 23 1 14 17
M  V30 24 1 15 18
M  V30 25 1 16 18
M  V30 26 1 16 19
M  V30 27 1 17 20
M  V30 28 2 19 20
M  V30 29 2 21 22
M  V30 30 1 21 23
M  V30 31 1 22 24
M  V30 32 2 23 25
M  V30 33 2 24 26
M  V30 34 1 25 26
M  V30 35 2 27 28
M  V30 36 1 27 29
M  V30 37 1 28 30
M  V30 38 2 29 31
M  V30 39 2 30 32
M  V30 40 1 31 32
M  V30 41 1 33 34
M  V30 42 1 33 35
M  V30 43 1 33 36
M  V30 44 1 33 37
M  V30 45 1 33 38
M  V30 46 1 33 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1268669-30-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1268669-40-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-5352743
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 17084-13-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 1693-74-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A labile and catalytically active imidazol-2-yl fragment system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miranda-Soto, Valentin; Grotjahn, Douglas B.; Cooksy, Andrew L.; Golen,
James A.; Moore, Curtis E.; Rheingold, Arnold L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2011), 50(3), 631-635,
S631/1-S631/26

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[3-Chloro-6-cyclopropyl-8-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]carb...
C22H22ClF3N4O3
1284244-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9538 6.8291 0.0 0
M  V30 2 F 4.6200 7.5991 0.0 0
M  V30 3 F 6.7238 8.1629 0.0 0
M  V30 4 F 7.2874 6.0591 0.0 0
M  V30 5 Cl 5.8940 0.1774 0.0 0
M  V30 6 C 8.9548 1.5400 0.0 0
M  V30 7 O 8.9548 0.0000 0.0 0
M  V30 8 O 14.2895 1.5400 0.0 0
M  V30 9 O 18.2906 6.9300 0.0 0
M  V30 10 C 5.9538 4.1619 0.0 0
M  V30 11 N 5.1838 2.8282 0.0 0
M  V30 12 C 5.1838 5.4955 0.0 0
M  V30 13 N 7.4601 3.8417 0.0 0
M  V30 14 C 6.2142 1.6837 0.0 0
M  V30 15 C 3.6438 2.8282 0.0 0
M  V30 16 C 3.6438 5.4955 0.0 0
M  V30 17 C 7.6210 2.3100 0.0 0
M  V30 18 C 2.8738 4.1619 0.0 0
M  V30 19 C 1.3338 4.1619 0.0 0
M  V30 20 C 0.0000 3.3919 0.0 0
M  V30 21 C 0.0000 4.9319 0.0 0
M  V30 22 N 10.2884 2.3100 0.0 0
M  V30 23 C 11.6221 1.5400 0.0 0
M  V30 24 C 10.2884 3.8500 0.0 0
M  V30 25 C 12.9559 2.3100 0.0 0
M  V30 26 C 11.6221 4.6200 0.0 0
M  V30 27 N 12.9559 3.8500 0.0 0
M  V30 28 C 14.2895 4.6200 0.0 0
M  V30 29 C 14.2895 6.1600 0.0 0
M  V30 30 C 15.6231 3.8500 0.0 0
M  V30 31 C 15.6231 6.9300 0.0 0
M  V30 32 C 16.9568 4.6200 0.0 0
M  V30 33 C 16.9568 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 14
M  V30 6 2 6 7
M  V30 7 1 6 17
M  V30 8 1 6 22
M  V30 9 2 8 25
M  V30 10 2 9 33
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 1 27 28
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[3-Chloro-6-cyclopropyl-8-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]carb...
C23H27ClF3N5O2
1284249-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9539 6.8292 0.0 0
M  V30 2 F 4.6201 7.5992 0.0 0
M  V30 3 F 6.7239 8.1630 0.0 0
M  V30 4 F 7.2875 6.0592 0.0 0
M  V30 5 Cl 5.8941 0.1774 0.0 0
M  V30 6 C 8.9549 1.5400 0.0 0
M  V30 7 O 8.9549 0.0000 0.0 0
M  V30 8 O 14.2897 1.5400 0.0 0
M  V30 9 N 18.2906 6.9301 0.0 0
M  V30 10 C 19.6244 6.1601 0.0 0
M  V30 11 C 5.9539 4.1619 0.0 0
M  V30 12 N 5.1839 2.8282 0.0 0
M  V30 13 C 5.1839 5.4956 0.0 0
M  V30 14 N 7.4601 3.8417 0.0 0
M  V30 15 C 6.2143 1.6837 0.0 0
M  V30 16 C 3.6438 2.8282 0.0 0
M  V30 17 C 3.6438 5.4956 0.0 0
M  V30 18 C 7.6211 2.3100 0.0 0
M  V30 19 C 2.8738 4.1619 0.0 0
M  V30 20 C 1.3338 4.1619 0.0 0
M  V30 21 C 0.0000 3.3919 0.0 0
M  V30 22 C 0.0000 4.9319 0.0 0
M  V30 23 N 10.2885 2.3100 0.0 0
M  V30 24 C 11.6222 1.5400 0.0 0
M  V30 25 C 10.2885 3.8500 0.0 0
M  V30 26 C 12.9559 2.3100 0.0 0
M  V30 27 C 11.6222 4.6201 0.0 0
M  V30 28 N 12.9559 3.8500 0.0 0
M  V30 29 C 14.2897 4.6201 0.0 0
M  V30 30 C 14.2897 6.1601 0.0 0
M  V30 31 C 15.6233 3.8500 0.0 0
M  V30 32 C 15.6233 6.9301 0.0 0
M  V30 33 C 16.9570 4.6201 0.0 0
M  V30 34 C 16.9570 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 5 15
M  V30 6 2 6 7
M  V30 7 1 6 18
M  V30 8 1 6 23
M  V30 9 2 8 26
M  V30 10 1 9 10
M  V30 11 1 9 34
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 2 16 19
M  V30 21 1 17 19
M  V30 22 1 19 20
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 1 28 29
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1284244-29-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1284249-60-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5186347
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-{[3-chloro-6-cyclopropyl-8-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]carbonyl}-1
-(4(methylamino)cyclohexyl]-2-piperazinone To a solution of
4-{[3-chloro-6-cyclopropyl-8-(trifluoromethyl)imidazo[1 ,2-
a]pyridin-2-yl]carbonyl}-1 -(4-oxocyclohexyl)-2-piperazinone (0.360 g,
0.00075 mol) in methanol (10 mL) was added sodium sulfate (0.635 g,
0.0045 mol) and methylamine (2M in THF) (1.1 mL,0.0022 mol). The mixture
was stirred at room temperature for 1 hour before sodium borohydride
(0.034 g, 0.00089 mol) was added. After 1 hour, most of the methanol was
evaporated, and the residue was extracted with ethyl acetate. The
combined organic phases were washed with brine, dried over sodium sulfate
and concentrated to give the title compound (0.354 g, 91 %) as a mixture
of isomers (90:10). 1H NMR (400 MHz, DMSO- d 6) δ ppm 8.45 (d, 1 H) 7.36
- 7.67 (m, 1 H) 4.43 (s, 1 H) 4.10 - 4.32 (m, 2 H) 3.96 - 4.00 (m, 1 H)
3.82 (t, 1 H) 3.34 - 3.42 (m, 2 H) 2.24 (s, 3 H) 2.1 1 - 2.25 (m, 2 H) 1
.87 - 1.96 (m, 2 H) 1.44 - 1.60 (m, 4 H) 0.95 - 1.11 (m, 4 H) 0.81 - 0.94
(m, 2 H). MS (ESI) m/z 498 (M+1 ).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Banka, Anna; Catalano, John G.; Chong, Pek Yoke; Fang, Jing; Garrido,
Dulce Maria; Peat, Andrew James; Price, Daniel J.; Shotwell, John Brad;
Tai, Vincent; Zhang, Huichang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011041713 A2 2011-04-07

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(2,4-Dichlorophenoxy)methyl]-6,7-dimethoxy-4H-3,1-benzoxazin-4-one
C17H13Cl2NO5
1312035-58-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 8.0021 0.0 0
M  V30 2 O 2.3100 1.3336 0.0 0
M  V30 3 C 3.0800 0.0000 0.0 0
M  V30 4 C 9.2400 5.3347 0.0 0
M  V30 5 O 10.0100 6.6684 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3347 0.0 0
M  V30 8 Cl 11.5500 9.3358 0.0 0
M  V30 9 Cl 16.1700 6.6684 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 N 6.9300 4.0011 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 5.3900 6.6684 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 7.7000 5.3347 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 O 6.9300 6.6684 0.0 0
M  V30 20 C 11.5500 6.6684 0.0 0
M  V30 21 C 12.3200 8.0021 0.0 0
M  V30 22 C 12.3200 5.3347 0.0 0
M  V30 23 C 13.8600 8.0021 0.0 0
M  V30 24 C 13.8600 5.3347 0.0 0
M  V30 25 C 14.6300 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 18
M  V30 9 1 8 21
M  V30 10 1 9 25
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(2,4-Dichlorophenoxy)methyl]-6,7-dimethoxy-3-methyl-4(3H)-quinazolinone
C18H16Cl2N2O4
1376711-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 8.0022 0.0 0
M  V30 2 C 9.2401 5.3348 0.0 0
M  V30 3 O 10.0101 4.0011 0.0 0
M  V30 4 O 2.3100 1.3337 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3348 0.0 0
M  V30 8 C 7.7001 8.0022 0.0 0
M  V30 9 Cl 11.5501 1.3337 0.0 0
M  V30 10 Cl 16.1702 4.0011 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 3.0800 5.3348 0.0 0
M  V30 16 C 5.3901 6.6686 0.0 0
M  V30 17 C 7.7001 5.3348 0.0 0
M  V30 18 C 3.0800 2.6675 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 N 6.9301 6.6686 0.0 0
M  V30 21 C 11.5501 4.0011 0.0 0
M  V30 22 C 12.3201 2.6675 0.0 0
M  V30 23 C 12.3201 5.3348 0.0 0
M  V30 24 C 13.8602 2.6675 0.0 0
M  V30 25 C 13.8602 5.3348 0.0 0
M  V30 26 C 14.6302 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 3 21
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 1 8 20
M  V30 10 1 9 22
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1312035-58-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1376711-23-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11207586
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis and herbicidal evaluation of 4H-3,1-benzoxazin-4-ones
and 3H-quinazolin-4-ones with 2-phenoxymethyl substituents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aibibuli, Zumuretiguli; Wang, Yufeng; Tu, Haiyang; Huang, Xiaoting;
Zhang, Aidong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2012), 173181-3201

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thymidine, 3′-azido-3′-deoxy-, 5′-[hydrogen (ethoxycarbonyl)phosphonate]
C13H18N5O8P
131219-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 4.2105 0.0 0
M  V30 2 C 9.3038 5.3934 0.0 0
M  V30 3 O 9.9301 6.8003 0.0 0
M  V30 4 P 11.4617 6.9613 0.0 0 VAL=5
M  V30 5 C 12.9933 7.1222 0.0 0
M  V30 6 O 11.6226 5.4297 0.0 0
M  V30 7 O 11.3008 8.4928 0.0 0
M  V30 8 O 13.6197 8.5292 0.0 0
M  V30 9 O 13.8985 5.8763 0.0 0
M  V30 10 C 15.1513 8.6901 0.0 0
M  V30 11 C 15.7776 10.0969 0.0 0
M  V30 12 N 7.6286 2.4918 0.0 0
M  V30 13 N 6.7233 1.2459 0.0 0 CHG=1 VAL=4
M  V30 14 N 5.8181 0.0000 0.0 0 CHG=-1
M  V30 15 C 2.6673 10.3706 0.0 0
M  V30 16 O 0.0000 8.8306 0.0 0
M  V30 17 C 5.3348 5.7505 0.0 0 CFG=1
M  V30 18 O 6.7417 6.3768 0.0 0
M  V30 19 C 5.4958 4.2189 0.0 0
M  V30 20 C 7.7721 5.2324 0.0 0 CFG=2
M  V30 21 C 7.0021 3.8987 0.0 0 CFG=2
M  V30 22 N 4.0010 6.5205 0.0 0
M  V30 23 C 2.6673 5.7505 0.0 0
M  V30 24 C 4.0010 8.0605 0.0 0
M  V30 25 N 1.3337 6.5205 0.0 0
M  V30 26 C 2.6673 8.8306 0.0 0
M  V30 27 C 1.3337 8.0605 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 23
M  V30 2 1 2 3
M  V30 3 1 20 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 21 12 CFG=1
M  V30 14 2 13 14
M  V30 15 1 15 26
M  V30 16 2 16 27
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 22 CFG=3
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 17 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Thymidine, 3′-azido-3′-deoxy-, 5′-[hydrogen P-[(methylamino)carbonyl]phosphon...
C12H17N6O7P
725246-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 4.2105 0.0 0
M  V30 2 C 9.3038 5.3934 0.0 0
M  V30 3 O 9.9303 6.8003 0.0 0
M  V30 4 P 11.4619 6.9613 0.0 0 VAL=5
M  V30 5 C 12.9934 7.1222 0.0 0
M  V30 6 O 11.6228 5.4297 0.0 0
M  V30 7 O 11.3009 8.4928 0.0 0
M  V30 8 N 13.6197 8.5292 0.0 0
M  V30 9 O 13.8986 5.8763 0.0 0
M  V30 10 C 15.1515 8.6901 0.0 0
M  V30 11 N 7.6286 2.4918 0.0 0
M  V30 12 N 6.7235 1.2459 0.0 0 CHG=1 VAL=4
M  V30 13 N 5.8182 0.0000 0.0 0 CHG=-1
M  V30 14 C 2.6675 10.3706 0.0 0
M  V30 15 O 0.0000 8.8306 0.0 0
M  V30 16 C 5.3348 5.7505 0.0 0 CFG=1
M  V30 17 O 6.7418 6.3768 0.0 0
M  V30 18 C 5.4959 4.2189 0.0 0
M  V30 19 C 7.7722 5.2324 0.0 0 CFG=2
M  V30 20 C 7.0022 3.8987 0.0 0 CFG=2
M  V30 21 N 4.0012 6.5205 0.0 0
M  V30 22 C 2.6675 5.7505 0.0 0
M  V30 23 C 4.0012 8.0605 0.0 0
M  V30 24 N 1.3338 6.5205 0.0 0
M  V30 25 C 2.6675 8.8306 0.0 0
M  V30 26 C 1.3338 8.0605 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 22
M  V30 2 1 2 3
M  V30 3 1 19 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 20 11 CFG=1
M  V30 13 2 12 13
M  V30 14 1 14 25
M  V30 15 2 15 26
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 21 CFG=3
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 131219-88-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 725246-01-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12984918
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 3'-Azido-3'-deoxythymidine
5'-(methylaminocarbonyl)phosphonate 14. A solution of phosphonate 9 (80
mg, 0.2 mmol) in 25% aqueous methylamine (3 mL) was kept for 1 h at 20 °C
and evaporated. The residue was dissolved in water and purified on a
DEAE-Toyopearl column in a linear gradient of NH4HCO3 (0-0.2 M).
3'-Azido-3'-deoxythymidine 5'-(methylaminocarbonyl)phosphonate 14, 71 mg
(91%). 1H NMR (D2O): 7.52 (1H, s, H6), 6.06 (1H, t, J6.7, H1'), 4.32 (1H,
m, H3'), 4.01 (3H, m, H4' + H5'), 2.61 (3H, s, CH3N), 2.32 (2H, m, H2'),
1.72 (3H, s, CH3-Thy). 31P NMR (D2O):-1.40 s.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Uncharged AZT and D4T Derivatives of Phosphonoformic and Phosphonoacetic
Acids as Anti-HIV Pronucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shirokova, Elena A.; Jasko, Maxim V.; Khandazhinskaya, Anastasiya L.;
Ivanov, Alexander V.; Yanvarev, Dmitry V.; Skoblov, Yury S.; Mitkevich,
Vladimir A.; Bocharov, Eduard V.; Pronyaeva, Tatyana R.; Fedyuk, Nina V.;
Kukhanova, Marina K.; Pokrovsky, Andrey G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(14), 3606-3614

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thymidine, 3′-azido-3′-deoxy-, 5′-[hydrogen (ethoxycarbonyl)phosphonate]
C13H18N5O8P
131219-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 4.2105 0.0 0
M  V30 2 C 9.3038 5.3934 0.0 0
M  V30 3 O 9.9301 6.8003 0.0 0
M  V30 4 P 11.4617 6.9613 0.0 0 VAL=5
M  V30 5 C 12.9933 7.1222 0.0 0
M  V30 6 O 11.6226 5.4297 0.0 0
M  V30 7 O 11.3008 8.4928 0.0 0
M  V30 8 O 13.6197 8.5292 0.0 0
M  V30 9 O 13.8985 5.8763 0.0 0
M  V30 10 C 15.1513 8.6901 0.0 0
M  V30 11 C 15.7776 10.0969 0.0 0
M  V30 12 N 7.6286 2.4918 0.0 0
M  V30 13 N 6.7233 1.2459 0.0 0 CHG=1 VAL=4
M  V30 14 N 5.8181 0.0000 0.0 0 CHG=-1
M  V30 15 C 2.6673 10.3706 0.0 0
M  V30 16 O 0.0000 8.8306 0.0 0
M  V30 17 C 5.3348 5.7505 0.0 0 CFG=1
M  V30 18 O 6.7417 6.3768 0.0 0
M  V30 19 C 5.4958 4.2189 0.0 0
M  V30 20 C 7.7721 5.2324 0.0 0 CFG=2
M  V30 21 C 7.0021 3.8987 0.0 0 CFG=2
M  V30 22 N 4.0010 6.5205 0.0 0
M  V30 23 C 2.6673 5.7505 0.0 0
M  V30 24 C 4.0010 8.0605 0.0 0
M  V30 25 N 1.3337 6.5205 0.0 0
M  V30 26 C 2.6673 8.8306 0.0 0
M  V30 27 C 1.3337 8.0605 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 23
M  V30 2 1 2 3
M  V30 3 1 20 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 21 12 CFG=1
M  V30 14 2 13 14
M  V30 15 1 15 26
M  V30 16 2 16 27
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 22 CFG=3
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 17 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Thymidine, 3′-azido-3′-deoxy-, 5′-[hydrogen P-[(methylamino)carbonyl]phosphon...
C12H17N6O7P
725246-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 4.2105 0.0 0
M  V30 2 C 9.3038 5.3934 0.0 0
M  V30 3 O 9.9303 6.8003 0.0 0
M  V30 4 P 11.4619 6.9613 0.0 0 VAL=5
M  V30 5 C 12.9934 7.1222 0.0 0
M  V30 6 O 11.6228 5.4297 0.0 0
M  V30 7 O 11.3009 8.4928 0.0 0
M  V30 8 N 13.6197 8.5292 0.0 0
M  V30 9 O 13.8986 5.8763 0.0 0
M  V30 10 C 15.1515 8.6901 0.0 0
M  V30 11 N 7.6286 2.4918 0.0 0
M  V30 12 N 6.7235 1.2459 0.0 0 CHG=1 VAL=4
M  V30 13 N 5.8182 0.0000 0.0 0 CHG=-1
M  V30 14 C 2.6675 10.3706 0.0 0
M  V30 15 O 0.0000 8.8306 0.0 0
M  V30 16 C 5.3348 5.7505 0.0 0 CFG=1
M  V30 17 O 6.7418 6.3768 0.0 0
M  V30 18 C 5.4959 4.2189 0.0 0
M  V30 19 C 7.7722 5.2324 0.0 0 CFG=2
M  V30 20 C 7.0022 3.8987 0.0 0 CFG=2
M  V30 21 N 4.0012 6.5205 0.0 0
M  V30 22 C 2.6675 5.7505 0.0 0
M  V30 23 C 4.0012 8.0605 0.0 0
M  V30 24 N 1.3338 6.5205 0.0 0
M  V30 25 C 2.6675 8.8306 0.0 0
M  V30 26 C 1.3338 8.0605 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 22
M  V30 2 1 2 3
M  V30 3 1 19 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 20 11 CFG=1
M  V30 13 2 12 13
M  V30 14 1 14 25
M  V30 15 2 15 26
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 21 CFG=3
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 131219-88-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 725246-01-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9492470
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General procedure for the preparation of amides (Va)-(Vd). Phosphonate
(IV) (0.2 mmol) was kept for 18 h at room temperature in 25% ammonia (5
ml), in 25% aqueous methylamine (5 ml), or phenylethylamine (2 ml), or
refluxed in morpholine (3 ml) for 3 h. The solution was evaporated, the
residue was dissolved in water and chromatographed on a DEAE-Toyopearl
column (2 × 18 cm), eluted with a linear gradient of NH4HCO3 in water
(0→0.1 M). The target fractions were evaporated, the residue was
dissolved in water (1 ml) and chromatographed on a LiChroprep RP-18
column (2 × 18 cm) for (Va) and (Vb) or LiChroprep RP-8 for (Vc) and (Vd)
eluted with water. The UVabsorbing target fractions were evaporated.
3'-Azido-3'-deoxythymidine 5'-(methylaminocarbonyl) phosphonate (Vb);
yield 91%. 1H NMR (D2O): 7.52 (1 H, s, H6), 6.06 (1 H, t, J 6.7, H1'),
4.32 (1 H, m, H3'), 4.01 (3 H, m, H4' and H5'), 2.61 (3 H, s, CH 3NH),
2.32 (2 H, m, H2'), 1.72 (3 H, s, 5-CH3); 31P NMR (D2O): -1.40 (s); MS,
m/z: 388.1 [M +], M calc 388.09.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Phosphonoformic Acid Derivatives of 3'-Azido-3'-Deoxythymidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shirokova, E. A.; Jasko, M. V.; Khandazhinskaya, A. L.; Ivanov, A. V.;
Yanvarev, D. V.; Skoblov, Yu. S.; Pronyaeva, T. R.; Fedyuk, N. V.;
Pokrovskii, A. G.; Kukhanova, M. K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Bioorganic Chemistry (Translation of Bioorganicheskaya
Khimiya) (2004), 30(3), 242-249

$RFMT $RIREG SCHEME119 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-[(phenylmethyl)thio]benzaldehyde
C14H11ClOS
132483-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 3.0800 1.3338 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 Cl 3.0800 6.6685 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 0.0000 4.0011 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 7.7000 6.6685 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 2 3 4
M  V30 5 1 3 7
M  V30 6 1 5 8
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Methoxyethylidene)glycine ethyl ester
C7H13NO3
2135836-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 2.6673 2.3101 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 1.3337 1.5400 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4 CFG=2
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z)-5-[[3-Chloro-2-[(phenylmethyl)thio]phenyl]methylene]-3,5-dihydro-2,3-dim...
C19H17ClN2OS
2848680-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 S 7.9700 5.5687 0.0 0
M  V30 3 C 9.3037 6.3387 0.0 0
M  V30 4 Cl 7.9700 8.6487 0.0 0
M  V30 5 O 4.9524 0.6965 0.0 0
M  V30 6 C 1.6752 0.0000 0.0 0
M  V30 7 C 0.0000 2.9015 0.0 0
M  V30 8 C 5.3026 5.5687 0.0 0
M  V30 9 C 6.6364 6.3387 0.0 0
M  V30 10 C 3.9689 6.3387 0.0 0
M  V30 11 C 6.6364 7.8787 0.0 0
M  V30 12 C 3.9689 7.8787 0.0 0
M  V30 13 C 5.3026 8.6487 0.0 0
M  V30 14 C 3.9689 3.2587 0.0 0
M  V30 15 C 3.8080 1.7271 0.0 0
M  V30 16 N 2.5621 3.8850 0.0 0
M  V30 17 N 2.3016 1.4070 0.0 0
M  V30 18 C 1.5315 2.7406 0.0 0
M  V30 19 C 10.6374 5.5687 0.0 0
M  V30 20 C 11.9712 6.3387 0.0 0
M  V30 21 C 10.6374 4.0287 0.0 0
M  V30 22 C 13.3048 5.5687 0.0 0
M  V30 23 C 11.9712 3.2587 0.0 0
M  V30 24 C 13.3048 4.0287 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 1 14
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 19
M  V30 6 1 4 11
M  V30 7 2 5 15
M  V30 8 1 6 17
M  V30 9 1 7 18
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 132483-94-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2135836-32-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2848680-03-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34407636
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of spiro[imidazole-4,3'-thiochroman]ones from
[2-(benzylsulfanyl)benzylidene]imidazolones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zaitseva, Elvira R.; Sokolov, Anatolii I.; Mikhaylov, Andrey A.; Baleeva,
Nadezhda S.; Baranov, Mikhail S.; Smirnov, Alexander Yu.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2022),
58(8-9), 477-480

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,2R,3S,4R,5S)-2-Azido-4-(2,6-dichloro-9H-purin-9-yl)bicyclo[3.1.0]hexan-3-ol
C11H9Cl2N7O
1339886-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.5083 1.8198 0.0 0
M  V30 2 N 9.8402 2.1700 0.0 0
M  V30 3 N 11.3467 2.4902 0.0 0 CHG=1 VAL=4
M  V30 4 N 12.8530 2.8104 0.0 0 CHG=-1
M  V30 5 Cl 0.0000 4.6200 0.0 0
M  V30 6 Cl 2.6673 0.0000 0.0 0
M  V30 7 C 6.6518 4.5603 0.0 0 CFG=1
M  V30 8 C 7.7963 5.5909 0.0 0 CFG=1
M  V30 9 C 7.2783 3.1535 0.0 0 CFG=2
M  V30 10 C 9.1300 4.8209 0.0 0 CFG=2
M  V30 11 C 9.1300 6.3609 0.0 0
M  V30 12 C 8.8098 3.3144 0.0 0 CFG=2
M  V30 13 N 5.1455 4.8805 0.0 0
M  V30 14 C 4.0010 3.8500 0.0 0
M  V30 15 C 4.5192 6.2874 0.0 0
M  V30 16 C 2.6673 4.6200 0.0 0
M  V30 17 N 4.0011 2.3100 0.0 0
M  V30 18 N 2.9875 6.1265 0.0 0
M  V30 19 C 1.3337 3.8500 0.0 0
M  V30 20 C 2.6673 1.5400 0.0 0
M  V30 21 N 1.3337 2.3100 0.0 0
M  V30 22 H 6.8911 6.8367 0.0 0
M  V30 23 H 10.6615 4.6598 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 2 2 3
M  V30 3 1 12 2 CFG=1
M  V30 4 2 3 4
M  V30 5 1 5 19
M  V30 6 1 6 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13 CFG=3
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 22 CFG=3
M  V30 13 1 9 12
M  V30 14 1 10 11
M  V30 15 1 10 12
M  V30 16 1 10 23 CFG=3
M  V30 17 1 13 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 2 14 17
M  V30 21 2 15 18
M  V30 22 1 16 18
M  V30 23 2 16 19
M  V30 24 1 17 20
M  V30 25 1 19 21
M  V30 26 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 7 8 9 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,2R,3S,4R,5S)-2-Azido-4-[2-chloro-6-(methylamino)-9H-purin-9-yl]bicyclo[3....
C12H13ClN8O
1339886-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.8419 1.8198 0.0 0
M  V30 2 N 11.1738 2.1700 0.0 0
M  V30 3 N 12.6803 2.4902 0.0 0 CHG=1 VAL=4
M  V30 4 N 14.1866 2.8104 0.0 0 CHG=-1
M  V30 5 N 1.3336 4.6200 0.0 0
M  V30 6 C 0.0000 3.8500 0.0 0
M  V30 7 Cl 4.0009 0.0000 0.0 0
M  V30 8 C 9.1299 5.5908 0.0 0 CFG=1
M  V30 9 C 7.9856 4.5603 0.0 0 CFG=1
M  V30 10 C 10.4636 4.8208 0.0 0 CFG=2
M  V30 11 C 10.4636 6.3608 0.0 0
M  V30 12 C 8.6119 3.1535 0.0 0 CFG=2
M  V30 13 C 10.1434 3.3144 0.0 0 CFG=1
M  V30 14 N 6.4791 4.8804 0.0 0
M  V30 15 C 5.3347 3.8500 0.0 0
M  V30 16 C 5.8528 6.2874 0.0 0
M  V30 17 C 4.0009 4.6200 0.0 0
M  V30 18 N 5.3347 2.3100 0.0 0
M  V30 19 N 4.3211 6.1265 0.0 0
M  V30 20 C 2.6673 3.8500 0.0 0
M  V30 21 C 4.0009 1.5400 0.0 0
M  V30 22 N 2.6673 2.3100 0.0 0
M  V30 23 H 8.2247 6.8367 0.0 0
M  V30 24 H 11.9951 4.6598 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 2 2 3
M  V30 3 1 13 2 CFG=1
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 7 21
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 23 CFG=3
M  V30 12 1 9 12
M  V30 13 1 9 14 CFG=3
M  V30 14 1 10 11
M  V30 15 1 10 13
M  V30 16 1 10 24 CFG=3
M  V30 17 1 12 13
M  V30 18 1 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 15 18
M  V30 22 2 16 19
M  V30 23 1 17 19
M  V30 24 2 17 20
M  V30 25 1 18 21
M  V30 26 1 20 22
M  V30 27 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 8 9 10 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1339886-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1339886-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2169784
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regio- and stereoselective synthesis of truncated
3'-aminocarbanucleosides and their binding affinity at the A3 adenosine
receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Mun Ju; Chandra, Girish; Lee, Hyuk Woo; Hou, Xiyan; Choi, Won Jun;
Phan, Khai; Jacobson, Kenneth A.; Jeong, Lak Shin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2011), 9(20), 6955-6962

$RFMT $RIREG SCHEME121 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Thiazoledimethanol, α4-[(1S,2E,4E,6S,7R,8R)-8-[[(1,1-dimethylethyl)dimeth...
C31H53NO5SSi
1346111-58-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.6300 4.0011 0.0 0 CFG=1
M  V30 2 C 13.8600 5.3347 0.0 0 CFG=1
M  V30 3 O 13.8600 2.6673 0.0 0
M  V30 4 C 12.3200 5.3347 0.0 0
M  V30 5 C 14.6300 6.6684 0.0 0
M  V30 6 C 14.6300 1.3336 0.0 0
M  V30 7 C 11.5500 6.6684 0.0 0
M  V30 8 C 13.8600 0.0000 0.0 0
M  V30 9 O 16.1700 1.3336 0.0 0
M  V30 10 C 10.0100 6.6684 0.0 0
M  V30 11 C 9.2400 8.0020 0.0 0
M  V30 12 C 7.7000 8.0020 0.0 0 CFG=1
M  V30 13 C 10.0100 9.3358 0.0 0
M  V30 14 C 6.9300 9.3358 0.0 0 CFG=1
M  V30 15 O 6.9300 6.6684 0.0 0
M  V30 16 C 5.3900 9.3358 0.0 0 CFG=1
M  V30 17 C 7.7000 10.6694 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 O 4.6200 8.0020 0.0 0
M  V30 20 C 4.6200 10.6694 0.0 0
M  V30 21 Si 3.0800 8.0020 0.0 0
M  V30 22 C 5.3900 12.0031 0.0 0
M  V30 23 C 1.5400 8.0020 0.0 0
M  V30 24 C 3.0800 9.5420 0.0 0
M  V30 25 C 3.0800 6.4620 0.0 0
M  V30 26 C 1.5400 9.5420 0.0 0
M  V30 27 C 0.0000 8.0020 0.0 0
M  V30 28 C 1.5400 6.4620 0.0 0
M  V30 29 C 19.7858 5.6761 0.0 0 CFG=1
M  V30 30 C 21.1926 5.0498 0.0 0
M  V30 31 O 19.6247 7.2078 0.0 0
M  V30 32 C 22.4384 5.9550 0.0 0
M  V30 33 C 23.8454 5.3287 0.0 0
M  V30 34 C 22.2775 7.4866 0.0 0
M  V30 35 C 16.1700 4.0011 0.0 0
M  V30 36 N 17.0752 5.2469 0.0 0
M  V30 37 C 17.0752 2.7551 0.0 0
M  V30 38 C 18.5399 4.7711 0.0 0
M  V30 39 S 18.5399 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 35
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 3 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 10 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15 CFG=1
M  V30 16 1 14 16
M  V30 17 1 14 17 CFG=3
M  V30 18 1 15 18
M  V30 19 1 16 19 CFG=3
M  V30 20 1 16 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 1 23 26
M  V30 27 1 23 27
M  V30 28 1 23 28
M  V30 29 1 29 30
M  V30 30 1 29 31 CFG=1
M  V30 31 1 29 38
M  V30 32 1 30 32
M  V30 33 1 32 33
M  V30 34 1 32 34
M  V30 35 1 35 36
M  V30 36 2 35 37
M  V30 37 2 36 38
M  V30 38 1 37 39
M  V30 39 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 1 2 12 14 16 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Thiazoledimethanol, α4-[(1S,2E,4E,6S,7R,8R)-8-[[(1,1-dimethylethyl)dimeth...
C33H56N2O6SSi
1346111-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1303 4.0011 0.0 0 CFG=1
M  V30 2 C 8.9003 5.3347 0.0 0 CFG=1
M  V30 3 O 8.9003 2.6673 0.0 0
M  V30 4 C 10.4403 5.3347 0.0 0
M  V30 5 C 8.1303 6.6684 0.0 0
M  V30 6 C 8.1303 1.3336 0.0 0
M  V30 7 C 11.2103 6.6684 0.0 0
M  V30 8 C 8.9003 0.0000 0.0 0
M  V30 9 O 6.5903 1.3336 0.0 0
M  V30 10 C 12.7503 6.6684 0.0 0
M  V30 11 C 13.5203 8.0020 0.0 0
M  V30 12 C 15.0603 8.0020 0.0 0 CFG=1
M  V30 13 C 12.7503 9.3358 0.0 0
M  V30 14 C 15.8303 9.3358 0.0 0 CFG=1
M  V30 15 O 15.8303 6.6684 0.0 0
M  V30 16 C 17.3703 9.3358 0.0 0 CFG=1
M  V30 17 C 15.0603 10.6694 0.0 0
M  V30 18 C 15.0603 5.3347 0.0 0
M  V30 19 O 18.1403 8.0020 0.0 0
M  V30 20 C 18.1403 10.6694 0.0 0
M  V30 21 Si 19.6803 8.0020 0.0 0
M  V30 22 C 17.3703 12.0031 0.0 0
M  V30 23 C 21.2203 8.0020 0.0 0
M  V30 24 C 19.6803 9.5420 0.0 0
M  V30 25 C 19.6803 6.4620 0.0 0
M  V30 26 C 21.2203 9.5420 0.0 0
M  V30 27 C 22.7603 8.0020 0.0 0
M  V30 28 C 21.2203 6.4620 0.0 0
M  V30 29 C 2.9747 5.6761 0.0 0 CFG=2
M  V30 30 O 3.1356 7.2078 0.0 0
M  V30 31 C 1.5677 5.0498 0.0 0
M  V30 32 C 1.8897 8.1130 0.0 0
M  V30 33 C 1.4068 3.5183 0.0 0
M  V30 34 N 2.0507 9.6446 0.0 0
M  V30 35 O 0.4828 7.4866 0.0 0
M  V30 36 C 0.0000 2.8920 0.0 0
M  V30 37 C 2.6526 2.6131 0.0 0
M  V30 38 C 0.8048 10.5498 0.0 0
M  V30 39 C 6.5903 4.0011 0.0 0
M  V30 40 N 5.6852 5.2469 0.0 0
M  V30 41 C 5.6852 2.7551 0.0 0
M  V30 42 C 4.2205 4.7711 0.0 0
M  V30 43 S 4.2205 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 39
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 3 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 10 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15 CFG=3
M  V30 16 1 14 16
M  V30 17 1 14 17 CFG=1
M  V30 18 1 15 18
M  V30 19 1 16 19 CFG=1
M  V30 20 1 16 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 1 23 26
M  V30 27 1 23 27
M  V30 28 1 23 28
M  V30 29 1 29 30
M  V30 30 1 29 31 CFG=3
M  V30 31 1 29 42
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 32 35
M  V30 36 1 33 36
M  V30 37 1 33 37
M  V30 38 1 34 38
M  V30 39 1 39 40
M  V30 40 2 39 41
M  V30 41 2 40 42
M  V30 42 1 41 43
M  V30 43 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 1 2 12 14 16 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1346111-58-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1346111-59-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-12354101
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and activity of the archazolid western hemisphere
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tran, Ann B.; Melly, Geoffrey C.; Doucette, Ryan; Ashcraft, Brook;
Sebren, Leanne J.; Havko, Nathan; Young, Jeffery C.; O'Neil, Gregory W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2011), 9(22), 7671-7674

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-methoxypyridine
C6H6BrNO
13472-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 N 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-N-methyl-3-pyridinamine
C7H10N2O
61771-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 N 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13472-85-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61771-67-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2174066
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7758-98-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyridine compounds for the treatment of parasitic
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chatterjee, Arnab Kumar; Nagle, Advait Suresh; Paraselli, Prasuna;
Kondreddi, Ravinder Reddy; Leong, Seh Yong; Mishra, Pranab Kumar; Moreau,
Robert Joseph; Roland, Jason Thomas; Sim, Wei Lin Sandra; Simon, Oliver;
Tan, Liying Jocelyn; Yeung, Bryan Ks; Zou, Bin; Bollu, Venkatataiah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014078802 A1 2014-05-22

$RFMT $RIREG SCHEME123 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzil
C14H10O2
134-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxybenzaldehyde
C8H8O2
135-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 4.6201 4.0010 0.0 0
M  V30 4 C 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Methoxyphenyl)-1-methyl-4,5-diphenyl-1H-imidazole
C23H20N2O
2086287-02-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7283 8.2051 0.0 0
M  V30 2 O 1.3338 4.5323 0.0 0
M  V30 3 C 0.0000 3.7623 0.0 0
M  V30 4 C 6.4385 5.5542 0.0 0
M  V30 5 C 5.6685 4.2206 0.0 0
M  V30 6 N 5.4081 6.6988 0.0 0
M  V30 7 N 4.1621 4.5408 0.0 0
M  V30 8 C 4.0011 6.0723 0.0 0
M  V30 9 C 7.9701 5.7153 0.0 0
M  V30 10 C 8.5966 7.1221 0.0 0
M  V30 11 C 8.8753 4.4693 0.0 0
M  V30 12 C 10.1281 7.2831 0.0 0
M  V30 13 C 10.4069 4.6304 0.0 0
M  V30 14 C 11.0333 6.0372 0.0 0
M  V30 15 C 6.2948 2.8138 0.0 0
M  V30 16 C 5.3896 1.5677 0.0 0
M  V30 17 C 7.8265 2.6527 0.0 0
M  V30 18 C 6.0161 0.1609 0.0 0
M  V30 19 C 8.4529 1.2459 0.0 0
M  V30 20 C 7.5476 0.0000 0.0 0
M  V30 21 C 2.6675 6.8423 0.0 0
M  V30 22 C 1.3338 6.0723 0.0 0
M  V30 23 C 2.6675 8.3823 0.0 0
M  V30 24 C 0.0000 6.8423 0.0 0
M  V30 25 C 1.3338 9.1524 0.0 0
M  V30 26 C 0.0000 8.3823 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 5 15
M  V30 9 1 6 8
M  V30 10 2 7 8
M  V30 11 1 8 21
M  V30 12 2 9 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134-81-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 135-02-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2086287-02-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-17274429
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1306-38-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of 1,2,4,5-tetrasubstituted
imidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fang, Yue; Yuan, Rui; Ge, Wen-hui; Wang, Yuan-jiang; Liu, Gui-xiang; Li,
Ming-qi; Xu, Jiang-biao; Wan, Yu; Zhou, Sheng-liang; Han, Xi-guang;
Zhang, Peng; Liu, Jin-juan; Wu, Hui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2017), 43(8), 4413-4421

$RFMT $RIREG SCHEME124 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzil
C14H10O2
134-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluorobenzaldehyde
C7H5FO
456-48-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 F 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Fluorophenyl)-1-methyl-4,5-diphenyl-1H-imidazole
C22H17FN2
2086287-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3051 8.2051 0.0 0
M  V30 2 F 12.3670 6.0723 0.0 0
M  V30 3 C 5.3648 4.2206 0.0 0
M  V30 4 C 4.5948 5.5543 0.0 0
M  V30 5 N 6.8711 4.5408 0.0 0
M  V30 6 N 5.6252 6.6988 0.0 0
M  V30 7 C 7.0322 6.0723 0.0 0
M  V30 8 C 4.7385 2.8138 0.0 0
M  V30 9 C 3.2068 2.6527 0.0 0
M  V30 10 C 5.6436 1.5677 0.0 0
M  V30 11 C 2.5805 1.2459 0.0 0
M  V30 12 C 5.0172 0.1609 0.0 0
M  V30 13 C 3.4857 0.0000 0.0 0
M  V30 14 C 3.0633 5.7153 0.0 0
M  V30 15 C 2.4368 7.1221 0.0 0
M  V30 16 C 2.1580 4.4693 0.0 0
M  V30 17 C 0.9052 7.2831 0.0 0
M  V30 18 C 0.6265 4.6304 0.0 0
M  V30 19 C 0.0000 6.0372 0.0 0
M  V30 20 C 8.3659 6.8423 0.0 0
M  V30 21 C 9.6995 6.0723 0.0 0
M  V30 22 C 8.3659 8.3824 0.0 0
M  V30 23 C 11.0332 6.8423 0.0 0
M  V30 24 C 9.6995 9.1524 0.0 0
M  V30 25 C 11.0332 8.3824 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 23
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 4 14
M  V30 8 2 5 7
M  V30 9 1 6 7
M  V30 10 1 7 20
M  V30 11 2 8 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134-81-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 456-48-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2086287-01-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-17274426
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1306-38-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of 1,2,4,5-tetrasubstituted
imidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fang, Yue; Yuan, Rui; Ge, Wen-hui; Wang, Yuan-jiang; Liu, Gui-xiang; Li,
Ming-qi; Xu, Jiang-biao; Wan, Yu; Zhou, Sheng-liang; Han, Xi-guang;
Zhang, Peng; Liu, Jin-juan; Wu, Hui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2017), 43(8), 4413-4421

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Phenyl-1-isoquinolinyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid
C20H12F3N3O2
1355361-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3594 6.7117 0.0 0
M  V30 2 F 5.8947 6.2356 0.0 0
M  V30 3 F 6.8834 8.1762 0.0 0
M  V30 4 F 8.8239 7.1875 0.0 0
M  V30 5 C 10.5458 5.6763 0.0 0
M  V30 6 O 10.3847 7.2079 0.0 0
M  V30 7 O 11.9526 5.0498 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 4.6200 5.3347 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 4.6200 0.0000 0.0 0
M  V30 17 C 3.0800 0.0000 0.0 0
M  V30 18 N 6.9300 4.0011 0.0 0
M  V30 19 C 7.8353 5.2470 0.0 0
M  V30 20 N 7.8353 2.7552 0.0 0
M  V30 21 C 9.2998 4.7711 0.0 0
M  V30 22 C 9.2998 3.2311 0.0 0
M  V30 23 C 2.3100 6.6684 0.0 0
M  V30 24 C 3.0800 8.0022 0.0 0
M  V30 25 C 0.7700 6.6684 0.0 0
M  V30 26 C 2.3100 9.3358 0.0 0
M  V30 27 C 0.0000 8.0022 0.0 0
M  V30 28 C 0.7700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 19
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 18
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 2 13 14
M  V30 18 1 13 23
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1-(3-phenyl-1-isoquinolinyl)-5-(trifluoromethyl)-1H-pyrazole-4-carbo...
C21H15F3N4O
1355361-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3594 6.7117 0.0 0
M  V30 2 F 5.8947 6.2356 0.0 0
M  V30 3 F 6.8834 8.1762 0.0 0
M  V30 4 F 8.8239 7.1875 0.0 0
M  V30 5 C 10.5457 5.6763 0.0 0
M  V30 6 N 11.9526 5.0498 0.0 0
M  V30 7 O 10.3847 7.2079 0.0 0
M  V30 8 C 13.1985 5.9551 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 N 4.6200 5.3347 0.0 0
M  V30 12 C 3.0800 2.6674 0.0 0
M  V30 13 C 5.3900 1.3336 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 2.3100 1.3336 0.0 0
M  V30 17 C 4.6200 0.0000 0.0 0
M  V30 18 C 3.0800 0.0000 0.0 0
M  V30 19 N 6.9300 4.0011 0.0 0
M  V30 20 C 7.8353 5.2470 0.0 0
M  V30 21 N 7.8353 2.7552 0.0 0
M  V30 22 C 9.2998 4.7711 0.0 0
M  V30 23 C 9.2998 3.2311 0.0 0
M  V30 24 C 2.3100 6.6684 0.0 0
M  V30 25 C 0.7700 6.6684 0.0 0
M  V30 26 C 3.0800 8.0022 0.0 0
M  V30 27 C 0.0000 8.0022 0.0 0
M  V30 28 C 2.3100 9.3358 0.0 0
M  V30 29 C 0.7700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 20
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 22
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 19
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 2 14 15
M  V30 19 1 14 24
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1355361-06-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1355361-15-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1636547
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the synthesis of
5-(trifluoromethyl)-N-alkyl-1-(3-phenylisoquinolin-1-yl)-1H-pyrazole-4-carboxamide
4 To a 20-mL vial TBTU (0.46 g, 1.43 mmol) and diisopropyl ethylamine
(0.336 g; 2.60 mmol; in case of aliphatic amines not necessary to add
additional base) were added to a mixture of 2 (0.5 g; 1.30 mmol), amine 3
(1.43 mmol), acetonitrile (8 mL) at room temperature under nitrogen
atmosphere. This reaction mixture was stirred vigorously for 20-30 min
and its completion was monitored by TLC analysis. The reaction mixture
was quenched by the addition of water (15 mL) and the solid precipitate
was filtered off and dried under vacuum for 2 h. 4a-4n in high yields.
4i: Yield: 377 mg (91%) of white solid. Mp 218-219°C; 1H NMR (400 MHz,
DMSO-D6) δ 8.78 (s, 1H), 8.65 (d, J = 4.0 Hz, 1H), 8.35 (s, 1H),
8.26-8.20 (m, 3H), 7.95 (app. t, J = 7.2 Hz, 1H), 7.79-7.70 (m, 2H),
7.58-7.47 (m, 3H), 2.84-2.83 (d, J = 4.4 Hz, 3H); 13C NMR (100 MHz,
DMSO-D6) δ 160.8, 148.9, 148.5, 140.7, 139.5, 137.6, 132.4, 129.8, 129.7,
129.5, 128.2, 126.9, 124.5, 122.7, 122.1, 119.3, 118.5, 26.9; IR (cm-1),
3,230, 3,054, 2,930, 2,851, 2,029, 2,015, 1,984, 1,636, 1,660, 1,588,
1,549, 1,495, 1,470, 1,405, 1,380, 1,325, 1,295, 1,251, 1,163, 1,023,
954, 852, 795, 751, 727, 694, 661, 564, 521, 500; LC-MS: m/z 397.1,
398.1. C21H15F3N4O requires 396.12. Anal Calcd for C21H15F3N4O: C, 63.63;
H, 3.81; N, 14.14%. Found: C, 63.66; H, 3.81; N, 14.12%.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry (non-toxic reagent), alternative
reaction conditions gave lower yield, optimization study, optimized on
solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium
tetrafluoroborate (TBTU)-mediated synthesis of
5-(trifluoromethyl)-N-alkyl-1-(3-phenylisoquinolin-1-yl)-1H-pyrazole-4-carboxamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Prabakaran, K.; Khan, F. Nawaz; Jin, Jong Sung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2012), 38(2), 615-627

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
2,4,6-Tribromo-3-methoxybenzeneacetaldehyde
C9H7Br3O2
1359715-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 1.5400 0.0 0
M  V30 4 Br 4.0012 0.0000 0.0 0
M  V30 5 Br 6.6685 4.6201 0.0 0
M  V30 6 O 1.3337 1.5400 0.0 0
M  V30 7 C 0.0000 2.3101 0.0 0
M  V30 8 Br 1.3337 4.6201 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6-Tribromo-3-methoxy-N-methylbenzeneethanamine
C10H12Br3NO
243858-10-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 9.3360 1.5400 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 Br 4.0012 0.0000 0.0 0
M  V30 6 Br 6.6685 4.6201 0.0 0
M  V30 7 O 1.3337 1.5400 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 Br 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 1 7 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1359715-08-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 243858-10-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5350313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Convolutamine F (9). To a solution of aldehyde
25 (200 mg, 0.52 mmol) in anhydrous MeOH (3 mL) was added a 40% aqueous
solution of methylamine (100.1 mg, 1.29 mmol). The reaction was stirred
for 30 min at room temperatureand then cooled to 0°C, and NaBH4 (15.7 mg,
0.41 mmol) was added in three portions over a period of 10 min. The
reaction was stirred for 24 h at room temperature, then water (2.5 mL)
was added, and all MeOH was removed under reduced pressure. The obtained
aqueous phase was extracted with CH2Cl2 (3 × 10 mL). The combined organic
phases were dried over Na2SO4 and concentrated under reduced pressure.
The residue was purified by silica gel column chromatography (10- 25%
MeOH/CHCl3). Product 9 (188 mg, 91%) as a colorless viscous liquid. 1H
NMR (500 MHz, CDCl3) δ 7.72 (s, 1H), 3.85 (s, 3H), 3.16 (t, 2H, J= 7.8
Hz), 2.76 (t, 2H, J= 7.9 Hz), 2.49 (s, 3H), 1.45 (s, 1H); 13C NMR (125
MHz, CDCl3) δ 154.0, 139.9, 135.4, 121.8, 120.0, 116.0, 60.6, 49.7, 37.7,
36.4; IR (Neat) 3331, 2934, 2842, 1558, 1451, 1358, 1075, 864 cm-1; HRMS
(ESI) calcd for C10H13Br3NO (M + H), 399.8547; found, 399.8540.
$DTYPE RXN:VAR(1):NOTES
$DATUM third stage added in three portions; fourth stage quench
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Reported and Revised Structures of Amathamide D and
Synthesis of Convolutamine F, H and Lutamide A, C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khan, Faiz Ahmed; Ahmad, Saeed
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(5), 2389-2397

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,5-bis(1,1-dimethylethyl)-4-hydroxy-β-oxobenzenepropanoate
C18H26O4
1361383-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 C 0.5637 4.8265 0.0 0
M  V30 3 C 0.0000 6.9302 0.0 0
M  V30 4 C 2.1037 7.4938 0.0 0
M  V30 5 O 1.3337 3.0801 0.0 0
M  V30 6 C 4.0012 1.5400 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 6.6685 6.1601 0.0 0
M  V30 11 C 8.0022 5.3901 0.0 0
M  V30 12 O 6.6685 7.7002 0.0 0
M  V30 13 C 9.3360 6.1601 0.0 0
M  V30 14 O 10.6697 5.3901 0.0 0
M  V30 15 O 9.3360 7.7002 0.0 0
M  V30 16 C 12.0033 6.1601 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 4.0012 6.1601 0.0 0
M  V30 20 C 4.0012 3.0801 0.0 0
M  V30 21 C 5.3348 5.3901 0.0 0
M  V30 22 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 20
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 21
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Bis(1,1-dimethylethyl)-4-hydroxy-N-methyl-β-oxobenzenepropanamide
C18H27NO3
1361383-61-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 C 0.5637 4.8265 0.0 0
M  V30 3 C 0.0000 6.9302 0.0 0
M  V30 4 C 2.1037 7.4938 0.0 0
M  V30 5 O 1.3337 3.0801 0.0 0
M  V30 6 C 4.0012 1.5400 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 6.6685 6.1601 0.0 0
M  V30 11 C 8.0022 5.3901 0.0 0
M  V30 12 O 6.6685 7.7002 0.0 0
M  V30 13 C 9.3360 6.1601 0.0 0
M  V30 14 N 10.6697 5.3901 0.0 0
M  V30 15 O 9.3360 7.7002 0.0 0
M  V30 16 C 12.0033 6.1601 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 4.0012 6.1601 0.0 0
M  V30 20 C 4.0012 3.0801 0.0 0
M  V30 21 C 5.3348 5.3901 0.0 0
M  V30 22 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 20
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 21
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1361383-60-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1361383-61-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-104704
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine carboxamide derivatives as antiinflammatory
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maehr, Hubert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150087665 A1 2015-03-26

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,5-bis(1,1-dimethylethyl)-4-hydroxy-β-oxobenzenepropanoate
C18H26O4
1361383-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 C 0.5637 4.8265 0.0 0
M  V30 3 C 0.0000 6.9302 0.0 0
M  V30 4 C 2.1037 7.4938 0.0 0
M  V30 5 O 1.3337 3.0801 0.0 0
M  V30 6 C 4.0012 1.5400 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 6.6685 6.1601 0.0 0
M  V30 11 C 8.0022 5.3901 0.0 0
M  V30 12 O 6.6685 7.7002 0.0 0
M  V30 13 C 9.3360 6.1601 0.0 0
M  V30 14 O 10.6697 5.3901 0.0 0
M  V30 15 O 9.3360 7.7002 0.0 0
M  V30 16 C 12.0033 6.1601 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 4.0012 6.1601 0.0 0
M  V30 20 C 4.0012 3.0801 0.0 0
M  V30 21 C 5.3348 5.3901 0.0 0
M  V30 22 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 20
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 21
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Bis(1,1-dimethylethyl)-4-hydroxy-N-methyl-β-oxobenzenepropanamide
C18H27NO3
1361383-61-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 C 0.5637 4.8265 0.0 0
M  V30 3 C 0.0000 6.9302 0.0 0
M  V30 4 C 2.1037 7.4938 0.0 0
M  V30 5 O 1.3337 3.0801 0.0 0
M  V30 6 C 4.0012 1.5400 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 6.6685 6.1601 0.0 0
M  V30 11 C 8.0022 5.3901 0.0 0
M  V30 12 O 6.6685 7.7002 0.0 0
M  V30 13 C 9.3360 6.1601 0.0 0
M  V30 14 N 10.6697 5.3901 0.0 0
M  V30 15 O 9.3360 7.7002 0.0 0
M  V30 16 C 12.0033 6.1601 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 4.0012 6.1601 0.0 0
M  V30 20 C 4.0012 3.0801 0.0 0
M  V30 21 C 5.3348 5.3901 0.0 0
M  V30 22 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 20
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 21
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1361383-60-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1361383-61-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18763846
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine carboxamide derivatives as antiinflammatory
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maehr, Hubert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013032522 A1 2013-03-07

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,5-bis(1,1-dimethylethyl)-4-hydroxy-β-oxobenzenepropanoate
C18H26O4
1361383-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 C 0.5637 4.8265 0.0 0
M  V30 3 C 0.0000 6.9302 0.0 0
M  V30 4 C 2.1037 7.4938 0.0 0
M  V30 5 O 1.3337 3.0801 0.0 0
M  V30 6 C 4.0012 1.5400 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 6.6685 6.1601 0.0 0
M  V30 11 C 8.0022 5.3901 0.0 0
M  V30 12 O 6.6685 7.7002 0.0 0
M  V30 13 C 9.3360 6.1601 0.0 0
M  V30 14 O 10.6697 5.3901 0.0 0
M  V30 15 O 9.3360 7.7002 0.0 0
M  V30 16 C 12.0033 6.1601 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 4.0012 6.1601 0.0 0
M  V30 20 C 4.0012 3.0801 0.0 0
M  V30 21 C 5.3348 5.3901 0.0 0
M  V30 22 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 20
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 21
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Bis(1,1-dimethylethyl)-4-hydroxy-N-methyl-β-oxobenzenepropanamide
C18H27NO3
1361383-61-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 C 0.5637 4.8265 0.0 0
M  V30 3 C 0.0000 6.9302 0.0 0
M  V30 4 C 2.1037 7.4938 0.0 0
M  V30 5 O 1.3337 3.0801 0.0 0
M  V30 6 C 4.0012 1.5400 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 6.6685 6.1601 0.0 0
M  V30 11 C 8.0022 5.3901 0.0 0
M  V30 12 O 6.6685 7.7002 0.0 0
M  V30 13 C 9.3360 6.1601 0.0 0
M  V30 14 N 10.6697 5.3901 0.0 0
M  V30 15 O 9.3360 7.7002 0.0 0
M  V30 16 C 12.0033 6.1601 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 4.0012 6.1601 0.0 0
M  V30 20 C 4.0012 3.0801 0.0 0
M  V30 21 C 5.3348 5.3901 0.0 0
M  V30 22 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 20
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 21
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1361383-60-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1361383-61-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13947618
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-(3,5-di-tert-butyl-4-hydroxy-phenyl)-3-oxo-propanoic acid methyl amide
A 500-mL flask was charged with
3-(3,5-di-tert-butyl-4-hydroxy-phenyl)-3-oxo-propanoic acid methyl ester
(24.3 g, 79.3 mmol) and a 40% methylamine solution (55 g). The solution
was stirred for 2 h. The conversion of the starting material (Rf 0.91) to
the title compound (Rf 0.4) was monitored by TLC using 1 : 1 ethyl
acetate-hexane as solvent and UV detection of the substances. The
solution was diluted with 2-propanol (100 mL) and evaporated. The solid
residue was taken up in boiling 2-propanol (ca. 100 mL) and evaporated
again. The residue was again taken up in boiling toluene (ca. 75 mL) and
the hot solution was concentrated to afford a crystalline suspension.
This suspension was re-dissolved by heating and the hot solution was
diluted with cyclohexane (80 mL) to cause immediate crystallization. The
suspension was homogenized by reheating, allowed to cool to room
temperature, then refrigerated overnight and filtered. The filter cake
washed with cyclohexane and hexane, dried to constant weight at 65°C. and
20 torr to afford 22.77 g of the title compound. This material was
recrystallized by dissolving in boiling toluene (ca. 120 mL) followed by
the addition of cyclohexane (100 mL). The suspension was allowed to cool
to room temperature, then refrigerated and filtered. The filter cake was
washed with cyclohexane then hexane and dried to constant weight at 65°C.
and 20 torr. Yield 22.03 g, 91%. TLC (1:1 ethyl acetate-hexane) Rf 0.48;
1H-NMR (300 MHz, DMSO-d6) δ 1.37 (9H, s), 2.57 (3H, d, J 4.6 Hz), 3.73
(2H s), 7.73 (2H, s), 7.85 (1H, s), 8.08 (1H, br s).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine carboxamide derivatives as antiinflammatory
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maehr, Hubert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20120053346 A1 2012-03-01

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bis(1-methylethyl) P-(10-bromo-1,1-difluorodecyl)phosphonate
C16H32BrF2O3P
1363335-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.0801 3.0801 0.0 0 VAL=5
M  V30 2 C 4.4137 3.8501 0.0 0
M  V30 3 O 1.7462 2.3101 0.0 0
M  V30 4 O 2.3101 4.4137 0.0 0
M  V30 5 O 3.8501 1.7462 0.0 0
M  V30 6 C 5.7474 4.6201 0.0 0
M  V30 7 F 3.6437 5.1838 0.0 0
M  V30 8 F 5.1838 2.5163 0.0 0
M  V30 9 C 1.7462 0.7700 0.0 0
M  V30 10 C 0.7700 4.4137 0.0 0
M  V30 11 C 7.0811 3.8501 0.0 0
M  V30 12 C 3.0801 0.0000 0.0 0
M  V30 13 C 0.4126 0.0000 0.0 0
M  V30 14 C 0.0000 5.7474 0.0 0
M  V30 15 C 0.0000 3.0801 0.0 0
M  V30 16 C 8.4149 4.6201 0.0 0
M  V30 17 C 9.7486 3.8501 0.0 0
M  V30 18 C 11.0822 4.6201 0.0 0
M  V30 19 C 12.4159 3.8501 0.0 0
M  V30 20 C 13.7497 4.6201 0.0 0
M  V30 21 C 15.0834 3.8501 0.0 0
M  V30 22 C 16.4171 4.6201 0.0 0
M  V30 23 Br 17.7507 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 20 21
M  V30 21 1 21 22
M  V30 22 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bis(1-methylethyl) P-[1,1-difluoro-10-(methylamino)decyl]phosphonate
C17H36F2NO3P
1446348-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.0801 3.0801 0.0 0 VAL=5
M  V30 2 C 4.4139 3.8501 0.0 0
M  V30 3 O 1.7464 2.3101 0.0 0
M  V30 4 O 2.3101 4.4137 0.0 0
M  V30 5 O 3.8501 1.7462 0.0 0
M  V30 6 C 5.7476 4.6201 0.0 0
M  V30 7 F 5.1839 2.5163 0.0 0
M  V30 8 F 3.6439 5.1838 0.0 0
M  V30 9 C 1.7464 0.7700 0.0 0
M  V30 10 C 0.7700 4.4137 0.0 0
M  V30 11 C 7.0812 3.8501 0.0 0
M  V30 12 C 3.0801 0.0000 0.0 0
M  V30 13 C 0.4127 0.0000 0.0 0
M  V30 14 C 0.0000 5.7474 0.0 0
M  V30 15 C 0.0000 3.0801 0.0 0
M  V30 16 C 8.4149 4.6201 0.0 0
M  V30 17 C 9.7487 3.8501 0.0 0
M  V30 18 C 11.0824 4.6201 0.0 0
M  V30 19 C 12.4161 3.8501 0.0 0
M  V30 20 C 13.7499 4.6201 0.0 0
M  V30 21 C 15.0836 3.8501 0.0 0
M  V30 22 C 16.4172 4.6201 0.0 0
M  V30 23 N 17.7509 3.8501 0.0 0
M  V30 24 C 19.0847 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 20 21
M  V30 21 1 21 22
M  V30 22 1 22 23
M  V30 23 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1363335-68-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1446348-19-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2640659
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Preparation of
Acrylamide Derivatives. The bromoalkanes (1 equiv) were diluted in
absolute EtOH (30 mL), and MeNH2 in CH3OH 33 wt % (20 equiv) was added
dropwise. The mixture was stirred under N2 at 40 °C over 18 h. Then the
solvents were removed under reduced pressure, and H2O (20 mL) was added.
A solution of NaOHaq (10%) was introduced until pH ≥11. The aqueous layer
was extracted with CH2Cl2 twice. Combined organic layers were washed with
brine, dried over MgSO4, filtered, and concentrated under reduced
pressure. The product was then involved in the next step without any
purification. The reaction was placed at 40 °C, and starting from 15e
(1.93 g, 4.58 mmol), the corresponding methylamine derivative (1.54 g,
91%) was isolated as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 4.77
(dsept, J = 6.2 Hz, J = 6.2 Hz, 2H), 2.48 (t, J = 7.2 Hz, 2H), 2.35 (s,
3H), 1.99-1.86 (m, 2H), 1.81 (m, 1H), 1.59- 1.29 (m, 4H), 1.30 (d, J =
6.2 Hz, 6H), 1.29 (d, J = 6.2 Hz, 6H), 1.28-1.21 (m, 10H); 19F NMR (376
MHz, CDCl3) δ -112.8 (dt, J = 109.0 Hz, 18.8 Hz, 2F); 31P NMR (161 MHz,
CDCl3) δ 5.79 (t, J = 109.0 Hz, 1P); 13C NMR (101 MHz, CDCl3) δ 120.4
(dt, J = 260.2 Hz, 218.1 Hz), 73.1 (d, J = 7.1 Hz), 51.9, 36.2, 33.6 (dt,
J = 21.0 Hz, 14.2 Hz), 29.6, 29.2, 29.1, 29.0, 28.9, 27.0, 23.9 (d, J =
3.4 Hz), 23.5 (d, J = 4.9 Hz), 20.3 (q, J = 4.7 Hz); IR: 2977, 2926,
2855, 1467, 1377, 1267, 1178, 1103, 987. HRMS (ESI) m/z: calcd for
C17H37NO3F2P.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorophosphonylated Monomers for Dental Applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Derbanne, Mathieu; Zulauf, Anais; Le Goff, Stephane; Pfund, Emmanuel;
Sadoun, Michael; Pham, Thi-Nhan; Lequeux, Thierry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2014), 18(8), 1010-1019

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[4-[[[(2-fluorophenyl)amino]iminomethyl]amino]phenyl]-α,α-dimethyl-2...
C23H25FN4O2S
1363362-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.1658 7.0099 0.0 0
M  V30 2 C 16.5726 6.3836 0.0 0
M  V30 3 C 17.8186 7.2888 0.0 0
M  V30 4 C 18.7236 6.0428 0.0 0
M  V30 5 C 19.0644 8.1939 0.0 0
M  V30 6 C 16.9134 8.5347 0.0 0
M  V30 7 O 20.2553 6.2039 0.0 0
M  V30 8 O 18.0973 4.6360 0.0 0
M  V30 9 C 21.1605 4.9580 0.0 0
M  V30 10 N 5.3900 5.3347 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 N 3.0800 4.0011 0.0 0
M  V30 13 N 5.3900 2.6674 0.0 0
M  V30 14 F 0.0000 4.0011 0.0 0
M  V30 15 C 11.5500 5.3347 0.0 0
M  V30 16 S 12.4552 6.5806 0.0 0
M  V30 17 C 12.4552 4.0889 0.0 0
M  V30 18 C 13.9199 6.1047 0.0 0
M  V30 19 N 13.9199 4.5647 0.0 0
M  V30 20 C 10.0100 5.3347 0.0 0
M  V30 21 C 9.2400 6.6685 0.0 0
M  V30 22 C 9.2400 4.0011 0.0 0
M  V30 23 C 7.7000 6.6685 0.0 0
M  V30 24 C 7.7000 4.0011 0.0 0
M  V30 25 C 6.9300 5.3347 0.0 0
M  V30 26 C 2.3100 2.6674 0.0 0
M  V30 27 C 0.7700 2.6674 0.0 0
M  V30 28 C 3.0800 1.3336 0.0 0
M  V30 29 C 0.0000 1.3336 0.0 0
M  V30 30 C 2.3100 0.0000 0.0 0
M  V30 31 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 25
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 26
M  V30 15 1 14 27
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 20
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[4-[[[(2-fluorophenyl)amino](methylimino)methyl]amino]phenyl]-α,α-di...
C24H27FN4O2S
1363362-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.1658 5.6763 0.0 0
M  V30 2 C 16.5726 5.0500 0.0 0
M  V30 3 C 17.8186 5.9550 0.0 0
M  V30 4 C 18.7237 4.7092 0.0 0
M  V30 5 C 19.0645 6.8603 0.0 0
M  V30 6 C 16.9134 7.2011 0.0 0
M  V30 7 O 20.2554 4.8703 0.0 0
M  V30 8 O 18.0974 3.3024 0.0 0
M  V30 9 C 21.1606 3.6242 0.0 0
M  V30 10 N 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 N 3.0800 2.6674 0.0 0
M  V30 13 N 5.3900 1.3338 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 F 0.0000 2.6674 0.0 0
M  V30 16 C 11.5500 4.0011 0.0 0
M  V30 17 S 12.4552 5.2469 0.0 0
M  V30 18 C 12.4552 2.7552 0.0 0
M  V30 19 C 13.9199 4.7711 0.0 0
M  V30 20 N 13.9199 3.2311 0.0 0
M  V30 21 C 10.0100 4.0011 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 23 C 9.2400 2.6674 0.0 0
M  V30 24 C 7.7000 5.3347 0.0 0
M  V30 25 C 7.7000 2.6674 0.0 0
M  V30 26 C 6.9300 4.0011 0.0 0
M  V30 27 C 2.3100 4.0011 0.0 0
M  V30 28 C 0.7700 4.0011 0.0 0
M  V30 29 C 3.0800 5.3347 0.0 0
M  V30 30 C 0.0000 5.3347 0.0 0
M  V30 31 C 2.3100 6.6685 0.0 0
M  V30 32 C 0.7700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 7 9
M  V30 10 2 10 11 CFG=2
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 21
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1363362-49-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1363362-51-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28074080
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 21908-53-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Methyl
4-(5-(4-(3-(2-fluorophenyl)quanidino)phenyl)thiazol-2-yl)-2,2-dimethyl
butanoate To a solution of the compound of example 266 (250 mg, 0.546
mmol) in 7N methanolic ammonia (7.80 mL, 54.6 mmol) was added mercuric
oxide yellow (296 mg, 1.366 mmol) and the reaction mixture was stirred at
room temperature for 2 h. After completion of the reaction, the solvent
was removed and chloroform was added. The black residue was filtered
through Celite® and the filtrate was concentrated. The residue obtained
was purified by column chromatography (silica gel, 40-50 % ethyl acetate
in chloroform), Methyl
4-(5-(4-(3-(2-fluorophenyl)-2-methylquanidino)phenyl)thiazol-2-yl)-2,2-dimethylbutanoate
The compound of example 270 was prepared analogous to the compound of
example 268 by reaction of the compound of example 266 with methanamine.
Yield: 91 %; 1H NMR (DMSO-d6, 300MHz): δ 7.95 (s, 1H), 7.86 (s, 1H),
7.42-7.39 (d, 2H), 7.25-7.22 (d, 2H), 7.01-6.93 (m, 2H), 6.91-6.82 (m,
2H), 5.89 (s, 1H), 3.61 (s, 3H), 2.89 (m, 2H), 2.72 (s, 3H), 1.95 (m,
2H), 1.19 (s, 6H); MS: m/z 455.2 (M+1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as DGAT-1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharma, Rajiv; Kadam, Kishorkumar Shivajirao; Jadhav, Ravindra Dnyandev;
Kandre, Shivaji Sadashiv; Gupte, Amol
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012029032 A2 2012-03-08

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
1-Methyl-5-nitro-1H-indazole-3-carboxylic acid
C9H7N3O4
1363382-25-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5064 5.4210 0.0 0
M  V30 2 O 2.5369 6.5654 0.0 0
M  V30 3 O 0.0000 5.7411 0.0 0
M  V30 4 C 1.5064 0.0000 0.0 0
M  V30 5 N 7.4479 4.2504 0.0 0 VAL=5
M  V30 6 O 8.7817 3.4804 0.0 0
M  V30 7 O 7.4479 5.7904 0.0 0
M  V30 8 C 3.4470 3.4804 0.0 0
M  V30 9 C 3.4470 1.9404 0.0 0
M  V30 10 C 1.9823 3.9563 0.0 0
M  V30 11 C 4.7806 4.2504 0.0 0
M  V30 12 N 1.9823 1.4645 0.0 0
M  V30 13 C 4.7806 1.1704 0.0 0
M  V30 14 N 1.0771 2.7104 0.0 0
M  V30 15 C 6.1143 3.4804 0.0 0
M  V30 16 C 6.1143 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C10H10N4O3
3050907-75-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 4.6948 0.0 0
M  V30 2 N 8.7355 4.2189 0.0 0
M  V30 3 O 6.9506 6.2013 0.0 0
M  V30 4 C 9.8799 5.2495 0.0 0
M  V30 5 C 4.5603 0.0000 0.0 0
M  V30 6 N 1.5400 6.6520 0.0 0 VAL=5
M  V30 7 O 0.0000 6.6520 0.0 0
M  V30 8 O 2.3101 7.9857 0.0 0
M  V30 9 C 4.6201 3.9845 0.0 0
M  V30 10 C 3.8501 2.6509 0.0 0
M  V30 11 C 6.1264 3.6644 0.0 0
M  V30 12 C 3.8501 5.3182 0.0 0
M  V30 13 N 4.8805 1.5065 0.0 0
M  V30 14 C 2.3101 2.6509 0.0 0
M  V30 15 N 6.2873 2.1328 0.0 0
M  V30 16 C 2.3101 5.3182 0.0 0
M  V30 17 C 1.5400 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 14 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1363382-25-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3050907-75-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41431404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimization of a series of potent, selective and orally bioavailable SYK
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grimster, Neil P.; Gingipalli, Lakshmaiah; Barlaam, Bernard; Su, Qibin;
Zheng, XiaoLan; Watson, David; Wang, Haixia; Simpson, Iain; Pike, Andy;
Balazs, Amber; Boiko, Scott; Ikeda, Timothy P.; Impastato, Anna C.;
Jones, Natalie H.; Kawatkar, Sameer; Kemmitt, Paul; Lamont, Scott; Patel,
Joe; Read, Jon; Sarkar, Ujjal; Sha, Li; Tomlinson, Ronald C.; Wang,
Haiyun; Wilson, David M.; Zehnder, Troy E.; Wang, Lianghe; Wang, Peng;
Goldberg, Frederick W.; Shao, Wenlin; Fawell, Stephen; Dry, Hannah;
Dowling, James E.; Edmondson, Scott D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127433

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C110H124N16O19
1374822-22-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  145 160 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 15.7308 17.3875 0.0 0
M  V30 2 O 14.2661 17.8634 0.0 0
M  V30 3 C 15.3804 20.7195 0.0 0
M  V30 4 N 15.3804 22.2595 0.0 0
M  V30 5 O 14.0468 19.9495 0.0 0
M  V30 6 C 16.7142 23.0295 0.0 0
M  V30 7 C 13.4419 15.3265 0.0 0
M  V30 8 N 12.2974 14.2961 0.0 0
M  V30 9 C 10.8328 14.7720 0.0 0
M  V30 10 O 9.6883 13.7416 0.0 0
M  V30 11 C 19.3815 24.5695 0.0 0
M  V30 12 O 19.3815 23.0295 0.0 0
M  V30 13 C 7.7721 16.1347 0.0 0
M  V30 14 O 7.7721 14.5947 0.0 0
M  V30 15 C 22.4423 23.2069 0.0 0
M  V30 16 N 23.9070 22.7309 0.0 0
M  V30 17 O 21.2979 22.1763 0.0 0
M  V30 18 C 24.2271 21.2246 0.0 0
M  V30 19 C 5.1046 14.5947 0.0 0
M  V30 20 N 3.7710 13.8247 0.0 0
M  V30 21 C 3.7710 12.2847 0.0 0
M  V30 22 O 5.1046 11.5147 0.0 0
M  V30 23 C 24.8675 18.2119 0.0 0
M  V30 24 O 23.4028 18.6877 0.0 0
M  V30 25 C 3.4208 8.9526 0.0 0
M  V30 26 O 4.8855 9.4287 0.0 0
M  V30 27 C 22.6257 15.7220 0.0 0
M  V30 28 N 21.7205 14.4762 0.0 0
M  V30 29 O 21.9992 17.1290 0.0 0
M  V30 30 C 22.3468 13.0694 0.0 0
M  V30 31 C 5.7097 6.8918 0.0 0
M  V30 32 N 6.8541 5.8614 0.0 0
M  V30 33 C 8.3188 6.3373 0.0 0
M  V30 34 O 9.4631 5.3067 0.0 0
M  V30 35 C 23.5996 10.2556 0.0 0
M  V30 36 O 24.5048 11.5015 0.0 0
M  V30 37 C 11.3795 7.7000 0.0 0
M  V30 38 O 11.3795 6.1600 0.0 0
M  V30 39 C 26.8767 9.5591 0.0 0
M  V30 40 N 28.3414 9.0831 0.0 0
M  V30 41 O 26.5565 11.0654 0.0 0
M  V30 42 C 29.4858 10.1136 0.0 0
M  V30 43 C 14.0468 6.1600 0.0 0
M  V30 44 N 15.3806 5.3900 0.0 0
M  V30 45 C 15.3806 3.8500 0.0 0
M  V30 46 O 14.0468 3.0800 0.0 0
M  V30 47 O 16.7142 3.0800 0.0 0
M  V30 48 C 14.0468 1.5400 0.0 0
M  V30 49 C 15.5868 1.5400 0.0 0
M  V30 50 C 14.0468 0.0000 0.0 0
M  V30 51 C 12.5068 1.5400 0.0 0
M  V30 52 C 31.7747 12.1745 0.0 0
M  V30 53 O 30.3100 12.6503 0.0 0
M  V30 54 C 31.4245 15.5066 0.0 0
M  V30 55 O 31.4245 17.0466 0.0 0
M  V30 56 O 30.0908 14.7366 0.0 0
M  V30 57 C 32.7581 17.8166 0.0 0
M  V30 58 N 16.8752 18.4179 0.0 0
M  V30 59 C 16.7142 19.9495 0.0 0 CFG=2
M  V30 60 C 18.3814 18.0978 0.0 0
M  V30 61 C 18.1210 20.5759 0.0 0
M  V30 62 C 19.1514 19.4314 0.0 0
M  V30 63 C 16.0510 15.8811 0.0 0
M  V30 64 C 14.9064 14.8507 0.0 0
M  V30 65 C 17.5155 15.4052 0.0 0
M  V30 66 C 15.2266 13.3444 0.0 0
M  V30 67 C 17.8357 13.8990 0.0 0
M  V30 68 C 16.6913 12.8684 0.0 0
M  V30 69 C 16.7142 24.5695 0.0 0
M  V30 70 C 18.0479 25.3395 0.0 0
M  V30 71 C 15.3804 25.3395 0.0 0
M  V30 72 C 18.0479 26.8795 0.0 0
M  V30 73 C 15.3804 26.8795 0.0 0
M  V30 74 C 16.7142 27.6495 0.0 0
M  V30 75 C 10.5127 16.2784 0.0 0 CFG=2
M  V30 76 N 9.1057 16.9047 0.0 0
M  V30 77 C 11.5431 17.4228 0.0 0
M  V30 78 C 9.2666 18.4363 0.0 0
M  V30 79 C 10.7731 18.7564 0.0 0
M  V30 80 N 20.7152 25.3395 0.0 0
M  V30 81 C 22.1221 24.7132 0.0 0 CFG=2
M  V30 82 C 20.8762 26.8712 0.0 0
M  V30 83 C 23.1525 25.8577 0.0 0
M  V30 84 C 22.3825 27.1913 0.0 0
M  V30 85 C 6.4384 16.9047 0.0 0
M  V30 86 C 5.1046 16.1347 0.0 0
M  V30 87 C 6.4384 18.4447 0.0 0
M  V30 88 C 3.7710 16.9047 0.0 0
M  V30 89 C 5.1046 19.2147 0.0 0
M  V30 90 C 3.7710 18.4447 0.0 0
M  V30 91 C 25.6917 20.7487 0.0 0
M  V30 92 C 26.0118 19.2423 0.0 0
M  V30 93 C 26.8362 21.7791 0.0 0
M  V30 94 C 27.4765 18.7664 0.0 0
M  V30 95 C 28.3007 21.3033 0.0 0
M  V30 96 C 28.6209 19.7969 0.0 0
M  V30 97 C 2.4374 11.5147 0.0 0 CFG=2
M  V30 98 N 2.2764 9.9832 0.0 0
M  V30 99 C 1.0304 12.1411 0.0 0
M  V30 100 C 0.7700 9.6630 0.0 0
M  V30 101 C 0.0000 10.9967 0.0 0
M  V30 102 N 25.1876 16.7056 0.0 0
M  V30 103 C 24.1572 15.5611 0.0 0 CFG=2
M  V30 104 C 26.5946 16.0791 0.0 0
M  V30 105 C 24.9272 14.2274 0.0 0
M  V30 106 C 26.4335 14.5476 0.0 0
M  V30 107 C 3.1006 7.4464 0.0 0
M  V30 108 C 4.2450 6.4159 0.0 0
M  V30 109 C 1.6359 6.9705 0.0 0
M  V30 110 C 3.9248 4.9095 0.0 0
M  V30 111 C 1.3158 5.4641 0.0 0
M  V30 112 C 2.4603 4.4337 0.0 0
M  V30 113 C 21.4416 11.8235 0.0 0
M  V30 114 C 22.0680 10.4166 0.0 0
M  V30 115 C 19.9100 11.9844 0.0 0
M  V30 116 C 21.1628 9.1707 0.0 0
M  V30 117 C 19.0048 10.7386 0.0 0
M  V30 118 C 19.6313 9.3316 0.0 0
M  V30 119 C 8.6389 7.8435 0.0 0 CFG=2
M  V30 120 N 10.0457 8.4700 0.0 0
M  V30 121 C 7.6085 8.9881 0.0 0
M  V30 122 C 9.8848 10.0015 0.0 0
M  V30 123 C 8.3785 10.3217 0.0 0
M  V30 124 N 24.2259 8.8487 0.0 0
M  V30 125 C 25.7323 8.5285 0.0 0 CFG=2
M  V30 126 C 23.4559 7.5150 0.0 0
M  V30 127 C 25.8933 6.9970 0.0 0
M  V30 128 C 24.4863 6.3707 0.0 0
M  V30 129 C 12.7132 8.4700 0.0 0
M  V30 130 C 14.0468 7.7000 0.0 0
M  V30 131 C 12.7132 10.0100 0.0 0
M  V30 132 C 15.3806 8.4700 0.0 0
M  V30 133 C 14.0468 10.7800 0.0 0
M  V30 134 C 15.3806 10.0100 0.0 0
M  V30 135 C 30.9505 9.6378 0.0 0
M  V30 136 C 32.0948 10.6682 0.0 0
M  V30 137 C 31.2706 8.1314 0.0 0
M  V30 138 C 33.5595 10.1923 0.0 0
M  V30 139 C 32.7352 7.6555 0.0 0
M  V30 140 C 33.8797 8.6859 0.0 0
M  V30 141 N 32.9190 13.2050 0.0 0
M  V30 142 C 32.7581 14.7366 0.0 0 CFG=2
M  V30 143 C 34.4255 12.8849 0.0 0
M  V30 144 C 34.1651 15.3629 0.0 0
M  V30 145 C 35.1955 14.2185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 58
M  V30 3 1 1 63
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 59 3 CFG=3
M  V30 7 1 4 6
M  V30 8 1 6 69
M  V30 9 1 7 8
M  V30 10 1 7 64
M  V30 11 1 8 9
M  V30 12 2 9 10
M  V30 13 1 75 9 CFG=1
M  V30 14 2 11 12
M  V30 15 1 11 70
M  V30 16 1 11 80
M  V30 17 2 13 14
M  V30 18 1 13 76
M  V30 19 1 13 85
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 81 15 CFG=1
M  V30 23 1 16 18
M  V30 24 1 18 91
M  V30 25 1 19 20
M  V30 26 1 19 86
M  V30 27 1 20 21
M  V30 28 2 21 22
M  V30 29 1 97 21 CFG=1
M  V30 30 2 23 24
M  V30 31 1 23 92
M  V30 32 1 23 102
M  V30 33 2 25 26
M  V30 34 1 25 98
M  V30 35 1 25 107
M  V30 36 1 27 28
M  V30 37 2 27 29
M  V30 38 1 103 27 CFG=1
M  V30 39 1 28 30
M  V30 40 1 30 113
M  V30 41 1 31 32
M  V30 42 1 31 108
M  V30 43 1 32 33
M  V30 44 2 33 34
M  V30 45 1 119 33 CFG=3
M  V30 46 2 35 36
M  V30 47 1 35 114
M  V30 48 1 35 124
M  V30 49 2 37 38
M  V30 50 1 37 120
M  V30 51 1 37 129
M  V30 52 1 39 40
M  V30 53 2 39 41
M  V30 54 1 125 39 CFG=3
M  V30 55 1 40 42
M  V30 56 1 42 135
M  V30 57 1 43 44
M  V30 58 1 43 130
M  V30 59 1 44 45
M  V30 60 1 45 46
M  V30 61 2 45 47
M  V30 62 1 46 48
M  V30 63 1 48 49
M  V30 64 1 48 50
M  V30 65 1 48 51
M  V30 66 2 52 53
M  V30 67 1 52 136
M  V30 68 1 52 141
M  V30 69 1 54 55
M  V30 70 2 54 56
M  V30 71 1 142 54 CFG=3
M  V30 72 1 55 57
M  V30 73 1 58 59
M  V30 74 1 58 60
M  V30 75 1 59 61
M  V30 76 1 60 62
M  V30 77 1 61 62
M  V30 78 2 63 64
M  V30 79 1 63 65
M  V30 80 1 64 66
M  V30 81 2 65 67
M  V30 82 2 66 68
M  V30 83 1 67 68
M  V30 84 2 69 70
M  V30 85 1 69 71
M  V30 86 1 70 72
M  V30 87 2 71 73
M  V30 88 2 72 74
M  V30 89 1 73 74
M  V30 90 1 75 76
M  V30 91 1 75 77
M  V30 92 1 76 78
M  V30 93 1 77 79
M  V30 94 1 78 79
M  V30 95 1 80 81
M  V30 96 1 80 82
M  V30 97 1 81 83
M  V30 98 1 82 84
M  V30 99 1 83 84
M  V30 100 2 85 86
M  V30 101 1 85 87
M  V30 102 1 86 88
M  V30 103 2 87 89
M  V30 104 2 88 90
M  V30 105 1 89 90
M  V30 106 2 91 92
M  V30 107 1 91 93
M  V30 108 1 92 94
M  V30 109 2 93 95
M  V30 110 2 94 96
M  V30 111 1 95 96
M  V30 112 1 97 98
M  V30 113 1 97 99
M  V30 114 1 98 100
M  V30 115 1 99 101
M  V30 116 1 100 101
M  V30 117 1 102 103
M  V30 118 1 102 104
M  V30 119 1 103 105
M  V30 120 1 104 106
M  V30 121 1 105 106
M  V30 122 2 107 108
M  V30 123 1 107 109
M  V30 124 1 108 110
M  V30 125 2 109 111
M  V30 126 2 110 112
M  V30 127 1 111 112
M  V30 128 2 113 114
M  V30 129 1 113 115
M  V30 130 1 114 116
M  V30 131 2 115 117
M  V30 132 2 116 118
M  V30 133 1 117 118
M  V30 134 1 119 120
M  V30 135 1 119 121
M  V30 136 1 120 122
M  V30 137 1 121 123
M  V30 138 1 122 123
M  V30 139 1 124 125
M  V30 140 1 124 126
M  V30 141 1 125 127
M  V30 142 1 126 128
M  V30 143 1 127 128
M  V30 144 2 129 130
M  V30 145 1 129 131
M  V30 146 1 130 132
M  V30 147 2 131 133
M  V30 148 2 132 134
M  V30 149 1 133 134
M  V30 150 2 135 136
M  V30 151 1 135 137
M  V30 152 1 136 138
M  V30 153 2 137 139
M  V30 154 2 138 140
M  V30 155 1 139 140
M  V30 156 1 141 142
M  V30 157 1 141 143
M  V30 158 1 142 144
M  V30 159 1 143 145
M  V30 160 1 144 145
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 59 75 81 97 103 119 125 142)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C110H125N17O18
1374822-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  145 160 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 16.0590 16.3588 0.0 0
M  V30 2 O 15.0286 15.2144 0.0 0
M  V30 3 C 18.0283 19.0694 0.0 0
M  V30 4 N 18.7983 20.4030 0.0 0
M  V30 5 O 18.7983 17.7357 0.0 0
M  V30 6 C 20.3383 20.4030 0.0 0
M  V30 7 C 17.0108 13.4296 0.0 0
M  V30 8 N 17.4867 11.9650 0.0 0
M  V30 9 C 16.4561 10.8205 0.0 0
M  V30 10 O 14.9499 11.1407 0.0 0
M  V30 11 C 23.4183 20.4032 0.0 0
M  V30 12 O 22.6483 19.0694 0.0 0
M  V30 13 C 14.4869 8.1101 0.0 0
M  V30 14 O 13.7169 9.4437 0.0 0
M  V30 15 C 25.3875 17.6926 0.0 0
M  V30 16 N 26.4181 16.5481 0.0 0
M  V30 17 O 23.8812 17.3724 0.0 0
M  V30 18 C 25.9422 15.0835 0.0 0
M  V30 19 C 11.4069 8.1099 0.0 0
M  V30 20 N 12.1769 9.4437 0.0 0
M  V30 21 C 11.4069 10.7774 0.0 0
M  V30 22 O 12.1769 12.1110 0.0 0
M  V30 23 C 24.9904 12.1543 0.0 0
M  V30 24 O 26.4968 12.4745 0.0 0
M  V30 25 C 9.4376 13.4879 0.0 0
M  V30 26 O 10.9440 13.8081 0.0 0
M  V30 27 C 26.9597 9.4437 0.0 0
M  V30 28 N 27.7297 8.1101 0.0 0
M  V30 29 O 27.7297 10.7774 0.0 0
M  V30 30 C 29.2697 8.1101 0.0 0
M  V30 31 C 6.4249 12.8475 0.0 0
M  V30 32 N 4.9186 12.5273 0.0 0
M  V30 33 C 4.4426 11.0627 0.0 0
M  V30 34 O 5.4732 9.9182 0.0 0
M  V30 35 C 32.3497 8.1101 0.0 0
M  V30 36 O 31.5797 9.4437 0.0 0
M  V30 37 C 3.0800 8.0020 0.0 0
M  V30 38 O 4.6200 8.0020 0.0 0
M  V30 39 C 34.3191 10.8207 0.0 0
M  V30 40 N 35.3495 11.9650 0.0 0
M  V30 41 O 32.8126 11.1408 0.0 0
M  V30 42 C 34.8736 13.4297 0.0 0
M  V30 43 C 4.6200 5.3347 0.0 0
M  V30 44 N 5.3900 4.0009 0.0 0
M  V30 45 C 6.9300 4.0011 0.0 0
M  V30 46 O 7.7000 2.6673 0.0 0
M  V30 47 O 7.7000 5.3347 0.0 0
M  V30 48 C 6.9300 1.3336 0.0 0
M  V30 49 C 8.2638 0.5636 0.0 0
M  V30 50 C 6.1600 0.0000 0.0 0
M  V30 51 C 5.5964 2.1036 0.0 0
M  V30 52 C 33.9219 16.3590 0.0 0
M  V30 53 O 32.8913 15.2144 0.0 0
M  V30 54 C 30.7355 17.3943 0.0 0
M  V30 55 N 30.8964 15.8626 0.0 0
M  V30 56 O 29.3285 18.0206 0.0 0
M  V30 57 C 29.6505 14.9574 0.0 0
M  V30 58 N 15.5831 17.8235 0.0 0
M  V30 59 C 16.4883 19.0694 0.0 0 CFG=2
M  V30 60 C 14.1184 18.2994 0.0 0
M  V30 61 C 15.5831 20.3152 0.0 0
M  V30 62 C 14.1184 19.8394 0.0 0
M  V30 63 C 17.5654 16.0386 0.0 0
M  V30 64 C 18.0413 14.5741 0.0 0
M  V30 65 C 18.5958 17.1832 0.0 0
M  V30 66 C 19.5475 14.2539 0.0 0
M  V30 67 C 20.1021 16.8630 0.0 0
M  V30 68 C 20.5781 15.3983 0.0 0
M  V30 69 C 21.1083 21.7368 0.0 0
M  V30 70 C 22.6483 21.7368 0.0 0
M  V30 71 C 20.3383 23.0704 0.0 0
M  V30 72 C 23.4183 23.0704 0.0 0
M  V30 73 C 21.1083 24.4041 0.0 0
M  V30 74 C 22.6483 24.4041 0.0 0
M  V30 75 C 16.9321 9.3560 0.0 0 CFG=2
M  V30 76 N 16.0269 8.1101 0.0 0
M  V30 77 C 18.3967 8.8801 0.0 0
M  V30 78 C 16.9321 6.8641 0.0 0
M  V30 79 C 18.3967 7.3401 0.0 0
M  V30 80 N 24.9583 20.4032 0.0 0
M  V30 81 C 25.8635 19.1571 0.0 0 CFG=2
M  V30 82 C 25.8635 21.6490 0.0 0
M  V30 83 C 27.3281 19.6332 0.0 0
M  V30 84 C 27.3281 21.1732 0.0 0
M  V30 85 C 13.7169 6.7763 0.0 0
M  V30 86 C 12.1769 6.7763 0.0 0
M  V30 87 C 14.4869 5.4427 0.0 0
M  V30 88 C 11.4069 5.4427 0.0 0
M  V30 89 C 13.7169 4.1090 0.0 0
M  V30 90 C 12.1769 4.1090 0.0 0
M  V30 91 C 24.4358 14.7634 0.0 0
M  V30 92 C 23.9599 13.2987 0.0 0
M  V30 93 C 23.4054 15.9077 0.0 0
M  V30 94 C 22.4537 12.9785 0.0 0
M  V30 95 C 21.8990 15.5876 0.0 0
M  V30 96 C 21.4231 14.1229 0.0 0
M  V30 97 C 9.8669 10.7774 0.0 0 CFG=2
M  V30 98 N 8.9617 12.0232 0.0 0
M  V30 99 C 8.9617 9.5315 0.0 0
M  V30 100 C 7.4970 11.5474 0.0 0
M  V30 101 C 7.4970 10.0074 0.0 0
M  V30 102 N 24.5145 10.6896 0.0 0
M  V30 103 C 25.4197 9.4437 0.0 0 CFG=2
M  V30 104 C 23.0500 10.2137 0.0 0
M  V30 105 C 24.5145 8.1979 0.0 0
M  V30 106 C 23.0500 8.6737 0.0 0
M  V30 107 C 8.4072 14.6323 0.0 0
M  V30 108 C 6.9007 14.3121 0.0 0
M  V30 109 C 8.8830 16.0970 0.0 0
M  V30 110 C 5.8703 15.4565 0.0 0
M  V30 111 C 7.8526 17.2414 0.0 0
M  V30 112 C 6.3462 16.9212 0.0 0
M  V30 113 C 30.0397 6.7765 0.0 0
M  V30 114 C 31.5797 6.7765 0.0 0
M  V30 115 C 29.2697 5.4427 0.0 0
M  V30 116 C 32.3497 5.4427 0.0 0
M  V30 117 C 30.0397 4.1090 0.0 0
M  V30 118 C 31.5797 4.1090 0.0 0
M  V30 119 C 2.9363 10.7426 0.0 0 CFG=2
M  V30 120 N 2.3100 9.3356 0.0 0
M  V30 121 C 1.7919 11.7730 0.0 0
M  V30 122 C 0.7783 9.4966 0.0 0
M  V30 123 C 0.4581 11.0030 0.0 0
M  V30 124 N 33.8897 8.1101 0.0 0
M  V30 125 C 34.7949 9.3560 0.0 0 CFG=2
M  V30 126 C 34.7949 6.8642 0.0 0
M  V30 127 C 36.2596 8.8801 0.0 0
M  V30 128 C 36.2596 7.3401 0.0 0
M  V30 129 C 2.3100 6.6684 0.0 0
M  V30 130 C 3.0800 5.3346 0.0 0
M  V30 131 C 0.7700 6.6682 0.0 0
M  V30 132 C 2.3100 4.0009 0.0 0
M  V30 133 C 0.0000 5.3346 0.0 0
M  V30 134 C 0.7700 4.0009 0.0 0
M  V30 135 C 35.9040 14.5741 0.0 0
M  V30 136 C 35.4282 16.0388 0.0 0
M  V30 137 C 37.4105 14.2539 0.0 0
M  V30 138 C 36.4586 17.1832 0.0 0
M  V30 139 C 38.4409 15.3983 0.0 0
M  V30 140 C 37.9650 16.8630 0.0 0
M  V30 141 N 33.4460 17.8235 0.0 0
M  V30 142 C 31.9813 18.2994 0.0 0 CFG=2
M  V30 143 C 34.3511 19.0694 0.0 0
M  V30 144 C 31.9813 19.8394 0.0 0
M  V30 145 C 33.4460 20.3154 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 58
M  V30 3 1 1 63
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 59 3 CFG=1
M  V30 7 1 4 6
M  V30 8 1 6 69
M  V30 9 1 7 8
M  V30 10 1 7 64
M  V30 11 1 8 9
M  V30 12 2 9 10
M  V30 13 1 75 9 CFG=3
M  V30 14 2 11 12
M  V30 15 1 11 70
M  V30 16 1 11 80
M  V30 17 2 13 14
M  V30 18 1 13 76
M  V30 19 1 13 85
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 81 15 CFG=1
M  V30 23 1 16 18
M  V30 24 1 18 91
M  V30 25 1 19 20
M  V30 26 1 19 86
M  V30 27 1 20 21
M  V30 28 2 21 22
M  V30 29 1 97 21 CFG=3
M  V30 30 2 23 24
M  V30 31 1 23 92
M  V30 32 1 23 102
M  V30 33 2 25 26
M  V30 34 1 25 98
M  V30 35 1 25 107
M  V30 36 1 27 28
M  V30 37 2 27 29
M  V30 38 1 103 27 CFG=3
M  V30 39 1 28 30
M  V30 40 1 30 113
M  V30 41 1 31 32
M  V30 42 1 31 108
M  V30 43 1 32 33
M  V30 44 2 33 34
M  V30 45 1 119 33 CFG=1
M  V30 46 2 35 36
M  V30 47 1 35 114
M  V30 48 1 35 124
M  V30 49 2 37 38
M  V30 50 1 37 120
M  V30 51 1 37 129
M  V30 52 1 39 40
M  V30 53 2 39 41
M  V30 54 1 125 39 CFG=3
M  V30 55 1 40 42
M  V30 56 1 42 135
M  V30 57 1 43 44
M  V30 58 1 43 130
M  V30 59 1 44 45
M  V30 60 1 45 46
M  V30 61 2 45 47
M  V30 62 1 46 48
M  V30 63 1 48 49
M  V30 64 1 48 50
M  V30 65 1 48 51
M  V30 66 2 52 53
M  V30 67 1 52 136
M  V30 68 1 52 141
M  V30 69 1 54 55
M  V30 70 2 54 56
M  V30 71 1 142 54 CFG=3
M  V30 72 1 55 57
M  V30 73 1 58 59
M  V30 74 1 58 60
M  V30 75 1 59 61
M  V30 76 1 60 62
M  V30 77 1 61 62
M  V30 78 2 63 64
M  V30 79 1 63 65
M  V30 80 1 64 66
M  V30 81 2 65 67
M  V30 82 2 66 68
M  V30 83 1 67 68
M  V30 84 2 69 70
M  V30 85 1 69 71
M  V30 86 1 70 72
M  V30 87 2 71 73
M  V30 88 2 72 74
M  V30 89 1 73 74
M  V30 90 1 75 76
M  V30 91 1 75 77
M  V30 92 1 76 78
M  V30 93 1 77 79
M  V30 94 1 78 79
M  V30 95 1 80 81
M  V30 96 1 80 82
M  V30 97 1 81 83
M  V30 98 1 82 84
M  V30 99 1 83 84
M  V30 100 2 85 86
M  V30 101 1 85 87
M  V30 102 1 86 88
M  V30 103 2 87 89
M  V30 104 2 88 90
M  V30 105 1 89 90
M  V30 106 2 91 92
M  V30 107 1 91 93
M  V30 108 1 92 94
M  V30 109 2 93 95
M  V30 110 2 94 96
M  V30 111 1 95 96
M  V30 112 1 97 98
M  V30 113 1 97 99
M  V30 114 1 98 100
M  V30 115 1 99 101
M  V30 116 1 100 101
M  V30 117 1 102 103
M  V30 118 1 102 104
M  V30 119 1 103 105
M  V30 120 1 104 106
M  V30 121 1 105 106
M  V30 122 2 107 108
M  V30 123 1 107 109
M  V30 124 1 108 110
M  V30 125 2 109 111
M  V30 126 2 110 112
M  V30 127 1 111 112
M  V30 128 2 113 114
M  V30 129 1 113 115
M  V30 130 1 114 116
M  V30 131 2 115 117
M  V30 132 2 116 118
M  V30 133 1 117 118
M  V30 134 1 119 120
M  V30 135 1 119 121
M  V30 136 1 120 122
M  V30 137 1 121 123
M  V30 138 1 122 123
M  V30 139 1 124 125
M  V30 140 1 124 126
M  V30 141 1 125 127
M  V30 142 1 126 128
M  V30 143 1 127 128
M  V30 144 2 129 130
M  V30 145 1 129 131
M  V30 146 1 130 132
M  V30 147 2 131 133
M  V30 148 2 132 134
M  V30 149 1 133 134
M  V30 150 2 135 136
M  V30 151 1 135 137
M  V30 152 1 136 138
M  V30 153 2 137 139
M  V30 154 2 138 140
M  V30 155 1 139 140
M  V30 156 1 141 142
M  V30 157 1 141 143
M  V30 158 1 142 144
M  V30 159 1 143 145
M  V30 160 1 144 145
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 59 75 81 97 103 119 125 142)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1374822-22-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1374822-23-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3851742
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Expanding the structural repertoire of β/α Ant-Pro (anthranilic
acid-proline) oligomers into γ/α 2-Amb-Pro (2-aminomethyl benzoic
acid-proline) oligomers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramesh, Veera V. E.; Priya, Gowri; Rajamohanan, P. R.; Hofmann,
Hans-Jorg; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(23), 4399-4405

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl N′-[(2-chloro-5-thiazolyl)methyl]-N-nitrocarbamimidothioate
C6H7ClN4O2S2
138149-97-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 2.3101 0.0 0
M  V30 2 N 5.3348 3.0801 0.0 0
M  V30 3 C 4.0012 2.3101 0.0 0
M  V30 4 N 2.6675 3.0801 0.0 0
M  V30 5 S 4.0012 0.7700 0.0 0
M  V30 6 N 1.3338 2.3101 0.0 0 VAL=5
M  V30 7 C 5.3348 0.0000 0.0 0
M  V30 8 O 1.3338 0.7700 0.0 0
M  V30 9 O 0.0000 3.0801 0.0 0
M  V30 10 Cl 11.9713 3.4372 0.0 0
M  V30 11 C 8.0023 3.0801 0.0 0
M  V30 12 C 8.1633 4.6116 0.0 0
M  V30 13 S 9.4091 2.4536 0.0 0
M  V30 14 N 9.6697 4.9318 0.0 0
M  V30 15 C 10.4397 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 10 15
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Clothianidin
C6H8ClN5O2S
210880-92-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8501 0.0 0
M  V30 2 N 4.0011 4.6201 0.0 0
M  V30 3 C 2.6675 3.8501 0.0 0
M  V30 4 N 2.6675 2.3100 0.0 0
M  V30 5 N 1.3338 4.6201 0.0 0
M  V30 6 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 7 C 1.3338 6.1601 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 9 O 0.0000 2.3100 0.0 0
M  V30 10 Cl 10.6376 4.9772 0.0 0
M  V30 11 C 6.6686 4.6201 0.0 0
M  V30 12 C 6.8295 6.1516 0.0 0
M  V30 13 S 8.0754 3.9936 0.0 0
M  V30 14 N 8.3358 6.4718 0.0 0
M  V30 15 C 9.1059 5.1381 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 10 15
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 138149-97-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 210880-92-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-852510
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Comparative analysis of neonicotinoid binding to insect membranes: I. A
structure-activity study of the mode of [3H]imidacloprid displacement in
Myzus persicae and Aphis craccivora
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kayser, Hartmut; Lee, Connie; Decock, Arnaud; Baur, Markus;
Haettenschwiler, Joerg; Maienfisch, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pest Management Science (2004), 60(10), 945-958

$RFMT $RIREG SCHEME133 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8,9-Dihydro-1,3-dimethyl-8-[[(4-methylphenyl)thio]methyl]-2H-pyrimido[5′,4′:4...
C19H19N3O4S
1391712-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.8735 6.9787 0.0 0
M  V30 2 O 7.3930 0.0000 0.0 0
M  V30 3 C 10.0605 4.6200 0.0 0
M  V30 4 S 11.3941 3.8500 0.0 0
M  V30 5 O 1.2528 1.9951 0.0 0
M  V30 6 O 1.8104 7.3006 0.0 0
M  V30 7 C 0.0000 4.8089 0.0 0
M  V30 8 C 16.7289 6.9301 0.0 0
M  V30 9 N 6.0593 3.8500 0.0 0
M  V30 10 C 4.5948 4.3259 0.0 0
M  V30 11 C 6.0593 2.3100 0.0 0
M  V30 12 C 7.3930 4.6200 0.0 0
M  V30 13 C 3.6896 3.0800 0.0 0
M  V30 14 N 3.9683 5.7327 0.0 0
M  V30 15 C 4.5948 1.8342 0.0 0
M  V30 16 C 7.3930 1.5400 0.0 0
M  V30 17 C 8.7268 3.8500 0.0 0
M  V30 18 C 2.1579 3.2410 0.0 0
M  V30 19 C 2.4368 5.8938 0.0 0
M  V30 20 O 8.7268 2.3100 0.0 0
M  V30 21 N 1.5315 4.6479 0.0 0
M  V30 22 C 12.7278 4.6200 0.0 0
M  V30 23 C 14.0616 3.8500 0.0 0
M  V30 24 C 12.7278 6.1601 0.0 0
M  V30 25 C 15.3952 4.6200 0.0 0
M  V30 26 C 14.0616 6.9301 0.0 0
M  V30 27 C 15.3952 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 16
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 1 4 22
M  V30 6 2 5 18
M  V30 7 2 6 19
M  V30 8 1 7 21
M  V30 9 1 8 27
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 16 20
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 1 19 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4,7-Tetrahydro-7-[2-hydroxy-3-[(4-methylphenyl)thio]propyl]-N,1,3-trimeth...
C20H24N4O4S
1391712-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5188 5.3196 0.0 0
M  V30 2 C 7.2888 6.6533 0.0 0
M  V30 3 C 8.8288 6.6533 0.0 0
M  V30 4 O 6.5188 7.9871 0.0 0
M  V30 5 S 9.5988 7.9871 0.0 0
M  V30 6 C 5.8585 8.5478 0.0 0
M  V30 7 C 4.5496 2.6091 0.0 0
M  V30 8 N 3.5191 1.4647 0.0 0
M  V30 9 O 6.0559 2.2889 0.0 0
M  V30 10 C 3.9949 0.0000 0.0 0
M  V30 11 O 0.0000 6.6442 0.0 0
M  V30 12 O 3.5696 10.6088 0.0 0
M  V30 13 C 0.6403 9.6569 0.0 0
M  V30 14 C 15.7588 7.9871 0.0 0
M  V30 15 C 4.0736 6.5655 0.0 0
M  V30 16 N 4.9788 5.3196 0.0 0
M  V30 17 C 2.6091 6.0896 0.0 0
M  V30 18 N 4.3938 8.0719 0.0 0
M  V30 19 C 4.0736 4.0738 0.0 0
M  V30 20 C 2.6091 4.5496 0.0 0
M  V30 21 C 1.4645 7.1200 0.0 0
M  V30 22 C 3.2494 9.1023 0.0 0
M  V30 23 N 1.7847 8.6265 0.0 0
M  V30 24 C 11.1388 7.9871 0.0 0
M  V30 25 C 11.9088 6.6533 0.0 0
M  V30 26 C 11.9088 9.3207 0.0 0
M  V30 27 C 13.4488 6.6533 0.0 0
M  V30 28 C 13.4488 9.3207 0.0 0
M  V30 29 C 14.2188 7.9871 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 5 24
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 19
M  V30 11 1 8 10
M  V30 12 2 11 21
M  V30 13 2 12 22
M  V30 14 1 13 23
M  V30 15 1 14 29
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 2 19 20
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1391712-66-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1391712-69-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4160333
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Reaction of the
Pyrimido[5',4':4,5]pyrrolo[2,1-c][1,4]oxazines 5, 7a,b, 8a,b with
Methylamine (General Method). A mixture of one of the
pyrimido[5',4':4,5][pyrrolo[2,1-c][1,4]oxazines 5, 7a,b, 8a,b (0.8 mmol)
and MeNH2 (4.0 mmol) in MeOH (10 ml) was refluxed for 3 h, and the
precipitate formed was filtered off and purified by crystallization.
7-{2-Hydroxy-3-[(4-methylphenyl)sulfanyl]propyl}-N,1,3-trimethyl-2,4-dioxo-2,3,4,7-tetrahydro-1H-pyrrolo[2,3-d]pyrimidine-6-carboxamide
(11a). Yield 91%. Empirical formula: C20H24N4O4S; Found, %: C 57.72, H
5.87, N13.52, S 7.66; Calculated, %: C 57.68, H 5.81, N 13.45, S 7.70;
Mp*, °CС: 202-204 °C; Chemical shifts, δ, ppm (J, Hz): 2.27 (3H, s, CH3);
2.71 (3H, d, J = 4.5, NНCH3); 2.94-2.99 (2H, m, SCH2); 3.22 (3H, s,
NCH3); 3.72-3.74 (4H, m, NCH3, СН); 4.58-4.60 (1Н, m) and 5.07-5.09 (1Н,
m, СН; 5.45 (1Н, d, J = 5.5, OН); 7.10 (2Н, d, J = 8.0, H Ar); 7.12 (1Н,
s, Н; 7.22 (2H, d, J = 8.0, H Ar); 8.27 (1Н, br. s, NН). IR spectrum, ν,
cm-1: 1650 (br., C=O), 1703 (C=O), 3393 (NH), 3453 (OH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pyrrolo[2,3-d]pyrimidines with 3-amino-2-hydroxypropyl
substituents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Muzychka, L. V.; Verves, E. V.; Yaremchuk, I. O.; Smolii, O. B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2012),
48(3), 481-487

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Altronic acid, 5-azido-5-deoxy-3,6-bis-O-(phenylmethyl)-, γ-lactone, 2-meth...
C21H23N3O7S
1395068-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.3159 4.3816 0.0 0
M  V30 2 C 2.7843 4.2207 0.0 0
M  V30 3 C 7.9886 6.1086 0.0 0 CFG=2
M  V30 4 C 8.7586 4.7749 0.0 0
M  V30 5 N 8.7586 7.4424 0.0 0
M  V30 6 O 10.2986 4.7749 0.0 0
M  V30 7 N 10.2986 7.4424 0.0 0 CHG=1 VAL=4
M  V30 8 C 11.0687 3.4413 0.0 0
M  V30 9 N 11.8387 7.4424 0.0 0 CHG=-1
M  V30 10 O 2.6407 7.2832 0.0 0
M  V30 11 S 2.0143 8.6900 0.0 0 VAL=6
M  V30 12 C 0.6074 8.0636 0.0 0
M  V30 13 O 1.3880 10.0969 0.0 0
M  V30 14 O 3.4211 9.3164 0.0 0
M  V30 15 O 4.8826 9.7730 0.0 0
M  V30 16 C 4.9423 5.7884 0.0 0 CFG=1
M  V30 17 C 6.4486 6.1086 0.0 0 CFG=1
M  V30 18 C 4.1723 7.1222 0.0 0 CFG=2
M  V30 19 O 6.6096 7.6403 0.0 0
M  V30 20 C 5.2028 8.2666 0.0 0
M  V30 21 C 2.1580 2.8137 0.0 0
M  V30 22 C 0.6263 2.6528 0.0 0
M  V30 23 C 3.0631 1.5679 0.0 0
M  V30 24 C 0.0000 1.2459 0.0 0
M  V30 25 C 2.4368 0.1611 0.0 0
M  V30 26 C 0.9052 0.0000 0.0 0
M  V30 27 C 12.6087 3.4413 0.0 0
M  V30 28 C 13.3787 2.1077 0.0 0
M  V30 29 C 13.3787 4.7749 0.0 0
M  V30 30 C 14.9187 2.1077 0.0 0
M  V30 31 C 14.9187 4.7749 0.0 0
M  V30 32 C 15.6887 3.4413 0.0 0
M  V30 33 H 6.6096 4.5771 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 21
M  V30 4 1 3 4 CFG=3
M  V30 5 1 3 5
M  V30 6 1 3 17
M  V30 7 1 4 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 1 8 27
M  V30 12 1 10 11
M  V30 13 1 18 10 CFG=3
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 2 11 14
M  V30 17 2 15 20
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 33 CFG=1
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 3 16 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-Altronamide, 5-azido-5-deoxy-N-methyl-3,6-bis-O-(phenylmethyl)-, 2-methanes...
C22H28N4O7S
1591783-39-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.9302 0.0 0 CFG=2
M  V30 2 C 4.0012 7.7002 0.0 0 CFG=1
M  V30 3 C 6.6687 7.7002 0.0 0 CFG=2
M  V30 4 O 5.3348 5.3901 0.0 0
M  V30 5 O 2.6675 6.9302 0.0 0
M  V30 6 C 4.0012 9.2402 0.0 0
M  V30 7 C 8.0023 6.9302 0.0 0 CFG=2
M  V30 8 O 6.6687 9.2402 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 S 1.3338 7.7002 0.0 0 VAL=6
M  V30 11 N 2.6675 10.0102 0.0 0
M  V30 12 O 5.3348 10.0102 0.0 0
M  V30 13 C 9.3360 7.7002 0.0 0
M  V30 14 N 8.0023 5.3901 0.0 0
M  V30 15 C 2.1038 9.0338 0.0 0
M  V30 16 O 0.0000 8.4702 0.0 0
M  V30 17 O 0.5638 6.3665 0.0 0
M  V30 18 C 2.6675 11.5503 0.0 0
M  V30 19 O 10.6698 6.9302 0.0 0
M  V30 20 N 9.3360 4.6201 0.0 0 CHG=1 VAL=4
M  V30 21 C 12.0035 7.7002 0.0 0
M  V30 22 N 10.6698 3.8501 0.0 0 CHG=-1
M  V30 23 C 4.0012 3.0801 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 25 C 5.3348 2.3101 0.0 0
M  V30 26 C 2.6675 0.7700 0.0 0
M  V30 27 C 5.3348 0.7700 0.0 0
M  V30 28 C 4.0012 0.0000 0.0 0
M  V30 29 C 13.3372 6.9302 0.0 0
M  V30 30 C 14.6708 7.7002 0.0 0
M  V30 31 C 13.3372 5.3901 0.0 0
M  V30 32 C 16.0046 6.9302 0.0 0
M  V30 33 C 14.6708 4.6201 0.0 0
M  V30 34 C 16.0046 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13 CFG=1
M  V30 13 1 7 14
M  V30 14 1 9 23
M  V30 15 1 10 15
M  V30 16 2 10 16
M  V30 17 2 10 17
M  V30 18 1 11 18
M  V30 19 1 13 19
M  V30 20 2 14 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 1 21 29
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 3 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1395068-69-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1591783-39-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5498315
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methyl 5-Azido-3,6-di-O-benzyl-5-deoxy-2-O-methanesulfonyl-D-altronamide
52D. Methylamine (33% in ethanol, 2.75 mL, 22.3 mmol) was added to a
solution of the mesylate 50D (3.43 g, 7.43 mmol) in 1,4-dioxane (75 mL)
at rt. The reaction was stirred for 18 h, after which TLC analysis (3:1,
toluene-acetone) indicated complete consumption of the starting material
and the formation of a major product. The reaction mixture was
concentrated in vacuo and the residue purified by flash chromatography
(7:3 to 13:7, cyclohexane-ethyl acetate) to afford the product. Yield:
(3.31 g, 91%) as a white crystalline solid. (Rf 0.37). mp 86-88 °C.[α]25D
-1.50 (c 1.72 in CHCl3). νmax (thin film): 3402 (br s, OH), 2101 (s, N3),
1666 (s, CO), 1544 (s, CO), 1360 (s, SO2) 1176 (s, SO2). δH (400 MHz,
CD3CN): 2.76 (3 H, d, N-Me, JH,NH 4.8), 3.16 (3 H, s, SO2-Me), 3.63 (1 H,
dd, H-6, J6,5 7.7, J6,6' 10.4), 3.69 (1 H, dd, H-6', J6',5 3.8, J6',6
10.4), 3.71 (1 H, d, 4-OH, JOH,4 6.6), 3.80 (1 H, ddd, H-4, J4,5 3.0,
J4,OH 6.6, J4,3 9.3), 3.87 (1 H, a-dt, H-5, J5,4 = J5,6' 3.5, J5,6 7.7),
4.05 (1 H, dd, H-3, J3,2 1.8, J3,4 9.3), 4.43 (1 H, d, OCH2Ph, Jgem
11.1), 4.46 (1 H, d, OCH2Ph, Jgem 11.1), 4.48 (1 H, d, OCH2Ph, Jgem
12.0), 4.51 (1 H, d, OCH2Ph, Jgem 12.0), 5.12 (1 H, d, H-2, J2,3 1.8),
7.05 (1 H, br q, N-H, JNH,H 4.8), 7.25-7.38 (10 H, m, Ar-H). δC (100 MHz,
CD3CN): 26.5 (N-Me), 38.7 (SO2-Me), 64.5 (C-5), 70.3 (C-6), 71.0 (C-4),
73.8, 74.8 (OCH2Ph), 79.1 (C-2), 79.9 (C-3), 128.7, 128.8, 129.3, 129.4
(ArCH), 138.4, 139.1 (ArCC), 168.9 (C-1). m/z (ESI +ve): 493 (M + H+,
16), 515 (M + Na+, 100). (ESI -ve): 491 ([M - H]-, 100), 427 (M + 35Cl-,
65), 429 (M + 37Cl-, 25), 983 ([2M - H]-, 45). HRMS m/z (ESI +ve): found
515.1570 [M + Na+], C22H28N4NaO7S requires 515.1571.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nine of 16 Stereoisomeric Polyhydroxylated Proline Amides Are Potent
β-N-Acetylhexosaminidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ayers, Benjamin J.; Glawar, Andreas F. G.; Martinez, R. Fernando; Ngo,
Nigel; Liu, Zilei; Fleet, George W. J.; Butters, Terry D.; Nash, Robert
J.; Yu, Chu-Yi; Wormald, Mark R.; Nakagawa, Shinpei; Adachi, Isao; Kato,
Atsushi; Jenkinson, Sarah F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(8), 3398-3409

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Thiopyran-2-carbodithioic acid, 3,6-dihydro-2,4,5-trimethyl-, methyl ester...
C10H16OS3
1401826-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7998 3.6573 0.0 0
M  V30 2 S 7.2468 3.1307 0.0 0
M  V30 3 S 5.5323 5.1739 0.0 0
M  V30 4 C 8.4266 4.1206 0.0 0
M  V30 5 C 5.7998 1.6775 0.0 0
M  V30 6 O 4.6200 5.3349 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 0.0000 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0 CFG=1
M  V30 10 S 3.8500 4.0011 0.0 0 CFG=3 VAL=4
M  V30 11 C 3.8500 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 2.3100 1.3338 0.0 0
M  V30 14 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 9 5 CFG=3
M  V30 6 2 6 10
M  V30 7 1 7 13
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2H-Thiopyran-2-carbothioamide, 3,6-dihydro-N,2,4,5-tetramethyl-, 1-oxide, (2R)-
C10H17NOS2
1401860-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7998 3.6573 0.0 0
M  V30 2 N 7.2468 3.1307 0.0 0
M  V30 3 S 5.5323 5.1739 0.0 0
M  V30 4 C 8.4266 4.1206 0.0 0
M  V30 5 C 5.7998 1.6775 0.0 0
M  V30 6 O 4.6200 5.3349 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 0.0000 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0 CFG=1
M  V30 10 S 3.8500 4.0011 0.0 0 CFG=3 VAL=4
M  V30 11 C 3.8500 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 2.3100 1.3338 0.0 0
M  V30 14 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 9 5 CFG=3
M  V30 6 2 6 10
M  V30 7 1 7 13
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1401826-78-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1401860-75-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9982074
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl 2,4,5-trimethyl-1-oxo-3,6-dihydro-2H-thiopyran-2-carbothioamide
(9b): To a solution of the dithioester (1.0 mmol) in 10 mL of
tetrahydrofuran at room temperature was gradually added 40 % aqueous
solution of methylamine in 0.1 mL portions with 10 min intervals. During
the reaction a slow stream of nitrogen was passed over the reaction
mixture to remove the formed methanethiol more efficiently, leading to
shorter reaction times. After every addition the reaction was monitored
by TLC (ethyl acetate or ethylacetate/heptane = 1:1). After completion of
the reaction the solvent was evaporated in vacuo and the residue was
purified by column chromatography over a short path of silica gel.
Obtained as a white microcrystalline solid, 210 mg (91 %) after column
chromatography (heptane:ethyl acetate = 1:1) Small colorless crystals
from di-i-propyl ether. mp 130-135 degC (dec.).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfine-Based Synthesis of Four-, Five- and Six Membered Heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lucassen, Andreas Christianus Bernadus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2003), (20121004), No pp.

$RFMT $RIREG SCHEME136 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propen-1-one, 3-(3-bromo-2-hydroxyphenyl)-1-phenyl-, (2E)-
C15H11BrO2
1801658-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 O 9.3360 0.0000 0.0 0
M  V30 6 Br 12.0033 1.5400 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 C 8.0022 3.8501 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 13
M  V30 6 1 5 8
M  V30 7 1 6 10
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-7-(methylamino)-9-phenyl-6H-dibenzo[b,d]pyran-6-one
C20H14BrNO2
2119617-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.7700 0.0 0
M  V30 2 C 4.0012 0.0000 0.0 0
M  V30 3 O 8.0022 0.7700 0.0 0
M  V30 4 Br 12.0033 4.6201 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 C 8.0022 5.3901 0.0 0
M  V30 8 C 5.3348 5.3901 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 C 8.0022 6.9302 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 4.0012 3.0801 0.0 0
M  V30 15 O 9.3360 3.0801 0.0 0
M  V30 16 C 10.6697 5.3901 0.0 0
M  V30 17 C 9.3360 7.7002 0.0 0
M  V30 18 C 10.6697 6.9302 0.0 0
M  V30 19 C 2.6673 5.3901 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 2.6673 6.9302 0.0 0
M  V30 22 C 0.0000 5.3901 0.0 0
M  V30 23 C 1.3337 7.7002 0.0 0
M  V30 24 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 10
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 11 15
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 2 13 14
M  V30 19 1 13 19
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1801658-94-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2119617-08-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-357-CAS-18473977
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 118-75-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3109-63-5
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 55120-75-7
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, no solvent, global time 5 h, beta-enamino ester
formation/Michael addition/intramolecular aldol
reaction/elimination/aromatization/oxidative debenzylation/lactonization
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amine-Triggered Highly Facile Oxidative Benzannulation Reaction for the
Synthesis of Anthranilates under Solvent-Free Calcium(II) Catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yaragorla, Srinivasarao; Dada, Ravikrishna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2017), 2(8), 4859-4869

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
1-Methyl 4-chloro-6-fluoro-1,3-benzenedicarboxylate
C9H6ClFO4
1427082-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 C 8.4700 2.6674 0.0 0
M  V30 5 F 4.6200 6.6685 0.0 0
M  V30 6 C 1.5400 1.3338 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 O 0.0000 1.3338 0.0 0
M  V30 9 Cl 0.0000 4.0011 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 3.8500 2.6674 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-2-fluoro-5-[(methylamino)carbonyl]benzoate
C10H9ClFNO3
2572553-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6674 0.0 0
M  V30 2 N 2.3100 1.3336 0.0 0
M  V30 3 O 0.0000 2.6674 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 Cl 0.0000 5.3347 0.0 0
M  V30 6 C 6.1600 5.3347 0.0 0
M  V30 7 O 6.9300 4.0011 0.0 0
M  V30 8 O 6.9300 6.6685 0.0 0
M  V30 9 C 8.4700 4.0011 0.0 0
M  V30 10 F 4.6200 8.0021 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 1.5400 5.3347 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 C 3.8500 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1427082-55-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2572553-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23916051
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of furosemide analogs as
therapeutics for the proteopathy and immunopathy of Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Zhiyu; Wang, Yanfei; Pasangulapati, Jagadeesh Prasad; Stover, Kurt
R.; Liu, Xiaojing; Schier, Stephanie; Weaver, Donald F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 222113565

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
1-Methyl 4-chloro-6-fluoro-1,3-benzenedicarboxylate
C9H6ClFO4
1427082-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 C 8.4700 2.6674 0.0 0
M  V30 5 F 4.6200 6.6685 0.0 0
M  V30 6 C 1.5400 1.3338 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 O 0.0000 1.3338 0.0 0
M  V30 9 Cl 0.0000 4.0011 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 3.8500 2.6674 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-2-fluoro-5-[(methylamino)carbonyl]benzoate
C10H9ClFNO3
2572553-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6674 0.0 0
M  V30 2 N 2.3100 1.3336 0.0 0
M  V30 3 O 0.0000 2.6674 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 Cl 0.0000 5.3347 0.0 0
M  V30 6 C 6.1600 5.3347 0.0 0
M  V30 7 O 6.9300 4.0011 0.0 0
M  V30 8 O 6.9300 6.6685 0.0 0
M  V30 9 C 8.4700 4.0011 0.0 0
M  V30 10 F 4.6200 8.0021 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 1.5400 5.3347 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 C 3.8500 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1427082-55-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2572553-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23461627
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of furosemide analogs and uses thereof for treatment of
Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weaver, Donald Fredric; Wang, Zhiyu; Doyle, Lisa; Villar, Laura; Vilekar,
Prachi S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020257940 A1 2020-12-30

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-oxo-2H-1-benzopyran-7-yl 3-chlorobenzenesulfonate
C16H10Cl2O5S
1427203-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 Cl 0.0000 5.3348 0.0 0
M  V30 3 O 8.4702 4.0012 0.0 0
M  V30 4 S 9.2402 5.3348 0.0 0 VAL=6
M  V30 5 O 10.0102 6.6687 0.0 0
M  V30 6 O 7.9065 6.1048 0.0 0
M  V30 7 O 1.5400 0.0000 0.0 0
M  V30 8 Cl 14.5752 5.3348 0.0 0
M  V30 9 C 3.8501 4.0012 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 2.3101 4.0012 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 C 6.1601 2.6675 0.0 0
M  V30 14 O 3.8501 1.3338 0.0 0
M  V30 15 C 1.5400 2.6675 0.0 0
M  V30 16 C 6.1601 5.3348 0.0 0
M  V30 17 C 6.9302 4.0012 0.0 0
M  V30 18 C 2.3101 1.3338 0.0 0
M  V30 19 C 10.5740 4.5648 0.0 0
M  V30 20 C 11.9077 5.3348 0.0 0
M  V30 21 C 10.5740 3.0248 0.0 0
M  V30 22 C 13.2414 4.5648 0.0 0
M  V30 23 C 11.9077 2.2548 0.0 0
M  V30 24 C 13.2414 3.0248 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 19
M  V30 8 2 7 18
M  V30 9 1 8 22
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 2 16 17
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-2,3-Dihydro-3-[2-(methylamino)-2-oxoethylidene]-6-benzofuranyl 3-chlorob...
C17H14ClNO5S
1427203-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2888 2.5369 0.0 0
M  V30 2 C 2.6091 1.0306 0.0 0
M  V30 3 N 1.4646 0.0000 0.0 0
M  V30 4 O 4.0737 0.5546 0.0 0
M  V30 5 C 0.0000 0.4759 0.0 0
M  V30 6 O 9.5598 3.2472 0.0 0
M  V30 7 S 10.3298 4.5808 0.0 0 VAL=6
M  V30 8 O 11.0998 5.9147 0.0 0
M  V30 9 O 8.9961 5.3508 0.0 0
M  V30 10 Cl 15.6646 4.5808 0.0 0
M  V30 11 C 5.7097 4.5808 0.0 0
M  V30 12 C 4.9397 3.2472 0.0 0
M  V30 13 C 7.2497 4.5808 0.0 0
M  V30 14 O 4.6792 5.7254 0.0 0
M  V30 15 C 3.4334 3.5673 0.0 0
M  V30 16 C 5.7097 1.9135 0.0 0
M  V30 17 C 8.0197 3.2472 0.0 0
M  V30 18 C 3.2724 5.0991 0.0 0
M  V30 19 C 7.2497 1.9135 0.0 0
M  V30 20 C 11.6636 3.8108 0.0 0
M  V30 21 C 12.9973 4.5808 0.0 0
M  V30 22 C 11.6636 2.2708 0.0 0
M  V30 23 C 14.3309 3.8108 0.0 0
M  V30 24 C 12.9973 1.5008 0.0 0
M  V30 25 C 14.3309 2.2708 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 20
M  V30 11 1 10 23
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1427203-61-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1427203-78-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12242872
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of Final
Compounds 20-38. A suitable sulfonate intermediate, 3-19 (2.0 mmol), was
suspended in dry THF (8.0 mL), and a commercially available 2.0 N
solution of methylamine (for compounds 20-36) or ethylamine (for compound
37) in THF (10 mL, 20 mmol) was added. For the synthesis of compound 38
isopropylamine (1.7 mL, 20 mmol) was previously dissolved in dry THF (2.0
mL) before addition to the reaction mixture. The resulting mixture was
stirred at room temperature until completion of the reaction as checked
by TLC control (3-24 h). The inorganic precipitate was filtered off, and
the solution was concentrated to dryness and purified by flash
chromatography (gradient eluent, different mixtures of ethyl acetate in
n-hexane). Product was purified by flash chromatography (gradient eluent,
ethyl acetate in n-hexane 20% → 80%).
(3E)-3-[2-(Methylamino)-2-oxoethylidene]-2,3-dihydro-1-benzofuran-6-yl
3-Chlorobenzenesulfonate (21). 21 was purified by flash chromatography
(gradient eluent, ethyl acetate in n-hexane 10% → 80%). Yield: 91%. 1H
NMR (300 MHz, DMSO-d6) δ: 2.64 (d, J = 4.7 Hz, 3H), 5.23 (d, J = 2.5 Hz,
2H), 5.86 (t, J = 2.5 Hz, 1H), 6.58 (dd, J1 = 2.2 Hz, J2 = 8.8 Hz, 1H),
6.70 (d, J = 2.2 Hz, 1H), 7.66-7.71 (m, 1H), 7.82-7.85 (m, 1H), 7.89-7.95
(m, 2H), 8.04 (br q, J = 4.7 Hz, 1H, disappears with D2O), 8.86 (d, J =
8.8 Hz, 1H). IC50 ± SD (nM), MAO-A: 41 ± 3.3. Calculated: C 53.76, H
3.72, N 3.69; Found: C 53.91, H 3.78, N 3.73.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery, Biological Evaluation, and Structure-Activity and -Selectivity
Relationships of 6'-Substituted
(E)-2-(Benzofuran-3(2H)-ylidene)-N-methylacetamides, a Novel Class of
Potent and Selective Monoamine Oxidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pisani, Leonardo; Barletta, Maria; Soto-Otero, Ramon; Nicolotti, Orazio;
Mendez-Alvarez, Estefania; Catto, Marco; Introcaso, Antonellina;
Stefanachi, Angela; Cellamare, Saverio; Altomare, Cosimo; Carotti, Angelo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(6), 2651-2664

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanone, 1-[4-chloro-2-(methylthio)-5-pyrimidinyl]-2-(2,6-dichlorophenyl)-
C13H9Cl3N2OS
1431323-75-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0012 0.0 0
M  V30 2 C 4.6201 2.6675 0.0 0
M  V30 3 O 4.6201 5.3348 0.0 0
M  V30 4 Cl 6.9302 6.6687 0.0 0
M  V30 5 S 11.5503 4.0012 0.0 0
M  V30 6 C 12.3203 2.6675 0.0 0
M  V30 7 Cl 3.0801 5.3348 0.0 0
M  V30 8 Cl 3.0801 0.0000 0.0 0
M  V30 9 C 6.9302 4.0012 0.0 0
M  V30 10 C 7.7002 5.3348 0.0 0
M  V30 11 C 7.7002 2.6675 0.0 0
M  V30 12 N 9.2402 5.3348 0.0 0
M  V30 13 N 9.2402 2.6675 0.0 0
M  V30 14 C 10.0102 4.0012 0.0 0
M  V30 15 C 3.0801 2.6675 0.0 0
M  V30 16 C 2.3101 4.0012 0.0 0
M  V30 17 C 2.3101 1.3338 0.0 0
M  V30 18 C 0.7700 4.0012 0.0 0
M  V30 19 C 0.7700 1.3338 0.0 0
M  V30 20 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 15
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 7 16
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanone, 2-(2,6-dichlorophenyl)-1-[4-(methylamino)-2-(methylthio)-5-pyrimidi...
C14H13Cl2N3OS
1431323-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0012 0.0 0
M  V30 2 C 4.6201 5.3348 0.0 0
M  V30 3 O 4.6201 2.6675 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 7.7002 0.0000 0.0 0
M  V30 6 S 11.5503 4.0012 0.0 0
M  V30 7 C 12.3203 5.3348 0.0 0
M  V30 8 Cl 3.0801 2.6675 0.0 0
M  V30 9 Cl 3.0801 8.0023 0.0 0
M  V30 10 C 6.9302 4.0012 0.0 0
M  V30 11 C 7.7002 2.6675 0.0 0
M  V30 12 C 7.7002 5.3348 0.0 0
M  V30 13 N 9.2402 2.6675 0.0 0
M  V30 14 N 9.2402 5.3348 0.0 0
M  V30 15 C 10.0102 4.0012 0.0 0
M  V30 16 C 3.0801 5.3348 0.0 0
M  V30 17 C 2.3101 4.0012 0.0 0
M  V30 18 C 2.3101 6.6687 0.0 0
M  V30 19 C 0.7700 4.0012 0.0 0
M  V30 20 C 0.7700 6.6687 0.0 0
M  V30 21 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 16
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 1 8 17
M  V30 10 1 9 18
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1431323-75-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1431323-89-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20194703
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Investigation of biaryl heterocycles as inhibitors of Wee1 kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mastracchio, Anthony; Lai, Chunqiu; Torrent, Maricel; Bromberg, Kenneth;
Buchanan, Fritz G.; Ferguson, Debra; Bontcheva, Velitchka; Johnson, Eric
F.; Lasko, Loren; Maag, David; Soni, Nirupama; Shoemaker, Alexander R.;
Penning, Thomas D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2019), 29(12), 1481-1486

$RFMT $RIREG SCHEME140 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[(1E)-2-(dimethylamino)ethenyl]-2,5-dihydro-5-methyl-2-oxo-5-phenyl-3...
C18H21NO4
1432024-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0959 4.3792 0.0 0
M  V30 2 C 4.9845 3.0631 0.0 0
M  V30 3 C 3.5777 2.4368 0.0 0
M  V30 4 N 3.4167 0.9051 0.0 0
M  V30 5 C 2.0099 0.2787 0.0 0
M  V30 6 C 4.6627 0.0000 0.0 0
M  V30 7 C 7.8861 4.7383 0.0 0
M  V30 8 O 9.1319 5.6435 0.0 0
M  V30 9 O 8.0470 3.2068 0.0 0
M  V30 10 C 10.5389 5.0170 0.0 0
M  V30 11 C 11.7848 5.9223 0.0 0
M  V30 12 O 7.1895 8.0154 0.0 0
M  V30 13 C 4.0011 5.6250 0.0 0 CFG=3
M  V30 14 C 5.1455 4.5946 0.0 0
M  V30 15 O 4.6274 7.0320 0.0 0
M  V30 16 C 6.4793 5.3646 0.0 0
M  V30 17 C 6.1590 6.8711 0.0 0
M  V30 18 C 2.6674 6.3950 0.0 0
M  V30 19 C 2.6674 7.9350 0.0 0
M  V30 20 C 1.3336 5.6250 0.0 0
M  V30 21 C 1.3336 8.7050 0.0 0
M  V30 22 C 0.0000 6.3950 0.0 0
M  V30 23 C 0.0000 7.9350 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 2 2 3
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 2 12 17
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 18
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dimethyl-1-phenylfuro[3,4-c]pyridine-3,4(1H,5H)-dione
C15H13NO3
1432024-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4591 5.1960 0.0 0
M  V30 2 O 6.1862 0.0000 0.0 0
M  V30 3 O 9.2064 1.3172 0.0 0
M  V30 4 C 10.7464 3.9844 0.0 0
M  V30 5 C 4.6200 3.6643 0.0 0
M  V30 6 C 6.1264 3.9844 0.0 0
M  V30 7 O 4.4591 2.1327 0.0 0
M  V30 8 C 6.8964 2.6508 0.0 0
M  V30 9 C 6.8964 5.3182 0.0 0
M  V30 10 C 5.8659 1.5064 0.0 0
M  V30 11 C 8.4364 2.6508 0.0 0
M  V30 12 C 8.4364 5.3182 0.0 0
M  V30 13 N 9.2064 3.9844 0.0 0
M  V30 14 C 3.0800 3.6643 0.0 0
M  V30 15 C 2.3100 2.3306 0.0 0
M  V30 16 C 2.3100 4.9981 0.0 0
M  V30 17 C 0.7700 2.3306 0.0 0
M  V30 18 C 0.7700 4.9981 0.0 0
M  V30 19 C 0.0000 3.6643 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 10
M  V30 3 2 3 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 9 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1432024-60-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1432024-55-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6264653
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 1330-20-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM C1 and N5 derivatives of cerpegin: Synthesis of a new series based on
structure-activity relationships to optimize their inhibitory effect on
20S proteasome
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hovhannisyan, Anna; Pham, The Hien; Bouvier, Dominique; Qin, Lixian;
Melikyan, Gagik; Reboud-Ravaux, Michele; Bouvier-Durand, Michelle
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2013), 23(9), 2696-2703

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
P,P,P′,P′-Tetraethyl P,P′-[2-[[(methylsulfonyl)oxy]methyl]-1,3-propanediyl]bi...
C13H30O9P2S
1443216-00-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 7.0812 0.0 0
M  V30 2 C 5.3348 6.3112 0.0 0
M  V30 3 P 8.0022 6.3112 0.0 0 VAL=5
M  V30 4 C 5.3348 4.7712 0.0 0
M  V30 5 C 4.0012 7.0812 0.0 0
M  V30 6 O 9.3360 5.5412 0.0 0
M  V30 7 O 8.7722 7.6450 0.0 0
M  V30 8 O 7.2322 4.9775 0.0 0
M  V30 9 P 4.0012 4.0012 0.0 0 VAL=5
M  V30 10 O 4.0012 8.6213 0.0 0
M  V30 11 C 10.6697 6.3112 0.0 0
M  V30 12 C 8.0022 8.9787 0.0 0
M  V30 13 O 2.6673 3.2311 0.0 0
M  V30 14 O 4.7712 2.6675 0.0 0
M  V30 15 O 3.2311 5.3350 0.0 0
M  V30 16 S 2.6673 9.3913 0.0 0 VAL=6
M  V30 17 C 12.0033 5.5412 0.0 0
M  V30 18 C 8.7722 10.3124 0.0 0
M  V30 19 C 1.3337 4.0012 0.0 0
M  V30 20 C 4.0012 1.3338 0.0 0
M  V30 21 C 3.4374 10.7251 0.0 0
M  V30 22 O 1.3337 10.1613 0.0 0
M  V30 23 O 1.8973 8.0576 0.0 0
M  V30 24 C 0.0000 3.2311 0.0 0
M  V30 25 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 1 9 14
M  V30 14 2 9 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 12 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 16 21
M  V30 21 2 16 22
M  V30 22 2 16 23
M  V30 23 1 19 24
M  V30 24 1 20 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[3-(diethoxyphosphinyl)-2-[(methylamino)methyl]propyl]phosphonate
C13H31NO6P2
1639050-50-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 8.6211 5.3348 0.0 0 VAL=5
M  V30 2 C 7.0811 5.3348 0.0 0
M  V30 3 O 10.1611 5.3348 0.0 0
M  V30 4 O 8.6211 6.8749 0.0 0
M  V30 5 O 8.6211 3.7948 0.0 0
M  V30 6 C 6.3111 4.0012 0.0 0
M  V30 7 C 10.9312 6.6685 0.0 0
M  V30 8 C 7.2874 7.6449 0.0 0
M  V30 9 C 4.7710 4.0012 0.0 0
M  V30 10 C 7.0811 2.6675 0.0 0
M  V30 11 C 12.4712 6.6685 0.0 0
M  V30 12 C 7.2874 9.1849 0.0 0
M  V30 13 P 4.0010 5.3348 0.0 0 VAL=5
M  V30 14 N 6.3111 1.3337 0.0 0
M  V30 15 O 3.2310 6.6685 0.0 0
M  V30 16 O 2.6673 4.5648 0.0 0
M  V30 17 O 5.3348 6.1048 0.0 0
M  V30 18 C 7.0811 0.0000 0.0 0
M  V30 19 C 4.0010 8.0023 0.0 0
M  V30 20 C 1.3337 5.3348 0.0 0
M  V30 21 C 3.2310 9.3360 0.0 0
M  V30 22 C 0.0000 4.5648 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1443216-00-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1639050-50-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8963034
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Monomers for adhesive polymers, 13.1 Synthesis, radical
photopolymerization and adhesive properties of polymerizable
2-substituted 1,3-propylidenediphosphonic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Catel, Yohann; Fischer, Urs Karl; Moszner, Norbert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Designed Monomers and Polymers (2014), 17(3), 286-299

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C36H40N4O6
1467050-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.9924 3.0801 0.0 0
M  V30 2 O 13.9924 4.6201 0.0 0
M  V30 3 C 17.0531 4.4428 0.0 0
M  V30 4 O 18.5178 4.9187 0.0 0
M  V30 5 O 15.9087 5.4733 0.0 0
M  V30 6 C 18.8380 6.4252 0.0 0
M  V30 7 N 11.3249 4.6201 0.0 0
M  V30 8 C 9.9913 5.3901 0.0 0
M  V30 9 O 8.6576 4.6201 0.0 0
M  V30 10 N 7.3238 6.9302 0.0 0
M  V30 11 C 5.9901 7.7002 0.0 0
M  V30 12 O 5.9901 9.2402 0.0 0
M  V30 13 C 2.9293 9.0629 0.0 0
M  V30 14 C 1.4647 9.5388 0.0 0
M  V30 15 O 4.0739 10.0934 0.0 0
M  V30 16 C 0.9889 8.0742 0.0 0
M  V30 17 C 0.0000 10.0147 0.0 0
M  V30 18 C 1.9406 11.0035 0.0 0
M  V30 19 N 15.3261 2.3101 0.0 0
M  V30 20 C 16.7329 2.9365 0.0 0 CFG=1
M  V30 21 C 15.4870 0.7785 0.0 0
M  V30 22 C 17.7635 1.7920 0.0 0
M  V30 23 C 16.9935 0.4583 0.0 0
M  V30 24 C 12.6586 2.3101 0.0 0
M  V30 25 C 11.3249 3.0801 0.0 0
M  V30 26 C 12.6586 0.7700 0.0 0
M  V30 27 C 9.9913 2.3101 0.0 0
M  V30 28 C 11.3249 0.0000 0.0 0
M  V30 29 C 9.9913 0.7700 0.0 0
M  V30 30 C 20.3027 6.9010 0.0 0
M  V30 31 C 20.6229 8.4074 0.0 0
M  V30 32 C 21.4471 5.8706 0.0 0
M  V30 33 C 22.0875 8.8834 0.0 0
M  V30 34 C 22.9119 6.3465 0.0 0
M  V30 35 C 23.2320 7.8528 0.0 0
M  V30 36 C 9.9913 6.9302 0.0 0
M  V30 37 C 8.6576 7.7002 0.0 0
M  V30 38 C 11.3249 7.7002 0.0 0
M  V30 39 C 8.6576 9.2402 0.0 0
M  V30 40 C 11.3249 9.2402 0.0 0
M  V30 41 C 9.9913 10.0102 0.0 0
M  V30 42 C 4.6564 6.9302 0.0 0 CFG=2
M  V30 43 N 3.2495 7.5566 0.0 0
M  V30 44 C 4.4955 5.3986 0.0 0
M  V30 45 C 2.2190 6.4121 0.0 0
M  V30 46 C 2.9891 5.0784 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 19
M  V30 3 1 1 24
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 20 3 CFG=1
M  V30 7 1 4 6
M  V30 8 1 6 30
M  V30 9 1 7 8
M  V30 10 1 7 25
M  V30 11 2 8 9
M  V30 12 1 8 36
M  V30 13 1 10 11
M  V30 14 1 10 37
M  V30 15 2 11 12
M  V30 16 1 42 11 CFG=3
M  V30 17 1 13 14
M  V30 18 2 13 15
M  V30 19 1 13 43
M  V30 20 1 14 16
M  V30 21 1 14 17
M  V30 22 1 14 18
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 46 1 42 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 20 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C30H37N5O5
1467050-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 5.3196 0.0 0
M  V30 2 O 4.6798 3.9860 0.0 0
M  V30 3 N 6.9898 5.3196 0.0 0
M  V30 4 C 8.5298 5.3196 0.0 0
M  V30 5 O 9.2998 6.6533 0.0 0
M  V30 6 C 1.9406 2.6091 0.0 0
M  V30 7 N 0.9100 1.4647 0.0 0
M  V30 8 O 3.4468 2.2889 0.0 0
M  V30 9 C 1.3860 0.0000 0.0 0
M  V30 10 N 11.6098 5.3196 0.0 0
M  V30 11 C 13.1498 5.3196 0.0 0
M  V30 12 O 13.9198 3.9860 0.0 0
M  V30 13 C 16.4819 5.6698 0.0 0
M  V30 14 C 17.9881 5.9900 0.0 0
M  V30 15 O 16.0060 4.2053 0.0 0
M  V30 16 C 17.6680 7.4964 0.0 0
M  V30 17 C 19.4946 6.3102 0.0 0
M  V30 18 C 18.3084 4.4837 0.0 0
M  V30 19 C 4.6798 6.6533 0.0 0
M  V30 20 C 6.2198 6.6533 0.0 0
M  V30 21 C 3.9098 7.9871 0.0 0
M  V30 22 C 6.9898 7.9871 0.0 0
M  V30 23 C 4.6798 9.3207 0.0 0
M  V30 24 C 6.2198 9.3207 0.0 0
M  V30 25 N 2.3698 5.3196 0.0 0
M  V30 26 C 1.4647 4.0738 0.0 0 CFG=1
M  V30 27 C 1.4647 6.5655 0.0 0
M  V30 28 C 0.0000 4.5496 0.0 0
M  V30 29 C 0.0000 6.0896 0.0 0
M  V30 30 C 9.2998 3.9860 0.0 0
M  V30 31 C 10.8398 3.9860 0.0 0
M  V30 32 C 8.5298 2.6522 0.0 0
M  V30 33 C 11.6098 2.6522 0.0 0
M  V30 34 C 9.2998 1.3185 0.0 0
M  V30 35 C 10.8398 1.3185 0.0 0
M  V30 36 C 13.9198 6.6533 0.0 0 CFG=2
M  V30 37 N 15.4514 6.8143 0.0 0
M  V30 38 C 13.2934 8.0602 0.0 0
M  V30 39 C 15.7716 8.3206 0.0 0
M  V30 40 C 14.4380 9.0906 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 3 4
M  V30 5 1 3 20
M  V30 6 2 4 5
M  V30 7 1 4 30
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 26 6 CFG=1
M  V30 11 1 7 9
M  V30 12 1 10 11
M  V30 13 1 10 31
M  V30 14 2 11 12
M  V30 15 1 36 11 CFG=3
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 13 37
M  V30 19 1 14 16
M  V30 20 1 14 17
M  V30 21 1 14 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 26 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1467050-23-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1467050-24-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15521252
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Switching the H-bonding network of a foldamer by modulating the backbone
chirality and constitutional ratio of amino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramesh, Veera V. E.; Vijayadas, Kuruppanthara N.; Dhokale, Snehal;
Gonnade, Rajesh G.; Rajamohanan, Pattuparambil R.; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2013), 11(41), 7072-7075

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[1-[4-(2-Bromoethoxy)phenyl]-2-phenyl-1-buten-1-yl]phenol
C24H23BrO2
147323-02-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 6.6684 0.0 0
M  V30 3 C 5.3900 8.0021 0.0 0
M  V30 4 C 4.6200 9.3358 0.0 0
M  V30 5 O 11.5500 5.3347 0.0 0
M  V30 6 C 12.3200 6.6684 0.0 0
M  V30 7 C 13.8600 6.6684 0.0 0
M  V30 8 Br 14.6300 8.0021 0.0 0
M  V30 9 O 2.3100 0.0000 0.0 0
M  V30 10 C 6.9300 5.3347 0.0 0
M  V30 11 C 7.7000 4.0011 0.0 0
M  V30 12 C 7.7000 6.6684 0.0 0
M  V30 13 C 9.2400 4.0011 0.0 0
M  V30 14 C 9.2400 6.6684 0.0 0
M  V30 15 C 10.0100 5.3347 0.0 0
M  V30 16 C 4.6200 4.0011 0.0 0
M  V30 17 C 3.0800 4.0011 0.0 0
M  V30 18 C 5.3900 2.6674 0.0 0
M  V30 19 C 2.3100 2.6674 0.0 0
M  V30 20 C 4.6200 1.3336 0.0 0
M  V30 21 C 3.0800 1.3336 0.0 0
M  V30 22 C 3.0800 6.6684 0.0 0
M  V30 23 C 2.3100 5.3347 0.0 0
M  V30 24 C 2.3100 8.0021 0.0 0
M  V30 25 C 0.7700 5.3347 0.0 0
M  V30 26 C 0.7700 8.0021 0.0 0
M  V30 27 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 1 2 22
M  V30 6 1 3 4
M  V30 7 1 5 6
M  V30 8 1 5 15
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 9 21
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[1-[4-[2-(Methylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]phenol
C25H27NO2
110025-28-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 6.6684 0.0 0
M  V30 3 C 5.3900 8.0021 0.0 0
M  V30 4 C 4.6200 9.3358 0.0 0
M  V30 5 O 11.5500 5.3347 0.0 0
M  V30 6 C 12.3200 6.6684 0.0 0
M  V30 7 C 13.8600 6.6684 0.0 0
M  V30 8 N 14.6300 8.0021 0.0 0
M  V30 9 C 16.1700 8.0021 0.0 0
M  V30 10 O 2.3100 0.0000 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 C 7.7000 6.6684 0.0 0
M  V30 13 C 7.7000 4.0011 0.0 0
M  V30 14 C 9.2400 6.6684 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 17 C 4.6200 4.0011 0.0 0
M  V30 18 C 5.3900 2.6674 0.0 0
M  V30 19 C 3.0800 4.0011 0.0 0
M  V30 20 C 4.6200 1.3336 0.0 0
M  V30 21 C 2.3100 2.6674 0.0 0
M  V30 22 C 3.0800 1.3336 0.0 0
M  V30 23 C 3.0800 6.6684 0.0 0
M  V30 24 C 2.3100 8.0021 0.0 0
M  V30 25 C 2.3100 5.3347 0.0 0
M  V30 26 C 0.7700 8.0021 0.0 0
M  V30 27 C 0.7700 5.3347 0.0 0
M  V30 28 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 2 3
M  V30 5 1 2 23
M  V30 6 1 3 4
M  V30 7 1 5 6
M  V30 8 1 5 16
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 10 22
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 147323-02-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 110025-28-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4837230
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM E/Z-1- (4-Hydroxyphenyl)-1- [4- (2-methylamino-ethoxy)-phenyl]-2-phenyl-
butene (6). Bromide 5 (344 mg, 0.81 mmol) was dissolved in 8.1 mL of a 2
M solution of methylamine (16.2 mmol) in THF. The reaction was stirred in
a sealed tube for 48 h at 60 °C. After 48 h analytical HPLC revealed
complete consumption of starting material. Reaction workup was
accomplished via the addition of 100 mL CH2Cl2. The organic phase was
washed lx with 50 mL of a pH-10 Na2CO3 : NaHCO3 aqueous buffer. The
aqueous phase was then extracted 4x with 50 mL CH2Cl2. The combined
organics were then dried (Na2SO4) and concentrated in vacuo to yield a
yellow, oily reaction product. The material was purified via flash
chromatography on silica gel (90% chloroform: 10% methanol) providing
E/Z-desmethylhydroxytamoxifen 6 as an equimolar mixture of diastereomers,
yield 276 mg, 91%. TLC (SiO2, 4: 1 chloroform : methanol): Rf = 0.21. 1H
NMR (500 MHz, CDCl3) δ 0.93 (3H, dt, J = 7.5 Hz, 4), 2.49 (1.5H, s, N-Me
diast. 1), 2.51 (2H, dq, J = 7.5 Hz, 3), 2.55 (1. SH, s, N-Me diast. 2),
2.94 (1H, t, J = 5.1 Hz, -N- CH2-diast. 1), 3.04 (1H, t, J = 5.1 Hz,
-N-CH2-diast. 2), 3.95 (1H, t, J = 5.1 Hz,-O-CH2- diast. 1), 4.11 (1H, t,
J = 5.1 Hz,-O-CH2-diast. 2), 6.43 (1H, d, J = 8.6 Hz, HO-Ph 3 diast. 2),
6.49 (1H, d, J = 8. 8 Hz, HO-Ph 3 diast. 1), 6.67 (1H, d, J = 8.6 Hz,
RO-Ph 3 diast. 2), 6.75 (2H, dd, J = 8.4, 8. 8 Hz, HO-Ph 2 both diast. )
6.83 (1H, d, J = 8.6 Hz, RO- Ph 3 diast. 1), 7.03 (1H, d, J = 8.6 Hz,
RO-Ph 2 diast. 2), 7.11 (3H, m, RO-Ph 2 diast. 1 and phenyl-ortho), 7.16
(3H, m, phenyl-meta, para). HRMS [M+H]+ calculated 374. 2115, found 374.
2113.
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube, product obtained as equimolar mixture of E and
Z stereoisomers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Targeted drug-formaldehyde conjugates and methods of making and using the
same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koch, Tad H.; Coleman, Michael P.; Cogan, Peter S.; Burke, Patrick J.;
Post, Glen C.; Burkhart, David J.; McKenzie, Andrew R.; Jackson, Katrina
L.; Kalet, Brian T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005034856 A2 2005-04-21

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
rel-(1R,2R)-2-(1-Pyrrolidinyl)cyclohexanol
C10H19NO
14909-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 0.0000 0.0 0
M  V30 2 N 2.3698 2.6673 0.0 0
M  V30 3 C 1.4646 1.4215 0.0 0
M  V30 4 C 1.4646 3.9132 0.0 0
M  V30 5 C 0.0000 1.8973 0.0 0
M  V30 6 C 0.0000 3.4374 0.0 0
M  V30 7 C 3.9098 2.6673 0.0 0 CFG=2
M  V30 8 C 4.6799 1.3337 0.0 0 CFG=2
M  V30 9 C 4.6799 4.0010 0.0 0
M  V30 10 C 6.2199 1.3337 0.0 0
M  V30 11 C 6.2199 4.0010 0.0 0
M  V30 12 C 6.9899 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 7 2 CFG=3
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R)-N-Methyl-2-(1-pyrrolidinyl)cyclohexanamine
C11H22N2
99239-39-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0 CFG=2
M  V30 4 C 2.3100 2.6674 0.0 0 CFG=2
M  V30 5 C 2.3100 5.3349 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 0.7700 5.3349 0.0 0
M  V30 8 C 0.0000 4.0011 0.0 0
M  V30 9 N 4.6200 4.0011 0.0 0
M  V30 10 C 5.5252 5.2469 0.0 0
M  V30 11 C 5.5252 2.7552 0.0 0
M  V30 12 C 6.9898 4.7711 0.0 0
M  V30 13 C 6.9898 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 4 1 CFG=3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 3 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 14909-81-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99239-39-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-39098
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (+/-)-trans-N-Methyl-2-(pyrrolidin-1-yl)cyclohexanamine ((+/-)-2): To a
solution of compound (+/-)-1 (1.01 g, 6 mmol) and TEA (0.98 mL, 7 mmol)
in DCM (20 mL) was added methanesulfonyl chloride (0.51 mL, 6.6 mmol)
dropwise. The reaction mixture was stirred for 2 h at room temperature.
The solvent was removed under reduced pressure, and 5 mL methylamine (40%
in H2O) was added at room temperature. The solution was stirred at room
temperature for an additional 16 h. The reaction mixture was then added
to DCM (50 mL) and washed with sat. NaHCO3 solution (2×25 mL). The
organic phases were combined and dried with anhydrous Na2SO4. After
removing the Na2SO4 by filtration, the solvent was removed and the
material dried under vacuum. The desired compound (+/-)-2 (1.0 g, 5.5
mmol, yield 91%). 1H NMR (CDCl3) δ 2.61 (s, 1H), 2.49-2.30 (m, 6H), 2.29
(s, 3H), 2.09-1.96 (m, 2H), 1.67-1.52 (m, 7H), 1.11-1.02 (m, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oligomer-opioid agonist conjugates for treatment of pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riggs-Sauthier, Jennifer; Deng, Bo-Liang; Riley, Timothy A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US8575196 B2 2013-11-05

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
rel-(1R,2R)-2-(1-Pyrrolidinyl)cyclohexanol
C10H19NO
14909-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 0.0000 0.0 0
M  V30 2 N 2.3698 2.6673 0.0 0
M  V30 3 C 1.4646 1.4215 0.0 0
M  V30 4 C 1.4646 3.9132 0.0 0
M  V30 5 C 0.0000 1.8973 0.0 0
M  V30 6 C 0.0000 3.4374 0.0 0
M  V30 7 C 3.9098 2.6673 0.0 0 CFG=2
M  V30 8 C 4.6799 1.3337 0.0 0 CFG=2
M  V30 9 C 4.6799 4.0010 0.0 0
M  V30 10 C 6.2199 1.3337 0.0 0
M  V30 11 C 6.2199 4.0010 0.0 0
M  V30 12 C 6.9899 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 7 2 CFG=3
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R)-N-Methyl-2-(1-pyrrolidinyl)cyclohexanamine
C11H22N2
99239-39-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0 CFG=2
M  V30 4 C 2.3100 2.6674 0.0 0 CFG=2
M  V30 5 C 2.3100 5.3349 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 0.7700 5.3349 0.0 0
M  V30 8 C 0.0000 4.0011 0.0 0
M  V30 9 N 4.6200 4.0011 0.0 0
M  V30 10 C 5.5252 5.2469 0.0 0
M  V30 11 C 5.5252 2.7552 0.0 0
M  V30 12 C 6.9898 4.7711 0.0 0
M  V30 13 C 6.9898 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 4 1 CFG=3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 3 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 14909-81-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99239-39-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-34344
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (+/-)-trans-N-Methyl-2-(pyrrolidin-1-yl)cyclohexanamine ((+/-)-2): To a
solution of compound (+/-)- 1 (1.01 g, 6 mmol) and TEA (0.98 mL, 7 mmol)
in DCM (20 mL) was added methanesulfonyl chloride (0.51 mL, 6.6 mmol)
dropwise. The reaction mixture was stirred for 2 h at room temperature.
The solvent was removed under reduced pressure, and 5 mL methylamine (40%
in H2O) was added at room temperature. The solution was stirred at room
temperature for an additional 16 h. The reaction mixture was then added
to DCM (50 mL) and washed with sat. NaHCO3 solution (2 x 25 mL). The
organic phases were combined and dried with anhydrous Na2SO4. After
removing the Na2SO4 by filtration, the solvent was removed and the
material dried under vacuum to afford the desired compound (+/-)-2 (1.0
g, 5.5 mmol, yield 91%). 1H NMR (CDCl3) δ 2.61 (s, 1H), 2.49-2.30 (m,
6H), 2.29 (s, 3H), 2.09-1.96 (m, 2H), 1.67-1.52 (m, 7H), 1.11-1.02 (m,
3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective (in stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polyethylene glycol oligomer-opioid agonist conjugates as analgesics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riggs-Sauthier, Jennifer; Deng, Bo-Liang; Riley, Timothy A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011011543 A1 2011-01-27

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
rel-(1R,2R)-2-(1-Pyrrolidinyl)cyclohexanol
C10H19NO
14909-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 0.0000 0.0 0
M  V30 2 N 2.3698 2.6673 0.0 0
M  V30 3 C 1.4646 1.4215 0.0 0
M  V30 4 C 1.4646 3.9132 0.0 0
M  V30 5 C 0.0000 1.8973 0.0 0
M  V30 6 C 0.0000 3.4374 0.0 0
M  V30 7 C 3.9098 2.6673 0.0 0 CFG=2
M  V30 8 C 4.6799 1.3337 0.0 0 CFG=2
M  V30 9 C 4.6799 4.0010 0.0 0
M  V30 10 C 6.2199 1.3337 0.0 0
M  V30 11 C 6.2199 4.0010 0.0 0
M  V30 12 C 6.9899 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 7 2 CFG=3
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R)-N-Methyl-2-(1-pyrrolidinyl)cyclohexanamine
C11H22N2
99239-39-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0 CFG=2
M  V30 4 C 2.3100 2.6674 0.0 0 CFG=2
M  V30 5 C 2.3100 5.3349 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 0.7700 5.3349 0.0 0
M  V30 8 C 0.0000 4.0011 0.0 0
M  V30 9 N 4.6200 4.0011 0.0 0
M  V30 10 C 5.5252 5.2469 0.0 0
M  V30 11 C 5.5252 2.7552 0.0 0
M  V30 12 C 6.9898 4.7711 0.0 0
M  V30 13 C 6.9898 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 4 1 CFG=3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 3 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 14909-81-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99239-39-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-40982
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (+/-)-trans-N-Methyl-2-(pyrrolidin-1-yl)cyclohexanamine((+/-)-2): To a
solution of compound (+/-)-1 (1.01 g, 6 mmol) and TEA (0.98 mL, 7 mmol)
in DCM (20 mL) was added methanesulfonyl chloride (0.51 mL, 6.6 mmol)
dropwise. The reaction mixture was stirred for 2 h at room temperature.
The solvent was removed under reduced pressure, and 5 mL methylamine (40%
in H2O) was added at room temperature. The solution was stirred at room
temperature for an additional 16 h. The reaction mixture was then added
to DCM (50 mL) and washed with sat. NaHCO3 solution (2x25 mL). The
organic phases were combined and dried with anhydrous Na2SO4. After
removing the Na2SO4 by filtration, the solvent was removed and the
material dried under vacuum to afford the desired compound (+/-)-2 (1.0
g, 5.5 mmol, yield 91%).
(+/-)-trans-N-Methyl-2-(pyrrolidin-1-yl)cyclohexanamine((+/-)-2), yield
1.0 g, 5.5 mmol, 91% 1H NMR (CDCl3) δ 2.61 (s, 1H), 2.49-2.30 (m, 6H),
2.29 (s,3H), 2.09-1.96 (m,2H), 1.67-1.52 (m,7H), 1.11-1.02 (m, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective (in stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oligomer-opioid agonist conjugates as analgesics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riggs-Sauthier, Jennifer; Deng, Bo-Liang; Riley, Timothy A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20100048602 A1 2010-02-25

$RFMT $RIREG SCHEME145 STEP1
$RXN



  3  1
$MOL
Trimethyl orthoformate
C4H10O3
149-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6676 0.7700 0.0 0
M  V30 2 O 1.3340 0.0000 0.0 0
M  V30 3 O 4.0013 0.0000 0.0 0
M  V30 4 O 2.6676 2.3101 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3350 0.7700 0.0 0
M  V30 7 C 4.0013 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-methoxy-5-(phenylmethoxy)benzoic acid
C15H15NO4
909912-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 O 4.6200 1.3336 0.0 0
M  V30 4 C 3.8500 0.0000 0.0 0
M  V30 5 C 1.5400 6.6685 0.0 0
M  V30 6 O 0.0000 6.6685 0.0 0
M  V30 7 O 2.3100 8.0021 0.0 0
M  V30 8 N 0.0000 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 3.8500 5.3347 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 15 C 8.4700 5.3347 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 10.7800 4.0011 0.0 0
M  V30 19 C 10.7800 6.6685 0.0 0
M  V30 20 C 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 3 10
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 1 8 14
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-3-methyl-6-(phenylmethoxy)-4(3H)-quinazolinone
C17H16N2O3
1311509-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 8.0021 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 C 0.0000 8.0021 0.0 0
M  V30 5 O 5.3900 1.3336 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 3.0800 5.3347 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 5.3347 0.0 0
M  V30 10 C 2.3100 6.6685 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 N 0.7700 4.0011 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 N 0.7700 6.6685 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 C 9.2400 5.3347 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 19 C 10.0100 6.6685 0.0 0
M  V30 20 C 11.5500 4.0011 0.0 0
M  V30 21 C 11.5500 6.6685 0.0 0
M  V30 22 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 3 17
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 149-73-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 909912-09-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1311509-51-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10695148
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of Key Intermediates in Scheme 6 Toward Preparation of
Compound 27. Step A:
6-(Benzyloxy)-7-methoxy-3-methylquinazolin-4(3H)-one. A solution of
2-amino-5-(benzyloxy)-4-methoxybenzoic acid (Scheme 5, Step E) (100 mg,
0.37 mmol) in trimethyl orthoformate (1 mL, 9 mmol) was heated at 105 °C
for 2 h. The solvent was removed in vacuo, dry toluene was added,
followed by methylamine (2Min THF, 1.83 mL). The mixture was heated to 80
°C for 24 h, the solvent was removed in vacuo, and the residue was
purified by silica gel chromatography (ethyl acetate-methanol, 50:1) to
afford 99 mg (91% yield) of the title compound. 1H NMR (400 MHz, CDCl3) δ
(ppm) = 7.94 (s, 1H), 7.68 (s, 1H), 7.47 (m, 2H), 7.38-7.25 (m, 3H), 7.09
(s, 1H), 5.23 (s, 2H), 3.97 (s, 3H), 3.55 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ (ppm) = 161.12, 155.50, 148.69, 145.82, 144.88, 136.36, 128.86,
128.36, 127.79, 115.50, 108.20, 107.45, 71.19, 56.47, 34.28. MS (ES+):
297.5 (M + H)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Use of Structure-Based Design to Discover a Potent, Selective, In Vivo
Active Phosphodiesterase 10A Inhibitor Lead Series for the Treatment of
Schizophrenia
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Helal, Christopher J.; Kang, Zhijun; Hou, Xinjun; Pandit, Jayvardhan;
Chappie, Thomas A.; Humphrey, John M.; Marr, Eric S.; Fennell, Kimberly
F.; Chenard, Lois K.; Fox, Carol; Schmidt, Christopher J.; Williams,
Robert D.; Chapin, Douglas S.; Siuciak, Judith; Lebel, Lorraine; Menniti,
Frank; Cianfrogna, Julia; Fonseca, Kari R.; Nelson, Frederick R.;
O'Connor, Rebecca; MacDougall, Mary; McDowell, Laura; Liras, Spiros
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2011), 54(13), 4536-4547

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(6S)-10-Bromo-N-[[2-(3-buten-1-yloxy)-4-fluorophenyl]methyl]-6-ethyl-6,7,9,10...
C28H29BrFN3O7S
1538555-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.4783 9.3359 0.0 0
M  V30 2 C 1.5015 8.3695 0.0 0
M  V30 3 C 0.0000 8.7124 0.0 0
M  V30 4 Br 4.7331 2.7723 0.0 0
M  V30 5 O 6.5583 9.3359 0.0 0
M  V30 6 S 5.7883 10.6696 0.0 0 VAL=6
M  V30 7 O 5.0183 12.0032 0.0 0
M  V30 8 O 4.4545 9.8996 0.0 0
M  V30 9 C 8.0983 6.6684 0.0 0
M  V30 10 N 8.8684 5.3348 0.0 0
M  V30 11 O 8.8684 8.0023 0.0 0
M  V30 12 C 10.4084 5.3348 0.0 0
M  V30 13 O 13.4884 5.3348 0.0 0
M  V30 14 C 15.0284 5.3348 0.0 0
M  V30 15 C 15.7984 6.6684 0.0 0
M  V30 16 C 17.3385 6.6684 0.0 0
M  V30 17 C 18.1085 8.0023 0.0 0
M  V30 18 F 13.4884 0.0000 0.0 0
M  V30 19 N 3.4783 6.6684 0.0 0
M  V30 20 C 4.2483 5.3348 0.0 0
M  V30 21 C 4.2483 8.0023 0.0 0
M  V30 22 C 1.9554 6.8981 0.0 0 CFG=1
M  V30 23 N 5.7883 5.3348 0.0 0
M  V30 24 C 3.6856 3.9012 0.0 0 CFG=3
M  V30 25 C 5.7883 8.0023 0.0 0
M  V30 26 C 0.8265 5.8505 0.0 0
M  V30 27 C 6.5583 6.6684 0.0 0
M  V30 28 C 2.2139 3.4473 0.0 0
M  V30 29 O 0.9416 4.3148 0.0 0
M  V30 30 C 7.1220 11.4396 0.0 0
M  V30 31 C 8.4556 10.6696 0.0 0
M  V30 32 C 7.1220 12.9796 0.0 0
M  V30 33 C 9.7893 11.4396 0.0 0
M  V30 34 C 8.4556 13.7496 0.0 0
M  V30 35 C 9.7893 12.9796 0.0 0
M  V30 36 C 11.1784 4.0011 0.0 0
M  V30 37 C 12.7184 4.0011 0.0 0
M  V30 38 C 10.4084 2.6673 0.0 0
M  V30 39 C 13.4884 2.6673 0.0 0
M  V30 40 C 11.1784 1.3337 0.0 0
M  V30 41 C 12.7184 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 3
M  V30 3 1 22 2 CFG=3
M  V30 4 1 4 24
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 30
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 27
M  V30 13 1 10 12
M  V30 14 1 12 36
M  V30 15 1 13 14
M  V30 16 1 13 37
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 2 16 17
M  V30 20 1 18 41
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 2 20 23
M  V30 25 1 20 24
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 1 23 27
M  V30 29 1 24 28
M  V30 30 2 25 27
M  V30 31 1 26 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6S,10S)-N-[[2-(3-Buten-1-yloxy)-4-fluorophenyl]methyl]-6-ethyl-6,7,9,10-tetr...
C23H29FN4O5
1538555-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.7331 1.4715 0.0 0
M  V30 2 C 4.2791 0.0000 0.0 0
M  V30 3 C 1.5015 7.0688 0.0 0
M  V30 4 C 0.0000 7.4114 0.0 0
M  V30 5 O 3.4783 8.0350 0.0 0
M  V30 6 C 8.0983 5.3677 0.0 0
M  V30 7 N 8.8683 6.7014 0.0 0
M  V30 8 O 8.8683 4.0341 0.0 0
M  V30 9 C 10.4083 6.7014 0.0 0
M  V30 10 O 6.5583 8.0350 0.0 0
M  V30 11 O 13.4883 6.7014 0.0 0
M  V30 12 C 15.0283 6.7014 0.0 0
M  V30 13 C 15.7983 5.3677 0.0 0
M  V30 14 C 17.3383 5.3677 0.0 0
M  V30 15 C 18.1084 4.0341 0.0 0
M  V30 16 F 13.4883 12.0361 0.0 0
M  V30 17 C 4.2483 4.0341 0.0 0
M  V30 18 N 3.4783 5.3677 0.0 0
M  V30 19 N 5.7883 4.0341 0.0 0
M  V30 20 C 3.6856 2.6005 0.0 0 CFG=2
M  V30 21 C 1.9553 5.5972 0.0 0 CFG=1
M  V30 22 C 4.2483 6.7014 0.0 0
M  V30 23 C 6.5583 5.3677 0.0 0
M  V30 24 C 2.2139 2.1465 0.0 0
M  V30 25 C 0.8265 4.5498 0.0 0
M  V30 26 C 5.7883 6.7014 0.0 0
M  V30 27 O 0.9416 3.0141 0.0 0
M  V30 28 C 11.1783 8.0350 0.0 0
M  V30 29 C 12.7183 8.0350 0.0 0
M  V30 30 C 10.4083 9.3688 0.0 0
M  V30 31 C 13.4883 9.3688 0.0 0
M  V30 32 C 11.1783 10.7024 0.0 0
M  V30 33 C 12.7183 10.7024 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 20 1 CFG=3
M  V30 3 1 3 4
M  V30 4 1 21 3 CFG=3
M  V30 5 2 5 22
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 23
M  V30 9 1 7 9
M  V30 10 1 9 28
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 1 11 29
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 2 14 15
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 25 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1538555-09-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1538555-10-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12015466
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic compounds as HIV integrase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reger, Thomas; Walji, Abbas M.; Sanders, John M.; Wai, John S.; Hu,
Lihong; Fang, Shunda; Wang, Liping; Yang, Pengyu; Ma, Zonghui; Sun,
Liansheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014008636 A1 2014-01-16

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(6S)-10-Bromo-N-[[2-(3-buten-1-yloxy)-4-fluorophenyl]methyl]-6-ethyl-6,7,9,10...
C28H29BrFN3O7S
1538555-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.4783 9.3359 0.0 0
M  V30 2 C 1.5015 8.3695 0.0 0
M  V30 3 C 0.0000 8.7124 0.0 0
M  V30 4 Br 4.7331 2.7723 0.0 0
M  V30 5 O 6.5583 9.3359 0.0 0
M  V30 6 S 5.7883 10.6696 0.0 0 VAL=6
M  V30 7 O 5.0183 12.0032 0.0 0
M  V30 8 O 4.4545 9.8996 0.0 0
M  V30 9 C 8.0983 6.6684 0.0 0
M  V30 10 N 8.8684 5.3348 0.0 0
M  V30 11 O 8.8684 8.0023 0.0 0
M  V30 12 C 10.4084 5.3348 0.0 0
M  V30 13 O 13.4884 5.3348 0.0 0
M  V30 14 C 15.0284 5.3348 0.0 0
M  V30 15 C 15.7984 6.6684 0.0 0
M  V30 16 C 17.3385 6.6684 0.0 0
M  V30 17 C 18.1085 8.0023 0.0 0
M  V30 18 F 13.4884 0.0000 0.0 0
M  V30 19 N 3.4783 6.6684 0.0 0
M  V30 20 C 4.2483 5.3348 0.0 0
M  V30 21 C 4.2483 8.0023 0.0 0
M  V30 22 C 1.9554 6.8981 0.0 0 CFG=1
M  V30 23 N 5.7883 5.3348 0.0 0
M  V30 24 C 3.6856 3.9012 0.0 0 CFG=3
M  V30 25 C 5.7883 8.0023 0.0 0
M  V30 26 C 0.8265 5.8505 0.0 0
M  V30 27 C 6.5583 6.6684 0.0 0
M  V30 28 C 2.2139 3.4473 0.0 0
M  V30 29 O 0.9416 4.3148 0.0 0
M  V30 30 C 7.1220 11.4396 0.0 0
M  V30 31 C 8.4556 10.6696 0.0 0
M  V30 32 C 7.1220 12.9796 0.0 0
M  V30 33 C 9.7893 11.4396 0.0 0
M  V30 34 C 8.4556 13.7496 0.0 0
M  V30 35 C 9.7893 12.9796 0.0 0
M  V30 36 C 11.1784 4.0011 0.0 0
M  V30 37 C 12.7184 4.0011 0.0 0
M  V30 38 C 10.4084 2.6673 0.0 0
M  V30 39 C 13.4884 2.6673 0.0 0
M  V30 40 C 11.1784 1.3337 0.0 0
M  V30 41 C 12.7184 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 3
M  V30 3 1 22 2 CFG=3
M  V30 4 1 4 24
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 30
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 27
M  V30 13 1 10 12
M  V30 14 1 12 36
M  V30 15 1 13 14
M  V30 16 1 13 37
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 2 16 17
M  V30 20 1 18 41
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 2 20 23
M  V30 25 1 20 24
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 1 23 27
M  V30 29 1 24 28
M  V30 30 2 25 27
M  V30 31 1 26 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6S,10S)-N-[[2-(3-Buten-1-yloxy)-4-fluorophenyl]methyl]-6-ethyl-6,7,9,10-tetr...
C23H29FN4O5
1538555-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.7331 1.4715 0.0 0
M  V30 2 C 4.2791 0.0000 0.0 0
M  V30 3 C 1.5015 7.0688 0.0 0
M  V30 4 C 0.0000 7.4114 0.0 0
M  V30 5 O 3.4783 8.0350 0.0 0
M  V30 6 C 8.0983 5.3677 0.0 0
M  V30 7 N 8.8683 6.7014 0.0 0
M  V30 8 O 8.8683 4.0341 0.0 0
M  V30 9 C 10.4083 6.7014 0.0 0
M  V30 10 O 6.5583 8.0350 0.0 0
M  V30 11 O 13.4883 6.7014 0.0 0
M  V30 12 C 15.0283 6.7014 0.0 0
M  V30 13 C 15.7983 5.3677 0.0 0
M  V30 14 C 17.3383 5.3677 0.0 0
M  V30 15 C 18.1084 4.0341 0.0 0
M  V30 16 F 13.4883 12.0361 0.0 0
M  V30 17 C 4.2483 4.0341 0.0 0
M  V30 18 N 3.4783 5.3677 0.0 0
M  V30 19 N 5.7883 4.0341 0.0 0
M  V30 20 C 3.6856 2.6005 0.0 0 CFG=2
M  V30 21 C 1.9553 5.5972 0.0 0 CFG=1
M  V30 22 C 4.2483 6.7014 0.0 0
M  V30 23 C 6.5583 5.3677 0.0 0
M  V30 24 C 2.2139 2.1465 0.0 0
M  V30 25 C 0.8265 4.5498 0.0 0
M  V30 26 C 5.7883 6.7014 0.0 0
M  V30 27 O 0.9416 3.0141 0.0 0
M  V30 28 C 11.1783 8.0350 0.0 0
M  V30 29 C 12.7183 8.0350 0.0 0
M  V30 30 C 10.4083 9.3688 0.0 0
M  V30 31 C 13.4883 9.3688 0.0 0
M  V30 32 C 11.1783 10.7024 0.0 0
M  V30 33 C 12.7183 10.7024 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 20 1 CFG=3
M  V30 3 1 3 4
M  V30 4 1 21 3 CFG=3
M  V30 5 2 5 22
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 23
M  V30 9 1 7 9
M  V30 10 1 9 28
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 1 11 29
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 2 14 15
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 25 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1538555-09-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1538555-10-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5926127
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic compounds as HIV integrase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reger, Thomas; Walji, Abbas; Sanders, John; Wai, John; Wang, Liping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014011769 A1 2014-01-16

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-nitro-4-[(trifluoromethyl)sulfonyl]benzene
C7H3ClF3NO4S
1550-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 2.3101 0.0 0 VAL=6
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 3.4375 0.9764 0.0 0
M  V30 4 O 1.8975 3.6437 0.0 0
M  V30 5 F 0.0000 2.3101 0.0 0
M  V30 6 F 0.0000 0.7700 0.0 0
M  V30 7 F 1.3337 0.0000 0.0 0
M  V30 8 N 8.0023 2.3101 0.0 0 VAL=5
M  V30 9 O 8.0023 0.7700 0.0 0
M  V30 10 O 9.3360 3.0801 0.0 0
M  V30 11 Cl 8.0023 5.3901 0.0 0
M  V30 12 C 4.0012 3.0801 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitro-4-[(trifluoromethyl)sulfonyl]benzenamine
C8H7F3N2O4S
634176-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 2 C 8.4700 4.0009 0.0 0
M  V30 3 O 6.9300 5.5409 0.0 0
M  V30 4 O 6.9300 2.4609 0.0 0
M  V30 5 F 9.2400 5.3347 0.0 0
M  V30 6 F 10.0100 4.0009 0.0 0
M  V30 7 F 9.2400 2.6673 0.0 0
M  V30 8 N 2.3100 1.3336 0.0 0 VAL=5
M  V30 9 O 0.7700 1.3336 0.0 0
M  V30 10 O 3.0800 0.0000 0.0 0
M  V30 11 N 0.7700 4.0009 0.0 0
M  V30 12 C 0.0000 5.3347 0.0 0
M  V30 13 C 5.3900 4.0009 0.0 0
M  V30 14 C 4.6200 2.6673 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 3.0800 2.6673 0.0 0
M  V30 17 C 3.0800 5.3347 0.0 0
M  V30 18 C 2.3100 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1550-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 634176-69-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15174496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives containing fluoro-, difluoro- and
trifluoromethylsulfonyl groups as new compounds with biological activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizerski, A.; Gajadhur, A.; Zalecki, S.; Ochal, Z.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Environmental Research (2002), 11(1 & 2), 63-75

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
S-Phenyl (βR)-β-hydroxy-2-thiophenepropanethioate
C13H12O2S2
1555974-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0010 1.8517 0.0 0
M  V30 2 C 5.3348 2.6218 0.0 0
M  V30 3 C 6.6685 1.8517 0.0 0
M  V30 4 O 5.3348 4.1618 0.0 0
M  V30 5 C 8.0022 2.6218 0.0 0 CFG=2
M  V30 6 O 8.0022 4.1618 0.0 0
M  V30 7 C 2.6673 2.6218 0.0 0
M  V30 8 C 1.3337 1.8517 0.0 0
M  V30 9 C 2.6673 4.1618 0.0 0
M  V30 10 C 0.0000 2.6218 0.0 0
M  V30 11 C 1.3337 4.9318 0.0 0
M  V30 12 C 0.0000 4.1618 0.0 0
M  V30 13 C 9.3360 1.8517 0.0 0
M  V30 14 C 9.4969 0.3202 0.0 0
M  V30 15 S 10.7428 2.4782 0.0 0
M  V30 16 C 11.0032 0.0000 0.0 0
M  V30 17 C 11.7732 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6 CFG=1
M  V30 7 1 5 13
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(βR)-β-Hydroxy-N-methyl-2-thiophenepropanamide
C8H11NO2S
603996-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0 CFG=2
M  V30 2 C 5.1047 1.8517 0.0 0
M  V30 3 O 3.7711 4.1618 0.0 0
M  V30 4 C 6.4385 2.6217 0.0 0
M  V30 5 N 7.7722 1.8517 0.0 0
M  V30 6 O 6.4385 4.1618 0.0 0
M  V30 7 C 9.1059 2.6217 0.0 0
M  V30 8 C 2.4374 1.8517 0.0 0
M  V30 9 C 1.0304 2.4782 0.0 0
M  V30 10 S 2.2763 0.3202 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1555974-50-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 603996-86-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9707303
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM ee =82%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalytic Enantioselective Decarboxylative Aldol Reaction of
Malonic Acid Half Thioesters with Aldehydes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bae, Han Yong; Sim, Jae Hun; Lee, Ji-Woong; List, Benjamin; Song, Choong
Eui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2013), 52(46), 12143-12147

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-6-(2-thienyl)-4-(trifluoromethyl)furo[2,3-b]pyridine-2-carboxylate
C15H11F3N2O3S
1581726-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1046 1.5400 0.0 0
M  V30 2 F 3.5646 1.5400 0.0 0
M  V30 3 F 5.1046 0.0000 0.0 0
M  V30 4 F 6.6446 1.5400 0.0 0
M  V30 5 N 8.3788 1.9094 0.0 0
M  V30 6 C 10.3482 4.6200 0.0 0
M  V30 7 O 11.1182 5.9536 0.0 0
M  V30 8 O 11.1182 3.2864 0.0 0
M  V30 9 C 12.6582 5.9536 0.0 0
M  V30 10 C 13.4282 7.2873 0.0 0
M  V30 11 C 6.4384 3.8500 0.0 0
M  V30 12 C 5.1046 3.0800 0.0 0
M  V30 13 C 6.4384 5.3900 0.0 0
M  V30 14 C 7.9030 3.3741 0.0 0
M  V30 15 C 3.7710 3.8500 0.0 0
M  V30 16 O 7.9030 5.8659 0.0 0
M  V30 17 N 5.1046 6.1600 0.0 0
M  V30 18 C 8.8082 4.6200 0.0 0
M  V30 19 C 3.7710 5.3900 0.0 0
M  V30 20 C 2.4374 6.1600 0.0 0
M  V30 21 C 2.2764 7.6915 0.0 0
M  V30 22 S 1.0304 5.5335 0.0 0
M  V30 23 C 0.7700 8.0117 0.0 0
M  V30 24 C 0.0000 6.6781 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-N-methyl-6-(2-thienyl)-4-(trifluoromethyl)furo[2,3-b]pyridine-2-carbo...
C14H10F3N3O2S
2228865-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1046 1.5400 0.0 0
M  V30 2 F 3.5646 1.5400 0.0 0
M  V30 3 F 5.1046 0.0000 0.0 0
M  V30 4 F 6.6446 1.5400 0.0 0
M  V30 5 N 8.3788 1.9094 0.0 0
M  V30 6 C 10.3482 4.6200 0.0 0
M  V30 7 N 11.1182 5.9536 0.0 0
M  V30 8 O 11.1182 3.2864 0.0 0
M  V30 9 C 12.6582 5.9536 0.0 0
M  V30 10 C 6.4384 3.8500 0.0 0
M  V30 11 C 5.1046 3.0800 0.0 0
M  V30 12 C 6.4384 5.3900 0.0 0
M  V30 13 C 7.9030 3.3741 0.0 0
M  V30 14 C 3.7710 3.8500 0.0 0
M  V30 15 O 7.9030 5.8659 0.0 0
M  V30 16 N 5.1046 6.1600 0.0 0
M  V30 17 C 8.8082 4.6200 0.0 0
M  V30 18 C 3.7710 5.3900 0.0 0
M  V30 19 C 2.4374 6.1600 0.0 0
M  V30 20 C 1.0304 5.5335 0.0 0
M  V30 21 S 2.2764 7.6915 0.0 0
M  V30 22 C 0.0000 6.6781 0.0 0
M  V30 23 C 0.7700 8.0117 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 17
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1581726-07-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2228865-71-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20154784
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Novel Alkyl Amide Functionalized Trifluoromethyl Substituted
Furo/thieno Pyridine Derivatives: Their Anticancer Activity and CoMFA and
CoMSIA Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhoomandla, Srinu; Gunda, Shravan Kumar; Kotoori, Srawanthi; Kanuparthy,
Phani Raja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2019), 56(7), 1986-1998

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, α-(methoxyimino)-2-[[3-[1-(methoxyimino)ethyl]phenoxy]met...
C20H22N2O5
159916-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 2.6675 2.3100 0.0 0
M  V30 4 O 5.3348 0.7700 0.0 0
M  V30 5 O 6.6686 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6686 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6686 4.6201 0.0 0
M  V30 10 O 8.0022 5.3901 0.0 0
M  V30 11 C 13.3370 5.3901 0.0 0
M  V30 12 N 14.6707 4.6201 0.0 0
M  V30 13 C 13.3370 6.9301 0.0 0
M  V30 14 O 16.0043 5.3901 0.0 0
M  V30 15 C 17.3381 4.6201 0.0 0
M  V30 16 C 4.0011 4.6201 0.0 0
M  V30 17 C 5.3348 5.3901 0.0 0
M  V30 18 C 2.6675 5.3901 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 2.6675 6.9301 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 9.3359 4.6201 0.0 0
M  V30 23 C 10.6695 5.3901 0.0 0
M  V30 24 C 9.3359 3.0800 0.0 0
M  V30 25 C 12.0034 4.6201 0.0 0
M  V30 26 C 10.6695 2.3100 0.0 0
M  V30 27 C 12.0034 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 25
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetamide, α-(methoxyimino)-2-[[3-[1-(methoxyimino)ethyl]phenoxy]methy...
C20H23N3O4
159915-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 2.6675 2.3100 0.0 0
M  V30 4 N 5.3348 0.7700 0.0 0
M  V30 5 O 6.6686 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6686 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6686 4.6201 0.0 0
M  V30 10 O 8.0022 5.3901 0.0 0
M  V30 11 C 13.3370 5.3901 0.0 0
M  V30 12 N 14.6707 4.6201 0.0 0
M  V30 13 C 13.3370 6.9301 0.0 0
M  V30 14 O 16.0043 5.3901 0.0 0
M  V30 15 C 17.3381 4.6201 0.0 0
M  V30 16 C 4.0011 4.6201 0.0 0
M  V30 17 C 5.3348 5.3901 0.0 0
M  V30 18 C 2.6675 5.3901 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 2.6675 6.9301 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 9.3359 4.6201 0.0 0
M  V30 23 C 10.6695 5.3901 0.0 0
M  V30 24 C 9.3359 3.0800 0.0 0
M  V30 25 C 12.0034 4.6201 0.0 0
M  V30 26 C 10.6695 2.3100 0.0 0
M  V30 27 C 12.0034 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 25
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159916-45-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 159915-54-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36471925
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, crystal structure, biological evaluation, docking study and
DFT calculation of novel strobilurins containing oxime ether phenyl ring
or dihydrobenzofuran moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Mingfang; Li, Kangming; Yi, Yangjie; Luo, Xianfu; Qiu, Longjian;
Zhang, Lijuan; Wang, Man; Ye, Jiao; Ou, Xiaoming; Li, Jianming; Chen,
Yun; Hu, Aixi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2023), 1286135636

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
1-(Phenylmethyl) (3R)-1,3-piperidinedicarboxylate
C14H17NO4
160706-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 C 12.0033 1.5400 0.0 0
M  V30 6 O 12.0033 0.0000 0.0 0
M  V30 7 O 13.3370 2.3101 0.0 0
M  V30 8 N 8.0022 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 12 C 9.3360 4.6201 0.0 0
M  V30 13 C 10.6697 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 11 5 CFG=1
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (3R)-3-[(methylamino)carbonyl]-1-piperidinecarboxylate
C15H20N2O3
1124199-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 C 12.0033 1.5400 0.0 0
M  V30 6 N 13.3370 2.3101 0.0 0
M  V30 7 O 12.0033 0.0000 0.0 0
M  V30 8 C 14.6707 1.5400 0.0 0
M  V30 9 N 8.0022 2.3101 0.0 0
M  V30 10 C 9.3358 1.5400 0.0 0
M  V30 11 C 8.0022 3.8501 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 13 C 9.3358 4.6201 0.0 0
M  V30 14 C 10.6697 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 1.3337 1.5400 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 12 5 CFG=1
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 160706-62-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1124199-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13783507
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparative Example 31. (3R)-N-methylpiperidine-3-carboxamide. A solution
of D-Cbz-Nipecotic acid ((R)-Piperdine-1,3,-dicarboxylic acid 1-benzyl
ester) (1.32 g, 5.0 mmol) in toluene (25 mL) was treated with DMF ( 20
νL) followed by oxalyl chloride (646 νL, 7.5 mmol). The reaction mixture
was stirred for 3 hr and evaporated to an oil. The crude acid chloride
was then dissolved in THF (20 mL), cooled to 0-5 °C, and treated with a 2
M THF solution of methylamine (7.5 mL, 15 mmol). The reaction mixture was
stirred for 2 hr, allowed to warm to room temperature and evaporated in
vacuo to afford solids which were filtered with the aid of water to
afford Cbz-protected intermediate, as a colorless solid, yield 1.25 g,
91% . LC/MS 5.05 min, [M+1]+ 277.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoxazole compounds as monoamine oxidase B inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaplan, Alan P.; Keenan, Terence P.; McRiner, Andrew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009029632 A1 2009-03-05

$RFMT $RIREG SCHEME152 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S,3E,5E,7S,8R,9R)-9-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1-[2-[(1S)-1-hy...
C29H49NO4SSi
1636901-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.6300 8.0021 0.0 0
M  V30 2 C 13.8600 6.6685 0.0 0 CFG=1
M  V30 3 O 13.8600 9.3358 0.0 0
M  V30 4 C 12.3200 6.6685 0.0 0
M  V30 5 C 14.6300 5.3347 0.0 0
M  V30 6 C 11.5500 5.3347 0.0 0
M  V30 7 C 10.0100 5.3347 0.0 0
M  V30 8 C 9.2400 4.0011 0.0 0
M  V30 9 C 7.7000 4.0011 0.0 0 CFG=1
M  V30 10 C 10.0100 2.6674 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0 CFG=1
M  V30 12 O 6.9300 5.3347 0.0 0
M  V30 13 C 5.3900 2.6674 0.0 0 CFG=1
M  V30 14 C 7.7000 1.3338 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 O 4.6200 4.0011 0.0 0
M  V30 17 C 4.6200 1.3338 0.0 0
M  V30 18 Si 3.0800 4.0011 0.0 0
M  V30 19 C 5.3900 0.0000 0.0 0
M  V30 20 C 1.5400 4.0011 0.0 0
M  V30 21 C 3.0800 2.4611 0.0 0
M  V30 22 C 3.0800 5.5411 0.0 0
M  V30 23 C 1.5400 5.5411 0.0 0
M  V30 24 C 0.0000 4.0011 0.0 0
M  V30 25 C 1.5400 2.4611 0.0 0
M  V30 26 C 19.7858 9.6774 0.0 0 CFG=1
M  V30 27 C 21.1926 9.0509 0.0 0
M  V30 28 O 19.6247 11.2089 0.0 0
M  V30 29 C 22.4384 9.9561 0.0 0
M  V30 30 C 23.8454 9.3298 0.0 0
M  V30 31 C 22.2775 11.4878 0.0 0
M  V30 32 C 16.1700 8.0021 0.0 0
M  V30 33 N 17.0752 9.2480 0.0 0
M  V30 34 C 17.0752 6.7563 0.0 0
M  V30 35 C 18.5399 8.7721 0.0 0
M  V30 36 S 18.5399 7.2321 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 32
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 2 4 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 11 14 CFG=1
M  V30 15 1 12 15
M  V30 16 1 13 16 CFG=1
M  V30 17 1 13 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 25
M  V30 26 1 26 27
M  V30 27 1 26 28 CFG=1
M  V30 28 1 26 35
M  V30 29 1 27 29
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 1 32 33
M  V30 33 2 32 34
M  V30 34 2 33 35
M  V30 35 1 34 36
M  V30 36 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 2 9 11 13 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S,3E,5E,7S,8R,9R)-9-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-7-methoxy-2,6,8...
C31H52N2O5SSi
1636901-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 19.9733 3.8986 0.0 0 CFG=2
M  V30 2 O 20.5997 5.3055 0.0 0
M  V30 3 C 20.8786 2.6527 0.0 0
M  V30 4 C 22.1314 5.4665 0.0 0
M  V30 5 C 20.2521 1.2459 0.0 0
M  V30 6 N 22.7577 6.8734 0.0 0
M  V30 7 O 23.0365 4.2206 0.0 0
M  V30 8 C 21.1573 0.0000 0.0 0
M  V30 9 C 18.7205 1.0848 0.0 0
M  V30 10 C 24.2893 7.0344 0.0 0
M  V30 11 C 14.6707 5.0257 0.0 0
M  V30 12 C 13.3369 4.2557 0.0 0 CFG=1
M  V30 13 O 14.6707 6.5657 0.0 0
M  V30 14 C 12.0033 5.0257 0.0 0
M  V30 15 C 13.3369 2.7157 0.0 0
M  V30 16 C 10.6696 4.2557 0.0 0
M  V30 17 C 9.3359 5.0257 0.0 0
M  V30 18 C 8.0021 4.2557 0.0 0
M  V30 19 C 6.6685 5.0257 0.0 0 CFG=1
M  V30 20 C 8.0021 2.7157 0.0 0
M  V30 21 C 5.3348 4.2557 0.0 0 CFG=1
M  V30 22 O 6.6685 6.5657 0.0 0
M  V30 23 C 4.0011 5.0257 0.0 0 CFG=1
M  V30 24 C 5.3348 2.7157 0.0 0
M  V30 25 C 8.0021 7.3358 0.0 0
M  V30 26 O 4.0011 6.5657 0.0 0
M  V30 27 C 2.6673 4.2557 0.0 0
M  V30 28 Si 2.6673 7.3358 0.0 0
M  V30 29 C 2.6673 2.7157 0.0 0
M  V30 30 C 1.3337 8.1058 0.0 0
M  V30 31 C 3.4373 8.6694 0.0 0
M  V30 32 C 1.8973 6.0021 0.0 0
M  V30 33 C 2.1037 9.4394 0.0 0
M  V30 34 C 0.0000 8.8758 0.0 0
M  V30 35 C 0.5636 6.7721 0.0 0
M  V30 36 C 18.4418 3.7376 0.0 0
M  V30 37 N 17.4112 4.8822 0.0 0
M  V30 38 S 17.6718 2.4040 0.0 0
M  V30 39 C 16.0044 4.2557 0.0 0
M  V30 40 C 16.1653 2.7241 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 36
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 39
M  V30 14 1 12 14
M  V30 15 1 12 15 CFG=1
M  V30 16 2 14 16
M  V30 17 1 16 17
M  V30 18 2 17 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 22 CFG=3
M  V30 23 1 21 23
M  V30 24 1 21 24 CFG=1
M  V30 25 1 22 25
M  V30 26 1 23 26 CFG=1
M  V30 27 1 23 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 1 28 30
M  V30 31 1 28 31
M  V30 32 1 28 32
M  V30 33 1 30 33
M  V30 34 1 30 34
M  V30 35 1 30 35
M  V30 36 2 36 37
M  V30 37 1 36 38
M  V30 38 1 37 39
M  V30 39 1 38 40
M  V30 40 2 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 12 19 21 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1636901-34-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1636901-35-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-18119563
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploring a ring-closing metathesis approach to the archazolid macrocycle
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM King, Brianne R.; Swick, Steven M.; Schaefer, Sara L.; Welch, Jamie R.;
Hunter, Emily F.; O'Neil, Gregory W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2014), 46(21), 2927-2936, 10 pp.

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitro-2-[(trifluoromethyl)thio]benzaldehyde
C8H4F3NO3S
1640357-86-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 2.3101 0.0 0
M  V30 2 C 1.3337 3.0801 0.0 0
M  V30 3 F 1.3337 4.6201 0.0 0
M  V30 4 F 0.0000 3.8501 0.0 0
M  V30 5 F 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 O 6.6685 0.0000 0.0 0
M  V30 8 N 8.0023 5.3901 0.0 0 VAL=5
M  V30 9 O 8.0023 6.9302 0.0 0
M  V30 10 O 9.3360 4.6201 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 6.6685 3.0801 0.0 0
M  V30 15 C 5.3348 5.3901 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-nitro-2-[(trifluoromethyl)thio]benzenemethanamine
C9H9F3N2O2S
1640357-87-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 N 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 S 6.6685 3.8501 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 F 9.3360 3.8501 0.0 0
M  V30 7 F 9.3360 5.3901 0.0 0
M  V30 8 F 8.0023 6.1601 0.0 0
M  V30 9 N 1.3337 6.9302 0.0 0 VAL=5
M  V30 10 O 1.3337 8.4702 0.0 0
M  V30 11 O 0.0000 6.1601 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 2.6675 6.1601 0.0 0
M  V30 17 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1640357-86-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1640357-87-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3993196
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic compounds as factor VIIa inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Richter, Jeremy; Bates, J. Alex; Cheney, Daniel L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014201073 A1 2014-12-18

$RFMT $RIREG SCHEME154 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acridinium, 10-amino-9-(2,6-dimethoxyphenyl)-1,8-dimethoxy-, tetrafluoroborat...
C23H23N2O4.BF4
1643129-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 5.9537 0.0 0
M  V30 2 C 6.9301 4.6200 0.0 0
M  V30 3 O 6.1601 11.2886 0.0 0
M  V30 4 C 6.9301 12.6222 0.0 0
M  V30 5 O 8.4701 5.9537 0.0 0
M  V30 6 C 9.2401 4.6200 0.0 0
M  V30 7 O 8.4701 11.2886 0.0 0
M  V30 8 C 9.2401 12.6222 0.0 0
M  V30 9 N 0.0000 8.6211 0.0 0
M  V30 10 C 4.6201 8.6211 0.0 0
M  V30 11 C 3.8500 7.2875 0.0 0
M  V30 12 C 3.8500 9.9548 0.0 0
M  V30 13 C 2.3100 7.2875 0.0 0
M  V30 14 C 4.6201 5.9537 0.0 0
M  V30 15 C 2.3100 9.9548 0.0 0
M  V30 16 C 4.6201 11.2886 0.0 0
M  V30 17 N 1.5400 8.6211 0.0 0 CHG=1 VAL=4
M  V30 18 C 1.5400 5.9537 0.0 0
M  V30 19 C 3.8500 4.6200 0.0 0
M  V30 20 C 1.5400 11.2886 0.0 0
M  V30 21 C 3.8500 12.6222 0.0 0
M  V30 22 C 2.3100 4.6200 0.0 0
M  V30 23 C 2.3100 12.6222 0.0 0
M  V30 24 C 8.4701 8.6211 0.0 0
M  V30 25 C 9.2401 7.2875 0.0 0
M  V30 26 C 9.2401 9.9548 0.0 0
M  V30 27 C 10.7801 7.2875 0.0 0
M  V30 28 C 10.7801 9.9548 0.0 0
M  V30 29 C 11.5501 8.6211 0.0 0
M  V30 30 B 5.7751 1.5400 0.0 0 CHG=3 VAL=4
M  V30 31 F 4.2351 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 32 F 7.3151 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 33 F 5.7751 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 34 F 5.7751 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 1 7 8
M  V30 8 1 7 26
M  V30 9 1 9 17
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 24
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 2 14 19
M  V30 20 2 15 17
M  V30 21 1 15 20
M  V30 22 2 16 21
M  V30 23 2 18 22
M  V30 24 1 19 22
M  V30 25 2 20 23
M  V30 26 1 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 1 30 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,13-Dimethoxy-5-methyl-5H-quino[2,3,4-kl]acridine
C22H18N2O2
1643129-35-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3957 4.4514 0.0 0
M  V30 2 C 0.0000 5.1023 0.0 0
M  V30 3 O 1.3957 3.5508 0.0 0
M  V30 4 C 0.0000 2.8998 0.0 0
M  V30 5 C 7.2771 8.0021 0.0 0
M  V30 6 C 4.9671 4.0011 0.0 0
M  V30 7 C 6.5071 4.0011 0.0 0
M  V30 8 C 4.1971 5.3347 0.0 0
M  V30 9 C 4.1971 2.6674 0.0 0
M  V30 10 C 7.2771 5.3347 0.0 0
M  V30 11 C 7.2771 2.6674 0.0 0
M  V30 12 C 4.9671 6.6685 0.0 0
M  V30 13 C 2.6571 5.3347 0.0 0
M  V30 14 C 4.9671 1.3336 0.0 0
M  V30 15 C 2.6571 2.6674 0.0 0
M  V30 16 N 6.5071 6.6685 0.0 0
M  V30 17 C 8.8171 5.3347 0.0 0
M  V30 18 N 6.5071 1.3336 0.0 0
M  V30 19 C 8.8171 2.6674 0.0 0
M  V30 20 C 4.1971 8.0021 0.0 0
M  V30 21 C 1.8871 6.6685 0.0 0
M  V30 22 C 4.1971 0.0000 0.0 0
M  V30 23 C 1.8871 1.3336 0.0 0
M  V30 24 C 9.5871 4.0011 0.0 0
M  V30 25 C 2.6571 8.0021 0.0 0
M  V30 26 C 2.6571 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 10 17
M  V30 17 1 11 18
M  V30 18 2 11 19
M  V30 19 1 12 16
M  V30 20 2 12 20
M  V30 21 1 13 21
M  V30 22 2 14 18
M  V30 23 1 14 22
M  V30 24 2 15 23
M  V30 25 2 17 24
M  V30 26 1 19 24
M  V30 27 1 20 25
M  V30 28 2 21 25
M  V30 29 2 22 26
M  V30 30 1 23 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1643129-29-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1643129-35-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2864662
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM in the dark
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modular Synthesis of pH-Sensitive Fluorescent Diaza[4]helicenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wallabregue, Antoine; Sherin, Petr; Guin, Joyram; Besnard, Celine;
Vauthey, Eric; Lacour, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2014), 2014(29), 6431-6438

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,3-Benzodioxol-5-yl)-2-oxocyclohexaneacetaldehyde
C15H16O4
1668557-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5065 4.2597 0.0 0
M  V30 2 C 0.9899 3.9924 0.0 0
M  V30 3 O 0.0000 5.1720 0.0 0
M  V30 4 O 0.8290 3.0800 0.0 0
M  V30 5 C 3.4965 3.0800 0.0 0
M  V30 6 C 2.1628 2.3100 0.0 0
M  V30 7 C 4.8301 2.3100 0.0 0
M  V30 8 C 2.1628 0.7700 0.0 0
M  V30 9 C 4.8301 0.7700 0.0 0
M  V30 10 C 3.4965 0.0000 0.0 0
M  V30 11 C 4.4864 4.2597 0.0 0
M  V30 12 C 6.0030 3.9924 0.0 0
M  V30 13 C 3.9597 5.7069 0.0 0
M  V30 14 C 6.9929 5.1720 0.0 0
M  V30 15 C 4.9495 6.8867 0.0 0
M  V30 16 C 6.4661 6.6192 0.0 0
M  V30 17 O 8.5320 5.2258 0.0 0
M  V30 18 O 7.6798 7.5674 0.0 0
M  V30 19 C 8.9565 6.7062 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 2 4 6
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 15 16
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,7aR)-3a-1,3-Benzodioxol-5-yloctahydro-1-methyl-1H-indole
C16H21NO2
886028-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 4.9466 0.0 0
M  V30 2 C 3.2587 2.6528 0.0 0 CFG=1
M  V30 3 C 1.7270 2.8138 0.0 0 CFG=2
M  V30 4 C 3.8850 4.0597 0.0 0
M  V30 5 C 3.8850 1.2460 0.0 0
M  V30 6 N 1.4068 4.3202 0.0 0
M  V30 7 C 0.8218 1.5679 0.0 0
M  V30 8 C 2.7405 5.0902 0.0 0
M  V30 9 C 2.9798 0.0000 0.0 0
M  V30 10 C 1.4482 0.1611 0.0 0
M  V30 11 C 4.7987 2.6528 0.0 0
M  V30 12 C 5.5687 3.9865 0.0 0
M  V30 13 C 5.5687 1.3192 0.0 0
M  V30 14 C 7.1088 3.9865 0.0 0
M  V30 15 C 7.1088 1.3192 0.0 0
M  V30 16 C 7.8788 2.6528 0.0 0
M  V30 17 O 8.1392 5.1311 0.0 0
M  V30 18 O 9.3851 2.9730 0.0 0
M  V30 19 C 9.5460 4.5046 0.0 0
M  V30 20 H 0.2207 3.1339 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 11 CFG=1
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 20 CFG=1
M  V30 9 1 4 8
M  V30 10 1 5 9
M  V30 11 1 6 8
M  V30 12 1 7 10
M  V30 13 1 9 10
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 2 15 16
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 2 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1668557-67-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 886028-82-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15918890
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Concise Total Syntheses of (±)-Joubertiamine, (±)-O-Methyljoubertiamine,
(±)-3'-Methoxy-4'-O-methyljoubertiamine, (±)-Mesembrane, and (±)-Crinane
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Das, Mrinal Kanti; De, Subhadip; Bisai, Alakesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2016), 48(13), 2093-2104

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,3-Benzodioxol-5-yl)-2-oxocyclohexaneacetaldehyde
C15H16O4
1668557-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5065 4.2597 0.0 0
M  V30 2 C 0.9899 3.9924 0.0 0
M  V30 3 O 0.0000 5.1720 0.0 0
M  V30 4 O 0.8290 3.0800 0.0 0
M  V30 5 C 3.4965 3.0800 0.0 0
M  V30 6 C 2.1628 2.3100 0.0 0
M  V30 7 C 4.8301 2.3100 0.0 0
M  V30 8 C 2.1628 0.7700 0.0 0
M  V30 9 C 4.8301 0.7700 0.0 0
M  V30 10 C 3.4965 0.0000 0.0 0
M  V30 11 C 4.4864 4.2597 0.0 0
M  V30 12 C 6.0030 3.9924 0.0 0
M  V30 13 C 3.9597 5.7069 0.0 0
M  V30 14 C 6.9929 5.1720 0.0 0
M  V30 15 C 4.9495 6.8867 0.0 0
M  V30 16 C 6.4661 6.6192 0.0 0
M  V30 17 O 8.5320 5.2258 0.0 0
M  V30 18 O 7.6798 7.5674 0.0 0
M  V30 19 C 8.9565 6.7062 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 2 4 6
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 15 16
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,7aR)-3a-1,3-Benzodioxol-5-yloctahydro-1-methyl-1H-indole
C16H21NO2
886028-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 4.9466 0.0 0
M  V30 2 C 3.2587 2.6528 0.0 0 CFG=1
M  V30 3 C 1.7270 2.8138 0.0 0 CFG=2
M  V30 4 C 3.8850 4.0597 0.0 0
M  V30 5 C 3.8850 1.2460 0.0 0
M  V30 6 N 1.4068 4.3202 0.0 0
M  V30 7 C 0.8218 1.5679 0.0 0
M  V30 8 C 2.7405 5.0902 0.0 0
M  V30 9 C 2.9798 0.0000 0.0 0
M  V30 10 C 1.4482 0.1611 0.0 0
M  V30 11 C 4.7987 2.6528 0.0 0
M  V30 12 C 5.5687 3.9865 0.0 0
M  V30 13 C 5.5687 1.3192 0.0 0
M  V30 14 C 7.1088 3.9865 0.0 0
M  V30 15 C 7.1088 1.3192 0.0 0
M  V30 16 C 7.8788 2.6528 0.0 0
M  V30 17 O 8.1392 5.1311 0.0 0
M  V30 18 O 9.3851 2.9730 0.0 0
M  V30 19 C 9.5460 4.5046 0.0 0
M  V30 20 H 0.2207 3.1339 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 11 CFG=1
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 20 CFG=1
M  V30 9 1 4 8
M  V30 10 1 5 9
M  V30 11 1 6 8
M  V30 12 1 7 10
M  V30 13 1 9 10
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 2 15 16
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 2 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1668557-67-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 886028-82-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-953514
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate catalyst gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Concise total syntheses of (±)-mesembrane and (±)-crinane
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Das, Mrinal Kanti; De, Subhadip; Shubhashish; Bisai, Alakesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2015), 13(12), 3585-3588

$RFMT $RIREG SCHEME156 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-bromo-1H-indole-2-carboxylate
C11H10BrNO2
16732-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6211 1.5400 0.0 0
M  V30 2 O 8.9547 2.3100 0.0 0
M  V30 3 O 7.6211 0.0000 0.0 0
M  V30 4 C 10.2885 1.5400 0.0 0
M  V30 5 C 11.6222 2.3100 0.0 0
M  V30 6 Br 0.0000 4.1617 0.0 0
M  V30 7 C 3.8500 2.8281 0.0 0
M  V30 8 C 4.6201 4.1617 0.0 0
M  V30 9 C 4.8805 1.6835 0.0 0
M  V30 10 C 2.3100 2.8281 0.0 0
M  V30 11 N 6.1265 3.8416 0.0 0
M  V30 12 C 3.8500 5.4954 0.0 0
M  V30 13 C 6.2874 2.3100 0.0 0
M  V30 14 C 1.5400 4.1617 0.0 0
M  V30 15 C 2.3100 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-2-carboxamide, 5-bromo-N-methyl-
C10H9BrN2O
352359-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6211 1.5400 0.0 0
M  V30 2 N 8.9549 2.3100 0.0 0
M  V30 3 O 7.6211 0.0000 0.0 0
M  V30 4 C 10.2886 1.5400 0.0 0
M  V30 5 Br 0.0000 4.1618 0.0 0
M  V30 6 C 4.6201 4.1618 0.0 0
M  V30 7 C 3.8501 2.8281 0.0 0
M  V30 8 N 6.1265 3.8416 0.0 0
M  V30 9 C 3.8501 5.4954 0.0 0
M  V30 10 C 4.8806 1.6836 0.0 0
M  V30 11 C 2.3100 2.8281 0.0 0
M  V30 12 C 6.2875 2.3100 0.0 0
M  V30 13 C 2.3100 5.4954 0.0 0
M  V30 14 C 1.5400 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16732-70-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 352359-15-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22177343
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu(OAc)2-Promoted Oxidative Cross-Dehydrogenative Coupling Reaction of
α-Acylmethyl Malonates with Indole Derivatives to Access 3-Functionalized
Indoles and Polycyclic Indoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Li-Jin; Wang, Kun; Guan, Hong-Rong; Zheng, An-Qi; Yang, Hai-Tao;
Miao, Chun-Bao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2020), 85(12), 7925-7938

$RFMT $RIREG SCHEME157 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methyl-2-propen-1-ylamino)-3-pyridinecarboxaldehyde
C10H12N2O
173312-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 3.8500 5.3349 0.0 0
M  V30 4 C 6.9300 5.3349 0.0 0
M  V30 5 C 8.4700 5.3349 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 N 4.6200 1.3338 0.0 0
M  V30 11 C 1.5400 1.3338 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 2 6 7
M  V30 7 1 6 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7,8,9-Tetrahydro-9,10-dimethyl-5,8-imino-5H-pyrido[2,3-b]azepine
C11H15N3
1668603-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.1948 0.0 0
M  V30 2 C 4.2189 0.0000 0.0 0
M  V30 3 C 3.1272 3.7949 0.0 0
M  V30 4 C 1.6021 4.0088 0.0 0
M  V30 5 C 3.8972 2.4611 0.0 0
M  V30 6 C 3.8972 5.1286 0.0 0
M  V30 7 N 2.3002 2.4075 0.0 0
M  V30 8 C 0.6288 3.0568 0.0 0
M  V30 9 N 3.2382 1.1874 0.0 0
M  V30 10 N 5.4372 2.4611 0.0 0
M  V30 11 C 5.4372 5.1286 0.0 0
M  V30 12 C 1.9296 0.8007 0.0 0
M  V30 13 C 0.7880 1.5311 0.0 0
M  V30 14 C 6.2072 3.7949 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 12
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 173312-70-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1668603-75-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27788354
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituent-directed reduction of cyclic aminals leading to two different
heterocycles selectively: syntheses of functionalized nicotines and
pyrido[2,3-b]azepines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yuewei; Zheng, Lianyou; Yang, Fengzhi; Zhang, Zhuoqi; Dang, Qun;
Bai, Xu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2015), 71(13), 1930-1939

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-2-nitrobenzo[b]thiophene
C8H4BrNO2S
17402-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 3.0205 0.1773 0.0 0
M  V30 2 N 6.0811 1.5400 0.0 0 VAL=5
M  V30 3 O 7.4149 2.3100 0.0 0
M  V30 4 O 6.0811 0.0000 0.0 0
M  V30 5 C 2.3100 2.8281 0.0 0
M  V30 6 C 3.0801 4.1618 0.0 0
M  V30 7 C 3.3406 1.6836 0.0 0
M  V30 8 C 0.7700 2.8281 0.0 0
M  V30 9 S 4.5865 3.8416 0.0 0
M  V30 10 C 2.3100 5.4954 0.0 0
M  V30 11 C 4.7474 2.3100 0.0 0
M  V30 12 C 0.0000 4.1618 0.0 0
M  V30 13 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzo[b]thiophen-3-amine
C9H8N2O2S
132715-18-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0204 0.4759 0.0 0
M  V30 2 C 1.5557 0.0000 0.0 0
M  V30 3 N 6.0810 1.8386 0.0 0 VAL=5
M  V30 4 O 7.4148 2.6086 0.0 0
M  V30 5 O 6.0810 0.2986 0.0 0
M  V30 6 C 2.3100 3.1267 0.0 0
M  V30 7 C 3.3406 1.9823 0.0 0
M  V30 8 C 3.0800 4.4605 0.0 0
M  V30 9 C 0.7700 3.1267 0.0 0
M  V30 10 C 4.7474 2.6086 0.0 0
M  V30 11 S 4.5864 4.1401 0.0 0
M  V30 12 C 2.3100 5.7941 0.0 0
M  V30 13 C 0.0000 4.4605 0.0 0
M  V30 14 C 0.7700 5.7941 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17402-78-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132715-18-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2939967
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel 2-aminoimidazo[4,5-b]pyridines, including the thieno
analogue of the cooked-food mutagen IFP
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bjoerk, Malin; Grivas, Spiros
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2006), 43(1), 101-109

$RFMT $RIREG SCHEME159 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,3,5-trimethyl-1H-pyrrole-2-carboxylic acid
C8H10BrNO2
1784036-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.0287 0.0 0
M  V30 2 O 0.0000 3.2587 0.0 0
M  V30 3 O 1.3337 5.5687 0.0 0
M  V30 4 C 4.3945 5.3915 0.0 0
M  V30 5 C 1.6839 0.6966 0.0 0
M  V30 6 Br 6.6363 2.9016 0.0 0
M  V30 7 C 4.9610 0.0000 0.0 0
M  V30 8 C 2.6673 3.2587 0.0 0
M  V30 9 C 4.0743 3.8850 0.0 0
M  V30 10 N 2.8284 1.7271 0.0 0
M  V30 11 C 5.1047 2.7406 0.0 0
M  V30 12 C 4.3347 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N,1,3,5-tetramethyl-1H-pyrrole-2-carboxamide
C9H13BrN2O
2246721-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 N 6.6363 3.2587 0.0 0
M  V30 3 O 5.3026 5.5688 0.0 0
M  V30 4 C 7.9700 4.0287 0.0 0
M  V30 5 C 2.2418 5.3915 0.0 0
M  V30 6 C 4.9524 0.6966 0.0 0
M  V30 7 Br 0.0000 2.9016 0.0 0
M  V30 8 C 1.6751 0.0000 0.0 0
M  V30 9 C 3.9690 3.2587 0.0 0
M  V30 10 C 2.5620 3.8850 0.0 0
M  V30 11 N 3.8079 1.7271 0.0 0
M  V30 12 C 1.5316 2.7406 0.0 0
M  V30 13 C 2.3016 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1784036-77-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2246721-65-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20729516
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of naphthyridine compounds as inhibitors of HPK1 useful for
treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chan, Bryan; Daniels, Blake; Drobnick, Joy; Gazzard, Lewis; Heffron,
Timothy; Huestis, Malcolm; Liang, Jun; Malhotra, Sushant; Mendonca,
Rohan; Rajapaksa, Naomi; Siu, Michael; Stivala, Craig; Tellis, John;
Wang, Weiru; Wei, Binqing; Zhou, Aihe; Cartwright, Matthew W.; Gancia,
Emanuela; Jones, Graham; Lainchbury, Michael; Madin, Andrew; Seward,
Eileen; Favor, David; Fong, Kin Chiu; Hu, Yonghan; Good, Andrew; Hu,
Baihua; Lu, Aijun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018183956 A1 2018-10-04

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-3-methyl-2-benzofurancarboxaldehyde
C10H7FO2
1784086-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 3.0800 0.0000 0.0 0
M  V30 2 C 3.0204 6.6519 0.0 0
M  V30 3 C 6.0810 5.2891 0.0 0
M  V30 4 O 7.4148 4.5191 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 O 4.5864 2.9876 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 C 3.3406 5.1454 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 4.7474 4.5191 0.0 0
M  V30 12 C 0.7700 1.3336 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 2 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-N,3-dimethyl-2-benzofuranmethanamine
C11H12FNO
1524738-31-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.3336 5.7904 0.0 0
M  V30 2 C 4.6078 0.0000 0.0 0
M  V30 3 C 6.5770 2.7104 0.0 0
M  V30 4 N 7.3470 4.0442 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 3.4804 0.0 0
M  V30 7 C 2.6673 1.9404 0.0 0
M  V30 8 O 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2504 0.0 0
M  V30 10 C 4.1320 1.4645 0.0 0
M  V30 11 C 1.3336 1.1704 0.0 0
M  V30 12 C 5.0370 2.7104 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1784086-44-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1524738-31-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32777142
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and use of novel antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gerusz, Vincent; Bravo, Juan; Pauls, Heinz; Berman, Judd; Finn, Terry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021123372 A1 2021-06-24

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
6-Amino-5-bromo-3-pyridinecarboxylic acid
C6H5BrN2O2
180340-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Br 5.3901 0.0000 0.0 0
M  V30 5 N 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 N 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-5-bromo-N-methyl-3-pyridinecarboxamide
C7H8BrN3O
1862904-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 Br 1.5400 0.0000 0.0 0
M  V30 6 N 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 N 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 180340-69-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1862904-66-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-23938334
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors
Based on an o-Aminopyridyl Alkynyl Scaffold as Potential Treatment for
Inflammatory Disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xie, Zhicheng; Wu, Bing; Liu, Yingqiang; Ren, Wenming; Tong, Linjiang;
Xiang, Caigui; Wei, Aihuan; Gao, Yuanzhuo; Zeng, Limin; Xie, Hua; Tang,
Wei; Hu, Youhong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(3), 1397-1414

$RFMT $RIREG SCHEME162 STEP1
$RXN



  2  1
$MOL
2-Iodo-6-nitrobenzenepropanoic acid
C9H8INO4
1804227-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 6.1600 2.6674 0.0 0
M  V30 3 C 6.9300 1.3338 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 O 8.4700 1.3338 0.0 0
M  V30 6 N 1.5400 2.6674 0.0 0 VAL=5
M  V30 7 O 2.3100 1.3338 0.0 0
M  V30 8 O 0.0000 2.6674 0.0 0
M  V30 9 I 6.1600 5.3347 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 1.5400 5.3347 0.0 0
M  V30 14 C 3.8500 6.6685 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 9 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-N-methyl-6-nitrobenzenepropanamide
C10H11IN2O3
2169806-75-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 3.0800 0.0 0
M  V30 3 C 6.6684 2.3100 0.0 0
M  V30 4 N 8.0022 3.0800 0.0 0
M  V30 5 O 6.6684 0.7700 0.0 0
M  V30 6 C 9.3359 2.3100 0.0 0
M  V30 7 N 1.3337 0.7700 0.0 0 VAL=5
M  V30 8 O 0.0000 0.0000 0.0 0
M  V30 9 O 2.6675 0.0000 0.0 0
M  V30 10 I 4.0011 5.3901 0.0 0
M  V30 11 C 2.6675 3.0800 0.0 0
M  V30 12 C 1.3337 2.3100 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 1 10 13
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1804227-20-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2169806-75-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18399313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed, Norbornene-Mediated, ortho-Amination ipso-Amidation:
Sequential C-N Bond Formation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Whyte, Andrew; Olson, Maxwell E.; Lautens, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2018), 20(2), 345-348

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Chlorophenyl)-2-hydroxycyclohexanone
C12H13ClO2
1823362-29-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.8943 1.1507 0.0 0
M  V30 2 Cl 4.1669 0.0000 0.0 0
M  V30 3 O 0.9123 0.6240 0.0 0
M  V30 4 C 4.1669 2.6673 0.0 0
M  V30 5 C 4.9369 1.3336 0.0 0
M  V30 6 C 4.9369 4.0011 0.0 0
M  V30 7 C 6.4769 1.3336 0.0 0
M  V30 8 C 6.4769 4.0011 0.0 0
M  V30 9 C 7.2469 2.6673 0.0 0
M  V30 10 C 2.6269 2.6673 0.0 0
M  V30 11 C 1.1798 2.1406 0.0 0
M  V30 12 C 2.8943 4.1839 0.0 0
M  V30 13 C 0.0000 3.1305 0.0 0
M  V30 14 C 1.7146 5.1738 0.0 0
M  V30 15 C 0.2675 4.6471 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 5
M  V30 3 2 3 11
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-2-(methylimino)cyclohexanol
C13H16ClNO
2589775-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6088 4.1839 0.0 0
M  V30 2 N 6.6514 4.0010 0.0 0
M  V30 3 C 8.1914 4.0010 0.0 0
M  V30 4 Cl 3.8065 5.7006 0.0 0
M  V30 5 C 4.3413 2.6673 0.0 0
M  V30 6 C 5.8814 2.6673 0.0 0
M  V30 7 C 3.5713 1.3337 0.0 0
M  V30 8 C 6.6514 1.3337 0.0 0
M  V30 9 C 4.3413 0.0000 0.0 0
M  V30 10 C 5.8814 0.0000 0.0 0
M  V30 11 C 2.8942 3.1940 0.0 0
M  V30 12 C 2.6268 4.7106 0.0 0
M  V30 13 C 1.7145 2.2042 0.0 0
M  V30 14 C 1.1797 5.2375 0.0 0
M  V30 15 C 0.2673 2.7309 0.0 0
M  V30 16 C 0.0000 4.2475 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 3
M  V30 3 2 2 6 CFG=2
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1823362-29-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589775-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23295205
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):NOTES
$DATUM in the dark
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of ketamine from a nontoxic procedure: a new and efficient
route
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zekri, Negar; Fareghi-Alamdari, Reza; Momeni-Fard, Behnaz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Sciences (Berlin, Germany) (2020), 132(1), 134

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Methyl (1S,5S,6S)-5-(5-bromo-2-fluorophenyl)-3-[[(1,1-dimethylethoxy)carbonyl...
C25H36BrFN2O5SSi
1874240-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6534 2.6673 0.0 0
M  V30 2 O 5.8834 1.3336 0.0 0
M  V30 3 O 8.1934 2.6673 0.0 0
M  V30 4 C 6.6534 0.0000 0.0 0
M  V30 5 C 4.0231 7.7581 0.0 0
M  V30 6 N 8.5509 7.0809 0.0 0
M  V30 7 C 8.5509 8.6209 0.0 0
M  V30 8 C 9.8845 6.3109 0.0 0
M  V30 9 O 9.8845 9.3909 0.0 0
M  V30 10 O 7.2171 9.3909 0.0 0
M  V30 11 O 11.2181 7.0809 0.0 0
M  V30 12 C 9.8845 10.9309 0.0 0
M  V30 13 C 12.5518 6.3109 0.0 0
M  V30 14 C 11.4245 10.9309 0.0 0
M  V30 15 C 9.8845 12.4709 0.0 0
M  V30 16 C 8.3445 10.9309 0.0 0
M  V30 17 C 13.8856 7.0809 0.0 0
M  V30 18 Si 15.2192 6.3109 0.0 0
M  V30 19 C 16.5528 5.5409 0.0 0
M  V30 20 C 15.9892 7.6447 0.0 0
M  V30 21 C 14.4492 4.9773 0.0 0
M  V30 22 F 2.5700 8.6704 0.0 0
M  V30 23 Br 0.4631 2.8820 0.0 0
M  V30 24 C 5.8834 4.0009 0.0 0 CFG=2
M  V30 25 C 4.5498 4.7709 0.0 0 CFG=2
M  V30 26 C 4.5498 3.2309 0.0 0
M  V30 27 S 7.2171 4.7709 0.0 0
M  V30 28 C 4.5498 6.3109 0.0 0 CFG=2
M  V30 29 C 7.2171 6.3109 0.0 0
M  V30 30 N 5.8834 7.0809 0.0 0
M  V30 31 C 3.0332 6.0436 0.0 0
M  V30 32 C 2.0433 7.2232 0.0 0
M  V30 33 C 2.5065 4.5964 0.0 0
M  V30 34 C 0.5267 6.9559 0.0 0
M  V30 35 C 0.9899 4.3289 0.0 0
M  V30 36 C 0.0000 5.5087 0.0 0
M  V30 37 H 3.0098 4.7709 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 24 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 28 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 29
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 22 32
M  V30 23 1 23 35
M  V30 24 1 24 25
M  V30 25 1 24 26
M  V30 26 1 24 27
M  V30 27 1 25 26
M  V30 28 1 25 28
M  V30 29 1 25 37 CFG=3
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 28 31 CFG=1
M  V30 33 2 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 24 25 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S,5S,6S)-5-(5-bromo-2-fluorophenyl)-5-methyl-1-[(methy...
C25H37BrFN3O4SSi
2079949-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6534 2.6673 0.0 0
M  V30 2 N 5.8834 1.3336 0.0 0
M  V30 3 O 8.1934 2.6673 0.0 0
M  V30 4 C 6.6534 0.0000 0.0 0
M  V30 5 C 4.0231 7.7581 0.0 0
M  V30 6 N 8.5509 7.0809 0.0 0
M  V30 7 C 8.5509 8.6209 0.0 0
M  V30 8 C 9.8845 6.3109 0.0 0
M  V30 9 O 9.8845 9.3909 0.0 0
M  V30 10 O 7.2171 9.3909 0.0 0
M  V30 11 O 11.2181 7.0809 0.0 0
M  V30 12 C 9.8845 10.9309 0.0 0
M  V30 13 C 12.5518 6.3109 0.0 0
M  V30 14 C 8.3445 10.9309 0.0 0
M  V30 15 C 9.8845 12.4709 0.0 0
M  V30 16 C 11.4245 10.9309 0.0 0
M  V30 17 C 13.8856 7.0809 0.0 0
M  V30 18 Si 15.2192 6.3109 0.0 0
M  V30 19 C 16.5528 5.5409 0.0 0
M  V30 20 C 15.9892 7.6447 0.0 0
M  V30 21 C 14.4492 4.9773 0.0 0
M  V30 22 F 2.5700 8.6704 0.0 0
M  V30 23 Br 0.4631 2.8820 0.0 0
M  V30 24 C 5.8834 4.0009 0.0 0 CFG=2
M  V30 25 C 4.5498 4.7709 0.0 0 CFG=2
M  V30 26 C 4.5498 3.2309 0.0 0
M  V30 27 S 7.2171 4.7709 0.0 0
M  V30 28 C 4.5498 6.3109 0.0 0 CFG=2
M  V30 29 C 7.2171 6.3109 0.0 0
M  V30 30 N 5.8834 7.0809 0.0 0
M  V30 31 C 3.0332 6.0436 0.0 0
M  V30 32 C 2.0433 7.2232 0.0 0
M  V30 33 C 2.5065 4.5964 0.0 0
M  V30 34 C 0.5267 6.9559 0.0 0
M  V30 35 C 0.9899 4.3289 0.0 0
M  V30 36 C 0.0000 5.5087 0.0 0
M  V30 37 H 3.0098 4.7709 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 24 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 28 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 29
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 22 32
M  V30 23 1 23 35
M  V30 24 1 24 25
M  V30 25 1 24 26
M  V30 26 1 24 27
M  V30 27 1 25 26
M  V30 28 1 25 28
M  V30 29 1 25 37 CFG=3
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 28 31 CFG=1
M  V30 33 2 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 24 25 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1874240-63-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2079949-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22707890
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The development of a structurally distinct series of BACE1 inhibitors via
the (Z)-fluoro-olefin amide bioisosteric replacement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Frohn, Michael; Liu, Longbin; Siegmund, Aaron C.; Qian, Wenyuan;
Amegadzie, Albert; Chen, Ning; Tan, Helming; Hickman, Dean; Wood,
Stephen; Wen, Paul H.; Bartberger, Michael D.; Whittington, Douglas A.;
Allen, Jennifer R.; Bourbeau, Matthew P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(14), 127240

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
Monomethyl isophthalate
C9H8O4
1877-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[(methylamino)carbonyl]benzoate
C10H11NO3
23668-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.0801 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 O 2.6673 4.6201 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 O 9.3360 2.3101 0.0 0
M  V30 7 O 8.0023 4.6201 0.0 0
M  V30 8 C 10.6697 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1877-71-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23668-00-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15842531
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Induced europium CPL for the selective signaling of phosphorylated amino
acids and O-phosphorylated hexapeptides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neil, Emily R.; Fox, Mark A.; Pal, Robert; Parker, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2016), 45(20), 8355-8366

$RFMT $RIREG SCHEME166 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Pentanedione, 5-(2-bromophenyl)-1-[4-methoxy-3-(phenylmethoxy)phenyl]-
C25H23BrO4
1879947-75-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.8600 4.0011 0.0 0
M  V30 2 C 14.6300 5.3347 0.0 0
M  V30 3 O 12.3200 1.3336 0.0 0
M  V30 4 C 11.5500 0.0000 0.0 0
M  V30 5 C 9.2400 6.6684 0.0 0
M  V30 6 C 7.7000 6.6684 0.0 0
M  V30 7 O 10.0100 8.0020 0.0 0
M  V30 8 C 6.9300 8.0020 0.0 0
M  V30 9 C 5.3900 8.0020 0.0 0
M  V30 10 O 7.7000 9.3358 0.0 0
M  V30 11 C 4.6200 9.3358 0.0 0
M  V30 12 Br 3.0800 12.0031 0.0 0
M  V30 13 C 12.3200 4.0011 0.0 0
M  V30 14 C 11.5500 2.6673 0.0 0
M  V30 15 C 11.5500 5.3347 0.0 0
M  V30 16 C 10.0100 2.6673 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 16.1700 5.3347 0.0 0
M  V30 20 C 16.9400 6.6684 0.0 0
M  V30 21 C 16.9400 4.0011 0.0 0
M  V30 22 C 18.4800 6.6684 0.0 0
M  V30 23 C 18.4800 4.0011 0.0 0
M  V30 24 C 19.2500 5.3347 0.0 0
M  V30 25 C 3.0800 9.3358 0.0 0
M  V30 26 C 2.3100 10.6694 0.0 0
M  V30 27 C 2.3100 8.0020 0.0 0
M  V30 28 C 0.7700 10.6694 0.0 0
M  V30 29 C 0.7700 8.0020 0.0 0
M  V30 30 C 0.0000 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 3 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 17
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 25
M  V30 14 1 12 26
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C26H26BrNO3
2173253-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.8600 4.0011 0.0 0
M  V30 2 C 14.6300 5.3347 0.0 0
M  V30 3 O 12.3200 1.3336 0.0 0
M  V30 4 C 11.5500 0.0000 0.0 0
M  V30 5 C 9.2400 6.6684 0.0 0
M  V30 6 C 7.7000 6.6684 0.0 0
M  V30 7 O 10.0100 8.0020 0.0 0
M  V30 8 C 6.9300 8.0020 0.0 0
M  V30 9 C 5.3900 8.0020 0.0 0
M  V30 10 N 7.7000 9.3358 0.0 0
M  V30 11 C 4.6200 9.3358 0.0 0
M  V30 12 C 6.9300 10.6694 0.0 0
M  V30 13 Br 3.0800 12.0031 0.0 0
M  V30 14 C 12.3200 4.0011 0.0 0
M  V30 15 C 11.5500 2.6673 0.0 0
M  V30 16 C 11.5500 5.3347 0.0 0
M  V30 17 C 10.0100 2.6673 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 16.1700 5.3347 0.0 0
M  V30 21 C 16.9400 6.6684 0.0 0
M  V30 22 C 16.9400 4.0011 0.0 0
M  V30 23 C 18.4800 6.6684 0.0 0
M  V30 24 C 18.4800 4.0011 0.0 0
M  V30 25 C 19.2500 5.3347 0.0 0
M  V30 26 C 3.0800 9.3358 0.0 0
M  V30 27 C 2.3100 10.6694 0.0 0
M  V30 28 C 2.3100 8.0020 0.0 0
M  V30 29 C 0.7700 10.6694 0.0 0
M  V30 30 C 0.7700 8.0020 0.0 0
M  V30 31 C 0.0000 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 18
M  V30 9 2 6 8 CFG=2
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 26
M  V30 15 1 13 27
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1879947-75-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173253-83-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-18703494
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-Substituted Condensed Tetrahydropyridine-Based Enaminones
via Palladium-Catalyzed Intramolecular C-N Cross-coupling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dousova, Hana; Ruzickova, Zdenka; Simunek, Petr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2018), 55(3), 670-684

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,3-Benzodioxol-5-yl)-5-(2-bromophenyl)-1,3-pentanedione
C18H15BrO4
1879947-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 O 9.3358 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 C 4.0010 1.5400 0.0 0
M  V30 8 Br 1.3337 0.0000 0.0 0
M  V30 9 C 13.3370 2.3101 0.0 0
M  V30 10 C 13.3370 3.8501 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 O 14.8017 1.8342 0.0 0
M  V30 13 C 12.0033 4.6201 0.0 0
M  V30 14 O 14.8017 4.3260 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 15.7068 3.0801 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 1.3337 1.5400 0.0 0
M  V30 20 C 2.6673 3.8501 0.0 0
M  V30 21 C 0.0000 2.3101 0.0 0
M  V30 22 C 1.3337 4.6201 0.0 0
M  V30 23 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 18
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Penten-1-one, 1-(1,3-benzodioxol-5-yl)-5-(2-bromophenyl)-3-(methylamino)-
C19H18BrNO3
2173253-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 2.3101 0.0 0
M  V30 2 C 8.0022 3.0801 0.0 0
M  V30 3 O 9.3358 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 5.3348 3.0801 0.0 0
M  V30 6 N 6.6685 0.7700 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 5.3348 0.0000 0.0 0
M  V30 9 Br 1.3337 0.7700 0.0 0
M  V30 10 C 13.3370 3.0801 0.0 0
M  V30 11 C 13.3370 4.6201 0.0 0
M  V30 12 C 12.0033 2.3101 0.0 0
M  V30 13 O 14.8017 2.6042 0.0 0
M  V30 14 C 12.0033 5.3901 0.0 0
M  V30 15 O 14.8017 5.0960 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 15.7068 3.8501 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 2.6673 3.0801 0.0 0
M  V30 20 C 1.3337 2.3101 0.0 0
M  V30 21 C 2.6673 4.6201 0.0 0
M  V30 22 C 0.0000 3.0801 0.0 0
M  V30 23 C 1.3337 5.3901 0.0 0
M  V30 24 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 19
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1879947-76-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173253-82-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-18703493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-Substituted Condensed Tetrahydropyridine-Based Enaminones
via Palladium-Catalyzed Intramolecular C-N Cross-coupling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dousova, Hana; Ruzickova, Zdenka; Simunek, Petr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2018), 55(3), 670-684

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-oxo-6-phenyl-8-(trifluoromethyl)-4H-pyrido[1,2-a]pyrimidine-3-carboxy...
C18H13F3N2O3
1883691-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 O 10.6697 5.3901 0.0 0
M  V30 4 O 9.3360 3.0801 0.0 0
M  V30 5 C 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 5.3901 0.0 0
M  V30 7 C 1.3337 7.7002 0.0 0
M  V30 8 F 0.5637 6.3665 0.0 0
M  V30 9 F 0.0000 8.4702 0.0 0
M  V30 10 F 2.1037 9.0338 0.0 0
M  V30 11 N 5.3348 5.3901 0.0 0
M  V30 12 C 4.0010 4.6201 0.0 0
M  V30 13 C 5.3348 6.9302 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 2.6673 5.3901 0.0 0
M  V30 16 C 4.0010 7.7002 0.0 0
M  V30 17 N 6.6685 7.7002 0.0 0
M  V30 18 C 8.0022 5.3901 0.0 0
M  V30 19 C 2.6673 6.9302 0.0 0
M  V30 20 C 8.0022 6.9302 0.0 0
M  V30 21 C 4.0010 3.0801 0.0 0
M  V30 22 C 5.3348 2.3101 0.0 0
M  V30 23 C 2.6673 2.3101 0.0 0
M  V30 24 C 5.3348 0.7700 0.0 0
M  V30 25 C 2.6673 0.7700 0.0 0
M  V30 26 C 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 19
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 2 12 15
M  V30 15 1 12 21
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 2 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-oxo-6-phenyl-8-(trifluoromethyl)-4H-pyrido[1,2-a]pyrimidine-3-carb...
C17H12F3N3O2
1883691-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 4.0011 0.0 0
M  V30 2 C 2.3100 6.6685 0.0 0
M  V30 3 N 1.5400 8.0021 0.0 0
M  V30 4 O 1.5400 5.3347 0.0 0
M  V30 5 C 0.0000 8.0021 0.0 0
M  V30 6 C 10.7800 5.3347 0.0 0
M  V30 7 F 10.7800 3.7947 0.0 0
M  V30 8 F 12.3200 5.3347 0.0 0
M  V30 9 F 10.7800 6.8747 0.0 0
M  V30 10 N 6.1600 5.3347 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 6.9300 6.6685 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 8.4700 6.6685 0.0 0
M  V30 16 N 6.1600 8.0021 0.0 0
M  V30 17 C 3.8500 6.6685 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 19 C 4.6200 8.0021 0.0 0
M  V30 20 C 6.1600 2.6674 0.0 0
M  V30 21 C 6.9300 1.3336 0.0 0
M  V30 22 C 4.6200 2.6674 0.0 0
M  V30 23 C 6.1600 0.0000 0.0 0
M  V30 24 C 3.8500 1.3336 0.0 0
M  V30 25 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 20
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1883691-28-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1883691-30-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1392008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel pyrido[1,2-a]pyrimidine-3-carboxamide derivatives and
their anticancer activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumar, Gautham Santhosh; Dev, Gaddameedi Jitender; Kumar, Nagiri Ravi;
Swaroop, Desireddy Krishna; Chandra, Yedla Poorna; Kumar, Chityala
Ganesh; Narsaiah, Banda
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2015), 63(8), 584-590

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-1,4-benzodioxin-6-carbonitrile
C9H7NO2
19102-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 2.6673 0.0 0
M  V30 2 N 8.4702 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 O 2.3101 0.0000 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 O 0.7700 2.6673 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-N-methyl-1,4-benzodioxin-6-methanamine
C10H13NO2
613656-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 2.6675 2.3101 0.0 0
M  V30 5 C 2.6675 0.7700 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 O 1.3337 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19102-07-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 613656-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32794898
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 22031-12-5
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 60871-84-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-89-8
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel-catalyzed hydrogenative coupling of nitriles and amines for
general amine synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chandrashekhar, Vishwas G.; Baumann, Wolfgang; Beller, Matthias;
Jagadeesh, Rajenahally V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Science (Washington, DC, United States) (2022), 376(6600), 1433-1441

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR)-α-Azido-4-methoxy-3,5-bis(phenylmethoxy)benzeneacetic acid
C23H21N3O5
191542-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 2 N 6.6685 3.0800 0.0 0
M  V30 3 C 9.3358 3.0800 0.0 0
M  V30 4 N 6.6685 1.5400 0.0 0 CHG=1 VAL=4
M  V30 5 O 10.6696 3.8500 0.0 0
M  V30 6 O 9.3358 1.5400 0.0 0
M  V30 7 N 6.6685 0.0000 0.0 0 CHG=-1
M  V30 8 O 5.3347 8.4700 0.0 0
M  V30 9 C 4.0011 7.7000 0.0 0
M  V30 10 O 10.6696 8.4700 0.0 0
M  V30 11 C 12.0032 7.7000 0.0 0
M  V30 12 O 8.0021 10.0100 0.0 0
M  V30 13 C 6.6685 10.7800 0.0 0
M  V30 14 C 8.0021 5.3900 0.0 0
M  V30 15 C 6.6685 6.1600 0.0 0
M  V30 16 C 9.3358 6.1600 0.0 0
M  V30 17 C 6.6685 7.7000 0.0 0
M  V30 18 C 9.3358 7.7000 0.0 0
M  V30 19 C 8.0021 8.4700 0.0 0
M  V30 20 C 2.6674 8.4700 0.0 0
M  V30 21 C 1.3338 7.7000 0.0 0
M  V30 22 C 2.6674 10.0100 0.0 0
M  V30 23 C 0.0000 8.4700 0.0 0
M  V30 24 C 1.3338 10.7800 0.0 0
M  V30 25 C 0.0000 10.0100 0.0 0
M  V30 26 C 13.3369 8.4700 0.0 0
M  V30 27 C 13.3369 10.0100 0.0 0
M  V30 28 C 14.6705 7.7000 0.0 0
M  V30 29 C 14.6705 10.7800 0.0 0
M  V30 30 C 16.0043 8.4700 0.0 0
M  V30 31 C 16.0043 10.0100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 1 10 18
M  V30 13 1 11 26
M  V30 14 1 12 13
M  V30 15 1 12 19
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-Azido-4-methoxy-N-methyl-3,5-bis(phenylmethoxy)benzeneacetamide
C24H24N4O4
299179-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 3.8500 0.0 0 CFG=1
M  V30 2 C 6.6685 3.0800 0.0 0
M  V30 3 N 9.3358 3.0800 0.0 0
M  V30 4 N 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 N 9.3358 1.5400 0.0 0 CHG=1 VAL=4
M  V30 7 C 5.3347 0.7700 0.0 0
M  V30 8 N 9.3358 0.0000 0.0 0 CHG=-1
M  V30 9 O 5.3347 8.4700 0.0 0
M  V30 10 C 4.0011 7.7000 0.0 0
M  V30 11 O 10.6696 8.4700 0.0 0
M  V30 12 C 12.0032 7.7000 0.0 0
M  V30 13 O 8.0021 10.0100 0.0 0
M  V30 14 C 9.3358 10.7800 0.0 0
M  V30 15 C 8.0021 5.3900 0.0 0
M  V30 16 C 6.6685 6.1600 0.0 0
M  V30 17 C 9.3358 6.1600 0.0 0
M  V30 18 C 6.6685 7.7000 0.0 0
M  V30 19 C 9.3358 7.7000 0.0 0
M  V30 20 C 8.0021 8.4700 0.0 0
M  V30 21 C 2.6674 8.4700 0.0 0
M  V30 22 C 1.3338 7.7000 0.0 0
M  V30 23 C 2.6674 10.0100 0.0 0
M  V30 24 C 0.0000 8.4700 0.0 0
M  V30 25 C 1.3338 10.7800 0.0 0
M  V30 26 C 0.0000 10.0100 0.0 0
M  V30 27 C 13.3369 8.4700 0.0 0
M  V30 28 C 14.6705 7.7000 0.0 0
M  V30 29 C 13.3369 10.0100 0.0 0
M  V30 30 C 16.0043 8.4700 0.0 0
M  V30 31 C 14.6705 10.7800 0.0 0
M  V30 32 C 16.0043 10.0100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 10 21
M  V30 12 1 11 12
M  V30 13 1 11 19
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 20
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 191542-07-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 299179-30-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6361020
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic studies on the DEF ring system of ristocetin A via
ruthenium-promoted SNAr reaction: problems and solutions using
arylserine-Ru complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pearson, Anthony J.; Heo, Jung-Nyoung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2000), 41(32), 5991-5996

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3,4-Dimethoxyphenyl)-3,4-dihydro-6,7-dimethoxy-1(2H)-naphthalenone
C20H22O5
19611-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7002 2.6675 0.0 0
M  V30 2 O 2.3101 1.3337 0.0 0
M  V30 3 C 3.0801 0.0000 0.0 0
M  V30 4 O 0.7700 4.0012 0.0 0
M  V30 5 C 0.0000 5.3348 0.0 0
M  V30 6 O 12.3203 8.0023 0.0 0
M  V30 7 C 11.5503 9.3360 0.0 0
M  V30 8 O 13.8603 5.3348 0.0 0
M  V30 9 C 14.6303 4.0012 0.0 0
M  V30 10 C 5.3901 4.0012 0.0 0
M  V30 11 C 4.6201 5.3348 0.0 0
M  V30 12 C 6.9302 4.0012 0.0 0
M  V30 13 C 4.6201 2.6675 0.0 0
M  V30 14 C 3.0801 5.3348 0.0 0
M  V30 15 C 5.3901 6.6685 0.0 0
M  V30 16 C 7.7002 5.3348 0.0 0
M  V30 17 C 3.0801 2.6675 0.0 0
M  V30 18 C 2.3101 4.0012 0.0 0
M  V30 19 C 6.9302 6.6685 0.0 0
M  V30 20 C 9.2402 5.3348 0.0 0
M  V30 21 C 10.0102 6.6685 0.0 0
M  V30 22 C 10.0102 4.0012 0.0 0
M  V30 23 C 11.5503 6.6685 0.0 0
M  V30 24 C 11.5503 4.0012 0.0 0
M  V30 25 C 12.3203 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 6 7
M  V30 7 1 6 23
M  V30 8 1 8 9
M  V30 9 1 8 25
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 2 17 18
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2S)-2-(3,4-Dimethoxyphenyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-N-methyl...
C21H27NO4
1403560-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7002 6.6685 0.0 0
M  V30 2 C 6.9302 8.0023 0.0 0
M  V30 3 O 2.3101 8.0023 0.0 0
M  V30 4 C 3.0801 9.3360 0.0 0
M  V30 5 O 0.7700 5.3348 0.0 0
M  V30 6 C 0.0000 4.0012 0.0 0
M  V30 7 O 12.3203 1.3337 0.0 0
M  V30 8 C 11.5503 0.0000 0.0 0
M  V30 9 O 13.8603 4.0012 0.0 0
M  V30 10 C 14.6303 5.3348 0.0 0
M  V30 11 C 5.3901 5.3348 0.0 0
M  V30 12 C 6.9302 5.3348 0.0 0 CFG=1
M  V30 13 C 4.6201 4.0012 0.0 0
M  V30 14 C 4.6201 6.6685 0.0 0
M  V30 15 C 7.7002 4.0012 0.0 0 CFG=1
M  V30 16 C 3.0801 4.0012 0.0 0
M  V30 17 C 5.3901 2.6675 0.0 0
M  V30 18 C 3.0801 6.6685 0.0 0
M  V30 19 C 6.9302 2.6675 0.0 0
M  V30 20 C 2.3101 5.3348 0.0 0
M  V30 21 C 9.2402 4.0012 0.0 0
M  V30 22 C 10.0102 2.6675 0.0 0
M  V30 23 C 10.0102 5.3348 0.0 0
M  V30 24 C 11.5503 2.6675 0.0 0
M  V30 25 C 11.5503 5.3348 0.0 0
M  V30 26 C 12.3203 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 9 10
M  V30 10 1 9 26
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 15 21 CFG=1
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19611-21-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1403560-00-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14971155
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM dropwise addition of reactant mixture stage 1, portionwise addition of
borohydride stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Benzo[c]phenanthridine Alkaloids by Pd(OAc)2-Induced Direct
Aromatic Carbonylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumazawa, Eri; Tokuhashi, Takashi; Horibata, Akiyoshi; Kurono, Nobuhito;
Senboku, Hisanori; Tokuda, Masao; Ohkuma, Takashi; Orito, Kazuhiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2012), 2012(24), 4622-4633,
S4622/1-S4622/53

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(8-Bromooctyl)-3-methyl-5-(phenylmethoxy)-2-[4-(phenylmethoxy)phenyl]-1H-in...
C37H40BrNO2
1973474-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2762 10.4363 0.0 0
M  V30 2 C 10.2458 9.2917 0.0 0
M  V30 3 C 10.7216 7.8272 0.0 0
M  V30 4 C 9.6912 6.6827 0.0 0
M  V30 5 C 10.1671 5.2181 0.0 0
M  V30 6 C 9.1367 4.0736 0.0 0
M  V30 7 C 9.6125 2.6091 0.0 0
M  V30 8 C 8.5821 1.4645 0.0 0
M  V30 9 Br 9.0580 0.0000 0.0 0
M  V30 10 C 11.2762 15.8572 0.0 0
M  V30 11 O 5.3347 14.6867 0.0 0
M  V30 12 C 4.0011 13.9167 0.0 0
M  V30 13 O 17.8655 13.1467 0.0 0
M  V30 14 C 18.6355 14.4805 0.0 0
M  V30 15 N 10.8003 11.9008 0.0 0
M  V30 16 C 11.7055 13.1467 0.0 0
M  V30 17 C 9.3358 12.3767 0.0 0
M  V30 18 C 10.8003 14.3927 0.0 0
M  V30 19 C 9.3358 13.9167 0.0 0
M  V30 20 C 8.0020 11.6067 0.0 0
M  V30 21 C 8.0020 14.6867 0.0 0
M  V30 22 C 6.6684 12.3767 0.0 0
M  V30 23 C 6.6684 13.9167 0.0 0
M  V30 24 C 13.2455 13.1467 0.0 0
M  V30 25 C 14.0155 11.8130 0.0 0
M  V30 26 C 14.0155 14.4805 0.0 0
M  V30 27 C 15.5555 11.8130 0.0 0
M  V30 28 C 15.5555 14.4805 0.0 0
M  V30 29 C 16.3255 13.1467 0.0 0
M  V30 30 C 2.6673 14.6867 0.0 0
M  V30 31 C 1.3336 13.9167 0.0 0
M  V30 32 C 2.6673 16.2267 0.0 0
M  V30 33 C 0.0000 14.6867 0.0 0
M  V30 34 C 1.3336 16.9967 0.0 0
M  V30 35 C 0.0000 16.2267 0.0 0
M  V30 36 C 20.1755 14.4805 0.0 0
M  V30 37 C 20.9455 13.1467 0.0 0
M  V30 38 C 20.9455 15.8141 0.0 0
M  V30 39 C 22.4855 13.1467 0.0 0
M  V30 40 C 22.4855 15.8141 0.0 0
M  V30 41 C 23.2555 14.4805 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 18
M  V30 11 1 11 12
M  V30 12 1 11 23
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 29
M  V30 16 1 14 36
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 1 16 24
M  V30 21 1 17 19
M  V30 22 2 17 20
M  V30 23 1 18 19
M  V30 24 2 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-5-(phenylmethoxy)-2-[4-(phenylmethoxy)phenyl]-1H-indole-1-octana...
C38H44N2O2
1973474-31-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2762 11.5807 0.0 0
M  V30 2 C 10.2458 10.4363 0.0 0
M  V30 3 C 10.7217 8.9716 0.0 0
M  V30 4 C 9.6913 7.8272 0.0 0
M  V30 5 C 10.1671 6.3625 0.0 0
M  V30 6 C 9.1367 5.2182 0.0 0
M  V30 7 C 9.6126 3.7535 0.0 0
M  V30 8 C 8.5822 2.6091 0.0 0
M  V30 9 N 9.0580 1.1444 0.0 0
M  V30 10 C 8.0276 0.0000 0.0 0
M  V30 11 C 11.2762 17.0018 0.0 0
M  V30 12 O 5.3347 15.8313 0.0 0
M  V30 13 C 4.0011 15.0613 0.0 0
M  V30 14 O 17.8656 14.2913 0.0 0
M  V30 15 C 18.6356 15.6249 0.0 0
M  V30 16 N 10.8004 13.0454 0.0 0
M  V30 17 C 11.7056 14.2913 0.0 0
M  V30 18 C 9.3358 13.5213 0.0 0
M  V30 19 C 10.8004 15.5371 0.0 0
M  V30 20 C 9.3358 15.0613 0.0 0
M  V30 21 C 8.0020 12.7513 0.0 0
M  V30 22 C 8.0020 15.8313 0.0 0
M  V30 23 C 6.6684 13.5213 0.0 0
M  V30 24 C 6.6684 15.0613 0.0 0
M  V30 25 C 13.2456 14.2913 0.0 0
M  V30 26 C 14.0156 12.9576 0.0 0
M  V30 27 C 14.0156 15.6249 0.0 0
M  V30 28 C 15.5556 12.9576 0.0 0
M  V30 29 C 15.5556 15.6249 0.0 0
M  V30 30 C 16.3256 14.2913 0.0 0
M  V30 31 C 2.6673 15.8313 0.0 0
M  V30 32 C 1.3336 15.0613 0.0 0
M  V30 33 C 2.6673 17.3713 0.0 0
M  V30 34 C 0.0000 15.8313 0.0 0
M  V30 35 C 1.3336 18.1413 0.0 0
M  V30 36 C 0.0000 17.3713 0.0 0
M  V30 37 C 20.1756 15.6249 0.0 0
M  V30 38 C 20.9456 14.2913 0.0 0
M  V30 39 C 20.9456 16.9587 0.0 0
M  V30 40 C 22.4857 14.2913 0.0 0
M  V30 41 C 22.4857 16.9587 0.0 0
M  V30 42 C 23.2557 15.6249 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 19
M  V30 12 1 12 13
M  V30 13 1 12 24
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 30
M  V30 17 1 15 37
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 1 17 25
M  V30 22 1 18 20
M  V30 23 2 18 21
M  V30 24 1 19 20
M  V30 25 2 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1973474-26-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1973474-31-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15986114
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, antiproliferative and pro-apoptotic activity of
2-phenylindoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kelly, Patrick M.; Bright, Sandra A.; Fayne, Darren; Pollock, Jade K.;
Zisterer, Daniela M.; Williams, D. Clive; Meegan, Mary J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(18), 4075-4099

$RFMT $RIREG SCHEME173 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Acetyl-4-isocyano-L-phenylalanine methyl ester
C13H14N2O3
2029140-95-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 C 3.8500 4.0011 0.0 0 CFG=2
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 N 2.3100 4.0011 0.0 0
M  V30 5 O 3.8500 1.3338 0.0 0
M  V30 6 O 6.1600 2.6674 0.0 0
M  V30 7 C 1.5400 5.3347 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 2.3100 6.6685 0.0 0
M  V30 10 O 0.0000 5.3347 0.0 0
M  V30 11 N 10.7800 5.3347 0.0 0 CHG=1 VAL=4
M  V30 12 C 12.3200 5.3347 0.0 0 CHG=-1
M  V30 13 C 6.1600 5.3347 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 6.9300 6.6685 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 8.4700 6.6685 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 3 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-(Acetylamino)-4-isocyano-N-methylbenzenepropanamide
C13H15N3O2
2029140-97-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 C 3.8500 4.0011 0.0 0 CFG=2
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 N 2.3100 4.0011 0.0 0
M  V30 5 N 3.8500 1.3338 0.0 0
M  V30 6 O 6.1600 2.6674 0.0 0
M  V30 7 C 1.5400 5.3347 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 2.3100 6.6685 0.0 0
M  V30 10 O 0.0000 5.3347 0.0 0
M  V30 11 N 10.7800 5.3347 0.0 0 CHG=1 VAL=4
M  V30 12 C 12.3200 5.3347 0.0 0 CHG=-1
M  V30 13 C 6.1600 5.3347 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 6.9300 6.6685 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 8.4700 6.6685 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 3 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2029140-95-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2029140-97-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16388146
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isonitrile as an Ultrasensitive Infrared Reporter of Hydrogen-Bonding
Structure and Dynamics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maj, Michal; Ahn, Changwoo; Blasiak, Bartosz; Kwak, Kyungwon; Han, Hogyu;
Cho, Minhaeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Physical Chemistry B (2016), 120(39), 10167-10180

$RFMT $RIREG SCHEME174 STEP1
$RXN



  4  1
$MOL
1-Phenyl-2-(triphenylphosphoranylidene)ethanone
C26H21OP
859-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.6200 4.6200 0.0 0 VAL=5
M  V30 2 C 6.1600 4.6200 0.0 0
M  V30 3 C 6.9300 5.9537 0.0 0
M  V30 4 O 6.1600 7.2875 0.0 0
M  V30 5 C 3.0800 4.6200 0.0 0
M  V30 6 C 2.3100 5.9537 0.0 0
M  V30 7 C 2.3100 3.2864 0.0 0
M  V30 8 C 0.7700 5.9537 0.0 0
M  V30 9 C 0.7700 3.2864 0.0 0
M  V30 10 C 0.0000 4.6200 0.0 0
M  V30 11 C 4.6200 3.0800 0.0 0
M  V30 12 C 5.9537 2.3100 0.0 0
M  V30 13 C 3.2864 2.3100 0.0 0
M  V30 14 C 5.9537 0.7700 0.0 0
M  V30 15 C 3.2864 0.7700 0.0 0
M  V30 16 C 4.6200 0.0000 0.0 0
M  V30 17 C 4.2215 6.1075 0.0 0
M  V30 18 C 2.7340 6.5062 0.0 0
M  V30 19 C 5.3104 7.1964 0.0 0
M  V30 20 C 2.3353 7.9937 0.0 0
M  V30 21 C 4.9118 8.6841 0.0 0
M  V30 22 C 3.4242 9.0826 0.0 0
M  V30 23 C 8.4700 5.9537 0.0 0
M  V30 24 C 9.2400 4.6200 0.0 0
M  V30 25 C 9.2400 7.2875 0.0 0
M  V30 26 C 10.7800 4.6200 0.0 0
M  V30 27 C 10.7800 7.2875 0.0 0
M  V30 28 C 11.5500 5.9537 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 1 17
M  V30 5 1 2 3
M  V30 6 2 3 4
M  V30 7 1 3 23
M  V30 8 2 5 6
M  V30 9 1 5 7
M  V30 10 1 6 8
M  V30 11 2 7 9
M  V30 12 2 8 10
M  V30 13 1 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylisatin
C9H7NO2
2058-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 C 4.6078 5.4211 0.0 0
M  V30 3 O 6.5770 2.7106 0.0 0
M  V30 4 C 2.6673 1.9406 0.0 0
M  V30 5 C 2.6673 3.4806 0.0 0
M  V30 6 C 4.1320 1.4647 0.0 0
M  V30 7 C 1.3336 1.1706 0.0 0
M  V30 8 N 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2506 0.0 0
M  V30 10 C 5.0370 2.7106 0.0 0
M  V30 11 C 0.0000 1.9406 0.0 0
M  V30 12 C 0.0000 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 8
M  V30 3 2 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Indol-2-one, 1,3-dihydro-3-[(4R,5S)-4-hydroxy-3-methyl-4-phenyl-2-thioxo-5...
C19H18N2O2S2
3052403-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.3944 5.1959 0.0 0
M  V30 2 O 6.6218 6.1056 0.0 0
M  V30 3 C 8.7281 1.3628 0.0 0
M  V30 4 S 5.6673 0.0000 0.0 0
M  V30 5 C 4.3800 8.5955 0.0 0
M  V30 6 C 5.7271 3.9845 0.0 0 CFG=1
M  V30 7 C 7.2335 3.6643 0.0 0 CFG=2
M  V30 8 S 4.9570 2.6509 0.0 0
M  V30 9 N 7.3944 2.1328 0.0 0
M  V30 10 C 5.9876 1.5065 0.0 0
M  V30 11 C 4.3202 4.6110 0.0 0 CFG=2
M  V30 12 C 2.8138 4.9312 0.0 0
M  V30 13 C 5.0903 5.9447 0.0 0
M  V30 14 C 2.6529 6.4627 0.0 0
M  V30 15 C 1.5679 4.0259 0.0 0
M  V30 16 N 4.0597 7.0891 0.0 0
M  V30 17 C 1.2460 7.0891 0.0 0
M  V30 18 C 0.1611 4.6523 0.0 0
M  V30 19 C 0.0000 6.1840 0.0 0
M  V30 20 C 8.7735 3.6643 0.0 0
M  V30 21 C 9.5436 4.9980 0.0 0
M  V30 22 C 9.5436 2.3307 0.0 0
M  V30 23 C 11.0836 4.9980 0.0 0
M  V30 24 C 11.0836 2.3307 0.0 0
M  V30 25 C 11.8536 3.6643 0.0 0
M  V30 26 H 6.2029 5.4492 0.0 0
M  V30 27 H 3.8444 3.1463 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 7 1 CFG=3
M  V30 2 2 2 13
M  V30 3 1 3 9
M  V30 4 2 4 10
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 6 26 CFG=1
M  V30 10 1 7 9
M  V30 11 1 7 20 CFG=1
M  V30 12 1 8 10
M  V30 13 1 9 10
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 27 CFG=3
M  V30 17 1 12 14
M  V30 18 2 12 15
M  V30 19 1 13 16
M  V30 20 1 14 16
M  V30 21 2 14 17
M  V30 22 1 15 18
M  V30 23 1 17 19
M  V30 24 2 18 19
M  V30 25 2 20 21
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 2 22 24
M  V30 29 2 23 25
M  V30 30 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 6 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 859-65-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2058-74-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3052403-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41257926
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, stereoselective, Wittig reaction in
stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regio- and diastereoselective synthesis of
thioxothiazolidin-indolin-2-ones, oxoindolin-carbamodithioate hybrids,
and their base-catalyzed conversion into dispirocyclopentanebisoxindoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aghamiri, Bagher; Moghaddam, F. Matloubi; Badpa, Sara; Kavoosi, Leila
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Scientific Reports (2024), 14(1), 14222

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[4-Fluoro-2-[2-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethoxy]phenyl]-1-methyl-1H-...
C23H23FN4O2
2059147-83-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.5065 5.9581 0.0 0
M  V30 2 O 16.9712 6.4340 0.0 0
M  V30 3 C 12.7961 10.6528 0.0 0
M  V30 4 O 7.4658 5.3347 0.0 0
M  V30 5 C 5.9258 5.3347 0.0 0
M  V30 6 C 5.1558 6.6684 0.0 0
M  V30 7 F 7.4658 0.0000 0.0 0
M  V30 8 C 3.1864 9.3790 0.0 0
M  V30 9 C 3.1864 3.9578 0.0 0
M  V30 10 C 0.0000 8.3436 0.0 0
M  V30 11 C 12.8558 6.6684 0.0 0
M  V30 12 C 12.0858 8.0020 0.0 0
M  V30 13 C 12.0858 5.3347 0.0 0
M  V30 14 C 14.3621 6.9886 0.0 0
M  V30 15 C 10.5458 8.0020 0.0 0
M  V30 16 N 13.1162 9.1466 0.0 0
M  V30 17 C 10.5458 5.3347 0.0 0
M  V30 18 N 14.5230 8.5201 0.0 0
M  V30 19 C 9.7758 6.6684 0.0 0
M  V30 20 C 9.7758 4.0011 0.0 0
M  V30 21 C 8.2358 4.0011 0.0 0
M  V30 22 C 10.5458 2.6673 0.0 0
M  V30 23 C 7.4658 2.6673 0.0 0
M  V30 24 C 9.7758 1.3336 0.0 0
M  V30 25 C 8.2358 1.3336 0.0 0
M  V30 26 C 3.6158 6.6684 0.0 0
M  V30 27 C 2.7106 7.9143 0.0 0
M  V30 28 C 2.7106 5.4225 0.0 0
M  V30 29 N 1.2459 7.4384 0.0 0
M  V30 30 N 1.2459 5.8984 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 21
M  V30 6 1 5 6
M  V30 7 1 6 26
M  V30 8 1 7 25
M  V30 9 1 8 27
M  V30 10 1 9 28
M  V30 11 1 10 29
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 1 17 20
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[4-Fluoro-2-[2-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethoxy]phenyl]-N,1-dimethyl...
C24H28FN5O
2059148-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.5066 5.9581 0.0 0
M  V30 2 N 16.9712 6.4340 0.0 0
M  V30 3 C 18.1157 5.4036 0.0 0
M  V30 4 C 12.7960 10.6528 0.0 0
M  V30 5 O 7.4658 5.3347 0.0 0
M  V30 6 C 5.9258 5.3347 0.0 0
M  V30 7 C 5.1558 6.6684 0.0 0
M  V30 8 F 7.4658 0.0000 0.0 0
M  V30 9 C 3.1864 3.9578 0.0 0
M  V30 10 C 3.1864 9.3789 0.0 0
M  V30 11 C 0.0000 8.3436 0.0 0
M  V30 12 C 12.8558 6.6684 0.0 0
M  V30 13 C 12.0858 8.0020 0.0 0
M  V30 14 C 14.3621 6.9885 0.0 0
M  V30 15 C 12.0858 5.3347 0.0 0
M  V30 16 C 10.5458 8.0020 0.0 0
M  V30 17 N 13.1162 9.1465 0.0 0
M  V30 18 N 14.5232 8.5201 0.0 0
M  V30 19 C 10.5458 5.3347 0.0 0
M  V30 20 C 9.7758 6.6684 0.0 0
M  V30 21 C 9.7758 4.0011 0.0 0
M  V30 22 C 8.2358 4.0011 0.0 0
M  V30 23 C 10.5458 2.6673 0.0 0
M  V30 24 C 7.4658 2.6673 0.0 0
M  V30 25 C 9.7758 1.3336 0.0 0
M  V30 26 C 8.2358 1.3336 0.0 0
M  V30 27 C 3.6158 6.6684 0.0 0
M  V30 28 C 2.7106 5.4225 0.0 0
M  V30 29 C 2.7106 7.9142 0.0 0
M  V30 30 N 1.2459 5.8984 0.0 0
M  V30 31 N 1.2459 7.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 4 17
M  V30 5 1 5 6
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 1 7 27
M  V30 9 1 8 26
M  V30 10 1 9 28
M  V30 11 1 10 29
M  V30 12 1 11 31
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2059147-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2059148-59-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17439625
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazole derivatives as inhibitors of N-myristoyl
transferase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bell, Andrew Simon; Tate, Edward William; Leatherbarrow, Robin John;
Hutton, Jennie Ann; Brannigan, James Antony
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017001812 A1 2017-01-05

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanol, 2-methyl-1-[(2,6,8-trichloropyrimido[5,4-d]pyrimidin-4-yl)amino]-
C10H10Cl3N5O
2060002-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 4.6201 0.0 0
M  V30 2 C 8.0022 3.8500 0.0 0
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 C 10.1059 3.2864 0.0 0
M  V30 5 C 10.6695 5.3901 0.0 0
M  V30 6 O 8.5659 5.9537 0.0 0
M  V30 7 Cl 0.0000 3.8500 0.0 0
M  V30 8 Cl 2.6673 8.4701 0.0 0
M  V30 9 Cl 4.0011 0.0000 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 N 4.0011 6.1601 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 N 2.6673 2.3100 0.0 0
M  V30 16 N 5.3348 2.3100 0.0 0
M  V30 17 C 2.6673 6.9301 0.0 0
M  V30 18 N 1.3337 6.1601 0.0 0
M  V30 19 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 14
M  V30 8 1 8 17
M  V30 9 1 9 19
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanol, 2-methyl-1-[[2,6,8-tris(methylamino)pyrimido[5,4-d]pyrimidin-4-yl...
C13H22N8O
2060002-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 5.3901 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 C 10.6697 5.3901 0.0 0
M  V30 4 C 11.4397 4.0564 0.0 0
M  V30 5 C 12.0033 6.1601 0.0 0
M  V30 6 O 9.8996 6.7238 0.0 0
M  V30 7 N 1.3337 4.6201 0.0 0
M  V30 8 C 0.0000 5.3901 0.0 0
M  V30 9 N 4.0012 9.2402 0.0 0
M  V30 10 C 2.6673 10.0102 0.0 0
M  V30 11 N 5.3348 0.7700 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 5.3901 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 N 5.3348 6.9302 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 N 4.0012 3.0801 0.0 0
M  V30 19 N 6.6685 3.0801 0.0 0
M  V30 20 C 4.0012 7.7002 0.0 0
M  V30 21 N 2.6673 6.9302 0.0 0
M  V30 22 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 11 12
M  V30 12 1 11 22
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 1 19 22
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2060002-04-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2060002-33-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18357899
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product further converted into HCl salt with 84% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimido[5,4-d]pyrimidine derivatives as novel breathing
control modulating compounds for preventing and/or treating respiratory
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dax, Scott L.; Mencel, James Joseph; Ozola, Vita; Suna, Edgars; Shubin,
Kirill
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017003822 A1 2017-01-05

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Sulfoxonium, dimethyl(2-oxo-2-phenylethyl)-, inner salt
C10H12O2S
20718-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.8736 0.0 0
M  V30 2 C 5.3900 1.5400 0.0 0 CHG=-1
M  V30 3 O 5.3900 4.2073 0.0 0
M  V30 4 S 6.9300 1.5400 0.0 0 CHG=1 VAL=5
M  V30 5 C 8.4700 1.5400 0.0 0
M  V30 6 C 6.9300 3.0800 0.0 0
M  V30 7 O 6.9300 0.0000 0.0 0
M  V30 8 C 3.0800 2.8736 0.0 0
M  V30 9 C 2.3100 4.2073 0.0 0
M  V30 10 C 2.3100 1.5400 0.0 0
M  V30 11 C 0.7700 4.2073 0.0 0
M  V30 12 C 0.7700 1.5400 0.0 0
M  V30 13 C 0.0000 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-α-oxobenzeneacetamide
C9H9NO2
83490-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 N 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20718-17-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83490-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34645367
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal-Free Syntheses of α-Ketothioamide and α-Ketoamide Derivatives from
Sulfoxonium Ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chaubey, Trayambek Nath; Borpatra, Paran J.; Sharma, Ajay; Pandey,
Satyendra Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(43), 8062-8066

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
2-[4-Phenyl-5-(2-phenylethynyl)-1H-1,2,3-triazol-1-yl]benzoic acid
C23H15N3O2
2095051-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7117 5.8391 0.0 0
M  V30 2 C 8.1762 6.3151 0.0 0
M  V30 3 C 1.3336 7.8085 0.0 0
M  V30 4 O 1.3336 6.2684 0.0 0
M  V30 5 O 0.0000 8.5785 0.0 0
M  V30 6 N 4.0011 6.2684 0.0 0
M  V30 7 C 5.2470 5.3632 0.0 0
M  V30 8 N 2.7552 5.3632 0.0 0
M  V30 9 C 4.7711 3.8987 0.0 0
M  V30 10 N 3.2311 3.8987 0.0 0
M  V30 11 C 4.0011 7.8085 0.0 0
M  V30 12 C 2.6674 8.5785 0.0 0
M  V30 13 C 5.3347 8.5785 0.0 0
M  V30 14 C 2.6674 10.1185 0.0 0
M  V30 15 C 5.3347 10.1185 0.0 0
M  V30 16 C 4.0011 10.8885 0.0 0
M  V30 17 C 5.6763 2.6528 0.0 0
M  V30 18 C 7.2079 2.8137 0.0 0
M  V30 19 C 5.0498 1.2459 0.0 0
M  V30 20 C 8.1131 1.5679 0.0 0
M  V30 21 C 5.9551 0.0000 0.0 0
M  V30 22 C 7.4866 0.1609 0.0 0
M  V30 23 C 9.6409 6.7910 0.0 0
M  V30 24 C 10.7853 5.7604 0.0 0
M  V30 25 C 9.9611 8.2973 0.0 0
M  V30 26 C 12.2500 6.2364 0.0 0
M  V30 27 C 11.4256 8.7731 0.0 0
M  V30 28 C 12.5702 7.7427 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 12
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 11
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 1 9 17
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-[4-phenyl-5-(2-phenylethynyl)-1H-1,2,3-triazol-1-yl]benzamide
C24H18N4O
2408726-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8585 5.8391 0.0 0
M  V30 2 C 4.3940 6.3151 0.0 0
M  V30 3 C 11.2364 7.8085 0.0 0
M  V30 4 N 12.5702 8.5785 0.0 0
M  V30 5 O 11.2364 6.2684 0.0 0
M  V30 6 C 13.9038 7.8085 0.0 0
M  V30 7 N 8.5691 6.2684 0.0 0
M  V30 8 C 7.3232 5.3632 0.0 0
M  V30 9 N 9.8149 5.3632 0.0 0
M  V30 10 C 7.7991 3.8987 0.0 0
M  V30 11 N 9.3391 3.8987 0.0 0
M  V30 12 C 8.5691 7.8085 0.0 0
M  V30 13 C 9.9027 8.5785 0.0 0
M  V30 14 C 7.2354 8.5785 0.0 0
M  V30 15 C 9.9027 10.1185 0.0 0
M  V30 16 C 7.2354 10.1185 0.0 0
M  V30 17 C 8.5691 10.8885 0.0 0
M  V30 18 C 6.8938 2.6528 0.0 0
M  V30 19 C 5.3623 2.8137 0.0 0
M  V30 20 C 7.5202 1.2459 0.0 0
M  V30 21 C 4.4571 1.5679 0.0 0
M  V30 22 C 6.6151 0.0000 0.0 0
M  V30 23 C 5.0834 0.1609 0.0 0
M  V30 24 C 2.9292 6.7910 0.0 0
M  V30 25 C 2.6091 8.2973 0.0 0
M  V30 26 C 1.7849 5.7604 0.0 0
M  V30 27 C 1.1444 8.7731 0.0 0
M  V30 28 C 0.3202 6.2364 0.0 0
M  V30 29 C 0.0000 7.7427 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 2 24
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 12
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 1 10 18
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2095051-57-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2408726-28-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21455661
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst-Controlled Regioselective Synthesis of
Benzotriazolodiazepin-7-ones and Benzotriazolodiazocin-8-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Kai-Chi; Barve, Indrajeet J.; Sun, Chung-Ming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2020), 22(2), 428-432

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[[1-(2-Chloro-4-pyrimidinyl)cyclopropyl]carbonyl]amino]-4-methyl-N-[4-[3-(...
C30H31ClF3N5O4
2095854-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0236 8.0022 0.0 0
M  V30 2 N 7.5636 8.0022 0.0 0
M  V30 3 O 5.2536 6.6684 0.0 0
M  V30 4 Cl 0.0000 10.2621 0.0 0
M  V30 5 C 6.0236 5.3347 0.0 0
M  V30 6 C 12.1836 5.3347 0.0 0
M  V30 7 N 12.9536 4.0011 0.0 0
M  V30 8 O 12.9536 6.6684 0.0 0
M  V30 9 C 17.5736 1.3336 0.0 0
M  V30 10 F 18.9074 2.1036 0.0 0
M  V30 11 F 18.3436 0.0000 0.0 0
M  V30 12 F 16.2399 0.5636 0.0 0
M  V30 13 O 19.1136 4.0011 0.0 0
M  V30 14 C 19.8836 5.3347 0.0 0
M  V30 15 C 21.4236 5.3347 0.0 0
M  V30 16 C 22.1936 6.6684 0.0 0
M  V30 17 C 5.2536 9.3358 0.0 0
M  V30 18 C 4.9862 10.8524 0.0 0
M  V30 19 C 6.4334 10.3257 0.0 0
M  V30 20 C 3.8064 8.8091 0.0 0
M  V30 21 N 2.6268 9.7990 0.0 0
M  V30 22 C 3.5391 7.2925 0.0 0
M  V30 23 C 1.1796 9.2722 0.0 0
M  V30 24 C 2.0919 6.7657 0.0 0
M  V30 25 N 0.9123 7.7556 0.0 0
M  V30 26 C 8.3336 6.6684 0.0 0
M  V30 27 C 9.8736 6.6684 0.0 0
M  V30 28 C 7.5636 5.3347 0.0 0
M  V30 29 C 10.6436 5.3347 0.0 0
M  V30 30 C 8.3336 4.0011 0.0 0
M  V30 31 C 9.8736 4.0011 0.0 0
M  V30 32 C 14.4936 4.0011 0.0 0
M  V30 33 C 15.2636 2.6674 0.0 0
M  V30 34 C 15.2636 5.3347 0.0 0
M  V30 35 C 16.8036 2.6674 0.0 0
M  V30 36 C 16.8036 5.3347 0.0 0
M  V30 37 C 17.5736 4.0011 0.0 0
M  V30 38 N 23.7336 6.6684 0.0 0
M  V30 39 C 24.5036 5.3347 0.0 0
M  V30 40 C 24.5036 8.0022 0.0 0
M  V30 41 C 26.0436 5.3347 0.0 0
M  V30 42 C 26.0436 8.0022 0.0 0
M  V30 43 O 26.8136 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 26
M  V30 5 1 4 23
M  V30 6 1 5 28
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 29
M  V30 10 1 7 32
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 35
M  V30 15 1 13 14
M  V30 16 1 13 37
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 1 16 38
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 1 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-3-[[[1-[2-(methylamino)-4-pyrimidinyl]cyclopropyl]carbonyl]amino]-N-...
C31H35F3N6O4
1980821-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4708 8.0021 0.0 0
M  V30 2 N 9.0108 8.0021 0.0 0
M  V30 3 O 6.7008 6.6684 0.0 0
M  V30 4 N 1.4471 10.2621 0.0 0
M  V30 5 C 0.0000 9.7354 0.0 0
M  V30 6 C 7.4708 5.3347 0.0 0
M  V30 7 C 13.6308 5.3347 0.0 0
M  V30 8 N 14.4008 4.0011 0.0 0
M  V30 9 O 14.4008 6.6684 0.0 0
M  V30 10 C 19.0208 1.3336 0.0 0
M  V30 11 F 17.6872 0.5636 0.0 0
M  V30 12 F 19.7908 0.0000 0.0 0
M  V30 13 F 20.3545 2.1036 0.0 0
M  V30 14 O 20.5608 4.0011 0.0 0
M  V30 15 C 21.3308 5.3347 0.0 0
M  V30 16 C 22.8708 5.3347 0.0 0
M  V30 17 C 23.6408 6.6684 0.0 0
M  V30 18 C 6.7008 9.3358 0.0 0
M  V30 19 C 6.4334 10.8524 0.0 0
M  V30 20 C 7.8805 10.3257 0.0 0
M  V30 21 C 5.2537 8.8091 0.0 0
M  V30 22 N 4.0739 9.7990 0.0 0
M  V30 23 C 4.9862 7.2925 0.0 0
M  V30 24 C 2.6269 9.2722 0.0 0
M  V30 25 C 3.5391 6.7657 0.0 0
M  V30 26 N 2.3594 7.7556 0.0 0
M  V30 27 C 9.7808 6.6684 0.0 0
M  V30 28 C 11.3208 6.6684 0.0 0
M  V30 29 C 9.0108 5.3347 0.0 0
M  V30 30 C 12.0908 5.3347 0.0 0
M  V30 31 C 9.7808 4.0011 0.0 0
M  V30 32 C 11.3208 4.0011 0.0 0
M  V30 33 C 15.9408 4.0011 0.0 0
M  V30 34 C 16.7108 2.6674 0.0 0
M  V30 35 C 16.7108 5.3347 0.0 0
M  V30 36 C 18.2508 2.6674 0.0 0
M  V30 37 C 18.2508 5.3347 0.0 0
M  V30 38 C 19.0208 4.0011 0.0 0
M  V30 39 N 25.1808 6.6684 0.0 0
M  V30 40 C 25.9508 8.0021 0.0 0
M  V30 41 C 25.9508 5.3347 0.0 0
M  V30 42 C 27.4908 8.0021 0.0 0
M  V30 43 C 27.4908 5.3347 0.0 0
M  V30 44 O 28.2608 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 27
M  V30 5 1 4 5
M  V30 6 1 4 24
M  V30 7 1 6 29
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 30
M  V30 11 1 8 33
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 36
M  V30 16 1 14 15
M  V30 17 1 14 38
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 1 17 39
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 18 21
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 43 1 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2095854-37-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1980821-46-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17233432
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational design, synthesis, and biological evaluation of Pan-Raf
inhibitors to overcome resistance
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Lu; Zhu, Gaoyuan; Zhang, Qing; Duan, Chunqi; Zhang, Yanmin; Zhang,
Zhimin; Zhou, Yujun; Lu, Tao; Tang, Weifang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2017), 15(16), 3455-3465

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[[1-(2-Chloro-4-pyrimidinyl)cyclopropyl]carbonyl]amino]-N-[4-chloro-3-(tri...
C23H17Cl2F3N4O2
2095854-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9690 4.0011 0.0 0
M  V30 2 N 5.7390 2.6673 0.0 0
M  V30 3 O 5.7390 5.3347 0.0 0
M  V30 4 Cl 0.0000 8.0876 0.0 0
M  V30 5 C 7.2790 0.0000 0.0 0
M  V30 6 C 10.3590 5.3347 0.0 0
M  V30 7 N 11.8990 5.3347 0.0 0
M  V30 8 O 9.5890 6.6684 0.0 0
M  V30 9 C 16.5190 8.0021 0.0 0
M  V30 10 F 16.5190 9.5421 0.0 0
M  V30 11 F 18.0590 8.0021 0.0 0
M  V30 12 F 16.5190 6.4621 0.0 0
M  V30 13 Cl 14.9790 10.6694 0.0 0
M  V30 14 C 3.4290 4.0011 0.0 0
M  V30 15 C 3.1616 2.4845 0.0 0
M  V30 16 C 1.9818 3.4744 0.0 0
M  V30 17 C 3.1616 5.5177 0.0 0
M  V30 18 N 1.7145 6.0443 0.0 0
M  V30 19 C 4.3413 6.5076 0.0 0
M  V30 20 C 1.4471 7.5609 0.0 0
M  V30 21 C 4.0739 8.0242 0.0 0
M  V30 22 N 2.6268 8.5509 0.0 0
M  V30 23 C 7.2790 2.6673 0.0 0
M  V30 24 C 8.0490 4.0011 0.0 0
M  V30 25 C 8.0490 1.3336 0.0 0
M  V30 26 C 9.5890 4.0011 0.0 0
M  V30 27 C 9.5890 1.3336 0.0 0
M  V30 28 C 10.3590 2.6673 0.0 0
M  V30 29 C 12.6690 6.6684 0.0 0
M  V30 30 C 14.2090 6.6684 0.0 0
M  V30 31 C 11.8990 8.0021 0.0 0
M  V30 32 C 14.9790 8.0021 0.0 0
M  V30 33 C 12.6690 9.3358 0.0 0
M  V30 34 C 14.2090 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 23
M  V30 5 1 4 20
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 26
M  V30 10 1 7 29
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 32
M  V30 15 1 13 34
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-Chloro-3-(trifluoromethyl)phenyl]-4-methyl-3-[[[1-[2-(methylamino)-4-pyr...
C24H21ClF3N5O2
1980821-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2366 4.0011 0.0 0
M  V30 2 N 6.0066 2.6673 0.0 0
M  V30 3 O 6.0066 5.3347 0.0 0
M  V30 4 N 0.2675 8.0876 0.0 0
M  V30 5 C 0.0000 9.6042 0.0 0
M  V30 6 C 7.5466 0.0000 0.0 0
M  V30 7 C 10.6266 5.3347 0.0 0
M  V30 8 N 12.1666 5.3347 0.0 0
M  V30 9 O 9.8566 6.6684 0.0 0
M  V30 10 C 16.7866 8.0021 0.0 0
M  V30 11 F 16.7866 6.4621 0.0 0
M  V30 12 F 18.3266 8.0021 0.0 0
M  V30 13 F 16.7866 9.5421 0.0 0
M  V30 14 Cl 15.2466 10.6694 0.0 0
M  V30 15 C 3.6966 4.0011 0.0 0
M  V30 16 C 3.4291 2.4845 0.0 0
M  V30 17 C 2.2495 3.4744 0.0 0
M  V30 18 C 3.4291 5.5177 0.0 0
M  V30 19 N 1.9820 6.0443 0.0 0
M  V30 20 C 4.6089 6.5076 0.0 0
M  V30 21 C 1.7146 7.5609 0.0 0
M  V30 22 C 4.3414 8.0242 0.0 0
M  V30 23 N 2.8943 8.5508 0.0 0
M  V30 24 C 7.5466 2.6673 0.0 0
M  V30 25 C 8.3166 4.0011 0.0 0
M  V30 26 C 8.3166 1.3336 0.0 0
M  V30 27 C 9.8566 4.0011 0.0 0
M  V30 28 C 9.8566 1.3336 0.0 0
M  V30 29 C 10.6266 2.6673 0.0 0
M  V30 30 C 12.9366 6.6684 0.0 0
M  V30 31 C 14.4766 6.6684 0.0 0
M  V30 32 C 12.1666 8.0021 0.0 0
M  V30 33 C 15.2466 8.0021 0.0 0
M  V30 34 C 12.9366 9.3358 0.0 0
M  V30 35 C 14.4766 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 24
M  V30 5 1 4 5
M  V30 6 1 4 21
M  V30 7 1 6 26
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 27
M  V30 11 1 8 30
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 33
M  V30 16 1 14 35
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2095854-69-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1980821-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17233412
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational design, synthesis, and biological evaluation of Pan-Raf
inhibitors to overcome resistance
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Lu; Zhu, Gaoyuan; Zhang, Qing; Duan, Chunqi; Zhang, Yanmin; Zhang,
Zhimin; Zhou, Yujun; Lu, Tao; Tang, Weifang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2017), 15(16), 3455-3465

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2,3-dihydro-2-[(4-methoxyphenyl)methyl]-7-methyl-3,3-bis[2-[(methylsu...
C23H28BrNO8S2
2097013-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4826 5.3348 0.0 0
M  V30 2 C 6.7125 4.0012 0.0 0
M  V30 3 O 7.4826 2.6675 0.0 0
M  V30 4 S 6.7125 1.3338 0.0 0 VAL=6
M  V30 5 C 5.3789 2.1038 0.0 0
M  V30 6 O 5.9425 0.0000 0.0 0
M  V30 7 O 8.0462 0.5638 0.0 0
M  V30 8 C 5.4667 5.7634 0.0 0
M  V30 9 C 4.0597 6.3898 0.0 0
M  V30 10 O 2.8138 5.4845 0.0 0
M  V30 11 S 1.4070 6.1110 0.0 0 VAL=6
M  V30 12 C 2.0333 7.5178 0.0 0
M  V30 13 O 0.0000 6.7373 0.0 0
M  V30 14 O 0.7805 4.7040 0.0 0
M  V30 15 C 9.4532 6.5250 0.0 0
M  V30 16 O 9.1028 9.8570 0.0 0
M  V30 17 C 6.4521 11.8142 0.0 0
M  V30 18 Br 1.8320 9.1467 0.0 0
M  V30 19 O 14.7880 9.6050 0.0 0
M  V30 20 C 16.1217 8.8350 0.0 0
M  V30 21 C 6.7125 6.6687 0.0 0
M  V30 22 C 5.6821 7.8131 0.0 0
M  V30 23 N 8.1194 7.2950 0.0 0
M  V30 24 C 6.4521 9.1467 0.0 0
M  V30 25 C 4.1421 7.8131 0.0 0
M  V30 26 C 7.9584 8.8265 0.0 0
M  V30 27 C 5.6821 10.4804 0.0 0
M  V30 28 C 3.3721 9.1467 0.0 0
M  V30 29 C 4.1421 10.4804 0.0 0
M  V30 30 C 10.7869 7.2950 0.0 0
M  V30 31 C 10.7869 8.8350 0.0 0
M  V30 32 C 12.1205 6.5250 0.0 0
M  V30 33 C 12.1205 9.6050 0.0 0
M  V30 34 C 13.4542 7.2950 0.0 0
M  V30 35 C 13.4542 8.8350 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 8 9
M  V30 9 1 8 21
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 11 14
M  V30 15 1 15 23
M  V30 16 1 15 30
M  V30 17 2 16 26
M  V30 18 1 17 27
M  V30 19 1 18 28
M  V30 20 1 19 20
M  V30 21 1 19 35
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 22 25
M  V30 26 1 23 26
M  V30 27 1 24 26
M  V30 28 2 24 27
M  V30 29 1 25 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[1H-isoindole-1,4′-piperidin]-3(2H)-one, 6-bromo-2-[(4-methoxyphenyl)met...
C22H25BrN2O2
2096979-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6211 4.3753 0.0 0
M  V30 2 O 7.2709 7.7075 0.0 0
M  V30 3 C 4.6201 9.6645 0.0 0
M  V30 4 Br 0.0000 6.9972 0.0 0
M  V30 5 C 3.9200 0.0000 0.0 0
M  V30 6 O 12.9559 7.4554 0.0 0
M  V30 7 C 14.2895 6.6854 0.0 0
M  V30 8 C 4.8805 4.5190 0.0 0
M  V30 9 C 3.8500 5.6636 0.0 0
M  V30 10 N 6.2874 5.1454 0.0 0
M  V30 11 C 3.4159 4.0432 0.0 0
M  V30 12 C 6.0250 3.4886 0.0 0
M  V30 13 C 4.6201 6.9972 0.0 0
M  V30 14 C 2.3100 5.6636 0.0 0
M  V30 15 C 6.1263 6.6771 0.0 0
M  V30 16 C 3.0956 2.5367 0.0 0
M  V30 17 C 5.7047 1.9822 0.0 0
M  V30 18 C 3.8500 8.3309 0.0 0
M  V30 19 C 1.5400 6.9972 0.0 0
M  V30 20 N 4.2401 1.5063 0.0 0
M  V30 21 C 2.3100 8.3309 0.0 0
M  V30 22 C 8.9547 5.1454 0.0 0
M  V30 23 C 10.2884 4.3753 0.0 0
M  V30 24 C 8.9547 6.6854 0.0 0
M  V30 25 C 11.6222 5.1454 0.0 0
M  V30 26 C 10.2884 7.4554 0.0 0
M  V30 27 C 11.6222 6.6854 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 22
M  V30 3 2 2 15
M  V30 4 1 3 18
M  V30 5 1 4 19
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 27
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 2 13 18
M  V30 20 1 14 19
M  V30 21 1 16 20
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2097013-93-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2096979-86-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-17325811
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoindoline, azaisoindoline, dihydroindenone and
dihydroazaindenone inhibitors of Mnk1 and Mnk2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sprengeler, Paul A.; Reich, Siegfried H.; Ernst, Justin T.; Webber,
Stephen E.; Shaghafi, Mike; Murphy, Douglas; Tran, Chinh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017075394 A1 2017-05-04

$RFMT $RIREG SCHEME182 STEP1
$RXN



  2  1
$MOL
rel-(4bR,5S,6S,7R,7aS)-7a-(4-Bromophenyl)-4b,6,7,7a-tetrahydro-4b,5-dihydroxy...
C24H20BrNO6
2098194-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4389 3.8782 0.0 0
M  V30 2 O 8.0156 1.9426 0.0 0
M  V30 3 C 4.7383 1.2459 0.0 0
M  V30 4 O 3.2068 1.0849 0.0 0
M  V30 5 O 5.6435 0.0000 0.0 0
M  V30 6 O 10.3726 4.3153 0.0 0
M  V30 7 C 11.9126 4.3153 0.0 0
M  V30 8 Br 1.5839 9.7800 0.0 0
M  V30 9 C 5.6252 5.1308 0.0 0 CFG=1
M  V30 10 C 7.0321 4.5045 0.0 0 CFG=2
M  V30 11 C 4.5948 3.9865 0.0 0 CFG=2
M  V30 12 O 5.7861 6.6625 0.0 0
M  V30 13 C 8.0626 5.6491 0.0 0
M  V30 14 C 6.8711 2.9730 0.0 0 CFG=2
M  V30 15 C 5.3648 2.6528 0.0 0 CFG=1
M  V30 16 C 7.2926 6.9827 0.0 0
M  V30 17 C 9.6026 5.6491 0.0 0
M  V30 18 C 8.0626 8.3164 0.0 0
M  V30 19 C 10.3726 6.9827 0.0 0
M  V30 20 N 9.6026 8.3164 0.0 0
M  V30 21 C 4.6149 6.2932 0.0 0
M  V30 22 C 3.1031 5.9993 0.0 0
M  V30 23 C 5.1162 7.7493 0.0 0
M  V30 24 C 2.0929 7.1617 0.0 0
M  V30 25 C 4.1060 8.9116 0.0 0
M  V30 26 C 2.5941 8.6177 0.0 0
M  V30 27 C 3.0632 4.1474 0.0 0
M  V30 28 C 2.4368 5.5543 0.0 0
M  V30 29 C 2.1580 2.9015 0.0 0
M  V30 30 C 0.9052 5.7153 0.0 0
M  V30 31 C 0.6265 3.0625 0.0 0
M  V30 32 C 0.0000 4.4694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=1
M  V30 2 1 14 2 CFG=3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 15 3 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 8 26
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 21 CFG=1
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 11 27 CFG=1
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 13 17
M  V30 20 1 14 15
M  V30 21 2 16 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 9 10 11 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5H-Cyclopenta[4,5]furo[2,3-c]pyridine-6-carboxamide, 7a-(4-bromophenyl)-4b,6,...
C25H23BrN2O5
2098194-89-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4390 5.2850 0.0 0
M  V30 2 O 8.0157 3.3494 0.0 0
M  V30 3 C 4.7383 2.6528 0.0 0
M  V30 4 N 5.6436 1.4070 0.0 0
M  V30 5 O 3.2068 2.4919 0.0 0
M  V30 6 C 5.0172 0.0000 0.0 0
M  V30 7 O 10.3727 5.7223 0.0 0
M  V30 8 C 11.9127 5.7223 0.0 0
M  V30 9 Br 1.5839 11.1870 0.0 0
M  V30 10 C 5.6252 6.5379 0.0 0 CFG=1
M  V30 11 C 7.0322 5.9115 0.0 0 CFG=2
M  V30 12 C 4.5948 5.3935 0.0 0 CFG=2
M  V30 13 O 5.7862 8.0694 0.0 0
M  V30 14 C 8.0626 7.0559 0.0 0
M  V30 15 C 6.8711 4.3800 0.0 0 CFG=2
M  V30 16 C 5.3648 4.0597 0.0 0 CFG=1
M  V30 17 C 7.2926 8.3897 0.0 0
M  V30 18 C 9.6027 7.0559 0.0 0
M  V30 19 C 8.0626 9.7234 0.0 0
M  V30 20 C 10.3727 8.3897 0.0 0
M  V30 21 N 9.6027 9.7234 0.0 0
M  V30 22 C 4.6150 7.7001 0.0 0
M  V30 23 C 3.1031 7.4063 0.0 0
M  V30 24 C 5.1163 9.1562 0.0 0
M  V30 25 C 2.0929 8.5685 0.0 0
M  V30 26 C 4.1060 10.3186 0.0 0
M  V30 27 C 2.5942 10.0246 0.0 0
M  V30 28 C 3.0633 5.5544 0.0 0
M  V30 29 C 2.1580 4.3085 0.0 0
M  V30 30 C 2.4368 6.9612 0.0 0
M  V30 31 C 0.6265 4.4695 0.0 0
M  V30 32 C 0.9052 7.1223 0.0 0
M  V30 33 C 0.0000 5.8764 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 1 15 2 CFG=3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 16 3 CFG=3
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 18
M  V30 9 1 9 27
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 22 CFG=1
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 28 CFG=1
M  V30 18 1 13 17
M  V30 19 1 14 17
M  V30 20 2 14 18
M  V30 21 1 15 16
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 10 11 12 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2098194-70-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2098194-89-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22369239
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design of Development Candidate eFT226, a First in Class Inhibitor of
Eukaryotic Initiation Factor 4A RNA Helicase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ernst, Justin T.; Thompson, Peggy A.; Nilewski, Christian; Sprengeler,
Paul A.; Sperry, Samuel; Packard, Garrick; Michels, Theodore; Xiang,
Alan; Tran, Chinh; Wegerski, Christopher J.; Eam, Boreth; Young, Nathan
P.; Fish, Sarah; Chen, Joan; Howard, Haleigh; Staunton, Jocelyn; Molter,
Jolene; Clarine, Jeff; Nevarez, Andres; Chiang, Gary G.; Appleman, Jim
R.; Webster, Kevin R.; Reich, Siegfried H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(11), 5879-5955

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(Cyclopentyloxy)-1,2,3,4-tetrahydro-6-methoxy-2-[4-(trifluoromethoxy)benzoy...
C24H24F3NO6
2106853-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 9.5517 0.0 0
M  V30 2 O 8.0021 11.0917 0.0 0
M  V30 3 O 4.0011 2.6217 0.0 0
M  V30 4 C 5.3347 11.0917 0.0 0
M  V30 5 O 6.6685 11.8617 0.0 0
M  V30 6 O 4.0011 11.8617 0.0 0
M  V30 7 O 1.3338 4.1617 0.0 0
M  V30 8 C 0.0000 4.9317 0.0 0
M  V30 9 O 13.3369 6.4717 0.0 0
M  V30 10 C 14.6705 7.2417 0.0 0
M  V30 11 F 16.0043 6.4717 0.0 0
M  V30 12 F 16.0043 8.0117 0.0 0
M  V30 13 F 14.6705 8.7817 0.0 0
M  V30 14 C 5.3347 6.4717 0.0 0
M  V30 15 C 4.0011 7.2417 0.0 0
M  V30 16 C 6.6685 7.2417 0.0 0
M  V30 17 C 5.3347 4.9317 0.0 0
M  V30 18 C 4.0011 8.7817 0.0 0
M  V30 19 C 2.6674 6.4717 0.0 0
M  V30 20 N 6.6685 8.7817 0.0 0
M  V30 21 C 4.0011 4.1617 0.0 0
M  V30 22 C 5.3347 9.5517 0.0 0
M  V30 23 C 2.6674 4.9317 0.0 0
M  V30 24 C 9.3358 8.7817 0.0 0
M  V30 25 C 9.3358 7.2417 0.0 0
M  V30 26 C 10.6696 9.5517 0.0 0
M  V30 27 C 10.6696 6.4717 0.0 0
M  V30 28 C 12.0032 8.7817 0.0 0
M  V30 29 C 12.0032 7.2417 0.0 0
M  V30 30 C 5.3347 1.8517 0.0 0
M  V30 31 C 6.7417 2.4782 0.0 0
M  V30 32 C 5.4958 0.3202 0.0 0
M  V30 33 C 7.7721 1.3336 0.0 0
M  V30 34 C 7.0021 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 20
M  V30 3 1 1 24
M  V30 4 1 3 21
M  V30 5 1 3 30
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 4 22
M  V30 9 1 7 8
M  V30 10 1 7 23
M  V30 11 1 9 10
M  V30 12 1 9 29
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(Cyclopentyloxy)-1,2,3,4-tetrahydro-6-methoxy-N-methyl-2-[4-(trifluorometho...
C25H27F3N2O5
2106853-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 9.5517 0.0 0
M  V30 2 O 8.0021 11.0917 0.0 0
M  V30 3 O 4.0011 2.6217 0.0 0
M  V30 4 C 5.3349 11.0917 0.0 0
M  V30 5 N 4.0011 11.8617 0.0 0
M  V30 6 O 6.6685 11.8617 0.0 0
M  V30 7 C 4.0011 13.4017 0.0 0
M  V30 8 O 1.3338 4.1617 0.0 0
M  V30 9 C 0.0000 4.9317 0.0 0
M  V30 10 O 13.3369 6.4717 0.0 0
M  V30 11 C 14.6705 7.2417 0.0 0
M  V30 12 F 16.0043 6.4717 0.0 0
M  V30 13 F 16.0043 8.0117 0.0 0
M  V30 14 F 14.6705 8.7817 0.0 0
M  V30 15 C 5.3347 6.4717 0.0 0
M  V30 16 C 4.0011 7.2417 0.0 0
M  V30 17 C 6.6685 7.2417 0.0 0
M  V30 18 C 5.3347 4.9317 0.0 0
M  V30 19 C 4.0011 8.7817 0.0 0
M  V30 20 C 2.6674 6.4717 0.0 0
M  V30 21 N 6.6685 8.7817 0.0 0
M  V30 22 C 4.0011 4.1617 0.0 0
M  V30 23 C 5.3349 9.5517 0.0 0
M  V30 24 C 2.6674 4.9317 0.0 0
M  V30 25 C 9.3358 8.7817 0.0 0
M  V30 26 C 10.6696 9.5517 0.0 0
M  V30 27 C 9.3358 7.2417 0.0 0
M  V30 28 C 12.0032 8.7817 0.0 0
M  V30 29 C 10.6696 6.4717 0.0 0
M  V30 30 C 12.0032 7.2417 0.0 0
M  V30 31 C 5.3347 1.8517 0.0 0
M  V30 32 C 5.4958 0.3202 0.0 0
M  V30 33 C 6.7417 2.4782 0.0 0
M  V30 34 C 7.0021 0.0000 0.0 0
M  V30 35 C 7.7721 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 21
M  V30 3 1 1 25
M  V30 4 1 3 22
M  V30 5 1 3 31
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 4 23
M  V30 9 1 5 7
M  V30 10 1 8 9
M  V30 11 1 8 24
M  V30 12 1 10 11
M  V30 13 1 10 30
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2106853-14-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2106853-22-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18850785
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design and structure-activity relationships of
1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liao, Yixian; Guo, Yiming; Li, Sumei; Wang, Lei; Tang, Yongmei; Li,
Tianmiao; Chen, Weihao; Zhong, Guohua; Song, Gaopeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2018), 28(7), 1188-1193

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[2-(Acetylamino)-4-methyl-5-thiazolyl]-2-[(1S)-1-cyclopropylethyl]-2,3-dihy...
C19H20ClN3O4S2
2132961-85-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 7.3472 1.5400 0.0 0 VAL=6
M  V30 2 Cl 7.3472 0.0000 0.0 0
M  V30 3 O 8.8872 1.5400 0.0 0
M  V30 4 O 5.8072 1.5400 0.0 0
M  V30 5 O 4.0730 1.9095 0.0 0
M  V30 6 C 2.1037 4.6200 0.0 0 CFG=1
M  V30 7 C 1.3336 3.2864 0.0 0
M  V30 8 C 9.0311 8.7220 0.0 0
M  V30 9 N 13.9834 6.5172 0.0 0
M  V30 10 C 14.8886 7.7630 0.0 0
M  V30 11 C 14.2623 9.1698 0.0 0
M  V30 12 O 16.4202 7.6019 0.0 0
M  V30 13 C 6.0134 3.8500 0.0 0
M  V30 14 C 6.0134 5.3900 0.0 0
M  V30 15 C 7.3472 3.0800 0.0 0
M  V30 16 C 4.5489 3.3742 0.0 0
M  V30 17 C 7.3472 6.1600 0.0 0
M  V30 18 C 4.5489 5.8659 0.0 0
M  V30 19 C 8.6809 3.8500 0.0 0
M  V30 20 N 3.6437 4.6200 0.0 0
M  V30 21 C 8.6809 5.3900 0.0 0
M  V30 22 C 10.0145 6.1600 0.0 0
M  V30 23 S 11.4215 5.5336 0.0 0
M  V30 24 C 10.1754 7.6916 0.0 0
M  V30 25 C 12.4519 6.6781 0.0 0
M  V30 26 N 11.6819 8.0117 0.0 0
M  V30 27 C 1.3336 5.9537 0.0 0
M  V30 28 C 0.0000 6.7237 0.0 0
M  V30 29 C 1.3336 7.4937 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 15
M  V30 5 2 5 16
M  V30 6 1 6 7 CFG=1
M  V30 7 1 6 20
M  V30 8 1 6 27
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 1 9 25
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[5-[2-[(1S)-1-Cyclopropylethyl]-2,3-dihydro-7-[(methylamino)sulfonyl]-1-oxo...
C20H24N4O4S2
2132961-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 7.3472 2.3100 0.0 0 VAL=6
M  V30 2 N 7.3472 0.7700 0.0 0
M  V30 3 O 8.8872 2.3100 0.0 0
M  V30 4 O 5.8072 2.3100 0.0 0
M  V30 5 C 8.6809 0.0000 0.0 0
M  V30 6 O 4.0730 2.6795 0.0 0
M  V30 7 C 2.1037 5.3900 0.0 0 CFG=1
M  V30 8 C 1.3336 4.0564 0.0 0
M  V30 9 C 9.0311 9.4920 0.0 0
M  V30 10 N 13.9834 7.2872 0.0 0
M  V30 11 C 14.8886 8.5330 0.0 0
M  V30 12 C 14.2623 9.9398 0.0 0
M  V30 13 O 16.4202 8.3719 0.0 0
M  V30 14 C 6.0134 4.6200 0.0 0
M  V30 15 C 6.0134 6.1600 0.0 0
M  V30 16 C 7.3472 3.8500 0.0 0
M  V30 17 C 4.5489 4.1442 0.0 0
M  V30 18 C 7.3472 6.9300 0.0 0
M  V30 19 C 4.5489 6.6359 0.0 0
M  V30 20 C 8.6809 4.6200 0.0 0
M  V30 21 N 3.6437 5.3900 0.0 0
M  V30 22 C 8.6809 6.1600 0.0 0
M  V30 23 C 10.0145 6.9300 0.0 0
M  V30 24 S 11.4215 6.3036 0.0 0
M  V30 25 C 10.1754 8.4616 0.0 0
M  V30 26 C 12.4519 7.4481 0.0 0
M  V30 27 N 11.6819 8.7817 0.0 0
M  V30 28 C 1.3336 6.7237 0.0 0
M  V30 29 C 0.0000 7.4937 0.0 0
M  V30 30 C 1.3336 8.2637 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 16
M  V30 5 1 2 5
M  V30 6 2 6 17
M  V30 7 1 7 8 CFG=1
M  V30 8 1 7 21
M  V30 9 1 7 28
M  V30 10 1 9 25
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 2 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2132961-85-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2132961-51-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-19062535
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Highly Isoform Selective Orally Bioavailable
Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pemberton, Nils; Mogemark, Mickael; Arlbrandt, Susanne; Bold, Peter; Cox,
Rhona J.; Gardelli, Cristina; Holden, Neil S.; Karabelas, Kostas;
Karlsson, Johan; Lever, Sarah; Li, Xueshan; Lindmark, Helena; Norberg,
Monica; Perry, Matthew W. D.; Petersen, Jens; Rodrigo Blomqvist, Sandra;
Thomas, Matthew; Tyrchan, Christian; Westin Eriksson, Annika; Zlatoidsky,
Pavol; Oester, Linda
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2018), 61(12), 5435-5441

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[2-(Acetylamino)-4-methyl-5-thiazolyl]-2-[(1S)-1-cyclopropylethyl]-2,3-dihy...
C19H20ClN3O4S2
2132961-85-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 7.3472 1.5400 0.0 0 VAL=6
M  V30 2 Cl 7.3472 0.0000 0.0 0
M  V30 3 O 8.8872 1.5400 0.0 0
M  V30 4 O 5.8072 1.5400 0.0 0
M  V30 5 O 4.0730 1.9095 0.0 0
M  V30 6 C 2.1037 4.6200 0.0 0 CFG=1
M  V30 7 C 1.3336 3.2864 0.0 0
M  V30 8 C 9.0311 8.7220 0.0 0
M  V30 9 N 13.9834 6.5172 0.0 0
M  V30 10 C 14.8886 7.7630 0.0 0
M  V30 11 C 14.2623 9.1698 0.0 0
M  V30 12 O 16.4202 7.6019 0.0 0
M  V30 13 C 6.0134 3.8500 0.0 0
M  V30 14 C 6.0134 5.3900 0.0 0
M  V30 15 C 7.3472 3.0800 0.0 0
M  V30 16 C 4.5489 3.3742 0.0 0
M  V30 17 C 7.3472 6.1600 0.0 0
M  V30 18 C 4.5489 5.8659 0.0 0
M  V30 19 C 8.6809 3.8500 0.0 0
M  V30 20 N 3.6437 4.6200 0.0 0
M  V30 21 C 8.6809 5.3900 0.0 0
M  V30 22 C 10.0145 6.1600 0.0 0
M  V30 23 S 11.4215 5.5336 0.0 0
M  V30 24 C 10.1754 7.6916 0.0 0
M  V30 25 C 12.4519 6.6781 0.0 0
M  V30 26 N 11.6819 8.0117 0.0 0
M  V30 27 C 1.3336 5.9537 0.0 0
M  V30 28 C 0.0000 6.7237 0.0 0
M  V30 29 C 1.3336 7.4937 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 15
M  V30 5 2 5 16
M  V30 6 1 6 7 CFG=1
M  V30 7 1 6 20
M  V30 8 1 6 27
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 1 9 25
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[5-[2-[(1S)-1-Cyclopropylethyl]-2,3-dihydro-7-[(methylamino)sulfonyl]-1-oxo...
C20H24N4O4S2
2132961-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 7.3472 2.3100 0.0 0 VAL=6
M  V30 2 N 7.3472 0.7700 0.0 0
M  V30 3 O 8.8872 2.3100 0.0 0
M  V30 4 O 5.8072 2.3100 0.0 0
M  V30 5 C 8.6809 0.0000 0.0 0
M  V30 6 O 4.0730 2.6795 0.0 0
M  V30 7 C 2.1037 5.3900 0.0 0 CFG=1
M  V30 8 C 1.3336 4.0564 0.0 0
M  V30 9 C 9.0311 9.4920 0.0 0
M  V30 10 N 13.9834 7.2872 0.0 0
M  V30 11 C 14.8886 8.5330 0.0 0
M  V30 12 C 14.2623 9.9398 0.0 0
M  V30 13 O 16.4202 8.3719 0.0 0
M  V30 14 C 6.0134 4.6200 0.0 0
M  V30 15 C 6.0134 6.1600 0.0 0
M  V30 16 C 7.3472 3.8500 0.0 0
M  V30 17 C 4.5489 4.1442 0.0 0
M  V30 18 C 7.3472 6.9300 0.0 0
M  V30 19 C 4.5489 6.6359 0.0 0
M  V30 20 C 8.6809 4.6200 0.0 0
M  V30 21 N 3.6437 5.3900 0.0 0
M  V30 22 C 8.6809 6.1600 0.0 0
M  V30 23 C 10.0145 6.9300 0.0 0
M  V30 24 S 11.4215 6.3036 0.0 0
M  V30 25 C 10.1754 8.4616 0.0 0
M  V30 26 C 12.4519 7.4481 0.0 0
M  V30 27 N 11.6819 8.7817 0.0 0
M  V30 28 C 1.3336 6.7237 0.0 0
M  V30 29 C 0.0000 7.4937 0.0 0
M  V30 30 C 1.3336 8.2637 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 16
M  V30 5 1 2 5
M  V30 6 2 6 17
M  V30 7 1 7 8 CFG=1
M  V30 8 1 7 21
M  V30 9 1 7 28
M  V30 10 1 9 25
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 2 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2132961-85-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2132961-51-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-18930143
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted isoindolones as novel inhibitors of
phosphatidylinositol 3-kinase gamma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mogemark, Mickael; Pemberton, Nils; Petersen, Jens; Perry, Matthew;
Karabelas, Konstantinos; Zlatoidsky, Pavol; Cox, Rhona; Tyrchan,
Christian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017153527 A1 2017-09-14

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
2-[(1E)-2-[4-(1,1-Dimethylethyl)phenyl]ethenyl]benzoic acid
C19H20O2
2135942-87-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3349 0.0 0
M  V30 3 C 3.0800 1.3338 0.0 0
M  V30 4 O 4.6200 1.3338 0.0 0
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 C 11.5500 5.3349 0.0 0
M  V30 7 C 11.5500 3.7949 0.0 0
M  V30 8 C 13.0900 5.3349 0.0 0
M  V30 9 C 11.5500 6.8749 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.7700 5.3349 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 16 C 6.9300 5.3349 0.0 0
M  V30 17 C 7.7000 6.6685 0.0 0
M  V30 18 C 7.7000 4.0011 0.0 0
M  V30 19 C 9.2400 6.6685 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 21 C 10.0100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-[4-(1,1-Dimethylethyl)phenyl]ethenyl]-N-methylbenzamide
C20H23NO
2180952-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 C 5.3900 6.6685 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 N 2.3100 1.3338 0.0 0
M  V30 5 O 4.6200 2.6674 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 11.5500 6.6685 0.0 0
M  V30 8 C 11.5500 8.2085 0.0 0
M  V30 9 C 13.0900 6.6685 0.0 0
M  V30 10 C 11.5500 5.1285 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 2.3100 6.6685 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 C 7.7000 8.0021 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 9.2400 8.0021 0.0 0
M  V30 22 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 12
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2135942-87-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2180952-15-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35010600
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM 0.35 mmol scale used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal- and Oxidant-Free Electrosynthesis of Heterocycles from
1,2-Diarylalkene Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yu, Eunsoo; Kim, Hyungguk; Park, Cheol-Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2022), 364(23), 4088-4096

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL

C34H50O6
2172642-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.5893 5.3778 0.0 0
M  V30 2 C 8.6531 10.4304 0.0 0
M  V30 3 C 8.6257 4.0738 0.0 0
M  V30 4 O 9.1015 2.6091 0.0 0
M  V30 5 C 8.0711 1.4647 0.0 0
M  V30 6 C 6.5647 1.7849 0.0 0
M  V30 7 O 8.5470 0.0000 0.0 0
M  V30 8 C 7.5518 11.0661 0.0 0
M  V30 9 C 12.7194 7.7101 0.0 0
M  V30 10 O 14.2509 7.5490 0.0 0
M  V30 11 C 15.1561 8.7949 0.0 0
M  V30 12 C 16.6877 8.6340 0.0 0
M  V30 13 O 14.5297 10.2019 0.0 0
M  V30 14 C 13.1478 5.6941 0.0 0
M  V30 15 C 4.0011 12.8848 0.0 0
M  V30 16 O 2.6675 13.6548 0.0 0
M  V30 17 O 5.3348 13.6548 0.0 0
M  V30 18 C 2.6675 7.4947 0.0 0
M  V30 19 C 0.0000 9.0347 0.0 0
M  V30 20 C 8.0023 7.4947 0.0 0 CFG=1
M  V30 21 C 9.3359 6.7247 0.0 0 CFG=2
M  V30 22 C 8.0023 9.0347 0.0 0 CFG=2
M  V30 23 C 6.6685 6.7247 0.0 0
M  V30 24 C 10.6696 7.4947 0.0 0 CFG=1
M  V30 25 C 9.6561 5.2182 0.0 0
M  V30 26 C 6.6685 9.8047 0.0 0 CFG=1
M  V30 27 C 9.3359 9.8047 0.0 0
M  V30 28 C 5.3348 7.4947 0.0 0
M  V30 29 C 11.8141 6.4641 0.0 0 CFG=2
M  V30 30 C 10.6696 9.0347 0.0 0
M  V30 31 C 11.1876 5.0573 0.0 0
M  V30 32 C 5.3348 9.0347 0.0 0
M  V30 33 C 6.6685 11.3447 0.0 0
M  V30 34 C 4.0011 9.8047 0.0 0 CFG=2
M  V30 35 C 5.3348 12.1147 0.0 0
M  V30 36 C 4.0011 11.3447 0.0 0 CFG=1
M  V30 37 C 2.6675 9.0347 0.0 0 CFG=1
M  V30 38 C 2.6675 12.1147 0.0 0
M  V30 39 C 1.3337 9.8047 0.0 0 CFG=2
M  V30 40 C 1.3337 11.3447 0.0 0
M  V30 41 H 7.3515 6.0990 0.0 0
M  V30 42 H 12.0766 8.1210 0.0 0
M  V30 43 H 4.0011 8.2647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 21 1 CFG=1
M  V30 2 1 22 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 25
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 26 8 CFG=3
M  V30 9 1 9 10
M  V30 10 1 29 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 29 14 CFG=1
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 36 15 CFG=1
M  V30 18 1 37 18 CFG=1
M  V30 19 1 39 19 CFG=3
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 20 41 CFG=3
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 22 27
M  V30 28 1 23 28
M  V30 29 1 24 29
M  V30 30 1 24 30
M  V30 31 1 24 42 CFG=3
M  V30 32 2 25 31
M  V30 33 1 26 32
M  V30 34 1 26 33
M  V30 35 1 27 30
M  V30 36 2 28 32
M  V30 37 1 29 31
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 34 37
M  V30 42 1 34 43 CFG=1
M  V30 43 1 35 36
M  V30 44 1 36 38
M  V30 45 1 37 39
M  V30 46 1 38 40
M  V30 47 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 20 21 22 24 26 29 34 36 37 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C35H53NO5
2172642-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.3667 5.5277 0.0 0
M  V30 2 C 8.6255 4.0738 0.0 0
M  V30 3 O 9.1014 2.6091 0.0 0
M  V30 4 C 8.0710 1.4647 0.0 0
M  V30 5 C 6.5646 1.7849 0.0 0
M  V30 6 O 8.5468 0.0000 0.0 0
M  V30 7 C 8.6530 10.4303 0.0 0
M  V30 8 C 12.7192 7.7100 0.0 0
M  V30 9 O 14.2507 7.5489 0.0 0
M  V30 10 C 15.1559 8.7949 0.0 0
M  V30 11 C 14.5294 10.2017 0.0 0
M  V30 12 O 16.6874 8.6339 0.0 0
M  V30 13 C 13.1476 5.6940 0.0 0
M  V30 14 C 7.7574 10.8935 0.0 0
M  V30 15 C 4.0011 12.8846 0.0 0
M  V30 16 N 2.6674 13.6546 0.0 0
M  V30 17 O 5.3347 13.6546 0.0 0
M  V30 18 C 2.6674 15.1946 0.0 0
M  V30 19 C 2.6674 7.4946 0.0 0
M  V30 20 C 0.0000 9.0346 0.0 0
M  V30 21 C 9.3358 6.7246 0.0 0 CFG=2
M  V30 22 C 8.0021 7.4946 0.0 0 CFG=1
M  V30 23 C 10.6694 7.4946 0.0 0 CFG=1
M  V30 24 C 9.6560 5.2181 0.0 0
M  V30 25 C 8.0021 9.0346 0.0 0 CFG=2
M  V30 26 C 6.6684 6.7246 0.0 0
M  V30 27 C 11.8140 6.4640 0.0 0 CFG=2
M  V30 28 C 10.6694 9.0346 0.0 0
M  V30 29 C 11.1875 5.0572 0.0 0
M  V30 30 C 6.6684 9.8046 0.0 0 CFG=1
M  V30 31 C 9.3358 9.8046 0.0 0
M  V30 32 C 5.3347 7.4946 0.0 0
M  V30 33 C 5.3347 9.0346 0.0 0
M  V30 34 C 6.6684 11.3446 0.0 0
M  V30 35 C 4.0011 9.8046 0.0 0 CFG=2
M  V30 36 C 5.3347 12.1146 0.0 0
M  V30 37 C 4.0011 11.3446 0.0 0 CFG=1
M  V30 38 C 2.6674 9.0346 0.0 0 CFG=1
M  V30 39 C 2.6674 12.1146 0.0 0
M  V30 40 C 1.3336 9.8046 0.0 0 CFG=2
M  V30 41 C 1.3336 11.3446 0.0 0
M  V30 42 H 7.6036 6.0069 0.0 0
M  V30 43 H 12.0764 8.1209 0.0 0
M  V30 44 H 4.0011 8.2646 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 21 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 24
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 25 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 27 8 CFG=3
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 27 13 CFG=1
M  V30 14 1 30 14 CFG=3
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 37 15 CFG=1
M  V30 18 1 16 18
M  V30 19 1 38 19 CFG=1
M  V30 20 1 40 20 CFG=3
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 22 26
M  V30 26 1 22 42 CFG=3
M  V30 27 1 23 27
M  V30 28 1 23 28
M  V30 29 1 23 43 CFG=3
M  V30 30 2 24 29
M  V30 31 1 25 30
M  V30 32 1 25 31
M  V30 33 1 26 32
M  V30 34 1 27 29
M  V30 35 1 28 31
M  V30 36 1 30 33
M  V30 37 1 30 34
M  V30 38 2 32 33
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 35 38
M  V30 43 1 35 44 CFG=1
M  V30 44 1 36 37
M  V30 45 1 37 39
M  V30 46 1 38 40
M  V30 47 1 39 41
M  V30 48 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 21 22 23 25 27 30 35 37 38 40)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2172642-48-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2172642-53-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18533173
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Schotten-Baumann reaction (stage 3)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of novel asiatic acid
derivatives as potential anticancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goncalves, Bruno M. F.; Salvador, Jorge A. R.; Santos, Diana S. M.;
Marin, Silvia; Cascante, Marta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2016), 6(45), 39296-39309

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
1-Carboxy-1′-[[(1,1-dimethylethoxy)carbonyl]amino]ferrocene
C16H19FeNO4
219718-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0049 8.2852 0.0 0
M  V30 2 O 5.7634 7.8480 0.0 0
M  V30 3 O 5.0049 9.1620 0.0 0
M  V30 4 N 4.9590 0.9155 0.0 0
M  V30 5 C 5.7175 1.3527 0.0 0
M  V30 6 O 6.4760 0.9155 0.0 0
M  V30 7 O 5.7175 2.2295 0.0 0
M  V30 8 C 7.2345 1.3527 0.0 0
M  V30 9 C 7.9929 0.9155 0.0 0
M  V30 10 C 7.6741 2.1112 0.0 0
M  V30 11 C 6.7972 2.1112 0.0 0
M  V30 12 Fe 2.1281 4.5798 0.0 0 CHG=2 VAL=10
M  V30 13 C 4.2465 7.8480 0.0 0 CHG=-1 VAL=4
M  V30 14 C 4.2006 1.3527 0.0 0 CHG=-1 VAL=4
M  V30 15 C 2.8672 2.1232 0.0 0 VAL=5
M  V30 16 C 2.0822 0.0000 0.0 0 VAL=5
M  V30 17 C 2.9155 7.0774 0.0 0 VAL=5
M  V30 18 C 2.1281 9.1983 0.0 0 VAL=5
M  V30 19 C 0.0483 7.8480 0.0 0 VAL=5
M  V30 20 C 1.3768 7.0774 0.0 0 VAL=5
M  V30 21 C 0.0000 1.3527 0.0 0 VAL=5
M  V30 22 C 1.3261 2.1232 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 17 1 12 18
M  V30 18 1 12 19
M  V30 19 1 12 20
M  V30 20 1 12 21
M  V30 21 1 12 22
M  V30 22 1 13 17
M  V30 23 1 13 18
M  V30 24 1 14 15
M  V30 25 1 14 16
M  V30 26 2 15 22
M  V30 27 2 16 21
M  V30 28 2 17 20
M  V30 29 2 18 19
M  V30 30 1 19 20
M  V30 31 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[[(1,1-dimethylethoxy)carbonyl]amino]-1′-[(methylamino)carbonyl]-
C17H22FeN2O3
219718-18-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.0071 8.2888 0.0 0
M  V30 2 C 5.7659 7.8514 0.0 0
M  V30 3 O 6.5247 8.2888 0.0 0
M  V30 4 O 5.7659 6.9742 0.0 0
M  V30 5 C 7.2835 7.8514 0.0 0
M  V30 6 C 8.0423 8.2888 0.0 0
M  V30 7 C 7.7209 7.0926 0.0 0
M  V30 8 C 6.8461 7.0926 0.0 0
M  V30 9 C 4.9612 0.9159 0.0 0
M  V30 10 N 5.7200 1.3533 0.0 0
M  V30 11 O 4.9612 0.0387 0.0 0
M  V30 12 C 6.5537 0.8724 0.0 0
M  V30 13 Fe 2.1290 4.5818 0.0 0 CHG=2 VAL=10
M  V30 14 C 4.2483 7.8514 0.0 0 CHG=-1 VAL=4
M  V30 15 C 4.2024 1.3533 0.0 0 CHG=-1 VAL=4
M  V30 16 C 2.8684 2.1241 0.0 0 VAL=5
M  V30 17 C 2.0831 0.0000 0.0 0 VAL=5
M  V30 18 C 2.9168 7.0805 0.0 0 VAL=5
M  V30 19 C 2.1290 9.2022 0.0 0 VAL=5
M  V30 20 C 0.0000 1.3533 0.0 0 VAL=5
M  V30 21 C 1.3267 2.1241 0.0 0 VAL=5
M  V30 22 C 0.0483 7.8514 0.0 0 VAL=5
M  V30 23 C 1.3774 7.0805 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 13 19
M  V30 19 1 13 20
M  V30 20 1 13 21
M  V30 21 1 13 22
M  V30 22 1 13 23
M  V30 23 1 14 18
M  V30 24 1 14 19
M  V30 25 1 15 16
M  V30 26 1 15 17
M  V30 27 2 16 21
M  V30 28 2 17 20
M  V30 29 2 18 23
M  V30 30 2 19 22
M  V30 31 1 20 21
M  V30 32 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 219718-13-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 219718-18-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10112455
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Helically chiral ferrocene peptides containing
1'-aminoferrocene-1-carboxylic acid subunits as turn inducers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barisic, Lidija; Cakic, Mojca; Mahmoud, Khaled A.; Liu, You-nian; Kraatz,
Heinz-Bernhard; Pritzkow, Hans; Kirin, Srecko I.; Metzler-Nolte, Nils;
Rapic, Vladimir
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2006), 12(19), 4965-4980

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S,6S)-2-(2-Methylpropyl)-6-propyl-4-oxa-1-azabicyclo[4.2.0]octan-5-one
C13H23NO2
2201150-58-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.5765 2.5022 0.0 0
M  V30 2 C 1.4875 1.4133 0.0 0
M  V30 3 C 0.0000 1.8118 0.0 0
M  V30 4 O 2.7303 4.4137 0.0 0
M  V30 5 C 8.0652 1.3337 0.0 0
M  V30 6 C 9.3988 2.1037 0.0 0
M  V30 7 C 10.7325 1.3337 0.0 0
M  V30 8 C 9.3988 3.6437 0.0 0
M  V30 9 C 4.0640 2.1037 0.0 0 CFG=1
M  V30 10 N 5.3977 1.3337 0.0 0
M  V30 11 C 3.2940 0.7700 0.0 0
M  V30 12 C 4.0640 3.6437 0.0 0
M  V30 13 C 6.7315 2.1037 0.0 0 CFG=1
M  V30 14 C 4.6276 0.0000 0.0 0
M  V30 15 O 5.3977 4.4137 0.0 0
M  V30 16 C 6.7315 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 4 12
M  V30 5 1 5 6
M  V30 6 1 13 5 CFG=3
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-1-[(1S)-1-(Hydroxymethyl)-3-methylbutyl]-N-methyl-2-propyl-2-azetidineca...
C14H28N2O2
2201150-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 3.8500 0.0 0
M  V30 2 N 1.5400 5.1837 0.0 0
M  V30 3 O 1.5400 2.5164 0.0 0
M  V30 4 C 0.0000 5.1837 0.0 0
M  V30 5 C 3.8500 2.3100 0.0 0
M  V30 6 C 2.5162 1.5400 0.0 0
M  V30 7 C 2.5162 0.0000 0.0 0
M  V30 8 C 6.4790 2.7611 0.0 0 CFG=2
M  V30 9 C 7.9665 3.1596 0.0 0
M  V30 10 C 6.0804 1.2736 0.0 0
M  V30 11 C 9.0554 2.0707 0.0 0
M  V30 12 O 7.1694 0.1846 0.0 0
M  V30 13 C 10.5429 2.4692 0.0 0
M  V30 14 C 8.6568 0.5832 0.0 0
M  V30 15 C 3.8500 3.8500 0.0 0 CFG=2
M  V30 16 N 5.3900 3.8500 0.0 0
M  V30 17 C 3.8500 5.3900 0.0 0
M  V30 18 C 5.3900 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 15 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10 CFG=1
M  V30 10 1 8 16
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2201150-58-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2201150-64-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18669970
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Reductive Elimination at Alkyl Palladium(IV) by Dissociative
Ligand Ionization: Catalytic C(sp3)-H Amination to Azetidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nappi, Manuel; He, Chuan; Whitehurst, William G.; Chappell, Ben G. N.;
Gaunt, Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2018), 57(12), 3178-3182

$RFMT $RIREG SCHEME189 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-1-nitro-4-(phenylmethoxy)benzene
C13H10FNO3
221040-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6674 0.0 0 VAL=5
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 O 6.9300 2.6674 0.0 0
M  V30 6 C 7.7000 4.0011 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 9.2400 4.0011 0.0 0
M  V30 14 C 10.0100 2.6674 0.0 0
M  V30 15 C 10.0100 5.3349 0.0 0
M  V30 16 C 11.5500 2.6674 0.0 0
M  V30 17 C 11.5500 5.3349 0.0 0
M  V30 18 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 13
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoyl isothiocyanate
C8H5NOS
532-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 S 8.4702 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.7700 2.6673 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 2 4
M  V30 5 2 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-Methyl-6-(phenylmethoxy)-1H-benzimidazol-2-yl]benzamide
C22H19N3O2
496838-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3595 1.1395 0.0 0
M  V30 2 N 5.3901 3.8501 0.0 0
M  V30 3 C 4.6201 5.1838 0.0 0
M  V30 4 O 5.3901 6.5174 0.0 0
M  V30 5 O 13.3011 2.3101 0.0 0
M  V30 6 C 14.6348 3.0801 0.0 0
M  V30 7 C 9.3000 3.0801 0.0 0
M  V30 8 C 9.3000 4.6201 0.0 0
M  V30 9 N 7.8354 2.6042 0.0 0
M  V30 10 C 10.6338 2.3101 0.0 0
M  V30 11 N 7.8354 5.0960 0.0 0
M  V30 12 C 10.6338 5.3901 0.0 0
M  V30 13 C 6.9302 3.8501 0.0 0
M  V30 14 C 11.9674 3.0801 0.0 0
M  V30 15 C 11.9674 4.6201 0.0 0
M  V30 16 C 3.0801 5.1838 0.0 0
M  V30 17 C 2.3101 6.5174 0.0 0
M  V30 18 C 2.3101 3.8501 0.0 0
M  V30 19 C 0.7700 6.5174 0.0 0
M  V30 20 C 0.7700 3.8501 0.0 0
M  V30 21 C 0.0000 5.1838 0.0 0
M  V30 22 C 15.9686 2.3101 0.0 0
M  V30 23 C 17.3023 3.0801 0.0 0
M  V30 24 C 15.9686 0.7700 0.0 0
M  V30 25 C 18.6359 2.3101 0.0 0
M  V30 26 C 17.3023 0.0000 0.0 0
M  V30 27 C 18.6359 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 2 3 4
M  V30 5 1 3 16
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 6 22
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 2 11 13
M  V30 17 1 12 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221040-07-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 532-55-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 496838-02-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3364011
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-02-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Raney nickel used in stage 2, Trisamine resin used in stage 4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient solution phase synthesis of 2-(N-acylamino)benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seth, Punit P.; Robinson, Dale E.; Jefferson, Elizabeth A.; Swayze, Eric
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(41), 7303-7306

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-[4-[(1R,2R)-2-formylcyclopropyl]-1-piperidinyl]-N,N-dimethyl-3-pyr...
C17H22ClN3O2
2222553-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 15.1940 4.7712 0.0 0
M  V30 2 O 16.7340 4.7712 0.0 0
M  V30 3 Cl 3.8501 0.0000 0.0 0
M  V30 4 C 2.3101 2.6675 0.0 0
M  V30 5 N 1.5400 4.0012 0.0 0
M  V30 6 O 1.5400 1.3338 0.0 0
M  V30 7 C 2.3101 5.3350 0.0 0
M  V30 8 C 0.0000 4.0012 0.0 0
M  V30 9 C 13.0903 2.6675 0.0 0 CFG=1
M  V30 10 C 14.4240 3.4375 0.0 0 CFG=2
M  V30 11 C 14.4240 1.8975 0.0 0
M  V30 12 C 11.5503 2.6675 0.0 0
M  V30 13 C 10.7802 1.3338 0.0 0
M  V30 14 C 10.7802 4.0012 0.0 0
M  V30 15 C 9.2402 1.3338 0.0 0
M  V30 16 C 9.2402 4.0012 0.0 0
M  V30 17 N 8.4702 2.6675 0.0 0
M  V30 18 C 6.9302 2.6675 0.0 0
M  V30 19 N 6.1601 1.3338 0.0 0
M  V30 20 C 6.1601 4.0012 0.0 0
M  V30 21 C 4.6201 1.3338 0.0 0
M  V30 22 C 4.6201 4.0012 0.0 0
M  V30 23 C 3.8501 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 10 1 CFG=3
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 23
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12 CFG=3
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Chloro-N,N-dimethyl-6-[4-[(1R,2R)-2-[(methylamino)methyl]cyclopropyl]-1-pip...
C18H27ClN4O
2222553-03-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 15.1938 1.3338 0.0 0
M  V30 2 N 16.7338 1.3338 0.0 0
M  V30 3 C 17.5038 0.0000 0.0 0
M  V30 4 Cl 3.8500 6.1049 0.0 0
M  V30 5 C 2.3100 3.4375 0.0 0
M  V30 6 N 1.5400 2.1038 0.0 0
M  V30 7 O 1.5400 4.7711 0.0 0
M  V30 8 C 2.3100 0.7700 0.0 0
M  V30 9 C 0.0000 2.1038 0.0 0
M  V30 10 C 13.0901 3.4375 0.0 0 CFG=1
M  V30 11 C 14.4238 2.6675 0.0 0 CFG=2
M  V30 12 C 14.4238 4.2075 0.0 0
M  V30 13 C 11.5501 3.4375 0.0 0
M  V30 14 C 10.7801 2.1038 0.0 0
M  V30 15 C 10.7801 4.7711 0.0 0
M  V30 16 C 9.2401 2.1038 0.0 0
M  V30 17 C 9.2401 4.7711 0.0 0
M  V30 18 N 8.4701 3.4375 0.0 0
M  V30 19 C 6.9301 3.4375 0.0 0
M  V30 20 N 6.1601 4.7711 0.0 0
M  V30 21 C 6.1601 2.1038 0.0 0
M  V30 22 C 4.6201 4.7711 0.0 0
M  V30 23 C 4.6201 2.1038 0.0 0
M  V30 24 C 3.8500 3.4375 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 24
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13 CFG=1
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2222553-02-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2222553-03-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-20056476
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-aryl and N-heteroaryl piperidine derivatives as liver X
receptor β agonists, compositions, and their use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rudd, Michael T.; Meng, Zhaoyang; Wai, Jenny; Bennett, David Jonathan;
Brnardic, Edward J.; Liverton, Nigel J.; Stachel, Shawn J.; Han, Yongxin;
Tempest, Paul; Zhu, Jiuxiang; Xu, Xuewang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018071313 A1 2018-04-19

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-[4-[(1R,2R)-2-formylcyclopropyl]-1-piperidinyl]-N,N-dimethyl-3-pyr...
C17H22ClN3O2
2222553-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 15.1940 4.7712 0.0 0
M  V30 2 O 16.7340 4.7712 0.0 0
M  V30 3 Cl 3.8501 0.0000 0.0 0
M  V30 4 C 2.3101 2.6675 0.0 0
M  V30 5 N 1.5400 4.0012 0.0 0
M  V30 6 O 1.5400 1.3338 0.0 0
M  V30 7 C 2.3101 5.3350 0.0 0
M  V30 8 C 0.0000 4.0012 0.0 0
M  V30 9 C 13.0903 2.6675 0.0 0 CFG=1
M  V30 10 C 14.4240 3.4375 0.0 0 CFG=2
M  V30 11 C 14.4240 1.8975 0.0 0
M  V30 12 C 11.5503 2.6675 0.0 0
M  V30 13 C 10.7802 1.3338 0.0 0
M  V30 14 C 10.7802 4.0012 0.0 0
M  V30 15 C 9.2402 1.3338 0.0 0
M  V30 16 C 9.2402 4.0012 0.0 0
M  V30 17 N 8.4702 2.6675 0.0 0
M  V30 18 C 6.9302 2.6675 0.0 0
M  V30 19 N 6.1601 1.3338 0.0 0
M  V30 20 C 6.1601 4.0012 0.0 0
M  V30 21 C 4.6201 1.3338 0.0 0
M  V30 22 C 4.6201 4.0012 0.0 0
M  V30 23 C 3.8501 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 10 1 CFG=3
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 23
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12 CFG=3
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Chloro-N,N-dimethyl-6-[4-[(1R,2R)-2-[(methylamino)methyl]cyclopropyl]-1-pip...
C18H27ClN4O
2222553-03-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 15.1938 1.3338 0.0 0
M  V30 2 N 16.7338 1.3338 0.0 0
M  V30 3 C 17.5038 0.0000 0.0 0
M  V30 4 Cl 3.8500 6.1049 0.0 0
M  V30 5 C 2.3100 3.4375 0.0 0
M  V30 6 N 1.5400 2.1038 0.0 0
M  V30 7 O 1.5400 4.7711 0.0 0
M  V30 8 C 2.3100 0.7700 0.0 0
M  V30 9 C 0.0000 2.1038 0.0 0
M  V30 10 C 13.0901 3.4375 0.0 0 CFG=1
M  V30 11 C 14.4238 2.6675 0.0 0 CFG=2
M  V30 12 C 14.4238 4.2075 0.0 0
M  V30 13 C 11.5501 3.4375 0.0 0
M  V30 14 C 10.7801 2.1038 0.0 0
M  V30 15 C 10.7801 4.7711 0.0 0
M  V30 16 C 9.2401 2.1038 0.0 0
M  V30 17 C 9.2401 4.7711 0.0 0
M  V30 18 N 8.4701 3.4375 0.0 0
M  V30 19 C 6.9301 3.4375 0.0 0
M  V30 20 N 6.1601 4.7711 0.0 0
M  V30 21 C 6.1601 2.1038 0.0 0
M  V30 22 C 4.6201 4.7711 0.0 0
M  V30 23 C 4.6201 2.1038 0.0 0
M  V30 24 C 3.8500 3.4375 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 24
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13 CFG=1
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2222553-02-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2222553-03-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-20153281
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-aryl and N-heteroaryl piperidine derivatives as liver X
receptor β agonists, compositions, and their use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rudd, Michael T.; Meng, Zhaoyang; Wai, Jenny; Bennett, David Jonathan;
Brnardic, Edward J.; Liverton, Nigel J.; Stachel, Shawn J.; Han, Yongxin;
Tempest, Paul; Zhu, Jiuxiang; Xu, Xuewang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018068297 A1 2018-04-19

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-(2-furanyl)-2,4,5,6-tetrahydro-5-methyl-4,6-dioxopyrrolo[3,4-c]pyrrol...
C14H12N2O5
2242709-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.1706 2.7104 0.0 0
M  V30 2 C 7.5257 4.7263 0.0 0
M  V30 3 O 8.2957 6.0601 0.0 0
M  V30 4 O 8.2957 3.3926 0.0 0
M  V30 5 C 9.8357 6.0601 0.0 0
M  V30 6 C 10.6057 7.3937 0.0 0
M  V30 7 O 6.3263 1.0352 0.0 0
M  V30 8 C 3.1399 0.0000 0.0 0
M  V30 9 C 3.6158 3.9563 0.0 0
M  V30 10 C 5.0805 3.4804 0.0 0
M  V30 11 C 3.6158 5.4963 0.0 0
M  V30 12 C 2.7106 2.7104 0.0 0
M  V30 13 C 5.9857 4.7263 0.0 0
M  V30 14 C 5.0805 1.9404 0.0 0
M  V30 15 N 5.0805 5.9723 0.0 0
M  V30 16 N 3.6158 1.4645 0.0 0
M  V30 17 C 2.3699 6.4015 0.0 0
M  V30 18 C 0.9052 5.9256 0.0 0
M  V30 19 O 2.3699 7.9415 0.0 0
M  V30 20 C 0.0000 7.1715 0.0 0
M  V30 21 C 0.9052 8.4173 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 14
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 17
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2-Furanyl)-N2,N3,N4-trimethyl-1H-pyrrole-2,3,4-tricarboxamide
C14H16N4O4
2242709-41-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3196 7.8085 0.0 0
M  V30 2 N 3.9860 8.5785 0.0 0
M  V30 3 O 6.6533 8.5785 0.0 0
M  V30 4 C 3.9860 10.1185 0.0 0
M  V30 5 C 2.6091 5.8391 0.0 0
M  V30 6 N 1.4647 4.8087 0.0 0
M  V30 7 O 2.2889 7.3455 0.0 0
M  V30 8 C 0.0000 5.2845 0.0 0
M  V30 9 C 3.6444 2.6528 0.0 0
M  V30 10 N 4.2707 1.2459 0.0 0
M  V30 11 O 2.1129 2.8137 0.0 0
M  V30 12 C 3.3657 0.0000 0.0 0
M  V30 13 C 5.3196 6.2684 0.0 0
M  V30 14 C 4.0738 5.3632 0.0 0
M  V30 15 C 6.5655 5.3632 0.0 0
M  V30 16 C 4.5496 3.8987 0.0 0
M  V30 17 N 6.0897 3.8987 0.0 0
M  V30 18 C 8.0302 5.8391 0.0 0
M  V30 19 C 8.5061 7.3038 0.0 0
M  V30 20 O 9.2761 4.9340 0.0 0
M  V30 21 C 10.0461 7.3038 0.0 0
M  V30 22 C 10.5219 5.8391 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2242709-30-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2242709-41-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-19137705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and facile access to highly functionalized pyrrole
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Meng; Zhao, Wenting; Zhao, Hongyi; Lin, Ziyun; Zhang, Dongfeng;
Huang, Haihong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Beilstein Journal of Organic Chemistry (2018), 14884-890

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2,4,5,6-tetrahydro-5-methyl-4,6-dioxo-3-(2-thienyl)pyrrolo[3,4-c]pyrrol...
C14H12N2O4S
2242709-31-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.1706 2.7104 0.0 0
M  V30 2 C 7.5257 4.7263 0.0 0
M  V30 3 O 8.2957 6.0601 0.0 0
M  V30 4 O 8.2957 3.3926 0.0 0
M  V30 5 C 9.8357 6.0601 0.0 0
M  V30 6 C 10.6057 7.3937 0.0 0
M  V30 7 O 6.3263 1.0352 0.0 0
M  V30 8 C 3.1399 0.0000 0.0 0
M  V30 9 C 3.6158 3.9563 0.0 0
M  V30 10 C 5.0805 3.4804 0.0 0
M  V30 11 C 3.6158 5.4963 0.0 0
M  V30 12 C 2.7106 2.7104 0.0 0
M  V30 13 C 5.9857 4.7263 0.0 0
M  V30 14 C 5.0805 1.9404 0.0 0
M  V30 15 N 5.0805 5.9723 0.0 0
M  V30 16 N 3.6158 1.4645 0.0 0
M  V30 17 C 2.3699 6.4015 0.0 0
M  V30 18 C 0.9052 5.9256 0.0 0
M  V30 19 S 2.3699 7.9415 0.0 0
M  V30 20 C 0.0000 7.1715 0.0 0
M  V30 21 C 0.9052 8.4173 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 14
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 17
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2,N3,N4-Trimethyl-5-(2-thienyl)-1H-pyrrole-2,3,4-tricarboxamide
C14H16N4O3S
2242709-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3196 7.8085 0.0 0
M  V30 2 N 3.9860 8.5785 0.0 0
M  V30 3 O 6.6533 8.5785 0.0 0
M  V30 4 C 3.9860 10.1185 0.0 0
M  V30 5 C 2.6091 5.8391 0.0 0
M  V30 6 N 1.4647 4.8087 0.0 0
M  V30 7 O 2.2889 7.3455 0.0 0
M  V30 8 C 0.0000 5.2845 0.0 0
M  V30 9 C 3.6444 2.6528 0.0 0
M  V30 10 N 4.2707 1.2459 0.0 0
M  V30 11 O 2.1129 2.8137 0.0 0
M  V30 12 C 3.3657 0.0000 0.0 0
M  V30 13 C 5.3196 6.2684 0.0 0
M  V30 14 C 4.0738 5.3632 0.0 0
M  V30 15 C 6.5655 5.3632 0.0 0
M  V30 16 C 4.5496 3.8987 0.0 0
M  V30 17 N 6.0897 3.8987 0.0 0
M  V30 18 C 8.0302 5.8391 0.0 0
M  V30 19 C 8.5061 7.3038 0.0 0
M  V30 20 S 9.2761 4.9340 0.0 0
M  V30 21 C 10.0461 7.3038 0.0 0
M  V30 22 C 10.5219 5.8391 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2242709-31-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2242709-42-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-19137706
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and facile access to highly functionalized pyrrole
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Meng; Zhao, Wenting; Zhao, Hongyi; Lin, Ziyun; Zhang, Dongfeng;
Huang, Haihong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Beilstein Journal of Organic Chemistry (2018), 14884-890

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5S,9R)-9-(2,4-Dibromo-5-methoxyphenyl)-7-oxa-1-azaspiro[4.4]nonan-6-one
C14H15Br2NO3
2245192-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.3427 0.0 0
M  V30 2 Br 5.1556 0.0000 0.0 0
M  V30 3 O 8.2356 5.3347 0.0 0
M  V30 4 C 9.7756 5.3347 0.0 0
M  V30 5 Br 9.7756 2.6674 0.0 0
M  V30 6 C 2.7104 3.9133 0.0 0 CFG=1
M  V30 7 C 3.6156 2.6674 0.0 0 CFG=1
M  V30 8 C 1.2459 3.4374 0.0 0
M  V30 9 C 4.1751 4.3892 0.0 0
M  V30 10 N 1.8053 5.1592 0.0 0
M  V30 11 C 2.7104 1.4216 0.0 0
M  V30 12 O 1.2459 1.8974 0.0 0
M  V30 13 C 4.1751 5.9292 0.0 0
M  V30 14 C 2.7104 6.4052 0.0 0
M  V30 15 C 5.1556 2.6674 0.0 0
M  V30 16 C 5.9256 4.0011 0.0 0
M  V30 17 C 5.9256 1.3338 0.0 0
M  V30 18 C 7.4656 4.0011 0.0 0
M  V30 19 C 7.4656 1.3338 0.0 0
M  V30 20 C 8.2356 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8 CFG=3
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 15 CFG=1
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-2-[(1R)-1-(2,4-Dibromo-5-methoxyphenyl)-2-hydroxyethyl]-N-methyl-2-pyrro...
C15H20Br2N2O3
2245192-76-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 3.8118 0.0 0 CFG=2
M  V30 2 C 6.9300 5.1455 0.0 0
M  V30 3 O 6.1600 6.4791 0.0 0
M  V30 4 C 8.1759 3.3832 0.0 0
M  V30 5 N 9.5829 2.7569 0.0 0
M  V30 6 O 8.0150 4.9149 0.0 0
M  V30 7 C 10.8287 3.6621 0.0 0
M  V30 8 Br 4.6200 6.4791 0.0 0
M  V30 9 O 1.5400 1.1444 0.0 0
M  V30 10 C 0.0000 1.1444 0.0 0
M  V30 11 Br 0.0000 3.8118 0.0 0
M  V30 12 C 6.9300 2.4780 0.0 0 CFG=1
M  V30 13 C 7.9605 1.3336 0.0 0
M  V30 14 N 5.5232 1.8517 0.0 0
M  V30 15 C 7.1905 0.0000 0.0 0
M  V30 16 C 5.6842 0.3202 0.0 0
M  V30 17 C 4.6200 3.8118 0.0 0
M  V30 18 C 3.8500 2.4780 0.0 0
M  V30 19 C 3.8500 5.1455 0.0 0
M  V30 20 C 2.3100 2.4780 0.0 0
M  V30 21 C 2.3100 5.1455 0.0 0
M  V30 22 C 1.5400 3.8118 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 12
M  V30 3 1 1 17
M  V30 4 1 2 3
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 12 4 CFG=1
M  V30 8 1 5 7
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 20
M  V30 12 1 11 22
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2245192-75-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2245192-76-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19252990
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Cα-Alkylation of Proline via Chirality Transfers of
Conformationally Restricted Proline Derivative: Application to the Total
Synthesis of (-)-Amathaspiramide F
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cho, Hyunkyung; Shin, Jae Eui; Lee, Seokwoo; Jeon, Hongjun; Park, Soojun;
Kim, Sanghee
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2018), 20(19), 6121-6125

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C22H22N4O8
2250287-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 4.0012 0.0 0
M  V30 2 C 10.7802 4.0012 0.0 0
M  V30 3 C 11.5503 5.3348 0.0 0
M  V30 4 O 11.5503 2.6675 0.0 0
M  V30 5 N 13.0903 5.3348 0.0 0
M  V30 6 O 10.7802 6.6685 0.0 0
M  V30 7 N 6.1601 4.0012 0.0 0
M  V30 8 C 4.6201 4.0012 0.0 0
M  V30 9 C 3.8501 5.3348 0.0 0
M  V30 10 O 3.8501 2.6675 0.0 0
M  V30 11 O 2.3101 5.3348 0.0 0
M  V30 12 O 4.6201 6.6685 0.0 0
M  V30 13 C 1.5400 6.6685 0.0 0
M  V30 14 C 0.0000 6.6685 0.0 0
M  V30 15 N 16.1704 5.3348 0.0 0
M  V30 16 C 17.7104 5.3348 0.0 0
M  V30 17 C 18.4804 4.0012 0.0 0
M  V30 18 O 18.4804 6.6685 0.0 0
M  V30 19 O 20.0204 4.0012 0.0 0
M  V30 20 O 17.7104 2.6675 0.0 0
M  V30 21 C 20.7905 2.6675 0.0 0
M  V30 22 C 22.3305 2.6675 0.0 0
M  V30 23 C 8.4702 2.6675 0.0 0
M  V30 24 C 6.9302 2.6675 0.0 0
M  V30 25 C 9.2402 1.3337 0.0 0
M  V30 26 C 6.1601 1.3337 0.0 0
M  V30 27 C 8.4702 0.0000 0.0 0
M  V30 28 C 6.9302 0.0000 0.0 0
M  V30 29 C 13.8603 6.6685 0.0 0
M  V30 30 C 15.4003 6.6685 0.0 0
M  V30 31 C 13.0903 8.0023 0.0 0
M  V30 32 C 16.1704 8.0023 0.0 0
M  V30 33 C 13.8603 9.3360 0.0 0
M  V30 34 C 15.4003 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 29
M  V30 8 1 7 8
M  V30 9 1 7 24
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 30
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C20H20N6O6
2250287-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7002 4.0012 0.0 0
M  V30 2 C 9.2402 4.0012 0.0 0
M  V30 3 C 10.0102 5.3348 0.0 0
M  V30 4 O 10.0102 2.6675 0.0 0
M  V30 5 N 11.5503 5.3348 0.0 0
M  V30 6 O 9.2402 6.6685 0.0 0
M  V30 7 N 4.6201 4.0012 0.0 0
M  V30 8 C 3.0801 4.0012 0.0 0
M  V30 9 C 2.3101 5.3348 0.0 0
M  V30 10 O 2.3101 2.6675 0.0 0
M  V30 11 N 0.7700 5.3348 0.0 0
M  V30 12 O 3.0801 6.6685 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 N 14.6303 5.3348 0.0 0
M  V30 15 C 16.1704 5.3348 0.0 0
M  V30 16 C 16.9404 4.0012 0.0 0
M  V30 17 O 16.9404 6.6685 0.0 0
M  V30 18 N 18.4804 4.0012 0.0 0
M  V30 19 O 16.1704 2.6675 0.0 0
M  V30 20 C 19.2504 2.6675 0.0 0
M  V30 21 C 6.9302 2.6675 0.0 0
M  V30 22 C 5.3901 2.6675 0.0 0
M  V30 23 C 7.7002 1.3337 0.0 0
M  V30 24 C 4.6201 1.3337 0.0 0
M  V30 25 C 6.9302 0.0000 0.0 0
M  V30 26 C 5.3901 0.0000 0.0 0
M  V30 27 C 12.3203 6.6685 0.0 0
M  V30 28 C 13.8603 6.6685 0.0 0
M  V30 29 C 11.5503 8.0023 0.0 0
M  V30 30 C 14.6303 8.0023 0.0 0
M  V30 31 C 12.3203 9.3360 0.0 0
M  V30 32 C 13.8603 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 27
M  V30 8 1 7 8
M  V30 9 1 7 22
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 28
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 18 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2250287-56-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2250287-58-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19713197
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reactant stoichiometry dependent product formation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Promotion of antiferromagnetic exchange interaction in multinuclear
copper(II) complexes via fused oxamato/oxamidato ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weheabby, Saddam; Abdulmalic, Mohammad A.; Atzori, Matteo; Sessoli,
Roberta; Aliabadi, Azar; Rueffer, Tobias
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2018), 47(45), 16164-16181

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[3,5-bis(trifluoromethyl)phenyl]-1,3,4,9-tetrahydro-6-methoxy-2H-pyr...
C22H18F6N2O3
2294850-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 O 5.3348 0.7700 0.0 0
M  V30 3 O 4.0011 3.0800 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 C 4.0011 9.2401 0.0 0
M  V30 6 F 2.4611 9.2401 0.0 0
M  V30 7 F 4.0011 10.7801 0.0 0
M  V30 8 F 5.5411 9.2401 0.0 0
M  V30 9 C 1.3338 4.6200 0.0 0
M  V30 10 F 0.5638 5.9537 0.0 0
M  V30 11 F 0.0000 3.8500 0.0 0
M  V30 12 F 2.1038 3.2864 0.0 0
M  V30 13 O 14.4487 6.5745 0.0 0
M  V30 14 C 15.3539 7.8203 0.0 0
M  V30 15 C 8.0022 5.3901 0.0 0
M  V30 16 C 6.6686 4.6200 0.0 0
M  V30 17 C 9.3359 4.6200 0.0 0
M  V30 18 N 8.3224 6.8963 0.0 0
M  V30 19 N 6.6686 3.0800 0.0 0
M  V30 20 C 10.4804 5.6505 0.0 0
M  V30 21 C 9.3359 3.0800 0.0 0
M  V30 22 C 9.8539 7.0574 0.0 0
M  V30 23 C 8.0022 2.3100 0.0 0
M  V30 24 C 12.0120 5.4895 0.0 0
M  V30 25 C 10.7592 8.3033 0.0 0
M  V30 26 C 12.9172 6.7354 0.0 0
M  V30 27 C 12.2907 8.1424 0.0 0
M  V30 28 C 5.3348 5.3901 0.0 0
M  V30 29 C 5.3348 6.9301 0.0 0
M  V30 30 C 4.0011 4.6200 0.0 0
M  V30 31 C 4.0011 7.7001 0.0 0
M  V30 32 C 2.6675 5.3901 0.0 0
M  V30 33 C 2.6675 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 31
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 32
M  V30 13 1 13 14
M  V30 14 1 13 26
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 28
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 2 20 24
M  V30 26 1 21 23
M  V30 27 2 22 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl N-[2-[2-[(Z)-[3,5-bis(trifluoromethyl)phenyl](methylimino)methyl]-5-me...
C23H21F6N3O3
2294850-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9536 7.6210 0.0 0
M  V30 2 N 6.7236 8.9546 0.0 0
M  V30 3 C 8.2636 8.9546 0.0 0
M  V30 4 C 9.2857 7.2708 0.0 0
M  V30 5 C 10.7920 6.9506 0.0 0
M  V30 6 N 11.8226 8.0950 0.0 0
M  V30 7 C 13.3289 7.7748 0.0 0
M  V30 8 O 14.3593 8.9194 0.0 0
M  V30 9 O 13.8047 6.3103 0.0 0
M  V30 10 C 15.8657 8.5992 0.0 0
M  V30 11 O 11.2428 1.5400 0.0 0
M  V30 12 C 11.2428 0.0000 0.0 0
M  V30 13 C 1.3336 4.9537 0.0 0
M  V30 14 F 2.6674 4.1837 0.0 0
M  V30 15 F 0.5636 3.6199 0.0 0
M  V30 16 F 0.0000 5.7237 0.0 0
M  V30 17 C 1.3336 10.2884 0.0 0
M  V30 18 F 0.0000 9.5184 0.0 0
M  V30 19 F 0.5636 11.6221 0.0 0
M  V30 20 F 2.6674 11.0584 0.0 0
M  V30 21 C 6.7236 6.2874 0.0 0
M  V30 22 C 8.2553 6.1264 0.0 0
M  V30 23 N 6.0973 4.8804 0.0 0
M  V30 24 C 8.5755 4.6200 0.0 0
M  V30 25 C 7.2417 3.8500 0.0 0
M  V30 26 C 9.9091 3.8500 0.0 0
M  V30 27 C 7.2417 2.3100 0.0 0
M  V30 28 C 9.9091 2.3100 0.0 0
M  V30 29 C 8.5755 1.5400 0.0 0
M  V30 30 C 4.4136 7.6210 0.0 0
M  V30 31 C 3.6436 6.2874 0.0 0
M  V30 32 C 3.6436 8.9546 0.0 0
M  V30 33 C 2.1036 6.2874 0.0 0
M  V30 34 C 2.1036 8.9546 0.0 0
M  V30 35 C 1.3336 7.6210 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 21
M  V30 3 1 1 30
M  V30 4 1 2 3
M  V30 5 1 4 5
M  V30 6 1 4 22
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 28
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 17 34
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2294850-22-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2294850-09-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-123-CAS-19864212
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7775-14-6
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indole based antimalarial compounds targeting the melatonin pathway:
their design, synthesis and biological evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luthra, Tania; Nayak, Akshay Kumar; Bose, Sarpita; Chakrabarti, Saikat;
Gupta, Ashish; Sen, Subhabrata
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2019), 16811-27

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Bromophenyl)methyl β-oxobenzenepropanoate
C16H13BrO3
2304416-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 O 8.0022 2.3101 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 Br 14.6707 4.6201 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 12.0033 1.5400 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 13.3370 2.3101 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 20 C 13.3370 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 15
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Bromophenyl)methyl (2Z)-3-(methylamino)-3-phenyl-2-propenoate
C17H16BrNO2
2304416-28-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 N 4.0010 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 O 8.0022 3.0801 0.0 0
M  V30 7 O 6.6685 0.7700 0.0 0
M  V30 8 C 9.3358 2.3101 0.0 0
M  V30 9 Br 14.6707 5.3901 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 20 C 13.3370 3.0801 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 16
M  V30 10 1 9 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2304416-42-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-28-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946820
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cycloocten-1-yl β-oxobenzenepropanoate
C17H20O3
2304416-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.5643 2.0120 0.0 0
M  V30 2 C 6.3343 3.3458 0.0 0
M  V30 3 C 7.8743 3.3458 0.0 0
M  V30 4 O 5.5643 4.6794 0.0 0
M  V30 5 C 8.6443 4.6794 0.0 0
M  V30 6 O 7.8743 6.0131 0.0 0
M  V30 7 C 4.0243 2.0120 0.0 0
M  V30 8 C 3.4350 0.5894 0.0 0
M  V30 9 C 3.4350 3.4348 0.0 0
M  V30 10 C 2.0122 0.0000 0.0 0
M  V30 11 C 2.0122 4.0242 0.0 0
M  V30 12 C 0.5894 0.5894 0.0 0
M  V30 13 C 0.5894 3.4348 0.0 0
M  V30 14 C 0.0000 2.0120 0.0 0
M  V30 15 C 10.1843 4.6794 0.0 0
M  V30 16 C 10.9543 6.0131 0.0 0
M  V30 17 C 10.9543 3.3458 0.0 0
M  V30 18 C 12.4943 6.0131 0.0 0
M  V30 19 C 12.4943 3.3458 0.0 0
M  V30 20 C 13.2643 4.6794 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 5 6
M  V30 7 1 5 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cycloocten-1-yl (2Z)-3-(methylamino)-3-phenyl-2-propenoate
C18H23NO2
2304416-32-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6443 2.6673 0.0 0
M  V30 2 C 7.8743 4.0009 0.0 0
M  V30 3 N 7.8743 1.3336 0.0 0
M  V30 4 C 6.3343 4.0009 0.0 0
M  V30 5 C 8.6443 0.0000 0.0 0
M  V30 6 O 5.5643 5.3347 0.0 0
M  V30 7 O 5.5643 2.6673 0.0 0
M  V30 8 C 10.1843 2.6673 0.0 0
M  V30 9 C 10.9543 1.3336 0.0 0
M  V30 10 C 10.9543 4.0009 0.0 0
M  V30 11 C 12.4943 1.3336 0.0 0
M  V30 12 C 12.4943 4.0009 0.0 0
M  V30 13 C 13.2643 2.6673 0.0 0
M  V30 14 C 4.0243 5.3347 0.0 0 CFG=3
M  V30 15 C 3.4350 6.7574 0.0 0
M  V30 16 C 3.4350 3.9119 0.0 0
M  V30 17 C 2.0122 7.3467 0.0 0
M  V30 18 C 2.0122 3.3225 0.0 0
M  V30 19 C 0.5894 6.7574 0.0 0
M  V30 20 C 0.5894 3.9119 0.0 0
M  V30 21 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 14
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2304416-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-32-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946824
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C24H19ClFN5O5
2305793-09-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3212 11.1496 0.0 0
M  V30 2 F 7.3054 11.5780 0.0 0
M  V30 3 O 5.3348 10.3880 0.0 0
M  V30 4 C 4.0011 9.6180 0.0 0
M  V30 5 O 4.0011 8.0780 0.0 0
M  V30 6 C 5.6850 7.0559 0.0 0
M  V30 7 O 6.0051 5.5496 0.0 0
M  V30 8 C 4.8607 4.5192 0.0 0
M  V30 9 O 3.3960 4.9950 0.0 0
M  V30 10 Cl 15.7276 8.4641 0.0 0
M  V30 11 C 9.1058 9.0999 0.0 0 CFG=2
M  V30 12 C 8.0754 10.2443 0.0 0 CFG=1
M  V30 13 O 8.3358 7.7663 0.0 0
M  V30 14 C 6.6684 9.6180 0.0 0 CFG=2
M  V30 15 C 6.8295 8.0865 0.0 0 CFG=2
M  V30 16 N 10.6373 9.2609 0.0 0
M  V30 17 C 11.6679 8.1165 0.0 0
M  V30 18 N 11.4074 10.5945 0.0 0
M  V30 19 C 13.0747 8.7428 0.0 0
M  V30 20 N 11.5068 6.5848 0.0 0
M  V30 21 N 12.9138 10.2744 0.0 0
M  V30 22 C 14.3206 7.8376 0.0 0
M  V30 23 C 12.7529 5.6797 0.0 0
M  V30 24 N 14.1597 6.3061 0.0 0
M  V30 25 C 2.6675 10.3880 0.0 0
M  V30 26 C 2.6675 11.9280 0.0 0
M  V30 27 C 1.3337 9.6180 0.0 0
M  V30 28 C 1.3337 12.6980 0.0 0
M  V30 29 C 0.0000 10.3880 0.0 0
M  V30 30 C 0.0000 11.9280 0.0 0
M  V30 31 C 5.1809 3.0127 0.0 0
M  V30 32 C 6.6456 2.5369 0.0 0
M  V30 33 C 4.0365 1.9823 0.0 0
M  V30 34 C 6.9658 1.0304 0.0 0
M  V30 35 C 4.3567 0.4759 0.0 0
M  V30 36 C 5.8213 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 12 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 14 3 CFG=1
M  V30 5 2 4 5
M  V30 6 1 4 25
M  V30 7 1 6 7
M  V30 8 1 15 6 CFG=3
M  V30 9 1 7 8
M  V30 10 2 8 9
M  V30 11 1 8 31
M  V30 12 1 10 22
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 16 CFG=3
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 17 20
M  V30 23 2 18 21
M  V30 24 1 19 21
M  V30 25 2 19 22
M  V30 26 1 20 23
M  V30 27 1 22 24
M  V30 28 2 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 11 12 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C11H15FN6O3
2305792-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8851 5.9159 0.0 0
M  V30 2 F 1.8354 6.1314 0.0 0
M  V30 3 O 0.0000 4.7418 0.0 0
M  V30 4 C 0.6967 1.4647 0.0 0
M  V30 5 O 1.1726 0.0000 0.0 0
M  V30 6 N 10.5368 3.9147 0.0 0
M  V30 7 C 11.8706 3.1447 0.0 0
M  V30 8 C 3.8851 3.8549 0.0 0 CFG=2
M  V30 9 C 2.7406 4.8855 0.0 0 CFG=1
M  V30 10 O 3.2586 2.4481 0.0 0
M  V30 11 C 1.4069 4.1155 0.0 0 CFG=2
M  V30 12 C 1.7271 2.6091 0.0 0 CFG=2
M  V30 13 N 5.3914 4.1751 0.0 0
M  V30 14 C 6.5359 3.1447 0.0 0
M  V30 15 N 6.0177 5.5820 0.0 0
M  V30 16 C 7.8696 3.9147 0.0 0
M  V30 17 N 6.5359 1.6047 0.0 0
M  V30 18 N 7.5494 5.4211 0.0 0
M  V30 19 C 9.2032 3.1447 0.0 0
M  V30 20 C 7.8696 0.8347 0.0 0
M  V30 21 N 9.2032 1.6047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=3
M  V30 2 1 9 2 CFG=1
M  V30 3 1 11 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 12 4 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13 CFG=3
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 9 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2305793-09-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2305792-85-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20393070
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of novel
2'-deoxy-2'-fluoro-2'-C-methyl 8-azanebularine derivatives as potent
anti-HBV agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Wu; Peng, Youmei; Wang, Jingwen; Song, Chuanjun; Yu, Wenquan; Zhou,
Yubing; Jiang, Jinhua; Wang, Qingduan; Wu, Jie; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2019), 29(11), 1291-1297

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3-[[3-(4-Chlorophenyl)-4,5-dihydro-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hydroxy...
C20H14Cl2F3N7O3
2308525-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.4886 7.0618 0.0 0
M  V30 2 C 3.0128 8.5265 0.0 0 CFG=2
M  V30 3 C 1.5063 8.8467 0.0 0
M  V30 4 O 4.0432 9.6709 0.0 0
M  V30 5 F 1.1861 7.3402 0.0 0
M  V30 6 F 0.0000 9.1669 0.0 0
M  V30 7 F 1.8265 10.3530 0.0 0
M  V30 8 O 5.9785 9.3038 0.0 0
M  V30 9 C 8.8801 7.6285 0.0 0
M  V30 10 Cl 2.5414 0.0000 0.0 0
M  V30 11 C 14.0358 3.2858 0.0 0
M  V30 12 Cl 12.4958 3.2858 0.0 0
M  V30 13 O 14.8058 1.9521 0.0 0
M  V30 14 C 5.6214 5.3348 0.0 0
M  V30 15 N 4.9949 6.7416 0.0 0
M  V30 16 N 7.1530 5.4957 0.0 0
M  V30 17 C 6.1395 7.7721 0.0 0
M  V30 18 N 7.4731 7.0020 0.0 0
M  V30 19 C 4.8514 4.0010 0.0 0
M  V30 20 C 5.6214 2.6673 0.0 0
M  V30 21 C 3.3114 4.0010 0.0 0
M  V30 22 C 4.8514 1.3337 0.0 0
M  V30 23 C 2.5414 2.6673 0.0 0
M  V30 24 C 3.3114 1.3337 0.0 0
M  V30 25 C 10.1260 6.7233 0.0 0
M  V30 26 N 11.5906 7.1992 0.0 0
M  V30 27 N 10.1260 5.1833 0.0 0
M  V30 28 N 12.4958 5.9533 0.0 0
M  V30 29 C 11.5906 4.7074 0.0 0
M  V30 30 C 14.0358 5.9533 0.0 0
M  V30 31 C 14.8058 4.6196 0.0 0
M  V30 32 N 14.8058 7.2870 0.0 0
M  V30 33 C 16.3459 4.6196 0.0 0
M  V30 34 C 16.3459 7.2870 0.0 0
M  V30 35 C 17.1159 5.9533 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 2 8 17
M  V30 9 1 9 18
M  V30 10 1 9 25
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 31
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 19
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[3-[[3-(4-Chlorophenyl)-4,5-dihydro-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hydroxy...
C21H18ClF3N8O3
2308523-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.4886 7.0618 0.0 0
M  V30 2 C 3.0128 8.5265 0.0 0 CFG=2
M  V30 3 C 1.5063 8.8467 0.0 0
M  V30 4 O 4.0432 9.6709 0.0 0
M  V30 5 F 1.1861 7.3403 0.0 0
M  V30 6 F 0.0000 9.1669 0.0 0
M  V30 7 F 1.8265 10.3530 0.0 0
M  V30 8 O 5.9786 9.3038 0.0 0
M  V30 9 C 8.8801 7.6286 0.0 0
M  V30 10 Cl 2.5414 0.0000 0.0 0
M  V30 11 C 14.0359 3.2858 0.0 0
M  V30 12 N 14.8059 1.9521 0.0 0
M  V30 13 O 12.4958 3.2858 0.0 0
M  V30 14 C 14.0359 0.6185 0.0 0
M  V30 15 C 5.6214 5.3348 0.0 0
M  V30 16 N 4.9949 6.7417 0.0 0
M  V30 17 N 7.1530 5.4958 0.0 0
M  V30 18 C 6.1395 7.7721 0.0 0
M  V30 19 N 7.4732 7.0021 0.0 0
M  V30 20 C 4.8514 4.0010 0.0 0
M  V30 21 C 5.6214 2.6673 0.0 0
M  V30 22 C 3.3114 4.0010 0.0 0
M  V30 23 C 4.8514 1.3337 0.0 0
M  V30 24 C 2.5414 2.6673 0.0 0
M  V30 25 C 3.3114 1.3337 0.0 0
M  V30 26 C 10.1260 6.7233 0.0 0
M  V30 27 N 11.5906 7.1992 0.0 0
M  V30 28 N 10.1260 5.1833 0.0 0
M  V30 29 N 12.4958 5.9533 0.0 0
M  V30 30 C 11.5906 4.7074 0.0 0
M  V30 31 C 14.0359 5.9533 0.0 0
M  V30 32 C 14.8059 4.6196 0.0 0
M  V30 33 N 14.8059 7.2870 0.0 0
M  V30 34 C 16.3459 4.6196 0.0 0
M  V30 35 C 16.3459 7.2870 0.0 0
M  V30 36 C 17.1159 5.9533 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 2 8 18
M  V30 9 1 9 19
M  V30 10 1 9 26
M  V30 11 1 10 25
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 32
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 20
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2308525-20-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2308523-63-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20929337
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted triazole derivatives for treating diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Collin-Kroepelin, Marie-Pierre; Kolkhof, Peter; Neubauer, Thomas;
Fuerstner, Chantal; Pook, Elisabeth; Wittwer, Matthias Beat; Lustig,
Klemens; Tinel, Hanna; Lindner, Niels; Schirmer, Heiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019081307 A1 2019-05-02

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Methylethenyl)benzaldehyde
C10H10O
23417-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(1-methylethenyl)benzenemethanamine
C11H15N
710339-38-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0011 0.0 0
M  V30 2 C 2.3100 5.3349 0.0 0
M  V30 3 C 0.0000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 N 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 23417-79-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 710339-38-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15350886
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and cycloaddition chemistry of 1-amino substituted
isobenzofurans
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Padwa, Albert; Eidell, Cheryl K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2003), (14), 62-76

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C23H25NO4S
2345666-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.5907 0.9035 0.0 0
M  V30 2 S 9.7990 4.3323 0.0 0 VAL=6
M  V30 3 O 9.7990 2.7923 0.0 0
M  V30 4 O 9.7990 5.8723 0.0 0
M  V30 5 O 0.8133 5.2206 0.0 0
M  V30 6 C 0.0000 6.5283 0.0 0
M  V30 7 C 6.1436 2.8980 0.0 0 CFG=1
M  V30 8 C 7.1120 1.7520 0.0 0 CFG=1
M  V30 9 C 4.7050 4.0138 0.0 0
M  V30 10 C 7.2780 4.2555 0.0 0
M  V30 11 C 4.6280 2.6252 0.0 0
M  V30 12 C 7.1596 3.0443 0.0 0 CFG=2
M  V30 13 C 6.6161 0.2729 0.0 0
M  V30 14 C 5.4308 5.3721 0.0 0
M  V30 15 C 3.1658 3.9633 0.0 0
M  V30 16 C 7.2877 5.4704 0.0 0
M  V30 17 C 4.1064 1.1762 0.0 0
M  V30 18 N 8.2590 4.3323 0.0 0
M  V30 19 C 5.7511 4.0993 0.0 0
M  V30 20 C 5.1005 0.0000 0.0 0
M  V30 21 C 4.6175 6.6799 0.0 0
M  V30 22 C 2.3525 5.2711 0.0 0
M  V30 23 C 3.0783 6.6294 0.0 0
M  V30 24 C 11.3390 4.3323 0.0 0
M  V30 25 C 12.1090 2.9987 0.0 0
M  V30 26 C 12.1090 5.6659 0.0 0
M  V30 27 C 13.6489 2.9987 0.0 0
M  V30 28 C 13.6489 5.6659 0.0 0
M  V30 29 C 14.4189 4.3323 0.0 0
M  V30 30 H 8.6270 1.4762 0.0 0
M  V30 31 H 8.5944 2.4849 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 2 24
M  V30 6 1 5 6
M  V30 7 1 5 22
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=3
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 8 13 CFG=3
M  V30 14 1 8 30 CFG=1
M  V30 15 1 9 14
M  V30 16 2 9 15
M  V30 17 1 10 16
M  V30 18 1 11 17
M  V30 19 1 12 18
M  V30 20 1 12 19
M  V30 21 1 12 31 CFG=1
M  V30 22 1 13 20
M  V30 23 1 14 19
M  V30 24 2 14 21
M  V30 25 1 15 22
M  V30 26 1 16 18
M  V30 27 1 17 20
M  V30 28 1 21 23
M  V30 29 2 22 23
M  V30 30 2 24 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 8 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6α)-3-Methoxy-N-methyl-17-(phenylsulfonyl)morphinan-6-amine
C24H30N2O3S
2345665-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 2.5907 1.4490 0.0 0
M  V30 2 C 2.0691 0.0000 0.0 0
M  V30 3 S 9.7990 4.8778 0.0 0 VAL=6
M  V30 4 O 9.7990 6.4178 0.0 0
M  V30 5 O 9.7990 3.3378 0.0 0
M  V30 6 O 0.8133 5.7661 0.0 0
M  V30 7 C 0.0000 7.0738 0.0 0
M  V30 8 C 6.1437 3.4436 0.0 0 CFG=1
M  V30 9 C 7.1120 2.2977 0.0 0 CFG=1
M  V30 10 C 4.7050 4.5595 0.0 0
M  V30 11 C 7.2780 4.8011 0.0 0
M  V30 12 C 4.6280 3.1707 0.0 0
M  V30 13 C 7.1596 3.5899 0.0 0 CFG=1
M  V30 14 C 6.6161 0.8184 0.0 0
M  V30 15 C 5.4308 5.9176 0.0 0
M  V30 16 C 3.1658 4.5090 0.0 0
M  V30 17 C 7.2877 6.0158 0.0 0
M  V30 18 C 4.1064 1.7217 0.0 0 CFG=1
M  V30 19 N 8.2590 4.8778 0.0 0
M  V30 20 C 5.7511 4.6449 0.0 0
M  V30 21 C 5.1005 0.5456 0.0 0
M  V30 22 C 4.6175 7.2254 0.0 0
M  V30 23 C 2.3525 5.8166 0.0 0
M  V30 24 C 3.0783 7.1748 0.0 0
M  V30 25 C 11.3390 4.8778 0.0 0
M  V30 26 C 12.1090 3.5441 0.0 0
M  V30 27 C 12.1090 6.2116 0.0 0
M  V30 28 C 13.6490 3.5441 0.0 0
M  V30 29 C 13.6490 6.2116 0.0 0
M  V30 30 C 14.4190 4.8778 0.0 0
M  V30 31 H 8.6271 2.0217 0.0 0
M  V30 32 H 8.5944 3.0306 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=3
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 19
M  V30 6 1 3 25
M  V30 7 1 6 7
M  V30 8 1 6 23
M  V30 9 1 8 9
M  V30 10 1 8 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=3
M  V30 15 1 9 31 CFG=1
M  V30 16 1 10 15
M  V30 17 2 10 16
M  V30 18 1 11 17
M  V30 19 1 12 18
M  V30 20 1 13 19
M  V30 21 1 13 20
M  V30 22 1 13 32 CFG=3
M  V30 23 1 14 21
M  V30 24 1 15 20
M  V30 25 2 15 22
M  V30 26 1 16 23
M  V30 27 1 17 19
M  V30 28 1 18 21
M  V30 29 1 22 24
M  V30 30 2 23 24
M  V30 31 2 25 26
M  V30 32 1 25 27
M  V30 33 1 26 28
M  V30 34 2 27 29
M  V30 35 2 28 30
M  V30 36 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 9 13 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2345666-33-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2345665-87-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-20427665
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Essential structure of orexin 1 receptor antagonist YNT-707, part III:
Role of the 14-hydroxy and the 3-methoxy groups in antagonistic activity
toward the orexin 1 receptor in YNT-707 derivatives lacking the 4,5-epoxy
ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamamoto, Naoshi; Ohrui, Sayaka; Okada, Takahiro; Saitoh, Tsuyoshi;
Kutsumura, Noriki; Nagumo, Yasuyuki; Irukayama-Tomobe, Yoko; Ogawa,
Yasuhiro; Ishikawa, Yukiko; Watanabe, Yurie; Hayakawa, Daichi; Gouda,
Hiroaki; Yanagisawa, Masashi; Nagase, Hiroshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2019), 27(8), 1747-1758

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
4-Bromo-1,2-dihydro-2-methyl-1-oxo-6-isoquinolinecarboxylic acid
C11H8BrNO3
2369068-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 2.6674 6.1600 0.0 0
M  V30 2 O 2.6674 0.0000 0.0 0
M  V30 3 C 8.0021 4.6200 0.0 0
M  V30 4 O 9.3358 3.8500 0.0 0
M  V30 5 O 8.0021 6.1600 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 5.3347 4.6200 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 2.6674 1.5400 0.0 0
M  V30 12 C 5.3347 1.5400 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 1.3336 3.8500 0.0 0
M  V30 15 N 1.3336 2.3100 0.0 0
M  V30 16 C 6.6684 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 16
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,2-dihydro-N,2-dimethyl-1-oxo-6-isoquinolinecarboxamide
C12H11BrN2O2
2369068-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.6200 0.0000 0.0 0
M  V30 2 O 1.5400 5.3349 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 N 9.2400 5.3349 0.0 0
M  V30 5 O 9.2400 2.6674 0.0 0
M  V30 6 C 10.7800 5.3349 0.0 0
M  V30 7 C 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 6.1600 2.6674 0.0 0
M  V30 11 C 3.8500 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 2.3100 1.3338 0.0 0
M  V30 16 N 1.5400 2.6674 0.0 0
M  V30 17 C 6.1600 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 17
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2369068-28-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2369068-29-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21582935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds for treating cancer and viral
infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Qianhe; Bocker, Michael; Millan, David Simon; Chan, Ho Man; Soares,
Luis; Netherton, Matthew Russell; Ruppel, Sabine K.; Yang, Zhaoxia; Lowe,
Jason T.; Brucelle, Francois
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019152440 A1 2019-08-08

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3′-(2-Methoxy-2-oxoethyl)[1,1′-biphenyl]-3-yl]-1-propyl-1H-imidazole-5-car...
C22H22N2O4
2376307-85-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1471 1.9822 0.0 0
M  V30 2 C 1.6825 1.5063 0.0 0
M  V30 3 C 1.3622 0.0000 0.0 0
M  V30 4 C 0.9052 4.4721 0.0 0
M  V30 5 O 0.0000 5.7180 0.0 0
M  V30 6 O 0.2787 3.0653 0.0 0
M  V30 7 C 14.2100 3.3450 0.0 0
M  V30 8 C 15.5439 4.1150 0.0 0
M  V30 9 O 16.8775 3.3450 0.0 0
M  V30 10 O 15.5439 5.6550 0.0 0
M  V30 11 C 18.2112 4.1150 0.0 0
M  V30 12 C 4.8742 4.1150 0.0 0
M  V30 13 N 3.4672 3.4886 0.0 0
M  V30 14 N 4.7131 5.6465 0.0 0
M  V30 15 C 2.4368 4.6330 0.0 0
M  V30 16 C 3.2068 5.9669 0.0 0
M  V30 17 C 6.2079 3.3450 0.0 0
M  V30 18 C 7.5415 4.1150 0.0 0
M  V30 19 C 6.2079 1.8049 0.0 0
M  V30 20 C 8.8752 3.3450 0.0 0
M  V30 21 C 7.5415 1.0349 0.0 0
M  V30 22 C 8.8752 1.8049 0.0 0
M  V30 23 C 10.2090 4.1150 0.0 0
M  V30 24 C 11.5427 3.3450 0.0 0
M  V30 25 C 10.2090 5.6550 0.0 0
M  V30 26 C 12.8764 4.1150 0.0 0
M  V30 27 C 11.5427 6.4250 0.0 0
M  V30 28 C 12.8764 5.6550 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 7 8
M  V30 8 1 7 26
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 17
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 20 23
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3′-[2-(Methylamino)-2-oxoethyl][1,1′-biphenyl]-3-yl]-1-propyl-1H-imidazole...
C22H23N3O3
2376323-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1471 1.9822 0.0 0
M  V30 2 C 1.6825 1.5063 0.0 0
M  V30 3 C 1.3622 0.0000 0.0 0
M  V30 4 C 0.9052 4.4721 0.0 0
M  V30 5 O 0.0000 5.7180 0.0 0
M  V30 6 O 0.2787 3.0653 0.0 0
M  V30 7 C 14.2100 3.3450 0.0 0
M  V30 8 C 15.5439 4.1150 0.0 0
M  V30 9 N 16.8775 3.3450 0.0 0
M  V30 10 O 15.5439 5.6550 0.0 0
M  V30 11 C 18.2112 4.1150 0.0 0
M  V30 12 C 4.8742 4.1150 0.0 0
M  V30 13 N 3.4672 3.4886 0.0 0
M  V30 14 N 4.7131 5.6465 0.0 0
M  V30 15 C 2.4368 4.6330 0.0 0
M  V30 16 C 3.2068 5.9669 0.0 0
M  V30 17 C 6.2079 3.3450 0.0 0
M  V30 18 C 7.5415 4.1150 0.0 0
M  V30 19 C 6.2079 1.8049 0.0 0
M  V30 20 C 8.8752 3.3450 0.0 0
M  V30 21 C 7.5415 1.0349 0.0 0
M  V30 22 C 8.8752 1.8049 0.0 0
M  V30 23 C 10.2090 4.1150 0.0 0
M  V30 24 C 11.5427 3.3450 0.0 0
M  V30 25 C 10.2090 5.6550 0.0 0
M  V30 26 C 12.8764 4.1150 0.0 0
M  V30 27 C 11.5427 6.4250 0.0 0
M  V30 28 C 12.8764 5.6550 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 7 8
M  V30 8 1 7 26
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 17
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 20 23
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2376307-85-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376323-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20970445
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Angle on MK2 Inhibition-Optimization and Evaluation of Prevention of
Activation Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hedstroem, Ulf; Norberg, Monica; Evertsson, Emma; Lever, Sarah R.; Munck
af Rosenschoeld, Magnus; Loenn, Hans; Bold, Peter; Kaeck, Helena;
Berntsson, Pia; Vinblad, Johanna; Liu, Jianming; Welinder, Anette;
Karlsson, Johan; Snijder, Arjan; Pardali, Katerina; Andersson, Ulf;
Davis, Andrew M.; Mogemark, Mickael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2019), 14(19), 1701-1709

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-3-(3-chloro-2-fluorophenyl)-1-[(4-methoxyphenyl)methyl]-1H-pyrazolo[...
C19H13Cl2FN4O
2377299-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 7.5808 3.3419 0.0 0
M  V30 2 C 6.0551 8.3657 0.0 0
M  V30 3 Cl 7.9028 0.2787 0.0 0
M  V30 4 Cl 0.0000 8.4561 0.0 0
M  V30 5 O 12.2152 8.3657 0.0 0
M  V30 6 C 12.9852 9.6994 0.0 0
M  V30 7 C 4.7670 4.5947 0.0 0
M  V30 8 C 3.4333 5.3647 0.0 0
M  V30 9 N 5.9116 5.6253 0.0 0
M  V30 10 C 3.7535 6.8711 0.0 0
M  V30 11 N 1.9686 4.8888 0.0 0
M  V30 12 N 5.2851 7.0321 0.0 0
M  V30 13 N 2.6091 7.9016 0.0 0
M  V30 14 C 0.8242 5.9193 0.0 0
M  V30 15 C 1.1444 7.4257 0.0 0
M  V30 16 C 4.9281 3.0631 0.0 0
M  V30 17 C 6.3349 2.4368 0.0 0
M  V30 18 C 3.6821 2.1579 0.0 0
M  V30 19 C 6.4958 0.9051 0.0 0
M  V30 20 C 3.8431 0.6263 0.0 0
M  V30 21 C 5.2500 0.0000 0.0 0
M  V30 22 C 7.5951 8.3657 0.0 0
M  V30 23 C 8.3651 9.6994 0.0 0
M  V30 24 C 8.3651 7.0321 0.0 0
M  V30 25 C 9.9052 9.6994 0.0 0
M  V30 26 C 9.9052 7.0321 0.0 0
M  V30 27 C 10.6752 8.3657 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 12
M  V30 3 1 2 22
M  V30 4 1 3 19
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 5 27
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 16
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 10 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Chloro-2-fluorophenyl)-1-[(4-methoxyphenyl)methyl]-N-methyl-1H-pyrazolo[...
C20H17ClFN5O
2377299-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 9.0455 3.3419 0.0 0
M  V30 2 C 7.5200 8.3658 0.0 0
M  V30 3 Cl 9.3676 0.2787 0.0 0
M  V30 4 N 1.4647 8.4562 0.0 0
M  V30 5 C 0.0000 7.9803 0.0 0
M  V30 6 O 13.6801 8.3658 0.0 0
M  V30 7 C 14.4501 9.6994 0.0 0
M  V30 8 C 6.2319 4.5947 0.0 0
M  V30 9 C 4.8981 5.3647 0.0 0
M  V30 10 N 7.3763 5.6253 0.0 0
M  V30 11 C 5.2183 6.8712 0.0 0
M  V30 12 N 3.4335 4.8888 0.0 0
M  V30 13 N 6.7500 7.0321 0.0 0
M  V30 14 N 4.0739 7.9016 0.0 0
M  V30 15 C 2.2890 5.9193 0.0 0
M  V30 16 C 2.6091 7.4257 0.0 0
M  V30 17 C 6.3928 3.0631 0.0 0
M  V30 18 C 7.7997 2.4368 0.0 0
M  V30 19 C 5.1469 2.1579 0.0 0
M  V30 20 C 7.9607 0.9051 0.0 0
M  V30 21 C 5.3079 0.6263 0.0 0
M  V30 22 C 6.7147 0.0000 0.0 0
M  V30 23 C 9.0600 8.3658 0.0 0
M  V30 24 C 9.8300 9.6994 0.0 0
M  V30 25 C 9.8300 7.0321 0.0 0
M  V30 26 C 11.3701 9.6994 0.0 0
M  V30 27 C 11.3701 7.0321 0.0 0
M  V30 28 C 12.1401 8.3658 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 13
M  V30 3 1 2 23
M  V30 4 1 3 20
M  V30 5 1 4 5
M  V30 6 1 4 16
M  V30 7 1 6 7
M  V30 8 1 6 28
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 17
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2377299-81-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2377299-73-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23022077
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors
useful in treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taylor, Alexander M.; Giordanetto, Fabrizio; Greisman, Jack Benjamin;
Maragakis, Paul; Schoenherr, Heike
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019183364 A1 2019-09-26

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Chlorothieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone
C16H13ClN2O4S
2377788-44-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 5.3901 0.0 0
M  V30 2 O 5.1456 6.9302 0.0 0
M  V30 3 Cl 2.4782 0.7700 0.0 0
M  V30 4 O 7.8131 0.7700 0.0 0
M  V30 5 C 9.1467 0.0000 0.0 0
M  V30 6 O 10.4804 5.3901 0.0 0
M  V30 7 C 10.4804 6.9302 0.0 0
M  V30 8 O 10.4804 2.3101 0.0 0
M  V30 9 C 11.8142 3.0801 0.0 0
M  V30 10 C 2.4782 5.3901 0.0 0
M  V30 11 C 3.8119 4.6201 0.0 0
M  V30 12 C 1.1446 4.6201 0.0 0
M  V30 13 S 2.1580 6.8964 0.0 0
M  V30 14 N 3.8119 3.0801 0.0 0
M  V30 15 N 1.1446 3.0801 0.0 0
M  V30 16 C 0.0000 5.6505 0.0 0
M  V30 17 C 0.6265 7.0574 0.0 0
M  V30 18 C 2.4782 2.3101 0.0 0
M  V30 19 C 6.4794 4.6201 0.0 0
M  V30 20 C 6.4794 3.0801 0.0 0
M  V30 21 C 7.8131 5.3901 0.0 0
M  V30 22 C 7.8131 2.3101 0.0 0
M  V30 23 C 9.1467 4.6201 0.0 0
M  V30 24 C 9.1467 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 1 19
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 1 4 22
M  V30 7 1 6 7
M  V30 8 1 6 23
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 15 18
M  V30 20 2 16 17
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [2-(methylamino)thieno[3,2-d]pyrimidin-4-yl](3,4,5-trimethoxyphenyl)-
C17H17N3O4S
3033300-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 5.3901 0.0 0
M  V30 2 O 5.1456 6.9302 0.0 0
M  V30 3 N 2.4782 0.7700 0.0 0
M  V30 4 C 1.1446 0.0000 0.0 0
M  V30 5 O 7.8131 0.7700 0.0 0
M  V30 6 C 9.1467 0.0000 0.0 0
M  V30 7 O 10.4804 5.3901 0.0 0
M  V30 8 C 10.4804 6.9302 0.0 0
M  V30 9 O 10.4804 2.3101 0.0 0
M  V30 10 C 11.8142 3.0801 0.0 0
M  V30 11 C 2.4782 5.3901 0.0 0
M  V30 12 C 3.8119 4.6201 0.0 0
M  V30 13 C 1.1446 4.6201 0.0 0
M  V30 14 S 2.1580 6.8964 0.0 0
M  V30 15 N 3.8119 3.0801 0.0 0
M  V30 16 N 1.1446 3.0801 0.0 0
M  V30 17 C 0.0000 5.6505 0.0 0
M  V30 18 C 0.6265 7.0574 0.0 0
M  V30 19 C 2.4782 2.3101 0.0 0
M  V30 20 C 6.4794 4.6201 0.0 0
M  V30 21 C 6.4794 3.0801 0.0 0
M  V30 22 C 7.8131 5.3901 0.0 0
M  V30 23 C 7.8131 2.3101 0.0 0
M  V30 24 C 9.1467 4.6201 0.0 0
M  V30 25 C 9.1467 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 12
M  V30 3 1 1 20
M  V30 4 1 3 4
M  V30 5 1 3 19
M  V30 6 1 5 6
M  V30 7 1 5 23
M  V30 8 1 7 8
M  V30 9 1 7 24
M  V30 10 1 9 10
M  V30 11 1 9 25
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 19
M  V30 21 2 17 18
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2377788-44-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3033300-07-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32534547
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
(2-(pyrrolidin-1-yl)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone
as a novel potent tubulin depolymerizing and vascular disrupting agent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tian, Chao; Wang, Meng; Shi, Xueqi; Chen, Xuanzhen; Wang, Xiaowei; Zhang,
Zhili; Liu, Junyi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 238114466

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[[2-Chloro-9-(1-methylethyl)-9H-purin-6-yl]amino]methyl]-4,6-dimethyl-2(1H...
C16H19ClN6O
2379756-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.0304 4.5603 0.0 0
M  V30 2 C 0.0000 5.7048 0.0 0
M  V30 3 C 0.5546 3.0957 0.0 0
M  V30 4 N 7.6823 4.6200 0.0 0
M  V30 5 C 9.0160 3.8500 0.0 0
M  V30 6 Cl 5.0149 0.0000 0.0 0
M  V30 7 C 11.6834 2.3100 0.0 0
M  V30 8 O 9.0160 6.9300 0.0 0
M  V30 9 C 14.3507 6.9300 0.0 0
M  V30 10 C 3.6812 3.8500 0.0 0
M  V30 11 C 5.0149 4.6200 0.0 0
M  V30 12 N 2.5369 4.8804 0.0 0
M  V30 13 N 3.6812 2.3100 0.0 0
M  V30 14 C 6.3487 3.8500 0.0 0
M  V30 15 N 4.6947 6.1263 0.0 0
M  V30 16 C 3.1632 6.2874 0.0 0
M  V30 17 C 5.0149 1.5400 0.0 0
M  V30 18 N 6.3487 2.3100 0.0 0
M  V30 19 C 10.3496 4.6200 0.0 0
M  V30 20 C 11.6834 3.8500 0.0 0
M  V30 21 C 10.3496 6.1600 0.0 0
M  V30 22 C 13.0171 4.6200 0.0 0
M  V30 23 N 11.6834 6.9300 0.0 0
M  V30 24 C 13.0171 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 19
M  V30 7 1 6 17
M  V30 8 1 7 20
M  V30 9 2 8 21
M  V30 10 1 9 24
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dimethyl-3-[[[2-(methylamino)-9-(1-methylethyl)-9H-purin-6-yl]amino]methy...
C17H23N7O
2414607-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.0304 5.3303 0.0 0
M  V30 2 C 0.0000 6.4749 0.0 0
M  V30 3 C 0.5546 3.8658 0.0 0
M  V30 4 N 7.6824 5.3901 0.0 0
M  V30 5 C 9.0161 4.6201 0.0 0
M  V30 6 N 5.0149 0.7700 0.0 0
M  V30 7 C 3.6813 0.0000 0.0 0
M  V30 8 C 9.0161 7.7001 0.0 0
M  V30 9 O 11.6835 3.0800 0.0 0
M  V30 10 C 14.3508 7.7001 0.0 0
M  V30 11 C 3.6813 4.6201 0.0 0
M  V30 12 C 5.0149 5.3901 0.0 0
M  V30 13 N 2.5369 5.6505 0.0 0
M  V30 14 N 3.6813 3.0800 0.0 0
M  V30 15 C 6.3487 4.6201 0.0 0
M  V30 16 N 4.6948 6.8964 0.0 0
M  V30 17 C 3.1632 7.0575 0.0 0
M  V30 18 C 5.0149 2.3100 0.0 0
M  V30 19 N 6.3487 3.0800 0.0 0
M  V30 20 C 10.3497 5.3901 0.0 0
M  V30 21 C 10.3497 6.9301 0.0 0
M  V30 22 C 11.6835 4.6201 0.0 0
M  V30 23 C 11.6835 7.7001 0.0 0
M  V30 24 N 13.0172 5.3901 0.0 0
M  V30 25 C 13.0172 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 18
M  V30 9 1 8 21
M  V30 10 2 9 22
M  V30 11 1 10 25
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2379756-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414607-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22378333
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of a novel tubulin inhibitor
SKLB0565 targeting the colchicine binding site
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Xi; Li, Lu; Zhang, Qiangsheng; Wang, Qianqian; Feng, Zhanzhan; Xu,
Ying; Xia, Yong; Yu, Luoting
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 97103695

$RFMT $RIREG SCHEME207 STEP1
$RXN



  3  1
$MOL
Ethenesulfonyl fluoride
C2H3FO2S
677-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 1.3337 0.0 0 VAL=6
M  V30 2 C 2.6673 2.1037 0.0 0
M  V30 3 F 0.0000 0.5637 0.0 0
M  V30 4 O 2.1037 0.0000 0.0 0
M  V30 5 O 0.5637 2.6673 0.0 0
M  V30 6 C 4.0010 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 1 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrophenylboronic acid
C6H6BNO4
24067-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 6.6686 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6686 0.0000 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 5 O 0.0000 3.8500 0.0 0
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 2.6675 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Thiazetidine, 2-methyl-3-(4-nitrophenyl)-, 1,1-dioxide
C9H10N2O4S
2059882-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1780 0.0000 0.0 0
M  V30 2 O 0.0000 1.5400 0.0 0
M  V30 3 O 0.0000 3.7179 0.0 0
M  V30 4 N 9.4270 2.6289 0.0 0 VAL=5
M  V30 5 O 10.1970 1.2953 0.0 0
M  V30 6 O 10.1970 3.9627 0.0 0
M  V30 7 C 3.2670 2.6289 0.0 0
M  V30 8 N 2.1780 1.5400 0.0 0
M  V30 9 C 2.1780 3.7179 0.0 0
M  V30 10 S 1.0889 2.6289 0.0 0 VAL=6
M  V30 11 C 4.8070 2.6289 0.0 0
M  V30 12 C 5.5770 3.9627 0.0 0
M  V30 13 C 5.5770 1.2953 0.0 0
M  V30 14 C 7.1170 3.9627 0.0 0
M  V30 15 C 7.1170 1.2953 0.0 0
M  V30 16 C 7.8870 2.6289 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 10
M  V30 3 2 3 10
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 11
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 677-25-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24067-17-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2059882-50-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-179-CAS-16530602
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-89-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, Boron Heck coupling, one-pot two step reaction, sealed
tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Synthesis of "Dual Warhead" β-Aryl Ethenesulfonyl Fluorides and One-Pot
Reaction to β-Sultams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chinthakindi, Praveen K.; Govender, Kimberleigh B.; Kumar, A. Sanjeeva;
Kruger, Hendrik G.; Govender, Thavendran; Naicker, Tricia; Arvidsson, Per
I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(3), 480-483

$RFMT $RIREG SCHEME208 STEP1
$RXN



  1  1
$MOL

C6H4N18O4.2H4N2
2407062-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6363 8.3266 0.0 0
M  V30 2 N 7.2628 6.9196 0.0 0
M  V30 3 N 1.3337 7.1995 0.0 0 VAL=5
M  V30 4 O 1.3337 5.6594 0.0 0
M  V30 5 O 0.0000 7.9695 0.0 0
M  V30 6 N 12.5654 8.0468 0.0 0 VAL=5
M  V30 7 O 12.5654 9.5868 0.0 0
M  V30 8 O 13.8991 7.2768 0.0 0
M  V30 9 N 4.3347 9.8212 0.0 0
M  V30 10 C 5.1048 8.4876 0.0 0
M  V30 11 N 2.8284 9.5011 0.0 0
M  V30 12 N 4.0743 7.3432 0.0 0
M  V30 13 C 2.6673 7.9695 0.0 0
M  V30 14 C 4.9611 11.2282 0.0 0
M  V30 15 N 6.4675 11.5484 0.0 0
M  V30 16 N 4.1910 12.5619 0.0 0
M  V30 17 N 6.6285 13.0799 0.0 0
M  V30 18 N 5.2216 13.7063 0.0 0
M  V30 19 C 8.7944 6.7587 0.0 0
M  V30 20 N 9.5644 5.4250 0.0 0
M  V30 21 N 9.8248 7.9031 0.0 0
M  V30 22 N 11.0707 5.7452 0.0 0
M  V30 23 C 11.2318 7.2768 0.0 0
M  V30 24 C 8.9380 4.0181 0.0 0
M  V30 25 N 9.7081 2.6844 0.0 0
M  V30 26 N 7.4316 3.6979 0.0 0
M  V30 27 N 8.6775 1.5400 0.0 0
M  V30 28 N 7.2707 2.1663 0.0 0
M  V30 29 N 6.1796 0.0000 0.0 0
M  V30 30 N 7.7196 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 19
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 23
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 20 24
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C6H4N18O4
2378143-41-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6363 6.7866 0.0 0
M  V30 2 N 7.2628 5.3796 0.0 0
M  V30 3 N 1.3337 5.6595 0.0 0 VAL=5
M  V30 4 O 1.3337 4.1194 0.0 0
M  V30 5 O 0.0000 6.4295 0.0 0
M  V30 6 N 12.5654 6.5068 0.0 0 VAL=5
M  V30 7 O 12.5654 8.0468 0.0 0
M  V30 8 O 13.8991 5.7368 0.0 0
M  V30 9 N 4.3347 8.2812 0.0 0
M  V30 10 C 5.1048 6.9476 0.0 0
M  V30 11 N 2.8284 7.9611 0.0 0
M  V30 12 N 4.0743 5.8032 0.0 0
M  V30 13 C 2.6673 6.4295 0.0 0
M  V30 14 C 4.9611 9.6882 0.0 0
M  V30 15 N 6.4675 10.0084 0.0 0
M  V30 16 N 4.1910 11.0219 0.0 0
M  V30 17 N 6.6285 11.5399 0.0 0
M  V30 18 N 5.2216 12.1663 0.0 0
M  V30 19 C 8.7944 5.2187 0.0 0
M  V30 20 N 9.5644 3.8850 0.0 0
M  V30 21 N 9.8248 6.3631 0.0 0
M  V30 22 N 11.0707 4.2052 0.0 0
M  V30 23 C 11.2318 5.7368 0.0 0
M  V30 24 C 8.9380 2.4781 0.0 0
M  V30 25 N 9.7081 1.1444 0.0 0
M  V30 26 N 7.4316 2.1579 0.0 0
M  V30 27 N 8.6775 0.0000 0.0 0
M  V30 28 N 7.2707 0.6263 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 19
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 23
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 20 24
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2407062-77-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378143-41-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-20939090
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel facile transformation to
1,2-bis(3-nitro-1-(1H-tetrazol-5-yl)-1H-1,2,4-triazol-5-yl)hydrazine
salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Baojing; Li, Xingye; Wang, Piaopiao; Ding, Yongzhi; Zhou, Zhiming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2018), 42(17), 14087-14090

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[[2-Chloro-9-(1-methylethyl)-9H-purin-6-yl]amino]methyl]-4,6-diethyl-2(1H)...
C18H23ClN6O
2414606-93-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9350 5.3347 0.0 0
M  V30 2 C 7.7050 4.0011 0.0 0
M  V30 3 C 1.1444 8.6090 0.0 0
M  V30 4 C 0.0000 7.5785 0.0 0
M  V30 5 C 0.8242 10.1154 0.0 0
M  V30 6 Cl 2.3149 2.6674 0.0 0
M  V30 7 C 9.2450 1.3338 0.0 0
M  V30 8 C 10.0150 0.0000 0.0 0
M  V30 9 O 9.2450 6.6685 0.0 0
M  V30 10 C 13.8650 4.0011 0.0 0
M  V30 11 C 14.6350 5.3347 0.0 0
M  V30 12 C 4.6250 6.6685 0.0 0
M  V30 13 C 3.0849 6.6685 0.0 0
M  V30 14 C 5.3950 5.3347 0.0 0
M  V30 15 N 5.1008 8.1331 0.0 0
M  V30 16 N 2.6091 8.1331 0.0 0
M  V30 17 N 2.3149 5.3347 0.0 0
M  V30 18 N 4.6250 4.0011 0.0 0
M  V30 19 C 3.8549 9.0383 0.0 0
M  V30 20 C 3.0849 4.0011 0.0 0
M  V30 21 C 9.2450 4.0011 0.0 0
M  V30 22 C 10.0150 2.6674 0.0 0
M  V30 23 C 10.0150 5.3347 0.0 0
M  V30 24 C 11.5550 2.6674 0.0 0
M  V30 25 N 11.5550 5.3347 0.0 0
M  V30 26 C 12.3250 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 16
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 1 7 22
M  V30 10 2 9 23
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Diethyl-3-[[[2-(methylamino)-9-(1-methylethyl)-9H-purin-6-yl]amino]methyl...
C19H27N7O
2414607-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.1444 8.6090 0.0 0
M  V30 2 C 0.8242 10.1154 0.0 0
M  V30 3 C 0.0000 7.5785 0.0 0
M  V30 4 N 6.9350 5.3347 0.0 0
M  V30 5 C 7.7050 4.0011 0.0 0
M  V30 6 N 2.3149 2.6674 0.0 0
M  V30 7 C 0.7749 2.6674 0.0 0
M  V30 8 C 9.2450 1.3338 0.0 0
M  V30 9 C 10.0150 0.0000 0.0 0
M  V30 10 O 9.2450 6.6685 0.0 0
M  V30 11 C 13.8650 4.0011 0.0 0
M  V30 12 C 14.6350 5.3347 0.0 0
M  V30 13 C 3.0849 6.6685 0.0 0
M  V30 14 C 4.6250 6.6685 0.0 0
M  V30 15 N 2.6091 8.1331 0.0 0
M  V30 16 N 2.3149 5.3347 0.0 0
M  V30 17 C 5.3950 5.3347 0.0 0
M  V30 18 N 5.1008 8.1331 0.0 0
M  V30 19 C 3.8549 9.0383 0.0 0
M  V30 20 C 3.0849 4.0011 0.0 0
M  V30 21 N 4.6250 4.0011 0.0 0
M  V30 22 C 9.2450 4.0011 0.0 0
M  V30 23 C 10.0150 2.6674 0.0 0
M  V30 24 C 10.0150 5.3347 0.0 0
M  V30 25 C 11.5550 2.6674 0.0 0
M  V30 26 N 11.5550 5.3347 0.0 0
M  V30 27 C 12.3250 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 1 6 20
M  V30 9 1 8 9
M  V30 10 1 8 23
M  V30 11 2 10 24
M  V30 12 1 11 12
M  V30 13 1 11 27
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2414606-93-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414607-24-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22378335
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of a novel tubulin inhibitor
SKLB0565 targeting the colchicine binding site
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Xi; Li, Lu; Zhang, Qiangsheng; Wang, Qianqian; Feng, Zhanzhan; Xu,
Ying; Xia, Yong; Yu, Luoting
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 97103695

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[(2-Chloro-9-cyclopentyl-9H-purin-6-yl)amino]methyl]-4,6-diethyl-2(1H)-pyr...
C20H25ClN6O
2414607-10-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.2824 5.3347 0.0 0
M  V30 2 C 9.0524 4.0009 0.0 0
M  V30 3 Cl 3.6624 2.6673 0.0 0
M  V30 4 C 10.5924 1.3336 0.0 0
M  V30 5 C 11.3624 0.0000 0.0 0
M  V30 6 O 10.5924 6.6684 0.0 0
M  V30 7 C 15.2124 4.0009 0.0 0
M  V30 8 C 15.9824 5.3347 0.0 0
M  V30 9 C 5.9724 6.6684 0.0 0
M  V30 10 C 4.4324 6.6684 0.0 0
M  V30 11 C 6.7424 5.3347 0.0 0
M  V30 12 N 6.4483 8.1330 0.0 0
M  V30 13 N 3.9564 8.1330 0.0 0
M  V30 14 N 3.6624 5.3347 0.0 0
M  V30 15 N 5.9724 4.0009 0.0 0
M  V30 16 C 5.2024 9.0381 0.0 0
M  V30 17 C 4.4324 4.0009 0.0 0
M  V30 18 C 2.4919 8.6089 0.0 0
M  V30 19 C 1.2460 7.7037 0.0 0
M  V30 20 C 2.0160 10.0734 0.0 0
M  V30 21 C 0.0000 8.6089 0.0 0
M  V30 22 C 0.4760 10.0734 0.0 0
M  V30 23 C 10.5924 4.0009 0.0 0
M  V30 24 C 11.3624 2.6673 0.0 0
M  V30 25 C 11.3624 5.3347 0.0 0
M  V30 26 C 12.9024 2.6673 0.0 0
M  V30 27 N 12.9024 5.3347 0.0 0
M  V30 28 C 13.6724 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 23
M  V30 4 1 3 17
M  V30 5 1 4 5
M  V30 6 1 4 24
M  V30 7 2 6 25
M  V30 8 1 7 8
M  V30 9 1 7 28
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 16
M  V30 18 1 13 18
M  V30 19 1 14 17
M  V30 20 2 15 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[[9-Cyclopentyl-2-(methylamino)-9H-purin-6-yl]amino]methyl]-4,6-diethyl-2(...
C21H29N7O
2414607-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.2824 5.3347 0.0 0
M  V30 2 C 9.0524 4.0009 0.0 0
M  V30 3 N 3.6624 2.6673 0.0 0
M  V30 4 C 2.1224 2.6673 0.0 0
M  V30 5 C 10.5924 1.3336 0.0 0
M  V30 6 C 11.3624 0.0000 0.0 0
M  V30 7 O 10.5924 6.6684 0.0 0
M  V30 8 C 15.2124 4.0009 0.0 0
M  V30 9 C 15.9824 5.3347 0.0 0
M  V30 10 C 4.4324 6.6684 0.0 0
M  V30 11 C 5.9724 6.6684 0.0 0
M  V30 12 N 3.9564 8.1330 0.0 0
M  V30 13 N 3.6624 5.3347 0.0 0
M  V30 14 C 6.7424 5.3347 0.0 0
M  V30 15 N 6.4483 8.1330 0.0 0
M  V30 16 C 5.2024 9.0381 0.0 0
M  V30 17 C 4.4324 4.0009 0.0 0
M  V30 18 N 5.9724 4.0009 0.0 0
M  V30 19 C 2.4919 8.6089 0.0 0
M  V30 20 C 2.0160 10.0734 0.0 0
M  V30 21 C 1.2460 7.7037 0.0 0
M  V30 22 C 0.4760 10.0734 0.0 0
M  V30 23 C 0.0000 8.6089 0.0 0
M  V30 24 C 10.5924 4.0009 0.0 0
M  V30 25 C 11.3624 2.6673 0.0 0
M  V30 26 C 11.3624 5.3347 0.0 0
M  V30 27 C 12.9024 2.6673 0.0 0
M  V30 28 N 12.9024 5.3347 0.0 0
M  V30 29 C 13.6724 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 24
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 5 6
M  V30 7 1 5 25
M  V30 8 2 7 26
M  V30 9 1 8 9
M  V30 10 1 8 29
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 19
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 2 15 16
M  V30 21 2 17 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2414607-10-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414607-30-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22378338
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of a novel tubulin inhibitor
SKLB0565 targeting the colchicine binding site
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Xi; Li, Lu; Zhang, Qiangsheng; Wang, Qianqian; Feng, Zhanzhan; Xu,
Ying; Xia, Yong; Yu, Luoting
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 97103695

$RFMT $RIREG SCHEME211 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-4-chlorobenzaldehyde
C7H4BrClO
84459-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 Br 2.3101 0.0000 0.0 0
M  V30 4 Cl 6.9302 2.6673 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[(2-bromo-4-chlorophenyl)methyl]-N-methyl-, 1,1-dimethylethy...
C13H17BrClNO2
2250107-89-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 C 3.8500 4.0011 0.0 0
M  V30 4 C 6.1600 5.3349 0.0 0
M  V30 5 O 3.0800 5.3349 0.0 0
M  V30 6 O 3.0800 2.6674 0.0 0
M  V30 7 C 1.5400 5.3349 0.0 0
M  V30 8 C 1.5400 3.7949 0.0 0
M  V30 9 C 0.0000 5.3349 0.0 0
M  V30 10 C 1.5400 6.8749 0.0 0
M  V30 11 Br 7.7000 0.0000 0.0 0
M  V30 12 Cl 12.3200 2.6674 0.0 0
M  V30 13 C 7.7000 2.6674 0.0 0
M  V30 14 C 8.4700 1.3338 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 10.0100 1.3338 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.7800 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 14
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 84459-33-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2250107-89-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-20958959
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted heterocyclic compounds derivatives as
allosteric modulators of group II metabotropic glutamate receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blayo, Anne-Laure; Catelain, Thomas; Dorange, Ismet; Genet, Cedric;
Manteau, Baptiste; Mayer, Stanislas; Schann, Stephan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018206820 A1 2018-11-15

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[3-chloro-4-(2,5-dichlorophenoxy)phenyl]acetamide
C14H9Cl4NO2
2442526-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 4.6201 0.0 0
M  V30 2 Cl 1.3337 6.1601 0.0 0
M  V30 3 Cl 1.3337 0.0000 0.0 0
M  V30 4 Cl 6.6685 6.1601 0.0 0
M  V30 5 N 9.3360 1.5400 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 12.0033 1.5400 0.0 0
M  V30 8 O 10.6697 3.8501 0.0 0
M  V30 9 Cl 13.3370 2.3101 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 5.3348 3.8501 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 C 8.0022 3.8501 0.0 0
M  V30 20 C 6.6685 1.5400 0.0 0
M  V30 21 C 8.0022 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 11
M  V30 4 1 3 14
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-Chloro-4-(2,5-dichlorophenoxy)phenyl]-2-(methylamino)acetamide
C15H13Cl3N2O2
2442526-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 1.5400 0.0 0
M  V30 2 Cl 1.3337 0.0000 0.0 0
M  V30 3 Cl 1.3337 6.1601 0.0 0
M  V30 4 Cl 6.6685 0.0000 0.0 0
M  V30 5 N 9.3358 4.6201 0.0 0
M  V30 6 C 10.6697 3.8501 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 O 10.6697 2.3101 0.0 0
M  V30 9 N 13.3370 3.8501 0.0 0
M  V30 10 C 14.6707 4.6201 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 17 C 5.3348 2.3101 0.0 0
M  V30 18 C 6.6685 1.5400 0.0 0
M  V30 19 C 5.3348 3.8501 0.0 0
M  V30 20 C 8.0022 2.3101 0.0 0
M  V30 21 C 6.6685 4.6201 0.0 0
M  V30 22 C 8.0022 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 1 2 12
M  V30 4 1 3 15
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 5 22
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2442526-18-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2442526-41-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22746474
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrazole derivatives as caspase inhibitors for the
treatment of inflammatory, infectious and neoplastic diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Doemling, Alexander Stephan Siegfried; Spanu, Pietro; Ulgheri, Fausta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3666769 A1 2020-06-17

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Acetyl-5-(4-bromophenyl)-2-(methylthio)-7-phenyl-4H-pyrano[2,3-b]pyridin-4-one
C23H16BrNO3S
2489549-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 5.3348 0.0 0
M  V30 2 C 0.7700 8.0022 0.0 0
M  V30 3 C 0.0000 9.3360 0.0 0
M  V30 4 O 0.0000 6.6685 0.0 0
M  V30 5 S 2.3101 10.6697 0.0 0
M  V30 6 C 3.0801 12.0033 0.0 0
M  V30 7 Br 2.3101 0.0000 0.0 0
M  V30 8 C 5.3901 5.3348 0.0 0
M  V30 9 C 4.6201 6.6685 0.0 0
M  V30 10 C 6.9302 5.3348 0.0 0
M  V30 11 C 5.3901 8.0022 0.0 0
M  V30 12 C 3.0801 6.6685 0.0 0
M  V30 13 C 7.7002 6.6685 0.0 0
M  V30 14 N 6.9302 8.0022 0.0 0
M  V30 15 O 4.6201 9.3360 0.0 0
M  V30 16 C 2.3101 8.0022 0.0 0
M  V30 17 C 3.0801 9.3360 0.0 0
M  V30 18 C 4.6201 4.0012 0.0 0
M  V30 19 C 5.3901 2.6673 0.0 0
M  V30 20 C 3.0801 4.0012 0.0 0
M  V30 21 C 4.6201 1.3337 0.0 0
M  V30 22 C 2.3101 2.6673 0.0 0
M  V30 23 C 3.0801 1.3337 0.0 0
M  V30 24 C 9.2402 6.6685 0.0 0
M  V30 25 C 10.0102 8.0022 0.0 0
M  V30 26 C 10.0102 5.3348 0.0 0
M  V30 27 C 11.5503 8.0022 0.0 0
M  V30 28 C 11.5503 5.3348 0.0 0
M  V30 29 C 12.3203 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 23
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 13 24
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Acetyl-5-(4-bromophenyl)-2-(methylamino)-7-phenyl-4H-pyrano[2,3-b]pyridin-4...
C23H17BrN2O3
2489549-87-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 5.3348 0.0 0
M  V30 2 C 0.7700 8.0022 0.0 0
M  V30 3 C 0.0000 9.3360 0.0 0
M  V30 4 O 0.0000 6.6685 0.0 0
M  V30 5 N 2.3101 10.6697 0.0 0
M  V30 6 C 3.0801 12.0033 0.0 0
M  V30 7 Br 2.3101 0.0000 0.0 0
M  V30 8 C 5.3901 5.3348 0.0 0
M  V30 9 C 4.6201 6.6685 0.0 0
M  V30 10 C 6.9302 5.3348 0.0 0
M  V30 11 C 5.3901 8.0022 0.0 0
M  V30 12 C 3.0801 6.6685 0.0 0
M  V30 13 C 7.7002 6.6685 0.0 0
M  V30 14 N 6.9302 8.0022 0.0 0
M  V30 15 O 4.6201 9.3360 0.0 0
M  V30 16 C 2.3101 8.0022 0.0 0
M  V30 17 C 3.0801 9.3360 0.0 0
M  V30 18 C 4.6201 4.0012 0.0 0
M  V30 19 C 5.3901 2.6673 0.0 0
M  V30 20 C 3.0801 4.0012 0.0 0
M  V30 21 C 4.6201 1.3337 0.0 0
M  V30 22 C 2.3101 2.6673 0.0 0
M  V30 23 C 3.0801 1.3337 0.0 0
M  V30 24 C 9.2402 6.6685 0.0 0
M  V30 25 C 10.0102 5.3348 0.0 0
M  V30 26 C 10.0102 8.0022 0.0 0
M  V30 27 C 11.5503 5.3348 0.0 0
M  V30 28 C 11.5503 8.0022 0.0 0
M  V30 29 C 12.3203 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 23
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 13 24
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2489549-68-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2489549-87-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28256801
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM safety, toxic methanethiol release during reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-(Substituted amino)-8-azachromones from 4,6-Diaryl-2-pyridones: A
Synthetic Strategy toward Compounds of Broad Structural Diversity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saulnier, Steve; Ghoteimi, Rayane; Mathe, Christophe; Peyrottes, Suzanne;
Uttaro, Jean-Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2020), 85(18), 11778-11793

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-(3-amino-2,6-difluorophenyl)-7-fluoro-1H-pyrazolo[4,3-c]pyridine-3-c...
C14H9F3N4O2
2505373-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3508 1.9572 0.0 0
M  V30 2 O 11.8155 2.4331 0.0 0
M  V30 3 O 10.0306 0.4508 0.0 0
M  V30 4 C 12.9599 1.4027 0.0 0
M  V30 5 F 4.6201 5.3350 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 F 3.0800 5.3350 0.0 0
M  V30 8 N 0.0000 0.0000 0.0 0
M  V30 9 C 7.7001 2.6675 0.0 0
M  V30 10 C 6.9301 4.0011 0.0 0
M  V30 11 C 9.2064 2.9876 0.0 0
M  V30 12 C 6.9301 1.3338 0.0 0
M  V30 13 C 5.3901 4.0011 0.0 0
M  V30 14 N 7.9605 5.1457 0.0 0
M  V30 15 N 9.3674 4.5192 0.0 0
M  V30 16 N 5.3901 1.3338 0.0 0
M  V30 17 C 4.6201 2.6675 0.0 0
M  V30 18 C 3.0800 2.6675 0.0 0
M  V30 19 C 2.3100 1.3338 0.0 0
M  V30 20 C 2.3100 4.0011 0.0 0
M  V30 21 C 0.7700 1.3338 0.0 0
M  V30 22 C 0.7700 4.0011 0.0 0
M  V30 23 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 1 6 19
M  V30 7 1 7 20
M  V30 8 1 8 21
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 17 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(3-Amino-2,6-difluorophenyl)-7-fluoro-N-methyl-1H-pyrazolo[4,3-c]pyridine-3...
C14H10F3N5O
2505373-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3508 1.9572 0.0 0
M  V30 2 N 11.8155 2.4331 0.0 0
M  V30 3 O 10.0306 0.4508 0.0 0
M  V30 4 C 12.9599 1.4027 0.0 0
M  V30 5 F 4.6201 5.3350 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 F 3.0800 5.3350 0.0 0
M  V30 8 N 0.0000 0.0000 0.0 0
M  V30 9 C 7.7001 2.6675 0.0 0
M  V30 10 C 6.9301 4.0011 0.0 0
M  V30 11 C 9.2064 2.9876 0.0 0
M  V30 12 C 6.9301 1.3338 0.0 0
M  V30 13 C 5.3901 4.0011 0.0 0
M  V30 14 N 7.9605 5.1457 0.0 0
M  V30 15 N 9.3674 4.5192 0.0 0
M  V30 16 N 5.3901 1.3338 0.0 0
M  V30 17 C 4.6201 2.6675 0.0 0
M  V30 18 C 3.0800 2.6675 0.0 0
M  V30 19 C 2.3100 1.3338 0.0 0
M  V30 20 C 2.3100 4.0011 0.0 0
M  V30 21 C 0.7700 1.3338 0.0 0
M  V30 22 C 0.7700 4.0011 0.0 0
M  V30 23 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 1 6 19
M  V30 7 1 7 20
M  V30 8 1 8 21
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 17 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2505373-15-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2505373-16-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23550855
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of (aza)indazolyl-aryl sulfonamide and related compounds for
inhibiting GCN2 activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramurthy, Savithri; Mulvihill, Mark J.; Sherborne, Bradley; Talbot, Eric;
Thomson, Chris; Aicher, Thomas Daniel; Padilla, Fernando; Taylor, Clarke
B.; Toogood, Peter L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020210828 A1 2020-10-15

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[4-[[(3,4,6-tri-O-acetyl-2-deoxy-β-D-arabino-hexopyranosyl)oxy]methy...
C28H29NO11S
251996-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 15.4000 6.6684 0.0 0
M  V30 2 C 21.4810 6.7139 0.0 0
M  V30 3 O 22.8148 7.4839 0.0 0
M  V30 4 O 21.4810 5.1739 0.0 0
M  V30 5 C 24.1484 6.7139 0.0 0
M  V30 6 C 9.2400 6.6684 0.0 0
M  V30 7 O 8.4700 5.3347 0.0 0
M  V30 8 O 3.8500 2.6673 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 6.1600 1.3336 0.0 0
M  V30 11 O 3.8500 0.0000 0.0 0
M  V30 12 C 3.8500 8.0020 0.0 0
M  V30 13 O 4.6200 9.3358 0.0 0
M  V30 14 C 3.8500 10.6694 0.0 0
M  V30 15 C 2.3100 10.6694 0.0 0
M  V30 16 O 4.6200 12.0031 0.0 0
M  V30 17 O 2.3100 5.3347 0.0 0
M  V30 18 C 1.5400 4.0011 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 20 O 2.3100 2.6673 0.0 0
M  V30 21 C 17.7100 8.0020 0.0 0
M  V30 22 C 18.4800 9.3358 0.0 0
M  V30 23 C 16.1700 8.0020 0.0 0
M  V30 24 C 18.7406 6.8576 0.0 0
M  V30 25 S 19.9864 9.0156 0.0 0
M  V30 26 C 17.7100 10.6694 0.0 0
M  V30 27 C 15.4000 9.3358 0.0 0
M  V30 28 C 20.1474 7.4839 0.0 0
M  V30 29 N 16.1700 10.6694 0.0 0
M  V30 30 C 13.8600 6.6684 0.0 0
M  V30 31 C 13.0900 8.0020 0.0 0
M  V30 32 C 13.0900 5.3347 0.0 0
M  V30 33 C 11.5500 8.0020 0.0 0
M  V30 34 C 11.5500 5.3347 0.0 0
M  V30 35 C 10.7800 6.6684 0.0 0
M  V30 36 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 37 C 6.1600 4.0011 0.0 0
M  V30 38 O 6.1600 6.6684 0.0 0
M  V30 39 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 40 C 4.6200 6.6684 0.0 0 CFG=2
M  V30 41 C 3.8500 5.3347 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 23
M  V30 2 1 1 30
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 28
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 35
M  V30 9 1 36 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 39 8 CFG=1
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 12 13
M  V30 15 1 40 12 CFG=1
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 1 17 18
M  V30 20 1 41 17 CFG=3
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 1 21 24
M  V30 26 1 22 25
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 2 24 28
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 2 27 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 36 39 40 41)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-[4-[[(2-Deoxy-β-D-arabino-hexopyranosyl)oxy]methyl]phenoxy]-N-methylthieno[...
C22H24N2O7S
251994-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 13.0900 5.3347 0.0 0
M  V30 2 C 19.1710 5.3803 0.0 0
M  V30 3 N 20.5048 6.1503 0.0 0
M  V30 4 O 19.1710 3.8403 0.0 0
M  V30 5 C 21.8384 5.3803 0.0 0
M  V30 6 C 6.9300 5.3347 0.0 0
M  V30 7 O 6.1600 4.0011 0.0 0
M  V30 8 C 1.5400 1.3336 0.0 0
M  V30 9 O 2.3100 0.0000 0.0 0
M  V30 10 O 1.5400 6.6684 0.0 0
M  V30 11 O 0.0000 4.0011 0.0 0
M  V30 12 C 15.4000 6.6684 0.0 0
M  V30 13 C 16.1700 8.0021 0.0 0
M  V30 14 C 13.8600 6.6684 0.0 0
M  V30 15 C 16.4306 5.5240 0.0 0
M  V30 16 S 17.6764 7.6820 0.0 0
M  V30 17 C 15.4000 9.3358 0.0 0
M  V30 18 C 13.0900 8.0021 0.0 0
M  V30 19 C 17.8374 6.1503 0.0 0
M  V30 20 N 13.8600 9.3358 0.0 0
M  V30 21 C 11.5500 5.3347 0.0 0
M  V30 22 C 10.7800 6.6684 0.0 0
M  V30 23 C 10.7800 4.0011 0.0 0
M  V30 24 C 9.2400 6.6684 0.0 0
M  V30 25 C 9.2400 4.0011 0.0 0
M  V30 26 C 8.4700 5.3347 0.0 0
M  V30 27 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 28 O 3.8500 2.6674 0.0 0
M  V30 29 C 3.8500 5.3347 0.0 0
M  V30 30 C 2.3100 2.6674 0.0 0 CFG=2
M  V30 31 C 2.3100 5.3347 0.0 0 CFG=1
M  V30 32 C 1.5400 4.0011 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 26
M  V30 9 1 27 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 30 8 CFG=3
M  V30 12 1 31 10 CFG=3
M  V30 13 1 32 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 2 18 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 27 30 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 251996-58-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 251994-44-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-17637473
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienopyridines and thienopyrimidines as cell
adhesion-inhibiting antiinflammatory compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stewart, Andrew O.; Boyd, Steven A.; Arendsen, David L.; Bhatia, Pramila;
Condroski, Kevin R.; Freeman, Jennifer C.; Gunawardana, Indrani W.; Zhu,
Gui-dong; Lartey, Kraig; Mccarty, Catherine M.; Mort, Nicholas A.; Patel,
Meena V.; Staeger, Michael A.; Stout, David M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6232320 B1 2001-05-15

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[4-[[(3,4,6-tri-O-acetyl-2-deoxy-β-D-arabino-hexopyranosyl)oxy]methy...
C28H29NO11S
251996-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 15.4000 6.6684 0.0 0
M  V30 2 C 21.4810 6.7139 0.0 0
M  V30 3 O 22.8148 7.4839 0.0 0
M  V30 4 O 21.4810 5.1739 0.0 0
M  V30 5 C 24.1484 6.7139 0.0 0
M  V30 6 C 9.2400 6.6684 0.0 0
M  V30 7 O 8.4700 5.3347 0.0 0
M  V30 8 O 3.8500 2.6673 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 6.1600 1.3336 0.0 0
M  V30 11 O 3.8500 0.0000 0.0 0
M  V30 12 C 3.8500 8.0020 0.0 0
M  V30 13 O 4.6200 9.3358 0.0 0
M  V30 14 C 3.8500 10.6694 0.0 0
M  V30 15 C 2.3100 10.6694 0.0 0
M  V30 16 O 4.6200 12.0031 0.0 0
M  V30 17 O 2.3100 5.3347 0.0 0
M  V30 18 C 1.5400 4.0011 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 20 O 2.3100 2.6673 0.0 0
M  V30 21 C 17.7100 8.0020 0.0 0
M  V30 22 C 18.4800 9.3358 0.0 0
M  V30 23 C 16.1700 8.0020 0.0 0
M  V30 24 C 18.7406 6.8576 0.0 0
M  V30 25 S 19.9864 9.0156 0.0 0
M  V30 26 C 17.7100 10.6694 0.0 0
M  V30 27 C 15.4000 9.3358 0.0 0
M  V30 28 C 20.1474 7.4839 0.0 0
M  V30 29 N 16.1700 10.6694 0.0 0
M  V30 30 C 13.8600 6.6684 0.0 0
M  V30 31 C 13.0900 8.0020 0.0 0
M  V30 32 C 13.0900 5.3347 0.0 0
M  V30 33 C 11.5500 8.0020 0.0 0
M  V30 34 C 11.5500 5.3347 0.0 0
M  V30 35 C 10.7800 6.6684 0.0 0
M  V30 36 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 37 C 6.1600 4.0011 0.0 0
M  V30 38 O 6.1600 6.6684 0.0 0
M  V30 39 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 40 C 4.6200 6.6684 0.0 0 CFG=2
M  V30 41 C 3.8500 5.3347 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 23
M  V30 2 1 1 30
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 28
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 35
M  V30 9 1 36 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 39 8 CFG=1
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 12 13
M  V30 15 1 40 12 CFG=1
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 1 17 18
M  V30 20 1 41 17 CFG=3
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 1 21 24
M  V30 26 1 22 25
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 2 24 28
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 2 27 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 36 39 40 41)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-[4-[[(2-Deoxy-β-D-arabino-hexopyranosyl)oxy]methyl]phenoxy]-N-methylthieno[...
C22H24N2O7S
251994-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 13.0900 5.3347 0.0 0
M  V30 2 C 19.1710 5.3803 0.0 0
M  V30 3 N 20.5048 6.1503 0.0 0
M  V30 4 O 19.1710 3.8403 0.0 0
M  V30 5 C 21.8384 5.3803 0.0 0
M  V30 6 C 6.9300 5.3347 0.0 0
M  V30 7 O 6.1600 4.0011 0.0 0
M  V30 8 C 1.5400 1.3336 0.0 0
M  V30 9 O 2.3100 0.0000 0.0 0
M  V30 10 O 1.5400 6.6684 0.0 0
M  V30 11 O 0.0000 4.0011 0.0 0
M  V30 12 C 15.4000 6.6684 0.0 0
M  V30 13 C 16.1700 8.0021 0.0 0
M  V30 14 C 13.8600 6.6684 0.0 0
M  V30 15 C 16.4306 5.5240 0.0 0
M  V30 16 S 17.6764 7.6820 0.0 0
M  V30 17 C 15.4000 9.3358 0.0 0
M  V30 18 C 13.0900 8.0021 0.0 0
M  V30 19 C 17.8374 6.1503 0.0 0
M  V30 20 N 13.8600 9.3358 0.0 0
M  V30 21 C 11.5500 5.3347 0.0 0
M  V30 22 C 10.7800 6.6684 0.0 0
M  V30 23 C 10.7800 4.0011 0.0 0
M  V30 24 C 9.2400 6.6684 0.0 0
M  V30 25 C 9.2400 4.0011 0.0 0
M  V30 26 C 8.4700 5.3347 0.0 0
M  V30 27 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 28 O 3.8500 2.6674 0.0 0
M  V30 29 C 3.8500 5.3347 0.0 0
M  V30 30 C 2.3100 2.6674 0.0 0 CFG=2
M  V30 31 C 2.3100 5.3347 0.0 0 CFG=1
M  V30 32 C 1.5400 4.0011 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 26
M  V30 9 1 27 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 30 8 CFG=3
M  V30 12 1 31 10 CFG=3
M  V30 13 1 32 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 2 18 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 27 30 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 251996-58-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 251994-44-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-1207733
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 201B. 4-[4-({[(2R, 4R, 5S,
6R)-4,5-Dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)phenoxy]-N-methylthieno[2,3-c]pyridine-2-carboxamide.
A solution of Example 201A (167 mg) in a 2M solution of methylamine in
methanol (10 mL) was heated at 45°C for 12 hours, and was concentrated.
The residual oil was chromatographed on silica gel with 8% MeOH/CH2Cl2 to
give the designated compound. yield: (120 mg, 91%). MS (ESI/NH3) m/e: 443
(M-OH)+; 1HNMR (300 MHz, DMSO-d6) δ 2.79 (d, 3H, J = 4.8 Hz), 3.53 (m,
3H), 3.67 (m, 1H), 3.87 (m, 1H), 4.50 (d, 1H, J = 11.5 Hz), 4.64 (t, 1H,
J = 5.4 Hz), 4.76 (d, 1H, J = 11.5 Hz), 5.06 (m, 2H), 5.70 (dt, 1H, J =
10.2, 2.4 Hz), 5.86 (d, 1H, J = 10.2 Hz), 7.08 (d, 2H, J = 8.5 Hz), 7.40
(d, 2H, J = 8.5 Hz), 8.10 (s, 1H), 8.11 (s, 1H), 8.95 (q, 1H, J = 4.8
Hz), 9.12 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienopyridines and thienopyrimidines as cell
adhesion-inhibiting antiinflammatory compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arendsen, David L.; Bhatia, Pramila; Boyd, Steven A.; Condroski, Kevin
R.; Freeman, Jennifer C.; Gunawardana, Indrani W.; Lartey, Kraig;
McCarty, Catherine M.; Mort, Nicholas A.; Patel, Meena V.; Staeger,
Michael A.; Stewart, Andrew O.; Stout, David M.; Zhu, Gui-Dong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000075145 A1 2000-12-14

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-1-(2-phenylethyl)[1,2,4]triazolo[4,3-a]quinoxaline
C17H13ClN4
2529934-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 5.3302 0.0 0
M  V30 2 C 7.6823 6.4748 0.0 0
M  V30 3 Cl 0.0000 5.3900 0.0 0
M  V30 4 N 4.0011 4.6200 0.0 0
M  V30 5 C 4.0011 3.0800 0.0 0
M  V30 6 C 2.6674 5.3900 0.0 0
M  V30 7 C 5.1454 5.6504 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 N 2.9876 6.8963 0.0 0
M  V30 11 C 1.3338 4.6200 0.0 0
M  V30 12 N 4.5191 7.0574 0.0 0
M  V30 13 N 1.3338 3.0800 0.0 0
M  V30 14 C 2.6674 0.7700 0.0 0
M  V30 15 C 5.3347 0.7700 0.0 0
M  V30 16 C 4.0011 0.0000 0.0 0
M  V30 17 C 9.1887 6.1546 0.0 0
M  V30 18 C 10.2191 7.2990 0.0 0
M  V30 19 C 9.6646 4.6899 0.0 0
M  V30 20 C 11.7256 6.9788 0.0 0
M  V30 21 C 11.1709 4.3698 0.0 0
M  V30 22 C 12.2014 5.5141 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 17
M  V30 4 1 3 11
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 2 6 10
M  V30 11 1 6 11
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 2 8 14
M  V30 15 1 9 15
M  V30 16 1 10 12
M  V30 17 2 11 13
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1-(2-phenylethyl)[1,2,4]triazolo[4,3-a]quinoxalin-4-amine
C18H17N5
2529934-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9855 5.3302 0.0 0
M  V30 2 C 9.0159 6.4748 0.0 0
M  V30 3 N 1.3336 5.3900 0.0 0
M  V30 4 C 0.0000 4.6200 0.0 0
M  V30 5 N 5.3347 4.6200 0.0 0
M  V30 6 C 5.3347 3.0800 0.0 0
M  V30 7 C 4.0011 5.3900 0.0 0
M  V30 8 C 6.4792 5.6504 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 6.6684 2.3100 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 N 4.3212 6.8964 0.0 0
M  V30 13 N 5.8528 7.0574 0.0 0
M  V30 14 N 2.6674 3.0800 0.0 0
M  V30 15 C 4.0011 0.7700 0.0 0
M  V30 16 C 6.6684 0.7700 0.0 0
M  V30 17 C 5.3347 0.0000 0.0 0
M  V30 18 C 10.5224 6.1546 0.0 0
M  V30 19 C 11.5528 7.2990 0.0 0
M  V30 20 C 10.9982 4.6899 0.0 0
M  V30 21 C 13.0592 6.9788 0.0 0
M  V30 22 C 12.5046 4.3698 0.0 0
M  V30 23 C 13.5351 5.5141 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 2 9 15
M  V30 16 1 10 16
M  V30 17 2 11 14
M  V30 18 1 12 13
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2529934-44-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2529934-37-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22839739
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole
derivatives as potent antiproliferative agents via a hybrid pharmacophore
approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaneko, Daiki; Ninomiya, Masayuki; Yoshikawa, Rina; Ono, Yukari;
Sonawane, Amol D.; Tanaka, Kaori; Nishina, Atsuyoshi; Koketsu, Mamoru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 104104293

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
4-[4-(2-Methoxyethoxy)phenyl]-1-piperazineethan-α,α,β,β-d4-ol
C15H20D4N2O3
2532103-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.8600 2.6673 0.0 0
M  V30 2 C 14.6300 1.3336 0.0 0
M  V30 3 C 16.1700 1.3336 0.0 0
M  V30 4 O 16.9400 0.0000 0.0 0
M  V30 5 C 18.4800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 1.5400 2.6673 0.0 0
M  V30 8 O 0.0000 2.6673 0.0 0
M  V30 9 C 9.2400 2.6673 0.0 0
M  V30 10 C 10.0100 4.0011 0.0 0
M  V30 11 C 10.0100 1.3336 0.0 0
M  V30 12 C 11.5500 4.0011 0.0 0
M  V30 13 C 11.5500 1.3336 0.0 0
M  V30 14 C 12.3200 2.6673 0.0 0
M  V30 15 N 7.7000 2.6673 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 6.9300 1.3336 0.0 0
M  V30 18 C 5.3900 4.0011 0.0 0
M  V30 19 C 5.3900 1.3336 0.0 0
M  V30 20 N 4.6200 2.6673 0.0 0
M  V30 21 H 3.0800 4.2073 0.0 0 MASS=2
M  V30 22 H 3.0800 1.1273 0.0 0 MASS=2
M  V30 23 H 1.5400 4.2073 0.0 0 MASS=2
M  V30 24 H 1.5400 1.1273 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 20
M  V30 8 1 6 21
M  V30 9 1 6 22
M  V30 10 1 7 8
M  V30 11 1 7 23
M  V30 12 1 7 24
M  V30 13 2 9 10
M  V30 14 1 9 11
M  V30 15 1 9 15
M  V30 16 1 10 12
M  V30 17 2 11 13
M  V30 18 2 12 14
M  V30 19 1 13 14
M  V30 20 1 15 16
M  V30 21 1 15 17
M  V30 22 1 16 18
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methan-d3-amine
CH2D3N
5581-55-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3337 0.0 0
M  V30 2 N 0.7700 0.0000 0.0 0
M  V30 3 H 0.0000 1.3337 0.0 0 MASS=2
M  V30 4 H 0.7700 2.6673 0.0 0 MASS=2
M  V30 5 H 3.0800 1.3337 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H20D7N3O2
2532103-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 16.1700 2.6674 0.0 0
M  V30 2 C 16.9400 4.0011 0.0 0
M  V30 3 C 18.4800 4.0011 0.0 0
M  V30 4 O 19.2500 5.3349 0.0 0
M  V30 5 C 20.7900 5.3349 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 N 2.3100 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 11.5500 2.6674 0.0 0
M  V30 11 C 12.3200 4.0011 0.0 0
M  V30 12 C 12.3200 1.3338 0.0 0
M  V30 13 C 13.8600 4.0011 0.0 0
M  V30 14 C 13.8600 1.3338 0.0 0
M  V30 15 C 14.6300 2.6674 0.0 0
M  V30 16 N 10.0100 2.6674 0.0 0
M  V30 17 C 9.2400 1.3338 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 7.7000 1.3338 0.0 0
M  V30 20 C 7.7000 4.0011 0.0 0
M  V30 21 N 6.9300 2.6674 0.0 0
M  V30 22 H 5.3900 1.1274 0.0 0 MASS=2
M  V30 23 H 5.3900 4.2074 0.0 0 MASS=2
M  V30 24 H 3.8500 1.1274 0.0 0 MASS=2
M  V30 25 H 3.8500 4.2074 0.0 0 MASS=2
M  V30 26 H 2.3100 0.0000 0.0 0 MASS=2
M  V30 27 H 0.7700 0.0000 0.0 0 MASS=2
M  V30 28 H 0.0000 1.3338 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 21
M  V30 8 1 6 22
M  V30 9 1 6 23
M  V30 10 1 7 8
M  V30 11 1 7 24
M  V30 12 1 7 25
M  V30 13 1 8 9
M  V30 14 1 9 26
M  V30 15 1 9 27
M  V30 16 1 9 28
M  V30 17 2 10 11
M  V30 18 1 10 12
M  V30 19 1 10 16
M  V30 20 1 11 13
M  V30 21 2 12 14
M  V30 22 2 13 15
M  V30 23 1 14 15
M  V30 24 1 16 17
M  V30 25 1 16 18
M  V30 26 1 17 19
M  V30 27 1 18 20
M  V30 28 1 19 21
M  V30 29 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2532103-06-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5581-55-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2532103-08-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-23380261
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube in stage 4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazolopyrimidine diamine compounds and salts thereof as
selective adenosine A2 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anand, Neel K.; Aurrecoechea, Natalia; Brockway, Anthony James; Cai,
Haiying; Cheng, Lin; Deng, Bo-Liang; O'Mahony, Donogh John Roger; Ren,
Zhongxu; Zhang, Wen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020227156 A1 2020-11-12

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl β-(acetyloxy)-5-cyano-2-fluoro-α-methylenebenzenepropanoate
C15H14FNO4
2565611-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.8501 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 O 6.6685 2.3101 0.0 0
M  V30 4 C 9.3360 3.8501 0.0 0
M  V30 5 C 8.0022 6.1601 0.0 0
M  V30 6 C 5.3348 1.5400 0.0 0
M  V30 7 O 10.6697 4.6201 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 O 4.0010 2.3101 0.0 0
M  V30 11 C 12.0033 3.8501 0.0 0
M  V30 12 C 13.3370 4.6201 0.0 0
M  V30 13 F 6.6685 6.9302 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 15 N 0.0000 3.0801 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 5.3348 6.1601 0.0 0
M  V30 18 C 4.0010 3.8501 0.0 0
M  V30 19 C 4.0010 6.9302 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 2.6673 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 11 12
M  V30 13 1 13 17
M  V30 14 3 14 15
M  V30 15 1 14 20
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-cyano-1,2-dihydro-1-methyl-3-quinolinecarboxylate
C14H14N2O2
2633025-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.0000 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 O 10.6697 3.8501 0.0 0
M  V30 4 O 9.3360 6.1601 0.0 0
M  V30 5 C 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 1.3337 4.6201 0.0 0
M  V30 8 N 0.0000 5.3901 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 N 6.6685 1.5400 0.0 0
M  V30 12 C 4.0010 1.5400 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 8.0022 3.8501 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 3 7 8
M  V30 8 1 7 18
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2565611-23-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2633025-86-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23515572
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dihydroquinolines, dihydronaphthyridines and quinolones by domino
reactions of Morita-Baylis-Hillman acetates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Annor-Gyamfi, Joel K.; Ametsetor, Ebenezer; Meraz, Kevin; Bunce, Richard
A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2021), 26(4), 890

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[[(5-bromo-2-hydroxyphenyl)sulfonyl]amino]-5-cyclopropyl-6-fluoro-2-...
C17H15BrFNO6S
2581113-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.6697 2.8737 0.0 0
M  V30 2 C 10.6697 5.9538 0.0 0
M  V30 3 O 12.0033 5.1838 0.0 0
M  V30 4 O 10.6697 7.4938 0.0 0
M  V30 5 C 13.3370 5.9538 0.0 0
M  V30 6 N 5.3348 5.9538 0.0 0
M  V30 7 S 4.0010 5.1838 0.0 0 VAL=6
M  V30 8 O 4.7710 3.8501 0.0 0
M  V30 9 O 3.2310 6.5174 0.0 0
M  V30 10 O 8.0022 7.4938 0.0 0
M  V30 11 O 1.3337 6.7238 0.0 0
M  V30 12 Br 1.3337 0.5637 0.0 0
M  V30 13 C 8.0022 2.8737 0.0 0
M  V30 14 C 9.3360 3.6437 0.0 0
M  V30 15 C 6.6685 3.6437 0.0 0
M  V30 16 C 9.3360 5.1838 0.0 0
M  V30 17 C 6.6685 5.1838 0.0 0
M  V30 18 C 8.0022 5.9538 0.0 0
M  V30 19 C 8.0022 1.3337 0.0 0
M  V30 20 C 7.2322 0.0000 0.0 0
M  V30 21 C 8.7722 0.0000 0.0 0
M  V30 22 C 2.6673 4.4137 0.0 0
M  V30 23 C 1.3337 5.1838 0.0 0
M  V30 24 C 2.6673 2.8737 0.0 0
M  V30 25 C 0.0000 4.4137 0.0 0
M  V30 26 C 1.3337 2.1037 0.0 0
M  V30 27 C 0.0000 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 22
M  V30 11 1 10 18
M  V30 12 1 11 23
M  V30 13 1 12 26
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[(5-Bromo-2-hydroxyphenyl)sulfonyl]amino]-5-cyclopropyl-6-fluoro-2-hydroxy...
C17H16BrFN2O5S
2581112-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.6697 2.8737 0.0 0
M  V30 2 C 10.6697 5.9538 0.0 0
M  V30 3 N 12.0033 5.1838 0.0 0
M  V30 4 O 10.6697 7.4938 0.0 0
M  V30 5 C 13.3370 5.9538 0.0 0
M  V30 6 N 5.3348 5.9538 0.0 0
M  V30 7 S 4.0010 5.1838 0.0 0 VAL=6
M  V30 8 O 4.7710 3.8501 0.0 0
M  V30 9 O 3.2310 6.5174 0.0 0
M  V30 10 O 8.0022 7.4938 0.0 0
M  V30 11 O 1.3337 6.7238 0.0 0
M  V30 12 Br 1.3337 0.5637 0.0 0
M  V30 13 C 8.0022 2.8737 0.0 0
M  V30 14 C 9.3360 3.6437 0.0 0
M  V30 15 C 6.6685 3.6437 0.0 0
M  V30 16 C 9.3360 5.1838 0.0 0
M  V30 17 C 6.6685 5.1838 0.0 0
M  V30 18 C 8.0022 5.9538 0.0 0
M  V30 19 C 8.0022 1.3337 0.0 0
M  V30 20 C 7.2322 0.0000 0.0 0
M  V30 21 C 8.7722 0.0000 0.0 0
M  V30 22 C 2.6673 4.4137 0.0 0
M  V30 23 C 1.3337 5.1838 0.0 0
M  V30 24 C 2.6673 2.8737 0.0 0
M  V30 25 C 0.0000 4.4137 0.0 0
M  V30 26 C 1.3337 2.1037 0.0 0
M  V30 27 C 0.0000 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 22
M  V30 11 1 10 18
M  V30 12 1 11 23
M  V30 13 1 12 26
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2581113-25-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2581112-78-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23483600
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted N-phenyl sulfonamides as WDR5-MYC inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tansey, William P.; Fesik, Stephen W.; Stauffer, Shaun R.; Waterson, Alex
G.; Han, Changho; Alvarado, Joseph R.; Macdonald, Jonathan D.; Chacon
Simon, Selena; Nikhar, Sameer S.; Kuznetsov, Alexey
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021021951 A1 2021-02-04

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[[(5-bromo-2-hydroxyphenyl)sulfonyl]amino]-5-cyclopropyl-6-fluoro-2-...
C17H15BrFNO6S
2581113-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.6697 2.8737 0.0 0
M  V30 2 C 10.6697 5.9538 0.0 0
M  V30 3 O 12.0033 5.1838 0.0 0
M  V30 4 O 10.6697 7.4938 0.0 0
M  V30 5 C 13.3370 5.9538 0.0 0
M  V30 6 N 5.3348 5.9538 0.0 0
M  V30 7 S 4.0010 5.1838 0.0 0 VAL=6
M  V30 8 O 4.7710 3.8501 0.0 0
M  V30 9 O 3.2310 6.5174 0.0 0
M  V30 10 O 8.0022 7.4938 0.0 0
M  V30 11 O 1.3337 6.7238 0.0 0
M  V30 12 Br 1.3337 0.5637 0.0 0
M  V30 13 C 8.0022 2.8737 0.0 0
M  V30 14 C 9.3360 3.6437 0.0 0
M  V30 15 C 6.6685 3.6437 0.0 0
M  V30 16 C 9.3360 5.1838 0.0 0
M  V30 17 C 6.6685 5.1838 0.0 0
M  V30 18 C 8.0022 5.9538 0.0 0
M  V30 19 C 8.0022 1.3337 0.0 0
M  V30 20 C 7.2322 0.0000 0.0 0
M  V30 21 C 8.7722 0.0000 0.0 0
M  V30 22 C 2.6673 4.4137 0.0 0
M  V30 23 C 1.3337 5.1838 0.0 0
M  V30 24 C 2.6673 2.8737 0.0 0
M  V30 25 C 0.0000 4.4137 0.0 0
M  V30 26 C 1.3337 2.1037 0.0 0
M  V30 27 C 0.0000 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 22
M  V30 11 1 10 18
M  V30 12 1 11 23
M  V30 13 1 12 26
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[(5-Bromo-2-hydroxyphenyl)sulfonyl]amino]-5-cyclopropyl-6-fluoro-2-hydroxy...
C17H16BrFN2O5S
2581112-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.6697 2.8737 0.0 0
M  V30 2 C 10.6697 5.9538 0.0 0
M  V30 3 N 12.0033 5.1838 0.0 0
M  V30 4 O 10.6697 7.4938 0.0 0
M  V30 5 C 13.3370 5.9538 0.0 0
M  V30 6 N 5.3348 5.9538 0.0 0
M  V30 7 S 4.0010 5.1838 0.0 0 VAL=6
M  V30 8 O 4.7710 3.8501 0.0 0
M  V30 9 O 3.2310 6.5174 0.0 0
M  V30 10 O 8.0022 7.4938 0.0 0
M  V30 11 O 1.3337 6.7238 0.0 0
M  V30 12 Br 1.3337 0.5637 0.0 0
M  V30 13 C 8.0022 2.8737 0.0 0
M  V30 14 C 9.3360 3.6437 0.0 0
M  V30 15 C 6.6685 3.6437 0.0 0
M  V30 16 C 9.3360 5.1838 0.0 0
M  V30 17 C 6.6685 5.1838 0.0 0
M  V30 18 C 8.0022 5.9538 0.0 0
M  V30 19 C 8.0022 1.3337 0.0 0
M  V30 20 C 7.2322 0.0000 0.0 0
M  V30 21 C 8.7722 0.0000 0.0 0
M  V30 22 C 2.6673 4.4137 0.0 0
M  V30 23 C 1.3337 5.1838 0.0 0
M  V30 24 C 2.6673 2.8737 0.0 0
M  V30 25 C 0.0000 4.4137 0.0 0
M  V30 26 C 1.3337 2.1037 0.0 0
M  V30 27 C 0.0000 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 22
M  V30 11 1 10 18
M  V30 12 1 11 23
M  V30 13 1 12 26
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2581113-25-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2581112-78-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23351043
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Optimization of Salicylic Acid-Derived Sulfonamide
Inhibitors of the WD Repeat-Containing Protein 5-MYC Protein-Protein
Interaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Macdonald, Jonathan D.; Chacon Simon, Selena; Han, Changho; Wang, Feng;
Shaw, J. Grace; Howes, Jennifer E.; Sai, Jiqing; Yuh, Joannes P.; Camper,
Demarco; Alicie, Bethany M.; Alvarado, Joseph; Nikhar, Sameer; Payne,
William; Aho, Erin R.; Bauer, Joshua A.; Zhao, Bin; Phan, Jason; Thomas,
Lance R.; Rossanese, Olivia W.; Tansey, William P.; Waterson, Alex G.;
Stauffer, Shaun R.; Fesik, Stephen W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(24), 11232-11259

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl β-(acetyloxy)-2,5-difluoro-α-methylenebenzenepropanoate
C14H14F2O4
2633026-16-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8500 0.0 0
M  V30 2 C 6.6684 4.6201 0.0 0
M  V30 3 O 5.3348 2.3100 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 C 6.6684 6.1601 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 O 9.3359 4.6201 0.0 0
M  V30 8 O 8.0021 2.3100 0.0 0
M  V30 9 C 4.0011 0.0000 0.0 0
M  V30 10 O 2.6673 2.3100 0.0 0
M  V30 11 C 10.6695 3.8500 0.0 0
M  V30 12 C 12.0032 4.6201 0.0 0
M  V30 13 F 5.3348 6.9301 0.0 0
M  V30 14 F 0.0000 3.8500 0.0 0
M  V30 15 C 4.0011 4.6201 0.0 0
M  V30 16 C 4.0011 6.1601 0.0 0
M  V30 17 C 2.6673 3.8500 0.0 0
M  V30 18 C 2.6673 6.9301 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 11 12
M  V30 13 1 13 16
M  V30 14 1 14 19
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-fluoro-1,2-dihydro-1-methyl-3-quinolinecarboxylate
C13H14FNO2
2633026-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.0000 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 O 9.3360 3.8501 0.0 0
M  V30 4 O 8.0022 6.1601 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 C 12.0033 3.8501 0.0 0
M  V30 7 F 0.0000 4.6201 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 N 5.3348 1.5400 0.0 0
M  V30 13 C 2.6673 1.5400 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2633026-16-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2633026-09-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23513408
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM anaerobic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dihydroquinolines, dihydronaphthyridines and quinolones by domino
reactions of Morita-Baylis-Hillman acetates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Annor-Gyamfi, Joel K.; Ametsetor, Ebenezer; Meraz, Kevin; Bunce, Richard
A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2021), 26(4), 890

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[[(1,1-dimethylethoxy)carbonyl]-2-propyn-1-ylamino]-4-methoxy-2-pyri...
C16H20N2O5
2637449-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.4137 4.0012 0.0 0
M  V30 2 C 3.6437 5.3348 0.0 0
M  V30 3 C 3.6437 2.6675 0.0 0
M  V30 4 O 2.1037 5.3348 0.0 0
M  V30 5 O 4.4137 6.6687 0.0 0
M  V30 6 C 2.1037 2.6675 0.0 0
M  V30 7 C 1.3337 6.6687 0.0 0
M  V30 8 C 0.5637 2.6675 0.0 0
M  V30 9 C 2.6673 7.4387 0.0 0
M  V30 10 C 0.5637 8.0023 0.0 0
M  V30 11 C 0.0000 5.8986 0.0 0
M  V30 12 O 5.9538 1.3337 0.0 0
M  V30 13 C 6.7238 0.0000 0.0 0
M  V30 14 C 10.5739 4.0012 0.0 0
M  V30 15 O 11.3439 5.3348 0.0 0
M  V30 16 O 11.3439 2.6675 0.0 0
M  V30 17 C 12.8839 5.3348 0.0 0
M  V30 18 C 5.9538 4.0012 0.0 0
M  V30 19 C 6.7238 2.6675 0.0 0
M  V30 20 C 6.7238 5.3348 0.0 0
M  V30 21 C 8.2638 2.6675 0.0 0
M  V30 22 N 8.2638 5.3348 0.0 0
M  V30 23 C 9.0338 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 3 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 12 13
M  V30 13 1 12 19
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 23
M  V30 17 1 15 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[4-methoxy-6-[(methylamino)carbonyl]-3-pyridinyl]-N-2-propyn...
C16H21N3O4
2637449-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.4137 4.0012 0.0 0
M  V30 2 C 3.6437 5.3348 0.0 0
M  V30 3 C 3.6437 2.6675 0.0 0
M  V30 4 O 2.1037 5.3348 0.0 0
M  V30 5 O 4.4137 6.6687 0.0 0
M  V30 6 C 2.1037 2.6675 0.0 0
M  V30 7 C 1.3337 6.6687 0.0 0
M  V30 8 C 0.5637 2.6675 0.0 0
M  V30 9 C 2.6673 7.4387 0.0 0
M  V30 10 C 0.5637 8.0023 0.0 0
M  V30 11 C 0.0000 5.8986 0.0 0
M  V30 12 O 5.9538 1.3337 0.0 0
M  V30 13 C 6.7238 0.0000 0.0 0
M  V30 14 C 10.5739 4.0012 0.0 0
M  V30 15 N 11.3439 5.3348 0.0 0
M  V30 16 O 11.3439 2.6675 0.0 0
M  V30 17 C 12.8839 5.3348 0.0 0
M  V30 18 C 5.9538 4.0012 0.0 0
M  V30 19 C 6.7238 2.6675 0.0 0
M  V30 20 C 6.7238 5.3348 0.0 0
M  V30 21 C 8.2638 2.6675 0.0 0
M  V30 22 N 8.2638 5.3348 0.0 0
M  V30 23 C 9.0338 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 3 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 12 13
M  V30 13 1 12 19
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 23
M  V30 17 1 15 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2637449-66-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2637449-67-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24572285
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl compounds for restoring mutant p53 function
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, Binh; Dominique, Romyr; Li, Hongju; Fahr, Bruce; Good, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021061643 A1 2021-04-01

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (3α)-3-[[(4-nitrophenoxy)carbonyl]oxy]lupan-28-oate
C44H59NO7
2640642-92-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 62 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5514 5.5119 0.0 0
M  V30 2 O 5.3055 4.6066 0.0 0
M  V30 3 O 6.3904 7.0434 0.0 0
M  V30 4 C 3.8985 5.2330 0.0 0
M  V30 5 C 10.0022 1.4647 0.0 0
M  V30 6 C 9.5264 0.0000 0.0 0
M  V30 7 C 11.5085 1.7849 0.0 0
M  V30 8 C 9.9748 7.8213 0.0 0
M  V30 9 C 10.8703 8.2845 0.0 0
M  V30 10 C 15.2775 5.7997 0.0 0
M  V30 11 C 16.9503 10.6852 0.0 0
M  V30 12 C 14.9705 10.6852 0.0 0
M  V30 13 O 18.6278 9.5056 0.0 0
M  V30 14 C 19.9615 8.7356 0.0 0
M  V30 15 O 21.2951 9.5056 0.0 0
M  V30 16 O 19.9615 7.1955 0.0 0
M  V30 17 N 26.6299 6.4255 0.0 0 VAL=5
M  V30 18 O 26.6299 4.8855 0.0 0
M  V30 19 O 27.9635 7.1955 0.0 0
M  V30 20 C 7.9583 4.8855 0.0 0 CFG=1
M  V30 21 C 9.2920 4.1155 0.0 0 CFG=2
M  V30 22 C 7.9583 6.4255 0.0 0
M  V30 23 C 6.8138 3.8550 0.0 0
M  V30 24 C 10.6256 4.8855 0.0 0 CFG=1
M  V30 25 C 8.9718 2.6091 0.0 0 CFG=2
M  V30 26 C 9.2920 7.1955 0.0 0
M  V30 27 C 7.4401 2.4482 0.0 0
M  V30 28 C 10.6256 6.4255 0.0 0 CFG=1
M  V30 29 C 11.9593 4.1155 0.0 0
M  V30 30 C 11.9593 7.1955 0.0 0 CFG=1
M  V30 31 C 13.2931 4.8855 0.0 0
M  V30 32 C 13.2931 6.4255 0.0 0 CFG=1
M  V30 33 C 11.9593 8.7356 0.0 0
M  V30 34 C 14.6267 7.1955 0.0 0 CFG=2
M  V30 35 C 13.2931 9.5056 0.0 0
M  V30 36 C 14.6267 8.7356 0.0 0 CFG=2
M  V30 37 C 15.9604 6.4255 0.0 0
M  V30 38 C 15.9604 9.5056 0.0 0
M  V30 39 C 17.2940 7.1955 0.0 0
M  V30 40 C 17.2940 8.7356 0.0 0 CFG=2
M  V30 41 C 2.6527 4.3279 0.0 0
M  V30 42 C 1.2459 4.9542 0.0 0
M  V30 43 C 2.8138 2.7962 0.0 0
M  V30 44 C 0.0000 4.0490 0.0 0
M  V30 45 C 1.5677 1.8910 0.0 0
M  V30 46 C 0.1609 2.5175 0.0 0
M  V30 47 C 22.6288 8.7356 0.0 0
M  V30 48 C 22.6288 7.1955 0.0 0
M  V30 49 C 23.9626 9.5056 0.0 0
M  V30 50 C 23.9626 6.4255 0.0 0
M  V30 51 C 25.2962 8.7356 0.0 0
M  V30 52 C 25.2962 7.1955 0.0 0
M  V30 53 H 10.2611 2.9186 0.0 0
M  V30 54 H 11.0242 3.3979 0.0 0
M  V30 55 H 14.1763 5.1640 0.0 0
M  V30 56 H 14.6267 10.2756 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 20 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 41
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 25 5 CFG=3
M  V30 9 1 28 8 CFG=3
M  V30 10 1 30 9 CFG=1
M  V30 11 1 34 10 CFG=1
M  V30 12 1 11 38
M  V30 13 1 12 38
M  V30 14 1 13 14
M  V30 15 1 40 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 47
M  V30 19 2 17 18
M  V30 20 2 17 19
M  V30 21 1 17 52
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 1 21 53 CFG=3
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 24 28
M  V30 31 1 24 29
M  V30 32 1 24 54 CFG=1
M  V30 33 1 25 27
M  V30 34 1 26 28
M  V30 35 1 28 30
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 1 30 33
M  V30 39 1 31 32
M  V30 40 1 32 34
M  V30 41 1 32 55 CFG=3
M  V30 42 1 33 35
M  V30 43 1 34 36
M  V30 44 1 34 37
M  V30 45 1 35 36
M  V30 46 1 36 38
M  V30 47 1 36 56 CFG=3
M  V30 48 1 37 39
M  V30 49 1 38 40
M  V30 50 1 39 40
M  V30 51 2 41 42
M  V30 52 1 41 43
M  V30 53 1 42 44
M  V30 54 2 43 45
M  V30 55 2 44 46
M  V30 56 1 45 46
M  V30 57 2 47 48
M  V30 58 1 47 49
M  V30 59 1 48 50
M  V30 60 2 49 51
M  V30 61 2 50 52
M  V30 62 1 51 52
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 20 21 24 25 28 30 32 34 36 40)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (3α)-3-[[(methylamino)carbonyl]oxy]lupan-28-oate
C39H59NO4
2756818-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 53 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0314 6.2608 0.0 0
M  V30 2 O 5.4999 6.0999 0.0 0
M  V30 3 O 7.6579 7.6678 0.0 0
M  V30 4 C 4.5947 7.3458 0.0 0
M  V30 5 C 7.9964 1.0304 0.0 0
M  V30 6 C 9.4611 0.5546 0.0 0
M  V30 7 C 6.8520 0.0000 0.0 0
M  V30 8 C 11.1510 6.5491 0.0 0
M  V30 9 C 12.4226 6.5491 0.0 0
M  V30 10 C 14.7326 2.1471 0.0 0
M  V30 11 C 18.6240 5.5416 0.0 0
M  V30 12 C 16.9094 6.5315 0.0 0
M  V30 13 O 19.4868 3.6813 0.0 0
M  V30 14 C 20.2568 2.3476 0.0 0
M  V30 15 N 21.7969 2.3476 0.0 0
M  V30 16 O 19.4868 1.0138 0.0 0
M  V30 17 C 22.5669 1.0138 0.0 0
M  V30 18 C 7.9367 5.0149 0.0 0 CFG=1
M  V30 19 C 8.7067 3.6813 0.0 0 CFG=2
M  V30 20 C 8.7067 6.3486 0.0 0
M  V30 21 C 6.4304 4.6948 0.0 0
M  V30 22 C 10.2467 3.6813 0.0 0 CFG=1
M  V30 23 C 7.6762 2.5369 0.0 0 CFG=2
M  V30 24 C 10.2467 6.3486 0.0 0
M  V30 25 C 6.2694 3.1632 0.0 0
M  V30 26 C 11.0167 5.0149 0.0 0 CFG=1
M  V30 27 C 11.0167 2.3476 0.0 0
M  V30 28 C 12.5567 5.0149 0.0 0 CFG=1
M  V30 29 C 12.5567 2.3476 0.0 0
M  V30 30 C 13.3267 3.6813 0.0 0 CFG=1
M  V30 31 C 13.3267 6.3486 0.0 0
M  V30 32 C 14.8668 3.6813 0.0 0 CFG=2
M  V30 33 C 14.8668 6.3486 0.0 0
M  V30 34 C 15.6368 5.0149 0.0 0 CFG=2
M  V30 35 C 15.6368 2.3476 0.0 0
M  V30 36 C 17.1768 5.0149 0.0 0
M  V30 37 C 17.1768 2.3476 0.0 0
M  V30 38 C 17.9468 3.6813 0.0 0 CFG=2
M  V30 39 C 3.0631 7.1848 0.0 0
M  V30 40 C 2.1579 8.4307 0.0 0
M  V30 41 C 2.4368 5.7780 0.0 0
M  V30 42 C 0.6263 8.2698 0.0 0
M  V30 43 C 0.9052 5.6169 0.0 0
M  V30 44 C 0.0000 6.8628 0.0 0
M  V30 45 H 8.6799 2.1416 0.0 0
M  V30 46 H 10.1126 2.1471 0.0 0
M  V30 47 H 13.4610 2.1471 0.0 0
M  V30 48 H 16.4068 6.3486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 39
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 23 5 CFG=3
M  V30 9 1 26 8 CFG=3
M  V30 10 1 28 9 CFG=1
M  V30 11 1 32 10 CFG=1
M  V30 12 1 11 36
M  V30 13 1 12 36
M  V30 14 1 13 14
M  V30 15 1 38 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 1 19 45 CFG=3
M  V30 25 1 20 24
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 1 22 27
M  V30 29 1 22 46 CFG=1
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 28 31
M  V30 36 1 29 30
M  V30 37 1 30 32
M  V30 38 1 30 47 CFG=3
M  V30 39 1 31 33
M  V30 40 1 32 34
M  V30 41 1 32 35
M  V30 42 1 33 34
M  V30 43 1 34 36
M  V30 44 1 34 48 CFG=3
M  V30 45 1 35 37
M  V30 46 1 36 38
M  V30 47 1 37 38
M  V30 48 2 39 40
M  V30 49 1 39 41
M  V30 50 1 40 42
M  V30 51 2 41 43
M  V30 52 2 42 44
M  V30 53 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 18 19 22 23 26 28 30 32 34 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2640642-92-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2756818-94-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31187938
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of Betulinic Acid Derivatives as Potent TGR5 Agonists with
Antidiabetic Effects via Humanized TGR5H88Y Mutant Mice
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yun, Ying; Zhang, Chenlu; Guo, Shimeng; Liang, Xiaoying; Lan, Yuan; Wang,
Min; Zhuo, Ning; Yin, Jianpeng; Liu, Huanan; Gu, Min; Li, Jing; Xie, Xin;
Nan, Fajun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(16), 12181-12199

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3,5-difluoro-2-nitropyridine
C5HClF2N2O2
2738980-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Cl 5.3901 0.0000 0.0 0
M  V30 6 F 6.9302 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 N 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-5-fluoro-N-methyl-2-nitro-3-pyridinamine
C6H5ClFN3O2
2738980-90-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 5.3900 1.3338 0.0 0
M  V30 7 F 6.9300 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 N 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 10
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2738980-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2738980-90-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36781808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Forms and compositions of inhibitors of JAK2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Masse, Craig E.; Greenwood, Jeremy R.; Xu, Jiayi; Mondal, Sayan;
Ghanakota, Phani
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20230146125 A1 2023-05-11

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Monomethyl fumarate
C5H6O4
2756-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 O 6.6686 1.5400 0.0 0
M  V30 4 O 5.3348 3.8500 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl hydrogen N-methylaspartate
C6H11NO4
98549-12-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3336 1.5400 0.0 0
M  V30 4 N 2.6674 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 O 6.6685 1.5400 0.0 0
M  V30 10 O 5.3347 3.8500 0.0 0
M  V30 11 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2756-87-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98549-12-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-9474748
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-methyl-DL-aspartic acid β -methyl ester 8 Method A: 2.5 ml of 8M
ethanol solution of methylamine (0.02mol) was added to an ethanolic
solution (8 ml) of methyl maleate 7a or methyl fumarate 7b (1.31 g,
0.01mol) at 0 °C. After stirring at 0 °C for 1h, ethanol and excess of
methylamine were evaporated in vacuo to dryness. crystals of 8 were
obtained, which contained small amounts of methylamine. The crude product
was dried overnight in vacuum desiccator over cc. sulfuric acid, then it
was suspended in acetone, filtered off and washed with acetone to give
amine free product. White crystals, yield (1.48 g, 91%). mp 206-207 °C.
mp 207-8 C (lit. 206 °C; Zilkha and Bachi, 1959). 1H-NMR (DMSO-d6,
600MHz): δ = 3.58 (3H, s, OCH3), 3.42 (1H, d-d, 3J1(H,H) = 5.17 Hz,
3J2(H,H) = 6.84 Hz, C-H), 2.81 (1H, d-d, 3J1(H,H) = 5.17Hz, 2J3(H,H) =
16.91Hz, H-CH), 2.67 (1H, d-d, 3J2(H,H) = 6.84 Hz, 2J3(H,H) = 16.91Hz,
HC-H), 2.47 (3H, s, NCH3) MW = 161.16 ESI-MS m/z: 161.2 [M+H]+ Anal.
Calc. for C6H11NO4 C = 45.43% H = 6.06% N = 9.35% Found C = 44.93% H =
6.35% N = 9.28%.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for syntheses of N-methyl-DL-aspartic acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boros, M.; Koekoesi, J.; Vamos, J.; Koevesdi, I.; Noszal, B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Amino Acids (2007), 33(4), 709-717

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-α-(methoxyimino)-3-methyl-2-[[[(E)-[1-[4-(trifluoromethyl)-2-pyri...
C20H20F3N3O4
2761369-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 2.6675 2.3101 0.0 0
M  V30 4 O 5.3348 0.7700 0.0 0
M  V30 5 O 6.6687 3.0801 0.0 0
M  V30 6 O 1.3338 3.0801 0.0 0
M  V30 7 C 6.6687 0.0000 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 6.6687 4.6201 0.0 0
M  V30 10 O 8.0023 5.3901 0.0 0
M  V30 11 N 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 5.3901 0.0 0
M  V30 13 C 10.6697 6.9302 0.0 0
M  V30 14 C 6.6687 7.7002 0.0 0
M  V30 15 C 16.0045 5.3901 0.0 0
M  V30 16 F 16.7745 4.0564 0.0 0
M  V30 17 F 17.3383 6.1601 0.0 0
M  V30 18 F 15.2345 6.7238 0.0 0
M  V30 19 C 4.0012 4.6201 0.0 0
M  V30 20 C 5.3348 5.3901 0.0 0
M  V30 21 C 2.6675 5.3901 0.0 0
M  V30 22 C 5.3348 6.9302 0.0 0
M  V30 23 C 2.6675 6.9302 0.0 0
M  V30 24 C 4.0012 7.7002 0.0 0
M  V30 25 C 12.0035 4.6201 0.0 0
M  V30 26 C 13.3372 5.3901 0.0 0
M  V30 27 N 12.0035 3.0801 0.0 0
M  V30 28 C 14.6708 4.6201 0.0 0
M  V30 29 C 13.3372 2.3101 0.0 0
M  V30 30 C 14.6708 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 1 14 22
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 28
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C20H21F3N4O3
2761369-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 2.6675 2.3101 0.0 0
M  V30 4 N 5.3348 0.7700 0.0 0
M  V30 5 O 6.6687 3.0801 0.0 0
M  V30 6 O 1.3338 3.0801 0.0 0
M  V30 7 C 6.6687 0.0000 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 6.6687 4.6201 0.0 0
M  V30 10 O 8.0023 5.3901 0.0 0
M  V30 11 N 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 5.3901 0.0 0
M  V30 13 C 10.6697 6.9302 0.0 0
M  V30 14 C 6.6687 7.7002 0.0 0
M  V30 15 C 16.0045 5.3901 0.0 0
M  V30 16 F 15.2345 6.7238 0.0 0
M  V30 17 F 17.3383 6.1601 0.0 0
M  V30 18 F 16.7745 4.0564 0.0 0
M  V30 19 C 4.0012 4.6201 0.0 0
M  V30 20 C 5.3348 5.3901 0.0 0
M  V30 21 C 2.6675 5.3901 0.0 0
M  V30 22 C 5.3348 6.9302 0.0 0
M  V30 23 C 2.6675 6.9302 0.0 0
M  V30 24 C 4.0012 7.7002 0.0 0
M  V30 25 C 12.0035 4.6201 0.0 0
M  V30 26 C 13.3372 5.3901 0.0 0
M  V30 27 N 12.0035 3.0801 0.0 0
M  V30 28 C 14.6708 4.6201 0.0 0
M  V30 29 C 13.3372 2.3101 0.0 0
M  V30 30 C 14.6708 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 1 14 22
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 28
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761369-62-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761369-63-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31600299
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Use of strobilurin type compounds for combating phytopathogenic fungi
containing an amino acid substitution F129L in the mitochondrial
cytochrome b protein conferring resistance to Qo inhibitors VIII
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koch, Andreas; Fehr, Marcus; Tegge, Vanessa; Dey, Chandan; Poonoth,
Manojkumar; Kulkarni, Sarang; Le Vezouet, Ronan; Winter, Christian
Harald; Rudolf, Georg Christoph; Rath, Rakesh; Khanna, Smriti; Craig, Ian
Robert; Grammenos, Wassilios; Grote, Thomas; Stammler, Gerd; Mentzel,
Tobias; Haden, Egon; Rheinheimer, Joachim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022033906 A1 2022-02-17

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-(4-chlorophenyl)-4-[[1-[(1,1-dimethylethoxy)carbonyl]-3-azetidinyl]me...
C24H26ClN3O4S
2763484-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0821 9.3358 0.0 0
M  V30 2 C 7.0021 4.0011 0.0 0
M  V30 3 O 7.7721 2.6673 0.0 0
M  V30 4 O 5.4621 4.0011 0.0 0
M  V30 5 C 7.0021 1.3336 0.0 0
M  V30 6 C 7.7721 0.0000 0.0 0
M  V30 7 C 15.3399 9.3358 0.0 0
M  V30 8 O 16.1099 10.6694 0.0 0
M  V30 9 O 16.1099 8.0021 0.0 0
M  V30 10 C 17.6499 10.6694 0.0 0
M  V30 11 C 17.6499 9.1294 0.0 0
M  V30 12 C 19.1899 10.6694 0.0 0
M  V30 13 C 17.6499 12.2094 0.0 0
M  V30 14 Cl 0.0000 11.6002 0.0 0
M  V30 15 C 7.7721 8.0021 0.0 0
M  V30 16 C 7.0021 6.6684 0.0 0
M  V30 17 C 9.3121 8.0021 0.0 0
M  V30 18 C 6.7417 9.1465 0.0 0
M  V30 19 C 7.7721 5.3347 0.0 0
M  V30 20 S 5.4956 6.9885 0.0 0
M  V30 21 N 10.0821 6.6684 0.0 0
M  V30 22 C 5.3347 8.5202 0.0 0
M  V30 23 N 9.3121 5.3347 0.0 0
M  V30 24 C 11.6221 9.3358 0.0 0
M  V30 25 C 12.7110 10.4247 0.0 0
M  V30 26 C 12.7110 8.2469 0.0 0
M  V30 27 N 13.7999 9.3358 0.0 0
M  V30 28 C 4.0011 9.2902 0.0 0
M  V30 29 C 4.0011 10.8302 0.0 0
M  V30 30 C 2.6674 8.5202 0.0 0
M  V30 31 C 2.6674 11.6002 0.0 0
M  V30 32 C 1.3336 9.2902 0.0 0
M  V30 33 C 1.3336 10.8302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 27
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 33
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 2 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 1 22 28
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[[2-(4-chlorophenyl)-7-[(methylamino)carbonyl]thieno[2,3-...
C23H25ClN4O3S
2763484-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0821 8.0021 0.0 0
M  V30 2 C 7.0021 2.6674 0.0 0
M  V30 3 N 7.7721 1.3336 0.0 0
M  V30 4 O 5.4621 2.6674 0.0 0
M  V30 5 C 7.0021 0.0000 0.0 0
M  V30 6 C 15.3399 8.0021 0.0 0
M  V30 7 O 16.1099 9.3358 0.0 0
M  V30 8 O 16.1099 6.6684 0.0 0
M  V30 9 C 17.6499 9.3358 0.0 0
M  V30 10 C 17.6499 7.7958 0.0 0
M  V30 11 C 19.1899 9.3358 0.0 0
M  V30 12 C 17.6499 10.8758 0.0 0
M  V30 13 Cl 0.0000 10.2664 0.0 0
M  V30 14 C 7.7721 6.6684 0.0 0
M  V30 15 C 7.0021 5.3347 0.0 0
M  V30 16 C 9.3121 6.6684 0.0 0
M  V30 17 C 6.7417 7.8129 0.0 0
M  V30 18 C 7.7721 4.0011 0.0 0
M  V30 19 S 5.4956 5.6549 0.0 0
M  V30 20 N 10.0821 5.3347 0.0 0
M  V30 21 C 5.3347 7.1864 0.0 0
M  V30 22 N 9.3121 4.0011 0.0 0
M  V30 23 C 11.6221 8.0021 0.0 0
M  V30 24 C 12.7110 6.9132 0.0 0
M  V30 25 C 12.7110 9.0911 0.0 0
M  V30 26 N 13.7999 8.0021 0.0 0
M  V30 27 C 4.0011 7.9564 0.0 0
M  V30 28 C 4.0011 9.4964 0.0 0
M  V30 29 C 2.6674 7.1864 0.0 0
M  V30 30 C 2.6674 10.2664 0.0 0
M  V30 31 C 1.3336 7.9564 0.0 0
M  V30 32 C 1.3336 9.4964 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 26
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 32
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 2 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 1 21 27
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2763484-39-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2763484-21-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31531195
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of novel thienopyridazine derivatives as
Chk1/2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shen, Dadong; Liu, Hanyu; Qian, Feng; Wang, Pu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2022), 121105704

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
Methyl 6-chloro-4-[[3-[1-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-1H-1,...
C22H26ClN7O5
2770470-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 5.3347 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 C 12.8557 9.6773 0.0 0
M  V30 5 C 14.2626 9.0509 0.0 0
M  V30 6 N 15.5085 9.9562 0.0 0
M  V30 7 C 16.9153 9.3297 0.0 0
M  V30 8 O 18.1612 10.2349 0.0 0
M  V30 9 O 17.0764 7.7981 0.0 0
M  V30 10 C 19.5681 9.6086 0.0 0
M  V30 11 C 20.1944 11.0154 0.0 0
M  V30 12 C 20.9749 8.9821 0.0 0
M  V30 13 C 18.9418 8.2016 0.0 0
M  V30 14 C 3.0800 2.6673 0.0 0
M  V30 15 O 2.3100 1.3336 0.0 0
M  V30 16 O 4.6200 2.6673 0.0 0
M  V30 17 C 3.0800 0.0000 0.0 0
M  V30 18 Cl 0.0000 8.0020 0.0 0
M  V30 19 C 7.7000 8.0020 0.0 0
M  V30 20 C 6.9300 6.6684 0.0 0
M  V30 21 C 6.9300 9.3358 0.0 0
M  V30 22 C 5.3900 6.6684 0.0 0
M  V30 23 C 5.3900 9.3358 0.0 0
M  V30 24 C 4.6200 8.0020 0.0 0
M  V30 25 C 9.2400 8.0020 0.0 0
M  V30 26 N 10.1451 9.2479 0.0 0
M  V30 27 N 10.1451 6.7562 0.0 0
M  V30 28 N 11.6098 8.7720 0.0 0
M  V30 29 C 11.6098 7.2320 0.0 0
M  V30 30 C 3.0800 5.3347 0.0 0
M  V30 31 C 2.3100 4.0011 0.0 0
M  V30 32 C 2.3100 6.6684 0.0 0
M  V30 33 N 0.7700 4.0011 0.0 0
M  V30 34 C 0.7700 6.6684 0.0 0
M  V30 35 N 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 3 22
M  V30 4 1 3 30
M  V30 5 1 4 5
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 31
M  V30 18 1 15 17
M  V30 19 1 18 34
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 19 25
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-[3-[3-[[6-chloro-3-[(methylamino)carbonyl]-4-pyridazin...
C22H27ClN8O4
2770470-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 5.3347 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 C 12.8557 9.6773 0.0 0
M  V30 5 C 14.2626 9.0509 0.0 0
M  V30 6 N 15.5085 9.9562 0.0 0
M  V30 7 C 16.9153 9.3297 0.0 0
M  V30 8 O 18.1612 10.2349 0.0 0
M  V30 9 O 17.0764 7.7981 0.0 0
M  V30 10 C 19.5681 9.6086 0.0 0
M  V30 11 C 18.9418 8.2016 0.0 0
M  V30 12 C 20.9749 8.9821 0.0 0
M  V30 13 C 20.1944 11.0154 0.0 0
M  V30 14 C 3.0800 2.6673 0.0 0
M  V30 15 N 2.3100 1.3336 0.0 0
M  V30 16 O 4.6200 2.6673 0.0 0
M  V30 17 C 3.0800 0.0000 0.0 0
M  V30 18 Cl 0.0000 8.0020 0.0 0
M  V30 19 C 7.7000 8.0020 0.0 0
M  V30 20 C 6.9300 6.6684 0.0 0
M  V30 21 C 6.9300 9.3358 0.0 0
M  V30 22 C 5.3900 6.6684 0.0 0
M  V30 23 C 5.3900 9.3358 0.0 0
M  V30 24 C 4.6200 8.0020 0.0 0
M  V30 25 C 9.2400 8.0020 0.0 0
M  V30 26 N 10.1451 9.2479 0.0 0
M  V30 27 N 10.1451 6.7562 0.0 0
M  V30 28 N 11.6098 8.7720 0.0 0
M  V30 29 C 11.6098 7.2320 0.0 0
M  V30 30 C 3.0800 5.3347 0.0 0
M  V30 31 C 2.3100 4.0011 0.0 0
M  V30 32 C 2.3100 6.6684 0.0 0
M  V30 33 N 0.7700 4.0011 0.0 0
M  V30 34 C 0.7700 6.6684 0.0 0
M  V30 35 N 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 3 22
M  V30 4 1 3 30
M  V30 5 1 4 5
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 31
M  V30 18 1 15 17
M  V30 19 1 18 34
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 19 25
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2770470-67-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2770470-68-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32460655
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7786-30-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional PROTAC tyrosine kinase 2 (TYK2)degradation
compounds and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Jing; Chen, Liqun; Wang, Jialiang; Han, Xiaoran; Wu, Zhaohui; Yang,
Ting; Zhang, Chengwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022100710 A1 2022-05-19

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2S,6R,9S)-2,6,13,13-tetramethyl-9-(2-methylpropyl)-4,8,11-trioxo-6-(t...
C20H34F3N3O6
2781122-20-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 2.6673 0.0 0 CFG=1
M  V30 2 N 9.0338 3.4374 0.0 0
M  V30 3 C 6.9302 4.0012 0.0 0
M  V30 4 C 8.4702 1.3337 0.0 0
M  V30 5 C 6.3665 1.8973 0.0 0
M  V30 6 C 9.0338 4.9774 0.0 0
M  V30 7 C 5.3901 4.0012 0.0 0
M  V30 8 F 7.1365 0.5637 0.0 0
M  V30 9 F 9.2402 0.0000 0.0 0
M  V30 10 F 9.8039 2.1037 0.0 0
M  V30 11 C 10.3677 5.7474 0.0 0 CFG=2
M  V30 12 O 7.7002 5.7474 0.0 0
M  V30 13 N 4.6201 5.3348 0.0 0
M  V30 14 O 4.6201 2.6673 0.0 0
M  V30 15 N 11.7013 4.9774 0.0 0
M  V30 16 C 10.3677 7.2874 0.0 0
M  V30 17 C 3.0801 5.3348 0.0 0 CFG=1
M  V30 18 C 13.0350 5.7474 0.0 0
M  V30 19 C 9.0338 8.0575 0.0 0
M  V30 20 C 2.3101 6.6685 0.0 0
M  V30 21 C 2.3101 4.0012 0.0 0
M  V30 22 O 14.3687 4.9774 0.0 0
M  V30 23 O 13.0350 7.2874 0.0 0
M  V30 24 C 9.0338 9.5975 0.0 0
M  V30 25 C 7.7002 7.2874 0.0 0
M  V30 26 O 0.7700 6.6685 0.0 0
M  V30 27 O 3.0801 8.0022 0.0 0
M  V30 28 C 15.7025 5.7474 0.0 0
M  V30 29 C 0.0000 8.0022 0.0 0
M  V30 30 C 16.4725 4.4137 0.0 0
M  V30 31 C 17.0362 6.5174 0.0 0
M  V30 32 C 14.9325 7.0812 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 1 11 15
M  V30 15 1 11 16 CFG=3
M  V30 16 1 13 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 22
M  V30 22 2 18 23
M  V30 23 1 19 24
M  V30 24 1 19 25
M  V30 25 1 20 26
M  V30 26 2 20 27
M  V30 27 1 22 28
M  V30 28 1 26 29
M  V30 29 1 28 30
M  V30 30 1 28 31
M  V30 31 1 28 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 11 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S,6R,10S)-6,10-dimethyl-3-(2-methylpropyl)-4,8,11-trioxo-...
C20H35F3N4O5
2781122-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 2.6673 0.0 0 CFG=1
M  V30 2 N 9.0338 3.4374 0.0 0
M  V30 3 C 6.9302 4.0012 0.0 0
M  V30 4 C 8.4702 1.3337 0.0 0
M  V30 5 C 6.3665 1.8973 0.0 0
M  V30 6 C 9.0338 4.9774 0.0 0
M  V30 7 C 5.3901 4.0012 0.0 0
M  V30 8 F 7.1365 0.5637 0.0 0
M  V30 9 F 9.2402 0.0000 0.0 0
M  V30 10 F 9.8039 2.1037 0.0 0
M  V30 11 C 10.3677 5.7474 0.0 0 CFG=2
M  V30 12 O 7.7002 5.7474 0.0 0
M  V30 13 N 4.6201 5.3348 0.0 0
M  V30 14 O 4.6201 2.6673 0.0 0
M  V30 15 N 11.7013 4.9774 0.0 0
M  V30 16 C 10.3677 7.2874 0.0 0
M  V30 17 C 3.0801 5.3348 0.0 0 CFG=1
M  V30 18 C 13.0350 5.7474 0.0 0
M  V30 19 C 9.0338 8.0575 0.0 0
M  V30 20 C 2.3101 6.6685 0.0 0
M  V30 21 C 2.3101 4.0012 0.0 0
M  V30 22 O 14.3687 4.9774 0.0 0
M  V30 23 O 13.0350 7.2874 0.0 0
M  V30 24 C 9.0338 9.5975 0.0 0
M  V30 25 C 7.7002 7.2874 0.0 0
M  V30 26 N 0.7700 6.6685 0.0 0
M  V30 27 O 3.0801 8.0022 0.0 0
M  V30 28 C 15.7025 5.7474 0.0 0
M  V30 29 C 0.0000 8.0022 0.0 0
M  V30 30 C 16.4725 4.4137 0.0 0
M  V30 31 C 17.0362 6.5174 0.0 0
M  V30 32 C 14.9325 7.0812 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 1 11 15
M  V30 15 1 11 16 CFG=3
M  V30 16 1 13 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 22
M  V30 22 2 18 23
M  V30 23 1 19 24
M  V30 24 1 19 25
M  V30 25 1 20 26
M  V30 26 2 20 27
M  V30 27 1 22 28
M  V30 28 1 26 29
M  V30 29 1 28 30
M  V30 30 1 28 31
M  V30 31 1 28 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 11 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2781122-20-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2781122-24-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32911936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantiopure β3-Trifluoromethyl-β3-homoalanine derivatives: Coupling with
Boc-protected amino acids and conformational studies of peptides in solid
state
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saraiva Rosa, Nathalie; Grellepois, Fabienne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2022), 54(13), 3025-3046

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(8-Fluoro-3,4,5,6-tetrahydro-6-oxo-1H-pyrrolo[4,3,2-ef][2]benzazepin-2-yl)b...
C18H13FN2O2
283173-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.0828 0.5637 0.0 0
M  V30 2 F 0.0000 5.6595 0.0 0
M  V30 3 C 12.5476 4.1715 0.0 0
M  V30 4 O 13.3176 5.5052 0.0 0
M  V30 5 C 4.0269 3.4053 0.0 0
M  V30 6 C 5.4797 2.9225 0.0 0
M  V30 7 C 4.0141 4.9410 0.0 0
M  V30 8 C 2.7128 2.6145 0.0 0
M  V30 9 C 6.3874 4.1715 0.0 0
M  V30 10 C 5.9943 1.4624 0.0 0
M  V30 11 N 5.4824 5.4169 0.0 0
M  V30 12 C 2.6681 5.6935 0.0 0
M  V30 13 C 1.3668 3.3679 0.0 0
M  V30 14 C 2.5346 1.0773 0.0 0
M  V30 15 C 5.1593 0.1694 0.0 0
M  V30 16 C 1.3440 4.9075 0.0 0
M  V30 17 N 3.6336 0.0000 0.0 0
M  V30 18 C 7.9275 4.1715 0.0 0
M  V30 19 C 8.6975 5.5052 0.0 0
M  V30 20 C 8.6975 2.8378 0.0 0
M  V30 21 C 10.2375 5.5052 0.0 0
M  V30 22 C 10.2375 2.8378 0.0 0
M  V30 23 C 11.0075 4.1715 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 16
M  V30 3 2 3 4
M  V30 4 1 3 23
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 11
M  V30 15 1 9 18
M  V30 16 1 10 15
M  V30 17 1 12 16
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 15 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(E)-(methylimino)methyl]phenyl]-6H-pyrrolo[...
C19H16FN3O
1424059-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.0828 0.5637 0.0 0
M  V30 2 F 0.0000 5.6595 0.0 0
M  V30 3 C 12.5476 4.1715 0.0 0
M  V30 4 N 13.3176 5.5052 0.0 0
M  V30 5 C 14.8576 5.5052 0.0 0
M  V30 6 C 4.0269 3.4053 0.0 0
M  V30 7 C 5.4797 2.9225 0.0 0
M  V30 8 C 4.0141 4.9410 0.0 0
M  V30 9 C 2.7128 2.6145 0.0 0
M  V30 10 C 6.3874 4.1715 0.0 0
M  V30 11 C 5.9943 1.4624 0.0 0
M  V30 12 N 5.4824 5.4169 0.0 0
M  V30 13 C 2.6681 5.6935 0.0 0
M  V30 14 C 1.3668 3.3679 0.0 0
M  V30 15 C 2.5346 1.0773 0.0 0
M  V30 16 C 5.1593 0.1694 0.0 0
M  V30 17 C 1.3440 4.9075 0.0 0
M  V30 18 N 3.6336 0.0000 0.0 0
M  V30 19 C 7.9275 4.1715 0.0 0
M  V30 20 C 8.6975 2.8378 0.0 0
M  V30 21 C 8.6975 5.5052 0.0 0
M  V30 22 C 10.2375 2.8378 0.0 0
M  V30 23 C 10.2375 5.5052 0.0 0
M  V30 24 C 11.0075 4.1715 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 17
M  V30 3 2 3 4
M  V30 4 1 3 24
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 1 9 15
M  V30 15 1 10 12
M  V30 16 1 10 19
M  V30 17 1 11 16
M  V30 18 1 13 17
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 283173-84-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1424059-28-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6379833
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a mixture of methanol (313 L, 43 L/kg) and THF (153 L, 21 L/kg) was
added 11 (7.30 kg, 23.7 mol). A solution of methylamine was then added (8
M in ethanol, 2.0 equiv, 4.44 kg), and the mixture was stirred for 2 h.
The reaction mixture was then concentrated by distillation under
atmospheric pressure to approximately 73 L, and the solvent was replaced
with methanol to give a final solvent volume of 73 L (10 L/kg). The
resultant slurry was cooled to 20 °C and stirred for 4 h. The solid was
filtered under nitrogen pressure, washed with methanol (37 L, 5 L/kg),
and dried under vacuum at 45 °C to give 18. Solid ,yield 6.92kg, 21.5
mol, 91%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multkilogram Scale-Up of a Reductive Alkylation Route to a Novel PARP
Inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gillmore, Adam T.; Badland, Matthew; Crook, Clare L.; Castro, Nieves M.;
Critcher, Douglas J.; Fussell, Steven J.; Jones, Katherine J.; Jones,
Matthew C.; Kougoulos, Eleftherios; Mathew, Jinu S.; McMillan, Lynne;
Pearce, John E.; Rawlinson, Fiona L.; Sherlock, Alexandra E.; Walton,
Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2012), 16(12), 1897-1904

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-[(1,2-benzisothiazol-3-ylcarbonyl)amino]-8-(2-chloro-5-fluorophenyl)-...
C23H17ClFN5O4S
2891904-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.2708 8.2619 0.0 0
M  V30 2 C 8.7353 7.7861 0.0 0
M  V30 3 O 9.0555 6.2798 0.0 0
M  V30 4 C 4.5602 3.5673 0.0 0
M  V30 5 O 5.7046 2.5368 0.0 0
M  V30 6 O 3.0956 3.0914 0.0 0
M  V30 7 C 5.3845 1.0304 0.0 0
M  V30 8 C 6.5290 0.0000 0.0 0
M  V30 9 O 0.0000 7.5517 0.0 0
M  V30 10 Cl 2.3100 11.5528 0.0 0
M  V30 11 F 8.4700 11.5528 0.0 0
M  V30 12 C 4.6200 7.5517 0.0 0
M  V30 13 N 3.8500 6.2181 0.0 0
M  V30 14 C 3.8500 8.8853 0.0 0
M  V30 15 C 6.1263 7.2315 0.0 0
M  V30 16 C 4.8804 5.0735 0.0 0
M  V30 17 C 2.3100 6.2181 0.0 0
M  V30 18 N 2.3100 8.8853 0.0 0
M  V30 19 N 6.2874 5.7000 0.0 0
M  V30 20 C 1.5400 7.5517 0.0 0
M  V30 21 C 4.6200 10.2191 0.0 0
M  V30 22 C 3.8500 11.5528 0.0 0
M  V30 23 C 6.1600 10.2191 0.0 0
M  V30 24 C 4.6200 12.8864 0.0 0
M  V30 25 C 6.9300 11.5528 0.0 0
M  V30 26 C 6.1600 12.8864 0.0 0
M  V30 27 C 9.8799 8.8165 0.0 0
M  V30 28 C 11.3861 8.4963 0.0 0
M  V30 29 N 9.7188 10.3482 0.0 0
M  V30 30 C 12.1561 9.8301 0.0 0
M  V30 31 C 12.1561 7.1627 0.0 0
M  V30 32 S 11.1257 10.9745 0.0 0
M  V30 33 C 13.6961 9.8301 0.0 0
M  V30 34 C 13.6961 7.1627 0.0 0
M  V30 35 C 14.4661 8.4963 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 2 2 3
M  V30 4 1 2 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 16
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 2 9 20
M  V30 11 1 10 22
M  V30 12 1 11 25
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 14 21
M  V30 20 1 15 19
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 18 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 2 28 31
M  V30 34 1 29 32
M  V30 35 1 30 32
M  V30 36 2 30 33
M  V30 37 1 31 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imidazo[1,5-a]pyrazine-3-carboxamide, 1-[(1,2-benzisothiazol-3-ylcarbonyl)ami...
C22H16ClFN6O3S
2891771-70-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.2709 7.2316 0.0 0
M  V30 2 C 8.7354 6.7556 0.0 0
M  V30 3 O 9.0556 5.2493 0.0 0
M  V30 4 C 4.5603 2.5367 0.0 0
M  V30 5 N 5.7047 1.5063 0.0 0
M  V30 6 O 3.0956 2.0608 0.0 0
M  V30 7 C 5.3845 0.0000 0.0 0
M  V30 8 O 0.0000 6.5212 0.0 0
M  V30 9 Cl 2.3100 10.5223 0.0 0
M  V30 10 F 8.4701 10.5223 0.0 0
M  V30 11 C 4.6200 6.5212 0.0 0
M  V30 12 N 3.8500 5.1875 0.0 0
M  V30 13 C 3.8500 7.8550 0.0 0
M  V30 14 C 6.1263 6.2010 0.0 0
M  V30 15 C 4.8804 4.0431 0.0 0
M  V30 16 C 2.3100 5.1875 0.0 0
M  V30 17 N 2.3100 7.8550 0.0 0
M  V30 18 N 6.2874 4.6695 0.0 0
M  V30 19 C 1.5400 6.5212 0.0 0
M  V30 20 C 4.6200 9.1886 0.0 0
M  V30 21 C 3.8500 10.5223 0.0 0
M  V30 22 C 6.1600 9.1886 0.0 0
M  V30 23 C 4.6200 11.8559 0.0 0
M  V30 24 C 6.9300 10.5223 0.0 0
M  V30 25 C 6.1600 11.8559 0.0 0
M  V30 26 C 9.8799 7.7861 0.0 0
M  V30 27 C 11.3862 7.4660 0.0 0
M  V30 28 N 9.7189 9.3177 0.0 0
M  V30 29 C 12.1562 8.7996 0.0 0
M  V30 30 C 12.1562 6.1322 0.0 0
M  V30 31 S 11.1258 9.9440 0.0 0
M  V30 32 C 13.6962 8.7996 0.0 0
M  V30 33 C 13.6962 6.1322 0.0 0
M  V30 34 C 14.4662 7.4660 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 26
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 15
M  V30 8 1 5 7
M  V30 9 2 8 19
M  V30 10 1 9 21
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 13 20
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 17 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 2 27 30
M  V30 33 1 28 31
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 1 30 33
M  V30 37 1 32 34
M  V30 38 2 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2891904-71-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2891771-70-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42068631
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PI3K inhibitors and methods of making and applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Che, Qinglin; Samanta, Sanjay; Lescarbeau, Andre; Singh, Surendra; Lewis,
Paul; Suleiman, Osama
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024151930 A1 2024-07-18

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C22H19O2.ClO4
2904546-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.5500 9.9547 0.0 0
M  V30 2 C 12.3200 8.6211 0.0 0
M  V30 3 C 5.3900 9.9547 0.0 0
M  V30 4 C 6.9300 9.9547 0.0 0
M  V30 5 C 4.6200 11.2885 0.0 0
M  V30 6 O 4.6200 8.6211 0.0 0 CHG=1 VAL=3
M  V30 7 C 7.7000 11.2885 0.0 0
M  V30 8 C 7.7000 8.6211 0.0 0
M  V30 9 C 3.0800 11.2885 0.0 0
M  V30 10 C 5.3900 12.6221 0.0 0
M  V30 11 C 3.0800 8.6211 0.0 0
M  V30 12 C 6.9300 12.6221 0.0 0
M  V30 13 C 9.2400 11.2885 0.0 0
M  V30 14 C 9.2400 8.6211 0.0 0
M  V30 15 C 2.3100 9.9547 0.0 0
M  V30 16 C 2.3100 7.2874 0.0 0
M  V30 17 C 10.0100 9.9547 0.0 0
M  V30 18 C 0.7700 9.9547 0.0 0
M  V30 19 C 0.7700 7.2874 0.0 0
M  V30 20 C 3.0800 5.9536 0.0 0
M  V30 21 C 0.0000 8.6211 0.0 0
M  V30 22 C 0.0000 5.9536 0.0 0
M  V30 23 C 2.3100 4.6200 0.0 0
M  V30 24 C 0.7700 4.6200 0.0 0
M  V30 25 Cl 6.1600 1.5400 0.0 0 VAL=7
M  V30 26 O 4.6200 1.5400 0.0 0
M  V30 27 O 7.7000 1.5400 0.0 0
M  V30 28 O 6.1600 0.0000 0.0 0
M  V30 29 O 6.1600 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 12
M  V30 16 2 11 15
M  V30 17 1 11 16
M  V30 18 1 13 17
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 2 16 20
M  V30 23 1 18 21
M  V30 24 1 19 21
M  V30 25 2 19 22
M  V30 26 1 20 23
M  V30 27 1 22 24
M  V30 28 2 23 24
M  V30 29 2 25 26
M  V30 30 2 25 27
M  V30 31 2 25 28
M  V30 32 1 25 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibenz[c,h]acridinium, 5,6,8,9-tetrahydro-3-methoxy-14-methyl-, perchlorate (...
C23H22NO.ClO4
2904546-60-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 7.2874 0.0 0
M  V30 2 O 11.5500 9.9547 0.0 0
M  V30 3 C 12.3200 8.6211 0.0 0
M  V30 4 C 5.3900 9.9547 0.0 0
M  V30 5 C 6.9300 9.9547 0.0 0
M  V30 6 C 4.6200 11.2885 0.0 0
M  V30 7 N 4.6200 8.6211 0.0 0 CHG=1 VAL=4
M  V30 8 C 7.7000 11.2885 0.0 0
M  V30 9 C 7.7000 8.6211 0.0 0
M  V30 10 C 3.0800 11.2885 0.0 0
M  V30 11 C 5.3900 12.6221 0.0 0
M  V30 12 C 3.0800 8.6211 0.0 0
M  V30 13 C 6.9300 12.6221 0.0 0
M  V30 14 C 9.2400 11.2885 0.0 0
M  V30 15 C 9.2400 8.6211 0.0 0
M  V30 16 C 2.3100 9.9547 0.0 0
M  V30 17 C 2.3100 7.2874 0.0 0
M  V30 18 C 10.0100 9.9547 0.0 0
M  V30 19 C 0.7700 9.9547 0.0 0
M  V30 20 C 0.7700 7.2874 0.0 0
M  V30 21 C 3.0800 5.9536 0.0 0
M  V30 22 C 0.0000 8.6211 0.0 0
M  V30 23 C 0.0000 5.9536 0.0 0
M  V30 24 C 2.3100 4.6200 0.0 0
M  V30 25 C 0.7700 4.6200 0.0 0
M  V30 26 Cl 6.1600 1.5400 0.0 0 VAL=7
M  V30 27 O 4.6200 1.5400 0.0 0
M  V30 28 O 7.7000 1.5400 0.0 0
M  V30 29 O 6.1600 0.0000 0.0 0
M  V30 30 O 6.1600 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 13
M  V30 17 2 12 16
M  V30 18 1 12 17
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 2 17 21
M  V30 24 1 19 22
M  V30 25 1 20 22
M  V30 26 2 20 23
M  V30 27 1 21 24
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 2 26 28
M  V30 32 2 26 29
M  V30 33 1 26 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2904546-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2904546-60-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35001821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM IndiFluors: A New Full-Visible Color-Tunable Donor-Acceptor-Donor
(D1-A-D2) Fluorophore Family for Ratiometric pH Imaging during Mitophagy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Munan, Subrata; Kottarathil, Shamna; Joseph, Manu M.; Jana, Anal; Ali,
Mudassar; Mapa, Koyeli; Maiti, Kaustabh Kumar; Samanta, Animesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sensors (2024), 9(7), 3502-3510

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C27H28Cl2N6O3
2911640-57-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 10.7733 0.0 0
M  V30 2 O 2.3101 10.7733 0.0 0
M  V30 3 O 4.6201 12.1070 0.0 0
M  V30 4 C 1.5400 12.1070 0.0 0
M  V30 5 C 0.0000 12.1070 0.0 0
M  V30 6 N 11.5809 10.3114 0.0 0
M  V30 7 Cl 6.9899 0.0000 0.0 0
M  V30 8 Cl 10.0700 0.0000 0.0 0
M  V30 9 C 16.2757 13.0221 0.0 0
M  V30 10 O 15.7998 14.4868 0.0 0
M  V30 11 N 7.6164 6.7418 0.0 0
M  V30 12 C 6.4718 7.7722 0.0 0
M  V30 13 C 6.9899 5.3348 0.0 0
M  V30 14 C 5.1382 7.0022 0.0 0
M  V30 15 C 6.1517 9.2787 0.0 0
M  V30 16 N 5.4583 5.4959 0.0 0
M  V30 17 C 3.9936 8.0328 0.0 0
M  V30 18 C 4.6201 9.4396 0.0 0 CFG=3
M  V30 19 C 9.1227 7.0620 0.0 0
M  V30 20 N 9.5986 8.5267 0.0 0
M  V30 21 C 10.1531 5.9176 0.0 0
M  V30 22 C 11.1050 8.8469 0.0 0
M  V30 23 C 11.6596 6.2378 0.0 0
M  V30 24 N 12.1355 7.7023 0.0 0
M  V30 25 C 7.7599 4.0012 0.0 0
M  V30 26 C 6.9899 2.6675 0.0 0
M  V30 27 C 9.3000 4.0012 0.0 0
M  V30 28 C 7.7599 1.3338 0.0 0
M  V30 29 C 10.0700 2.6675 0.0 0
M  V30 30 C 9.3000 1.3338 0.0 0
M  V30 31 C 13.0872 10.6316 0.0 0 CFG=1
M  V30 32 C 13.7137 12.0386 0.0 0
M  V30 33 C 14.2318 9.6012 0.0 0
M  V30 34 N 15.2453 11.8777 0.0 0
M  V30 35 C 15.5654 10.3712 0.0 0
M  V30 36 C 17.7822 12.7019 0.0 0
M  V30 37 C 18.9266 11.6715 0.0 0
M  V30 38 C 19.2467 13.1778 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 22
M  V30 7 1 31 6 CFG=3
M  V30 8 1 7 28
M  V30 9 1 8 30
M  V30 10 2 9 10
M  V30 11 1 9 34
M  V30 12 1 9 36
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 19
M  V30 16 2 12 14
M  V30 17 1 12 15
M  V30 18 2 13 16
M  V30 19 1 13 25
M  V30 20 1 14 16
M  V30 21 1 14 17
M  V30 22 1 15 18
M  V30 23 1 17 18
M  V30 24 2 19 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 24
M  V30 30 2 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 36 1 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 35
M  V30 41 1 36 37
M  V30 42 1 36 38
M  V30 43 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C26H27Cl2N7O2
2911640-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7599 2.6673 0.0 0
M  V30 2 N 6.9899 1.3336 0.0 0
M  V30 3 O 9.2999 2.6673 0.0 0
M  V30 4 C 7.7599 0.0000 0.0 0
M  V30 5 N 11.2252 9.5931 0.0 0
M  V30 6 Cl 0.0000 10.7731 0.0 0
M  V30 7 Cl 1.5400 13.4403 0.0 0
M  V30 8 C 15.9199 12.3037 0.0 0
M  V30 9 O 16.9505 11.1593 0.0 0
M  V30 10 N 6.1515 7.9447 0.0 0
M  V30 11 C 6.4717 6.4383 0.0 0
M  V30 12 C 4.6200 8.1056 0.0 0
M  V30 13 C 5.1381 5.6683 0.0 0
M  V30 14 C 7.6162 5.4079 0.0 0
M  V30 15 N 3.9937 6.6988 0.0 0
M  V30 16 C 5.4582 4.1620 0.0 0
M  V30 17 C 6.9899 4.0011 0.0 0 CFG=3
M  V30 18 C 7.1821 9.0891 0.0 0
M  V30 19 N 8.6884 8.7689 0.0 0
M  V30 20 C 6.7061 10.5538 0.0 0
M  V30 21 C 9.7188 9.9134 0.0 0
M  V30 22 C 7.7367 11.6981 0.0 0
M  V30 23 N 9.2429 11.3780 0.0 0
M  V30 24 C 3.8500 9.4393 0.0 0
M  V30 25 C 2.3100 9.4393 0.0 0
M  V30 26 C 4.6200 10.7731 0.0 0
M  V30 27 C 1.5400 10.7731 0.0 0
M  V30 28 C 3.8500 12.1067 0.0 0
M  V30 29 C 2.3100 12.1067 0.0 0
M  V30 30 C 12.2556 10.7377 0.0 0 CFG=1
M  V30 31 C 13.7872 10.5767 0.0 0
M  V30 32 C 11.9355 12.2439 0.0 0
M  V30 33 N 14.4136 11.9835 0.0 0
M  V30 34 C 13.2691 13.0139 0.0 0
M  V30 35 C 16.3958 13.7684 0.0 0
M  V30 36 C 17.5403 14.7988 0.0 0
M  V30 37 C 16.0756 15.2746 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 30 5 CFG=1
M  V30 7 1 6 27
M  V30 8 1 7 29
M  V30 9 2 8 9
M  V30 10 1 8 33
M  V30 11 1 8 35
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 18
M  V30 15 2 11 13
M  V30 16 1 11 14
M  V30 17 2 12 15
M  V30 18 1 12 24
M  V30 19 1 13 15
M  V30 20 1 13 16
M  V30 21 1 14 17
M  V30 22 1 16 17
M  V30 23 2 18 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 2 20 22
M  V30 27 2 21 23
M  V30 28 1 22 23
M  V30 29 2 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 2 26 28
M  V30 33 2 27 29
M  V30 34 1 28 29
M  V30 35 1 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 34
M  V30 40 1 35 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2911640-57-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2911640-65-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34862271
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 1,4,5,6-tetrahydrocyclopenta[d]imidazole-5-carboxamide-based JNK3
inhibitors: Design, synthesis, molecular docking, and therapeutic
potential in neurodegenerative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jun, Joonhong; Baek, Jihyun; Kang, Dahyun; Moon, Hyungwoo; Kim, Hyejin;
Cho, Hyunwook; Hah, Jung-Mi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 245(Part_1), 114917

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 3-(methylthio)-4-oxo-4-phenyl-, methyl ester, (2E)-
C12H12O3S
2922561-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 S 4.6200 1.3338 0.0 0
M  V30 5 O 5.3900 5.3349 0.0 0
M  V30 6 C 7.7000 4.0011 0.0 0
M  V30 7 C 5.3900 0.0000 0.0 0
M  V30 8 O 9.2400 4.0011 0.0 0
M  V30 9 O 6.9300 5.3349 0.0 0
M  V30 10 C 10.0100 5.3349 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 0.7700 5.3349 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 11
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Pyrrol-2-one, 1,5-dihydro-5-hydroxy-1-methyl-4-(methylthio)-5-phenyl-
C12H13NO2S
2922561-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.4592 5.1959 0.0 0
M  V30 2 S 6.7529 5.3915 0.0 0
M  V30 3 C 8.2845 5.5524 0.0 0
M  V30 4 C 3.1253 1.3628 0.0 0
M  V30 5 O 6.1862 0.0000 0.0 0
M  V30 6 C 4.6201 3.6644 0.0 0
M  V30 7 C 6.1264 3.9845 0.0 0
M  V30 8 N 4.4592 2.1328 0.0 0
M  V30 9 C 6.8964 2.6509 0.0 0
M  V30 10 C 5.8660 1.5065 0.0 0
M  V30 11 C 3.0801 3.6644 0.0 0
M  V30 12 C 2.3101 2.3307 0.0 0
M  V30 13 C 2.3101 4.9980 0.0 0
M  V30 14 C 0.7700 2.3307 0.0 0
M  V30 15 C 0.7700 4.9980 0.0 0
M  V30 16 C 0.0000 3.6644 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 3
M  V30 3 1 2 7
M  V30 4 1 4 8
M  V30 5 2 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2922561-49-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2922561-70-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36150635
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM scalable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM I2-DMSO Promoted Deaminative Coupling Reactions of Glycine Esters: Access
to 5-(Methylthio)pyridazin-3(2H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhat, Showkat Ahmad; Bhat, Mohammad Yaqoob; Rather, Suhail Ahmad; Jameel,
Salman; Bhat, Khursheed Ahmad; Ahmed, Qazi Naveed
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2023), 25(14), 2382-2387

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 4-(5-bromo-2-thienyl)-3-(methylthio)-4-oxo-, ethyl ester, (2Z)-
C11H11BrO3S2
2922561-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0287 2.6675 0.0 0
M  V30 2 C 5.5688 2.6675 0.0 0
M  V30 3 O 3.2587 1.3338 0.0 0
M  V30 4 C 6.3388 4.0012 0.0 0
M  V30 5 S 6.3388 1.3338 0.0 0
M  V30 6 C 7.8788 4.0012 0.0 0
M  V30 7 C 5.5688 0.0000 0.0 0
M  V30 8 O 8.6488 5.3348 0.0 0
M  V30 9 O 8.6488 2.6675 0.0 0
M  V30 10 C 10.1889 5.3348 0.0 0
M  V30 11 C 10.9589 6.6687 0.0 0
M  V30 12 Br 0.0000 6.2949 0.0 0
M  V30 13 C 3.2587 4.0012 0.0 0
M  V30 14 C 3.8850 5.4081 0.0 0
M  V30 15 S 1.7271 4.1621 0.0 0
M  V30 16 C 2.7406 6.4386 0.0 0
M  V30 17 C 1.4070 5.6686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 2 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Pyrrol-2-one, 5-(5-bromo-2-thienyl)-1,5-dihydro-5-hydroxy-1-methyl-4-(meth...
C10H10BrNO2S2
2922561-75-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.9524 5.3479 0.0 0
M  V30 2 S 7.2541 5.3026 0.0 0
M  V30 3 C 8.7941 5.3026 0.0 0
M  V30 4 C 3.2254 1.6752 0.0 0
M  V30 5 O 6.1270 0.0000 0.0 0
M  V30 6 Br 0.0000 6.0129 0.0 0
M  V30 7 C 4.9524 3.8079 0.0 0
M  V30 8 C 6.4841 3.9689 0.0 0
M  V30 9 N 4.6322 2.3016 0.0 0
M  V30 10 C 7.1104 2.5620 0.0 0
M  V30 11 C 5.9660 1.5316 0.0 0
M  V30 12 C 3.4209 3.9689 0.0 0
M  V30 13 S 2.6508 5.3026 0.0 0
M  V30 14 C 2.3904 2.8244 0.0 0
M  V30 15 C 1.1445 4.9824 0.0 0
M  V30 16 C 0.9835 3.4509 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 8
M  V30 4 1 4 9
M  V30 5 2 5 11
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2922561-69-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2922561-75-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36150638
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM I2-DMSO Promoted Deaminative Coupling Reactions of Glycine Esters: Access
to 5-(Methylthio)pyridazin-3(2H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhat, Showkat Ahmad; Bhat, Mohammad Yaqoob; Rather, Suhail Ahmad; Jameel,
Salman; Bhat, Khursheed Ahmad; Ahmed, Qazi Naveed
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2023), 25(14), 2382-2387

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, 2-[[[2,3-dihydro-2,2-dimethyl-5-(1-oxobutyl)-7-benzofuran...
C25H29NO6
2925227-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2537 9.3360 0.0 0
M  V30 2 C 7.7938 9.3360 0.0 0
M  V30 3 C 0.0000 8.2000 0.0 0
M  V30 4 C 1.0304 9.9849 0.0 0
M  V30 5 C 6.2537 4.0010 0.0 0
M  V30 6 C 5.4837 2.6673 0.0 0
M  V30 7 O 7.7938 4.0010 0.0 0
M  V30 8 C 6.2537 1.3337 0.0 0
M  V30 9 C 5.4837 0.0000 0.0 0
M  V30 10 C 10.8738 9.3360 0.0 0
M  V30 11 C 10.1038 8.0021 0.0 0
M  V30 12 N 12.4139 9.3360 0.0 0
M  V30 13 O 10.8738 6.6685 0.0 0
M  V30 14 O 8.5638 8.0021 0.0 0
M  V30 15 O 13.1839 10.6696 0.0 0
M  V30 16 C 12.4139 6.6685 0.0 0
M  V30 17 C 14.7239 10.6696 0.0 0
M  V30 18 C 3.9437 8.0021 0.0 0
M  V30 19 C 3.1737 6.6685 0.0 0
M  V30 20 C 5.4837 8.0021 0.0 0
M  V30 21 O 2.9133 9.1467 0.0 0
M  V30 22 C 3.9437 5.3348 0.0 0
M  V30 23 C 1.6674 6.9886 0.0 0
M  V30 24 C 6.2537 6.6685 0.0 0
M  V30 25 C 1.5063 8.5202 0.0 0
M  V30 26 C 5.4837 5.3348 0.0 0
M  V30 27 C 8.5638 10.6696 0.0 0
M  V30 28 C 10.1038 10.6696 0.0 0
M  V30 29 C 7.7938 12.0033 0.0 0
M  V30 30 C 10.8738 12.0033 0.0 0
M  V30 31 C 8.5638 13.3369 0.0 0
M  V30 32 C 10.1038 13.3369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 27
M  V30 4 1 3 25
M  V30 5 1 4 25
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 26
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 28
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 18 21
M  V30 22 2 19 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetamide, 2-[[[2,3-dihydro-2,2-dimethyl-5-(1-oxobutyl)-7-benzofuranyl...
C25H30N2O5
2925227-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2537 9.3360 0.0 0
M  V30 2 C 7.7938 9.3360 0.0 0
M  V30 3 C 0.0000 8.2000 0.0 0
M  V30 4 C 1.0304 9.9849 0.0 0
M  V30 5 C 6.2537 4.0010 0.0 0
M  V30 6 C 5.4837 2.6673 0.0 0
M  V30 7 O 7.7938 4.0010 0.0 0
M  V30 8 C 6.2537 1.3337 0.0 0
M  V30 9 C 5.4837 0.0000 0.0 0
M  V30 10 C 10.8738 9.3360 0.0 0
M  V30 11 C 10.1038 8.0021 0.0 0
M  V30 12 N 12.4139 9.3360 0.0 0
M  V30 13 N 10.8738 6.6685 0.0 0
M  V30 14 O 8.5638 8.0021 0.0 0
M  V30 15 O 13.1839 10.6696 0.0 0
M  V30 16 C 12.4139 6.6685 0.0 0
M  V30 17 C 14.7239 10.6696 0.0 0
M  V30 18 C 3.9437 8.0021 0.0 0
M  V30 19 C 3.1737 6.6685 0.0 0
M  V30 20 C 5.4837 8.0021 0.0 0
M  V30 21 O 2.9133 9.1467 0.0 0
M  V30 22 C 3.9437 5.3348 0.0 0
M  V30 23 C 1.6674 6.9886 0.0 0
M  V30 24 C 6.2537 6.6685 0.0 0
M  V30 25 C 1.5063 8.5202 0.0 0
M  V30 26 C 5.4837 5.3348 0.0 0
M  V30 27 C 8.5638 10.6696 0.0 0
M  V30 28 C 10.1038 10.6696 0.0 0
M  V30 29 C 7.7938 12.0033 0.0 0
M  V30 30 C 10.8738 12.0033 0.0 0
M  V30 31 C 8.5638 13.3369 0.0 0
M  V30 32 C 10.1038 13.3369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 27
M  V30 4 1 3 25
M  V30 5 1 4 25
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 26
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 28
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 18 21
M  V30 22 2 19 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2925227-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925227-11-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36471939
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, crystal structure, biological evaluation, docking study and
DFT calculation of novel strobilurins containing oxime ether phenyl ring
or dihydrobenzofuran moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Mingfang; Li, Kangming; Yi, Yangjie; Luo, Xianfu; Qiu, Longjian;
Zhang, Lijuan; Wang, Man; Ye, Jiao; Ou, Xiaoming; Li, Jianming; Chen,
Yun; Hu, Aixi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2023), 1286135636

$RFMT $RIREG SCHEME236 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2(1H)-Quinoxalinone, 3-bromo-7-ethenyl-8-fluoro-1-[(4-methoxyphenyl)methyl]-
C18H14BrFN2O2
2958610-67-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0
M  V30 2 F 4.6200 6.6685 0.0 0
M  V30 3 O 8.4700 2.6674 0.0 0
M  V30 4 C 1.5400 6.6685 0.0 0
M  V30 5 C 0.0000 6.6685 0.0 0
M  V30 6 Br 6.9300 0.0000 0.0 0
M  V30 7 O 13.0900 5.3347 0.0 0
M  V30 8 C 13.8600 6.6685 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 N 6.1600 4.0011 0.0 0
M  V30 11 C 3.8500 2.6674 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 N 4.6200 1.3338 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 6.1600 1.3338 0.0 0
M  V30 18 C 1.5400 4.0011 0.0 0
M  V30 19 C 8.4700 5.3347 0.0 0
M  V30 20 C 9.2400 6.6685 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 10.7800 6.6685 0.0 0
M  V30 23 C 10.7800 4.0011 0.0 0
M  V30 24 C 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 19
M  V30 3 1 2 12
M  V30 4 2 3 13
M  V30 5 2 4 5
M  V30 6 1 4 16
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 7 24
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 2 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2(1H)-Quinoxalinone, 7-ethenyl-8-fluoro-1-[(4-methoxyphenyl)methyl]-3-(methyl...
C19H18FN3O2
2958610-68-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6685 0.0 0
M  V30 2 F 4.6200 8.0021 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 C 1.5400 8.0021 0.0 0
M  V30 5 C 0.0000 8.0021 0.0 0
M  V30 6 N 6.9300 1.3336 0.0 0
M  V30 7 C 6.1600 0.0000 0.0 0
M  V30 8 O 13.0900 6.6685 0.0 0
M  V30 9 C 13.8600 8.0021 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 N 6.1600 5.3347 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 3.8500 6.6685 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 N 4.6200 2.6674 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 6.1600 2.6674 0.0 0
M  V30 19 C 1.5400 5.3347 0.0 0
M  V30 20 C 8.4700 6.6685 0.0 0
M  V30 21 C 9.2400 8.0021 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 23 C 10.7800 8.0021 0.0 0
M  V30 24 C 10.7800 5.3347 0.0 0
M  V30 25 C 11.5500 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 20
M  V30 3 1 2 13
M  V30 4 2 3 14
M  V30 5 2 4 5
M  V30 6 1 4 17
M  V30 7 1 6 7
M  V30 8 1 6 18
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2958610-67-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2958610-68-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37655674
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Piperazine derivatives as PARP1 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoffman, Robert L.; Va, Porino Jinjo; Pinchman, Joseph Robert; Trzoss,
Lynnie; Dong, Qing; Kaldor, Stephen W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023146957 A1 2023-08-03

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-1,4-benzodioxin-5-carboxaldehyde
C9H8O3
29668-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0010 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 O 2.3101 4.0010 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 O 0.7700 1.3337 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 4.6201 0.0000 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-N-methyl-1,4-benzodioxin-5-methanamine
C10H13NO2
709649-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 C 8.0021 3.0800 0.0 0
M  V30 4 C 2.6674 3.0800 0.0 0
M  V30 5 C 1.3336 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 O 2.6674 4.6200 0.0 0
M  V30 8 C 1.3336 0.7700 0.0 0
M  V30 9 O 0.0000 3.0800 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3336 5.3900 0.0 0
M  V30 12 C 2.6674 0.0000 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29668-43-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-647438
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 67 Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine Preparation 99 Preparation
of (2,3-Dihydro-benzo[1.4]dioxin-5-ylmethyl)methylamine [0854] According
to the procedure of Preparation 67, except substituting
2,3-dihydro-benzo[1,4]dioxine-5-carbaldehyde for
1-propyl-naphthalene-2-carbaldehyde. The title compound (1.97 g, 91%) was
prepared as a yellow oil. 1H NMR (300 MHz, DMSO-d6) δ 6.85-6.82 (m, 1H),
6.77-6.70 (m, 2H), 4.25-4.20 (m, 4H), 3.56 (s, 2H), 2.25 (s, 3H), 1.76
(br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-1,4-benzodioxin-5-carboxaldehyde
C9H8O3
29668-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0010 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 O 2.3101 4.0010 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 O 0.7700 1.3337 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 4.6201 0.0000 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-N-methyl-1,4-benzodioxin-5-methanamine
C10H13NO2
709649-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 C 8.0021 3.0800 0.0 0
M  V30 4 C 2.6674 3.0800 0.0 0
M  V30 5 C 1.3336 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 O 2.6674 4.6200 0.0 0
M  V30 8 C 1.3336 0.7700 0.0 0
M  V30 9 O 0.0000 3.0800 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3336 5.3900 0.0 0
M  V30 12 C 2.6674 0.0000 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29668-43-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7765116
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-1,4-benzodioxin-5-carboxaldehyde
C9H8O3
29668-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0010 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 O 2.3101 4.0010 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 O 0.7700 1.3337 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 4.6201 0.0000 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-N-methyl-1,4-benzodioxin-5-methanamine
C10H13NO2
709649-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 C 8.0021 3.0800 0.0 0
M  V30 4 C 2.6674 3.0800 0.0 0
M  V30 5 C 1.3336 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 O 2.6674 4.6200 0.0 0
M  V30 8 C 1.3336 0.7700 0.0 0
M  V30 9 O 0.0000 3.0800 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3336 5.3900 0.0 0
M  V30 12 C 2.6674 0.0000 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29668-43-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12282806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine A solution of 2.0 M
methylamine in methanol (20 mL) was added to
1-propylnaphthalene-2-carbaldehyde (0.983 g, 4.95 mmol) under N2 and
allowed to stir for 18 h. The solution was concentrated under reduced
pressure. Then the resulting dark yellow oil was solvated in EtOH (20 mL)
under N2. To the solution was added NaBH4 (0.187 g, 4.95 mmol) and the
mixture allowed to stir for 6.5 h. The reaction was concentrated under
reduced pressure, then solvated in 1 N NaOH (20 mL) and extracted with
Et2O (3 x 50 mL). The organics were combined, washed with brine (2 x 100
mL), dried over Na2SO4, filtered and concentrated to yield the title
compound as a yellow oil. Preparation of
(2,3-Dihydro-benzo[1,4]dioxin-5-ylmethyl)methylamine According to the
procedure of Preparation 1, except substituting
2,3-dihydrobenzo[1,4]dioxine-5-carbaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (1.97 g, 91%) was
prepared as a yellow oil. 1H NMR (300 MHz, DMSO-d6) δ 6.85-6.82 (m, 1H),
6.77-6.70 (m, 2H), 4.25-4.20 (m, 4H), 3.56 (s, 2H), 2.25 (s, 3H), 1.76
(br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4(5H)-Oxazolone, 2-amino-5-[1-(5-bromo-1H-indol-3-yl)ethyl]-
C13H12BrN3O2
3033532-20-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9416 3.0608 0.0 0
M  V30 2 C 4.9111 1.9164 0.0 0
M  V30 3 Br 0.0000 4.2314 0.0 0
M  V30 4 O 7.3043 0.0000 0.0 0
M  V30 5 N 11.3330 3.6275 0.0 0
M  V30 6 C 4.0011 5.0014 0.0 0
M  V30 7 C 5.4657 4.5255 0.0 0
M  V30 8 C 4.0011 6.5414 0.0 0
M  V30 9 C 2.6673 4.2314 0.0 0
M  V30 10 C 6.3709 5.7714 0.0 0
M  V30 11 C 2.6673 7.3114 0.0 0
M  V30 12 N 5.4657 7.0173 0.0 0
M  V30 13 C 1.3337 5.0014 0.0 0
M  V30 14 C 1.3337 6.5414 0.0 0
M  V30 15 C 7.4480 2.7406 0.0 0
M  V30 16 C 8.0743 1.3337 0.0 0
M  V30 17 O 8.5924 3.7711 0.0 0
M  V30 18 N 9.6059 1.4947 0.0 0
M  V30 19 C 9.9262 3.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 15
M  V30 4 1 3 13
M  V30 5 2 4 16
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4(5H)-Oxazolone, 5-[1-(5-bromo-1H-indol-3-yl)ethyl]-2-(methylamino)-
C14H14BrN3O2
3033532-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9415 3.0608 0.0 0
M  V30 2 C 4.9111 1.9164 0.0 0
M  V30 3 Br 0.0000 4.2313 0.0 0
M  V30 4 O 7.3043 0.0000 0.0 0
M  V30 5 N 11.3330 3.6275 0.0 0
M  V30 6 C 12.5788 2.7223 0.0 0
M  V30 7 C 4.0011 5.0014 0.0 0
M  V30 8 C 5.4657 4.5255 0.0 0
M  V30 9 C 4.0011 6.5414 0.0 0
M  V30 10 C 2.6673 4.2313 0.0 0
M  V30 11 C 6.3709 5.7714 0.0 0
M  V30 12 C 2.6673 7.3114 0.0 0
M  V30 13 N 5.4657 7.0172 0.0 0
M  V30 14 C 1.3337 5.0014 0.0 0
M  V30 15 C 1.3337 6.5414 0.0 0
M  V30 16 C 7.4480 2.7406 0.0 0
M  V30 17 C 8.0743 1.3337 0.0 0
M  V30 18 O 8.5924 3.7710 0.0 0
M  V30 19 N 9.6058 1.4947 0.0 0
M  V30 20 C 9.9262 3.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 16
M  V30 4 1 3 14
M  V30 5 2 4 17
M  V30 6 1 5 6
M  V30 7 1 5 20
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3033532-20-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3033532-66-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33810339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and antibacterial activity of derivatives of
Tryptophanyl-tRNA synthetase inhibitor indolmycin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Lianqi; Zhang, Shuo; Kou, Shibo; Yi, Hong; Cui, Along; Li, Zhuorong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 241114647

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-(2,6-dichloro-9H-purin-9-yl)-, 1,1-dimethylethyl ester
C16H14Cl2N4O2
3038727-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 5.2181 0.0 0
M  V30 2 Cl 1.1093 0.0000 0.0 0
M  V30 3 C 10.3089 3.8759 0.0 0
M  V30 4 O 11.6426 3.1059 0.0 0
M  V30 5 O 10.3089 5.4159 0.0 0
M  V30 6 C 12.9762 3.8759 0.0 0
M  V30 7 C 12.2062 5.2095 0.0 0
M  V30 8 C 14.3100 4.6459 0.0 0
M  V30 9 C 13.7462 2.5421 0.0 0
M  V30 10 C 3.5673 3.2494 0.0 0
M  V30 11 N 4.9742 3.8759 0.0 0
M  V30 12 C 2.5368 4.3939 0.0 0
M  V30 13 N 3.0914 1.7849 0.0 0
M  V30 14 C 4.8133 5.4074 0.0 0
M  V30 15 N 3.3068 5.7276 0.0 0
M  V30 16 C 1.0306 4.0738 0.0 0
M  V30 17 C 1.5851 1.4647 0.0 0
M  V30 18 N 0.5546 2.6091 0.0 0
M  V30 19 C 6.3078 3.1059 0.0 0
M  V30 20 C 7.6415 3.8759 0.0 0
M  V30 21 C 6.3078 1.5659 0.0 0
M  V30 22 C 8.9753 3.1059 0.0 0
M  V30 23 C 7.6415 0.7959 0.0 0
M  V30 24 C 8.9753 1.5659 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 22
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 11 19
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-[2-chloro-6-(methylamino)-9H-purin-9-yl]-, 1,1-dimethylethyl ...
C17H18ClN5O2
3038726-97-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5063 5.2182 0.0 0
M  V30 2 C 0.0000 4.8981 0.0 0
M  V30 3 Cl 2.6154 0.0000 0.0 0
M  V30 4 C 11.8154 3.8760 0.0 0
M  V30 5 O 13.1491 3.1059 0.0 0
M  V30 6 O 11.8154 5.4160 0.0 0
M  V30 7 C 14.4828 3.8760 0.0 0
M  V30 8 C 15.2528 2.5421 0.0 0
M  V30 9 C 15.8165 4.6460 0.0 0
M  V30 10 C 13.7128 5.2096 0.0 0
M  V30 11 C 5.0736 3.2495 0.0 0
M  V30 12 N 6.4806 3.8760 0.0 0
M  V30 13 C 4.0432 4.3940 0.0 0
M  V30 14 N 4.5978 1.7849 0.0 0
M  V30 15 C 6.3195 5.4075 0.0 0
M  V30 16 C 2.5367 4.0739 0.0 0
M  V30 17 N 4.8132 5.7277 0.0 0
M  V30 18 C 3.0915 1.4647 0.0 0
M  V30 19 N 2.0609 2.6091 0.0 0
M  V30 20 C 7.8143 3.1059 0.0 0
M  V30 21 C 9.1480 3.8760 0.0 0
M  V30 22 C 7.8143 1.5659 0.0 0
M  V30 23 C 10.4816 3.1059 0.0 0
M  V30 24 C 9.1480 0.7959 0.0 0
M  V30 25 C 10.4816 1.5659 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 23
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 12 20
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 17
M  V30 20 1 16 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3038727-71-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3038726-97-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40947829
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Design of a Potent and Selective YTHDC1 Ligand
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zalesak, Frantisek; Nai, Francesco; Herok, Marcin; Bochenkova, Elena;
Bedi, Rajiv K.; Li, Yaozong; Errani, Francesco; Caflisch, Amedeo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 9516-9535

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Monomethyl maleate
C5H6O4
3052-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0
M  V30 3 O 0.7700 1.3337 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 5.3901 1.3337 0.0 0
M  V30 8 O 4.6201 0.0000 0.0 0
M  V30 9 O 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl hydrogen N-methylaspartate
C6H11NO4
98549-12-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3336 1.5400 0.0 0
M  V30 4 N 2.6674 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 O 6.6685 1.5400 0.0 0
M  V30 10 O 5.3347 3.8500 0.0 0
M  V30 11 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3052-50-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98549-12-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-5181244
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Method B: To the stirred solution of methyl maleate 7a (13 g, 0.1mol) in
dry pyridine (100ml), methylamine hydrochloride (13.5 g, 0.2mol) was
added, and the reaction mixture was warmed up to 100 °C. Triethylamine
(20.23 g, 27.3 ml, 0.2mol) was added dropwise to the suspension in 2 h.
When the addition was finished, the reaction mixture was stirred under
reflux for 1 additional hour. The solvent was evaporated in vacuo to
dryness. The residue was dissolved in minimal amount of pyridine (25ml)
and the solution was poured on ion exchange chromatographic column (80 g,
strongly acidic resin) and the product was eluted with pyridine water
(79:18) mixture (150ml). The eluent solution was evaporated in vacuo to
dryness. The product 8 was crystallized from methanol.
N-methyl-DL-aspartic acid β -methyl ester 8. White crystals, yield (24.4
g, 76%). mp 206-207 °C. mp 207-8 C (lit. 206 °C; Zilkha and Bachi, 1959).
1H-NMR (DMSO-d6, 600MHz): δ = 3.58 (3H, s, OCH3), 3.42 (1H, d-d, 3J1(H,H)
= 5.17 Hz, 3J2(H,H) = 6.84 Hz, C-H), 2.81 (1H, d-d, 3J1(H,H) = 5.17Hz,
2J3(H,H) = 16.91Hz, H-CH), 2.67 (1H, d-d, 3J2(H,H) = 6.84 Hz, 2J3(H,H) =
16.91Hz, HC-H), 2.47 (3H, s, NCH3) MW = 161.16 ESI-MS m/z: 161.2 [M+H]+
Anal. Calc. for C6H11NO4 C = 45.43% H = 6.06% N = 9.35% Found C = 44.93%
H = 6.35% N = 9.28%.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for syntheses of N-methyl-DL-aspartic acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boros, M.; Koekoesi, J.; Vamos, J.; Koevesdi, I.; Noszal, B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Amino Acids (2007), 33(4), 709-717

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[3H-indole-3,4′(1′H)-pyridin]-2′(3′H)-one, 5,5′-dichloro-2-methoxy-1′-me...
C14H12Cl2N2O2
3054153-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 1.1444 5.0494 0.0 0
M  V30 2 C 0.0000 6.0798 0.0 0
M  V30 3 Cl 6.5222 4.6200 0.0 0
M  V30 4 O 1.1875 1.5400 0.0 0
M  V30 5 Cl 9.1440 6.0293 0.0 0
M  V30 6 C 3.8549 0.0000 0.0 0
M  V30 7 C 3.8549 4.6200 0.0 0 CFG=1
M  V30 8 C 5.1008 5.5252 0.0 0
M  V30 9 C 2.6091 5.5252 0.0 0
M  V30 10 C 5.1886 3.8500 0.0 0
M  V30 11 C 2.5213 3.8500 0.0 0
M  V30 12 C 4.6250 6.9898 0.0 0
M  V30 13 C 6.6072 5.2051 0.0 0
M  V30 14 N 3.0849 6.9898 0.0 0
M  V30 15 C 5.1886 2.3100 0.0 0
M  V30 16 C 2.5213 2.3100 0.0 0
M  V30 17 C 5.6554 8.1343 0.0 0
M  V30 18 C 7.6377 6.3495 0.0 0
M  V30 19 N 3.8549 1.5400 0.0 0
M  V30 20 C 7.1618 7.8142 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 2 4 16
M  V30 5 1 5 18
M  V30 6 1 6 19
M  V30 7 1 7 8 CFG=3
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 2 9 14
M  V30 14 2 10 15
M  V30 15 1 11 16
M  V30 16 1 12 14
M  V30 17 2 12 17
M  V30 18 1 13 18
M  V30 19 1 15 19
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Spiro[3H-indole-3,4′(1′H)-pyridin]-2′(3′H)-one, 5,5′-dichloro-1′-methyl-2-(me...
C14H13Cl2N3O
3054153-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 1.1444 5.0494 0.0 0
M  V30 2 C 0.0000 6.0798 0.0 0
M  V30 3 Cl 6.5222 4.6200 0.0 0
M  V30 4 O 1.1875 1.5400 0.0 0
M  V30 5 Cl 9.1440 6.0293 0.0 0
M  V30 6 C 3.8549 0.0000 0.0 0
M  V30 7 C 3.8549 4.6200 0.0 0 CFG=1
M  V30 8 C 5.1008 5.5252 0.0 0
M  V30 9 C 2.6091 5.5252 0.0 0
M  V30 10 C 5.1886 3.8500 0.0 0
M  V30 11 C 2.5213 3.8500 0.0 0
M  V30 12 C 4.6250 6.9898 0.0 0
M  V30 13 C 6.6072 5.2051 0.0 0
M  V30 14 N 3.0849 6.9898 0.0 0
M  V30 15 C 5.1886 2.3100 0.0 0
M  V30 16 C 2.5213 2.3100 0.0 0
M  V30 17 C 5.6554 8.1343 0.0 0
M  V30 18 C 7.6377 6.3495 0.0 0
M  V30 19 N 3.8549 1.5400 0.0 0
M  V30 20 C 7.1618 7.8142 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 2 4 16
M  V30 5 1 5 18
M  V30 6 1 6 19
M  V30 7 1 7 8 CFG=3
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 2 9 14
M  V30 14 2 10 15
M  V30 15 1 11 16
M  V30 16 1 12 14
M  V30 17 2 12 17
M  V30 18 1 13 18
M  V30 19 1 15 19
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3054153-20-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3054153-21-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42872403
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 304-59-6
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Total Synthesis of (-)-Caulamidine A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Zhouyang; Maimone, Thomas J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2023), 145(26), 14215-14220

$RFMT $RIREG SCHEME242 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Chloromethyl)-3-methyl-1,4-naphthoquinone
C12H9ClO2
31599-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 C 6.6685 4.6200 0.0 0
M  V30 4 Cl 8.0021 3.8500 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1,4-Dihydro-3-methyl-1,4-dioxo-2-naphthalenyl)methyl N-methylcarbamodithioate
C14H13NO2S2
2113739-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 6.1601 0.0 0
M  V30 2 O 4.0012 0.0000 0.0 0
M  V30 3 C 6.6685 4.6201 0.0 0
M  V30 4 S 8.0022 3.8501 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 10.6697 3.8501 0.0 0
M  V30 7 S 9.3360 6.1601 0.0 0
M  V30 8 C 12.0033 4.6201 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 5.3348 3.8501 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 14
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 31599-79-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2113739-91-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-318-CAS-17727005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel naphthoquinone derivatives as inhibitors of the tumor
cell specific M2 isoform of pyruvate kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ning, Xianling; Qi, Hailong; Li, Ridong; Li, Yunqiao; Jin, Yan; McNutt,
Michael A.; Liu, Junyi; Yin, Yuxin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2017), 138343-352

$RFMT $RIREG SCHEME243 STEP1
$RXN



  3  1
$MOL
Triphosgene
C3Cl6O3
32315-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.5637 0.0 0
M  V30 2 C 6.6687 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 Cl 8.0023 2.1037 0.0 0
M  V30 5 Cl 5.8986 2.6673 0.0 0
M  V30 6 Cl 7.4387 0.0000 0.0 0
M  V30 7 O 2.6675 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 Cl 0.0000 2.1037 0.0 0
M  V30 11 Cl 2.1037 2.6673 0.0 0
M  V30 12 Cl 0.5637 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-[2-(trimethylsilyl)ethynyl]benzenamine
C11H14BrNSi
952116-25-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6673 0.0 0
M  V30 2 C 3.0800 2.6673 0.0 0
M  V30 3 Si 1.5400 2.6673 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 1.5400 1.1273 0.0 0
M  V30 6 C 1.5400 4.2073 0.0 0
M  V30 7 N 6.1600 0.0000 0.0 0
M  V30 8 Br 10.7800 2.6673 0.0 0
M  V30 9 C 6.1600 2.6673 0.0 0
M  V30 10 C 6.9300 1.3336 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 8.4700 1.3336 0.0 0
M  V30 13 C 8.4700 4.0011 0.0 0
M  V30 14 C 9.2400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 10
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-Bromo-2-[2-(trimethylsilyl)ethynyl]phenyl]-N′-methylurea
C13H17BrN2OSi
952116-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 3.8500 2.6674 0.0 0
M  V30 3 N 4.6200 1.3338 0.0 0
M  V30 4 O 2.3100 2.6674 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 6.1600 6.6685 0.0 0
M  V30 7 C 7.7000 6.6685 0.0 0
M  V30 8 Si 9.2400 6.6685 0.0 0
M  V30 9 C 10.7800 6.6685 0.0 0
M  V30 10 C 9.2400 5.1285 0.0 0
M  V30 11 C 9.2400 8.2085 0.0 0
M  V30 12 Br 0.0000 6.6685 0.0 0
M  V30 13 C 3.8500 5.3347 0.0 0
M  V30 14 C 4.6200 6.6685 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 3.8500 8.0021 0.0 0
M  V30 17 C 1.5400 6.6685 0.0 0
M  V30 18 C 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 3 6 7
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 32315-10-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 952116-25-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 952116-26-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-1848407
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-[5-Bromo-2-[2-(trimethylsilyl)ethynyl]phenyl]-3-methylurea (14).To a
solution of 13 (862 mg, 3.21 mmol) and Et3N (4.9 mL, 35 mmol) in CH2Cl2
(30 mL) was added triphosgene (1.00 g, 3.37 mmol) at 0 °C. After the
solution was stirred for 30 min at room temperature, MeNH2•HCl (1.10 g,
16.3 mmol) was added to the reaction mixture, which was then stirred for
1 h, quenched by addition of water, and extracted with CH2Cl2. The
extract was washed with water and brine, dried, and concentrated to
dryness. The residue was chromatographed with hexane-AcOEt (3:1) to
afford 14 (950 mg, 91%) as colorless needles: mp 175-176 °C
(hexane-AcOEt); IR 3456, 3393, 2149, 1697 cm-1; 1H NMR δ 8.45 (d, 1H, J =
2.0 Hz), 7.22 (d, 1H,J = 8.2 Hz), 7.08-7.05 (m, 2H), 4.80 (s, 1H), 2.91
(d, 3H, J = 4.9 Hz), 0.28 (s, 9H); 13C NMR δ 154.9, 141.4, 132.7, 124.9,
124.1, 121.2, 109.8, 102.8, 99.9, 27.3, -0.1; MS m/z 324 (M+, 41.1); HRMS
calcd for C13H17BrN2OSi 324.0294, found 324.0303.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Hexahydropyrrolo[2,3-b]indole Alkaloids Based on the
Aza-Pauson-Khand-Type Reaction of Alkynecarbodiimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aburano, Daisuke; Yoshida, Tatsunori; Miyakoshi, Naoki; Mukai, Chisato
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(18), 6878-6884

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
Isocyanoferrocene
C11H9FeN
32993-35-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0673 5.0777 0.0 0 CHG=1 VAL=4
M  V30 2 C 3.6047 5.0777 0.0 0 CHG=-1
M  V30 3 Fe 1.3042 2.8068 0.0 0 CHG=2 VAL=10
M  V30 4 C 2.6025 4.8098 0.0 0 CHG=-1 VAL=4
M  V30 5 C 1.7868 4.3375 0.0 0 VAL=5
M  V30 6 C 1.3042 5.6373 0.0 0 VAL=5
M  V30 7 C 0.0296 4.8098 0.0 0 VAL=5
M  V30 8 C 0.8438 4.3375 0.0 0 VAL=5
M  V30 9 C 0.0000 0.8290 0.0 0 CHG=-1 VAL=4
M  V30 10 C 2.5744 0.8290 0.0 0 VAL=5
M  V30 11 C 1.7572 1.3013 0.0 0 VAL=5
M  V30 12 C 0.8127 1.3013 0.0 0 VAL=5
M  V30 13 C 1.2761 0.0000 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 3 12
M  V30 12 1 3 13
M  V30 13 1 4 5
M  V30 14 1 4 6
M  V30 15 2 5 8
M  V30 16 2 6 7
M  V30 17 1 7 8
M  V30 18 1 9 12
M  V30 19 1 9 13
M  V30 20 1 10 11
M  V30 21 2 10 13
M  V30 22 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C12H14AuClFeN2
3031956-42-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.1063 5.1421 0.0 0
M  V30 2 C 3.5770 4.8708 0.0 0
M  V30 3 Au 4.0477 5.1421 0.0 0 VAL=3
M  V30 4 N 3.5770 4.3266 0.0 0
M  V30 5 Cl 4.6369 4.8033 0.0 0
M  V30 6 C 4.0942 4.0282 0.0 0
M  V30 7 Fe 1.3208 2.8424 0.0 0 CHG=2 VAL=10
M  V30 8 C 2.6355 4.8708 0.0 0 CHG=-1 VAL=4
M  V30 9 C 1.8095 4.3925 0.0 0 VAL=5
M  V30 10 C 1.3208 5.7088 0.0 0 VAL=5
M  V30 11 C 0.0300 4.8708 0.0 0 VAL=5
M  V30 12 C 0.8530 4.3925 0.0 0 VAL=5
M  V30 13 C 0.0000 0.8395 0.0 0 CHG=-1 VAL=4
M  V30 14 C 2.6070 0.8395 0.0 0 VAL=5
M  V30 15 C 1.7795 1.3178 0.0 0 VAL=5
M  V30 16 C 0.8230 1.3178 0.0 0 VAL=5
M  V30 17 C 1.2923 0.0000 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3 CFG=2
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 7 15
M  V30 15 1 7 16
M  V30 16 1 7 17
M  V30 17 1 8 9
M  V30 18 1 8 10
M  V30 19 2 9 12
M  V30 20 2 10 11
M  V30 21 1 11 12
M  V30 22 1 13 16
M  V30 23 1 13 17
M  V30 24 1 14 15
M  V30 25 2 14 17
M  V30 26 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 32993-35-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3031956-42-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40560816
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 29892-37-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM product depends upon the stoichiometry of the reactant and reaction
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of gold(I) diaminocarbene complexes by the addition of amines
across coordinated isocyanoferrocene
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vosahlo, Petr; Franc, Michal; Harmach, Petr; Schulz, Jiri; Stepnicka,
Petr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2023), 1000122874

$RFMT $RIREG SCHEME245 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, octacarbonyl[μ-[η:η6-ethoxy(2-methoxy-3-methylphenyl)methylene]]di-
C19H14Cr2O10
332847-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3325 0.7709 0.0 0
M  V30 2 O 6.1034 0.7709 0.0 0 VAL=3
M  V30 3 C 2.6652 0.7709 0.0 0
M  V30 4 O 1.8943 0.7709 0.0 0 VAL=3
M  V30 5 C 3.9989 0.0000 0.0 0
M  V30 6 O 4.7676 0.0000 0.0 0 VAL=3
M  V30 7 C 8.4564 7.7684 0.0 0 CHG=-2 VAL=4
M  V30 8 Cr 8.4564 9.3101 0.0 0 CHG=1 VAL=7
M  V30 9 O 9.1233 7.3840 0.0 0
M  V30 10 C 7.7089 10.6565 0.0 0
M  V30 11 C 9.2040 7.9616 0.0 0
M  V30 12 C 9.8028 10.0555 0.0 0
M  V30 13 C 8.4564 10.8498 0.0 0
M  V30 14 C 7.1100 8.5626 0.0 0
M  V30 15 C 9.1233 6.6131 0.0 0
M  V30 16 O 7.0421 11.0409 0.0 0 VAL=3
M  V30 17 O 9.8708 7.5772 0.0 0 VAL=3
M  V30 18 O 10.4697 9.6712 0.0 0 VAL=3
M  V30 19 O 7.7896 11.2342 0.0 0 VAL=3
M  V30 20 O 6.4411 8.9470 0.0 0 VAL=3
M  V30 21 C 9.7901 6.2287 0.0 0
M  V30 22 O 5.3283 9.5905 0.0 0
M  V30 23 C 5.9951 9.9748 0.0 0
M  V30 24 C 2.2596 9.5650 0.0 0
M  V30 25 Cr 3.9989 1.5418 0.0 0 CHG=1 VAL=9
M  V30 26 C 7.7896 7.3840 0.0 0 VAL=5
M  V30 27 C 5.3283 8.8196 0.0 0 VAL=5
M  V30 28 C 5.3283 5.9484 0.0 0 VAL=5
M  V30 29 C 2.4592 8.8196 0.0 0 VAL=5
M  V30 30 C 0.0000 7.3840 0.0 0 VAL=5
M  V30 31 C 2.4592 5.9484 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 25
M  V30 3 3 3 4
M  V30 4 1 3 25
M  V30 5 3 5 6
M  V30 6 1 5 25
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 9
M  V30 9 1 7 26
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 3 10 16
M  V30 17 3 11 17
M  V30 18 3 12 18
M  V30 19 3 13 19
M  V30 20 3 14 20
M  V30 21 1 15 21
M  V30 22 1 22 23
M  V30 23 1 22 27
M  V30 24 1 24 29
M  V30 25 1 25 26
M  V30 26 1 25 27
M  V30 27 1 25 28
M  V30 28 1 25 29
M  V30 29 1 25 30
M  V30 30 1 25 31
M  V30 31 1 26 27
M  V30 32 2 26 28
M  V30 33 2 27 29
M  V30 34 1 28 31
M  V30 35 1 29 30
M  V30 36 2 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, octacarbonyl[μ-[η:η6-(2-methoxy-3-methylphenyl)(methylamino)methyle...
C18H13Cr2NO9
332847-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3325 0.7709 0.0 0
M  V30 2 O 6.1034 0.7709 0.0 0 VAL=3
M  V30 3 C 2.6652 0.7709 0.0 0
M  V30 4 O 1.8943 0.7709 0.0 0 VAL=3
M  V30 5 C 3.9989 0.0000 0.0 0
M  V30 6 O 4.7676 0.0000 0.0 0 VAL=3
M  V30 7 C 8.4564 7.7684 0.0 0 CHG=-2 VAL=4
M  V30 8 Cr 8.4564 9.3101 0.0 0 CHG=1 VAL=7
M  V30 9 N 9.1233 7.3840 0.0 0
M  V30 10 C 7.7089 10.6565 0.0 0
M  V30 11 C 9.2040 7.9616 0.0 0
M  V30 12 C 9.8028 10.0555 0.0 0
M  V30 13 C 8.4564 10.8498 0.0 0
M  V30 14 C 7.1100 8.5626 0.0 0
M  V30 15 C 9.1233 6.6131 0.0 0
M  V30 16 O 7.0421 11.0409 0.0 0 VAL=3
M  V30 17 O 9.8708 7.5772 0.0 0 VAL=3
M  V30 18 O 10.4697 9.6712 0.0 0 VAL=3
M  V30 19 O 7.7896 11.2342 0.0 0 VAL=3
M  V30 20 O 6.4411 8.9470 0.0 0 VAL=3
M  V30 21 O 5.3283 9.5905 0.0 0
M  V30 22 C 5.9951 9.9748 0.0 0
M  V30 23 C 2.2596 9.5650 0.0 0
M  V30 24 Cr 3.9989 1.5418 0.0 0 CHG=1 VAL=9
M  V30 25 C 7.7896 7.3840 0.0 0 VAL=5
M  V30 26 C 5.3283 8.8196 0.0 0 VAL=5
M  V30 27 C 5.3283 5.9484 0.0 0 VAL=5
M  V30 28 C 2.4592 8.8196 0.0 0 VAL=5
M  V30 29 C 0.0000 7.3840 0.0 0 VAL=5
M  V30 30 C 2.4592 5.9484 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 24
M  V30 3 3 3 4
M  V30 4 1 3 24
M  V30 5 3 5 6
M  V30 6 1 5 24
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 9
M  V30 9 1 7 25
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 3 10 16
M  V30 17 3 11 17
M  V30 18 3 12 18
M  V30 19 3 13 19
M  V30 20 3 14 20
M  V30 21 1 21 22
M  V30 22 1 21 26
M  V30 23 1 23 28
M  V30 24 1 24 25
M  V30 25 1 24 26
M  V30 26 1 24 27
M  V30 27 1 24 28
M  V30 28 1 24 29
M  V30 29 1 24 30
M  V30 30 1 25 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 30
M  V30 34 1 28 29
M  V30 35 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 332847-67-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 332847-84-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-12801123
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solution and solid state conformation of Fischer carbene complexes
vis-a-vis conformation of aryl carboxamides: complexation of the aromatic
ring by tricarbonylchromium makes a difference
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jayaprakash, K. N.; Hazra, Debasis; Hagen, Karl S.; Samanta, Uttamkumar;
Bhadbhade, Mohan M.; Puranik, Vedavati G.; Sarkar, Amitabha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2001), 617-618709-722

$RFMT $RIREG SCHEME246 STEP1
$RXN



  3  1
$MOL
4-Formylbenzoic acid
C8H6O3
619-66-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxy-5,5-dimethyl-2-cyclohexen-1-one
C8H12O2
3471-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 C 1.5166 2.3101 0.0 0
M  V30 7 C 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,2,3,4,5,6,7,8,9,10-Decahydro-3,3,6,6,10-pentamethyl-1,8-dioxo-9-acridiny...
C25H29NO4
1233142-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.5178 8.8798 0.0 0
M  V30 2 O 8.1851 4.2597 0.0 0
M  V30 3 C 1.5166 3.4897 0.0 0
M  V30 4 C 0.0000 7.8425 0.0 0
M  V30 5 C 0.9899 9.5570 0.0 0
M  V30 6 C 6.5077 0.0000 0.0 0
M  V30 7 C 4.5279 0.0000 0.0 0
M  V30 8 C 10.8526 8.8798 0.0 0
M  V30 9 O 12.1863 8.1098 0.0 0
M  V30 10 O 10.8526 10.4199 0.0 0
M  V30 11 C 5.5178 5.7998 0.0 0
M  V30 12 C 4.1841 6.5698 0.0 0
M  V30 13 C 5.5178 4.2597 0.0 0
M  V30 14 C 2.8503 5.7998 0.0 0
M  V30 15 C 4.1841 8.1098 0.0 0
M  V30 16 C 4.1841 3.4897 0.0 0
M  V30 17 C 6.8515 3.4897 0.0 0
M  V30 18 N 2.8503 4.2597 0.0 0
M  V30 19 C 1.5166 6.5698 0.0 0
M  V30 20 C 2.8503 8.8798 0.0 0
M  V30 21 C 4.1841 1.9497 0.0 0
M  V30 22 C 6.8515 1.9497 0.0 0
M  V30 23 C 1.5166 8.1098 0.0 0
M  V30 24 C 5.5178 1.1797 0.0 0
M  V30 25 C 6.8515 6.5698 0.0 0
M  V30 26 C 6.8515 8.1098 0.0 0
M  V30 27 C 8.1851 5.7998 0.0 0
M  V30 28 C 8.1851 8.8798 0.0 0
M  V30 29 C 9.5189 6.5698 0.0 0
M  V30 30 C 9.5189 8.1098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 2 2 17
M  V30 3 1 3 18
M  V30 4 1 4 23
M  V30 5 1 5 23
M  V30 6 1 6 24
M  V30 7 1 7 24
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 30
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 25
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 1 16 18
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 1 19 23
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 1 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 619-66-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3471-13-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1233142-81-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25806348
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acridine-1, 8-diones - A new class of thermally stable NLOphores:
Photophysical, (hyper)polarizability and TD-DFT studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thorat, Kishor G.; Tayade, Rajratna P.; Sekar, Nagaiyan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Optical Materials (Amsterdam, Netherlands) (2016), 62306-319

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-2-carboxylic acid, 5-fluoro-, ethyl ester
C11H10FNO2
348-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6211 1.5400 0.0 0
M  V30 2 O 8.9547 2.3100 0.0 0
M  V30 3 O 7.6211 0.0000 0.0 0
M  V30 4 C 10.2885 1.5400 0.0 0
M  V30 5 C 11.6222 2.3100 0.0 0
M  V30 6 F 0.0000 4.1617 0.0 0
M  V30 7 C 3.8500 2.8281 0.0 0
M  V30 8 C 4.6201 4.1617 0.0 0
M  V30 9 C 4.8805 1.6835 0.0 0
M  V30 10 C 2.3100 2.8281 0.0 0
M  V30 11 N 6.1265 3.8416 0.0 0
M  V30 12 C 3.8500 5.4954 0.0 0
M  V30 13 C 6.2874 2.3100 0.0 0
M  V30 14 C 1.5400 4.1617 0.0 0
M  V30 15 C 2.3100 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-N-methyl-1H-indole-2-carboxamide
C10H9FN2O
518059-00-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6211 1.5400 0.0 0
M  V30 2 N 8.9549 2.3100 0.0 0
M  V30 3 O 7.6211 0.0000 0.0 0
M  V30 4 C 10.2886 1.5400 0.0 0
M  V30 5 F 0.0000 4.1618 0.0 0
M  V30 6 C 4.6201 4.1618 0.0 0
M  V30 7 C 3.8501 2.8281 0.0 0
M  V30 8 N 6.1265 3.8416 0.0 0
M  V30 9 C 3.8501 5.4954 0.0 0
M  V30 10 C 4.8806 1.6836 0.0 0
M  V30 11 C 2.3100 2.8281 0.0 0
M  V30 12 C 6.2875 2.3100 0.0 0
M  V30 13 C 2.3100 5.4954 0.0 0
M  V30 14 C 1.5400 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 348-36-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 518059-00-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22177344
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu(OAc)2-Promoted Oxidative Cross-Dehydrogenative Coupling Reaction of
α-Acylmethyl Malonates with Indole Derivatives to Access 3-Functionalized
Indoles and Polycyclic Indoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Li-Jin; Wang, Kun; Guan, Hong-Rong; Zheng, An-Qi; Yang, Hai-Tao;
Miao, Chun-Bao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2020), 85(12), 7925-7938

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Bis(trifluoromethyl)benzenesulfonyl chloride
C8H3ClF6O2S
351003-22-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.1629 1.4875 0.0 0 VAL=6
M  V30 2 Cl 2.7643 0.0000 0.0 0
M  V30 3 O 4.6504 1.0890 0.0 0
M  V30 4 O 1.6754 1.8861 0.0 0
M  V30 5 C 1.3957 4.9596 0.0 0
M  V30 6 F 0.0000 5.6105 0.0 0
M  V30 7 F 2.0465 6.3554 0.0 0
M  V30 8 F 0.7449 3.5639 0.0 0
M  V30 9 C 7.4115 4.3088 0.0 0
M  V30 10 F 7.4115 5.8489 0.0 0
M  V30 11 F 8.9515 4.3088 0.0 0
M  V30 12 F 7.4115 2.7688 0.0 0
M  V30 13 C 3.5615 2.9752 0.0 0
M  V30 14 C 2.7914 4.3088 0.0 0
M  V30 15 C 5.1015 2.9752 0.0 0
M  V30 16 C 3.5615 5.6425 0.0 0
M  V30 17 C 5.8715 4.3088 0.0 0
M  V30 18 C 5.1015 5.6425 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,5-bis(trifluoromethyl)benzenesulfonamide
C9H7F6NO2S
2831360-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.1629 2.5766 0.0 0 VAL=6
M  V30 2 N 2.7643 1.0891 0.0 0
M  V30 3 O 1.6754 2.9751 0.0 0
M  V30 4 O 4.6503 2.1780 0.0 0
M  V30 5 C 3.8532 0.0000 0.0 0
M  V30 6 C 1.3957 6.0485 0.0 0
M  V30 7 F 0.7449 4.6528 0.0 0
M  V30 8 F 2.0465 7.4444 0.0 0
M  V30 9 F 0.0000 6.6995 0.0 0
M  V30 10 C 7.4114 5.3977 0.0 0
M  V30 11 F 7.4114 3.8577 0.0 0
M  V30 12 F 8.9514 5.3977 0.0 0
M  V30 13 F 7.4114 6.9377 0.0 0
M  V30 14 C 3.5614 4.0641 0.0 0
M  V30 15 C 2.7914 5.3977 0.0 0
M  V30 16 C 5.1014 4.0641 0.0 0
M  V30 17 C 3.5614 6.7315 0.0 0
M  V30 18 C 5.8714 5.3977 0.0 0
M  V30 19 C 5.1014 6.7315 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 18
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 351003-22-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2831360-86-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34014910
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of α-Aryl Acrylamides via Lewis-Base-Mediated Aryl/Hydrogen
Exchange
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lemmerer, Miran; Zhang, Haoqi; Fernandes, Anthony J.; Fischer, Tobias;
Miesskes, Marianne; Xiao, Yi; Maulide, Nuno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2022), 61(40), e202207475

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile
C11H11NO2
35202-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2111 4.3725 0.0 0
M  V30 2 N 9.6986 3.9740 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 O 2.3100 1.3338 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 4.6200 5.3349 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 5.9536 6.1049 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 6.7236 4.7711 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-methylbicyclo[4.2.0]octa-1,3,5-triene-7-methanamine
C12H17NO2
148870-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2113 4.3725 0.0 0
M  V30 2 N 9.3002 5.4615 0.0 0
M  V30 3 C 10.7877 5.0629 0.0 0
M  V30 4 O 2.3100 1.3338 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 4.6200 5.3349 0.0 0
M  V30 10 C 6.7236 4.7711 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 5.9536 6.1049 0.0 0
M  V30 13 C 3.0800 5.3349 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35202-54-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 148870-56-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26549694
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM supported on carbon
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved process for the synthesis of ivabradine and its
pharmaceutically acceptable salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nandepu, Venkateswara Rao; Boppana, Durga Prasad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019202611 A1 2019-10-24

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile
C11H11NO2
35202-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2111 4.3725 0.0 0
M  V30 2 N 9.6986 3.9740 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 O 2.3100 1.3338 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 4.6200 5.3349 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 5.9536 6.1049 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 6.7236 4.7711 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-methylbicyclo[4.2.0]octa-1,3,5-triene-7-methanamine
C12H17NO2
148870-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2113 4.3725 0.0 0
M  V30 2 N 9.3002 5.4615 0.0 0
M  V30 3 C 10.7877 5.0629 0.0 0
M  V30 4 O 2.3100 1.3338 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 4.6200 5.3349 0.0 0
M  V30 10 C 6.7236 4.7711 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 5.9536 6.1049 0.0 0
M  V30 13 C 3.0800 5.3349 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35202-54-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 148870-56-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29120593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM supported on carbon
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved process for the synthesis of ivabradine and its
pharmaceutically acceptable salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nandepu, Venkateswara Rao; Boppana, Durga Prasad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN201841015175 A 2019-10-25

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [6-(chlorosulfonyl)-1,2-dihydro-2-oxo-7-(trifluoromethyl)-3-...
C14H14ClF3NO6PS
355408-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 9.7214 5.6424 0.0 0 VAL=5
M  V30 2 O 11.2614 5.6424 0.0 0
M  V30 3 O 9.7214 4.1024 0.0 0
M  V30 4 O 9.7214 7.1824 0.0 0
M  V30 5 C 12.0314 6.9762 0.0 0
M  V30 6 C 11.0551 3.3324 0.0 0
M  V30 7 C 13.5714 6.9762 0.0 0
M  V30 8 C 11.0551 1.7924 0.0 0
M  V30 9 O 8.1814 8.3099 0.0 0
M  V30 10 S 3.1629 1.4875 0.0 0 VAL=6
M  V30 11 Cl 2.7643 0.0000 0.0 0
M  V30 12 O 1.6754 1.8862 0.0 0
M  V30 13 O 4.6503 1.0889 0.0 0
M  V30 14 C 1.3957 4.9596 0.0 0
M  V30 15 F 0.7449 3.5639 0.0 0
M  V30 16 F 2.0465 6.3553 0.0 0
M  V30 17 F 0.0000 5.6104 0.0 0
M  V30 18 C 8.1814 5.6424 0.0 0
M  V30 19 C 7.4114 4.3088 0.0 0
M  V30 20 C 7.4114 6.9762 0.0 0
M  V30 21 C 5.8714 4.3088 0.0 0
M  V30 22 N 5.8714 6.9762 0.0 0
M  V30 23 C 5.1014 5.6424 0.0 0
M  V30 24 C 5.1014 2.9751 0.0 0
M  V30 25 C 3.5614 5.6424 0.0 0
M  V30 26 C 3.5614 2.9751 0.0 0
M  V30 27 C 2.7914 4.3088 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 1 18
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 9 20
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 10 13
M  V30 13 1 10 26
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 27
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 21 24
M  V30 24 1 22 23
M  V30 25 2 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [1,2-dihydro-6-[(methylamino)sulfonyl]-2-oxo-7-(trifluoromet...
C11H10F3N2O6PS
355824-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.1629 2.5765 0.0 0 VAL=6
M  V30 2 N 2.7643 1.0890 0.0 0
M  V30 3 O 4.6504 2.1779 0.0 0
M  V30 4 O 1.6754 2.9750 0.0 0
M  V30 5 C 3.8533 0.0000 0.0 0
M  V30 6 C 1.3957 6.0486 0.0 0
M  V30 7 F 2.0465 7.4443 0.0 0
M  V30 8 F 0.0000 6.6994 0.0 0
M  V30 9 F 0.7449 4.6529 0.0 0
M  V30 10 P 9.7215 6.7314 0.0 0 VAL=5
M  V30 11 O 11.2616 6.7314 0.0 0
M  V30 12 O 9.7215 5.1914 0.0 0
M  V30 13 O 9.7215 8.2715 0.0 0
M  V30 14 O 8.1815 9.3988 0.0 0
M  V30 15 C 3.5615 4.0640 0.0 0
M  V30 16 C 2.7914 5.3978 0.0 0
M  V30 17 C 5.1015 4.0640 0.0 0
M  V30 18 C 3.5615 6.7314 0.0 0
M  V30 19 C 5.8715 5.3978 0.0 0
M  V30 20 C 5.1015 6.7314 0.0 0
M  V30 21 C 7.4115 5.3978 0.0 0
M  V30 22 N 5.8715 8.0651 0.0 0
M  V30 23 C 8.1815 6.7314 0.0 0
M  V30 24 C 7.4115 8.0651 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 15
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 16
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 23
M  V30 14 2 14 24
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 355408-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 355824-53-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-11207387
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2857-97-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel quinolinone-phosphonic acid AMPA antagonists devoid of
nephrotoxicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cordi, Alex A.; Desos, Patrice; Ruano, Elisabeth; Al-Badri, Hashim;
Fugier, Claude; Chapman, Astrid G.; Meldrum, Brian S.; Thomas, Jean-Yves;
Roger, Anita; Lestage, Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Farmaco (2002), 57(10), 787-802

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[[4-[(2-methyl-4-quinolinyl)methoxy]benzoyl]amino]-4-oxocyclohexanea...
C27H28N2O5
362706-34-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.4203 5.1113 0.0 0
M  V30 2 C 6.7540 4.3413 0.0 0
M  V30 3 O 6.7540 2.8013 0.0 0
M  V30 4 C 3.5600 5.7884 0.0 0
M  V30 5 C 2.0434 6.0559 0.0 0
M  V30 6 O 1.5166 7.5030 0.0 0
M  V30 7 O 1.0535 4.8761 0.0 0
M  V30 8 C 0.0000 7.7704 0.0 0
M  V30 9 O 2.5065 0.0000 0.0 0
M  V30 10 O 12.0887 7.4213 0.0 0
M  V30 11 C 13.4225 6.6513 0.0 0
M  V30 12 C 16.0898 11.2713 0.0 0
M  V30 13 C 4.0867 4.3413 0.0 0
M  V30 14 C 2.5701 4.0739 0.0 0
M  V30 15 C 5.0766 3.1616 0.0 0
M  V30 16 C 2.0434 2.6268 0.0 0
M  V30 17 C 4.5499 1.7145 0.0 0
M  V30 18 C 3.0332 1.4471 0.0 0
M  V30 19 C 8.0878 5.1113 0.0 0
M  V30 20 C 9.4214 4.3413 0.0 0
M  V30 21 C 8.0878 6.6513 0.0 0
M  V30 22 C 10.7551 5.1113 0.0 0
M  V30 23 C 9.4214 7.4213 0.0 0
M  V30 24 C 10.7551 6.6513 0.0 0
M  V30 25 C 14.7561 7.4213 0.0 0
M  V30 26 C 16.0898 6.6513 0.0 0
M  V30 27 C 14.7561 8.9613 0.0 0
M  V30 28 C 17.4234 7.4213 0.0 0
M  V30 29 C 16.0898 5.1113 0.0 0
M  V30 30 C 16.0898 9.7313 0.0 0
M  V30 31 N 17.4234 8.9613 0.0 0
M  V30 32 C 18.7572 6.6513 0.0 0
M  V30 33 C 17.4234 4.3413 0.0 0
M  V30 34 C 18.7572 5.1113 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 19
M  V30 5 1 4 5
M  V30 6 1 4 13
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 2 9 18
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 11 25
M  V30 14 1 12 30
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 26 29
M  V30 31 1 27 30
M  V30 32 1 28 31
M  V30 33 1 28 32
M  V30 34 2 29 33
M  V30 35 2 30 31
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(methylamino)-1-[[4-[(2-methyl-4-quinolinyl)methoxy]benzoyl]amino]cy...
C28H33N3O4
362706-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.3200 5.0130 0.0 0
M  V30 2 C 11.5500 6.3468 0.0 0
M  V30 3 O 12.3200 7.6804 0.0 0
M  V30 4 C 13.5925 3.4964 0.0 0
M  V30 5 C 14.7723 2.5065 0.0 0
M  V30 6 O 14.5048 0.9899 0.0 0
M  V30 7 O 16.2194 3.0333 0.0 0
M  V30 8 C 15.6846 0.0000 0.0 0
M  V30 9 N 17.3991 7.9827 0.0 0
M  V30 10 C 18.8462 7.4561 0.0 0
M  V30 11 O 5.3900 6.3468 0.0 0
M  V30 12 C 4.6200 7.6804 0.0 0
M  V30 13 C 0.0000 5.0130 0.0 0
M  V30 14 C 13.8600 5.0130 0.0 0
M  V30 15 C 13.5925 6.5296 0.0 0
M  V30 16 C 15.3071 4.4863 0.0 0
M  V30 17 C 14.7723 7.5195 0.0 0
M  V30 18 C 16.4868 5.4762 0.0 0
M  V30 19 C 16.2194 6.9928 0.0 0
M  V30 20 C 10.0100 6.3468 0.0 0
M  V30 21 C 9.2400 7.6804 0.0 0
M  V30 22 C 9.2400 5.0130 0.0 0
M  V30 23 C 7.7000 7.6804 0.0 0
M  V30 24 C 7.7000 5.0130 0.0 0
M  V30 25 C 6.9300 6.3468 0.0 0
M  V30 26 C 3.0800 7.6804 0.0 0
M  V30 27 C 2.3100 9.0141 0.0 0
M  V30 28 C 2.3100 6.3468 0.0 0
M  V30 29 C 0.7700 9.0141 0.0 0
M  V30 30 C 3.0800 10.3477 0.0 0
M  V30 31 C 0.7700 6.3468 0.0 0
M  V30 32 N 0.0000 7.6804 0.0 0
M  V30 33 C 0.0000 10.3477 0.0 0
M  V30 34 C 2.3100 11.6815 0.0 0
M  V30 35 C 0.7700 11.6815 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 19
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 12 26
M  V30 15 1 13 31
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 27 30
M  V30 32 1 28 31
M  V30 33 1 29 32
M  V30 34 1 29 33
M  V30 35 2 30 34
M  V30 36 2 31 32
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 362706-34-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 362706-37-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-18817085
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as 3:1 mixture of diastereomers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of β-amino acid derivatives as inhibitors of matrix
metalloproteases and TNF-α
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Duan, Jingwu; King, Bryan W.; Decicco, Carl; Maduskuie, Thomas P.; Voss,
Mathew E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040072802 A1 2004-04-15

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[[4-[(2-methyl-4-quinolinyl)methoxy]benzoyl]amino]-4-oxocyclohexanea...
C27H28N2O5
362706-34-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.4203 5.1113 0.0 0
M  V30 2 C 6.7540 4.3413 0.0 0
M  V30 3 O 6.7540 2.8013 0.0 0
M  V30 4 C 3.5600 5.7884 0.0 0
M  V30 5 C 2.0434 6.0559 0.0 0
M  V30 6 O 1.5166 7.5030 0.0 0
M  V30 7 O 1.0535 4.8761 0.0 0
M  V30 8 C 0.0000 7.7704 0.0 0
M  V30 9 O 2.5065 0.0000 0.0 0
M  V30 10 O 12.0887 7.4213 0.0 0
M  V30 11 C 13.4225 6.6513 0.0 0
M  V30 12 C 16.0898 11.2713 0.0 0
M  V30 13 C 4.0867 4.3413 0.0 0
M  V30 14 C 2.5701 4.0739 0.0 0
M  V30 15 C 5.0766 3.1616 0.0 0
M  V30 16 C 2.0434 2.6268 0.0 0
M  V30 17 C 4.5499 1.7145 0.0 0
M  V30 18 C 3.0332 1.4471 0.0 0
M  V30 19 C 8.0878 5.1113 0.0 0
M  V30 20 C 9.4214 4.3413 0.0 0
M  V30 21 C 8.0878 6.6513 0.0 0
M  V30 22 C 10.7551 5.1113 0.0 0
M  V30 23 C 9.4214 7.4213 0.0 0
M  V30 24 C 10.7551 6.6513 0.0 0
M  V30 25 C 14.7561 7.4213 0.0 0
M  V30 26 C 16.0898 6.6513 0.0 0
M  V30 27 C 14.7561 8.9613 0.0 0
M  V30 28 C 17.4234 7.4213 0.0 0
M  V30 29 C 16.0898 5.1113 0.0 0
M  V30 30 C 16.0898 9.7313 0.0 0
M  V30 31 N 17.4234 8.9613 0.0 0
M  V30 32 C 18.7572 6.6513 0.0 0
M  V30 33 C 17.4234 4.3413 0.0 0
M  V30 34 C 18.7572 5.1113 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 19
M  V30 5 1 4 5
M  V30 6 1 4 13
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 2 9 18
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 11 25
M  V30 14 1 12 30
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 26 29
M  V30 31 1 27 30
M  V30 32 1 28 31
M  V30 33 1 28 32
M  V30 34 2 29 33
M  V30 35 2 30 31
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(methylamino)-1-[[4-[(2-methyl-4-quinolinyl)methoxy]benzoyl]amino]cy...
C28H33N3O4
362706-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.3200 5.0130 0.0 0
M  V30 2 C 11.5500 6.3468 0.0 0
M  V30 3 O 12.3200 7.6804 0.0 0
M  V30 4 C 13.5925 3.4964 0.0 0
M  V30 5 C 14.7723 2.5065 0.0 0
M  V30 6 O 14.5048 0.9899 0.0 0
M  V30 7 O 16.2194 3.0333 0.0 0
M  V30 8 C 15.6846 0.0000 0.0 0
M  V30 9 N 17.3991 7.9827 0.0 0
M  V30 10 C 18.8462 7.4561 0.0 0
M  V30 11 O 5.3900 6.3468 0.0 0
M  V30 12 C 4.6200 7.6804 0.0 0
M  V30 13 C 0.0000 5.0130 0.0 0
M  V30 14 C 13.8600 5.0130 0.0 0
M  V30 15 C 13.5925 6.5296 0.0 0
M  V30 16 C 15.3071 4.4863 0.0 0
M  V30 17 C 14.7723 7.5195 0.0 0
M  V30 18 C 16.4868 5.4762 0.0 0
M  V30 19 C 16.2194 6.9928 0.0 0
M  V30 20 C 10.0100 6.3468 0.0 0
M  V30 21 C 9.2400 7.6804 0.0 0
M  V30 22 C 9.2400 5.0130 0.0 0
M  V30 23 C 7.7000 7.6804 0.0 0
M  V30 24 C 7.7000 5.0130 0.0 0
M  V30 25 C 6.9300 6.3468 0.0 0
M  V30 26 C 3.0800 7.6804 0.0 0
M  V30 27 C 2.3100 9.0141 0.0 0
M  V30 28 C 2.3100 6.3468 0.0 0
M  V30 29 C 0.7700 9.0141 0.0 0
M  V30 30 C 3.0800 10.3477 0.0 0
M  V30 31 C 0.7700 6.3468 0.0 0
M  V30 32 N 0.0000 7.6804 0.0 0
M  V30 33 C 0.0000 10.3477 0.0 0
M  V30 34 C 2.3100 11.6815 0.0 0
M  V30 35 C 0.7700 11.6815 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 19
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 12 26
M  V30 15 1 13 31
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 27 30
M  V30 32 1 28 31
M  V30 33 1 29 32
M  V30 34 1 29 33
M  V30 35 2 30 34
M  V30 36 2 31 32
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 362706-34-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 362706-37-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11184782
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (706a,707a) Sodium triacetoxyborohydride (162mg, 0.76 mmol) was added in
one portion to 703a (0.22g, 0.48 mmol), methylamine (2M in THE, 0.25 mL),
and acetic acid (86mg, 1.43 mmol) in anhydrous tetrahydrofuran (4 mL) at
ambient temperature under nitrogen. After stirring overnight the reaction
was quenched by the careful addition of saturated sodium bicarbonate (10
mL), and then was extracted with ethyl acetate (3X). The combined organic
layers were washed with brine (1X) then dried over magnesium sulfate. The
solvent was removed in vacua to provide 706a,707a as a 3:1 mixture of
diastereomers, that were taken forward without further purification.
Yield (206mg, 91%). MS: ESI [M+H]+=476.
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as 3:1 mixture of diastereomers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of β-amino acid derivatives as inhibitors of matrix
metalloproteases and TNF-α
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Duan, Jingwu; King, Bryan W.; Decicco, Carl; Maduskuie, Thomas P., Jr.;
Voss, Matthew E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001070734 A2 2001-09-27

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
4,5-Dihydro-8-(propylthio)-1-(2,2,2-trifluoroethyl)-1H-thieno[3,4-g]indazole-...
C15H15F3N2O2S2
364759-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.9258 3.9683 0.0 0
M  V30 2 C 5.7649 2.4367 0.0 0
M  V30 3 C 7.0107 1.5315 0.0 0
M  V30 4 C 6.8498 0.0000 0.0 0
M  V30 5 C 8.1260 5.9492 0.0 0
M  V30 6 C 9.6660 5.9492 0.0 0
M  V30 7 F 9.6660 4.4092 0.0 0
M  V30 8 F 11.2060 5.9492 0.0 0
M  V30 9 F 9.6660 7.4892 0.0 0
M  V30 10 C 0.7700 5.6435 0.0 0
M  V30 11 O 0.0000 6.9771 0.0 0
M  V30 12 O 0.0000 4.3097 0.0 0
M  V30 13 C 4.6799 6.4135 0.0 0
M  V30 14 C 5.8243 7.4439 0.0 0
M  V30 15 C 3.2152 6.8894 0.0 0
M  V30 16 C 4.6799 4.8735 0.0 0
M  V30 17 N 7.3560 7.2830 0.0 0
M  V30 18 C 5.5041 8.9502 0.0 0
M  V30 19 C 2.3100 5.6435 0.0 0
M  V30 20 C 2.8951 8.3956 0.0 0
M  V30 21 S 3.2152 4.3976 0.0 0
M  V30 22 N 7.9823 8.6898 0.0 0
M  V30 23 C 4.0396 9.4262 0.0 0
M  V30 24 C 6.8378 9.7202 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 19
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 15 20
M  V30 20 1 16 21
M  V30 21 1 17 22
M  V30 22 1 18 23
M  V30 23 1 18 24
M  V30 24 1 19 21
M  V30 25 1 20 23
M  V30 26 2 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dihydro-N-methyl-8-(propylthio)-1-(2,2,2-trifluoroethyl)-1H-thieno[3,4-g]...
C16H18F3N3OS2
364759-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.2802 3.9683 0.0 0
M  V30 2 C 5.4411 2.4367 0.0 0
M  V30 3 C 4.1953 1.5315 0.0 0
M  V30 4 C 4.3562 0.0000 0.0 0
M  V30 5 C 3.0800 5.9492 0.0 0
M  V30 6 C 1.5400 5.9492 0.0 0
M  V30 7 F 1.5400 7.4892 0.0 0
M  V30 8 F 0.0000 5.9492 0.0 0
M  V30 9 F 1.5400 4.4092 0.0 0
M  V30 10 C 10.4360 5.6435 0.0 0
M  V30 11 N 11.2060 4.3097 0.0 0
M  V30 12 O 11.2060 6.9771 0.0 0
M  V30 13 C 12.7460 4.3097 0.0 0
M  V30 14 C 6.5261 6.4135 0.0 0
M  V30 15 C 5.3817 7.4439 0.0 0
M  V30 16 C 7.9908 6.8893 0.0 0
M  V30 17 C 6.5261 4.8735 0.0 0
M  V30 18 N 3.8500 7.2830 0.0 0
M  V30 19 C 5.7018 8.9502 0.0 0
M  V30 20 C 8.8960 5.6435 0.0 0
M  V30 21 C 8.3109 8.3956 0.0 0
M  V30 22 S 7.9908 4.3976 0.0 0
M  V30 23 N 3.2237 8.6898 0.0 0
M  V30 24 C 7.1664 9.4262 0.0 0
M  V30 25 C 4.3682 9.7202 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 20
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 16 21
M  V30 21 1 17 22
M  V30 22 1 18 23
M  V30 23 1 19 24
M  V30 24 1 19 25
M  V30 25 1 20 22
M  V30 26 1 21 24
M  V30 27 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 364759-61-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 364759-67-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14201264
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
4,5-Dihydro-6-inorpholinocarbony8-(phenylamino)
thieno[3,4-g]-1,2-benzisoxazole: To a solution of
4,5-dihyciro-8-(phenylamino)thieno[3,4-g]-1,2-benzisoxazole-6-carboxylic
acid (0.20 g) in anhydrous THF (10 ml) were added oxalyl chloride (84 ml)
and DMF (1 drop) under ice-cooling and the resulting solution was stirred
at room temperature for 2 hours. The reaction solution was cooled and
morpholine (0.20 ml) was added. After stirring under ice cooling for 1
hour, the reaction solution was poured into an aqueous solution of citric
acid and extracted with ethyl acetate. The extract was washed with water
and an aqueous, saturated solution of sodium chloride and then dried
(MgSO4) . The solvent was evaporated under reduced pressure and the thus
obtained, yellow prisms were washed with ethyl acetate-hexane to obtain
the title compound. N-Methy4 , 5-dihydro-8-n-propylsulfanyl- (2,2,2-
trifluoroethyl) -1H-thieno [3, 4-g] indazole-6-carboxamide : According to
the same manner as that in Example 33, the title compound (yield: 91%)
was obtained as light yellow needles from the compound obtained in
Example 101. Melting point: 75-76°C (recrystallization solvent: i-Pr2O-
hexane) .
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienobenzisoxazoles and thienoindazoles for prevention
and treatment of bone or articular diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yasuma, Tsuneo; Mori, Akira; Kawase, Masahiro; Takizawa, Masayuki; Miki,
Shokyo; Takeda, Mitsuhiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001074823 A2 2001-10-11

$RFMT $RIREG SCHEME253 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-3-carboxaldehyde
C9H7NO
487-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1884 0.0 0
M  V30 2 O 7.1954 2.7125 0.0 0
M  V30 3 C 3.0800 2.4782 0.0 0
M  V30 4 C 2.3100 1.1444 0.0 0
M  V30 5 C 4.5864 2.1580 0.0 0
M  V30 6 C 2.3100 3.8118 0.0 0
M  V30 7 N 3.3405 0.0000 0.0 0
M  V30 8 C 0.7700 1.1444 0.0 0
M  V30 9 C 4.7473 0.6263 0.0 0
M  V30 10 C 0.7700 3.8118 0.0 0
M  V30 11 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tosylmethyl isocyanide
C9H9NO2S
36635-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 1.3337 0.0 0 VAL=6
M  V30 2 C 6.6685 0.5637 0.0 0
M  V30 3 O 4.5648 0.0000 0.0 0
M  V30 4 O 6.1048 2.6673 0.0 0
M  V30 5 N 8.0023 1.3337 0.0 0 CHG=1 VAL=4
M  V30 6 C 9.3360 2.1037 0.0 0 CHG=-1
M  V30 7 C 0.0000 4.4137 0.0 0
M  V30 8 C 4.0012 2.1037 0.0 0
M  V30 9 C 2.6675 1.3337 0.0 0
M  V30 10 C 4.0012 3.6437 0.0 0
M  V30 11 C 1.3337 2.1037 0.0 0
M  V30 12 C 2.6675 4.4137 0.0 0
M  V30 13 C 1.3337 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 3 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1-Methyl-1H-imidazol-5-yl)-1H-indole
C12H11N3
908139-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.1435 3.8850 0.0 0
M  V30 2 C 3.4209 3.1885 0.0 0
M  V30 3 C 4.9271 2.8683 0.0 0
M  V30 4 C 3.2598 4.7200 0.0 0
M  V30 5 C 5.6972 4.2020 0.0 0
M  V30 6 C 5.6972 1.5345 0.0 0
M  V30 7 N 4.6667 5.3463 0.0 0
M  V30 8 C 7.2372 4.2020 0.0 0
M  V30 9 C 7.2372 1.5345 0.0 0
M  V30 10 C 8.0072 2.8683 0.0 0
M  V30 11 C 2.2763 2.1579 0.0 0
M  V30 12 N 0.7700 2.4780 0.0 0
M  V30 13 C 2.4374 0.6263 0.0 0
M  V30 14 C 0.0000 1.1444 0.0 0
M  V30 15 N 1.0304 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 487-89-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 36635-61-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 908139-76-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-20038665
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazolylindole derivatives for use as 5-HT7 serotonin
receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hogendorf, Adam; Hogendorf, Agata; Satala, Grzegorz; Kurczab, Rafal;
Bugno, Ryszard; Staron, Jakub; Lenda, Tomasz; Bojarski, Andrzej J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3272745 A1 2018-01-24

$RFMT $RIREG SCHEME253 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-3-carboxaldehyde
C9H7NO
487-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1884 0.0 0
M  V30 2 O 7.1954 2.7125 0.0 0
M  V30 3 C 3.0800 2.4782 0.0 0
M  V30 4 C 2.3100 1.1444 0.0 0
M  V30 5 C 4.5864 2.1580 0.0 0
M  V30 6 C 2.3100 3.8118 0.0 0
M  V30 7 N 3.3405 0.0000 0.0 0
M  V30 8 C 0.7700 1.1444 0.0 0
M  V30 9 C 4.7473 0.6263 0.0 0
M  V30 10 C 0.7700 3.8118 0.0 0
M  V30 11 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tosylmethyl isocyanide
C9H9NO2S
36635-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 1.3337 0.0 0 VAL=6
M  V30 2 C 6.6685 0.5637 0.0 0
M  V30 3 O 4.5648 0.0000 0.0 0
M  V30 4 O 6.1048 2.6673 0.0 0
M  V30 5 N 8.0023 1.3337 0.0 0 CHG=1 VAL=4
M  V30 6 C 9.3360 2.1037 0.0 0 CHG=-1
M  V30 7 C 0.0000 4.4137 0.0 0
M  V30 8 C 4.0012 2.1037 0.0 0
M  V30 9 C 2.6675 1.3337 0.0 0
M  V30 10 C 4.0012 3.6437 0.0 0
M  V30 11 C 1.3337 2.1037 0.0 0
M  V30 12 C 2.6675 4.4137 0.0 0
M  V30 13 C 1.3337 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 3 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1-Methyl-1H-imidazol-5-yl)-1H-indole
C12H11N3
908139-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.1435 3.8850 0.0 0
M  V30 2 C 3.4209 3.1885 0.0 0
M  V30 3 C 4.9271 2.8683 0.0 0
M  V30 4 C 3.2598 4.7200 0.0 0
M  V30 5 C 5.6972 4.2020 0.0 0
M  V30 6 C 5.6972 1.5345 0.0 0
M  V30 7 N 4.6667 5.3463 0.0 0
M  V30 8 C 7.2372 4.2020 0.0 0
M  V30 9 C 7.2372 1.5345 0.0 0
M  V30 10 C 8.0072 2.8683 0.0 0
M  V30 11 C 2.2763 2.1579 0.0 0
M  V30 12 N 0.7700 2.4780 0.0 0
M  V30 13 C 2.4374 0.6263 0.0 0
M  V30 14 C 0.0000 1.1444 0.0 0
M  V30 15 N 1.0304 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 487-89-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 36635-61-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 908139-76-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-18624254
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazolylindole derivatives for use as 5-HT7 serotonin
receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hogendorf, Adam; Hogendorf, Agata; Satala, Grzegorz; Kurczab, Rafal;
Bugno, Ryszard; Staron, Jakub; Lenda, Tomasz; Bojarski, Andrzej J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018015558 A1 2018-01-25

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dibromopyrimidine
C4H2Br2N2
36847-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.0800 0.0 0
M  V30 2 Br 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 1.3338 0.7700 0.0 0
M  V30 7 N 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-4-pyrimidinamine
C5H6BrN3
1209458-21-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 N 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 N 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36847-10-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1209458-21-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42202611
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of a Novel 6H-Benzo[c]chromen Series as Selective PI3Kα
Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shi, Xue; Feng, Heng; Tian, Haigang; Ma, Haibiao; Pang, Xiaomeng; Mao,
Chenhan; Xiang, Peng; Xu, Zhengze; Han, Weidong; Yan, Yuxiang; Chen, Wei;
Nan, Yuqing; Nan, Guanjun; Hu, Zhenyue; Hui, Lingyun; Li, Chenglong; Li,
Yiping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(17), 15387-15410

$RFMT $RIREG SCHEME255 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-5-nitrobenzenamine
C6H5FN2O2
369-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoyl isothiocyanate
C8H5NOS
532-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 S 8.4702 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.7700 2.6673 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 2 4
M  V30 5 2 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Methyl-5-nitro-1H-benzimidazol-2-yl)benzamide
C15H12N4O3
496838-03-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3594 0.0000 0.0 0
M  V30 2 N 5.3900 2.7104 0.0 0
M  V30 3 C 4.6200 4.0442 0.0 0
M  V30 4 O 5.3900 5.3778 0.0 0
M  V30 5 N 13.3008 4.2504 0.0 0 VAL=5
M  V30 6 O 14.6346 3.4804 0.0 0
M  V30 7 O 13.3008 5.7904 0.0 0
M  V30 8 C 9.2999 3.4804 0.0 0
M  V30 9 C 9.2999 1.9404 0.0 0
M  V30 10 N 7.8352 3.9564 0.0 0
M  V30 11 C 10.6335 4.2504 0.0 0
M  V30 12 N 7.8352 1.4645 0.0 0
M  V30 13 C 10.6335 1.1704 0.0 0
M  V30 14 C 6.9300 2.7104 0.0 0
M  V30 15 C 11.9672 3.4804 0.0 0
M  V30 16 C 11.9672 1.9404 0.0 0
M  V30 17 C 3.0800 4.0442 0.0 0
M  V30 18 C 2.3100 5.3778 0.0 0
M  V30 19 C 2.3100 2.7104 0.0 0
M  V30 20 C 0.7700 5.3778 0.0 0
M  V30 21 C 0.7700 2.7104 0.0 0
M  V30 22 C 0.0000 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 2 3 4
M  V30 5 1 3 17
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 369-36-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 532-55-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 496838-03-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9618958
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-02-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Raney nickel used in stage 2, Trisamine resin used in stage 4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient solution phase synthesis of 2-(N-acylamino)benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seth, Punit P.; Robinson, Dale E.; Jefferson, Elizabeth A.; Swayze, Eric
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(41), 7303-7306

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Iodo-1-methyl-1H-indole-2-carboxaldehyde
C10H8INO
372954-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 5.7308 4.6948 0.0 0
M  V30 2 C 3.0204 0.0000 0.0 0
M  V30 3 C 6.0810 1.3627 0.0 0
M  V30 4 O 7.4147 2.1327 0.0 0
M  V30 5 C 3.0800 3.9844 0.0 0
M  V30 6 C 2.3100 2.6508 0.0 0
M  V30 7 C 4.5864 3.6643 0.0 0
M  V30 8 C 2.3100 5.3182 0.0 0
M  V30 9 N 3.3405 1.5064 0.0 0
M  V30 10 C 0.7700 2.6508 0.0 0
M  V30 11 C 4.7473 2.1327 0.0 0
M  V30 12 C 0.7700 5.3182 0.0 0
M  V30 13 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 2 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Iodo-N,1-dimethyl-1H-indole-2-methanamine
C11H13IN2
1313739-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.6078 0.0000 0.0 0
M  V30 2 C 4.6078 5.4211 0.0 0
M  V30 3 C 6.5770 2.7106 0.0 0
M  V30 4 N 7.3470 4.0442 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 1.9406 0.0 0
M  V30 7 C 2.6673 3.4806 0.0 0
M  V30 8 C 4.1320 1.4647 0.0 0
M  V30 9 C 1.3336 1.1706 0.0 0
M  V30 10 N 4.1320 3.9564 0.0 0
M  V30 11 C 1.3336 4.2506 0.0 0
M  V30 12 C 5.0370 2.7106 0.0 0
M  V30 13 C 0.0000 1.9406 0.0 0
M  V30 14 C 0.0000 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 372954-67-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1313739-63-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9476563
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular palladium-catalysed enolate arylation of 2- and
3-iodoindole derivatives for the synthesis of β-carbolines, γ-carbolines,
and pyrrolo[3,4-b]indoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sole, Daniel; Bennasar, M.-Lluisa; Jimenez, Ivan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2011), 9(12), 4535-4544

$RFMT $RIREG SCHEME257 STEP1
$RXN



  3  1
$MOL
Ethyl 1H-indole-2-carboxylate
C11H11NO2
3770-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 O 7.4148 2.3101 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 8.7486 1.5400 0.0 0
M  V30 5 C 10.0823 2.3101 0.0 0
M  V30 6 C 2.3101 2.8281 0.0 0
M  V30 7 C 3.0801 4.1618 0.0 0
M  V30 8 C 3.3405 1.6836 0.0 0
M  V30 9 C 0.7700 2.8281 0.0 0
M  V30 10 N 4.5865 3.8416 0.0 0
M  V30 11 C 2.3101 5.4955 0.0 0
M  V30 12 C 4.7475 2.3101 0.0 0
M  V30 13 C 0.0000 4.1618 0.0 0
M  V30 14 C 0.7700 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Benzyloxybenzyl chloride
C14H13ClO
836-42-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 2.6673 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 C 11.5503 2.6673 0.0 0
M  V30 4 Cl 12.3203 4.0010 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 7.7002 1.3337 0.0 0
M  V30 7 C 7.7002 4.0010 0.0 0
M  V30 8 C 9.2402 1.3337 0.0 0
M  V30 9 C 9.2402 4.0010 0.0 0
M  V30 10 C 10.0102 2.6673 0.0 0
M  V30 11 C 3.0801 1.3337 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 13 C 2.3101 0.0000 0.0 0
M  V30 14 C 0.7700 2.6673 0.0 0
M  V30 15 C 0.7700 0.0000 0.0 0
M  V30 16 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 3 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1-[[4-(phenylmethoxy)phenyl]methyl]-1H-indole-2-carboxamide
C24H22N2O2
302790-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8689 5.7533 0.0 0
M  V30 2 C 2.5368 5.4031 0.0 0
M  V30 3 N 1.0306 5.0829 0.0 0
M  V30 4 O 3.0127 6.8678 0.0 0
M  V30 5 C 0.0000 6.2273 0.0 0
M  V30 6 O 12.0289 5.7533 0.0 0
M  V30 7 C 12.7989 7.0869 0.0 0
M  V30 8 N 5.0989 4.4196 0.0 0
M  V30 9 C 5.7253 3.0127 0.0 0
M  V30 10 C 3.5673 4.2587 0.0 0
M  V30 11 C 4.5809 1.9823 0.0 0
M  V30 12 C 7.1900 2.5368 0.0 0
M  V30 13 C 3.2471 2.7523 0.0 0
M  V30 14 C 4.9011 0.4760 0.0 0
M  V30 15 C 7.5101 1.0306 0.0 0
M  V30 16 C 6.3656 0.0000 0.0 0
M  V30 17 C 7.4089 5.7533 0.0 0
M  V30 18 C 8.1789 7.0869 0.0 0
M  V30 19 C 8.1789 4.4196 0.0 0
M  V30 20 C 9.7189 7.0869 0.0 0
M  V30 21 C 9.7189 4.4196 0.0 0
M  V30 22 C 10.4889 5.7533 0.0 0
M  V30 23 C 14.3389 7.0869 0.0 0
M  V30 24 C 15.1089 5.7533 0.0 0
M  V30 25 C 15.1089 8.4207 0.0 0
M  V30 26 C 16.6489 5.7533 0.0 0
M  V30 27 C 16.6489 8.4207 0.0 0
M  V30 28 C 17.4189 7.0869 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 10
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 22
M  V30 9 1 7 23
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 2 10 13
M  V30 15 1 11 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3770-50-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 836-42-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302790-43-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3818713
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 1. Preparation of
1-methyl-2-(methylaminomethyl)indole. a)
N,1-Dimethylindole-2-carboxamide. To a stirred solution of ethyl
indole-2-carboxylate (25.0 g, 132.1 mmole) in dry DMF (100 mL) at 5 °C
was added 60% NaH (6.9 g, 171.7 mmole). After 10 min, methyl iodide (56.2
g, 396.3 mmole) was added and the reaction slurry was allowed to warm RT
and stirred for 12 hr. The reaction contents were poured into H2O (200
mL) and extracted with EtOAc (2 × 150 mL). The combined organic phases
were washed sequentially with H20 and brine, then were dried over Na2SO4.
Concentration under reduced pressure gave a yellow oil. This oil was
suspended in a 40% methylaminefH2O solution (100 mL) containing THF (50
mL) and stirred vigorously at RT for 24 hr. The reaction solution was
concentrated under vacuum to remove the THF and then poured into H2O (400
mL). The precipitate was filtered, washed with H2O and dried under vacuum
at RT. Preparation of 1-(4-hydroxybenzyl)-2-(methylaminomethyl)indole. a)
1-(4-Benzyloxybenzyl)-N-methylindole-2-carboxamide. According to the
procedure of Preparation 1 (a), except substituting 4-benzyloxybenzyl
chloride (33.8 g, 145.2 mmole) for methyl iodide, the title compound
(44.4 g, 91%) was prepared as a white solid. MS (ES) m/e 371 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-carboxamides as Fab I
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000063187 A1 2000-10-26

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-3-cyano-6-methyl-4-pyridinecarboxylate
C9H9N3O2
378757-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 C 2.6674 6.1600 0.0 0
M  V30 6 N 2.6674 7.7000 0.0 0
M  V30 7 N 0.0000 4.6200 0.0 0
M  V30 8 C 2.6674 0.0000 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 1.3336 3.8500 0.0 0
M  V30 13 C 2.6674 1.5400 0.0 0
M  V30 14 N 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 10
M  V30 7 1 7 12
M  V30 8 1 8 13
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-2,6-dimethyl-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione
C9H9N3O2
836682-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.9694 0.3694 0.0 0
M  V30 2 N 5.2435 0.0000 0.0 0
M  V30 3 O 1.9694 5.7904 0.0 0
M  V30 4 C 0.0000 3.0800 0.0 0
M  V30 5 C 7.9110 4.6200 0.0 0
M  V30 6 C 3.9099 2.3100 0.0 0
M  V30 7 C 3.9099 3.8500 0.0 0
M  V30 8 C 2.4452 1.8340 0.0 0
M  V30 9 C 5.2435 1.5400 0.0 0
M  V30 10 C 2.4452 4.3259 0.0 0
M  V30 11 C 5.2435 4.6200 0.0 0
M  V30 12 N 1.5400 3.0800 0.0 0
M  V30 13 N 6.5772 2.3100 0.0 0
M  V30 14 C 6.5772 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 9
M  V30 3 2 3 10
M  V30 4 1 4 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 378757-15-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 836682-26-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11455514
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
6,7-Dialkyl-4-amino-2-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-1,3-diones
(4a-c) (Table 2). A suspension of pyridine 1a-c (1 mmol) in a saturated
solution of methylamine in dioxane (5 ml) was heated at 130°C in a sealed
ampul for 48 h. The end of the reaction was determined by TLC (eluent
ethyl acetate, the compound fluoresces yellow-green on UV irradiation).
After cooling to -10°C the ampul was opened carefully. The contents were
diluted with 1,4-dioxane (5 ml), the yellow solid was filtered off,
washed with 1,4-dioxane (10 ml), and purified by vacuum sublimation or
recrystallization from DMF. The product was dried in a vacuum desiccator
over P2O5. 4c. mp: 192°C; C9H9N3O2. 1H NMR spectrum, δ, ppm: 2.4 (3H, s,
CH3); 2.95 (3H, s, CH3); 6.83 (1H, s, CH); 6.59 (2H, s, NH2).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Interaction of methyl 5,6-dialkyl-2-amino-3-cyanopyridine-4-carboxylates
with primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vasiliev, A. N.; Lyshchikov, A. N.; Nasakin, O. E.; Kayukov, Ya. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United
States)(Translation of Khimiya Geterotsiklicheskikh Soedinenii) (2004),
40(4), 460-464

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphorochloridic acid, bis(2,2,2-trifluoroethyl) ester
C4H4ClF6O3P
381-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 5.3900 2.8736 0.0 0 VAL=5
M  V30 2 O 3.8500 2.8736 0.0 0
M  V30 3 O 6.9300 2.8736 0.0 0
M  V30 4 Cl 5.3900 4.4136 0.0 0
M  V30 5 O 5.3900 1.3336 0.0 0
M  V30 6 C 3.0800 4.2073 0.0 0
M  V30 7 C 7.7000 1.5400 0.0 0
M  V30 8 C 1.5400 4.2073 0.0 0
M  V30 9 C 9.2400 1.5400 0.0 0
M  V30 10 F 1.5400 5.7473 0.0 0
M  V30 11 F 0.0000 4.2073 0.0 0
M  V30 12 F 1.5400 2.6673 0.0 0
M  V30 13 F 9.2400 3.0800 0.0 0
M  V30 14 F 10.7800 1.5400 0.0 0
M  V30 15 F 9.2400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14
M  V30 14 1 9 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bis(2,2,2-trifluoroethyl) N-methylphosphoramidate
C5H8F6NO3P
287931-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 5.3900 2.3100 0.0 0 VAL=5
M  V30 2 O 3.8500 2.3100 0.0 0
M  V30 3 O 6.9300 2.3100 0.0 0
M  V30 4 N 5.3900 0.7700 0.0 0
M  V30 5 O 5.3900 3.8500 0.0 0
M  V30 6 C 3.0800 3.6436 0.0 0
M  V30 7 C 7.7000 3.6436 0.0 0
M  V30 8 C 4.0564 0.0000 0.0 0
M  V30 9 C 1.5400 3.6436 0.0 0
M  V30 10 C 9.2400 3.6436 0.0 0
M  V30 11 F 1.5400 5.1836 0.0 0
M  V30 12 F 0.0000 3.6436 0.0 0
M  V30 13 F 1.5400 2.1036 0.0 0
M  V30 14 F 9.2400 2.1036 0.0 0
M  V30 15 F 10.7800 3.6436 0.0 0
M  V30 16 F 9.2400 5.1836 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 10 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 381-44-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 287931-23-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-569-CAS-16780566
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bis(2,2,2-trifluoroethyl)chlorophosphate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spinelli, Domenico; Petrillo, Giovanni
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM e-EROS Encyclopedia of Reagents for Organic Synthesis (2005), 1-6

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Dimethyl-β-alanine methyl ester
C6H13NO2
3853-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 O 6.6686 1.5400 0.0 0
M  V30 4 O 5.3348 3.8500 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Dimethylamino)-N-methylpropanamide
C6H14N2O
116882-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 N 6.6686 1.5400 0.0 0
M  V30 4 O 5.3348 3.8500 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3853-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 116882-92-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10645399
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of biomimetic polyamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Annenkov, Vadim V.; Zelinskiy, Stanislav N.; Danilovtseva, Elena N.;
Perry, Carole C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2009), (13), 116-130

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-benzothiazolecarboxylic acid
C8H4ClNO2S
3855-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 9.2446 3.0800 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 S 6.7994 1.8341 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 N 6.7994 4.3259 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 7.7046 3.0800 0.0 0
M  V30 13 C 2.6674 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-6-benzothiazolecarboxamide
C9H7ClN2OS
37525-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9109 1.5400 0.0 0
M  V30 2 N 9.2447 2.3100 0.0 0
M  V30 3 O 7.9109 0.0000 0.0 0
M  V30 4 C 10.5783 1.5400 0.0 0
M  V30 5 Cl 0.0000 3.0800 0.0 0
M  V30 6 C 3.9099 2.3100 0.0 0
M  V30 7 C 3.9099 3.8500 0.0 0
M  V30 8 C 5.2436 1.5400 0.0 0
M  V30 9 S 2.4452 1.8341 0.0 0
M  V30 10 N 2.4452 4.3259 0.0 0
M  V30 11 C 5.2436 4.6200 0.0 0
M  V30 12 C 6.5772 2.3100 0.0 0
M  V30 13 C 1.5400 3.0800 0.0 0
M  V30 14 C 6.5772 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3855-95-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 37525-63-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3247224
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-48-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 2-chloro-N-methyl-1,3-benzothiazole-6-carboxamide: To
2-chloro-1,3-benzothiazole-6-carboxylic acid (300 mg, 1.40 mmol) in DMF
(6 ml) is added a THF solution of methylamine (1.05 ml of 2M, 2.106
mmol), 2,6-lutidine (488 μl, 4.212 mmol) followed by HATU (640.7 mg,
1.685 mmol). The reaction mixture is stirred at room temperature for 3h,
diluted with H2O, extracted with EtOAc. The organic phase is washed with
sat sol NaHCO3, brine, dried over Na2SO4 filtered and dried. The residue
is purified on 25 g SNAP silica gel cartridge using EtOAc in Hexanes 50
to 100%. Yield: (290 mg, 91%) as a white solid. LC-MS: m/z = 227.1
(M+H+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of mannose nucleoside analogs and aryl C-glycosides for
treating bacterial infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bennani, Youssef Laafiret; Cadilhac, Caroline; Das, Sanjoy Kumar;
Dietrich, Evelyne; Gallant, Michel; Liu, Bingcan; Pereira, Oswy Z.;
Ramtohul, Yeeman K.; Reddy, T. Jagadeeswar; Vaillancourt, Louis;
Yannopoulos, Constantin; Vallee, Frederic
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013134415 A1 2013-09-12

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Hexafluorobenzene
C6F6
392-56-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 2.6674 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 F 1.5400 5.3349 0.0 0
M  V30 4 F 4.6200 0.0000 0.0 0
M  V30 5 F 4.6200 5.3349 0.0 0
M  V30 6 F 6.1600 2.6674 0.0 0
M  V30 7 C 1.5400 2.6674 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 8
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluoro-N-methylbenzenamine
C7H4F5N
1201-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 F 4.6200 5.3349 0.0 0
M  V30 4 F 4.6200 0.0000 0.0 0
M  V30 5 F 1.5400 5.3349 0.0 0
M  V30 6 F 1.5400 0.0000 0.0 0
M  V30 7 F 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 392-56-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1201-02-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7972442
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polyfluorinated arylnitramines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Platonov, V. E.; Haas, A.; Schelvis, M.; Lieb, M.; Dvornikova, K. V.;
Osina, O. I.; Gatilov, Y. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2001), 109(2), 131-139

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-3-nitroquinoline
C9H4Cl2N2O2
39487-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 Cl 9.3359 1.5400 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 5.3348 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 N 4.0011 4.6201 0.0 0
M  V30 11 C 6.6684 4.6201 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 8.0022 2.3100 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 15 C 8.0022 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methyl-3-nitro-4-quinolinamine
C10H8ClN3O2
1217302-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.7700 0.0 0
M  V30 2 C 4.0012 0.0000 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0 VAL=5
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 O 9.3360 3.0801 0.0 0
M  V30 6 Cl 0.0000 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 6.6685 3.0801 0.0 0
M  V30 12 N 5.3348 5.3901 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39487-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1217302-66-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13708209
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azoloquinoxaline compounds as inhibitors of histamine receptors for the
treatment of disease and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Borchardt, Allen; Davis, Robert; Beauregard, Clay; Becker, Daniel;
Gamache, Daniel; Noble, Stewart A.; Hellberg, Mark; Klimko, Peter; Qiu,
Zhihai; Payne, Joseph; Yanni, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20110257137 A1 2011-10-20

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-3-nitroquinoline
C9H4Cl2N2O2
39487-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 Cl 9.3359 1.5400 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 5.3348 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 N 4.0011 4.6201 0.0 0
M  V30 11 C 6.6684 4.6201 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 8.0022 2.3100 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 15 C 8.0022 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methyl-3-nitro-4-quinolinamine
C10H8ClN3O2
1217302-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.7700 0.0 0
M  V30 2 C 4.0012 0.0000 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0 VAL=5
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 O 9.3360 3.0801 0.0 0
M  V30 6 Cl 0.0000 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 6.6685 3.0801 0.0 0
M  V30 12 N 5.3348 5.3901 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39487-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1217302-66-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9549421
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 4.
6-Chloro-N-methyl-3-nitroquinolin-4-amine: A 100 mL round bottom flask
was charged with 4,6-dichloro-3-nitroquinoline (2.0 g, 8.3 mmol) and THF
(50 mL). To the above was added methylamine (2 M in THF, 6.2 mL) at 0 °C.
The resulting solution was stirred at room temperature for 1h. Work-up:
the solvent was removed. The residue was dissolved in CH2Cl2 (300 mL) and
washed with water (50 mL). The organic layer was dried over anhydrous
Na2SO4 and concentrated in vacuo. It was further purified by flash column
chromatography on silica gel with a 1:2:2 EtOAc/Petroleum ether/CH2Cl2.
6-Chloro-N-methyl-3-nitroquinolin-4-amine, 1.8 g (91%) of the product as
yellow solid. MS m/z: 238 (M+H+).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused nitrogen heterocycles as histamine receptor inhibitors, their
preparation, pharmaceutical compositions, and use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Borchardt, Allen; Davis, Robert; Beauregard, Clay; Becker, Daniel;
Gamache, Daniel; Noble, Stewart A.; Hellberg, Mark R.; Klimko, Peter G.;
Zhihai, Qui; Payne, Joseph E.; Yanni, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011112731 A2 2011-09-15

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-3-nitroquinoline
C9H4Cl2N2O2
39487-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 Cl 9.3359 1.5400 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 5.3348 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 N 4.0011 4.6201 0.0 0
M  V30 11 C 6.6684 4.6201 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 8.0022 2.3100 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 15 C 8.0022 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methyl-3-nitro-4-quinolinamine
C10H8ClN3O2
1217302-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.7700 0.0 0
M  V30 2 C 4.0012 0.0000 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0 VAL=5
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 O 9.3360 3.0801 0.0 0
M  V30 6 Cl 0.0000 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 6.6685 3.0801 0.0 0
M  V30 12 N 5.3348 5.3901 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39487-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1217302-66-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9315593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6-Chloro-N-methyl-3-nitroquinolin-4-amine: A 100 mL round bottom flask
was charged with 4,6-dichloro-3-nitroquinoline (2.0 g, 8.3 mmol) and THF
(50 mL). To the above was added methylamine (2 M in THF, 6.2 mL) at 0 °C.
The resulting solution was stirred at room temperature for 1 h. Work-up:
the solvent was removed. The residue was dissolved in CH2Cl2 (300 mL) and
washed with water (50 mL). The organic layer was dried over anhydrous
Na2SO4 and concentrated in vacuo. It was further purified by flash column
chromatography on silica gel with a 1 :2:2 EtO Ac/Petroleum ether/CH2Cl2.
1.8 g (91%) of the product as yellow solid. MS m/z: 238 (M+H+).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinoxaline-based heterocyclic inhibitors of histamine
receptors for the treatment of disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Borchardt, Allen J.; Beauregard, Clay; Cook, Travis; Davis, Robert L.;
Gamache, Daniel A.; Yanni, John M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010030785 A2 2010-03-18

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzyl-3-piperidone
C12H15NO
40114-49-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 O 9.3358 3.0800 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 C 6.6684 3.0800 0.0 0
M  V30 5 C 5.3347 0.7700 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 6.6684 0.0000 0.0 0
M  V30 8 C 8.0021 0.7700 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 1.3336 3.0800 0.0 0
M  V30 12 C 1.3336 0.0000 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 2 2 6
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1-(phenylmethyl)-3-piperidinamine
C13H20N2
60717-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 N 9.3360 3.0801 0.0 0
M  V30 3 C 10.6697 2.3101 0.0 0
M  V30 4 N 5.3348 2.3101 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 8.0023 2.3101 0.0 0
M  V30 8 C 6.6685 0.0000 0.0 0
M  V30 9 C 8.0023 0.7700 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 7
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40114-49-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60717-45-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42419052
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 83722-98-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Engineered Imine Reductase for Highly Diastereo- and Enantioselective
Synthesis of β-Branched Amines with Contiguous Stereocenters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Zhen-Yu; Shi, Min; Li, Chen-Lin; Gao, Yun-Fei; Shen, Xin-Yuan; Ding,
Xu-Wei; Chen, Fei-Fei; Xu, Jian-He; Chen, Qi; Zheng, Gao-Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(47), e202408686

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-4-nitrobenzoic acid
C7H4FNO4
403-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-4-nitrobenzoic acid
C8H8N2O4
49565-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 C 1.3336 1.5400 0.0 0
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3336 0.0000 0.0 0
M  V30 6 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6685 6.1600 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-24-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 49565-62-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20149714
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of lactams, imides and related nitrogen heterocycles as CRBN
ligands for the treatment of CRBN-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Zhang, Yi; Weiss, Matthew M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019060693 A1 2019-03-28

$RFMT $RIREG SCHEME266 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(βS)-β-[4-(Trifluoromethyl)phenoxy]benzenepropanoic acid
C16H13F3O3
406945-08-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 O 5.3900 5.3349 0.0 0
M  V30 3 C 5.3900 2.6674 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 O 5.3900 0.0000 0.0 0
M  V30 6 O 3.0800 1.3338 0.0 0
M  V30 7 C 11.5500 5.3349 0.0 0
M  V30 8 F 11.5500 3.7949 0.0 0
M  V30 9 F 13.0900 5.3349 0.0 0
M  V30 10 F 11.5500 6.8749 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.7700 5.3349 0.0 0
M  V30 16 C 0.0000 4.0011 0.0 0
M  V30 17 C 6.9300 5.3349 0.0 0
M  V30 18 C 7.7000 6.6685 0.0 0
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 9.2400 6.6685 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 10.0100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 11
M  V30 4 1 2 17
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(βS)-N-Methyl-β-[4-(trifluoromethyl)phenoxy]benzenepropanamide
C17H16F3NO2
406945-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=2
M  V30 2 O 5.3900 6.6685 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 N 5.3900 1.3338 0.0 0
M  V30 6 O 3.0800 2.6674 0.0 0
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 C 11.5500 6.6685 0.0 0
M  V30 9 F 11.5500 5.1285 0.0 0
M  V30 10 F 13.0900 6.6685 0.0 0
M  V30 11 F 11.5500 8.2085 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 17 C 0.0000 5.3347 0.0 0
M  V30 18 C 6.9300 6.6685 0.0 0
M  V30 19 C 7.7000 8.0021 0.0 0
M  V30 20 C 7.7000 5.3347 0.0 0
M  V30 21 C 9.2400 8.0021 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 23 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 12
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 406945-08-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 406945-09-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1210133
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective synthesis of (S)- and (R)-fluoxetine hydrochloride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miles, William H.; Fialcowitz, Elizabeth J.; Scott Halstead, E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2001), 57(50), 9925-9929

$RFMT $RIREG SCHEME267 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-(phenylmethoxy)-6...
C27H22ClN3O5
417720-22-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.3200 4.2074 0.0 0
M  V30 2 C 6.9300 2.8738 0.0 0
M  V30 3 O 7.7000 1.5400 0.0 0
M  V30 4 O 5.3900 2.8738 0.0 0
M  V30 5 O 5.3900 5.5411 0.0 0
M  V30 6 C 4.6200 6.8747 0.0 0
M  V30 7 Cl 16.9400 6.8747 0.0 0
M  V30 8 N 18.4800 4.2074 0.0 0
M  V30 9 C 19.2500 2.8738 0.0 0
M  V30 10 N 20.7900 2.8738 0.0 0
M  V30 11 O 18.4800 1.5400 0.0 0
M  V30 12 C 10.0100 5.5411 0.0 0
M  V30 13 C 9.2400 6.8747 0.0 0
M  V30 14 C 11.5500 5.5411 0.0 0
M  V30 15 C 9.2400 4.2074 0.0 0
M  V30 16 C 7.7000 6.8747 0.0 0
M  V30 17 N 10.0100 8.2085 0.0 0
M  V30 18 C 12.3200 6.8747 0.0 0
M  V30 19 C 7.7000 4.2074 0.0 0
M  V30 20 C 6.9300 5.5411 0.0 0
M  V30 21 C 11.5500 8.2085 0.0 0
M  V30 22 C 13.8600 4.2074 0.0 0
M  V30 23 C 14.6300 5.5411 0.0 0
M  V30 24 C 14.6300 2.8738 0.0 0
M  V30 25 C 16.1700 5.5411 0.0 0
M  V30 26 C 16.1700 2.8738 0.0 0
M  V30 27 C 16.9400 4.2074 0.0 0
M  V30 28 C 3.0800 6.8747 0.0 0
M  V30 29 C 2.3100 8.2085 0.0 0
M  V30 30 C 2.3100 5.5411 0.0 0
M  V30 31 C 0.7700 8.2085 0.0 0
M  V30 32 C 0.7700 5.5411 0.0 0
M  V30 33 C 0.0000 6.8747 0.0 0
M  V30 34 C 21.5600 1.5400 0.0 0
M  V30 35 C 21.5600 0.0000 0.0 0
M  V30 36 C 22.8936 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 5 6
M  V30 7 1 5 20
M  V30 8 1 6 28
M  V30 9 1 7 25
M  V30 10 1 8 9
M  V30 11 1 8 27
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 34
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 18 1 13 16
M  V30 19 1 13 17
M  V30 20 2 14 18
M  V30 21 2 15 19
M  V30 22 2 16 20
M  V30 23 2 17 21
M  V30 24 1 18 21
M  V30 25 1 19 20
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-N-methyl-7-(phenylm...
C28H25ClN4O4
417720-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.3200 4.2074 0.0 0
M  V30 2 C 6.9300 2.8738 0.0 0
M  V30 3 N 7.7000 1.5400 0.0 0
M  V30 4 O 5.3900 2.8738 0.0 0
M  V30 5 C 6.9300 0.2064 0.0 0
M  V30 6 O 5.3900 5.5411 0.0 0
M  V30 7 C 4.6200 6.8747 0.0 0
M  V30 8 Cl 16.9400 6.8747 0.0 0
M  V30 9 N 18.4800 4.2074 0.0 0
M  V30 10 C 19.2500 2.8738 0.0 0
M  V30 11 N 20.7900 2.8738 0.0 0
M  V30 12 O 18.4800 1.5400 0.0 0
M  V30 13 C 10.0100 5.5411 0.0 0
M  V30 14 C 9.2400 6.8747 0.0 0
M  V30 15 C 11.5500 5.5411 0.0 0
M  V30 16 C 9.2400 4.2074 0.0 0
M  V30 17 C 7.7000 6.8747 0.0 0
M  V30 18 N 10.0100 8.2085 0.0 0
M  V30 19 C 12.3200 6.8747 0.0 0
M  V30 20 C 7.7000 4.2074 0.0 0
M  V30 21 C 6.9300 5.5411 0.0 0
M  V30 22 C 11.5500 8.2085 0.0 0
M  V30 23 C 13.8600 4.2074 0.0 0
M  V30 24 C 14.6300 5.5411 0.0 0
M  V30 25 C 14.6300 2.8738 0.0 0
M  V30 26 C 16.1700 5.5411 0.0 0
M  V30 27 C 16.1700 2.8738 0.0 0
M  V30 28 C 16.9400 4.2074 0.0 0
M  V30 29 C 3.0800 6.8747 0.0 0
M  V30 30 C 2.3100 8.2085 0.0 0
M  V30 31 C 2.3100 5.5411 0.0 0
M  V30 32 C 0.7700 8.2085 0.0 0
M  V30 33 C 0.7700 5.5411 0.0 0
M  V30 34 C 0.0000 6.8747 0.0 0
M  V30 35 C 21.5600 1.5400 0.0 0
M  V30 36 C 21.5600 0.0000 0.0 0
M  V30 37 C 22.8936 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 20
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 21
M  V30 9 1 7 29
M  V30 10 1 8 26
M  V30 11 1 9 10
M  V30 12 1 9 28
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 1 11 35
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 14 18
M  V30 21 2 15 19
M  V30 22 2 16 20
M  V30 23 2 17 21
M  V30 24 2 18 22
M  V30 25 1 19 22
M  V30 26 1 20 21
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 1 35 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 417720-22-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 417720-23-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5344519
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 661.
N6-Methyl-7-(benzyloxy)-4-(3-chloro-4-(((cyclopropylamino)carbonyl)amino)phenoxy)-6-quinolinecarboxamide.
After dissolving
7-(benzyloxy)-4-(3-chloro-(4-((cyclopropylamino)carbonyl)amino)phenoxy)-6-quinolinecarboxylic
acid (1.056g, 2.10 mmol) in dimethylformamide (10 ml) under a nitrogen
atmosphere, there were added a 40% methylamine-methanol solution (2 ml),
triethylamine (1 ml) and (1H-1,2,3-benzotriazol-1-yloxy)
(tri(dimethylamino))phosphonium hexafluorophosphate (1.11 g, 2.52 mmol)
in that order at room temperature, and the mixture was stirred for 6
hours. Water was added to the reaction solution to precipitate crystals,
and these were filtered out, washed thoroughly with water and dried at 70
°C.
N6-Methyl-7-(benzyloxy)-4-(3-chloro-4-(((cyclopropylamino)carbonyl)amino)phenoxy)-6-quinolinecarboxamide
(988 mg, 1.91 mmol, 91.2%) as white crystals. 1H-NMR Spectrum (DMSO-d6) δ
(ppm): 0.42 (2H, m), 0.65 (2H, m), 2.56 (1H, m), 2.82 (3H, d, J = 4.4
Hz), 5.42 (2H, s), 6.51 (1H, d, J = 5.2 Hz), 7.18 (1H, d, J = 2.8 Hz),
7.21 (1H, dd, J = 2.8, 8.8 Hz), 7.30-7.55 (7H, m), 7.96 (1H, s), 8.25
(1H, d, J = 8.8 Hz) 8.38 (1H, q, J = 4.4 Hz), 8.49 (1H, s), 8.62 (1H, d,
J = 5.2 Hz).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of urea derivatives containing nitrogenous aromatic ring
compounds as inhibitors of angiogenesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Funahashi, Yasuhiro; Tsuruoka, Akihiko; Matsukura, Masayuki; Haneda,
Toru; Fukuda, Yoshio; Kamata, Junichi; Takahashi, Keiko; Matsushima,
Tomohiro; Miyazaki, Kazuki; Nomoto, Ken-Ichi; Watanabe, Tatsuo; Obaishi,
Hiroshi; Yamaguchi, Atsumi; Suzuki, Sachi; Nakamura, Katsuji; Mimura,
Fusayo; Yamamoto, Yuji; Matsui, Junji; Matsui, Kenji; Yoshiba, Takako;
Suzuki, Yasuyuki; Arimoto, Itaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US7253286 B2 2007-08-07

$RFMT $RIREG SCHEME268 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2,3-dihydro-6-nitro-1H-indole-2-carboxylate
C10H10N2O4
428861-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2447 3.0800 0.0 0
M  V30 2 O 10.0147 4.4137 0.0 0
M  V30 3 O 10.0147 1.7464 0.0 0
M  V30 4 C 11.5547 4.4137 0.0 0
M  V30 5 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 8 C 5.3347 2.3100 0.0 0
M  V30 9 C 5.3347 3.8500 0.0 0
M  V30 10 N 6.7994 1.8341 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 6.7994 4.3259 0.0 0
M  V30 13 C 4.0011 4.6200 0.0 0
M  V30 14 C 7.7047 3.0800 0.0 0
M  V30 15 C 2.6674 2.3100 0.0 0
M  V30 16 C 2.6674 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-N-methyl-6-nitro-1H-indole-2-carboxamide
C10H11N3O3
2752375-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2447 3.0800 0.0 0
M  V30 2 N 10.0147 4.4137 0.0 0
M  V30 3 O 10.0147 1.7464 0.0 0
M  V30 4 C 11.5547 4.4137 0.0 0
M  V30 5 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 8 C 5.3347 2.3100 0.0 0
M  V30 9 C 5.3347 3.8500 0.0 0
M  V30 10 N 6.7994 1.8341 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 6.7994 4.3259 0.0 0
M  V30 13 C 4.0011 4.6200 0.0 0
M  V30 14 C 7.7047 3.0800 0.0 0
M  V30 15 C 2.6674 2.3100 0.0 0
M  V30 16 C 2.6674 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 428861-43-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2752375-37-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24894224
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of (-)-Glionitrin A and B Enabled by an Asymmetric
Oxidative Sulfenylation of Triketopiperazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koning, Nicolas R.; Sundin, Anders P.; Strand, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2021), 143(50), 21218-21222

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-hydroxy-3-(1-phenyl-2-propen-1-yl)benzoate
C17H16O3
452897-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 4.0012 0.7700 0.0 0
M  V30 3 C 2.6673 0.0000 0.0 0
M  V30 4 O 6.6685 0.7700 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 O 10.6697 3.0801 0.0 0
M  V30 7 O 9.3360 0.7700 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 8.0022 3.0801 0.0 0
M  V30 13 C 6.6685 5.3901 0.0 0
M  V30 14 C 8.0022 4.6201 0.0 0
M  V30 15 C 2.6673 3.0801 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 1.3337 5.3901 0.0 0
M  V30 19 C 0.0000 3.0801 0.0 0
M  V30 20 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 1 15
M  V30 4 2 2 3
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 12
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-N-methyl-3-(1-phenyl-2-propen-1-yl)benzamide
C17H17NO2
2138474-89-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 4.0012 0.7700 0.0 0
M  V30 3 C 2.6673 0.0000 0.0 0
M  V30 4 O 6.6685 0.7700 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 N 10.6697 3.0801 0.0 0
M  V30 7 O 9.3360 0.7700 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 8.0022 3.0801 0.0 0
M  V30 13 C 6.6685 5.3901 0.0 0
M  V30 14 C 8.0022 4.6201 0.0 0
M  V30 15 C 2.6673 3.0801 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 0.0000 3.0801 0.0 0
M  V30 19 C 1.3337 5.3901 0.0 0
M  V30 20 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 1 15
M  V30 4 2 2 3
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 12
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 452897-49-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2138474-89-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24250341
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the
Bromodomain and Extra-Terminal (BET) Family
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Preston, Alex; Atkinson, Stephen J.; Bamborough, Paul; Chung, Chun-wa;
Gordon, Laurie J.; Grandi, Paola; Gray, James R. J.; Harrison, Lee A.;
Lewis, Antonia J.; Lugo, David; Messenger, Cassie; Michon, Anne-Marie;
Mitchell, Darren J.; Prinjha, Rab K.; Rioja, Inmaculada; Seal, Jon;
Taylor, Simon; Thesmar, Pierre; Wall, Ian D.; Watson, Robert J.; Woolven,
James M.; Demont, Emmanuel H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2020), 11(8), 1581-1587

$RFMT $RIREG SCHEME270 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitrobenzoic acid
C7H4FNO4
453-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methyl-3-nitrobenzamide
C8H7FN2O3
475216-25-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 1.5400 0.0 0
M  V30 2 N 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 0.0000 0.0 0
M  V30 4 C 9.3359 1.5400 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 F 1.3337 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 453-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 475216-25-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7392795
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Fluoro-3-nitrobenzoic acid (3.00 g, 16.2 mmoles) was dissolved in
dichloromethane (100 mL) and cooled in an ice bath to 0-5 °C. EDC (3.73
g, 19.5 mmoles) was added followed by dropwise addition of methylamine
solution (8.1 mL, 16.2 mmoles, 2.0 M solution in THF). The mixture was
allowed to slowly warm to room temperature and stirred for 2 h. The
mixture was then diluted with ethyl acetate and washed successively with
1 M HCl, saturated aqueous NaHCO3 and brine. The organic extracts were
dried over MgSO4, filtered and concentrated in vacuo to leave
4-fluoro-3-nitro-N-methylbenzamide which was used directly in the next
step. Yellow solid, yield 2.94 g, 91%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted benzimidazoles as interleukin-2 tyrosine
kinase (Itk) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cywin, Charles; Pullen, Steven S.; Roth, Gregory Paul; Snow, Roger John;
Fleck, Roman Wolfgang; Takahashi, Hidenori; Winters, Michael; Qiao, Lei;
Nemoto, Peter Allen; Moriarity, Kevin J.; Wang, Ji; Bentzien, Joerg;
Cook, Brian; Lo, Ho-yin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004014905 A1 2004-02-19

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[2-(2-amino-5-chlorophenyl)-2-(2-chlorophenyl)ethyl]thio]acetate
C17H17Cl2NO2S
488828-90-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 5.3901 0.0 0
M  V30 3 S 8.0022 4.6201 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 O 12.0033 5.3901 0.0 0
M  V30 7 O 10.6697 3.0801 0.0 0
M  V30 8 C 13.3370 4.6201 0.0 0
M  V30 9 N 5.3348 7.7002 0.0 0
M  V30 10 Cl 2.6673 3.0801 0.0 0
M  V30 11 Cl 0.0000 4.6201 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 C 4.0010 6.9302 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 2.6673 7.7002 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 1.3337 6.9302 0.0 0
M  V30 18 C 5.3348 3.0801 0.0 0
M  V30 19 C 4.0010 2.3101 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 C 4.0010 0.7700 0.0 0
M  V30 22 C 6.6685 0.7700 0.0 0
M  V30 23 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 13
M  V30 11 1 10 19
M  V30 12 1 11 16
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[2-(2-Amino-5-chlorophenyl)-2-(2-chlorophenyl)ethyl]thio]-N-methylacetamide
C17H18Cl2N2OS
581059-00-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 5.3901 0.0 0
M  V30 3 S 8.0022 4.6201 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 N 12.0033 5.3901 0.0 0
M  V30 7 O 10.6697 3.0801 0.0 0
M  V30 8 C 13.3370 4.6201 0.0 0
M  V30 9 N 5.3348 7.7002 0.0 0
M  V30 10 Cl 2.6673 3.0801 0.0 0
M  V30 11 Cl 0.0000 4.6201 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 C 4.0010 6.9302 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 2.6673 7.7002 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 1.3337 6.9302 0.0 0
M  V30 18 C 5.3348 3.0801 0.0 0
M  V30 19 C 4.0010 2.3101 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 C 4.0010 0.7700 0.0 0
M  V30 22 C 6.6685 0.7700 0.0 0
M  V30 23 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 13
M  V30 11 1 10 19
M  V30 12 1 11 16
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 488828-90-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 581059-00-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11868535
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzene derivatives for inhibiting insulin secretion
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pei, Yazhong; James, Ian W.; Ghosh, Soumitra S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003066035 A2 2003-08-14

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,2,3,3a-tetrahydro-7-hydroxy-9-oxo-9H-pyrrolo[2,1-b][1,3]benzoxazine-6...
C14H15NO5
537034-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.6672 1.3337 0.0 0
M  V30 2 C 8.5974 2.6673 0.0 0
M  V30 3 O 9.3674 4.0012 0.0 0
M  V30 4 O 9.3674 1.3337 0.0 0
M  V30 5 C 10.9074 4.0012 0.0 0
M  V30 6 C 11.6775 5.3348 0.0 0
M  V30 7 O 7.0574 0.0000 0.0 0
M  V30 8 C 4.7473 4.0012 0.0 0
M  V30 9 C 3.9773 2.6673 0.0 0
M  V30 10 C 6.2873 4.0012 0.0 0
M  V30 11 O 3.9773 5.3348 0.0 0
M  V30 12 C 2.4373 2.6673 0.0 0
M  V30 13 C 4.7473 1.3337 0.0 0
M  V30 14 C 7.0574 2.6673 0.0 0
M  V30 15 C 2.4373 5.3348 0.0 0
M  V30 16 N 1.6672 4.0012 0.0 0
M  V30 17 C 6.2873 1.3337 0.0 0
M  V30 18 C 1.4068 6.4792 0.0 0
M  V30 19 C 0.1609 4.3213 0.0 0
M  V30 20 C 0.0000 5.8529 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 17
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 17
M  V30 18 1 15 16
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3,3a-Tetrahydro-7-hydroxy-N-methyl-9-oxo-9H-pyrrolo[2,1-b][1,3]benzoxazin...
C13H14N2O4
537035-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.6672 1.3337 0.0 0
M  V30 2 O 7.0574 0.0000 0.0 0
M  V30 3 C 8.5974 2.6673 0.0 0
M  V30 4 N 9.3674 4.0012 0.0 0
M  V30 5 O 9.3674 1.3337 0.0 0
M  V30 6 C 10.9074 4.0012 0.0 0
M  V30 7 C 3.9773 2.6673 0.0 0
M  V30 8 C 4.7473 4.0012 0.0 0
M  V30 9 C 2.4373 2.6673 0.0 0
M  V30 10 C 4.7473 1.3337 0.0 0
M  V30 11 O 3.9773 5.3348 0.0 0
M  V30 12 C 6.2873 4.0012 0.0 0
M  V30 13 N 1.6672 4.0012 0.0 0
M  V30 14 C 6.2873 1.3337 0.0 0
M  V30 15 C 2.4373 5.3348 0.0 0
M  V30 16 C 7.0574 2.6673 0.0 0
M  V30 17 C 0.1609 4.3213 0.0 0
M  V30 18 C 1.4068 6.4792 0.0 0
M  V30 19 C 0.0000 5.8529 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 16
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 13 17
M  V30 18 2 14 16
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 537034-53-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 537035-31-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7373518
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-24-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition (AlMe3 and methlamine in THF)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic
responses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rogers, Gary A.; Allan, Matthew; Harris, Clayton; Huang, Jianjie; Marrs,
Christopher M.; Mueller, Rudolf; Rachwal, Stanislaw
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003045315 A2 2003-06-05

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-3-(2-oxopropyl)-2(3H)-benzoxazolone
C10H8ClNO3
54080-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 3.3320 0.0 0
M  V30 2 C 1.1444 2.8561 0.0 0
M  V30 3 C 0.8242 1.3498 0.0 0
M  V30 4 O 0.0000 3.8866 0.0 0
M  V30 5 O 2.2588 0.0000 0.0 0
M  V30 6 Cl 9.8799 2.6218 0.0 0
M  V30 7 C 5.2598 2.6218 0.0 0
M  V30 8 N 3.7535 2.3016 0.0 0
M  V30 9 C 6.0298 1.2881 0.0 0
M  V30 10 C 6.0298 3.9554 0.0 0
M  V30 11 C 3.5926 0.7700 0.0 0
M  V30 12 O 4.9994 0.1435 0.0 0
M  V30 13 C 7.5699 1.2881 0.0 0
M  V30 14 C 7.5699 3.9554 0.0 0
M  V30 15 C 8.3399 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 11
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Chloro-2-hydroxyphenyl)-1,3-dihydro-3,4-dimethyl-2H-imidazol-2-one
C11H11ClN2O2
2094004-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.1864 0.0000 0.0 0
M  V30 2 O 5.1556 5.3780 0.0 0
M  V30 3 C 0.0000 1.0353 0.0 0
M  V30 4 C 0.0000 4.3858 0.0 0
M  V30 5 Cl 9.7757 2.7106 0.0 0
M  V30 6 N 3.6156 2.7106 0.0 0
M  V30 7 C 2.7104 1.4647 0.0 0
M  V30 8 C 2.7104 3.9564 0.0 0
M  V30 9 N 1.2459 1.9406 0.0 0
M  V30 10 C 1.2459 3.4806 0.0 0
M  V30 11 C 5.1556 2.7106 0.0 0
M  V30 12 C 5.9256 4.0442 0.0 0
M  V30 13 C 5.9256 1.3769 0.0 0
M  V30 14 C 7.4656 4.0442 0.0 0
M  V30 15 C 7.4656 1.3769 0.0 0
M  V30 16 C 8.2357 2.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 12
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54080-67-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2094004-46-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-16928221
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-23-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of a new polycyclic heterocyclic ring system. Part III.
Benzo[b]imidazo[1,5-d][1,4]oxazepine-1,4(2H,5H)-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stanisheva, Desislava V.; Gerova, Mariana S.; Petrov, Ognyan I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocyclic Communications (2017), 23(1), 23-27

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
rel-1,6-Diethyl (2R,5S)-2,5-dibromohexanedioate
C10H16Br2O4
54221-37-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0 CFG=2
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 Br 5.3348 3.8501 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 O 2.6673 2.3101 0.0 0
M  V30 7 O 4.0010 0.0000 0.0 0
M  V30 8 C 9.3358 1.5400 0.0 0 CFG=1
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 Br 9.3358 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 O 12.0033 1.5400 0.0 0
M  V30 14 O 10.6697 3.8501 0.0 0
M  V30 15 C 13.3370 2.3101 0.0 0
M  V30 16 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 8 11 CFG=3
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-2,5-Diethyl (2R,5S)-1-methyl-2,5-pyrrolidinedicarboxylate
C11H19NO4
52321-02-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6446 3.4580 0.0 0
M  V30 2 O 9.9783 2.6880 0.0 0
M  V30 3 O 8.6446 4.9980 0.0 0
M  V30 4 C 11.3121 3.4580 0.0 0
M  V30 5 C 12.6457 2.6880 0.0 0
M  V30 6 C 5.5838 4.8207 0.0 0
M  V30 7 C 3.3420 2.3308 0.0 0
M  V30 8 O 2.4368 1.0849 0.0 0
M  V30 9 O 2.7157 3.7378 0.0 0
M  V30 10 C 0.9052 1.2459 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 C 7.3109 2.6880 0.0 0 CFG=2
M  V30 13 N 5.9040 3.3143 0.0 0
M  V30 14 C 7.1500 1.1564 0.0 0
M  V30 15 C 4.8735 2.1699 0.0 0 CFG=1
M  V30 16 C 5.6436 0.8362 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 15 7 CFG=3
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 54221-37-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52321-02-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8664655
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Diethyl cis-1-methylpyrrolidine-2,5-dicarboxylate (Intermediate Compound)
Diethyl mezo-2,5-dibromoadipate (101.7 g; 0.283 mol) was dissolved by
heating under argon in THF (400 ml) and then cooled to 0° C. To the
obtained solution a pre-cooled solution of methylamine (27.3 g; 0.88 mol)
in THF (150 ml) was added and the mixture was stirred at room temperature
for 18 hours. The separated crystalline material was filtered off, the
filtrate concentrated and the residue chromatographed on a silica gel
column (10 cm long) with hexane-ethyl acetate 4:1 as eluent 58.9 g (91%).
1H NMR (300 MHz, CDCl3): 1.15 (t, 6H); 1.9-2.0 (m, 4H); 2.38 (s, 3H);
2.99 (m, 2H); 4.07 (q, 4H). 13C l NMR (75 MHz, CDCl3): 13.98; 27.68;
40.82; 60.39; 67.93; 68.06; 172.32.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel 3,8-diaza-bicyclo[3.2.1]octane- and
3,9-diaza-bicyclo[3.3.1]-nonane-3-carboxylic acid ester derivatives and
their use as monoamine neurotransmitter re-uptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peters, Dan; Redrobe, John Paul; Nielsen, Elsebet Oestergaard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009109517 A1 2009-09-11

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,6-Diethyl (2R,5S)-2,5-dibromohexanedioate
C10H16Br2O4
54221-37-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0 CFG=2
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 Br 5.3348 3.8501 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 O 2.6673 2.3101 0.0 0
M  V30 7 O 4.0010 0.0000 0.0 0
M  V30 8 C 9.3358 1.5400 0.0 0 CFG=1
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 Br 9.3358 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 O 12.0033 1.5400 0.0 0
M  V30 14 O 10.6697 3.8501 0.0 0
M  V30 15 C 13.3370 2.3101 0.0 0
M  V30 16 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 8 11 CFG=3
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-2,5-Diethyl (2R,5S)-1-methyl-2,5-pyrrolidinedicarboxylate
C11H19NO4
52321-02-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6446 3.4580 0.0 0
M  V30 2 O 9.9783 2.6880 0.0 0
M  V30 3 O 8.6446 4.9980 0.0 0
M  V30 4 C 11.3121 3.4580 0.0 0
M  V30 5 C 12.6457 2.6880 0.0 0
M  V30 6 C 5.5838 4.8207 0.0 0
M  V30 7 C 3.3420 2.3308 0.0 0
M  V30 8 O 2.4368 1.0849 0.0 0
M  V30 9 O 2.7157 3.7378 0.0 0
M  V30 10 C 0.9052 1.2459 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 C 7.3109 2.6880 0.0 0 CFG=2
M  V30 13 N 5.9040 3.3143 0.0 0
M  V30 14 C 7.1500 1.1564 0.0 0
M  V30 15 C 4.8735 2.1699 0.0 0 CFG=1
M  V30 16 C 5.6436 0.8362 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 15 7 CFG=3
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54221-37-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52321-02-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-61600
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Diethyl cis-1-methylpyrrolidine-2,5-dicarboxylate (intermediate compound)
Diethyl mezo-2,5-dibromoadipate (101.7 g, 0.283 mol) was dissolved by
heating under argon in THF (400 ml) and then cooled to 0°C. To the
obtained solution a precooled solution of methylamine (27.3 g, 0.88 mol)
in THF (150 ml) was added and the mixture was stirred at room temperature
for 18 h. The separated crystalline material was filtered off, the
filtrate concentrated and the residue chromatographed on a silica gel
column (10 cm long) with hexane-ethyl acetate 4:1 as eluent to afford
58.9 g (91%). Diethyl cis-1-methylpyrrolidine-2,5-dicarboxylate, Yield
58.9 g (91%). 1H NMR (300 MHz, CDCl3): δ 1.15 (t, 6H); 1.9-2.0 (m, 4H);
2.38 (s, 3H); 2.99 (m, 2H); 4.07 (q, 4H). 13C NMR (75 MHz, CDCl3): δ
13.98; 27.68; 40.82; 60.39; 67.93; 68.06; 172.32.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel substituted diazabicyclooctane derivatives as
monoamine neurotransmitter re-uptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peters, Dan; Nielsen, Elsebet Oestergaard; Redrobe, John Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006106090 A1 2006-10-12

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,6-Diethyl (2R,5S)-2,5-dibromohexanedioate
C10H16Br2O4
54221-37-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0 CFG=2
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 Br 5.3348 3.8501 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 O 2.6673 2.3101 0.0 0
M  V30 7 O 4.0010 0.0000 0.0 0
M  V30 8 C 9.3358 1.5400 0.0 0 CFG=1
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 Br 9.3358 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 O 12.0033 1.5400 0.0 0
M  V30 14 O 10.6697 3.8501 0.0 0
M  V30 15 C 13.3370 2.3101 0.0 0
M  V30 16 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 8 11 CFG=3
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-2,5-Diethyl (2R,5S)-1-methyl-2,5-pyrrolidinedicarboxylate
C11H19NO4
52321-02-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6446 3.4580 0.0 0
M  V30 2 O 9.9783 2.6880 0.0 0
M  V30 3 O 8.6446 4.9980 0.0 0
M  V30 4 C 11.3121 3.4580 0.0 0
M  V30 5 C 12.6457 2.6880 0.0 0
M  V30 6 C 5.5838 4.8207 0.0 0
M  V30 7 C 3.3420 2.3308 0.0 0
M  V30 8 O 2.4368 1.0849 0.0 0
M  V30 9 O 2.7157 3.7378 0.0 0
M  V30 10 C 0.9052 1.2459 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 C 7.3109 2.6880 0.0 0 CFG=2
M  V30 13 N 5.9040 3.3143 0.0 0
M  V30 14 C 7.1500 1.1564 0.0 0
M  V30 15 C 4.8735 2.1699 0.0 0 CFG=1
M  V30 16 C 5.6436 0.8362 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 15 7 CFG=3
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54221-37-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52321-02-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10790952
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1. Preparatory Example. All reactions involving air sensitive
reagents or intermediates were performed under nitrogen and in anhydrous
solvents. Magnesium sulphate was used as drying agent in the
workup-procedures and solvents were evaporated under reduced pressure.
Diethyl cis-1-methylpyrrolidine-2,5-dicarboxylate (Intermediate
compound). Diethyl mezo-2,5-dibromoadipate (101.7 g; 0.283 mol) was
dissolved by heating under argon in THF (400 ml) and then cooled to 0°C.
To the obtained solution a pre-cooled solution of methylamine (27.3 g;
0.88 mol) in THF (150 ml) was added and the mixture was stirred at room
temperature for 18 hours. The separated crystalline material was filtered
off, the filtrate concentrated and the residue chromatographed on a
silica gel column (10 cm long) with hexane-ethyl acetate 4:1 as eluent to
afford 58.9 g (91%). 1H NMR (300 MHz, CDCl3): δ 1.15 (t, 6H); 1.9-2.0 (m,
4H); 2.38 (s, 3H); 2.99 (m, 2H); 4.07 (q, 4H). 13C NMR (75 MHz, CDCl3): δ
13.98; 27.68; 40.82; 60.39; 67.93; 68.06; 172.32.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel diazabicyclic aryl derivatives as 3H-α-bungarotoxin inhibitor and
their preparation, pharmaceutical compositions and medical use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peters, Dan; Timmermann, Daniel B.; Olsen, Gunnar M.; Nielsen, Elsebet
Oestergaard; Joergensen, Tino Dyhring
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006087306 A2 2006-08-24

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,6-Diethyl (2R,5S)-2,5-dibromohexanedioate
C10H16Br2O4
54221-37-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0 CFG=2
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 Br 5.3348 3.8501 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 O 2.6673 2.3101 0.0 0
M  V30 7 O 4.0010 0.0000 0.0 0
M  V30 8 C 9.3358 1.5400 0.0 0 CFG=1
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 Br 9.3358 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 O 12.0033 1.5400 0.0 0
M  V30 14 O 10.6697 3.8501 0.0 0
M  V30 15 C 13.3370 2.3101 0.0 0
M  V30 16 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 8 11 CFG=3
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-2,5-Diethyl (2R,5S)-1-methyl-2,5-pyrrolidinedicarboxylate
C11H19NO4
52321-02-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6446 3.4580 0.0 0
M  V30 2 O 9.9783 2.6880 0.0 0
M  V30 3 O 8.6446 4.9980 0.0 0
M  V30 4 C 11.3121 3.4580 0.0 0
M  V30 5 C 12.6457 2.6880 0.0 0
M  V30 6 C 5.5838 4.8207 0.0 0
M  V30 7 C 3.3420 2.3308 0.0 0
M  V30 8 O 2.4368 1.0849 0.0 0
M  V30 9 O 2.7157 3.7378 0.0 0
M  V30 10 C 0.9052 1.2459 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 C 7.3109 2.6880 0.0 0 CFG=2
M  V30 13 N 5.9040 3.3143 0.0 0
M  V30 14 C 7.1500 1.1564 0.0 0
M  V30 15 C 4.8735 2.1699 0.0 0 CFG=1
M  V30 16 C 5.6436 0.8362 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 15 7 CFG=3
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54221-37-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52321-02-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9667479
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1 Preparatory Example All reactions involving air sensitive
reagents or intermediates were performed under nitrogen and in anhydrous
solvents. Magnesium sulphate was used as drying agent in the
workup-procedures and solvents were evaporated under reduced pressure.
Diethyl cis-1-methylpyrrolidine-2,5-dicarboxylate (Intermediate Compound)
Diethyl mezo-2,5-dibromoadipate (101.7 g, 0.283 mol) was dissolved by
heating under argon in THF (400 ml) and then cooled to 0°C. To the
obtained solution a precooled solution of methylamine (27.3 g; 0.88 mol)
in THF (150 ml) was added and the mixture was stirred at room temperature
for 18 hours. The separated crystalline material was filtered off, the
filtrate concentrated and the residue chromatographed on a silica gel
column (10 cm long) with hexane-ethyl acetate 4:1 as eluent to afford
58.9 g (91%). 1H NMR (300 MHz, CDCl3): δ 1.15 (t, 6H); 1.9-2.0 (m, 4H);
2.38 (s, 3H); 2.99 (m, 2H); 4.07 (q, 4H). 13C NMR (75 MHz, CDCl3): δ
13.98; 27.68; 40.82; 60.39; 67.93; 68.06; 172.32.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel diazabicyclic aryl derivatives as cholinergic
ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peters, Dan; Timmermann, Daniel B.; Olsen, Gunnar M.; Nielsen, Elsebet
Oestergaard; Joergensen, Tino Dyhring
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006058879 A1 2006-06-08

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,6-Diethyl (2R,5S)-2,5-dibromohexanedioate
C10H16Br2O4
54221-37-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0 CFG=2
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 Br 5.3348 3.8501 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 O 2.6673 2.3101 0.0 0
M  V30 7 O 4.0010 0.0000 0.0 0
M  V30 8 C 9.3358 1.5400 0.0 0 CFG=1
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 Br 9.3358 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 O 12.0033 1.5400 0.0 0
M  V30 14 O 10.6697 3.8501 0.0 0
M  V30 15 C 13.3370 2.3101 0.0 0
M  V30 16 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 8 11 CFG=3
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-2,5-Diethyl (2R,5S)-1-methyl-2,5-pyrrolidinedicarboxylate
C11H19NO4
52321-02-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6446 3.4580 0.0 0
M  V30 2 O 9.9783 2.6880 0.0 0
M  V30 3 O 8.6446 4.9980 0.0 0
M  V30 4 C 11.3121 3.4580 0.0 0
M  V30 5 C 12.6457 2.6880 0.0 0
M  V30 6 C 5.5838 4.8207 0.0 0
M  V30 7 C 3.3420 2.3308 0.0 0
M  V30 8 O 2.4368 1.0849 0.0 0
M  V30 9 O 2.7157 3.7378 0.0 0
M  V30 10 C 0.9052 1.2459 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 C 7.3109 2.6880 0.0 0 CFG=2
M  V30 13 N 5.9040 3.3143 0.0 0
M  V30 14 C 7.1500 1.1564 0.0 0
M  V30 15 C 4.8735 2.1699 0.0 0 CFG=1
M  V30 16 C 5.6436 0.8362 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 15 7 CFG=3
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54221-37-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52321-02-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4753434
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Diethyl cis-1-methylpyrrolidine-2,5-dicarboxylate (Intermediate compound)
Diethyl mezo-2,5-dibromoadipate (101.7 g, 0.283 mol) was dissolved by
heating under argon in THF (400 ml) and then cooled to 0°C. To the
obtained solution a pre-cooled solution of methylamine (27.3 g, 0.88 mol)
in THF (150 ml) was added and the mixture was stirred at room temperature
for 18 hours. The separated crystalline material was filtered off, the
filtrate concentrated and the residue chromatographied on a silica gel
column (10 cm long) with hexane-ethyl acetate 4:1 as eluent to afford
58.9 g (91%). Diethyl cis-1-methylpyrrolidine-2,5-dicarboxylate, yield
58.9 g, 91% 1H NMR (300 MHz, CDCl3): δ 1.15 (t, 6H); 1.9-2.0 (m, 4H);
2.38 (s, 3H); 2.99 (m, 2H); 4.07 (q, 4H). 13C NMR (75 MHz, CDCl3): δ
13.98; 27.68; 40.82; 60.39; 67.93; 68.06; 172.32.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diazabicyclic aryl derivatives as α7 nicotinic acetylcholine receptor
ligands, their preparation, pharmaceutical compositions, and use in
therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peters, Dan; Timmermann, Daniel B.; Olsen, Gunnar M.; Nielsen, Elsebet
Oestergaard; Joergensen, Tino Dyhring
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006045716 A1 2006-05-04

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,6-Diethyl (2R,5S)-2,5-dibromohexanedioate
C10H16Br2O4
54221-37-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0 CFG=2
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 Br 5.3348 3.8501 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 O 2.6673 2.3101 0.0 0
M  V30 7 O 4.0010 0.0000 0.0 0
M  V30 8 C 9.3358 1.5400 0.0 0 CFG=1
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 Br 9.3358 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 O 12.0033 1.5400 0.0 0
M  V30 14 O 10.6697 3.8501 0.0 0
M  V30 15 C 13.3370 2.3101 0.0 0
M  V30 16 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 8 11 CFG=3
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-2,5-Diethyl (2R,5S)-1-methyl-2,5-pyrrolidinedicarboxylate
C11H19NO4
52321-02-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6446 3.4580 0.0 0
M  V30 2 O 9.9783 2.6880 0.0 0
M  V30 3 O 8.6446 4.9980 0.0 0
M  V30 4 C 11.3121 3.4580 0.0 0
M  V30 5 C 12.6457 2.6880 0.0 0
M  V30 6 C 5.5838 4.8207 0.0 0
M  V30 7 C 3.3420 2.3308 0.0 0
M  V30 8 O 2.4368 1.0849 0.0 0
M  V30 9 O 2.7157 3.7378 0.0 0
M  V30 10 C 0.9052 1.2459 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 C 7.3109 2.6880 0.0 0 CFG=2
M  V30 13 N 5.9040 3.3143 0.0 0
M  V30 14 C 7.1500 1.1564 0.0 0
M  V30 15 C 4.8735 2.1699 0.0 0 CFG=1
M  V30 16 C 5.6436 0.8362 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 15 7 CFG=3
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54221-37-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52321-02-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6020933
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Diethyl cis-1-Methylpyrrolidine-2,5-dicarboxylate (2).- Diethyl
meso-2,5-dibromoadipoate (1) (203.4 g, 0.566 mol) was placed into a three
necked round bottom flask (2000 mL) fitted with a reflux condenser, a
thermometer and a dropping funnel and dissolved in absolute THF (600 mL)
at 0°C under argon. A precooled (0°C) solution of methylamine (54.6 g,
1.76 mol) in absolute THF (300 mL) was added dropwise to the solution of
1 maintaining the reaction temperature below 20°C with the ice bath. Then
the reaction mixture was stirred at room temperature for 18 h, the
separated methylammonium bromide was removed by filtration and washed
thoroughly with THF. The filtrate was concentrated on a rotary evaporator
under reduced pressure and the residue was purified on a silica gel
chromatographic column with hexane-ethyl acetate (4:1) as eluent. The
collected eluate (4 L) was concentrated under reduced pressure, and the
residue was dried with stirring at room temperature in vacuo for 1 h.
117.8 g (91%) of a colorless oil. The product, when stored below 4°C,
crystallized fully, while at 12°C it is in equilibrium with a liquid
phase. 1H NMR (CDCl3): δ 1.15 (t, J = 7.2 Hz, 6H, 2 x CH2CH3), 1.90-2.10
(m, 4H, H-3, H-4), 2.43 (s, 3H, NCH3), 3.00-3.10 (m, 2H, H-2, H-5), 4.13
(q, J = 7.2 Hz, 4H, 2 x CH2CH3). 13C NMR (CDCl3): δ 14.06 (CH2CH3), 27.79
(C-3, C-4), 40.96 (NCH3), 60.57 (CH2CH3), 68.15 (C-2, C-5), 172.48 (C=O).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, other solvent gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved synthesis of 8-methyl-3,8-diazabicyclo[3.2.1]octane
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Paliulis, Osvaldas; Peters, Dan; Miknius, Linas; Sackus, Algirdas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Preparations and Procedures International (2006), 39(1), 86-90

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)-3-oxobutanamide
C11H13NO3
5437-98-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 2.6673 3.0801 0.0 0
M  V30 4 O 4.0012 0.7700 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 C 0.0000 3.0801 0.0 0
M  V30 7 O 1.3337 0.7700 0.0 0
M  V30 8 O 10.6697 0.0000 0.0 0
M  V30 9 C 12.0033 0.7700 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 6.6685 0.7700 0.0 0
M  V30 12 C 8.0022 3.0801 0.0 0
M  V30 13 C 8.0022 0.0000 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 9.3360 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)-3-(methylamino)-2-butenamide
C12H16N2O2
1002555-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 8.0022 0.7700 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 N 12.0033 3.0801 0.0 0
M  V30 7 C 10.6697 0.7700 0.0 0
M  V30 8 C 13.3370 2.3101 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 4.0010 3.0801 0.0 0
M  V30 14 C 4.0010 0.0000 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5437-98-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1002555-68-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24906856
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1643-19-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Tandem Hofmann-Type Rearrangement and Cyclization Reaction
of α-Acyl-β-aminoacrylamides: Access to Polysubstituted Oxazol-2(3H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Baibin; Yuan, Jingwen; Ye, Xuebei; Zhang, Rui; Li, Jiacheng; Wang,
Yu; Hu, Jiana; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2021), 86(24), 17944-17954

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl vinyl sulfone
C8H8O2S
5535-48-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 C 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 2.3100 0.2064 0.0 0
M  V30 8 C 2.3100 2.8736 0.0 0
M  V30 9 C 0.7700 0.2064 0.0 0
M  V30 10 C 0.7700 2.8736 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(phenylsulfonyl)ethanamine
C9H13NO2S
404033-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 C 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 N 8.0023 3.8501 0.0 0
M  V30 7 C 9.3360 3.0801 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5535-48-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 404033-91-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-3155914
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of substituted aziridines via intramolecular reactions of
β-N-chloroethylamino carbanions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Makosza, Mieczyslaw; Bobryk, Karolina; Krajewski, Dariusz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2008), 76(2), 1511-1524

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
4,6-Dichloro-2-pyrimidinamine
C4H3Cl2N3
56-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6200 0.0 0
M  V30 2 Cl 5.3349 4.6200 0.0 0
M  V30 3 N 2.6674 0.0000 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N4-methyl-2,4-pyrimidinediamine
C5H7ClN4
1005-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 6.6686 3.8500 0.0 0
M  V30 3 Cl 2.6675 0.0000 0.0 0
M  V30 4 N 0.0000 4.6201 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 N 2.6675 4.6201 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 N 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 56-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1005-37-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15859400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diaminopyrimidines as MTH1 inhibitors for treatment of inflammatory and
autoimmune conditions and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Scobie, Martin; Wallner, Olov; Koolmeister, Tobias; Vallin, Karl Sven
Axel; Henriksson, Carl Martin; Homan, Evert; Helleday, Thomas; Jacques,
Sylvain; Desroses, Matthieu; Jacques-Cordonnier, Marie-Caroline;
Fiskesund, Roland Julius Yu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015187089 A1 2015-12-10

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
4,6-Dichloro-2-pyrimidinamine
C4H3Cl2N3
56-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6200 0.0 0
M  V30 2 Cl 5.3349 4.6200 0.0 0
M  V30 3 N 2.6674 0.0000 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N4-methyl-2,4-pyrimidinediamine
C5H7ClN4
1005-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 6.6686 3.8500 0.0 0
M  V30 3 Cl 2.6675 0.0000 0.0 0
M  V30 4 N 0.0000 4.6201 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 N 2.6675 4.6201 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 N 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 56-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1005-37-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13572403
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine-2,4-diamine derivatives for treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Scobie, Martin; Helleday, Thomas; Koolmeister, Tobias; Jacques, Sylvain;
Desroses, Matthieu; Jacques-Cordonnier, Marie-Caroline
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014084778 A1 2014-06-05

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
1,3-Dimethyl-1H-pyrazole-5-carboxylic acid
C6H8N2O2
5744-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 1.6839 4.8720 0.0 0
M  V30 5 C 6.6363 2.6672 0.0 0
M  V30 6 C 2.6673 2.3100 0.0 0
M  V30 7 C 4.0743 1.6836 0.0 0
M  V30 8 N 2.8284 3.8416 0.0 0
M  V30 9 C 5.1047 2.8281 0.0 0
M  V30 10 N 4.3347 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1,3-Trimethyl-1H-pyrazole-5-carboxamide
C7H11N3O
136679-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 2.7104 0.0 0
M  V30 2 N 5.9256 4.0442 0.0 0
M  V30 3 O 5.9256 1.3768 0.0 0
M  V30 4 C 7.4656 4.0442 0.0 0
M  V30 5 C 3.1864 0.0000 0.0 0
M  V30 6 C 0.0000 4.3856 0.0 0
M  V30 7 C 3.6156 2.7104 0.0 0
M  V30 8 C 2.7104 3.9564 0.0 0
M  V30 9 N 2.7104 1.4645 0.0 0
M  V30 10 C 1.2459 3.4804 0.0 0
M  V30 11 N 1.2459 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5744-56-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 136679-01-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10115447
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-(4-Bromo-1,3-dimethyl-1H-pyrazol-5-yl)-N-methylmethanamine (50). CDI
(2.8 g, 17 mmol) was added to a suspension of
1,3-dimethyl-1H-pyrazole-5-carboxylic acid (2.0 g, 14 mmol) in THF (25
mL) at 20 °C. The mixture was then warmed to 50 °C with stirring for 30
min (gas evolution was observed). The mixture was then cooled to -10 °C
and methylamine (2 M in THF, 20 mL, 40.0 mmol) was added in one portion.
The ice bath was removed and the reaction was stirred at room temperature
for 1 h. The mixture was then concentrated and purified by column
chromatography over silica gel, which was eluted with 100% EtOAc.
N-1,3-trimethyl-1H-pyrazole-5-carboxamide. Yield: (2.0 g, 91%), clear
oil. TLC: Rf = 0.60 (100% EtOAc). LC-MS (ESI), m/z 154 [M+H]+; 1H NMR
(400 MHz, CDCl3) δ 6.12 (s, 1 H), 6.00 (br s, 1 H), 4.09 (s, 3 H), 2.93
(d, 3 H), 2.23 (s, 3 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
(10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile
(PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase
(ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and
Broad-Spectrum Potency against ALK-Resistant Mutations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johnson, Ted W.; Richardson, Paul F.; Bailey, Simon; Brooun, Alexei;
Burke, Benjamin J.; Collins, Michael R.; Cui, J. Jean; Deal, Judith G.;
Deng, Ya-Li; Dinh, Dac; Engstrom, Lars D.; He, Mingying; Hoffman, Jacqui;
Hoffman, Robert L.; Huang, Qinhua; Kania, Robert S.; Kath, John C.; Lam,
Hieu; Lam, Justine L.; Le, Phuong T.; Lingardo, Laura; Liu, Wei; McTigue,
Michele; Palmer, Cynthia L.; Sach, Neal W.; Smeal, Tod; Smith, Graham L.;
Stewart, Albert E.; Timofeevski, Sergei; Zhu, Huichun; Zhu, Jinjiang;
Zou, Helen Y.; Edwards, Martin P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2014), 57(11), 4720-4744

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
1,3-Dimethyl-1H-pyrazole-5-carboxylic acid
C6H8N2O2
5744-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 1.6839 4.8720 0.0 0
M  V30 5 C 6.6363 2.6672 0.0 0
M  V30 6 C 2.6673 2.3100 0.0 0
M  V30 7 C 4.0743 1.6836 0.0 0
M  V30 8 N 2.8284 3.8416 0.0 0
M  V30 9 C 5.1047 2.8281 0.0 0
M  V30 10 N 4.3347 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1,3-Trimethyl-1H-pyrazole-5-carboxamide
C7H11N3O
136679-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 2.7104 0.0 0
M  V30 2 N 5.9256 4.0442 0.0 0
M  V30 3 O 5.9256 1.3768 0.0 0
M  V30 4 C 7.4656 4.0442 0.0 0
M  V30 5 C 3.1864 0.0000 0.0 0
M  V30 6 C 0.0000 4.3856 0.0 0
M  V30 7 C 3.6156 2.7104 0.0 0
M  V30 8 C 2.7104 3.9564 0.0 0
M  V30 9 N 2.7104 1.4645 0.0 0
M  V30 10 C 1.2459 3.4804 0.0 0
M  V30 11 N 1.2459 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5744-56-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 136679-01-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7960380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: CDI (2.8 g, 17 mmol) was added to a suspension of compound 53
(2.0 g, 14 mmol) in THF (25 mL) at 20 °C. The mixture was then warmed to
50 °C with stirring for 30 mins (gas evolution). The mixture was then
cooled to -10 °C and MeNH2 (2 M in THF, 20 mL, 40.0 mmol) was added in
one portion. The ice bath was removed and the reaction was stirred at
room temperature for 60 minutes. The mixture was then concentrated and
purified by column chromatography over silica gel, which was eluted with
100% EtOAc. Compound 54 (2.0 g, 91% yield) as a clear oil. TLC: Rf = 0.60
(100% EtOAc). 1H NMR (400 MHz, CDCl3) δ 2.23 (s, 3 H), 2.93 (d, 3 H),
4.09 (s, 3 H), 6.00 (br s, 1 H), 6.12 (s, 1 H). LCMS ES m/z 154 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic derivatives for the treatment of proliferative diseases and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bailey, Simon; Burke, Benjamin Joseph; Collins, Michael Raymond; Cui,
Jingrong Jean; Deal, Judith Gail; Hoffman, Robert Louis; Huang, Qinhua;
Johnson, Ted William; Kania, Robert Steven; Kath, John Charles; Le,
Phuong Thi Quy; McTigue, Michele Ann; Palmer, Cynthia Louise; Richardson,
Paul Francis; Sach, Neal William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013132376 A1 2013-09-12

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
16-Oxabicyclo[10.3.1]hexadeca-12,15-dien-14-one
C15H22O2
575429-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.6395 2.8142 0.0 0
M  V30 2 C 5.7774 1.4727 0.0 0
M  V30 3 O 5.0020 2.8142 0.0 0
M  V30 4 C 7.3299 1.4698 0.0 0
M  V30 5 C 5.0443 0.1223 0.0 0
M  V30 6 C 5.7774 4.1558 0.0 0
M  V30 7 C 8.1054 2.8142 0.0 0
M  V30 8 C 3.5193 0.0000 0.0 0
M  V30 9 C 7.3299 4.1587 0.0 0
M  V30 10 C 5.0443 5.5062 0.0 0
M  V30 11 C 2.5867 1.2469 0.0 0
M  V30 12 C 3.5193 5.6285 0.0 0
M  V30 13 C 1.0610 1.0381 0.0 0
M  V30 14 C 2.5867 4.3816 0.0 0
M  V30 15 C 0.0000 2.0774 0.0 0
M  V30 16 C 1.0610 4.5904 0.0 0
M  V30 17 C 0.0000 3.5511 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
16-Methyl-16-azabicyclo[10.3.1]hexadeca-12,15-dien-14-one
C16H25NO
575429-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4679 2.8142 0.0 0
M  V30 2 O 9.6395 2.8142 0.0 0
M  V30 3 C 5.7774 4.1558 0.0 0
M  V30 4 N 5.0020 2.8142 0.0 0
M  V30 5 C 7.3299 4.1587 0.0 0
M  V30 6 C 5.0443 5.5062 0.0 0
M  V30 7 C 5.7774 1.4727 0.0 0
M  V30 8 C 8.1054 2.8142 0.0 0
M  V30 9 C 3.5193 5.6285 0.0 0
M  V30 10 C 7.3299 1.4698 0.0 0
M  V30 11 C 5.0443 0.1223 0.0 0
M  V30 12 C 2.5867 4.3816 0.0 0
M  V30 13 C 3.5193 0.0000 0.0 0
M  V30 14 C 1.0610 4.5904 0.0 0
M  V30 15 C 2.5867 1.2469 0.0 0
M  V30 16 C 0.0000 3.5511 0.0 0
M  V30 17 C 1.0610 1.0381 0.0 0
M  V30 18 C 0.0000 2.0774 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 575429-34-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 575429-46-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-13771360
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative prepn. shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly efficient methods for metacyclophane synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sato, Masayuki; Oda, Tsunehisa; Iwamoto, Ken-Ichi; Murakami, Emi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2003), 59(15), 2651-2655

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
(7R,7aR,10aR,11R)-7,7a,10a,11-Tetrahydro-9,9-dimethyl-7,11-epoxy-1H,6H-8,10-d...
C12H13N5O5
57901-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.1187 0.0000 0.0 0
M  V30 2 C 0.4184 2.2414 0.0 0
M  V30 3 C 0.0000 4.2594 0.0 0
M  V30 4 O 11.6627 2.6693 0.0 0
M  V30 5 C 5.3972 3.0075 0.0 0 CFG=2
M  V30 6 N 7.0973 2.6113 0.0 0
M  V30 7 C 3.8067 3.2099 0.0 0 CFG=2
M  V30 8 O 5.7182 4.3785 0.0 0
M  V30 9 C 7.8530 4.0078 0.0 0
M  V30 10 C 7.8647 1.3472 0.0 0
M  V30 11 C 3.4940 4.7179 0.0 0 CFG=2
M  V30 12 O 2.4691 2.4465 0.0 0
M  V30 13 C 4.8724 5.5227 0.0 0 CFG=2
M  V30 14 N 7.4770 5.4128 0.0 0
M  V30 15 C 9.3757 3.9610 0.0 0
M  V30 16 N 9.3700 1.3679 0.0 0
M  V30 17 O 1.9632 4.8865 0.0 0
M  V30 18 C 1.3298 3.4828 0.0 0
M  V30 19 C 6.3471 6.4919 0.0 0
M  V30 20 N 8.7032 6.3040 0.0 0
M  V30 21 N 9.9043 5.3732 0.0 0
M  V30 22 C 10.1227 2.6693 0.0 0
M  V30 23 H 5.1249 1.4917 0.0 0
M  V30 24 H 4.1067 1.6994 0.0 0
M  V30 25 H 3.1739 6.2242 0.0 0
M  V30 26 H 4.0609 6.8316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 18
M  V30 3 1 3 18
M  V30 4 2 4 22
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 23 CFG=3
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 7 24 CFG=1
M  V30 14 1 8 13
M  V30 15 1 9 14
M  V30 16 2 9 15
M  V30 17 1 10 16
M  V30 18 1 11 13
M  V30 19 1 11 17
M  V30 20 1 11 25 CFG=1
M  V30 21 1 12 18
M  V30 22 1 13 19
M  V30 23 1 13 26 CFG=3
M  V30 24 1 14 19
M  V30 25 1 14 20
M  V30 26 1 15 21
M  V30 27 1 15 22
M  V30 28 1 16 22
M  V30 29 1 17 18
M  V30 30 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 5 7 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(7R,7aR,10aR,11R)-7,7a,10a,11-Tetrahydro-9,9-dimethyl-3-(methylamino)-7,11-ep...
C13H16N6O4
656809-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.1187 0.0000 0.0 0
M  V30 2 N 11.6627 2.6693 0.0 0
M  V30 3 C 12.4327 1.3355 0.0 0
M  V30 4 C 0.4184 2.2414 0.0 0
M  V30 5 C 0.0000 4.2594 0.0 0
M  V30 6 C 7.8530 4.0078 0.0 0
M  V30 7 N 7.0973 2.6113 0.0 0
M  V30 8 C 9.3757 3.9610 0.0 0
M  V30 9 N 7.4770 5.4128 0.0 0
M  V30 10 C 5.3972 3.0075 0.0 0 CFG=2
M  V30 11 C 7.8647 1.3472 0.0 0
M  V30 12 C 10.1227 2.6693 0.0 0
M  V30 13 N 9.9043 5.3732 0.0 0
M  V30 14 C 6.3471 6.4919 0.0 0
M  V30 15 N 8.7032 6.3040 0.0 0
M  V30 16 C 3.8067 3.2099 0.0 0 CFG=2
M  V30 17 O 5.7182 4.3785 0.0 0
M  V30 18 N 9.3700 1.3679 0.0 0
M  V30 19 C 4.8724 5.5227 0.0 0 CFG=2
M  V30 20 C 3.4940 4.7179 0.0 0 CFG=2
M  V30 21 O 2.4691 2.4465 0.0 0
M  V30 22 O 1.9632 4.8865 0.0 0
M  V30 23 C 1.3298 3.4828 0.0 0
M  V30 24 H 5.1249 1.4917 0.0 0
M  V30 25 H 4.1067 1.6994 0.0 0
M  V30 26 H 4.0609 6.8316 0.0 0
M  V30 27 H 3.1739 6.2242 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 23
M  V30 5 1 5 23
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 10 17
M  V30 17 1 10 24 CFG=3
M  V30 18 1 11 18
M  V30 19 2 12 18
M  V30 20 2 13 15
M  V30 21 1 14 19
M  V30 22 1 16 20
M  V30 23 1 16 21
M  V30 24 1 16 25 CFG=1
M  V30 25 1 17 19
M  V30 26 1 19 20
M  V30 27 1 19 26 CFG=3
M  V30 28 1 20 22
M  V30 29 1 20 27 CFG=1
M  V30 30 1 21 23
M  V30 31 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 10 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 57901-63-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 656809-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14182181
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 53176-11-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N
9,5'-Cyclo-3-(2,3-O-isopropylidine-β-D-ribofuranosyl)-6-methylamino-8-azapurine-2-one
(10b). Triethylamine (0.4 mL, 2.83 mmol) was added to a mixture of 6 (200
mg, 0.65 mmol), DMAP (200 mg, 1.64 mmol), and triisopropylbenzenesulfonyl
chloride (400 mg, 1.32 mmol) in CH3CN (10 mL) at ca. 0°C, and the mixture
was stirred at room temperature for 12 h. To the mixture was CH3NH2 (2
mL), and the stirring continued for 2 h. The solventwas removed in vacuo,
and the residue purified on a silica gel column (eluate; EtOAc:hexanes
3:1). (181 mg, 91%, white solid) of 10b as a mixture of tautomers
(6-MeNH-: 6-MeN=; 20:1 at room temperature). 1H NMR (DMSO-d 6) δ 8.93
(1H, q, 6-NH, J = 4.8 Hz), 6.34 (1H, s, H-1'), 5.15 (1H, d, H-5'a, J =
14.0 Hz), 4.87-4.84 (2H, dd, H-4', and H-3', J = 4.4, J = 5.6 Hz), 4.70
(1H, d, H-2', J = 6.0 Hz), 4.59 (1H, dd, H-5'b, J = 4.4, J = 14.0 Hz),
2.90 (3H, d, N-CH3, J = 4.8 Hz), 1.46 (3H, s, CH3), 1.24 (3H, s, CH3).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Anti-HCV Activity of
N9,5'-Cyclo-3-(β-D-Ribofuranosyl)-8-Azapurin-2-One Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hassan, Abdalla; Wang, Peiyuan; McBrayer, Tamara; Tharnish, Philip;
Stuyver, Lieven; Otto, Michael; Watanabe, Kyoichi; Schinazi, Raymond
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleosides, Nucleotides & Nucleic Acids (2005), 24(10-12), 1531-1542

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
(7R,7aR,10aR,11R)-7,7a,10a,11-Tetrahydro-9,9-dimethyl-7,11-epoxy-1H,6H-8,10-d...
C12H13N5O5
57901-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.1187 0.0000 0.0 0
M  V30 2 C 0.4184 2.2414 0.0 0
M  V30 3 C 0.0000 4.2594 0.0 0
M  V30 4 O 11.6627 2.6693 0.0 0
M  V30 5 C 5.3972 3.0075 0.0 0 CFG=2
M  V30 6 N 7.0973 2.6113 0.0 0
M  V30 7 C 3.8067 3.2099 0.0 0 CFG=2
M  V30 8 O 5.7182 4.3785 0.0 0
M  V30 9 C 7.8530 4.0078 0.0 0
M  V30 10 C 7.8647 1.3472 0.0 0
M  V30 11 C 3.4940 4.7179 0.0 0 CFG=2
M  V30 12 O 2.4691 2.4465 0.0 0
M  V30 13 C 4.8724 5.5227 0.0 0 CFG=2
M  V30 14 N 7.4770 5.4128 0.0 0
M  V30 15 C 9.3757 3.9610 0.0 0
M  V30 16 N 9.3700 1.3679 0.0 0
M  V30 17 O 1.9632 4.8865 0.0 0
M  V30 18 C 1.3298 3.4828 0.0 0
M  V30 19 C 6.3471 6.4919 0.0 0
M  V30 20 N 8.7032 6.3040 0.0 0
M  V30 21 N 9.9043 5.3732 0.0 0
M  V30 22 C 10.1227 2.6693 0.0 0
M  V30 23 H 5.1249 1.4917 0.0 0
M  V30 24 H 4.1067 1.6994 0.0 0
M  V30 25 H 3.1739 6.2242 0.0 0
M  V30 26 H 4.0609 6.8316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 18
M  V30 3 1 3 18
M  V30 4 2 4 22
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 23 CFG=3
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 7 24 CFG=1
M  V30 14 1 8 13
M  V30 15 1 9 14
M  V30 16 2 9 15
M  V30 17 1 10 16
M  V30 18 1 11 13
M  V30 19 1 11 17
M  V30 20 1 11 25 CFG=1
M  V30 21 1 12 18
M  V30 22 1 13 19
M  V30 23 1 13 26 CFG=3
M  V30 24 1 14 19
M  V30 25 1 14 20
M  V30 26 1 15 21
M  V30 27 1 15 22
M  V30 28 1 16 22
M  V30 29 1 17 18
M  V30 30 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 5 7 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(7R,7aR,10aR,11R)-7,7a,10a,11-Tetrahydro-9,9-dimethyl-3-(methylamino)-7,11-ep...
C13H16N6O4
656809-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.1187 0.0000 0.0 0
M  V30 2 N 11.6627 2.6693 0.0 0
M  V30 3 C 12.4327 1.3355 0.0 0
M  V30 4 C 0.4184 2.2414 0.0 0
M  V30 5 C 0.0000 4.2594 0.0 0
M  V30 6 C 7.8530 4.0078 0.0 0
M  V30 7 N 7.0973 2.6113 0.0 0
M  V30 8 C 9.3757 3.9610 0.0 0
M  V30 9 N 7.4770 5.4128 0.0 0
M  V30 10 C 5.3972 3.0075 0.0 0 CFG=2
M  V30 11 C 7.8647 1.3472 0.0 0
M  V30 12 C 10.1227 2.6693 0.0 0
M  V30 13 N 9.9043 5.3732 0.0 0
M  V30 14 C 6.3471 6.4919 0.0 0
M  V30 15 N 8.7032 6.3040 0.0 0
M  V30 16 C 3.8067 3.2099 0.0 0 CFG=2
M  V30 17 O 5.7182 4.3785 0.0 0
M  V30 18 N 9.3700 1.3679 0.0 0
M  V30 19 C 4.8724 5.5227 0.0 0 CFG=2
M  V30 20 C 3.4940 4.7179 0.0 0 CFG=2
M  V30 21 O 2.4691 2.4465 0.0 0
M  V30 22 O 1.9632 4.8865 0.0 0
M  V30 23 C 1.3298 3.4828 0.0 0
M  V30 24 H 5.1249 1.4917 0.0 0
M  V30 25 H 4.1067 1.6994 0.0 0
M  V30 26 H 4.0609 6.8316 0.0 0
M  V30 27 H 3.1739 6.2242 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 23
M  V30 5 1 5 23
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 10 17
M  V30 17 1 10 24 CFG=3
M  V30 18 1 11 18
M  V30 19 2 12 18
M  V30 20 2 13 15
M  V30 21 1 14 19
M  V30 22 1 16 20
M  V30 23 1 16 21
M  V30 24 1 16 25 CFG=1
M  V30 25 1 17 19
M  V30 26 1 19 20
M  V30 27 1 19 26 CFG=3
M  V30 28 1 20 22
M  V30 29 1 20 27 CFG=1
M  V30 30 1 21 23
M  V30 31 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 10 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 57901-63-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 656809-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3024728
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 6553-96-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclo[4.2.1]nonane nucleoside analogs for the treatment
of Flaviviridae infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Peiyuan; Stuyver, Lieven J.; Watanabe, Kyoichi A.; Hassan, Abdalla;
Chun, Byoung-Known; Hollecker, Laurent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004013300 A2 2004-02-12

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[2,3-c]furan-4,6-dione
C6H2O3S
6007-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.7796 0.0 0
M  V30 2 O 5.3026 3.6527 0.0 0
M  V30 3 C 1.4946 2.4781 0.0 0
M  V30 4 C 3.0011 2.1579 0.0 0
M  V30 5 C 1.3337 4.0096 0.0 0
M  V30 6 C 0.7246 1.1444 0.0 0
M  V30 7 C 3.7711 3.4916 0.0 0
M  V30 8 S 3.1620 0.6263 0.0 0
M  V30 9 O 2.7406 4.6361 0.0 0
M  V30 10 C 1.7552 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methyl-4H-thieno[2,3-c]pyrrole-4,6(5H)-dione
C7H5NO2S
1296865-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.7798 5.3026 0.0 0
M  V30 2 O 3.6527 0.0000 0.0 0
M  V30 3 C 6.1426 2.2418 0.0 0
M  V30 4 C 2.4782 3.8080 0.0 0
M  V30 5 C 2.1580 2.3016 0.0 0
M  V30 6 C 4.0098 3.9690 0.0 0
M  V30 7 C 1.1446 4.5781 0.0 0
M  V30 8 C 3.4917 1.5316 0.0 0
M  V30 9 S 0.6263 2.1406 0.0 0
M  V30 10 N 4.6361 2.5620 0.0 0
M  V30 11 C 0.0000 3.5475 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6007-83-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1296865-90-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-6738557
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-property relationships in multifunctional
thieno(bis)imide-based semiconductors with different sized and shaped
N-alkyl ends
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Melucci, Manuela; Durso, Margherita; Bettini, Cristian; Gazzano, Massimo;
Maini, Lucia; Toffanin, Stefano; Cavallini, Susanna; Cavallini,
Massimiliano; Gentili, Denis; Biondo, Viviana; Generali, Gianluca;
Gallino, Federico; Capelli, Raffaella; Muccini, Michele
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Materials Chemistry C: Materials for Optical and Electronic
Devices (2014), 2(17), 3448-3456

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-Mandelic acid
C8H8O3
611-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0 CFG=1
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 O 6.9302 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.7700 1.3337 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(-)-Methyl mandelate
C9H10O3
20698-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 O 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(1):AMD
$DATUM reaction products with divinylbenzene-styrene copolymer diazonium salt
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20698-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-019-CAS-11428436
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer-supported triazenes as smart reagents for the alkylation of
carboxylic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Erb, Bernhard; Kucma, Jean-Philippe; Mourey, Sandrine; Struber, Fritz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2003), 9(11), 2582-2588

$RFMT $RIREG SCHEME283 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-5-chloroimidazo[1,2-a]thieno[3,2-e]pyrazine
C8H3BrClN3S
615535-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 4.6877 0.0 0
M  V30 2 Cl 6.6520 4.7474 0.0 0
M  V30 3 N 2.6508 3.9774 0.0 0
M  V30 4 C 2.6508 2.4374 0.0 0
M  V30 5 C 3.9845 4.7474 0.0 0
M  V30 6 C 1.5064 5.0078 0.0 0
M  V30 7 C 3.9845 1.6674 0.0 0
M  V30 8 S 1.5064 1.4070 0.0 0
M  V30 9 C 5.3183 3.9774 0.0 0
M  V30 10 N 3.6643 6.2537 0.0 0
M  V30 11 C 2.1328 6.4148 0.0 0
M  V30 12 N 5.3183 2.4374 0.0 0
M  V30 13 C 3.6643 0.1611 0.0 0
M  V30 14 C 2.1328 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 2 9 12
M  V30 15 1 10 11
M  V30 16 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-N-methylimidazo[1,2-a]thieno[3,2-e]pyrazin-5-amine
C9H7BrN4S
615528-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 4.6877 0.0 0
M  V30 2 N 6.6520 4.7475 0.0 0
M  V30 3 C 7.9857 3.9774 0.0 0
M  V30 4 N 2.6509 3.9774 0.0 0
M  V30 5 C 2.6509 2.4374 0.0 0
M  V30 6 C 3.9845 4.7475 0.0 0
M  V30 7 C 1.5065 5.0079 0.0 0
M  V30 8 C 3.9845 1.6674 0.0 0
M  V30 9 S 1.5065 1.4070 0.0 0
M  V30 10 C 5.3182 3.9774 0.0 0
M  V30 11 N 3.6644 6.2538 0.0 0
M  V30 12 C 2.1328 6.4149 0.0 0
M  V30 13 N 5.3182 2.4374 0.0 0
M  V30 14 C 3.6644 0.1611 0.0 0
M  V30 15 C 2.1328 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 2 10 13
M  V30 16 1 11 12
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 615535-10-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 615528-47-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7603406
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazothienopyrazines for treatment of inflammatory and
immune diseases.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Belema, Makonen; Bunker, Amy; Nguyen, Van; Beaulieu, Francis; Ouellet,
Carl; Marinier, Anne; Roy, Stephan; Yang, Xuejie; Qiu, Yuping; Zhang,
Yunhui; Martel, Alain; Zusi, Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003084959 A1 2003-10-16

$RFMT $RIREG SCHEME284 STEP1
$RXN



  2  1
$MOL
4-Bromobenzonitrile
C7H4BrN
623-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.3336 0.0 0
M  V30 2 N 7.7000 1.3336 0.0 0
M  V30 3 Br 0.0000 1.3336 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzenecarbothioamide
C8H8BrNS
920510-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 S 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 623-00-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 920510-22-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30573167
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 12135-76-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 349081-21-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 349081-21-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a mixture of nitrile (1 mmol) in
C6(mim)2Cl2 (1.1 mmol), ammonium sulfide (1.2 mmol) was added. The
resulting mixture was stirred at 70 °C for the appropriate time shown in
Table 2. After the completion of the reaction, as indicated by TLC, amine
(5 mmol) was added to the reaction and stirred at 70 °C for 10 min to 5 h
(Table 3). Then the reaction took place, was quenched with ice-water (10
ml) and stirred at room temperature for 10 min. The above mixture was
extracted with ethyl acetate (3 × 5 ml) and the organic layers were
combined. When the residue was dried and concentrated in vacuo, it was
chromatographied on silica gel (n-heptane/ethyl acetate as eluent) to
afford the pure products in 70-95% yields. Compound: 3d, Yield (%): 91,
Time (min): 10.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, ionic liquid used (catalytic media)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient and green protocol for the synthesis of thioamides in
C6(mim)2Cl2 as a dicationic ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khosropour, A. R.; Noei, J.; Mirjafari, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2010), 7(3), 752-758

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-1-naphthalenesulfonyl chloride
C10H6Cl2O2S
6291-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 Cl 8.0023 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 6.6687 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 13 C 5.3348 5.3901 0.0 0
M  V30 14 C 6.6687 4.6201 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-1-naphthalenesulfonamide
C11H10ClNO2S
109961-88-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 3.0801 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8985 4.4137 0.0 0
M  V30 4 O 7.4385 1.7464 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 Cl 0.0000 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 2.6675 5.3901 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6291-07-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 109961-88-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-15954701
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazolopyrimidines useful for inhibiting BMP
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Arthur; Mckew, John C.; Patel, Paresma R.; Yu, Paul B.; Mohedas,
Agustin H.; Sanderson, Philip E.; Zheng, Wei; Huang, Xiuli; Cuny, Gregory
D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016011019 A1 2016-01-21

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[(1R,2S,4S,5S)-2-[[Bis(phenylmethoxy)phosphinyl]oxy]-4-[6-chloro-2-(methylthi...
C41H41ClN4O8P2S
630103-34-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 65 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.3222 10.5698 0.0 0
M  V30 2 O 11.0922 11.9034 0.0 0
M  V30 3 P 12.6322 11.9034 0.0 0 VAL=5
M  V30 4 O 14.1722 11.9034 0.0 0
M  V30 5 O 12.6322 13.4435 0.0 0
M  V30 6 O 12.6322 10.3634 0.0 0
M  V30 7 C 14.9422 13.2371 0.0 0
M  V30 8 C 11.2985 14.2135 0.0 0
M  V30 9 O 9.7656 8.0077 0.0 0
M  V30 10 P 9.4454 6.5014 0.0 0 VAL=5
M  V30 11 O 9.1252 4.9949 0.0 0
M  V30 12 O 10.9519 6.1812 0.0 0
M  V30 13 O 7.9391 6.8215 0.0 0
M  V30 14 C 7.6605 4.5190 0.0 0
M  V30 15 C 11.4277 4.7165 0.0 0
M  V30 16 Cl 0.0000 12.0505 0.0 0
M  V30 17 S 3.9645 15.6201 0.0 0
M  V30 18 C 2.9340 16.7645 0.0 0
M  V30 19 C 8.7821 10.5698 0.0 0 CFG=2
M  V30 20 C 7.3753 11.1961 0.0 0 CFG=1
M  V30 21 C 8.6212 9.0382 0.0 0 CFG=1
M  V30 22 C 8.6212 12.1013 0.0 0
M  V30 23 C 6.3447 10.0517 0.0 0 CFG=1
M  V30 24 C 7.1147 8.7181 0.0 0
M  V30 25 N 4.8132 10.2127 0.0 0
M  V30 26 C 4.0432 11.5463 0.0 0
M  V30 27 C 3.7828 9.0683 0.0 0
M  V30 28 C 2.5369 11.2261 0.0 0
M  V30 29 N 4.5190 13.0110 0.0 0
M  V30 30 N 2.3758 9.6946 0.0 0
M  V30 31 C 1.5063 12.3707 0.0 0
M  V30 32 C 3.4886 14.1554 0.0 0
M  V30 33 N 1.9823 13.8352 0.0 0
M  V30 34 C 7.3404 3.0127 0.0 0
M  V30 35 C 5.8758 2.5369 0.0 0
M  V30 36 C 8.4849 1.9822 0.0 0
M  V30 37 C 5.5556 1.0304 0.0 0
M  V30 38 C 8.1647 0.4759 0.0 0
M  V30 39 C 6.7000 0.0000 0.0 0
M  V30 40 C 12.9340 4.3963 0.0 0
M  V30 41 C 13.4099 2.9317 0.0 0
M  V30 42 C 13.9646 5.5408 0.0 0
M  V30 43 C 14.9163 2.6114 0.0 0
M  V30 44 C 15.4709 5.2205 0.0 0
M  V30 45 C 15.9468 3.7560 0.0 0
M  V30 46 C 16.4822 13.2371 0.0 0
M  V30 47 C 17.2522 11.9034 0.0 0
M  V30 48 C 17.2522 14.5709 0.0 0
M  V30 49 C 18.7923 11.9034 0.0 0
M  V30 50 C 18.7923 14.5709 0.0 0
M  V30 51 C 19.5623 13.2371 0.0 0
M  V30 52 C 11.2985 15.7535 0.0 0
M  V30 53 C 9.9649 16.5235 0.0 0
M  V30 54 C 12.6322 16.5235 0.0 0
M  V30 55 C 9.9649 18.0635 0.0 0
M  V30 56 C 12.6322 18.0635 0.0 0
M  V30 57 C 11.2985 18.8335 0.0 0
M  V30 58 H 6.3447 12.3407 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 46
M  V30 10 1 8 52
M  V30 11 1 9 10
M  V30 12 1 21 9 CFG=1
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 1 14 34
M  V30 19 1 15 40
M  V30 20 1 16 31
M  V30 21 1 17 18
M  V30 22 1 17 32
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 19 22
M  V30 26 1 20 22
M  V30 27 1 20 23
M  V30 28 1 20 58 CFG=3
M  V30 29 1 21 24
M  V30 30 1 23 24
M  V30 31 1 23 25 CFG=3
M  V30 32 1 25 26
M  V30 33 1 25 27
M  V30 34 1 26 28
M  V30 35 2 26 29
M  V30 36 2 27 30
M  V30 37 1 28 30
M  V30 38 2 28 31
M  V30 39 1 29 32
M  V30 40 1 31 33
M  V30 41 2 32 33
M  V30 42 2 34 35
M  V30 43 1 34 36
M  V30 44 1 35 37
M  V30 45 2 36 38
M  V30 46 2 37 39
M  V30 47 1 38 39
M  V30 48 2 40 41
M  V30 49 1 40 42
M  V30 50 1 41 43
M  V30 51 2 42 44
M  V30 52 2 43 45
M  V30 53 1 44 45
M  V30 54 2 46 47
M  V30 55 1 46 48
M  V30 56 1 47 49
M  V30 57 2 48 50
M  V30 58 2 49 51
M  V30 59 1 50 51
M  V30 60 2 52 53
M  V30 61 1 52 54
M  V30 62 1 53 55
M  V30 63 2 54 56
M  V30 64 2 55 57
M  V30 65 1 56 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 19 20 21 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[(1R,2S,4S,5S)-2-[[Bis(phenylmethoxy)phosphinyl]oxy]-4-[6-(methylamino)-2-(me...
C42H45N5O8P2S
630103-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  59 66 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 10.5696 0.0 0
M  V30 2 O 8.4700 11.9033 0.0 0
M  V30 3 P 6.9300 11.9033 0.0 0 VAL=5
M  V30 4 O 5.3900 11.9033 0.0 0
M  V30 5 O 6.9300 13.4433 0.0 0
M  V30 6 O 6.9300 10.3633 0.0 0
M  V30 7 C 4.6200 13.2369 0.0 0
M  V30 8 C 8.2636 14.2133 0.0 0
M  V30 9 O 9.7966 8.0075 0.0 0
M  V30 10 P 10.1167 6.5013 0.0 0 VAL=5
M  V30 11 O 10.4369 4.9948 0.0 0
M  V30 12 O 8.6104 6.1811 0.0 0
M  V30 13 O 11.6232 6.8214 0.0 0
M  V30 14 C 11.9016 4.5190 0.0 0
M  V30 15 C 8.1346 4.7164 0.0 0
M  V30 16 N 19.5620 12.0503 0.0 0
M  V30 17 C 20.5926 13.1947 0.0 0
M  V30 18 S 15.5976 15.6199 0.0 0
M  V30 19 C 15.1217 17.0846 0.0 0
M  V30 20 C 10.7800 10.5696 0.0 0 CFG=2
M  V30 21 C 12.1869 11.1960 0.0 0 CFG=1
M  V30 22 C 10.9411 9.0381 0.0 0 CFG=1
M  V30 23 C 10.9411 12.1012 0.0 0
M  V30 24 C 13.2174 10.0516 0.0 0 CFG=1
M  V30 25 C 12.4474 8.7179 0.0 0
M  V30 26 N 14.7489 10.2125 0.0 0
M  V30 27 C 15.5189 11.5461 0.0 0
M  V30 28 C 15.7795 9.0681 0.0 0
M  V30 29 C 17.0253 11.2260 0.0 0
M  V30 30 N 15.0430 13.0108 0.0 0
M  V30 31 N 17.1862 9.6945 0.0 0
M  V30 32 C 18.0557 12.3705 0.0 0
M  V30 33 C 16.0734 14.1552 0.0 0
M  V30 34 N 17.5799 13.8351 0.0 0
M  V30 35 C 12.2217 3.0127 0.0 0
M  V30 36 C 11.0774 1.9821 0.0 0
M  V30 37 C 13.6864 2.5368 0.0 0
M  V30 38 C 11.3975 0.4759 0.0 0
M  V30 39 C 14.0066 1.0304 0.0 0
M  V30 40 C 12.8621 0.0000 0.0 0
M  V30 41 C 6.6282 4.3962 0.0 0
M  V30 42 C 5.5977 5.5408 0.0 0
M  V30 43 C 6.1523 2.9317 0.0 0
M  V30 44 C 4.0913 5.2204 0.0 0
M  V30 45 C 4.6459 2.6114 0.0 0
M  V30 46 C 3.6155 3.7559 0.0 0
M  V30 47 C 3.0800 13.2369 0.0 0
M  V30 48 C 2.3100 11.9033 0.0 0
M  V30 49 C 2.3100 14.5707 0.0 0
M  V30 50 C 0.7700 11.9033 0.0 0
M  V30 51 C 0.7700 14.5707 0.0 0
M  V30 52 C 0.0000 13.2369 0.0 0
M  V30 53 C 8.2636 15.7533 0.0 0
M  V30 54 C 6.9300 16.5233 0.0 0
M  V30 55 C 9.5974 16.5233 0.0 0
M  V30 56 C 6.9300 18.0633 0.0 0
M  V30 57 C 9.5974 18.0633 0.0 0
M  V30 58 C 8.2636 18.8333 0.0 0
M  V30 59 H 13.2174 12.3405 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 20 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 47
M  V30 10 1 8 53
M  V30 11 1 9 10
M  V30 12 1 22 9 CFG=3
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 1 14 35
M  V30 19 1 15 41
M  V30 20 1 16 17
M  V30 21 1 16 32
M  V30 22 1 18 19
M  V30 23 1 18 33
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 20 23
M  V30 27 1 21 23
M  V30 28 1 21 24
M  V30 29 1 21 59 CFG=1
M  V30 30 1 22 25
M  V30 31 1 24 25
M  V30 32 1 24 26 CFG=1
M  V30 33 1 26 27
M  V30 34 1 26 28
M  V30 35 1 27 29
M  V30 36 2 27 30
M  V30 37 2 28 31
M  V30 38 1 29 31
M  V30 39 2 29 32
M  V30 40 1 30 33
M  V30 41 1 32 34
M  V30 42 2 33 34
M  V30 43 2 35 36
M  V30 44 1 35 37
M  V30 45 1 36 38
M  V30 46 2 37 39
M  V30 47 2 38 40
M  V30 48 1 39 40
M  V30 49 2 41 42
M  V30 50 1 41 43
M  V30 51 1 42 44
M  V30 52 2 43 45
M  V30 53 2 44 46
M  V30 54 1 45 46
M  V30 55 2 47 48
M  V30 56 1 47 49
M  V30 57 1 48 50
M  V30 58 2 49 51
M  V30 59 2 50 52
M  V30 60 1 51 52
M  V30 61 2 53 54
M  V30 62 1 53 55
M  V30 63 1 54 56
M  V30 64 2 55 57
M  V30 65 2 56 58
M  V30 66 1 57 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 20 21 22 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 630103-34-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 630103-36-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6930820
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (1'R,2'S,4'S,5'S)-4-(6-Methylamino-2-methylthio-9H-purin-9-yl)-1-[(dibenzylphosphato)-methyl]-2-(dibenzylphosphato)
bicyclo[3.1.0]hexane (28). Compound 26 (3.0 mg, 0.0035 mmol) was
dissolved in 2.0 M MeNH2 in THF (0.50 mL) and stirred for 2.5 h at room
temperature. The solvent was removed under reduced pressure. The residue
obtained was purified by preparative thin-layer chromatography (AcOEt),
which furnished 28 (2.7 mg, 91%). 1H NMR (CDCl3) δ 7.77 (s, 1H),
7.30-7.25 (m, 20H), 5.72 (bs, 1H), 5.38 (dd, 1H, J = 7.5, 14.1 Hz),
5.03-4.91 (m, 9H), 4.59 (dd, 1H, J = 6.3, 11.4 Hz), 3.78 (dd, 1H, J =
5.1, 11.4 Hz), 3.19 (bs, 3H), 2.57 (s, 3H), 2.19-2.10 (m, 1H), 1.96-1.82
(m, 1H), 1.60-1.55 (m, 1H), 1.04-1.00 (m, 1H), 0.88-0.78 (m, 1H); MS
(m/e) (positive- FAB) 842 (M+ + 1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Substitution of Adenine Nucleotide Analogues Containing a
Bicyclo[3.1.0]hexane Ring System Locked in a Northern Conformation:
Enhanced Potency as P2Y1 Receptor Antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Hak Sung; Ohno, Michihiro; Xu, Bin; Kim, Hea Ok; Choi, Yongseok; Ji,
Xiao D.; Maddileti, Savitri; Marquez, Victor E.; Harden, T. Kendall;
Jacobson, Kenneth A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(23), 4974-4987

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
2-[(Diphenylmethyl)thio]acetic acid
C15H14O2S
63547-22-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 S 5.3348 5.3901 0.0 0
M  V30 3 C 6.6685 4.6201 0.0 0
M  V30 4 C 8.0023 5.3901 0.0 0
M  V30 5 O 9.3360 4.6201 0.0 0
M  V30 6 O 8.0023 6.9302 0.0 0
M  V30 7 C 2.6675 5.3901 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 C 2.6675 6.9302 0.0 0
M  V30 10 C 0.0000 5.3901 0.0 0
M  V30 11 C 1.3337 7.7002 0.0 0
M  V30 12 C 0.0000 6.9302 0.0 0
M  V30 13 C 4.0012 3.0801 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 2.6675 0.7700 0.0 0
M  V30 18 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Diphenylmethyl)thio]-N-methylacetamide
C16H17NOS
344761-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6201 0.0 0
M  V30 2 S 5.3348 5.3901 0.0 0
M  V30 3 C 6.6684 4.6201 0.0 0
M  V30 4 C 8.0022 5.3901 0.0 0
M  V30 5 N 9.3359 4.6201 0.0 0
M  V30 6 O 8.0022 6.9301 0.0 0
M  V30 7 C 10.6695 5.3901 0.0 0
M  V30 8 C 2.6673 5.3901 0.0 0
M  V30 9 C 2.6673 6.9301 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 1.3337 7.7001 0.0 0
M  V30 12 C 0.0000 5.3901 0.0 0
M  V30 13 C 0.0000 6.9301 0.0 0
M  V30 14 C 4.0011 3.0800 0.0 0
M  V30 15 C 5.3348 2.3100 0.0 0
M  V30 16 C 2.6673 2.3100 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 2.6673 0.7700 0.0 0
M  V30 19 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 14
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 63547-22-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 344761-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-662600
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simple synthesis of modafinil derivatives and their antiinflammatory
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Jae-Chul; Lee, Yeonju; Son, Jee-Young; Lim, Eunyoung; Jung, Mankil;
Oh, Seikwan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2012), 1710446-10458

$RFMT $RIREG SCHEME288 STEP1
$RXN



  2  1
$MOL
Modafinil acid
C15H14O3S
63547-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6201 0.0 0
M  V30 2 S 5.3348 5.3901 0.0 0 VAL=4
M  V30 3 C 6.6684 4.6201 0.0 0
M  V30 4 O 5.3348 6.9301 0.0 0
M  V30 5 C 8.0022 5.3901 0.0 0
M  V30 6 O 9.3359 4.6201 0.0 0
M  V30 7 O 8.0022 6.9301 0.0 0
M  V30 8 C 2.6675 5.3901 0.0 0
M  V30 9 C 2.6675 6.9301 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 1.3337 7.7001 0.0 0
M  V30 12 C 0.0000 5.3901 0.0 0
M  V30 13 C 0.0000 6.9301 0.0 0
M  V30 14 C 4.0011 3.0800 0.0 0
M  V30 15 C 2.6675 2.3100 0.0 0
M  V30 16 C 5.3348 2.3100 0.0 0
M  V30 17 C 2.6675 0.7700 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 19 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 14
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Diphenylmethyl)sulfinyl]-N-methylacetamide
C16H17NO2S
90280-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 S 5.3347 5.3900 0.0 0 VAL=4
M  V30 3 C 6.6684 4.6200 0.0 0
M  V30 4 O 5.3347 6.9300 0.0 0
M  V30 5 C 8.0021 5.3900 0.0 0
M  V30 6 N 9.3358 4.6200 0.0 0
M  V30 7 O 8.0021 6.9300 0.0 0
M  V30 8 C 10.6694 5.3900 0.0 0
M  V30 9 C 2.6673 5.3900 0.0 0
M  V30 10 C 2.6673 6.9300 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 1.3336 7.7000 0.0 0
M  V30 13 C 0.0000 5.3900 0.0 0
M  V30 14 C 0.0000 6.9300 0.0 0
M  V30 15 C 4.0011 3.0800 0.0 0
M  V30 16 C 5.3347 2.3100 0.0 0
M  V30 17 C 2.6673 2.3100 0.0 0
M  V30 18 C 5.3347 0.7700 0.0 0
M  V30 19 C 2.6673 0.7700 0.0 0
M  V30 20 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 1 15
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 63547-24-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90280-08-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-278336
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simple synthesis of modafinil derivatives and their antiinflammatory
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Jae-Chul; Lee, Yeonju; Son, Jee-Young; Lim, Eunyoung; Jung, Mankil;
Oh, Seikwan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2012), 1710446-10458

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxystyrene
C9H10O
637-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-[2-(4-methoxyphenyl)ethyl]-N-methylbenzeneethanamine
C19H25NO2
879725-00-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 9.3360 1.5400 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 9.3360 0.0000 0.0 0
M  V30 6 C 12.0035 1.5400 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 C 0.0000 3.8501 0.0 0
M  V30 9 O 17.3383 4.6201 0.0 0
M  V30 10 C 18.6720 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 15 C 4.0012 4.6201 0.0 0
M  V30 16 C 2.6675 3.8501 0.0 0
M  V30 17 C 13.3372 2.3101 0.0 0
M  V30 18 C 14.6708 1.5400 0.0 0
M  V30 19 C 13.3372 3.8501 0.0 0
M  V30 20 C 16.0045 2.3101 0.0 0
M  V30 21 C 14.6708 4.6201 0.0 0
M  V30 22 C 16.0045 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 7 16
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 637-69-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 879725-00-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41528656
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3037071-70-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed tube used, no solvent, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Approach to Substrate Activation or How Heterobimetallic Complexes
{[(p-tBu-C6H4)2CH]3M}K (M = Ca and Yb) Make Intermolecular Olefin
Hydroamination and NH3 Cascade Hydroamination/Hydroaminomethylation
Feasible
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Selikhov, Alexander N.; Cherkasov, Anton V.; Nelyubina, Yulia V.;
Trifonov, Alexander A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2023), 13(19), 12582-12590

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
2-(7-Chlorothieno[3,2-b]pyridin-2-yl)-4-thiazolecarboxylic acid
C11H5ClN2O2S2
638217-64-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.3336 0.0000 0.0 0
M  V30 2 C 10.1928 4.7552 0.0 0
M  V30 3 O 11.5996 4.1289 0.0 0
M  V30 4 O 10.0319 6.2869 0.0 0
M  V30 5 C 2.6673 2.3100 0.0 0
M  V30 6 C 2.6673 3.8500 0.0 0
M  V30 7 S 4.1320 1.8341 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 4.1320 4.3260 0.0 0
M  V30 10 N 1.3336 4.6200 0.0 0
M  V30 11 C 5.0370 3.0800 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 C 6.5770 3.0800 0.0 0
M  V30 15 N 7.4822 4.3260 0.0 0
M  V30 16 S 7.4822 1.8341 0.0 0
M  V30 17 C 8.9469 3.8500 0.0 0
M  V30 18 C 8.9469 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(7-Chlorothieno[3,2-b]pyridin-2-yl)-N-methyl-4-thiazolecarboxamide
C12H8ClN3OS2
638217-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.1930 4.7552 0.0 0
M  V30 2 N 11.5997 4.1289 0.0 0
M  V30 3 O 10.0320 6.2869 0.0 0
M  V30 4 C 12.8458 5.0341 0.0 0
M  V30 5 Cl 1.3338 0.0000 0.0 0
M  V30 6 C 5.0372 3.0800 0.0 0
M  V30 7 S 4.1320 1.8341 0.0 0
M  V30 8 C 4.1321 4.3260 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 1.3338 1.5400 0.0 0
M  V30 12 N 1.3338 4.6200 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 15 C 6.5772 3.0800 0.0 0
M  V30 16 N 7.4824 4.3260 0.0 0
M  V30 17 S 7.4824 1.8341 0.0 0
M  V30 18 C 8.9471 3.8500 0.0 0
M  V30 19 C 8.9471 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 638217-64-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 638217-66-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11335537
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofused heteroaryl amide derivatives of thienopyridines
as tyrosine kinase inhibitors useful against hyperproliferative disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Romines, William Henry, III; Kania, Robert Steven; Lou, Jihong; Collins,
Michael Raymond; Cripps, Stephan James; He, Mingying; Zhou, Ru; Palmer,
Cynthia Louise; Deal, Judith Gail
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003106462 A1 2003-12-24

$RFMT $RIREG SCHEME291 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2(1H)-Quinoxalinone, 1-methyl-
C9H8N2O
6479-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0010 0.0 0
M  V30 2 O 6.9302 1.3337 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 N 4.6201 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 N 3.0801 0.0000 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 4.6201 0.0000 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-3-(methylamino)-2(1H)-quinoxalinone
C10H11N3O
99055-90-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 0.0000 0.0 0
M  V30 2 N 6.9300 2.6674 0.0 0
M  V30 3 C 7.7000 4.0011 0.0 0
M  V30 4 O 5.3900 0.0000 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 N 3.0800 1.3338 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 2 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6479-18-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99055-90-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39944647
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, photochemical, 30 W purple LED used, reaction conducted
in the presence of air, sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Photoinduced Dehydrogenative Amination of Quinoxalin-2(1H)-ones with Air
as an Oxidant
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Haoran; Jing, Yue; Niu, Kaikai; Song, Hongjian; Liu, Yuxiu; Wang,
Qingmin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(8), 5371-5381

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2,2-Trifluoro-1-(1-naphthalenyl)ethanone
C12H7F3O
6500-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0009 0.0 0
M  V30 2 C 6.9300 4.0009 0.0 0
M  V30 3 O 4.6200 5.3347 0.0 0
M  V30 4 F 6.9300 5.5409 0.0 0
M  V30 5 F 8.4700 4.0009 0.0 0
M  V30 6 F 6.9300 2.4609 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 2.3100 1.3336 0.0 0
M  V30 10 C 2.3100 4.0009 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 3.0800 0.0000 0.0 0
M  V30 13 C 0.7700 1.3336 0.0 0
M  V30 14 C 0.7700 4.0009 0.0 0
M  V30 15 C 4.6200 0.0000 0.0 0
M  V30 16 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2,2,2-Trifluoro-1-(1-naphthalenyl)ethylidene]methanamine
C13H10F3N
1200401-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 N 4.6200 1.3338 0.0 0
M  V30 4 F 6.9300 4.2074 0.0 0
M  V30 5 F 8.4700 2.6674 0.0 0
M  V30 6 F 6.9300 1.1274 0.0 0
M  V30 7 C 5.3900 0.0000 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 5.3900 5.3347 0.0 0
M  V30 13 C 3.0800 6.6685 0.0 0
M  V30 14 C 0.7700 5.3347 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 4.6200 6.6685 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 3 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6500-37-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1200401-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9007892
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chiral derivatives of Butenafine and Terbinafine: synthesis and
antifungal activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fuglseth, Erik; Otterholt, Eli; Hoegmoen, Hanne; Sundby, Eirik; Charnock,
Colin; Hoff, Baard Helge
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2009), 65(47), 9807-9813

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-[(3aS,4R,6aS)-3a,6a-dihydro-2,2-dimethyl-6a-[(triphenylmethoxy)met...
C33H29ClN4O3
661463-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.8479 0.0 0
M  V30 2 O 6.1600 4.8479 0.0 0
M  V30 3 C 6.9300 3.5143 0.0 0
M  V30 4 C 8.2094 0.0000 0.0 0
M  V30 5 C 10.2704 0.0000 0.0 0
M  V30 6 Cl 16.2763 8.2532 0.0 0
M  V30 7 C 4.6200 3.3079 0.0 0
M  V30 8 C 5.9536 2.5379 0.0 0
M  V30 9 C 3.2862 2.5379 0.0 0
M  V30 10 C 5.9536 0.9979 0.0 0
M  V30 11 C 3.2862 0.9979 0.0 0
M  V30 12 C 4.6200 0.2279 0.0 0
M  V30 13 C 3.0800 4.8479 0.0 0
M  V30 14 C 2.3100 6.1817 0.0 0
M  V30 15 C 2.3100 3.5143 0.0 0
M  V30 16 C 0.7700 6.1817 0.0 0
M  V30 17 C 0.7700 3.5143 0.0 0
M  V30 18 C 0.0000 4.8479 0.0 0
M  V30 19 C 4.6200 6.3879 0.0 0
M  V30 20 C 3.2862 7.1579 0.0 0
M  V30 21 C 5.9536 7.1579 0.0 0
M  V30 22 C 3.2862 8.6979 0.0 0
M  V30 23 C 5.9536 8.6979 0.0 0
M  V30 24 C 4.6200 9.4679 0.0 0
M  V30 25 C 8.4700 3.5143 0.0 0 CFG=1
M  V30 26 C 10.0100 3.5143 0.0 0 CFG=1
M  V30 27 C 7.9940 4.9790 0.0 0
M  V30 28 O 7.9940 2.0496 0.0 0
M  V30 29 C 10.4859 4.9790 0.0 0 CFG=2
M  V30 30 O 10.4859 2.0496 0.0 0
M  V30 31 C 9.2400 5.8840 0.0 0
M  V30 32 C 9.2400 1.1445 0.0 0
M  V30 33 N 11.9504 5.4548 0.0 0
M  V30 34 C 12.4263 6.9194 0.0 0
M  V30 35 C 13.1963 4.5496 0.0 0
M  V30 36 C 13.9663 6.9194 0.0 0
M  V30 37 N 11.6563 8.2532 0.0 0
M  V30 38 N 14.4423 5.4548 0.0 0
M  V30 39 C 14.7363 8.2532 0.0 0
M  V30 40 C 12.4263 9.5868 0.0 0
M  V30 41 N 13.9663 9.5868 0.0 0
M  V30 42 H 11.5500 3.5143 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 1 19
M  V30 5 1 2 3
M  V30 6 1 25 3 CFG=1
M  V30 7 1 4 32
M  V30 8 1 5 32
M  V30 9 1 6 39
M  V30 10 2 7 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 2 9 11
M  V30 14 2 10 12
M  V30 15 1 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 1 26 30
M  V30 33 1 26 42 CFG=1
M  V30 34 2 27 31
M  V30 35 1 28 32
M  V30 36 1 29 31
M  V30 37 1 29 33 CFG=1
M  V30 38 1 30 32
M  V30 39 1 33 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 2 34 37
M  V30 43 2 35 38
M  V30 44 1 36 38
M  V30 45 2 36 39
M  V30 46 1 37 40
M  V30 47 1 39 41
M  V30 48 2 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 25 26 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
9-[(3aS,4R,6aS)-3a,6a-Dihydro-2,2-dimethyl-6a-[(triphenylmethoxy)methyl]-4H-c...
C34H33N5O3
661463-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 7.0238 0.0 0
M  V30 2 O 5.3348 6.2538 0.0 0
M  V30 3 C 5.3348 4.7137 0.0 0
M  V30 4 C 4.6857 1.0304 0.0 0
M  V30 5 C 6.4706 0.0000 0.0 0
M  V30 6 N 15.7986 4.1444 0.0 0
M  V30 7 C 17.1323 4.9144 0.0 0
M  V30 8 C 4.7710 8.3575 0.0 0
M  V30 9 C 4.0010 9.6911 0.0 0
M  V30 10 C 6.3111 8.3575 0.0 0
M  V30 11 C 4.7710 11.0248 0.0 0
M  V30 12 C 7.0811 9.6911 0.0 0
M  V30 13 C 6.3111 11.0248 0.0 0
M  V30 14 C 2.6673 7.7938 0.0 0
M  V30 15 C 2.6673 9.3338 0.0 0
M  V30 16 C 1.3337 7.0238 0.0 0
M  V30 17 C 1.3337 10.1039 0.0 0
M  V30 18 C 0.0000 7.7938 0.0 0
M  V30 19 C 0.0000 9.3338 0.0 0
M  V30 20 C 3.2310 5.6900 0.0 0
M  V30 21 C 4.0010 4.3563 0.0 0
M  V30 22 C 1.6910 5.6900 0.0 0
M  V30 23 C 3.2310 3.0226 0.0 0
M  V30 24 C 0.9209 4.3563 0.0 0
M  V30 25 C 1.6910 3.0226 0.0 0
M  V30 26 C 6.6685 3.9437 0.0 0 CFG=2
M  V30 27 C 8.0022 3.1737 0.0 0 CFG=1
M  V30 28 O 5.5239 2.9131 0.0 0
M  V30 29 C 6.9887 5.4500 0.0 0
M  V30 30 C 9.1467 4.2041 0.0 0 CFG=2
M  V30 31 O 7.6820 1.6672 0.0 0
M  V30 32 C 6.1504 1.5063 0.0 0
M  V30 33 C 8.5202 5.6111 0.0 0
M  V30 34 N 10.6530 3.8840 0.0 0
M  V30 35 C 11.7974 4.9144 0.0 0
M  V30 36 C 11.2794 2.4770 0.0 0
M  V30 37 C 13.1313 4.1444 0.0 0
M  V30 38 N 11.7974 6.4544 0.0 0
M  V30 39 N 12.8111 2.6381 0.0 0
M  V30 40 C 14.4649 4.9144 0.0 0
M  V30 41 C 13.1313 7.2245 0.0 0
M  V30 42 N 14.4649 6.4544 0.0 0
M  V30 43 H 9.3358 2.4037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 14
M  V30 4 1 1 20
M  V30 5 1 2 3
M  V30 6 1 26 3 CFG=1
M  V30 7 1 4 32
M  V30 8 1 5 32
M  V30 9 1 6 7
M  V30 10 1 6 40
M  V30 11 2 8 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 1 27 31
M  V30 34 1 27 43 CFG=1
M  V30 35 1 28 32
M  V30 36 2 29 33
M  V30 37 1 30 33
M  V30 38 1 30 34 CFG=1
M  V30 39 1 31 32
M  V30 40 1 34 35
M  V30 41 1 34 36
M  V30 42 1 35 37
M  V30 43 2 35 38
M  V30 44 2 36 39
M  V30 45 1 37 39
M  V30 46 2 37 40
M  V30 47 1 38 41
M  V30 48 1 40 42
M  V30 49 2 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 26 27 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 661463-51-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 661463-47-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10374150
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (-)-1S,2S,5R)-2-Hydroxymethyl-5-(6-methylaminopurin-9-yl)cyclopent-3-ene-1,2-diol
(5b). A solution of 15 (41 mg, 0.07 mmol) and 40% methylamine (4.4 mL) in
methanol (8 mL) was heated at 80 °C for 30 min, and the reaction mixture
was evaporated in vacuo. The resulting residue was purified by silica gel
column chromatography using methylene chloride and methanol (25:1) as the
eluent to give the corresponding 6-methylamino purine nucleoside (37 mg,
91%) as a colorless oil: UV (CH2Cl2) λ max 263.5 nm; 1H NMR (400 MHz,
CDCl3) δ 8.16 (s, 1 H), 7.63 (s, 1 H), 7.36-7.19 (m, 16 H), 6.31 (dd, 1
H, J = 0.8, 6.0 Hz), 6.07 (dd, 1 H, J = 2.8, 6.0 Hz), 5.52 (br s, 1 H),
4.38 (s, 1 H), 3.42 (d, 1 H, J = 10.0 Hz), 3.36 (d, 1 H, J = 10.0 Hz),
3.11 (s, 3 H), 1.45 (s, 3 H), 1.39 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ
155.7, 153.7, 149.6, 143.6, 140.5, 137.6, 129.1, 128.9, 128.1, 127.4,
120.4, 113.2, 95.3, 87.2, 86.7, 66.6, 66.0, 29.9, 28.4, 28.1. Anal. Calcd
for C34H33N5O3: C, 72.97; H, 5.94; N, 12.51. Found: C, 73.10; H, 5.68; N,
12.25.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Novel Apio Carbocyclic Nucleoside Analogues as Selective A3
Adenosine Receptor Agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Jeong A.; Moon, Hyung Ryong; Kim, Hea Ok; Kim, Kyung Ran; Lee, Kang
Man; Kim, Bum Tae; Hwang, Ki Jun; Chun, Moon Woo; Jacobson, Kenneth A.;
Jeong, Lak Shin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(13), 5006-5013

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-nitrobenzaldehyde
C7H4ClNO3
6628-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenemethanamine
C8H9ClN2O2
860770-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 5.3347 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 6.6685 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 N 3.0800 1.3338 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 Cl 6.9300 5.3347 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 3.0800 6.6685 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 4.6200 6.6685 0.0 0
M  V30 13 C 5.3900 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6628-86-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 860770-47-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8719697
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 7: (5-Chloro-2-nitro-benzyl)-methyl-amine (IX): To a solution
of 15.0 g of 5-chloro-2-nitrobenzaldehyde (VIII) (81 mmoles, 1 eq.) in
400 ml of methylene chloride were added 33.8 ml of triethylamine (243
mmoles, 3 eq.) and 16.4 g of methylamine hydrochloride (243 mmoles, 3
eq.). The reaction mixture was stirred for 16 hours. An aqueous solution
of sodium bicarbonate was added, the methylene chloride phase dried
(MgSO4), and the volatiles were removed under reduced pressure. The
residue was dissolved in methanol, the solution cooled to 0°C, and 2.4 g
of sodium borohydride (65 mmoles, 0.8 eq.) added portionwise. The
solution was stirred for 4 hours, the solvent removed under reduced
pressure and the residue partitioned between methylene chloride and an
aqueous solution of sodium bicarbonate. The organic phase was dried over
magnesium sulfate and filtered. The volatiles were removed under reduced
pressure affording 14.8 g of the title compound as a brown solid (91%).
1H NMR (400MHz, CDCl3): δ 2.45 (s, 3H), 4.00 (s, 2H), 7.40 (d, 1 H,),
7.65 (s, 1 H), 7.95 (d, 1 H); LCMS: m/z APCI+, 201 [MH]+
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetraazabenzoazulene derivatives as vasopressin V1a
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ryckmans, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005068466 A1 2005-07-28

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
2-Chloro-5-(cyanomethyl)benzoic acid
C9H6ClNO2
66658-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 Cl 1.3337 4.6201 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 N 9.3360 3.0801 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 3 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-(cyanomethyl)-N-methylbenzamide
C10H9ClN2O
2530029-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 N 1.5400 4.0011 0.0 0
M  V30 3 O 1.5400 1.3338 0.0 0
M  V30 4 C 0.0000 4.0011 0.0 0
M  V30 5 Cl 3.8500 0.0000 0.0 0
M  V30 6 C 6.9300 5.3349 0.0 0
M  V30 7 C 8.4700 5.3349 0.0 0
M  V30 8 N 10.0100 5.3349 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 6.1600 4.0011 0.0 0
M  V30 13 C 6.1600 1.3338 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 3 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 66658-58-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2530029-86-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35489188
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Human Constitutive Androstane Receptor Agonists with
the Imidazo[1,2-a]pyridine Structure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mejdrova, Ivana; Dusek, Jan; Skach, Krystof; Stefela, Alzbeta; Skoda,
Josef; Chalupsky, Karel; Dohnalova, Klara; Pavkova, Ivona; Kronenberger,
Thales; Rashidian, Azam; Smutna, Lucie; Duchoslav, Vojtech; Smutny,
Tomas; Pavek, Petr; Nencka, Radim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(4), 2422-2456

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
2-Chloro-5-(cyanomethyl)benzoic acid
C9H6ClNO2
66658-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 Cl 1.3337 4.6201 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 N 9.3360 3.0801 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 3 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-(cyanomethyl)-N-methylbenzamide
C10H9ClN2O
2530029-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 N 1.5400 4.0011 0.0 0
M  V30 3 O 1.5400 1.3338 0.0 0
M  V30 4 C 0.0000 4.0011 0.0 0
M  V30 5 Cl 3.8500 0.0000 0.0 0
M  V30 6 C 6.9300 5.3349 0.0 0
M  V30 7 C 8.4700 5.3349 0.0 0
M  V30 8 N 10.0100 5.3349 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 6.1600 4.0011 0.0 0
M  V30 13 C 6.1600 1.3338 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 3 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 66658-58-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2530029-86-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23172170
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as selective ligands of human
constitutive androstane receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nencka, Radim; Mejdrova, Ivana; Pavek, Petr; Dusek, Jan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020221380 A1 2020-11-05

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
5-Chloro-7-(trifluoromethyl)thieno[3,2-b]pyridine-3-carboxylic acid
C9H3ClF3NO2S
680210-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 4.6201 0.0 0
M  V30 2 F 0.5638 3.2863 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 2.1038 5.9538 0.0 0
M  V30 5 C 7.9857 4.5603 0.0 0
M  V30 6 O 9.0163 5.7047 0.0 0
M  V30 7 O 8.4615 3.0956 0.0 0
M  V30 8 Cl 4.0011 0.0000 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 S 4.3213 6.1264 0.0 0
M  V30 13 C 6.4794 4.8805 0.0 0
M  V30 14 N 5.3348 2.3100 0.0 0
M  V30 15 C 2.6675 2.3100 0.0 0
M  V30 16 C 5.8529 6.2873 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-7-(trifluoromethyl)thieno[3,2-b]pyridine-3-carboxamide
C10H6ClF3N2OS
2414357-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9857 4.5603 0.0 0
M  V30 2 N 9.0161 5.7047 0.0 0
M  V30 3 O 8.4616 3.0956 0.0 0
M  V30 4 C 10.5224 5.3846 0.0 0
M  V30 5 C 1.3337 4.6201 0.0 0
M  V30 6 F 2.1037 5.9538 0.0 0
M  V30 7 F 0.0000 5.3901 0.0 0
M  V30 8 F 0.5637 3.2863 0.0 0
M  V30 9 Cl 4.0010 0.0000 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 C 6.4792 4.8805 0.0 0
M  V30 13 N 5.3348 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 S 4.3213 6.1264 0.0 0
M  V30 16 C 5.8529 6.2873 0.0 0
M  V30 17 C 4.0010 1.5400 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 9 17
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 680210-98-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414357-83-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22317618
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted thienopyridines and thienopyrimidines as UDP
glycosyltransferase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lim, Sungtaek; Barker, Robert H., Jr.; Cromwell, Mary A.; Makino, Elina;
Hirth, Bradford; Jiang, John; Maniar, Sachin; Munson, Mark; Choi,
Yong-Mi; Thurairatnam, Sukanthini; Musick, Kwon Yon; Pribish, James;
Angelastro, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20200102324 A1 2020-04-02

$RFMT $RIREG SCHEME297 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Formyl-1-phenyl-1H-pyrazol-3-yl)ferrocene
C20H16FeN2O
918342-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7013 9.2475 0.0 0
M  V30 2 O 3.9407 8.8091 0.0 0
M  V30 3 Fe 2.1363 4.5923 0.0 0 CHG=2 VAL=10
M  V30 4 C 4.2580 7.8694 0.0 0 CHG=-1 VAL=4
M  V30 5 C 2.9259 7.0967 0.0 0 VAL=5
M  V30 6 C 2.1363 9.2257 0.0 0 VAL=5
M  V30 7 C 0.0484 7.8694 0.0 0 VAL=5
M  V30 8 C 1.3806 7.0967 0.0 0 VAL=5
M  V30 9 C 0.0000 1.3588 0.0 0 CHG=-1 VAL=4
M  V30 10 C 4.2120 1.3588 0.0 0 VAL=5
M  V30 11 C 2.8750 2.1314 0.0 0 VAL=5
M  V30 12 C 1.3321 2.1314 0.0 0 VAL=5
M  V30 13 C 2.0878 0.0000 0.0 0 VAL=5
M  V30 14 C 5.1372 7.8694 0.0 0
M  V30 15 C 5.4618 8.8091 0.0 0
M  V30 16 N 5.9293 7.2566 0.0 0
M  V30 17 C 6.4718 8.8091 0.0 0
M  V30 18 N 6.7625 7.8694 0.0 0
M  V30 19 C 7.5230 7.4310 0.0 0
M  V30 20 C 7.5230 6.4767 0.0 0
M  V30 21 C 8.3489 7.9081 0.0 0
M  V30 22 C 8.3489 6.0019 0.0 0
M  V30 23 C 9.1749 7.4310 0.0 0
M  V30 24 C 9.1749 6.4767 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 3 12
M  V30 12 1 3 13
M  V30 13 1 4 5
M  V30 14 1 4 6
M  V30 15 1 4 14
M  V30 16 2 5 8
M  V30 17 2 6 7
M  V30 18 1 7 8
M  V30 19 1 9 12
M  V30 20 1 9 13
M  V30 21 1 10 11
M  V30 22 2 10 13
M  V30 23 2 11 12
M  V30 24 1 14 15
M  V30 25 2 14 16
M  V30 26 2 15 17
M  V30 27 1 16 18
M  V30 28 1 17 18
M  V30 29 1 18 19
M  V30 30 2 19 20
M  V30 31 1 19 21
M  V30 32 1 20 22
M  V30 33 2 21 23
M  V30 34 2 22 24
M  V30 35 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thioglycolic acid
C2H4O2S
68-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C23H21FeN3OS
2245163-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6902 15.5400 0.0 0
M  V30 2 O 6.2808 17.2399 0.0 0
M  V30 3 Fe 3.1764 6.8318 0.0 0 CHG=2 VAL=10
M  V30 4 C 6.3313 11.7045 0.0 0 CHG=-1 VAL=4
M  V30 5 C 4.3505 10.5557 0.0 0 VAL=5
M  V30 6 C 3.1764 13.7177 0.0 0 VAL=5
M  V30 7 C 0.0720 11.7045 0.0 0 VAL=5
M  V30 8 C 2.0528 10.5557 0.0 0 VAL=5
M  V30 9 C 0.0000 2.0204 0.0 0 CHG=-1 VAL=4
M  V30 10 C 6.2628 2.0204 0.0 0 VAL=5
M  V30 11 C 4.2749 3.1692 0.0 0 VAL=5
M  V30 12 C 1.9808 3.1692 0.0 0 VAL=5
M  V30 13 C 3.1044 0.0000 0.0 0 VAL=5
M  V30 14 C 7.6386 11.7045 0.0 0
M  V30 15 C 8.1211 13.0983 0.0 0
M  V30 16 N 8.8162 10.7898 0.0 0
M  V30 17 C 9.6229 13.0983 0.0 0
M  V30 18 N 10.0551 11.7045 0.0 0
M  V30 19 C 6.9867 13.7501 0.0 0
M  V30 20 N 7.4513 15.1367 0.0 0
M  V30 21 S 5.6038 13.7285 0.0 0
M  V30 22 C 6.2808 15.9362 0.0 0
M  V30 23 C 5.1608 15.0862 0.0 0
M  V30 24 C 11.1859 11.0491 0.0 0
M  V30 25 C 11.1859 9.6337 0.0 0
M  V30 26 C 12.4140 11.7586 0.0 0
M  V30 27 C 12.4140 8.9243 0.0 0
M  V30 28 C 13.6421 11.0491 0.0 0
M  V30 29 C 13.6421 9.6337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 2 2 22
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 3 12
M  V30 12 1 3 13
M  V30 13 1 4 5
M  V30 14 1 4 6
M  V30 15 1 4 14
M  V30 16 2 5 8
M  V30 17 2 6 7
M  V30 18 1 7 8
M  V30 19 1 9 12
M  V30 20 1 9 13
M  V30 21 1 10 11
M  V30 22 2 10 13
M  V30 23 2 11 12
M  V30 24 1 14 15
M  V30 25 2 14 16
M  V30 26 2 15 17
M  V30 27 1 15 19
M  V30 28 1 16 18
M  V30 29 1 17 18
M  V30 30 1 18 24
M  V30 31 1 19 20
M  V30 32 1 19 21
M  V30 33 1 20 22
M  V30 34 1 21 23
M  V30 35 1 22 23
M  V30 36 2 24 25
M  V30 37 1 24 26
M  V30 38 1 25 27
M  V30 39 2 26 28
M  V30 40 2 27 29
M  V30 41 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 918342-45-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 68-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2245163-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19613869
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM ultrasound
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and antimicrobial activity of novel
3-ferrocenyl-2-pyrazolyl-1,3-thiazolidin-4-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pejovic, Anka; Minic, Aleksandra; Bugarinovic, Jovana; Pesic, Marko;
Damljanovic, Ivan; Stevanovic, Dragana; Mihailovic, Vladimir; Katanic,
Jelena; Bogdanovic, Goran A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polyhedron (2018), 155382-389

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
2-Ethyl 1-[5-[2-carboxy-4-[[(1,1-dimethylethoxy)carbonyl]amino]-1H-pyrrol-1-y...
C21H30N4O6
684243-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6376 4.1475 0.0 0
M  V30 2 C 11.2640 5.5544 0.0 0
M  V30 3 C 12.7955 5.7154 0.0 0
M  V30 4 C 13.4220 7.1222 0.0 0
M  V30 5 C 14.9536 7.2833 0.0 0
M  V30 6 C 8.9624 1.2459 0.0 0
M  V30 7 O 10.4939 1.0850 0.0 0
M  V30 8 O 8.0571 0.0000 0.0 0
M  V30 9 N 5.3348 5.2746 0.0 0
M  V30 10 C 4.0012 4.5046 0.0 0
M  V30 11 O 2.6675 5.2746 0.0 0
M  V30 12 O 4.0012 2.9646 0.0 0
M  V30 13 C 1.3338 4.5046 0.0 0
M  V30 14 C 2.1038 3.1709 0.0 0
M  V30 15 C 0.0000 3.7346 0.0 0
M  V30 16 C 0.5638 5.8383 0.0 0
M  V30 17 C 18.2308 7.9798 0.0 0
M  V30 18 O 19.6955 8.4557 0.0 0
M  V30 19 O 17.9106 6.4735 0.0 0
M  V30 20 C 20.8399 7.4253 0.0 0
M  V30 21 C 22.3046 7.9011 0.0 0
M  V30 22 N 9.1059 3.9865 0.0 0
M  V30 23 C 8.3359 2.6529 0.0 0
M  V30 24 C 8.0755 5.1309 0.0 0
M  V30 25 C 6.8296 2.9730 0.0 0
M  V30 26 C 6.6687 4.5046 0.0 0
M  V30 27 N 15.5799 8.6901 0.0 0
M  V30 28 C 17.0864 9.0103 0.0 0
M  V30 29 C 14.8099 10.0238 0.0 0
M  V30 30 N 17.2473 10.5420 0.0 0
M  V30 31 C 15.8403 11.1683 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 27
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 23
M  V30 10 1 9 10
M  V30 11 1 9 26
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 17 28
M  V30 21 1 18 20
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-[5-[4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-[(methylamino)carbonyl]...
C22H33N5O5
616236-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.9623 2.6528 0.0 0
M  V30 2 N 8.0571 1.4070 0.0 0
M  V30 3 O 10.4939 2.4919 0.0 0
M  V30 4 C 8.6834 0.0000 0.0 0
M  V30 5 C 10.6376 5.5544 0.0 0
M  V30 6 C 11.2639 6.9612 0.0 0
M  V30 7 C 12.7954 7.1223 0.0 0
M  V30 8 C 13.4219 8.5291 0.0 0
M  V30 9 C 14.9535 8.6900 0.0 0
M  V30 10 N 5.3348 6.6815 0.0 0
M  V30 11 C 4.0011 5.9115 0.0 0
M  V30 12 O 2.6675 6.6815 0.0 0
M  V30 13 O 4.0011 4.3715 0.0 0
M  V30 14 C 1.3338 5.9115 0.0 0
M  V30 15 C 2.1038 4.5779 0.0 0
M  V30 16 C 0.0000 5.1415 0.0 0
M  V30 17 C 0.5638 7.2452 0.0 0
M  V30 18 C 18.2307 9.3868 0.0 0
M  V30 19 O 19.6954 9.8626 0.0 0
M  V30 20 O 17.9105 7.8803 0.0 0
M  V30 21 C 20.8398 8.8322 0.0 0
M  V30 22 C 22.3045 9.3081 0.0 0
M  V30 23 C 8.3358 4.0597 0.0 0
M  V30 24 N 9.1059 5.3935 0.0 0
M  V30 25 C 6.8295 4.3800 0.0 0
M  V30 26 C 8.0754 6.5379 0.0 0
M  V30 27 C 6.6686 5.9115 0.0 0
M  V30 28 N 15.5798 10.0970 0.0 0
M  V30 29 C 17.0863 10.4172 0.0 0
M  V30 30 C 14.8098 11.4307 0.0 0
M  V30 31 N 17.2472 11.9487 0.0 0
M  V30 32 C 15.8402 12.5752 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 28
M  V30 11 1 10 11
M  V30 12 1 10 27
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 18 29
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 23 24
M  V30 25 2 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 27
M  V30 29 1 28 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 684243-18-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 616236-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5506809
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM U-pin polyamide motif for recognition of the DNA minor groove
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heckel, Alexander; Dervan, Peter B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2003), 9(14), 3353-3366

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[2-(Trifluoromethyl)phenyl]-3-pyridinecarboxaldehyde
C13H8F3NO
726136-60-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.3338 0.0 0
M  V30 2 F 1.7464 0.5638 0.0 0
M  V30 3 F 3.8500 0.0000 0.0 0
M  V30 4 F 4.4136 2.1038 0.0 0
M  V30 5 C 9.2400 4.0011 0.0 0
M  V30 6 O 10.0100 5.3349 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 5.3900 2.6674 0.0 0
M  V30 15 N 5.3900 5.3349 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 6.9300 5.3349 0.0 0
M  V30 18 C 7.7000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 1 5 18
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-[2-(trifluoromethyl)phenyl]-3-pyridinemethanamine
C14H13F3N2
726136-57-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.3338 0.0 0
M  V30 2 F 1.7464 0.5638 0.0 0
M  V30 3 F 3.8500 0.0000 0.0 0
M  V30 4 F 4.4136 2.1038 0.0 0
M  V30 5 C 9.2400 4.0011 0.0 0
M  V30 6 N 10.0100 5.3349 0.0 0
M  V30 7 C 11.5500 5.3349 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 0.7700 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 5.3900 5.3349 0.0 0
M  V30 16 N 5.3900 2.6674 0.0 0
M  V30 17 C 6.9300 5.3349 0.0 0
M  V30 18 C 6.9300 2.6674 0.0 0
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 726136-60-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 726136-57-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15176683
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 149-73-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure 3: A solution of Ra1NH2 in
MeOH (2 M, 5 equiv.) was added to a mixture of the aldehyde (XI, 1
equiv.) and CH(OCH3)3 (10 equiv) in CH2Cl2 (7.5 mL/mmol aldehyde). The
resulting mixture was stirred overnight at room temperature, and then
NaBH4 (2.5 equiv.) was added. When the starting aldehyde/intermediate
imine had been completely consumed, the reaction was concentrated in
vacuo. The residue was taken into EtOAc (10 mL/mmol aldehyde used) and
the product was extracted into 1 N HCl (3 x 7.5 mL/mmol aldehyde used).
The EtOAc layer was discarded, the combined aqueous layers were
basicified with 6 N NaOH, and the product was back extracted with EtOAc
(3x10 mL/mmol aldehyde used). The combined organic phases were then dried
over Na2SO4 filtered, and concentrated in vacuo to provide the compound
(XII). The compound (XII) was used for subsequent steps, or purified by
silica gel column chromatography when necessary. Compound 11a:
N-Methyl-6-[2-(trifluoromethyl)phenyl]-3-pyridinemethanamine
6-[2-(Trifluoromethyl)phenyl]-3-pyridinecarboxaldehyde (0.360 g, 1.43
mmol) was treated according to General Procedure 3 to provide the title
compound (0.312 g, 91%). The crude material was of sufficient purity
(>90%) to be used in subsequent steps. 1H-NMR (CDCl3) : δ 8.62 (d, J=1.6
Hz, 1H), 7.76 (d, J=7.6 Hz, 1H), 7.73 (d, J=2.0 Hz, 1H), 7.61 (t, J=1.6
Hz, 1H), 7.54-7.48 (m, 2H), 7.40 (d, J=8.0 Hz, 1H), 3.84 (s, 2H), 2.50
(s, 3H). MS (ESI) (M+H)+ = 267.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of biarylmethylamines as CB1/CB2 receptor ligands and their
use in the treatment of pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leung, Carmen; Tomaszewski, Miroslaw; Woo, Simon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004060882 A1 2004-07-22

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Chloromethyl)-5-(2-furanyl)-1,3,4-oxadiazole
C7H5ClN2O2
727374-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7400 2.6217 0.0 0
M  V30 2 Cl 9.0738 1.8517 0.0 0
M  V30 3 C 3.9689 1.3337 0.0 0
M  V30 4 O 4.9995 2.4782 0.0 0
M  V30 5 N 4.7390 0.0000 0.0 0
M  V30 6 C 6.4063 1.8517 0.0 0
M  V30 7 N 6.2454 0.3202 0.0 0
M  V30 8 C 2.4374 1.4947 0.0 0
M  V30 9 C 1.4070 0.3502 0.0 0
M  V30 10 O 1.6674 2.8284 0.0 0
M  V30 11 C 0.0000 0.9767 0.0 0
M  V30 12 C 0.1611 2.5082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2-Furanyl)-N-methyl-1,3,4-oxadiazole-2-methanamine
C8H9N3O2
1247425-24-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7400 2.6217 0.0 0
M  V30 2 N 9.0737 1.8517 0.0 0
M  V30 3 C 10.4075 2.6217 0.0 0
M  V30 4 C 3.9689 1.3337 0.0 0
M  V30 5 O 4.9995 2.4782 0.0 0
M  V30 6 N 4.7390 0.0000 0.0 0
M  V30 7 C 6.4063 1.8517 0.0 0
M  V30 8 N 6.2454 0.3202 0.0 0
M  V30 9 C 2.4374 1.4947 0.0 0
M  V30 10 C 1.6674 2.8284 0.0 0
M  V30 11 O 1.4070 0.3502 0.0 0
M  V30 12 C 0.1611 2.5082 0.0 0
M  V30 13 C 0.0000 0.9767 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 727374-86-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1247425-24-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-19299548
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7681-82-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of
Mycobacterium tuberculosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Martinez-Grau, Maria Angeles; Valcarcel, Isabel C. Gonzalez; Early, Julie
V.; Gessner, Richard Klaus; Soares de Melo, Candice; Martin de la Nava,
Eva Maria; Korkegian, Aaron; Ovechkina, Yulia; Flint, Lindsay; Gravelle,
Anisa; Cramer, Jeff W.; Desai, Prashant V.; Street, Leslie J.; Odingo,
Joshua; Masquelin, Thierry; Chibale, Kelly; Parish, Tanya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2018), 28(10), 1758-1764

$RFMT $RIREG SCHEME301 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-(2,4-Difluorophenyl)-2,3-epoxypropyl]-1H-1,2,4-triazole
C11H9F2N3O
86386-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9373 4.1839 0.0 0
M  V30 2 F 5.7448 0.0000 0.0 0
M  V30 3 F 10.3648 2.6673 0.0 0
M  V30 4 C 4.2048 2.6673 0.0 0
M  V30 5 C 2.7577 2.1406 0.0 0
M  V30 6 O 3.9373 1.1507 0.0 0
M  V30 7 C 5.7448 2.6673 0.0 0
M  V30 8 C 6.5148 1.3336 0.0 0
M  V30 9 C 6.5148 4.0011 0.0 0
M  V30 10 C 8.0548 1.3336 0.0 0
M  V30 11 C 8.0548 4.0011 0.0 0
M  V30 12 C 8.8248 2.6673 0.0 0
M  V30 13 N 2.4903 4.7107 0.0 0
M  V30 14 C 2.0658 6.1910 0.0 0
M  V30 15 N 1.2135 3.8495 0.0 0
M  V30 16 N 0.5267 6.2447 0.0 0
M  V30 17 C 0.0000 4.7976 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 13
M  V30 3 1 2 8
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 6
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2,4-Difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl N-methylcarb...
C13H14F2N4OS2
1453218-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.6799 0.0 0
M  V30 2 C 4.0564 3.9099 0.0 0
M  V30 3 C 4.6200 6.0135 0.0 0
M  V30 4 O 6.1600 3.3463 0.0 0
M  V30 5 S 3.0800 6.0135 0.0 0
M  V30 6 C 2.3100 7.3472 0.0 0
M  V30 7 N 0.7700 7.3472 0.0 0
M  V30 8 S 3.0800 8.6810 0.0 0
M  V30 9 C 0.0000 8.6810 0.0 0
M  V30 10 F 8.0574 3.1399 0.0 0
M  V30 11 F 10.7249 7.7599 0.0 0
M  V30 12 C 6.7238 5.4499 0.0 0
M  V30 13 C 8.0574 4.6799 0.0 0
M  V30 14 C 6.7238 6.9899 0.0 0
M  V30 15 C 9.3911 5.4499 0.0 0
M  V30 16 C 8.0574 7.7599 0.0 0
M  V30 17 C 9.3911 6.9899 0.0 0
M  V30 18 N 4.0564 2.3699 0.0 0
M  V30 19 C 5.3022 1.4647 0.0 0
M  V30 20 N 2.8105 1.4647 0.0 0
M  V30 21 N 4.8264 0.0000 0.0 0
M  V30 22 C 3.2864 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 13
M  V30 12 1 11 17
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 86386-76-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1453218-86-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29556090
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, antifungal activities and molecular docking studies of novel
2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl
dithiocarbamates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zou, Yan; Yu, Shichong; Li, Renwu; Zhao, Qingjie; Li, Xiang; Wu,
Maocheng; Huang, Ting; Chai, Xiaoxun; Hu, Honggang; Wu, Qiuye
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2014), 74366-374

$RFMT $RIREG SCHEME302 STEP1
$RXN



  3  1
$MOL
1-Bromo-2-ethynylbenzene
C8H5Br
766-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 6.1601 2.6673 0.0 0
M  V30 3 Br 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl chloroformate
C2H3ClO2
79-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 Cl 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2-Bromophenyl)-N-methyl-2-propynamide
C10H8BrNO
2370974-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 6.1601 2.6673 0.0 0
M  V30 3 C 7.7002 2.6673 0.0 0
M  V30 4 N 8.4702 4.0010 0.0 0
M  V30 5 O 8.4702 1.3337 0.0 0
M  V30 6 C 10.0102 4.0010 0.0 0
M  V30 7 Br 3.0801 0.0000 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 0.7700 1.3337 0.0 0
M  V30 12 C 0.7700 4.0010 0.0 0
M  V30 13 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 766-46-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79-22-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2370974-95-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30324839
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM trans-Hydroboration of Propiolamides: Access to Primary and Secondary
(E)-β-Borylacrylamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grams, R. Justin; Fritzemeier, Russell G.; Slebodnick, Carla; Santos,
Webster L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(17), 6795-6799

$RFMT $RIREG SCHEME303 STEP1
$RXN



  2  1
$MOL
4,4,5,5,5-Pentafluoro-1-phenyl-1-pentyn-3-one
C11H5F5O
77063-22-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.5400 0.0 0
M  V30 2 C 3.8500 2.8736 0.0 0
M  V30 3 C 1.5400 1.5400 0.0 0
M  V30 4 F 4.4136 0.7700 0.0 0
M  V30 5 F 3.0800 0.0000 0.0 0
M  V30 6 C 5.3900 2.8736 0.0 0
M  V30 7 O 3.0800 4.2073 0.0 0
M  V30 8 F 1.5400 3.0800 0.0 0
M  V30 9 F 0.0000 1.5400 0.0 0
M  V30 10 F 1.5400 0.0000 0.0 0
M  V30 11 C 6.9300 2.8736 0.0 0
M  V30 12 C 8.4700 2.8736 0.0 0
M  V30 13 C 9.2400 1.5400 0.0 0
M  V30 14 C 9.2400 4.2073 0.0 0
M  V30 15 C 10.7800 1.5400 0.0 0
M  V30 16 C 10.7800 4.2073 0.0 0
M  V30 17 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 3 6 11
M  V30 11 1 11 12
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-(1,1,2,2,2-Pentafluoroethyl)-3-phenyl-2-propyn-1-ylidene]methanamine
C12H8F5N
2432912-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 2.6673 3.0801 0.0 0
M  V30 3 C 5.3348 3.0801 0.0 0
M  V30 4 N 4.0012 0.7700 0.0 0
M  V30 5 C 1.3337 3.8501 0.0 0
M  V30 6 F 1.8973 1.7464 0.0 0
M  V30 7 F 3.4374 4.4137 0.0 0
M  V30 8 C 6.6685 3.8501 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 F 0.0000 4.6201 0.0 0
M  V30 11 F 0.5637 2.5164 0.0 0
M  V30 12 F 2.1037 5.1838 0.0 0
M  V30 13 C 8.0023 4.6201 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 8.0023 6.1601 0.0 0
M  V30 16 C 10.6697 4.6201 0.0 0
M  V30 17 C 9.3360 6.9302 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4 CFG=2
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 3 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 1 8 13
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 77063-22-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2432912-39-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22222178
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1-Fluoroalkyl-prop-2-yne 1-imines and 1-iminium salts as building blocks:
A new synthesis of α-(trifluoromethyl)pyrroles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schneider, Thomas; Seitz, Bianca; Schiwek, Maximilian; Maas, Gerhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2020), 235109567

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
7-Methoxy-3-benzofuranacetic acid
C11H10O4
79477-01-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9857 3.0203 0.0 0
M  V30 2 C 9.0161 4.1649 0.0 0
M  V30 3 O 10.5224 3.8445 0.0 0
M  V30 4 O 8.5402 5.6294 0.0 0
M  V30 5 O 1.3337 3.0801 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 C 4.0010 3.0801 0.0 0
M  V30 9 C 6.4792 3.3405 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6673 2.3100 0.0 0
M  V30 12 O 4.3213 4.5864 0.0 0
M  V30 13 C 5.8529 4.7474 0.0 0
M  V30 14 C 4.0010 0.0000 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-N-methyl-3-benzofuranacetamide
C12H13NO3
2776231-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9856 3.0203 0.0 0
M  V30 2 C 9.0161 4.1648 0.0 0
M  V30 3 N 10.5225 3.8445 0.0 0
M  V30 4 O 8.5402 5.6294 0.0 0
M  V30 5 C 11.5529 4.9891 0.0 0
M  V30 6 O 1.3337 3.0800 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 6.4792 3.3405 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 O 4.3213 4.5863 0.0 0
M  V30 14 C 5.8529 4.7474 0.0 0
M  V30 15 C 4.0011 0.0000 0.0 0
M  V30 16 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79477-01-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2776231-42-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32330407
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Schotten-Baumann reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of galantamine and deconstructed analogs as α7 nAChR and AChE
ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Argade, Malaika D.; DeCristofano, Laura; Bhattarai, Nirajan; Schulte,
Marvin K.; Dukat, Malgorzata
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Results in Chemistry (2022), 4100286

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
2-(Phenylmethyl) 1H-indole-2,5-dicarboxylate
C17H13NO4
796870-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3912 1.5400 0.0 0
M  V30 2 O 9.7249 2.3101 0.0 0
M  V30 3 O 8.3912 0.0000 0.0 0
M  V30 4 C 11.0585 1.5400 0.0 0
M  V30 5 C 0.7700 4.1618 0.0 0
M  V30 6 O 0.0000 2.8281 0.0 0
M  V30 7 O 0.0000 5.4955 0.0 0
M  V30 8 C 4.6201 2.8281 0.0 0
M  V30 9 C 5.3901 4.1618 0.0 0
M  V30 10 C 5.6505 1.6836 0.0 0
M  V30 11 C 3.0801 2.8281 0.0 0
M  V30 12 N 6.8964 3.8416 0.0 0
M  V30 13 C 4.6201 5.4955 0.0 0
M  V30 14 C 7.0575 2.3101 0.0 0
M  V30 15 C 2.3101 4.1618 0.0 0
M  V30 16 C 3.0801 5.4955 0.0 0
M  V30 17 C 12.3923 2.3101 0.0 0
M  V30 18 C 12.3923 3.8501 0.0 0
M  V30 19 C 13.7260 1.5400 0.0 0
M  V30 20 C 13.7260 4.6201 0.0 0
M  V30 21 C 15.0597 2.3101 0.0 0
M  V30 22 C 15.0597 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 5-[(methylamino)carbonyl]-1H-indole-2-carboxylate
C18H16N2O3
796871-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0012 1.5400 0.0 0
M  V30 5 C 14.2897 4.1618 0.0 0
M  V30 6 N 15.0597 5.4955 0.0 0
M  V30 7 O 15.0597 2.8281 0.0 0
M  V30 8 C 16.5997 5.4955 0.0 0
M  V30 9 C 10.4396 2.8281 0.0 0
M  V30 10 C 9.6696 4.1618 0.0 0
M  V30 11 C 9.4091 1.6836 0.0 0
M  V30 12 C 11.9796 2.8281 0.0 0
M  V30 13 N 8.1633 3.8416 0.0 0
M  V30 14 C 10.4396 5.4955 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 12.7496 4.1618 0.0 0
M  V30 17 C 11.9796 5.4955 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 1.3337 1.5400 0.0 0
M  V30 20 C 2.6673 3.8501 0.0 0
M  V30 21 C 0.0000 2.3101 0.0 0
M  V30 22 C 1.3337 4.6201 0.0 0
M  V30 23 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 796870-64-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 796871-03-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3469122
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 191 (17.7 mg, 0.06 mmol) and 1 μL DMF in 3 mL of CH2Cl2 were treated with
oxalyl chloride (11.4 mg, 0.09 mmol) at 0 °C. The reaction mixture was
allowed to warm over 40 min to 25 °C, then cooled to 0 °C, and 300 μL 40%
MeNH2 was added. The reaction mixture was stirred 10 min at 0 °C, then
quenched with 1 M HCl (5 mL), and extracted with CH2Cl2 (3 x 40 mL). The
combined organic layers were dried (Na2SO4), and concentrated in vacuo to
afford benzyl 5-methylcarbamoylindole-2-carboxylate. Yield 16.9 mg, 91%.
mp 197 °C; MALDIFT-HRMS m/z 309.1235 (M+H+, C18H17N2O3 requires
309.1234).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of CBI analogues of the duocarmycins and CC-1065 as antitumor
agents with DNA alkylating activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boger, Dale L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004101767 A2 2004-11-25

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
1-Ethyl-1,4-dihydro-6-iodo-4-oxo-3-quinolinecarboxylic acid
C12H10INO3
797052-44-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 O 4.0011 6.9301 0.0 0
M  V30 4 C 1.3337 5.3901 0.0 0
M  V30 5 O 0.0000 4.6201 0.0 0
M  V30 6 O 1.3337 6.9301 0.0 0
M  V30 7 I 9.3359 5.3901 0.0 0
M  V30 8 C 5.3348 3.0800 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 N 4.0011 2.3100 0.0 0
M  V30 11 C 6.6684 2.3100 0.0 0
M  V30 12 C 4.0011 5.3901 0.0 0
M  V30 13 C 6.6684 5.3901 0.0 0
M  V30 14 C 2.6675 3.0800 0.0 0
M  V30 15 C 8.0022 3.0800 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 7 17
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl-1,4-dihydro-6-iodo-N-methyl-4-oxo-3-quinolinecarboxamide
C13H13IN2O2
2304353-43-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 O 5.3348 6.9302 0.0 0
M  V30 4 C 8.0023 5.3901 0.0 0
M  V30 5 N 9.3360 4.6201 0.0 0
M  V30 6 O 8.0023 6.9302 0.0 0
M  V30 7 C 10.6697 5.3901 0.0 0
M  V30 8 I 0.0000 5.3901 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 5.3348 5.3901 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 1.3337 3.0801 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 3 13
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 17
M  V30 7 1 5 7
M  V30 8 1 8 18
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 797052-44-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304353-43-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20110921
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and structure-activity relationships of novel
macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl
quinolones with highly improved activity against resistant pathogens
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ma, Cong-Xuan; Lv, Wei; Li, Ya-Xin; Fan, Bing-Zhi; Han, Xu; Kong,
Fan-Sheng; Tian, Jing-Chao; Cushman, Mark; Liang, Jian-Hua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2019), 1691-20

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Methylenebis[5-(2-chloroethyl)-2-methoxybenzene]
C19H22Cl2O2
848035-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 6.9302 0.0 0
M  V30 2 O 1.3337 5.3901 0.0 0
M  V30 3 C 0.0000 4.6201 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 6.6685 0.7700 0.0 0
M  V30 6 Cl 8.0022 0.0000 0.0 0
M  V30 7 O 4.0012 10.0102 0.0 0
M  V30 8 C 4.0012 11.5503 0.0 0
M  V30 9 C 9.3360 6.9302 0.0 0
M  V30 10 C 10.6697 7.7002 0.0 0
M  V30 11 Cl 12.0033 6.9302 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 2.6673 3.0801 0.0 0
M  V30 16 C 5.3348 3.0801 0.0 0
M  V30 17 C 4.0012 2.3101 0.0 0
M  V30 18 C 5.3348 7.7002 0.0 0
M  V30 19 C 5.3348 9.2402 0.0 0
M  V30 20 C 6.6685 6.9302 0.0 0
M  V30 21 C 6.6685 10.0102 0.0 0
M  V30 22 C 8.0022 7.7002 0.0 0
M  V30 23 C 8.0022 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 1 4 5
M  V30 6 1 4 16
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 19
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′-Methylenebis[4-methoxy-N-methylbenzeneethanamine]
C21H30N2O2
5839-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 8.4701 0.0 0
M  V30 2 O 1.3337 6.9301 0.0 0
M  V30 3 C 0.0000 6.1601 0.0 0
M  V30 4 C 6.6684 3.8500 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0
M  V30 6 N 8.0021 1.5400 0.0 0
M  V30 7 C 8.0021 0.0000 0.0 0
M  V30 8 O 4.0010 11.5501 0.0 0
M  V30 9 C 4.0010 13.0901 0.0 0
M  V30 10 C 9.3359 8.4701 0.0 0
M  V30 11 C 10.6695 9.2401 0.0 0
M  V30 12 N 12.0032 8.4701 0.0 0
M  V30 13 C 13.3369 9.2401 0.0 0
M  V30 14 C 4.0010 6.9301 0.0 0
M  V30 15 C 2.6673 6.1601 0.0 0
M  V30 16 C 5.3348 6.1601 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 5.3348 4.6201 0.0 0
M  V30 19 C 4.0010 3.8500 0.0 0
M  V30 20 C 5.3348 9.2401 0.0 0
M  V30 21 C 5.3348 10.7801 0.0 0
M  V30 22 C 6.6684 8.4701 0.0 0
M  V30 23 C 6.6684 11.5501 0.0 0
M  V30 24 C 8.0021 9.2401 0.0 0
M  V30 25 C 8.0021 10.7801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 15
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 848035-19-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5839-66-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3947833
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Benzeneethanamine-3,3’-methylenebis(4-methoxy-N-methyl)dihydrochloride A
mixture of the dimer
3,3'-methylenebis[1-(2-chloroethyl)-4-methoxybenzene] (0.21 g, 0.60 mmol)
and 33% methylamine in ethanol (5.6 g, 59.8 mmol) were stirrred for 12
days. The solvent was removed in vacuo to give a white solid. 1 M
Hydrochloric acid (20 ml) was used to acidify the mixture to pH 1 and
then the starting material was extracted using diethyl ether (3 x 50 ml).
Then 2 M potassium hydroxide (30ml) was added to the aqueous layer to a
pH of 10. The product was extracted using diethyl ether (4 x 60 ml) and
dried (sodium sulphate). The solvent was removed in vacuo to yield the
dimer (0.18 g, 91%). 20% HCl-methanol was added to give a white solid.
The solid was collected to give the hydrochloride salt (0.03 g, 13%).
νmax(flilm)/cm-1 1465m, 1504s, 1602w, 2419w, 2744m, 2942m; δ H(300 MHz;
D2O) 2.62 (6H, s, 2 x NMe), 2.85 (2H, t, J 7.5 Hz, ArCH2), 3.17 (2H, t, J
7.5 Hz, CH2N), 3.77 (6H, s, 2 x OMe), 3.86 (2H, s, ArCH2Ar), 6.99 (2H, d,
J 6.1 Hz, 2 x 5-H ), 6.02 (2H, s, 2 x 2-H), 7.15 (2H, d, J 6.1 Hz, 2 x
6-H); δ c(300 MHz; D2O) 30.16 (ArCH2Ar), 31.16 (CH2Ar), 33.13 (CH3N),
50.56 (CH2N), 56.29 (OMe), 112.6 (CH), 128.5, 129.1 (CH-6), 129.8, 131.0,
156.7 (C-OMe); m/z (FAB) 535 (M+, 40), 520 ([M-CH3]+, 100).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenol oligomers as inhibitors and/activators of protein
kinase B (PKB/Akt)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Woscholski, Rudiger; Hailes, Helen Claire; Numbere, Macba Golda
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005023744 A2 2005-03-17

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
2-Azido-4-methoxybenzoic acid
C8H7N3O3
848142-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 3.0800 0.0 0
M  V30 2 N 1.3336 1.5400 0.0 0 CHG=1 VAL=4
M  V30 3 N 1.3336 0.0000 0.0 0 CHG=-1
M  V30 4 C 1.3336 6.1600 0.0 0
M  V30 5 O 1.3336 7.7000 0.0 0
M  V30 6 O 0.0000 5.3900 0.0 0
M  V30 7 O 6.6685 3.0800 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 2.6674 5.3900 0.0 0
M  V30 11 C 4.0011 3.0800 0.0 0
M  V30 12 C 4.0011 6.1600 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 5.3347 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 1 7 8
M  V30 8 1 7 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 2-azido-4-methoxy-N-methyl-
C9H10N4O2
2943944-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 N 1.5400 6.6685 0.0 0
M  V30 3 O 1.5400 4.0011 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 N 3.8500 2.6674 0.0 0
M  V30 6 N 4.6200 1.3338 0.0 0 CHG=1 VAL=4
M  V30 7 N 5.3900 0.0000 0.0 0 CHG=-1
M  V30 8 O 8.4700 5.3347 0.0 0
M  V30 9 C 9.2400 6.6685 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 4.6200 6.6685 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 6.1600 6.6685 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 848142-85-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2943944-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36891568
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Divergent cyclization of 2-(5-iodo-1,2,3-triazolyl)benzamides toward
triazole-fused lactams and cyclic imidates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kotovshchikov, Yury N.; Tatevosyan, Stepan S.; Latyshev, Gennadij V.;
Kugusheva, Zoya R.; Lukashev, Nikolay V.; Beletskaya, Irina P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2023), 47(26), 12239-12247

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N3-(4,6-Dichloro-1,3,5-triazin-2-yl)-N1,N1-diethyl-4-[2-(4-nitrophenyl)diazen...
C19H18Cl2N8O2
848409-39-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 5.3347 0.0 0
M  V30 2 N 8.4700 8.0021 0.0 0
M  V30 3 N 9.2400 9.3358 0.0 0
M  V30 4 N 2.3100 8.0021 0.0 0
M  V30 5 C 1.5400 9.3358 0.0 0
M  V30 6 C 1.5400 6.6684 0.0 0
M  V30 7 C 0.0000 9.3358 0.0 0
M  V30 8 C 0.0000 6.6684 0.0 0
M  V30 9 Cl 2.3100 2.6673 0.0 0
M  V30 10 Cl 6.9300 0.0000 0.0 0
M  V30 11 N 15.4000 9.3358 0.0 0 VAL=5
M  V30 12 O 16.1700 8.0021 0.0 0
M  V30 13 O 16.1700 10.6694 0.0 0
M  V30 14 C 6.1600 6.6684 0.0 0
M  V30 15 C 6.9300 8.0021 0.0 0
M  V30 16 C 4.6200 6.6684 0.0 0
M  V30 17 C 6.1600 9.3358 0.0 0
M  V30 18 C 3.8500 8.0021 0.0 0
M  V30 19 C 4.6200 9.3358 0.0 0
M  V30 20 C 6.1600 4.0011 0.0 0
M  V30 21 N 4.6200 4.0011 0.0 0
M  V30 22 N 6.9300 2.6673 0.0 0
M  V30 23 C 3.8500 2.6673 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 N 4.6200 1.3336 0.0 0
M  V30 26 C 10.7800 9.3358 0.0 0
M  V30 27 C 11.5500 8.0021 0.0 0
M  V30 28 C 11.5500 10.6694 0.0 0
M  V30 29 C 13.0900 8.0021 0.0 0
M  V30 30 C 13.0900 10.6694 0.0 0
M  V30 31 C 13.8600 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 2 2 3 CFG=2
M  V30 4 1 2 15
M  V30 5 1 3 26
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 18
M  V30 9 1 5 7
M  V30 10 1 6 8
M  V30 11 1 9 23
M  V30 12 1 10 24
M  V30 13 2 11 12
M  V30 14 2 11 13
M  V30 15 1 11 31
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2-[5-(diethylamino)-2-[2-(4-nitrophenyl)diazenyl]phenyl]-N4-methyl-...
C20H22ClN9O2
943918-69-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 6.6684 0.0 0
M  V30 2 N 8.4700 9.3358 0.0 0
M  V30 3 N 9.2400 10.6694 0.0 0
M  V30 4 N 2.3100 9.3358 0.0 0
M  V30 5 C 1.5400 10.6694 0.0 0
M  V30 6 C 1.5400 8.0020 0.0 0
M  V30 7 C 0.0000 10.6694 0.0 0
M  V30 8 C 0.0000 8.0020 0.0 0
M  V30 9 N 6.9300 1.3336 0.0 0
M  V30 10 C 6.1600 0.0000 0.0 0
M  V30 11 Cl 2.3100 4.0011 0.0 0
M  V30 12 N 15.4000 10.6694 0.0 0 VAL=5
M  V30 13 O 16.1700 12.0031 0.0 0
M  V30 14 O 16.1700 9.3358 0.0 0
M  V30 15 C 6.1600 8.0020 0.0 0
M  V30 16 C 6.9300 9.3358 0.0 0
M  V30 17 C 4.6200 8.0020 0.0 0
M  V30 18 C 6.1600 10.6694 0.0 0
M  V30 19 C 3.8500 9.3358 0.0 0
M  V30 20 C 4.6200 10.6694 0.0 0
M  V30 21 C 6.1600 5.3347 0.0 0
M  V30 22 N 6.9300 4.0011 0.0 0
M  V30 23 N 4.6200 5.3347 0.0 0
M  V30 24 C 6.1600 2.6673 0.0 0
M  V30 25 C 3.8500 4.0011 0.0 0
M  V30 26 N 4.6200 2.6673 0.0 0
M  V30 27 C 10.7800 10.6694 0.0 0
M  V30 28 C 11.5500 12.0031 0.0 0
M  V30 29 C 11.5500 9.3358 0.0 0
M  V30 30 C 13.0900 12.0031 0.0 0
M  V30 31 C 13.0900 9.3358 0.0 0
M  V30 32 C 13.8600 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 21
M  V30 3 2 2 3 CFG=2
M  V30 4 1 2 16
M  V30 5 1 3 27
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 19
M  V30 9 1 5 7
M  V30 10 1 6 8
M  V30 11 1 9 10
M  V30 12 1 9 24
M  V30 13 1 11 25
M  V30 14 2 12 13
M  V30 15 2 12 14
M  V30 16 1 12 32
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 848409-39-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 943918-69-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1953996
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acid-catalyzed methanolysis reaction of non-polar triazinyl reactive dyes
in supercritical carbon dioxide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fernandez Cid, M. V.; van Spronsen, J.; van der Kraan, M.; Veugelers, W.
J. T.; Woerlee, G. F.; Witkamp, G. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Supercritical Fluids (2007), 39(3), 389-398

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[[(1,1-Dimethylethoxy)carbonyl]amino]methyl]-N-[(phenylmethoxy)carbonyl]ph...
C23H28N2O6
854006-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 2.6674 0.0 0
M  V30 2 C 7.7000 2.6674 0.0 0
M  V30 3 N 6.9300 4.0011 0.0 0
M  V30 4 C 6.9300 1.3336 0.0 0
M  V30 5 C 5.3900 4.0011 0.0 0
M  V30 6 O 7.7000 0.0000 0.0 0
M  V30 7 O 5.3900 1.3336 0.0 0
M  V30 8 O 4.6200 5.3347 0.0 0
M  V30 9 O 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 13.8600 5.3347 0.0 0
M  V30 12 N 14.6300 6.6685 0.0 0
M  V30 13 C 16.1700 6.6685 0.0 0
M  V30 14 O 16.9400 8.0021 0.0 0
M  V30 15 O 16.9400 5.3347 0.0 0
M  V30 16 C 18.4800 8.0021 0.0 0
M  V30 17 C 18.4800 6.4621 0.0 0
M  V30 18 C 20.0200 8.0021 0.0 0
M  V30 19 C 18.4800 9.5421 0.0 0
M  V30 20 C 10.0100 4.0011 0.0 0
M  V30 21 C 11.5500 4.0011 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 23 C 12.3200 5.3347 0.0 0
M  V30 24 C 10.0100 6.6685 0.0 0
M  V30 25 C 11.5500 6.6685 0.0 0
M  V30 26 C 2.3100 6.6685 0.0 0
M  V30 27 C 0.7700 6.6685 0.0 0
M  V30 28 C 3.0800 8.0021 0.0 0
M  V30 29 C 0.0000 8.0021 0.0 0
M  V30 30 C 2.3100 9.3358 0.0 0
M  V30 31 C 0.7700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 1 11 23
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [1-[[3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]phenyl]met...
C24H31N3O5
854006-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.5739 5.3348 0.0 0
M  V30 2 C 11.3439 4.0012 0.0 0
M  V30 3 N 12.8839 4.0012 0.0 0
M  V30 4 C 10.5739 2.6673 0.0 0
M  V30 5 C 13.6539 5.3348 0.0 0
M  V30 6 N 11.3439 1.3337 0.0 0
M  V30 7 O 9.0338 2.6673 0.0 0
M  V30 8 O 15.1940 5.3348 0.0 0
M  V30 9 O 12.8839 6.6685 0.0 0
M  V30 10 C 10.5739 0.0000 0.0 0
M  V30 11 C 15.9640 6.6685 0.0 0
M  V30 12 C 5.9538 8.0022 0.0 0
M  V30 13 N 4.4137 8.0022 0.0 0
M  V30 14 C 3.6437 9.3360 0.0 0
M  V30 15 O 2.1037 9.3360 0.0 0
M  V30 16 O 4.4137 10.6697 0.0 0
M  V30 17 C 1.3337 10.6697 0.0 0
M  V30 18 C 0.0000 9.8996 0.0 0
M  V30 19 C 0.5637 12.0033 0.0 0
M  V30 20 C 2.6673 11.4397 0.0 0
M  V30 21 C 9.0338 5.3348 0.0 0
M  V30 22 C 8.2638 6.6685 0.0 0
M  V30 23 C 8.2638 4.0012 0.0 0
M  V30 24 C 6.7238 6.6685 0.0 0
M  V30 25 C 6.7238 4.0012 0.0 0
M  V30 26 C 5.9538 5.3348 0.0 0
M  V30 27 C 17.5040 6.6685 0.0 0
M  V30 28 C 18.2740 5.3348 0.0 0
M  V30 29 C 18.2740 8.0022 0.0 0
M  V30 30 C 19.8141 5.3348 0.0 0
M  V30 31 C 19.8141 8.0022 0.0 0
M  V30 32 C 20.5841 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 27
M  V30 13 1 12 13
M  V30 14 1 12 24
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 854006-44-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 854006-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10597419
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Affinity chromatography of tryptases: Design, synthesis and
characterization of a novel matrix-bound bivalent inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schaschke, Norbert; Gabrijelcic-Geiger, Dusica; Dominik, Andreas;
Sommerhoff, Christian P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemBioChem (2005), 6(1), 95-103

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-2-Cyano-3-(ethylthio)-3-(4,5,6,7-tetrahydro-1H-indol-2-yl)-2-propenamide
C14H17N3OS
854275-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5771 4.0011 0.0 0
M  V30 2 C 7.3471 5.3348 0.0 0
M  V30 3 S 7.3471 2.6675 0.0 0
M  V30 4 C 6.5771 6.6686 0.0 0
M  V30 5 C 8.8871 5.3348 0.0 0
M  V30 6 C 6.5771 1.3337 0.0 0
M  V30 7 N 5.0371 6.6686 0.0 0
M  V30 8 O 7.3471 8.0022 0.0 0
M  V30 9 N 10.4271 5.3348 0.0 0
M  V30 10 C 7.3471 0.0000 0.0 0
M  V30 11 C 5.0371 4.0011 0.0 0
M  V30 12 C 4.1320 2.7552 0.0 0
M  V30 13 N 4.1320 5.2470 0.0 0
M  V30 14 C 2.6673 3.2311 0.0 0
M  V30 15 C 2.6673 4.7711 0.0 0
M  V30 16 C 1.3337 2.4611 0.0 0
M  V30 17 C 1.3337 5.5411 0.0 0
M  V30 18 C 0.0000 3.2311 0.0 0
M  V30 19 C 0.0000 4.7711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 3 5 9
M  V30 10 1 6 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro-3-imino-1-(methylamino)-3H-pyrrolo[1,2-a]indole-2-carboxamide
C13H16N4O
194204-40-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.1472 6.6371 0.0 0
M  V30 2 N 2.5804 1.2459 0.0 0
M  V30 3 C 3.4857 0.0000 0.0 0
M  V30 4 C 0.9052 4.1474 0.0 0
M  V30 5 N 0.2789 5.5542 0.0 0
M  V30 6 O 0.0000 2.9015 0.0 0
M  V30 7 N 4.8741 4.5045 0.0 0
M  V30 8 C 4.7132 2.9728 0.0 0
M  V30 9 C 6.3806 4.8247 0.0 0
M  V30 10 C 3.4673 5.1308 0.0 0
M  V30 11 C 3.2068 2.6527 0.0 0
M  V30 12 C 6.1200 2.3465 0.0 0
M  V30 13 C 7.1506 3.4909 0.0 0
M  V30 14 C 7.1506 6.1583 0.0 0
M  V30 15 C 2.4368 3.9863 0.0 0
M  V30 16 C 8.6906 3.4909 0.0 0
M  V30 17 C 8.6906 6.1583 0.0 0
M  V30 18 C 9.4606 4.8247 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 2 11 15
M  V30 16 1 12 13
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 854275-22-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 194204-40-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-3470079
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile coupling of 2-(1-ethylthioethenyl)pyrroles with amines: a route to
2-(1-aminoethenyl)pyrroles and 1-amino-3-iminopyrrolizines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trofimov, Boris A.; Sobenina, Lyubov' N.; Mikhaleva, Al'bina I.; Petrova,
Ol'ga V.; Drichkov, Vladislav N.; Ushakov, Igor A.; Tarasova, Ol'ga A.;
Toryashinova, Darya-Suren D.; Rusakov, Yuriy Yu.; Krivdin, Leonid B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2007), 44(3), 505-513

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
2,3-Dihydro-1-methyl-2-oxo-3-phenyl-1H-indole-3-butanoic acid
C19H19NO3
855604-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.4656 3.4507 0.0 0
M  V30 2 C 6.7993 4.2207 0.0 0
M  V30 3 C 8.1331 3.4507 0.0 0
M  V30 4 C 9.4667 4.2207 0.0 0
M  V30 5 O 10.8004 3.4507 0.0 0
M  V30 6 O 9.4667 5.7607 0.0 0
M  V30 7 O 6.5772 5.4666 0.0 0
M  V30 8 C 4.6079 8.1771 0.0 0
M  V30 9 C 4.1320 4.2207 0.0 0
M  V30 10 C 2.6673 4.6966 0.0 0
M  V30 11 C 5.0372 5.4666 0.0 0
M  V30 12 C 2.6673 6.2366 0.0 0
M  V30 13 C 1.3336 3.9266 0.0 0
M  V30 14 N 4.1320 6.7124 0.0 0
M  V30 15 C 1.3336 7.0066 0.0 0
M  V30 16 C 0.0000 4.6966 0.0 0
M  V30 17 C 0.0000 6.2366 0.0 0
M  V30 18 C 3.5057 2.8137 0.0 0
M  V30 19 C 4.4107 1.5679 0.0 0
M  V30 20 C 1.9740 2.6528 0.0 0
M  V30 21 C 3.7844 0.1611 0.0 0
M  V30 22 C 1.3477 1.2460 0.0 0
M  V30 23 C 2.2529 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 7 11
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 18
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-N,1-dimethyl-2-oxo-3-phenyl-1H-indole-3-butanamide
C20H22N2O2
2135587-94-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.4657 3.4507 0.0 0
M  V30 2 C 6.7993 4.2207 0.0 0
M  V30 3 C 8.1331 3.4507 0.0 0
M  V30 4 C 9.4668 4.2207 0.0 0
M  V30 5 N 10.8004 3.4507 0.0 0
M  V30 6 O 9.4668 5.7607 0.0 0
M  V30 7 C 12.1341 4.2207 0.0 0
M  V30 8 O 6.5772 5.4666 0.0 0
M  V30 9 C 4.6079 8.1772 0.0 0
M  V30 10 C 4.1320 4.2207 0.0 0
M  V30 11 C 2.6673 4.6966 0.0 0
M  V30 12 C 5.0372 5.4666 0.0 0
M  V30 13 C 2.6673 6.2366 0.0 0
M  V30 14 C 1.3337 3.9266 0.0 0
M  V30 15 N 4.1320 6.7125 0.0 0
M  V30 16 C 1.3337 7.0066 0.0 0
M  V30 17 C 0.0000 4.6966 0.0 0
M  V30 18 C 0.0000 6.2366 0.0 0
M  V30 19 C 3.5055 2.8138 0.0 0
M  V30 20 C 4.4108 1.5679 0.0 0
M  V30 21 C 1.9740 2.6528 0.0 0
M  V30 22 C 3.7844 0.1611 0.0 0
M  V30 23 C 1.3477 1.2460 0.0 0
M  V30 24 C 2.2529 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 12
M  V30 9 1 9 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 19
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 855604-68-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2135587-94-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17966785
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-22-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct Allylic C-H Bond Activation To Synthesize [Pd(η3-cin)(IPr)Cl]
Complex: Application in the Allylation of Oxindoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Rong-Bin; Wang, Chun-Hai; Ren, Wei; Liu, Zhong; Yang, Shang-Dong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2017), 7(11), 7400-7404

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-6-phenyl-4-(trifluoromethyl)-3-pyridinecarbonitrile
C13H6F3IN2
858358-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 1.3338 0.0 0
M  V30 2 F 1.7464 2.1038 0.0 0
M  V30 3 F 2.3101 0.0000 0.0 0
M  V30 4 F 4.4137 0.5638 0.0 0
M  V30 5 C 1.5400 4.0012 0.0 0
M  V30 6 N 0.0000 4.0012 0.0 0
M  V30 7 I 3.0801 6.6687 0.0 0
M  V30 8 C 3.8501 2.6675 0.0 0
M  V30 9 C 3.0801 4.0012 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 3.8501 5.3348 0.0 0
M  V30 12 C 6.1601 4.0012 0.0 0
M  V30 13 N 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 C 8.4702 5.3348 0.0 0
M  V30 16 C 8.4702 2.6675 0.0 0
M  V30 17 C 10.0102 5.3348 0.0 0
M  V30 18 C 10.0102 2.6675 0.0 0
M  V30 19 C 10.7802 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 3 5 6
M  V30 6 1 5 9
M  V30 7 1 7 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-6-phenyl-4-(trifluoromethyl)-3-pyridinecarbonitrile
C14H10F3N3
338749-57-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 6.6687 0.0 0
M  V30 2 F 4.4137 7.4387 0.0 0
M  V30 3 F 2.3101 8.0023 0.0 0
M  V30 4 F 1.7464 5.8986 0.0 0
M  V30 5 N 3.0801 1.3337 0.0 0
M  V30 6 C 3.8501 0.0000 0.0 0
M  V30 7 C 1.5400 4.0012 0.0 0
M  V30 8 N 0.0000 4.0012 0.0 0
M  V30 9 C 6.1601 4.0012 0.0 0
M  V30 10 C 5.3901 5.3348 0.0 0
M  V30 11 N 5.3901 2.6675 0.0 0
M  V30 12 C 3.8501 5.3348 0.0 0
M  V30 13 C 3.8501 2.6675 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 7.7002 4.0012 0.0 0
M  V30 16 C 8.4702 5.3348 0.0 0
M  V30 17 C 8.4702 2.6675 0.0 0
M  V30 18 C 10.0102 5.3348 0.0 0
M  V30 19 C 10.0102 2.6675 0.0 0
M  V30 20 C 10.7802 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 3 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 858358-62-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 338749-57-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1617096
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multistep synthesis of
pyrido[3',2':4,5]pyrrolo[3,2-d][1,3]oxazin-4(5H)-one from
2-aminonicotinonitriles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kanth, Sribhashyam R.; Maitraie, Dravidum; Reddy, Ghojala V.; Narsaiah,
Banda; Rao, Pamulaparty S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2005), 65(6), 1415-1423

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Trifluoromethoxy)benzoyl chloride
C8H4ClF3O2
86270-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 F 1.3337 3.8501 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.0000 1.5400 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 Cl 8.0023 0.0000 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 5.3348 1.5400 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(trifluoromethoxy)benzamide
C9H8F3NO2
1042443-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 1.5400 0.0 0
M  V30 2 N 9.3360 2.3101 0.0 0
M  V30 3 O 8.0023 0.0000 0.0 0
M  V30 4 C 10.6697 1.5400 0.0 0
M  V30 5 O 2.6673 1.5400 0.0 0
M  V30 6 C 1.3337 2.3101 0.0 0
M  V30 7 F 0.0000 1.5400 0.0 0
M  V30 8 F 0.0000 3.0801 0.0 0
M  V30 9 F 1.3337 3.8501 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 4.0012 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86270-03-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1042443-56-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20231814
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromium-catalyzed para-selective formation of quaternary carbon centers
by alkylation of benzamide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Pei; Chen, Changpeng; Cong, Xuefeng; Tang, Jinghua; Zeng, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2018), 9(1), 1-8

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-N-[(2,4-difluorophenyl)methyl]-5-pyrimidinamine
C11H7Cl2F2N3
867151-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 2.6674 0.0 0
M  V30 3 F 4.6200 6.6685 0.0 0
M  V30 4 F 0.0000 4.0011 0.0 0
M  V30 5 Cl 8.4700 0.0000 0.0 0
M  V30 6 Cl 13.0900 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 13 C 8.4700 2.6674 0.0 0
M  V30 14 C 9.2400 1.3338 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 N 10.7800 1.3338 0.0 0
M  V30 17 N 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 8
M  V30 5 1 4 12
M  V30 6 1 5 14
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N5-[(2,4-difluorophenyl)methyl]-N4-methyl-4,5-pyrimidinediamine
C12H11ClF2N4
867151-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 N 4.6200 1.3336 0.0 0
M  V30 4 C 3.8500 0.0000 0.0 0
M  V30 5 Cl 0.0000 4.0011 0.0 0
M  V30 6 F 8.4700 8.0021 0.0 0
M  V30 7 F 13.0900 5.3347 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 N 2.3100 2.6674 0.0 0
M  V30 12 N 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 C 8.4700 5.3347 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.7800 6.6685 0.0 0
M  V30 18 C 10.7800 4.0011 0.0 0
M  V30 19 C 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 3 9
M  V30 6 1 5 13
M  V30 7 1 6 15
M  V30 8 1 7 19
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 867151-52-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 867151-58-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8777939
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
N5-Benzyl-2-chloro-N4-methylpyrimidine-4,5-diamine (4a); Typical
Procedure To a solution of 3a (200 mg, 0.79 mmol) in EtOH (3 mL) were
added 0.1 M aq HCl (5 mL) and methylamine (33 weight% in EtOH, 1 mL, 7.9
mmol). The mixture was heated at reflux for 1 h and concentrated under
reduced pressure until crystals appeared in the flask (2 mL). The
crystals were collected by filtration and washed with water to afford 4a.
2-Chloro-N5-(2,4-difluorobenzyl)-N4-methylpyrimidine-4,5-diamine (4f)
From 3f (250 mg, 0.86 mmol) 4f (221 mg, 91%) was obtained as an off-white
solid. 1H NMR (250 MHz, DMSO-d6): δ = 2.85 (d, J = 4.5 Hz, 3 H, CH3NH),
4.27 (d, J = 5.3 Hz, 2 H, CH2), 5.33 (t, J = 5.3 Hz, 1 H, NHCH2),
7.04-7.34 (m, 4 H, H-c, H-e, H-6, NHCH3), 7.46 (td, J = 8.6, 6.9 Hz, 1 H,
H-f). 13C NMR (62.5 MHz, DMSO-d6): δ = 27.4 (CH3), 39.9 (CH2), 103.7 (t,
JC-F 7 Hz, C-c), 111.2 (dd, JC-F 1, 3.6 Hz, C-e), 121.4 (dd, JC-F 8, 3.5
Hz, C-a), 126.8 (C-5), 131.1 (dd, JC-F , 6.1 Hz, C-f), 131.7 (C-6), 147.5
(C-2), 154.3 (C-4), 160.0 (d, JC-F .4 Hz, C-b), 161.0 (d, JC-F .5 Hz,
C-d).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A general and facile route to new trisubstituted purin-8-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gaulon, Catherine; Dijkstra, Harmen P.; Springer, Caroline J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2005), (13), 2227-2233

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxylic acid, 6,6′-[1,3-propanediylbis(iminocarbonyl)]bis-, dime...
C19H20N4O6
869768-79-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.0801 0.0 0
M  V30 2 N 9.3358 2.3101 0.0 0
M  V30 3 O 8.0022 4.6201 0.0 0
M  V30 4 C 10.6697 3.0801 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 C 13.3370 3.0801 0.0 0
M  V30 7 N 14.6708 2.3101 0.0 0
M  V30 8 C 16.0045 3.0801 0.0 0
M  V30 9 O 16.0045 4.6201 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 O 1.3337 2.3101 0.0 0
M  V30 12 O 2.6673 4.6201 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 21.3393 3.0801 0.0 0
M  V30 15 O 22.6730 2.3101 0.0 0
M  V30 16 O 21.3393 4.6201 0.0 0
M  V30 17 C 24.0067 3.0801 0.0 0
M  V30 18 C 6.6685 2.3101 0.0 0
M  V30 19 N 5.3348 3.0801 0.0 0
M  V30 20 C 6.6685 0.7700 0.0 0
M  V30 21 C 4.0010 2.3101 0.0 0
M  V30 22 C 5.3348 0.0000 0.0 0
M  V30 23 C 4.0010 0.7700 0.0 0
M  V30 24 C 17.3382 2.3101 0.0 0
M  V30 25 N 18.6718 3.0801 0.0 0
M  V30 26 C 17.3382 0.7700 0.0 0
M  V30 27 C 20.0057 2.3101 0.0 0
M  V30 28 C 18.6718 0.0000 0.0 0
M  V30 29 C 20.0057 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 8 9
M  V30 10 1 8 24
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 21
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 27
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 25 1 24 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2,N2′-1,3-Propanediylbis[N6-methyl-2,6-pyridinedicarboxamide]
C19H22N6O4
869768-80-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.0045 3.0801 0.0 0
M  V30 2 N 14.6708 2.3101 0.0 0
M  V30 3 O 16.0045 4.6201 0.0 0
M  V30 4 C 13.3370 3.0801 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 C 10.6697 3.0801 0.0 0
M  V30 7 N 9.3358 2.3101 0.0 0
M  V30 8 C 8.0022 3.0801 0.0 0
M  V30 9 O 8.0022 4.6201 0.0 0
M  V30 10 C 21.3393 3.0801 0.0 0
M  V30 11 N 22.6730 2.3101 0.0 0
M  V30 12 O 21.3393 4.6201 0.0 0
M  V30 13 C 24.0067 3.0801 0.0 0
M  V30 14 C 2.6673 3.0801 0.0 0
M  V30 15 N 1.3337 2.3101 0.0 0
M  V30 16 O 2.6673 4.6201 0.0 0
M  V30 17 C 0.0000 3.0801 0.0 0
M  V30 18 C 17.3382 2.3101 0.0 0
M  V30 19 N 18.6718 3.0801 0.0 0
M  V30 20 C 17.3382 0.7700 0.0 0
M  V30 21 C 20.0057 2.3101 0.0 0
M  V30 22 C 18.6718 0.0000 0.0 0
M  V30 23 C 20.0057 0.7700 0.0 0
M  V30 24 C 6.6685 2.3101 0.0 0
M  V30 25 N 5.3348 3.0801 0.0 0
M  V30 26 C 6.6685 0.7700 0.0 0
M  V30 27 C 4.0010 2.3101 0.0 0
M  V30 28 C 5.3348 0.0000 0.0 0
M  V30 29 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 8 9
M  V30 10 1 8 24
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 21
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 27
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 25 1 24 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869768-79-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 869768-80-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1380421
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anion recognition by neutral macrocyclic amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chmielewski, Michal J.; Jurczak, Janusz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2005), 11(20), 6080-6094

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,5-Dihydro-1,2,2,5,5-pentamethyl-1H-imidazol-4-yl)-N-methylglycine ethyl ...
C13H25N3O2
871209-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3026 4.0863 0.0 0
M  V30 2 C 6.6364 3.3163 0.0 0
M  V30 3 C 5.3026 5.6263 0.0 0
M  V30 4 C 7.9701 4.0863 0.0 0
M  V30 5 O 9.3038 3.3163 0.0 0
M  V30 6 O 7.9701 5.6263 0.0 0
M  V30 7 C 10.6374 4.0863 0.0 0
M  V30 8 C 11.9713 3.3163 0.0 0
M  V30 9 C 1.3163 4.8480 0.0 0
M  V30 10 C 3.3322 5.2764 0.0 0
M  V30 11 C 0.0000 2.9593 0.0 0
M  V30 12 C 2.7776 0.0000 0.0 0
M  V30 13 C 0.8948 0.8382 0.0 0
M  V30 14 C 3.9690 3.3163 0.0 0
M  V30 15 C 2.5621 3.9428 0.0 0
M  V30 16 N 3.8080 1.7847 0.0 0
M  V30 17 N 1.5316 2.7982 0.0 0
M  V30 18 C 2.3016 1.4646 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 15
M  V30 10 1 10 15
M  V30 11 1 11 17
M  V30 12 1 12 18
M  V30 13 1 13 18
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(2,5-Dihydro-1,2,2,5,5-pentamethyl-1H-imidazol-4-yl)methylamino]-N-methyla...
C12H24N4O
871209-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.9593 0.0 0
M  V30 2 C 3.3322 5.2764 0.0 0
M  V30 3 C 1.3163 4.8480 0.0 0
M  V30 4 C 0.8948 0.8382 0.0 0
M  V30 5 C 2.7776 0.0000 0.0 0
M  V30 6 N 5.3028 4.0863 0.0 0
M  V30 7 C 6.6364 3.3163 0.0 0
M  V30 8 C 5.3028 5.6263 0.0 0
M  V30 9 C 7.9701 4.0863 0.0 0
M  V30 10 N 9.3037 3.3163 0.0 0
M  V30 11 O 7.9701 5.6263 0.0 0
M  V30 12 C 10.6376 4.0863 0.0 0
M  V30 13 N 1.5317 2.7982 0.0 0
M  V30 14 C 2.5621 3.9428 0.0 0
M  V30 15 C 2.3017 1.4646 0.0 0
M  V30 16 C 3.9690 3.3163 0.0 0
M  V30 17 N 3.8080 1.7847 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 3 14
M  V30 4 1 4 15
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 871209-53-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 871209-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5771321
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of
N-(1,2,2,5,5-Pentamethyl-3-imidazolin-4- yl)-N-R-amino Acetic Acid
N-Methyl Amides 8 (General Procedure). A solution of ester 7 (0.02 mol)
in 2 M CH3NH2 ethanol solution (50 mL) was allowed to stay at ambient
temperature for a few days. After the reaction was complete (control by
TLC, 7a: Al2O3, petroleum ether/EtOAc, 1:1, treatment in iodine vapors,
Rf =0.79 for 7a, Rf ) 0.3 for 8a; 7b: SiO2, CHCl3 + 1% CH3OH), the
solvent was removed under reduced pressure, the residue was dissolved in
H2O (25 mL) and extracted with CHCl3 (5 ×20 mL), and the chloroform
solution was extracted with 3% HCl (5 ×15 mL). The acidic solution was
extracted with CHCl3 (2 ×15 mL, chloroform extract was discarded),
neutralized with NaHCO3, and then extracted with CHCl3 (2 ×15 mL), the
extract was dried over MgSO4, the solvent was removed under reduced
pressure, and the chromatographically pure residue solidified upon
standing to give amides 8a,b. N-Methyl-2-[(1,2,2,5,5-pentamethyl-
2,5-dihydro-1H-imidazol-4-yl)phenylamino]acetamide 8a was isolated as
colorless crystals (6.3 g of 7a afforded 4.6 g of 8a, 76%):
N-Methyl-2-[(1,2,2,5,5-pentamethyl-2,5-dihydro-
1H-imidazol-4-yl)methylamino]acetamide 8b was isolated as colorless
crystals (4.8 g of 7b afforded 4.4 g of 8b, 91%): colorless crystals. mp
105-107 °C (hexane); IR (KBr) 1650 (C=O), 1601 (C=N), 3401 (N-H); UV
(C2H5OH), λmax (lg ε) 213 (3.86); 1H NMR (CDCl3), δ = 1.22, 1.34 (both s,
6H, 2CH3), 2.26 (s, 3H, N(1)-CH3), 3.61 (s, 3H, N-CH3), 2.74 (d, 3H,
NHCH3), 3.98 (s, 2H, CH2), 7.45 (br s, 1H, NH). Anal. Calcd for
C12H24N4O. H2O: C, 55.81; H, 10.08; N, 21.70. Found: C, 55.97; H, 10.10;
N, 21.53.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Structure, and X-Band (9.5 GHz) EPR Characterization of the
New Series of pH-Sensitive Spin Probes: N,N-Disubstituted
4-Amino-2,2,5,5-tetramethyl-3-imidazoline 1-Oxyls
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Voinov, Maxim A.; Polienko, Julya F.; Schanding, Thomas; Bobko, Andrey
A.; Khramtsov, Valery V.; Gatilov, Yury V.; Rybalova, Tatyana V.;
Smirnov, Alex I.; Grigor'ev, Igor A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(24), 9702-9711

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Methylthio-BODIPY
C10H9BF2N2S
892505-41-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7036 0.7700 0.0 0
M  V30 2 C 2.3699 0.0000 0.0 0
M  V30 3 F 4.6935 6.5697 0.0 0 CHG=-1 VAL=1
M  V30 4 F 2.7136 6.5697 0.0 0 CHG=-1 VAL=1
M  V30 5 C 2.3699 3.0800 0.0 0
M  V30 6 N 2.3699 4.6200 0.0 0 CHG=-1 VAL=3
M  V30 7 C 3.7036 2.3100 0.0 0
M  V30 8 C 0.9052 2.6042 0.0 0
M  V30 9 B 3.7036 5.3900 0.0 0 CHG=3 VAL=4
M  V30 10 C 0.9052 5.0959 0.0 0
M  V30 11 C 5.0372 3.0800 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 N 5.0372 4.6200 0.0 0 VAL=4
M  V30 14 C 6.5019 2.6042 0.0 0
M  V30 15 C 6.5019 5.0959 0.0 0
M  V30 16 C 7.4071 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(T-4)-Difluoro[N-methyl-α-(2H-pyrrol-2-ylidene-κN)-1H-pyrrole-2-methanaminato...
C10H10BF2N3
1309918-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7036 0.7700 0.0 0
M  V30 2 C 2.3699 0.0000 0.0 0
M  V30 3 F 4.6935 6.5697 0.0 0 CHG=-1 VAL=1
M  V30 4 F 2.7136 6.5697 0.0 0 CHG=-1 VAL=1
M  V30 5 C 2.3699 3.0800 0.0 0
M  V30 6 N 2.3699 4.6200 0.0 0 CHG=-1 VAL=3
M  V30 7 C 3.7036 2.3100 0.0 0
M  V30 8 C 0.9052 2.6042 0.0 0
M  V30 9 B 3.7036 5.3900 0.0 0 CHG=3 VAL=4
M  V30 10 C 0.9052 5.0959 0.0 0
M  V30 11 C 5.0372 3.0800 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 N 5.0372 4.6200 0.0 0 VAL=4
M  V30 14 C 6.5019 2.6042 0.0 0
M  V30 15 C 6.5019 5.0959 0.0 0
M  V30 16 C 7.4071 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 892505-41-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1309918-20-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27243232
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM capped vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New 8-Amino-BODIPY Derivatives: Surpassing Laser Dyes at Blue-Edge
Wavelengths
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Banuelos, Jorge; Martin, Virginia; Gomez-Duran, C. F. Azael; Cordoba,
Ismael J. Arroyo; Pena-Cabrera, Eduardo; Garcia-Moreno, Inmaculada;
Costela, Angel; Perez-Ojeda, M. Eugenia; Arbeloa, Teresa; Arbeloa, Inigo
Lopez
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2011), 17(26), 7261-7270,
S7261/1-S7261/12

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl-1H-indole-4-carboxaldehyde
C11H11NO
894852-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6825 3.0801 0.0 0
M  V30 2 O 9.0163 2.3101 0.0 0
M  V30 3 C 1.0306 3.0203 0.0 0
M  V30 4 C 0.0000 4.1647 0.0 0
M  V30 5 C 5.0151 3.0801 0.0 0
M  V30 6 C 3.6815 2.3101 0.0 0
M  V30 7 C 6.3488 2.3101 0.0 0
M  V30 8 C 4.6949 4.5864 0.0 0
M  V30 9 N 2.5369 3.3405 0.0 0
M  V30 10 C 3.6815 0.7700 0.0 0
M  V30 11 C 6.3488 0.7700 0.0 0
M  V30 12 C 3.1634 4.7473 0.0 0
M  V30 13 C 5.0151 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl-N-methyl-1H-indole-4-methanamine
C12H16N2
894852-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6825 3.0801 0.0 0
M  V30 2 N 9.0163 2.3101 0.0 0
M  V30 3 C 10.3500 3.0801 0.0 0
M  V30 4 C 1.0306 3.0203 0.0 0
M  V30 5 C 0.0000 4.1647 0.0 0
M  V30 6 C 5.0151 3.0801 0.0 0
M  V30 7 C 3.6813 2.3101 0.0 0
M  V30 8 C 6.3488 2.3101 0.0 0
M  V30 9 C 4.6949 4.5864 0.0 0
M  V30 10 N 2.5369 3.3405 0.0 0
M  V30 11 C 3.6813 0.7700 0.0 0
M  V30 12 C 6.3488 0.7700 0.0 0
M  V30 13 C 3.1632 4.7473 0.0 0
M  V30 14 C 5.0151 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894852-86-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894852-87-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9774076
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) ((1-ethyl-1H-indol-4-yl)-N-methylmethanamine) [1465]
1-Ethyl-1H-indole-4-carbaldehyde (2.40 mg, 13.8 mmol) was dissolved in
anhydrous methanol (62 mL). Methylamine (6.00 mL of 33% solution in
ethanol, 48.2 mmol) was added and the reaction was stirred for 3 h. The
solution was concentrated to a greenish brown oil and then dissolved in
anhydrous methanol (62 mL). Sodium borohydride (539 mg, 14.3 mmol) was
added and the mixture was stirred overnight at room temperature. Water
(90 mL) was added and the solution was concentrated. Sodium hydroxide (15
mL, 1N) was added and the aqueous layer was extracted with ethyl acetate
(3×50 mL). Combined organic layers were dried over Na2SO4, filtered and
concentrated to afford the title compound
((1-ethyl-1H-indol-4-yl)-N-methylmethanamine) (2.36 g, 91%) as a yellow
oil. 1H NMR (300 MHz, DMSO-d6) δ 7.33-7.30 (m, 2H), 7.10-6.97 (m, 2H),
6.52 (d, J=3.0 Hz, 1H), 4.17 (q, J=7.2 Hz, 2H), 3.88 (s, 2H), 2.30 (s,
3H), 1.33 (t, J=7.2 Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl-1H-indole-4-carboxaldehyde
C11H11NO
894852-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6825 3.0801 0.0 0
M  V30 2 O 9.0163 2.3101 0.0 0
M  V30 3 C 1.0306 3.0203 0.0 0
M  V30 4 C 0.0000 4.1647 0.0 0
M  V30 5 C 5.0151 3.0801 0.0 0
M  V30 6 C 3.6815 2.3101 0.0 0
M  V30 7 C 6.3488 2.3101 0.0 0
M  V30 8 C 4.6949 4.5864 0.0 0
M  V30 9 N 2.5369 3.3405 0.0 0
M  V30 10 C 3.6815 0.7700 0.0 0
M  V30 11 C 6.3488 0.7700 0.0 0
M  V30 12 C 3.1634 4.7473 0.0 0
M  V30 13 C 5.0151 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl-N-methyl-1H-indole-4-methanamine
C12H16N2
894852-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6825 3.0801 0.0 0
M  V30 2 N 9.0163 2.3101 0.0 0
M  V30 3 C 10.3500 3.0801 0.0 0
M  V30 4 C 1.0306 3.0203 0.0 0
M  V30 5 C 0.0000 4.1647 0.0 0
M  V30 6 C 5.0151 3.0801 0.0 0
M  V30 7 C 3.6813 2.3101 0.0 0
M  V30 8 C 6.3488 2.3101 0.0 0
M  V30 9 C 4.6949 4.5864 0.0 0
M  V30 10 N 2.5369 3.3405 0.0 0
M  V30 11 C 3.6813 0.7700 0.0 0
M  V30 12 C 6.3488 0.7700 0.0 0
M  V30 13 C 3.1632 4.7473 0.0 0
M  V30 14 C 5.0151 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894852-86-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894852-87-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14458055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) ((1-ethyl-1H-indol-4-yl)-N-methylmethanamine)
1-Ethyl-1H-indole-4-carbaldehyde (2.40 mg, 13.8 mmol) was dissolved in
anhydrous methanol (62 mL). Methylamine (6.00 mL of 33% solution in
ethanol, 48.2 mmol) was added and the reaction was stirred for 3 h. The
solution was concentrated to a greenish brown oil and then dissolved in
anhydrous methanol (62 mL). Sodium borohydride (539 mg, 14.3 mmol) was
added and the mixture was stirred overnight at room temperature. Water
(90 mL) was added and the solution was concentrated. Sodium hydroxide (15
mL, 1N) was added and the aqueous layer was extracted with ethyl acetate
(3×50 mL). Combined organic layers were dried over Na2SO4, filtered and
concentrated to afford the title compound
((1-ethyl-1H-indol-4-yl)-N-methylmethanamine) (2.36 g, 91%) as a yellow
oil: 1H NMR (300 MHz, DMSO-d 6) δ 7.33-7.30 (m, 2H), 7.10-6.97 (m, 2H),
6.52 (d, J = 3.0 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 3.88 (s, 2H), 2.30
(s, 3H), 1.33 (t, J = 7.2 Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl acrylamide compounds as FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manning, David Douglas; Decornez, Helene Yvonne; Surman, Matthew David;
Martin, Fernando J. L.; Ramnauth, Jailall; Toro, Andras; Berman, Judd M.;
Sampson, Peter; Pauls, Henry; Sargent, Bruce Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2568914 A1 2005-12-04

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
(4aR,5R,6R,7R)-2,4,4a,5,6,7-Hexahydro-7-methoxy-3,4a,5-trimethyl-2-oxonaphtho...
C20H22N2O5
902462-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.1058 5.3900 0.0 0
M  V30 2 C 7.7720 6.1600 0.0 0
M  V30 3 O 5.1047 4.6200 0.0 0
M  V30 4 C 3.7710 3.8500 0.0 0
M  V30 5 O 3.7710 2.3100 0.0 0
M  V30 6 O 5.1047 1.5400 0.0 0
M  V30 7 C 5.1047 0.0000 0.0 0
M  V30 8 C 13.7137 5.7906 0.0 0
M  V30 9 O 15.6829 3.0800 0.0 0
M  V30 10 C 9.1058 3.8500 0.0 0 CFG=1
M  V30 11 C 9.1058 2.3100 0.0 0
M  V30 12 C 7.7720 4.6200 0.0 0 CFG=1
M  V30 13 C 10.4394 4.6200 0.0 0
M  V30 14 C 10.4394 1.5400 0.0 0
M  V30 15 C 7.7720 1.5400 0.0 0
M  V30 16 C 6.4383 3.8500 0.0 0 CFG=1
M  V30 17 C 11.7731 3.8500 0.0 0
M  V30 18 C 11.7731 2.3100 0.0 0
M  V30 19 C 6.4383 2.3100 0.0 0 CFG=1
M  V30 20 C 13.2378 4.3259 0.0 0
M  V30 21 O 13.2378 1.8342 0.0 0
M  V30 22 C 14.1429 3.0800 0.0 0
M  V30 23 N 2.4372 4.6200 0.0 0
M  V30 24 C 2.2763 6.1516 0.0 0
M  V30 25 C 1.0304 3.9936 0.0 0
M  V30 26 C 0.7700 6.4717 0.0 0
M  V30 27 N 0.0000 5.1381 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=3
M  V30 2 1 12 2 CFG=3
M  V30 3 1 3 4
M  V30 4 1 16 3 CFG=3
M  V30 5 2 4 5
M  V30 6 1 4 23
M  V30 7 1 6 7
M  V30 8 1 19 6 CFG=1
M  V30 9 1 8 20
M  V30 10 2 9 22
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 19
M  V30 21 1 17 18
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 10 12 16 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4aR,5R,6R,7R)-4a,5,6,7-Tetrahydro-7-methoxy-3,4a,5-trimethyl-6-[[(methylamin...
C18H23NO5
902462-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5772 5.3900 0.0 0
M  V30 2 C 7.9109 6.1600 0.0 0
M  V30 3 O 10.5782 4.6200 0.0 0
M  V30 4 C 11.9120 3.8500 0.0 0
M  V30 5 N 13.2456 4.6200 0.0 0
M  V30 6 O 11.9120 2.3100 0.0 0
M  V30 7 C 14.5793 3.8500 0.0 0
M  V30 8 O 10.5782 1.5400 0.0 0
M  V30 9 C 10.5782 0.0000 0.0 0
M  V30 10 C 1.9692 5.7906 0.0 0
M  V30 11 O 0.0000 3.0800 0.0 0
M  V30 12 C 6.5772 3.8500 0.0 0 CFG=1
M  V30 13 C 6.5772 2.3100 0.0 0
M  V30 14 C 7.9109 4.6200 0.0 0 CFG=1
M  V30 15 C 5.2434 4.6200 0.0 0
M  V30 16 C 5.2434 1.5400 0.0 0
M  V30 17 C 7.9109 1.5400 0.0 0
M  V30 18 C 9.2445 3.8500 0.0 0 CFG=1
M  V30 19 C 3.9098 3.8500 0.0 0
M  V30 20 C 3.9098 2.3100 0.0 0
M  V30 21 C 9.2445 2.3100 0.0 0 CFG=1
M  V30 22 C 2.4452 4.3259 0.0 0
M  V30 23 O 2.4452 1.8341 0.0 0
M  V30 24 C 1.5400 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 1 14 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 18 3 CFG=1
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 21 8 CFG=3
M  V30 10 1 10 22
M  V30 11 2 11 24
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 21
M  V30 22 1 19 20
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 14 18 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 902462-93-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 902462-92-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-11916076
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 333-27-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nonsteroidal progesterone receptor ligands (I): Synthesis and SAR of new
tetrahydronaphthofuranone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shinei, Rie; Kurihara, Ken-ichi; Tanabe, Kiyoshi; Tabata, Yuji; Kurata,
Yasushi; Hoshiko, Shigeru; Okonogi, Tsuneo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2006), 14(14), 4850-4861

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
4′-Methoxy-2′-methyl[1,1′-biphenyl]-2-carboxaldehyde
C15H14O2
929554-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 1.3338 0.0 0
M  V30 2 O 2.3101 0.0000 0.0 0
M  V30 3 C 4.6201 6.6687 0.0 0
M  V30 4 O 9.2402 4.0012 0.0 0
M  V30 5 C 10.0102 2.6675 0.0 0
M  V30 6 C 3.0801 4.0012 0.0 0
M  V30 7 C 2.3101 2.6675 0.0 0
M  V30 8 C 2.3101 5.3348 0.0 0
M  V30 9 C 0.7700 2.6675 0.0 0
M  V30 10 C 0.7700 5.3348 0.0 0
M  V30 11 C 0.0000 4.0012 0.0 0
M  V30 12 C 4.6201 4.0012 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 5.3901 2.6675 0.0 0
M  V30 15 C 6.9302 5.3348 0.0 0
M  V30 16 C 6.9302 2.6675 0.0 0
M  V30 17 C 7.7002 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-Methoxy-N,2′-dimethyl[1,1′-biphenyl]-2-carboxamide
C16H17NO2
2097256-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 N 2.3100 1.3336 0.0 0
M  V30 3 O 4.6200 2.6674 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 C 4.6200 8.0021 0.0 0
M  V30 6 O 9.2400 5.3347 0.0 0
M  V30 7 C 10.0100 6.6685 0.0 0
M  V30 8 C 3.0800 5.3347 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 6.6685 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.7700 6.6685 0.0 0
M  V30 13 C 0.0000 5.3347 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 5.3900 6.6685 0.0 0
M  V30 16 C 5.3900 4.0011 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 929554-57-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2097256-07-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-211-CAS-17176181
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 513-35-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7558-80-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7758-19-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amide-Directed C-H Sodiation by a Sodium Hydride/Iodide Composite
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yinhua; Chan, Guo Hao; Chiba, Shunsuke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2017), 56(23), 6544-6547

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
2-Azido-6-methylbenzoic acid
C8H7N3O2
937245-27-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.7700 0.0 0
M  V30 2 O 1.3336 0.0000 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 N 5.3347 2.3100 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 CHG=1 VAL=4
M  V30 6 N 8.0021 3.8500 0.0 0 CHG=-1
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 1.3336 3.0800 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 2.6674 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 2 5 6
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 2-azido-N,6-dimethyl-
C9H10N4O
2943944-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 N 0.7700 4.0011 0.0 0
M  V30 3 O 3.0800 5.3349 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 N 6.9300 4.0011 0.0 0 CHG=1 VAL=4
M  V30 7 N 8.4700 4.0011 0.0 0 CHG=-1
M  V30 8 C 0.7700 1.3338 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 5.3900 1.3338 0.0 0
M  V30 13 C 3.0800 0.0000 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 2 6 7
M  V30 8 1 8 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 937245-27-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2943944-28-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36891564
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Divergent cyclization of 2-(5-iodo-1,2,3-triazolyl)benzamides toward
triazole-fused lactams and cyclic imidates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kotovshchikov, Yury N.; Tatevosyan, Stepan S.; Latyshev, Gennadij V.;
Kugusheva, Zoya R.; Lukashev, Nikolay V.; Beletskaya, Irina P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2023), 47(26), 12239-12247

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloromethyl (3R)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2,3-dihydro-1H-inde...
C16H20ClNO5
947674-88-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.9950 3.6115 0.0 0
M  V30 2 C 3.4887 3.2913 0.0 0
M  V30 3 O 3.0127 1.8266 0.0 0
M  V30 4 O 2.4582 4.4357 0.0 0
M  V30 5 C 1.5064 1.5064 0.0 0
M  V30 6 C 1.1863 3.0127 0.0 0
M  V30 7 C 0.0000 1.1863 0.0 0
M  V30 8 C 1.8266 0.0000 0.0 0
M  V30 9 O 10.9366 4.7820 0.0 0
M  V30 10 C 12.2703 5.5520 0.0 0
M  V30 11 O 13.6039 4.7820 0.0 0
M  V30 12 O 12.2703 7.0920 0.0 0
M  V30 13 C 14.9376 5.5520 0.0 0
M  V30 14 Cl 16.2714 4.7820 0.0 0
M  V30 15 C 6.9356 5.5520 0.0 0
M  V30 16 C 5.4709 5.0760 0.0 0 CFG=2
M  V30 17 C 6.9356 7.0920 0.0 0
M  V30 18 C 8.2692 4.7820 0.0 0
M  V30 19 C 4.5656 6.3220 0.0 0
M  V30 20 C 5.4709 7.5679 0.0 0
M  V30 21 C 8.2692 7.8620 0.0 0
M  V30 22 C 9.6028 5.5520 0.0 0
M  V30 23 C 9.6028 7.0920 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 22
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 1 19 20
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R)-2,3-dihydro-6-[[(methylamino)carbonyl]oxy]-1H-inden...
C16H22N2O4
947674-90-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.5809 3.2907 0.0 0
M  V30 2 C 11.0455 3.7667 0.0 0
M  V30 3 O 12.1900 2.7362 0.0 0
M  V30 4 O 11.3658 5.2730 0.0 0
M  V30 5 C 13.6546 3.2120 0.0 0
M  V30 6 C 13.1787 4.6767 0.0 0
M  V30 7 C 15.1193 3.6880 0.0 0
M  V30 8 C 14.1306 1.7475 0.0 0
M  V30 9 O 3.8501 1.3337 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 11 N 1.5400 0.0000 0.0 0
M  V30 12 O 1.5400 2.6673 0.0 0
M  V30 13 C 0.0000 0.0000 0.0 0
M  V30 14 C 6.9301 4.0011 0.0 0
M  V30 15 C 8.4364 4.3213 0.0 0 CFG=2
M  V30 16 C 6.1601 5.3348 0.0 0
M  V30 17 C 6.1601 2.6673 0.0 0
M  V30 18 C 8.5975 5.8529 0.0 0
M  V30 19 C 7.1905 6.4792 0.0 0
M  V30 20 C 4.6201 5.3348 0.0 0
M  V30 21 C 4.6201 2.6673 0.0 0
M  V30 22 C 3.8501 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 19
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 947674-88-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 947674-90-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1729129
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of methyl-carbamic acid 3-R-(N-Boc-amino)-indan-5-yl ester
Carbonic acid 3-R-(N-Boc-amino)-indan-5-yl ester chloromethyl ester
prepared in Example 5 (12.6 g) was combined with ethanolic methylamine
(14 ml of a 33% solution) in dioxane (110 ml) and was stirred at rt for 3
h and evaporated to dryness. The residue was dissolved in EtOAc (200 ml),
and the solution was filtered, washed with water, dried and evaporated to
dryness. The residue was crystallized from EtOAc/ether to give the title
compound (10.3 g, 91.1%) methyl-carbamic acid
3-R-(N-Boc-amino)-indan-5-yl ester, yield 10.3 g, 91.1%. 'H NMR (DMSO-d6,
δ): 7.60 (m, 1H, NHMe), 7.33 (d, 1H, NHBoc), 7.20 (d, 1H, Ph), 6.90 (m,
2H, Ph), 4.95 (q, 1H, C3-H), 2.9-2.6 (m, 2H, CI), 2.65 (d, 3H, Me), 2.35
(m, 1H, C2-H), 1.85 (m, 1H, C2-H'), 1.44 (s, 9H, tBu) ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of (propargylated) aminoindans as monoamine oxidase and
acetylcholinesterase inhibitors for treatment of psychiatric and
neurological disorders.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piryatinsky, Victor; Cohen, Bronka; Lerner, David; Pinkert, Dalia;
Miskolczi, Istvan; Herzig, Yaacov; Gottlieb, Hugo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070203232 A1 2007-08-30

$RFMT $RIREG SCHEME324 STEP1
$RXN



  2  1
$MOL
p-Nitrophenylalanine
C9H10N2O4
949-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 4.6201 0.0 0
M  V30 2 C 2.6675 6.1601 0.0 0 CFG=2
M  V30 3 C 1.3337 6.9302 0.0 0
M  V30 4 N 4.0012 6.9302 0.0 0
M  V30 5 O 0.0000 6.1601 0.0 0
M  V30 6 O 1.3337 8.4702 0.0 0
M  V30 7 N 8.0023 1.5400 0.0 0 VAL=5
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 O 8.0023 0.0000 0.0 0
M  V30 10 C 4.0012 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-Amino-N-methyl-4-nitrobenzenepropanamide
C10H13N3O3
140372-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 N 8.0021 2.3100 0.0 0
M  V30 5 N 10.6695 3.8500 0.0 0
M  V30 6 O 9.3359 6.1601 0.0 0
M  V30 7 C 12.0032 4.6201 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3100 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 949-99-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 140372-91-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16611662
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chiral GAP catalysts of phosphonylated imidazolidinones and their
applications in asymmetric Diels-Alder and Friedel-Crafts reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qiao, Shuo; Mo, Junming; Wilcox, Cody B.; Jiang, Bo; Li, Guigen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2017), 15(7), 1718-1724

$RFMT $RIREG SCHEME325 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-3,6,8-trinitro-2(1H)-quinolinone
C10H6N4O7
98993-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 0.7700 0.0 0 VAL=5
M  V30 2 O 5.3347 0.0000 0.0 0
M  V30 3 O 8.0021 0.0000 0.0 0
M  V30 4 C 4.0011 0.7700 0.0 0
M  V30 5 O 1.3336 2.3100 0.0 0
M  V30 6 N 1.3336 5.3900 0.0 0 VAL=5
M  V30 7 O 0.0000 4.6200 0.0 0
M  V30 8 O 1.3336 6.9300 0.0 0
M  V30 9 N 9.3358 5.3900 0.0 0 VAL=5
M  V30 10 O 10.6694 4.6200 0.0 0
M  V30 11 O 9.3358 6.9300 0.0 0
M  V30 12 C 5.3347 3.0800 0.0 0
M  V30 13 C 5.3347 4.6200 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 N 4.0011 2.3100 0.0 0
M  V30 16 C 4.0011 5.3900 0.0 0
M  V30 17 C 6.6684 5.3900 0.0 0
M  V30 18 C 8.0021 3.0800 0.0 0
M  V30 19 C 2.6673 3.0800 0.0 0
M  V30 20 C 2.6673 4.6200 0.0 0
M  V30 21 C 8.0021 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 15
M  V30 5 2 5 19
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 21
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 2 18 21
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2(1H)-Quinolinone, 3,4-dihydro-1-methyl-4-(methylamino)-3,6,8-trinitro-, comp...
C11H11N5O7.CH5N
864497-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 8.4700 0.0 0
M  V30 2 C 5.3347 9.2400 0.0 0
M  V30 3 N 6.6684 2.3100 0.0 0 VAL=5
M  V30 4 O 8.0021 1.5400 0.0 0
M  V30 5 O 5.3347 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 N 1.3336 6.9300 0.0 0 VAL=5
M  V30 8 O 1.3336 8.4700 0.0 0
M  V30 9 O 0.0000 6.1600 0.0 0
M  V30 10 N 9.3358 6.9300 0.0 0 VAL=5
M  V30 11 O 9.3358 8.4700 0.0 0
M  V30 12 O 10.6694 6.1600 0.0 0
M  V30 13 O 1.3336 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 5.3347 4.6200 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 17 C 6.6684 6.9300 0.0 0
M  V30 18 C 6.6684 3.8500 0.0 0
M  V30 19 N 4.0011 3.8500 0.0 0
M  V30 20 C 2.6673 6.1600 0.0 0
M  V30 21 C 8.0021 6.1600 0.0 0
M  V30 22 C 8.0021 4.6200 0.0 0
M  V30 23 C 2.6673 4.6200 0.0 0
M  V30 24 C 4.5647 0.0000 0.0 0
M  V30 25 N 6.1047 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 18
M  V30 6 1 6 19
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 2 10 11
M  V30 11 2 10 12
M  V30 12 1 10 21
M  V30 13 2 13 23
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 23
M  V30 24 2 21 22
M  V30 25 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98993-72-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 864497-15-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-9459124
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Effective C-N bond formation on the 1-methyl-2-quinolone skeleton
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Asahara, Motoki; Nagamatsu, Moriaki; Tohda, Yasuo; Nishiwaki, Nagatoshi;
Ariga, Masahiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2005), (1), 1-6

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-carboxaldehyde
C8H6O3
120-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 O 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylpiperonylamine
C9H11NO2
15205-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 O 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 O 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15205-27-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-18973262
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel piperonyl derivatives as diapophytoene desaturase
inhibitors for the treatment of methicillin-, vancomycin- and
linezolid-resistant Staphylococcus aureus infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wei, Hanwen; Mao, Fei; Ni, Shuaishuai; Chen, Feifei; Li, Baoli; Qiu,
Xiaoxia; Hu, Linghao; Wang, Manjiong; Zheng, Xinyu; Zhu, Jin; Lan, Lefu;
Li, Jian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 145235-251

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-carboxaldehyde
C8H6O3
120-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 O 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylpiperonylamine
C9H11NO2
15205-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 O 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 O 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15205-27-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14548054
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aromatic secondary amines with flavor-modifying properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Elings, Jacob Antonius; Furrer, Stefan; Kaouas, Abdelmajid; Winkel,
Cornelis
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015082645 A1 2015-06-11

$RFMT $RIREG SCHEME327 STEP1
$RXN



  2  1
$MOL
(4-Methoxyphenyl)acetic acid
C9H10O3
104-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0801 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 1.3337 0.7700 0.0 0
M  V30 4 O 0.0000 3.0801 0.0 0
M  V30 5 O 8.0023 0.0000 0.0 0
M  V30 6 C 9.3360 0.7700 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzeneacetamide
C10H13NO2
59907-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 9.3360 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-01-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59907-36-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1409496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM ansa-Ruthenium(II) Complexes of DPEN-SO2N(Me)(CH2)n(η6-aryl) Conjugate
Ligands for Asymmetric Transfer Hydrogenation of Aryl Ketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kisic, Andrea; Stephan, Michel; Mohar, Barbara
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(14-15), 3193-3198

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Vinylpyridine
C7H7N
100-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Betahistine
C8H12N2
5638-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 6.6686 3.0800 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 N 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-69-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5638-76-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-17383151
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1370509-16-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, catalyst prepared and used in stage
1,anion-exchanged ionic liquid supported on diatomaceous used as catalyst
in stage 1,aza-Michael-type addition,recyclable catalyst,alternate
reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The catalytic effect of anion-exchanged supported ionic liquid on
aza-Michael-type addition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghasemi, Mohammad Hadi; Kowsari, Elaheh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2017), 43(7), 3691-3709

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Maleic anhydride
C4H2O3
108-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6218 0.0 0
M  V30 2 O 5.3026 1.4946 0.0 0
M  V30 3 O 2.7406 2.4782 0.0 0
M  V30 4 C 1.3337 1.8517 0.0 0
M  V30 5 C 3.7711 1.3337 0.0 0
M  V30 6 C 1.4946 0.3202 0.0 0
M  V30 7 C 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylmaleimide
C5H5NO2
930-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7106 0.0000 0.0 0
M  V30 2 O 0.0000 1.9692 0.0 0
M  V30 3 O 5.4211 1.9692 0.0 0
M  V30 4 N 2.7106 1.5400 0.0 0
M  V30 5 C 1.4647 2.4452 0.0 0
M  V30 6 C 3.9564 2.4452 0.0 0
M  V30 7 C 1.9406 3.9098 0.0 0
M  V30 8 C 3.4806 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 2 3 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 930-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-18849780
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cp*Co(III)-Catalyzed C-H Alkylation with Maleimides Using Weakly
Coordinating Carbonyl Directing Groups
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mandal, Rajib; Emayavaramban, Balakumar; Sundararaju, Basker
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2018), 20(10), 2835-2838

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Maleic anhydride
C4H2O3
108-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6218 0.0 0
M  V30 2 O 5.3026 1.4946 0.0 0
M  V30 3 O 2.7406 2.4782 0.0 0
M  V30 4 C 1.3337 1.8517 0.0 0
M  V30 5 C 3.7711 1.3337 0.0 0
M  V30 6 C 1.4946 0.3202 0.0 0
M  V30 7 C 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylmaleimide
C5H5NO2
930-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7106 0.0000 0.0 0
M  V30 2 O 0.0000 1.9692 0.0 0
M  V30 3 O 5.4211 1.9692 0.0 0
M  V30 4 N 2.7106 1.5400 0.0 0
M  V30 5 C 1.4647 2.4452 0.0 0
M  V30 6 C 3.9564 2.4452 0.0 0
M  V30 7 C 1.9406 3.9098 0.0 0
M  V30 8 C 3.4806 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 2 3 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 930-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-4721395
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-98-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 1330-20-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 9,10-Dibromo-N-alkyl-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-diones:
Synthesis and Investigation of Their Effects on Carbonic Anhydrase
Isozymes I, II, IX, and XII
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goeksu, Haydar; Topal, Meryem; Keskin, Ali; Gueltekin, Mehmet S.; Celik,
Murat; Guelcin, Ilhami; Tanc, Muhammet; Supuran, Claudiu T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2016), 349(6), 466-474

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Cyanuric chloride
C3Cl3N3
108-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6200 0.0 0
M  V30 2 Cl 5.3349 4.6200 0.0 0
M  V30 3 Cl 2.6674 0.0000 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, compd. with trinitromethane (1:1)
CH5N.CHN3O6
14147-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.8500 0.0 0
M  V30 2 N 1.3338 4.6200 0.0 0 VAL=5
M  V30 3 N 4.0011 4.6200 0.0 0 VAL=5
M  V30 4 N 2.6674 2.3100 0.0 0 VAL=5
M  V30 5 O 0.0000 3.8500 0.0 0
M  V30 6 O 1.3338 6.1600 0.0 0
M  V30 7 O 4.0011 6.1600 0.0 0
M  V30 8 O 5.3349 3.8500 0.0 0
M  V30 9 O 4.0011 1.5400 0.0 0
M  V30 10 O 1.3338 1.5400 0.0 0
M  V30 11 C 1.8974 0.0000 0.0 0
M  V30 12 N 3.4374 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 7 2 3 8
M  V30 8 2 4 9
M  V30 9 2 4 10
M  V30 10 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,5-Triazin-2(1H)-one, 4,6-bis(trinitromethyl)-, compd. with methanamine (1:1)
C5HN9O13.CH5N
1246616-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 6.1601 0.0 0
M  V30 2 N 9.3360 6.9301 0.0 0 VAL=5
M  V30 3 N 8.7723 4.8263 0.0 0 VAL=5
M  V30 4 N 7.2323 7.4938 0.0 0 VAL=5
M  V30 5 O 10.6697 6.1601 0.0 0
M  V30 6 O 9.3360 8.4702 0.0 0
M  V30 7 O 10.3124 4.8263 0.0 0
M  V30 8 O 8.0023 3.4926 0.0 0
M  V30 9 O 8.0023 8.8274 0.0 0
M  V30 10 O 5.6923 7.4938 0.0 0
M  V30 11 C 2.6673 6.1601 0.0 0
M  V30 12 N 1.3337 6.9301 0.0 0 VAL=5
M  V30 13 N 3.4374 7.4938 0.0 0 VAL=5
M  V30 14 N 1.8973 4.8263 0.0 0 VAL=5
M  V30 15 O 0.0000 6.1601 0.0 0
M  V30 16 O 1.3337 8.4702 0.0 0
M  V30 17 O 2.6673 8.8274 0.0 0
M  V30 18 O 4.9774 7.4938 0.0 0
M  V30 19 O 2.6673 3.4926 0.0 0
M  V30 20 O 0.3573 4.8263 0.0 0
M  V30 21 O 5.3348 1.5400 0.0 0
M  V30 22 C 6.6685 5.3901 0.0 0
M  V30 23 N 5.3348 6.1601 0.0 0
M  V30 24 N 6.6685 3.8501 0.0 0
M  V30 25 C 4.0012 5.3901 0.0 0
M  V30 26 C 5.3348 3.0800 0.0 0
M  V30 27 N 4.0012 3.8501 0.0 0
M  V30 28 C 4.5648 0.0000 0.0 0
M  V30 29 N 6.1048 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 22
M  V30 5 2 2 5
M  V30 6 2 2 6
M  V30 7 2 3 7
M  V30 8 2 3 8
M  V30 9 2 4 9
M  V30 10 2 4 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 25
M  V30 15 2 12 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 2 13 18
M  V30 19 2 14 19
M  V30 20 2 14 20
M  V30 21 2 21 26
M  V30 22 1 22 23
M  V30 23 2 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 28 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14147-71-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1246616-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-168-CAS-11942725
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The interaction of 2,4,6-trichloro-1,3,5-triazine with trinitromethane
salts and adamantyl alkanols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gidaspov, Alexander A.; Bakharev, Vladimir V.; Zalomlenkov, Vladimir A.;
Burkov, Pavel S.; Artemyeva, Irina I.; Kuleshova, Irina A.Pachman, Jiri;
Selesovsky, Jakub; Matyas, Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Trends in Research of Energetic Materials, Proceedings of the
Seminar, 16th, Pardubice, Czech Republic, Apr. 10-12, 2013 (2013), (Part
2), 613-616

$RFMT $RIREG SCHEME331 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Vinylpyridine
C7H7N
100-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 N 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-pyridineethanamine
C8H12N2
55496-55-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 6.6686 3.0800 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 N 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-43-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 55496-55-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-17383162
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1370509-16-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, catalyst prepared and used in stage
1,anion-exchanged ionic liquid supported on diatomaceous used as catalyst
in stage 1,aza-Michael-type addition,recyclable catalyst,alternate
reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The catalytic effect of anion-exchanged supported ionic liquid on
aza-Michael-type addition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghasemi, Mohammad Hadi; Kowsari, Elaheh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2017), 43(7), 3691-3709

$RFMT $RIREG SCHEME332 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclopentanone
C5H8O
120-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 1.2459 0.0 0
M  V30 2 C 2.3698 1.2459 0.0 0
M  V30 3 C 1.4645 2.4917 0.0 0
M  V30 4 C 1.4645 0.0000 0.0 0
M  V30 5 C 0.0000 2.0159 0.0 0
M  V30 6 C 0.0000 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimedone
C8H12O2
126-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 C 1.5166 2.3101 0.0 0
M  V30 7 C 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl-1,3-dioxane-4,6-dione
C6H8O4
2033-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 O 1.5166 2.3101 0.0 0
M  V30 7 O 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7′,8′-Dihydro-1′,7′,7′-trimethylspiro[cyclopentane-1,4′(1′H)-quinoline]-2′,5′...
C16H23NO2
1800597-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 6.1600 0.0 0
M  V30 2 O 0.0000 1.5400 0.0 0
M  V30 3 C 2.6674 0.0000 0.0 0
M  V30 4 C 8.1851 2.5774 0.0 0
M  V30 5 C 7.1952 0.8629 0.0 0
M  V30 6 C 2.6674 4.6200 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 3.8500 0.0 0
M  V30 9 C 1.4216 5.5252 0.0 0
M  V30 10 C 3.9133 5.5252 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 1.3338 2.3100 0.0 0
M  V30 14 C 1.8974 6.9898 0.0 0
M  V30 15 C 3.4375 6.9898 0.0 0
M  V30 16 N 2.6674 1.5400 0.0 0
M  V30 17 C 5.3347 1.5400 0.0 0
M  V30 18 C 6.6685 3.8500 0.0 0
M  V30 19 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 13
M  V30 3 1 3 16
M  V30 4 1 4 19
M  V30 5 1 5 19
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 11 17
M  V30 17 1 12 18
M  V30 18 1 13 16
M  V30 19 1 14 15
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-92-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 126-81-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 2033-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1800597-63-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23565775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction products with silylated carbon nanotube and complexes with
copper
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 919-30-2
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM reaction products wit hydroxylated carbon nanotube, Schiff base with
2-hydroxybenzaldehyde and complexes with copper
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, supported on carbon, catalyst prepared and
used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper(II)-Schiff Base Complex Embedded on multiwalled Carbon Nanotubes
(APTMS@MWCNTs/Schiff Base/Cu): A Novel Versatile Nanostructure to Promote
Four-Component Preparation of
Dihydro-spiro[cycloalkane-1,4'-quinoline]-2',5'-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nikoofar, Kobra; Mehrikaram, Fatemeh; Lashanizadegan, Maryam; Aghaei,
Arezoo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2021), 41(3), 663-675

$RFMT $RIREG SCHEME333 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethylamino)benzaldehyde
C9H11NO
100-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,4′-Dimethoxybenzil
C16H14O4
1226-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0
M  V30 2 C 8.0022 3.0801 0.0 0
M  V30 3 O 6.6685 0.7700 0.0 0
M  V30 4 O 8.0022 4.6201 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 O 13.3370 0.0000 0.0 0
M  V30 8 C 14.6707 0.7700 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 4.0010 2.3101 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 9.3358 2.3101 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 9.3358 0.7700 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 10.6697 0.0000 0.0 0
M  V30 20 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4,5-Bis(4-methoxyphenyl)-1-methyl-1H-imidazol-2-yl]-N,N-dimethylbenzenamine
C26H27N3O2
1415639-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4629 10.8578 0.0 0
M  V30 2 O 0.6263 8.8509 0.0 0
M  V30 3 C 0.0000 10.2578 0.0 0
M  V30 4 O 5.0172 1.2459 0.0 0
M  V30 5 C 5.9224 0.0000 0.0 0
M  V30 6 N 14.5247 11.8051 0.0 0
M  V30 7 C 15.8584 11.0351 0.0 0
M  V30 8 C 14.5247 13.3451 0.0 0
M  V30 9 C 6.7526 8.2070 0.0 0
M  V30 10 C 7.5226 6.8734 0.0 0
M  V30 11 N 7.7830 9.3515 0.0 0
M  V30 12 N 9.0291 7.1935 0.0 0
M  V30 13 C 9.1900 8.7251 0.0 0
M  V30 14 C 5.2211 8.3679 0.0 0
M  V30 15 C 4.3159 7.1221 0.0 0
M  V30 16 C 4.5948 9.7749 0.0 0
M  V30 17 C 2.7843 7.2830 0.0 0
M  V30 18 C 3.0631 9.9358 0.0 0
M  V30 19 C 2.1579 8.6900 0.0 0
M  V30 20 C 6.8963 5.4664 0.0 0
M  V30 21 C 5.3648 5.3055 0.0 0
M  V30 22 C 7.8015 4.2205 0.0 0
M  V30 23 C 4.7383 3.8987 0.0 0
M  V30 24 C 7.1751 2.8137 0.0 0
M  V30 25 C 5.6435 2.6527 0.0 0
M  V30 26 C 10.5236 9.4951 0.0 0
M  V30 27 C 11.8573 8.7251 0.0 0
M  V30 28 C 10.5236 11.0351 0.0 0
M  V30 29 C 13.1911 9.4951 0.0 0
M  V30 30 C 11.8573 11.8051 0.0 0
M  V30 31 C 13.1911 11.0351 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 19
M  V30 4 1 4 5
M  V30 5 1 4 25
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 31
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 10 20
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 13 26
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-10-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1226-42-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1415639-21-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8287280
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7558-80-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Cyclic Voltammetry Measurements. Cyclic
voltammograms were measured using a 273A Potentiostat/Galvanostat
(Princeton Applied Research) equipped with an electrochemical analysis
software, using a conventional three-electrode cell. The working
electrode was a glassy carbon disk electrode (ca. ϕ = 3 mm). The
auxiliary and reference electrodes for these studies corresponded to a Pt
wire and Ag/AgCl (in 3 M KCl), respectively; LiClO4 (0.2 mol L−1) in a
solution of acetonitrile and dichloromethane (4:1 by volume) was used as
the supporting electrolyte system. The concentration of each
triarylimidazole was 1 mmol L−1.
4-(4,5-Bis(4-methoxyphenyl)-1-methyl-1H-imidazol-2-yl)-N,N-dimethylaniline
(3ba): 372.2 mg, 90% yield; yellow powder. mp: 153−154 °C; IR (KBr): ν
3436, 2920, 1612, 1563, 1518, 1247 cm−1; 1H NMR (400 MHz, CDCl3): δ 3.02
(s, 6H), 3.46 (s, 3H), 3.76 (s, 3H), 3.87 (s, 3H), 6.76 (d, J = 8.8 Hz,
2H), 6.80 (d, J = 8.8 Hz, 2H), 6.99 (d, J = 8.8 Hz, 2H), 7.31 (d, J = 8.4
Hz, 2H), 7.50 (d, J = 8.4 Hz, 2H), 7.60 (d, J = 8.4 Hz, 2H); 13C NMR (100
MHz, CDCl3): δ 33.0, 40.4, 55.1, 55.3, 112.0, 113.4, 114.4, 118.9, 123.8,
127.9, 128.0, 128.7, 129.9, 132.2, 136.9, 148.2, 150.5, 158.0, 159.5.
HRESI-MS (m/z) calcd. for C26H28N3O2 (M + H) 414.2182, found 414.2177.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Triarylimidazole Redox Catalysts: Electrochemical Analysis and Empirical
Correlations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Ni-tao; Zeng, Cheng-chu; Lam, Chiu Marco; Gbur, Randi K.; Little,
R. Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2013), 78(5), 2104-2110

$RFMT $RIREG SCHEME334 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethylamino)benzaldehyde
C9H11NO
100-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,4′-Dibromobenzil
C14H8Br2O2
35578-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 O 6.1601 0.0000 0.0 0
M  V30 5 Br 0.0000 2.6673 0.0 0
M  V30 6 Br 13.0903 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 3.8501 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 2.3101 1.3337 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 13 C 8.4702 1.3337 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.7802 2.6673 0.0 0
M  V30 17 C 10.7802 0.0000 0.0 0
M  V30 18 C 11.5503 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 12
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4,5-Bis(4-bromophenyl)-1-methyl-1H-imidazol-2-yl]-N,N-dimethylbenzenamine
C24H21Br2N3
1415639-22-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8366 9.6120 0.0 0
M  V30 2 Br 0.0000 7.6051 0.0 0
M  V30 3 Br 4.3907 0.0000 0.0 0
M  V30 4 N 13.8983 10.5593 0.0 0
M  V30 5 C 15.2320 9.7893 0.0 0
M  V30 6 C 13.8983 12.0993 0.0 0
M  V30 7 C 6.1262 6.9612 0.0 0
M  V30 8 C 6.8962 5.6275 0.0 0
M  V30 9 N 7.1568 8.1056 0.0 0
M  V30 10 N 8.4026 5.9477 0.0 0
M  V30 11 C 8.5636 7.4792 0.0 0
M  V30 12 C 4.5946 7.1221 0.0 0
M  V30 13 C 3.6894 5.8762 0.0 0
M  V30 14 C 3.9683 8.5291 0.0 0
M  V30 15 C 2.1579 6.0372 0.0 0
M  V30 16 C 2.4368 8.6900 0.0 0
M  V30 17 C 1.5315 7.4441 0.0 0
M  V30 18 C 6.2699 4.2206 0.0 0
M  V30 19 C 4.7383 4.0596 0.0 0
M  V30 20 C 7.1751 2.9747 0.0 0
M  V30 21 C 4.1118 2.6528 0.0 0
M  V30 22 C 6.5488 1.5679 0.0 0
M  V30 23 C 5.0171 1.4068 0.0 0
M  V30 24 C 9.8972 8.2493 0.0 0
M  V30 25 C 9.8972 9.7893 0.0 0
M  V30 26 C 11.2310 7.4792 0.0 0
M  V30 27 C 11.2310 10.5593 0.0 0
M  V30 28 C 12.5647 8.2493 0.0 0
M  V30 29 C 12.5647 9.7893 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 17
M  V30 3 1 3 23
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 29
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 8 18
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 11 24
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-10-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 35578-47-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1415639-22-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5826483
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7558-80-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Cyclic Voltammetry Measurements. Cyclic
voltammograms were measured using a 273A Potentiostat/Galvanostat
(Princeton Applied Research) equipped with an electrochemical analysis
software, using a conventional three-electrode cell. The working
electrode was a glassy carbon disk electrode (ca. ϕ = 3 mm). The
auxiliary and reference electrodes for these studies corresponded to a Pt
wire and Ag/AgCl (in 3 M KCl), respectively; LiClO4 (0.2 mol L−1) in a
solution of acetonitrile and dichloromethane (4:1 by volume) was used as
the supporting electrolyte system. The concentration of each
triarylimidazole was 1 mmol L−1.
4-(4,5-Bis(4-bromophenyl)-1-methyl-1H-imidazol-2-yl)-N,N-dimethylaniline
(3ca): 460.1 mg, 90% yield; yellow powder. mp: 212−214 °C; IR (KBr): ν
3434, 2920, 2838, 1612, 1543, 1487, 1443 cm−1; 1H NMR (400 MHz, CDCl3): δ
3.03 (s, 6H), 3.48 (s, 3H), 6.80 (d, J = 8.8 Hz, 2H), 7.26 (d, J = 8.4
Hz, 2H), 7.34 (d, J = 8.4 Hz, 2H), 7.40 (d, J = 8.4 Hz, 2H), 7.58 (d, J =
8.4 Hz, 2H), 7.60 (d, J = 8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3): δ 33.3,
40.3, 112.0, 118.0, 120.2, 122.9, 128.6, 128.8, 129.9, 130.2, 131.2,
132.3, 132.4, 133.7, 149.3, 150.7; HREI-MS (m/z) calcd. for C24H21N3Br2
(M) 509.0102, found 509.0089, calcd. for C24H20N3Br2 (M − H) 508.0024,
found 508.0006.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Triarylimidazole Redox Catalysts: Electrochemical Analysis and Empirical
Correlations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Ni-tao; Zeng, Cheng-chu; Lam, Chiu Marco; Gbur, Randi K.; Little,
R. Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2013), 78(5), 2104-2110

$RFMT $RIREG SCHEME335 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-(chloromethyl)pyridine
C6H5BrClN
1001463-32-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 Cl 6.6687 2.3101 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 N 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-pyridinemethanamine
C7H9BrN2
886371-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 Br 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 N 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1001463-32-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 886371-85-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15806782
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of green oxidation catalytic system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Caradonna, John Philip; Tarves, Paul C.; Mcnally, Joshua; Gregor, Lauren
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016100850 A2 2016-06-23

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
(αS)-α-[(1S)-1-[(3,3-Dimethylbutyl)methylamino]ethyl]benzenemethanol
C16H27NO
1001909-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 2 C 5.3348 2.3100 0.0 0 CFG=2
M  V30 3 O 4.0011 4.6201 0.0 0
M  V30 4 N 6.6684 3.0800 0.0 0
M  V30 5 C 5.3348 0.7700 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 6.6684 4.6201 0.0 0
M  V30 8 C 9.3359 3.0800 0.0 0
M  V30 9 C 10.6695 2.3100 0.0 0
M  V30 10 C 10.6695 3.8500 0.0 0
M  V30 11 C 12.0032 3.0800 0.0 0
M  V30 12 C 10.6695 0.7700 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 1.3337 3.0800 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 1.3337 0.0000 0.0 0
M  V30 18 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2S)-N2-(3,3-Dimethylbutyl)-N1,N2-dimethyl-1-phenyl-1,2-propanediamine
C17H30N2
1001909-44-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0 CFG=2
M  V30 2 C 5.3348 3.0801 0.0 0 CFG=2
M  V30 3 N 4.0012 0.7700 0.0 0
M  V30 4 N 6.6685 2.3101 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 2.6673 0.0000 0.0 0
M  V30 7 C 8.0022 3.0801 0.0 0
M  V30 8 C 6.6685 0.7700 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 10.6697 3.0801 0.0 0
M  V30 11 C 9.8996 4.4137 0.0 0
M  V30 12 C 12.0033 3.8501 0.0 0
M  V30 13 C 11.4397 1.7464 0.0 0
M  V30 14 C 2.6673 3.0801 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 C 1.3337 5.3901 0.0 0
M  V30 18 C 0.0000 3.0801 0.0 0
M  V30 19 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1001909-43-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1001909-44-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-1937067
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and application of a new pseudo C2-symmetric tertiary diamine
for the enantioselective addition of MeLi to aromatic imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Perron, Quentin; Alexakis, Alexandre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2007), 18(21), 2503-2506

$RFMT $RIREG SCHEME337 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(+)-3-Chloro-1-phenyl-1-propanol
C9H11ClO
100306-33-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 Cl 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-[2-(Dimethylamino)ethyl]benzenemethanol
C11H17NO
40116-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6684 1.5400 0.0 0
M  V30 5 N 8.0021 2.3100 0.0 0
M  V30 6 C 9.3358 1.5400 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 1.3336 1.5400 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100306-33-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 40116-79-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26113278
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric synthesis of (R)-fluoxetine: a practical approach using
recyclable and in-situ generated oxazaborolidine catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Padiya, Kamlesh; Gagare, Pravin; Gagare, Manjiri; Lal, Bansi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Journal of Chemistry (2009), 27(6), 1137-1140

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
4-Cyanopyridine
C6H4N2
100-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 N 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-pyridinecarbothioamide
C7H8N2S
5255-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 S 5.3901 0.0000 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 N 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-48-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5255-09-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25514118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 12135-76-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 349081-21-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 349081-21-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a mixture of nitrile (1 mmol) in
C6(mim)2Cl2 (1.1 mmol), ammonium sulfide (1.2 mmol) was added. The
resulting mixture was stirred at 70 °C for the appropriate time shown in
Table 2. After the completion of the reaction, as indicated by TLC, amine
(5 mmol) was added to the reaction and stirred at 70 °C for 10 min to 5 h
(Table 3). Then the reaction took place, was quenched with ice-water (10
ml) and stirred at room temperature for 10 min. The above mixture was
extracted with ethyl acetate (3 × 5 ml) and the organic layers were
combined. When the residue was dried and concentrated in vacuo, it was
chromatographied on silica gel (n-heptane/ethyl acetate as eluent) to
afford the pure products in 70-95% yields. Compound: 3e, Yield (%): 90,
Time (min): 10.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, ionic liquid used (catalytic media)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient and green protocol for the synthesis of thioamides in
C6(mim)2Cl2 as a dicationic ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khosropour, A. R.; Noei, J.; Mirjafari, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2010), 7(3), 752-758

$RFMT $RIREG SCHEME339 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-6-[(4-iodophenyl)amino]-5-pyrimidinecarboxaldehyde
C11H6Cl2IN3O
1007197-13-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3347 0.0 0
M  V30 2 O 0.0000 5.3347 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 Cl 0.0000 2.6674 0.0 0
M  V30 5 Cl 4.6200 0.0000 0.0 0
M  V30 6 I 10.7800 5.3347 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 1.5400 2.6674 0.0 0
M  V30 10 N 4.6200 2.6674 0.0 0
M  V30 11 N 2.3100 1.3338 0.0 0
M  V30 12 C 3.8500 1.3338 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0
M  V30 14 C 6.9300 6.6685 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 8.4700 6.6685 0.0 0
M  V30 17 C 8.4700 4.0011 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 1 3 13
M  V30 5 1 4 9
M  V30 6 1 5 12
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-6-[(4-iodophenyl)amino]-2-(methylamino)-5-pyrimidinecarboxaldehyde
C12H10ClIN4O
1007197-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 6.6685 0.0 0
M  V30 2 O 0.0000 6.6685 0.0 0
M  V30 3 N 4.6200 6.6685 0.0 0
M  V30 4 Cl 0.0000 4.0011 0.0 0
M  V30 5 N 4.6200 1.3336 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 I 10.7800 6.6685 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.8500 5.3347 0.0 0
M  V30 10 C 1.5400 4.0011 0.0 0
M  V30 11 N 4.6200 4.0011 0.0 0
M  V30 12 N 2.3100 2.6674 0.0 0
M  V30 13 C 3.8500 2.6674 0.0 0
M  V30 14 C 6.1600 6.6685 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 8.0021 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 8.0021 0.0 0
M  V30 19 C 9.2400 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 9
M  V30 4 1 3 14
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 5 13
M  V30 8 1 7 19
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1007197-13-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1007197-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3471256
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 298-14-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 311-28-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Chloro-6-(4-iodophenylamino)-2-(methylamino)pyrimidine-5-carbaldehyde
(15a) : A mixture of 12a (8.00 g, 20.3 mmol), KHCO3 (2.44 g, 24.4 mmol),
tetrabutylammonium iodide (0.37 g, 1.0 mmol) and methylamine (5.3 mL, 40
wt % solution in water, 61 mmol) in toluene/H2O (150 mL/150 mL) was
stirred at rt for 48h. The resulting precipitate was collected by
filtration, washed with EtOAc and dried under high vacuum to provide 15a
as yellow solid, yield 7.13 g, 90%. Rf = 0.75 (SiO2, 30% EtOAc/hexane).
Mp = 274-275 °C. 1H-NMR (300 MHz, CDCl3) δ (ppm): 11.40 (NHC6, s, br, 1
H), 11.14 (NHC6, s, br, 1H, minor isomer), 10.12 (C5H, s, 1H, minor
isomer), 10.09 (C5H, s, 1H), 7.65 (C8H, C10H, d, 3J = 8.7 Hz, 2H), 7.61
(C8H, C10H, d, 3J = 8.7 Hz, 2H, minor isomer), 7.51 (C7, C11, d, 3J = 8.7
Hz, 2H), 7.41 (C7, C11, d, 3J = 8.7 Hz, 2H, minor isomer), 5.60 (C12NH,
br, 1H), 5.48 (C12NH, br, 1H, minor isomer), 3.04 (C12H, d, 3J = 5.1 Hz,
3H, minor isomer), 3.07 (C12H, d, 3J = 5.1 Hz, 3H). C12H10ClIN4O EI-MS:
Expected mass for M+/z: 387.96/389.96, Observed: 388/390 (M+/z, 60%/20%),
76 (C6H4+/z, 100%). CI-MS: Expected mass for [M+H+]/z: 388.17/390.96,
Observed: 388/391 ([M+H+]/z, 87%/25%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Regioselective Approach to Trisubstituted 2(or
6)-Arylaminopyrimidine-5-carbaldehydes and Their Application in the
Synthesis of Structurally and Electronically Unique G-C Base Precursors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beingessner, Rachel L.; Deng, Bo-Liang; Fanwick, Phillip E.; Fenniri,
Hicham
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(3), 931-939

$RFMT $RIREG SCHEME340 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(4-Bromophenyl)amino]-2,6-dichloro-5-pyrimidinecarboxaldehyde
C11H6BrCl2N3O
1007197-26-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3347 0.0 0
M  V30 2 O 0.0000 5.3347 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 Cl 0.0000 2.6674 0.0 0
M  V30 5 Cl 4.6200 0.0000 0.0 0
M  V30 6 Br 10.7800 5.3347 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 1.5400 2.6674 0.0 0
M  V30 10 N 4.6200 2.6674 0.0 0
M  V30 11 N 2.3100 1.3338 0.0 0
M  V30 12 C 3.8500 1.3338 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0
M  V30 14 C 6.9300 6.6685 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 8.4700 6.6685 0.0 0
M  V30 17 C 8.4700 4.0011 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 1 3 13
M  V30 5 1 4 9
M  V30 6 1 5 12
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(4-Bromophenyl)amino]-6-chloro-2-(methylamino)-5-pyrimidinecarboxaldehyde
C12H10BrClN4O
1007197-28-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 6.6685 0.0 0
M  V30 2 O 0.0000 6.6685 0.0 0
M  V30 3 N 4.6200 6.6685 0.0 0
M  V30 4 Cl 0.0000 4.0011 0.0 0
M  V30 5 N 4.6200 1.3336 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 Br 10.7800 6.6685 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.8500 5.3347 0.0 0
M  V30 10 C 1.5400 4.0011 0.0 0
M  V30 11 N 4.6200 4.0011 0.0 0
M  V30 12 N 2.3100 2.6674 0.0 0
M  V30 13 C 3.8500 2.6674 0.0 0
M  V30 14 C 6.1600 6.6685 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 8.0021 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 8.0021 0.0 0
M  V30 19 C 9.2400 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 9
M  V30 4 1 3 14
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 5 13
M  V30 8 1 7 19
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1007197-26-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1007197-28-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5587476
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 298-14-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 311-28-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-(4-Bromophenylamino)-6-chloro-2-(methylamino)pyrimidine-5-carbaldehyde
(15b) : A mixture of 12b (5.58 g, 16.1 mmol), KHCO3 (1.93 g, 19.3 mmol),
tetrabutylammonium iodide (0.30 g, 0.80 mmol) and methylamine (4.2 mL, 40
wt % solution in water, 48 mmol) in toluene/H2O (100 mL/100 mL) was
stirred at rt for 48h. The resulting precipitate was collected by
filtration, washed with EtOAc and dried under high vacuum to provide 15b
as white solid, yield 4.92 g, 90% Rf = 0.60 (SiO2, 30% EtOAc/hexane). Mp
= 277 °C (decomposed).1H-NMR (300 MHz, CDCl3) δ (ppm): 11.40 (NHC6, s,
br, 1H), 11.14 (NHC6, s , br, 1H, minor isomer) 10.12 (C5H, s, 1H, minor
isomer), 10.11 (C5H, s, 1H), 7.64-7.41 (C7H-C11H, m, 4H), 5.59 (C12NH,
br, 1H), 5.50 (C12NH, br, 1H, minor isomer), 3.07 (C12H, d, 3J = 5.1 Hz,
3H, minor isomer), 3.04 (C12H, d, 3J = 5.1 Hz, 3H). (C12H10BrClN4O,
ESI-MS: Expected mass for [M+H+]/z: 340.98/342.98, Observed: 341.0/343.0
([M+H+]/z, 77%/100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Regioselective Approach to Trisubstituted 2(or
6)-Arylaminopyrimidine-5-carbaldehydes and Their Application in the
Synthesis of Structurally and Electronically Unique G-C Base Precursors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beingessner, Rachel L.; Deng, Bo-Liang; Fanwick, Phillip E.; Fenniri,
Hicham
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(3), 931-939

$RFMT $RIREG SCHEME341 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-tert-Butylbenzaldehyde
C11H14O
939-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 1.5400 0.0000 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 3.0800 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 O 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 0.2064 0.0 0
M  V30 9 C 3.8500 2.8736 0.0 0
M  V30 10 C 5.3900 0.2064 0.0 0
M  V30 11 C 5.3900 2.8736 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxybenzaldehyde
C7H6O2
100-83-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[[[4-(1,1-Dimethylethyl)phenyl]methyl]methylamino]methyl]phenol
C19H25NO
209046-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.4137 0.0 0
M  V30 2 N 8.0022 3.6437 0.0 0
M  V30 3 C 9.3358 4.4137 0.0 0
M  V30 4 C 8.0022 2.1037 0.0 0
M  V30 5 C 1.3337 1.3337 0.0 0
M  V30 6 C 2.1037 0.0000 0.0 0
M  V30 7 C 0.0000 0.5637 0.0 0
M  V30 8 C 0.5637 2.6673 0.0 0
M  V30 9 O 14.6707 4.4137 0.0 0
M  V30 10 C 5.3348 3.6437 0.0 0
M  V30 11 C 5.3348 2.1037 0.0 0
M  V30 12 C 4.0010 4.4137 0.0 0
M  V30 13 C 4.0010 1.3337 0.0 0
M  V30 14 C 2.6673 3.6437 0.0 0
M  V30 15 C 2.6673 2.1037 0.0 0
M  V30 16 C 10.6697 3.6437 0.0 0
M  V30 17 C 12.0033 4.4137 0.0 0
M  V30 18 C 10.6697 2.1037 0.0 0
M  V30 19 C 13.3370 3.6437 0.0 0
M  V30 20 C 12.0033 1.3337 0.0 0
M  V30 21 C 13.3370 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 16
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 15
M  V30 10 1 9 19
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 939-97-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100-83-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 209046-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38031437
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Divergent and Selective Light Alkene Cross-Coupling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Zi-Chao; Zhang, Jia-Wen; Koh, Ming Joo; Shi, Shi-Liang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2023), 62(45), e202310203

$RFMT $RIREG SCHEME342 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitrobenzonitrile
C7H3FN2O2
1009-35-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 F 1.3337 4.6201 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 N 8.0022 0.7700 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 3 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoyl isothiocyanate
C8H5NOS
532-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 S 8.4702 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.7700 2.6673 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 2 4
M  V30 5 2 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Cyano-1-methyl-1H-benzimidazol-2-yl)benzamide
C16H12N4O
496837-96-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3594 0.0000 0.0 0
M  V30 2 N 5.3900 2.7106 0.0 0
M  V30 3 C 4.6200 4.0442 0.0 0
M  V30 4 O 5.3900 5.3780 0.0 0
M  V30 5 C 13.3008 4.2506 0.0 0
M  V30 6 N 14.6346 5.0206 0.0 0
M  V30 7 C 9.2999 1.9406 0.0 0
M  V30 8 C 9.2999 3.4806 0.0 0
M  V30 9 N 7.8352 1.4647 0.0 0
M  V30 10 C 10.6335 1.1706 0.0 0
M  V30 11 N 7.8352 3.9564 0.0 0
M  V30 12 C 10.6335 4.2506 0.0 0
M  V30 13 C 6.9300 2.7106 0.0 0
M  V30 14 C 11.9672 1.9406 0.0 0
M  V30 15 C 11.9672 3.4806 0.0 0
M  V30 16 C 3.0800 4.0442 0.0 0
M  V30 17 C 2.3100 5.3780 0.0 0
M  V30 18 C 2.3100 2.7106 0.0 0
M  V30 19 C 0.7700 5.3780 0.0 0
M  V30 20 C 0.7700 2.7106 0.0 0
M  V30 21 C 0.0000 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 2 3 4
M  V30 5 1 3 16
M  V30 6 3 5 6
M  V30 7 1 5 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1009-35-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 532-55-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 496837-96-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9730982
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Trisamine resin used in stage 4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient solution phase synthesis of 2-(N-acylamino)benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seth, Punit P.; Robinson, Dale E.; Jefferson, Elizabeth A.; Swayze, Eric
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(41), 7303-7306

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromophenyl)-1,4-pentanedione
C11H11BrO2
1009842-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 C 10.6695 1.5400 0.0 0
M  V30 7 O 9.3359 3.8500 0.0 0
M  V30 8 Br 0.0000 1.5400 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0
M  V30 11 C 4.0011 3.8500 0.0 0
M  V30 12 C 1.3337 2.3100 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Bromophenyl)-1,5-dimethyl-1H-pyrrole
C12H12BrN
1225495-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0618 0.9473 0.0 0
M  V30 2 Br 0.0000 3.0801 0.0 0
M  V30 3 C 9.3037 3.4372 0.0 0
M  V30 4 C 4.0010 2.3101 0.0 0
M  V30 5 C 2.6673 3.0801 0.0 0
M  V30 6 C 4.0010 0.7700 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 2.6673 0.0000 0.0 0
M  V30 9 C 1.3337 0.7700 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 N 6.7417 2.4536 0.0 0
M  V30 12 C 5.4958 4.6116 0.0 0
M  V30 13 C 7.7721 3.5981 0.0 0
M  V30 14 C 7.0021 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 7
M  V30 3 1 3 13
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1009842-77-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1225495-70-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5345144
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 5329-14-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-(3-Bromophenyl)pentane-1,4-dione (2.0 g, 1 equiv, 8 mmol), methylamine
(33 wt % in absolute ethanol, 2.0 mL, 2.5 equiv, 16 mmol) and sulfamic
acid (0.078 g, 0.1 equiv, 0.8 mmol) were used to yield P5 as a yellow oil
(1.79 g, 90% yield). P5, 1.79 g, 90% yield. 1H NMR (500 MHz, CDCl3): δ
7.53 (s, 1H), 7.40 (d, J = 6.5 Hz, 1H), 7.30 (d, J = 7.5 Hz, 1H), 7.25
(m, 1H), 6.15 (d, J = 3 Hz, 1H), 5.97 (d, J = 3 Hz, 1H), 3.52 (s, 3H),
2.30 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 135.8, 132.2, 131.0, 129.7,
129.0, 126.8, 122.2, 108.1, 106.6, 31.6, 12.6 (two aromatic signals are
coincidentally overlapping). HRMS electrospray (m/z): [M+] calcd for
C12H12BrN, 250.0231; found, 250.0234.
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed C-H Arylation of 2,5-Substituted Pyrroles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wagner, Anna M.; Sanford, Melanie S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2011), 13(2), 288-291

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-pyridinecarboxaldehyde
C6H4ClNO
101066-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 N 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-4-pyridinemethanamine
C7H9ClN2
748187-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 Cl 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 N 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101066-61-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 748187-76-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14271300
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A practical synthesis of tetrasubstituted imidazole p38 MAP kinase
inhibitors: A new method for the synthesis of α-amidoketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murry, Jerry A.; Frantz, Doug; Frey, Lisa; Soheili, Arash; Marcantonio,
Karen; Tillyer, Richard; Grabowski, Edward J. J.; Reider, Paul J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Symposium Series (2004), 870161-180

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-8-cyclopentyl-4-methyl-2-(methylsulfinyl)pyrido[2,3-d]pyrimidin-7(8H)...
C14H16BrN3O2S
1013101-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.9098 0.0 0
M  V30 2 C 5.3347 8.5298 0.0 0
M  V30 3 S 8.0022 3.9098 0.0 0 VAL=4
M  V30 4 C 9.3358 4.6798 0.0 0
M  V30 5 O 8.0022 2.3698 0.0 0
M  V30 6 Br 0.0000 6.9898 0.0 0
M  V30 7 C 4.0011 4.6798 0.0 0
M  V30 8 N 2.6674 3.9098 0.0 0
M  V30 9 C 4.0011 6.2198 0.0 0
M  V30 10 N 5.3347 3.9098 0.0 0
M  V30 11 C 1.3336 4.6798 0.0 0
M  V30 12 C 5.3347 6.9898 0.0 0
M  V30 13 C 2.6674 6.9898 0.0 0
M  V30 14 C 6.6684 4.6798 0.0 0
M  V30 15 C 1.3336 6.2198 0.0 0
M  V30 16 N 6.6684 6.2198 0.0 0
M  V30 17 C 2.6674 2.3698 0.0 0
M  V30 18 C 3.9133 1.4645 0.0 0
M  V30 19 C 1.4214 1.4645 0.0 0
M  V30 20 C 3.4375 0.0000 0.0 0
M  V30 21 C 1.8974 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 17
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-8-cyclopentyl-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one
C14H17BrN4O
1013098-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.9098 0.0 0
M  V30 2 C 5.3348 8.5299 0.0 0
M  V30 3 N 8.0023 3.9098 0.0 0
M  V30 4 C 9.3359 4.6798 0.0 0
M  V30 5 Br 0.0000 6.9898 0.0 0
M  V30 6 C 4.0011 4.6798 0.0 0
M  V30 7 N 2.6675 3.9098 0.0 0
M  V30 8 C 4.0011 6.2198 0.0 0
M  V30 9 N 5.3348 3.9098 0.0 0
M  V30 10 C 1.3337 4.6798 0.0 0
M  V30 11 C 5.3348 6.9898 0.0 0
M  V30 12 C 2.6675 6.9898 0.0 0
M  V30 13 C 6.6684 4.6798 0.0 0
M  V30 14 C 1.3337 6.2198 0.0 0
M  V30 15 N 6.6684 6.2198 0.0 0
M  V30 16 C 2.6675 2.3698 0.0 0
M  V30 17 C 1.4214 1.4646 0.0 0
M  V30 18 C 3.9133 1.4646 0.0 0
M  V30 19 C 1.8975 0.0000 0.0 0
M  V30 20 C 3.4375 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 7 16
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1013101-72-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013098-89-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3347847
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 2.
2-Amino-6-bromo-8-cyclopentyl-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one.
To a solution of
6-bromo-8-cyclopentyl-4-methyl-2-(methylsulfinyl)pyrido[2,3-djpyrimidin-7(8H)-one
(0.80 g, 2.16 mmol) in dioxane (5 mL) was added ammonium hydroxide (30%,
2.6 mL). The mixture was then heated at 110°C in a sealed tube for 30
minues. The solution was concentrated in vacuo and extracted with ethyl
acetate (3 × 30 mL). The combined organics were washed with saturated
aqueous sodium chloride, dried (anhydrous sodium sulfate), filtered and
concentrated to dryness.
6-Bromo-8-cyclopentyl-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one.
Following the procedure described in Example 2, using methylamine (2M in
THF) in place of ammonium hydroxide, the title compound was obtained in
90% yield. LRMS: 338 (M+H)+. 1H NMR (DMSO-d6, 400 MHz): 8.36 (1H, s),
7.82 (1H, bs), 5.98-5.94 (1H, m), 2.86 (3H, s), 2.51 (3H, s), 2.28 (2H,
m), 1.99-1.97 (2H, m),1.75-1.72 (2H, m), 1.62 (2H, m).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrido[2, 3-d]pyrimidinone compounds as PI3 inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of
abnormal cell growth
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cheng, Hengmiao; Bhumralkar, Dilip; Dress, Klaus Ruprecht; Hoffman,
Jacqui Elizabet; Johnson, Mary Catherine; Kania, Robert Steven; Le,
Phuong Thi Quy; Nambu, Michell David; Pairish, Mason Alan; Plewe, Michael
Bruno; Tran, Khanh Tuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008032162 A1 2008-03-20

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Benzotriazol-1-yl (αE)-4-[(1Z)-2-bromoethenyl]-α-[(4-methoxyphenyl)methyle...
C30H26BrN5O4S
1013366-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9081 7.5409 0.0 0
M  V30 2 C 11.2417 6.7709 0.0 0
M  V30 3 C 8.5744 6.7709 0.0 0
M  V30 4 O 8.5744 5.2309 0.0 0
M  V30 5 O 7.2408 7.5409 0.0 0
M  V30 6 C 6.7802 8.7415 0.0 0
M  V30 7 O 5.4080 9.4407 0.0 0
M  V30 8 C 4.1166 8.6020 0.0 0
M  V30 9 C 12.0165 10.1446 0.0 0
M  V30 10 C 12.8553 11.4362 0.0 0
M  V30 11 Br 12.1562 12.8084 0.0 0
M  V30 12 S 6.9556 12.0873 0.0 0
M  V30 13 C 7.1964 13.6084 0.0 0
M  V30 14 O 16.5764 9.8509 0.0 0
M  V30 15 C 17.9102 9.0809 0.0 0
M  V30 16 C 9.5095 9.0284 0.0 0
M  V30 17 N 8.0718 9.5802 0.0 0
M  V30 18 C 10.4786 10.2252 0.0 0
M  V30 19 C 8.1523 11.1182 0.0 0
M  V30 20 N 9.6400 11.5168 0.0 0
M  V30 21 C 12.5755 7.5409 0.0 0
M  V30 22 C 12.5755 9.0809 0.0 0
M  V30 23 C 13.9091 6.7709 0.0 0
M  V30 24 C 13.9091 9.8509 0.0 0
M  V30 25 C 15.2428 7.5409 0.0 0
M  V30 26 C 15.2428 9.0809 0.0 0
M  V30 27 N 7.2408 4.4609 0.0 0
M  V30 28 C 7.0797 2.9292 0.0 0
M  V30 29 N 5.8338 5.0872 0.0 0
M  V30 30 C 5.5734 2.6091 0.0 0
M  V30 31 C 8.1103 1.7849 0.0 0
M  V30 32 N 4.8034 3.9427 0.0 0
M  V30 33 C 5.0976 1.1445 0.0 0
M  V30 34 C 7.6343 0.3202 0.0 0
M  V30 35 C 6.1280 0.0000 0.0 0
M  V30 36 C 2.7444 9.3010 0.0 0
M  V30 37 C 1.4528 8.4623 0.0 0
M  V30 38 C 2.6637 10.8390 0.0 0
M  V30 39 C 0.0807 9.1615 0.0 0
M  V30 40 C 1.2916 11.5382 0.0 0
M  V30 41 C 0.0000 10.6993 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 21
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 27
M  V30 8 1 6 7
M  V30 9 1 6 17
M  V30 10 1 7 8
M  V30 11 1 8 36
M  V30 12 2 9 10
M  V30 13 1 9 18
M  V30 14 1 10 11
M  V30 15 1 12 13
M  V30 16 1 12 19
M  V30 17 1 14 15
M  V30 18 1 14 26
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 28 31
M  V30 34 2 29 32
M  V30 35 1 30 32
M  V30 36 2 30 33
M  V30 37 1 31 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-4-[(1Z)-2-Bromoethenyl]-α-[(4-methoxyphenyl)methylene]-N-methyl-2-(methy...
C25H26BrN3O3S
1013367-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.5094 3.0800 0.0 0
M  V30 2 C 10.8430 2.3100 0.0 0
M  V30 3 C 8.1757 2.3100 0.0 0
M  V30 4 N 8.1757 0.7700 0.0 0
M  V30 5 O 6.8419 3.0800 0.0 0
M  V30 6 C 6.8419 0.0000 0.0 0
M  V30 7 C 6.7800 4.3331 0.0 0
M  V30 8 O 5.4079 5.0323 0.0 0
M  V30 9 C 4.1164 4.1936 0.0 0
M  V30 10 C 12.0163 5.7362 0.0 0
M  V30 11 C 12.8552 7.0278 0.0 0
M  V30 12 Br 12.1560 8.3999 0.0 0
M  V30 13 S 6.9554 7.6789 0.0 0
M  V30 14 C 7.1963 9.2000 0.0 0
M  V30 15 O 16.1777 5.3900 0.0 0
M  V30 16 C 17.5114 4.6200 0.0 0
M  V30 17 C 9.5094 4.6200 0.0 0
M  V30 18 N 8.0716 5.1719 0.0 0
M  V30 19 C 10.4785 5.8167 0.0 0
M  V30 20 C 8.1523 6.7098 0.0 0
M  V30 21 N 9.6398 7.1083 0.0 0
M  V30 22 C 12.1766 3.0800 0.0 0
M  V30 23 C 12.1766 4.6200 0.0 0
M  V30 24 C 13.5104 2.3100 0.0 0
M  V30 25 C 13.5104 5.3900 0.0 0
M  V30 26 C 14.8441 3.0800 0.0 0
M  V30 27 C 14.8441 4.6200 0.0 0
M  V30 28 C 2.7443 4.8927 0.0 0
M  V30 29 C 2.6636 6.4306 0.0 0
M  V30 30 C 1.4527 4.0539 0.0 0
M  V30 31 C 1.2914 7.1297 0.0 0
M  V30 32 C 0.0805 4.7531 0.0 0
M  V30 33 C 0.0000 6.2909 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 22
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 18
M  V30 10 1 8 9
M  V30 11 1 9 28
M  V30 12 2 10 11
M  V30 13 1 10 19
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 20
M  V30 17 1 15 16
M  V30 18 1 15 27
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1013366-98-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013367-01-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-748532
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-[3-Benzyloxymethyl-5-(2-bromo-vinyl)-2-methylsulfanyl-3H-imidazol-4-yl]-3-(4-
methoxy-phenyl)-N-methyl-acrylamide (34). HOBt ester 33 (240 mg, 0.37
mmol) was dissolved in 1 mL DCM. MeNH2 (2.0 M in THF) was added (approx 3
mL) until the bright yellow color disappeared. The solution was stirred
for 1 min, and then extracted into EtOAc. The organic phase was washed
with 2 x 0.5 M hydrochloric acid, 1 x H2O, 1 x satd NaHCO3. The organic
phase was dried over Na2SO4, filtered and concentrated to yield 34 (175
mg, 0.33 mmol, 90%) as a slightly yellow foam.
2-[3-Benzyloxymethyl-5-(2-bromo-vinyl)-2-methylsulfanyl-3H-imidazol-4-yl]-3-(4-
methoxy-phenyl)-N-methyl-acrylamide (34), yield (175 mg, 0.33 mmol, 90%)
1H NMR (600 MHz, CD2Cl2) δ 2.71 (d, J = 4.7 Hz, 1H), 2.78 (s, 3H), 3.76
(s, 3H), 4.40 (s, 2H), 4.93 (d, J = 10.8 Hz, 1H), 5.07 (d, J = 10.8 Hz,
1H), 5.71 (s, br, 1H), 6.27 (d, J = 8.0 Hz, 1H), 6.74 (d, J = 8.0 Hz,
1H), 6.78 (d, J = 8.9 Hz, 2H), 7.02 (d, J = 8.9 Hz, 2H), 7.15 (m, 2H),
7.29 (m, 3H), 8.02 (s, 1H); 13C NMR (150 MHz, CD2Cl2) δ 15.2, 26.2, 54.8,
70.4, 72.7, 104.8, 113.8, 117.6, 121.8, 126.0, 127.0, 127.4, 127.8,
128.1, 131.4, 136.1, 136.2, 142.2, 146.6, 160.6, 165.3; ESIMS [M+Na]+
calcd for C25H26N3O3S79BrNa 550.0776, found 550.0757.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic Approaches to the Microtubule-Stabilizing Sponge Alkaloid
Ceratamine A and Desbromo Analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nodwell, Matt; Pereira, Alban; Riffell, Jenna L.; Zimmerman, Carla;
Patrick, Brian O.; Roberge, Michel; Andersen, Raymond J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(3), 995-1006

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Benzotriazol-1-yl (αE)-4-[(1Z)-2-bromoethenyl]-α-[(4-methoxyphenyl)methyle...
C30H26BrN5O4S
1013366-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9081 7.5409 0.0 0
M  V30 2 C 11.2417 6.7709 0.0 0
M  V30 3 C 8.5744 6.7709 0.0 0
M  V30 4 O 8.5744 5.2309 0.0 0
M  V30 5 O 7.2408 7.5409 0.0 0
M  V30 6 C 6.7802 8.7415 0.0 0
M  V30 7 O 5.4080 9.4407 0.0 0
M  V30 8 C 4.1166 8.6020 0.0 0
M  V30 9 C 12.0165 10.1446 0.0 0
M  V30 10 C 12.8553 11.4362 0.0 0
M  V30 11 Br 12.1562 12.8084 0.0 0
M  V30 12 S 6.9556 12.0873 0.0 0
M  V30 13 C 7.1964 13.6084 0.0 0
M  V30 14 O 16.5764 9.8509 0.0 0
M  V30 15 C 17.9102 9.0809 0.0 0
M  V30 16 C 9.5095 9.0284 0.0 0
M  V30 17 N 8.0718 9.5802 0.0 0
M  V30 18 C 10.4786 10.2252 0.0 0
M  V30 19 C 8.1523 11.1182 0.0 0
M  V30 20 N 9.6400 11.5168 0.0 0
M  V30 21 C 12.5755 7.5409 0.0 0
M  V30 22 C 12.5755 9.0809 0.0 0
M  V30 23 C 13.9091 6.7709 0.0 0
M  V30 24 C 13.9091 9.8509 0.0 0
M  V30 25 C 15.2428 7.5409 0.0 0
M  V30 26 C 15.2428 9.0809 0.0 0
M  V30 27 N 7.2408 4.4609 0.0 0
M  V30 28 C 7.0797 2.9292 0.0 0
M  V30 29 N 5.8338 5.0872 0.0 0
M  V30 30 C 5.5734 2.6091 0.0 0
M  V30 31 C 8.1103 1.7849 0.0 0
M  V30 32 N 4.8034 3.9427 0.0 0
M  V30 33 C 5.0976 1.1445 0.0 0
M  V30 34 C 7.6343 0.3202 0.0 0
M  V30 35 C 6.1280 0.0000 0.0 0
M  V30 36 C 2.7444 9.3010 0.0 0
M  V30 37 C 1.4528 8.4623 0.0 0
M  V30 38 C 2.6637 10.8390 0.0 0
M  V30 39 C 0.0807 9.1615 0.0 0
M  V30 40 C 1.2916 11.5382 0.0 0
M  V30 41 C 0.0000 10.6993 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 21
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 27
M  V30 8 1 6 7
M  V30 9 1 6 17
M  V30 10 1 7 8
M  V30 11 1 8 36
M  V30 12 2 9 10
M  V30 13 1 9 18
M  V30 14 1 10 11
M  V30 15 1 12 13
M  V30 16 1 12 19
M  V30 17 1 14 15
M  V30 18 1 14 26
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 28 31
M  V30 34 2 29 32
M  V30 35 1 30 32
M  V30 36 2 30 33
M  V30 37 1 31 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-4-[(1Z)-2-Bromoethenyl]-α-[(4-methoxyphenyl)methylene]-N-methyl-2-(methy...
C25H26BrN3O3S
1013367-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.5094 3.0800 0.0 0
M  V30 2 C 10.8430 2.3100 0.0 0
M  V30 3 C 8.1757 2.3100 0.0 0
M  V30 4 N 8.1757 0.7700 0.0 0
M  V30 5 O 6.8419 3.0800 0.0 0
M  V30 6 C 6.8419 0.0000 0.0 0
M  V30 7 C 6.7800 4.3331 0.0 0
M  V30 8 O 5.4079 5.0323 0.0 0
M  V30 9 C 4.1164 4.1936 0.0 0
M  V30 10 C 12.0163 5.7362 0.0 0
M  V30 11 C 12.8552 7.0278 0.0 0
M  V30 12 Br 12.1560 8.3999 0.0 0
M  V30 13 S 6.9554 7.6789 0.0 0
M  V30 14 C 7.1963 9.2000 0.0 0
M  V30 15 O 16.1777 5.3900 0.0 0
M  V30 16 C 17.5114 4.6200 0.0 0
M  V30 17 C 9.5094 4.6200 0.0 0
M  V30 18 N 8.0716 5.1719 0.0 0
M  V30 19 C 10.4785 5.8167 0.0 0
M  V30 20 C 8.1523 6.7098 0.0 0
M  V30 21 N 9.6398 7.1083 0.0 0
M  V30 22 C 12.1766 3.0800 0.0 0
M  V30 23 C 12.1766 4.6200 0.0 0
M  V30 24 C 13.5104 2.3100 0.0 0
M  V30 25 C 13.5104 5.3900 0.0 0
M  V30 26 C 14.8441 3.0800 0.0 0
M  V30 27 C 14.8441 4.6200 0.0 0
M  V30 28 C 2.7443 4.8927 0.0 0
M  V30 29 C 2.6636 6.4306 0.0 0
M  V30 30 C 1.4527 4.0539 0.0 0
M  V30 31 C 1.2914 7.1297 0.0 0
M  V30 32 C 0.0805 4.7531 0.0 0
M  V30 33 C 0.0000 6.2909 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 22
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 18
M  V30 10 1 8 9
M  V30 11 1 9 28
M  V30 12 2 10 11
M  V30 13 1 10 19
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 20
M  V30 17 1 15 16
M  V30 18 1 15 27
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1013366-98-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013367-01-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4315604
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Biologically Active Marine Natural Product Analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nodwell, Matthew B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2009), (20140701), No pp.

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Benzotriazol-1-yl (αE)-4-[(1Z)-2-bromoethenyl]-α-[(4-methoxyphenyl)methyle...
C30H26BrN5O4S
1013366-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9081 7.5409 0.0 0
M  V30 2 C 11.2417 6.7709 0.0 0
M  V30 3 C 8.5744 6.7709 0.0 0
M  V30 4 O 8.5744 5.2309 0.0 0
M  V30 5 O 7.2408 7.5409 0.0 0
M  V30 6 C 6.7802 8.7415 0.0 0
M  V30 7 O 5.4080 9.4407 0.0 0
M  V30 8 C 4.1166 8.6020 0.0 0
M  V30 9 C 12.0165 10.1446 0.0 0
M  V30 10 C 12.8553 11.4362 0.0 0
M  V30 11 Br 12.1562 12.8084 0.0 0
M  V30 12 S 6.9556 12.0873 0.0 0
M  V30 13 C 7.1964 13.6084 0.0 0
M  V30 14 O 16.5764 9.8509 0.0 0
M  V30 15 C 17.9102 9.0809 0.0 0
M  V30 16 C 9.5095 9.0284 0.0 0
M  V30 17 N 8.0718 9.5802 0.0 0
M  V30 18 C 10.4786 10.2252 0.0 0
M  V30 19 C 8.1523 11.1182 0.0 0
M  V30 20 N 9.6400 11.5168 0.0 0
M  V30 21 C 12.5755 7.5409 0.0 0
M  V30 22 C 12.5755 9.0809 0.0 0
M  V30 23 C 13.9091 6.7709 0.0 0
M  V30 24 C 13.9091 9.8509 0.0 0
M  V30 25 C 15.2428 7.5409 0.0 0
M  V30 26 C 15.2428 9.0809 0.0 0
M  V30 27 N 7.2408 4.4609 0.0 0
M  V30 28 C 7.0797 2.9292 0.0 0
M  V30 29 N 5.8338 5.0872 0.0 0
M  V30 30 C 5.5734 2.6091 0.0 0
M  V30 31 C 8.1103 1.7849 0.0 0
M  V30 32 N 4.8034 3.9427 0.0 0
M  V30 33 C 5.0976 1.1445 0.0 0
M  V30 34 C 7.6343 0.3202 0.0 0
M  V30 35 C 6.1280 0.0000 0.0 0
M  V30 36 C 2.7444 9.3010 0.0 0
M  V30 37 C 1.4528 8.4623 0.0 0
M  V30 38 C 2.6637 10.8390 0.0 0
M  V30 39 C 0.0807 9.1615 0.0 0
M  V30 40 C 1.2916 11.5382 0.0 0
M  V30 41 C 0.0000 10.6993 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 21
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 27
M  V30 8 1 6 7
M  V30 9 1 6 17
M  V30 10 1 7 8
M  V30 11 1 8 36
M  V30 12 2 9 10
M  V30 13 1 9 18
M  V30 14 1 10 11
M  V30 15 1 12 13
M  V30 16 1 12 19
M  V30 17 1 14 15
M  V30 18 1 14 26
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 28 31
M  V30 34 2 29 32
M  V30 35 1 30 32
M  V30 36 2 30 33
M  V30 37 1 31 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-4-[(1Z)-2-Bromoethenyl]-α-[(4-methoxyphenyl)methylene]-N-methyl-2-(methy...
C25H26BrN3O3S
1013367-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.5094 3.0800 0.0 0
M  V30 2 C 10.8430 2.3100 0.0 0
M  V30 3 C 8.1757 2.3100 0.0 0
M  V30 4 N 8.1757 0.7700 0.0 0
M  V30 5 O 6.8419 3.0800 0.0 0
M  V30 6 C 6.8419 0.0000 0.0 0
M  V30 7 C 6.7800 4.3331 0.0 0
M  V30 8 O 5.4079 5.0323 0.0 0
M  V30 9 C 4.1164 4.1936 0.0 0
M  V30 10 C 12.0163 5.7362 0.0 0
M  V30 11 C 12.8552 7.0278 0.0 0
M  V30 12 Br 12.1560 8.3999 0.0 0
M  V30 13 S 6.9554 7.6789 0.0 0
M  V30 14 C 7.1963 9.2000 0.0 0
M  V30 15 O 16.1777 5.3900 0.0 0
M  V30 16 C 17.5114 4.6200 0.0 0
M  V30 17 C 9.5094 4.6200 0.0 0
M  V30 18 N 8.0716 5.1719 0.0 0
M  V30 19 C 10.4785 5.8167 0.0 0
M  V30 20 C 8.1523 6.7098 0.0 0
M  V30 21 N 9.6398 7.1083 0.0 0
M  V30 22 C 12.1766 3.0800 0.0 0
M  V30 23 C 12.1766 4.6200 0.0 0
M  V30 24 C 13.5104 2.3100 0.0 0
M  V30 25 C 13.5104 5.3900 0.0 0
M  V30 26 C 14.8441 3.0800 0.0 0
M  V30 27 C 14.8441 4.6200 0.0 0
M  V30 28 C 2.7443 4.8927 0.0 0
M  V30 29 C 2.6636 6.4306 0.0 0
M  V30 30 C 1.4527 4.0539 0.0 0
M  V30 31 C 1.2914 7.1297 0.0 0
M  V30 32 C 0.0805 4.7531 0.0 0
M  V30 33 C 0.0000 6.2909 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 22
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 18
M  V30 10 1 8 9
M  V30 11 1 9 28
M  V30 12 2 10 11
M  V30 13 1 10 19
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 20
M  V30 17 1 15 16
M  V30 18 1 15 27
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1013366-98-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013367-01-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1464015
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-[3-Benzyloxymethyl-5-(2-bromo-vinyl)-2-methylsulfanyl-3H-imidazol-4-yl]-3-(4-methoxy-phenyl)-N-methyl-acrylamide.
HOBt ester (240mg, 0.37mmol) was dissolved in 1mL DCM. MeNH2 (2.0M in
THF) was added (approx 3mL) until the bright yellow color disappeared.
The solution was stirred for 1 min,and then extracted into EtOAc. The
organic phase was washed with 2 x 0.5M HCl, 1 x H2O, 1 x satd NaHCO3. The
organic phase was dried over Na2SO4, filtered and concentrated to
2-[3-Benzyloxymethyl-5-(2-bromo-vinyl)-2-methylsulfanyl-3H-imidazol-4-yl]-3-(4-methoxy-phenyl)-N-methyl-acrylamide
as a slightly yellow foam, yield 175 mg, 0.33 mmol, 90%. 1H NMR (600 MHz,
CD2Cl2) δ 2.71 (d, 4.7Hz, 1H), 2.78 (s, 3H), 3.76 (s, 3H), 4.40 (s, 2H),
4.93 (d, 10.8Hz, 1H), 5.07 (d, 10.8Hz, 1H), 5.71 (s, br, 1H), 6.27 (d,
8.0Hz, 1H), 6.74 (d, 8.0Hz, 1H), 6.78 (d, 8.9Hz, 2H), 7.02 (d, 8.9Hz,
2H), 7.15 (m, 2H), 7.29 (m, 3H), 8.02 (s, 1H); 13C NMR (150 MHz, CD2Cl2)
δ 15.2, 26.2, 54.8, 70.4, 72.7, 104.8, 113.8, 117.6, 121.8, 126.0, 127.0,
127.4, 127.8, 128.1, 131.4, 136.1, 136.2, 142.2, 146.6, 160.6, 165.3
HRESIMS calcd for C25H26N3O3S79BrNa 550.0776, found 550.0757
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Antimitotic Analogs of the Microtubule Stabilizing Sponge
Alkaloid Ceratamine A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nodwell, Matt; Riffell, Jenna L.; Roberge, Michel; Andersen, Raymond J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2008), 10(6), 1051-1054

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-cyano-β-oxobenzenepropanoate
C11H9NO3
101341-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 3.8501 1.3337 0.0 0
M  V30 3 O 3.8501 4.0010 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 O 1.5400 2.6673 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 10.7802 2.6673 0.0 0
M  V30 9 N 12.3203 2.6673 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 6.9302 4.0010 0.0 0
M  V30 13 C 8.4702 1.3337 0.0 0
M  V30 14 C 8.4702 4.0010 0.0 0
M  V30 15 C 9.2402 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 3 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-(4-cyanophenyl)-3-(methylamino)-2-propenoate
C12H12N2O2
2304416-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 3.8500 4.0011 0.0 0
M  V30 3 N 3.8500 1.3338 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 O 1.5400 5.3349 0.0 0
M  V30 7 O 1.5400 2.6674 0.0 0
M  V30 8 C 0.0000 5.3349 0.0 0
M  V30 9 C 10.7800 2.6674 0.0 0
M  V30 10 N 12.3200 2.6674 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 6.9300 1.3338 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 8.4700 1.3338 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 3 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101341-45-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-17-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946809
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
4-(Trifluoromethyl)benzenepropanamine
C10H12F3N
101488-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 4.2073 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 1.1273 0.0 0
M  V30 5 C 7.7000 2.6673 0.0 0
M  V30 6 C 8.4700 1.3336 0.0 0
M  V30 7 C 10.0100 1.3336 0.0 0
M  V30 8 N 10.7800 0.0000 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 3.8500 1.3336 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(trifluoromethyl)benzenepropanamine
C11H14F3N
459872-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 1.1273 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 4.2073 0.0 0
M  V30 5 C 7.7000 2.6673 0.0 0
M  V30 6 C 8.4700 1.3336 0.0 0
M  V30 7 C 10.0100 1.3336 0.0 0
M  V30 8 N 10.7800 0.0000 0.0 0
M  V30 9 C 12.3200 0.0000 0.0 0
M  V30 10 C 3.0800 2.6673 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 3.8500 1.3336 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 5.3900 1.3336 0.0 0
M  V30 15 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 101488-60-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 459872-43-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-10964761
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16853-85-3
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the synthesis of
phenylpropylamines. A stirred solution of the appropriately substituted
phenylpropionic acid in 20 mL of DCM (ca. 0.5-1.0 M total cone.) was
reacted with 1.2 equiv. of 1,1’-carbonyldiimidazole by addition of 500 mg
portions over a 15 min period, during which time significant evolution of
CO was observed. The resulting solution was stirred 90 min at RT, then
cooled to 0 °C and treated with 8 mL of a cold (0 °C) 40% aqueous
solution of methylamine. The resulting mixture was allowed to warm to RT
and stirred vigorously for 14 h. The reaction mixture was then acidified
to pH =1 by careful addition of cone. HCl, diluted with 70 mL of
chloroform and extracted with H2O (1 x 100 mL). The organic layer was
separated, dried (MgSO4), and concentrated in vacuo to afford a white
solid. This material was immediately dissolved in 80 mL of THF, and 1.2
equiv. (assuming 100% conversion) of a 1.0 M solution of LiAlH4 in THF
was added dropwise over 10 min. After the addition was complete, the
resulting solution was stirred 10 min at RT and then was heated to 60 °C
for 6 h. The reaction mixture was then cooled to 0 °C and the reaction
was quenched by careful addition of 0.76 mL of H2O, followed by 0.76 mL
of 15% NaOH and then 2.7 mL of H2O. The resulting slurry was stirred
vigorously for 10 min. and then filtered through a pad of Celite to
remove the salts. The salts were isolated, triturated with EtOAc, and
refiltered through a pad of Celite. The filtrates were combined, dried
(MgSO4), and concentrated in vacuo. The material was used without further
purification unless otherwise noted.
N-[3-(4-trifluoromethylphenyl)propyl]-N-methylamine. The title compound
was prepared in 90% yield to give a colorless oil. 1H NMR (CDCl3, 400
MHz) δ 7.53 (d, 2 H, J = 8.0), 7.29 (d, 2 H, J = 8.0), 2.71 (m, 2 H),
2.61 (m, 2 H), 2.44 (s, 3 H), 1.83 (m, 2 H), 1.55 (s, br, 1 H); GCMS
(DB-5, 30m x 0.25mm x 0.25um; 100 °C-300 °C, initial hold 1min; ramp rate
25 °C/min for 8min, final hold 1 min; total 10 min) tR = 3.74 min, 94.7%
purity; low-resolution MS (ES+) m/e 217(M+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new series of estrogen receptor modulators that display selectivity for
estrogen receptor β
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Henke, Brad R.; Consler, Thomas G.; Go, Ning; Hale, Ron L.; Hohman, Dana
R.; Jones, Stacey A.; Lu, Amy T.; Moore, Linda B.; Moore, John T.;
Orband-Miller, Lisa A.; Robinett, R. Graham; Shearin, Jean; Spearing,
Paul K.; Stewart, Eugene L.; Turnbull, Philip S.; Weaver, Susan L.;
Williams, Shawn P.; Wisely, G. Bruce; Lambert, Millard H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2002), 45(25), 5492-5505

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-Garner aldehyde
C11H19NO4
102308-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9865 4.8385 0.0 0
M  V30 2 O 5.3202 4.0685 0.0 0
M  V30 3 O 3.9865 6.3785 0.0 0
M  V30 4 C 6.6539 4.8385 0.0 0
M  V30 5 C 5.8839 6.1721 0.0 0
M  V30 6 C 7.9875 5.6085 0.0 0
M  V30 7 C 7.4239 3.5048 0.0 0
M  V30 8 C 3.6362 1.5063 0.0 0
M  V30 9 O 3.3160 0.0000 0.0 0
M  V30 10 C 2.0159 6.0286 0.0 0
M  V30 11 C 0.0000 5.6000 0.0 0
M  V30 12 N 2.6527 4.0685 0.0 0
M  V30 13 C 2.4918 2.5369 0.0 0 CFG=2
M  V30 14 C 1.2459 4.6948 0.0 0
M  V30 15 C 0.9855 2.2167 0.0 0
M  V30 16 O 0.2155 3.5504 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 13 8 CFG=3
M  V30 10 1 10 14
M  V30 11 1 11 14
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (4R)-2,2-dimethyl-4-[(methylamino)methyl]-3-oxazolidinecarb...
C12H24N2O3
2052994-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9759 3.6363 0.0 0
M  V30 2 N 8.4822 3.3160 0.0 0
M  V30 3 C 9.5128 4.4606 0.0 0
M  V30 4 C 3.6437 3.9865 0.0 0
M  V30 5 O 2.1037 3.9865 0.0 0
M  V30 6 O 4.4137 5.3202 0.0 0
M  V30 7 C 1.3337 5.3202 0.0 0
M  V30 8 C 2.6675 6.0902 0.0 0
M  V30 9 C 0.5637 6.6539 0.0 0
M  V30 10 C 0.0000 4.5502 0.0 0
M  V30 11 C 2.8822 0.0000 0.0 0
M  V30 12 C 2.4537 2.0159 0.0 0
M  V30 13 C 5.9455 2.4918 0.0 0 CFG=2
M  V30 14 N 4.4137 2.6527 0.0 0
M  V30 15 C 6.2656 0.9855 0.0 0
M  V30 16 C 3.7874 1.2459 0.0 0
M  V30 17 O 4.9320 0.2155 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 16
M  V30 12 1 12 16
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 102308-32-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2052994-09-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16622721
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bisaminoquinolines, bisaminoquinazolines and related
compounds with varied linkers autophagy inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deckwerth, Thomas; Kleinman, Edward; Ruan, Fuqiang; Baker, William;
Klinghoffer, Richard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016196393 A2 2016-12-08

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[[S(S)]-N-[[5-[2-(3-hydroxyphenyl)ethynyl]-3-pyridinyl]carbonyl]-S-ph...
C24H20N2O5S
1027726-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 5.3901 0.0 0 CFG=2 VAL=6
M  V30 2 N 5.3348 6.1601 0.0 0
M  V30 3 C 2.6675 4.6201 0.0 0
M  V30 4 O 4.7712 4.0563 0.0 0
M  V30 5 C 6.6685 5.3901 0.0 0
M  V30 6 C 2.6675 3.0801 0.0 0
M  V30 7 O 6.6685 3.8501 0.0 0
M  V30 8 O 1.3337 2.3101 0.0 0
M  V30 9 O 4.0012 2.3101 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 C 12.0035 5.3901 0.0 0
M  V30 13 C 13.3372 4.6201 0.0 0
M  V30 14 O 18.6720 4.6201 0.0 0
M  V30 15 C 3.2311 6.7238 0.0 0
M  V30 16 C 1.6911 6.7238 0.0 0
M  V30 17 C 4.0012 8.0575 0.0 0
M  V30 18 C 0.9211 8.0575 0.0 0
M  V30 19 C 3.2311 9.3911 0.0 0
M  V30 20 C 1.6911 9.3911 0.0 0
M  V30 21 C 8.0023 6.1601 0.0 0
M  V30 22 C 9.3360 5.3901 0.0 0
M  V30 23 C 8.0023 7.7002 0.0 0
M  V30 24 C 10.6697 6.1601 0.0 0
M  V30 25 N 9.3360 8.4702 0.0 0
M  V30 26 C 10.6697 7.7002 0.0 0
M  V30 27 C 14.6708 3.8501 0.0 0
M  V30 28 C 16.0045 4.6201 0.0 0
M  V30 29 C 14.6708 2.3101 0.0 0
M  V30 30 C 17.3383 3.8501 0.0 0
M  V30 31 C 16.0045 1.5400 0.0 0
M  V30 32 C 17.3383 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 2 1 4
M  V30 4 1 1 15 CFG=1
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 5 7
M  V30 8 1 5 21
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 3 12 13
M  V30 14 1 12 24
M  V30 15 1 13 27
M  V30 16 1 14 30
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[2-(3-Hydroxyphenyl)ethynyl]-N-[(S)-[2-(methylamino)-2-oxoethyl]oxidophenyl...
C23H19N3O4S
1027726-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 5.3350 0.0 0 CFG=2 VAL=6
M  V30 2 N 5.3348 4.5650 0.0 0
M  V30 3 C 3.2311 4.0012 0.0 0
M  V30 4 O 4.7712 6.6687 0.0 0
M  V30 5 C 6.6685 5.3350 0.0 0
M  V30 6 C 4.0012 2.6675 0.0 0
M  V30 7 O 6.6685 6.8750 0.0 0
M  V30 8 N 3.2311 1.3338 0.0 0
M  V30 9 O 5.5412 2.6675 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 12.0035 5.3350 0.0 0
M  V30 12 C 13.3372 6.1050 0.0 0
M  V30 13 O 18.6720 6.1050 0.0 0
M  V30 14 C 2.6675 6.1048 0.0 0
M  V30 15 C 1.3337 5.3348 0.0 0
M  V30 16 C 2.6675 7.6449 0.0 0
M  V30 17 C 0.0000 6.1048 0.0 0
M  V30 18 C 1.3337 8.4149 0.0 0
M  V30 19 C 0.0000 7.6449 0.0 0
M  V30 20 C 8.0023 4.5650 0.0 0
M  V30 21 C 9.3360 5.3350 0.0 0
M  V30 22 C 8.0023 3.0249 0.0 0
M  V30 23 C 10.6697 4.5650 0.0 0
M  V30 24 N 9.3360 2.2549 0.0 0
M  V30 25 C 10.6697 3.0249 0.0 0
M  V30 26 C 14.6708 6.8750 0.0 0
M  V30 27 C 16.0045 6.1050 0.0 0
M  V30 28 C 14.6708 8.4151 0.0 0
M  V30 29 C 17.3383 6.8750 0.0 0
M  V30 30 C 16.0045 9.1851 0.0 0
M  V30 31 C 17.3383 8.4151 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 2 1 4
M  V30 4 1 1 14 CFG=3
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 5 7
M  V30 8 1 5 20
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 8 10
M  V30 12 3 11 12
M  V30 13 1 11 23
M  V30 14 1 12 26
M  V30 15 1 13 29
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1027726-52-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1027726-62-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8554476
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
(S)-N-[(2-{[2-(diethylamino)ethyl]amino}-2-oxoethyl)(oxo)phenyl-λ6-sulfanylidene]-5-[(3-hydroxyphenyl)ethynyl]nicotinamide
(S)-Ethyl
[N-({5-[(3-hydroxyphenyl)ethynyl]pyridin-3-yl}carbonyl)-S-phenylsulfonimidoyl]acetate
(73 mg, 0.16 mmol) in anhydrous MeOH (1.5 mL) was added
N,N-diethylethylenediamine (0.12 mL, 0.84 mmol) dropwise. The reaction
mixture was heated at 30 °C for 4 hours. The reaction mixture was
evaporated and the residue was partitioned between EtOAc and saturated
aqueous NaHCO3. The organic layer was washed once with brine, dried
(anhydrous Na2SO4), concentrated. The residue was purified by
chromatography (silica gel, 50:1 CHCl3: MeOH to 10:1 CHCl3:MeOH). The
product containing fractions were concentrated.
5-[(3-hydroxyphenyl)ethynyl]-N-{[2-(methylamino)-2-oxoethyl](oxo)phenyl-λ6-sulfanylidene}
nicotinamide In a manner similar to that described for Example 471,
(S)-Ethyl
[N-({5-[(3-hydroxyphenyl)ethynyl]pyridin-3-yl}carbonyl)-S-phenylsulfonimidoyl]acetate
(50 mg, 0.11 mmol) and methylamine (2.0 M solution in MeOH, 0.5 mL, 1.0
mmol) were reacted to give the title compound as colorless oil (43 mg, 90
%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ocular implants comprising N-sulfanylidene nicotinamides as tyrosine
kinase inhibitors for treatment of abnormal proliferation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spada, Lon T.; Shiah, Jane Guo; Hughes, Patrick M.; Malone, Thomas C.;
Devries, Gerald W.; Edelman, Jeffrey L.; Wurster, Julie A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010078393 A1 2010-07-08

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[[S(S)]-N-[[5-[2-(3-hydroxyphenyl)ethynyl]-3-pyridinyl]carbonyl]-S-ph...
C24H20N2O5S
1027726-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 5.3901 0.0 0 CFG=2 VAL=6
M  V30 2 N 5.3348 6.1601 0.0 0
M  V30 3 C 2.6675 4.6201 0.0 0
M  V30 4 O 4.7712 4.0563 0.0 0
M  V30 5 C 6.6685 5.3901 0.0 0
M  V30 6 C 2.6675 3.0801 0.0 0
M  V30 7 O 6.6685 3.8501 0.0 0
M  V30 8 O 1.3337 2.3101 0.0 0
M  V30 9 O 4.0012 2.3101 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 C 12.0035 5.3901 0.0 0
M  V30 13 C 13.3372 4.6201 0.0 0
M  V30 14 O 18.6720 4.6201 0.0 0
M  V30 15 C 3.2311 6.7238 0.0 0
M  V30 16 C 1.6911 6.7238 0.0 0
M  V30 17 C 4.0012 8.0575 0.0 0
M  V30 18 C 0.9211 8.0575 0.0 0
M  V30 19 C 3.2311 9.3911 0.0 0
M  V30 20 C 1.6911 9.3911 0.0 0
M  V30 21 C 8.0023 6.1601 0.0 0
M  V30 22 C 9.3360 5.3901 0.0 0
M  V30 23 C 8.0023 7.7002 0.0 0
M  V30 24 C 10.6697 6.1601 0.0 0
M  V30 25 N 9.3360 8.4702 0.0 0
M  V30 26 C 10.6697 7.7002 0.0 0
M  V30 27 C 14.6708 3.8501 0.0 0
M  V30 28 C 16.0045 4.6201 0.0 0
M  V30 29 C 14.6708 2.3101 0.0 0
M  V30 30 C 17.3383 3.8501 0.0 0
M  V30 31 C 16.0045 1.5400 0.0 0
M  V30 32 C 17.3383 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 2 1 4
M  V30 4 1 1 15 CFG=1
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 5 7
M  V30 8 1 5 21
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 3 12 13
M  V30 14 1 12 24
M  V30 15 1 13 27
M  V30 16 1 14 30
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[2-(3-Hydroxyphenyl)ethynyl]-N-[(S)-[2-(methylamino)-2-oxoethyl]oxidophenyl...
C23H19N3O4S
1027726-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 5.3350 0.0 0 CFG=2 VAL=6
M  V30 2 N 5.3348 4.5650 0.0 0
M  V30 3 C 3.2311 4.0012 0.0 0
M  V30 4 O 4.7712 6.6687 0.0 0
M  V30 5 C 6.6685 5.3350 0.0 0
M  V30 6 C 4.0012 2.6675 0.0 0
M  V30 7 O 6.6685 6.8750 0.0 0
M  V30 8 N 3.2311 1.3338 0.0 0
M  V30 9 O 5.5412 2.6675 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 12.0035 5.3350 0.0 0
M  V30 12 C 13.3372 6.1050 0.0 0
M  V30 13 O 18.6720 6.1050 0.0 0
M  V30 14 C 2.6675 6.1048 0.0 0
M  V30 15 C 1.3337 5.3348 0.0 0
M  V30 16 C 2.6675 7.6449 0.0 0
M  V30 17 C 0.0000 6.1048 0.0 0
M  V30 18 C 1.3337 8.4149 0.0 0
M  V30 19 C 0.0000 7.6449 0.0 0
M  V30 20 C 8.0023 4.5650 0.0 0
M  V30 21 C 9.3360 5.3350 0.0 0
M  V30 22 C 8.0023 3.0249 0.0 0
M  V30 23 C 10.6697 4.5650 0.0 0
M  V30 24 N 9.3360 2.2549 0.0 0
M  V30 25 C 10.6697 3.0249 0.0 0
M  V30 26 C 14.6708 6.8750 0.0 0
M  V30 27 C 16.0045 6.1050 0.0 0
M  V30 28 C 14.6708 8.4151 0.0 0
M  V30 29 C 17.3383 6.8750 0.0 0
M  V30 30 C 16.0045 9.1851 0.0 0
M  V30 31 C 17.3383 8.4151 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 2 1 4
M  V30 4 1 1 14 CFG=3
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 5 7
M  V30 8 1 5 20
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 8 10
M  V30 12 3 11 12
M  V30 13 1 11 23
M  V30 14 1 12 26
M  V30 15 1 13 29
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1027726-52-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1027726-62-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5419268
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
(S)-N-[(2-{[2-(diethylamino)ethyl]amino}-2-oxoethyl)(oxo)phenyl-λ
6-sulfanylidene]-5-[(3-hydroxyphenyl)ethynyl]nicotinamide (S)-Ethyl
[N-({5-[(3-hydroxyphenyl)ethynyl]pyridin-3-yl}carbonyl)-S-phenylsulfonimidoyl]acetate
(73 mg, 0.16 mmol) in anhydrous MeOH (1.5 mL) was added
N,N-diethylethylenediamine (0.12 mL, 0.84 mmol) dropwise. The reaction
mixture was heated at 30°C. for 4 hours. The reaction mixture was
evaporated and the residue was partitioned between EtOAc and saturated
aqueous NaHCO3. The organic layer was washed once with brine, dried
(anhydrous Na2SO4), concentrated. The residue was purified by
chromatography (silica gel, 50:1 CHCl3:MeOH to 10:1 CHCl3: MeOH). The
product containing fractions were concentrated to give the title compound
as a foamy solid (50 mg, 59%).
5-[(3-hydroxyphenyl)ethynyl]-N-{[2-(methylamino)-2-oxoethyl](oxo)phenyl-λ
6-sulfanylidene]nicotinamide In a manner similar to that described for
Example 471, (S)-Ethyl
[N-({5-[(3-hydroxyphenyl)ethynyl]pyridin-3-yl}carbonyl)-S-phenylsulfonimidoyl]acetate
(50 mg, 0.11 mmol) and methylamine (2.0 M solution in MeOH, 0.5 mL, 1.0
mmol) were reacted to give the title compound as colorless oil (43 mg,
90%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ocular implants comprising tyrosine kinase inhibitors for treatment of
abnormal proliferation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spada, Lon T.; Shiah, Jane Guo; Hughes, Patrick; Malone, Thomas C.;
Devries, Gerald W.; Edelman, Jeffrey L.; Wurster, Julie A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090196906 A1 2009-08-06

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[[S(S)]-N-[[5-[2-(3-hydroxyphenyl)ethynyl]-3-pyridinyl]carbonyl]-S-ph...
C24H20N2O5S
1027726-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 5.3901 0.0 0 CFG=2 VAL=6
M  V30 2 N 5.3348 6.1601 0.0 0
M  V30 3 C 2.6675 4.6201 0.0 0
M  V30 4 O 4.7712 4.0563 0.0 0
M  V30 5 C 6.6685 5.3901 0.0 0
M  V30 6 C 2.6675 3.0801 0.0 0
M  V30 7 O 6.6685 3.8501 0.0 0
M  V30 8 O 1.3337 2.3101 0.0 0
M  V30 9 O 4.0012 2.3101 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 C 12.0035 5.3901 0.0 0
M  V30 13 C 13.3372 4.6201 0.0 0
M  V30 14 O 18.6720 4.6201 0.0 0
M  V30 15 C 3.2311 6.7238 0.0 0
M  V30 16 C 1.6911 6.7238 0.0 0
M  V30 17 C 4.0012 8.0575 0.0 0
M  V30 18 C 0.9211 8.0575 0.0 0
M  V30 19 C 3.2311 9.3911 0.0 0
M  V30 20 C 1.6911 9.3911 0.0 0
M  V30 21 C 8.0023 6.1601 0.0 0
M  V30 22 C 9.3360 5.3901 0.0 0
M  V30 23 C 8.0023 7.7002 0.0 0
M  V30 24 C 10.6697 6.1601 0.0 0
M  V30 25 N 9.3360 8.4702 0.0 0
M  V30 26 C 10.6697 7.7002 0.0 0
M  V30 27 C 14.6708 3.8501 0.0 0
M  V30 28 C 16.0045 4.6201 0.0 0
M  V30 29 C 14.6708 2.3101 0.0 0
M  V30 30 C 17.3383 3.8501 0.0 0
M  V30 31 C 16.0045 1.5400 0.0 0
M  V30 32 C 17.3383 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 2 1 4
M  V30 4 1 1 15 CFG=1
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 5 7
M  V30 8 1 5 21
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 3 12 13
M  V30 14 1 12 24
M  V30 15 1 13 27
M  V30 16 1 14 30
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[2-(3-Hydroxyphenyl)ethynyl]-N-[(S)-[2-(methylamino)-2-oxoethyl]oxidophenyl...
C23H19N3O4S
1027726-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 5.3350 0.0 0 CFG=2 VAL=6
M  V30 2 N 5.3348 4.5650 0.0 0
M  V30 3 C 3.2311 4.0012 0.0 0
M  V30 4 O 4.7712 6.6687 0.0 0
M  V30 5 C 6.6685 5.3350 0.0 0
M  V30 6 C 4.0012 2.6675 0.0 0
M  V30 7 O 6.6685 6.8750 0.0 0
M  V30 8 N 3.2311 1.3338 0.0 0
M  V30 9 O 5.5412 2.6675 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 12.0035 5.3350 0.0 0
M  V30 12 C 13.3372 6.1050 0.0 0
M  V30 13 O 18.6720 6.1050 0.0 0
M  V30 14 C 2.6675 6.1048 0.0 0
M  V30 15 C 1.3337 5.3348 0.0 0
M  V30 16 C 2.6675 7.6449 0.0 0
M  V30 17 C 0.0000 6.1048 0.0 0
M  V30 18 C 1.3337 8.4149 0.0 0
M  V30 19 C 0.0000 7.6449 0.0 0
M  V30 20 C 8.0023 4.5650 0.0 0
M  V30 21 C 9.3360 5.3350 0.0 0
M  V30 22 C 8.0023 3.0249 0.0 0
M  V30 23 C 10.6697 4.5650 0.0 0
M  V30 24 N 9.3360 2.2549 0.0 0
M  V30 25 C 10.6697 3.0249 0.0 0
M  V30 26 C 14.6708 6.8750 0.0 0
M  V30 27 C 16.0045 6.1050 0.0 0
M  V30 28 C 14.6708 8.4151 0.0 0
M  V30 29 C 17.3383 6.8750 0.0 0
M  V30 30 C 16.0045 9.1851 0.0 0
M  V30 31 C 17.3383 8.4151 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 2 1 4
M  V30 4 1 1 14 CFG=3
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 5 7
M  V30 8 1 5 20
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 8 10
M  V30 12 3 11 12
M  V30 13 1 11 23
M  V30 14 1 12 26
M  V30 15 1 13 29
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1027726-52-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1027726-62-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14478442
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
(S)-N-[(2-{[2-(diethylamino)ethyl]amino}-2-oxoethyl)(oxo)phenyl-λ6-sulfanylidene]-5-[(3-hydroxyphenyl)ethynyl]nicotinamide.
(S)-Ethyl[N-({5-[(3-hydroxyphenyl)ethynyl]pyridin-3-yl}carbonyl)-S-phenylsulfonimidoyl]acetate
(73 mg, 0.16 mmol) in anhydrous MeOH (1.5 mL) was added
N,N-diethylethylenediamine(0.12 mL, 0.84 mmol) dropwise. The reaction
mixture was heated at 30 °C for 4 hours. The reaction mixture was
evaporated and the residue was partitioned between EtOAc and saturated
aqueous NaHCO3. The organic layer was washed once with brine, dried
(anhydrous Na2SO4), concentrated. The residue was purified by
chromatography (silica gel, 50:1 CHCl3:MeOH to 10:1 CHCl3:MeOH). The
product containing fractions were concentrated to give the title compound
as a foamy solid (50 mg, 59 %).
5-[(3-hydroxyphenyl)ethynyl]-N-{[2-(methylamino)-2-oxoethyl](oxo)phenyl-λ6-sulfanylidene}nicotinamide.
In a manner similar to that described for Example 471, (S)-Ethyl
[N-({5-[(3-hydroxyphenyl)ethynyl]pyridin-3-yl}carbonyl)-S-phenylsulfonimidoyl]
acetate (50 mg, 0.11 mmol) and methylamine (2.0 M solution in MeOH, 0.5
mL, 1.0 mmol) were reacted to give the title compound as colorless oil
(43 mg, 90 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfoximine-nicotine derivatives as kinase inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of
proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wurster, Julie A.; Hull, Eugene C., III; Yee, Richard D.; Boral, Sougato;
Malone, Thomas C.; Wang, Shimiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008061236 A2 2008-05-22

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl-3-(1H-imidazol-1-ylcarbonyl)-2-methyl-4(1H)-quinolinone
C16H15N3O2
1030471-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 O 5.3901 6.6685 0.0 0
M  V30 4 C 5.3901 1.3337 0.0 0
M  V30 5 C 6.9302 4.0012 0.0 0
M  V30 6 O 7.7002 2.6675 0.0 0
M  V30 7 C 2.3101 4.0012 0.0 0
M  V30 8 C 3.0801 5.3348 0.0 0
M  V30 9 N 3.0801 2.6675 0.0 0
M  V30 10 C 0.7700 4.0012 0.0 0
M  V30 11 C 4.6201 5.3348 0.0 0
M  V30 12 C 2.3101 6.6685 0.0 0
M  V30 13 C 4.6201 2.6675 0.0 0
M  V30 14 C 0.0000 5.3348 0.0 0
M  V30 15 C 5.3901 4.0012 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 17 N 7.7002 5.3348 0.0 0
M  V30 18 C 7.0737 6.7418 0.0 0
M  V30 19 C 9.2317 5.4958 0.0 0
M  V30 20 C 8.2182 7.7722 0.0 0
M  V30 21 N 9.5519 7.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 11
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 15
M  V30 7 1 5 17
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl-1,4-dihydro-N,2-dimethyl-4-oxo-3-quinolinecarboxamide
C14H16N2O2
1030471-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 5.3900 6.6685 0.0 0
M  V30 4 C 5.3900 1.3338 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 7.7000 5.3347 0.0 0
M  V30 7 O 7.7000 2.6674 0.0 0
M  V30 8 C 9.2400 5.3347 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 N 3.0800 2.6674 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 C 5.3900 4.0011 0.0 0
M  V30 18 C 0.7700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 3 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1030471-04-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1030471-03-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-1916394
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation, x-ray structure and propylaminolysis of
7,7-dichloro-5,7-dihydro-thieno[3,4-b]pyridin-5-one
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM van Es, Theodorus; Staskun, Benjamin; Fernandes, Manuel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2007), (6), 373-376

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,10-Dihydro-4,11-dimethoxy-5,10-dioxoanthra[2,3-b]thiophene-2-carboxylic acid
C19H12O6S
1030618-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 0.7700 0.0 0
M  V30 2 C 8.0021 0.0000 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 O 6.6684 6.9300 0.0 0
M  V30 5 C 8.0021 7.7000 0.0 0
M  V30 6 O 4.0011 6.9300 0.0 0
M  V30 7 C 11.9119 3.8500 0.0 0
M  V30 8 O 12.6819 2.5164 0.0 0
M  V30 9 O 12.6819 5.1836 0.0 0
M  V30 10 C 5.3347 3.0800 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0
M  V30 12 C 6.6684 2.3100 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 6.6684 5.3900 0.0 0
M  V30 15 C 4.0011 5.3900 0.0 0
M  V30 16 C 8.0021 3.0800 0.0 0
M  V30 17 C 2.6674 3.0800 0.0 0
M  V30 18 C 8.0021 4.6200 0.0 0
M  V30 19 C 2.6674 4.6200 0.0 0
M  V30 20 C 9.4667 2.6041 0.0 0
M  V30 21 C 1.3336 2.3100 0.0 0
M  V30 22 S 9.4667 5.0959 0.0 0
M  V30 23 C 1.3336 5.3900 0.0 0
M  V30 24 C 10.3719 3.8500 0.0 0
M  V30 25 C 0.0000 3.0800 0.0 0
M  V30 26 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 3 13
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 2 6 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 24
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 16 18
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 1 22 24
M  V30 28 1 23 26
M  V30 29 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,10-Dihydro-4,11-dimethoxy-N-methyl-5,10-dioxoanthra[2,3-b]thiophene-2-carbo...
C20H15NO5S
1147123-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 0.7700 0.0 0
M  V30 2 C 8.0021 0.0000 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 O 6.6684 6.9300 0.0 0
M  V30 5 C 8.0021 7.7000 0.0 0
M  V30 6 O 4.0011 6.9300 0.0 0
M  V30 7 C 11.9119 3.8500 0.0 0
M  V30 8 N 12.6819 5.1836 0.0 0
M  V30 9 O 12.6819 2.5164 0.0 0
M  V30 10 C 14.2219 5.1836 0.0 0
M  V30 11 C 5.3347 3.0800 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 2.3100 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 C 6.6684 5.3900 0.0 0
M  V30 16 C 4.0011 5.3900 0.0 0
M  V30 17 C 8.0021 3.0800 0.0 0
M  V30 18 C 2.6674 3.0800 0.0 0
M  V30 19 C 8.0021 4.6200 0.0 0
M  V30 20 C 2.6674 4.6200 0.0 0
M  V30 21 C 9.4667 2.6041 0.0 0
M  V30 22 C 1.3336 2.3100 0.0 0
M  V30 23 S 9.4667 5.0959 0.0 0
M  V30 24 C 1.3336 5.3900 0.0 0
M  V30 25 C 10.3719 3.8500 0.0 0
M  V30 26 C 0.0000 3.0800 0.0 0
M  V30 27 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 3 14
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 2 6 16
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 25
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 2 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 17 19
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 2 20 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 1 23 25
M  V30 29 1 24 27
M  V30 30 2 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1030618-80-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1147123-80-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2531890
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and cytotoxic properties of
4,11-bis[(aminoethyl)amino]anthra[2,3-b]thiophene-5,10-diones, novel
analogues of antitumor anthracene-9,10-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shchekotikhin, Andrey E.; Glazunova, Valeria A.; Dezhenkova, Lyubov G.;
Luzikov, Yuri N.; Sinkevich, Yuri B.; Kovalenko, Leonid V.; Buyanov,
Vladimir N.; Balzarini, Jan; Huang, Fong-Chun; Lin, Jing-Jer; Huang,
Hsu-Shan; Shtil, Alexander A.; Preobrazhenskaya, Maria N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2009), 17(5), 1861-1869

$RFMT $RIREG SCHEME353 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Bicyclo[2.2.1]hept-2-yl-2′,3′-O-(1-methylethylidene)adenosine
C20H27N5O4
103626-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8840 1.0306 0.0 0
M  V30 2 O 5.0285 0.0000 0.0 0
M  V30 3 C 0.0000 5.2130 0.0 0
M  V30 4 C 1.0304 6.9979 0.0 0
M  V30 5 N 11.1810 8.0725 0.0 0
M  V30 6 C 5.4500 4.6949 0.0 0 CFG=2
M  V30 7 C 3.9437 5.0151 0.0 0 CFG=2
M  V30 8 O 5.6111 3.1634 0.0 0
M  V30 9 C 3.1737 3.6815 0.0 0 CFG=2
M  V30 10 O 2.9133 6.1595 0.0 0
M  V30 11 C 4.2041 2.5369 0.0 0 CFG=2
M  V30 12 O 1.6672 4.0016 0.0 0
M  V30 13 C 1.5063 5.5332 0.0 0
M  V30 14 N 6.5946 5.7254 0.0 0
M  V30 15 C 8.1009 5.4052 0.0 0
M  V30 16 C 6.4336 7.2569 0.0 0
M  V30 17 C 8.8709 6.7389 0.0 0
M  V30 18 N 8.8709 4.0715 0.0 0
M  V30 19 N 7.8405 7.8834 0.0 0
M  V30 20 C 10.4109 6.7389 0.0 0
M  V30 21 C 10.4109 4.0715 0.0 0
M  V30 22 N 11.1810 5.4052 0.0 0
M  V30 23 C 12.7210 8.0725 0.0 0 CFG=3
M  V30 24 C 14.1394 8.5108 0.0 0 CFG=3
M  V30 25 C 13.9539 7.6917 0.0 0
M  V30 26 C 16.0456 6.7013 0.0 0
M  V30 27 C 14.6006 9.8328 0.0 0
M  V30 28 C 15.2765 7.8958 0.0 0 CFG=3
M  V30 29 C 15.7056 9.4119 0.0 0
M  V30 30 H 4.7137 6.3488 0.0 0
M  V30 31 H 2.4037 2.3476 0.0 0
M  V30 32 H 13.0701 9.6192 0.0 0
M  V30 33 H 16.7996 8.1231 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=3
M  V30 3 1 3 13
M  V30 4 1 4 13
M  V30 5 1 5 20
M  V30 6 1 5 23
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 14 CFG=3
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 7 30 CFG=3
M  V30 13 1 8 11
M  V30 14 1 9 11
M  V30 15 1 9 12
M  V30 16 1 9 31 CFG=3
M  V30 17 1 10 13
M  V30 18 1 12 13
M  V30 19 1 14 15
M  V30 20 1 14 16
M  V30 21 1 15 17
M  V30 22 2 15 18
M  V30 23 2 16 19
M  V30 24 1 17 19
M  V30 25 2 17 20
M  V30 26 1 18 21
M  V30 27 1 20 22
M  V30 28 2 21 22
M  V30 29 1 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 1 24 27
M  V30 33 1 24 32
M  V30 34 1 25 28
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 1 28 29
M  V30 38 1 28 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 6 7 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Adenosine, N-bicyclo[2.2.1]hept-2-yl-2′,3′-O-(1-methylethylidene)-, 5′-(N-met...
C22H30N6O5
1020259-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8840 5.0738 0.0 0
M  V30 2 O 5.0285 4.0434 0.0 0
M  V30 3 C 4.7082 2.5369 0.0 0
M  V30 4 N 5.8527 1.5065 0.0 0
M  V30 5 O 3.2436 2.0610 0.0 0
M  V30 6 C 5.5326 0.0000 0.0 0
M  V30 7 C 0.0000 9.2562 0.0 0
M  V30 8 C 1.0304 11.0411 0.0 0
M  V30 9 N 11.1810 12.1159 0.0 0
M  V30 10 C 5.4500 8.7382 0.0 0 CFG=2
M  V30 11 C 3.9437 9.0583 0.0 0 CFG=2
M  V30 12 O 5.6111 7.2066 0.0 0
M  V30 13 C 3.1737 7.7247 0.0 0 CFG=2
M  V30 14 O 2.9133 10.2027 0.0 0
M  V30 15 C 4.2041 6.5801 0.0 0 CFG=2
M  V30 16 O 1.6672 8.0448 0.0 0
M  V30 17 C 1.5063 9.5764 0.0 0
M  V30 18 N 6.5946 9.7686 0.0 0
M  V30 19 C 8.1009 9.4484 0.0 0
M  V30 20 C 6.4336 11.3002 0.0 0
M  V30 21 C 8.8709 10.7821 0.0 0
M  V30 22 N 8.8709 8.1147 0.0 0
M  V30 23 N 7.8405 11.9266 0.0 0
M  V30 24 C 10.4109 10.7821 0.0 0
M  V30 25 C 10.4109 8.1147 0.0 0
M  V30 26 N 11.1810 9.4484 0.0 0
M  V30 27 C 12.7210 12.1159 0.0 0 CFG=3
M  V30 28 C 14.1394 12.5540 0.0 0 CFG=3
M  V30 29 C 13.9539 11.7349 0.0 0
M  V30 30 C 16.0456 10.7445 0.0 0
M  V30 31 C 14.6006 13.8760 0.0 0
M  V30 32 C 15.2765 11.9390 0.0 0 CFG=3
M  V30 33 C 15.7056 13.4551 0.0 0
M  V30 34 H 4.7137 10.3920 0.0 0
M  V30 35 H 2.4037 6.3910 0.0 0
M  V30 36 H 13.0701 13.6624 0.0 0
M  V30 37 H 16.7996 12.1664 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 17
M  V30 8 1 8 17
M  V30 9 1 9 24
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 18 CFG=3
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 11 34 CFG=3
M  V30 17 1 12 15
M  V30 18 1 13 15
M  V30 19 1 13 16
M  V30 20 1 13 35 CFG=3
M  V30 21 1 14 17
M  V30 22 1 16 17
M  V30 23 1 18 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 2 19 22
M  V30 27 2 20 23
M  V30 28 1 21 23
M  V30 29 2 21 24
M  V30 30 1 22 25
M  V30 31 1 24 26
M  V30 32 2 25 26
M  V30 33 1 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 1 28 31
M  V30 37 1 28 36
M  V30 38 1 29 32
M  V30 39 1 30 32
M  V30 40 1 31 33
M  V30 41 1 32 33
M  V30 42 1 32 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 10 11 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103626-24-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1020259-78-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-9150508
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N6-substituted C5'-modified adenosines as A1 adenosine receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ashton, T. D.; Baker, Stephen P.; Hutchinson, Sally A.; Scammells, Peter
J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2008), 16(4), 1861-1873

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]-5-nitrobenzaldehyde
C24H25NO4Si
1037083-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 5.3349 0.0 0
M  V30 2 O 6.1600 5.3349 0.0 0
M  V30 3 C 4.6200 6.8749 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 C 3.0800 6.8749 0.0 0
M  V30 6 C 4.6200 8.4149 0.0 0
M  V30 7 C 6.1600 6.8749 0.0 0
M  V30 8 C 8.4700 1.3338 0.0 0
M  V30 9 O 9.2400 0.0000 0.0 0
M  V30 10 N 13.0900 4.0011 0.0 0 VAL=5
M  V30 11 O 13.8600 5.3349 0.0 0
M  V30 12 O 13.8600 2.6674 0.0 0
M  V30 13 C 3.0800 5.3349 0.0 0
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 17 C 0.7700 4.0011 0.0 0
M  V30 18 C 0.0000 5.3349 0.0 0
M  V30 19 C 4.6200 3.7949 0.0 0
M  V30 20 C 3.2864 3.0249 0.0 0
M  V30 21 C 5.9536 3.0249 0.0 0
M  V30 22 C 3.2864 1.4849 0.0 0
M  V30 23 C 5.9536 1.4849 0.0 0
M  V30 24 C 4.6200 0.7149 0.0 0
M  V30 25 C 8.4700 4.0011 0.0 0
M  V30 26 C 9.2400 2.6674 0.0 0
M  V30 27 C 9.2400 5.3349 0.0 0
M  V30 28 C 10.7800 2.6674 0.0 0
M  V30 29 C 10.7800 5.3349 0.0 0
M  V30 30 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 1 19
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 25
M  V30 10 2 8 9
M  V30 11 1 8 26
M  V30 12 2 10 11
M  V30 13 2 10 12
M  V30 14 1 10 30
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]-N-methyl-5-nitrobenzenemeth...
C25H30N2O3Si
1037083-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 6.6685 0.0 0
M  V30 2 O 6.1600 6.6685 0.0 0
M  V30 3 C 4.6200 8.2085 0.0 0
M  V30 4 C 6.9300 5.3347 0.0 0
M  V30 5 C 6.1600 8.2085 0.0 0
M  V30 6 C 4.6200 9.7485 0.0 0
M  V30 7 C 3.0800 8.2085 0.0 0
M  V30 8 C 8.4700 2.6674 0.0 0
M  V30 9 N 9.2400 1.3338 0.0 0
M  V30 10 C 8.4700 0.0000 0.0 0
M  V30 11 N 13.0900 5.3347 0.0 0 VAL=5
M  V30 12 O 13.8600 4.0011 0.0 0
M  V30 13 O 13.8600 6.6685 0.0 0
M  V30 14 C 3.0800 6.6685 0.0 0
M  V30 15 C 2.3100 8.0021 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 0.7700 8.0021 0.0 0
M  V30 18 C 0.7700 5.3347 0.0 0
M  V30 19 C 0.0000 6.6685 0.0 0
M  V30 20 C 4.6200 5.1285 0.0 0
M  V30 21 C 5.9536 4.3585 0.0 0
M  V30 22 C 3.2864 4.3585 0.0 0
M  V30 23 C 5.9536 2.8185 0.0 0
M  V30 24 C 3.2864 2.8185 0.0 0
M  V30 25 C 4.6200 2.0485 0.0 0
M  V30 26 C 8.4700 5.3347 0.0 0
M  V30 27 C 9.2400 4.0011 0.0 0
M  V30 28 C 9.2400 6.6685 0.0 0
M  V30 29 C 10.7800 4.0011 0.0 0
M  V30 30 C 10.7800 6.6685 0.0 0
M  V30 31 C 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 1 20
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 26
M  V30 10 1 8 9
M  V30 11 1 8 27
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 2 11 13
M  V30 15 1 11 31
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1037083-52-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037083-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14061816
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 21D: In a 500 mL round-bottomed flask 21C (15 g, 35.8 mmol) was dissolved
in methanol (400 mL) to give a yellow solution. Methylamine (33%wt in
EtOH, 10.09 mL, 107 mmol) was added and the solution was stirred at rt
for 1 h before cooling to 0°C and adding sodium borohydride (2.71 g, 71.5
mmol) portionwise and allowing to warm to rt. and stir for 2 h. The
reaction mixture was quenched with water (400mL) and diluted with ethyl
acetate (500mL). The organics were separated, washed with 1N HCl
(1×100mL), brine, dried (MgSO4) and cone. in vacuo to yield 210 (14 g, 32
mmol, 90% yield) as an orange oil. MS (ESI) m/z 435.3 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic amino acid derivatives as factor VIIa
inhibitors useful as anticoagulants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wurtz, Nicholas Ronald; Priestley, Eldon Scott; Cheney, Daniel L.; Glunz,
Peter W.; Zhang, Xiaojun; Ladziata, Vladimir; Parkhurst, Brandon;
Mueller, Luciano
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008079836 A2 2008-07-03

$RFMT $RIREG SCHEME355 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethyl-5-isoxazolyl)-2′-formyl-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulf...
C21H17N3O5S
176961-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 8.5299 0.0 0 VAL=6
M  V30 2 N 8.0023 7.7599 0.0 0
M  V30 3 O 7.4385 9.8636 0.0 0
M  V30 4 O 5.8985 7.1963 0.0 0
M  V30 5 C 1.3337 6.9899 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 11.0630 6.3971 0.0 0
M  V30 8 C 13.3050 8.8871 0.0 0
M  V30 9 C 4.0012 8.5299 0.0 0
M  V30 10 C 5.3348 9.3000 0.0 0
M  V30 11 C 2.6675 9.3000 0.0 0
M  V30 12 C 5.3348 10.8400 0.0 0
M  V30 13 C 2.6675 10.8400 0.0 0
M  V30 14 C 4.0012 11.6100 0.0 0
M  V30 15 C 4.0012 6.9899 0.0 0
M  V30 16 C 2.6675 6.2199 0.0 0
M  V30 17 C 5.3348 6.2199 0.0 0
M  V30 18 C 2.6675 4.6799 0.0 0
M  V30 19 C 5.3348 4.6799 0.0 0
M  V30 20 C 4.0012 3.9098 0.0 0
M  V30 21 C 9.3360 8.5299 0.0 0
M  V30 22 C 10.7428 7.9036 0.0 0
M  V30 23 O 9.4969 10.0615 0.0 0
M  V30 24 C 11.7734 9.0480 0.0 0
M  V30 25 N 11.0034 10.3818 0.0 0
M  V30 26 C 4.0012 2.3698 0.0 0
M  V30 27 N 2.7553 1.4646 0.0 0
M  V30 28 O 5.2470 1.4646 0.0 0
M  V30 29 C 3.2311 0.0000 0.0 0
M  V30 30 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 21
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 1 7 22
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetic acid
C8H8O2
103-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 4.6201 0.0000 0.0 0
M  V30 4 O 6.9302 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphe...
C30H28N4O5S
195444-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6363 8.5298 0.0 0 VAL=6
M  V30 2 N 5.3027 7.7598 0.0 0
M  V30 3 O 7.4063 7.1961 0.0 0
M  V30 4 O 5.8663 9.8634 0.0 0
M  V30 5 C 11.9710 6.9898 0.0 0
M  V30 6 N 13.3047 6.2198 0.0 0
M  V30 7 C 14.6383 6.9898 0.0 0
M  V30 8 C 13.3047 4.6798 0.0 0
M  V30 9 C 15.9721 6.2198 0.0 0
M  V30 10 O 14.6383 8.5298 0.0 0
M  V30 11 C 2.2419 6.3970 0.0 0
M  V30 12 C 0.0000 8.8869 0.0 0
M  V30 13 C 9.3036 8.5298 0.0 0
M  V30 14 C 7.9700 9.2998 0.0 0
M  V30 15 C 10.6374 9.2998 0.0 0
M  V30 16 C 7.9700 10.8398 0.0 0
M  V30 17 C 10.6374 10.8398 0.0 0
M  V30 18 C 9.3036 11.6098 0.0 0
M  V30 19 C 9.3036 6.9898 0.0 0
M  V30 20 C 10.6374 6.2198 0.0 0
M  V30 21 C 7.9700 6.2198 0.0 0
M  V30 22 C 10.6374 4.6798 0.0 0
M  V30 23 C 7.9700 4.6798 0.0 0
M  V30 24 C 9.3036 3.9098 0.0 0
M  V30 25 C 3.9689 8.5298 0.0 0
M  V30 26 C 2.5621 7.9034 0.0 0
M  V30 27 O 3.8080 10.0613 0.0 0
M  V30 28 C 1.5317 9.0478 0.0 0
M  V30 29 N 2.3017 10.3816 0.0 0
M  V30 30 C 9.3036 2.3698 0.0 0
M  V30 31 N 10.5496 1.4645 0.0 0
M  V30 32 O 8.0577 1.4645 0.0 0
M  V30 33 C 10.0736 0.0000 0.0 0
M  V30 34 C 8.5336 0.0000 0.0 0
M  V30 35 C 17.3057 6.9898 0.0 0
M  V30 36 C 18.6394 6.2198 0.0 0
M  V30 37 C 17.3057 8.5298 0.0 0
M  V30 38 C 19.9732 6.9898 0.0 0
M  V30 39 C 18.6394 9.2998 0.0 0
M  V30 40 C 19.9732 8.5298 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 25
M  V30 6 1 5 6
M  V30 7 1 5 20
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 9 35
M  V30 13 1 11 26
M  V30 14 1 12 28
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 13 19
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 24 30
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176961-45-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 103-82-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195444-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10230054
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Procedure for Compounds 5a-p.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). To a solution of 0.15 g (0.35 mmol) of 417 in 15 mL of
dichloromethane, methylamine (33% solution in absolute ethanol, 0.13 mL,
1.06 mmol), glacial acetic acid (0.12 g, 2 mmol), and 1 g of 3 Å
molecular sieves were added. The mixture was stirred at room temperature
for 1 h. Sodium triacetoxyboro-hydride (0.22 g, 1.06 mmol) was added, and
the mixture was stirred overnight. The solution was then filtered, washed
once with water, dried, and evaporated to afford 0.15 g of
2'-[(methylamino)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-
4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide as a colorless gum. To a
solution of this material (32.9 mg, 0.075 mmol) and tertbutylacetic acid
(0.075 mol) in 0.3 mL of CH2Cl2 was added 0.1 mL of DMF followed by a
solution of 1,3-diisopropylcarbodiimide in CH2Cl2 (0.28N, 0.320 mL, 0.09
mmol). The reaction mixture was vortexed for 3 min and then let stand at
room temperature for 24 h. The mixture was then loaded onto 1.5 g of a
Strong Anion Exchange (Quaternary Amine) resin and eluted with 20 mL of
CH2Cl2 followed by 10 mL of 3% TFA in CH2Cl2 to give 5g as a white solid.
Compound 5j
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, first stage mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of
N-[[2'-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(BMS-207940), a Highly Potent and Orally Active ETA Selective Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Gu, Zhengxiang; Spergel, Steven; Young, Marian; Chen,
Ping; Mathur, Arvind; Leith, Leslie; Hermsmeier, Mark; Liu, Eddie C.-K.;
Zhang, Rongan; Bird, Eileen; Waldron, Tom; Marino, Anthony; Koplowitz,
Barry; Humphreys, W. Griffith; Chong, Saeho; Morrison, Richard A.; Webb,
Maria L.; Moreland, Suzanne; Trippodo, Nick; Barrish, Joel C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(1), 125-137

$RFMT $RIREG SCHEME356 STEP1
$RXN



  3  1
$MOL
Oxalyl chloride
C2Cl2O2
79-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 Cl 4.0010 2.3101 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[2-(2-Methylpropyl)-1-(phenylmethyl)-1H-indol-4-yl]oxy]-N-(phenylsulfonyl)...
C28H30N2O4S
1048660-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7534 4.2794 0.0 0
M  V30 2 O 9.5440 7.5535 0.0 0
M  V30 3 C 10.3140 8.8872 0.0 0
M  V30 4 C 11.8540 8.8872 0.0 0
M  V30 5 C 9.5440 10.2210 0.0 0
M  V30 6 N 12.6240 10.2210 0.0 0
M  V30 7 O 12.6240 7.5535 0.0 0
M  V30 8 S 14.1640 10.2210 0.0 0 VAL=6
M  V30 9 O 14.1640 11.7610 0.0 0
M  V30 10 O 14.1640 8.6810 0.0 0
M  V30 11 C 6.4640 2.3100 0.0 0
M  V30 12 C 7.7976 1.5400 0.0 0
M  V30 13 C 7.7976 0.0000 0.0 0
M  V30 14 C 9.1314 2.3100 0.0 0
M  V30 15 C 5.6940 6.2199 0.0 0
M  V30 16 C 7.2340 6.2199 0.0 0
M  V30 17 N 5.2181 4.7552 0.0 0
M  V30 18 C 4.9240 7.5535 0.0 0
M  V30 19 C 8.0040 7.5535 0.0 0
M  V30 20 C 7.7099 4.7552 0.0 0
M  V30 21 C 6.4640 3.8500 0.0 0
M  V30 22 C 5.6940 8.8872 0.0 0
M  V30 23 C 7.2340 8.8872 0.0 0
M  V30 24 C 2.6091 5.3098 0.0 0
M  V30 25 C 2.9292 6.8162 0.0 0
M  V30 26 C 1.1444 4.8339 0.0 0
M  V30 27 C 1.7849 7.8466 0.0 0
M  V30 28 C 0.0000 5.8645 0.0 0
M  V30 29 C 0.3202 7.3707 0.0 0
M  V30 30 C 15.7040 10.2210 0.0 0
M  V30 31 C 16.4740 8.8872 0.0 0
M  V30 32 C 16.4740 11.5546 0.0 0
M  V30 33 C 18.0140 8.8872 0.0 0
M  V30 34 C 18.0140 11.5546 0.0 0
M  V30 35 C 18.7840 10.2210 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 6 8
M  V30 10 2 8 9
M  V30 11 2 8 10
M  V30 12 1 8 30
M  V30 13 1 11 12
M  V30 14 1 11 21
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 2 16 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 21
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(2-methylpropyl)-α-oxo-4-[2-oxo-2-[(phenylsulfonyl)amino]ethoxy]-1...
C30H31N3O6S
1048660-57-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1746 4.2794 0.0 0
M  V30 2 C 9.4947 2.7731 0.0 0
M  V30 3 O 10.3189 5.3098 0.0 0
M  V30 4 N 10.9594 2.2971 0.0 0
M  V30 5 O 8.3503 1.7425 0.0 0
M  V30 6 C 11.2796 0.7908 0.0 0
M  V30 7 O 9.5440 7.5535 0.0 0
M  V30 8 C 10.3140 8.8872 0.0 0
M  V30 9 C 11.8540 8.8872 0.0 0
M  V30 10 N 12.6240 10.2210 0.0 0
M  V30 11 O 12.6240 7.5535 0.0 0
M  V30 12 S 14.1640 10.2210 0.0 0 VAL=6
M  V30 13 O 14.1640 8.6810 0.0 0
M  V30 14 O 14.1640 11.7610 0.0 0
M  V30 15 C 3.7534 4.2794 0.0 0
M  V30 16 C 6.4640 2.3100 0.0 0
M  V30 17 C 5.1304 1.5400 0.0 0
M  V30 18 C 5.1304 0.0000 0.0 0
M  V30 19 C 3.7967 2.3100 0.0 0
M  V30 20 C 7.2340 6.2199 0.0 0
M  V30 21 C 5.6940 6.2199 0.0 0
M  V30 22 C 7.7099 4.7552 0.0 0
M  V30 23 C 8.0040 7.5535 0.0 0
M  V30 24 N 5.2181 4.7552 0.0 0
M  V30 25 C 4.9240 7.5535 0.0 0
M  V30 26 C 6.4640 3.8500 0.0 0
M  V30 27 C 7.2340 8.8872 0.0 0
M  V30 28 C 5.6940 8.8872 0.0 0
M  V30 29 C 2.6091 5.3098 0.0 0
M  V30 30 C 2.9292 6.8162 0.0 0
M  V30 31 C 1.1444 4.8339 0.0 0
M  V30 32 C 1.7849 7.8466 0.0 0
M  V30 33 C 0.0000 5.8645 0.0 0
M  V30 34 C 0.3202 7.3707 0.0 0
M  V30 35 C 15.7040 10.2210 0.0 0
M  V30 36 C 16.4740 11.5546 0.0 0
M  V30 37 C 16.4740 8.8872 0.0 0
M  V30 38 C 18.0140 11.5546 0.0 0
M  V30 39 C 18.0140 8.8872 0.0 0
M  V30 40 C 18.7840 10.2210 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 12 13
M  V30 14 2 12 14
M  V30 15 1 12 35
M  V30 16 1 15 24
M  V30 17 1 15 29
M  V30 18 1 16 17
M  V30 19 1 16 26
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 2 20 23
M  V30 25 1 21 24
M  V30 26 2 21 25
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 1 24 26
M  V30 30 1 25 28
M  V30 31 2 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1048660-87-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1048660-57-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-091-CAS-3607012
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: tert-butyl
2-(3-(2-amino-2-oxoacetyl)-1-benzyl-2-isobutyl-1H-indol- 4-yloxy)acetate
(11b). General Procedure: The 2-isobutyl indole (10b) (34.5 mg, 0.0867
mmol) was dissolved in 7.5 mL CH2Cl2 and added dropwise to a solution of
15 mL CH2Cl2 containing 3.0 equivalents of oxalyl chloride and stirred
for 1 hour at room temperature. After stirring 1 hour, NH3(g) was bubbled
into the reaction mixture for 5 minutes. The reaction was then poured
onto 20 mL H2O and 20 mL CH2Cl2 in a separatory funnel. The layers were
separated and the aqueous layer was extracted with 2 x 20 mL CH2Cl2. The
combined organic layer was dried over MgSO4, filtered, and the solvent
removed by rotary evaporation. The crude yellow solid was purified by
column chromatography (70% EtOAc/30% Hexanes) to afford 11b as a yellow
solid (34.7 mg). Benzenesulfonyl-2-(3-(2-N-methylamino-2-oxoacetyl)-1-
benzyl-2-isobutyl-1H-indol-4-yloxy)acetamide (15a) (3.3 mg). 1H NMR (300
MHz, CDCl3) δ 0.93 (d, J = 6.6 Hz, 6H), 1.92 (m, 6.9 Hz, 1H), 2.95 (d, J
= 7.2 Hz, 2H), 3.07 (d, J = 5.1 Hz, 3H), 4.55 (s, 2H), 5.40 (s, 2H), 6.25
(d, J = 7.2 Hz, 1H), 6.83-6.91 (m, 2H), 7.00 (d, 2H), 7.26-7.40 (m, 6H),
7.41 (t, J = 8.1 Hz, 1H), 7.54 (t, J = 7.5 Hz, 1H), 7.90 (d, J = 7.2 Hz,
2H) MS (ESI pos. ion) 562 (M+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Specific and Broadly Potent Inhibitors of Mammalian Secreted
Phospholipases A2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Oslund, Rob C.; Cermak, Nathan; Gelb, Michael H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(15), 4708-4714

$RFMT $RIREG SCHEME357 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatoic anhydride
C8H5NO3
118-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Chlorophenyl)-2,3-dihydro-3-methyl-4(1H)-quinazolinone
C15H13ClN2O
74375-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 0.0000 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 Cl 11.5500 2.6674 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 N 4.6200 4.0011 0.0 0
M  V30 6 N 4.6200 1.3338 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 2.3100 5.3349 0.0 0
M  V30 11 C 0.7700 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 7.7000 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 9.2400 1.3338 0.0 0
M  V30 19 C 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 8
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 9
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 118-48-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 74375-08-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21139778
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM silica-supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, ultrasound, alternate method gave lower yield,
silica supported iron oxide imidazole molybdophosphoric acid nanocatalyst
prepared and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis of 2,3-dihydroquinazolin-4(1H)-ones by
Fe3O4@SiO2-imid-PMAn nano-catalyst under ultrasonic irradiation and
reflux conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Esmaeilpour, Mohsen; Javidi, Jaber; Zahmatkesh, Saeed; Fahimi, Nafiseh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Monatshefte fuer Chemie (2017), 148(5), 947-956

$RFMT $RIREG SCHEME358 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzil
C14H10O2
134-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Chlorophenyl)-1-methyl-4,5-diphenyl-1H-imidazole
C22H17ClN2
38696-75-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0157 3.5103 0.0 0
M  V30 2 Cl 12.3670 9.1524 0.0 0
M  V30 3 C 5.3648 4.2206 0.0 0
M  V30 4 C 4.5948 5.5542 0.0 0
M  V30 5 N 6.8711 4.5408 0.0 0
M  V30 6 N 5.6252 6.6988 0.0 0
M  V30 7 C 7.0322 6.0723 0.0 0
M  V30 8 C 4.7385 2.8138 0.0 0
M  V30 9 C 5.6436 1.5677 0.0 0
M  V30 10 C 3.2068 2.6527 0.0 0
M  V30 11 C 5.0172 0.1609 0.0 0
M  V30 12 C 2.5805 1.2459 0.0 0
M  V30 13 C 3.4857 0.0000 0.0 0
M  V30 14 C 3.0633 5.7153 0.0 0
M  V30 15 C 2.1580 4.4693 0.0 0
M  V30 16 C 2.4368 7.1221 0.0 0
M  V30 17 C 0.6265 4.6304 0.0 0
M  V30 18 C 0.9052 7.2831 0.0 0
M  V30 19 C 0.0000 6.0372 0.0 0
M  V30 20 C 8.3659 6.8423 0.0 0
M  V30 21 C 8.3659 8.3823 0.0 0
M  V30 22 C 9.6995 6.0723 0.0 0
M  V30 23 C 9.6995 9.1524 0.0 0
M  V30 24 C 11.0332 6.8423 0.0 0
M  V30 25 C 11.0332 8.3823 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 25
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 4 14
M  V30 8 1 5 7
M  V30 9 2 6 7
M  V30 10 1 7 20
M  V30 11 2 8 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 134-81-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 38696-75-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-17274422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1306-38-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of 1,2,4,5-tetrasubstituted
imidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fang, Yue; Yuan, Rui; Ge, Wen-hui; Wang, Yuan-jiang; Liu, Gui-xiang; Li,
Ming-qi; Xu, Jiang-biao; Wan, Yu; Zhou, Sheng-liang; Han, Xi-guang;
Zhang, Peng; Liu, Jin-juan; Wu, Hui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2017), 43(8), 4413-4421

$RFMT $RIREG SCHEME359 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Bis(methylthio)-2-nitroethylene
C4H7NO2S2
13623-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 C 3.8500 2.6674 0.0 0
M  V30 3 S 1.5400 1.3338 0.0 0
M  V30 4 S 1.5400 4.0011 0.0 0
M  V30 5 N 4.6200 4.0011 0.0 0 VAL=5
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 O 6.1600 4.0011 0.0 0
M  V30 9 O 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-1,4-naphthoquinone
C10H6O3
83-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 O 6.9300 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Chlorophenyl)-2-(methylamino)-3-nitro-4H-naphtho[2,3-b]pyran-5,10-dione
C20H13ClN2O5
1477526-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 9.3358 0.0 0 VAL=5
M  V30 2 O 6.1600 9.3358 0.0 0
M  V30 3 O 3.8500 10.6694 0.0 0
M  V30 4 O 6.1600 4.0011 0.0 0
M  V30 5 N 1.5400 9.3358 0.0 0
M  V30 6 C 0.0000 9.3358 0.0 0
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 Cl 10.7800 6.6684 0.0 0
M  V30 9 C 4.6200 6.6684 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 3.8500 8.0021 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 2.3100 8.0021 0.0 0
M  V30 15 C 1.5400 4.0011 0.0 0
M  V30 16 O 1.5400 6.6684 0.0 0
M  V30 17 C 3.8500 2.6673 0.0 0
M  V30 18 C 2.3100 2.6673 0.0 0
M  V30 19 C 4.6200 1.3336 0.0 0
M  V30 20 C 1.5400 1.3336 0.0 0
M  V30 21 C 3.8500 0.0000 0.0 0
M  V30 22 C 2.3100 0.0000 0.0 0
M  V30 23 C 6.1600 6.6684 0.0 0
M  V30 24 C 6.9300 5.3347 0.0 0
M  V30 25 C 6.9300 8.0021 0.0 0
M  V30 26 C 8.4700 5.3347 0.0 0
M  V30 27 C 8.4700 8.0021 0.0 0
M  V30 28 C 9.2400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 4 13
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 2 7 15
M  V30 8 1 8 28
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 23
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 18
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13623-94-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 83-72-7
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1477526-61-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22434918
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM Knoevenagel condensation/Michael addition/imine-enamine
tautomerization/O-cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new functionalized
2-(alkylamino)-3-nitro-4-(aryl)-4H-benzo[g]chromene-5,10-dione
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Afsharnezhad, Milad; Bayat, Mohammad; Hosseini, Fahimeh Sadat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2020), 24(2), 379-389

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl cyanoacetate
C4H5NO2
105-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 O 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 N 6.6686 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylcyanoacetamide
C4H6N2O
6330-25-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 N 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 N 6.6686 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-34-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6330-25-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16551526
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of a marine alkaloid, rigidin E
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cao, Banpeng; Ding, Haixin; Yang, Ruchun; Wang, Xiaoji; Xiao, Qiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Marine Drugs (2012), 101412-1421

$RFMT $RIREG SCHEME361 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl chloroacetate
C4H7ClO2
105-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 Cl 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[1-[(3-Chlorophenyl)methyl]-1,2-dihydro-2-oxo-3H-indol-3-ylidene]propanedin...
C18H10ClN3O
2758146-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9695 3.7827 0.0 0
M  V30 2 C 2.8137 5.4579 0.0 0
M  V30 3 C 1.4069 4.8316 0.0 0
M  V30 4 C 2.9747 6.9894 0.0 0
M  V30 5 N 0.0000 4.2051 0.0 0
M  V30 6 N 3.1357 8.5211 0.0 0
M  V30 7 O 6.0001 6.4933 0.0 0
M  V30 8 Cl 12.5895 6.4501 0.0 0
M  V30 9 C 5.5243 2.5368 0.0 0
M  V30 10 C 4.0596 3.0127 0.0 0
M  V30 11 N 6.4295 3.7827 0.0 0
M  V30 12 C 5.8445 1.0306 0.0 0
M  V30 13 C 4.0596 4.5527 0.0 0
M  V30 14 C 2.9152 1.9823 0.0 0
M  V30 15 C 5.5243 5.0286 0.0 0
M  V30 16 C 4.7001 0.0000 0.0 0
M  V30 17 C 3.2354 0.4760 0.0 0
M  V30 18 C 8.7395 5.1165 0.0 0
M  V30 19 C 10.2795 5.1165 0.0 0
M  V30 20 C 7.9695 6.4501 0.0 0
M  V30 21 C 11.0495 6.4501 0.0 0
M  V30 22 C 8.7395 7.7838 0.0 0
M  V30 23 C 10.2795 7.7838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 2 13
M  V30 6 3 3 5
M  V30 7 3 4 6
M  V30 8 2 7 15
M  V30 9 1 8 21
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3Z)-1-[(3-Chlorophenyl)methyl]-1,3-dihydro-3-(3-methyl-4-oxo-2-thioxo-5-thia...
C19H13ClN2O2S2
2758146-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.0963 6.4933 0.0 0
M  V30 2 O 1.9694 3.5174 0.0 0
M  V30 3 C 9.0655 3.7827 0.0 0
M  V30 4 C 0.0000 6.2279 0.0 0
M  V30 5 S 1.9694 8.9385 0.0 0
M  V30 6 Cl 13.6857 6.4501 0.0 0
M  V30 7 C 5.1558 4.5527 0.0 0
M  V30 8 C 5.1558 3.0127 0.0 0
M  V30 9 C 6.6205 5.0286 0.0 0
M  V30 10 C 6.6205 2.5368 0.0 0
M  V30 11 C 4.0114 1.9823 0.0 0
M  V30 12 N 7.5255 3.7827 0.0 0
M  V30 13 C 6.9406 1.0306 0.0 0
M  V30 14 C 4.3316 0.4759 0.0 0
M  V30 15 C 5.7961 0.0000 0.0 0
M  V30 16 C 3.9099 5.4579 0.0 0
M  V30 17 C 2.4452 4.9821 0.0 0
M  V30 18 S 3.9099 6.9979 0.0 0
M  V30 19 N 1.5400 6.2279 0.0 0
M  V30 20 C 2.4452 7.4738 0.0 0
M  V30 21 C 9.8355 5.1163 0.0 0
M  V30 22 C 11.3757 5.1163 0.0 0
M  V30 23 C 9.0657 6.4501 0.0 0
M  V30 24 C 12.1457 6.4501 0.0 0
M  V30 25 C 9.8357 7.7838 0.0 0
M  V30 26 C 11.3757 7.7838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 17
M  V30 3 1 3 12
M  V30 4 1 3 21
M  V30 5 1 4 19
M  V30 6 2 5 20
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 16
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 10 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 105-39-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 2758146-28-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2758146-17-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30037337
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 25322-68-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, stereoselective, product formed via Michael
addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile one-pot, four-component synthesis of (Z)-isomer of
rhodanine-oxindole derivatives under environmentally benevolent
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moghaddam, F. Matloubi; Aghamiri, Bagher; Jalalinik, Mahbod
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2022), 52(2), 175-184

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[Bis(ethylthio)methylene]-5-(4-fluorophenyl)-3-oxo-4-pentenamide
C16H18FNO2S2
1055323-64-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.8501 0.0 0
M  V30 2 C 5.3348 4.6201 0.0 0
M  V30 3 S 2.6673 4.6201 0.0 0
M  V30 4 S 4.0010 2.3101 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 C 5.3348 6.1601 0.0 0
M  V30 7 C 1.3337 3.8501 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 O 8.0022 4.6201 0.0 0
M  V30 11 N 6.6685 6.9302 0.0 0
M  V30 12 O 4.0010 6.9302 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 8.0022 1.5400 0.0 0
M  V30 16 F 13.3370 4.6201 0.0 0
M  V30 17 C 9.3360 2.3101 0.0 0
M  V30 18 C 9.3360 3.8501 0.0 0
M  V30 19 C 10.6697 1.5400 0.0 0
M  V30 20 C 10.6697 4.6201 0.0 0
M  V30 21 C 12.0033 2.3101 0.0 0
M  V30 22 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 2 9 15 CFG=2
M  V30 15 1 15 17
M  V30 16 1 16 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Fluorophenyl)-1,4,5,6-tetrahydro-1-methyl-2-(methylamino)-4-oxo-3-pyridi...
C14H16FN3O2
1055323-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 C 0.7700 4.0012 0.0 0
M  V30 4 N 0.0000 2.6675 0.0 0
M  V30 5 O 0.0000 5.3348 0.0 0
M  V30 6 C 5.3901 1.3338 0.0 0
M  V30 7 O 2.3101 6.6687 0.0 0
M  V30 8 F 11.5503 4.0012 0.0 0
M  V30 9 C 3.0801 2.6675 0.0 0
M  V30 10 C 2.3101 4.0012 0.0 0
M  V30 11 N 4.6201 2.6675 0.0 0
M  V30 12 C 3.0801 5.3348 0.0 0
M  V30 13 C 5.3901 4.0012 0.0 0
M  V30 14 C 4.6201 5.3348 0.0 0
M  V30 15 C 6.9302 4.0012 0.0 0
M  V30 16 C 7.7002 5.3348 0.0 0
M  V30 17 C 7.7002 2.6675 0.0 0
M  V30 18 C 9.2402 5.3348 0.0 0
M  V30 19 C 9.2402 2.6675 0.0 0
M  V30 20 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 1 6 11
M  V30 7 2 7 12
M  V30 8 1 8 20
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1055323-64-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1055323-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-4345750
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
1-Methyl-2-(methylamino)-4-oxo-6-p-tolyl-1,4,5,6-tetrahydropyridine-3-carboxamide
(3a); Typical Procedure To a soln of 1a (323 mg, 1.0 mmol) in DMF (5 mL)
was added aq 30% MeNH2 (0.31 mL, 3.0 mmol) at r.t. The reaction mixture
was stirred for 12 h at r.t. and then poured into brine (50 mL); the
resulting mixture was extracted with CH2Cl2 (3 × 20 mL). The combined
organic phase was washed with H2O (3 × 30 mL), dried (anhyd MgSO4),
filtered and concentrated under reduced pressure. The crude product was
purified by flash chromatography (silica gel, petroleum ether-Et2O, 2:1)
to give 3a
6-(4-Fluorophenyl)-1-methyl-2-(methylamino)-4-oxo-1,4,5,6-tetrahydropyridine-3-carboxamide
(3f). Pale-yellow solid, yield 90% Mp 202-203 °C. IR (KBr): 1218, 1406,
1586, 2996, 3303 cm-1. 1H NMR (500 MHz, CDCl3): δ = 2.71 (dd, J = 16.0,
6.0 Hz, 1 H), 2.99 (dd, J = 16.0, 5.5 Hz, 1 H), 3.03 (d, J = 5.0 Hz, 3
H), 3.07 (s, 3 H), 4.43 (dd, J = 6.0, 5.5 Hz, 1 H), 5.23 (br, 1 H), 7.02
(d, J = 8.5 Hz, 2 H), 7.22 (d, J = 8.5 Hz, 2 H), 9.71 (br, 1 H), 11.36
(br, 1 H). 13C NMR (125 MHz, CDCl3): δ = 31.7, 39.5, 40.2, 59.8, 91.4,
114.8 (d, J = 21.5 Hz), 127.1 (d, J = 8.1 Hz), 133.8, 161.3 (d, J = 245.5
Hz), 169.1, 170.4, 186.5. Anal. Calcd for C14H16FN3O2: C, 60.64; H, 5.82;
N, 15.15. Found: C, 60.75; H, 5.68; N, 15.20.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [5C + 1C/N/S/Se] annulations of α-alkenoyl α-carbamoyl ketene
dithioacetals: a facile and convenient synthesis of salicylamide,
nicotinamide and thio/selenopyran-3-carboxamide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Dongwei; Xu, Xianxiu; Liu, Qun; Dong, Song
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2008), (12), 1895-1901

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2,2-Dimethyl-1-oxopropyl)-D-prolyl-L-prolyl-D-alanine methyl ester
C19H31N3O5
1058727-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9816 3.4208 0.0 0
M  V30 2 O 5.4575 4.8854 0.0 0
M  V30 3 C 2.4917 5.6626 0.0 0
M  V30 4 C 1.2459 6.5679 0.0 0
M  V30 5 O 3.8987 6.2891 0.0 0
M  V30 6 C 0.3407 5.3220 0.0 0
M  V30 7 C 0.0000 7.4731 0.0 0
M  V30 8 C 2.1511 7.8137 0.0 0
M  V30 9 C 8.3136 3.7710 0.0 0
M  V30 10 N 9.8536 3.7710 0.0 0
M  V30 11 O 7.5436 5.1047 0.0 0
M  V30 12 C 10.6236 5.1047 0.0 0 CFG=2
M  V30 13 C 12.1637 5.1047 0.0 0
M  V30 14 C 9.8536 6.4383 0.0 0
M  V30 15 O 12.9337 6.4383 0.0 0
M  V30 16 O 12.9337 3.7710 0.0 0
M  V30 17 C 14.4737 6.4383 0.0 0
M  V30 18 C 3.4752 3.1007 0.0 0 CFG=1
M  V30 19 N 2.3308 4.1311 0.0 0
M  V30 20 C 2.8489 1.6937 0.0 0
M  V30 21 C 0.9972 3.3611 0.0 0
M  V30 22 C 1.3173 1.8546 0.0 0
M  V30 23 N 6.0121 2.2763 0.0 0
M  V30 24 C 7.5436 2.4374 0.0 0 CFG=2
M  V30 25 C 5.6919 0.7700 0.0 0
M  V30 26 C 8.1701 1.0304 0.0 0
M  V30 27 C 7.0255 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 18 1 CFG=1
M  V30 3 1 1 23
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 19
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 4 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 24 9 CFG=3
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14 CFG=3
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 18 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(2,2-Dimethyl-1-oxopropyl)-D-prolyl-L-prolyl-N-methyl-D-alaninamide
C19H32N4O4
1058727-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9816 3.4208 0.0 0
M  V30 2 O 5.4575 4.8854 0.0 0
M  V30 3 C 2.4917 5.6626 0.0 0
M  V30 4 C 1.2459 6.5679 0.0 0
M  V30 5 O 3.8987 6.2891 0.0 0
M  V30 6 C 0.3407 5.3220 0.0 0
M  V30 7 C 0.0000 7.4731 0.0 0
M  V30 8 C 2.1511 7.8137 0.0 0
M  V30 9 C 8.3136 3.7710 0.0 0
M  V30 10 N 9.8536 3.7710 0.0 0
M  V30 11 O 7.5436 5.1047 0.0 0
M  V30 12 C 10.6236 5.1047 0.0 0 CFG=2
M  V30 13 C 12.1637 5.1047 0.0 0
M  V30 14 C 9.8536 6.4383 0.0 0
M  V30 15 N 12.9337 6.4383 0.0 0
M  V30 16 O 12.9337 3.7710 0.0 0
M  V30 17 C 14.4737 6.4383 0.0 0
M  V30 18 C 3.4752 3.1007 0.0 0 CFG=1
M  V30 19 N 2.3308 4.1311 0.0 0
M  V30 20 C 2.8489 1.6937 0.0 0
M  V30 21 C 0.9972 3.3611 0.0 0
M  V30 22 C 1.3173 1.8546 0.0 0
M  V30 23 N 6.0121 2.2763 0.0 0
M  V30 24 C 7.5436 2.4374 0.0 0 CFG=2
M  V30 25 C 5.6919 0.7700 0.0 0
M  V30 26 C 8.1701 1.0304 0.0 0
M  V30 27 C 7.0255 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 18 1 CFG=1
M  V30 3 1 1 23
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 19
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 4 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 24 9 CFG=3
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14 CFG=3
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 18 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1058727-20-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1058727-08-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-655911
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Designed peptides with homochiral and heterochiral diproline templates as
conformational constraints
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chatterjee, Bhaswati; Saha, Indranil; Raghothama, Srinivasarao; Aravinda,
Subrayashastry; Rai, Rajkishor; Shamala, Narayanaswamy; Balaram,
Padmanabham
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2008), 14(20), 6192-6204

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2,2-Dimethyl-1-oxopropyl)-D-prolyl-L-prolylglycine methyl ester
C18H29N3O5
1058727-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9816 3.4208 0.0 0
M  V30 2 O 5.4575 4.8854 0.0 0
M  V30 3 C 2.4917 5.6626 0.0 0
M  V30 4 C 1.2459 6.5678 0.0 0
M  V30 5 O 3.8987 6.2891 0.0 0
M  V30 6 C 0.3406 5.3220 0.0 0
M  V30 7 C 0.0000 7.4730 0.0 0
M  V30 8 C 2.1511 7.8137 0.0 0
M  V30 9 C 8.3136 3.7710 0.0 0
M  V30 10 N 9.8536 3.7710 0.0 0
M  V30 11 O 7.5436 5.1047 0.0 0
M  V30 12 C 10.6236 5.1047 0.0 0
M  V30 13 C 12.1636 5.1047 0.0 0
M  V30 14 O 12.9336 6.4383 0.0 0
M  V30 15 O 12.9336 3.7710 0.0 0
M  V30 16 C 14.4736 6.4383 0.0 0
M  V30 17 C 3.4752 3.1007 0.0 0 CFG=1
M  V30 18 N 2.3308 4.1311 0.0 0
M  V30 19 C 2.8489 1.6937 0.0 0
M  V30 20 C 0.9972 3.3611 0.0 0
M  V30 21 C 1.3173 1.8546 0.0 0
M  V30 22 N 6.0120 2.2763 0.0 0
M  V30 23 C 7.5436 2.4374 0.0 0 CFG=2
M  V30 24 C 5.6919 0.7700 0.0 0
M  V30 25 C 8.1701 1.0304 0.0 0
M  V30 26 C 7.0255 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 1 22
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 18
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 4 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 23 9 CFG=3
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 17 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(2,2-Dimethyl-1-oxopropyl)-D-prolyl-L-prolyl-N-methylglycinamide
C18H30N4O4
1058727-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9816 3.4208 0.0 0
M  V30 2 O 5.4575 4.8854 0.0 0
M  V30 3 C 2.4917 5.6626 0.0 0
M  V30 4 C 1.2459 6.5678 0.0 0
M  V30 5 O 3.8987 6.2891 0.0 0
M  V30 6 C 0.3406 5.3220 0.0 0
M  V30 7 C 0.0000 7.4730 0.0 0
M  V30 8 C 2.1511 7.8137 0.0 0
M  V30 9 C 8.3136 3.7710 0.0 0
M  V30 10 N 9.8536 3.7710 0.0 0
M  V30 11 O 7.5436 5.1047 0.0 0
M  V30 12 C 10.6236 5.1047 0.0 0
M  V30 13 C 12.1636 5.1047 0.0 0
M  V30 14 N 12.9336 6.4383 0.0 0
M  V30 15 O 12.9336 3.7710 0.0 0
M  V30 16 C 14.4736 6.4383 0.0 0
M  V30 17 C 3.4752 3.1007 0.0 0 CFG=1
M  V30 18 N 2.3308 4.1311 0.0 0
M  V30 19 C 2.8489 1.6937 0.0 0
M  V30 20 C 0.9972 3.3611 0.0 0
M  V30 21 C 1.3173 1.8546 0.0 0
M  V30 22 N 6.0120 2.2763 0.0 0
M  V30 23 C 7.5436 2.4374 0.0 0 CFG=2
M  V30 24 C 5.6919 0.7700 0.0 0
M  V30 25 C 8.1701 1.0304 0.0 0
M  V30 26 C 7.0255 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 1 22
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 18
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 4 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 23 9 CFG=3
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 17 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1058727-21-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1058727-11-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11909888
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Designed peptides with homochiral and heterochiral diproline templates as
conformational constraints
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chatterjee, Bhaswati; Saha, Indranil; Raghothama, Srinivasarao; Aravinda,
Subrayashastry; Rai, Rajkishor; Shamala, Narayanaswamy; Balaram,
Padmanabham
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2008), 14(20), 6192-6204

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromophenol
C6H5BrO
106-41-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-p-aminophenol
C7H9NO
150-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-41-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 150-75-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2126253
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 58509-59-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed tube used, alternative preparation shown, oxime
catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Room-Temperature Copper-Catalyzed Arylation of Dimethylamine and
Methylamine in Neat Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Deping; Kuang, Daizhi; Zhang, Fuxing; Yang, Chunlin; Zhu, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2015), 357(4), 714-718

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5,6,8,9-tetrahydro-2-(1-phenylethyl)-4-[[(trifluoromethyl)s...
C22H26F3N3O5S
1065112-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5378 3.6437 0.0 0
M  V30 2 S 7.3078 2.3101 0.0 0 VAL=6
M  V30 3 C 5.9741 1.5400 0.0 0
M  V30 4 O 8.0778 0.9764 0.0 0
M  V30 5 O 8.6414 3.0801 0.0 0
M  V30 6 F 4.6404 2.3101 0.0 0
M  V30 7 F 4.6404 0.7700 0.0 0
M  V30 8 F 5.9741 0.0000 0.0 0
M  V30 9 C 11.1579 6.3112 0.0 0
M  V30 10 C 11.9279 4.9774 0.0 0
M  V30 11 C 2.6673 9.4349 0.0 0
M  V30 12 O 2.6673 10.9749 0.0 0
M  V30 13 O 1.3337 8.6648 0.0 0
M  V30 14 C 1.3337 11.7449 0.0 0
M  V30 15 C 2.1037 13.0786 0.0 0
M  V30 16 C 0.0000 12.5149 0.0 0
M  V30 17 C 0.5637 10.4112 0.0 0
M  V30 18 C 7.3078 4.9774 0.0 0
M  V30 19 C 6.5378 6.3112 0.0 0
M  V30 20 N 8.8478 4.9774 0.0 0
M  V30 21 C 7.3078 7.6449 0.0 0
M  V30 22 C 5.0150 6.0816 0.0 0
M  V30 23 C 9.6178 6.3112 0.0 0
M  V30 24 N 8.8478 7.6449 0.0 0
M  V30 25 C 6.7452 9.0785 0.0 0
M  V30 26 C 3.8860 7.1291 0.0 0
M  V30 27 C 5.2735 9.5323 0.0 0
M  V30 28 N 4.0012 8.6648 0.0 0
M  V30 29 C 11.9279 7.6449 0.0 0
M  V30 30 C 11.1579 8.9786 0.0 0
M  V30 31 C 13.4679 7.6449 0.0 0
M  V30 32 C 11.9279 10.3122 0.0 0
M  V30 33 C 14.2379 8.9786 0.0 0
M  V30 34 C 13.4679 10.3122 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 9 23
M  V30 11 1 9 29
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 28
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 24
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5,6,8,9-tetrahydro-4-(methylamino)-2-(1-phenylethyl)-7H-pyr...
C22H30N4O2
1065112-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 0.7700 0.0 0
M  V30 2 C 5.3347 0.0000 0.0 0
M  V30 3 C 4.0011 5.3900 0.0 0
M  V30 4 C 4.0011 6.9300 0.0 0
M  V30 5 C 12.9157 3.8500 0.0 0
M  V30 6 O 13.6857 5.1836 0.0 0
M  V30 7 O 13.6857 2.5164 0.0 0
M  V30 8 C 15.2257 5.1836 0.0 0
M  V30 9 C 15.2257 6.7236 0.0 0
M  V30 10 C 16.7657 5.1836 0.0 0
M  V30 11 C 15.2257 3.6436 0.0 0
M  V30 12 C 8.0021 3.0800 0.0 0
M  V30 13 C 8.0021 4.6200 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 9.2061 2.1198 0.0 0
M  V30 16 N 6.6684 5.3900 0.0 0
M  V30 17 C 9.2061 5.5802 0.0 0
M  V30 18 N 5.3347 3.0800 0.0 0
M  V30 19 C 10.7075 2.4625 0.0 0
M  V30 20 C 5.3347 4.6200 0.0 0
M  V30 21 C 10.7075 5.2375 0.0 0
M  V30 22 N 11.3757 3.8500 0.0 0
M  V30 23 C 2.6674 4.6200 0.0 0
M  V30 24 C 2.6674 3.0800 0.0 0
M  V30 25 C 1.3336 5.3900 0.0 0
M  V30 26 C 1.3336 2.3100 0.0 0
M  V30 27 C 0.0000 4.6200 0.0 0
M  V30 28 C 0.0000 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 3 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 22
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 20
M  V30 23 1 19 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1065112-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1065112-78-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4121170
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-Butyl
4-(methylamino)-2-(1-phenylethyl)-5,6,8,9-tetrahydro-7H-p[4,5-d]azepine-7-carboxylate.
A solution of methylamine (2.0M, 0.65 mL, 1.30 mmol) was added to a
solution of tert-butyl
2-(1-phenylethyl)-4-{[(trifluoromethyl)sulfonyl]oxy}-5,6,8,9-tetrahydro-7H-p[4,5-d]azepine-7-carboxylate
(130 mg, 0.26 mmol) in acetonitrile (4.0 mL) at room temperature. The
mixture was stirred at room temperature for 20 h. The solvent was
evaporated under reduced pressure to provide the crude title compound as
a yellow gum. The crude material was purified by flash column
chromatography eluting with CH2Cl2 :EtOAc 100:0 to 50:50 to yield the
desired product. White crystalline solid, yield:89mg,90%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multiparameter Optimization in CNS Drug Discovery: Design of
Pyrimido[4,5-d]azepines as Potent 5-Hydroxytryptamine 2C (5-HT2C)
Receptor Agonists with Exquisite Functional Selectivity over 5-HT2A and
5-HT2B Receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Storer, R. Ian; Brennan, Paul E.; Brown, Alan D.; Bungay, Peter J.;
Conlon, Kelly M.; Corbett, Matthew S.; DePianta, Robert P.; Fish, Paul
V.; Heifetz, Alexander; Ho, Danny K. H.; Jessiman, Alan S.; McMurray,
Gordon; de Oliveira, Cesar Augusto F.; Roberts, Lee R.; Root, James A.;
Shanmugasundaram, Veerabahu; Shapiro, Michael J.; Skerten, Melanie;
Westbrook, Dominique; Wheeler, Simon; Whitlock, Gavin A.; Wright, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2014), 57(12), 5258-5269

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5,6,8,9-tetrahydro-2-(1-phenylethyl)-4-[[(trifluoromethyl)s...
C22H26F3N3O5S
1065112-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5378 3.6437 0.0 0
M  V30 2 S 7.3078 2.3101 0.0 0 VAL=6
M  V30 3 C 5.9741 1.5400 0.0 0
M  V30 4 O 8.0778 0.9764 0.0 0
M  V30 5 O 8.6414 3.0801 0.0 0
M  V30 6 F 4.6404 2.3101 0.0 0
M  V30 7 F 4.6404 0.7700 0.0 0
M  V30 8 F 5.9741 0.0000 0.0 0
M  V30 9 C 11.1579 6.3112 0.0 0
M  V30 10 C 11.9279 4.9774 0.0 0
M  V30 11 C 2.6673 9.4349 0.0 0
M  V30 12 O 2.6673 10.9749 0.0 0
M  V30 13 O 1.3337 8.6648 0.0 0
M  V30 14 C 1.3337 11.7449 0.0 0
M  V30 15 C 2.1037 13.0786 0.0 0
M  V30 16 C 0.0000 12.5149 0.0 0
M  V30 17 C 0.5637 10.4112 0.0 0
M  V30 18 C 7.3078 4.9774 0.0 0
M  V30 19 C 6.5378 6.3112 0.0 0
M  V30 20 N 8.8478 4.9774 0.0 0
M  V30 21 C 7.3078 7.6449 0.0 0
M  V30 22 C 5.0150 6.0816 0.0 0
M  V30 23 C 9.6178 6.3112 0.0 0
M  V30 24 N 8.8478 7.6449 0.0 0
M  V30 25 C 6.7452 9.0785 0.0 0
M  V30 26 C 3.8860 7.1291 0.0 0
M  V30 27 C 5.2735 9.5323 0.0 0
M  V30 28 N 4.0012 8.6648 0.0 0
M  V30 29 C 11.9279 7.6449 0.0 0
M  V30 30 C 11.1579 8.9786 0.0 0
M  V30 31 C 13.4679 7.6449 0.0 0
M  V30 32 C 11.9279 10.3122 0.0 0
M  V30 33 C 14.2379 8.9786 0.0 0
M  V30 34 C 13.4679 10.3122 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 9 23
M  V30 11 1 9 29
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 28
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 24
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5,6,8,9-tetrahydro-4-(methylamino)-2-(1-phenylethyl)-7H-pyr...
C22H30N4O2
1065112-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 0.7700 0.0 0
M  V30 2 C 5.3347 0.0000 0.0 0
M  V30 3 C 4.0011 5.3900 0.0 0
M  V30 4 C 4.0011 6.9300 0.0 0
M  V30 5 C 12.9157 3.8500 0.0 0
M  V30 6 O 13.6857 5.1836 0.0 0
M  V30 7 O 13.6857 2.5164 0.0 0
M  V30 8 C 15.2257 5.1836 0.0 0
M  V30 9 C 15.2257 6.7236 0.0 0
M  V30 10 C 16.7657 5.1836 0.0 0
M  V30 11 C 15.2257 3.6436 0.0 0
M  V30 12 C 8.0021 3.0800 0.0 0
M  V30 13 C 8.0021 4.6200 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 9.2061 2.1198 0.0 0
M  V30 16 N 6.6684 5.3900 0.0 0
M  V30 17 C 9.2061 5.5802 0.0 0
M  V30 18 N 5.3347 3.0800 0.0 0
M  V30 19 C 10.7075 2.4625 0.0 0
M  V30 20 C 5.3347 4.6200 0.0 0
M  V30 21 C 10.7075 5.2375 0.0 0
M  V30 22 N 11.3757 3.8500 0.0 0
M  V30 23 C 2.6674 4.6200 0.0 0
M  V30 24 C 2.6674 3.0800 0.0 0
M  V30 25 C 1.3336 5.3900 0.0 0
M  V30 26 C 1.3336 2.3100 0.0 0
M  V30 27 C 0.0000 4.6200 0.0 0
M  V30 28 C 0.0000 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 3 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 22
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 20
M  V30 23 1 19 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1065112-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1065112-78-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13845548
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Tert-butyl
4-(methylamino}-2-(1-phenylethyl)-5,6,8,9-tetrahydro-7H-pyrimido[4,5-d]azepine-7-carboxylate
A solution of methylamine (2.0M, 0.65 mL, 1.30 mmol) was added to a
solution of Tert-butyl 2-(1
-phenylethyl)-4-{[(trifluoromethyl)sulfonyl]oxy}-5,6,8,9-tetrahydro-7H-pyrimido[4,5-d]azepine-7-carboxylate
of preparation 2, step B (130 mg, 0.26 mmol) in MeCN (4.0 mL) at room
temperature with stirring. The mixture was stirred at room temperature
for 20 h. The solvent was evaporated in vacuo to provide the crude title
compound as a yellow gum. The crude material was purified by flash column
chromatography eluting with CH2Cl2:ethyl acetate (100:0 to 50:50) to
yield the desired product as a white crystalline solid (89 mg, 90%
yield).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimido[4,5-d]azepine derivatives as 5-HT2C agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, Mark David; Blagg, Julian; Brennan, Paul Edward; Fish, Paul
Vincent; Roberts, Lee Richard; Storer, Robert Ian; Whitlock, Gavin
Alistair
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008117169 A1 2008-10-02

$RFMT $RIREG SCHEME367 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tosyl chloride
C7H7ClO2S
98-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propargyl bromide
C3H3Br
106-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 Br 4.0010 0.7700 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4-Dimethyl-N-2-propyn-1-ylbenzenesulfonamide
C11H13NO2S
240132-49-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 8.4700 0.2064 0.0 0
M  V30 7 C 10.0100 2.8736 0.0 0
M  V30 8 C 11.5500 2.8736 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 4.6200 1.5400 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 3.8500 0.2064 0.0 0
M  V30 13 C 2.3100 2.8736 0.0 0
M  V30 14 C 2.3100 0.2064 0.0 0
M  V30 15 C 1.5400 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 3 7 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-59-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 106-96-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 240132-49-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-17380961
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-82-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 78-93-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Indole-2-methylsulfonamides by Domino Sonogashira Coupling
and Hydroamination Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Debnath, Sudarshan; Malakar, Suniti; Mondal, Shovan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2017), 2(10), 3147-3151

$RFMT $RIREG SCHEME368 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethyl-5-isoxazolyl)-2′-formyl-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulf...
C21H17N3O5S
176961-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 8.5299 0.0 0 VAL=6
M  V30 2 N 8.0023 7.7599 0.0 0
M  V30 3 O 7.4385 9.8636 0.0 0
M  V30 4 O 5.8985 7.1963 0.0 0
M  V30 5 C 1.3337 6.9899 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 11.0630 6.3971 0.0 0
M  V30 8 C 13.3050 8.8871 0.0 0
M  V30 9 C 4.0012 8.5299 0.0 0
M  V30 10 C 5.3348 9.3000 0.0 0
M  V30 11 C 2.6675 9.3000 0.0 0
M  V30 12 C 5.3348 10.8400 0.0 0
M  V30 13 C 2.6675 10.8400 0.0 0
M  V30 14 C 4.0012 11.6100 0.0 0
M  V30 15 C 4.0012 6.9899 0.0 0
M  V30 16 C 2.6675 6.2199 0.0 0
M  V30 17 C 5.3348 6.2199 0.0 0
M  V30 18 C 2.6675 4.6799 0.0 0
M  V30 19 C 5.3348 4.6799 0.0 0
M  V30 20 C 4.0012 3.9098 0.0 0
M  V30 21 C 9.3360 8.5299 0.0 0
M  V30 22 C 10.7428 7.9036 0.0 0
M  V30 23 O 9.4969 10.0615 0.0 0
M  V30 24 C 11.7734 9.0480 0.0 0
M  V30 25 N 11.0034 10.3818 0.0 0
M  V30 26 C 4.0012 2.3698 0.0 0
M  V30 27 N 2.7553 1.4646 0.0 0
M  V30 28 O 5.2470 1.4646 0.0 0
M  V30 29 C 3.2311 0.0000 0.0 0
M  V30 30 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 21
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 1 7 22
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3-Dimethylbutanoic acid
C6H12O2
1070-83-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.5400 0.0 0
M  V30 2 C 1.5400 1.5400 0.0 0
M  V30 3 C 3.8500 2.8736 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 1.5400 3.0800 0.0 0
M  V30 7 O 3.0800 4.2073 0.0 0
M  V30 8 O 5.3900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphe...
C28H32N4O5S
195444-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.9899 0.0 0
M  V30 2 N 5.3348 6.2199 0.0 0
M  V30 3 C 4.0010 6.9899 0.0 0
M  V30 4 C 5.3348 4.6799 0.0 0
M  V30 5 C 2.6673 6.2199 0.0 0
M  V30 6 O 4.0010 8.5299 0.0 0
M  V30 7 C 1.3337 6.9899 0.0 0
M  V30 8 C 2.1037 8.3236 0.0 0
M  V30 9 C 0.0000 7.7599 0.0 0
M  V30 10 C 0.5637 5.6562 0.0 0
M  V30 11 S 12.0033 8.5299 0.0 0 VAL=6
M  V30 12 N 13.3370 7.7599 0.0 0
M  V30 13 O 12.7733 9.8636 0.0 0
M  V30 14 O 11.2333 7.1963 0.0 0
M  V30 15 C 16.3978 6.3971 0.0 0
M  V30 16 C 18.6396 8.8871 0.0 0
M  V30 17 C 9.3358 6.9899 0.0 0
M  V30 18 C 8.0022 6.2199 0.0 0
M  V30 19 C 10.6697 6.2199 0.0 0
M  V30 20 C 8.0022 4.6799 0.0 0
M  V30 21 C 10.6697 4.6799 0.0 0
M  V30 22 C 9.3358 3.9098 0.0 0
M  V30 23 C 9.3358 8.5299 0.0 0
M  V30 24 C 10.6697 9.3000 0.0 0
M  V30 25 C 8.0022 9.3000 0.0 0
M  V30 26 C 10.6697 10.8400 0.0 0
M  V30 27 C 8.0022 10.8400 0.0 0
M  V30 28 C 9.3358 11.6100 0.0 0
M  V30 29 C 9.3358 2.3698 0.0 0
M  V30 30 N 8.0900 1.4646 0.0 0
M  V30 31 O 10.5819 1.4646 0.0 0
M  V30 32 C 8.5658 0.0000 0.0 0
M  V30 33 C 10.1059 0.0000 0.0 0
M  V30 34 C 14.6707 8.5299 0.0 0
M  V30 35 C 16.0776 7.9036 0.0 0
M  V30 36 O 14.8318 10.0615 0.0 0
M  V30 37 C 17.1081 9.0480 0.0 0
M  V30 38 N 16.3381 10.3818 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 11 14
M  V30 14 1 11 24
M  V30 15 1 12 34
M  V30 16 1 15 35
M  V30 17 1 16 37
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 23
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 22 29
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176961-45-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1070-83-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195444-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1423924
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Representative Procedure for Compounds 5a-p.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). To a solution of 0.15 g (0.35 mmol) of 417 in 15 mL of
dichloromethane, methylamine (33% solution in absolute ethanol, 0.13 mL,
1.06 mmol), glacial acetic acid (0.12 g, 2 mmol), and 1 g of 3 Å
molecular sieves were added. The mixture was stirred at room temperature
for 1 h. Sodium triacetoxyboro-hydride (0.22 g, 1.06 mmol) was added, and
the mixture was stirred overnight. The solution was then filtered, washed
once with water, dried, and evaporated to afford 0.15 g of
2'-[(methylamino)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-
4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide as a colorless gum. To a
solution of this material (32.9 mg, 0.075 mmol) and tertbutylacetic acid
(0.075 mol) in 0.3 mL of CH2Cl2 was added 0.1 mL of DMF followed by a
solution of 1,3-diisopropylcarbodiimide in CH2Cl2 (0.28N, 0.320 mL, 0.09
mmol). The reaction mixture was vortexed for 3 min and then let stand at
room temperature for 24 h. The mixture was then loaded onto 1.5 g of a
Strong Anion Exchange (Quaternary Amine) resin and eluted with 20 mL of
CH2Cl2 followed by 10 mL of 3% TFA in CH2Cl2 to give 5g as a white solid.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). 1H NMR (CDCl3): δ 0.95 (s, 9H), 1.92 (s, 3H), 2.16 (s, 3H), 2.30
(m, 2H), 3.25 (s, 3H), 4.0-4.6 (m, 2H), 7.25-8.00 (m, 9H). Anal.
(C28H32N4O5S) C, H, N, S.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, first stage mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of
N-[[2'-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(BMS-207940), a Highly Potent and Orally Active ETA Selective Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Gu, Zhengxiang; Spergel, Steven; Young, Marian; Chen,
Ping; Mathur, Arvind; Leith, Leslie; Hermsmeier, Mark; Liu, Eddie C.-K.;
Zhang, Rongan; Bird, Eileen; Waldron, Tom; Marino, Anthony; Koplowitz,
Barry; Humphreys, W. Griffith; Chong, Saeho; Morrison, Richard A.; Webb,
Maria L.; Moreland, Suzanne; Trippodo, Nick; Barrish, Joel C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(1), 125-137

$RFMT $RIREG SCHEME369 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloroacetaldehyde
C2H3ClO
107-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 Cl 0.0000 0.7700 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dioxo-1,5-cyclohexadiene-1-carboxylic acid
C7H4O4
75435-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 5.3901 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 9
M  V30 5 2 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Chloromethyl)-1-methyl-1H-benzimidazole-5-carboxylic acid
C10H9ClN2O2
1020718-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2753 0.0000 0.0 0
M  V30 2 C 1.3338 4.2504 0.0 0
M  V30 3 O 0.0000 3.4804 0.0 0
M  V30 4 O 1.3338 5.7904 0.0 0
M  V30 5 C 9.2446 2.7104 0.0 0
M  V30 6 Cl 10.0146 4.0442 0.0 0
M  V30 7 C 5.3347 3.4804 0.0 0
M  V30 8 C 5.3347 1.9404 0.0 0
M  V30 9 C 4.0011 4.2504 0.0 0
M  V30 10 N 6.7994 3.9564 0.0 0
M  V30 11 N 6.7994 1.4645 0.0 0
M  V30 12 C 4.0011 1.1704 0.0 0
M  V30 13 C 2.6674 3.4804 0.0 0
M  V30 14 C 7.7046 2.7104 0.0 0
M  V30 15 C 2.6674 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107-20-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75435-17-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1020718-30-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37248576
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1066-33-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel process for the preparation of dabigatran
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Surendra Kumar; Puja; Singh, Nripendra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN202311032336 A 2023-07-14

$RFMT $RIREG SCHEME370 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-3-methyl-1-(2R)-2-oxiranylbutyl]carbamate
C12H23NO3
107202-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.9870 4.0011 0.0 0 CFG=2
M  V30 2 N 3.7570 5.3347 0.0 0
M  V30 3 C 3.7570 2.6674 0.0 0
M  V30 4 C 5.2970 5.3347 0.0 0
M  V30 5 C 2.9870 1.3338 0.0 0
M  V30 6 O 6.0670 6.6685 0.0 0
M  V30 7 O 6.0670 4.0011 0.0 0
M  V30 8 C 3.7570 0.0000 0.0 0
M  V30 9 C 1.4470 1.3338 0.0 0
M  V30 10 C 7.6070 6.6685 0.0 0
M  V30 11 C 7.6070 5.1285 0.0 0
M  V30 12 C 9.1470 6.6685 0.0 0
M  V30 13 C 7.6070 8.2085 0.0 0
M  V30 14 C 1.4470 4.0011 0.0 0 CFG=1
M  V30 15 C 1.1796 5.5177 0.0 0
M  V30 16 O 0.0000 4.5278 0.0 0
M  V30 17 H 1.1796 2.4845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15 CFG=3
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S)-1-[(1S)-1-hydroxy-2-(methylamino)ethyl]-3-methylbutyl]-,...
C13H28N2O3
527677-00-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0 CFG=2
M  V30 2 C 7.7000 4.0011 0.0 0 CFG=1
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 C 8.4700 5.3347 0.0 0
M  V30 6 O 8.4700 2.6674 0.0 0
M  V30 7 C 3.8500 5.3347 0.0 0
M  V30 8 C 6.1600 1.3338 0.0 0
M  V30 9 N 10.0100 5.3347 0.0 0
M  V30 10 O 3.0800 6.6685 0.0 0
M  V30 11 O 3.0800 4.0011 0.0 0
M  V30 12 C 7.7000 1.3338 0.0 0
M  V30 13 C 5.3900 0.0000 0.0 0
M  V30 14 C 10.7800 6.6685 0.0 0
M  V30 15 C 1.5400 6.6685 0.0 0
M  V30 16 C 1.5400 8.2085 0.0 0
M  V30 17 C 0.0000 6.6685 0.0 0
M  V30 18 C 1.5400 5.1285 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107202-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 527677-00-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-12054182
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compounds which inhibit beta-secretase activity and methods of use
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghosh, Arun K.; Tang, Jordan J. N.; Bilcer, Geoffrey; Chang, Wanpin;
Hong, Lin; Koelsch, Gerald E.; Loy, Jeffrey A.; Turner, Robert T.;
Devasumadram, Thippeswamy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040121947 A1 2004-06-24

$RFMT $RIREG SCHEME370 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-3-methyl-1-(2R)-2-oxiranylbutyl]carbamate
C12H23NO3
107202-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.9870 4.0011 0.0 0 CFG=2
M  V30 2 N 3.7570 5.3347 0.0 0
M  V30 3 C 3.7570 2.6674 0.0 0
M  V30 4 C 5.2970 5.3347 0.0 0
M  V30 5 C 2.9870 1.3338 0.0 0
M  V30 6 O 6.0670 6.6685 0.0 0
M  V30 7 O 6.0670 4.0011 0.0 0
M  V30 8 C 3.7570 0.0000 0.0 0
M  V30 9 C 1.4470 1.3338 0.0 0
M  V30 10 C 7.6070 6.6685 0.0 0
M  V30 11 C 7.6070 5.1285 0.0 0
M  V30 12 C 9.1470 6.6685 0.0 0
M  V30 13 C 7.6070 8.2085 0.0 0
M  V30 14 C 1.4470 4.0011 0.0 0 CFG=1
M  V30 15 C 1.1796 5.5177 0.0 0
M  V30 16 O 0.0000 4.5278 0.0 0
M  V30 17 H 1.1796 2.4845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15 CFG=3
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S)-1-[(1S)-1-hydroxy-2-(methylamino)ethyl]-3-methylbutyl]-,...
C13H28N2O3
527677-00-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0 CFG=2
M  V30 2 C 7.7000 4.0011 0.0 0 CFG=1
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 C 8.4700 5.3347 0.0 0
M  V30 6 O 8.4700 2.6674 0.0 0
M  V30 7 C 3.8500 5.3347 0.0 0
M  V30 8 C 6.1600 1.3338 0.0 0
M  V30 9 N 10.0100 5.3347 0.0 0
M  V30 10 O 3.0800 6.6685 0.0 0
M  V30 11 O 3.0800 4.0011 0.0 0
M  V30 12 C 7.7000 1.3338 0.0 0
M  V30 13 C 5.3900 0.0000 0.0 0
M  V30 14 C 10.7800 6.6685 0.0 0
M  V30 15 C 1.5400 6.6685 0.0 0
M  V30 16 C 1.5400 8.2085 0.0 0
M  V30 17 C 0.0000 6.6685 0.0 0
M  V30 18 C 1.5400 5.1285 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107202-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 527677-00-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-14794392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design of β-secretase inhibitors for treatment of Alzheimer's disease
based on crystal structures of β-secretase and side chain interactions in
inhibitor complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghosh, Arun K.; Tang, Jordan; Bilcer, Geoffrey; Chang, Wanpin; Hong, Lin;
Koelsch, Gerald; Loy, Jeff; Turner, Robert T., III
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003039454 A2 2003-05-15

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-hydroxy-3-benzofurancarboxylic acid
C15H9FO4
1072844-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9417 1.1444 0.0 0
M  V30 2 O 4.9112 0.0000 0.0 0
M  V30 3 O 7.4479 0.8242 0.0 0
M  V30 4 O 0.0000 2.3149 0.0 0
M  V30 5 F 12.5310 3.8549 0.0 0
M  V30 6 C 6.3710 3.8549 0.0 0
M  V30 7 C 5.4658 2.6091 0.0 0
M  V30 8 O 5.4658 5.1008 0.0 0
M  V30 9 C 4.0011 3.0849 0.0 0
M  V30 10 C 4.0011 4.6250 0.0 0
M  V30 11 C 2.6674 2.3149 0.0 0
M  V30 12 C 2.6674 5.3950 0.0 0
M  V30 13 C 1.3338 3.0849 0.0 0
M  V30 14 C 1.3338 4.6250 0.0 0
M  V30 15 C 7.9110 3.8549 0.0 0
M  V30 16 C 8.6810 5.1886 0.0 0
M  V30 17 C 8.6810 2.5213 0.0 0
M  V30 18 C 10.2210 5.1886 0.0 0
M  V30 19 C 10.2210 2.5213 0.0 0
M  V30 20 C 10.9910 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 13
M  V30 5 1 5 20
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-hydroxy-N-methyl-3-benzofurancarboxamide
C16H12FNO3
1072844-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9416 2.6091 0.0 0
M  V30 2 N 4.9112 1.4645 0.0 0
M  V30 3 O 7.4479 2.2889 0.0 0
M  V30 4 C 5.3871 0.0000 0.0 0
M  V30 5 O 0.0000 3.7795 0.0 0
M  V30 6 F 12.5310 5.3195 0.0 0
M  V30 7 C 6.3710 5.3195 0.0 0
M  V30 8 C 5.4658 4.0736 0.0 0
M  V30 9 O 5.4658 6.5655 0.0 0
M  V30 10 C 4.0011 4.5495 0.0 0
M  V30 11 C 4.0011 6.0895 0.0 0
M  V30 12 C 2.6674 3.7795 0.0 0
M  V30 13 C 2.6674 6.8595 0.0 0
M  V30 14 C 1.3338 4.5495 0.0 0
M  V30 15 C 1.3338 6.0895 0.0 0
M  V30 16 C 7.9110 5.3195 0.0 0
M  V30 17 C 8.6810 6.6533 0.0 0
M  V30 18 C 8.6810 3.9858 0.0 0
M  V30 19 C 10.2210 6.6533 0.0 0
M  V30 20 C 10.2210 3.9858 0.0 0
M  V30 21 C 10.9910 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 21
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1072844-14-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072844-15-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13820411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(4-fluorophenyl)-5-hydroxy-N-methylbenzofuran-3-carboxamide. To a
mixture of 2-(4-fluorophenyl)-5-hydroxybenzofuran-3-carboxylic acid (1 g,
3.7mmol, 1 eq), methylamine in THF (2 M solution) (0.689 g, 21.5 mmol, 1
eq), HOBT (0.83 g, 6.2 mmol, 1.7 eq), EDC.HCl (1.24 g, 6.6 mmol, 1.8 eq)
in DMF at ambient temperature under nitrogen was added Diisopropyl
ethylamine (2.32 g, 18.5 mmol, 3.0 eq). The clear mixture was stirred at
ambient temperature for 12 h. The LCMS indicated the desired product. The
mixture was concentrated cooled in an ice-water bath, further diluted
with water. The white solid was filtered and washed with water and dried
in vaccum. Yield 0.85 g, 90 %. 1H NMR (400MHz, DMSO-d6): δ 2.81-2.82 (d,
3H, J= 4.5Hz), 6.80-6.83 (m, 1H), 6.94-6.95 (d, 1H, J= 2.3 Hz), 7.34-
7.38 (t, 2H, J= 8.7 Hz), 7.44-7.47 (d, 1H, J= 8.8 Hz), 7.90-7.93 (m, 2H),
8.39-8.40 (d, 1H, J= 4.4 Hz), 9.3 (s, 1H). LCMS : (ES+) m/z = 286.1(M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofurancarboxamide derivatives and their preparation
and use for the treatment of hepatitis C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yeung, Kap-Sun; Parcella, Kyle E.; Bender, John A.; Beno, Brett R.;
Grant-Young, Katharine A.; Han, Ying; Hewawasam, Piyasena; Kadow, John
F.; Nickel, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011112191 A1 2011-09-15

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-hydroxy-3-benzofurancarboxylic acid
C15H9FO4
1072844-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9417 1.1444 0.0 0
M  V30 2 O 4.9112 0.0000 0.0 0
M  V30 3 O 7.4479 0.8242 0.0 0
M  V30 4 O 0.0000 2.3149 0.0 0
M  V30 5 F 12.5310 3.8549 0.0 0
M  V30 6 C 6.3710 3.8549 0.0 0
M  V30 7 C 5.4658 2.6091 0.0 0
M  V30 8 O 5.4658 5.1008 0.0 0
M  V30 9 C 4.0011 3.0849 0.0 0
M  V30 10 C 4.0011 4.6250 0.0 0
M  V30 11 C 2.6674 2.3149 0.0 0
M  V30 12 C 2.6674 5.3950 0.0 0
M  V30 13 C 1.3338 3.0849 0.0 0
M  V30 14 C 1.3338 4.6250 0.0 0
M  V30 15 C 7.9110 3.8549 0.0 0
M  V30 16 C 8.6810 5.1886 0.0 0
M  V30 17 C 8.6810 2.5213 0.0 0
M  V30 18 C 10.2210 5.1886 0.0 0
M  V30 19 C 10.2210 2.5213 0.0 0
M  V30 20 C 10.9910 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 13
M  V30 5 1 5 20
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-hydroxy-N-methyl-3-benzofurancarboxamide
C16H12FNO3
1072844-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9416 2.6091 0.0 0
M  V30 2 N 4.9112 1.4645 0.0 0
M  V30 3 O 7.4479 2.2889 0.0 0
M  V30 4 C 5.3871 0.0000 0.0 0
M  V30 5 O 0.0000 3.7795 0.0 0
M  V30 6 F 12.5310 5.3195 0.0 0
M  V30 7 C 6.3710 5.3195 0.0 0
M  V30 8 C 5.4658 4.0736 0.0 0
M  V30 9 O 5.4658 6.5655 0.0 0
M  V30 10 C 4.0011 4.5495 0.0 0
M  V30 11 C 4.0011 6.0895 0.0 0
M  V30 12 C 2.6674 3.7795 0.0 0
M  V30 13 C 2.6674 6.8595 0.0 0
M  V30 14 C 1.3338 4.5495 0.0 0
M  V30 15 C 1.3338 6.0895 0.0 0
M  V30 16 C 7.9110 5.3195 0.0 0
M  V30 17 C 8.6810 6.6533 0.0 0
M  V30 18 C 8.6810 3.9858 0.0 0
M  V30 19 C 10.2210 6.6533 0.0 0
M  V30 20 C 10.2210 3.9858 0.0 0
M  V30 21 C 10.9910 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 21
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1072844-14-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072844-15-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13241375
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(4-fluorophenyl)-5-hydroxy-N-methylbenzofuran-3-carboxamide. To a
mixture of 2-(4-flourophenyl)-5-hydroxybenzofuran-3-carboxylic acid (1 g,
3.7 mmol, 1 eq), methylamine in THF (2 M solution) (0.689 g, 21.5 mmol, 1
eq), HOBT (0.83 g, 6.2 mmol, 1.7 eq), EDC.HCl (1.24 g, 6.6 mmol, 1.8 eq)
in DMF at ambient temperature under nitrogen was added Diisopropyl
ethylamine (2.32 g, 18.5 mmol, 3.0 eq). The clear mixture was stirred at
ambient temperature for 12 h. The LCMS indicated the desired product. The
mixture was concentrated cooled in an ice-water bath, further diluted
with water. The white solid was filtered and washed with water and dried
in vaccum. Yield: 0.85 g (90%). 1H NMR (400 MHz, DMSO-d6): δ 2.81-2.82
(d, 3H, J=4.5 Hz), 6.80-6.83 (m, 1H), 6.94-6.95 (d, 1H, J=2.3 Hz),
7.34-7.38 (t, 2H, J=8.7 Hz), 7.44-7.47 (d, 1H, J=8.8 Hz), 7.90-7.93 (m,
2H), 8.39-8.40 (d, 1H, J=4.4 Hz), 9.3 (s, 1H). LCMS: (ES+)
m/z=286.1(M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofurancarboxamide derivatives for the treatment of
hepatitis C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yeung, Kap-Sun; Parcella, Kyle E.; Bender, John A.; Beno, Brett R.;
Grant-Young, Katharine A.; Han, Ying; Hewawasam, Piyasena; Kadow, John
F.; Nickel, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20100249094 A1 2010-09-30

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-hydroxy-3-benzofurancarboxylic acid
C15H9FO4
1072844-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9417 1.1444 0.0 0
M  V30 2 O 4.9112 0.0000 0.0 0
M  V30 3 O 7.4479 0.8242 0.0 0
M  V30 4 O 0.0000 2.3149 0.0 0
M  V30 5 F 12.5310 3.8549 0.0 0
M  V30 6 C 6.3710 3.8549 0.0 0
M  V30 7 C 5.4658 2.6091 0.0 0
M  V30 8 O 5.4658 5.1008 0.0 0
M  V30 9 C 4.0011 3.0849 0.0 0
M  V30 10 C 4.0011 4.6250 0.0 0
M  V30 11 C 2.6674 2.3149 0.0 0
M  V30 12 C 2.6674 5.3950 0.0 0
M  V30 13 C 1.3338 3.0849 0.0 0
M  V30 14 C 1.3338 4.6250 0.0 0
M  V30 15 C 7.9110 3.8549 0.0 0
M  V30 16 C 8.6810 5.1886 0.0 0
M  V30 17 C 8.6810 2.5213 0.0 0
M  V30 18 C 10.2210 5.1886 0.0 0
M  V30 19 C 10.2210 2.5213 0.0 0
M  V30 20 C 10.9910 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 13
M  V30 5 1 5 20
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-hydroxy-N-methyl-3-benzofurancarboxamide
C16H12FNO3
1072844-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9416 2.6091 0.0 0
M  V30 2 N 4.9112 1.4645 0.0 0
M  V30 3 O 7.4479 2.2889 0.0 0
M  V30 4 C 5.3871 0.0000 0.0 0
M  V30 5 O 0.0000 3.7795 0.0 0
M  V30 6 F 12.5310 5.3195 0.0 0
M  V30 7 C 6.3710 5.3195 0.0 0
M  V30 8 C 5.4658 4.0736 0.0 0
M  V30 9 O 5.4658 6.5655 0.0 0
M  V30 10 C 4.0011 4.5495 0.0 0
M  V30 11 C 4.0011 6.0895 0.0 0
M  V30 12 C 2.6674 3.7795 0.0 0
M  V30 13 C 2.6674 6.8595 0.0 0
M  V30 14 C 1.3338 4.5495 0.0 0
M  V30 15 C 1.3338 6.0895 0.0 0
M  V30 16 C 7.9110 5.3195 0.0 0
M  V30 17 C 8.6810 6.6533 0.0 0
M  V30 18 C 8.6810 3.9858 0.0 0
M  V30 19 C 10.2210 6.6533 0.0 0
M  V30 20 C 10.2210 3.9858 0.0 0
M  V30 21 C 10.9910 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 21
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1072844-14-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072844-15-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8216561
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(4-Fluorophenyl)-5-hydroxy-N-methylbenzofuran-3-carboxamide [00513]To a
mixture of 2-(4-flourophenyl)-5-hydroxybenzofuran-3-carboxylic acid (1 g,
3.7 mmol, 1 eq), methylamine in THF (2 M solution) (0.689 g, 21.5 mmol, 1
eq), HOBT (0.83 g, 6.2 mmol, 1.7 eq), EDC.HCl (1.24 g, 6.6 mmol, 1.8 eq)
in DMF at ambient temperature under nitrogen was added Diisopropyl
ethylamine (2.32 g, 18.5 mmol, 3.0 eq). The clear mixture was stirred at
ambient temperature for 12 h. The LCMS indicated the desired product. The
mixture was concentrated cooled in an ice-water bath, further diluted
with water. The white solid was filtered and washed with water and dried
in vaccum. Yield: 0.85 g (90%). 1H NMR (400 MHz, DMSO-d6): δ 2.81-2.82
(d, 3H, J=4.5 Hz), 6.80-6.83 (m, 1H), 6.94-6.95 (d, 1H, J=2.3 Hz),
7.34-7.38 (t, 2H, J=8.7 Hz), 7.44-7.47 (d, 1H, J=8.8 Hz), 7.90-7.93 (m,
2H), 8.39-8.40 (d, 1H, J=4.4 Hz), 9.3 (s, 1H). LCMS: (ES+)
m/z=286.1(M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofurancarboxamide derivatives for the treatment of
hepatitis C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yeung, Kap-Sun; Parcella, Kyle E.; Bender, John A.; Beno, Brett R.;
Grant-Young, Katharine A.; Han, Ying; Hewawasam, Piyasena; Kadow, John
F.; Nickel, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010030592 A1 2010-03-18

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5E,10S)-5-(3-Bromopropylidene)-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-10-ol
C18H17BrO
1076130-64-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4633 4.9154 0.0 0
M  V30 2 C 7.5108 3.7866 0.0 0
M  V30 3 C 9.0122 4.1293 0.0 0
M  V30 4 Br 10.0597 3.0004 0.0 0
M  V30 5 O 0.0000 4.9154 0.0 0
M  V30 6 C 4.9620 4.5728 0.0 0
M  V30 7 C 4.0017 5.7769 0.0 0
M  V30 8 C 4.6191 3.0714 0.0 0
M  V30 9 C 2.4617 5.7769 0.0 0
M  V30 10 C 4.7718 7.1106 0.0 0
M  V30 11 C 3.2317 2.4032 0.0 0
M  V30 12 C 5.8917 2.2039 0.0 0
M  V30 13 C 1.5015 4.5728 0.0 0 CFG=1
M  V30 14 C 1.6917 7.1106 0.0 0
M  V30 15 C 4.0017 8.4443 0.0 0
M  V30 16 C 1.8442 3.0714 0.0 0
M  V30 17 C 3.1165 0.8675 0.0 0
M  V30 18 C 5.7765 0.6682 0.0 0
M  V30 19 C 2.4617 8.4443 0.0 0
M  V30 20 C 4.3891 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 13 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 1 12 18
M  V30 18 1 13 16
M  V30 19 1 14 19
M  V30 20 2 15 19
M  V30 21 1 17 20
M  V30 22 2 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5E)-(-)-10,11-Dihydro-5-[3-(methylamino)propylidene]-5H-dibenzo[a,d]cyclohep...
C19H21NO
112839-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1760 5.3085 0.0 0
M  V30 2 C 7.5098 4.5385 0.0 0
M  V30 3 C 8.8435 5.3085 0.0 0
M  V30 4 N 10.1771 4.5385 0.0 0
M  V30 5 C 11.5108 5.3085 0.0 0
M  V30 6 O 0.0000 3.4035 0.0 0
M  V30 7 C 4.8423 4.5385 0.0 0
M  V30 8 C 3.5699 5.4060 0.0 0
M  V30 9 C 4.9574 3.0028 0.0 0
M  V30 10 C 2.0983 4.9521 0.0 0
M  V30 11 C 3.9126 6.9075 0.0 0
M  V30 12 C 3.8285 1.9552 0.0 0
M  V30 13 C 6.4290 2.5489 0.0 0
M  V30 14 C 1.5357 3.5185 0.0 0 CFG=3
M  V30 15 C 0.9694 5.9996 0.0 0
M  V30 16 C 2.7836 7.9549 0.0 0
M  V30 17 C 2.3057 2.1848 0.0 0
M  V30 18 C 4.1712 0.4538 0.0 0
M  V30 19 C 6.7717 1.0474 0.0 0
M  V30 20 C 1.3121 7.5010 0.0 0
M  V30 21 C 5.6428 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 10 15
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 2 12 18
M  V30 18 1 13 19
M  V30 19 1 14 17
M  V30 20 1 15 20
M  V30 21 2 16 20
M  V30 22 1 18 21
M  V30 23 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1076130-64-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 112839-35-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9714840
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of +VE-10-OH-NT. compound (+)-8. (+)-E-10-OH-NT was synthesize
by heating a solution of (+)-7 (0.95 g, 2.6 mmol, 1.00 eq) and methyl
amine (40% by weig in water, 7.00 mL, 81 mmol, 31 eq) in acetonitrile (10
mL) at 60°C for 16 hours in a press vessel. The reaction was concentrated
to near dryness and purified by flash silica gel colu chromatography
using a 5-9% methanol/chloroform gradient (plus 1% ammonium hydroxide) to
give 650 mg of a light orange foam in 90% yield. Because there was some Z
isomer present, i.e., (+)-Z-10-OH-NT, the impure free base (650 mg, 2.33
mmol, 1.00 eq) was dissolved in acetonitrile and filtered to remove any
insoluble particles. The filtrate wa concentrated, dissolved in
acetonitrile (15 mL) and maleic acid (324 mg, 2.79 mmol, 1.20 was added.
The mixture was stirred for 30 minutes and a solid precipitated out. The
mixt was concentrated, dried and recrystallized from isopropanol (100 mL)
to give 535 mg of a white crystalline solid, i.e., (+)-E-10-OH-NT as the
maleate salt. Chiral LC Analysis: 99.4% chiral purity. Column: Chromtech
CHIRAL-AGP 150 x 4.0 mm, 5μ Flow: 1.0 mL/ min. Mobile Phase: 80% 20 mM
sodium phosphate pH 6.0,20% IPA. Detector: 1H NMR (400MHz, DMSO-d6) δ
8.29 (brs, 2H), 7.50-7.12 (m, 8H), 6.02 (s, 2H), 5.90 (brm, 1/3H), 5.71
(brm, 2/3H), 5.31 (brs, 1/3H), 5.08 (brs, 1/3H), 4.60 (brs, 1/3H), 3.36
(m, 1H), 3.06-2.86 (brm, 3H), 2.52 (d, 3H), 2.36 (brm, 2H). Mass Spectral
Analysis m/z = 280.1 (M+H)+.UV at 240nm. Peak Retention Time: Peak 1
[(+)-E-10-OH-NT] = 5.4 min. Peak 2 [(-)-E-10-OH-NT] - 7.3 min. Elemental
analysis: C19H21NOC4H4O4. Theory: %C 69.86; %H 6.37; %N 3.54. Found: %C
69.91; %H 6.43; %N 3.61. [α]D 23 3 = +27.79 (c. 10.1 mg/mL, MeOH). m.p. =
180.5-182.0°C.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions of (-)-E-10-hydroxynortriptyline, and methods for synthesis
and therapeutic use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Le Bourdonnec, Bertrand; Dolle, Roland
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008134325 A1 2008-11-06

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(2-chloro-5-β-D-glucopyranosylphenyl)methyl]benzoate
C21H23ClO7
1079083-50-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 0.0000 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 O 2.3100 6.6685 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 9.2400 5.3347 0.0 0
M  V30 6 O 0.0000 2.6674 0.0 0
M  V30 7 Cl 10.7800 2.6674 0.0 0
M  V30 8 C 15.4000 5.3347 0.0 0
M  V30 9 O 16.1700 6.6685 0.0 0
M  V30 10 O 16.1700 4.0011 0.0 0
M  V30 11 C 17.7100 6.6685 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0 CFG=1
M  V30 13 O 3.8500 4.0011 0.0 0
M  V30 14 C 3.8500 1.3338 0.0 0 CFG=2
M  V30 15 C 2.3100 4.0011 0.0 0 CFG=2
M  V30 16 C 2.3100 1.3338 0.0 0 CFG=1
M  V30 17 C 1.5400 2.6674 0.0 0 CFG=1
M  V30 18 C 6.1600 2.6674 0.0 0
M  V30 19 C 6.9300 4.0011 0.0 0
M  V30 20 C 6.9300 1.3338 0.0 0
M  V30 21 C 8.4700 4.0011 0.0 0
M  V30 22 C 8.4700 1.3338 0.0 0
M  V30 23 C 9.2400 2.6674 0.0 0
M  V30 24 C 10.7800 5.3347 0.0 0
M  V30 25 C 11.5500 4.0011 0.0 0
M  V30 26 C 11.5500 6.6685 0.0 0
M  V30 27 C 13.0900 4.0011 0.0 0
M  V30 28 C 13.0900 6.6685 0.0 0
M  V30 29 C 13.8600 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 15 2 CFG=1
M  V30 4 1 16 4 CFG=1
M  V30 5 1 5 21
M  V30 6 1 5 24
M  V30 7 1 17 6 CFG=3
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 29
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18 CFG=1
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 12 14 15 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-[(2-Chloro-5-β-D-glucopyranosylphenyl)methyl]-N-methylbenzamide
C21H24ClNO6
1079083-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 0.0000 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 O 2.3100 6.6685 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 9.2400 5.3347 0.0 0
M  V30 6 O 0.0000 2.6674 0.0 0
M  V30 7 Cl 10.7800 2.6674 0.0 0
M  V30 8 C 15.4000 5.3347 0.0 0
M  V30 9 N 16.1700 6.6685 0.0 0
M  V30 10 O 16.1700 4.0011 0.0 0
M  V30 11 C 17.7100 6.6685 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0 CFG=1
M  V30 13 O 3.8500 4.0011 0.0 0
M  V30 14 C 3.8500 1.3338 0.0 0 CFG=2
M  V30 15 C 2.3100 4.0011 0.0 0 CFG=2
M  V30 16 C 2.3100 1.3338 0.0 0 CFG=1
M  V30 17 C 1.5400 2.6674 0.0 0 CFG=1
M  V30 18 C 6.1600 2.6674 0.0 0
M  V30 19 C 6.9300 4.0011 0.0 0
M  V30 20 C 6.9300 1.3338 0.0 0
M  V30 21 C 8.4700 4.0011 0.0 0
M  V30 22 C 8.4700 1.3338 0.0 0
M  V30 23 C 9.2400 2.6674 0.0 0
M  V30 24 C 10.7800 5.3347 0.0 0
M  V30 25 C 11.5500 4.0011 0.0 0
M  V30 26 C 11.5500 6.6685 0.0 0
M  V30 27 C 13.0900 4.0011 0.0 0
M  V30 28 C 13.0900 6.6685 0.0 0
M  V30 29 C 13.8600 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 15 2 CFG=1
M  V30 4 1 16 4 CFG=1
M  V30 5 1 5 21
M  V30 6 1 5 24
M  V30 7 1 17 6 CFG=3
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 29
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18 CFG=1
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 12 14 15 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1079083-50-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1079083-94-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9324017
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of fluorescent SGLT2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lansdell, Mark I.; Burring, Denise J.; Hepworth, David; Strawbridge,
Matthew; Graham, Emily; Guyot, Thierry; Betson, Mark S.; Hart, James D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(18), 4944-4947

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-(bromomethyl)benzoate
C12H15BrO2
108052-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 Br 10.7800 4.2073 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[(methylamino)methyl]benzoate
C13H19NO2
1326778-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 N 10.7800 4.2073 0.0 0
M  V30 10 C 12.3200 4.2073 0.0 0
M  V30 11 C 5.3900 2.8736 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 6.1600 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 7.7000 4.2073 0.0 0
M  V30 16 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108052-76-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1326778-84-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22871959
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of alkylamine reactant
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in
acute myeloid leukaemia
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gawel, Justyna M.; Shouksmith, Andrew E.; Raouf, Yasir S.; Nawar,
Nabanita; Toutah, Krimo; Bukhari, Shazreh; Manaswiyoungkul, Pimyupa;
Olaoye, Olasunkanmi O.; Israelian, Johan; Radu, Tudor B.; Cabral, Aaron
D.; Sina, Diana; Sedighi, Abootaleb; de Araujo, Elvin D.; Gunning,
Patrick T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 201112411

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,12-Bis(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctyl)perylo[3,4-cd...
C40H6F34O6
1080663-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  80 86 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.3200 9.3358 0.0 0
M  V30 2 C 10.7800 9.3358 0.0 0
M  V30 3 F 12.3200 7.7958 0.0 0
M  V30 4 F 12.3200 10.8758 0.0 0
M  V30 5 C 9.2400 9.3356 0.0 0
M  V30 6 F 10.7800 7.7958 0.0 0
M  V30 7 F 10.7800 10.8756 0.0 0
M  V30 8 C 7.7000 9.3356 0.0 0
M  V30 9 F 9.2400 7.7956 0.0 0
M  V30 10 F 9.2400 10.8756 0.0 0
M  V30 11 C 6.1600 9.3356 0.0 0
M  V30 12 F 7.7000 7.7956 0.0 0
M  V30 13 F 7.7000 10.8756 0.0 0
M  V30 14 C 4.6200 9.3356 0.0 0
M  V30 15 F 6.1600 7.7956 0.0 0
M  V30 16 F 6.1600 10.8756 0.0 0
M  V30 17 C 3.0800 9.3356 0.0 0
M  V30 18 F 4.6200 7.7956 0.0 0
M  V30 19 F 4.6200 10.8756 0.0 0
M  V30 20 C 1.5400 9.3356 0.0 0
M  V30 21 F 3.0800 7.7956 0.0 0
M  V30 22 F 3.0800 10.8756 0.0 0
M  V30 23 F 0.0000 9.3356 0.0 0
M  V30 24 F 1.5400 7.7956 0.0 0
M  V30 25 F 1.5400 10.8756 0.0 0
M  V30 26 C 18.4800 4.0009 0.0 0
M  V30 27 C 20.0200 4.0011 0.0 0
M  V30 28 F 18.4800 2.4609 0.0 0
M  V30 29 F 18.4800 5.5409 0.0 0
M  V30 30 C 21.5600 4.0011 0.0 0
M  V30 31 F 20.0200 2.4609 0.0 0
M  V30 32 F 20.0200 5.5411 0.0 0
M  V30 33 C 23.1000 4.0011 0.0 0
M  V30 34 F 21.5600 2.4611 0.0 0
M  V30 35 F 21.5600 5.5411 0.0 0
M  V30 36 C 24.6400 4.0011 0.0 0
M  V30 37 F 23.1000 2.4611 0.0 0
M  V30 38 F 23.1000 5.5411 0.0 0
M  V30 39 C 26.1800 4.0011 0.0 0
M  V30 40 F 24.6400 2.4611 0.0 0
M  V30 41 F 24.6400 5.5411 0.0 0
M  V30 42 C 27.7200 4.0011 0.0 0
M  V30 43 F 26.1800 2.4611 0.0 0
M  V30 44 F 26.1800 5.5411 0.0 0
M  V30 45 C 29.2600 4.0011 0.0 0
M  V30 46 F 27.7200 2.4611 0.0 0
M  V30 47 F 27.7200 5.5411 0.0 0
M  V30 48 F 30.8000 4.0011 0.0 0
M  V30 49 F 29.2600 2.4611 0.0 0
M  V30 50 F 29.2600 5.5411 0.0 0
M  V30 51 O 16.1700 13.3367 0.0 0
M  V30 52 O 20.7900 10.6694 0.0 0
M  V30 53 O 14.6300 0.0000 0.0 0
M  V30 54 O 10.0100 2.6673 0.0 0
M  V30 55 C 16.1700 8.0020 0.0 0
M  V30 56 C 14.6300 8.0020 0.0 0
M  V30 57 C 16.9400 6.6684 0.0 0
M  V30 58 C 16.9400 9.3358 0.0 0
M  V30 59 C 13.8600 6.6684 0.0 0
M  V30 60 C 13.8600 9.3358 0.0 0
M  V30 61 C 16.1700 5.3347 0.0 0
M  V30 62 C 18.4800 6.6684 0.0 0
M  V30 63 C 16.1700 10.6694 0.0 0
M  V30 64 C 18.4800 9.3358 0.0 0
M  V30 65 C 14.6300 5.3347 0.0 0
M  V30 66 C 12.3200 6.6684 0.0 0
M  V30 67 C 14.6300 10.6694 0.0 0
M  V30 68 C 16.9400 4.0009 0.0 0
M  V30 69 C 19.2500 8.0020 0.0 0
M  V30 70 C 16.9400 12.0031 0.0 0
M  V30 71 C 19.2500 10.6694 0.0 0
M  V30 72 C 13.8600 4.0009 0.0 0
M  V30 73 C 11.5500 5.3347 0.0 0
M  V30 74 C 16.1700 2.6673 0.0 0
M  V30 75 O 18.4800 12.0031 0.0 0
M  V30 76 C 14.6300 2.6673 0.0 0
M  V30 77 C 12.3200 4.0009 0.0 0
M  V30 78 C 13.8600 1.3336 0.0 0
M  V30 79 C 11.5500 2.6673 0.0 0
M  V30 80 O 12.3200 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 60
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 17 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 25
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 1 26 29
M  V30 29 1 26 68
M  V30 30 1 27 30
M  V30 31 1 27 31
M  V30 32 1 27 32
M  V30 33 1 30 33
M  V30 34 1 30 34
M  V30 35 1 30 35
M  V30 36 1 33 36
M  V30 37 1 33 37
M  V30 38 1 33 38
M  V30 39 1 36 39
M  V30 40 1 36 40
M  V30 41 1 36 41
M  V30 42 1 39 42
M  V30 43 1 39 43
M  V30 44 1 39 44
M  V30 45 1 42 45
M  V30 46 1 42 46
M  V30 47 1 42 47
M  V30 48 1 45 48
M  V30 49 1 45 49
M  V30 50 1 45 50
M  V30 51 2 51 70
M  V30 52 2 52 71
M  V30 53 2 53 78
M  V30 54 2 54 79
M  V30 55 1 55 56
M  V30 56 1 55 57
M  V30 57 2 55 58
M  V30 58 1 56 59
M  V30 59 2 56 60
M  V30 60 1 57 61
M  V30 61 2 57 62
M  V30 62 1 58 63
M  V30 63 1 58 64
M  V30 64 1 59 65
M  V30 65 2 59 66
M  V30 66 1 60 67
M  V30 67 1 61 65
M  V30 68 2 61 68
M  V30 69 1 62 69
M  V30 70 2 63 67
M  V30 71 1 63 70
M  V30 72 2 64 69
M  V30 73 1 64 71
M  V30 74 2 65 72
M  V30 75 1 66 73
M  V30 76 1 68 74
M  V30 77 1 70 75
M  V30 78 1 71 75
M  V30 79 1 72 76
M  V30 80 1 72 77
M  V30 81 2 73 77
M  V30 82 2 74 76
M  V30 83 1 76 78
M  V30 84 1 77 79
M  V30 85 1 78 80
M  V30 86 1 79 80
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-Heptadecafluorooctyl)-2,9-dimethylanthra...
C34H13F17N2O4
1224622-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 63 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 9.3358 0.0 0
M  V30 2 C 10.0100 9.3358 0.0 0
M  V30 3 F 8.4700 10.8758 0.0 0
M  V30 4 F 8.4700 7.7958 0.0 0
M  V30 5 C 11.5500 9.3358 0.0 0
M  V30 6 F 10.0100 10.8758 0.0 0
M  V30 7 F 10.0100 7.7958 0.0 0
M  V30 8 C 13.0900 9.3358 0.0 0
M  V30 9 F 11.5500 10.8758 0.0 0
M  V30 10 F 11.5500 7.7958 0.0 0
M  V30 11 C 14.6300 9.3358 0.0 0
M  V30 12 F 13.0900 10.8758 0.0 0
M  V30 13 F 13.0900 7.7958 0.0 0
M  V30 14 C 16.1700 9.3358 0.0 0
M  V30 15 F 14.6300 10.8758 0.0 0
M  V30 16 F 14.6300 7.7958 0.0 0
M  V30 17 C 17.7100 9.3358 0.0 0
M  V30 18 F 16.1700 10.8758 0.0 0
M  V30 19 F 16.1700 7.7958 0.0 0
M  V30 20 C 19.2500 9.3358 0.0 0
M  V30 21 F 17.7100 10.8758 0.0 0
M  V30 22 F 17.7100 7.7958 0.0 0
M  V30 23 F 20.7900 9.3358 0.0 0
M  V30 24 F 19.2500 10.8758 0.0 0
M  V30 25 F 19.2500 7.7958 0.0 0
M  V30 26 O 4.6200 13.3367 0.0 0
M  V30 27 O 0.0000 10.6694 0.0 0
M  V30 28 C 1.5400 13.3367 0.0 0
M  V30 29 O 10.7800 2.6673 0.0 0
M  V30 30 O 6.1600 0.0000 0.0 0
M  V30 31 C 9.2400 0.0000 0.0 0
M  V30 32 C 4.6200 8.0020 0.0 0
M  V30 33 C 6.1600 8.0020 0.0 0
M  V30 34 C 3.8500 9.3358 0.0 0
M  V30 35 C 3.8500 6.6684 0.0 0
M  V30 36 C 6.9300 6.6684 0.0 0
M  V30 37 C 6.9300 9.3358 0.0 0
M  V30 38 C 4.6200 10.6694 0.0 0
M  V30 39 C 2.3100 9.3358 0.0 0
M  V30 40 C 4.6200 5.3347 0.0 0
M  V30 41 C 2.3100 6.6684 0.0 0
M  V30 42 C 6.1600 5.3347 0.0 0
M  V30 43 C 8.4700 6.6684 0.0 0
M  V30 44 C 6.1600 10.6694 0.0 0
M  V30 45 C 3.8500 12.0031 0.0 0
M  V30 46 C 1.5400 8.0020 0.0 0
M  V30 47 C 1.5400 10.6694 0.0 0
M  V30 48 C 3.8500 4.0009 0.0 0
M  V30 49 C 6.9300 4.0009 0.0 0
M  V30 50 C 9.2400 5.3347 0.0 0
M  V30 51 N 2.3100 12.0031 0.0 0
M  V30 52 C 4.6200 2.6673 0.0 0
M  V30 53 C 8.4700 4.0009 0.0 0
M  V30 54 C 6.1600 2.6673 0.0 0
M  V30 55 C 9.2400 2.6673 0.0 0
M  V30 56 C 6.9300 1.3336 0.0 0
M  V30 57 N 8.4700 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 37
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 17 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 25
M  V30 26 2 26 45
M  V30 27 2 27 47
M  V30 28 1 28 51
M  V30 29 2 29 55
M  V30 30 2 30 56
M  V30 31 1 31 57
M  V30 32 1 32 33
M  V30 33 2 32 34
M  V30 34 1 32 35
M  V30 35 1 33 36
M  V30 36 2 33 37
M  V30 37 1 34 38
M  V30 38 1 34 39
M  V30 39 1 35 40
M  V30 40 2 35 41
M  V30 41 1 36 42
M  V30 42 2 36 43
M  V30 43 1 37 44
M  V30 44 2 38 44
M  V30 45 1 38 45
M  V30 46 2 39 46
M  V30 47 1 39 47
M  V30 48 1 40 42
M  V30 49 2 40 48
M  V30 50 1 41 46
M  V30 51 2 42 49
M  V30 52 1 43 50
M  V30 53 1 45 51
M  V30 54 1 47 51
M  V30 55 1 48 52
M  V30 56 1 49 53
M  V30 57 1 49 54
M  V30 58 2 50 53
M  V30 59 2 52 54
M  V30 60 1 53 55
M  V30 61 1 54 56
M  V30 62 1 55 57
M  V30 63 1 56 57
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1080663-53-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1224622-82-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-9178439
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 79-09-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of 7b, 7c,
7e, 8a-c, 8e-g, 80e, Mixture of 11b and 11'b, Mixture of 11d and 11'd,
20a-d, and 21a-d. A mixture of 5, 6, 6', mixture of 10 and 10', 18, or 19
and primary amine was stirred in propanoic acid at 100°C or at the
boiling point of the solvent for 2-3 h. After cooling to room
temperature, precipitations were filtered for 8a and 8g. After adding
water to the reaction mixture, precipitations were also filtered for the
other target compounds. For 8g, a filter cake was pure enough to be
characterized by 1H NMR was obtained. The other compounds were purified
by silica gel column chromatography with CH2Cl2 as eluent. Only the
synthesis of compounds 7b, 8a, 8'a, mixture of 11b and 11'b, 20c, and 21d
are listed here, and detailed syntheses of the other compounds are given
in the Supporting Information 8a: Compound 6 (0.24 g, 0.20 mmol), 30%
aqueous methylamine (0.5 mL, 4.8 mmol), and 15 mL of propanoic acid led
to 8a as a red solid (0.23 g, 0.18 mmol, 90%). Mp: 218-221°C; HRMS calcd
for C42H12N2O4F34 1254.0254, found 1254.0139 (M+ , MALDI-TOF); 1H NMR
(400 MHz, CDCl3) δ 6.25 (s, 6H), 8.31 (m, 2H), 8.76 (d, 2H), 9.00 ppm (s,
2H); 19F NMR (376.5 MHz, CDCl3) δ -126.13, -122.67, -121.80, -121.56,
-121.10, -115.81, -98.14, -80.71 ppm; 13C NMR (100 MHz, CDCl3) δ 27.4,
123.1, 123.6, 126.8, 127.9, 128.3, 131.0, 131.3, 132.4, 132.5, 135.5,
162.7, 163.0 ppm
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Core-perfluoroalkylated perylene diimides and naphthalene diimides:
Versatile synthesis, solubility, electrochemistry, and optical properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Zhongyi; Li, Jing; Xiao, Yi; Li, Zheng; Qian, Xuhong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2010), 75(9), 3007-3016

$RFMT $RIREG SCHEME376 STEP1
$RXN



  6  1
$MOL
Acetyl chloride
C2H3ClO
75-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 Cl 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatin
C8H5NO2
91-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6079 0.0000 0.0 0
M  V30 2 O 6.5771 2.7104 0.0 0
M  V30 3 C 2.6673 3.4804 0.0 0
M  V30 4 C 2.6673 1.9404 0.0 0
M  V30 5 N 4.1320 3.9565 0.0 0
M  V30 6 C 1.3337 4.2504 0.0 0
M  V30 7 C 4.1320 1.4646 0.0 0
M  V30 8 C 1.3337 1.1704 0.0 0
M  V30 9 C 5.0371 2.7104 0.0 0
M  V30 10 C 0.0000 3.4804 0.0 0
M  V30 11 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diisopropylamine
C6H15N
108-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 C 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl-5-(1-methylethylidene)-1,3-dioxane-4,6-dione
C9H12O4
2231-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5178 1.5400 0.0 0
M  V30 2 C 6.8516 2.3101 0.0 0
M  V30 3 C 5.5178 0.0000 0.0 0
M  V30 4 O 2.8504 0.0000 0.0 0
M  V30 5 O 5.5178 4.6201 0.0 0
M  V30 6 C 0.9899 5.2971 0.0 0
M  V30 7 C 0.0000 3.5826 0.0 0
M  V30 8 C 4.1841 2.3101 0.0 0
M  V30 9 C 2.8504 1.5400 0.0 0
M  V30 10 C 4.1841 3.8501 0.0 0
M  V30 11 O 1.5168 2.3101 0.0 0
M  V30 12 O 2.8504 4.6201 0.0 0
M  V30 13 C 1.5168 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 8
M  V30 4 2 4 9
M  V30 5 2 5 10
M  V30 6 1 6 13
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[pyrido[1,2-a]indole-10(6H),2′-pyrrolidine]-3′-carboxamide, 8-amino-9-cy...
C25H31N5O2
2851041-69-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.9593 2.4368 0.0 0
M  V30 2 N 1.7134 1.5315 0.0 0
M  V30 3 O 4.3662 1.8103 0.0 0
M  V30 4 C 1.8745 0.0000 0.0 0
M  V30 5 C 4.0864 7.7393 0.0 0
M  V30 6 C 5.6264 7.7393 0.0 0
M  V30 7 C 3.3164 9.0730 0.0 0
M  V30 8 C 6.7663 7.6988 0.0 0
M  V30 9 N 5.4325 8.4688 0.0 0
M  V30 10 C 0.8382 3.3313 0.0 0
M  V30 11 C 0.0000 5.2142 0.0 0
M  V30 12 C 0.2533 6.4057 0.0 0
M  V30 13 C 1.7849 7.7846 0.0 0
M  V30 14 O 12.1011 4.6188 0.0 0
M  V30 15 N 9.4336 9.2388 0.0 0
M  V30 16 C 5.4492 4.6785 0.0 0
M  V30 17 C 8.1000 5.3888 0.0 0
M  V30 18 C 2.7983 3.9683 0.0 0
M  V30 19 C 7.5819 2.9516 0.0 0
M  V30 20 N 3.3164 6.4057 0.0 0
M  V30 21 N 9.4336 4.6188 0.0 0
M  V30 22 C 8.1000 6.9288 0.0 0
M  V30 23 C 1.4647 4.7383 0.0 0
M  V30 24 C 9.1135 3.1125 0.0 0
M  V30 25 C 6.9556 1.5446 0.0 0
M  V30 26 C 1.7849 6.2446 0.0 0
M  V30 27 C 10.7673 5.3888 0.0 0
M  V30 28 C 9.4336 7.6988 0.0 0
M  V30 29 C 10.0187 1.8666 0.0 0
M  V30 30 C 7.8607 0.2988 0.0 0
M  V30 31 C 10.7673 6.9288 0.0 0
M  V30 32 C 9.3924 0.4597 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 20
M  V30 8 3 8 9
M  V30 9 1 8 22
M  V30 10 1 10 23
M  V30 11 1 11 23
M  V30 12 1 12 26
M  V30 13 1 13 26
M  V30 14 2 14 27
M  V30 15 1 15 28
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 17 22
M  V30 22 1 18 23
M  V30 23 1 19 24
M  V30 24 2 19 25
M  V30 25 1 20 26
M  V30 26 1 21 24
M  V30 27 1 21 27
M  V30 28 1 22 28
M  V30 29 1 23 26
M  V30 30 2 24 29
M  V30 31 1 25 30
M  V30 32 1 27 31
M  V30 33 2 28 31
M  V30 34 1 29 32
M  V30 35 2 30 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-56-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 108-18-9
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 2231-66-5
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2851041-69-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34484631
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM iron oxide and cadmium oxide nanoparticles on multi-walled carbon
nanotubes
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, catalyst prepared and used,
recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Six-component synthesis and biological activity of novel
spiropyridoindolepyrrolidine derivatives: a combined experimental and
theoretical investigation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hossaini, Zinatossadat; Mohammadi, Marziyeh; Sheikholeslami-Farahani,
Fatemeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Frontiers in Chemistry (Lausanne, Switzerland) (2022), 10949205

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Dimethylamino)methylene]-N-(4-methoxyphenyl)-3-oxobutanamide
C14H18N2O3
1088988-20-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 0.0000 5.3349 0.0 0
M  V30 12 O 11.5500 4.0011 0.0 0
M  V30 13 C 12.3200 5.3349 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 7.7000 5.3349 0.0 0
M  V30 16 C 7.7000 2.6674 0.0 0
M  V30 17 C 9.2400 5.3349 0.0 0
M  V30 18 C 9.2400 2.6674 0.0 0
M  V30 19 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 12 13
M  V30 13 1 12 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanamide, N-(4-methoxyphenyl)-2-[(methylamino)methylene]-3-oxo-
C13H16N2O3
2197964-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 11 O 11.5500 4.0011 0.0 0
M  V30 12 C 12.3200 5.3349 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 7.7000 5.3349 0.0 0
M  V30 15 C 7.7000 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 9.2400 2.6674 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1088988-20-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2197964-30-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18916620
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Oxidative Cyclization Reactions of α-Acyl Acrylamides: A
Synthetic Route to Substituted Isoxazol-3(2H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Jingwen; Rao, Chitturi Bhujanga; Zhang, Qian; Zhang, Rui; Liang,
Yongjiu; Zhang, Ning; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2018), 50(9), 1875-1882

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[3-(Bromomethyl)-6-chloro-2-fluorophenoxy]-5-chlorobenzonitrile
C14H7BrCl2FNO
1089178-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 F 4.0010 6.1601 0.0 0
M  V30 3 Cl 6.6685 1.5400 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 Br 0.0000 3.8501 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 N 13.3370 5.3901 0.0 0
M  V30 8 Cl 9.3360 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0010 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 4.0010 1.5400 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 19 C 9.3360 1.5400 0.0 0
M  V30 20 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 1 2 10
M  V30 4 1 3 11
M  V30 5 1 4 5
M  V30 6 1 4 12
M  V30 7 3 6 7
M  V30 8 1 6 18
M  V30 9 1 8 19
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-5-[6-chloro-2-fluoro-3-[(methylamino)methyl]phenoxy]benzonitrile
C15H11Cl2FN2O
1093261-42-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 F 9.3358 6.1601 0.0 0
M  V30 3 Cl 6.6685 1.5400 0.0 0
M  V30 4 C 12.0033 4.6201 0.0 0
M  V30 5 N 13.3370 3.8501 0.0 0
M  V30 6 C 14.6707 4.6201 0.0 0
M  V30 7 C 1.3337 4.6201 0.0 0
M  V30 8 N 0.0000 5.3901 0.0 0
M  V30 9 Cl 4.0010 0.0000 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 C 9.3358 4.6201 0.0 0
M  V30 12 C 8.0022 2.3101 0.0 0
M  V30 13 C 10.6697 3.8501 0.0 0
M  V30 14 C 9.3358 1.5400 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 5.3348 3.8501 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 20 C 4.0010 1.5400 0.0 0
M  V30 21 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 11
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 4 13
M  V30 7 1 5 6
M  V30 8 3 7 8
M  V30 9 1 7 19
M  V30 10 1 9 20
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1089178-83-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1093261-42-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4023286
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A:
3-chloro-5-({6-chloro-2-fluoro-3-[(methylamino)methyl]phenyl}oxy)benzonitrile
A solution of
3-{[3-(bromomethyl)-6-chloro-2-fluorophenyl]oxy}-5-chlorobenzonitrile
(1.04 g, 2.77 mmol) in CH2Cl2 (10 mL) was added dropwise to a 2M solution
of MeNH2 (13.9 mL, 27.73 mmol) in THF. The solution turned light yellow
and the flask was stoppered and stirred at RT overnight. Ethyl acetate
(200 ml) and saturated NaHCO3 solution (150 ml) were added. The organic
layer was separated, washed with brine (150 mL), dried over MgSO4,
filtered and concentrated to give the title compound (0.81 g, 90%) as a
yellow oil.
3-chloro-5-({6-chloro-2-fluoro-3-[(methylamino)methyl]phenyl}oxy)benzonitrile,
Yield 0.81 g, 90% 1H NMR (400 MHz, CDCl3) δ ppm 7.30 - 7.33 (m, 1 H),
7.24 - 7.30 (m, 2 H), 7.11 - 7.14 (m, 1 H), 6.98 (dd, 1 H), 3.81 (s, 2
H), 2.45 (s, 3 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(cyanophenoxybenzyl) (hetero)aryl carboxamides as a
non-nucleoside reverse transcriptase inhibitors for treating HIV
infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peat, Andrew James; Sebahar, Paul Richard; Youngman, Michael; Chong, Pek
Yoke; Zhang, Huichang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008154271 A1 2008-12-18

$RFMT $RIREG SCHEME379 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanone
C6H10O
108-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
BOC-L-Proline
C10H17NO4
15761-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 2.6218 0.0 0
M  V30 2 O 5.8592 1.8517 0.0 0
M  V30 3 O 4.5254 4.1618 0.0 0
M  V30 4 C 7.1929 2.6218 0.0 0
M  V30 5 C 6.4229 3.9554 0.0 0
M  V30 6 C 8.5266 3.3918 0.0 0
M  V30 7 C 7.9629 1.2881 0.0 0
M  V30 8 C 1.4646 3.9845 0.0 0
M  V30 9 O 2.6091 5.0150 0.0 0
M  V30 10 O 0.0000 4.4604 0.0 0
M  V30 11 N 3.1917 1.8517 0.0 0
M  V30 12 C 1.7849 2.4781 0.0 0 CFG=2
M  V30 13 C 3.0308 0.3202 0.0 0
M  V30 14 C 0.7543 1.3337 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (2S)-2-isocyanatopropanoate
C5H7NO3
30293-82-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 N 5.3348 1.5400 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 O 1.3337 2.3100 0.0 0
M  V30 6 O 2.6675 0.0000 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 O 8.0022 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[(1,1-Dimethylethoxy)carbonyl]-L-prolyl-1-(methylamino)cyclohexanecarbonyl-...
C22H37N3O6
1256239-30-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.5921 4.2048 0.0 0
M  V30 2 C 7.0755 3.9373 0.0 0
M  V30 3 C 9.5820 3.0250 0.0 0
M  V30 4 O 6.0856 5.1171 0.0 0
M  V30 5 C 10.4524 4.8818 0.0 0
M  V30 6 N 11.7861 5.6518 0.0 0
M  V30 7 O 10.4524 3.3418 0.0 0
M  V30 8 C 13.1199 4.8818 0.0 0 CFG=1
M  V30 9 C 14.4535 5.6518 0.0 0
M  V30 10 C 13.1199 3.3418 0.0 0
M  V30 11 O 15.7872 4.8818 0.0 0
M  V30 12 O 14.4535 7.1918 0.0 0
M  V30 13 C 17.1208 5.6518 0.0 0
M  V30 14 C 3.8549 3.0138 0.0 0
M  V30 15 O 2.4270 2.4369 0.0 0
M  V30 16 O 4.0691 4.5388 0.0 0
M  V30 17 C 1.2135 3.3851 0.0 0
M  V30 18 C 2.1615 4.5986 0.0 0
M  V30 19 C 0.0000 4.3333 0.0 0
M  V30 20 C 0.2653 2.1716 0.0 0
M  V30 21 C 9.1188 5.6518 0.0 0
M  V30 22 C 7.6022 5.9193 0.0 0
M  V30 23 C 10.1087 6.8316 0.0 0
M  V30 24 C 7.0755 7.3664 0.0 0
M  V30 25 C 9.5820 8.2787 0.0 0
M  V30 26 C 8.0653 8.5461 0.0 0
M  V30 27 C 6.5487 2.4902 0.0 0 CFG=2
M  V30 28 N 5.0684 2.0658 0.0 0
M  V30 29 C 7.4099 1.2135 0.0 0
M  V30 30 C 5.0147 0.5267 0.0 0
M  V30 31 C 6.4618 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 2 2 4
M  V30 5 1 27 2 CFG=3
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 21
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10 CFG=3
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 28
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-94-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 15761-39-4
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 30293-82-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1256239-30-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14748443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Procedure for the Ugi 4CR Ketones (9.48 mmol)
was added to a solution of 40% methylamine in MeOH (4.75 mL, 9.48 mmol)
and allowed to precondense for 1.5 h. N-Boc-L-proline (2.04g, 9.48 mmol)
added and resulting mixture stirred for 15 min., then isocyanide derived
from L-alanine methyl ester (1.08 g, 9.48 mmol) was added. Reaction was
left to stir for 5 days at room temperature, then concentrated in vacuo.
Crude product was loaded onto a 80 mm x 50 mm Si gel resin bed and eluted
with 7:3 EtOAc:hexanes. Cyelohexanone Ugi Tripeptide (8): Yield: 3.75 g
(8.53 mmol, 90%). stains white with p-anisaldehyde. Rf=0.25 (7:3
EtOAc:hexanes), 1H NMR (CDCl3, mixture of rotamers) 6.72 (1H, m), 4.51
(1H, m), 4.37 (1H, m) 3.54 (3H, s), 3.45 (1H, m), 3.35 (1H, m), 2.98 (3H,
s), (2.11-1.52 (14H, m) 1.43 (9H, s), 1.38 (3H, d). 13C NMR (CDCl3,
mixture of rotamers) 175.6, 173.7, 171.1, 154.5, 79.4, 66.6, 65.8, 60.2,
58.6, 52.2, 48.1, 46.7, 32.9, 32.4, 31.8, 30.4, 29.5, 28.5 (3C), 24.2,
22.8, 21.9, 20.9, 18.1, 17.7, 14.1. HRMS (FAB): calcd for C22H37N3O6Na
[M+Na]+ 462.2580, obsd 462.2562 (∆ = 3.9 ppm).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diversity oriented synthesis of enopeptins and their use as
antibacterials
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sello, Jason K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012135615 A2 2012-10-04

$RFMT $RIREG SCHEME380 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanone
C6H10O
108-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
BOC-L-Proline
C10H17NO4
15761-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 2.6218 0.0 0
M  V30 2 O 5.8592 1.8517 0.0 0
M  V30 3 O 4.5254 4.1618 0.0 0
M  V30 4 C 7.1929 2.6218 0.0 0
M  V30 5 C 6.4229 3.9554 0.0 0
M  V30 6 C 8.5266 3.3918 0.0 0
M  V30 7 C 7.9629 1.2881 0.0 0
M  V30 8 C 1.4646 3.9845 0.0 0
M  V30 9 O 2.6091 5.0150 0.0 0
M  V30 10 O 0.0000 4.4604 0.0 0
M  V30 11 N 3.1917 1.8517 0.0 0
M  V30 12 C 1.7849 2.4781 0.0 0 CFG=2
M  V30 13 C 3.0308 0.3202 0.0 0
M  V30 14 C 0.7543 1.3337 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (2S)-2-isocyanopropanoate
C5H7NO2
799779-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0 CFG=2
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 N 1.3338 2.3100 0.0 0 CHG=1 VAL=4
M  V30 4 C 2.6674 0.0000 0.0 0
M  V30 5 O 5.3347 1.5400 0.0 0
M  V30 6 O 4.0011 3.8500 0.0 0
M  V30 7 C 0.0000 3.0800 0.0 0 CHG=-1
M  V30 8 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 3 3 7
M  V30 7 1 5 8
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[(1,1-Dimethylethoxy)carbonyl]-L-prolyl-1-(methylamino)cyclohexanecarbonyl-...
C22H37N3O6
1256239-30-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.5921 4.2048 0.0 0
M  V30 2 C 7.0755 3.9373 0.0 0
M  V30 3 C 9.5820 3.0250 0.0 0
M  V30 4 O 6.0856 5.1171 0.0 0
M  V30 5 C 10.4524 4.8818 0.0 0
M  V30 6 N 11.7861 5.6518 0.0 0
M  V30 7 O 10.4524 3.3418 0.0 0
M  V30 8 C 13.1199 4.8818 0.0 0 CFG=1
M  V30 9 C 14.4535 5.6518 0.0 0
M  V30 10 C 13.1199 3.3418 0.0 0
M  V30 11 O 15.7872 4.8818 0.0 0
M  V30 12 O 14.4535 7.1918 0.0 0
M  V30 13 C 17.1208 5.6518 0.0 0
M  V30 14 C 3.8549 3.0138 0.0 0
M  V30 15 O 2.4270 2.4369 0.0 0
M  V30 16 O 4.0691 4.5388 0.0 0
M  V30 17 C 1.2135 3.3851 0.0 0
M  V30 18 C 2.1615 4.5986 0.0 0
M  V30 19 C 0.0000 4.3333 0.0 0
M  V30 20 C 0.2653 2.1716 0.0 0
M  V30 21 C 9.1188 5.6518 0.0 0
M  V30 22 C 7.6022 5.9193 0.0 0
M  V30 23 C 10.1087 6.8316 0.0 0
M  V30 24 C 7.0755 7.3664 0.0 0
M  V30 25 C 9.5820 8.2787 0.0 0
M  V30 26 C 8.0653 8.5461 0.0 0
M  V30 27 C 6.5487 2.4902 0.0 0 CFG=2
M  V30 28 N 5.0684 2.0658 0.0 0
M  V30 29 C 7.4099 1.2135 0.0 0
M  V30 30 C 5.0147 0.5267 0.0 0
M  V30 31 C 6.4618 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 2 2 4
M  V30 5 1 27 2 CFG=3
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 21
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10 CFG=3
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 28
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-94-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 15761-39-4
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 799779-64-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1256239-30-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4176005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Ugi 4-component reaction, key step
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the
discovery of a potent antibacterial agent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Socha, Aaron M.; Tan, Nicholas Y.; LaPlante, Kerry L.; Sello, Jason K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2010), 18(20), 7193-7202

$RFMT $RIREG SCHEME381 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imidazo[2,1-b]thiazole-3-methanol, 6-(2-nitrophenyl)-, 3-methanesulfonate
C13H11N3O5S2
1093403-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1227 6.3787 0.0 0
M  V30 2 O 10.1531 7.5231 0.0 0
M  V30 3 S 11.6593 7.2029 0.0 0 VAL=6
M  V30 4 C 11.3392 5.6966 0.0 0
M  V30 5 O 13.1658 6.8827 0.0 0
M  V30 6 O 11.9795 8.7093 0.0 0
M  V30 7 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 8 O 0.0000 4.0011 0.0 0
M  V30 9 O 2.3100 5.3347 0.0 0
M  V30 10 N 6.4719 5.6684 0.0 0
M  V30 11 C 5.1381 6.4384 0.0 0
M  V30 12 C 7.6162 6.6988 0.0 0
M  V30 13 C 6.1515 4.1620 0.0 0
M  V30 14 N 3.9937 5.4079 0.0 0
M  V30 15 S 5.4582 7.9447 0.0 0
M  V30 16 C 6.9899 8.1058 0.0 0
M  V30 17 C 4.6200 4.0011 0.0 0
M  V30 18 C 3.8500 2.6674 0.0 0
M  V30 19 C 2.3100 2.6674 0.0 0
M  V30 20 C 4.6200 1.3336 0.0 0
M  V30 21 C 1.5400 1.3336 0.0 0
M  V30 22 C 3.8500 0.0000 0.0 0
M  V30 23 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 17
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-(2-nitrophenyl)imidazo[2,1-b]thiazole-3-methanamine
C13H12N4O2S
1449583-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 2 O 0.0000 5.3901 0.0 0
M  V30 3 O 2.6673 5.3901 0.0 0
M  V30 4 C 9.0893 2.8879 0.0 0
M  V30 5 N 10.5540 3.3637 0.0 0
M  V30 6 C 11.6984 2.3333 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.4080 2.4537 0.0 0
M  V30 9 N 4.1621 4.6116 0.0 0
M  V30 10 N 6.4384 3.5981 0.0 0
M  V30 11 C 5.6684 4.9318 0.0 0
M  V30 12 C 7.9449 3.9183 0.0 0
M  V30 13 S 6.6990 6.0764 0.0 0
M  V30 14 C 8.1058 5.4500 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 1.3337 3.0801 0.0 0
M  V30 17 C 2.6673 0.7700 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 1.3337 0.0000 0.0 0
M  V30 20 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1093403-37-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1449583-95-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9779327
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Search for a novel SIRT1 activator: Structural modification of SRT1720
and biological evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matsuya, Yuji; Kobayashi, Yuta; Uchida, Sayumi; Itoh, Yukihiro; Sawada,
Hideyuki; Suzuki, Takayoshi; Miyata, Naoki; Sugimoto, Kenji; Toyooka,
Naoki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2013), 23(17), 4907-4910

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,O-Diacetyl-D-threonine methyl ester
C9H15NO5
1093754-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0 CFG=1
M  V30 2 C 4.6200 5.3347 0.0 0 CFG=2
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 N 4.6200 2.6674 0.0 0
M  V30 5 O 6.1600 5.3347 0.0 0
M  V30 6 C 3.8500 6.6685 0.0 0
M  V30 7 O 1.5400 5.3347 0.0 0
M  V30 8 O 1.5400 2.6674 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 6.9300 6.6685 0.0 0
M  V30 11 C 0.0000 5.3347 0.0 0
M  V30 12 C 2.3100 1.3336 0.0 0
M  V30 13 O 4.6200 0.0000 0.0 0
M  V30 14 C 8.4700 6.6685 0.0 0
M  V30 15 O 6.1600 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 10 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R,3S)-2-(Acetylamino)-3-hydroxy-N-methylbutanamide
C7H14N2O3
146504-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0 CFG=1
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 N 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0 CFG=1
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 O 5.3900 1.3338 0.0 0
M  V30 7 C 0.7700 4.0011 0.0 0
M  V30 8 C 0.7700 1.3338 0.0 0
M  V30 9 O 3.0800 0.0000 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 12 O 0.0000 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9 CFG=1
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1093754-12-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 146504-13-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-11179029
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Ac-D-Thr-NHMe (3b). 1 To 9b (9.6 g, 44.2 mmol) was added methylamine (40%
in H2O, 38.0 mL, 489 mmol) at 0 °C. After stirring at room temperature
for 6 h, the reaction mixture was concentrated in vacuo. The residue was
purified by flash chromatograpy (MeOH/CH2Cl2 = 1:9) to give 3b (6.9 g,
90%) as a white solid. TLC (MeOH/CH2Cl2 = 1:12) R f = 0.21; 1H NMR (500
MHz, DMSO-d 6) δ 7.66 (q, J = 4.5 Hz, 1H), 7.64 (d, J = 8.5 Hz, 1H), 4.76
(d, J = 5.0 Hz, 1H), 4.08 (dd, J = 8.8, 3.8 Hz, 1H), 3.97 (qdd, J = 6.5,
5.5, 4.0 Hz, 1H), 2.58 (d, J = 4.5 Hz, 3H), 1.90 (s, 3H), 1.00 (d, J =
6.5 Hz, 3H); 13C NMR (125 MHz, DMSO-d 6) δ 170.68, 169.51, 66.26, 58.36,
25.54, 22.63, 20.08; HRMS (CI+) for C7H15N2O3 (MH+), calcd 175.1082,
found 218.1081.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Site-selective intramolecular hydrogen-bonding interactions in
phosphorylated serine and threonine dipeptides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Kyung-Koo; Kim, Eunmyung; Joo, Cheonik; Song, Jaewook; Han, Hogyu;
Cho, Minhaeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Physical Chemistry B (2008), 112(51), 16782-16787

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-α-Fluorenylmethoxycarbonyl-N-δ-tert-butoxycarbonyl-L-ornithine
C25H30N2O6
109425-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 5.7534 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4209 6.7709 0.0 0
M  V30 6 C 8.4209 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7546 9.0810 0.0 0
M  V30 8 C 8.4209 11.3910 0.0 0
M  V30 9 C 11.0882 9.8510 0.0 0
M  V30 10 O 7.0871 12.1610 0.0 0
M  V30 11 O 9.7546 12.1610 0.0 0
M  V30 12 C 12.4219 9.0810 0.0 0
M  V30 13 N 13.7557 9.8510 0.0 0
M  V30 14 C 15.0894 9.0810 0.0 0
M  V30 15 O 16.4231 9.8510 0.0 0
M  V30 16 O 15.0894 7.5409 0.0 0
M  V30 17 C 17.7567 9.0810 0.0 0
M  V30 18 C 16.9867 7.7473 0.0 0
M  V30 19 C 19.0906 8.3109 0.0 0
M  V30 20 C 18.5268 10.4146 0.0 0
M  V30 21 C 4.4197 4.4609 0.0 0
M  V30 22 C 4.2588 2.9293 0.0 0
M  V30 23 C 3.0128 5.0873 0.0 0
M  V30 24 C 2.7523 2.6091 0.0 0
M  V30 25 C 5.2892 1.7849 0.0 0
M  V30 26 C 1.9823 3.9428 0.0 0
M  V30 27 C 2.5369 6.5519 0.0 0
M  V30 28 C 2.2765 1.1444 0.0 0
M  V30 29 C 4.8134 0.3202 0.0 0
M  V30 30 C 0.4760 4.2630 0.0 0
M  V30 31 C 1.0306 6.8721 0.0 0
M  V30 32 C 3.3069 0.0000 0.0 0
M  V30 33 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 22 25
M  V30 25 1 23 26
M  V30 26 2 23 27
M  V30 27 1 24 26
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 2 26 30
M  V30 31 1 27 31
M  V30 32 1 28 32
M  V30 33 2 29 32
M  V30 34 1 30 33
M  V30 35 2 31 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S)-4-[[(1,1-dimethylethoxy)carbonyl]amino]-1-[(methylamino)...
C26H33N3O5
817620-52-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2308 0.0 0
M  V30 2 O 5.7533 6.7708 0.0 0
M  V30 3 C 7.0870 7.5408 0.0 0
M  V30 4 N 7.0870 9.0809 0.0 0
M  V30 5 O 8.4208 6.7708 0.0 0
M  V30 6 C 8.4208 9.8509 0.0 0 CFG=2
M  V30 7 C 9.7545 9.0809 0.0 0
M  V30 8 C 8.4208 11.3909 0.0 0
M  V30 9 C 11.0881 9.8509 0.0 0
M  V30 10 N 7.0870 12.1609 0.0 0
M  V30 11 O 9.7545 12.1609 0.0 0
M  V30 12 C 12.4218 9.0809 0.0 0
M  V30 13 C 7.0870 13.7009 0.0 0
M  V30 14 N 13.7556 9.8509 0.0 0
M  V30 15 C 15.0892 9.0809 0.0 0
M  V30 16 O 16.4229 9.8509 0.0 0
M  V30 17 O 15.0892 7.5408 0.0 0
M  V30 18 C 17.7565 9.0809 0.0 0
M  V30 19 C 18.5266 10.4145 0.0 0
M  V30 20 C 19.0904 8.3109 0.0 0
M  V30 21 C 16.9865 7.7472 0.0 0
M  V30 22 C 4.4197 4.4608 0.0 0
M  V30 23 C 4.2588 2.9293 0.0 0
M  V30 24 C 3.0127 5.0873 0.0 0
M  V30 25 C 2.7523 2.6091 0.0 0
M  V30 26 C 5.2892 1.7849 0.0 0
M  V30 27 C 1.9823 3.9428 0.0 0
M  V30 28 C 2.5369 6.5518 0.0 0
M  V30 29 C 2.2765 1.1444 0.0 0
M  V30 30 C 4.8133 0.3202 0.0 0
M  V30 31 C 0.4760 4.2629 0.0 0
M  V30 32 C 1.0306 6.8720 0.0 0
M  V30 33 C 3.3069 0.0000 0.0 0
M  V30 34 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 23 26
M  V30 26 1 24 27
M  V30 27 2 24 28
M  V30 28 1 25 27
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 2 27 31
M  V30 32 1 28 32
M  V30 33 1 29 33
M  V30 34 2 30 33
M  V30 35 1 31 34
M  V30 36 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109425-55-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 817620-52-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1275256
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Fmoc-Orn(Boc)-NHMe (105): Fmoc-Orn(Boc)-OH (4.55 g, 10.0 mmol), HOBt
(1.84 g, 12.0 mmol), and EDC (2.30 g, 12.0 mmol) were dissolved in 4:1
CH2Cl2:DMF (50 mL). After the mixture was stirred for 30 min, methylamine
(2.0 M in THF, 10.0 mL, 20.0 mmol) was added and the mixture was stirred
for another 45 min. The mixture was diluted with CHCl3 (50 mL), washed
with NaHCO3 (3 x 20 mL), dried over Na2SO4, and concentrated.
Recrystallization from 4:1 Et2O:MeOH (cal. 60 mL) gave 4.2 g (90 %) of
105 as a white solid. mp 101-102 degC.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Syntheses, and Bioactivities of Conformationally Locked Pin1
Ground State Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xiaodong J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2005), (20121004), No pp.

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
N-α-Fluorenylmethoxycarbonyl-N-δ-tert-butoxycarbonyl-L-ornithine
C25H30N2O6
109425-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 5.7534 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4209 6.7709 0.0 0
M  V30 6 C 8.4209 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7546 9.0810 0.0 0
M  V30 8 C 8.4209 11.3910 0.0 0
M  V30 9 C 11.0882 9.8510 0.0 0
M  V30 10 O 7.0871 12.1610 0.0 0
M  V30 11 O 9.7546 12.1610 0.0 0
M  V30 12 C 12.4219 9.0810 0.0 0
M  V30 13 N 13.7557 9.8510 0.0 0
M  V30 14 C 15.0894 9.0810 0.0 0
M  V30 15 O 16.4231 9.8510 0.0 0
M  V30 16 O 15.0894 7.5409 0.0 0
M  V30 17 C 17.7567 9.0810 0.0 0
M  V30 18 C 16.9867 7.7473 0.0 0
M  V30 19 C 19.0906 8.3109 0.0 0
M  V30 20 C 18.5268 10.4146 0.0 0
M  V30 21 C 4.4197 4.4609 0.0 0
M  V30 22 C 4.2588 2.9293 0.0 0
M  V30 23 C 3.0128 5.0873 0.0 0
M  V30 24 C 2.7523 2.6091 0.0 0
M  V30 25 C 5.2892 1.7849 0.0 0
M  V30 26 C 1.9823 3.9428 0.0 0
M  V30 27 C 2.5369 6.5519 0.0 0
M  V30 28 C 2.2765 1.1444 0.0 0
M  V30 29 C 4.8134 0.3202 0.0 0
M  V30 30 C 0.4760 4.2630 0.0 0
M  V30 31 C 1.0306 6.8721 0.0 0
M  V30 32 C 3.3069 0.0000 0.0 0
M  V30 33 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 22 25
M  V30 25 1 23 26
M  V30 26 2 23 27
M  V30 27 1 24 26
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 2 26 30
M  V30 31 1 27 31
M  V30 32 1 28 32
M  V30 33 2 29 32
M  V30 34 1 30 33
M  V30 35 2 31 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S)-4-[[(1,1-dimethylethoxy)carbonyl]amino]-1-[(methylamino)...
C26H33N3O5
817620-52-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2308 0.0 0
M  V30 2 O 5.7533 6.7708 0.0 0
M  V30 3 C 7.0870 7.5408 0.0 0
M  V30 4 N 7.0870 9.0809 0.0 0
M  V30 5 O 8.4208 6.7708 0.0 0
M  V30 6 C 8.4208 9.8509 0.0 0 CFG=2
M  V30 7 C 9.7545 9.0809 0.0 0
M  V30 8 C 8.4208 11.3909 0.0 0
M  V30 9 C 11.0881 9.8509 0.0 0
M  V30 10 N 7.0870 12.1609 0.0 0
M  V30 11 O 9.7545 12.1609 0.0 0
M  V30 12 C 12.4218 9.0809 0.0 0
M  V30 13 C 7.0870 13.7009 0.0 0
M  V30 14 N 13.7556 9.8509 0.0 0
M  V30 15 C 15.0892 9.0809 0.0 0
M  V30 16 O 16.4229 9.8509 0.0 0
M  V30 17 O 15.0892 7.5408 0.0 0
M  V30 18 C 17.7565 9.0809 0.0 0
M  V30 19 C 18.5266 10.4145 0.0 0
M  V30 20 C 19.0904 8.3109 0.0 0
M  V30 21 C 16.9865 7.7472 0.0 0
M  V30 22 C 4.4197 4.4608 0.0 0
M  V30 23 C 4.2588 2.9293 0.0 0
M  V30 24 C 3.0127 5.0873 0.0 0
M  V30 25 C 2.7523 2.6091 0.0 0
M  V30 26 C 5.2892 1.7849 0.0 0
M  V30 27 C 1.9823 3.9428 0.0 0
M  V30 28 C 2.5369 6.5518 0.0 0
M  V30 29 C 2.2765 1.1444 0.0 0
M  V30 30 C 4.8133 0.3202 0.0 0
M  V30 31 C 0.4760 4.2629 0.0 0
M  V30 32 C 1.0306 6.8720 0.0 0
M  V30 33 C 3.3069 0.0000 0.0 0
M  V30 34 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 23 26
M  V30 26 1 24 27
M  V30 27 2 24 28
M  V30 28 1 25 27
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 2 27 31
M  V30 32 1 28 32
M  V30 33 1 29 33
M  V30 34 2 30 33
M  V30 35 1 31 34
M  V30 36 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109425-55-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 817620-52-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9701846
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Fmoc-Orn(Boc)-NHMe, 12. Fmoc-Orn(Boc)-OH (4.55 g, 10.0 mmol), HOBt (1.84
g, 12.0 mmol), and EDC (2.30 g, 12.0 mmol) were dissolved in 4:1
CH2Cl2:DMF (50 mL). After the mixture was stirred for 30 min, methylamine
(2.0 M in THF, 10.0 mL, 20.0 mmol) was added and the mixture was stirred
for another 45 min. The mixture was diluted with CHCl3 (50 mL), washed
with NaHCO3 (3 x 20 mL), dried over Na2SO4, and concentrated.
Recrystallization from 4:1 Et2O: MeOH gave 4.2 g (90%) of 12 as a white
solid. mp 101-102 °C. 1H NMR: δ 7.75 (d, J = 7.6, 2H), 7.58 (m, 2H), 7.38
(t, J = 7.3, 2H), 7.29 (t, J = 7.5, 2H), 6.62 (br s, 1H), 5.72 (d, J =
7.1, 1H), 4.74 (brs, 1H), 4.37 (m, 3H), 4.19 (t, J = 7.0, 1H), 3.38 (m,
1H), 3.06 (m, 1H), 2.78 (d, J = 4.4, 3H), 1.78 (br s, 1H), 1.63-1.46 (m,
3H), 1.43 (s, 9H). 13C NMR: δ 172.7, 156.9, 156.5, 144.0, 143.9, 141.4,
127.8,127.2, 125.2, 120.1, 79.5, 67.0, 53.5, 47.3, 39.0, 30.4, 28.5,
26.7, 26.3.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conformationally Locked Isostere of PhosphoSer-cis-Pro Inhibits Pin1
23-Fold Better than PhosphoSer-trans-Pro Isostere
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xiaodong J.; Xu, Bailing; Mullins, Ashley B.; Neiler, Freda K.;
Etzkorn, Felicia A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2004), 126(47), 15533-15542

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[[3-[4-(1,1-dimethylethyl)phenyl]-1-methyl-1H-pyrazol-5-yl]oxy...
C25H29N3O4
1097726-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 6.7115 0.0 0
M  V30 2 C 4.6200 6.7115 0.0 0
M  V30 3 N 2.3100 8.0453 0.0 0
M  V30 4 O 5.3900 8.0453 0.0 0
M  V30 5 O 5.3900 5.3779 0.0 0
M  V30 6 O 0.7700 8.0453 0.0 0
M  V30 7 C 4.6200 9.3790 0.0 0
M  V30 8 C 0.0000 9.3790 0.0 0
M  V30 9 C 4.6200 4.0442 0.0 0
M  V30 10 O 5.3900 2.7106 0.0 0
M  V30 11 C 7.3594 0.0000 0.0 0
M  V30 12 C 14.2834 7.1013 0.0 0
M  V30 13 C 15.1886 5.8554 0.0 0
M  V30 14 C 15.5294 8.0065 0.0 0
M  V30 15 C 13.3784 8.3471 0.0 0
M  V30 16 C 2.3100 5.3779 0.0 0
M  V30 17 C 3.0800 4.0442 0.0 0
M  V30 18 C 0.7700 5.3779 0.0 0
M  V30 19 C 2.3100 2.7106 0.0 0
M  V30 20 C 0.0000 4.0442 0.0 0
M  V30 21 C 0.7700 2.7106 0.0 0
M  V30 22 C 6.9300 2.7106 0.0 0
M  V30 23 C 7.8353 3.9564 0.0 0
M  V30 24 N 7.8353 1.4647 0.0 0
M  V30 25 C 9.3000 3.4806 0.0 0
M  V30 26 N 9.3000 1.9406 0.0 0
M  V30 27 C 10.5458 4.3858 0.0 0
M  V30 28 C 11.9526 3.7593 0.0 0
M  V30 29 C 10.3849 5.9173 0.0 0
M  V30 30 C 13.1986 4.6645 0.0 0
M  V30 31 C 11.6308 6.8225 0.0 0
M  V30 32 C 13.0376 6.1961 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 24
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 32
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[[3-[4-(1,1-Dimethylethyl)phenyl]-1-methyl-1H-pyrazol-5-yl]oxy]methyl...
C25H30N4O3
1097726-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 6.7115 0.0 0
M  V30 2 C 4.6200 6.7115 0.0 0
M  V30 3 N 2.3100 8.0453 0.0 0
M  V30 4 N 5.3900 8.0453 0.0 0
M  V30 5 O 5.3900 5.3779 0.0 0
M  V30 6 O 0.7700 8.0453 0.0 0
M  V30 7 C 4.6200 9.3790 0.0 0
M  V30 8 C 0.0000 9.3790 0.0 0
M  V30 9 C 4.6200 4.0442 0.0 0
M  V30 10 O 5.3900 2.7106 0.0 0
M  V30 11 C 7.3594 0.0000 0.0 0
M  V30 12 C 14.2834 7.1013 0.0 0
M  V30 13 C 15.1886 5.8554 0.0 0
M  V30 14 C 15.5294 8.0065 0.0 0
M  V30 15 C 13.3784 8.3471 0.0 0
M  V30 16 C 2.3100 5.3779 0.0 0
M  V30 17 C 3.0800 4.0442 0.0 0
M  V30 18 C 0.7700 5.3779 0.0 0
M  V30 19 C 2.3100 2.7106 0.0 0
M  V30 20 C 0.0000 4.0442 0.0 0
M  V30 21 C 0.7700 2.7106 0.0 0
M  V30 22 C 6.9300 2.7106 0.0 0
M  V30 23 C 7.8353 3.9564 0.0 0
M  V30 24 N 7.8353 1.4647 0.0 0
M  V30 25 C 9.3000 3.4806 0.0 0
M  V30 26 N 9.3000 1.9406 0.0 0
M  V30 27 C 10.5458 4.3858 0.0 0
M  V30 28 C 10.3849 5.9173 0.0 0
M  V30 29 C 11.9526 3.7593 0.0 0
M  V30 30 C 11.6308 6.8225 0.0 0
M  V30 31 C 13.1986 4.6645 0.0 0
M  V30 32 C 13.0376 6.1961 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 24
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 32
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1097726-48-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1097726-55-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13344436
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Procedure for the Synthesis of the Compounds
6. The compounds 5 (3.00 mmol) were dissolved in 5 mL of THF, and a
slight excess of a methylamine solution (25-30%) was added dropwise to
the solution. The mixture was refluxed for 1 h (the reaction was
monitored by TLC) and then concentrated. Water was added to the residue
and extracted three times with 50mL of ethyl acetate, and the combined
organic extracts were dried and concentrated. The crude product was
purified via silica gel column chromatography. The compounds 6. Compound
6c: Yield 90.3% of a white solid. m.p. 172-174°C; 1H NMR (300 MHz, CDCl3)
δ7.60-7.63 (d, J=7.5HZ, 1H, Ph-6-H), 7.41-7.47 (m, 4H, Ph-3,5-2H+
3-Ph-2,6-2H), 7.30-7.34 (m, 3H, 3-Ph-3,5-2H+Ph-4-H), 6.81-6.83 (d,
J=4.8HZ, 1H, NH), 5.68 (s, 1H, Py-4-H), 5.12 (s, 2H, CH2), 3.95 (s, 3H,
OCH3), 3.77 (s, 3H, NCH3), 2.91-2.93 (d, J=4.8HZ, 3H, NHCH3), 1.35 (s,
9H, t-Bu); Anal. Calcd for: C, 69.10; H, 6.96; N, 12.89; Found: C, 69.31;
H, 6.82; N, 12.96.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biological Activity of New
(E)-α-(Methoxyimino)benzeneacetate Derivatives Containing a Substituted
Pyrazole Ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Miao; Liu, Chang-Ling; Yang, Ji-Chun; Zhang, Jin-Bo; Li, Zhi-Nian;
Zhang, Hong; Li, Zheng-Ming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Agricultural and Food Chemistry (2010), 58(5), 2664-2667

$RFMT $RIREG SCHEME385 STEP1
$RXN



  4  1
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Carboxybenzaldehyde
C8H6O3
119-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexyl isocyanide
C7H11N
931-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0 CHG=1 VAL=4
M  V30 2 C 6.1601 1.3337 0.0 0 CHG=-1
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5′-Amino-1′-cyclohexyl-1′,2,2′,3-tetrahydro-2-methyl-2′,3-dioxospiro[1H-isoin...
C19H20N4O2
1465840-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6639 6.9979 0.0 0
M  V30 2 N 1.4180 7.9031 0.0 0
M  V30 3 O 5.8503 2.6121 0.0 0
M  V30 4 C 1.9692 6.4933 0.0 0
M  V30 5 N 5.8503 8.0333 0.0 0
M  V30 6 O 0.0000 3.7827 0.0 0
M  V30 7 C 3.9098 4.5527 0.0 0
M  V30 8 C 3.9098 3.0127 0.0 0
M  V30 9 C 3.9098 6.0927 0.0 0
M  V30 10 C 5.3744 4.0768 0.0 0
M  V30 11 N 2.4451 5.0286 0.0 0
M  V30 12 C 2.4451 2.5368 0.0 0
M  V30 13 C 5.0541 1.9823 0.0 0
M  V30 14 C 5.3744 6.5686 0.0 0
M  V30 15 N 6.2795 5.3227 0.0 0
M  V30 16 C 1.5400 3.7827 0.0 0
M  V30 17 C 2.1249 1.0304 0.0 0
M  V30 18 C 4.7340 0.4759 0.0 0
M  V30 19 C 3.2694 0.0000 0.0 0
M  V30 20 C 7.8195 5.3227 0.0 0
M  V30 21 C 8.5895 3.9891 0.0 0
M  V30 22 C 8.5895 6.6563 0.0 0
M  V30 23 C 10.1295 3.9891 0.0 0
M  V30 24 C 10.1295 6.6563 0.0 0
M  V30 25 C 10.8995 5.3227 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 2 3 10
M  V30 4 1 4 11
M  V30 5 1 5 14
M  V30 6 2 6 16
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 12 16
M  V30 17 2 12 17
M  V30 18 1 13 18
M  V30 19 1 14 15
M  V30 20 1 15 20
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119-67-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 931-53-3
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1465840-98-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-333-CAS-5820321
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isocyanide-based multicomponent reactions: synthesis of
2-(1-(alkylcarbamoyl)-2,2-dicyanoethyl)-N-alkylbenzamide and
1,7-diazaspiro[4,4]nonane-2,4-dione derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Soleimani, Ebrahim; Zainali, Mohsen; Ghasemi, Neda; Notash, Behrouz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2013), 69(46), 9832-9838

$RFMT $RIREG SCHEME386 STEP1
$RXN



  6  1
$MOL
Acetyl chloride
C2H3ClO
75-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 Cl 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatin
C8H5NO2
91-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6079 0.0000 0.0 0
M  V30 2 O 6.5771 2.7104 0.0 0
M  V30 3 C 2.6673 3.4804 0.0 0
M  V30 4 C 2.6673 1.9404 0.0 0
M  V30 5 N 4.1320 3.9565 0.0 0
M  V30 6 C 1.3337 4.2504 0.0 0
M  V30 7 C 4.1320 1.4646 0.0 0
M  V30 8 C 1.3337 1.1704 0.0 0
M  V30 9 C 5.0371 2.7104 0.0 0
M  V30 10 C 0.0000 3.4804 0.0 0
M  V30 11 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylamine
C2H7N
124-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl-5-(phenylmethylene)-1,3-dioxane-4,6-dione
C13H12O4
1214-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 6.6684 0.0000 0.0 0
M  V30 3 O 4.0011 4.6200 0.0 0
M  V30 4 C 8.5288 5.2970 0.0 0
M  V30 5 C 9.5187 3.5825 0.0 0
M  V30 6 C 5.3347 2.3100 0.0 0
M  V30 7 C 6.6684 1.5400 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 O 8.0021 2.3100 0.0 0
M  V30 10 O 6.6684 4.6200 0.0 0
M  V30 11 C 8.0021 3.8500 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 1.3336 1.5400 0.0 0
M  V30 14 C 2.6674 3.8500 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 1.3336 4.6200 0.0 0
M  V30 17 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 1 12
M  V30 3 2 2 7
M  V30 4 2 3 8
M  V30 5 1 4 11
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C25H23N5O2
2851041-73-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7914 7.3672 0.0 0
M  V30 2 N 5.7811 8.5295 0.0 0
M  V30 3 O 8.3031 7.6610 0.0 0
M  V30 4 C 6.2824 9.9855 0.0 0
M  V30 5 C 5.0019 2.1400 0.0 0
M  V30 6 C 5.3348 1.5400 0.0 0
M  V30 7 N 6.6685 0.7700 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 N 2.6673 0.0000 0.0 0
M  V30 10 C 5.1455 4.8805 0.0 0
M  V30 11 C 4.0011 3.8501 0.0 0
M  V30 12 C 4.5192 6.2875 0.0 0
M  V30 13 C 6.2901 5.9111 0.0 0
M  V30 14 N 5.7719 3.4737 0.0 0
M  V30 15 N 2.6673 4.6201 0.0 0
M  V30 16 C 4.0011 2.3100 0.0 0
M  V30 17 C 2.9875 6.1264 0.0 0
M  V30 18 C 5.1455 7.6943 0.0 0
M  V30 19 C 7.6238 5.1411 0.0 0
M  V30 20 C 7.3036 3.6346 0.0 0
M  V30 21 C 1.3337 3.8501 0.0 0
M  V30 22 C 2.6673 1.5400 0.0 0
M  V30 23 C 2.0824 7.3724 0.0 0
M  V30 24 C 4.2403 8.9402 0.0 0
M  V30 25 C 1.3337 2.3100 0.0 0
M  V30 26 C 2.7088 8.7792 0.0 0
M  V30 27 C 9.0306 5.7674 0.0 0
M  V30 28 C 10.2765 4.8622 0.0 0
M  V30 29 C 9.1917 7.2990 0.0 0
M  V30 30 C 11.6834 5.4885 0.0 0
M  V30 31 C 10.5985 7.9255 0.0 0
M  V30 32 C 11.8444 7.0202 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 3 6 7
M  V30 7 1 6 16
M  V30 8 2 8 21
M  V30 9 1 9 22
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 2 12 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 15 17
M  V30 21 1 15 21
M  V30 22 1 16 22
M  V30 23 2 17 23
M  V30 24 1 18 24
M  V30 25 1 19 20
M  V30 26 1 19 27
M  V30 27 1 21 25
M  V30 28 2 22 25
M  V30 29 1 23 26
M  V30 30 2 24 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-56-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 124-40-3
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 1214-54-6
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2851041-73-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34484635
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM iron oxide and cadmium oxide nanoparticles on multi-walled carbon
nanotubes
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, catalyst prepared and used,
recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Six-component synthesis and biological activity of novel
spiropyridoindolepyrrolidine derivatives: a combined experimental and
theoretical investigation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hossaini, Zinatossadat; Mohammadi, Marziyeh; Sheikholeslami-Farahani,
Fatemeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Frontiers in Chemistry (Lausanne, Switzerland) (2022), 10949205

$RFMT $RIREG SCHEME387 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dimethyl-2-(methylamino)-3-pyridinecarbonitrile
C9H11N3
783325-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 3.8500 0.0000 0.0 0
M  V30 3 C 6.1600 4.0011 0.0 0
M  V30 4 N 7.7000 4.0011 0.0 0
M  V30 5 C 4.6200 6.6685 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 2.6674 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 1.5400 4.0011 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 3 3 4
M  V30 4 1 3 8
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 783325-61-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29363309
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 495-18-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternatively reaction carried out using para-toluenesulfonic acid as
catalyst decreased yield increased reaction time, mechanism studied
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel synthesis of some new fluorescent 2-amino-3-cyanopyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zonouzi, Afsaneh; Izakian, Zakieh; Ng, Seik Weng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2012), 85(11), 2713-2721

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, pentacarbonyl[ethoxy(2-methoxyphenyl)methylene]-, (OC-6-21)-
C15H12CrO7
110681-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 7.6062 2.8338 0.0 0 CHG=2 VAL=7
M  V30 2 C 4.1627 4.7998 0.0 0 CHG=-2 VAL=4
M  V30 3 C 10.4439 2.8338 0.0 0
M  V30 4 C 4.7724 2.8338 0.0 0
M  V30 5 C 7.6062 0.0000 0.0 0
M  V30 6 C 10.0608 1.4188 0.0 0
M  V30 7 C 7.6062 5.6675 0.0 0
M  V30 8 O 4.1627 6.5587 0.0 0
M  V30 9 O 11.8588 2.8338 0.0 0 VAL=3
M  V30 10 O 3.3536 2.8338 0.0 0 VAL=3
M  V30 11 O 9.0250 0.0000 0.0 0 VAL=3
M  V30 12 O 11.4796 1.4188 0.0 0 VAL=3
M  V30 13 O 9.0250 5.6675 0.0 0 VAL=3
M  V30 14 C 5.3900 7.2661 0.0 0
M  V30 15 C 6.6173 6.5587 0.0 0
M  V30 16 O 1.6064 6.2773 0.0 0
M  V30 17 C 0.0000 7.2075 0.0 0
M  V30 18 C 2.9354 4.0923 0.0 0
M  V30 19 C 1.6064 4.8623 0.0 0
M  V30 20 C 2.9354 2.5523 0.0 0
M  V30 21 C 0.2697 4.0923 0.0 0
M  V30 22 C 1.6064 1.7823 0.0 0
M  V30 23 C 0.2697 2.5523 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 18
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 1 16 19
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, pentacarbonyl[(2-methoxyphenyl)(methylamino)methylene]-, (OC-6-21)-
C14H11CrNO6
332847-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 7.6255 2.8449 0.0 0 CHG=2 VAL=7
M  V30 2 C 4.1733 4.8159 0.0 0 CHG=-2 VAL=4
M  V30 3 C 10.4704 2.8449 0.0 0
M  V30 4 C 4.7846 2.8449 0.0 0
M  V30 5 C 7.6255 0.0000 0.0 0
M  V30 6 C 10.0864 1.4224 0.0 0
M  V30 7 C 7.6255 5.6859 0.0 0
M  V30 8 N 4.1733 6.2345 0.0 0
M  V30 9 O 11.8890 2.8449 0.0 0 VAL=3
M  V30 10 O 3.3621 2.8449 0.0 0 VAL=3
M  V30 11 O 9.0480 0.0000 0.0 0 VAL=3
M  V30 12 O 11.5089 1.4224 0.0 0 VAL=3
M  V30 13 O 9.0480 5.6859 0.0 0 VAL=3
M  V30 14 C 2.5157 7.1945 0.0 0
M  V30 15 O 1.6105 6.2972 0.0 0
M  V30 16 C 0.0000 7.2259 0.0 0
M  V30 17 C 2.9428 4.1027 0.0 0
M  V30 18 C 1.6105 4.8747 0.0 0
M  V30 19 C 2.9428 2.5627 0.0 0
M  V30 20 C 0.2704 4.1027 0.0 0
M  V30 21 C 1.6105 1.7908 0.0 0
M  V30 22 C 0.2704 2.5627 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 17
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 1 15 16
M  V30 16 1 15 18
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 110681-84-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 332847-73-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-4602978
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 25:75 syn:anti
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solution and solid state conformation of Fischer carbene complexes
vis-a-vis conformation of aryl carboxamides: complexation of the aromatic
ring by tricarbonylchromium makes a difference
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jayaprakash, K. N.; Hazra, Debasis; Hagen, Karl S.; Samanta, Uttamkumar;
Bhadbhade, Mohan M.; Puranik, Vedavati G.; Sarkar, Amitabha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2001), 617-618709-722

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(3-Chloro-1,4-dihydro-1,4-dioxo-2-naphthalenyl)amino]benzonitrile
C17H9ClN2O2
1106822-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 1.5400 0.0 0
M  V30 2 O 6.6684 7.7001 0.0 0
M  V30 3 N 4.0011 3.0800 0.0 0
M  V30 4 Cl 4.0011 6.1601 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 1.3337 0.0000 0.0 0
M  V30 7 C 8.0022 3.8500 0.0 0
M  V30 8 C 8.0022 5.3901 0.0 0
M  V30 9 C 6.6684 3.0800 0.0 0
M  V30 10 C 9.3359 3.0800 0.0 0
M  V30 11 C 6.6684 6.1601 0.0 0
M  V30 12 C 9.3359 6.1601 0.0 0
M  V30 13 C 5.3348 3.8500 0.0 0
M  V30 14 C 10.6695 3.8500 0.0 0
M  V30 15 C 5.3348 5.3901 0.0 0
M  V30 16 C 10.6695 5.3901 0.0 0
M  V30 17 C 2.6673 3.8500 0.0 0
M  V30 18 C 1.3337 3.0800 0.0 0
M  V30 19 C 2.6673 5.3901 0.0 0
M  V30 20 C 0.0000 3.8500 0.0 0
M  V30 21 C 1.3337 6.1601 0.0 0
M  V30 22 C 0.0000 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 13
M  V30 4 1 3 17
M  V30 5 1 4 15
M  V30 6 3 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
13-Amino-12-methyl-6H-benzo[e]naphtho[2,3-b][1,4]diazepine-6,11(12H)-dione
C18H13N3O2
1106822-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.1106 0.1515 0.0 0
M  V30 2 C 4.9155 0.0000 0.0 0
M  V30 3 O 7.1106 6.3117 0.0 0
M  V30 4 N 2.1112 0.6400 0.0 0
M  V30 5 C 5.7768 2.4616 0.0 0
M  V30 6 C 5.7768 4.0016 0.0 0
M  V30 7 C 7.1106 1.6916 0.0 0
M  V30 8 N 4.5728 1.5014 0.0 0
M  V30 9 C 7.1106 4.7716 0.0 0
M  V30 10 N 4.5728 4.9618 0.0 0
M  V30 11 C 8.4443 2.4616 0.0 0
M  V30 12 C 3.0714 1.8440 0.0 0
M  V30 13 C 8.4443 4.0016 0.0 0
M  V30 14 C 3.0714 4.6192 0.0 0
M  V30 15 C 9.7779 1.6916 0.0 0
M  V30 16 C 2.4032 3.2316 0.0 0
M  V30 17 C 9.7779 4.7716 0.0 0
M  V30 18 C 2.2039 5.8915 0.0 0
M  V30 19 C 11.1116 2.4616 0.0 0
M  V30 20 C 0.8675 3.1166 0.0 0
M  V30 21 C 11.1116 4.0016 0.0 0
M  V30 22 C 0.6681 5.7765 0.0 0
M  V30 23 C 0.0000 4.3889 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 2 3 9
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 2 19 21
M  V30 25 2 20 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1106822-14-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1106822-17-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-14389184
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel nitrogen and sulfur
containing hetero-1,4-naphthoquinones as potent antifungal and
antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tandon, Vishnu K.; Maurya, Hardesh K.; Mishra, Nripendra N.; Shukla,
Praveen K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2009), 44(8), 3130-3137

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(3-Chloro-1,4-dihydro-1,4-dioxo-2-naphthalenyl)amino]benzonitrile
C17H9ClN2O2
1106822-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 1.5400 0.0 0
M  V30 2 O 6.6684 7.7001 0.0 0
M  V30 3 N 4.0011 3.0800 0.0 0
M  V30 4 Cl 4.0011 6.1601 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 1.3337 0.0000 0.0 0
M  V30 7 C 8.0022 3.8500 0.0 0
M  V30 8 C 8.0022 5.3901 0.0 0
M  V30 9 C 6.6684 3.0800 0.0 0
M  V30 10 C 9.3359 3.0800 0.0 0
M  V30 11 C 6.6684 6.1601 0.0 0
M  V30 12 C 9.3359 6.1601 0.0 0
M  V30 13 C 5.3348 3.8500 0.0 0
M  V30 14 C 10.6695 3.8500 0.0 0
M  V30 15 C 5.3348 5.3901 0.0 0
M  V30 16 C 10.6695 5.3901 0.0 0
M  V30 17 C 2.6673 3.8500 0.0 0
M  V30 18 C 1.3337 3.0800 0.0 0
M  V30 19 C 2.6673 5.3901 0.0 0
M  V30 20 C 0.0000 3.8500 0.0 0
M  V30 21 C 1.3337 6.1601 0.0 0
M  V30 22 C 0.0000 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 13
M  V30 4 1 3 17
M  V30 5 1 4 15
M  V30 6 3 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
13-Amino-12-methyl-6H-benzo[e]naphtho[2,3-b][1,4]diazepine-6,11(12H)-dione
C18H13N3O2
1106822-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.1106 0.1515 0.0 0
M  V30 2 C 4.9155 0.0000 0.0 0
M  V30 3 O 7.1106 6.3117 0.0 0
M  V30 4 N 2.1112 0.6400 0.0 0
M  V30 5 C 5.7768 2.4616 0.0 0
M  V30 6 C 5.7768 4.0016 0.0 0
M  V30 7 C 7.1106 1.6916 0.0 0
M  V30 8 N 4.5728 1.5014 0.0 0
M  V30 9 C 7.1106 4.7716 0.0 0
M  V30 10 N 4.5728 4.9618 0.0 0
M  V30 11 C 8.4443 2.4616 0.0 0
M  V30 12 C 3.0714 1.8440 0.0 0
M  V30 13 C 8.4443 4.0016 0.0 0
M  V30 14 C 3.0714 4.6192 0.0 0
M  V30 15 C 9.7779 1.6916 0.0 0
M  V30 16 C 2.4032 3.2316 0.0 0
M  V30 17 C 9.7779 4.7716 0.0 0
M  V30 18 C 2.2039 5.8915 0.0 0
M  V30 19 C 11.1116 2.4616 0.0 0
M  V30 20 C 0.8675 3.1166 0.0 0
M  V30 21 C 11.1116 4.0016 0.0 0
M  V30 22 C 0.6681 5.7765 0.0 0
M  V30 23 C 0.0000 4.3889 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 2 3 9
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 2 19 21
M  V30 25 2 20 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1106822-14-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1106822-17-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-10443310
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile and efficient synthesis of 1,4-benzodiazepines from
1,4-naphthoquinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tandon, Vishnu K.; Maurya, Hardesh K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2008), 76(2), 1007-1010

$RFMT $RIREG SCHEME390 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-1-[(4Z)-4,5-dihydro-5-oxo-4-(phenylmethylene)-2-oxa...
C23H24N2O4
110697-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9537 5.3347 0.0 0 CFG=1
M  V30 2 C 6.7237 4.0011 0.0 0
M  V30 3 N 4.4137 5.3347 0.0 0
M  V30 4 C 3.6437 6.6685 0.0 0
M  V30 5 O 2.1037 6.6685 0.0 0
M  V30 6 O 4.4137 8.0022 0.0 0
M  V30 7 C 1.3336 8.0022 0.0 0
M  V30 8 C 2.6674 8.7722 0.0 0
M  V30 9 C 0.5636 9.3358 0.0 0
M  V30 10 C 0.0000 7.2322 0.0 0
M  V30 11 C 9.9823 8.9622 0.0 0
M  V30 12 O 7.0808 10.6375 0.0 0
M  V30 13 C 6.7237 6.6685 0.0 0
M  V30 14 N 8.2554 6.8295 0.0 0
M  V30 15 O 6.0974 8.0753 0.0 0
M  V30 16 C 8.5755 8.3358 0.0 0
M  V30 17 C 7.2417 9.1058 0.0 0
M  V30 18 C 5.9537 2.6674 0.0 0
M  V30 19 C 6.7237 1.3338 0.0 0
M  V30 20 C 4.4137 2.6674 0.0 0
M  V30 21 C 5.9537 0.0000 0.0 0
M  V30 22 C 3.6437 1.3338 0.0 0
M  V30 23 C 4.4137 0.0000 0.0 0
M  V30 24 C 11.2282 8.0570 0.0 0
M  V30 25 C 12.6351 8.6833 0.0 0
M  V30 26 C 11.0673 6.5255 0.0 0
M  V30 27 C 13.8810 7.7781 0.0 0
M  V30 28 C 12.3131 5.6203 0.0 0
M  V30 29 C 13.7201 6.2466 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 11 16
M  V30 13 1 11 24
M  V30 14 2 12 17
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C24H29N3O4
2230166-37-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9538 5.3348 0.0 0 CFG=2
M  V30 2 C 6.7238 4.0012 0.0 0
M  V30 3 C 6.7238 6.6685 0.0 0
M  V30 4 N 4.4137 5.3348 0.0 0
M  V30 5 N 8.2638 6.6685 0.0 0
M  V30 6 O 5.9538 8.0022 0.0 0
M  V30 7 C 3.6437 6.6685 0.0 0
M  V30 8 C 9.0338 8.0022 0.0 0
M  V30 9 O 2.1037 6.6685 0.0 0
M  V30 10 O 4.4137 8.0022 0.0 0
M  V30 11 C 10.5739 8.0022 0.0 0
M  V30 12 C 8.2638 9.3360 0.0 0
M  V30 13 C 1.3337 8.0022 0.0 0
M  V30 14 N 9.0338 10.6697 0.0 0
M  V30 15 O 6.7238 9.3360 0.0 0
M  V30 16 C 2.6673 8.7722 0.0 0
M  V30 17 C 0.5637 9.3360 0.0 0
M  V30 18 C 0.0000 7.2322 0.0 0
M  V30 19 C 8.2638 12.0033 0.0 0
M  V30 20 C 5.9538 2.6673 0.0 0
M  V30 21 C 6.7238 1.3337 0.0 0
M  V30 22 C 4.4137 2.6673 0.0 0
M  V30 23 C 5.9538 0.0000 0.0 0
M  V30 24 C 3.6437 1.3337 0.0 0
M  V30 25 C 4.4137 0.0000 0.0 0
M  V30 26 C 11.3439 6.6685 0.0 0
M  V30 27 C 12.8839 6.6685 0.0 0
M  V30 28 C 10.5739 5.3348 0.0 0
M  V30 29 C 13.6539 5.3348 0.0 0
M  V30 30 C 11.3439 4.0012 0.0 0
M  V30 31 C 12.8839 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 11 26
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 110697-93-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2230166-37-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19448095
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A general method for preparation of N-Boc-protected or N-Fmoc-protected
α,β-didehydropeptide building blocks and their use in the solid-phase
peptide synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wolczanski, Grzegorz; Lisowski, Marek
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Peptide Science (2018), 24(8-9), n/a

$RFMT $RIREG SCHEME391 STEP1
$RXN



  3  1
$MOL
Ethyl 1,2,3,3a-tetrahydro-7-hydroxy-9-oxo-9H-pyrrolo[2,1-b][1,3]benzoxazine-6...
C14H15NO5
537034-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.6672 1.3337 0.0 0
M  V30 2 C 8.5974 2.6673 0.0 0
M  V30 3 O 9.3674 4.0012 0.0 0
M  V30 4 O 9.3674 1.3337 0.0 0
M  V30 5 C 10.9074 4.0012 0.0 0
M  V30 6 C 11.6775 5.3348 0.0 0
M  V30 7 O 7.0574 0.0000 0.0 0
M  V30 8 C 4.7473 4.0012 0.0 0
M  V30 9 C 3.9773 2.6673 0.0 0
M  V30 10 C 6.2873 4.0012 0.0 0
M  V30 11 O 3.9773 5.3348 0.0 0
M  V30 12 C 2.4373 2.6673 0.0 0
M  V30 13 C 4.7473 1.3337 0.0 0
M  V30 14 C 7.0574 2.6673 0.0 0
M  V30 15 C 2.4373 5.3348 0.0 0
M  V30 16 N 1.6672 4.0012 0.0 0
M  V30 17 C 6.2873 1.3337 0.0 0
M  V30 18 C 1.4068 6.4792 0.0 0
M  V30 19 C 0.1609 4.3213 0.0 0
M  V30 20 C 0.0000 5.8529 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 17
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 17
M  V30 18 1 15 16
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,5-Trioxane
C3H6O3
110-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 O 0.7700 0.0000 0.0 0
M  V30 3 O 0.7700 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 O 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,6a,7,8,9-Hexahydro-3-methyl-1,3-oxazino[6,5-g]pyrrolo[2,1-b][1,3]benzoxaz...
C14H14N2O4
537034-68-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7036 0.0000 0.0 0
M  V30 2 O 9.0383 6.1600 0.0 0
M  V30 3 C 11.7056 4.6200 0.0 0
M  V30 4 C 5.0372 3.8500 0.0 0
M  V30 5 C 5.0372 2.3100 0.0 0
M  V30 6 C 6.3709 4.6200 0.0 0
M  V30 7 O 3.7036 4.6200 0.0 0
M  V30 8 C 3.7036 1.5400 0.0 0
M  V30 9 C 6.3709 1.5400 0.0 0
M  V30 10 C 7.7045 3.8500 0.0 0
M  V30 11 C 2.3698 3.8500 0.0 0
M  V30 12 N 2.3698 2.3100 0.0 0
M  V30 13 C 7.7045 2.3100 0.0 0
M  V30 14 C 9.0383 4.6200 0.0 0
M  V30 15 C 0.9052 4.3259 0.0 0
M  V30 16 C 0.9052 1.8341 0.0 0
M  V30 17 O 9.0383 1.5400 0.0 0
M  V30 18 N 10.3720 3.8500 0.0 0
M  V30 19 C 0.0000 3.0800 0.0 0
M  V30 20 C 10.3720 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 1 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 537034-53-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 110-88-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 537034-68-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9843899
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzoxazinones as potent positive allosteric AMPA receptor modulators:
Part I
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mueller, Rudolf; Li, Yong-Xin; Hampson, Aidan; Zhong, Sheng; Harris,
Clayton; Marrs, Christopher; Rachwal, Stanislaw; Ulas, Jolanta; Nielsson,
Lena; Rogers, Gary
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(13), 3923-3926

$RFMT $RIREG SCHEME392 STEP1
$RXN



  3  1
$MOL
Glucose
C6H12O6
50-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=2
M  V30 3 C 2.6674 2.3100 0.0 0 CFG=2
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 6.6684 1.5400 0.0 0 CFG=1
M  V30 6 O 5.3347 3.8500 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 O 2.6674 3.8500 0.0 0
M  V30 9 C 8.0021 2.3100 0.0 0
M  V30 10 O 6.6684 0.0000 0.0 0
M  V30 11 O 0.0000 2.3100 0.0 0
M  V30 12 O 9.3358 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=1
M  V30 8 1 5 9
M  V30 9 1 5 10 CFG=3
M  V30 10 1 7 11
M  V30 11 2 9 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 3 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl laurate
C13H26O2
111-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 8.0023 1.5400 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 O 1.3338 2.3101 0.0 0
M  V30 9 O 2.6675 0.0000 0.0 0
M  V30 10 C 12.0035 2.3101 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 13.3372 1.5400 0.0 0
M  V30 13 C 14.6708 2.3101 0.0 0
M  V30 14 C 16.0045 1.5400 0.0 0
M  V30 15 C 17.3383 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Lauroyl-N-methylglucamine
C19H39NO6
87246-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0 CFG=2
M  V30 2 C 8.0022 1.5400 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0 CFG=1
M  V30 4 O 6.6685 3.8501 0.0 0
M  V30 5 N 9.3358 2.3101 0.0 0
M  V30 6 C 4.0010 2.3101 0.0 0 CFG=2
M  V30 7 O 5.3348 0.0000 0.0 0
M  V30 8 C 10.6697 1.5400 0.0 0
M  V30 9 C 9.3358 3.8501 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0 CFG=2
M  V30 11 O 4.0010 3.8501 0.0 0
M  V30 12 C 12.0033 2.3101 0.0 0
M  V30 13 O 10.6697 0.0000 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 O 2.6673 0.0000 0.0 0
M  V30 16 C 13.3370 1.5400 0.0 0
M  V30 17 O 0.0000 1.5400 0.0 0
M  V30 18 C 14.6707 2.3101 0.0 0
M  V30 19 C 16.0045 1.5400 0.0 0
M  V30 20 C 17.3382 2.3101 0.0 0
M  V30 21 C 18.6718 1.5400 0.0 0
M  V30 22 C 20.0055 2.3101 0.0 0
M  V30 23 C 21.3393 1.5400 0.0 0
M  V30 24 C 22.6730 2.3101 0.0 0
M  V30 25 C 24.0067 1.5400 0.0 0
M  V30 26 C 25.3403 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7 CFG=1
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11 CFG=1
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 10 14
M  V30 14 1 10 15 CFG=3
M  V30 15 1 12 16
M  V30 16 1 14 17
M  V30 17 1 16 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 20 21
M  V30 21 1 21 22
M  V30 22 1 22 23
M  V30 23 1 23 24
M  V30 24 1 24 25
M  V30 25 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 3 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-99-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 111-82-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 87246-72-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12109483
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, unspecified catalyst used (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient renewable-derived surfactant for aqueous esterification
reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rajabi, Fatemeh; Luque, Rafael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(10), 5152-5155

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxaldehyde
C6H5NO
1121-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-pyridinemethanamine
C7H10N2
21035-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 N 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1121-60-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21035-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15806773
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of green oxidation catalytic system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Caradonna, John Philip; Tarves, Paul C.; Mcnally, Joshua; Gregor, Lauren
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016100850 A2 2016-06-23

$RFMT $RIREG SCHEME394 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl chloroformate
C7H5ClO2
1885-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl N-[(4-bromophenyl)methyl]-N-methylcarbamate
C15H14BrNO2
1304633-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0
M  V30 2 N 6.9300 2.6674 0.0 0
M  V30 3 C 5.3900 2.6674 0.0 0
M  V30 4 C 7.7000 1.3338 0.0 0
M  V30 5 O 4.6200 1.3338 0.0 0
M  V30 6 O 4.6200 4.0011 0.0 0
M  V30 7 Br 13.8600 4.0011 0.0 0
M  V30 8 C 9.2400 4.0011 0.0 0
M  V30 9 C 10.0100 2.6674 0.0 0
M  V30 10 C 10.0100 5.3349 0.0 0
M  V30 11 C 11.5500 2.6674 0.0 0
M  V30 12 C 11.5500 5.3349 0.0 0
M  V30 13 C 12.3200 4.0011 0.0 0
M  V30 14 C 3.0800 1.3338 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 2.3100 2.6674 0.0 0
M  V30 17 C 0.7700 0.0002 0.0 0
M  V30 18 C 0.7700 2.6674 0.0 0
M  V30 19 C 0.0000 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 14
M  V30 8 1 7 13
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1885-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1304633-64-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2947642
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedures for Synthesis of
Carbamates: Method B. Preparation of carbamates 5b, 6b, 7b, S1, S4, 10b,
11b, 12b, 13b, 13c, 13f, 13g, 14b, and 14g. To a stirred solution of
aldehyde (2.10 mmol) in MeOH (10.5 mL) was added at rt a 40% MeOH
solution of MeNH2 (0.429 mL, 4.20 mmol). After 1 h at rt, NaBH4 (159 mg,
4.20 mmol) was added at 0°C and the mixture was stirred at rt for 30 min.
The reaction mixture was quenched with acetone (20 mL) at 0°C and the new
mixture was concentrated under reduced pressure. The residual white
solids were used for the next step without purification. To a stirred
solution of the residue in a mixture of 1:1:1 THF-acetone-H2O (10.0 mL)
was added at 0°C ClCO2R (3.78 mmol) or FmocOSu (1.28 g, 3.78 mmol, for
17g and S15). After 2 h at rt, saturated aqueous NaHCO3 (10 mL) was added
at 0°C and the mixture was extracted with EtOAc (10 mL x 3). The extracts
were washed with saturated aqueous NaCl (10 mL), dried over Na2SO4, and
concentrated under reduced pressure. The residue was purified by column
chromatography on silica gel to afford carbamates 5b, 6b, 7b, S1, S4,
10b, 11b, 12b, 13b, 13c, 13f, 13g, 14b, and 14g. From
3-methoxybenzaldehyde. From 4-bromobenzaldehyde. Phenyl
4-bromobenzyl(methyl)carbamate (13f) as a colorless syrup, yield 90%. Rf
= 0.34 (5:1 hexane-EtOAc); IR (neat, cm-1) 3044, 2933, 1721,1594, 1488,
1474, 1397, 1205, 1130, 753; 1H NMR (500 MHz, (CD3)2SO, 80°C, solvent
residual peak = 2.50) δ 2.98 (3H, s), 4.55 (2H, s), 7.14 (2H, d, J = 8.3
Hz), 7.21 (1H, t, J = 7.2 Hz), 7.30 (2H, d, J = 7.8 Hz), 7.39 (2H, dd, J
= 7.8, 7.2 Hz), 7.57 (2H, d, J = 8.3 Hz); 13C NMR (125 MHz, 80°C,
(CD3)2SO) δ 34.1, 51.2, 120.0, 121.2, 124.6, 128.7, 129.2, 131.1, 136.5,
151.0, 153.7; LRMS (EI) m/z (M)+ 319.0; HRMS (EI) m/z (M)+ calcd for
C15H14NO2Br 319.0208, found 319.0194.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Smooth Isoindolinone Formation from Isopropyl Carbamates via
Bischler-Napieralski-Type Cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Adachi, Satoshi; Onozuka, Masao; Yoshida, Yuko; Ide, Mitsuaki; Saikawa,
Yoko; Nakata, Masaya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(2), 358-361

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
4-Bromo-2-fluorobenzoic acid
C7H4BrFO2
112704-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-N-methylbenzamide
C8H7BrFNO
749927-69-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 F 3.8501 0.0000 0.0 0
M  V30 6 Br 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 112704-79-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 749927-69-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20750364
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-21-4
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new series of bicalutamide, enzalutamide and enobosarm derivatives
carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5)
substituents: Improved antiproliferative agents against prostate cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pertusati, Fabrizio; Ferla, Salvatore; Bassetto, Marcella; Brancale,
Andrea; Khandil, Sahar; Westwell, Andrew D.; McGuigan, Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2019), 1801-14

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
4-Bromo-2-fluorobenzoic acid
C7H4BrFO2
112704-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-N-methylbenzamide
C8H7BrFNO
749927-69-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 F 3.8501 0.0000 0.0 0
M  V30 6 Br 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 112704-79-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 749927-69-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6074669
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-21-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1: Conversion of 4-bromo-2-fluorobenzoic acid to
4-bromo-2-fluoro-N-methylbenzamide. To a nitrogen flushed 50 L reactor
was charged the dry benzoic acid A-1 (1.8 kg, 8.22 mol) followed by
isopropylacetate (IPAc) (12.6 L, 7 vol) and DMF (36 mL, 0.02 equiv). To
the stirred slurry was added thionyl chloride (689 mL, 9.47 mol, 1.15
equiv) over 5 min (batch warmed from 21 °C to 23 °C). The batch was
heated to 60 °C over 2.5 h, maintained at 60-68 °C for 1 h and was
sampled for HPLC analysis. The batch was a thin slurry at this point. The
conversion to the acid chloride was found to be 99.9% (the acid chloride
intermediate was quenched with N-propylamine prior to analysis). After
stirring for an additional 1 h at 70-72 °C, the batch was cooled to 10 °C
over 1 h. To a nitrogen flushed 30 L reactor was charged aqueous MeNH2
(3.6 L, 41.1 mol, 5 equiv) which was then cooled to 2-10 °C. IPAc (3.6 L,
2 vol) was added to the MeNH2 and the MeNH2/IPAc mixture was cooled to
2-10 °C. The acid chloride was transferred to the MeNH2/IPAc mixture over
50 min, during which the reaction warmed to 35 °C. The reactor that
contained the acid chloride was rinsed with IPAc (1.8 L, 1 vol) into the
30-L reactor. The batch was allowed to stir for 15 min at 30-35 °C before
sampling for HPLC analysis. The conversion to the product was found to be
100%. Agitation was ceased and the phases were allowed to separate for 10
min. The green lower layer was removed. The IPAc phase was further washed
with water (3 vol followed by 1 vol). The last phase separation was
allowed to separate over 14 h at 30 °C. After the final separation, the
IPAc phase was filtered through a Celite pad which was rinsed with IPAc
(3.6 L, 2 vol) to remove the dark green material. The filtrate was then
reduced in volume by distillation to 9.5 L (5.3 vol) over 5 h (30-35 °C,
100-200 mbar, 1.5-2.9 psi). Precipitation initiated at 8-9 volumes.
n-Heptane (18 L, 10 vol) was added to the reactor and the mixture was
distilled to 8 L (4.4 vol) over 6 h (30-35 °C, 100-200 mbar, 1.5-2.9
psi). At this stage the IPAc/n-heptane ratio was 26:1. The resulting
slurry was allowed to stir for 12 h at 25 °C before cooling to 5-10 °C
over 1 h. The batch was stirred for 1.5 h at 5-10 °C before filtering,
rinsing with n-heptane (2x1 vol) and air-drying. The filter cake (1.87
kg) was vacuum dried at 55-60 °C for 141 h to yield 1.72 kg (90% yield)
of desired amide product A-2 with an HPLC purity of 99.5%, and 0.2% H2O.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Processes for the synthesis of diarylthiohydantoin and diarylhydantoin
compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jain, Rajendra Parasmal; Angelaud, Remy; Thompson, Andrew; Lamberson,
Carol; Greenfield, Scott
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011106570 A1 2011-09-01

$RFMT $RIREG SCHEME396 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-5-nitro-1,2-benzenediamine
C6H6FN3O2
113269-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 N 5.3901 5.3349 0.0 0
M  V30 6 N 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N4-Methyl-5-nitro-1,2,4-benzenetriamine
C7H10N4O2
934333-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 2 O 0.0000 2.6675 0.0 0
M  V30 3 O 0.0000 5.3348 0.0 0
M  V30 4 N 2.3101 1.3338 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 N 5.3901 6.6687 0.0 0
M  V30 7 N 6.9302 4.0012 0.0 0
M  V30 8 C 2.3101 4.0012 0.0 0
M  V30 9 C 3.0801 2.6675 0.0 0
M  V30 10 C 3.0801 5.3348 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 C 5.3901 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113269-06-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 934333-17-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13180536
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Syntheses. N 4-Methyl-5-nitro-benzene-1,2,4-triamine (2). A mixture of
4-fluoro-5-nitro-benzene-1,2-diamine (1) (50 mg, 0.29 mmol),
methylamine-HCl (194 mg, 2.9 mmol), and anhydrous sodium acetate (237 mg,
2.9 mmol) in anhydrous DMSO (10 mL) was stirred at 120 °C for 4 h. After
cooling, water (125 mL) was added, and the mixture was applied to a Baker
C18 SPE resin (1 g) prewashed with CH3OH and then water. After the
application of the sample, the cartridge was washed with water, and the
desired product was eluted with 10 bed volumes of CH3OH, which was
evaporated under vacuum to give 2 (48 mg, 0.26 mmol, 90%). 1H NMR (DMSO-d
6): δ 8.43 (d, J = 4.8 Hz, 1H, N4-H), 7.18 (s, 1H, H-6), 6.47 (s, 2H,
2-NH2), 5.83 (s, 1H, H-3), 4.52 (s, 2H, 1-NH2), 2.85 (d, J = 5.0 Hz, 3H,
N4-CH3). Positive ESI-MS (relative intensity) m/z 183.0 [M + H]+, MS/MS
of 183.0 (100%), 166.1 (20%), 148.0 (35%), 137.0 (25%).
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of 2-Amino-1,7-dimethylimidazo[4,5-g]quinoxaline: An
Abundant Mutagenic Heterocyclic Aromatic Amine Formed in Cooked Beef
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Turesky, Robert J.; Goodenough, Angela K.; Ni, Weijuan; McNaughton, Lynn;
LeMaster, David M.; Holland, Ricky D.; Wu, Rebekah W.; Felton, James S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Research in Toxicology (2007), 20(3), 520-530

$RFMT $RIREG SCHEME397 STEP1
$RXN



  2  1
$MOL
9′-Amino-10′-fluoro-2′,3′-dihydro-8′-oxo-11′-[[2-(2-pyridinylamino)ethyl]amin...
C23H24FN5O4
1132813-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3176 4.7549 0.0 0
M  V30 2 C 10.6512 3.9849 0.0 0
M  V30 3 C 11.9850 4.7549 0.0 0
M  V30 4 N 13.3186 3.9849 0.0 0
M  V30 5 O 4.0705 0.0818 0.0 0
M  V30 6 N 6.6551 0.1264 0.0 0
M  V30 7 C 1.3583 1.5391 0.0 0
M  V30 8 O 1.4088 0.0000 0.0 0
M  V30 9 O 0.0000 2.2649 0.0 0
M  V30 10 F 9.3151 1.6767 0.0 0
M  V30 11 C 5.2957 3.9826 0.0 0
M  V30 12 N 3.9105 4.7002 0.0 0
M  V30 13 C 6.6552 4.7476 0.0 0
M  V30 14 C 5.3225 2.4346 0.0 0
M  V30 15 C 3.5563 6.1769 0.0 0
M  V30 16 C 2.6091 3.8919 0.0 0
M  V30 17 C 7.9839 3.9849 0.0 0
M  V30 18 O 6.9582 6.2357 0.0 0
M  V30 19 C 4.0212 1.6210 0.0 0
M  V30 20 C 6.6509 1.6664 0.0 0
M  V30 21 C 2.6987 7.4560 0.0 0
M  V30 22 C 2.2772 5.3194 0.0 0
M  V30 23 C 4.4594 7.4283 0.0 0
M  V30 24 C 2.6660 2.3525 0.0 0
M  V30 25 C 7.9803 2.4444 0.0 0
M  V30 26 C 6.0124 7.4553 0.0 0
M  V30 27 C 1.4196 6.5986 0.0 0
M  V30 28 C 14.6523 4.7549 0.0 0
M  V30 29 C 15.9859 3.9849 0.0 0
M  V30 30 N 14.6523 6.2949 0.0 0
M  V30 31 C 17.3197 4.7549 0.0 0
M  V30 32 C 15.9859 7.0649 0.0 0
M  V30 33 C 17.3197 6.2949 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 28
M  V30 6 2 5 19
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 24
M  V30 11 1 10 25
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 13 18
M  V30 19 1 14 19
M  V30 20 1 14 20
M  V30 21 1 15 21
M  V30 22 1 15 22
M  V30 23 1 15 23
M  V30 24 2 16 24
M  V30 25 1 17 25
M  V30 26 1 18 26
M  V30 27 1 19 24
M  V30 28 2 20 25
M  V30 29 1 21 27
M  V30 30 1 22 27
M  V30 31 1 23 26
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9′-Amino-10′-fluoro-2′,3′-dihydro-N-methyl-8′-oxo-11′-[[2-(2-pyridinylamino)e...
C24H27FN6O3
1132813-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6252 4.7549 0.0 0
M  V30 2 C 11.9589 3.9849 0.0 0
M  V30 3 C 13.2925 4.7549 0.0 0
M  V30 4 N 14.6263 3.9849 0.0 0
M  V30 5 O 5.3780 0.0818 0.0 0
M  V30 6 N 7.9627 0.1264 0.0 0
M  V30 7 C 2.6659 1.5391 0.0 0
M  V30 8 N 1.3076 2.2649 0.0 0
M  V30 9 O 2.7164 0.0000 0.0 0
M  V30 10 C 0.0000 1.4516 0.0 0
M  V30 11 F 10.6228 1.6768 0.0 0
M  V30 12 C 6.6032 3.9826 0.0 0
M  V30 13 N 5.2181 4.7002 0.0 0
M  V30 14 C 7.9627 4.7477 0.0 0
M  V30 15 C 6.6300 2.4346 0.0 0
M  V30 16 C 4.8639 6.1769 0.0 0
M  V30 17 C 3.9165 3.8919 0.0 0
M  V30 18 C 9.2914 3.9849 0.0 0
M  V30 19 O 8.2658 6.2358 0.0 0
M  V30 20 C 5.3289 1.6210 0.0 0
M  V30 21 C 7.9586 1.6664 0.0 0
M  V30 22 C 3.5847 5.3195 0.0 0
M  V30 23 C 4.0063 7.4561 0.0 0
M  V30 24 C 5.7668 7.4283 0.0 0
M  V30 25 C 3.9735 2.3525 0.0 0
M  V30 26 C 9.2877 2.4444 0.0 0
M  V30 27 C 7.3201 7.4553 0.0 0
M  V30 28 C 2.7272 6.5986 0.0 0
M  V30 29 C 15.9599 4.7549 0.0 0
M  V30 30 C 15.9599 6.2949 0.0 0
M  V30 31 N 17.2936 3.9849 0.0 0
M  V30 32 C 17.2936 7.0649 0.0 0
M  V30 33 C 18.6272 4.7549 0.0 0
M  V30 34 C 18.6272 6.2949 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 29
M  V30 6 2 5 20
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 25
M  V30 11 1 8 10
M  V30 12 1 11 26
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 1 15 21
M  V30 22 1 16 22
M  V30 23 1 16 23
M  V30 24 1 16 24
M  V30 25 2 17 25
M  V30 26 1 18 26
M  V30 27 1 19 27
M  V30 28 1 20 25
M  V30 29 2 21 26
M  V30 30 1 22 28
M  V30 31 1 23 28
M  V30 32 1 24 27
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1132813-45-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1132813-97-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2268672
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 90:
9'-amino-10'-fluoro-2',3'-dihydro-N-methyl-8'-oxo-11'-[2-(2-pyridylamino)ethylamino]spiro[cyclobutane-1,4'-[4H,8H]Pyrido[1,2,3-ef][1,5]benzoxazepine]-7'-carboxamide.
Triethylamine (0.185 mL, 1.33 mmol) and ethyl chloroformate (0.100 mL,
1.04 mmol) were added to a solution of
9'-amino-10'-fluoro-2',3'-dihydro-8'-oxo-11'-[2-(2-pyridylamino)ethylamino]spiro[cyclobutane-1,4'-[4H,8H]pyrido[1,2,3-ef][1,5]benzoxazepine]-7'-carboxylic
acid (400 mg, 0.882 mmol) in DMF (6 mL) at 0°C. After stirring at 0°C for
1.5 hours, 2 M methylamine in THF (4 mL) was added. The mixture was
stirred at room temperature for 6 hours. The reaction mixture was poured
into water (60 mL) and extracted with EtOAc. The extraction mixture was
washed with water and brine, dried over Na2SO4, and concentrated in
vacuo. The residue was purified by column chromatography (CH2Cl2:MeOH
20:1) to give the title compound (370 mg, 90%) as a yellow solid. 1H-NMR
(400 MHz, DMSO-d6) δ 1.62-1.73 (1H, m), 1.84-1.97 (1H, m), 2.28-2.48 (6H,
m), 3.41 (3H, d, J = 4.9 Hz), 2.79 (2H, q, J = 5.5 Hz), 3.49-3.56 (2H,
m), 4.12-4.24 (2H, m), 5.85 (1H, td, J = 5.5, 2.4 Hz), 6.42-6.48 (2H, m),
6.61-6.66 (1H, m), 7.07 (2H, brs), 7.31-7.36 (1H, m), 7.94 (1H, dd, J =
4.9, 1.8 Hz), 8.25 (1H, s), 9.64 (1H, q, J = 4.9 Hz). HRESIMS (+):
467.2182 (calcd for C23H28FN6O3, 467.2207).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of spirocyclicaminoquinolone derivatives for use as GSK-3
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cociorva, Oana; Fukuda, Yasumichi; Kohno, Yasushi; Li, Bei; Okada, Kyoko;
Nakamura, Ayako; Nomura, Masahiro; Seto, Shigeki; Szardenings, Katrin;
Yumoto, Kazuhiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009035684 A1 2009-03-19

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
12-Bromo-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]dodeca...
C21H33BrN2O5
1136681-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6673 0.0 0 CFG=1
M  V30 2 C 6.1600 2.6673 0.0 0 CFG=1
M  V30 3 O 3.8500 1.3336 0.0 0
M  V30 4 N 6.9300 4.0011 0.0 0
M  V30 5 C 6.9300 1.3336 0.0 0
M  V30 6 C 8.4700 4.0011 0.0 0
M  V30 7 O 6.1600 0.0000 0.0 0
M  V30 8 C 9.2400 5.3347 0.0 0
M  V30 9 O 9.2400 2.6673 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 11.5500 6.6684 0.0 0
M  V30 12 C 13.0900 6.6684 0.0 0
M  V30 13 C 13.8600 8.0020 0.0 0
M  V30 14 C 15.4000 8.0020 0.0 0
M  V30 15 C 16.1700 9.3358 0.0 0
M  V30 16 C 17.7100 9.3358 0.0 0
M  V30 17 C 18.4800 10.6694 0.0 0
M  V30 18 C 20.0200 10.6694 0.0 0
M  V30 19 C 20.7900 12.0031 0.0 0
M  V30 20 Br 22.3300 12.0031 0.0 0
M  V30 21 N 1.5400 8.0020 0.0 0 VAL=5
M  V30 22 O 0.0000 8.0020 0.0 0
M  V30 23 O 2.3100 9.3358 0.0 0
M  V30 24 C 3.8500 4.0011 0.0 0
M  V30 25 C 4.6200 5.3347 0.0 0
M  V30 26 C 2.3100 4.0011 0.0 0
M  V30 27 C 3.8500 6.6684 0.0 0
M  V30 28 C 1.5400 5.3347 0.0 0
M  V30 29 C 2.3100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 2 21 22
M  V30 22 2 21 23
M  V30 23 1 21 29
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1R,2R)-2-Hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-12-(methylamin...
C22H37N3O5
1136681-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 10.6694 0.0 0 CFG=1
M  V30 2 C 6.1600 10.6694 0.0 0 CFG=1
M  V30 3 O 3.8500 12.0031 0.0 0
M  V30 4 N 6.9300 9.3358 0.0 0
M  V30 5 C 6.9300 12.0031 0.0 0
M  V30 6 C 8.4700 9.3358 0.0 0
M  V30 7 O 6.1600 13.3367 0.0 0
M  V30 8 C 9.2400 8.0020 0.0 0
M  V30 9 O 9.2400 10.6694 0.0 0
M  V30 10 C 10.7800 8.0020 0.0 0
M  V30 11 C 11.5500 6.6684 0.0 0
M  V30 12 C 13.0900 6.6684 0.0 0
M  V30 13 C 13.8600 5.3347 0.0 0
M  V30 14 C 15.4000 5.3347 0.0 0
M  V30 15 C 16.1700 4.0009 0.0 0
M  V30 16 C 17.7100 4.0009 0.0 0
M  V30 17 C 18.4800 2.6673 0.0 0
M  V30 18 C 20.0200 2.6673 0.0 0
M  V30 19 C 20.7900 1.3336 0.0 0
M  V30 20 N 22.3300 1.3336 0.0 0
M  V30 21 C 23.1000 0.0000 0.0 0
M  V30 22 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 23 O 2.3100 4.0009 0.0 0
M  V30 24 O 0.0000 5.3347 0.0 0
M  V30 25 C 3.8500 9.3358 0.0 0
M  V30 26 C 2.3100 9.3358 0.0 0
M  V30 27 C 4.6200 8.0020 0.0 0
M  V30 28 C 1.5400 8.0020 0.0 0
M  V30 29 C 3.8500 6.6684 0.0 0
M  V30 30 C 2.3100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 2 22 23
M  V30 23 2 22 24
M  V30 24 1 22 30
M  V30 25 2 25 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 2 27 29
M  V30 29 2 28 30
M  V30 30 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1136681-28-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1136681-31-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7811463
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of Glass E Inhibitors. General
procedure for the preparation of Glass E analogs: The Glass E inhibitors
were prepared from LGL429 or LGL509 and corresponding amines: ammonia,
methylamine, dimethylamine, imidazole, morpholine or octylamine and
purified by flash column chromatography. See Figure 1. Briefly, to a
well-stirred solution of LGL 429 or LGL509 (0.156 mmol) in a mixture of
1.5N NaOH (4 mL) and THF (8 mL), the corresponding amine was added at
room temperature (r.t.). The reaction mixture was kept r.t. or under
reflux until reaction was completed as observed by thin-layer
chromatography (TLC; elution with CHCl3/MeOH, 10:1, v/v). The organic
layer was separated, and the aqueous layer was extracted twice with THF
(2 × 5 mL). The combined organic phases were dried over anhydrous NaSO4
and evaporated under a reduced pressure to dryness to give a crude
product. This material was purified through column chromatography from
the suitable solvent systems to give a pure target compounds as a light
yellow oil. (1R,
2R)-2-[N-{12'-N-methyl-amino}-dodecanoyl)-amino]-1-(4"-nitrophenyl)-1,3-propandiol
(LCL506).90% yield as light yellow oil. TLC (CHCl3/MeOH/NH4OH, 4:1 :0.01,
v/v/v), Rf=0.12; 1H-NMR (CD3OD, 400MHz) δ 8.18 (d, 2H, phenyl-H. J=8.8),
7.63 (d, 2H, phenyl-H, J=8.8), 5.17 (d, 1H, J=3.2), 4.19 (m, 1H), 3.76
(dd, 1H, J=7.6, 7.6), 3.62 (dd, 1H, J=5.6, 5.6), 2.91 (t, 2H, J=8.0),
2.65 (S, 3H), 2.31 (S, 6H), 2.09 (t, 2H, J=7.2), 1.68 (m, 2H), 1.00-1.42
(m, 16H). Formula: C22H37N3O5,MS 424.15 [M+].
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Lysosomotropic inhibitors of acid ceramidase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bielawska, Alicja; Bai, Aiping; Szulc, Zdzislaw M.; Hannun, Yusef A.;
Norris, James; Xiang, Liu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010054223 A1 2010-05-14

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
12-Bromo-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]dodeca...
C21H33BrN2O5
1136681-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6673 0.0 0 CFG=1
M  V30 2 C 6.1600 2.6673 0.0 0 CFG=1
M  V30 3 O 3.8500 1.3336 0.0 0
M  V30 4 N 6.9300 4.0011 0.0 0
M  V30 5 C 6.9300 1.3336 0.0 0
M  V30 6 C 8.4700 4.0011 0.0 0
M  V30 7 O 6.1600 0.0000 0.0 0
M  V30 8 C 9.2400 5.3347 0.0 0
M  V30 9 O 9.2400 2.6673 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 11.5500 6.6684 0.0 0
M  V30 12 C 13.0900 6.6684 0.0 0
M  V30 13 C 13.8600 8.0020 0.0 0
M  V30 14 C 15.4000 8.0020 0.0 0
M  V30 15 C 16.1700 9.3358 0.0 0
M  V30 16 C 17.7100 9.3358 0.0 0
M  V30 17 C 18.4800 10.6694 0.0 0
M  V30 18 C 20.0200 10.6694 0.0 0
M  V30 19 C 20.7900 12.0031 0.0 0
M  V30 20 Br 22.3300 12.0031 0.0 0
M  V30 21 N 1.5400 8.0020 0.0 0 VAL=5
M  V30 22 O 0.0000 8.0020 0.0 0
M  V30 23 O 2.3100 9.3358 0.0 0
M  V30 24 C 3.8500 4.0011 0.0 0
M  V30 25 C 4.6200 5.3347 0.0 0
M  V30 26 C 2.3100 4.0011 0.0 0
M  V30 27 C 3.8500 6.6684 0.0 0
M  V30 28 C 1.5400 5.3347 0.0 0
M  V30 29 C 2.3100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 2 21 22
M  V30 22 2 21 23
M  V30 23 1 21 29
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1R,2R)-2-Hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-12-(methylamin...
C22H37N3O5
1136681-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 10.6694 0.0 0 CFG=1
M  V30 2 C 6.1600 10.6694 0.0 0 CFG=1
M  V30 3 O 3.8500 12.0031 0.0 0
M  V30 4 N 6.9300 9.3358 0.0 0
M  V30 5 C 6.9300 12.0031 0.0 0
M  V30 6 C 8.4700 9.3358 0.0 0
M  V30 7 O 6.1600 13.3367 0.0 0
M  V30 8 C 9.2400 8.0020 0.0 0
M  V30 9 O 9.2400 10.6694 0.0 0
M  V30 10 C 10.7800 8.0020 0.0 0
M  V30 11 C 11.5500 6.6684 0.0 0
M  V30 12 C 13.0900 6.6684 0.0 0
M  V30 13 C 13.8600 5.3347 0.0 0
M  V30 14 C 15.4000 5.3347 0.0 0
M  V30 15 C 16.1700 4.0009 0.0 0
M  V30 16 C 17.7100 4.0009 0.0 0
M  V30 17 C 18.4800 2.6673 0.0 0
M  V30 18 C 20.0200 2.6673 0.0 0
M  V30 19 C 20.7900 1.3336 0.0 0
M  V30 20 N 22.3300 1.3336 0.0 0
M  V30 21 C 23.1000 0.0000 0.0 0
M  V30 22 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 23 O 2.3100 4.0009 0.0 0
M  V30 24 O 0.0000 5.3347 0.0 0
M  V30 25 C 3.8500 9.3358 0.0 0
M  V30 26 C 2.3100 9.3358 0.0 0
M  V30 27 C 4.6200 8.0020 0.0 0
M  V30 28 C 1.5400 8.0020 0.0 0
M  V30 29 C 3.8500 6.6684 0.0 0
M  V30 30 C 2.3100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 2 22 23
M  V30 23 2 22 24
M  V30 24 1 22 30
M  V30 25 2 25 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 2 27 29
M  V30 29 2 28 30
M  V30 30 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1136681-28-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1136681-31-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6173666
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and bioevaluation of ω-N-amino analogs of B13
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bai, Aiping; Szulc, Zdzislaw M.; Bielawski, Jacek; Mayroo, Nalini; Liu,
Xiang; Norris, James; Hannun, Yusuf A.; Bielawska, Alicja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2009), 17(5), 1840-1848

$RFMT $RIREG SCHEME399 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenecarboxaldehyde, 5-[(2-chloro-4-pyridinyl)thio]-4-(2-fluoro-3-pyrid...
C15H8ClFN2OS2
1138034-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.5626 5.6399 0.0 0
M  V30 2 F 2.0565 2.1049 0.0 0
M  V30 3 C 1.4068 7.3149 0.0 0
M  V30 4 O 0.0000 6.6886 0.0 0
M  V30 5 Cl 11.1827 8.3072 0.0 0
M  V30 6 C 4.1174 4.3938 0.0 0
M  V30 7 C 5.0226 5.6399 0.0 0
M  V30 8 C 2.6528 4.8699 0.0 0
M  V30 9 S 4.1174 6.8857 0.0 0
M  V30 10 C 2.6528 6.4099 0.0 0
M  V30 11 C 4.5933 2.9293 0.0 0
M  V30 12 C 3.5628 1.7847 0.0 0
M  V30 13 C 6.0997 2.6091 0.0 0
M  V30 14 N 4.0387 0.3202 0.0 0
M  V30 15 C 6.5756 1.1444 0.0 0
M  V30 16 C 5.5452 0.0000 0.0 0
M  V30 17 C 7.3327 6.9735 0.0 0
M  V30 18 C 8.8727 6.9735 0.0 0
M  V30 19 C 6.5626 8.3072 0.0 0
M  V30 20 C 9.6427 8.3072 0.0 0
M  V30 21 C 7.3327 9.6408 0.0 0
M  V30 22 N 8.8727 9.6408 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 2 12
M  V30 4 2 3 4
M  V30 5 1 3 10
M  V30 6 1 5 20
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 11
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[5-[(2-chloro-4-pyridinyl)thio]-4-(2-fluoro-3-pyridinyl)...
C21H21ClFN3O2S2
1138034-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.3159 5.7153 0.0 0
M  V30 2 F 8.4279 1.7288 0.0 0
M  V30 3 C 9.6185 6.8425 0.0 0
M  V30 4 N 10.9522 6.0725 0.0 0
M  V30 5 C 12.2860 6.8425 0.0 0
M  V30 6 C 10.9522 4.5324 0.0 0
M  V30 7 O 13.6196 6.0725 0.0 0
M  V30 8 O 12.2860 8.3825 0.0 0
M  V30 9 C 14.9533 6.8425 0.0 0
M  V30 10 C 14.1833 8.1761 0.0 0
M  V30 11 C 16.2870 7.6125 0.0 0
M  V30 12 C 15.7233 5.5087 0.0 0
M  V30 13 Cl 0.0000 8.8510 0.0 0
M  V30 14 C 6.6175 4.2206 0.0 0
M  V30 15 C 5.8475 5.5542 0.0 0
M  V30 16 C 8.1239 4.5408 0.0 0
M  V30 17 S 6.8779 6.6988 0.0 0
M  V30 18 C 8.2849 6.0725 0.0 0
M  V30 19 C 5.9911 2.8138 0.0 0
M  V30 20 C 6.8964 1.5679 0.0 0
M  V30 21 C 4.4594 2.6527 0.0 0
M  V30 22 N 6.2699 0.1609 0.0 0
M  V30 23 C 3.8331 1.2459 0.0 0
M  V30 24 C 4.7383 0.0000 0.0 0
M  V30 25 C 3.6894 7.1221 0.0 0
M  V30 26 C 2.1579 7.2832 0.0 0
M  V30 27 C 4.5947 8.3680 0.0 0
M  V30 28 C 1.5316 8.6900 0.0 0
M  V30 29 C 3.9683 9.7750 0.0 0
M  V30 30 N 2.4368 9.9359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 25
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 28
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 14 19
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138034-36-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138034-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8828014
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 104 tert-butyl
({5-[(2-chloropyridin-4-yl)thio]-4-(2-fluoropyridin-3-yl)thiophen-2-yl}methyl)methylcarbamate
In the same manner as in Reference Example 99 and using
5-[(2-chloropyridin-4-yl)thio]-4-(2-fluoropyridin-3-yl)thiophene-2-carbaldehyde
(264 mg) as a starting material and 40% methylamine-methanol solution
(0.772 mL), sodium borohydride (143 mg) and di-tert-butyl bicarbonate
(0.237 mL), the title compound was obtained as a colorless oil (317 mg,
yield 90%). 1H-NMR (CDCl3) &#x03B4; : 1.50 (9H, s), 2.96 (3H, s), 4.60
(2H, brs), 6.82 (1H, dd, J=5.3, 1.5 Hz), 6.90-6.93 (1H, m), 7.15-7.24
(2H, m), 7.68-7.77 (1H, m), 8.14 (1H, d, J=5.3 Hz), 8.18-8.23 (1H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME400 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 5-[(3-bromophenyl)thio]-1-(2-chlorophenyl)-, e...
C18H14BrClN2O2S
1138037-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 5.6398 0.0 0
M  V30 2 Cl 9.1262 2.1049 0.0 0
M  V30 3 C 9.7758 7.3148 0.0 0
M  V30 4 O 11.1826 6.6885 0.0 0
M  V30 5 O 9.6147 8.8465 0.0 0
M  V30 6 C 12.4284 7.5937 0.0 0
M  V30 7 C 13.8354 6.9674 0.0 0
M  V30 8 Br 0.0000 8.3071 0.0 0
M  V30 9 N 7.0652 4.3938 0.0 0
M  V30 10 C 6.1600 5.6398 0.0 0
M  V30 11 N 8.5299 4.8698 0.0 0
M  V30 12 C 7.0652 6.8856 0.0 0
M  V30 13 C 8.5299 6.4098 0.0 0
M  V30 14 C 6.5894 2.9292 0.0 0
M  V30 15 C 7.6198 1.7847 0.0 0
M  V30 16 C 5.0829 2.6091 0.0 0
M  V30 17 C 7.1439 0.3202 0.0 0
M  V30 18 C 4.6071 1.1444 0.0 0
M  V30 19 C 5.6376 0.0000 0.0 0
M  V30 20 C 3.8500 6.9734 0.0 0
M  V30 21 C 2.3100 6.9734 0.0 0
M  V30 22 C 4.6200 8.3071 0.0 0
M  V30 23 C 1.5400 8.3071 0.0 0
M  V30 24 C 3.8500 9.6407 0.0 0
M  V30 25 C 2.3100 9.6407 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 23
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(3-Bromophenyl)thio]-1-(2-chlorophenyl)-N-methyl-1H-pyrazole-3-carboxamide
C17H13BrClN3OS
1138037-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.8085 5.6398 0.0 0
M  V30 2 Cl 3.3024 2.1049 0.0 0
M  V30 3 C 2.6528 7.3149 0.0 0
M  V30 4 N 1.2459 6.6886 0.0 0
M  V30 5 O 2.8137 8.8466 0.0 0
M  V30 6 C 0.0000 7.5938 0.0 0
M  V30 7 Br 12.4285 8.3071 0.0 0
M  V30 8 N 5.3632 4.3938 0.0 0
M  V30 9 C 6.2684 5.6398 0.0 0
M  V30 10 N 3.8987 4.8698 0.0 0
M  V30 11 C 5.3632 6.8857 0.0 0
M  V30 12 C 3.8987 6.4098 0.0 0
M  V30 13 C 5.8391 2.9292 0.0 0
M  V30 14 C 4.8087 1.7847 0.0 0
M  V30 15 C 7.3455 2.6091 0.0 0
M  V30 16 C 5.2845 0.3202 0.0 0
M  V30 17 C 7.8214 1.1444 0.0 0
M  V30 18 C 6.7910 0.0000 0.0 0
M  V30 19 C 8.5785 6.9735 0.0 0
M  V30 20 C 10.1185 6.9735 0.0 0
M  V30 21 C 7.8085 8.3071 0.0 0
M  V30 22 C 10.8885 8.3071 0.0 0
M  V30 23 C 8.5785 9.6408 0.0 0
M  V30 24 C 10.1185 9.6408 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 12
M  V30 7 1 4 6
M  V30 8 1 7 22
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 13
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-21-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-53-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12518945
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 275
5-[(3-bromophenyl)thio]-1-(2-chlorophenyl)-N-methyl-1H-pyrazole-3-carboxamide
To a solution of ethyl
5-[(3-bromophenyl)thio]-1-(2-chlorophenyl)-1H-pyrazole-3-carboxylate (687
mg) in methanol (8 mL) was added 40% methylamine-methanol solution (1.6
mL) at 0&#x00B0; C. The reaction mixture was stirred at room temperature
for 3 hr, and concentrated under reduced pressure. Saturated aqueous
sodium hydrogen carbonate solution was added to the residue, and the
mixture was extracted with ethyl acetate. The extract was washed
successively with saturated aqueous sodium hydrogen carbonate solution,
water and saturated brine, dried over anhydrous sodium sulfate, and
concentrated under reduced pressure to give the title compound as a
yellow oil (600 mg, yield 90%). 1H-NMR (CDCl3) &#x03B4; : 2.97 (3H, d,
J=5.1 Hz), 6.86 (1H, brs), 6.98-7.33 (7H, m), 7.38-7.51 (2H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME401 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 5-[(6-chloro-3-pyridinyl)thio]-1-(2-fluoro-3-m...
C18H15ClFN3O2S
1138037-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.3751 8.6446 0.0 0
M  V30 2 F 2.0608 6.5096 0.0 0
M  V30 3 C 6.2481 3.3420 0.0 0
M  V30 4 O 5.0021 2.4369 0.0 0
M  V30 5 O 7.6549 2.7156 0.0 0
M  V30 6 C 5.1632 0.9052 0.0 0
M  V30 7 C 3.9173 0.0000 0.0 0
M  V30 8 C 0.0000 8.7985 0.0 0
M  V30 9 Cl 13.5351 8.6446 0.0 0
M  V30 10 N 5.0735 7.1499 0.0 0
M  V30 11 C 6.6051 7.3108 0.0 0
M  V30 12 N 4.7534 5.6436 0.0 0
M  V30 13 C 7.2315 5.9041 0.0 0
M  V30 14 C 6.0870 4.8736 0.0 0
M  V30 15 C 4.0431 8.2944 0.0 0
M  V30 16 C 2.5367 7.9741 0.0 0
M  V30 17 C 4.5190 9.7590 0.0 0
M  V30 18 C 1.5063 9.1186 0.0 0
M  V30 19 C 3.4886 10.9035 0.0 0
M  V30 20 C 1.9821 10.5832 0.0 0
M  V30 21 C 8.9151 8.6446 0.0 0
M  V30 22 C 9.6851 9.9783 0.0 0
M  V30 23 C 9.6851 7.3108 0.0 0
M  V30 24 C 11.2251 9.9783 0.0 0
M  V30 25 N 11.2251 7.3108 0.0 0
M  V30 26 C 11.9951 8.6446 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 18
M  V30 10 1 9 26
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 5-[(6-chloro-3-pyridinyl)thio]-1-(2-fluoro-3-methy...
C17H14ClFN4OS
1138037-60-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.3751 7.7394 0.0 0
M  V30 2 F 2.0608 5.6044 0.0 0
M  V30 3 C 6.2481 2.4367 0.0 0
M  V30 4 N 5.0021 1.5317 0.0 0
M  V30 5 O 7.6549 1.8104 0.0 0
M  V30 6 C 5.1632 0.0000 0.0 0
M  V30 7 C 0.0000 7.8933 0.0 0
M  V30 8 Cl 13.5351 7.7394 0.0 0
M  V30 9 N 5.0735 6.2447 0.0 0
M  V30 10 C 6.6051 6.4056 0.0 0
M  V30 11 N 4.7534 4.7384 0.0 0
M  V30 12 C 7.2315 4.9988 0.0 0
M  V30 13 C 6.0870 3.9684 0.0 0
M  V30 14 C 4.0431 7.3892 0.0 0
M  V30 15 C 2.5367 7.0689 0.0 0
M  V30 16 C 4.5190 8.8538 0.0 0
M  V30 17 C 1.5063 8.2134 0.0 0
M  V30 18 C 3.4886 9.9983 0.0 0
M  V30 19 C 1.9821 9.6780 0.0 0
M  V30 20 C 8.9151 7.7394 0.0 0
M  V30 21 C 9.6851 9.0731 0.0 0
M  V30 22 C 9.6851 6.4056 0.0 0
M  V30 23 C 11.2251 9.0731 0.0 0
M  V30 24 N 11.2251 6.4056 0.0 0
M  V30 25 C 11.9951 7.7394 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 7 17
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-37-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-60-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3673361
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 282
5-[(6-chloropyridin-3-yl)thio]-1-(2-fluoro-3-methylphenyl)-N-methyl-1H-pyrazole-3-carboxamide
To a solution of ethyl
5-[(6-chloropyridin-3-yl)thio]-1-(2-fluoro-3-methylphenyl)-1H-pyrazole-3-carboxylate
(988 mg) in methanol (5 mL) was added 40% methylamine-methanol solution
(5 mL) at room temperature. The mixture was stirred for 2 hr, and
concentrated under reduced pressure, and the residue was purified by
silica gel column chromatography (eluent: hexane-ethyl
acetate=4:1&#x2192;1:1) to give the title compound as colorless crystals
(862 mg, yield 90%). 1H-NMR (CDCl3) &#x03B4; : 2.29-2.30 (3H, m), 2.97
(3H, d, J=5.1 Hz), 6.84 (1H, br), 7.06-7.19 (4H, m), 7.29-7.38 (2H, m),
7.99-8.00 (1H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME402 STEP1
$RXN



  3  1
$MOL
1-Bromo-3-[(1E)-2-nitroethenyl]benzene
C8H6BrNO2
115665-95-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 1.5400 0.0 0 VAL=5
M  V30 4 O 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 Br 0.0000 1.5400 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl P-(2-phenylacetyl)phosphonate
C10H13O4P
51463-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 2.3100 2.3100 0.0 0 VAL=5
M  V30 2 C 3.8500 2.3100 0.0 0
M  V30 3 O 0.7700 2.3100 0.0 0
M  V30 4 O 2.3100 0.7700 0.0 0
M  V30 5 O 2.3100 3.8500 0.0 0
M  V30 6 C 4.6200 3.6436 0.0 0
M  V30 7 O 4.6200 0.9762 0.0 0
M  V30 8 C 0.0000 3.6436 0.0 0
M  V30 9 C 0.9764 0.0000 0.0 0
M  V30 10 C 6.1600 3.6436 0.0 0
M  V30 11 C 6.9300 4.9773 0.0 0
M  V30 12 C 6.9300 2.3100 0.0 0
M  V30 13 C 8.4700 4.9773 0.0 0
M  V30 14 C 8.4700 2.3100 0.0 0
M  V30 15 C 9.2400 3.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 6 10
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR,βS)-3-Bromo-N-methyl-β-(nitromethyl)-α-phenylbenzenepropanamide
C17H17BrN2O3
1457935-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.8500 0.0 0 CFG=1
M  V30 2 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 4.0011 6.1600 0.0 0
M  V30 5 N 6.6684 1.5400 0.0 0 VAL=5
M  V30 6 N 2.6673 6.9300 0.0 0
M  V30 7 O 5.3347 6.9300 0.0 0
M  V30 8 O 6.6684 0.0000 0.0 0
M  V30 9 O 8.0021 2.3100 0.0 0
M  V30 10 C 2.6673 8.4700 0.0 0
M  V30 11 Br 10.6694 3.8500 0.0 0
M  V30 12 C 6.6684 4.6200 0.0 0
M  V30 13 C 8.0021 3.8500 0.0 0
M  V30 14 C 6.6684 6.1600 0.0 0
M  V30 15 C 9.3358 4.6200 0.0 0
M  V30 16 C 8.0021 6.9300 0.0 0
M  V30 17 C 9.3358 6.1600 0.0 0
M  V30 18 C 2.6673 3.8500 0.0 0
M  V30 19 C 2.6673 2.3100 0.0 0
M  V30 20 C 1.3336 4.6200 0.0 0
M  V30 21 C 1.3336 1.5400 0.0 0
M  V30 22 C 0.0000 3.8500 0.0 0
M  V30 23 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 12
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 2 5 8
M  V30 10 2 5 9
M  V30 11 1 6 10
M  V30 12 1 11 15
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 115665-95-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51463-66-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1457935-44-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-5014637
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1457935-39-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, dr=>95:5, 74% ee, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalyzed asymmetric Michael reaction of β-aryl-α-ketophosphonates
and nitroalkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guang, Jie; Zhao, John Cong-Gui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(42), 5703-5706

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[2-bromo-4-(2,2-dibromoethenyl)phenoxy]methyl]-α-(methoxyimino...
C19H16Br3NO4
1159342-70-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 2.6674 2.3100 0.0 0
M  V30 4 O 5.3347 0.7700 0.0 0
M  V30 5 O 6.6685 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6685 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 Br 10.6696 6.9300 0.0 0
M  V30 12 C 13.3369 2.3100 0.0 0
M  V30 13 C 14.6705 3.0800 0.0 0
M  V30 14 Br 16.0043 2.3100 0.0 0
M  V30 15 Br 14.6705 4.6200 0.0 0
M  V30 16 C 4.0011 4.6200 0.0 0
M  V30 17 C 5.3347 5.3900 0.0 0
M  V30 18 C 2.6674 5.3900 0.0 0
M  V30 19 C 5.3347 6.9300 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 4.0011 7.7000 0.0 0
M  V30 22 C 9.3358 4.6200 0.0 0
M  V30 23 C 10.6696 5.3900 0.0 0
M  V30 24 C 9.3358 3.0800 0.0 0
M  V30 25 C 12.0032 4.6200 0.0 0
M  V30 26 C 10.6696 2.3100 0.0 0
M  V30 27 C 12.0032 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[2-Bromo-4-(2,2-dibromoethenyl)phenoxy]methyl]-α-(methoxyimino)-N-met...
C19H17Br3N2O3
1159342-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 2.6674 2.3100 0.0 0
M  V30 4 N 5.3347 0.7700 0.0 0
M  V30 5 O 6.6685 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6685 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 Br 10.6696 6.9300 0.0 0
M  V30 12 C 13.3369 2.3100 0.0 0
M  V30 13 C 14.6705 3.0800 0.0 0
M  V30 14 Br 14.6705 4.6200 0.0 0
M  V30 15 Br 16.0043 2.3100 0.0 0
M  V30 16 C 4.0011 4.6200 0.0 0
M  V30 17 C 5.3347 5.3900 0.0 0
M  V30 18 C 2.6674 5.3900 0.0 0
M  V30 19 C 5.3347 6.9300 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 4.0011 7.7000 0.0 0
M  V30 22 C 9.3358 4.6200 0.0 0
M  V30 23 C 10.6696 5.3900 0.0 0
M  V30 24 C 9.3358 3.0800 0.0 0
M  V30 25 C 12.0032 4.6200 0.0 0
M  V30 26 C 10.6696 2.3100 0.0 0
M  V30 27 C 12.0032 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-70-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-71-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14721882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 40: Preparation of
(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
Example 78: Preparation of
(E)-2-(2-((2-bromo-4-(2,2-dibromovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
The procedure of Example 40 was repeated except for using
methyl-(E)-2-(2-((2-bromo-4-(2,2-dibromovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate(0.562g,
1mmol) obtained in Example 77 instead of
methyl-(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate
to obtain the title compound (0.505g, 90%). 1H-NMR(CDCl3, TMS)δ(ppm):
2.93(d, 3H), 3.98(s, 3H), 5.02(s, 2H), 6.74(s. 1H), 6.29-7.67(m, 8H) MS :
557.8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of methoxyiminobenzene compounds as agrochemical fungicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joo-Kyung; Kim, Hyung-Ho; Hwang, In-Cheon; Nam, Ho-Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009072837 A2 2009-06-11

$RFMT $RIREG SCHEME405 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[4-(2,2-dibromoethenyl)-2-ethoxyphenoxy]methyl]-α-(methoxyimin...
C21H21Br2NO5
1159342-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6695 6.1601 0.0 0
M  V30 2 C 9.3357 6.9301 0.0 0
M  V30 3 N 12.0032 6.9301 0.0 0
M  V30 4 O 9.3357 8.4701 0.0 0
M  V30 5 O 8.0021 6.1601 0.0 0
M  V30 6 O 13.3369 6.1601 0.0 0
M  V30 7 C 10.6695 9.2401 0.0 0
M  V30 8 C 14.6705 6.9301 0.0 0
M  V30 9 C 8.0021 4.6201 0.0 0
M  V30 10 O 6.6684 3.8500 0.0 0
M  V30 11 O 4.0010 2.3100 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 6.9301 0.0 0
M  V30 15 C 1.3337 8.4701 0.0 0
M  V30 16 Br 2.6673 9.2401 0.0 0
M  V30 17 Br 0.0000 9.2401 0.0 0
M  V30 18 C 10.6695 4.6201 0.0 0
M  V30 19 C 9.3357 3.8500 0.0 0
M  V30 20 C 12.0032 3.8500 0.0 0
M  V30 21 C 9.3357 2.3100 0.0 0
M  V30 22 C 12.0032 2.3100 0.0 0
M  V30 23 C 10.6695 1.5400 0.0 0
M  V30 24 C 5.3348 4.6201 0.0 0
M  V30 25 C 4.0010 3.8500 0.0 0
M  V30 26 C 5.3348 6.1601 0.0 0
M  V30 27 C 2.6673 4.6201 0.0 0
M  V30 28 C 4.0010 6.9301 0.0 0
M  V30 29 C 2.6673 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 29
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[4-(2,2-Dibromoethenyl)-2-ethoxyphenoxy]methyl]-α-(methoxyimino)-N-me...
C21H22Br2N2O4
1159342-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6695 6.1601 0.0 0
M  V30 2 C 9.3357 6.9301 0.0 0
M  V30 3 N 12.0032 6.9301 0.0 0
M  V30 4 N 9.3357 8.4701 0.0 0
M  V30 5 O 8.0021 6.1601 0.0 0
M  V30 6 O 13.3369 6.1601 0.0 0
M  V30 7 C 10.6695 9.2401 0.0 0
M  V30 8 C 14.6705 6.9301 0.0 0
M  V30 9 C 8.0021 4.6201 0.0 0
M  V30 10 O 6.6684 3.8500 0.0 0
M  V30 11 O 4.0010 2.3100 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 6.9301 0.0 0
M  V30 15 C 1.3337 8.4701 0.0 0
M  V30 16 Br 2.6673 9.2401 0.0 0
M  V30 17 Br 0.0000 9.2401 0.0 0
M  V30 18 C 10.6695 4.6201 0.0 0
M  V30 19 C 9.3357 3.8500 0.0 0
M  V30 20 C 12.0032 3.8500 0.0 0
M  V30 21 C 9.3357 2.3100 0.0 0
M  V30 22 C 12.0032 2.3100 0.0 0
M  V30 23 C 10.6695 1.5400 0.0 0
M  V30 24 C 5.3348 4.6201 0.0 0
M  V30 25 C 4.0010 3.8500 0.0 0
M  V30 26 C 5.3348 6.1601 0.0 0
M  V30 27 C 2.6673 4.6201 0.0 0
M  V30 28 C 4.0010 6.9301 0.0 0
M  V30 29 C 2.6673 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 29
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-77-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-78-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11986534
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 40: Preparation of
(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
Example 84: Preparation of
(E)-2-(2-((4-(2,2-dibromovinyl)-2-ethoxyphenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
The procedure of Example 40 was repeated except for using
methyl-(E)-2-(2-((4-(2,2-dibromovinyl)-2-ethoxyphenoxy)methyl)phenyl)-2-methoxyiminoacetate(0.527g,
1mmol) obtained in Example 83 instead of
methyl-(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate
to obtain the title compound (0.474g, 90%). 1H-NMR(CDCl3, TMS)δ(ppm):
1.42(t, 3H), 3.90(s, 3H), 3.98(m, 2H), 4.03(s, 3H), 5.02(s, 2H),
6.84-7.47(m, 8H) MS : 524.0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of methoxyiminobenzene compounds as agrochemical fungicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joo-Kyung; Kim, Hyung-Ho; Hwang, In-Cheon; Nam, Ho-Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009072837 A2 2009-06-11

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[4-[(3-chloropyrido[2,3-b]pyrazin-8-yl)oxy]-2-fluoropheny...
C18H16ClFN4O3
1163720-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.5736 4.0011 0.0 0
M  V30 2 Cl 17.5036 5.3347 0.0 0
M  V30 3 F 5.9536 6.6685 0.0 0
M  V30 4 N 4.4136 4.0011 0.0 0
M  V30 5 C 3.6436 2.6674 0.0 0
M  V30 6 O 2.1036 2.6674 0.0 0
M  V30 7 O 4.4136 1.3336 0.0 0
M  V30 8 C 1.3336 1.3336 0.0 0
M  V30 9 C 0.0000 2.1036 0.0 0
M  V30 10 C 0.5636 0.0000 0.0 0
M  V30 11 C 2.6673 0.5636 0.0 0
M  V30 12 C 12.8836 5.3347 0.0 0
M  V30 13 C 11.3436 5.3347 0.0 0
M  V30 14 C 13.6536 6.6685 0.0 0
M  V30 15 N 13.6536 4.0011 0.0 0
M  V30 16 C 10.5736 6.6685 0.0 0
M  V30 17 N 12.8836 8.0021 0.0 0
M  V30 18 N 15.1936 6.6685 0.0 0
M  V30 19 C 15.1936 4.0011 0.0 0
M  V30 20 C 11.3436 8.0021 0.0 0
M  V30 21 C 15.9636 5.3347 0.0 0
M  V30 22 C 9.0336 4.0011 0.0 0
M  V30 23 C 8.2636 5.3347 0.0 0
M  V30 24 C 8.2636 2.6674 0.0 0
M  V30 25 C 6.7236 5.3347 0.0 0
M  V30 26 C 6.7236 2.6674 0.0 0
M  V30 27 C 5.9536 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 22
M  V30 3 1 2 21
M  V30 4 1 3 25
M  V30 5 1 4 5
M  V30 6 1 4 27
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 20
M  V30 22 2 18 21
M  V30 23 1 19 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-fluoro-4-[[3-(methylamino)pyrido[2,3-b]pyrazin-8-yl]ox...
C19H20FN5O3
1163720-98-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.5736 4.0011 0.0 0
M  V30 2 N 17.5036 5.3347 0.0 0
M  V30 3 C 18.2736 4.0011 0.0 0
M  V30 4 F 5.9536 6.6685 0.0 0
M  V30 5 N 4.4136 4.0011 0.0 0
M  V30 6 C 3.6436 2.6674 0.0 0
M  V30 7 O 2.1036 2.6674 0.0 0
M  V30 8 O 4.4136 1.3336 0.0 0
M  V30 9 C 1.3336 1.3336 0.0 0
M  V30 10 C 2.6673 0.5636 0.0 0
M  V30 11 C 0.5636 0.0000 0.0 0
M  V30 12 C 0.0000 2.1036 0.0 0
M  V30 13 C 12.8836 5.3347 0.0 0
M  V30 14 C 11.3436 5.3347 0.0 0
M  V30 15 C 13.6536 6.6685 0.0 0
M  V30 16 N 13.6536 4.0011 0.0 0
M  V30 17 C 10.5736 6.6685 0.0 0
M  V30 18 N 15.1936 6.6685 0.0 0
M  V30 19 N 12.8836 8.0021 0.0 0
M  V30 20 C 15.1936 4.0011 0.0 0
M  V30 21 C 11.3436 8.0021 0.0 0
M  V30 22 C 15.9636 5.3347 0.0 0
M  V30 23 C 9.0336 4.0011 0.0 0
M  V30 24 C 8.2636 5.3347 0.0 0
M  V30 25 C 8.2636 2.6674 0.0 0
M  V30 26 C 6.7236 5.3347 0.0 0
M  V30 27 C 6.7236 2.6674 0.0 0
M  V30 28 C 5.9536 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 22
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 1 5 28
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1163720-94-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1163720-98-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6309525
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Hinge Binder Improves Activity and Pharmacokinetic Properties of
BRAF Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zambon, Alfonso; Menard, Delphine; Suijkerbuijk, Bart M. J. M.;
Niculescu-Duvaz, Ion; Whittaker, Steven; Niculescu-Duvaz, Dan; Nourry,
Arnaud; Davies, Lawrence; Manne, Helen A.; Lopes, Filipa; Preece,
Natasha; Hedley, Douglas; Ogilvie, Lesley M.; Kirk, Ruth; Marais,
Richard; Springer, Caroline J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(15), 5639-5655

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[4-[(3-chloropyrido[2,3-b]pyrazin-8-yl)oxy]-2-fluoropheny...
C18H16ClFN4O3
1163720-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.5736 4.0011 0.0 0
M  V30 2 Cl 17.5036 5.3347 0.0 0
M  V30 3 F 5.9536 6.6685 0.0 0
M  V30 4 N 4.4136 4.0011 0.0 0
M  V30 5 C 3.6436 2.6674 0.0 0
M  V30 6 O 2.1036 2.6674 0.0 0
M  V30 7 O 4.4136 1.3336 0.0 0
M  V30 8 C 1.3336 1.3336 0.0 0
M  V30 9 C 0.0000 2.1036 0.0 0
M  V30 10 C 0.5636 0.0000 0.0 0
M  V30 11 C 2.6673 0.5636 0.0 0
M  V30 12 C 12.8836 5.3347 0.0 0
M  V30 13 C 11.3436 5.3347 0.0 0
M  V30 14 C 13.6536 6.6685 0.0 0
M  V30 15 N 13.6536 4.0011 0.0 0
M  V30 16 C 10.5736 6.6685 0.0 0
M  V30 17 N 12.8836 8.0021 0.0 0
M  V30 18 N 15.1936 6.6685 0.0 0
M  V30 19 C 15.1936 4.0011 0.0 0
M  V30 20 C 11.3436 8.0021 0.0 0
M  V30 21 C 15.9636 5.3347 0.0 0
M  V30 22 C 9.0336 4.0011 0.0 0
M  V30 23 C 8.2636 5.3347 0.0 0
M  V30 24 C 8.2636 2.6674 0.0 0
M  V30 25 C 6.7236 5.3347 0.0 0
M  V30 26 C 6.7236 2.6674 0.0 0
M  V30 27 C 5.9536 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 22
M  V30 3 1 2 21
M  V30 4 1 3 25
M  V30 5 1 4 5
M  V30 6 1 4 27
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 20
M  V30 22 2 18 21
M  V30 23 1 19 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-fluoro-4-[[3-(methylamino)pyrido[2,3-b]pyrazin-8-yl]ox...
C19H20FN5O3
1163720-98-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.5736 4.0011 0.0 0
M  V30 2 N 17.5036 5.3347 0.0 0
M  V30 3 C 18.2736 4.0011 0.0 0
M  V30 4 F 5.9536 6.6685 0.0 0
M  V30 5 N 4.4136 4.0011 0.0 0
M  V30 6 C 3.6436 2.6674 0.0 0
M  V30 7 O 2.1036 2.6674 0.0 0
M  V30 8 O 4.4136 1.3336 0.0 0
M  V30 9 C 1.3336 1.3336 0.0 0
M  V30 10 C 2.6673 0.5636 0.0 0
M  V30 11 C 0.5636 0.0000 0.0 0
M  V30 12 C 0.0000 2.1036 0.0 0
M  V30 13 C 12.8836 5.3347 0.0 0
M  V30 14 C 11.3436 5.3347 0.0 0
M  V30 15 C 13.6536 6.6685 0.0 0
M  V30 16 N 13.6536 4.0011 0.0 0
M  V30 17 C 10.5736 6.6685 0.0 0
M  V30 18 N 15.1936 6.6685 0.0 0
M  V30 19 N 12.8836 8.0021 0.0 0
M  V30 20 C 15.1936 4.0011 0.0 0
M  V30 21 C 11.3436 8.0021 0.0 0
M  V30 22 C 15.9636 5.3347 0.0 0
M  V30 23 C 9.0336 4.0011 0.0 0
M  V30 24 C 8.2636 5.3347 0.0 0
M  V30 25 C 8.2636 2.6674 0.0 0
M  V30 26 C 6.7236 5.3347 0.0 0
M  V30 27 C 6.7236 2.6674 0.0 0
M  V30 28 C 5.9536 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 22
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 1 5 28
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1163720-94-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1163720-98-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1436606
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Tert-butyl
2-fluoro-4-(2-morpholinopyrido[2,3-b]pyrazin-8-yloxy)phenyl-carbamate.
Method D6: Morpholine (500 μL, excess) was added to tert-butyl
4-(2-chloropyrido[2,3-b]pyrazin-8-yloxy)-2-fluorophenylcarbamate (68 mg,
174 μmol) under argon and the yellow solution was stirred at RT for 45
min. Next, H2O (10 ml) was added and the precipitated yellow solid was
filtered. Tert-butyl
2-fluoro-4-(3-(methylamino)pyrido[2,3-b]pyrazin-8-yloxy)phenylcarbamate.
Method D6 was used with methylamine and Tert-butyl
4-(3-chloropyrido[2,3-b]pyrazin-8-yloxy)-2-fluorophenylcarbamate to give
the title compound as a white solid. Yield: 80 mg (90%). 1H-NMR
(DMSO-d6), δ (ppm), J (Hz): 1.47 (s, 9H, tert-Bu), 2.95 (d, J=4.7, 3H,
NHCH3), 6.62 (d, J=5.4, 1H, Hpy), 6.97 (m, 1H, Harom), 7.18 (m, 1H,
Harom), 7.61 (m, 1H, Harom), 8.03 (br q, J=4.7, 1H, NHCH3), 8.30 (s, 1H,
Harom), 8.55 (d, J=5.4, 1H, Hpy), 8.97 (s, 1H, NH); 13C-NMR (DMSO-d6), δ
(ppm), J (Hz): 27.1, 28.0, 79.4, 105.6, 108.3 (d, JFC=23.0), 115.8 (d,
JFC=2.9), 122.3, 123.4 (d, JFC=11.9), 125.8 (br), 139.7 (br), 151.3 (d,
JFC =10.0), 152.8, 153.2, 153.4, 154.7 (d, JFC =248), 155.3, 160.1;
19F-NMR (DMSO-d6), δ (ppm): -120.0; LC-MS (m/z): 386.1 (M+H, 100),
rt=3.13 min.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrido[2,3-b]pyrazine-8-substituted compounds as RAF
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Springer, Caroline Joy; Niculescu-Duvaz, Dan; Niculescu-Duvaz, Ion;
Marais, Richard; Suijkerbuijk, Bartholomeus Marinus Josephus Marie;
Zambon, Alfonso; Nourry, Arnaud; Menard, Delphine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009077766 A1 2009-06-25

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-1-[(4Z)-4,5-dihydro-5-oxo-4-(phenylmethylene)-2-oxa...
C17H20N2O4
116908-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.7844 2.9016 0.0 0
M  V30 2 O 4.4596 0.0000 0.0 0
M  V30 3 C 8.0870 4.0287 0.0 0 CFG=2
M  V30 4 N 9.4208 3.2587 0.0 0
M  V30 5 C 8.0870 5.5687 0.0 0
M  V30 6 C 10.7544 4.0287 0.0 0
M  V30 7 O 12.0881 3.2587 0.0 0
M  V30 8 O 10.7544 5.5687 0.0 0
M  V30 9 C 13.4218 4.0287 0.0 0
M  V30 10 C 12.6518 5.3624 0.0 0
M  V30 11 C 14.7556 4.7987 0.0 0
M  V30 12 C 14.1918 2.6950 0.0 0
M  V30 13 C 4.3159 2.7406 0.0 0
M  V30 14 N 5.3465 3.8850 0.0 0
M  V30 15 C 5.0859 1.4070 0.0 0
M  V30 16 C 6.7533 3.2587 0.0 0
M  V30 17 O 6.5924 1.7271 0.0 0
M  V30 18 C 2.1580 4.3085 0.0 0
M  V30 19 C 0.6265 4.4695 0.0 0
M  V30 20 C 3.0633 5.5544 0.0 0
M  V30 21 C 0.0000 5.8764 0.0 0
M  V30 22 C 2.4368 6.9612 0.0 0
M  V30 23 C 0.9052 7.1223 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 1 18
M  V30 3 2 2 15
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=3
M  V30 6 1 3 16
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylalaninamide, N-[(1,1-dimethylethoxy)carbonyl]-L-alanyl-α,β-didehydro-N-...
C18H25N3O4
124194-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0012 0.0 0
M  V30 2 C 3.0801 4.0012 0.0 0
M  V30 3 N 5.3901 5.3348 0.0 0
M  V30 4 C 5.3901 2.6673 0.0 0
M  V30 5 C 6.9302 5.3348 0.0 0
M  V30 6 N 4.6201 1.3337 0.0 0
M  V30 7 O 6.9302 2.6673 0.0 0
M  V30 8 C 7.7002 6.6685 0.0 0 CFG=2
M  V30 9 O 7.7002 4.0012 0.0 0
M  V30 10 C 5.3901 0.0000 0.0 0
M  V30 11 N 9.2402 6.6685 0.0 0
M  V30 12 C 6.9302 8.0023 0.0 0
M  V30 13 C 10.0102 8.0023 0.0 0
M  V30 14 O 11.5503 8.0023 0.0 0
M  V30 15 O 9.2402 9.3360 0.0 0
M  V30 16 C 12.3203 9.3360 0.0 0
M  V30 17 C 10.9866 10.1060 0.0 0
M  V30 18 C 13.0903 10.6697 0.0 0
M  V30 19 C 13.6539 8.5660 0.0 0
M  V30 20 C 2.3101 5.3348 0.0 0
M  V30 21 C 3.0801 6.6685 0.0 0
M  V30 22 C 0.7700 5.3348 0.0 0
M  V30 23 C 2.3101 8.0023 0.0 0
M  V30 24 C 0.0000 6.6685 0.0 0
M  V30 25 C 0.7700 8.0023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 116908-50-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 124194-24-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19448094
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A general method for preparation of N-Boc-protected or N-Fmoc-protected
α,β-didehydropeptide building blocks and their use in the solid-phase
peptide synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wolczanski, Grzegorz; Lisowski, Marek
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Peptide Science (2018), 24(8-9), n/a

$RFMT $RIREG SCHEME408 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Sulfoxonium, (2-methoxy-2-oxo-1-phenylethyl)dimethyl-, inner salt
C11H14O3S
1179348-58-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0 CHG=-1
M  V30 2 C 5.3347 3.8500 0.0 0
M  V30 3 S 4.0011 1.5400 0.0 0 CHG=1 VAL=5
M  V30 4 O 6.6685 3.0800 0.0 0
M  V30 5 O 5.3347 5.3900 0.0 0
M  V30 6 C 4.0011 0.0000 0.0 0
M  V30 7 C 2.4611 1.5400 0.0 0
M  V30 8 O 5.5411 1.5400 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 5.3900 0.0 0
M  V30 12 C 1.3336 3.0800 0.0 0
M  V30 13 C 1.3336 6.1600 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 15 C 0.0000 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 2 3 8
M  V30 9 1 4 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-5-phenyl-2-thioxo-4-thiazolidinone
C10H9NOS2
14673-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.1864 0.0000 0.0 0
M  V30 2 C 0.0000 1.0353 0.0 0
M  V30 3 S 0.0000 4.3856 0.0 0
M  V30 4 C 3.6156 2.7104 0.0 0
M  V30 5 C 2.7104 1.4645 0.0 0
M  V30 6 S 2.7104 3.9564 0.0 0
M  V30 7 N 1.2459 1.9404 0.0 0
M  V30 8 C 1.2459 3.4804 0.0 0
M  V30 9 C 5.1556 2.7104 0.0 0
M  V30 10 C 5.9256 1.3768 0.0 0
M  V30 11 C 5.9256 4.0442 0.0 0
M  V30 12 C 7.4656 1.3768 0.0 0
M  V30 13 C 7.4656 4.0442 0.0 0
M  V30 14 C 8.2357 2.7104 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 7
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1179348-58-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14673-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35442340
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst- and additive-free syntheses of rhodanine and S-alkyl
dithiocarbamate derivatives from sulfoxonium ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharma, Ajay; Pandey, Satyendra Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2023), 59(11),
1509-1512

$RFMT $RIREG SCHEME409 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatoic anhydride
C8H5NO3
118-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-2-(4-methoxyphenyl)-3-methyl-4(1H)-quinazolinone
C16H16N2O2
74375-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 0.0000 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 O 11.5500 2.6674 0.0 0
M  V30 4 C 12.3200 4.0011 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 N 4.6200 4.0011 0.0 0
M  V30 7 N 4.6200 1.3338 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 0.7700 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 7.7000 1.3338 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 9.2400 1.3338 0.0 0
M  V30 20 C 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 15
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 10
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-48-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 74375-07-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21430127
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13590-82-4
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cerium (IV) sulfate: A highly efficient reusable heterogeneous catalyst
for the one-pot synthesis of 2,3-dihydroquinazolin-4(1H)-ones under
solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Davoodnia, Abolghasem; Khashi, Maryam; Tavakoli-hoseini, Niloofar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Cuihua Xuebao (2014), 35(7), 1054-1058

$RFMT $RIREG SCHEME410 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatoic anhydride
C8H5NO3
118-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Methyl-2-oxo-3-phenyl-2H-1-benzopyran-6-carboxaldehyde
C17H12O3
2226098-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 0.0000 0.0 0
M  V30 2 O 2.6673 1.5400 0.0 0
M  V30 3 C 10.6697 4.6201 0.0 0
M  V30 4 O 12.0033 3.8501 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 C 6.6685 3.8501 0.0 0
M  V30 7 O 5.3348 1.5400 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 8.0022 4.6201 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 17 C 2.6673 6.1601 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 19 C 1.3337 6.9302 0.0 0
M  V30 20 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 11
M  V30 3 2 3 4
M  V30 4 1 3 14
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-3-methyl-2-(8-methyl-2-oxo-3-phenyl-2H-1-benzopyran-6-yl)-4(1H)-q...
C25H20N2O3
2226098-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 9.2402 0.0 0
M  V30 2 O 12.0033 7.7002 0.0 0
M  V30 3 C 2.6673 6.9302 0.0 0
M  V30 4 O 0.0000 5.3901 0.0 0
M  V30 5 C 8.0022 5.3901 0.0 0
M  V30 6 C 8.0022 6.9302 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 C 9.3358 4.6201 0.0 0
M  V30 9 C 6.6685 7.7002 0.0 0
M  V30 10 O 9.3358 7.7002 0.0 0
M  V30 11 C 5.3348 5.3901 0.0 0
M  V30 12 C 10.6697 5.3901 0.0 0
M  V30 13 C 5.3348 6.9302 0.0 0
M  V30 14 C 10.6697 6.9302 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 N 4.0010 3.0801 0.0 0
M  V30 17 N 2.6673 5.3901 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 1.3337 3.0801 0.0 0
M  V30 21 C 2.6673 0.7700 0.0 0
M  V30 22 C 0.0000 2.3101 0.0 0
M  V30 23 C 1.3337 0.0000 0.0 0
M  V30 24 C 0.0000 0.7700 0.0 0
M  V30 25 C 12.0033 4.6201 0.0 0
M  V30 26 C 13.3370 5.3901 0.0 0
M  V30 27 C 12.0033 3.0801 0.0 0
M  V30 28 C 14.6707 4.6201 0.0 0
M  V30 29 C 13.3370 2.3101 0.0 0
M  V30 30 C 14.6707 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 14
M  V30 3 1 3 17
M  V30 4 2 4 19
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 12 25
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 18 21
M  V30 24 1 19 20
M  V30 25 2 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-48-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2226098-70-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2226098-79-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29542958
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM acetic acid also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of coumarin-dihydroquinazolinone analogs as niacin receptor 1
agonist with in-vivo anti-obesity efficacy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, L. Ravithej; Kumar, Ajeet; Upadhyay, Akanksha; Gupta, Sampa;
Palanati, Gopala Reddy; Sikka, Kamakshi; Siddiqi, Mohammad Imran; Yadav,
Prem N.; Sashidhara, Koneni V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 152208-222

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3,5-dinitrobenzoic acid
C7H3ClN2O6
118-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 4.6201 0.0 0
M  V30 3 O 1.3337 6.9301 0.0 0
M  V30 4 Cl 4.0011 6.9301 0.0 0
M  V30 5 N 6.6686 5.3901 0.0 0 VAL=5
M  V30 6 O 6.6686 6.9301 0.0 0
M  V30 7 O 8.0022 4.6201 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 O 5.3348 0.0000 0.0 0
M  V30 10 O 2.6675 0.0000 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 4.0011 5.3901 0.0 0
M  V30 13 C 2.6675 3.0800 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 4.0011 2.3100 0.0 0
M  V30 16 C 5.3348 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(methylamino)-3,5-dinitro-
C8H7N3O6
64732-83-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 2.3101 0.0 0
M  V30 2 C 0.0000 3.0801 0.0 0
M  V30 3 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 7 O 1.3337 6.9302 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 6.6687 5.3901 0.0 0
M  V30 10 O 8.0023 4.6201 0.0 0
M  V30 11 O 6.6687 6.9302 0.0 0
M  V30 12 C 2.6675 3.0801 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 4.0012 5.3901 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-97-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 64732-83-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1799481
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM G. 4-Methylamino-3,5-dinitrobenzene-carboxylic acid 25.0 g (101 mmol)
4-chloro-3,5-dinitrobenzene-carboxylic acid were slowly added to 120 ml
aqueous methylamine (40 %) and the mixture was heated to reflux. After 1
h, the mixture was cooled down and evaporated to dryness. The residue was
dissolved in water and the pH was adjusted to pH ~ 5 by adding 6N
hydrochloric acid. The precipitate was collected, washed with water and
dried to yield 21.6 g (90 %) of the title compound as a yellow solid.
(m.p. 184-188 °C)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 7-substituted benzimidazoles as inhibitors of gastric acid
secretion
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chiesa, M. Vittoria; Palmer, Andreas; Brehm, Christof; Simon,
Wolfgang-Alexander; Postius, Stefan; Kromer, Wolfgang; Zimmermann, Peter
Jan; Buhr, Wilm
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005111000 A1 2005-11-24

$RFMT $RIREG SCHEME412 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(1S)-2-[(2R)-4-Benzoyl-2-methyl-1-piperazinyl]-1-methyl-2-oxoethoxy]-3-met...
C24H26N4O5
1190841-60-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 2.6507 0.0 0
M  V30 2 C 8.0022 3.4207 0.0 0 CFG=1
M  V30 3 C 9.3359 2.6507 0.0 0
M  V30 4 C 8.0022 4.9607 0.0 0
M  V30 5 O 9.3359 1.1107 0.0 0
M  V30 6 C 4.7114 0.0000 0.0 0
M  V30 7 C 1.3337 5.7307 0.0 0
M  V30 8 O 0.0000 4.9607 0.0 0
M  V30 9 O 1.3337 7.2707 0.0 0
M  V30 10 C 12.0033 1.1107 0.0 0
M  V30 11 C 14.6706 5.7307 0.0 0
M  V30 12 O 14.6706 7.2707 0.0 0
M  V30 13 C 4.0011 2.6507 0.0 0
M  V30 14 C 2.6675 3.4207 0.0 0
M  V30 15 C 5.3348 3.4207 0.0 0
M  V30 16 C 3.6809 1.1444 0.0 0
M  V30 17 C 2.6675 4.9607 0.0 0
M  V30 18 N 1.5229 2.3903 0.0 0
M  V30 19 C 5.3348 4.9607 0.0 0
M  V30 20 N 2.1494 0.9835 0.0 0
M  V30 21 C 4.0011 5.7307 0.0 0
M  V30 22 N 10.6695 3.4207 0.0 0
M  V30 23 C 12.0033 2.6507 0.0 0 CFG=2
M  V30 24 C 10.6695 4.9607 0.0 0
M  V30 25 C 13.3370 3.4207 0.0 0
M  V30 26 C 12.0033 5.7307 0.0 0
M  V30 27 N 13.3370 4.9607 0.0 0
M  V30 28 C 16.0043 4.9607 0.0 0
M  V30 29 C 17.3381 5.7307 0.0 0
M  V30 30 C 16.0043 3.4207 0.0 0
M  V30 31 C 18.6717 4.9607 0.0 0
M  V30 32 C 17.3381 2.6507 0.0 0
M  V30 33 C 18.6717 3.4207 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 17
M  V30 11 1 23 10 CFG=1
M  V30 12 2 11 12
M  V30 13 1 11 27
M  V30 14 1 11 28
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 13 16
M  V30 18 2 14 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-[(1S)-2-[(2R)-4-Benzoyl-2-methyl-1-piperazinyl]-1-methyl-2-oxoethoxy]-N,3-d...
C25H29N5O4
1190841-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 5.3901 0.0 0
M  V30 2 C 8.0023 4.6201 0.0 0 CFG=1
M  V30 3 C 9.3359 5.3901 0.0 0
M  V30 4 C 8.0023 3.0800 0.0 0
M  V30 5 O 9.3359 6.9301 0.0 0
M  V30 6 C 4.7114 8.0408 0.0 0
M  V30 7 C 1.3337 2.3100 0.0 0
M  V30 8 N 1.3337 0.7700 0.0 0
M  V30 9 O 0.0000 3.0800 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 11 C 12.0034 6.9301 0.0 0
M  V30 12 C 14.6707 2.3100 0.0 0
M  V30 13 O 14.6707 0.7700 0.0 0
M  V30 14 C 4.0011 5.3901 0.0 0
M  V30 15 C 2.6675 4.6201 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 3.6810 6.8964 0.0 0
M  V30 18 C 2.6675 3.0800 0.0 0
M  V30 19 N 1.5229 5.6505 0.0 0
M  V30 20 C 5.3348 3.0800 0.0 0
M  V30 21 N 2.1494 7.0573 0.0 0
M  V30 22 C 4.0011 2.3100 0.0 0
M  V30 23 N 10.6696 4.6201 0.0 0
M  V30 24 C 12.0034 5.3901 0.0 0 CFG=2
M  V30 25 C 10.6696 3.0800 0.0 0
M  V30 26 C 13.3371 4.6201 0.0 0
M  V30 27 C 12.0034 2.3100 0.0 0
M  V30 28 N 13.3371 3.0800 0.0 0
M  V30 29 C 16.0044 3.0800 0.0 0
M  V30 30 C 16.0044 4.6201 0.0 0
M  V30 31 C 17.3382 2.3100 0.0 0
M  V30 32 C 17.3382 5.3901 0.0 0
M  V30 33 C 18.6719 3.0800 0.0 0
M  V30 34 C 18.6719 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 2 3 5
M  V30 6 1 3 23
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 18
M  V30 11 1 8 10
M  V30 12 1 24 11 CFG=3
M  V30 13 2 12 13
M  V30 14 1 12 28
M  V30 15 1 12 29
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 2 15 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1190841-60-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1190841-37-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4428611
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and optimization of potent gp120-CD4 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tran, Thien-Duc; Adam, Fiona M.; Calo, Frederick; Fenwick, David R.;
Fok-Seang, Juin; Gardner, Iain; Hay, Duncan A.; Perros, Manos; Rawal,
Jaiessh; Middleton, Donald S.; Parkinson, Tanya; Pickford, Christopher;
Platts, Michelle; Randall, Amy; Stephenson, Peter T.; Vuong, Hannah;
Williams, David H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(17), 5250-5255

$RFMT $RIREG SCHEME413 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(1S)-2-[(2R)-4-Benzoyl-2-methyl-1-piperazinyl]-1-methyl-2-oxoethoxy]-8-iso...
C25H25N3O5
1190841-61-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 2.3100 0.0 0
M  V30 2 C 8.0021 3.0800 0.0 0 CFG=1
M  V30 3 C 9.3358 2.3100 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 O 9.3358 0.7700 0.0 0
M  V30 6 C 1.3336 5.3900 0.0 0
M  V30 7 O 0.0000 4.6200 0.0 0
M  V30 8 O 1.3336 6.9300 0.0 0
M  V30 9 C 12.0031 0.7700 0.0 0
M  V30 10 C 14.6705 5.3900 0.0 0
M  V30 11 O 14.6705 6.9300 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 2.6674 3.0800 0.0 0
M  V30 14 C 5.3347 3.0800 0.0 0
M  V30 15 C 4.0011 0.7700 0.0 0
M  V30 16 C 2.6674 4.6200 0.0 0
M  V30 17 C 1.3336 2.3100 0.0 0
M  V30 18 C 5.3347 4.6200 0.0 0
M  V30 19 C 2.6674 0.0000 0.0 0
M  V30 20 C 4.0011 5.3900 0.0 0
M  V30 21 N 1.3336 0.7700 0.0 0
M  V30 22 N 10.6694 3.0800 0.0 0
M  V30 23 C 12.0031 2.3100 0.0 0 CFG=2
M  V30 24 C 10.6694 4.6200 0.0 0
M  V30 25 C 13.3369 3.0800 0.0 0
M  V30 26 C 12.0031 5.3900 0.0 0
M  V30 27 N 13.3369 4.6200 0.0 0
M  V30 28 C 16.0041 4.6200 0.0 0
M  V30 29 C 17.3379 5.3900 0.0 0
M  V30 30 C 16.0041 3.0800 0.0 0
M  V30 31 C 18.6716 4.6200 0.0 0
M  V30 32 C 17.3379 2.3100 0.0 0
M  V30 33 C 18.6716 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 16
M  V30 10 1 23 9 CFG=1
M  V30 11 2 10 11
M  V30 12 1 10 27
M  V30 13 1 10 28
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[(1S)-2-[(2R)-4-Benzoyl-2-methyl-1-piperazinyl]-1-methyl-2-oxoethoxy]-N-met...
C26H28N4O4
1190841-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 5.3900 0.0 0
M  V30 2 C 8.0021 4.6200 0.0 0 CFG=1
M  V30 3 C 9.3358 5.3900 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 O 9.3358 6.9300 0.0 0
M  V30 6 C 1.3336 2.3100 0.0 0
M  V30 7 N 1.3336 0.7700 0.0 0
M  V30 8 O 0.0000 3.0800 0.0 0
M  V30 9 C 0.0000 0.0000 0.0 0
M  V30 10 C 12.0032 6.9300 0.0 0
M  V30 11 C 14.6705 2.3100 0.0 0
M  V30 12 O 14.6705 0.7700 0.0 0
M  V30 13 C 4.0011 5.3900 0.0 0
M  V30 14 C 2.6674 4.6200 0.0 0
M  V30 15 C 5.3347 4.6200 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 17 C 2.6674 3.0800 0.0 0
M  V30 18 C 1.3336 5.3900 0.0 0
M  V30 19 C 5.3347 3.0800 0.0 0
M  V30 20 C 2.6674 7.7000 0.0 0
M  V30 21 C 4.0011 2.3100 0.0 0
M  V30 22 N 1.3336 6.9300 0.0 0
M  V30 23 N 10.6694 4.6200 0.0 0
M  V30 24 C 12.0032 5.3900 0.0 0 CFG=2
M  V30 25 C 10.6694 3.0800 0.0 0
M  V30 26 C 13.3369 4.6200 0.0 0
M  V30 27 C 12.0032 2.3100 0.0 0
M  V30 28 N 13.3369 3.0800 0.0 0
M  V30 29 C 16.0041 3.0800 0.0 0
M  V30 30 C 17.3379 2.3100 0.0 0
M  V30 31 C 16.0041 4.6200 0.0 0
M  V30 32 C 18.6716 3.0800 0.0 0
M  V30 33 C 17.3379 5.3900 0.0 0
M  V30 34 C 18.6716 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 2 3 5
M  V30 6 1 3 23
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 17
M  V30 10 1 7 9
M  V30 11 1 24 10 CFG=3
M  V30 12 2 11 12
M  V30 13 1 11 28
M  V30 14 1 11 29
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 2 18 22
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1190841-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1190841-38-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6562182
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and optimization of potent gp120-CD4 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tran, Thien-Duc; Adam, Fiona M.; Calo, Frederick; Fenwick, David R.;
Fok-Seang, Juin; Gardner, Iain; Hay, Duncan A.; Perros, Manos; Rawal,
Jaiessh; Middleton, Donald S.; Parkinson, Tanya; Pickford, Christopher;
Platts, Michelle; Randall, Amy; Stephenson, Peter T.; Vuong, Hannah;
Williams, David H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(17), 5250-5255

$RFMT $RIREG SCHEME414 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(1S)-2-[(2R)-4-Benzoyl-2-methyl-1-piperazinyl]-1-methyl-2-oxoethoxy]-8-qui...
C25H25N3O5
1190841-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 2.3100 0.0 0
M  V30 2 C 8.0021 3.0800 0.0 0 CFG=1
M  V30 3 C 9.3358 2.3100 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 O 9.3358 0.7700 0.0 0
M  V30 6 C 1.3336 5.3900 0.0 0
M  V30 7 O 1.3336 6.9300 0.0 0
M  V30 8 O 0.0000 4.6200 0.0 0
M  V30 9 C 12.0032 0.7700 0.0 0
M  V30 10 C 14.6705 5.3900 0.0 0
M  V30 11 O 14.6705 6.9300 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 2.6674 3.0800 0.0 0
M  V30 14 C 5.3347 3.0800 0.0 0
M  V30 15 C 4.0011 0.7700 0.0 0
M  V30 16 C 2.6674 4.6200 0.0 0
M  V30 17 N 1.3336 2.3100 0.0 0
M  V30 18 C 5.3347 4.6200 0.0 0
M  V30 19 C 2.6674 0.0000 0.0 0
M  V30 20 C 4.0011 5.3900 0.0 0
M  V30 21 C 1.3336 0.7700 0.0 0
M  V30 22 N 10.6694 3.0800 0.0 0
M  V30 23 C 12.0032 2.3100 0.0 0 CFG=2
M  V30 24 C 10.6694 4.6200 0.0 0
M  V30 25 C 13.3369 3.0800 0.0 0
M  V30 26 C 12.0032 5.3900 0.0 0
M  V30 27 N 13.3369 4.6200 0.0 0
M  V30 28 C 16.0041 4.6200 0.0 0
M  V30 29 C 17.3379 5.3900 0.0 0
M  V30 30 C 16.0041 3.0800 0.0 0
M  V30 31 C 18.6716 4.6200 0.0 0
M  V30 32 C 17.3379 2.3100 0.0 0
M  V30 33 C 18.6716 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 16
M  V30 10 1 23 9 CFG=1
M  V30 11 2 10 11
M  V30 12 1 10 27
M  V30 13 1 10 28
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[(1S)-2-[(2R)-4-Benzoyl-2-methyl-1-piperazinyl]-1-methyl-2-oxoethoxy]-N-met...
C26H28N4O4
1190841-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 5.3900 0.0 0
M  V30 2 C 8.0021 4.6200 0.0 0 CFG=1
M  V30 3 C 9.3358 5.3900 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 O 9.3358 6.9300 0.0 0
M  V30 6 C 1.3336 2.3100 0.0 0
M  V30 7 N 1.3336 0.7700 0.0 0
M  V30 8 O 0.0000 3.0800 0.0 0
M  V30 9 C 0.0000 0.0000 0.0 0
M  V30 10 C 12.0032 6.9300 0.0 0
M  V30 11 C 14.6705 2.3100 0.0 0
M  V30 12 O 14.6705 0.7700 0.0 0
M  V30 13 C 4.0011 5.3900 0.0 0
M  V30 14 C 2.6674 4.6200 0.0 0
M  V30 15 C 5.3347 4.6200 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 17 C 2.6674 3.0800 0.0 0
M  V30 18 N 1.3336 5.3900 0.0 0
M  V30 19 C 5.3347 3.0800 0.0 0
M  V30 20 C 2.6674 7.7000 0.0 0
M  V30 21 C 4.0011 2.3100 0.0 0
M  V30 22 C 1.3336 6.9300 0.0 0
M  V30 23 N 10.6694 4.6200 0.0 0
M  V30 24 C 12.0032 5.3900 0.0 0 CFG=2
M  V30 25 C 10.6694 3.0800 0.0 0
M  V30 26 C 13.3369 4.6200 0.0 0
M  V30 27 C 12.0032 2.3100 0.0 0
M  V30 28 N 13.3369 3.0800 0.0 0
M  V30 29 C 16.0041 3.0800 0.0 0
M  V30 30 C 17.3379 2.3100 0.0 0
M  V30 31 C 16.0041 4.6200 0.0 0
M  V30 32 C 18.6716 3.0800 0.0 0
M  V30 33 C 17.3379 5.3900 0.0 0
M  V30 34 C 18.6716 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 2 3 5
M  V30 6 1 3 23
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 17
M  V30 10 1 7 9
M  V30 11 1 24 10 CFG=3
M  V30 12 2 11 12
M  V30 13 1 11 28
M  V30 14 1 11 29
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 2 18 22
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1190841-62-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1190841-39-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8685056
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and optimization of potent gp120-CD4 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tran, Thien-Duc; Adam, Fiona M.; Calo, Frederick; Fenwick, David R.;
Fok-Seang, Juin; Gardner, Iain; Hay, Duncan A.; Perros, Manos; Rawal,
Jaiessh; Middleton, Donald S.; Parkinson, Tanya; Pickford, Christopher;
Platts, Michelle; Randall, Amy; Stephenson, Peter T.; Vuong, Hannah;
Williams, David H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(17), 5250-5255

$RFMT $RIREG SCHEME415 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(1S)-2-[(2R)-4-Benzoyl-2-methyl-1-piperazinyl]-1-methyl-2-oxoethoxy]-1-iso...
C25H25N3O5
1190841-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 12.0031 4.6200 0.0 0
M  V30 2 C 10.6694 3.8500 0.0 0 CFG=1
M  V30 3 C 9.3358 4.6200 0.0 0
M  V30 4 C 10.6694 2.3100 0.0 0
M  V30 5 O 9.3358 6.1600 0.0 0
M  V30 6 C 18.6716 3.8500 0.0 0
M  V30 7 O 18.6716 2.3100 0.0 0
M  V30 8 O 20.0052 4.6200 0.0 0
M  V30 9 C 6.6684 6.1600 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 O 4.0011 0.0000 0.0 0
M  V30 12 C 14.6705 4.6200 0.0 0
M  V30 13 C 16.0041 3.8500 0.0 0
M  V30 14 C 13.3369 3.8500 0.0 0
M  V30 15 C 14.6705 6.1600 0.0 0
M  V30 16 C 17.3378 4.6200 0.0 0
M  V30 17 C 16.0041 2.3100 0.0 0
M  V30 18 C 13.3369 2.3100 0.0 0
M  V30 19 C 16.0041 6.9300 0.0 0
M  V30 20 N 17.3378 6.1600 0.0 0
M  V30 21 C 14.6705 1.5400 0.0 0
M  V30 22 N 8.0021 3.8500 0.0 0
M  V30 23 C 6.6684 4.6200 0.0 0 CFG=2
M  V30 24 C 8.0021 2.3100 0.0 0
M  V30 25 C 5.3347 3.8500 0.0 0
M  V30 26 C 6.6684 1.5400 0.0 0
M  V30 27 N 5.3347 2.3100 0.0 0
M  V30 28 C 2.6674 2.3100 0.0 0
M  V30 29 C 1.3336 1.5400 0.0 0
M  V30 30 C 2.6674 3.8500 0.0 0
M  V30 31 C 0.0000 2.3100 0.0 0
M  V30 32 C 1.3336 4.6200 0.0 0
M  V30 33 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 16
M  V30 10 1 23 9 CFG=1
M  V30 11 2 10 11
M  V30 12 1 10 27
M  V30 13 1 10 28
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 1 18 21
M  V30 24 1 19 20
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[(1S)-2-[(2R)-4-Benzoyl-2-methyl-1-piperazinyl]-1-methyl-2-oxoethoxy]-N-met...
C26H28N4O4
845654-81-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 12.0033 4.6201 0.0 0
M  V30 2 C 10.6697 3.8501 0.0 0 CFG=1
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 O 9.3360 6.1601 0.0 0
M  V30 6 C 18.6720 3.8501 0.0 0
M  V30 7 N 20.0057 4.6201 0.0 0
M  V30 8 O 18.6720 2.3101 0.0 0
M  V30 9 C 21.3393 3.8501 0.0 0
M  V30 10 C 6.6685 6.1601 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 O 4.0012 0.0000 0.0 0
M  V30 13 C 14.6708 4.6201 0.0 0
M  V30 14 C 16.0045 3.8501 0.0 0
M  V30 15 C 13.3372 3.8501 0.0 0
M  V30 16 C 14.6708 6.1601 0.0 0
M  V30 17 C 17.3382 4.6201 0.0 0
M  V30 18 C 16.0045 2.3101 0.0 0
M  V30 19 C 13.3372 2.3101 0.0 0
M  V30 20 C 16.0045 6.9302 0.0 0
M  V30 21 N 17.3382 6.1601 0.0 0
M  V30 22 C 14.6708 1.5400 0.0 0
M  V30 23 N 8.0022 3.8501 0.0 0
M  V30 24 C 6.6685 4.6201 0.0 0 CFG=2
M  V30 25 C 8.0022 2.3101 0.0 0
M  V30 26 C 5.3348 3.8501 0.0 0
M  V30 27 C 6.6685 1.5400 0.0 0
M  V30 28 N 5.3348 2.3101 0.0 0
M  V30 29 C 2.6673 2.3101 0.0 0
M  V30 30 C 1.3337 1.5400 0.0 0
M  V30 31 C 2.6673 3.8501 0.0 0
M  V30 32 C 0.0000 2.3101 0.0 0
M  V30 33 C 1.3337 4.6201 0.0 0
M  V30 34 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 2 3 5
M  V30 6 1 3 23
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 17
M  V30 10 1 7 9
M  V30 11 1 24 10 CFG=1
M  V30 12 2 11 12
M  V30 13 1 11 28
M  V30 14 1 11 29
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 2 18 22
M  V30 24 1 19 22
M  V30 25 1 20 21
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1190841-65-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 845654-81-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12596343
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and optimization of potent gp120-CD4 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tran, Thien-Duc; Adam, Fiona M.; Calo, Frederick; Fenwick, David R.;
Fok-Seang, Juin; Gardner, Iain; Hay, Duncan A.; Perros, Manos; Rawal,
Jaiessh; Middleton, Donald S.; Parkinson, Tanya; Pickford, Christopher;
Platts, Michelle; Randall, Amy; Stephenson, Peter T.; Vuong, Hannah;
Williams, David H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(17), 5250-5255

$RFMT $RIREG SCHEME416 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(1S)-2-[(2R)-4-Benzoyl-2-methyl-1-piperazinyl]-1-methyl-2-oxoethoxy]-2-qui...
C25H25N3O5
1190841-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 12.0031 3.8500 0.0 0
M  V30 2 C 10.6694 4.6200 0.0 0 CFG=1
M  V30 3 C 9.3358 3.8500 0.0 0
M  V30 4 C 10.6694 6.1600 0.0 0
M  V30 5 O 9.3358 2.3100 0.0 0
M  V30 6 C 18.6716 1.5400 0.0 0
M  V30 7 O 20.0052 2.3100 0.0 0
M  V30 8 O 18.6716 0.0000 0.0 0
M  V30 9 C 6.6684 2.3100 0.0 0
M  V30 10 C 4.0011 6.9300 0.0 0
M  V30 11 O 4.0011 8.4700 0.0 0
M  V30 12 C 14.6705 3.8500 0.0 0
M  V30 13 C 16.0041 4.6200 0.0 0
M  V30 14 C 13.3369 4.6200 0.0 0
M  V30 15 C 14.6705 2.3100 0.0 0
M  V30 16 N 17.3378 3.8500 0.0 0
M  V30 17 C 16.0041 6.1600 0.0 0
M  V30 18 C 13.3369 6.1600 0.0 0
M  V30 19 C 16.0041 1.5400 0.0 0
M  V30 20 C 17.3378 2.3100 0.0 0
M  V30 21 C 14.6705 6.9300 0.0 0
M  V30 22 N 8.0021 4.6200 0.0 0
M  V30 23 C 6.6684 3.8500 0.0 0 CFG=2
M  V30 24 C 8.0021 6.1600 0.0 0
M  V30 25 C 5.3347 4.6200 0.0 0
M  V30 26 C 6.6684 6.9300 0.0 0
M  V30 27 N 5.3347 6.1600 0.0 0
M  V30 28 C 2.6674 6.1600 0.0 0
M  V30 29 C 1.3336 6.9300 0.0 0
M  V30 30 C 2.6674 4.6200 0.0 0
M  V30 31 C 0.0000 6.1600 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 33 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 20
M  V30 10 1 23 9 CFG=3
M  V30 11 2 10 11
M  V30 12 1 10 27
M  V30 13 1 10 28
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 1 18 21
M  V30 24 1 19 20
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[(1S)-2-[(2R)-4-Benzoyl-2-methyl-1-piperazinyl]-1-methyl-2-oxoethoxy]-N-met...
C26H28N4O4
1190841-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 11.5500 5.3347 0.0 0
M  V30 2 C 10.0100 5.3347 0.0 0 CFG=1
M  V30 3 C 9.2400 4.0011 0.0 0
M  V30 4 C 9.2400 6.6684 0.0 0
M  V30 5 O 10.0100 2.6674 0.0 0
M  V30 6 C 18.4800 6.6684 0.0 0
M  V30 7 N 19.2500 5.3347 0.0 0
M  V30 8 O 19.2500 8.0021 0.0 0
M  V30 9 C 20.7900 5.3347 0.0 0
M  V30 10 C 7.7000 1.3336 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 O 2.3100 5.3347 0.0 0
M  V30 13 C 13.8600 6.6684 0.0 0
M  V30 14 C 14.6300 8.0021 0.0 0
M  V30 15 C 12.3200 6.6684 0.0 0
M  V30 16 C 14.6300 5.3347 0.0 0
M  V30 17 N 16.1700 8.0021 0.0 0
M  V30 18 C 13.8600 9.3358 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 16.1700 5.3347 0.0 0
M  V30 21 C 16.9400 6.6684 0.0 0
M  V30 22 C 12.3200 9.3358 0.0 0
M  V30 23 N 7.7000 4.0011 0.0 0
M  V30 24 C 6.9300 2.6674 0.0 0 CFG=2
M  V30 25 C 6.9300 5.3347 0.0 0
M  V30 26 C 5.3900 2.6674 0.0 0
M  V30 27 C 5.3900 5.3347 0.0 0
M  V30 28 N 4.6200 4.0011 0.0 0
M  V30 29 C 2.3100 2.6674 0.0 0
M  V30 30 C 3.0800 1.3336 0.0 0
M  V30 31 C 0.7700 2.6674 0.0 0
M  V30 32 C 2.3100 0.0000 0.0 0
M  V30 33 C 0.0000 1.3336 0.0 0
M  V30 34 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 2 3 5
M  V30 6 1 3 23
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 21
M  V30 10 1 7 9
M  V30 11 1 24 10 CFG=3
M  V30 12 2 11 12
M  V30 13 1 11 28
M  V30 14 1 11 29
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 2 18 22
M  V30 24 1 19 22
M  V30 25 1 20 21
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1190841-66-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1190841-43-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10488369
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and optimization of potent gp120-CD4 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tran, Thien-Duc; Adam, Fiona M.; Calo, Frederick; Fenwick, David R.;
Fok-Seang, Juin; Gardner, Iain; Hay, Duncan A.; Perros, Manos; Rawal,
Jaiessh; Middleton, Donald S.; Parkinson, Tanya; Pickford, Christopher;
Platts, Michelle; Randall, Amy; Stephenson, Peter T.; Vuong, Hannah;
Williams, David H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(17), 5250-5255

$RFMT $RIREG SCHEME417 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αS,3S)-2-acetyl-1,4-dihydro-α-methyl-2′-oxospiro[isoquinoline-3(2H),3...
C18H22N2O4
1191929-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 1.3336 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 O 6.9300 1.3336 0.0 0
M  V30 4 O 5.8194 6.7117 0.0 0
M  V30 5 C 9.0058 5.6763 0.0 0 CFG=1
M  V30 6 C 10.4126 5.0498 0.0 0
M  V30 7 C 8.8447 7.2079 0.0 0
M  V30 8 O 11.6585 5.9551 0.0 0
M  V30 9 O 10.5735 3.5183 0.0 0
M  V30 10 C 13.0654 5.3287 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 12 N 4.6200 2.6674 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 6.2952 5.2470 0.0 0
M  V30 15 C 6.2952 2.7552 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 3.0800 5.3347 0.0 0
M  V30 18 N 7.7599 4.7711 0.0 0
M  V30 19 C 7.7599 3.2311 0.0 0
M  V30 20 C 2.3100 4.0011 0.0 0
M  V30 21 C 2.3100 6.6684 0.0 0
M  V30 22 C 0.7700 4.0011 0.0 0
M  V30 23 C 0.7700 6.6684 0.0 0
M  V30 24 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 4 14
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=1
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15 CFG=1
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 19
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS,3S)-2-Acetyl-1,4-dihydro-N,α-dimethyl-2′-oxospiro[isoquinoline-3(2H),3′-p...
C18H23N3O3
1191929-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 1.3336 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 O 6.9300 1.3336 0.0 0
M  V30 4 O 5.8194 6.7117 0.0 0
M  V30 5 C 9.0058 5.6763 0.0 0 CFG=1
M  V30 6 C 10.4126 5.0498 0.0 0
M  V30 7 C 8.8447 7.2079 0.0 0
M  V30 8 N 11.6585 5.9551 0.0 0
M  V30 9 O 10.5735 3.5183 0.0 0
M  V30 10 C 13.0654 5.3287 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 12 N 4.6200 2.6674 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 6.2952 5.2470 0.0 0
M  V30 15 C 6.2952 2.7552 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 3.0800 5.3347 0.0 0
M  V30 18 N 7.7599 4.7711 0.0 0
M  V30 19 C 7.7599 3.2311 0.0 0
M  V30 20 C 2.3100 4.0011 0.0 0
M  V30 21 C 2.3100 6.6684 0.0 0
M  V30 22 C 0.7700 4.0011 0.0 0
M  V30 23 C 0.7700 6.6684 0.0 0
M  V30 24 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 4 14
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=1
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15 CFG=1
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 19
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1191929-78-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1191929-67-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5964166
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-2-((S)-2-acetyl-2'-oxo-2,4-dihydro-1H-spiro[isoquinoline-3,3'-pyrrolidine]-1'-yl)-N-methylpropanamide
3. Compound 9 (42 mg, 0.13 mmol) was dissolved at room temperature in a
solution of methylamine in EtOH (4 mL, 8.03 M). The reaction mixture was
stirred for 12 h and evaporated to give 3 (38 mg, 90%) as a white solid.
Rf = 0.58 (EtOAc/MeOH 8 : 1). [α]D 25 = -40.1 (c 0.6, CHCl3). 1H NMR (400
MHz, CDCl3, δ) 7.79 (br, s, 1H), 7.38-7.23 (m, 4H), 4.84 (q, J = 7.4 Hz,
1H), 4.68 (d, AB system, J = 14.2 Hz, 1H), 4.60 (d, AB system, J = 14.2
Hz, 1H), 3.42-3.28 (m, 2H), 3.27 (d, AB system, J = 14.6 Hz, 1H), 2.85
(d, J = 4.6 Hz, 3H), 2.72 (d, AB system, J = 14.6 Hz, 1H), 2.28 (s, 3H),
2.21-2.12 (m, 1H), 1.81-1.73 (m, 1H), 1.47 (d, 7.4 Hz, 3H). 13C NMR (100
MHz, CDC13, δ) 173.6, 170.8, 170.0, 134.3, 133.9, 128.3, 128.0, 127.4,
126.1, 63.9, 50.7, 48.5, 39.6, 37.5, 29.6, 26.6, 23.3, 13.8. HRMS (EI)
calcd. for C18H23N3O3 329.1739, found 329.1729.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetrahydroisoquinoline-based spirocyclic lactam as a type II' β-turn
inducing peptide mimetic
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lesma, Giordano; Landoni, Nicola; Pilati, Tullio; Sacchetti, Alessandro;
Silvani, Alessandra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(21), 8098-8105

$RFMT $RIREG SCHEME418 STEP1
$RXN



  2  1
$MOL
2-Cyano-3,12-dioxoolean-1-en-28-oyl azide
C31H42N4O3
1192122-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.3371 5.0297 0.0 0
M  V30 2 N 14.6707 4.2597 0.0 0
M  V30 3 O 13.3371 6.5697 0.0 0
M  V30 4 N 16.0044 5.0297 0.0 0 CHG=1 VAL=4
M  V30 5 N 17.3382 5.7997 0.0 0 CHG=-1
M  V30 6 C 9.9867 7.1954 0.0 0
M  V30 7 O 8.0023 1.9497 0.0 0
M  V30 8 C 12.9933 0.0000 0.0 0
M  V30 9 C 11.0135 0.0000 0.0 0
M  V30 10 C 8.8856 7.8313 0.0 0
M  V30 11 C 4.6840 5.1740 0.0 0
M  V30 12 C 3.0112 10.0594 0.0 0
M  V30 13 C 4.9911 10.0594 0.0 0
M  V30 14 C 1.3338 5.7997 0.0 0
M  V30 15 N 0.0000 5.0297 0.0 0
M  V30 16 O 1.3338 8.8798 0.0 0
M  V30 17 C 12.0034 4.2597 0.0 0 CFG=1
M  V30 18 C 10.6696 3.4897 0.0 0 CFG=1
M  V30 19 C 12.0034 5.7997 0.0 0
M  V30 20 C 13.3371 3.4897 0.0 0
M  V30 21 C 9.3359 4.2597 0.0 0 CFG=1
M  V30 22 C 10.6696 1.9497 0.0 0
M  V30 23 C 10.6696 6.5697 0.0 0
M  V30 24 C 13.3371 1.9497 0.0 0
M  V30 25 C 9.3359 5.7997 0.0 0 CFG=1
M  V30 26 C 8.0023 3.4897 0.0 0
M  V30 27 C 12.0034 1.1797 0.0 0
M  V30 28 C 8.0023 6.5697 0.0 0 CFG=1
M  V30 29 C 6.6686 4.2597 0.0 0
M  V30 30 C 6.6686 5.7997 0.0 0 CFG=1
M  V30 31 C 8.0023 8.1098 0.0 0
M  V30 32 C 5.3348 6.5697 0.0 0 CFG=2
M  V30 33 C 6.6686 8.8798 0.0 0
M  V30 34 C 5.3348 8.1098 0.0 0 CFG=2
M  V30 35 C 4.0011 5.7997 0.0 0
M  V30 36 C 4.0011 8.8798 0.0 0
M  V30 37 C 2.6675 6.5697 0.0 0
M  V30 38 C 2.6675 8.1098 0.0 0
M  V30 39 H 9.7864 2.2281 0.0 0
M  V30 40 H 8.6851 2.8640 0.0 0
M  V30 41 H 5.7852 4.5381 0.0 0
M  V30 42 H 5.3348 9.6498 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 17 1 CFG=3
M  V30 4 2 2 4
M  V30 5 2 4 5
M  V30 6 1 25 6 CFG=1
M  V30 7 2 7 26
M  V30 8 1 8 27
M  V30 9 1 9 27
M  V30 10 1 28 10 CFG=3
M  V30 11 1 32 11 CFG=3
M  V30 12 1 12 36
M  V30 13 1 13 36
M  V30 14 3 14 15
M  V30 15 1 14 37
M  V30 16 2 16 38
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 1 18 39 CFG=3
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 21 26
M  V30 27 1 21 40 CFG=3
M  V30 28 1 22 27
M  V30 29 1 23 25
M  V30 30 1 24 27
M  V30 31 1 25 28
M  V30 32 1 26 29
M  V30 33 1 28 30
M  V30 34 1 28 31
M  V30 35 1 29 30
M  V30 36 1 30 32
M  V30 37 1 30 41 CFG=1
M  V30 38 1 31 33
M  V30 39 1 32 34
M  V30 40 1 32 35
M  V30 41 1 33 34
M  V30 42 1 34 36
M  V30 43 1 34 42 CFG=1
M  V30 44 2 35 37
M  V30 45 1 36 38
M  V30 46 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 17 18 21 25 28 30 32 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Cyano-3,12-dioxo-28-norolean-1-en-17-yl)-N′-methylurea
C32H47N3O3
1192123-88-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 13.3371 5.0297 0.0 0
M  V30 2 C 14.6707 4.2597 0.0 0
M  V30 3 N 16.0044 5.0297 0.0 0
M  V30 4 O 14.6707 2.7197 0.0 0
M  V30 5 C 17.3382 4.2597 0.0 0
M  V30 6 C 9.9867 7.1954 0.0 0
M  V30 7 O 8.0023 1.9497 0.0 0
M  V30 8 C 12.9933 0.0000 0.0 0
M  V30 9 C 11.0135 0.0000 0.0 0
M  V30 10 C 8.8856 7.8313 0.0 0
M  V30 11 C 4.6840 5.1740 0.0 0
M  V30 12 C 3.0112 10.0594 0.0 0
M  V30 13 C 4.9911 10.0594 0.0 0
M  V30 14 C 1.3338 5.7997 0.0 0
M  V30 15 N 0.0000 5.0297 0.0 0
M  V30 16 O 1.3338 8.8798 0.0 0
M  V30 17 C 12.0034 4.2597 0.0 0 CFG=1
M  V30 18 C 10.6696 3.4897 0.0 0 CFG=1
M  V30 19 C 12.0034 5.7997 0.0 0
M  V30 20 C 13.3371 3.4897 0.0 0
M  V30 21 C 9.3359 4.2597 0.0 0 CFG=1
M  V30 22 C 10.6696 1.9497 0.0 0
M  V30 23 C 10.6696 6.5697 0.0 0
M  V30 24 C 13.3371 1.9497 0.0 0
M  V30 25 C 9.3359 5.7997 0.0 0 CFG=1
M  V30 26 C 8.0023 3.4897 0.0 0
M  V30 27 C 12.0034 1.1797 0.0 0
M  V30 28 C 8.0023 6.5697 0.0 0 CFG=1
M  V30 29 C 6.6686 4.2597 0.0 0
M  V30 30 C 6.6686 5.7997 0.0 0 CFG=1
M  V30 31 C 8.0023 8.1098 0.0 0
M  V30 32 C 5.3348 6.5697 0.0 0 CFG=2
M  V30 33 C 6.6686 8.8798 0.0 0
M  V30 34 C 5.3348 8.1098 0.0 0 CFG=2
M  V30 35 C 4.0011 5.7997 0.0 0
M  V30 36 C 4.0011 8.8798 0.0 0
M  V30 37 C 2.6675 6.5697 0.0 0
M  V30 38 C 2.6675 8.1098 0.0 0
M  V30 39 H 9.7864 2.2281 0.0 0
M  V30 40 H 8.6851 2.8640 0.0 0
M  V30 41 H 5.7852 4.5381 0.0 0
M  V30 42 H 5.3348 9.6498 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 25 6 CFG=1
M  V30 7 2 7 26
M  V30 8 1 8 27
M  V30 9 1 9 27
M  V30 10 1 28 10 CFG=3
M  V30 11 1 32 11 CFG=3
M  V30 12 1 12 36
M  V30 13 1 13 36
M  V30 14 3 14 15
M  V30 15 1 14 37
M  V30 16 2 16 38
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 1 18 39 CFG=3
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 21 26
M  V30 27 1 21 40 CFG=3
M  V30 28 1 22 27
M  V30 29 1 23 25
M  V30 30 1 24 27
M  V30 31 1 25 28
M  V30 32 1 26 29
M  V30 33 1 28 30
M  V30 34 1 28 31
M  V30 35 1 29 30
M  V30 36 1 30 32
M  V30 37 1 30 41 CFG=1
M  V30 38 1 31 33
M  V30 39 1 32 34
M  V30 40 1 32 35
M  V30 41 1 33 34
M  V30 42 1 34 36
M  V30 43 1 34 42 CFG=1
M  V30 44 2 35 37
M  V30 45 1 36 38
M  V30 46 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 17 18 21 25 28 30 32 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1192122-99-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1192123-88-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-527-CAS-4598318
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antioxidant inflammation modulators: C-17 homologated oleanolic acid
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anderson, Eric; Jiang, Xin; Visnick, Melean
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009129546 A1 2009-10-22

$RFMT $RIREG SCHEME419 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloropyrimidine
C4H2Cl2N2
1193-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.0800 0.0 0
M  V30 2 Cl 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 1.3338 0.7700 0.0 0
M  V30 7 N 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N4,N6-Dimethyl-4,6-pyrimidinediamine
C6H10N4
66131-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 N 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 N 2.6675 0.7700 0.0 0
M  V30 9 N 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1193-21-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 66131-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2993068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2. Synthetic procedures and characterization data for compounds: 2a-e,
3a-g, 4a-e, 5-8 Preparation of reactants 2a-e. 2a: An autoclave equipped
with a magnetic stir bar was charged with 1 (14.9 g, 100 mmol), aqueous
methylamine solution (25-30%) (400 mmol, 50 g) and H2O (50 mL). Then it
was heated at 150 ºC for 12 h. After cooling to room temperature, the
product precipitated as white solids. Filtration and repeated washing
with acetone gave pure product 2a (12.4 g, 90%) as a white solid1 mp
184-185 ºC; IR (KBr) 3246, 3093, 1601, 1265, 796 cm-1; 1H NMR (DMSO/300
MHz) δ 7.89 (s, 1H), 6.49 (d, br, J = 3.8 Hz, 2H), 5.24 (s, 1H), 2.70 (d,
J = 4.9 Hz, 6H).
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Highly Selective Bromination of Azacalix[4]pyrimidine
Macrocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Li-Xia; Wang, De-Xian; Huang, Zhi-Tang; Wang, Mei-Xiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2010), 75(3), 741-747

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methyl 3-[[4-[1-[[[1-(4-chlorophenyl)-5-methyl-1H-pyrazol-4-yl]carbonyl]amino...
C24H27ClN4O5S
1194055-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8367 2.4873 0.0 0
M  V30 2 C 9.8975 3.8501 0.0 0
M  V30 3 N 11.2312 4.6201 0.0 0
M  V30 4 O 9.8975 2.3101 0.0 0
M  V30 5 C 12.5648 3.8501 0.0 0
M  V30 6 C 12.5648 2.3101 0.0 0
M  V30 7 C 13.8985 1.5400 0.0 0
M  V30 8 C 13.8985 0.0000 0.0 0
M  V30 9 Cl 0.0000 4.4943 0.0 0
M  V30 10 S 17.8997 3.8501 0.0 0 VAL=6
M  V30 11 C 19.2333 3.0801 0.0 0
M  V30 12 O 18.6697 5.1838 0.0 0
M  V30 13 O 17.1296 2.5164 0.0 0
M  V30 14 C 20.5671 3.8501 0.0 0
M  V30 15 C 21.9008 3.0801 0.0 0
M  V30 16 O 23.2345 3.8501 0.0 0
M  V30 17 O 21.9008 1.5400 0.0 0
M  V30 18 C 24.5682 3.0801 0.0 0
M  V30 19 N 6.1264 5.1382 0.0 0
M  V30 20 C 7.1568 3.9938 0.0 0
M  V30 21 N 6.8964 6.4718 0.0 0
M  V30 22 C 8.5637 4.6201 0.0 0
M  V30 23 C 8.4027 6.1517 0.0 0
M  V30 24 C 4.5947 4.9772 0.0 0
M  V30 25 C 3.6895 6.2231 0.0 0
M  V30 26 C 3.9684 3.5703 0.0 0
M  V30 27 C 2.1579 6.0622 0.0 0
M  V30 28 C 2.4368 3.4093 0.0 0
M  V30 29 C 1.5316 4.6552 0.0 0
M  V30 30 C 13.8985 4.6201 0.0 0
M  V30 31 C 15.2323 3.8501 0.0 0
M  V30 32 C 13.8985 6.1601 0.0 0
M  V30 33 C 16.5660 4.6201 0.0 0
M  V30 34 C 15.2323 6.9302 0.0 0
M  V30 35 N 16.5660 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 30
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 29
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 10 13
M  V30 14 1 10 33
M  V30 15 1 11 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 1 30 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Chlorophenyl)-5-methyl-N-[1-[2-[(methylamino)sulfonyl]-4-pyridinyl]butyl...
C21H24ClN5O3S
1194055-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.5722 5.6850 0.0 0
M  V30 2 C 9.2402 5.3348 0.0 0
M  V30 3 N 7.7002 5.3348 0.0 0
M  V30 4 O 10.0102 4.0012 0.0 0
M  V30 5 C 6.9302 4.0012 0.0 0
M  V30 6 C 7.7002 2.6675 0.0 0
M  V30 7 C 6.9302 1.3337 0.0 0
M  V30 8 C 7.7002 0.0000 0.0 0
M  V30 9 Cl 17.4895 10.8415 0.0 0
M  V30 10 S 2.3101 6.6685 0.0 0 VAL=6
M  V30 11 N 1.5400 8.0023 0.0 0
M  V30 12 O 3.6437 7.4385 0.0 0
M  V30 13 O 0.9764 5.8985 0.0 0
M  V30 14 C 0.0000 8.0023 0.0 0
M  V30 15 N 11.8620 8.3359 0.0 0
M  V30 16 C 11.5418 6.8296 0.0 0
M  V30 17 N 10.5283 9.1059 0.0 0
M  V30 18 C 10.0102 6.6685 0.0 0
M  V30 19 C 9.3839 8.0755 0.0 0
M  V30 20 C 13.2689 8.9622 0.0 0
M  V30 21 C 13.4299 10.4939 0.0 0
M  V30 22 C 14.5148 8.0571 0.0 0
M  V30 23 C 14.8367 11.1203 0.0 0
M  V30 24 C 15.9216 8.6835 0.0 0
M  V30 25 C 16.0827 10.2150 0.0 0
M  V30 26 C 5.3901 4.0012 0.0 0
M  V30 27 C 4.6201 5.3348 0.0 0
M  V30 28 C 4.6201 2.6675 0.0 0
M  V30 29 C 3.0801 5.3348 0.0 0
M  V30 30 C 3.0801 2.6675 0.0 0
M  V30 31 N 2.3101 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 26
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 25
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 10 13
M  V30 14 1 10 29
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 20
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1194055-53-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1194055-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27116569
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 127-65-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 20: 1-(4-Chloro-phenyl)-5-methyl-1H-pyrazole-4-carboxylic acid
[1-(2-methylsulfamoyl-pyridin-4-yl)-butyl]-amide To a solution of
3-[4-(1-{[1-(4-chloro-phenyl)-5-methyl-1H-pyrazole-4-carbonyl]-amino}-butyl)-pyridine-2-sulfonyl]-propionic
acid methyl ester (200 mg, 0.39 mmol) in anhydrous THF (10 mL) is added
sodium methoxide in methanol (2.6 M solution freshly prepared by
dissolving 140 mg of sodium in 2.4 mL of methanol, 0.15 mL, 0.39 mmol).
After stirring at room temperature for 10 min, the reaction mixture is
concentrated in vacuo. Anhydrous THF (10 mL) is added and the
concentration process is repeated. The resultant residue is dried under
high vacuum for 5 min, dissolved in THF (10 mL) and treated with
chloramine T (180 mg, 0.77 mmol). The reaction mixture is stirred at room
temperature for 15 min and then treated with methyl amine in ethanol (33%
solution in ethanol, 0.48 mL, 3.9 mmol) in one portion. After 20 min the
reaction mixture is diluted with saturated aqueous sodium bicarbonate (20
mL) and water (8 mL), and extracted with EtOAc (2 x 35 mL). The combined
organic layers are washed with brine (10 mL), dried over sodium sulfate,
filtered and concentrated in vacuo. The residue is purified by
preparative reverse phase HPLC (eluted with 10 to 90 % CD3CN/H2O and 0.1
% TFA as additive) to afford
1-(4-chloro-phenyl)-5-methyl-1H-pyrazole-4-carboxylic acid
[1-(2-methylsulfamoyl-pyridin-4-yl)-butyl]-amide (160 mg, 90 %). Observed
mass: 369 (M+H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylpyrazolecarboxamides as chemotactic cytokine receptor
1 (CCR1) antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cook, Brian Nicholas; Harcken, Christian; Lee, Thomas Wai-Ho; Liu,
Pingrong; Mao, Can; Lord, John; Mao, Wang; Raudenbush, Brian Christopher;
Razavi, Hossein; Sarko, Christopher Ronald; Swinamer, Alan David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009137338 A1 2009-11-12

$RFMT $RIREG SCHEME421 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-[7-chloro-2-[(1S)-1-cyclopropylethyl]-2,3-dihydro-1-oxo-1H-isoindol-5...
C19H19ClN2O4
1198309-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0731 0.3695 0.0 0
M  V30 2 Cl 7.3473 0.0000 0.0 0
M  V30 3 C 2.1037 3.0800 0.0 0 CFG=1
M  V30 4 C 1.3337 1.7464 0.0 0
M  V30 5 C 13.9836 4.9772 0.0 0
M  V30 6 O 14.8888 6.2231 0.0 0
M  V30 7 O 14.6100 3.5702 0.0 0
M  V30 8 C 16.4203 6.0621 0.0 0
M  V30 9 C 17.3256 7.3080 0.0 0
M  V30 10 C 6.0136 3.8501 0.0 0
M  V30 11 C 6.0136 2.3100 0.0 0
M  V30 12 C 4.5489 4.3259 0.0 0
M  V30 13 C 7.3473 4.6201 0.0 0
M  V30 14 C 4.5489 1.8342 0.0 0
M  V30 15 C 7.3473 1.5400 0.0 0
M  V30 16 N 3.6437 3.0800 0.0 0
M  V30 17 C 8.6810 3.8501 0.0 0
M  V30 18 C 8.6810 2.3100 0.0 0
M  V30 19 C 10.0146 4.6201 0.0 0
M  V30 20 C 11.4216 3.9937 0.0 0
M  V30 21 O 10.1757 6.1516 0.0 0
M  V30 22 C 12.4520 5.1381 0.0 0
M  V30 23 N 11.6820 6.4718 0.0 0
M  V30 24 C 1.3337 4.4137 0.0 0
M  V30 25 C 1.3337 5.9537 0.0 0
M  V30 26 C 0.0000 5.1837 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 15
M  V30 3 1 3 4 CFG=1
M  V30 4 1 3 16
M  V30 5 1 3 24
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 22
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 18
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[7-Chloro-2-[(1S)-1-cyclopropylethyl]-2,3-dihydro-1-oxo-1H-isoindol-5-yl]-N...
C18H18ClN3O3
1198309-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0730 0.3694 0.0 0
M  V30 2 Cl 7.3472 0.0000 0.0 0
M  V30 3 C 2.1037 3.0800 0.0 0 CFG=1
M  V30 4 C 1.3336 1.7464 0.0 0
M  V30 5 C 13.9834 4.9772 0.0 0
M  V30 6 N 14.8886 6.2230 0.0 0
M  V30 7 O 14.6099 3.5702 0.0 0
M  V30 8 C 16.4202 6.0621 0.0 0
M  V30 9 C 6.0134 3.8500 0.0 0
M  V30 10 C 6.0134 2.3100 0.0 0
M  V30 11 C 4.5489 4.3259 0.0 0
M  V30 12 C 7.3472 4.6200 0.0 0
M  V30 13 C 4.5489 1.8341 0.0 0
M  V30 14 C 7.3472 1.5400 0.0 0
M  V30 15 N 3.6437 3.0800 0.0 0
M  V30 16 C 8.6809 3.8500 0.0 0
M  V30 17 C 8.6809 2.3100 0.0 0
M  V30 18 C 10.0145 4.6200 0.0 0
M  V30 19 C 11.4215 3.9935 0.0 0
M  V30 20 O 10.1754 6.1516 0.0 0
M  V30 21 C 12.4519 5.1381 0.0 0
M  V30 22 N 11.6819 6.4717 0.0 0
M  V30 23 C 1.3336 4.4137 0.0 0
M  V30 24 C 1.3336 5.9537 0.0 0
M  V30 25 C 0.0000 5.1837 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 14
M  V30 3 1 3 4 CFG=1
M  V30 4 1 3 15
M  V30 5 1 3 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 21
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1198309-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1198309-78-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13679708
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 2:
5-(7-chloro-2-((S)-1-cyclopropylethyl)-1-oxo-2,3-dihydro-1H-isomdolin-5-yl)-N-methylisoxazole-3-carboxamide.
Ethyl
5-(7-chloro-2-((S)-1-cyclopropylethyl)-1-oxoisoindolin-5-yl)isoxazole-3-carboxylate
(4.00 g, 10.67 mmol) was placed into a 200 mL pressure vessel followed by
the addition of ethanol (20 mL) and a 33% solution of ethanolic
methylamine (57.2 mL, 320.16 mmol). The solution was warmed to and held
at 55 °C for 10 minutes and then cooled to room temperature. A
precipitate formed, was collected by filtration and dried overnight in a
40 °C vacuum oven. Residual ethanol was removed from the isolated product
by dissolving the solids in a minimal amount of methylene chloride
followed by removal of the volatiles under reduced pressure to afford the
title compound (3.46 g, 90%).
5-(7-chloro-2-((S)-1-cyclopropylethyl)-1-oxo-2,3-dihydro-1H-isomdolin-5-yl)-N-methylisoxazole-3-carboxamide,
yield 3.46 g, 90%. Mp 212.3 °C. 1H NMR (300 MHz, CDCl3) δ ppm 0.28 - 0.46
(m, 3 H) 0.54 - 0.64 (m, 1 H) 0.90 - 1.02 (m, 1 H) 1.30 (d, 3 H) 2.98 (d,
3 H) 3.64 - 3.80 (m, 1 H) 4.35 - 4.57 (m, 2 H) 6.76 (d, 1 H) 7.00 (s, 1
H) 7.69 (s, 1 H) 7.75 (s, 1 H). MS APCI, m/z - 360 (M+H). HPLC Method B:
2.19 min.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoxazole derivatives and their use as metabotropic
glutamate receptor potentiators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cacciola, Joseph; Empfield, James; Folmer, James; Hunter, Angela M.;
Throner, Scott
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009148403 A1 2009-12-10

$RFMT $RIREG SCHEME422 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-1-(2-Thienyl)-3-(trimethylsilyl)-2-propen-1-one
C10H14OSSi
1201072-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 Si 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 3.0801 0.0 0
M  V30 7 C 8.5423 0.9764 0.0 0
M  V30 8 C 7.0022 3.6437 0.0 0
M  V30 9 C 2.4374 2.3101 0.0 0
M  V30 10 C 2.2763 3.8416 0.0 0
M  V30 11 S 1.0304 1.6836 0.0 0
M  V30 12 C 0.7700 4.1618 0.0 0
M  V30 13 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(Z)]-N-[(2E)-1-(2-Thienyl)-3-(trimethylsilyl)-2-propen-1-ylidene]methanamine
C11H17NSSi
1201071-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.3101 0.0 0
M  V30 2 C 5.1048 3.0801 0.0 0
M  V30 3 N 3.7711 0.7700 0.0 0
M  V30 4 C 6.4386 2.3101 0.0 0
M  V30 5 C 2.4374 0.0000 0.0 0
M  V30 6 Si 7.7722 3.0801 0.0 0
M  V30 7 C 9.1059 3.8501 0.0 0
M  V30 8 C 8.5423 1.7464 0.0 0
M  V30 9 C 7.0022 4.4137 0.0 0
M  V30 10 C 2.4374 3.0801 0.0 0
M  V30 11 C 1.0304 2.4536 0.0 0
M  V30 12 S 2.2763 4.6116 0.0 0
M  V30 13 C 0.0000 3.5981 0.0 0
M  V30 14 C 0.7700 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1201072-69-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1201071-86-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9954408
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 1:4 N(E):N(Z)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhodium(I)-Catalyzed [4+1] Cycloaddition Reactions of α,β-Unsaturated
Imines with Terminal Alkynes for the Preparation of Pyrrole Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizuno, Akio; Kusama, Hiroyuki; Iwasawa, Nobuharu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2009), 48(44), 8318-8320,
S8318/1-S8318/13

$RFMT $RIREG SCHEME423 STEP1
$RXN



  2  1
$MOL
(αR,βR,2S)-1-[(1,1-Dimethylethoxy)carbonyl]-β-methoxy-α-methyl-2-pyrrolidinep...
C14H25NO5
120205-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.8895 4.9614 0.0 0 CFG=2
M  V30 2 C 6.4295 4.9614 0.0 0 CFG=1
M  V30 3 O 4.1195 3.6278 0.0 0
M  V30 4 C 7.1995 3.6278 0.0 0
M  V30 5 C 7.1995 6.2952 0.0 0
M  V30 6 C 4.8895 2.2941 0.0 0
M  V30 7 O 8.7395 3.6278 0.0 0
M  V30 8 O 6.4295 2.2941 0.0 0
M  V30 9 C 2.8736 3.8500 0.0 0
M  V30 10 O 1.5400 3.0800 0.0 0
M  V30 11 O 4.2073 3.0800 0.0 0
M  V30 12 C 1.5400 1.5400 0.0 0
M  V30 13 C 3.0800 1.5400 0.0 0
M  V30 14 C 1.5400 0.0000 0.0 0
M  V30 15 C 0.0000 1.5400 0.0 0
M  V30 16 C 4.1195 6.2952 0.0 0 CFG=2
M  V30 17 N 2.8736 5.3900 0.0 0
M  V30 18 C 3.6436 7.7598 0.0 0
M  V30 19 C 1.6278 6.2952 0.0 0
M  V30 20 C 2.1036 7.7598 0.0 0
M  V30 21 H 5.5264 6.9215 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 21 CFG=3
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-(methylamino)-3-oxopro...
C15H28N2O4
329792-34-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.8895 4.9614 0.0 0 CFG=2
M  V30 2 C 6.4295 4.9614 0.0 0 CFG=1
M  V30 3 O 4.1195 3.6278 0.0 0
M  V30 4 C 7.1995 3.6278 0.0 0
M  V30 5 C 7.1995 6.2952 0.0 0
M  V30 6 C 4.8895 2.2941 0.0 0
M  V30 7 N 8.7395 3.6278 0.0 0
M  V30 8 O 6.4295 2.2941 0.0 0
M  V30 9 C 9.5095 2.2941 0.0 0
M  V30 10 C 2.8736 3.8500 0.0 0
M  V30 11 O 1.5400 3.0800 0.0 0
M  V30 12 O 4.2073 3.0800 0.0 0
M  V30 13 C 1.5400 1.5400 0.0 0
M  V30 14 C 3.0800 1.5400 0.0 0
M  V30 15 C 1.5400 0.0000 0.0 0
M  V30 16 C 0.0000 1.5400 0.0 0
M  V30 17 C 4.1195 6.2952 0.0 0 CFG=2
M  V30 18 N 2.8736 5.3900 0.0 0
M  V30 19 C 3.6436 7.7598 0.0 0
M  V30 20 C 1.6278 6.2952 0.0 0
M  V30 21 C 2.1036 7.7598 0.0 0
M  V30 22 H 5.5265 6.9215 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 18
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 22 CFG=3
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 120205-50-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 329792-34-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17640915
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2942-58-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dolastatin peptides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Petit, George R.; Srirangam, Jayaram K.; Williams, Michael D.; Durkin,
Kieran P. M.; Barlozzari, Teresa; Kling, Andreas; Janssen, Bernd; Haupt,
Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001018032 A2 2001-03-15

$RFMT $RIREG SCHEME424 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[[1,4-dimethyl-3-(4-methylphenyl)-1H-pyrazol-5-yl]oxy]methyl]-...
C23H25N3O4
1202873-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.0630 6.7528 0.0 0
M  V30 2 O 8.0023 5.3901 0.0 0
M  V30 3 C 6.6686 4.6201 0.0 0
M  V30 4 C 8.3525 2.0579 0.0 0
M  V30 5 C 17.8997 4.7459 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 N 2.6675 2.3100 0.0 0
M  V30 9 O 5.3348 0.7700 0.0 0
M  V30 10 O 6.6686 3.0800 0.0 0
M  V30 11 O 1.3338 3.0800 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 11.7733 4.1020 0.0 0
M  V30 15 C 10.7429 5.2464 0.0 0
M  V30 16 N 11.0033 2.7683 0.0 0
M  V30 17 C 9.3359 4.6201 0.0 0
M  V30 18 N 9.4968 3.0885 0.0 0
M  V30 19 C 13.3049 4.2629 0.0 0
M  V30 20 C 14.2101 3.0171 0.0 0
M  V30 21 C 13.9312 5.6699 0.0 0
M  V30 22 C 15.7416 3.1780 0.0 0
M  V30 23 C 15.4629 5.8308 0.0 0
M  V30 24 C 16.3680 4.5849 0.0 0
M  V30 25 C 5.3348 5.3901 0.0 0
M  V30 26 C 4.0011 4.6201 0.0 0
M  V30 27 C 5.3348 6.9301 0.0 0
M  V30 28 C 2.6675 5.3901 0.0 0
M  V30 29 C 4.0011 7.7001 0.0 0
M  V30 30 C 2.6675 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 3 25
M  V30 5 1 4 18
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 26
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 19
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[[1,4-Dimethyl-3-(4-methylphenyl)-1H-pyrazol-5-yl]oxy]methyl]-α-(meth...
C23H26N4O3
1202873-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.0630 6.7528 0.0 0
M  V30 2 O 8.0023 5.3901 0.0 0
M  V30 3 C 6.6686 4.6201 0.0 0
M  V30 4 C 8.3525 2.0579 0.0 0
M  V30 5 C 17.8997 4.7459 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 N 2.6675 2.3100 0.0 0
M  V30 9 N 5.3348 0.7700 0.0 0
M  V30 10 O 6.6686 3.0800 0.0 0
M  V30 11 O 1.3338 3.0800 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 11.7733 4.1020 0.0 0
M  V30 15 C 10.7429 5.2464 0.0 0
M  V30 16 N 11.0033 2.7683 0.0 0
M  V30 17 C 9.3359 4.6201 0.0 0
M  V30 18 N 9.4968 3.0885 0.0 0
M  V30 19 C 13.3049 4.2629 0.0 0
M  V30 20 C 13.9312 5.6699 0.0 0
M  V30 21 C 14.2101 3.0171 0.0 0
M  V30 22 C 15.4629 5.8308 0.0 0
M  V30 23 C 15.7416 3.1780 0.0 0
M  V30 24 C 16.3680 4.5849 0.0 0
M  V30 25 C 5.3348 5.3901 0.0 0
M  V30 26 C 4.0011 4.6201 0.0 0
M  V30 27 C 5.3348 6.9301 0.0 0
M  V30 28 C 2.6675 5.3901 0.0 0
M  V30 29 C 4.0011 7.7001 0.0 0
M  V30 30 C 2.6675 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 3 25
M  V30 5 1 4 18
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 26
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 19
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1202873-78-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1202873-89-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4487014
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Procedure for the Synthesis of the Compounds
6. The compounds 5 (3.00 mmol) were dissolved in 5 mL of THF, and a
slight excess of a methylamine solution (25-30%) was added dropwise to
the solution. The mixture was refluxed for 1 h (the reaction was
monitored by TLC) and then concentrated. Water was added to the residue
and extracted three times with 50mL of ethyl acetate, and the combined
organic extracts were dried and concentrated. The crude product was
purified via silica gel column chromatography. The compounds 6. Compound
6j: Yield 89.9% of oil. IR(KBr)ν: 3230(s, NH), 2940 (s, C-H), 1665 (s,
C=O), 1505 (s, C=N), 1465 (s, CH3), 1300 (m, C-N), 1185 (s, C-O), 820,
740 (s, Ph-H)cm-1; 1H NMR (300 MHz, CDCl3) δ7.61 (m, 1H, Ph-6-H),
7.41-7.47 (m, 4H, 3-Ph-2,3,5,6-4H), 7.24-7.28 (m, 2H, Ph-3,5-2H), 7.23
(m, 1H, Ph-4-H), 6.79 (b s, 1H, NH), 5.14 (s, 2H, CH2), 3.96 (s, 3H,
OCH3), 3.60 (s, 3H, NCH3), 2.89-2.91 (d, J=4.8HZ, 3H, NHCH3), 2.40 (s,
3H, Ph-CH3), 1.83 (s, 3H, Py-CH3); Anal. Calcd for: C, 67.96; H, 6.45; N,
13.78; Found: C, 67.78; H, 6.36; N, 13.69.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biological Activity of New
(E)-α-(Methoxyimino)benzeneacetate Derivatives Containing a Substituted
Pyrazole Ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Miao; Liu, Chang-Ling; Yang, Ji-Chun; Zhang, Jin-Bo; Li, Zhi-Nian;
Zhang, Hong; Li, Zheng-Ming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Agricultural and Food Chemistry (2010), 58(5), 2664-2667

$RFMT $RIREG SCHEME425 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[[1,4-dimethyl-3-[4-(2,2,2-trifluoroethoxy)phenyl]-1H-pyrazol-...
C24H24F3N3O5
1202873-83-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.0630 6.7529 0.0 0
M  V30 2 O 8.0023 5.3901 0.0 0
M  V30 3 C 6.6685 4.6201 0.0 0
M  V30 4 C 8.3525 2.0579 0.0 0
M  V30 5 O 17.8998 4.7459 0.0 0
M  V30 6 C 18.8049 3.5000 0.0 0
M  V30 7 C 20.3366 3.6610 0.0 0
M  V30 8 F 20.1755 5.1925 0.0 0
M  V30 9 F 21.8682 3.8219 0.0 0
M  V30 10 F 20.4975 2.1294 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 N 2.6675 2.3101 0.0 0
M  V30 14 O 5.3348 0.7700 0.0 0
M  V30 15 O 6.6685 3.0801 0.0 0
M  V30 16 O 1.3337 3.0801 0.0 0
M  V30 17 C 4.0012 0.0000 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 11.7734 4.1020 0.0 0
M  V30 20 C 10.7428 5.2464 0.0 0
M  V30 21 N 11.0034 2.7684 0.0 0
M  V30 22 C 9.3360 4.6201 0.0 0
M  V30 23 N 9.4969 3.0885 0.0 0
M  V30 24 C 13.3050 4.2630 0.0 0
M  V30 25 C 13.9313 5.6699 0.0 0
M  V30 26 C 14.2102 3.0171 0.0 0
M  V30 27 C 15.4629 5.8309 0.0 0
M  V30 28 C 15.7418 3.1780 0.0 0
M  V30 29 C 16.3681 4.5850 0.0 0
M  V30 30 C 5.3348 5.3901 0.0 0
M  V30 31 C 4.0012 4.6201 0.0 0
M  V30 32 C 5.3348 6.9302 0.0 0
M  V30 33 C 2.6675 5.3901 0.0 0
M  V30 34 C 4.0012 7.7002 0.0 0
M  V30 35 C 2.6675 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 3 30
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 5 29
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 31
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 19 24
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[[1,4-Dimethyl-3-[4-(2,2,2-trifluoroethoxy)phenyl]-1H-pyrazol-5-yl]ox...
C24H25F3N4O4
1202873-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.0631 6.7529 0.0 0
M  V30 2 O 8.0023 5.3901 0.0 0
M  V30 3 C 6.6685 4.6201 0.0 0
M  V30 4 C 8.3525 2.0579 0.0 0
M  V30 5 O 17.8998 4.7459 0.0 0
M  V30 6 C 18.8049 3.5000 0.0 0
M  V30 7 C 20.3366 3.6610 0.0 0
M  V30 8 F 20.1755 5.1925 0.0 0
M  V30 9 F 21.8682 3.8219 0.0 0
M  V30 10 F 20.4975 2.1294 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 N 2.6675 2.3101 0.0 0
M  V30 14 N 5.3348 0.7700 0.0 0
M  V30 15 O 6.6685 3.0801 0.0 0
M  V30 16 O 1.3337 3.0801 0.0 0
M  V30 17 C 4.0012 0.0000 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 11.7734 4.1020 0.0 0
M  V30 20 C 10.7428 5.2464 0.0 0
M  V30 21 N 11.0034 2.7684 0.0 0
M  V30 22 C 9.3360 4.6201 0.0 0
M  V30 23 N 9.4969 3.0885 0.0 0
M  V30 24 C 13.3050 4.2630 0.0 0
M  V30 25 C 13.9313 5.6699 0.0 0
M  V30 26 C 14.2102 3.0171 0.0 0
M  V30 27 C 15.4629 5.8309 0.0 0
M  V30 28 C 15.7418 3.1780 0.0 0
M  V30 29 C 16.3681 4.5850 0.0 0
M  V30 30 C 5.3348 5.3901 0.0 0
M  V30 31 C 4.0012 4.6201 0.0 0
M  V30 32 C 5.3348 6.9302 0.0 0
M  V30 33 C 2.6675 5.3901 0.0 0
M  V30 34 C 4.0012 7.7002 0.0 0
M  V30 35 C 2.6675 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 3 30
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 5 29
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 31
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 19 24
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1202873-83-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1202873-93-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6020969
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Procedure for the Synthesis of the Compounds
6. The compounds 5 (3.00 mmol) were dissolved in 5 mL of THF, and a
slight excess of a methylamine solution (25-30%) was added dropwise to
the solution. The mixture was refluxed for 1 h (the reaction was
monitored by TLC) and then concentrated. Water was added to the residue
and extracted three times with 50mL of ethyl acetate, and the combined
organic extracts were dried and concentrated. The crude product was
purified via silica gel column chromatography. The compounds 6. Compound
6r: Yield 90.2% of oil. IR(KBr)ν: 3240(s, NH), 2920 (s, C-H), 1660 (s,
C=O), 1500 (s, C=N), 1400 (s, CH3), 1280(m, C-N), 1150 (s, C-O), 830,
730(s, Ph-H)cm-1; 1H NMR (300 MHz, CDCl3) δ7.60 (m, 1H, Ph-6-H),
7.39-7.42 (m, 2H, 3-Ph-2,6-2H), 7.20-7.26 (m, 3H, Ph-3,4,5-3H), 7.00-7.03
(m, 2H, 3-Ph-3,5-2H), 6.77-6.79 (m, 1H, NH), 5.12 (s, 2H, CH2), 4.05 (m,
2H, CH2CF3), 3.96 (s, 3H, OCH3), 3.60 (s, 3H, NCH3), 2.90-2.91 (d,
J=4.8HZ, 3H, NHCH3), 1.81 (s, 3H, Py-4-CH3); Anal. Calcd for: C, 60.95;
H, 4.87; N, 10.15; Found: C, 61.04; H, 4.76; N, 10.12.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biological Activity of New
(E)-α-(Methoxyimino)benzeneacetate Derivatives Containing a Substituted
Pyrazole Ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Miao; Liu, Chang-Ling; Yang, Ji-Chun; Zhang, Jin-Bo; Li, Zhi-Nian;
Zhang, Hong; Li, Zheng-Ming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Agricultural and Food Chemistry (2010), 58(5), 2664-2667

$RFMT $RIREG SCHEME426 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibenzoylmethane
C15H12O2
120-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 0.0000 3.8501 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 9.3360 1.5400 0.0 0
M  V30 14 C 8.0023 3.8501 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 1 4 12
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propen-1-one, 3-(methylamino)-1,3-diphenyl-, (Z)-
C16H15NO
28640-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 N 4.0012 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 O 6.6685 0.7700 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 0.0000 4.6201 0.0 0
M  V30 13 C 8.0023 3.0801 0.0 0
M  V30 14 C 8.0023 4.6201 0.0 0
M  V30 15 C 9.3360 2.3101 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 10.6697 3.0801 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 1 4 13
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 28640-26-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946826
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME427 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-carboxaldehyde
C8H6O3
120-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 O 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-methanamine
C8H9NO2
2620-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 O 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2620-50-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28338034
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Reductive Amination
of Aldehydes with Methylamine Titanium(IV) isopropoxide (2 mL, 6.6 mmol)
was added to a commercially available solution of methylamine in methanol
(2M, 7.5 mL) followed by the addition of the starting aldehyde (5 mmol).
The reaction mixture was stirred at ambient temperature for 5 h, after
which sodium borohydride (0.2 g, 5 mmol) was added and the resulting
mixture was further stirred for another period of 2 h. The reaction was
then quenched by the addition of water (1 mL), the resulting inorganic
precipitate was filtered and washed with diethyl ether (20 mL). The
organic layer was separated and the aqueous part was further extracted
with diethyl ether (20 mL x 2). The combined ether extracts were dried
(K2CO3) and concentrated in vacuo to give N-methyl secondary amines in
high purity. Table I, Entry 13, yield 90%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-methyl secondary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumpaty, Hephzibah J.; Williamson, John S.; Bhattacharyya, Sukanta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2003), 33(8), 1411-1416

$RFMT $RIREG SCHEME428 STEP1
$RXN



  2  1
$MOL
1,3-Benzodioxole-5-carboxaldehyde
C8H6O3
120-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 O 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1,3-Benzodioxol-5-ylmethylene)methanamine
C9H9NO2
63254-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 O 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 O 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 120-57-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63254-33-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13210514
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Functional derivatives of
5-benzo[1,3]dioxol-5-yl-1-methyl-1H-imidazole-2-carbaldehyde and
evaluation of leishmanicidal activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vanelle, Patrice; Meuche, Jacobine; Maldonado, Jose; Crozet, Michel P.;
Delmas, Florence; Timon-David, Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2000), 35(1), 157-162

$RFMT $RIREG SCHEME429 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-[(4-chloro-2-butyn-1-yl)oxy]benzene
C10H8Cl2O
120625-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 C 10.0100 4.0011 0.0 0
M  V30 6 Cl 10.7800 5.3349 0.0 0
M  V30 7 Cl 3.0800 0.0000 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-4-[[(4-methylphenyl)sulfonyl]oxy]-2H-pyran-2-one
C13H12O5S
31913-41-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3349 6.1600 0.0 0 VAL=6
M  V30 2 O 5.3349 4.6200 0.0 0
M  V30 3 O 5.3349 7.7000 0.0 0
M  V30 4 O 3.7949 6.1600 0.0 0
M  V30 5 C 11.4949 6.1600 0.0 0
M  V30 6 C 0.0000 4.6200 0.0 0
M  V30 7 O 2.6674 0.0000 0.0 0
M  V30 8 C 6.8749 6.1600 0.0 0
M  V30 9 C 7.6449 4.8264 0.0 0
M  V30 10 C 7.6449 7.4936 0.0 0
M  V30 11 C 9.1849 4.8264 0.0 0
M  V30 12 C 9.1849 7.4936 0.0 0
M  V30 13 C 9.9549 6.1600 0.0 0
M  V30 14 C 4.0011 3.8500 0.0 0
M  V30 15 C 2.6674 4.6200 0.0 0
M  V30 16 C 4.0011 2.3100 0.0 0
M  V30 17 C 1.3338 3.8500 0.0 0
M  V30 18 C 2.6674 1.5400 0.0 0
M  V30 19 O 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 14
M  V30 6 1 5 13
M  V30 7 1 6 17
M  V30 8 2 7 18
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[4-(2-Chlorophenoxy)-2-butyn-1-yl]methylamino]-6-methyl-2H-pyran-2-one
C17H16ClNO3
336102-14-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6696 4.6200 0.0 0
M  V30 2 C 9.3358 3.8500 0.0 0
M  V30 3 C 10.6696 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 C 6.6685 5.3900 0.0 0
M  V30 6 C 5.3347 6.1600 0.0 0
M  V30 7 O 4.0011 5.3900 0.0 0
M  V30 8 C 16.0043 4.6200 0.0 0
M  V30 9 O 13.3369 0.0000 0.0 0
M  V30 10 Cl 1.3338 3.8500 0.0 0
M  V30 11 C 12.0032 3.8500 0.0 0
M  V30 12 C 13.3369 4.6200 0.0 0
M  V30 13 C 12.0032 2.3100 0.0 0
M  V30 14 C 14.6705 3.8500 0.0 0
M  V30 15 C 13.3369 1.5400 0.0 0
M  V30 16 O 14.6705 2.3100 0.0 0
M  V30 17 C 2.6674 6.1600 0.0 0
M  V30 18 C 1.3338 5.3900 0.0 0
M  V30 19 C 2.6674 7.7000 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 21 C 1.3338 8.4700 0.0 0
M  V30 22 C 0.0000 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 3 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 17
M  V30 9 1 8 14
M  V30 10 2 9 15
M  V30 11 1 10 18
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120625-04-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 31913-41-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 336102-14-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14263373
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Studies in sigmatropic rearrangement: synthesis of
4-aryloxy-methylene-1,7-dimethyl-1,2,3-trihydropyridino-[3,2-c]pyran-5-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Majumdar, K. C.; Ghosh, S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2001), 57(8), 1589-1592

$RFMT $RIREG SCHEME430 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(4-Methoxyphenyl)hydrazinylidene]propanedinitrile
C10H8N4O
1209-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 N 4.0012 3.8501 0.0 0
M  V30 3 C 2.6673 3.0801 0.0 0
M  V30 4 C 1.3337 3.8501 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 N 2.6673 0.0000 0.0 0
M  V30 8 O 10.6697 6.1601 0.0 0
M  V30 9 C 12.0033 5.3901 0.0 0
M  V30 10 C 6.6685 3.8501 0.0 0
M  V30 11 C 6.6685 5.3901 0.0 0
M  V30 12 C 8.0022 3.0801 0.0 0
M  V30 13 C 8.0022 6.1601 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 3 4 6
M  V30 7 3 5 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Methoxyphenyl)-5-(methylamino)-2H-1,2,3-triazole-4-carbonitrile
C11H11N5O
1088707-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.2459 4.8820 0.0 0
M  V30 2 N 0.0000 5.7870 0.0 0
M  V30 3 N 1.2459 1.5315 0.0 0
M  V30 4 C 1.4068 0.0000 0.0 0
M  V30 5 O 11.0215 3.2068 0.0 0
M  V30 6 C 11.7915 4.5404 0.0 0
M  V30 7 N 4.8615 3.2068 0.0 0
M  V30 8 N 3.9564 4.4526 0.0 0
M  V30 9 N 3.9564 1.9609 0.0 0
M  V30 10 C 2.4917 3.9768 0.0 0
M  V30 11 C 2.4917 2.4367 0.0 0
M  V30 12 C 6.4015 3.2068 0.0 0
M  V30 13 C 7.1715 1.8730 0.0 0
M  V30 14 C 7.1715 4.5404 0.0 0
M  V30 15 C 8.7115 1.8730 0.0 0
M  V30 16 C 8.7115 4.5404 0.0 0
M  V30 17 C 9.4815 3.2068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1209-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1088707-44-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28356951
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):NOTES
$DATUM aerobic (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 5-Amino-2-aryl-1,2,3-triazol-4-carboxylic acids: Synthesis, photophysical
properties, and application prospects
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Safronov, Nikita E.; Fomin, Timur O.; Minin, Artem S.; Todorov, Lozan;
Kostova, Irena; Benassi, Enrico; Belskaya, Nataliya P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dyes and Pigments (2020), 178108343

$RFMT $RIREG SCHEME431 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(4-Methoxyphenyl)hydrazinylidene]propanedinitrile
C10H8N4O
1209-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 N 4.0012 3.8501 0.0 0
M  V30 3 C 2.6673 3.0801 0.0 0
M  V30 4 C 1.3337 3.8501 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 N 2.6673 0.0000 0.0 0
M  V30 8 O 10.6697 6.1601 0.0 0
M  V30 9 C 12.0033 5.3901 0.0 0
M  V30 10 C 6.6685 3.8501 0.0 0
M  V30 11 C 6.6685 5.3901 0.0 0
M  V30 12 C 8.0022 3.0801 0.0 0
M  V30 13 C 8.0022 6.1601 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 3 4 6
M  V30 7 3 5 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Cyano-2-[2-(4-methoxyphenyl)hydrazinylidene]-N-methylethanimidamide
C11H13N5O
1157875-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 C 4.0010 3.0801 0.0 0
M  V30 4 C 2.6673 3.8501 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 N 1.3337 3.0801 0.0 0
M  V30 7 N 2.6673 5.3901 0.0 0
M  V30 8 N 4.0010 0.0000 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 O 12.0033 6.1601 0.0 0
M  V30 11 C 13.3370 5.3901 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 C 8.0022 5.3901 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 9.3360 6.1601 0.0 0
M  V30 16 C 10.6697 3.8501 0.0 0
M  V30 17 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 3 5 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1209-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1157875-41-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-2260129
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and oxidative cyclization of
2-arylhydrazono-2-cyanoacetamidines to
5-amino-2-aryl-2H-[1,2,3]triazole-4-carbonitrile
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bel'skaya, Natalia P.; Demina, Marina A.; Sapognikova, Svetlana G.; Fan,
Zhi-Jin; Zhang, Hai-Ke; Dehaen, Wim; Bakulev, Vasiliy A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2008), (16), 9-21

$RFMT $RIREG SCHEME432 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-(2-thienyl)-1H-pyrazole-3-carboxylate
C10H10N2O2S
121195-03-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7398 1.5400 0.0 0
M  V30 2 O 9.0734 2.3100 0.0 0
M  V30 3 O 7.7398 0.0000 0.0 0
M  V30 4 C 10.4072 1.5400 0.0 0
M  V30 5 C 11.7408 2.3100 0.0 0
M  V30 6 C 3.9688 2.8280 0.0 0
M  V30 7 C 4.9993 1.6835 0.0 0
M  V30 8 N 4.7388 4.1617 0.0 0
M  V30 9 C 6.4062 2.3100 0.0 0
M  V30 10 N 6.2453 3.8415 0.0 0
M  V30 11 C 2.4373 2.6671 0.0 0
M  V30 12 C 1.4069 3.8115 0.0 0
M  V30 13 S 1.6673 1.3333 0.0 0
M  V30 14 C 0.0000 3.1851 0.0 0
M  V30 15 C 0.1609 1.6535 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-(2-thienyl)-1H-pyrazole-3-carboxamide
C9H9N3OS
1239511-44-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7400 1.5400 0.0 0
M  V30 2 N 9.0737 2.3100 0.0 0
M  V30 3 O 7.7400 0.0000 0.0 0
M  V30 4 C 10.4075 1.5400 0.0 0
M  V30 5 C 3.9690 2.8281 0.0 0
M  V30 6 C 4.9995 1.6836 0.0 0
M  V30 7 N 4.7390 4.1618 0.0 0
M  V30 8 C 6.4063 2.3100 0.0 0
M  V30 9 N 6.2454 3.8416 0.0 0
M  V30 10 C 2.4374 2.6672 0.0 0
M  V30 11 C 1.4070 3.8116 0.0 0
M  V30 12 S 1.6674 1.3334 0.0 0
M  V30 13 C 0.0000 3.1852 0.0 0
M  V30 14 C 0.1611 1.6535 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121195-03-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1239511-44-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1442298
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 5-tert-Butyl-1H-pyrazole-3-carboxamide (IVa).
The ammonolysis of 167 g (0.85 mol) of ester IIIa was carried out in 1
liter of a mixture of ethanol with 25% aqueous ammonia, 1:1, at room
temperature over 7 days. Then the reaction mixture was boiled for 5 h,
ethanol and excess ammonia were removed, 0.5 liter of petroleum ether was
added, the white precipitate was filtered off and dried in a vacuum.
5-(2-Thienyl)-1H-pyrazole-3-(N-methyl)carboxamide (IVh) was obtained from
200 g (0.90 mol) of ester IIIc. Yield: 167 g (90%). mp 199-201°C. 1H NMR
spectrum, δ, ppm: 2.77 s (3H, CH3), 6.96 m (1H,H4), 7.12 m (1H, CHCHS),
7.38 m (1H, CHCS), 7.50 m (1H, CHS), 8.31 br.s (1H, NH amide), 13.54 br.s
(1H, NH). Found, %: C 51.94; H 4.31; N 20.31. C9H9N3OS. Calculated, %: C
52.16; H 4.38; N 20.27.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-aminomethyl-substituted pyrazoles and isoxazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Musatov, D. M.; Starodubtseva, E. V.; Rakishev, A. K.; Turova, O. V.;
Vinogradov, M. G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2011), 47(8), 1199-1203

$RFMT $RIREG SCHEME433 STEP1
$RXN



  2  1
$MOL
8-Bromo-4-quinolinecarboxylic acid
C10H6BrNO2
121490-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0800 0.0 0
M  V30 2 O 8.0021 2.3100 0.0 0
M  V30 3 O 6.6685 4.6200 0.0 0
M  V30 4 Br 0.0000 2.3100 0.0 0
M  V30 5 C 4.0011 3.0800 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 N 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 0.7700 0.0 0
M  V30 12 C 2.6674 5.3900 0.0 0
M  V30 13 C 1.3336 4.6200 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-N-methyl-4-quinolinecarboxamide
C11H9BrN2O
1476076-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0
M  V30 2 N 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 4.6201 0.0 0
M  V30 4 C 9.3359 3.0800 0.0 0
M  V30 5 Br 0.0000 2.3100 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 N 2.6675 0.7700 0.0 0
M  V30 11 C 1.3337 3.0800 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 121490-67-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1476076-33-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5950616
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM DNA-PK inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Charifson, Paul S.; Cottrell, Kevin Michael; Deng, Hongbo; Duffy, John
P.; Gao, Huai; Giroux, Simon; Green, Jeremy; Jackson, Katrina Lee;
Kennedy, Joseph M.; Lauffer, David J.; Ledeboer, Mark Willem; Li, Pan;
Maxwell, John Patrick; Morris, Mark A.; Pierce, Albert Charles; Waal,
Nathan D.; Xu, Jinwang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015058031 A1 2015-04-23

$RFMT $RIREG SCHEME433 STEP1
$RXN



  2  1
$MOL
8-Bromo-4-quinolinecarboxylic acid
C10H6BrNO2
121490-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0800 0.0 0
M  V30 2 O 8.0021 2.3100 0.0 0
M  V30 3 O 6.6685 4.6200 0.0 0
M  V30 4 Br 0.0000 2.3100 0.0 0
M  V30 5 C 4.0011 3.0800 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 N 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 0.7700 0.0 0
M  V30 12 C 2.6674 5.3900 0.0 0
M  V30 13 C 1.3336 4.6200 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-N-methyl-4-quinolinecarboxamide
C11H9BrN2O
1476076-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0
M  V30 2 N 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 4.6201 0.0 0
M  V30 4 C 9.3359 3.0800 0.0 0
M  V30 5 Br 0.0000 2.3100 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 N 2.6675 0.7700 0.0 0
M  V30 11 C 1.3337 3.0800 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 121490-67-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1476076-33-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12709844
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of methyl amine and THF in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cocrystals of
N-methyl-8-[(1S)-1-methyl-2-[(2'-methyl[4,5'-bipyrimidin]-6-yl)amino]ethyl]-4-q
uinolinecarboxamide and deuterated derivatives thereof as DNA-PK
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nti-Addae, Kwame Wiredu; O'Neil, Simon Adam; Zhang, Yuegang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015058067 A1 2015-04-23

$RFMT $RIREG SCHEME433 STEP1
$RXN



  2  1
$MOL
8-Bromo-4-quinolinecarboxylic acid
C10H6BrNO2
121490-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0800 0.0 0
M  V30 2 O 8.0021 2.3100 0.0 0
M  V30 3 O 6.6685 4.6200 0.0 0
M  V30 4 Br 0.0000 2.3100 0.0 0
M  V30 5 C 4.0011 3.0800 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 N 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 0.7700 0.0 0
M  V30 12 C 2.6674 5.3900 0.0 0
M  V30 13 C 1.3336 4.6200 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-N-methyl-4-quinolinecarboxamide
C11H9BrN2O
1476076-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0
M  V30 2 N 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 4.6201 0.0 0
M  V30 4 C 9.3359 3.0800 0.0 0
M  V30 5 Br 0.0000 2.3100 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 N 2.6675 0.7700 0.0 0
M  V30 11 C 1.3337 3.0800 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 121490-67-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1476076-33-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9982568
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM As shown in step 9-v of Scheme 9, to a suspension of
8-bromoquinoline-4-carboxylic acid (compound 2032,779.4 g, 3.092 mol) in
DCM (11.7 L) was added anhydrous DMF (7.182 mL, 92.76 rnmol). The
reaction mixture was cooled to 10° C. and oxalyl chloride (413 mL, 4.638
mol) was added dropwise over 30 minutes. The reaction mixture was stirred
an additional 30 minutes after addition was complete, transferred to an
evaporation flask, and the volatiles removed under reduced pressure
Anhydrous THF (2 L) was added and the volatiles were once more removed
under reduced pressure in order to remove any residual oxalyl chloride.
Anhydrous THF was added to the residue under an atmosphere of nitrogen
and the resulting suspension of intermediate
8-bromo-quinoline-4-carboxylic acid chloride was stored for later use.
Separately, the original reaction flask was thoroughly flushed with
nitrogen gas to remove any residual oxalyl chloride and the flask charged
with dry THF (1.16 L). After cooling to 5° C., aqueous methyl amine (2.14
L of 40% w/w MeNH2/water, 24.74 mol) was added followed by the addition
of additional THF (1.16 L). To this solution was added portionwise over I
hour the intermediate acid chloride suspension, keeping the reaction
mixture temperature below 20° C. during addition. The evaporation vessel
used to store the acid chloride was rinsed with anhydrous THF and aqueous
MeNH2 (500 mL) and this added to the reaction mixture, which was allowed
to come to room temperature over 16 hours. The organic volatiles were
removed under reduced pressure and the remaining mostly aqueous
suspension diluted with water (1.5 L). The solids were collected by
filtration, washed with water until the filtrate had a pH of less than
11, washed with MTBE (2x800 mL), and dried in a convection oven at 60° C.
8-bromo-N-methyl-quinoline-4-carboxamide (compound 2033, 740.4 g, 90%
yield) as a light brown solid. LC-MS=265.04 (M+H); 1H NMR (300 MHz,
DMSO-d6) δ 9.08 (d, J=4.3 Hz, 1H), 8.78 (d, J=4.7 Hz, 1H), 8.21 (dd,
J=7.5, 1.2 Hz, 1H), 8.16 (dd, J=8.5, 1.3 Hz, 1H), 7.65 (d, J=4.3 Hz, 1H),
7.58 (dd, J=8.5,7.5 Hz, 1H), 2.88 (d, J=4.6 Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM DNA-PK inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Charifson, Paul S.; Cottrell, Kevin Michael; Deng, Hongbo; Duffy, John
P.; Gao, Huai; Giroux, Simon; Green, Jeremy; Jackson, Katrina Lee;
Kennedy, Joseph M.; Lauffer, David J.; Ledeboer, Mark Willem; Li, Pan;
Maxwell, John Patrick; Morris, Mark A.; Pierce, Albert Charles; Waal,
Nathan D.; Xu, Jinwang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20130281431 A1 2013-10-24

